PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Haglund, S; Almer, S; Peterson, C; Soderman, J				Haglund, Sofie; Almer, Sven; Peterson, Curt; Soederman, Jan			Gene Expression and Thiopurine Metabolite Profiling in Inflammatory Bowel Disease - Novel Clues to Drug Targets and Disease Mechanisms?	PLOS ONE			English	Article							METHYLTRANSFERASE ACTIVITY; 6-THIOGUANINE NUCLEOTIDE; S-METHYLTRANSFERASE; T-LYMPHOCYTES; AZATHIOPRINE; 6-MERCAPTOPURINE; THERAPY; ALLOPURINOL; INHIBITION; PHARMACOGENETICS	Background and Aims: Thiopurines are effective to induce and maintain remission in inflammatory bowel disease (IBD). The methyl thioinosine monophosphate (meTIMP)/6-thioguanine nucleotide (6-TGN) concentration ratio has been associated with drug efficacy. Here we explored the molecular basis of differences in metabolite profiles and in relation to disease activity. Methods: Transcriptional profiles in blood samples from an exploratory IBD-patient cohort (n = 21) with a normal thiopurine S- methyltransferase phenotype and meTIMP/6-TGN ratios >20, 10.0-14.0 and <= 4, respectively, were assessed by hybridization to microarrays. Results were further evaluated with RT qPCR in an expanded patient cohort (n = 54). Additionally, 30 purine/thiopurine related genes were analysed separately. Results: Among 17 genes identified by microarray-screening, there were none with a known relationship to pathways of purines/thiopurines. For nine of them a correlation between expression level and the concentration of meTIMP, 6-TGN and/or the meTIMP/6-TGN ratio was confirmed in the expanded cohort. Nine of the purine/thiopurine related genes were identified in the expanded cohort to correlate with meTIMP, 6-TGN and/or the meTIMP/6-TGN ratio. However, only small differences in gene expression levels were noticed over the three different metabolite profiles. The expression levels of four genes identified by microarray screening (PLCB2, HVCN1, CTSS, and DEF8) and one purine/thiopurine related gene (NME6) correlated significantly with the clinical activity of Crohn's disease. Additionally, 16 of the genes from the expanded patient cohort interacted in networks with candidate IBD susceptibility genes. Conclusions: Seventeen of the 18 genes which correlated with thiopurine metabolite levels also correlated with disease activity or participated in networks with candidate IBD susceptibility genes involved in processes such as purine metabolism, cytokine signaling, and functioning of invariant natural killer T cells, T cells and B cells. Therefore, we conclude that the identified genes to a large extent are related to drug targets and disease mechanisms of IBD.	[Haglund, Sofie; Soederman, Jan] Ryhov Cty Hosp, Div Med Diagnost, Jonkoping, Sweden; [Haglund, Sofie; Almer, Sven] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Gastroenterol & Hepatol, Linkoping, Sweden; [Almer, Sven] Cty Council Ostergotland UHL, Dept Gastroenterol, Linkoping, Sweden; [Peterson, Curt] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth, Div Drug Res, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University	Haglund, S (corresponding author), Ryhov Cty Hosp, Div Med Diagnost, Jonkoping, Sweden.	sofie.haglund@lj.se		Soderman, Jan/0000-0001-7505-7210; Almer, Sven/0000-0001-9334-1821	Futurum - the Academy for Healthcare; County Council Jonkoping; Medical Research Council of Southeast Sweden (FORSS); Swedish Society of Medicine; County Council of Ostergotland; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Rut and Richard Juhlin's Foundation; Swedish Research Council	Futurum - the Academy for Healthcare; County Council Jonkoping; Medical Research Council of Southeast Sweden (FORSS); Swedish Society of Medicine; County Council of Ostergotland; Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Rut and Richard Juhlin's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by Futurum - the Academy for Healthcare, County Council Jonkoping, the Medical Research Council of Southeast Sweden (FORSS), the Swedish Society of Medicine, the County Council of Ostergotland, the Swedish Cancer Society, the Swedish Childhood Cancer Foundation, Rut and Richard Juhlin's Foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci A, 2010, J NEUROIMMUNOL, V218, P28, DOI 10.1016/j.jneuroim.2009.11.001; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ansari A, 2010, ALIMENT PHARM THER, V31, P640, DOI 10.1111/j.1365-2036.2009.04221.x; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Bierau J, 2007, PHARMACOGENOMICS, V8, P1221, DOI 10.2217/14622416.8.9.1221; BOKKERINK JPM, 1993, BIOCHEM PHARMACOL, V45, P1455, DOI 10.1016/0006-2952(93)90045-X; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Daperno M, 2009, ALIMENT PHARM THER, V30, P843, DOI 10.1111/j.1365-2036.2009.04106.x; de Boer NKH, 2007, AM J GASTROENTEROL, V102, P2747, DOI 10.1111/j.1572-0241.2007.01511.x; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Dubinsky MC, 2002, GASTROENTEROLOGY, V122, P904, DOI 10.1053/gast.2002.32420; Egmond Rv, 2011, GUT, V60, pA187; ELION GB, 1967, FED PROC, V26, P898; Gardiner SJ, 2008, EUR J GASTROEN HEPAT, V20, P1238, DOI 10.1097/MEG.0b013e3282ffda37; Haglund S, 2008, BRIT J CLIN PHARMACO, V65, P69, DOI 10.1111/j.1365-2125.2007.02985.x; Haglund S, 2011, THER DRUG MONIT, V33, P200, DOI 10.1097/FTD.0b013e31820b42bb; Hande S, 2006, INFLAMM BOWEL DIS, V12, P251, DOI 10.1097/01.MIB.0000206544.05661.9f; Hindorf U, 2006, GUT, V55, P1423, DOI 10.1136/gut.2005.074930; Hoentjen F, 2012, DIGEST DIS SCI, V57, P250, DOI 10.1007/s10620-011-1999-x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KLEMETSDAL B, 1992, CLIN PHARMACOL THER, V51, P24, DOI 10.1038/clpt.1992.4; Kruhoffer M, 2007, J MOL DIAGN, V9, P452, DOI 10.2353/jmoldx.2007.060175; LENNARD L, 1987, CLIN PHARMACOL THER, V41, P18, DOI 10.1038/clpt.1987.4; LENNARD L, 1992, J CHROMATOGR-BIOMED, V583, P83, DOI 10.1016/0378-4347(92)80347-S; Leung Y, 2009, J CROHNS COLITIS, V3, P162, DOI 10.1016/j.crohns.2009.02.003; Lewis LD, 1997, CLIN PHARMACOL THER, V62, P464, DOI 10.1016/S0009-9236(97)90125-9; Li F, 2010, DRUG METAB DISPOS, V38, P2329, DOI 10.1124/dmd.110.035220; Lowry PW, 2001, GUT, V49, P656, DOI 10.1136/gut.49.5.656; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Osterman MT, 2006, GASTROENTEROLOGY, V130, P1047, DOI 10.1053/j.gastro.2006.01.046; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Roberts RL, 2007, PHARMACOGENOMICS J, V7, P312, DOI 10.1038/sj.tpj.6500421; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Sandborn WJ, 1996, AM J GASTROENTEROL, V91, P423; Sparrow MP, 2007, CLIN GASTROENTEROL H, V5, P209, DOI 10.1016/j.cgh.2006.11.020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SZUMLANSKI CL, 1995, BRIT J CLIN PHARMACO, V39, P456, DOI 10.1111/j.1365-2125.1995.tb04478.x; Thomas CW, 2005, J PHARMACOL EXP THER, V312, P537, DOI 10.1124/jpet.104.074815; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Timmer A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub2; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Vikingsson S, 2009, THER DRUG MONIT, V31, P345, DOI 10.1097/FTD.0b013e3181a1ea58; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Xin H, 2005, ALIMENT PHARM THER, V21, P1105, DOI 10.1111/j.1365-2036.2005.02460.x	46	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56989	10.1371/journal.pone.0056989	http://dx.doi.org/10.1371/journal.pone.0056989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437289	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000065
J	Lane, DJR; Saletta, F; Rahmanto, YS; Kovacevic, Z; Richardson, DR				Lane, Darius J. R.; Saletta, Federica; Rahmanto, Yohan Suryo; Kovacevic, Zaklina; Richardson, Des R.			N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion	PLOS ONE			English	Article							PYRIDOXAL ISONICOTINOYL HYDRAZONE; EFFECTIVE ANTIPROLIFERATIVE AGENTS; METASTASIS SUPPRESSOR GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RIBONUCLEOTIDE REDUCTASE; ENDOTHELIAL-CELLS; MOLECULAR TARGETS; TUMOR-METASTASIS; FACTOR 1-ALPHA; EXPRESSION	Iron is critical for cellular proliferation and its depletion leads to a suppression of both DNA synthesis and global translation. These observations suggest that iron depletion may trigger a cellular "stress response". A canonical response of cells to stress is the formation of stress granules, which are dynamic cytoplasmic aggregates containing stalled pre-initiation complexes that function as mRNA triage centers. By differentially prioritizing mRNA translation, stress granules allow for the continued and selective translation of stress response proteins. Although the multi-subunit eukaryotic initiation factor 3 (eIF3) is required for translation initiation, its largest subunit, eIF3a, may not be essential for this activity. Instead, eIF3a is a vital constituent of stress granules and appears to act, in part, by differentially regulating specific mRNAs during iron depletion. Considering this, we investigated eIF3a's role in modulating iron-regulated genes/proteins that are critically involved in proliferation and metastasis. In this study, eIF3a was down-regulated and recruited into stress granules by iron depletion as well as by the classical stress-inducers, hypoxia and tunicamycin. Iron depletion also increased expression of the metastasis suppressor, N-myc downstream regulated gene-1 (NDRG1), and a known downstream repressed target of eIF3a, namely the cyclin-dependent kinase inhibitor, p27(kip1). To determine if eIF3a regulates NDRG1 expression, eIF3a was inducibly over-expressed or ablated. Importantly, eIF3a positively regulated NDRG1 expression and negatively regulated p27(kip1) expression during iron depletion. This activity of eIF3a could be due to its recruitment to stress granules and/or its ability to differentially regulate mRNA translation during cellular stress. Additionally, eIF3a positively regulated proliferation, but negatively regulated cell motility and invasion, which may be due to the eIF3a-dependent changes in expression of NDRG1 and p27(kip1) observed under these conditions.	[Lane, Darius J. R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Lane, DJR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia.	darius.lane@sydney.edu.au	Suryo Rahmanto, Yohan/K-8043-2018; Kovacevic, Zaklina/ABD-9581-2021	Suryo Rahmanto, Yohan/0000-0003-1453-7872; Kovacevic, Zaklina/0000-0002-4742-4690; Lane, Darius/0000-0001-8725-6903; Richardson, Des/0000-0002-5506-3274; Saletta, Federica/0000-0003-0598-3504; Richardson, Des/0000-0003-0960-6415	Cancer Institute NSW (CINSW) [10/ECF/2-18]; NHMRC; CINSW [07/RSA/1-22]; University of Sydney; CINSW Early Career Fellowship [08/ECF/1-36]; National Health and Medical Research Council (NHMRC)	Cancer Institute NSW (CINSW); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CINSW; University of Sydney(University of Sydney); CINSW Early Career Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	DJRL kindly thanks the Cancer Institute NSW (CINSW) for an Early Career Fellowship [10/ECF/2-18] and the NHMRC for an Early Career Postdoctoral Fellowship. FS thanks the CINSW for a Research Scholar Award [07/RSA/1-22] and the University of Sydney for a PhD Scholarship and University Postgraduate Award. YSR appreciates the support of a CINSW Early Career Fellowship [08/ECF/1-36]. ZK kindly thanks the National Health and Medical Research Council (NHMRC) or Australia for an Early Career Postdoctoral Fellowship. DRR thanks the NHMRC for a Senior Principal Research Fellowship and Project Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Bachmann F, 1997, CANCER RES, V57, P988; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Chaudhuri J, 1997, J BIOL CHEM, V272, P30975, DOI 10.1074/jbc.272.49.30975; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Farley J, 2011, GYNECOL ONCOL, V121, P395, DOI 10.1016/j.ygyno.2010.11.023; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOTO Y, 1983, J BIOL CHEM, V258, P5248; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Guang RJ, 2000, CANCER RES, V60, P749; Inagaki Y, 2009, DIGEST LIVER DIS, V41, P96, DOI 10.1016/j.dld.2008.04.003; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Leber MF, 2009, INT J ONCOL, V34, P881, DOI 10.3892/ijo_00000214; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Liu YL, 2011, TUMOR BIOL, V32, P99, DOI 10.1007/s13277-010-0103-z; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; MAITRA U, 1982, ANNU REV BIOCHEM, V51, P869, DOI 10.1146/annurev.bi.51.070182.004253; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Park H, 2000, BIOCHEM BIOPH RES CO, V276, P321, DOI 10.1006/bbrc.2000.3475; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; PONKA P, 1982, BIOCHIM BIOPHYS ACTA, V718, P151, DOI 10.1016/0304-4165(82)90213-6; Rahmanto YS, 2007, CARCINOGENESIS, V28, P2172, DOI 10.1093/carcin/bgm096; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Richardson DR, 1999, J BIOL INORG CHEM, V4, P266, DOI 10.1007/s007750050312; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Ryan HE, 2000, CANCER RES, V60, P4010; Saletta F, 2011, J BIOL CHEM, V286, P35396, DOI 10.1074/jbc.M111.273060; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Salnikow K, 2000, CANCER RES, V60, P38; Salnikow K, 2008, CARCINOGENESIS, V29, P1493, DOI 10.1093/carcin/bgn088; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Simpson J, 2011, MOL VIS, V17, P2212; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Van de Putte G, 2003, GYNECOL ONCOL, V89, P140, DOI 10.1016/S0090-8258(03)00010-6; vanBelzen N, 1997, LAB INVEST, V77, P85; Vengellur A, 2003, GENE EXPRESSION, V11, P181, DOI 10.3727/000000003108749062; Wang G, 2003, J CELL BIOCHEM, V90, P548, DOI 10.1002/jcb.10621; Wang G, 2004, BIOMETALS, V17, P15, DOI 10.1023/A:1024417309370; WRIGHT JA, 1990, BIOCHEM CELL BIOL, V68, P1364, DOI 10.1139/o90-199; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Zhou DJ, 1998, CANCER RES, V58, P2182	82	56	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57273	10.1371/journal.pone.0057273	http://dx.doi.org/10.1371/journal.pone.0057273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437357	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000092
J	Matsuoka, F; Takeuchi, I; Agata, H; Kagami, H; Shiono, H; Kiyota, Y; Honda, H; Kato, R				Matsuoka, Fumiko; Takeuchi, Ichiro; Agata, Hideki; Kagami, Hideaki; Shiono, Hirofumi; Kiyota, Yasujiro; Honda, Hiroyuki; Kato, Ryuji			Morphology-Based Prediction of Osteogenic Differentiation Potential of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							BONE-MARROW; PERIOSTEUM; REGENERATION; TISSUE	Human bone marrow mesenchymal stem cells (hBMSCs) are widely used cell source for clinical bone regeneration. Achieving the greatest therapeutic effect is dependent on the osteogenic differentiation potential of the stem cells to be implanted. However, there are still no practical methods to characterize such potential non-invasively or previously. Monitoring cellular morphology is a practical and non-invasive approach for evaluating osteogenic potential. Unfortunately, such image-based approaches had been historically qualitative and requiring experienced interpretation. By combining the non-invasive attributes of microscopy with the latest technology allowing higher throughput and quantitative imaging metrics, we studied the applicability of morphometric features to quantitatively predict cellular osteogenic potential. We applied computational machine learning, combining cell morphology features with their corresponding biochemical osteogenic assay results, to develop prediction model of osteogenic differentiation. Using a dataset of 9,990 images automatically acquired by BioStation CT during osteogenic differentiation culture of hBMSCs, 666 morphometric features were extracted as parameters. Two commonly used osteogenic markers, alkaline phosphatase (ALP) activity and calcium deposition were measured experimentally, and used as the true biological differentiation status to validate the prediction accuracy. Using time-course morphological features throughout differentiation culture, the prediction results highly correlated with the experimentally defined differentiation marker values (R>0.89 for both marker predictions). The clinical applicability of our morphology-based prediction was further examined with two scenarios: one using only historical cell images and the other using both historical images together with the patient's own cell images to predict a new patient's cellular potential. The prediction accuracy was found to be greatly enhanced by incorporation of patients' own cell features in the modeling, indicating the practical strategy for clinical usage. Consequently, our results provide strong evidence for the feasibility of using a quantitative time series of phase-contrast cellular morphology for non-invasive cell quality prediction in regenerative medicine.	[Matsuoka, Fumiko; Honda, Hiroyuki; Kato, Ryuji] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Dept Engn, Nagoya, Aichi, Japan; [Agata, Hideki; Kagami, Hideaki] Univ Tokyo, Inst Med Sci, Tissue Engn Res Grp, Div Mol Therapy, Tokyo, Japan; [Kagami, Hideaki] Matsumoto Dent Univ, Dept Oral & Maxillofacial Surg, Sch Dent, Nagano, Japan; [Shiono, Hirofumi; Kiyota, Yasujiro] Nikon Inc, Tokyo, Japan; [Kato, Ryuji] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya Institute of Technology; University of Tokyo; Matsumoto Dental University; Nikon Corporation; Nagoya University	Kato, R (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan.	kato-r@ps.nagoya-u.ac.jp	Kato, Ryuji/I-6952-2014	Kagami, Hideaki/0000-0003-2285-2602	New Energy and Industrial Technology Development Organization (NEDO) for the Grant for Industrial Technology Research [09C46036a]; Nikon Corporation	New Energy and Industrial Technology Development Organization (NEDO) for the Grant for Industrial Technology Research; Nikon Corporation	We are grateful to the New Energy and Industrial Technology Development Organization (NEDO) for the Grant for Industrial Technology Research (Financial Support to Young Researchers, 09C46036a) for the support. The research was also supported in part by a grant-in-aid from Nikon Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We have the following interests. This study was supported in part by a grant-in-aid from Nikon Corporation. Hirofumi Shiono and Yasujiro Kiyota are employed by Nikon Instruments. Ryuji Kato is one of the main investigators of 12 patents (pending) related to basic technologies of "algorithms of cellular image processing. Hirofumi Shiono, is one of the inventors of the hardware we used in our research, "BioStaion CT" which is the automatic cell culture system, and a member of this collaborative project with Nagoya Univ. The BioStation CT and relating software are marketed products of Nikon Corporation. Although the system and the software were used in this study, the result of this research does not depend on the system and the software. He is one of the inventors of related 12 patents. Yasujiro Kiyota, is one of the inventors of the hardware we used in our research work. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agata H, 2007, J DENT RES, V86, P79, DOI 10.1177/154405910708600113; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Hastie T, 2009, ELEMENTS STAT LEARNI, P43; Hayashi O, 2008, CALCIFIED TISSUE INT, V82, P238, DOI 10.1007/s00223-008-9112-y; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kagami H, 2011, INT J BIOCHEM CELL B, V43, P286, DOI 10.1016/j.biocel.2010.12.006; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Kino-oka M, 2009, J BIOSCI BIOENG, V107, P544, DOI 10.1016/j.jbiosc.2008.12.018; Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30; Mizuno D, 2008, CLIN ORAL IMPLAN RES, V19, P289, DOI 10.1111/j.1600-0501.2007.01452.x; Olivo C, 2008, J ORTHOP RES, V26, P901, DOI 10.1002/jor.20582; Platt MO, 2009, STEM CELLS, V27, P2804, DOI 10.1002/stem.215; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226	18	94	97	22	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55082	10.1371/journal.pone.0055082	http://dx.doi.org/10.1371/journal.pone.0055082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437049	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000006
J	Arora, A; Gera, S; Maheshwari, T; Raghav, D; Alam, MJ; Singh, RKB; Agarwal, SM				Arora, Akshit; Gera, Saurav; Maheshwari, Tanuj; Raghav, Dhwani; Alam, Md. Jahoor; Singh, R. K. Brojen; Agarwal, Subhash M.			The Dynamics of Stress p53-Mdm2 Network Regulated by p300 and HDAC1	PLOS ONE			English	Article							STOCHASTIC SIMULATION; P53 ACETYLATION; FEEDBACK LOOP; DNA-BINDING; IN-VITRO; OSCILLATIONS; PHOSPHORYLATION; DEACETYLATION; RESONANCE; GROWTH	We construct a stress p53-Mdm2-p300-HDAC1 regulatory network that is activated and stabilised by two regulatory proteins, p300 and HDAC1. Different activation levels of p53 observed due to these regulators during stress condition have been investigated using a deterministic as well as a stochastic approach to understand how the cell responds during stress conditions. We found that these regulators help in adjusting p53 to different conditions as identified by various oscillatory states, namely fixed point oscillations, damped oscillations and sustain oscillations. On assessing the impact of p300 on p53-Mdm2 network we identified three states: first stabilised or normal condition where the impact of p300 is negligible, second an interim region where p53 is activated due to interaction between p53 and p300, and finally the third regime where excess of p300 leads to cell stress condition. Similarly evaluation of HDAC1 on our model led to identification of the above three distinct states. Also we observe that noise in stochastic cellular system helps to reach each oscillatory state quicker than those in deterministic case. The constructed model validated different experimental findings qualitatively.	[Arora, Akshit; Gera, Saurav; Maheshwari, Tanuj; Raghav, Dhwani; Agarwal, Subhash M.] Inst Cytol & Prevent Oncol, Bioinformat Div, Noida, India; [Alam, Md. Jahoor; Singh, R. K. Brojen] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Jamia Millia Islamia	Singh, RKB (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	brojen2k@yahoo.com; smagarwal@yahoo.com	Agarwal, Subhash Mohan/L-3162-2019; Alam, Jahoor/F-5071-2012; Alam, MD JAHOOR/AAR-8528-2021	Alam, MD JAHOOR/0000-0003-0144-6517; Agarwal, Subhash Mohan/0000-0001-6685-789X	University Grants Commission	University Grants Commission(University Grants Commission, India)	Dr. Brojen Singh has received partial financial support for this work from University Grants Commission. However Dr. Subhash Agarwal has worked without any financial support from any funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2006, J CANC MOL, V2, P141; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cai XD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2710253; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LESLIE PH, 1958, BIOMETRIKA, V45, P16, DOI 10.1093/biomet/45.1-2.16; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; MCQUARRI.DA, 1967, J APPL PROBAB, V4, P413, DOI 10.2307/3212214; Meek DW, 2009, COLD SPRING HARB PER, V00; Pavithra L, 2009, J MOL BIOL, V388, P691, DOI 10.1016/j.jmb.2009.03.033; Press W. H., 1992, NUMERICAL RECIPE FOR; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Salis H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1835951; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wagner J, 2005, IEE P SYST BIOL, V152, P109, DOI 10.1049/ip-syb:20050025; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705	48	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e52736	10.1371/journal.pone.0052736	http://dx.doi.org/10.1371/journal.pone.0052736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437037	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200004
J	Brandt, ME; Smith, TB; Correa, AMS; Vega-Thurber, R				Brandt, Marilyn E.; Smith, Tyler B.; Correa, Adrienne M. S.; Vega-Thurber, Rebecca			Disturbance Driven Colony Fragmentation as a Driver of a Coral Disease Outbreak	PLOS ONE			English	Article							MULTIPLE STABLE STATES; NATIONAL-PARK; REEF; FLORIDA; CONSERVATION; POPULATIONS; THRESHOLDS; MACROALGAE; PATTERNS; BAHAMAS	In September of 2010, Brewer's Bay reef, located in St. Thomas (U.S. Virgin Islands), was simultaneously affected by abnormally high temperatures and the passage of a hurricane that resulted in the mass bleaching and fragmentation of its coral community. An outbreak of a rapid tissue loss disease among coral colonies was associated with these two disturbances. Gross lesion signs and lesion progression rates indicated that the disease was most similar to the Caribbean coral disease white plague type 1. Experiments indicated that the disease was transmissible through direct contact between colonies, and five-meter radial transects showed a clustered spatial distribution of disease, with diseased colonies being concentrated within the first meter of other diseased colonies. Disease prevalence and the extent to which colonies were bleached were both significantly higher on unattached colony fragments than on attached colonies, and disease occurred primarily on fragments found in direct contact with sediment. In contrast to other recent studies, disease presence was not related to the extent of bleaching on colonies. The results of this study suggest that colony fragmentation and contact with sediment played primary roles in the initial appearance of disease, but that the disease was capable of spreading among colonies, which suggests secondary transmission is possible through some other, unidentified mechanism.	[Brandt, Marilyn E.; Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Correa, Adrienne M. S.; Vega-Thurber, Rebecca] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Correa, Adrienne M. S.; Vega-Thurber, Rebecca] Florida Int Univ, Dept Biol Sci, N Miami, FL USA; [Correa, Adrienne M. S.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA	University of the Virgin Islands; Oregon State University; State University System of Florida; Florida International University; Rice University	Brandt, ME (corresponding author), Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA.	mbrandt@uvi.edu			Virgin Islands Experimental Program to Stimulate Competitive Research (VI-EPSCoR)	Virgin Islands Experimental Program to Stimulate Competitive Research (VI-EPSCoR)	Funding was provided by an incubator grant from the Virgin Islands Experimental Program to Stimulate Competitive Research (VI-EPSCoR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Borger JL, 2003, REV BIOL TROP, V51, P25; Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Brandt ME, 2012, B MAR SCI, V88, P1035, DOI 10.5343/bms.2011.1104; Brandt ME, 2009, DIS AQUAT ORGAN, V87, P117, DOI 10.3354/dao02137; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruckner AW, 1997, CORAL REEFS, V16, P260, DOI 10.1007/s003380050081; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Crabbe MJC, 2009, MAR ENVIRON RES, V67, P189, DOI 10.1016/j.marenvres.2009.01.003; Croquer A, 2005, CARIBB J SCI, V41, P815; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; DUSTAN P, 1977, ENVIRON GEOL, V2, P51, DOI 10.1007/BF02430665; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Knowlton N, 2004, PROG OCEANOGR, V60, P387, DOI 10.1016/j.pocean.2004.02.011; KNOWLTON N, 1992, AM ZOOL, V32, P674; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; MEESTERS EH, 1993, MAR ECOL PROG SER, V96, P189, DOI 10.3354/meps096189; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Miller J, 2012, 2012 INT COR REEF S; Miller MW, 2007, CORAL REEFS, V26, P97, DOI 10.1007/s00338-006-0165-y; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; NOAA, 2012, COR REEF WATCH COR B; NPS, 2012, 2181494 NPS; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pollock FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002183; Richardson LL, 1998, REV BIOL TROP, V46, P187; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Richardson LL, 2001, HYDROBIOLOGIA, V460, P71, DOI 10.1023/A:1013187723831; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Strong A.E., 1997, P 8 INT COR REEF S, V2, P1495; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Vega-Thurber R., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044246, DOI 10.1371/JOURNAL.PONE.00442463434190]; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Widder EA, 2005, DEEP-SEA RES PT I, V52, P2077, DOI 10.1016/j.dsr.2005.06.007; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155	50	46	46	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57164	10.1371/journal.pone.0057164	http://dx.doi.org/10.1371/journal.pone.0057164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437335	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200224
J	Dasgupta, T; Stillwagon, SJ; Ladd, AN				Dasgupta, Twishasri; Stillwagon, Samantha J.; Ladd, Andrea N.			Gene Expression Analyses Implicate an Alternative Splicing Program in Regulating Contractile Gene Expression and Serum Response Factor Activity in Mice	PLOS ONE			English	Article							RNA-BINDING PROTEINS; CARDIAC-HYPERTROPHY; ANKYRIN-B; TRANSGENIC MICE; HOMEOBOX GENE; CELF; CARDIOMYOCYTES; CARDIOMYOPATHY; HEART; OVEREXPRESSION	Members of the CUG-BP, Elav-like family (CELF) regulate alternative splicing in the heart. In MHC-CELF Delta transgenic mice, CELF splicing activity is inhibited postnatally in heart muscle via expression of a nuclear dominant negative CELF protein under an alpha-myosin heavy chain promoter. MHC-CELF Delta mice develop dilated cardiomyopathy characterized by alternative splicing defects, enlarged hearts, and severe contractile dysfunction. In this study, gene expression profiles in the hearts of wild type, high- and low-expressing lines of MHC-CELF Delta mice were compared using microarrays. Gene ontology and pathway analyses identified contraction and calcium signaling as the most affected processes. Network analysis revealed that the serum response factor (SRF) network is highly affected. Downstream targets of SRF were up-regulated in MHC-CELF Delta mice compared to the wild type, suggesting an increase in SRF activity. Although SRF levels remained unchanged, known inhibitors of SRF activity were down-regulated. Conversely, we found that these inhibitors are up-regulated and downstream SRF targets are down-regulated in the hearts of MCKCUG-BP1 mice, which mildly over-express CELF1 in heart and skeletal muscle. This suggests that changes in SRF activity are a consequence of changes in CELF-mediated regulation rather than a secondary result of compensatory pathways in heart failure. In MHC-CELF Delta males, where the phenotype is only partially penetrant, both alternative splicing changes and down-regulation of inhibitors of SRF correlate with the development of cardiomyopathy. Together, these results strongly support a role for CELF-mediated alternative splicing in the regulation of contractile gene expression, achieved in part through modulating the activity of SRF, a key cardiac transcription factor.	[Dasgupta, Twishasri; Stillwagon, Samantha J.; Ladd, Andrea N.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ladd, AN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	ladda@ccf.org		Ladd, Andrea/0000-0003-4725-5644; Auboeuf, Didier/0000-0002-3757-0002	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL089376]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089376] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant to ANL from the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL089376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P19, DOI 10.1152/physiolgenomics.2001.6.1.19; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Bovill E, 2009, J THORAC CARDIOV SUR, V137, P853, DOI 10.1016/j.jtcvs.2008.09.006; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Komamura K, 2004, J HUM GENET, V49, P129, DOI 10.1007/s10038-003-0121-4; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Kong YF, 2001, CIRCULATION, V103, P2731; Ladd AN, 2005, MOL CELL BIOL, V25, P6267, DOI 10.1128/MCB.25.14.6267-6278.2005; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Mango R, 2005, CIRC RES, V97, P152, DOI 10.1161/01.RES.0000174563.62625.8e; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022391; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Terenzi F, 2009, J MOL CELL CARDIOL, V46, P395, DOI 10.1016/j.yjmcc.2008.10.030; Treisman R, 1992, CURR OPIN GENET DEV, V2, P221, DOI 10.1016/S0959-437X(05)80277-1; Trivedi CM, 2011, J MOL CELL CARDIOL, V50, P1056, DOI 10.1016/j.yjmcc.2011.02.015; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yamaguchi S, 2009, INT J CANCER, V124, P2577, DOI 10.1002/ijc.24217; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56590	10.1371/journal.pone.0056590	http://dx.doi.org/10.1371/journal.pone.0056590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437181	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200117
J	De Palma, S; Leone, R; Grumati, P; Vasso, M; Polishchuk, R; Capitanio, D; Braghetta, P; Bernardi, P; Bonaldo, P; Gelfi, C				De Palma, Sara; Leone, Roberta; Grumati, Paolo; Vasso, Michele; Polishchuk, Roman; Capitanio, Daniele; Braghetta, Paola; Bernardi, Paolo; Bonaldo, Paolo; Gelfi, Cecilia			Changes in Muscle Cell Metabolism and Mechanotransduction Are Associated with Myopathic Phenotype in a Mouse Model of Collagen VI Deficiency	PLOS ONE			English	Article							FOCAL ADHESION KINASE; TENASCIN-C; SUBCELLULAR-LOCALIZATION; GLUTAMINE-METABOLISM; SKELETAL-MUSCLE; SIRT3; PROTEINS; BETHLEM; COMPLEX; COSTAMERES	This study identifies metabolic and protein phenotypic alterations in gastrocnemius, tibialis anterior and diaphragm muscles of Col6a1(-/-) mice, a model of human collagen VI myopathies. All three muscles of Col6a1(-/-) mice show some common changes in proteins involved in metabolism, resulting in decreased glycolysis and in changes of the TCA cycle fluxes. These changes lead to a different fate of alpha-ketoglutarate, with production of anabolic substrates in gastrocnemius and tibialis anterior, and with lipotoxicity in diaphragm. The metabolic changes are associated with changes of proteins involved in mechanotransduction at the myotendineous junction/costameric/sarcomeric level (TN-C, FAK, ROCK1, troponin I fast) and in energy metabolism (aldolase, enolase 3, triose phosphate isomerase, creatine kinase, adenylate kinase 1, parvalbumin, IDH1 and FASN). Together, these change may explain Ca2+ deregulation, impaired force development, increased muscle-relaxation-time and fiber damage found in the mouse model as well as in patients. The severity of these changes differs in the three muscles (gastrocnemius<tibialis anterior<diaphragm) and correlates to the mass-to-tendon (myotendineous junction) ratio and to muscle morphology.	[De Palma, Sara; Leone, Roberta; Vasso, Michele; Capitanio, Daniele; Gelfi, Cecilia] Univ Milan, Dept Biomed Sci Hlth, Segrate, MI, Italy; [De Palma, Sara; Vasso, Michele; Gelfi, Cecilia] Natl Res Council CNR, Inst Mol Bioimaging & Physiol, Segrate, MI, Italy; [Grumati, Paolo; Braghetta, Paola; Bernardi, Paolo; Bonaldo, Paolo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Polishchuk, Roman] Italian Natl Res Council CNR, Inst Prot Biochem, Telethon Inst Genet & Med, Naples, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Istituto di Neuroscienze (IN-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Gelfi, C (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Segrate, MI, Italy.	cecilia.gelfi@unimi.it	Bernardi, Paolo/C-3656-2008; Gelfi, Cecilia/L-1490-2016; Braghetta, Paola/K-5478-2016; Grumati, Paolo/AAA-5787-2019; CAPITANIO, DANIELE/AAC-4059-2019; Vasso, Michele/AAE-6208-2020; Capitanio, Daniele/J-9976-2018	Bernardi, Paolo/0000-0001-9187-3736; Gelfi, Cecilia/0000-0002-2996-6912; Braghetta, Paola/0000-0003-2547-8679; CAPITANIO, DANIELE/0000-0001-7701-728X; Capitanio, Daniele/0000-0001-7701-728X; Polishchuk, Roman/0000-0002-7698-1955; VASSO, MICHELE/0000-0003-0431-0981; Bonaldo, Paolo/0000-0002-9571-8140; De Palma, Sara/0000-0002-6795-4138	Telethon foundation [GGP08017, GGP08017A, GGP08017D]; FP7 BIO-NMD project [241665]; FIRB RBR [7BMCT]	Telethon foundation(Fondazione Telethon); FP7 BIO-NMD project; FIRB RBR	This work was supported by Telethon foundation (grant number GGP08017 to P. Bernardi, grant number GGP08017A to P. Bonaldo, grant no GGP08017D to C.G.), the FP7 BIO-NMD project (grant number 241665 to P. Bonaldo and C.G.), FIRB RBR (grant number 7BMCT to C.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009; BETHLEM J, 1976, BRAIN, V99, P91, DOI 10.1093/brain/99.1.91; Bishop-Bailey D, 2009, PHARMACOL THERAPEUT, V124, P141, DOI 10.1016/j.pharmthera.2009.06.011; Bloch RJ, 2003, EXERC SPORT SCI REV, V31, P73, DOI 10.1097/00003677-200304000-00004; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; Canato M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/981945; Chandrasekharan K, 2010, METHOD ENZYMOL, V479, P291, DOI 10.1016/S0076-6879(10)79017-0; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chopard A, 2005, FASEB J, V19, P1722, DOI 10.1096/fj.04-3336fje; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Deldicque L, 2011, EUR J APPL PHYSIOL, V111, P1553, DOI 10.1007/s00421-010-1783-1; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Durieux AC, 2007, BIOCHEM SOC T, V35, P1312, DOI 10.1042/BST0351312; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fluck M, 2002, J EXP BIOL, V205, P2337; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Gelfi C, 2006, J PROTEOME RES, V5, P1344, DOI 10.1021/pr050414x; Gizak A, 2004, FEBS LETT, V576, P445, DOI 10.1016/j.febslet.2004.09.050; Grossi M, 2005, P NATL ACAD SCI USA, V102, P11313, DOI 10.1073/pnas.0505011102; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; Grumati P, 2011, AUTOPHAGY, V7, P426, DOI 10.4161/auto.7.4.14392; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; HAMMARQVIST F, 1989, ANN SURG, V209, P455, DOI 10.1097/00000658-198904000-00011; Haq RU, 1999, NEUROLOGY, V52, P174, DOI 10.1212/WNL.52.1.174; Higdon A. N., 2012, ANTIOXID REDOX SIGNA; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Izu Y, 2012, TISSUE CELL, V44, P1, DOI 10.1016/j.tice.2011.08.002; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jarvinen TAH, 2003, J CELL SCI, V116, P857, DOI 10.1242/jcs.00303; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kannus P, 1998, HISTOCHEM J, V30, P799, DOI 10.1023/A:1003448106673; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Keller A, 2000, BIOL CELL, V92, P527, DOI 10.1016/S0248-4900(00)01103-5; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Knoll R, 2012, J MUSCLE RES CELL M, V33, P31, DOI 10.1007/s10974-011-9281-6; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Mamczur P, 2005, FEBS LETT, V579, P1607, DOI 10.1016/j.febslet.2005.01.071; Maraldi NM, 2009, ADV ENZYME REGUL, V49, P197, DOI 10.1016/j.advenzreg.2008.12.009; Mercuri E, 2002, NEUROLOGY, V58, P1354, DOI 10.1212/WNL.58.9.1354; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Merlini L, 2008, NEUROTHERAPEUTICS, V5, P613, DOI 10.1016/j.nurt.2008.08.004; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nadeau A, 2009, NEUROLOGY, V73, P25, DOI 10.1212/WNL.0b013e3181aae851; NONAKA I, 1981, NEUROPEDIATRICS, V12, P197, DOI 10.1055/s-2008-1059651; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rennie MJ, 1996, BIOCHEM SOC T, V24, P869, DOI 10.1042/bst0240869; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; Rotman N, 2010, PHYSIOLOGY, V25, P176, DOI 10.1152/physiol.00018.2010; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Terrasa A, 1998, MOL CELL BIOCHEM, V178, P181, DOI 10.1023/A:1006839413757; Ullrich O, 1930, Z GESAMTE NEUROL PSY, V126, P171, DOI 10.1007/BF02864097; Vigano A, 2011, PROTEOMICS, V11, P4202, DOI 10.1002/pmic.201000804; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yanez M, 2012, ADV EXP MED BIOL, V740, P461, DOI 10.1007/978-94-007-2888-2_19; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200	81	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56716	10.1371/journal.pone.0056716	http://dx.doi.org/10.1371/journal.pone.0056716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437220	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200150
J	Ye, YZ; Li, J; Yuan, ZX				Ye, Yizhou; Li, Jing; Yuan, Zhongxiang			Effect of Antioxidant Vitamin Supplementation on Cardiovascular Outcomes: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							BETA-CAROTENE; E CONSUMPTION; DISEASE; RISK; PREVENTION; ATHEROSCLEROSIS; WOMEN	Background: Antioxidant vitamin (vitamin E, beta-carotene, and vitamin C) are widely used for preventing major cardiovascular outcomes. However, the effect of antioxidant vitamin on cardiovascular events remains unclear. Methodology and Principal Findings: We searched PubMed, EmBase, the Cochrane Central Register of Controlled Trials, and the proceedings of major conferences for relevant literature. Eligible studies were randomized controlled trials that reported on the effects of antioxidant vitamin on cardiovascular outcomes as compared to placebo. Outcomes analyzed were major cardiovascular events, myocardial infarction, stroke, cardiac death, total death, and any possible adverse events. We used the I-2 statistic to measure heterogeneity between trials and calculated risk estimates for cardiovascular outcomes with random-effect meta-analysis. Independent extraction was performed by two reviewers and consensus was reached. Of 293 identified studies, we included 15 trials reporting data on 188209 participants. These studies reported 12749 major cardiovascular events, 6699 myocardial infarction, 3749 strokes, 14122 total death, and 5980 cardiac deaths. Overall, antioxidant vitamin supplementation as compared to placebo had no effect on major cardiovascular events (RR, 1.00; 95% CI, 0.96-1.03), myocardial infarction (RR, 0.98; 95% CI, 0.92-1.04), stroke (RR, 0.99; 95% CI, 0.93-1.05), total death (RR, 1.03; 95% CI, 0.98-1.07), cardiac death (RR, 1.02; 95% CI, 0.97-1.07), revascularization (RR, 1.00; 95% CI, 0.95-1.05), total CHD (RR, 0.96; 95% CI, 0.87-1.05), angina (RR, 0.98; 95% CI, 0.90-1.07), and congestive heart failure (RR, 1.07; 95% CI, 0.96 to 1.19). Conclusion/Significance: Antioxidant vitamin supplementation has no effect on the incidence of major cardiovascular events, myocardial infarction, stroke, total death, and cardiac death.	[Ye, Yizhou; Yuan, Zhongxiang] Shanghai Jiao Tong Univ, Dept Cardiovasc Surg, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Li, Jing] Fudan Univ, Childrens Hosp, Dept Cardiol, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Yuan, ZX (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiovasc Surg, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China.	yuanzhongxiangno1@126.com						Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIPLOCK AT, 1991, AM J CLIN NUTR, V53, pS189, DOI 10.1093/ajcn/53.1.189Sb; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FREI B, 1994, AM J MED, V97, pS5, DOI 10.1016/0002-9343(94)90292-5; Goodman GE, 2004, J NATL CANCER I, V96, P1743, DOI 10.1093/jnci/djh320; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 2010, INT J CANCER, V127, P1875, DOI 10.1002/ijc.25201; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Kataja-Tuomola MK, 2010, ANN MED, V42, P178, DOI 10.3109/07853890903508887; KOHLMEIER L, 1995, AM J CLIN NUTR, V62, P1370, DOI 10.1093/ajcn/62.6.1370S; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Leppala JM, 2000, ARCH NEUROL-CHICAGO, V57, P1503, DOI 10.1001/archneur.57.10.1503; Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; ODonnell CJ, 1997, CIRCULATION, V95, P1132; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pietinen P, 1996, CIRCULATION, V94, P2720, DOI 10.1161/01.CIR.94.11.2720; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805; Song YQ, 2009, AM J CLIN NUTR, V90, P429, DOI 10.3945/ajcn.2009.27491; STAMPFER MJ, 1995, AM J CLIN NUTR, V62, P1365, DOI 10.1093/ajcn/62.6.1365S; STAMPFER MJ, 1993, CAN J CARDIOL, V9, pB14; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; STEINBERG D, 1992, CIRCULATION, V85, P2338, DOI 10.1161/01.CIR.85.6.2337; STEINBERG D, 1991, CIRCULATION, V84, P1420, DOI 10.1161/01.CIR.84.3.1420; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; The ATBC Cancer Prevention Study Group, 1998, HEART, V79, P454; The ATBC Cancer Prevention Study Group, 2004, EUR HEART J, V25, P1171; The ATBC Cancer Prevention Study Group, 2000, ARTERIOSCLER THROMB, V20, P230; The PHS Study Group, 1996, NEW ENGL J MED, V334, P1145; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Virtamo J, 1998, ARCH INTERN MED, V158, P668, DOI 10.1001/archinte.158.6.668; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	52	129	130	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56803	10.1371/journal.pone.0056803	http://dx.doi.org/10.1371/journal.pone.0056803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437244	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200167
J	Yu, L; Chen, C; Wang, LF; Kuang, X; Liu, K; Zhang, H; Du, JR				Yu, Lu; Chen, Chu; Wang, Liang-Fen; Kuang, Xi; Liu, Ke; Zhang, Hao; Du, Jun-Rong			Neuroprotective Effect of Kaempferol Glycosides against Brain Injury and Neuroinflammation by Inhibiting the Activation of NF-kappa B and STAT3 in Transient Focal Stroke	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; NITRIC-OXIDE SYNTHASE; ISCHEMIA; INFLAMMATION; DAMAGE; FLAVONOIDS; PROTEIN; PHOSPHORYLATION; NICOTIFLORIN; INFILTRATION	Background: Ischemic brain injury is associated with neuroinflammatory response, which essentially involves glial activation and neutrophil infiltration. Transcription factors nuclear factor-kappa B (NF-kappa B) and signal transducer and activator of transcription 3 (STAT3) contribute to ischemic neuroinflammatory processes and secondary brain injury by releasing proinflammatory mediators. Kaempferol-3-O-rutinoside (KRS) and kaempferol-3-O- glucoside (KGS) are primary flavonoids found in Carthamus tinctorius L. Recent studies demonstrated that KRS protected against ischemic brain injury. However, little is known about the underlying mechanisms. Flavonoids have been reported to have antiinflammatory properties. Herein, we explored the effects of KRS and KGS in a transient focal stroke model. Methodology/Principal Findings: Rats were subjected to middle cerebral artery occlusion for 2 hours followed by 22 h reperfusion. An equimolar dose of KRS or KGS was administered i.v. at the beginning of reperfusion. The results showed that KRS or KGS significantly attenuated the neurological deficits, brain infarct volume, and neuron and axon injury, reflected by the upregulation of neuronal nuclear antigen-positive neurons and downregulation of amyloid precursor protein immunoreactivity in the ipsilateral ischemic hemisphere. Moreover, KRS and KGS inhibited the expression of OX-42, glial fibrillary acidic protein, phosphorylated STAT3 and NF-kappa B p65, and the nuclear content of NF-kappa B p65. Subsequently, these flavonoids inhibited the expression of tumor necrosis factor a, interleukin 1 beta, intercellular adhesion molecule 1, matrix metallopeptidase 9, inducible nitric oxide synthase, and myeloperoxidase. Conclusion/Significance: Our findings suggest that postischemic treatment with KRS or KGS prevents ischemic brain injury and neuroinflammation by inhibition of STAT3 and NF-kappa B activation and has the therapeutic potential for the neuroinflammation-related diseases, such as ischemic stroke.	[Yu, Lu; Wang, Liang-Fen; Kuang, Xi; Liu, Ke; Zhang, Hao; Du, Jun-Rong] Sichuan Univ, Projects Sci & Technol Innovat Platform Novel Dru, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ,Dept Pharmacol,W China Sch Pharm, Chengdu, Peoples R China; [Chen, Chu] Sichuan Acad Chinese Med Sci, Chengdu, Peoples R China; [Yu, Lu] Luzhou Med Coll, Luzhou, Sichuan, Peoples R China	Sichuan University; Southwest Medical University	Du, JR (corresponding author), Sichuan Univ, Projects Sci & Technol Innovat Platform Novel Dru, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ,Dept Pharmacol,W China Sch Pharm, Chengdu, Peoples R China.	dujr07@gmail.com			National Science Foundation of China [81072636]; Science Foundation from the Science & Technology Department of Sichuan Province, China [2009SZ0142]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation from the Science & Technology Department of Sichuan Province, China	This work was mainly supported by the National Science Foundation of China (81072636) and the Science Foundation from the Science & Technology Department of Sichuan Province, China (2009SZ0142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autore G, 2001, LIFE SCI, V70, P523, DOI 10.1016/S0024-3205(01)01425-4; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040165; Chu K, 2006, BRAIN RES, V1093, P208, DOI 10.1016/j.brainres.2006.03.114; del Zoppo GJ, 2010, J INTERN MED, V267, P156, DOI 10.1111/j.1365-2796.2009.02199.x; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; DEWAR D, 1995, BRAIN RES, V684, P70, DOI 10.1016/0006-8993(95)00417-O; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Emerich DF, 2002, EXP NEUROL, V173, P168, DOI 10.1006/exnr.2001.7835; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; Hamann GF, 1996, J CEREBR BLOOD F MET, V16, P1373, DOI 10.1097/00004647-199611000-00036; Huang JL, 2007, PHARMACOL BIOCHEM BE, V86, P741, DOI 10.1016/j.pbb.2007.03.003; Kuang X, 2009, PHARMACOL BIOCHEM BE, V92, P635, DOI 10.1016/j.pbb.2009.03.007; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li RP, 2006, J ETHNOPHARMACOL, V107, P143, DOI 10.1016/j.jep.2006.04.024; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Middleton E, 2000, PHARMACOL REV, V52, P673; Molina CA, 2009, CEREBROVASC DIS, V27, P162, DOI 10.1159/000200455; Muir KW, 2007, CURR OPIN NEUROL, V20, P334, DOI 10.1097/WCO.0b013e32813ba151; Oh H, 2004, J ETHNOPHARMACOL, V95, P421, DOI 10.1016/j.jep.2004.08.015; Park SE, 2011, BRIT J PHARMACOL, V164, P1008, DOI 10.1111/j.1476-5381.2011.01389.x; Parveen Z, 2007, YAKUGAKU ZASSHI, V127, P1275, DOI 10.1248/yakushi.127.1275; Peng HY, 2007, BIOL PHARM BULL, V30, P309, DOI 10.1248/bpb.30.309; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Shi F, 2006, LISHIZHEN MED MAT ME, V17, P1666; Suzuki S, 2001, EXP NEUROL, V170, P63, DOI 10.1006/exnr.2001.7701; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Tsuji K, 2005, STROKE, V36, P1954, DOI 10.1161/01.STR.0000177517.01203.eb; Weston RM, 2007, J CEREBR BLOOD F MET, V27, P100, DOI 10.1038/sj.jcbfm.9600324; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; [于丹 Yu Dan], 2010, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V25, P751	36	100	110	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55839	10.1371/journal.pone.0055839	http://dx.doi.org/10.1371/journal.pone.0055839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437066	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200025
J	Nieminen, L; Webb, S; Smith, MCM; Hoskisson, PA				Nieminen, Leena; Webb, Steven; Smith, Margaret C. M.; Hoskisson, Paul A.			A Flexible Mathematical Model Platform for Studying Branching Networks: Experimentally Validated Using the Model Actinomycete, Streptomyces coelicolor	PLOS ONE			English	Article							MORPHOLOGICALLY STRUCTURED MODEL; FILAMENTOUS MICROORGANISMS; ANTIBIOTIC PRODUCTION; SUBMERGED CULTURES; MYCELIAL NETWORKS; GROWTH; ANGIOGENESIS; A3(2); DESIGN; ENVIRONMENTS	Branching networks are ubiquitous in nature and their growth often responds to environmental cues dynamically. Using the antibiotic-producing soil bacterium Streptomyces as a model we have developed a flexible mathematical model platform for the study of branched biological networks. Streptomyces form large aggregates in liquid culture that can impair industrial antibiotic fermentations. Understanding the features of these could aid improvement of such processes. The model requires relatively few experimental values for parameterisation, yet delivers realistic simulations of Streptomyces pellet and is able to predict features, such as the density of hyphae, the number of growing tips and the location of antibiotic production within a pellet in response to pellet size and external nutrient supply. The model is scalable and will find utility in a range of branched biological networks such as angiogenesis, plant root growth and fungal hyphal networks.	[Nieminen, Leena; Hoskisson, Paul A.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Nieminen, Leena] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Webb, Steven] Univ Liverpool, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England; [Smith, Margaret C. M.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Strathclyde; University of Strathclyde; University of Liverpool; University of York - UK	Webb, S (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England.	steven.webb@liverpool.ac.uk; Paul.hoskisson@strath.ac.uk	Kerr, Leena/AAY-8332-2020	Kerr, Leena/0000-0003-0811-3264; Hoskisson, Paul/0000-0003-4332-1640; Smith, Maggie/0000-0002-4150-0496	Scottish Universities Life Science Alliance (SULSA)	Scottish Universities Life Science Alliance (SULSA)	The authors would like to thank the Scottish Universities Life Science Alliance (SULSA) for PhD studentship funding to LN (http://www.sulsa.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-202; ALLAN EJ, 1983, J GEN MICROBIOL, V129, P2029; Bastian P, 2008, J THEOR BIOL, V254, P99, DOI 10.1016/j.jtbi.2008.04.014; Bebber DP, 2007, P ROY SOC B-BIOL SCI, V274, P2307, DOI 10.1098/rspb.2007.0459; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Birol G, 2002, BIOTECHNOL BIOENG, V77, P538, DOI 10.1002/bit.10115; Boswell GP, 2002, J THEOR BIOL, V217, P459, DOI 10.1006/jtbi.2002.3048; Boswell GP, 2008, MYCOL RES, V112, P1015, DOI 10.1016/j.mycres.2008.02.006; Boswell Graeme P., 2012, Fungal Biology Reviews, V26, P30, DOI 10.1016/j.fbr.2012.02.002; Celler K, 2012, ANTON LEEUW INT J G, V102, P409, DOI 10.1007/s10482-012-9760-9; Davidson FA, 1998, J THEOR BIOL, V195, P281, DOI 10.1006/jtbi.1998.0739; Dupuy L, 2010, J EXP BOT, V61, P2131, DOI 10.1093/jxb/erp389; Fricker MD, 2008, J MICROSC-OXFORD, V231, P317, DOI 10.1111/j.1365-2818.2008.02043.x; Heaton Luke, 2012, Fungal Biology Reviews, V26, P12, DOI 10.1016/j.fbr.2012.02.001; Hille A, 2005, BIOTECHNOL BIOENG, V92, P614, DOI 10.1002/bit.20628; Jones Pamela F., 2006, Angiogenesis, V9, P127, DOI 10.1007/s10456-006-9039-8; Jyothikumar V, 2008, APPL ENVIRON MICROB, V74, P6774, DOI 10.1128/AEM.01233-08; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lejeune R, 1997, BIOTECHNOL BIOENG, V53, P139, DOI 10.1002/(SICI)1097-0290(19970120)53:2<139::AID-BIT3>3.0.CO;2-P; LEJEUNE R, 1995, BIOTECHNOL BIOENG, V47, P609, DOI 10.1002/bit.260470513; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Manteca A, 2008, APPL ENVIRON MICROB, V74, P3877, DOI 10.1128/AEM.02715-07; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Melzoch K, 1997, BIOTECHNOL BIOENG, V54, P577; MEYERHOFF J, 1995, BIOPROCESS ENG, V12, P305; MEYERHOFF J, 1995, J BIOTECHNOL, V38, P201, DOI 10.1016/0168-1656(94)00121-R; Murray J. D., 2001, MATH BIOL, V18; NIELSEN J, 1993, BIOTECHNOL BIOENG, V41, P715, DOI 10.1002/bit.260410706; OBERT M, 1990, J BACTERIOL, V172, P1180, DOI 10.1128/jb.172.3.1180-1185.1990; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Plank MJ, 2004, B MATH BIOL, V66, P1785, DOI 10.1016/j.bulm.2004.04.001; PROSSER JI, 1991, CRIT REV BIOTECHNOL, V10, P253, DOI 10.3109/07388559109038211; PROSSER JI, 1979, J GEN MICROBIOL, V111, P153, DOI 10.1099/00221287-111-1-153; Richards DM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002423; Shahab N, 1996, MICROBIOL-SGM, V142, P1927, DOI 10.1099/13500872-142-8-1927; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; STOKES CL, 1991, J CELL SCI, V99, P419; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Tough AJ, 1996, MICROBIOL-UK, V142, P639, DOI 10.1099/13500872-142-3-639; Traag BA, 2007, APPL ENVIRON MICROB, V73, P2085, DOI 10.1128/AEM.02755-06; van Wezel GP, 2006, APPL ENVIRON MICROB, V72, P5283, DOI 10.1128/AEM.00808-06; Wardell JN, 2002, BIOTECHNOL BIOENG, V78, P141, DOI 10.1002/bit.10210; WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222; YANG H, 1992, BIOTECHNOL BIOENG, V39, P44, DOI 10.1002/bit.260390108; YANG H, 1992, BIOTECHNOL BIOENG, V39, P49, DOI 10.1002/bit.260390109	45	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e54316	10.1371/journal.pone.0054316	http://dx.doi.org/10.1371/journal.pone.0054316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441147	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200005
J	Pernice, MC; Logares, R; Guillou, L; Massana, R				Pernice, Massimo C.; Logares, Ramiro; Guillou, Laure; Massana, Ramon			General Patterns of Diversity in Major Marine Microeukaryote Lineages	PLOS ONE			English	Article							OPERATIONAL TAXONOMIC UNITS; SEQUENCE ALIGNMENT; COMMUNITY; DIVERSIFICATION; PICOEUKARYOTES; CLASSIFICATION; EUKARYOTES; PHYLOGENY; PROTISTS; RATES	Microeukaryotes have vital roles for the functioning of marine ecosystems, but still some general characteristics of their current diversity and phylogeny remain unclear. Here we investigated both aspects in major oceanic microeukaryote lineages using 18S rDNA (V4-V5 hypervariable regions) sequences from public databases that derive from various marine environmental surveys. A very carefully and manually curated dataset of 8291 Sanger sequences was generated and subsequently split into 65 taxonomic groups (roughly to Class level based on KeyDNATools) prior to downstream analyses. First, we calculated genetic distances and clustered sequences into Operational Taxonomic Units (OTUs) using different distance cut-off levels. We found that most taxonomic groups had a maximum pairwise genetic distance of 0.25. Second, we used phylogenetic trees to study general evolutionary patterns. These trees confirmed our taxonomic classification and served to run Lineage Through Time (LTT) plots. LTT results indicated different cladogenesis dynamics across groups, with some displaying an early diversification and others a more recent one. Overall, our study provides an improved description of the microeukaryote diversity in the oceans in terms of genetic differentiation within groups as well as in the general phylogenetic structure. These results will be important to interpret the large amount of sequence data that is currently generated by High Throughput Sequencing technologies.	[Pernice, Massimo C.; Logares, Ramiro; Massana, Ramon] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Catalonia, Spain; [Guillou, Laure] Univ Paris 06, Stn Biol Roscoff, Roscoff, France; [Guillou, Laure] CNRS, Lab Adaptat & Diversite Milieu Marin, UMR 7144, Roscoff, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Pernice, MC (corresponding author), CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Catalonia, Spain.	pernice@icm.csic.es; ramonm@icm.csic.es	Massana, Ramon/F-4205-2016; Logares, Ramiro/D-5920-2011; Pernice, Massimo C./AAE-6214-2019; Logares, Ramiro/AAI-2306-2019	Logares, Ramiro/0000-0002-8213-0604; Pernice, Massimo Ciro/0000-0001-6917-8999; Guillou, Laure/0000-0003-1032-7958; Massana, Ramon/0000-0001-9172-5418	FLAME (MICINN, Spain) [CGL2010-16304]; BioMarKs (ERA-net Biodiversa, EU) [2008-6530]; project GEMMA (MEC, Spain) [CTM2007-63753-C02-01/MAR]; Spanish Ministry of Education and Science; Marie Curie Intra-European Fellowship grant [PIEF-GA-2009-235365]; Barcelona Supercomputing Center at the MareNostrum [BCV-2011-2-0003, BCV-2011-3-0005]	FLAME (MICINN, Spain); BioMarKs (ERA-net Biodiversa, EU); project GEMMA (MEC, Spain); Spanish Ministry of Education and Science(Spanish Government); Marie Curie Intra-European Fellowship grant; Barcelona Supercomputing Center at the MareNostrum	Funding has been provided by projects FLAME (CGL2010-16304, MICINN, Spain) and BioMarKs (2008-6530, ERA-net Biodiversa, EU) to RM, by project GEMMA (CTM2007-63753-C02-01/MAR, MEC, Spain) to Carlos Pedros-375 Alio, by a FPI fellowship from the Spanish Ministry of Education and Science to MCP, and by a Marie Curie Intra-European Fellowship grant PIEF-GA-2009-235365 to RL. Original sequence database was built under the frame of the French ANR-Biodiversite project AQUAPARADOX. High-performance computing resources were provided by the Barcelona Supercomputing Center at the MareNostrum (grants BCV-2011-2-0003 & BCV-2011-3-0005) to RM and RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Dunthorn M, 2012, J EUKARYOT MICROBIOL, V59, P185, DOI 10.1111/j.1550-7408.2011.00602.x; Epstein S, 2008, BIODIVERS CONSERV, V17, P261, DOI 10.1007/s10531-007-9250-y; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guillou L, 2008, ENVIRON MICROBIOL, V10, P397; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Krabberod AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023526; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Martin AP, 2004, EVOLUTION, V58, P946; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Massana R, 2011, ISME J, V5, P184, DOI 10.1038/ismej.2010.104; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Moreira D, 2004, INT J SYST EVOL MICR, V54, P1861, DOI 10.1099/ijs.0.63081-0; Nebel M, 2011, ENV MICROBIOL REP, V3, P154, DOI 10.1111/j.1758-2229.2010.00200.x; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; PURVIS A, 1995, P ROY SOC B-BIOL SCI, V260, P329, DOI 10.1098/rspb.1995.0100; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Terrado R, 2009, AQUAT MICROB ECOL, V56, P25, DOI 10.3354/ame01327; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	48	42	43	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57170	10.1371/journal.pone.0057170	http://dx.doi.org/10.1371/journal.pone.0057170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437337	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000082
J	Faiss, R; Leger, B; Vesin, JM; Fournier, PE; Eggel, Y; Deriaz, O; Millet, GP				Faiss, Raphael; Leger, Bertrand; Vesin, Jean-Marc; Fournier, Pierre-Etienne; Eggel, Yan; Deriaz, Olivier; Millet, Gregoire P.			Significant Molecular and Systemic Adaptations after Repeated Sprint Training in Hypoxia	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; NEAR-INFRARED SPECTROSCOPY; FIBER-TYPE; TRANSPORTER MCT4; OXYGEN-UPTAKE; BLOOD-FLOW; EXERCISE; INTENSITY; DEOXYGENATION; KINETICS	While intermittent hypoxic training (IHT) has been reported to evoke cellular responses via hypoxia inducible factors (HIFs) but without substantial performance benefits in endurance athletes, we hypothesized that repeated sprint training in hypoxia could enhance repeated sprint ability (RSA) performed in normoxia via improved glycolysis and O-2 utilization. 40 trained subjects completed 8 cycling repeated sprint sessions in hypoxia (RSH, 3000 m) or normoxia (RSN, 485 m). Before (Pre-) and after (Post-) training, muscular levels of selected mRNAs were analyzed from resting muscle biopsies and RSA tested until exhaustion (10-s sprint, work-to-rest ratio 1: 2) with muscle perfusion assessed by near-infrared spectroscopy. From Pre- to Post-, the average power output of all sprints in RSA was increased (p<0.01) to the same extent (6% vs 7%, NS) in RSH and in RSN but the number of sprints to exhaustion was increased in RSH (9.4+/-4.8 vs. 13.0+/-6.2 sprints, p<0.01) but not in RSN (9.3+/-4.2 vs. 8.9+/-3.5). mRNA concentrations of HIF-1 alpha (+55%), carbonic anhydrase III (+35%) and monocarboxylate transporter-4 (+20%) were augmented (p<0.05) whereas mitochondrial transcription factor A (-40%), peroxisome proliferator-activated receptor gamma coactivator 1 alpha (-23%) and monocarboxylate transporter-1 (-36%) were decreased (p<0.01) in RSH only. Besides, the changes in total hemoglobin variations (Delta[tHb]) during sprints throughout RSA test increased to a greater extent (p<0.01) in RSH. Our findings show larger improvement in repeated sprint performance in RSH than in RSN with significant molecular adaptations and larger blood perfusion variations in active muscles.	[Faiss, Raphael; Millet, Gregoire P.] Univ Lausanne, Fac Biol & Med, ISSUL Dept Physiol, CH-1015 Lausanne, Switzerland; [Faiss, Raphael; Leger, Bertrand; Deriaz, Olivier] SuvaCare Rehabil Clin, Inst Res Rehabil, Sion, Switzerland; [Faiss, Raphael; Fournier, Pierre-Etienne; Eggel, Yan] SuvaCare Rehabil Clin, Sport Med Unit, Sion, Switzerland; [Vesin, Jean-Marc] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Appl Signal Proc Grp, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Faiss, R (corresponding author), Univ Lausanne, Fac Biol & Med, ISSUL Dept Physiol, CH-1015 Lausanne, Switzerland.	raphael.faiss@unil.ch	Fournier, Pierre-Edouard/AAC-6155-2021; Faiss, Raphaël/AAX-3714-2021; Millet, Grégoire/M-3220-2019; Léger, Bertrand/AAK-4356-2020; Millet, Gregoire P/F-4104-2012	Fournier, Pierre-Edouard/0000-0001-8463-8885; Faiss, Raphaël/0000-0001-6029-9516; Millet, Grégoire/0000-0001-8081-4423; Millet, Gregoire P/0000-0001-8081-4423; Leger, Bertrand/0000-0003-2782-1442	Swiss Federal Research Grant (BASPO) [10-10]	Swiss Federal Research Grant (BASPO)	This research was funded by a Swiss Federal Research Grant (BASPO, Project 10-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billaut F, 2005, NEUROSCI LETT, V380, P265, DOI 10.1016/j.neulet.2005.01.048; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; Boushel R, 2000, ACTA PHYSIOL SCAND, V168, P615, DOI 10.1046/j.1365-201x.2000.00713.x; Buchheit M, 2009, INT J SPORTS MED, V30, P418, DOI 10.1055/s-0028-1105933; Burnley M, 2006, MED SCI SPORT EXER, V38, P1995, DOI 10.1249/01.mss.0000232024.06114.a6; Calbet JAL, 2009, HIGH ALT MED BIOL, V10, P123, DOI 10.1089/ham.2008.1099; Casey DP, 2012, J PHYSL; Cleland SM, 2012, APPL PHYSIOL NUTR ME, V37, P138, DOI [10.1139/H11-143, 10.1139/h11-143]; Delpy DT, 1997, PHILOS T R SOC B, V352, P649, DOI 10.1098/rstb.1997.0046; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; DOTAN R, 1983, EUR J APPL PHYSIOL O, V51, P409, DOI 10.1007/BF00429077; Endo M, 2005, EUR J APPL PHYSIOL, V95, P418, DOI 10.1007/s00421-005-0051-2; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; Ferguson SK, 2012, J PHYSL; Ferreira LF, 2006, EUR J APPL PHYSIOL, V96, P558, DOI 10.1007/s00421-005-0107-3; Foss O, 2004, EUR J APPL PHYSIOL, V92, P443, DOI 10.1007/s00421-004-1175-5; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; GRANGER HJ, 1973, MICROVASC RES, V5, P49, DOI 10.1016/S0026-2862(73)80006-8; Hanada A, 2003, J PHYSIOL-LONDON, V551, P635, DOI 10.1113/jphysiol.2003.044024; Hautier CA, 1996, EUR J APPL PHYSIOL, V74, P114, DOI 10.1007/BF00376503; He ZH, 2012, MED SCI SPORT EXER, V44, P1013, DOI 10.1249/MSS.0b013e3182442d82; Hoppeler H, 2008, SCAND J MED SCI SPOR, V18, P38, DOI 10.1111/j.1600-0838.2008.00831.x; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Jacobs TL, 2000, J PHYSIOL-LONDON, V524, P929, DOI 10.1111/j.1469-7793.2000.00929.x; Karatzaferi C, 2001, EXP PHYSIOL, V86, P411, DOI 10.1113/eph8602223; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Leger B, 2011, INT J CARDIOL, V146, P270, DOI 10.1016/j.ijcard.2010.10.078; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; Lundby C, 2012, BR J SPORTS MED; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; Messonnier L, 2007, J APPL PHYSIOL, V102, P1936, DOI 10.1152/japplphysiol.00691.2006; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Roels B, 2007, EUR J APPL PHYSIOL, V101, P359, DOI 10.1007/s00421-007-0506-8; Russell A, 2002, INT J OBESITY, V26, P157, DOI 10.1038/sj.ijo.0801885; Semenza G.L., 2007, SCI STKE, V2007, pcm8; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P8, DOI DOI 10.1002/9780470035009.CH2; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Szubski C, 2006, J APPL PHYSIOL, V101, P1673, DOI 10.1152/japplphysiol.00617.2006; Truijens MJ, 2003, J APPL PHYSIOL, V94, P733, DOI 10.1152/japplphysiol.00079.2002; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Umberger BR, 2006, J BIOMECH, V39, P1472, DOI 10.1016/j.jbiomech.2005.03.025; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; Vogt M, 2001, J APPL PHYSIOL, V91, P173, DOI 10.1152/jappl.2001.91.1.173; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; WILSON DF, 1977, AM J PHYSIOL, V233, pC135, DOI 10.1152/ajpcell.1977.233.5.C135; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005	51	178	183	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56522	10.1371/journal.pone.0056522	http://dx.doi.org/10.1371/journal.pone.0056522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437154	Green Published, gold			2022-12-27	WOS:000315184200092
J	Hu, M; Zhao, LY; Hu, SR; Yang, JT				Hu, Miao; Zhao, Lianying; Hu, Surong; Yang, Jingting			The Association between Two Common Polymorphisms in MicroRNAs and Hepatocellular Carcinoma Risk in Asian Population	PLOS ONE			English	Article							CANCER-RISK; GENETIC-VARIANTS; TURKISH POPULATION; PRE-MICRORNAS; EXPRESSION; EPIDEMIOLOGY; METAANALYSIS; RS2910164; MIRNA	Background: Emerging evidence has shown that microRNAs (miRNAs) participate in human carcinogenesis as tumor suppressors or oncogenes. Single nucleotide polymorphism (SNP) located in the miRNAs may influence the function of mature miRNAs and then affect the processing of carcinogenesis. It has been suggested that two common SNPs rs2910164 in miR-146a and rs3746444 in miR-499 are associated with susceptibility to hepatocellular carcinoma (HCC). However, published results are inconsistent and inconclusive. To acquire a more precise effect of the association between these polymorphisms and HCC risk, we performed this meta-analysis. Methodology/Principal Findings: We have conducted a search of case-control studies on the associations of SNPs rs2910164 and/or rs3746444 with susceptibility to HCC in PubMed, ScienceDirect, Cochrane Central Register of Controlled Trials, and Chinese National Knowledge Infrastructure databases for the period up to Sep 10th, 2012. A total of 6 studies were identified with 2071 cases and 2350 controls for miR-146a rs2910164 polymorphism, 667 cases and 1006 controls for miR-499 rs3746444 polymorphism. It was found that neither allele frequency nor genotype distribution of the two polymorphisms was associated with risk of HCC in all genetic models. Similarly, subgroup analysis in Asian population showed no associations between the two SNPs and the susceptibility to HCC. Conclusions/Significance: This meta-analysis suggests that miR-146a rs2910164 and miR-499 rs3746444 polymorphisms may not be associated with the risk of HCC, especially for Asian population. However, well-designed studies with larger sample size and more detailed data are needed to confirm these conclusions.	[Hu, Miao; Hu, Surong; Yang, Jingting] Nanjing Med Univ, Affiliated Hosp, Changzhou Peoples Hosp 2, Dept Geriatr, Changzhou, Peoples R China; [Zhao, Lianying] Kunshan Agcy Publ Hlth Inspect, Suzhou, Peoples R China	Nanjing Medical University	Hu, M (corresponding author), Nanjing Med Univ, Affiliated Hosp, Changzhou Peoples Hosp 2, Dept Geriatr, Changzhou, Peoples R China.	hongmo123@126.com						Akkiz H, 2011, ASIAN PAC J CANCER P, V12, P3107; Akkiz H, 2011, GENE, V486, P104, DOI 10.1016/j.gene.2011.07.006; Bartel B, 2005, NAT STRUCT MOL BIOL, V12, P569, DOI 10.1038/nsmb0705-569; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bouchard MJ, 2011, CANCER LETT, V305, P123, DOI 10.1016/j.canlet.2010.11.014; Braconi C, 2011, SEMIN ONCOL, V38, P752, DOI 10.1053/j.seminoncol.2011.08.001; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Hagymasi Krisztina, 2008, Orvosi Hetilap, V149, P541, DOI 10.1556/OH.2008.28313; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Kim WH, 2012, GENE, V504, P92, DOI 10.1016/j.gene.2012.05.014; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Law PTY, 2011, J GASTROEN HEPATOL, V26, P437, DOI 10.1111/j.1440-1746.2010.06512.x; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Nguyen Mindie H, 2004, Rev Gastroenterol Disord, V4 Suppl 1, pS14; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Pogribny IP, 2012, CANC LETT; Qiu LX, 2011, CYTOKINE, V56, P695, DOI 10.1016/j.cyto.2011.09.001; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tian T, 2010, INT J MOL EPIDEMIOL, V1, P358; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045042; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wang JB, 2012, MUTAGENESIS, V27, P779, DOI 10.1093/mutage/ges052; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; Wang LN, 2012, GENE, V508, P9, DOI 10.1016/j.gene.2012.08.005; Wang Y, 2012, GENE, V509, P267, DOI 10.1016/j.gene.2012.08.008; Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040039; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Zhang Xin-wei, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P239; Zhou J, 2012, DNA CELL BIOL, V31, P524, DOI 10.1089/dna.2011.1340	40	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57012	10.1371/journal.pone.0057012	http://dx.doi.org/10.1371/journal.pone.0057012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437296	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200199
J	Mino, T; Mori, T; Aoyama, Y; Sera, T				Mino, Takashi; Mori, Tomoaki; Aoyama, Yasuhiro; Sera, Takashi			Gene- and Protein-Delivered Zinc Finger-Staphylococcal Nuclease Hybrid for Inhibition of DNA Replication of Human Papillomavirus	PLOS ONE			English	Article							BINDING DOMAIN; TYPE-16 E1; CLEAVAGE; SELECTION; SPECIFICITY; PREVALENCE; ENHANCER; ORIGIN; CANCER; VIRUS	Previously, we reported that artificial zinc-finger proteins (AZPs) inhibited virus DNA replication in planta and in mammalian cells by blocking binding of a viral replication protein to its replication origin. However, the replication mechanisms of viruses of interest need to be disentangled for the application. To develop more widely applicable methods for antiviral therapy, we explored the feasibility of inhibition of HPV-18 replication as a model system by cleaving its viral genome. To this end, we fused the staphylococcal nuclease cleaving DNA as a monomer to an AZP that binds to the viral genome. The resulting hybrid nuclease (designated AZP-SNase) cleaved its target DNA plasmid efficiently and sequence-specifically in vitro. Then, we confirmed that transfection with a plasmid expressing AZP-SNase inhibited HPV-18 DNA replication in transient replication assays using mammalian cells. Linker-mediated PCR analysis revealed that the AZP-SNase cleaved an HPV-18 ori plasmid around its binding site. Finally, we demonstrated that the protein-delivered AZP-SNase inhibited HPV-18 DNA replication as well and did not show any significant cytotoxicity. Thus, both gene- and protein- delivered hybrid nucleases efficiently inhibited HPV-18 DNA replication, leading to development of a more universal antiviral therapy for human DNA viruses.	[Mino, Takashi; Mori, Tomoaki; Aoyama, Yasuhiro; Sera, Takashi] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan; [Mori, Tomoaki; Sera, Takashi] Okayama Univ, Dept Appl Chem & Biotechnol, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Aoyama, Yasuhiro] Doshisha Univ, Dept Mol Chem & Biochem, Fac Sci & Engn, Kyoto 602, Japan; [Mino, Takashi] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Kyoto 606, Japan	Kyoto University; Okayama University; Doshisha University; Kyoto University	Sera, T (corresponding author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan.	sera@cc.okayama-u.ac.jp	Mino, Takashi/GRO-0332-2022	Mino, Takashi/0000-0002-9562-008X	Grants-in-Aid for Scientific Research [25860355] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andrei G, 1998, ONCOL RES, V10, P523; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Chao SF, 1999, BIOCHEMISTRY-US, V38, P4586, DOI 10.1021/bi982616v; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168; DELVECCHIO AM, 1992, J VIROL, V66, P5949, DOI 10.1128/JVI.66.10.5949-5958.1992; DIMAIO D, 2001, FIELDS VIROLOGY, P119; DOWTY ME, 1995, P NATL ACAD SCI USA, V92, P4572, DOI 10.1073/pnas.92.10.4572; FRATTINI MG, 1994, P NATL ACAD SCI USA, V91, P12398, DOI 10.1073/pnas.91.26.12398; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Ho A, 2001, CANCER RES, V61, P474; Horner SM, 2007, J VIROL, V81, P6254, DOI 10.1128/JVI.00232-07; Howley P. M., 2001, FIELDS VIROLOGY, V2, P2197; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; LabatMoleur F, 1996, GENE THER, V3, P1010; Lee D, 1997, VIRUS RES, V52, P97, DOI 10.1016/S0168-1702(97)00114-7; Lowy DR, 2001, FIELDS VIROLOGY, P2231; Mineta Y, 2008, BIOCHEMISTRY-US, V47, P12257, DOI 10.1021/bi801800k; Mino T, 2008, ARCH VIROL, V153, P1291, DOI 10.1007/s00705-008-0125-7; Mino T, 2006, J VIROL, V80, P5405, DOI 10.1128/JVI.01795-05; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; PEI D, 1990, J AM CHEM SOC, V112, P4579, DOI 10.1021/ja00167a085; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; RUSSELL J, 1995, J VIROL, V69, P651, DOI 10.1128/JVI.69.2.651-660.1995; Sambrook JD, 2001, MOL CLONING LAB MANU, P1261; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Sera T, 2002, BIOCHEMISTRY-US, V41, P7074, DOI 10.1021/bi020095c; Sera T, 2005, J VIROL, V79, P2614, DOI 10.1128/JVI.79.4.2614-2619.2005; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Tachikawa K, 2004, P NATL ACAD SCI USA, V101, P15225, DOI 10.1073/pnas.0406473101; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; TUCKER PW, 1979, MOL CELL BIOCHEM, V23, P67; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wayengera M, 2012, THEOR BIOL MED MODEL, V9, P30; Wener PA, 2000, P NATL ACAD SCI USA, V97, P13003; Wilson VG, 2002, VIRUS GENES, V24, P275, DOI 10.1023/A:1015336817836; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; WU H, 1995, P NATL ACAD SCI USA, V92, P344, DOI 10.1073/pnas.92.2.344; Yasugi T, 1997, J VIROL, V71, P891, DOI 10.1128/JVI.71.2.891-899.1997; Zou NX, 1998, J VIROL, V72, P3436, DOI 10.1128/JVI.72.4.3436-3441.1998	52	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56633	10.1371/journal.pone.0056633	http://dx.doi.org/10.1371/journal.pone.0056633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437192	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200124
J	Morceli, G; Honorio-Franca, AC; Fagundes, DLG; Calderon, IMP; Franca, EL				Morceli, Gliciane; Honorio-Franca, Adenilda C.; Fagundes, Danny L. G.; Calderon, Iracema M. P.; Franca, Eduardo L.			Antioxidant Effect of Melatonin on the Functional Activity of Colostral Phagocytes in Diabetic Women	PLOS ONE			English	Article							BINDING-SITES; MICROBICIDAL ACTIVITY; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; RECEPTORS; MACROPHAGES; NEUTROPHILS; SUPEROXIDE; EXPRESSION; CALCIUM	Melatonin is involved in a number of physiological and oxidative processes, including functional regulation in human milk. The present study investigated the mechanisms of action of melatonin and its effects on the functional activity of colostral phagocytes in diabetic women. Colostrum samples were collected from normoglycemic (N = 38) and diabetic (N = 38) women. We determined melatonin concentration, superoxide release, bactericidal activity and intracellular Ca2+ release by colostral phagocytes treated or not with 8-(Diethylamino) octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8) and incubated with melatonin and its precursor (N-acetyl-serotonin-NAS), antagonist (luzindole) and agonist (chloromelatonin-CMLT). Melatonin concentration was higher in colostrum samples from hyperglycemic than normoglycemic mothers. Melatonin stimulated superoxide release by colostral phagocytes from normoglycemic but not hyperglycemic women. NAS increased superoxide, irrespective of glycemic status, whereas CMTL increased superoxide only in cells from the normoglycemic group. Phagocytic activity in colostrum increased significantly in the presence of melatonin, NAS and CMLT, irrespective of glycemic status. The bactericidal activity of colostral phagocytes against enterophatogenic Escherichia coli (EPEC) increased in the presence of melatonin or NAS in the normoglycemic group, but not in the hyperglycemic group. Luzindole blocked melatonin action on colostrum phagocytes. Phagocytes from the normoglycemic group treated with melatonin exhibited an increase in intracellular Ca2+ release. Phagocytes treated with TMB-8 (intracellular Ca2+ inhibitor) decreased superoxide, bactericidal activity and intracellular Ca2+ release in both groups. The results obtained suggest an interactive effect of glucose metabolism and melatonin on colostral phagocytes. In colostral phagocytes from normoglycemic mothers, melatonin likely increases the ability of colostrum to protect against EPEC and other infections. In diabetic mothers, because maternal hyperglycemia modifies the functional activity of colostrum phagocytes, melatonin effects are likely limited to anti-inflammatory processes, with low superoxide release and bactericidal activity.	[Morceli, Gliciane; Fagundes, Danny L. G.; Calderon, Iracema M. P.] Sao Paulo State Univ, UNESP, Botucatu Med Sch, Post Grad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil; [Honorio-Franca, Adenilda C.; Franca, Eduardo L.] Univ Fed Mato Grosso, Inst Biol & Hlth Sci, Barra Do Garcas, Mato Grosso, Brazil	Universidade Estadual Paulista; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul	Honorio-Franca, AC (corresponding author), Univ Fed Mato Grosso, Inst Biol & Hlth Sci, Barra Do Garcas, Mato Grosso, Brazil.	denifran@terra.com.br	Calderon, Iracema/W-4336-2019; França, Eduardo Luzia/W-8727-2019; Calderon, Iracema MP/C-8136-2012; Honorio-França, Adenilda C/C-8012-2012; Morceli, Glilciane/C-7487-2012; Triches, Danny Laura/AAE-2352-2022; França, Eduardo L/C-8053-2012	Calderon, Iracema/0000-0003-4761-4336; França, Eduardo Luzia/0000-0002-1854-5397; Calderon, Iracema MP/0000-0003-4761-4336; Honorio-França, Adenilda C/0000-0002-0452-9804; Morceli, Glilciane/0000-0001-8216-9931; Triches, Danny Laura/0000-0002-9971-1288; 	FAPESP [2008/09187-8, 2009/01188-8, 2011/18045-5]; FAPEMAT [299032/2010]; CNPq [475826/2010-8, 475739/2011-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPEMAT(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors declare non-financial competing interests. This research was supported by FAPESP (2008/09187-8; 2009/01188-8; 2011/18045-5) (http://www.fapesp.br), FAPEMAT (299032/2010) and CNPq (475826/2010-8; 475739/2011-6) (http://www.fapemat.mt.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103; Barjavel MJ, 1998, J IMMUNOL, V160, P1191; BellinatiPires R, 1995, J INVEST ALLERG CLIN, V5, P337; Belyaev O, 2011, J PINEAL RES, V50, P71, DOI 10.1111/j.1600-079X.2010.00811.x; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Bromme HJ, 2000, J PINEAL RES, V29, P201, DOI 10.1034/j.1600-0633.2002.290402.x; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Ferrari CKB, 2009, J APPL BIOMED, V7, P163, DOI 10.32725/jab.2009.019; Carneiro-Sampaio MMS, 1996, REV MICROBIOL, V26, P151; Carrichon L, 2011, BBA-BIOMEMBRANES, V1808, P78, DOI 10.1016/j.bbamem.2010.08.002; Chertok IRA, 2009, J HUM NUTR DIET, V22, P166, DOI 10.1111/j.1365-277X.2008.00921.x; Cutolo M, 1999, ANN NY ACAD SCI, V876, P246, DOI 10.1111/j.1749-6632.1999.tb07645.x; Davis MK, 2001, PEDIATR CLIN N AM, V48, P125, DOI 10.1016/S0031-3955(05)70289-3; Devi MMS, 2000, J PINEAL RES, V29, P108; Djaldetti M, 2002, MICROSC RES TECHNIQ, V57, P421, DOI 10.1002/jemt.10096; DUBOCOVICH ML, 1998, IUPHAR COMPENDIUM RE, P187; Erren TC, 2008, NEUROENDOCRINOL LETT, V29, P815; Franca EL, 2011, APMIS, V119, P710, DOI 10.1111/j.1600-0463.2011.02789.x; Franca EL, 2011, J MICROBIOL IMMUNOL, V44, P1, DOI 10.1016/j.jmii.2011.01.002; Franca EL, 2010, BIOL RHYTHM RES, V41, P333, DOI 10.1080/09291010903407441; Franca EL, 2009, BRATISL MED J, V7, P163; Franca-Botelho AC, 2006, ACTA PAEDIATR, V95, P438, DOI 10.1080/08035250500421592; Franca-Botelho AC, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-62; Fagundes DLG, 2012, INT J PHARMACOL, V8, P510, DOI 10.3923/ijp.2012.510.518; Hanson LA, 2007, P NUTR SOC, V66, P384, DOI 10.1017/S0029665107005654; Honorio-Franca A. C., 2009, INT J DIABETES METAB, V17, P87; Honorio-Fransa AC, 2001, J LEUKOCYTE BIOL, V69, P289; HonorioFranca AC, 1997, SCAND J IMMUNOL, V46, P59, DOI 10.1046/j.1365-3083.1997.d01-86.x; Hussain SA, 2006, SAUDI MED J, V27, P1483; ILLNEROVA H, 1993, J CLIN ENDOCR METAB, V77, P838, DOI 10.1210/jc.77.3.838; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kadhim HM, 2006, J PINEAL RES, V41, P189, DOI 10.1111/j.1600-079X.2006.00353.x; Kent JC, 2007, J MIDWIFERY WOM HEAL, V52, P564, DOI 10.1016/j.jmwh.2007.04.007; Kireev RA, 2008, J PINEAL RES, V45, P394, DOI 10.1111/j.1600-079X.2008.00606.x; Klepac N, 2006, BIOMED PHARMACOTHER, V60, P32, DOI 10.1016/j.biopha.2005.08.005; KOJIMA I, 1986, BIOCHIM BIOPHYS ACTA, V888, P25, DOI 10.1016/0167-4889(86)90066-2; Konakchieva R, 1999, ADV EXP MED BIOL, V460, P411; Korkmaz A, 2009, REV ENDOCR METAB DIS, V10, P261, DOI 10.1007/s11154-009-9117-5; Lopez-Gonzalez Miguel A., 1993, Biotechnology Therapeutics, V4, P253; Morceli G, 2011, ACTA PAEDIATR, V100, P550, DOI 10.1111/j.1651-2227.2010.02070.x; NOVELLI ELB, 1993, BRAZ J MED BIOL RES, V26, P31; Ogasawara T, 1991, Nihon Sanka Fujinka Gakkai Zasshi, V43, P335; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001; Pawlak J, 2005, MOL CELL BIOCHEM, V275, P207, DOI 10.1007/s11010-005-1995-6; Peschke E, 2012, J PINEAL RES, V52, P389, DOI 10.1111/j.1600-079X.2011.00951.x; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; PIOLI C, 1993, INT J IMMUNOPHARMACO, V15, P463, DOI 10.1016/0192-0561(93)90060-C; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Reiter RJ, 2008, NEUROENDOCRINOL LETT, V29, P391; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rudge MVC, 2000, GYNECOL OBSTET INVES, V50, P108, DOI 10.1159/000010293; Silva SO, 2006, MICROBES INFECT, V8, P420, DOI 10.1016/j.micinf.2005.07.004; Skwarlo-Sonta K, 2002, J PHYSIOL-LONDON, V543, p6S; Sudnikovich EJ, 2007, EUR J PHARMACOL, V569, P180, DOI 10.1016/j.ejphar.2007.05.018; Tutuncu NB, 2005, J PINEAL RES, V39, P43, DOI 10.1111/j.1600-079X.2005.00213.x; VACAS MI, 1992, J PINEAL RES, V13, P60, DOI 10.1111/j.1600-079X.1992.tb00055.x; Vidarsson G, 1998, CURR OPIN INFECT DIS, V11, P271, DOI 10.1097/00001432-199806000-00002	60	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56915	10.1371/journal.pone.0056915	http://dx.doi.org/10.1371/journal.pone.0056915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437270	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200184
J	Rodriguez-Gil, DJ; Hu, W; Greer, CA				Rodriguez-Gil, Diego J.; Hu, Wilbur; Greer, Charles A.			Dishevelled Proteins Are Associated with Olfactory Sensory Neuron Presynaptic Terminals	PLOS ONE			English	Article							ODORANT RECEPTOR GENES; CELL-ADHESION MOLECULE; BETA-CATENIN; COMPARTMENTAL ORGANIZATION; ZONAL SEGREGATION; AXON EXTENSION; FAMILY-MEMBERS; WNT PATHWAY; MOUSE; EXPRESSION	Olfactory sensory neurons (OSNs) project their axons from the olfactory epithelium toward the olfactory bulb (OB) in a heterogeneous and unsorted arrangement. However, as the axons approach the glomerular layer of the OB, axons from OSNs expressing the same odorant receptor (OR) sort and converge to form molecularly homogeneous glomeruli. Axon guidance cues, cell adhesion molecules, and OR induced activity have been implicated in the final targeting of OSN axons to specific glomeruli. Less understood, and often controversial, are the mechanisms used by OSN axons to initially navigate from the OE toward the OB. We previously demonstrated a role for Wnt and Frizzled (Fz) molecules in OSN axon extension and organization within the olfactory nerve. Building on that we now turned our attention to the downstream signaling cascades from Wnt-Fz interactions. Dishevelled (Dvl) is a key molecule downstream of Fz receptors. Three isoforms of Dvl with specific as well as overlapping functions are found in mammals. Here, we show that Dvl-1 expression is restricted to OSNs in the dorsal recess of the nasal cavity, and labels a unique subpopulation of glomeruli. Dvl-2 and Dvl-3 have a widespread distribution in both the OE and OB. Both Dvl-1 and Dvl-2 are associated with intra-glomerular pre-synaptic OSN terminals, suggesting a role in synapse formation/stabilization. Moreover, because Dvl proteins were observed in all OSN axons, we hypothesize that they are important determinants of OSN cell differentiation and axon extension.	[Rodriguez-Gil, Diego J.; Hu, Wilbur; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Greer, Charles A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University	Greer, CA (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	charles.greer@yale.edu			United States National Institutes of Health Grant [DC00210, DC010894]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007880, R01DC000210, R03DC010894, R01DC012441] Funding Source: NIH RePORTER	United States National Institutes of Health Grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by United States National Institutes of Health Grant DC00210 to Charles A. Greer and DC010894 to Diego Rodriguez-Gil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Booker-Dwyer T, 2008, DEV NEUROBIOL, V68, P859, DOI 10.1002/dneu.20606; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Gussing F, 2004, EUR J NEUROSCI, V19, P2511, DOI 10.1111/j.0953-816X.2004.03331.x; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; HINDS JW, 1976, J COMP NEUROL, V169, P41, DOI 10.1002/cne.901690104; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006729; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; Kafitz KW, 1998, J NEUROBIOL, V34, P271, DOI 10.1002/(SICI)1097-4695(19980215)34:3<271::AID-NEU6>3.0.CO;2-#; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mobley AS, 2010, J NEUROSCI, V30, P16498, DOI 10.1523/JNEUROSCI.4225-10.2010; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Oka Y, 2003, EUR J BIOCHEM, V270, P1995, DOI 10.1046/j.1432-1033.2003.03571.x; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Pluznick JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019694; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez-Gil DJ, 2008, J COMP NEUROL, V511, P301, DOI 10.1002/cne.21834; Rodriguez-Gil DJ, 2010, J NEUROSCI, V30, P10067, DOI 10.1523/JNEUROSCI.1776-10.2010; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shay EL, 2008, DEV DYNAM, V237, P1837, DOI 10.1002/dvdy.21595; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Treloar HB, 2009, J NEUROSCI, V29, P9405, DOI 10.1523/JNEUROSCI.2356-09.2009; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang YZ, 2008, DEV DYNAM, V237, P3157, DOI 10.1002/dvdy.21712; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Whitman MC, 2007, DEV NEUROBIOL, V67, P1079, DOI 10.1002/dneu.20389; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zaghetto AA, 2007, J NEUROSCI, V27, P9757, DOI 10.1523/JNEUROSCI.0763-07.2007; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhang XH, 2009, RESULTS PROBL CELL D, V47, P25, DOI 10.1007/400_2008_28; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	70	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56561	10.1371/journal.pone.0056561	http://dx.doi.org/10.1371/journal.pone.0056561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437169	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200105
J	Sakellariou, G; Scire, CA; Zambon, A; Caporali, R; Montecucco, C				Sakellariou, Garifallia; Scire, Carlo Alberto; Zambon, Antonella; Caporali, Roberto; Montecucco, Carlomaurizio			Performance of the 2010 Classification Criteria for Rheumatoid Arthritis: A Systematic Literature Review and a Meta-Analysis	PLOS ONE			English	Review							AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; DIAGNOSTIC-ACCURACY; 1987 ACR; SPECIFICITY; SENSITIVITY	Objectives: To evaluate the performance of the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) 2010 classification criteria for rheumatoid arthritis (RA) with a systematic literature review and a meta-analysis. Methods: PubMed, Embase, Cochrane Library and the abstracts of the ACR and EULAR meetings (2010-2012) were searched for original articles or abstracts with the following inclusion criteria: 1) recent onset arthritis, with at least one swollen joint and no alternative diagnosis; 2) the ACR/EULAR 2010 criteria as index test; 3) the prescription of methotrexate (MTX) or disease modifying antirheumatic drugs (DMARDs) at any time during follow-up as reference standard. Data were pooled using the bivariate model. Three meta-analyses were performed with MTX (primary analysis), DMARDs or their combination (secondary analyses) as reference standard. Heterogeneity was formally tested and explored performing an influence analysis. Results: The search identified 1,277 references. Six full papers and 4 abstracts met the inclusion criteria. With MTX as reference standard, sensitivity (95% confidence interval, CI) was 0.80 (0.74,0.85), specificity 0.61 (0.56,0.67), positive likelihood ratio (LR) 2.11 (1.92,2.32), negative LR 0.31 (0.25,0.38) and the diagnostic odds ratio (DOR) was 6.74 (5.49,8.28). Using DMARDs as reference standard, sensitivity was 0.73 (0.64,0.80), specificity was 0.74 (0.68,0.79), LR+2.85 (2.53,3.22), LR-0.35 (0.27,0.45) and DOR 8.03 (6.4,10.09). Using the combination of MTX and DMARDs as reference standard, intermediate results were obtained. The influence analysis detected one potentially influential study. However, its exclusion from the meta-analysis did not have a clinically relevant impact on the results. Conclusions: The new classification criteria have good sensitivity, lower specificity and an overall moderate diagnostic accuracy. These results confirm that the criteria have classificative and not diagnostic function.	[Sakellariou, Garifallia; Scire, Carlo Alberto; Caporali, Roberto; Montecucco, Carlomaurizio] IRCCS Policlin San Matteo Fdn, Chair & Div Rheumatol, Pavia, Italy; [Zambon, Antonella] Univ Milano Bicocca, Dept Biostat Stat & Quantitat Methods, Milan, Italy	IRCCS Fondazione San Matteo; University of Milano-Bicocca	Sakellariou, G (corresponding author), IRCCS Policlin San Matteo Fdn, Chair & Div Rheumatol, Pavia, Italy.	filiciasak@gmail.com	Montecucco, Carlomaurizio/K-5236-2018; Sakellariou, Garifallia/E-5468-2011; Scirè, Carlo Alberto/E-5774-2013; caporali, roberto/AAB-1873-2019	Montecucco, Carlomaurizio/0000-0001-8263-3925; Sakellariou, Garifallia/0000-0002-1849-5123; Scirè, Carlo Alberto/0000-0001-7451-0271; caporali, roberto/0000-0001-9300-6169; Zambon, Antonella/0000-0001-6443-3858				Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Alves C, 2011, ANN RHEUM DIS, V70, P1645, DOI 10.1136/ard.2010.142299; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Banal F, 2009, ANN RHEUM DIS, V68, P1184, DOI 10.1136/ard.2008.093187; Berglin EH, 2011, ARTHRITIS RHEUM-US, V63, pS117; Breedveld FC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3093; Britsemmer K, 2011, ANN RHEUM DIS, V70, P1468, DOI 10.1136/ard.2010.148619; Cader MZ, 2011, ANN RHEUM DIS, V70, P949, DOI 10.1136/ard.2010.143560; Chitale S, 2010, ARTHRITIS RHEUM S, V62, pS733; Cornec D, 2012, JOINT BONE SPINE, V79, P581, DOI 10.1016/j.jbspin.2012.01.015; Corrao S, 2011, EUR J INTERN MED, V22, P217, DOI 10.1016/j.ejim.2010.12.018; Deeks JJ., 2009, COCHRANE DATABASE SY; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Jaeschke R, 2002, USERS GUIDES MED LIT, P121; Kaneko Y, 2011, RHEUMATOLOGY, V50, P1268, DOI 10.1093/rheumatology/keq442; Kawashiri S, 2013, MOD RHEUMATOL, V23, P36, DOI 10.1007/s10165-012-0628-7; Knevel R, 2010, ANN RHEUM DIS, V69, P987, DOI 10.1136/ard.2009.126748; Leeflang MMG, 2006, J CLIN EPIDEMIOL, V59, P234, DOI 10.1016/j.jclinepi.2005.07.014; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nakagomi D, 2012, ANN RHEUM DIS, V71, P98; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Reitsma H, 2011, METAANALYSIS DIAGNOS; Sakellariou G, 2012, ANN RHEUM DIS, V71, pP334; Sakellariou G, 2013, ANN RHEUM DIS, V72, P245, DOI 10.1136/annrheumdis-2012-201817; Scire CA, 2011, ARTHRIT CARE RES, V63, P945, DOI 10.1002/acr.20453; Tamai M, 2011, ARTHRITIS RHEUM-US, V63, pS119; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100; Varache S, 2011, J RHEUMATOL, V38, P1250, DOI 10.3899/jrheum.101227; Visser H, 2004, ARTHRITIS RHEUM, V46, P357	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56528	10.1371/journal.pone.0056528	http://dx.doi.org/10.1371/journal.pone.0056528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437156	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200094
J	Takase, O; Yoshikawa, M; Idei, M; Hirahashi, J; Fujita, T; Takato, T; Isagawa, T; Nagae, G; Suemori, H; Aburatani, H; Hishikawa, K				Takase, Osamu; Yoshikawa, Masahiro; Idei, Mana; Hirahashi, Junichi; Fujita, Toshiro; Takato, Tsuyoshi; Isagawa, Takayuki; Nagae, Genta; Suemori, Hirofumi; Aburatani, Hiroyuki; Hishikawa, Keiichi			The Role of NF-kappa B Signaling in the Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							DIFFERENTIATION; INDUCTION; INHIBITION; EXPRESSION; APOPTOSIS; LINES	NF-kappa B signaling plays an essential role in maintaining the undifferentiated state of embryonic stem (ES) cells. However, opposing roles of NF-kappa B have been reported in mouse and human ES cells, and the role of NF-kappa B in human induced pluripotent stem (iPS) cells has not yet been clarified. Here, we report the role of NF-kappa B signaling in maintaining the undifferentiated state of human iPS cells. Compared with differentiated cells, undifferentiated human iPS cells showed an augmentation of NF-kappa B activity. During differentiation induced by the removal of feeder cells and FGF2, we observed a reduction in NF-kappa B activity, the expression of the undifferentiation markers Oct3/4 and Nanog, and the up-regulation of the differentiated markers WT-1 and Pax-2. The specific knockdown of NF-kappa B signaling using p65 siRNA also reduced the expression of Oct3/4 and Nanog and up-regulated WT-1 and Pax-2 but did not change the ES-like colony formation. Our results show that the augmentation of NF-kappa B signaling maintains the undifferentiated state of human iPS and suggest the importance of this signaling pathway in maintenance of human iPS cells.	[Takase, Osamu; Yoshikawa, Masahiro; Idei, Mana; Takato, Tsuyoshi; Hishikawa, Keiichi] Univ Tokyo, Grad Sch Med, Dept Adv Nephrol & Regenerat Med, Tokyo, Japan; [Takase, Osamu; Yoshikawa, Masahiro; Idei, Mana; Hirahashi, Junichi; Fujita, Toshiro; Hishikawa, Keiichi] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan; [Takato, Tsuyoshi] Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Isagawa, Takayuki; Nagae, Genta; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Suemori, Hirofumi] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Kyoto University	Hishikawa, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Adv Nephrol & Regenerat Med, Tokyo, Japan.	hishikawa-tky@umin.ac.jp	Nagae, Genta/AAN-1167-2021; Nagae, Genta/H-6579-2019; Hishikawa, Keiichi/A-8661-2011	Nagae, Genta/0000-0002-2929-7990; YOSHIKAWA, Masahiro/0000-0002-3682-9713	Mochida Pharmaceutical Co. Ltd.; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Daiwa Securities Health Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare	Mochida Pharmaceutical Co. Ltd.; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Daiwa Securities Health Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported, in part, by Mochida Pharmaceutical Co. Ltd., the Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care, the Daiwa Securities Health Foundation, a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Health Science Research Grants from the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen YJ, 2000, GENE EXPRESSION, V9, P103; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hayashi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045435; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Ichikawa H, 2012, CRYOBIOLOGY, V64, P12, DOI 10.1016/j.cryobiol.2011.11.005; Inowa T, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/782967; Kim YE, 2008, BMB REP, V41, P705, DOI 10.5483/BMBRep.2008.41.10.705; Nakatsuji N, 2005, E SCHERING RES FDN W, V54, P15; Ogawa S, 2011, IN VITRO CELL DEV-AN, V47, P464, DOI 10.1007/s11626-011-9435-2; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takase O, 2008, KIDNEY INT, V73, P567, DOI 10.1038/sj.ki.5002563; Takase O, 2011, EUR J PHARMACOL, V669, P128, DOI 10.1016/j.ejphar.2011.07.043; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Watabe M, 2004, J BIOL CHEM, V279, P6017, DOI 10.1074/jbc.M306040200; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yang CB, 2010, STEM CELLS, V28, P1970, DOI 10.1002/stem.528; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047306	26	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56399	10.1371/journal.pone.0056399	http://dx.doi.org/10.1371/journal.pone.0056399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437124	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200068
J	Zhang, B; Wang, ZJ; Wu, LL; Zhang, M; Li, W; Ding, JH; Zhu, J; Wei, HF; Zhao, K				Zhang, Bin; Wang, Zhijun; Wu, Liangliang; Zhang, Meng; Li, Wei; Ding, Jianhua; Zhu, Jun; Wei, Huafeng; Zhao, Ke			Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma	PLOS ONE			English	Article							CLINICAL-RELEVANCE; IMMUNE CELLS; T-CELLS; SUBSETS; INFLAMMATION; DOXORUBICIN; POPULATION; EXPANSION; CORRELATE; STAGE	Myeloid-derived suppressor cells (MDSCs) are a heterogeneous family of myeloid cells that suppress T cell immunity in tumor-bearing hosts. In patients with colon cancer, MDSCs have recently been described as Lin(-/low)HLA-DR(-)CD11b(+)CD33(+) cells correlating with cancer stage, metastasis and chemotherapy response. To learn in more detail the dynamic change and clinical relevance of circulating and tumor-infiltrating Lin(-)/lowHLA-DR(-)CD11b(+)CD33(+) MDSC in colorectal cancer, we harvested the blood from 64 patients with varying stage of colorectal cancer and tumor and matched paraneoplastic tissues from 5 patients with advanced colorectal cancer, subjected them to multicolor flow cytometric analysis of percentage, absolute number and phenotype of MDSC and finally characterized their immunosuppressive functions. Our results demonstrate that peripheral blood from colorectal cancer patients contains markedly increased percentage and absolute number of Lin(-/low)HLA-DR(-)CD11b(+)CD33(+) MDSCs compared with healthy individuals, and this increase is closely correlated with clinical cancer stage and tumor metastasis but not primary tumor size and serum concentrations of cancer biomarker. A similar increase of MDSCs was also observed in the tumor tissues. Phenotyping MDSCs shows that they express high CD13 and CD39, low CD115, CD117, CD124 and PD-L1, and devoid of CD14, CD15 and CD66b, reminiscent of precursor myeloid cells. MDSCs from cancer patients but not healthy donors have the immunosuppressive activity and were able to inhibit in vitro autologous T-cell proliferation. Collectively, this study substantiates the presence of increased immunosuppressive circulating and tumor-resident Lin(-/low)HLA-DR(-)CD11b(+)C33(+) MDSCs in patients with colorectal cancers correlating with cancer stage and metastasis, and suggests that pharmacologic blockade of MDSCs should be considered in future clinical trials.	[Zhang, Bin; Zhang, Meng; Ding, Jianhua; Zhu, Jun; Zhao, Ke] Second Artillery Gen Hosp, Dept Colorectal Dis Surg, Beijing, Peoples R China; [Wang, Zhijun] Peoples Liberat Army Gen Hosp, Dept Intervent Radiol, Beijing, Peoples R China; [Wu, Liangliang] Peoples Liberat Army Gen Hosp, Canc Ctr Lab, Beijing, Peoples R China; [Li, Wei] Nanjing Med Univ, Brain Hosp, Dept Geriatr Neurol, Nanjing, Jiangsu, Peoples R China; [Wei, Huafeng] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Nanjing Medical University; Naval Medical University	Wei, HF (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China.	foxp3_smmu@163.com; thalarus@126.com	Ding, Jian-Hua/AAK-4129-2020	Ding, Jian-Hua/0000-0002-0858-1941	Beijing Natural Science Foundation [7133254]; Beijing Nova Program; National Natural Science Foundation of China [30901380/C081501]; Shanghai Morning Light Program [09CG36]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Morning Light Program	This work was supported by the the Beijing Natural Science Foundation (7133254 to BZ), the Beijing Nova Program (to ZJW), the National Natural Science Foundation of China (No. 30901380/C081501 to HFW) and the Shanghai Morning Light Program (09CG36 to HFW). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamin LS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/959848; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Duffy A, 2012, CANC IMMUNOLOGY IMMU; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Eruslanov E, 2012, INT J CANCER, V130, P1109, DOI 10.1002/ijc.26123; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng PH, 2012, AM J RESP CRIT CARE, V186, P1025, DOI 10.1164/rccm.201204-0636OC; Fujimura T, 2010, J DERMATOL SCI, V59, P1, DOI 10.1016/j.jdermsci.2010.05.001; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ghiringhelli F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/473712; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Montero AJ, 2012, BREAST CANCER RES TR, V132, P215, DOI 10.1007/s10549-011-1889-0; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Mundy-Bosse BL, 2011, CANCER IMMUNOL IMMUN, V60, P1269, DOI 10.1007/s00262-011-1029-z; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Sun HL, 2012, WORLD J GASTROENTERO, V18, P3303, DOI 10.3748/wjg.v18.i25.3303; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Walter S., 2012, NAT MED; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Younos IH, 2012, INT IMMUNOPHARMACOL, V13, P245, DOI 10.1016/j.intimp.2012.05.002; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	45	185	200	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57114	10.1371/journal.pone.0057114	http://dx.doi.org/10.1371/journal.pone.0057114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437326	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200219
J	Zhi, F; Cao, XS; Xie, XB; Wang, B; Dong, WM; Gu, WY; Ling, Y; Wang, R; Yang, YL; Liu, Y				Zhi, Feng; Cao, Xiangshan; Xie, Xiaobao; Wang, Biao; Dong, Weimin; Gu, Weiying; Ling, Yun; Wang, Rong; Yang, Yilin; Liu, Yan			Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; EXPRESSION SIGNATURES; DOWN-REGULATION; CANCER; SERUM; GENE; CELLS; PROLIFERATION; ANGIOGENESIS; MUTATIONS	Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The disease is characterized by various cytogenetic and molecular abnormalities with distinct prognoses and gene expression profiles. Emerging evidence has suggested that circulating microRNAs (miRNAs) could serve as noninvasive biomarkers for cancer detection; however, little is known about circulating miRNA profiles in AML patients. In this study, a genome-wide serum miRNA expression analysis was performed using Solexa sequencing for initial screen, followed by validation with real-time PCR assays. The analysis was conducted on training and verification sets of serum samples from 140 newly diagnosed AML patients and 135 normal adult donors. After a two-phase selection and validation process, 6 miRNAs, miR-10a-5p, miR-93-5p, miR-129-5p, miR-155-5p, miR-181b-5p and miR-320d, were found to have significantly different expression levels in AML compared with control serum samples. Furthermore, unsupervised clustering analysis revealed the remarkable ability of the 6-miRNA profile to differentiate between AML patients and normal controls. The areas under the ROC curve for the selected miRNAs ranged from 0.8129 to 0.9531. More importantly, miR-181b-5p levels in serum were significantly associated with overall survival. These data demonstrated that the expression patterns of circulating miRNAs were systematically altered in AML and miR-181b-5p may serve as a predictor for overall survival in AML patients.	[Zhi, Feng; Wang, Rong; Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Jiangsu, Peoples R China; [Cao, Xiangshan; Xie, Xiaobao; Wang, Biao; Dong, Weimin; Gu, Weiying; Ling, Yun; Liu, Yan] Soochow Univ, Affiliated Hosp 3, Dept Hematol, Changzhou, Jiangsu, Peoples R China; [Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Yang, YL (corresponding author), Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Jiangsu, Peoples R China.	yilinyang.czfph@gmail.com; yanliu.czfph@gmail.com			Changzhou Social Science and Technology Development Project [CS20102004]	Changzhou Social Science and Technology Development Project	This work was supported by a grant from the Changzhou Social Science and Technology Development Project (CS20102004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Bryant A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-8; Campayo M, 2012, EUR RESP J; Cao P, 2012, HEAD NECK; Chen L, 2012, IUBMB LIFE, V64, P628, DOI 10.1002/iub.1030; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Cui Y, 2012, J CELL PHYSIOL, V227, P772, DOI 10.1002/jcp.22789; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Faraoni I, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-26; Fu X, 2012, FEBS LETT, V586, P1279, DOI 10.1016/j.febslet.2012.03.006; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gregory TK, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-23; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Li ZJ, 2012, BLOOD, V119, P2314, DOI 10.1182/blood-2011-10-386235; Liao RX, 2008, J CELL BIOCHEM, V104, P805, DOI 10.1002/jcb.21668; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926; Marcucci G, 2008, J CLIN ONCOL, V26, P5078, DOI 10.1200/JCO.2008.17.5554; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ovcharenko D, 2011, EXP HEMATOL, V39, P1030, DOI 10.1016/j.exphem.2011.07.008; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; Smith ML, 2011, BLOOD REV, V25, P39, DOI 10.1016/j.blre.2010.10.002; Sun SM, 2012, LEUKEMIA; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025; Wang F, 2012, MOL BIOL REP, V39, P2713, DOI 10.1007/s11033-011-1026-5; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xiong Y, 2011, BRIT J HAEMATOL, V153, P753, DOI 10.1111/j.1365-2141.2011.08662.x; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhang HL, 2011, BIOCHEM BIOPH RES CO, V404, P273, DOI 10.1016/j.bbrc.2010.11.106; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179; Zhu YD, 2012, MED ONCOL, V29, P2323, DOI 10.1007/s12032-011-0140-5	53	93	101	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56718	10.1371/journal.pone.0056718	http://dx.doi.org/10.1371/journal.pone.0056718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437222	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200152
J	Zou, SQ; Tian, C; Ge, SC; Hu, B				Zou, Suqi; Tian, Chen; Ge, Shuchao; Hu, Bing			Neurogenesis of Retinal Ganglion Cells Is Not Essential to Visual Functional Recovery after Optic Nerve Injury in Adult Zebrafish	PLOS ONE			English	Article							TIME-COURSE ANALYSIS; RETINOTECTAL PROJECTION; INTRAVITREAL INJECTION; AXONAL REGENERATION; ALBINO ZEBRAFISH; GENE-EXPRESSION; MULLER GLIA; STEM-CELLS; SYSTEM; DEATH	Zebrafish central nervous system (CNS) possesses a strong neural regeneration ability to restore visual function completely after optic nerve injury (ONI). However, whether neurogenesis of retinal ganglion cell (RGC) contributes to functional recovery remains controversial. Our quantitative analysis of RGCs in different ONI models showed that almost all RGCs survived in optic nerve crush (ONC) model; while over 90% of RGCs survived in the first 2 weeks with 75% remaining after 7 weeks in optic nerve transection (ONT) model. Retrograde labeling from tectum revealed a surprising regeneration rate, with over 90% and over 50% of RGCs regrowing axons to tectum at the first week in ONC and ONT model respectively. In the latter one, the number of regenerative RGCs after 4 weeks had no significant difference from the control group. As for neurogenesis, newborn RGCs were rarely detected either by double retrograde labeling or BrdU marker. Since few RGCs died, microglia number showed a temporary increase at 3 days post injury (dpi) and a decrease at 14 dpi. Finally, myelin structure within retina kept integrity and optomotor response (OMR) test demonstrated visual functional restoration at 5 weeks post injury (wpi). In conclusion, our results have directly shown that RGC survival and axon regrowth are responsible for functional recovery after ONI in adult zebrafish.	[Zou, Suqi; Tian, Chen; Ge, Shuchao; Hu, Bing] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hu, B (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China.	bhu@ustc.edu.cn	zou, suqi/AAI-9868-2021; hu, bing/B-1030-2010	hu, bing/0000-0001-8627-5272; Zou, Suqi/0000-0001-6816-6400; Ge, Shuchao/0000-0002-6590-9050	973 MOST grant [2011CB504402]; National Natural Science Foundation of China [30870950]; "Hundred Talents Project" of the Chinese Academy of Science	973 MOST grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talents Project" of the Chinese Academy of Science	This project is supported by 973 MOST grant (Grant No. 2011CB504402), National Natural Science Foundation of China (Grant No. 30870950) and the "Hundred Talents Project" of the Chinese Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo M, 2008, MOL VIS, V14, P1050; Ajuebor MN, 1998, IMMUNOLOGY, V95, P625; Bakken TE, 2012, J COMP NEUROL, V520, P142, DOI 10.1002/cne.22704; Beaver RS, 2001, VISION RES, V41, P1765, DOI 10.1016/S0042-6989(01)00053-0; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2007, J NEUROSCI RES, V85, P2793, DOI 10.1002/jnr.21121; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Callahan MP, 2007, VISUAL NEUROSCI, V24, P309, DOI 10.1017/S0952523807070289; Comyn O, 2010, CURR OPIN NEUROL, V23, P4, DOI 10.1097/WCO.0b013e3283352f96; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Germain F, 2004, EXP EYE RES, V78, P95, DOI 10.1016/j.exer.2003.09.012; Huang Yu-Bin, 2012, Yichuan, V34, P1193, DOI 10.3724/SP.J.1005.2012.01193; HUMPHREY MF, 1985, J COMP NEUROL, V236, P382, DOI 10.1002/cne.902360307; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Jeon GS, 2004, BRAIN RES, V1023, P15, DOI 10.1016/j.brainres.2004.01.093; Kaneda M, 2008, NEUROSCI RES, V61, P281, DOI 10.1016/j.neures.2008.03.008; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kato S, 1999, NEUROSCIENCE, V93, P907, DOI 10.1016/S0306-4522(99)00202-X; Kustermann S, 2008, CELL TISSUE RES, V332, P195, DOI 10.1007/s00441-008-0589-5; Lang DM, 2002, J NEUROBIOL, V52, P322, DOI 10.1002/neu.10099; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li L, 2000, J NEUROSCI, V20, P1883; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Lillo C, 2002, J HISTOCHEM CYTOCHEM, V50, P1289, DOI 10.1177/002215540205001002; Liu Q., 2003, Methods in Cell Science, V25, P71, DOI 10.1023/B:MICS.0000006854.18378.fc; Mack AF, 2007, NEUROSCIENCE, V144, P1004, DOI 10.1016/j.neuroscience.2006.10.029; Marcus RC, 1999, VISUAL NEUROSCI, V16, P417, DOI 10.1017/S095252389916303X; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Morcos Y, 1997, GLIA, V21, P163, DOI 10.1002/(SICI)1098-1136(199710)21:2<163::AID-GLIA1>3.3.CO;2-N; MUCHNICK N, 1980, EXP NEUROL, V68, P205, DOI 10.1016/0014-4886(80)90079-5; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Paulsen UJ, 2010, EXP EYE RES, V90, P514, DOI 10.1016/j.exer.2010.01.002; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Rodger J, 2005, MOL CELL NEUROSCI, V30, P452, DOI 10.1016/j.mcn.2005.08.009; SCALIA F, 1985, BRAIN RES, V344, P267, DOI 10.1016/0006-8993(85)90804-2; SCHWALB JM, 1995, J NEUROSCI, V15, P5514; Schweitzer J, 2007, MOL CELL NEUROSCI, V35, P194, DOI 10.1016/j.mcn.2007.02.018; Seo JH, 2001, J NEUROSCI RES, V65, P173, DOI 10.1002/jnr.1140; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Tokuoka H, 2002, J NEUROSCI, V22, P10324; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Vihtelic TS, 2006, EXP EYE RES, V82, P558, DOI 10.1016/j.exer.2005.08.015; Watanabe M, 2001, VISUAL NEUROSCI, V18, P137, DOI 10.1017/S0952523801181137; Wyatt C, 2010, J NEUROSCI, V30, P13838, DOI 10.1523/JNEUROSCI.3846-10.2010; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yin YQ, 2003, J NEUROSCI, V23, P2284; You SW, 2000, INVEST OPHTH VIS SCI, V41, P3165; Yurco P, 2005, VISION RES, V45, P991, DOI 10.1016/j.visres.2004.10.022; Zhou Lan Xia, 2002, Shi Yan Sheng Wu Xue Bao, V35, P159; Zou Su-Qi, 2010, J Vis Exp, DOI 10.3791/1742	62	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57280	10.1371/journal.pone.0057280	http://dx.doi.org/10.1371/journal.pone.0057280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437359	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200235
J	Bourquin, Y; Cooper, JM				Bourquin, Yannyk; Cooper, Jonathan M.			Swimming Using Surface Acoustic Waves	PLOS ONE			English	Article							MOTOR	Microactuation of free standing objects in fluids is currently dominated by the rotary propeller, giving rise to a range of potential applications in the military, aeronautic and biomedical fields. Previously, surface acoustic waves (SAWs) have been shown to be of increasing interest in the field of microfluidics, where the refraction of a SAW into a drop of fluid creates a convective flow, a phenomenon generally known as SAW streaming. We now show how SAWs, generated at microelectronic devices, can be used as an efficient method of propulsion actuated by localised fluid streaming. The direction of the force arising from such streaming is optimal when the devices are maintained at the Rayleigh angle. The technique provides propulsion without any moving parts, and, due to the inherent design of the SAW transducer, enables simple control of the direction of travel.	[Bourquin, Yannyk; Cooper, Jonathan M.] Univ Glasgow, Div Biomed Engn, Glasgow, Lanark, Scotland	University of Glasgow	Cooper, JM (corresponding author), Univ Glasgow, Div Biomed Engn, Glasgow, Lanark, Scotland.	Jon.Cooper@glasgow.ac.uk	Cooper, Jonathan/GLS-9195-2022; Cooper, Jonathan/E-9000-2010; Bourquin, Yannyk/E-5213-2010	Cooper, Jonathan/0000-0002-2358-1050; Cooper, Jonathan/0000-0002-2358-1050; Bourquin, Yannyk/0000-0003-0278-1640	RCUK "Listening to the Microworld" Basic Technology Grant; RCUK School of Engineering Scholarship; Engineering and Physical Sciences Research Council [EP/F040857/1] Funding Source: researchfish; EPSRC [EP/F040857/1] Funding Source: UKRI	RCUK "Listening to the Microworld" Basic Technology Grant; RCUK School of Engineering Scholarship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank RCUK "Listening to the Microworld" Basic Technology Grant and School of Engineering Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EM, 2008, J PROPUL POWER, V24, P547, DOI 10.2514/1.30044; Bourquin Y, 2011, LAB CHIP, V11, P2725, DOI 10.1039/c1lc20320g; Bourquin Y, 2011, ADV MATER, V23, P1458, DOI 10.1002/adma.201004455; Bourquin Y, 2010, LAB CHIP, V10, P1898, DOI 10.1039/c004506c; ECKART C, 1948, PHYS REV, V73, P68, DOI 10.1103/PhysRev.73.68; Ehlers KM, 1996, P NATL ACAD SCI USA, V93, P8340, DOI 10.1073/pnas.93.16.8340; Ehlers KM, 2011, MATH COMPUT MODEL, V53, P1489, DOI 10.1016/j.mcm.2010.03.054; Friend J, 2011, REV MOD PHYS, V83, P647, DOI 10.1103/RevModPhys.83.647; Hori K, 1997, INT J JPN S PREC ENG, V31, P1; Kurosawa M, 1996, IEEE T ULTRASON FERR, V43, P901, DOI 10.1109/58.535493; LIGHTHILL J, 1978, J SOUND VIB, V61, P391, DOI 10.1016/0022-460X(78)90388-7; Nyborg, 1965, PHYS ACOUSTICS, V2; Sankaranarayanan SKRS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066308; SHIOKAWA S, 1989, IEEE 1989 ULTRASONICS SYMPOSIUM : PROCEEDINGS, VOLS 1 AND 2, P643, DOI 10.1109/ULTSYM.1989.67063; Sinclair MJ, 2000, ITHERM 2000: SEVENTH INTERSOCIETY CONFERENCE ON THERMAL AND THERMOMECHANICAL PHENOMENA IN ELECTRONIC SYSTEMS, VOL I, PROCEEDINGS, P127, DOI 10.1109/ITHERM.2000.866818; Su YC, 2002, J MICROELECTROMECH S, V11, P736, DOI 10.1109/JMEMS.2002.805045; TAI YC, 1989, SENSOR ACTUATOR, V20, P49, DOI 10.1016/0250-6874(89)87101-X; Tan ACH, 2010, OCEANS 2010, P1; Tan MK, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.024501; Watson B, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/2/022001; Wixforth A., 2006, J ASS LAB AUTOM, V11, P399, DOI DOI 10.1016/J.JALA.2006.08.001; Yu HY, 2004, PROC IEEE MICR ELECT, P486, DOI 10.1109/MEMS.2004.1290628	22	14	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e42686	10.1371/journal.pone.0042686	http://dx.doi.org/10.1371/journal.pone.0042686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431358	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000315182800001
J	Kitagawa, M; Sugiyama, H; Morinaga, H; Inoue, T; Takiue, K; Ogawa, A; Yamanari, T; Kikumoto, Y; Uchida, HA; Kitamura, S; Maeshima, Y; Nakamura, K; Ito, H; Makino, H				Kitagawa, Masashi; Sugiyama, Hitoshi; Morinaga, Hiroshi; Inoue, Tatsuyuki; Takiue, Keiichi; Ogawa, Ayu; Yamanari, Toshio; Kikumoto, Yoko; Uchida, Haruhito Adam; Kitamura, Shinji; Maeshima, Yohei; Nakamura, Kazufumi; Ito, Hiroshi; Makino, Hirofumi			A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							IMPROVING GLOBAL OUTCOMES; COMMUNITY-DWELLING ADULTS; FLOW-MEDIATED DILATION; PULSE-WAVE VELOCITY; STAGE RENAL-DISEASE; GROWTH-FACTOR 23; ENDOTHELIAL DYSFUNCTION; AORTIC CALCIFICATION; PLASMA KLOTHO; ALPHA-KLOTHO	Background: Klotho was originally identified in a mutant mouse strain unable to express the gene that consequently showed shortened life spans. In humans, low serum Klotho levels are related to the prevalence of cardiovascular diseases in community-dwelling adults. However, it is unclear whether the serum Klotho levels are associated with signs of vascular dysfunction such as arterial stiffness, a major determinant of prognosis, in human subjects with chronic kidney disease (CKD). Methods: We determined the levels of serum soluble Klotho in 114 patients with CKD using ELISA and investigated the relationship between the level of Klotho and markers of CKD-mineral and bone disorder (CKD-MBD) and various types of vascular dysfunction, including flow-mediated dilatation, a marker of endothelial dysfunction, ankle-brachial pulse wave velocity (baPWV), a marker of arterial stiffness, intima-media thickness (IMT), a marker of atherosclerosis, and the aortic calcification index (ACI), a marker of vascular calcification. Results: The serum Klotho level significantly correlated with the 1,25-dihydroxyvitamin D level and inversely correlated with the parathyroid hormone level and the fractional excretion of phosphate. There were significant decreases in serum Klotho in patients with arterial stiffness defined as baPWV >= 1400 cm/sec, atherosclerosis defined as maximum IMT >= 1.1 mm and vascular calcification scores of ACI>0%. The serum Klotho level was a significant determinant of arterial stiffness, but not endothelial dysfunction, atherosclerosis or vascular calcification, in the multivariate analysis in either metabolic model, the CKD model or the CKD-MBD model. The adjusted odds ratio of serum Klotho for the baPWV was 0.60 (p = 0.0075). Conclusions: Decreases in the serum soluble Klotho levels are independently associated with signs of vascular dysfunction such as arterial stiffness in patients with CKD. Further research exploring whether therapeutic approaches to maintain or elevate the Klotho level could improve arterial stiffness in CKD patients is warranted.	[Kitagawa, Masashi; Sugiyama, Hitoshi; Morinaga, Hiroshi; Inoue, Tatsuyuki; Takiue, Keiichi; Ogawa, Ayu; Yamanari, Toshio; Kikumoto, Yoko; Uchida, Haruhito Adam; Kitamura, Shinji; Maeshima, Yohei; Makino, Hirofumi] Okayama Univ, Dept Med & Clin Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Sugiyama, Hitoshi; Morinaga, Hiroshi] Okayama Univ, Dept Chron Kidney Dis & Peritoneal Dialysis, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Dept Cardiovasc Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Sugiyama, H (corresponding author), Okayama Univ, Dept Med & Clin Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	hitoshis@md.okayama-u.ac.jp	Sugiyama, Hitoshi/B-2252-2011	Sugiyama, Hitoshi/0000-0002-4127-6471	Kidney Foundation Japan [JKFB10-20, JKFB12-44]; Chronic Kidney Disease Award; Japan Vascular Disease Research Foundation; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [23591193] Funding Source: KAKEN	Kidney Foundation Japan(Kidney Foundation, Japan); Chronic Kidney Disease Award; Japan Vascular Disease Research Foundation(Japan Vascular Disease Research Foundation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A portion of this study was supported by a Research Grant from the Kidney Foundation Japan (JKFB10-20 and JKFB12-44) and a 2011 Chronic Kidney Disease Award to M. K., a Research Grant from the Japan Vascular Disease Research Foundation to H. S. and a Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akimoto T, 2012, CLIN EXP NEPHROL, V16, P442, DOI 10.1007/s10157-011-0582-2; Asai O, 2012, KIDNEY INT, V81, P539, DOI 10.1038/ki.2011.423; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Briet M, 2006, KIDNEY INT, V69, P350, DOI 10.1038/sj.ki.5000047; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chue CD, 2012, HEART, V98, P219, DOI 10.1136/heartjnl-2011-300570; Desjardins L, 2012, OSTEOPOROSIS INT, V23, P2017, DOI 10.1007/s00198-011-1838-0; Devaraj S, 2012, AM J CLIN PATHOL, V137, P479, DOI 10.1309/AJCPGPMAF7SFRBO4; Di Marco GS, 2012, KIDNEY INT; Ford ML, 2012, NEPHROL DIAL TRANSPL, V27, P727, DOI 10.1093/ndt/gfr316; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guerin AP, 2001, CIRCULATION, V103, P987; Hanada S, 2010, NEPHROL DIAL TRANSPL, V25, P1888, DOI 10.1093/ndt/gfp728; HANDA N, 1990, STROKE, V21, P1567, DOI 10.1161/01.STR.21.11.1567; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kidney Disease: Improving Global Outcomes, 2009, KIDNEY INT S, pS1, DOI DOI 10.1038/KI.2009.188; Kidney Disease Outcomes Quality Initiative (K/DOQI), 2004, Am J Kidney Dis, V43, pS1; Kitagawa M, 2011, NEPHRON EXTRA, V1, P166, DOI 10.1159/000333801; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Komaba H, 2012, NEPHROL DIAL TRANSPL, V27, P1967, DOI 10.1093/ndt/gfr645; Kramann R, 2011, ARTERIOSCL THROM VAS, V31, pE45, DOI 10.1161/ATVBAHA.111.228601; Kuro-O M, 2011, KIDNEY INT, V79, pS20, DOI 10.1038/ki.2011.26; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Kuwahara N, 2008, INT J CARDIOL, V123, P84, DOI 10.1016/j.ijcard.2007.02.029; Lau WL, 2012, KIDNEY INT, V82, P1261, DOI 10.1038/ki.2012.322; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; London GM, 2007, J AM SOC NEPHROL, V18, P613, DOI 10.1681/ASN.2006060573; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Moe SM, 2008, CLIN J AM SOC NEPHRO, V3, pS127, DOI 10.2215/CJN.04331206; Morimoto S, 2009, AM J NEPHROL, V30, P55, DOI 10.1159/000201416; Morinaga H, 2012, PERITON DIALYSIS INT, V32, P453, DOI 10.3747/pdi.2011.00032; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; Nakano C, 2012, CLIN J AM SOC NEPHRO, V7, P810, DOI 10.2215/CJN.08680811; Ohya M, 2010, INTERNAL MED, V49, P2071, DOI 10.2169/internalmedicine.49.3752; Rosa J, 2011, HYPERTENS RES, V34, P296, DOI 10.1038/hr.2010.232; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schillaci G, 2011, ATHEROSCLEROSIS, V218, P96, DOI 10.1016/j.atherosclerosis.2011.05.010; Seiler S, 2012, KIDNEY INT; Semba RD, 2012, EUR J APPL PHYSIOL, V112, P1215, DOI 10.1007/s00421-011-2072-3; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Semba RD, 2011, J GERONTOL A-BIOL, V66, P794, DOI 10.1093/gerona/glr058; Shimamura Y, 2012, CLIN EXP NEPHROL, V16, P722, DOI 10.1007/s10157-012-0621-7; Six I, 2012, CARDIOVASC RES, V96, P130, DOI 10.1093/cvr/cvs240; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Teragawa H, 2001, AM J CARDIOL, V88, P1147, DOI 10.1016/S0002-9149(01)02051-3; Townsend RR, 2010, AM J HYPERTENS, V23, P282, DOI 10.1038/ajh.2009.240; Uchida HA, 2006, NEPHROL DIAL TRANSPL, V21, P3475, DOI 10.1093/ndt/gfl423; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194; Yokoyama K, 2012, CLIN NEPHROL, V77, P347, DOI 10.5414/CN107204; Yoon HE, 2011, NEPHROL DIAL TRANSPL, V26, P800, DOI 10.1093/ndt/gfq537; Yunoki K, 2011, ATHEROSCLEROSIS, V217, P486, DOI 10.1016/j.atherosclerosis.2011.04.019	72	138	144	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56695	10.1371/journal.pone.0056695	http://dx.doi.org/10.1371/journal.pone.0056695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431388	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800031
J	Lim, SG; Venkatraman, SS; Burnett, JC; Chen, HH				Lim, Soo Ghim; Venkatraman, Subbu S.; Burnett, John C., Jr.; Chen, Horng H.			In-Vivo Evaluation of an In Situ Polymer Precipitation Delivery System for a Novel Natriuretic Peptide	PLOS ONE			English	Article							PHASE INVERSION DYNAMICS; DRUG-DELIVERY; ATRIAL; NESIRITIDE; LEUPROLIDE; EFFICACY; IMPLANT	This study reports on the release of a novel natriuretic peptide, CD-NP, from an in situ polymer precipitation delivery system. Following extensive screening of in-vitro release profiles, an in-vivo evaluation of the efficacy of the delivery system was carried out in Wistar rats. Gel injection was performed subcutaneously on the back of the rats. A secondary messenger, cyclic Guanosine 3'5' Monophosphate (cGMP), was tested for verification of CD-NP bioactivity, in addition to direct measurements of CD-NP levels in plasma and urine using a radio-immuno assay. Plasma evaluation showed an elevated level of CD-NP over 3 weeks' duration. Unexpectedly, plasma cGMP level followed a decreasing trend over the same duration despite high CD-NP level. Loss of drug bioactivity was ruled out as a high level of CD-NP and cGMP excretion was observed in the treatment group as compared to baseline readings. This unexpected low-plasma cGMP levels and high-urinary cGMP excretion suggest that there might be other compensatory responses to regulation of the CDNP bioactivity as a result of the high drug dosing. The results stress the importance of assessing the overall bioactivity of released drug (in-vivo) concurrently in addition to measuring its concentrations, to determine the correct release profile.	[Lim, Soo Ghim; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Burnett, John C., Jr.; Chen, Horng H.] Mayo Clin, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Mayo Clinic	Chen, HH (corresponding author), Mayo Clin, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA.	chen.horng@mayo.edu	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070	National Institute of Health [RO1 HL36634, R01 HL83231, HL101439, PO1 HL76611]; Mayo Foundation; National Research Foundation - Competitive Research Programme; Singapore Economic Development Board - The Strategic Attachment and Training Programme; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101439, P01HL076611, R01HL036634, R01HL083231] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; National Research Foundation - Competitive Research Programme; Singapore Economic Development Board - The Strategic Attachment and Training Programme; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following grants: The National Institute of Health, http://www.nih.gov/(RO1 HL36634, R01 HL83231, HL101439-and PO1 HL76611); The Mayo Foundation, http://www.mayoclinic.com/; The National Research Foundation - Competitive Research Programme, http://www.nrf.gov.sg/; Singapore Economic Development Board - The Strategic Attachment and Training Programme, www.edb.gov.sg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson B, 1994, ARBETE OCH HALSA, P1; Andersen F, 2003, INT J TOXICOLOGY; Arora RR, 2006, AM HEART J, V152, P1084, DOI 10.1016/j.ahj.2006.07.002; Brodbeck KJ, 1999, J CONTROL RELEASE, V62, P333, DOI 10.1016/S0168-3659(99)00159-5; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; CLAVELL AL, 1993, AM J PHYSIOL, V264, pR290, DOI 10.1152/ajpregu.1993.264.2.R290; Del Ry S, 2005, CLIN CHEM LAB MED, V43, P641, DOI 10.1515/CCLM.2005.110; Dickey DM, 2008, J BIOL CHEM, V283, P35003, DOI 10.1074/jbc.M804538200; Dunn R.L., 1990, US Patent, Patent No. [4 938 763, 4938763, US patent no. 4,938,763]; Evans D, 2012, US Patent, Patent No. [us 20120178689, 20120178689]; Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8; Horio T, 2003, ENDOCRINOLOGY, V144, P2279, DOI 10.1210/en.2003-0128; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Igaki T, 1998, HYPERTENS RES-CLIN E, V21, P7, DOI 10.1291/hypres.21.7; Kim TK, 2002, J PHARM PHARMACOL, V54, P897, DOI 10.1211/002235702760089009; Kohzu H, 2007, J CARD FAIL, V13, pS40; La Villa G, 1998, CLIN SCI, V95, P595; Lee CYW, 2007, HEART FAIL REV, V12, P131, DOI 10.1007/s10741-007-9016-3; LEE KP, 1987, FUND APPL TOXICOL, V9, P222, DOI 10.1016/0272-0590(87)90045-5; Lisy O, 2003, J AM COLL CARDIOL, V41, p312A; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McKie Paul M, 2010, Curr Heart Fail Rep, V7, P93, DOI 10.1007/s11897-010-0016-6; MISONO KS, 1984, BIOCHEM BIOPH RES CO, V123, P444, DOI 10.1016/0006-291X(84)90250-X; Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/j.ejpb.2004.03.003; Peacock WF, 2004, J CARD FAIL, V10, P120, DOI 10.1016/j.cardfail.2003.08.012; Ravivarapu HB, 2000, INT J PHARM, V194, P181, DOI 10.1016/S0378-5173(99)00371-3; Royals MA, 1999, J BIOMED MATER RES, V45, P231, DOI 10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H; Sartor O, 2003, UROLOGY, V61, P25, DOI 10.1016/S0090-4295(02)02396-8; Sartor O, 2006, EUR UROL SUPPL, V5, P905, DOI 10.1016/j.eursup.2006.08.006; Shah SJ, 2010, J CARD FAIL, V16, P720, DOI 10.1016/j.cardfail.2010.04.008; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; Wei CM, 1993, AM J PHYSL HEART CIR, P264	33	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e52484	10.1371/journal.pone.0052484	http://dx.doi.org/10.1371/journal.pone.0052484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441143	gold, Green Published			2022-12-27	WOS:000315159200001
J	Caravagna, G; Mauri, G; d'Onofrio, A				Caravagna, Giulio; Mauri, Giancarlo; d'Onofrio, Alberto			The Interplay of Intrinsic and Extrinsic Bounded Noises in Biomolecular Networks	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; GENE-EXPRESSION; PERIODIC PERTURBATION; PROTEIN EXPRESSION; POSITIVE-FEEDBACK; SWITCHES; FLUCTUATIONS; MULTISTABILITY; BISTABILITY; SUPPRESSION	After being considered as a nuisance to be filtered out, it became recently clear that biochemical noise plays a complex role, often fully functional, for a biomolecular network. The influence of intrinsic and extrinsic noises on biomolecular networks has intensively been investigated in last ten years, though contributions on the co-presence of both are sparse. Extrinsic noise is usually modeled as an unbounded white or colored gaussian stochastic process, even though realistic stochastic perturbations are clearly bounded. In this paper we consider Gillespie-like stochastic models of nonlinear networks, i.e. the intrinsic noise, where the model jump rates are affected by colored bounded extrinsic noises synthesized by a suitable biochemical state-dependent Langevin system. These systems are described by a master equation, and a simulation algorithm to analyze them is derived. This new modeling paradigm should enlarge the class of systems amenable at modeling. We investigated the influence of both amplitude and autocorrelation time of a extrinsic Sine-Wiener noise on: (i) the Michaelis-Menten approximation of noisy enzymatic reactions, which we show to be applicable also in co-presence of both intrinsic and extrinsic noise, (ii) a model of enzymatic futile cycle and (iii) a genetic toggle switch. In (ii) and (iii) we show that the presence of a bounded extrinsic noise induces qualitative modifications in the probability densities of the involved chemicals, where new modes emerge, thus suggesting the possible functional role of bounded noises.	[Caravagna, Giulio; Mauri, Giancarlo] Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz, Milan, Italy; [d'Onofrio, Alberto] European Inst Oncol, Dept Expt Oncol, Milan, Italy	University of Milano-Bicocca; IRCCS European Institute of Oncology (IEO)	d'Onofrio, A (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.	alberto.donofrio@ieo.eu	Caravagna, Giulio/F-5011-2015; Mauri, Giancarlo/M-3258-2013; d'Onofrio, Alberto/R-4683-2016	Caravagna, Giulio/0000-0003-4240-3265; Mauri, Giancarlo/0000-0003-3520-4022; d'Onofrio, Alberto/0000-0002-2190-272X				ALFONSI A, 2005, ESAIM P, V14, P1, DOI DOI 10.1051/PROC:2005001; Alfonsi A., 2004, RR5435 INRIA; Alon U., 2006, INTRO SYSTEMS BIOL D; Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bena I, 2006, INT J MOD PHYS B, V20, P2825, DOI 10.1142/S0217979206034881; Bobryk RV, 2005, PHYSICA A, V358, P263, DOI 10.1016/j.physa.2005.03.055; Bouzas PR, 2007, COMPUTATION STAT, V22, P467, DOI 10.1007/s00180-007-0052-1; Cai GQ, 1996, PHYS REV E, V54, P299, DOI 10.1103/PhysRevE.54.299; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cao Y, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1824902, 10.1063/1.1924598]; Caravagna G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S8; Caravagna G, 2010, J THEOR BIOL, V265, P336, DOI 10.1016/j.jtbi.2010.05.013; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chen L, 2009, BIOMOLECULAR NETWORK; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; COX DR, 1955, J ROY STAT SOC B, V17, P129; d'Onofrio A, BOUNDED STOCHASTIC P; d'Onofrio A, 2013, ADV EXP MED BIOL, V734, P111, DOI 10.1007/978-1-4614-1445-2_7; d'Onofrio A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061901; d'Onofrio A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021923; Daley D.J., 2003, INTRO THEORY POINT P, V2nd ed; de Franciscis S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021118; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Doob JL, 1942, T AM MATH SOC, V52, P37, DOI 10.2307/1990152; DOOB JL, 1945, T AM MATH SOC, V58, P455, DOI 10.2307/1990339; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feller W, 1940, T AM MATH SOC, V48, P488, DOI 10.2307/1990095; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie D., 2006, SYSTEMS MODELLING CE, P331, DOI DOI 10.7551/MITPRESS/9780262195485.003.0016; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1980, J CHEM PHYS, V72, P5363, DOI 10.1063/1.439029; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; GRABERT H, 1983, PHYSICA A, V117, P300, DOI 10.1016/0378-4371(83)90119-X; GRIFFITH JS, 1968, J THEOR BIOL, V20, P209, DOI 10.1016/0022-5193(68)90190-2; Hallen M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002209; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Horsthemke W., 1984, NOISE INDUCED TRANSI; Iglesias PA., 2010, CONTROL THEORY SYSTE; Junker B. H., 2008, WILEY SERIES BIOINFO; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kolmogoroff A, 1931, MATH ANN, V104, P415, DOI 10.1007/BF01457949; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mateescu M, 2010, IET SYST BIOL, V4, P441, DOI 10.1049/iet-syb.2010.0005; Murray J. D., 2002, MATH BIOL; Nacher JC, 2011, OPEN BIOINF J, V5, P34; NoisySIM, 2012, NOISYSIM; Paulsson BO, 2011, SYSTEMS BIOL SIMULAT; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; RIGNEY DR, 1977, J THEOR BIOL, V69, P761, DOI 10.1016/0022-5193(77)90381-2; Rigney DR, 1979, KINETIC LOGIC BOOLEA; Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Sanft KR, 2011, IET SYST BIOL, V5, P58, DOI 10.1049/iet-syb.2009.0057; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Siegal-Gaskins D, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-96; SIMON Z, 1965, J THEOR BIOL, V8, P258, DOI 10.1016/0022-5193(65)90076-7; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Stratonovich RL, 1963, TOPICS THEORY RANDOM, V1; Sugita M, 1964, J TH BIO, V4, P437; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; Todorovic P, 1992, SPRINGER SERIES STAT; Tomas R, 1990, BIOL FEEDBACKS; Tze-Leung T, 2010, SCIENCE, V327, P1142; Ullah M, 2011, STOCHASTIC APPROACHES FOR SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4614-0478-1; Voet D, 1999, FOUNDAMENTALS BIOCH; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Wilkinson U, 2006, STOCHASTIC MODELLING; Wio HS, 2004, PHYSICA D, V193, P161, DOI 10.1016/j.physd.2004.01.017; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Zhdanov VP, 2012, CHAOS SOLITON FRACT, V45, P577, DOI 10.1016/j.chaos.2011.12.008; Zhdanov VP, 2011, PHYSICA A, V390, P57, DOI 10.1016/j.physa.2010.03.036; Zhdanov VP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/6/065102	95	30	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e51174	10.1371/journal.pone.0051174	http://dx.doi.org/10.1371/journal.pone.0051174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437034	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000001
J	Liu, ZP; Ma, LC; Nan, ZB; Wang, YR				Liu, Zhipeng; Ma, Lichao; Nan, Zhibiao; Wang, Yanrong			Comparative Transcriptional Profiling Provides Insights into the Evolution and Development of the Zygomorphic Flower of Vicia sativa (Papilionoideae)	PLOS ONE			English	Article							ORGAN IDENTITY GENES; MADS-BOX GENE; MEDICAGO-TRUNCATULA; EXPRESSION PROFILES; FLORAL DEVELOPMENT; SYMMETRY GENES; PISUM-SATIVUM; COMPOUND LEAF; CLADE GENES; CLASS-B	Background: Vicia sativa (the common vetch) possesses a predominant zygomorphic flower and belongs to the subfamily Papilionoideae, which is related to Arabidopsis thaliana in the eurosid II clade of the core eudicots. Each vetch flower consists of 21 concentrically arranged organs: the outermost five sepals, then five petals and ten stamens, and a single carpel in the center. Methodology/Principal Findings: We explored the floral transcriptome to examine a genome-scale genetic model of the zygomorphic flower of vetch. mRNA was obtained from an equal mixture of six floral organs, leaves and roots. De novo assembly of the vetch transcriptome using Illumina paired-end technology produced 71,553 unigenes with an average length of 511 bp. We then compared the expression changes in the 71,553 unigenes in the eight independent organs through RNA-Seq Quantification analysis. We predominantly analyzed gene expression patterns specific to each floral organ and combinations of floral organs that corresponded to the traditional ABC model domains. Comparative analyses were performed in the floral transcriptomes of vetch and Arabidopsis, and genomes of vetch and Medicago truncatula. Conclusions/Significance: Our comparative analysis of vetch and Arabidopsis showed that the vetch flowers conform to a strict ABC model. We analyzed the evolution and expression of the TCP gene family in vetch at a whole-genome level, and several unigenes specific to three different vetch petals, which might offer some clues toward elucidating the molecular mechanisms underlying floral zygomorphy. Our results provide the first insights into the genome-scale molecular regulatory network that controls the evolution and development of the zygomorphic flower in Papilionoideae.	[Liu, Zhipeng; Ma, Lichao; Nan, Zhibiao; Wang, Yanrong] Lanzhou Univ, Sch Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Liu, ZP (corresponding author), Lanzhou Univ, Sch Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China.	lzp@lzu.edu.cn; yrwang@lzu.edu.cn	liu, zhipeng/HCI-3638-2022; Liu, Zhipeng/E-1532-2014	Liu, Zhipeng/0000-0001-7687-8256	National Basic Research Program of China [2007CB108904]; National Natural Science Foundation of China [31072072, 31272492]; Fundamental Research Funds for the Central Universities [lzujbky-2012-94]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (2007CB108904), the National Natural Science Foundation of China (31072072 and 31272492) and the Fundamental Research Funds for the Central Universities (lzujbky-2012-94). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Ambrose BA, 2000, MOL CELL, V5, P569, DOI 10.1016/S1097-2765(00)80450-5; ANGENENT GC, 1993, PLANT J, V4, P101, DOI 10.1046/j.1365-313X.1993.04010101.x; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Becker A, 2002, MOL GENET GENOMICS, V266, P942, DOI 10.1007/s00438-001-0615-8; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Benlloch R, 2006, PLANT PHYSIOL, V142, P972, DOI 10.1104/pp.106.083543; Benloch R, 2003, SEX PLANT REPROD, V15, P231, DOI 10.1007/s00497-002-0157-1; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Chanderbali AS, 2010, P NATL ACAD SCI USA, V107, P22570, DOI 10.1073/pnas.1013395108; Chanderbali AS, 2009, P NATL ACAD SCI USA, V106, P8929, DOI 10.1073/pnas.0811476106; Citerne HL, 2006, P NATL ACAD SCI USA, V103, P12017, DOI 10.1073/pnas.0600986103; Citerne HL, 2003, PLANT PHYSIOL, V131, P1042, DOI 10.1104/pp.102.016311; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darwin C. R., 1857, GARD CHRON AGR GAZ, V43, P725; De Craene LPR, 2007, ANN BOT-LONDON, V100, P621, DOI 10.1093/aob/mcm076; DERSTINE KS, 1991, AM J BOT, V78, P816, DOI 10.2307/2445073; Domoney C, 2006, CURR OPIN PLANT BIOL, V9, P133, DOI 10.1016/j.pbi.2006.01.014; Dong ZC, 2005, PLANT PHYSIOL, V137, P1272, DOI 10.1104/pp.104.054288; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Endress PK, 2001, INT J PLANT SCI, V162, P1111, DOI 10.1086/321919; Feng XZ, 2006, P NATL ACAD SCI USA, V103, P4970, DOI 10.1073/pnas.0600681103; Ferrandiz C, 1999, DEV GENET, V25, P280, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;280::AID-DVG10&gt;3.0.CO;2-3; Fornara F, 2004, PLANT PHYSIOL, V135, P2207, DOI 10.1104/pp.104.045039; Foucher F, 2003, PLANT CELL, V15, P2742, DOI 10.1105/tpc.015701; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hileman LC, 2003, P NATL ACAD SCI USA, V100, P12814, DOI 10.1073/pnas.1835725100; Hofer J, 1997, CURR BIOL, V7, P581, DOI 10.1016/S0960-9822(06)00257-0; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Howarth DG, 2011, ANN BOT-LONDON, V107, P1521, DOI 10.1093/aob/mcr049; Kang HG, 1998, PLANT MOL BIOL, V38, P1021, DOI 10.1023/A:1006051911291; Kramer EM, 2005, CURR OPIN PLANT BIOL, V8, P13, DOI 10.1016/j.pbi.2004.09.019; Li MN, 2007, PLANT PHYSIOL, V144, P1797, DOI 10.1104/pp.107.101600; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Singer GAC, 2005, MOL BIOL EVOL, V22, P767, DOI 10.1093/molbev/msi062; SOMMER H, 1991, DEVELOPMENT, P169; Song CF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-244; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor SA, 2002, PLANT PHYSIOL, V129, P1150, DOI 10.1104/pp.001677; Tucker SC, 2003, PLANT PHYSIOL, V131, P911, DOI 10.1104/pp.102.017459; Voelckel C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009735; Wang HL, 2008, PLANT PHYSIOL, V146, P1759, DOI 10.1104/pp.108.117044; Wang Z, 2008, P NATL ACAD SCI USA, V105, P10414, DOI 10.1073/pnas.0803291105; Wei LQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-338; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yan J, 2010, PLANT PHYSIOL, V152, P797, DOI 10.1104/pp.109.140947; Yanai I, 2009, GENOME RES, V19, P2214, DOI 10.1101/gr.093815.109; Yang X, 2012, PLANT CELL, V24, P1834, DOI 10.1105/tpc.112.099457; Yoo MJ, 2010, PLANT J, V64, P687, DOI 10.1111/j.1365-313X.2010.04357.x; Yu DY, 1999, PLANT J, V17, P51, DOI 10.1046/j.1365-313X.1999.00351.x; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286; ZACHGO S, 1995, DEVELOPMENT, V121, P2861; Zahn LM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r101; Zhang JZ, 2005, MOL BIOL EVOL, V22, P1147, DOI 10.1093/molbev/msi101; Zhang WH, 2010, P NATL ACAD SCI USA, V107, P6388, DOI 10.1073/pnas.0910155107; Zik M, 2003, PLANT CELL, V15, P207, DOI 10.1105/tpc.006353	73	21	29	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57338	10.1371/journal.pone.0057338	http://dx.doi.org/10.1371/journal.pone.0057338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437373	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000097
J	Lubis, DU; Jaya, ES; Arjadi, R; Hanum, L; Astri, K; Decha, M; Putri, D				Lubis, Dharmayati Utoyo; Jaya, Edo Sebastian; Arjadi, Retha; Hanum, Lathifah; Astri, Kresna; Decha, Maha; Putri, Dwi			Preliminary Study on the Effectiveness of Short Group Cognitive Behavioral Therapy (GCBT) on Indonesian Older Adults	PLOS ONE			English	Article							CHRONIC PAIN; CRITERION VALIDITY; CES-D; DEPRESSION; INSOMNIA; ANXIETY; ACCEPTANCE; SAMPLE; SCALE; QUESTIONNAIRE	This research aims to develop evidence based affordable psychological therapy for Indonesian older adults. An affordable psychological therapy is important as there is virtually no managed care or health insurance that covers psychological therapy in Indonesia. Multicomponent group cognitive behavior therapy (GCBGT) was chosen as a starting point due to its extensive evidence, short sessions, and success for a wide range of psychological problems. The group format was chosen to address both the economic and the cultural context of Indonesia. Then, the developed treatment is tested to common psychological problems in older adults' population (anxiety, chronic pain, depression, and insomnia). The treatment consists of 8 sessions with twice a week meetings for 2.5 hours. There are similarities and differences among the techniques used in the treatment for the different psychological problems. The final participants are 38 older adults that are divided into the treatment groups; 8 participants joined the anxiety treatment, 10 participants for the chronic pain treatment, 10 participants for depression treatment, and lastly, 10 participants joined the insomnia treatment. The research design is pre-test post-test with within group analysis. We used principal outcome measure that is specific for each treatment group, as well as additional outcome measures. Overall, the result shows statistical significance change with large effect size for the principal outcome measure. In addition, the result for the additional measures varies from slight improvement with small effect size to statistically significant improvement with large effect size. The result indicates that short multicomponent GCBT is effective in alleviating various common psychological problems in Indonesian older adults. Therefore, multicomponent GCBT may be a good starting point to develop an effective and affordable psychological therapy for Indonesian older adults. Lastly, this result adds to the accumulating body of evidence on the effectiveness of multicomponent GCBT outside western context.	[Lubis, Dharmayati Utoyo; Jaya, Edo Sebastian; Arjadi, Retha; Hanum, Lathifah; Astri, Kresna; Decha, Maha; Putri, Dwi] Univ Indonesia, Fac Psychol, Depok, Indonesia	University of Indonesia	Jaya, ES (corresponding author), Univ Indonesia, Fac Psychol, Depok, Indonesia.	edojaya@hotmail.com	Jaya, Edo S./K-8961-2016	Jaya, Edo S./0000-0002-7232-6312; Hanum, Lathifah/0000-0003-1771-335X	Research and Public Service Directorate, University of Indonesia	Research and Public Service Directorate, University of Indonesia	This study is funded by the Research and Public Service Directorate, University of Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Badan Pusat Statistik, 2010, STAT PEND LANJ US IN, p[36, 186]; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck J, 2020, COGNITIVE BEHAV THER, V3rd; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Boswell E B, 1996, Am J Med, V101, p3S, DOI 10.1016/S0002-9343(96)00392-0; Butler AC, 2000, J NORWEGIAN PSYCHOL, V37, P1; Carvalho JP, 2011, J BEHAV THER EXP PSY, V42, P154, DOI 10.1016/j.jbtep.2010.10.001; Cohen CI, 2006, PSYCHIAT SERV, V57, P1719, DOI 10.1176/appi.ps.57.12.1719; Cohen J.E., 1988, STAT POWER ANAL BEHA; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Efron B, 2003, STAT SCI, V18, P135, DOI 10.1214/ss/1063994968; Fish RA, 2010, PAIN, V149, P435, DOI 10.1016/j.pain.2009.12.016; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Fujisawa D, 2010, BMC RES NOTES, V3; Goodwin R, 2003, J CROSS CULT PSYCHOL, V34, P240, DOI 10.1177/0022022102250227; Greenhoot AF, 2003, HDB RES METHODS CLIN; Hamilton NA, 2007, J CONSULT CLIN PSYCH, V75, P939, DOI 10.1037/0022-006X.75.6.939; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Jansson-Frojmark M, 2008, J PSYCHOSOM RES, V64, P443, DOI 10.1016/j.jpsychores.2007.10.016; Jeon ST, 2010, J EXP CHILD PSYCHOL, V107, P423, DOI 10.1016/j.jecp.2010.05.009; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Karlson CW, 2012, HLTH PSYCHO IN PRESS; Kley H, 2012, J BEHAV THER EXP PSY, V43, P548, DOI 10.1016/j.jbtep.2011.07.008; Knight BG, 2006, HDB PSYCHOL AGING; Laidlaw K., 2003, COGNITIVE BEHAV THER; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CME, 2004, INSOMNIA CLIN GUIDE; Mukhtar F, 2011, ASEAN J PSYCHIATR, V12, P50; Naeem F, 2011, BEHAV COGN PSYCHOTH, V39, P165, DOI 10.1017/S1352465810000822; Poedjiastutie D, 2009, TEFLIN J, V20, P25, DOI DOI 10.15639/TEFLINJOURNAL.V20I1/25-36; Pomerantz AM, 2011, CLIN PSYCHOL SCI PRA; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Slade M, 2010, BMC HLTH SERVICES RE, V10; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Suseno FM, 1988, ETIKA JAWA SEBUAH AN; Suwantara JR, 2005, BECK DEPRESSION INVE, V12, P69; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Tluczek A, 2009, J NURS MEAS, V17, P19, DOI 10.1891/1061-3749.17.1.19; Vowles KE, 2008, J CONSULT CLIN PSYCH, V76, P397, DOI 10.1037/0022-006X.76.3.397; Weingarden H, 2011, INT J COGN THER, V4, P381, DOI 10.1521/ijct.2011.4.4.381; Won AB, 2004, J AM GERIATR SOC, V52, P867, DOI 10.1111/j.1532-5415.2004.52251.x; Wong DFK, 2008, DEPRESS ANXIETY, V25, P142, DOI 10.1002/da.20286; Wright D.B., 2011, J EXPER PSYCHOPATHOL, V2, P252, DOI [10.5127/jep.013611, DOI 10.5127/JEP.013611]	54	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57198	10.1371/journal.pone.0057198	http://dx.doi.org/10.1371/journal.pone.0057198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437339	Green Published, gold			2022-12-27	WOS:000315186000083
J	Rolo, D; Simoes, AS; Domenech, A; Fenoll, A; Linares, J; de Lencastre, H; Ardanuy, C; Sa-Leao, R				Rolo, Dora; Simoes, Alexandra S.; Domenech, Arnau; Fenoll, Asuncion; Linares, Josefina; de Lencastre, Herminia; Ardanuy, Carmen; Sa-Leao, Raquel			Disease Isolates of Streptococcus pseudopneumoniae and Non-Typeable S. pneumoniae Presumptively Identified as Atypical S. pneumoniae in Spain	PLOS ONE			English	Article							VIRIDANS GROUP STREPTOCOCCI; PNEUMOCOCCAL STRAINS; MITIS; SEROTYPES; SEQUENCE; SAMPLES; GENE; LYTA; DISCRIMINATION; RESISTANCE	We aimed to obtain insights on the nature of a collection of isolates presumptively identified as atypical Streptococcus pneumoniae recovered from invasive and non-invasive infections in Spain. One-hundred and thirty-two isolates were characterized by: optochin susceptibility in ambient and CO2-enriched atmosphere; bile solubility; PCR-based assays targeting pneumococcal genes lytA, ply, pspA, cpsA, Spn9802, aliB-like ORF2, and a specific 16S rRNA region; multilocus sequence analysis; and antimicrobial susceptibility. By multilocus sequence analysis, 61 isolates were S. pseudopneumoniae, 34 were pneumococci, 13 were S. mitis, and 24 remained unclassified as non-pneumococci. Among S. pseudopneumoniae isolates, 51 (83.6%) were collected from respiratory tract samples; eight isolates were obtained from sterile sources. High frequency of non-susceptibility to penicillin (60.7%) and erythromycin (42.6%) was found. Only 50.8% of the S. pseudopneumoniae isolates displayed the typical optochin phenotype originally described for this species. None harbored the cpsA gene or the pneumococcal typical lytA restriction fragment length polymorphism. The Spn9802 and the specific 16S rRNA regions were detected among the majority of the S. pseudopneumoniae isolates (n = 59 and n = 49, respectively). The ply and pspA genes were rarely found. A high genetic diversity was found and 59 profiles were identified. Among the S. pneumoniae, 23 were capsulated and 11 were non-typeable. Three non-typeable isolates, associated to international non-capsulated lineages, were recovered from invasive disease sources. In conclusion, half of the atypical pneumococcal clinical isolates were, in fact, S. pseudopneumoniae and one-fourth were other streptococci. We identified S. pseudopneumoniae and non-typeable pneumococci as cause of disease in Spain including invasive disease.	[Rolo, Dora; Domenech, Arnau; Linares, Josefina; Ardanuy, Carmen] Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge, Barcelona, Spain; [Rolo, Dora; Domenech, Arnau; Linares, Josefina; Ardanuy, Carmen] Inst Salud Carlos III, Ctr Inves Red Enfermedades Resp, Madrid, Spain; [Simoes, Alexandra S.; de Lencastre, Herminia; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Simoes, Alexandra S.; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, P-2780156 Oeiras, Portugal; [Fenoll, Asuncion] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Instituto de Salud Carlos III; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Rockefeller University	Sa-Leao, R (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	rsaleao@itqb.unl.pt	Ardanuy, Carmen/C-4463-2015; Simões, Alexandra S/G-4884-2013; Rolo, Dora/G-4236-2015; Sá-Leão, Raquel/A-9341-2011; Rolo, Dora/AAI-4326-2021; Liñares, Josefina/N-9450-2014	Simões, Alexandra S/0000-0002-3234-7522; Sá-Leão, Raquel/0000-0001-9804-827X; Domenech, Arnau/0000-0002-0829-511X; /0000-0001-6816-8932; Rolo, Dora/0000-0003-4327-2279; Ardanuy, Carmen/0000-0003-0225-607X; Rolo, Dora/0000-0003-2704-8648	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI060647, PI090104]; Plan Nacional de I+D+I of Spain's Ministerio de Ciencia e Innovacion [BIO2008-02154]; Centro de investigacion en red de enfermedades respiratorias [CB06/06/0037]; Fundacao para a Ciencia e Tecnologia, Portugal [PDTC/BIA-MIC/64010/2006, PTDC/BIA-BEC/098289/2008, Pest-OE/EQB/LA004/2011]; Institut d'Investigacio Biomedica de Bellvitge; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/27325/2006]; Formacion de Profesorado Universitario (Ministerio de Educacion, Spain); Wellcome Trust	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); Plan Nacional de I+D+I of Spain's Ministerio de Ciencia e Innovacion; Centro de investigacion en red de enfermedades respiratorias; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Institut d'Investigacio Biomedica de Bellvitge; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Formacion de Profesorado Universitario (Ministerio de Educacion, Spain); Wellcome Trust(Wellcome Trust)	This work was supported by a grants from the Fondo de Investigaciones Sanitarias de la Seguridad Social (PI060647 and PI090104), Plan Nacional de I+D+I of Spain's Ministerio de Ciencia e Innovacion (BIO2008-02154), Centro de investigacion en red de enfermedades respiratorias (CB06/06/0037) run by the Instituto de Salud Carlos III (Madrid, Spain), Fundacao para a Ciencia e Tecnologia, Portugal (PDTC/BIA-MIC/64010/2006, PTDC/BIA-BEC/098289/2008 and Pest-OE/EQB/LA004/2011). DR was supported by a grant from Institut d'Investigacio Biomedica de Bellvitge. ASS was supported by a grant from Fundacao para a Ciencia e a Tecnologia (SFRH/BD/27325/2006). AD was supported by a grant from Formacion de Profesorado Universitario (Ministerio de Educacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the use of the pneumococcal MLST database, which is located at Imperial College London and is funded by the Wellcome Trust.	Abdeldaim G, 2010, CLIN MICROBIOL INFEC, V16, P1135, DOI 10.1111/j.1469-0691.2009.03069.x; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Balsalobre L, 2012, ANTIMICROB AGENTS CH; Balsalobre L, 2006, J CLIN MICROBIOL, V44, P4163, DOI 10.1128/JCM.01137-06; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Berron S, 2005, J CLIN MICROBIOL, V43, P1694, DOI 10.1128/JCM.43.4.1694-1698.2005; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Blasi F, 2012, CLIN MICROBIOL INFEC, V18, P7, DOI 10.1111/j.1469-0691.2012.03937.x; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; El Aila NA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-104; FENOLL A, 1994, MOL MICROBIOL, V12, P587, DOI 10.1111/j.1365-2958.1994.tb01045.x; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Harf-Monteil C, 2006, J CLIN MICROBIOL, V44, P2240, DOI 10.1128/JCM.02643-05; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Ing J, 2012, J CLIN MICROBIOL, V50, P1326, DOI 10.1128/JCM.05182-11; Ioannidou S, 2001, INT J ANTIMICROB AG, V17, P195, DOI 10.1016/S0924-8579(00)00338-1; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Johnston C, 2010, J CLIN MICROBIOL, V48, P2762, DOI 10.1128/JCM.01746-09; Keith ER, 2008, ANTIMICROB AGENTS CH, V52, P2998, DOI 10.1128/AAC.01526-07; Keith ER, 2006, J CLIN MICROBIOL, V44, P923, DOI 10.1128/JCM.44.3.923-927.2006; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Laurens C, 2012, ANTIMICROB AGENTS CH, V56, P4504, DOI 10.1128/AAC.06374-11; Leegaard TM, 2010, MICROBIOL-SGM, V156, P838, DOI 10.1099/mic.0.035345-0; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Martin M, 2003, NEW ENGL J MED, V348, P1112, DOI 10.1056/NEJMoa022521; Melchiorre S, 2012, MICROBIOL-SGM, V158, P338, DOI 10.1099/mic.0.054270-0; MUNOZ R, 1990, DIAGN MICR INFEC DIS, V13, P63, DOI 10.1016/0732-8893(90)90056-2; Nunes S, 2008, J CLIN MICROBIOL, V46, P321, DOI 10.1128/JCM.02097-07; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obregon V, 2002, J CLIN MICROBIOL, V40, P2545, DOI 10.1128/JCM.40.7.2545-2554.2002; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park HK, 2010, J MED MICROBIOL, V59, P1146, DOI 10.1099/jmm.0.017798-0; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; Ruoff KL, 2003, MANUAL CLIN MICROBIO, P405; Sa-Leao R, 2006, MICROBIOL-SGM, V152, P367, DOI 10.1099/mic.0.28596-0; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Scott JR, 2012, J INFECT DIS, V206, P73, DOI 10.1093/infdis/jis307; Shahinas D, 2011, J BACTERIOL, V193, P6102, DOI 10.1128/JB.06075-11; Simoes AS, 2011, DIAGN MICR INFEC DIS, V71, P208, DOI 10.1016/j.diagmicrobio.2011.07.009; Simoes AS, 2010, J CLIN MICROBIOL, V48, P238, DOI 10.1128/JCM.01313-09; Suzuki N, 2005, J CLIN MICROBIOL, V43, P4528, DOI 10.1128/JCM.43.9.4528-4534.2005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wessels E, 2012, J CLIN MICROBIOL, V50, P1171, DOI 10.1128/JCM.06609-11; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Xu QF, 2011, DIAGN MICR INFEC DIS, V69, P200, DOI 10.1016/j.diagmicrobio.2010.09.019	49	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57047	10.1371/journal.pone.0057047	http://dx.doi.org/10.1371/journal.pone.0057047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437306	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000070
J	Rothe, M; Alpert, C; Loh, G; Blaut, M				Rothe, Monique; Alpert, Carl; Loh, Gunnar; Blaut, Michael			Novel Insights into E-coli's Hexuronate Metabolism: KduI Facilitates the Conversion of Galacturonate and Glucuronate under Osmotic Stress Conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI; 5-KETO-4-DEOXYURONATE ISOMERASE; SYSTEM GENES; TRANSPORT; DIFFUSION; PROTEINS; PATHWAY; REGULON; CLONING	Using a gnotobiotic mouse model, we previously observed the upregulation of 2-deoxy-D-gluconate 3-dehydrogenase (KduD) in intestinal E. coli of mice fed a lactose-rich diet and the downregulation of this enzyme and of 5-keto 4-deoxyuronate isomerase (KduI) on a casein-rich diet. The present study aimed to define the role of the so far poorly characterized E. coli proteins KduD and KduI in vitro. Galacturonate and glucuronate induced kduD and kduI gene expression 3-fold and 7 to 11-fold, respectively, under aerobic conditions as well as 9 to 20-fold and 19 to 54-fold, respectively, under anaerobic conditions. KduI facilitated the breakdown of these hexuronates. In E. coli, galacturonate and glucuronate are normally degraded by UxaABC and UxuAB. However, osmotic stress represses the expression of the corresponding genes in an OxyR-dependent manner. When grown in the presence of galacturonate or glucuronate, kduID-deficient E. coli had a 30% to 80% lower maximal cell density and 1.5 to 2-fold longer doubling times under osmotic stress conditions than wild type E. coli. Growth on lactose promoted the intracellular formation of hexuronates, which possibly explain the induction of KduD on a lactose-rich diet. These results indicate a novel function of KduI and KduD in E. coli and demonstrate the crucial influence of osmotic stress on the gene expression of hexuronate degrading enzymes.	[Rothe, Monique; Alpert, Carl; Loh, Gunnar; Blaut, Michael] German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Blaut, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany.	blaut@dife.de		Blaut, Michael/0000-0002-6628-2907	Deutsche Forschungsgemeinschaft [BL 257/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by grant BL 257/7-1 from Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABENDANO JJ, 1973, BIOCHEM BIOPH RES CO, V54, P1342, DOI 10.1016/0006-291X(73)91134-0; Allen A, 1984, ATTACHMENT ORGANISMS, VII, P3; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BECKWITH JR, 1967, SCIENCE, V156, P597, DOI 10.1126/science.156.3775.597; COHN M, 1989, BIOCHIM BIOPHYS ACTA, V1000, P109, DOI 10.1016/S0006-3002(89)80012-5; CONDEMINE G, 1991, MOL MICROBIOL, V5, P2191, DOI 10.1111/j.1365-2958.1991.tb02149.x; CONDEMINE G, 1986, J BACTERIOL, V165, P937, DOI 10.1128/jb.165.3.937-941.1986; Crowther RL, 2005, PROTEINS, V61, P680, DOI 10.1002/prot.20598; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dunten P, 1998, ACTA CRYSTALLOGR D, V54, P678, DOI 10.1107/S090744499701785X; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hu WT, 2010, ANAL BIOCHEM, V398, P245, DOI 10.1016/j.ab.2009.11.002; Hugenholtz J, 1999, CURR OPIN BIOTECH, V10, P492, DOI 10.1016/S0958-1669(99)00016-6; Kageyama A, 1999, INT J SYST BACTERIOL, V49, P1725, DOI 10.1099/00207713-49-4-1725; Kamlage B, 1999, J NUTR, V129, P2212, DOI 10.1093/jn/129.12.2212; Kawano M, 2000, J BACTERIOL, V182, P2507, DOI 10.1128/JB.182.9.2507-2512.2000; Kleerebezem M, 1999, ANTON LEEUW INT J G, V76, P357, DOI 10.1023/A:1002084822851; Kornberg HL, 2000, P NATL ACAD SCI USA, V97, P1808, DOI 10.1073/pnas.97.4.1808; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGARDE AE, 1975, EUR J BIOCHEM, V55, P343, DOI 10.1111/j.1432-1033.1975.tb02168.x; LANCASTER JR, 1977, J BIOL CHEM, V252, P7662; MATAGILSINGER M, 1983, GENETICS, V105, P829; Moon TS, 2009, ANAL BIOCHEM, V392, P183, DOI 10.1016/j.ab.2009.05.032; MUIR M, 1985, J BACTERIOL, V163, P1237, DOI 10.1128/JB.163.3.1237-1242.1985; Patrone V, 2012, MICROBIOL-SGM, V158, P983, DOI 10.1099/mic.0.054247-0; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; PORTALIER R, 1980, J BACTERIOL, V143, P1095, DOI 10.1128/JB.143.3.1095-1107.1980; RICHEY DP, 1972, J BACTERIOL, V112, P784, DOI 10.1128/JB.112.2.784-790.1972; RITZENTHALER P, 1981, J BACTERIOL, V145, P181, DOI 10.1128/JB.145.1.181-190.1981; ROBERTBAUDOUY JM, 1973, BIOCHIM BIOPHYS ACTA, V309, P473, DOI 10.1016/0005-2744(73)90045-4; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Rodionov DA, 2000, MOL MICROBIOL, V38, P673, DOI 10.1046/j.1365-2958.2000.02115.x; Rothe M, 2012, APPL ENVIRON MICROB, V78, P3580, DOI 10.1128/AEM.00244-12; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; STOCK JB, 1977, J BIOL CHEM, V252, P7850; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	44	19	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56906	10.1371/journal.pone.0056906	http://dx.doi.org/10.1371/journal.pone.0056906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437267	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000055
J	Christie, GJ; Cook, CM; Ward, BJ; Tata, MS; Sutherland, J; Sutherland, RJ; Saucier, DM				Christie, Gregory J.; Cook, Charles M.; Ward, Brian J.; Tata, Matthew S.; Sutherland, Janice; Sutherland, Robert J.; Saucier, Deborah M.			Mental Rotational Ability Is Correlated with Spatial but Not Verbal Working Memory Performance and P300 Amplitude in Males	PLOS ONE			English	Article							SEX-DIFFERENCES; INDIVIDUAL-DIFFERENCES; GENDER-DIFFERENCES; COGNITIVE-ABILITIES; ACTIVATION PATTERNS; BRAIN ACTIVATION; OBJECT LOCATION; NEURAL ACTIVITY; TASK; DIFFERENCE	This study investigated how both sex and individual differences in a mental rotation test (MRT) influence performance on working memory (WM). To identify the neural substrate supporting these differences, brain electrical activity was measured using the event-related potential technique. No significant sex differences were observed in a test of verbal WM, however males were significantly faster than females to respond to probe stimuli in a test of spatial WM. This difference was no longer significant after controlling for differences in MRT score, suggesting that rotational ability mediates performance in the spatial memory task for both sexes. A posterior P300 was observed in both tasks as participants encoded information into memory, however the amplitude of the P300 correlated with RT in the spatial task but not in the verbal task. Individual differences in the MRT also correlated with RT and with the amplitude of the P300, but again only in the spatial task. After splitting the analysis by sex, partial correlations controlling for MRT revealed that for males, individual differences in rotational ability completely mediated the correlation between the P300 and RT in the spatial task. This mediating effect was not observed for the female participants. The results therefore suggest a relatively stronger association in males between innate mental rotational ability, spatial memory performance, and brain electrophysiological processes supporting spatial memory.	[Christie, Gregory J.; Cook, Charles M.; Ward, Brian J.; Tata, Matthew S.; Sutherland, Janice; Sutherland, Robert J.; Saucier, Deborah M.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Christie, Gregory J.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Saucier, Deborah M.] Univ Ontario, Fac Sci, Inst Technol, Oshawa, ON, Canada	University of Lethbridge; Simon Fraser University; Ontario Tech University	Saucier, DM (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	Debsaucier@mac.com			Natural Sciences and Engineering Research Council (NSERC); NSERC; Canada Research Chairs program; Canadian Foundation Innovation grant; Alberta Heritage Foundation for Medical Research	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation Innovation grant; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This research was supported by discovery grants from the Natural Sciences and Engineering Research Council (NSERC) to DMS, MST, and RJS; by an NSERC postdoctoral fellowship to CMC; by the Canada Research Chairs program and by a Canadian Foundation Innovation grant to DMS; and by an operating grant and a scientist award from the Alberta Heritage Foundation for Medical Research to RJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Baddeley A, 1974, PSYCHOL LEARN MOTIV, V8; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Beste C, 2010, BRAIN COGNITION, V72, P238, DOI 10.1016/j.bandc.2009.09.005; CAPITANI E, 1991, ITAL J NEUROL SCI, V12, P461, DOI 10.1007/BF02335507; Christova PS, 2008, EXP BRAIN RES, V189, P79, DOI 10.1007/s00221-008-1405-x; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Collins DW, 1997, BEHAV NEUROSCI, V111, P845, DOI 10.1037/0735-7044.111.4.845; Cook CM, 2010, PERS INDIV DIFFER, V49, P712, DOI 10.1016/j.paid.2010.06.010; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; Duff SJ, 2001, BRAIN COGNITION, V47, P470, DOI 10.1006/brcg.2001.1326; FABIANI M, 1986, PSYCHOPHYSIOLOGY, V23, P298, DOI 10.1111/j.1469-8986.1986.tb00636.x; Felix MC, 2011, PERCEPT MOTOR SKILL, V113, P38, DOI 10.2466/03.22.PMS.113.4.38-50; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; FISCHER SC, 1988, BRAIN COGNITION, V7, P1, DOI 10.1016/0278-2626(88)90017-6; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Geiger J. F., 2005, J INSTR PSYCHOL, V32, P49; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Halpern DF, 2000, EDUC PSYCHOL REV, V12, P229, DOI 10.1023/A:1009027516424; Halpern DF, 1997, AM PSYCHOL, V52, P1091, DOI 10.1037/0003-066X.52.10.1091; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; HARSHMAN RA, 1983, CAN J PSYCHOL, V37, P144, DOI 10.1037/h0080690; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P414, DOI 10.1017/S0048577202001105; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; Hoesing JM, 1998, EVALUATION SEX DIFFE; Hoesing JM, 1994, SOC NEUR ABSTR, V20; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; James TW, 1997, EVOL HUM BEHAV, V18, P155, DOI 10.1016/S1090-5138(97)00004-4; Jansen-Osmann P, 2007, BRAIN COGNITION, V64, P217, DOI 10.1016/j.bandc.2007.03.002; Jennings JR, 2006, BRAIN RES, V1092, P177, DOI 10.1016/j.brainres.2006.03.077; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; JUST MA, 1985, PSYCHOL REV, V92, P137, DOI 10.1037/0033-295X.92.2.137; Kaiser S, 2008, NEUROPSYCHOLOGIA, V46, P2524, DOI 10.1016/j.neuropsychologia.2008.04.013; Kaufman SB, 2007, INTELLIGENCE, V35, P211, DOI 10.1016/j.intell.2006.07.009; Kimura Doreen, 1999, SEX COGNITION; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Loehlin J.C., 2000, HDB INTELLIGENCE, P176, DOI [10.1017/cbo9780511807947.010, DOI 10.1017/CBO9780511807947]; Lycke C, 2008, SCAND J PSYCHOL, V49, P393, DOI 10.1111/j.1467-9450.2008.00672.x; LYNN R, 1994, PERS INDIV DIFFER, V17, P257, DOI 10.1016/0191-8869(94)90030-2; Mackintosh NJ, 2005, INTELLIGENCE, V33, P663, DOI 10.1016/j.intell.2005.03.004; MANN VA, 1990, NEUROPSYCHOLOGIA, V28, P1063, DOI 10.1016/0028-3932(90)90141-A; MASTERS MS, 1993, BEHAV GENET, V23, P337, DOI 10.1007/BF01067434; McBurney DH, 1997, EVOL HUM BEHAV, V18, P165, DOI 10.1016/S1090-5138(97)00001-9; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; Mecklinger A, 1996, COGNITIVE BRAIN RES, V4, P211, DOI 10.1016/S0926-6410(96)00034-1; Mecklinger A, 1998, MEM COGNITION, V26, P1068, DOI 10.3758/BF03201184; Moffat SD, 1998, EVOL HUM BEHAV, V19, P73, DOI 10.1016/S1090-5138(97)00104-9; Neubauer AC, 2010, INTELLIGENCE, V38, P529, DOI 10.1016/j.intell.2010.06.001; Nittono H, 1999, PSYCHOPHYSIOLOGY, V36, P745; ORSINI A, 1986, PERCEPT MOTOR SKILL, V63, P727, DOI 10.2466/pms.1986.63.2.727; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; OWEN K, 1993, J BIOSOC SCI, V25, P557, DOI 10.1017/S0021932000021933; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Postma A, 1999, PSYCHONEUROENDOCRINO, V24, P175, DOI 10.1016/S0306-4530(98)00073-0; Postma A, 1998, BRAIN COGNITION, V36, P334, DOI 10.1006/brcg.1997.0974; Postma A, 2004, BRAIN COGNITION, V54, P24, DOI 10.1016/S0278-2626(03)00238-0; Prime DJ, 2010, J COGNITIVE NEUROSCI, V22, P2437, DOI 10.1162/jocn.2009.21337; ROSSER RA, 1984, CHILD DEV, V55, P2204, DOI 10.2307/1129792; RUCHKIN DS, 1992, COGNITIVE BRAIN RES, V1, P53, DOI 10.1016/0926-6410(92)90005-C; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Silverman I., 1992, ADAPTED MIND EVOLUTI, P533; Simon-Thomas ER, 2003, COGNITIVE BRAIN RES, V16, P457, DOI 10.1016/S0926-6410(03)00060-0; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Thomsen T, 2000, Med Sci Monit, V6, P1186; Unterrainer JM, 2005, NEUROIMAGE, V24, P586, DOI 10.1016/j.neuroimage.2004.09.020; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Vecchi T, 1998, ACTA PSYCHOL, V99, P1, DOI 10.1016/S0001-6918(97)00052-8; VERLEGER R, 1994, COGNITIVE BRAIN RES, V2, P103, DOI 10.1016/0926-6410(94)90007-8; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Walter H, 2003, CORTEX, V39, P897, DOI 10.1016/S0010-9452(08)70869-4; WATSON NV, 1991, PERS INDIV DIFFER, V12, P375, DOI 10.1016/0191-8869(91)90053-E; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P452, DOI 10.1111/j.1469-8986.1989.tb01951.x; Yu QB, 2009, NEUROREPORT, V20, P43, DOI 10.1097/WNR.0b013e32831c50f4; Zurowski B, 2002, NEUROIMAGE, V15, P45, DOI 10.1006/nimg.2001.0968	85	18	19	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57390	10.1371/journal.pone.0057390	http://dx.doi.org/10.1371/journal.pone.0057390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437381	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200252
J	Hsu, KC; Hung, HC; Horng, JT; Fang, MY; Chang, CY; Li, LT; Chen, IJ; Chen, YC; Chou, DL; Chang, CW; Hsieh, HP; Yang, JM; Hsu, JTA				Hsu, Kai-Cheng; Hung, Hui-Chen; Horng, Jim-Tong; Fang, Ming-Yu; Chang, Chun-Yu; Li, Ling-Ting; Chen, I-Jung; Chen, Yun-Chu; Chou, Ding-Li; Chang, Chun-Wei; Hsieh, Hsing-Pang; Yang, Jinn-Moon; Hsu, John T. -A.			Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors	PLOS ONE			English	Article							INFLUENZA-VIRUS NEURAMINIDASE; CELL LUNG-CANCER; OSELTAMIVIR RESISTANCE; MOLECULAR DOCKING; CHEMICAL SPACE; H1N1 VIRUS; IN-VITRO; DESIGN; PROTEIN; ACID	Infection with influenza virus is a major public health problem, causing serious illness and death each year. Emergence of drug-resistant influenza virus strains limits the effectiveness of drug treatment. Importantly, a dual H275Y/I223R mutation detected in the pandemic influenza A 2009 virus strain results in multidrug resistance to current neuraminidase (NA) drugs. Therefore, discovery of new agents for treating multiple drug-resistant (MDR) influenza virus infections is important. Here, we propose a parallel screening strategy that simultaneously screens wild-type (WT) and MDR NAs, and identifies inhibitors matching the subsite characteristics of both NA-binding sites. These may maintain their potency when drug-resistant mutations arise. Initially, we analyzed the subsite of the dual H275Y/I223R NA mutant. Analysis of the site-moiety maps of NA protein structures show that the mutant subsite has a relatively small volume and is highly polar compared with the WT subsite. Moreover, the mutant subsite has a high preference for forming hydrogen-bonding interactions with polar moieties. These changes may drive multidrug resistance. Using this strategy, we identified a new inhibitor, Remazol Brilliant Blue R (RB19, an anthraquinone dye), which inhibited WT NA and MDR NA with IC50 values of 3.4 and 4.5 mu M, respectively. RB19 comprises a rigid core scaffold and a flexible chain with a large polar moiety. The former interacts with highly conserved residues, decreasing the probability of resistance. The latter forms van der Waals contacts with the WT subsite and yields hydrogen bonds with the mutant subsite by switching the orientation of its flexible side chain. Both scaffolds of RB19 are good starting points for lead optimization. The results reveal a parallel screening strategy for identifying resistance mechanisms and discovering anti-resistance neuraminidase inhibitors. We believe that this strategy may be applied to other diseases with high mutation rates, such as cancer and human immunodeficiency virus type 1.	[Hsu, Kai-Cheng; Li, Ling-Ting; Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Hung, Hui-Chen; Fang, Ming-Yu; Chang, Chun-Yu; Chen, I-Jung; Chang, Chun-Wei; Hsieh, Hsing-Pang; Hsu, John T. -A.] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan; [Horng, Jim-Tong; Chen, Yun-Chu; Chou, Ding-Li] Chang Gung Univ, Dept Biochem, Tao Yuan, Taiwan; [Yang, Jinn-Moon; Hsu, John T. -A.] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Yang, JM (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	moon@faculty.nctu.edu.tw; tsuanhsu@nhri.org.tw	Yang, Jinn-Moon/AAU-4400-2021; Hsu, John Tsu-An/C-1199-2010; Hsieh, Hsing-Pang/B-2649-2010; Fang, Ming Yu/K-8577-2013	Hsieh, Hsing-Pang/0000-0002-1332-005X; Fang, Ming Yu/0000-0002-2530-7522; Yang, Jinn-Moon/0000-0002-3205-4391; Horng, Jim-Tong/0000-0001-6294-9981	National Science Council; Ministry of Education and National Health Research Institutes [NHRI-EX100-10009PI]; National Science Council [NSC 98-2323-B-002-010, NSC 100-2325-B-009-002]; National Health Research Institutes of Taiwan, the Republic of China [NHRI-EX100-10009PI]; 'Aim for the Top University Plan' of the National Chiao Tung University and Ministry of Education, Taiwan; National Core Facility Program for Biotechnology	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education and National Health Research Institutes; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan, the Republic of China; 'Aim for the Top University Plan' of the National Chiao Tung University and Ministry of Education, Taiwan; National Core Facility Program for Biotechnology	J.-M. Yang was supported by National Science Council, partial supports of Ministry of Education and National Health Research Institutes (NHRI-EX100-10009PI). J.T.-A H was supported by the National Science Council (NSC 98-2323-B-002-010 and NSC 100-2325-B-009-002) and National Health Research Institutes (NHRI-EX100-10009PI) of Taiwan, the Republic of China. This paper is also particularly supported by 'Aim for the Top University Plan' of the National Chiao Tung University and Ministry of Education, Taiwan. J.-M. Yang also thanks Core Facility for Protein Structural Analysis supported by National Core Facility Program for Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, MED LETT DRUGS THERA, V47, P93; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Bharathi A, 1997, GENE, V198, P251, DOI 10.1016/S0378-1119(97)00322-3; BROWNING CH, 1967, BRIT MED J, V2, P111, DOI 10.1136/bmj.2.5544.111-a; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Chen LM, 2004, J VIROL, V78, P3722, DOI 10.1128/JVI.78.7.3722-3732.2004; Chen YF, 2010, NUCLEIC ACIDS RES, V38, pW424, DOI 10.1093/nar/gkq480; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dandapani S, 2010, NAT CHEM BIOL, V6, P861, DOI 10.1038/nchembio.479; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Duesberg P, 2000, P NATL ACAD SCI USA, V97, P14295, DOI 10.1073/pnas.97.26.14295; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Hsieh HP, 2007, CURR PHARM DESIGN, V13, P3531, DOI 10.2174/138161207782794248; Hsu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032142; Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33; Hung HC, 2009, ANTIVIR RES, V81, P123, DOI 10.1016/j.antiviral.2008.10.006; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JEDRZEJAS MJ, 1995, BIOCHEMISTRY-US, V34, P3144, DOI 10.1021/bi00010a003; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; Kim CU, 1998, J MED CHEM, V41, P2451, DOI 10.1021/jm980162u; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Li WX, 1998, ANTIMICROB AGENTS CH, V42, P647, DOI 10.1128/AAC.42.3.647; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; Luo M, 2006, NATURE, V443, P37, DOI 10.1038/nature05003; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Mandi G, 2005, TROP MED INT HEALTH, V10, P32, DOI 10.1111/j.1365-3156.2004.01356.x; Maring CJ, 2005, J MED CHEM, V48, P3980, DOI 10.1021/jm049276y; MEINDL P, 1974, VIROLOGY, V58, P457, DOI 10.1016/0042-6822(74)90080-4; Meissner PE, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-45; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; PALESE P, 1982, SCIENCE, V215, P1468, DOI 10.1126/science.7038875; PALESE P, 1974, VIROLOGY, V59, P490, DOI 10.1016/0042-6822(74)90458-9; PENNISI E, 1995, SCIENCE, V270, P1916, DOI 10.1126/science.270.5244.1916; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rambaut A, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1003; Ravindranathan KP, 2010, J MED CHEM, V53, P1662, DOI 10.1021/jm901386e; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sawatdichaikul O, 2012, J MOL MODEL, V18, P1241, DOI 10.1007/s00894-011-1135-z; Service RF, 1997, SCIENCE, V275, P756, DOI 10.1126/science.275.5301.756; SETO JT, 1966, VIROLOGY, V30, P731, DOI 10.1016/0042-6822(66)90178-4; Shih SR, 2010, J ANTIMICROB CHEMOTH, V65, P63, DOI 10.1093/jac/dkp393; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Smith J, 2005, CLIN THER, V27, P1513, DOI 10.1016/j.clinthera.2005.10.014; Steele RM, 2009, BIOORG MED CHEM LETT, V19, P6565, DOI 10.1016/j.bmcl.2009.10.036; Stoll V, 2003, BIOCHEMISTRY-US, V42, P718, DOI 10.1021/bi0205449; Tanrikulu Y, 2008, NAT REV DRUG DISCOV, V7, P667, DOI 10.1038/nrd2615; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Varghese JN, 1997, P NATL ACAD SCI USA, V94, P11808, DOI 10.1073/pnas.94.22.11808; Venkatramani L, 2006, J MOL BIOL, V356, P651, DOI 10.1016/j.jmb.2005.11.061; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wood JM, 2007, INFLUENZA OTHER RESP, V1, P5, DOI 10.1111/j.1750-2659.2006.00003.x; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Yang JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000428; Yang JM, 2005, J CHEM INF MODEL, V45, P1134, DOI 10.1021/ci050034w; Yang JM, 2005, PROTEINS, V59, P205, DOI 10.1002/prot.20387; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Yang M, 2008, INDIAN J TRADIT KNOW, V7, P3; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06	77	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56704	10.1371/journal.pone.0056704	http://dx.doi.org/10.1371/journal.pone.0056704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437217	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200147
J	Jang, CW; Magnuson, T				Jang, Chuan-Wei; Magnuson, Terry			A Novel Selection Marker for Efficient DNA Cloning and Recombineering in E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESISTANCE GENE; EXPRESSION; SEQUENCE; PBR322	Production of recombinant DNA in bacterial cells is an essential technique in molecular biology. Plasmids are usually maintained in an E. coli host by antibiotic selection. However, there are only a few antibiotic-resistance markers available in common use. Here we report the adoption of a novel selection marker, mfabl (mutant fabl) for plasmid propagation in E. coli. mfabl expands the limited repertoire of selection markers and allows for more efficient molecular manipulation and plasmid propagation in E. coli. We show that mfabl is not only an efficient plasmid selection marker, but it also possesses unique activity that may facilitate molecular manipulation of unstable sequences. Furthermore, we have incorporated mfabl in the recombineering tool kit for generating mouse gene targeting vectors and demonstrate the advantage of using mfabl-containing recombineering vectors.	[Jang, Chuan-Wei; Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Jang, Chuan-Wei; Magnuson, Terry] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Jang, Chuan-Wei; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	terry_magnuson@med.unc.edu			United States National Institutes of Health [R01GM101974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health [grant number R01GM101974]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Goh S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-61; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; HERSHFIE.V, 1974, P NATL ACAD SCI USA, V71, P3455, DOI 10.1073/pnas.71.9.3455; IZUMI M, 1991, EXP CELL RES, V197, P229, DOI 10.1016/0014-4827(91)90427-V; Kang YS, 2004, J BACTERIOL, V186, P4921, DOI 10.1128/JB.186.15.4921-4930.2004; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; OCONNOR M, 1989, SCIENCE, V244, P1307, DOI 10.1126/science.2660262; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SUTCLIFFE JG, 1978, P NATL ACAD SCI USA, V75, P3737, DOI 10.1073/pnas.75.8.3737; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu DG, 2003, P NATL ACAD SCI USA, V100, P7207, DOI 10.1073/pnas.1232375100	20	14	17	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57075	10.1371/journal.pone.0057075	http://dx.doi.org/10.1371/journal.pone.0057075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437314	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200210
J	Kovess, V; Pilowsky, DJ; Boyd, A; Pez, O; Bitfoi, A; Carta, M; Eke, C; Golitz, D; Kuijpers, R; Lesinskiene, S; Mihova, Z; Otten, R; Susser, E				Kovess, Viviane; Pilowsky, Daniel J.; Boyd, Anders; Pez, Ondine; Bitfoi, Adina; Carta, Mauro; Eke, Ceyda; Golitz, Dietmar; Kuijpers, Rowella; Lesinskiene, Sigita; Mihova, Zlatka; Otten, Roy; Susser, Ezra			Parental Smoking in the Vicinity of Children and Tobacco Control Policies in the European Region	PLOS ONE			English	Article							2ND-HAND SMOKE; EXPOSURE; HEALTH	Objective: To ascertain patterns of parental smoking in the vicinity of children in Eastern and Western Europe and their relation to Tobacco Control Scale (TCS) scores. Methods: Data on parental smoking patterns were obtained from the School Child Mental Health Europe (SCMHE), a 2010 cross-sectional survey of 5141 school children aged 6 to 11 years and their parents in six countries: Germany, Netherlands, Lithuania, Romania, Bulgaria and Turkey ranked by TCS into three level categories toward tobacco control policies. Results: A slightly higher proportion of Eastern compared to Western European mothers (42.4 vs. 35.1%) were currently smoking in but the difference was not statistically significant after adjusting for maternal age and maternal educational attainment. About a fifth (19.3%) and a tenth (10.0%) of Eastern and Western European mothers, respectively, smoked in the vicinity of their children, and the difference was significant even after adjustment for potential confounders (p<0.001). Parents with the highest educational attainment were significantly less likely to smoke in the vicinity of their children than those with the lowest attainment. After control of these covariates lax tobacco control policies, compared to intermediate policies, were associated with a 50% increase in the likelihood of maternal smoking in the vicinity of children adjusted odds ratio (AOR) = 1.52 and 1.64. Among fathers, however, the relationship with paternal smoking and TCS seems more complex since strict policy increases the risk as well AOR = 1,40. Only one country, however belongs to the strict group. Significance: Tobacco control policies seem to have influenced maternal smoking behaviors overall to a limited degree and smoking in the vicinity of children to a much greater degree. Children living in European countries with lax tobacco control policies are more likely to be exposed to second hand smoking from maternal and paternal smoking.	[Kovess, Viviane; Pez, Ondine] Univ Paris 05, EHESP Rennes, EA 4069, Paris, France; [Pilowsky, Daniel J.] Columbia Univ, Dept Epidemiol & Psychiat, New York, NY USA; [Boyd, Anders] EHESP, Inserm Unite Mixte Rech Sante 707, Paris, France; [Bitfoi, Adina] Romanian League Mental Hlth, Bucharest, Romania; [Carta, Mauro] Univ Cagliari, Dept Publ Hlth, Psychiat Unit, Cagliari, Italy; [Eke, Ceyda] Yeniden Hlth & Educ Soc, Istanbul, Turkey; [Golitz, Dietmar] Leuphana Univ Luneburg, Inst Psychol, Luneburg, Germany; [Kuijpers, Rowella] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Lesinskiene, Sigita] Vilnius State Univ, Psychiat Clin, Fac Med, Vilnius, Lithuania; [Mihova, Zlatka] Fdn Human Relat, Sofia, Bulgaria; [Otten, Roy] Radboud Univ Nijmegen, Fac Social Sci, NL-6525 ED Nijmegen, Netherlands; [Susser, Ezra] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Pilowsky, Daniel J.; Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	UDICE-French Research Universities; Universite Paris Cite; Columbia University; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Cagliari; Leuphana University Luneburg; Radboud University Nijmegen; Vilnius University; Radboud University Nijmegen; Columbia University; New York State Psychiatry Institute	Kovess, V (corresponding author), Univ Paris 05, EHESP Rennes, EA 4069, Paris, France.	Viviane.kovess@ehesp.fr	Boyd, Anders/GLQ-8906-2022	Boyd, Anders/0000-0001-9512-8928	European Union [2006336]	European Union(European Commission)	This project had been financed by the European Union, grant number 2006336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2012, TOB CONTROL, DOI [10.1136/tobaccocontrol-2011-050391, DOI 10.1136/TOBACCOCONTROL-2011-050391]; [Anonymous], FLASH EB 253 SURVEY; [Anonymous], 5 EUR C TOB HLTH AMS; Bogdanovica I, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.036103; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Glover M, 2011, ADDICT BEHAV, V36, P1027, DOI 10.1016/j.addbeh.2011.06.003; Gruer L, 2012, PUBLIC HEALTH, V126, P227, DOI 10.1016/j.puhe.2011.12.005; Herrmann M, 2008, CURR OPIN PEDIATR, V20, P184, DOI 10.1097/MOP.0b013e3282f56165; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Pattenden S, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015065; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pez O., 2011, SCH CHILDREN MENTAL; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Special Eurobarometer, 2006, ATTITUDES EUROPEAN T, V239, P641; Statistics Canada, 2007, CAN COMM HLTH SURV C; Wang HD, 2009, P NATL ACAD SCI USA, V106, P393, DOI 10.1073/pnas.0811809106; Winickoff JP, 2003, PEDIATRICS, V112, P1146, DOI 10.1542/peds.112.5.1146; World Health Organization (WHO), 2005, WHO FRAM CONV TOB CO	19	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56783	10.1371/journal.pone.0056783	http://dx.doi.org/10.1371/journal.pone.0056783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437236	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200160
J	Liu, YY; Fatheree, NY; Dingle, BM; Tran, DQ; Rhoads, JM				Liu, Yuying; Fatheree, Nicole Y.; Dingle, Bridgette M.; Tran, Dat Q.; Rhoads, Jon Marc			Lactobacillus reuteri DSM 17938 Changes the Frequency of Foxp3(+) Regulatory T Cells in the Intestine and Mesenteric Lymph Node in Experimental Necrotizing Enterocolitis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; NEONATAL-RAT MODEL; BACTERIAL-COLONIZATION; GUT DEVELOPMENT; LAMINA PROPRIA; BREAST-MILK; INFANTS; EXPRESSION; BIFIDOBACTERIA; STIMULATION	Necrotizing enterocolitis (NEC) is an inflammatory disease of the intestine in premature infants. Lactobacillus reuteri DSM 17938 improves survival and reduces the incidence and severity of NEC in a rodent model. Foxp3(+) regulatory T cells (Tregs) maintain intestinal homeostasis by controlling inflammation and inducing tolerance. To determine whether there are insufficient numbers of Tregs to control inflammation in NEC and to determine if LR17938 increases the frequency of Tregs, we studied selected groups of newborn Sprague-Dawley rats according to feeding plan: dam +/- LR17938, formula +/- LR17938, and NEC +/- LR17938. NEC was induced by gavage feeding with special formula and exposure to hypoxic conditions. Lymphocytes isolated from ileum, mesenteric lymph nodes (MLN), spleen and thymus were labeled for T cell surface markers (CD3, CD4, CD8) and intracellular Foxp3; and labeled cells were analyzed by flow cytometry. The percentage of CD3(+) T cells and Foxp3(+) Tregs in the ileum significantly decreased in pups with NEC, compared to normal controls. Feeding LR17938 to neonatal rats with NEC increased the % of Foxp3(+) T cells in the ileum while decreasing the percentage of cells in the MLN. Administration of LR17938 to dam-fed rats significantly increased Foxp3(+)Tregs in the ileum as early as day of life (DOL)1 but did not produce an increase in Tregs in formula-fed rats on DOL1. These results suggest that factors in breast milk may enhance the early immunomodulatory effects of LR17938. An anti-inflammatory effect of LR17938 in NEC was associated with the modulation of immune responses and induction and what appears to be migration of Foxp3(+) Tregs to the diseased gut. Probiotic-facilitated development of Tregs might play an important role in the prevention of NEC.	[Rhoads, Jon Marc] Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, Div Gastroenterol,Med Sch, Houston, TX 77225 USA; Univ Texas Houston, Hlth Sci Ctr, Div Allergy Immunol, Dept Pediat,Med Sch, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Rhoads, JM (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, Div Gastroenterol,Med Sch, Houston, TX 77225 USA.	j.marc.rhoads@uth.tmc.edu	Liu, Yuying/ABB-8417-2021	Liu, Yuying/0000-0003-3848-9254	public health service grant [DK56338]; Biogaia, Inc, Stockholm, Sweden; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	public health service grant(United States Department of Health & Human ServicesUnited States Public Health Service); Biogaia, Inc, Stockholm, Sweden; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by public health service grant DK56338, which funds the Texas medical center digestive diseases center and in part by by Biogaia, Inc, Stockholm, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-97; Bruder MC, 1999, TOXICOL PATHOL, V27, P171, DOI 10.1177/019262339902700204; Caicedo RA, 2005, PEDIATR RES, V58, P625, DOI 10.1203/01.PDR.0000180533.09295.84; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chen ML, 2009, EUR J IMMUNOL, V39, P3423, DOI 10.1002/eji.200939441; Cilieborg MS, 2012, EARLY HUM DEV, V88, pS41, DOI 10.1016/j.earlhumdev.2011.12.027; Claud EC, 2008, J CLIN GASTROENTEROL, V42, pS46, DOI 10.1097/MCG.0b013e31815a57a8; Dvorak B, 2003, PEDIATR RES, V53, P426, DOI 10.1203/01.PDR.0000050657.56817.E0; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Dvorak B, 2008, J PEDIATR GASTR NUTR, V47, P11, DOI 10.1097/MPG.0b013e3181788618; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Gueimonde M, 2007, NEONATOLOGY, V92, P64, DOI 10.1159/000100088; Hahn BH, 2005, J IMMUNOL, V175, P7728, DOI 10.4049/jimmunol.175.11.7728; Hunter CJ, 2008, PEDIATR RES, V63, P117, DOI 10.1203/PDR.0b013e31815ed64c; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Lee Jane S, 2003, Semin Neonatol, V8, P449, DOI 10.1016/S1084-2756(03)00123-4; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Liu Y, 2011, AM J PHYSL GASTROINT; Liu Y, 2010, AM J PHYSL GASTROINT; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Menezes JD, 2003, INT IMMUNOL, V15, P447, DOI 10.1093/intimm/dxg043; Mountzouris KC, 2002, BRIT J NUTR, V87, P405, DOI 10.1079/BJN2002563; Mshvildadze M, 2008, NUTR REV, V66, P658, DOI 10.1111/j.1753-4887.2008.00119.x; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Perez-Cano FJ, 2005, PEDIATR RES, V58, P164, DOI 10.1203/01.PDR.0000156367.60769.36; Reibke R, 2006, P NATL ACAD SCI USA, V103, P15142, DOI 10.1073/pnas.0602622103; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; SPENCER J, 1989, J PEDIATR GASTR NUTR, V9, P173, DOI 10.1097/00005176-198908000-00007; SPENCER J, 1986, CLIN EXP IMMUNOL, V65, P553; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Uss E, 2006, J IMMUNOL, V177, P2775, DOI 10.4049/jimmunol.177.5.2775; VAAGE JT, 1990, EUR J IMMUNOL, V20, P1193, DOI 10.1002/eji.1830200538; Wang QZ, 2012, J PEDIATR SURG, V47, P241, DOI 10.1016/j.jpedsurg.2011.09.064; Weitkamp JH, 2009, PEDIATR DEVEL PATHOL, V12, P443, DOI 10.2350/08-09-0533.1; Westerbeek EAM, 2006, CLIN NUTR, V25, P361, DOI 10.1016/j.clnu.2006.03.002; Zelenika D, 1998, J IMMUNOL, V161, P1868; Zhang L, 2009, J IMMUNOL, V183, P6346, DOI 10.4049/jimmunol.0901773	43	50	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56547	10.1371/journal.pone.0056547	http://dx.doi.org/10.1371/journal.pone.0056547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437165	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200103
J	Magle, SB; Samuel, MD; Van Deelen, TR; Robinson, SJ; Mathews, NE				Magle, Seth B.; Samuel, Michael D.; Van Deelen, Timothy R.; Robinson, Stacie J.; Mathews, Nancy E.			Evaluating Spatial Overlap and Relatedness of White-tailed Deer in a Chronic Wasting Disease Management Zone	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SOCIAL-ORGANIZATION; PRION TRANSMISSION; GENETIC-STRUCTURE; SPACE USE; ELK	Wildlife disease transmission, at a local scale, can occur from interactions between infected and susceptible conspecifics or from a contaminated environment. Thus, the degree of spatial overlap and rate of contact among deer is likely to impact both direct and indirect transmission of infectious diseases such chronic wasting disease (CWD) or bovine tuberculosis. We identified a strong relationship between degree of spatial overlap (volume of intersection) and genetic relatedness for female white-tailed deer in Wisconsin's area of highest CWD prevalence. We used volume of intersection as a surrogate for contact rates between deer and concluded that related deer are more likely to have contact, which may drive disease transmission dynamics. In addition, we found that age of deer influences overlap, with fawns exhibiting the highest degree of overlap with other deer. Our results further support the finding that female social groups have higher contact among related deer which can result in transmission of infectious diseases. We suggest that control of large social groups comprised of closely related deer may be an effective strategy in slowing the transmission of infectious pathogens, and CWD in particular.	[Magle, Seth B.] Urban Wildlife Inst, Chicago, IL 60614 USA; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Van Deelen, Timothy R.; Robinson, Stacie J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Mathews, Nancy E.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Magle, SB (corresponding author), Urban Wildlife Inst, Lincoln Pk Zoo, Chicago, IL 60614 USA.	SMagle@lpzoo.org		Magle, Seth/0000-0003-0275-3885	Wisconsin Department of Natural Resources; Whitetails Unlimited; University of Wisconsin; National Beef and Cattleman's Association; North Central Agricultural Experiment Station Hatch Program	Wisconsin Department of Natural Resources; Whitetails Unlimited; University of Wisconsin; National Beef and Cattleman's Association; North Central Agricultural Experiment Station Hatch Program	This project was supported by the Wisconsin Department of Natural Resources, Whitetails Unlimited, the University of Wisconsin, the National Beef and Cattleman's Association, and the North Central Agricultural Experiment Station Hatch Program. Thanks to the University of Wisconsin's Department of Forest & Wildlife Ecology and the Nelson Institute for Environmental Studies for assistance with publication costs. Note that any use of trade, product or firm names is for descriptive purposes, and does not imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Atwood TC, 2002, AM MIDL NAT, V148, P289, DOI 10.1674/0003-0031(2002)148[0289:SAASPO]2.0.CO;2; Aycrigg JL, 1997, J MAMMAL, V78, P468, DOI 10.2307/1382899; Blanchong JA, 2008, BIOL LETTERS, V4, P130, DOI 10.1098/rsbl.2007.0523; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; FORD RG, 1979, J THEOR BIOL, V76, P125, DOI 10.1016/0022-5193(79)90366-7; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Habib TJ, 2011, ECOL MODEL, V222, P2722, DOI 10.1016/j.ecolmodel.2011.05.007; HAWKINS RE, 1968, J WILDLIFE MANAGE, V32, P191, DOI 10.2307/3798258; HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027; Hirth DH, 1977, WILDLIFE MONOGR, V53, P3, DOI DOI 10.2307/3830446; Joly DO, 2003, EMERG INFECT DIS, V9, P599, DOI 10.3201/eid0905.020721; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kie JG, 1999, J MAMMAL, V80, P1004, DOI 10.2307/1383271; Kjaer LJ, 2008, J WILDLIFE MANAGE, V72, P1819, DOI 10.2193/2007-489; LASETER B. R., 2004, THESIS U GEORGIA ATH; LOCATION OF A SIGNAL TM, 2003, LOC SIGN; Mathews N.E., 1989, THESIS STATE U NEW Y; MATHEWS NE, 1993, J MAMMAL, V74, P33, DOI 10.2307/1381903; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Miller KV, 1997, WILDLIFE SOC B, V25, P279; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Milligan BG, 2003, GENETICS, V163, P1153; Millspaugh JSJ, 2004, WILDLIFE SOC B, V32, P148, DOI 10.2193/0091-7648(2004)32[148:COTATT]2.0.CO;2; Nelson ME, 1999, CAN J ZOOL, V77, P1128, DOI 10.1139/cjz-77-7-1128; NIXON CM, 1991, WILDLIFE MONOGR, P1; Oyer AM, 2007, J WILDLIFE MANAGE, V71, P1635, DOI 10.2193/2006-381; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; PORTER WF, 1991, ENVIRON MANAGE, V15, P809, DOI 10.1007/BF02394818; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAMSEY CW, 1968, J WILDLIFE MANAGE, V32, P187, DOI 10.2307/3798257; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robinson SJ, 2012, MOL ECOL, V21, P4190, DOI 10.1111/j.1365-294X.2012.05681.x; Rosenberry CS, 2009, J WILDLIFE MANAGE, V73, P357, DOI 10.2193/2007-050; Schauber EM, 2007, J WILDLIFE MANAGE, V71, P155, DOI 10.2193/2005-546; SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; Skuldt L. H., 2005, THESIS U WISCONSIN M; Skuldt LH, 2008, J WILDLIFE MANAGE, V72, P1156, DOI 10.2193/2006-469; Thompson AK, 2008, J WILDLIFE MANAGE, V72, P416, DOI 10.2193/2006-543; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; VerCauteren KC, 2007, J WILDLIFE DIS, V43, P784, DOI 10.7589/0090-3558-43.4.784; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123; Williams SC, 2008, CAN J ZOOL, V86, P1358, DOI 10.1139/Z08-126; Wolfe LL, 2002, J WILDLIFE MANAGE, V66, P564, DOI 10.2307/3803124; Zuur Alain F., 2009, P1	51	17	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56568	10.1371/journal.pone.0056568	http://dx.doi.org/10.1371/journal.pone.0056568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437171	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200107
J	Salinari, S; Debard, C; Bertuzzi, A; Durand, C; Zimmet, P; Vidal, H; Mingrone, G				Salinari, Serenella; Debard, Cyrille; Bertuzzi, Alessandro; Durand, Christine; Zimmet, Paul; Vidal, Hubert; Mingrone, Geltrude			Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SKELETAL-MUSCLE CELLS; BARIATRIC SURGERY; RECEPTOR SUBSTRATE-1; GLUCOSE-TRANSPORT; MEDICAL THERAPY; BYPASS-SURGERY; OBESE-PATIENTS; PHOSPHORYLATION; MTOR	Background: Two recent studies demonstrated that bariatric surgery induced remission of type 2 diabetes very soon after surgery and far too early to be attributed to weight loss. In this study, we sought to explore the mechanism/s of this phenomenon by testing the effects of proteins from the duodenum-jejunum conditioned-medium (CM) of db/db or Swiss mice on glucose uptake in vivo in Swiss mice and in vitro in both Swiss mice soleus and L6 cells. We studied the effect of sera and CM proteins from insulin resistant (IR) and insulin-sensitive subjects on insulin signaling in human myoblasts. Methodology/Principal Findings: db/db proteins induced massive IR either in vivo or in vitro, while Swiss proteins did not. In L6 cells, only db/db proteins produced a noticeable increase in basal (473)Ser-Akt phosphorylation, lack of GSK3 beta inhibition and a reduced basal (389)Thr-p70-S6K1 phosphorylation. Human IR serum markedly increased basal (473)Ser-Akt phosphorylation in a dose-dependent manner. Human CM IR proteins increased by about twofold both basal and insulin-stimulated (473)Ser-Akt. Basal (9)Ser-GSK3 beta phosphorylation was increased by IR subjects serum with a smaller potentiating effect of insulin. Conclusions: These findings show that jejunal proteins either from db/db mice or from insulin resistant subjects impair muscle insulin signaling, thus inducing insulin resistance.	[Salinari, Serenella] Univ Roma La Sapienza, Dept Comp & Syst Sci, Rome, Italy; [Debard, Cyrille; Durand, Christine; Vidal, Hubert] Univ Lyon 1, CarMeN Lab, INSERM, U1060, Oullins, France; [Bertuzzi, Alessandro] CNR, Inst Syst Anal & Comp Sci, Rome, Italy; [Zimmet, Paul] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Mingrone, Geltrude] Univ Cattolica Sacro Cuore, Dept Internal Med, Sch Med, Rome, Italy	Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Baker Heart and Diabetes Institute; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Mingrone, G (corresponding author), Univ Cattolica Sacro Cuore, Dept Internal Med, Sch Med, Rome, Italy.	gmingrone@rm.unicatt.it	Vidal, Hubert/M-6674-2017; Mingrone, Geltrude/AAB-9681-2019; Zimmet, Paul/H-7635-2013; Zimmet, Paul/O-8486-2019	Vidal, Hubert/0000-0002-9467-0317; Zimmet, Paul/0000-0003-0627-0776; BERTUZZI, ALESSANDRO/0000-0003-4969-7366; Mingrone, Geltrude/0000-0003-2021-528X	Catholic University	Catholic University	Financed by the Catholic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Brozinick JT, 2001, DIABETES, V50, P593, DOI 10.2337/diabetes.50.3.593; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Capristo E, 1998, J INTERN MED, V243, P339; Ciaraldi TP, 2007, ENDOCRINOLOGY, V148, P4393, DOI 10.1210/en.2006-0932; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Dokken BB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1188, DOI 10.1152/ajpendo.00547.2004; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Goni-Oliver P, 2007, J BIOL CHEM, V282, P22406, DOI 10.1074/jbc.M702793200; Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; KOIVISTO UM, 1991, J BIOL CHEM, V266, P2615; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Mari A, 2006, DIABETOLOGIA, V49, P2136, DOI 10.1007/s00125-006-0337-x; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Pacini G, 2001, AM J PHYSIOL-ENDOC M, V281, pE693, DOI 10.1152/ajpendo.2001.281.4.E693; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Russell M S, 2006, Drugs R D, V7, P111, DOI 10.2165/00126839-200607020-00005; Salinari S, 2009, DIABETES CARE, V32, P375, DOI 10.2337/dc08-1314; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; SHEINER LB, 1980, J PHARMACOKINET BIOP, V8, P553, DOI 10.1007/BF01060053; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; WANG QM, 1994, J BIOL CHEM, V269, P14566; WENTE SR, 1990, P NATL ACAD SCI USA, V87, P2805, DOI 10.1073/pnas.87.7.2805	50	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56258	10.1371/journal.pone.0056258	http://dx.doi.org/10.1371/journal.pone.0056258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437106	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200053
J	Turlin, E; Debarbouille, M; Augustyniak, K; Gilles, AM; Wandersman, C				Turlin, Evelyne; Debarbouille, Michel; Augustyniak, Katarzyna; Gilles, Anne-Marie; Wandersman, Cecile			Staphylococcus aureus FepA and FepB Proteins Drive Heme Iron Utilization in Escherichia coli	PLOS ONE			English	Article							BINDING; TRANSPORTER; HEMOGLOBIN; MEMBRANE; PERMEASE; RECEPTOR; ISDB	EfeUOB-like tripartite systems are widespread in bacteria and in many cases they are encoded by genes organized into iron-regulated operons. They consist of: EfeU, a protein similar to the yeast iron permease Ftrp1; EfeO, an extracytoplasmic protein of unknown function and EfeB, also an extracytoplasmic protein with heme peroxidase activity, belonging to the DyP family. Many bacterial EfeUOB systems have been implicated in iron uptake, but a prefential iron source remains undetermined. Nevertheless, in the case of Escherichia coli, the EfeUOB system has been shown to recognize heme and to allow extracytoplasmic heme iron extraction via a deferrochelation reaction. Given the high level of sequence conservations between EfeUOB orthologs, we hypothesized that heme might be the physiological iron substrate for the other orthologous systems. To test this hypothesis, we undertook characterization of the Staphylococcus aureus FepABC system. Results presented here indicate: i) that the S. aureus FepB protein binds both heme and PPIX with high affinity, like EfeB, the E. coli ortholog; ii) that it has low peroxidase activity, comparable to that of EfeB; iii) that both FepA and FepB drive heme iron utilization, and both are required for this activity and iv) that the E. coli FepA ortholog ( EfeO) cannot replace FepA in FepB-driven iron release from heme indicating protein specificity in these activities. Our results show that the function in heme iron extraction is conserved in the two orthologous systems.	[Turlin, Evelyne; Augustyniak, Katarzyna; Gilles, Anne-Marie; Wandersman, Cecile] Inst Pasteur, Unite Membranes Bacteriennes, Dept Microbiol, CNRS,ERL3526, Paris, France; [Debarbouille, Michel] Inst Pasteur, Unite Biol Bacteries Pathogenes Grampositif, Dept Microbiol, CNRS,ERL3526, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wandersman, C (corresponding author), Inst Pasteur, Unite Membranes Bacteriennes, Dept Microbiol, CNRS,ERL3526, Paris, France.	cecile.wandersman@pasteur.fr			Institut Pasteur, CNRS ERL3526; Agence nationale de la Recherche (ANR Grabiron)	Institut Pasteur, CNRS ERL3526; Agence nationale de la Recherche (ANR Grabiron)(French National Research Agency (ANR))	Institut Pasteur, CNRS ERL3526, Agence nationale de la Recherche (ANR Grabiron). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CML, 2003, BIOCHEM BIOPH RES CO, V304, P279, DOI 10.1016/S0006-291X(03)00583-7; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Gaballa A, 2011, MICROBIOL-SGM, V157, P3221, DOI 10.1099/mic.0.053579-0; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Hurd AF, 2012, FEMS MICROBIOL LETT, V329, P93, DOI 10.1111/j.1574-6968.2012.02502.x; KELLERMANN O, 1974, EUR J BIOCHEM, V47, P139, DOI 10.1111/j.1432-1033.1974.tb03677.x; Letoffe S, 2003, MOL MICROBIOL, V50, P77, DOI 10.1046/j.1365-2958.2003.03686.x; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; Maruyama Y, 2011, BIOCHEM BIOPH RES CO, V405, P411, DOI 10.1016/j.bbrc.2011.01.043; Mechold U, 2006, NUCLEIC ACIDS RES, V34, P2364, DOI 10.1093/nar/gkl247; Osborn M J, 1974, Methods Enzymol, V31, P642; Perrotte-Piquemal M, 1999, BIOCHIMIE, V81, P245, DOI 10.1016/S0300-9084(99)80058-3; Peschel A, 1996, J BACTERIOL, V178, P531, DOI 10.1128/jb.178.2.531-536.1996; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Rajasekaran MB, 2010, BIOCHEM BIOPH RES CO, V398, P366, DOI 10.1016/j.bbrc.2010.06.072; Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Xu QP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021875; Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673	33	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56529	10.1371/journal.pone.0056529	http://dx.doi.org/10.1371/journal.pone.0056529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437157	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200095
J	Wan, Q; Kozhaya, L; Imberg, K; Mercer, F; Zhong, S; Krogsgaard, M; Unutmaz, D				Wan, Qi; Kozhaya, Lina; Imberg, Keren; Mercer, Frances; Zhong, Shi; Krogsgaard, Michelle; Unutmaz, Derya			Probing the Effector and Suppressive Functions of Human T Cell Subsets Using Antigen-Specific Engineered T Cell Receptors	PLOS ONE			English	Article							CLASS-I MOLECULES; HIV-INFECTION; LYMPHOCYTES; EXPRESSION; NAIVE; TCR; ACTIVATION; SIGNALS; GENES; IDENTIFICATION	Activation of T cells through the engagement of the T cell receptors (TCRs) with specific peptide-MHC complexes on antigen presenting cells (APCs) is the major determinant for their proliferation, differentiation and display of effector functions. To assess the role of quantity and quality of peptide-MHC presentation in eliciting T cell activation and suppression functions, we genetically engineered human T cells with two TCRs that recognize HLA-A*0201-restricted peptides derived from either HIV or melanoma antigens. The engineered-TCRs are highly functional in both CD8(+) and CD4(+) T cells as assessed by the upregulation of activation markers, induction of cytokine secretion and cytotoxicity. We further demonstrated that engineered-TCRs can also be expressed on naive human T cells, which are stimulated through APCs presenting specific peptides to induce T cell proliferation and acquire effector functions. Furthermore, regulatory T cells (Tregs) ectopically expressing the engineered-TCRs are activated in an antigen-specific fashion and suppress T cell proliferation. In this system, the inhibitory activity of peptide-stimulated Tregs require the presence of dendritic cells (DCs) in the culture, either as presenters or as bystander cells, pointing to a critical role for DCs in suppression by Tregs. In conclusion, the engineered-TCR system reported here advances our ability to understand the differentiation pathways of naive T cells into antigen-specific effector cells and the role of antigen-specific signaling in Treg-mediated immune suppression.	[Wan, Qi; Kozhaya, Lina; Mercer, Frances; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Imberg, Keren; Krogsgaard, Michelle; Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA; [Unutmaz, Derya] NYU, Sch Med, Dept Med, New York, NY USA; [Zhong, Shi; Krogsgaard, Michelle] NYU, Sch Med, Inst Canc, New York, NY USA	New York University; New York University; New York University; New York University	Unutmaz, D (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Derya@mac.com	Wan, Qi/F-1694-2013	Wan, Qi/0000-0003-3726-5187	National Institute of Health (NIH) [R21AI087973, R01AI065303]; NIH/National Cancer Institute [U01CA137070]; National Institute of General Medical Sciences/NIH [R01GM085586]; American Cancer Society [RSG-09-070-01-LIB]; NATIONAL CANCER INSTITUTE [U01CA137070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087973, T32AI007180, R01AI065303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085586] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health (NIH) grants R21AI087973 and R01AI065303 to DU's laboratory. MK was supported by NIH/National Cancer Institute grants U01CA137070, National Institute of General Medical Sciences/NIH, R01GM085586 and American Cancer Society grant RSG-09-070-01-LIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brusko TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011726; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; DAY PM, 1995, IMMUNITY, V2, P137, DOI 10.1016/S1074-7613(95)80014-X; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; Frankel TL, 2010, J IMMUNOL, V184, P5988, DOI 10.4049/jimmunol.1000189; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Joseph A, 2008, J VIROL, V82, P3078, DOI 10.1128/JVI.01812-07; Kitchen SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002649; Kitchen SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008208; Kobayashi H, 2001, IMMUNOGENETICS, V53, P626, DOI 10.1007/s00251-001-0379-7; LEVY F, 1991, CELL, V67, P265, DOI 10.1016/0092-8674(91)90178-2; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Plesa G, 2012, BLOOD; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845	37	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56302	10.1371/journal.pone.0056302	http://dx.doi.org/10.1371/journal.pone.0056302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437112	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200058
J	Xu, J; Wu, X; Zhou, WH; Liu, AW; Wu, JB; Deng, JY; Yue, CF; Yang, SB; Wang, J; Yuan, ZY; Liu, QT				Xu, Jie; Wu, Xing; Zhou, Wei-hua; Liu, An-wen; Wu, Jian-bing; Deng, Jin-yun; Yue, Cai-feng; Yang, Shao-bing; Wang, Jing; Yuan, Zhong-yu; Liu, Quentin			Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; EXPRESSION; KINASE; OVEREXPRESSION; CLASSIFICATION; SURVIVAL; GROWTH; KI-67; AMPLIFICATION; ASSOCIATION	Triple negative breast cancer (TNBC) acquires an unfavorable prognosis, emerging as a major challenge for the treatment of breast cancer. In the present study, 122 TNBC patients were subjected to analysis of Aurora-A (Aur-A) expression and survival prognosis. We found that Aur-A high expression was positively associated with initial clinical stage (P = 0.025), the proliferation marker Ki-67 (P = 0.001), and the recurrence rate of TNBC patients (P<0.001). In TNBC patients with Aur-A high expression, the risk of distant recurrence peaked at the first 3 years and declined rapidly thereafter, whereas patients with Aur-A low expression showed a relatively constant risk of recurrence during the entire follow-up period. Univariate and multivariate analysis showed that overexpression of Aur-A predicted poor overall survival (P = 0.002) and progression-free survival (P = 0.012) in TNBC. Furthermore, overexpression of Aur-A, associated with high Ki-67, predicted an inferior prognosis compared with low expression of both Aur-A and Ki-67. Importantly, we further found that Aur-A was overexpressed in TNBC cells, and inhibition of this kinase inhibited cell proliferation and prevented cell migration in TNBC. Our findings demonstrated that Aur-A was a potential therapeutic target for TNBC and inhibition of Aur-A kinase was a promising regimen for TNBC cancer therapy.	[Xu, Jie; Wu, Xing; Zhou, Wei-hua; Yue, Cai-feng; Wang, Jing; Yuan, Zhong-yu; Liu, Quentin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Xu, Jie; Zhou, Wei-hua; Liu, An-wen; Wu, Jian-bing] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang, Peoples R China; [Wu, Xing; Liu, Quentin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Jin-yun] Jiangxi Prov Canc Hosp, Dept Internal Med 3, Nanchang, Peoples R China; [Yang, Shao-bing] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Anesthesiol, Wuhan 430074, Peoples R China; [Yuan, Zhong-yu] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Quentin] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China	Sun Yat Sen University; Nanchang University; Sun Yat Sen University; Huazhong University of Science & Technology; Sun Yat Sen University; Dalian Medical University	Yuan, ZY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	yuanzhy@sysucc.org.cn; liuq9@mail.sysu.edu.cn	CF, Yue/AAT-9821-2021		National Nature Science Foundation of China [81101521, 81160305, 81160306]; National Science Fund for Distinguished Young Scholars [30888003]; State Key Program of National Natural Science of China [81130040]; 973 Project from the Ministry of Science and Technology of China [2012CB967000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); 973 Project from the Ministry of Science and Technology of China(National Basic Research Program of China)	The work was supported by a National Nature Science Foundation of China (Grant No. 81101521 to J. Wang, Grant No. 81160305 to A.W. Liu and Grant No. 81160306 to J.B. Wu), the National Science Fund for Distinguished Young Scholars (Grant No. 30888003 to Q. Liu), the State Key Program of National Natural Science of China (Grant No. 81130040 to Q. Liu), and 973 Project from the Ministry of Science and Technology of China (Grants No. 2012CB967000 to Q. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Huang XF, 2008, BLOOD, V111, P2854, DOI 10.1182/blood-2007-07-099325; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Landen CN, 2007, CLIN CANCER RES, V13, P4098, DOI 10.1158/1078-0432.CCR-07-0431; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Linderholm BK, 2009, ANN ONCOL, V20, P1639, DOI 10.1093/annonc/mdp062; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Nadler Y, 2008, CLIN CANCER RES, V14, P4455, DOI 10.1158/1078-0432.CCR-07-5268; Pan CB, 2008, ORAL ONCOL, V44, P639, DOI 10.1016/j.oraloncology.2007.08.010; Perez EA, 2002, MAYO CLIN PROC, V77, P148; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Rakha EA, 2006, EUR J CANCER, V42, P3149, DOI 10.1016/j.ejca.2006.08.015; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Shang XY, 2009, MOL CANCER THER, V8, P2461, DOI 10.1158/1535-7163.MCT-08-0857; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Tanaka T, 1999, CANCER RES, V59, P2041; Traynor AM, 2011, CANCER CHEMOTH PHARM, V67, P305, DOI 10.1007/s00280-010-1318-9; Wan XB, 2008, CARCINOGENESIS, V29, P1930, DOI 10.1093/carcin/bgn176; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Xie D, 2003, INT J CANCER, V107, P896, DOI 10.1002/ijc.11514; Yamamoto Y, 2009, BREAST CANCER-TOKYO, V16, P260, DOI 10.1007/s12282-009-0150-8; Zhou WH, 2012, AUTOPHAGY, V8, P389, DOI 10.4161/auto.18641; Zhou WH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-397	44	49	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56919	10.1371/journal.pone.0056919	http://dx.doi.org/10.1371/journal.pone.0056919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437271	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200185
J	Weber, AAT; Pawlowski, J				Weber, Alexandra A-T; Pawlowski, Jan			Can Abundance of Protists Be Inferred from Sequence Data: A Case Study of Foraminifera	PLOS ONE			English	Article							COPY NUMBER; MICROBIAL COMMUNITIES; BENTHIC FORAMINIFERA; GENOME SIZE; DIVERSITY; PCR; SAMPLES; RDNA; QUANTIFICATION; INDICATORS	Protists are key players in microbial communities, yet our understanding of their role in ecosystem functioning is seriously impeded by difficulties in identification of protistan species and their quantification. Current microscopy-based methods used for determining the abundance of protists are tedious and often show a low taxonomic resolution. Recent development of next-generation sequencing technologies offered a very powerful tool for studying the richness of protistan communities. Still, the relationship between abundance of species and number of sequences remains subjected to various technical and biological biases. Here, we test the impact of some of these biological biases on sequence abundance of SSU rRNA gene in foraminifera. First, we quantified the rDNA copy number and rRNA expression level of three species of foraminifera by qPCR. Then, we prepared five mock communities with these species, two in equal proportions and three with one species ten times more abundant. The libraries of rDNA and cDNA of the mock communities were constructed, Sanger sequenced and the sequence abundance was calculated. The initial species proportions were compared to the raw sequence proportions as well as to the sequence abundance normalized by rDNA copy number and rRNA expression level per species. Our results showed that without normalization, all sequence data differed significantly from the initial proportions. After normalization, the congruence between the number of sequences and number of specimens was much better. We conclude that without normalization, species abundance determination based on sequence data was not possible because of the effect of biological biases. Nevertheless, by taking into account the variation of rDNA copy number and rRNA expression level we were able to infer species abundance, suggesting that our approach can be successful in controlled conditions.	[Weber, Alexandra A-T; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland; [Weber, Alexandra A-T] Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, Marine Endoume Stn, CNRS,IMBE,UMR 7263, Marseille, France	University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Pawlowski, J (corresponding author), Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland.	Jan.Pawlowski@unige.ch	Pawlowski, Jan/AAO-3306-2021	Pawlowski, Jan/0000-0003-2421-388X; Weber, Alexandra/0000-0002-7980-388X	Swiss National Foundation [31003A-140766]; G & L Claraz Donation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); G & L Claraz Donation	The study was supported by the Swiss National Foundation grant 31003A-140766 (JP) and G & L Claraz Donation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Barriuso J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-473; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Candela M, 2004, LETT APPL MICROBIOL, V38, P229, DOI 10.1111/j.1472-765X.2003.01475.x; Chernoff H, 1954, ANN MATH STAT, V25, P59; Crosby LD, 2003, BIOTECHNIQUES, V34, P790, DOI 10.2144/03344rr01; Denoyelle M, 2010, MAR POLLUT BULL, V60, P2007, DOI 10.1016/j.marpolbul.2010.07.024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; FOYN BJORN, 1934, ARCH PROTISTENK, V83, P1; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Heyse G, 2010, P NATL ACAD SCI USA, V107, P22134, DOI 10.1073/pnas.1009284107; Jorissen FJ, 2009, DEEP-SEA RES PT II, V56, P2270, DOI 10.1016/j.dsr2.2009.04.009; Lee J.J., 1991, BIOL FORAMINIFERA; Legendre L, 2001, CYTOMETRY, V44, P164, DOI 10.1002/1097-0320(20010701)44:3<164::AID-CYTO1108>3.0.CO;2-6; Lindner MS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks803; Liu XH, 2012, MICROBES ENVIRON, V27, P497, DOI 10.1264/jsme2.ME12056; Madoni P, 2006, ENVIRON POLLUT, V141, P1, DOI 10.1016/j.envpol.2005.08.025; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Mojtahid M, 2008, MAR POLLUT BULL, V56, P42, DOI 10.1016/j.marpolbul.2007.08.018; Mojtahid M, 2006, MAR MICROPALEONTOL, V61, P58, DOI 10.1016/j.marmicro.2006.05.004; Nigam R, 2006, ENVIRON INT, V32, P273, DOI 10.1016/j.envint.2005.08.024; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032; Parfrey LW, 2010, GENOME BIOL EVOL, V2, P678, DOI 10.1093/gbe/evq051; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Rimet F, 2011, ECOL INDIC, V11, P489, DOI 10.1016/j.ecolind.2010.07.004; Rodriguez-Martinez R, 2009, ENVIRON MICROBIOL, V11, P397, DOI 10.1111/j.1462-2920.2008.01779.x; ROTTGER R, 1989, EUR J PROTISTOL, V25, P60, DOI 10.1016/S0932-4739(89)80078-1; Shi XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018979; Taniguchi A, 2011, FISHERIES SCI, V77, P607, DOI 10.1007/s12562-011-0362-7; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhang T, 2006, APPL MICROBIOL BIOT, V70, P281, DOI 10.1007/s00253-006-0333-6; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	40	91	95	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56739	10.1371/journal.pone.0056739	http://dx.doi.org/10.1371/journal.pone.0056739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431390	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800033
J	Brown, NJ; Higham, SE; Perunovic, B; Arafa, M; Balasubramanian, S; Rehman, I				Brown, Nicola J.; Higham, Sue E.; Perunovic, Branko; Arafa, Mohammad; Balasubramanian, Sabapathy; Rehman, Ishtiaq			Lactate Dehydrogenase-B Is Silenced by Promoter Methylation in a High Frequency of Human Breast Cancers	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; STROMAL CELLS; HYPOXIA; HYPERMETHYLATION; METASTASIS; INHIBITION; GLYCOLYSIS; CARCINOMAS; ISOZYMES; PATHWAY	Objective: Under normoxia, non-malignant cells rely on oxidative phosphorylation for their ATP production, whereas cancer cells rely on Glycolysis; a phenomenon known as the Warburg effect. We aimed to elucidate the mechanisms contributing to the Warburg effect in human breast cancer. Experimental design: Lactate Dehydrogenase (LDH) isoenzymes were profiled using zymography. LDH-B subunit expression was assessed by reverse transcription PCR in cells, and by Immunohistochemistry in breast tissues. LDH-B promoter methylation was assessed by sequencing bisulfite modified DNA. Results: Absent or decreased expression of LDH isoenzymes 1-4, were seen in T-47D and MCF7 cells. Absence of LDH-B mRNA was seen in T-47D cells, and its expression was restored following treatment with the demethylating agent 5'Azacytadine. LDH-B promoter methylation was identified in T-47D and MCF7 cells, and in 25/ 25 cases of breast cancer tissues, but not in 5/ 5 cases of normal breast tissues. Absent immuno-expression of LDH-B protein (<10% cells stained), was seen in 23/ 26 (88%) breast cancer cases, and in 4/8 cases of adjacent ductal carcinoma in situ lesions. Exposure of breast cancer cells to hypoxia (1% O-2), for 48 hours resulted in significant increases in lactate levels in both MCF7 (14.0 fold, p = 0.002), and T-47D cells (2.9 fold, p = 0.009), but not in MDA-MB-436 (-0.9 fold, p = 0.229), or MCF10AT (1.2 fold, p = 0.09) cells. Conclusions: Loss of LDH-B expression is an early and frequent event in human breast cancer occurring due to promoter methylation, and is likely to contribute to an enhanced glycolysis of cancer cells under hypoxia.	[Brown, Nicola J.; Higham, Sue E.; Balasubramanian, Sabapathy] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Perunovic, Branko; Arafa, Mohammad] Royal Hallamshire Hosp, Dept Histopathol, Sheffield S10 2JF, S Yorkshire, England; [Rehman, Ishtiaq] Univ Sheffield, Sch Med, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Rehman, I (corresponding author), Univ Sheffield, Sch Med, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England.	i.rehman@sheffield.ac.uk	Perunovic, Branko/R-5570-2019; balasubramanian, saba prakash/H-2830-2019	balasubramanian, saba prakash/0000-0001-5953-2843; Brown, Nicola/0000-0002-2100-1905	Sheffield Breast Cancer [X/001592]	Sheffield Breast Cancer	Sheffield Breast Cancer support group funding to NJB is acknowledged (Grant code X/001592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antone PD, 2012, MED HYPOTHESES, V79, P388, DOI 10.1016/j.mehy.2012.06.002; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Biswas S, 2012, CANC METASTASIS REV; BURKE RE, 1978, CANCER RES, V38, P2773; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Dhup S, 2012, CURR PHARM DESIGN, V18, P1319, DOI 10.2174/138161212799504902; Draoui N, 2011, DIS MODEL MECH, V4, P727, DOI 10.1242/dmm.007724; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hussien R, 2011, PHYSIOL GENOMICS, V43, P255, DOI 10.1152/physiolgenomics.00177.2010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Koukourakis MI, 2003, TUMOR BIOL, V24, P199, DOI 10.1159/000074430; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Koukourakis MI, 2009, GYNECOL OBSTET INVES, V67, P162, DOI 10.1159/000183250; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Leiblich A, 2006, ONCOGENE, V25, P2953, DOI 10.1038/sj.onc.1209262; Liao AC, 2011, PATHOLOGY, V43, P707, DOI 10.1097/PAT.0b013e32834bf67a; Lopez-Lazaro M, 2008, ANTI-CANCER AGENT ME, V8, P305, DOI 10.2174/187152008783961932; Maekawa M, 2003, CLIN CHEM, V49, P1518, DOI 10.1373/49.9.1518; MARKERT CL, 1963, SCIENCE, V140, P1329, DOI 10.1126/science.140.3573.1329; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Montcourrier P, 1997, CLIN EXP METASTAS, V15, P382, DOI 10.1023/A:1018446104071; Ong ES, 2010, MOL CELL PROTEOMICS, P1, DOI DOI 10.1074/MCP.M900551-MCP200; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Rehman I, 1996, ONCOGENE, V12, P2483; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Tsoi SCM, 2001, PLACENTA, V22, P317, DOI 10.1053/plac.2000.0620; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; Ward RA, 2012, J MED CHEM, V55, P3285, DOI 10.1021/jm201734r; YOSHIKUNI K, 1986, ARCH DERMATOL, V122, P1420, DOI 10.1001/archderm.122.12.1420; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33; Zhou WD, 2012, ELECTROPHORESIS, V33, P1850, DOI 10.1002/elps.201200017	45	42	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57697	10.1371/journal.pone.0057697	http://dx.doi.org/10.1371/journal.pone.0057697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437403	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000315186000116
J	Jensen, A; Fago-Olsen, H; Sorensen, CH; Kilian, M				Jensen, Anders; Fago-Olsen, Helena; Sorensen, Christian Hjort; Kilian, Mogens			Molecular Mapping to Species Level of the Tonsillar Crypt Microbiota Associated with Health and Recurrent Tonsillitis	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; FUSOBACTERIUM-NECROPHORUM; HAEMOPHILUS-INFLUENZAE; NEISSERIA-LACTAMICA; SYMBIOTIC BACTERIA; ANAEROBIC-BACTERIA; LEMIERRES-SYNDROME; DIVERSITY; CHILDREN; IDENTIFICATION	The human palatine tonsils, which belong to the central antigen handling sites of the mucosal immune system, are frequently affected by acute and recurrent infections. This study compared the microbiota of the tonsillar crypts in children and adults affected by recurrent tonsillitis with that of healthy adults and children with tonsillar hyperplasia. An in-depth 16S rRNA gene based pyrosequencing approach combined with a novel strategy that included phylogenetic analysis and detection of species- specific sequence signatures enabled identification of the major part of the microbiota to species level. A complex microbiota consisting of between 42 and 110 taxa was demonstrated in both children and adults. This included a core microbiome of 12 abundant genera found in all samples regardless of age and health status. Yet, Haemophilus influenzae, Neisseria species, and Streptococcus pneumoniae were almost exclusively detected in children. In contrast, Streptococcus pseudopneumoniae was present in all samples. Obligate anaerobes like Porphyromonas, Prevotella, and Fusobacterium were abundantly present in children, but the species diversity of Porphyromonas and Prevotella was larger in adults and included species that are considered putative pathogens in periodontal diseases, i.e. Porphyromonas gingivalis, Porphyromonas endodontalis, and Tannerella forsythia. Unifrac analysis showed that recurrent tonsillitis is associated with a shift in the microbiota of the tonsillar crypts. Fusobacterium necrophorum, Streptococcus intermedius and Prevotella melaninogenica/histicola were associated with recurrent tonsillitis in adults, whereas species traditionally associated with acute tonsillitis like pyogenic streptococci and Staphylococcus aureus were scarce. The findings suggest that recurrent tonsillitis is a polymicrobial infection in which interactions within consortia of taxa play an etiologic role. The study contributes to the human microbiome data, to the understanding of the etiology of infections affecting the tonsils, and forms a basis for further insight into the consequences of the intense microbe-host interactions that take place in the tonsils.	[Jensen, Anders; Kilian, Mogens] Aarhus Univ, Dept Biomed, Fac Hlth Sci, Aarhus, Denmark; [Fago-Olsen, Helena; Sorensen, Christian Hjort] Univ Copenhagen, Gentofte Hosp, Dept Otorhinolaryngol Head & Neck Surg, Copenhagen, Denmark	Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital	Kilian, M (corresponding author), Aarhus Univ, Dept Biomed, Fac Hlth Sci, Aarhus, Denmark.	kilian@microbiology.au.dk	Jensen, Anders/B-1968-2016	Jensen, Anders/0000-0003-1185-3343; Kilian, Mogens/0000-0002-5861-0472	Faculty of Health Sciences, Aarhus University; Danish Medical Research Council [271-08-0808]	Faculty of Health Sciences, Aarhus University; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a stipend from the Faculty of Health Sciences, Aarhus University, to AJ and by a project grant to MK from the Danish Medical Research Council (271-08-0808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty A, 2005, BRIT J BIOMED SCI, V62, P66, DOI 10.1080/09674845.2005.11732687; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Brook I, 2005, INT J PEDIATR OTORHI, V69, P9, DOI 10.1016/j.ijporl.2004.08.007; Brook I, 2002, ANN OTO RHINOL LARYN, V111, P430, DOI 10.1177/000348940211100508; BROOK I, 1993, ANN OTO RHINOL LARYN, V102, P113, DOI 10.1177/000348949310200207; BROOK I, 1984, REV INFECT DIS, V6, P601; BROOK I, 1986, LARYNGOSCOPE, V96, P1385, DOI 10.1288/00005537-198612000-00013; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Centor RM, 2009, ANN INTERN MED, V151, P812, DOI 10.7326/0003-4819-151-11-200912010-00011; Chole RA, 2003, ARCH OTOLARYNGOL, V129, P634, DOI 10.1001/archotol.129.6.634; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; de Lillo A, 2004, J CLIN MICROBIOL, V42, P5523, DOI 10.1128/JCM.42.12.5523-5527.2004; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gaffney RJ, 1998, CLIN OTOLARYNGOL, V23, P181; Gebert A, 1999, SEMIN IMMUNOL, V11, P165, DOI 10.1006/smim.1999.0172; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gul M, 2007, AM J OTOLARYNG, V28, P173, DOI 10.1016/j.amjoto.2006.08.010; Hagelskjaer LH, 1998, EUR J CLIN MICROBIOL, V17, P561, DOI 10.1007/BF01708619; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Jeong JH, 2007, LARYNGOSCOPE, V117, P2146, DOI 10.1097/MLG.0b013e31814543c8; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Klug TE, 2011, DAN MED BULL, V58; Kononen E, 2000, ANN MED, V32, P107, DOI 10.3109/07853890009011759; Kristensen LH, 2008, EUR J CLIN MICROBIOL, V27, P779, DOI 10.1007/s10096-008-0496-4; KUHN JJ, 1995, ANN OTO RHINOL LARYN, V104, P646, DOI 10.1177/000348949510400810; Larsen N, 2011, FEMS MICROBIOL ECOL, V75, P482, DOI 10.1111/j.1574-6941.2010.01024.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Liu CM, 2011, ARCH OTOLARYNGOL, V137, P664, DOI 10.1001/archoto.2011.116; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; NORD CE, 1986, REV INFECT DIS, V8, pS543; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Riordan T, 2007, CLIN MICROBIOL REV, V20, P622, DOI 10.1128/CMR.00011-07; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; SINAVE CP, 1989, MEDICINE, V68, P85, DOI 10.1097/00005792-198903000-00002; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stjernquist-Desatnik A, 1999, ACTA OTO-LARYNGOL, V119, P102; STJERNQUISTDESATNIK A, 1990, ACTA OTO-LARYNGOL, V109, P314, DOI 10.3109/00016489009107448; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TUNER K, 1983, SCAND J INFECT DIS, P83; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner JC, 1997, J CLIN MICROBIOL, V35, P1; Van Cauwenberge P, 1976, Acta Otorhinolaryngol Belg, V30, P334; Vaughan AT, 2010, J IMMUNOL, V185, P3652, DOI 10.4049/jimmunol.0902468; Vaughan AT, 2009, J IMMUNOL, V182, P2231, DOI 10.4049/jimmunol.0802531; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	63	87	92	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56418	10.1371/journal.pone.0056418	http://dx.doi.org/10.1371/journal.pone.0056418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437130	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000027
J	Wang, C; Hu, SR; Han, XJ; Huang, W; Tian, LF				Wang, Chao; Hu, Surong; Han, Xijiang; Huang, Wen; Tian, Lunfu			Controlled Synthesis and Microwave Absorption Property of Chain-Like Co Flower	PLOS ONE			English	Article							ELECTROMAGNETIC PROPERTIES	Chain-like Co flower is synthesized by simply modulating the reaction conditions via a facile liquid-phase reduction method. The morphology evolution process and transformation mechanism from particle to flower and finally to chain-like flower have been systematically investigated. [001] is the preferred growth orientation due to the existence of easy magnetic axis. The microwave loss mechanism can be attributed to the synergistic effect of magnetic loss and dielectric loss, while magnetic loss is the main loss mechanism. In addition, the special microstructure of chain-like Co flower may further enhance microwave attenuation. The architectural design of functional material morphology is critical for improving its property toward future application.	[Wang, Chao; Hu, Surong; Huang, Wen; Tian, Lunfu] China Acad Engn Phys, Inst Mech Mfg Technol, Mianyang, Peoples R China; [Wang, Chao; Han, Xijiang] Harbin Inst Technol, Dept Chem, Harbin 150006, Peoples R China	Chinese Academy of Engineering Physics; Harbin Institute of Technology	Wang, C (corresponding author), China Acad Engn Phys, Inst Mech Mfg Technol, Mianyang, Peoples R China.	wangchaohit@126.com			Natural Science Foundation of China [51202228]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of China no. 51202228 (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZG, 2009, J PHYS CHEM C, V113, P2715, DOI 10.1021/jp809199s; Che RC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2165276; Chen YJ, 2009, J PHYS CHEM C, V113, P10061, DOI 10.1021/jp902296z; Chiu SC, 2010, J PHYS CHEM C, V114, P1947, DOI 10.1021/jp905127t; Deng LJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2755875; Guo L, 2007, ADV FUNCT MATER, V17, P425, DOI 10.1002/adfm.200600415; Hong JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040554; Kato Y, 2002, MATER TRANS, V43, P406, DOI 10.2320/matertrans.43.406; Li YL, 2009, COLLOID SURFACE A, V336, P41, DOI 10.1016/j.colsurfa.2008.11.012; Ni SB, 2010, MATER CHEM PHYS, V124, P353, DOI 10.1016/j.matchemphys.2010.06.046; Niu HL, 2003, J MATER CHEM, V13, P1803, DOI 10.1039/b303024e; Shi XL, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3250170; Wang C, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3555436; Wang C, 2010, J PHYS CHEM C, V114, P14826, DOI 10.1021/jp1050386; Wang C, 2010, J PHYS CHEM C, V114, P3196, DOI 10.1021/jp908839r; Yu SH, 2012, CRYSTENGCOMM, V14, P7531, DOI 10.1039/c2ce90082c; Zhu LP, 2008, CRYST GROWTH DES, V8, P1113, DOI 10.1021/cg701036k	17	8	11	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55928	10.1371/journal.pone.0055928	http://dx.doi.org/10.1371/journal.pone.0055928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437073	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000011
J	di Lernia, S; Tafuri, MA; Gallinaro, M; Alhaique, F; Balasse, M; Cavorsi, L; Fullagar, PD; Mercuri, AM; Monaco, A; Perego, A; Zerboni, A				di Lernia, Savino; Tafuri, Mary Anne; Gallinaro, Marina; Alhaique, Francesca; Balasse, Marie; Cavorsi, Lucia; Fullagar, Paul D.; Mercuri, Anna Maria; Monaco, Andrea; Perego, Alessandro; Zerboni, Andrea			Inside the "African Cattle Complex": Animal Burials in the Holocene Central Sahara	PLOS ONE			English	Article							MESSAK SETTAFET; MONUMENTS; ISOTOPES; ACACUS	Cattle pastoralism is an important trait of African cultures. Ethnographic studies describe the central role played by domestic cattle within many societies, highlighting its social and ideological value well beyond its mere function as 'walking larder'. Historical depth of this African legacy has been repeatedly assessed in an archaeological perspective, mostly emphasizing a continental vision. Nevertheless, in-depth site-specific studies, with a few exceptions, are lacking. Despite the long tradition of a multi-disciplinary approach to the analysis of pastoral systems in Africa, rarely do early and middle Holocene archaeological contexts feature in the same area the combination of settlement, ceremonial and rock art features so as to be multi-dimensionally explored: the Messak plateau in the Libyan central Sahara represents an outstanding exception. Known for its rich Pleistocene occupation and abundant Holocene rock art, the region, through our research, has also shown to preserve the material evidence of a complex ritual dated to the Middle Pastoral (6080-5120 BP or 5200-3800 BC). This was centred on the frequent deposition in stone monuments of disarticulated animal remains, mostly cattle. Animal burials are known also from other African contexts, but regional extent of the phenomenon, state of preservation of monuments, and associated rock art make the Messak case unique. GIS analysis, excavation data, radiocarbon dating, zooarchaeological and isotopic (Sr, C, O) analyses of animal remains, and botanical information are used to explore this highly formalized ritual and the lifeways of a pastoral community in the Holocene Sahara.	[di Lernia, Savino; Gallinaro, Marina; Cavorsi, Lucia; Monaco, Andrea] Univ Roma La Sapienza, Dipartimento Sci Antichita, Rome, Italy; [di Lernia, Savino] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Tafuri, Mary Anne] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Tafuri, Mary Anne; Alhaique, Francesca] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Alhaique, Francesca] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Balasse, Marie] CNRS, MNHN, UMR Archeozool Archeobot Soc Prat & Environm 7209, Paris, France; [Fullagar, Paul D.] Univ N Carolina, Dept Geol Sci, Chapel Hill, NC USA; [Mercuri, Anna Maria] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Lab Palinol & Paleobot, Modena, Italy; [Perego, Alessandro; Zerboni, Andrea] Univ Milan, Dipartimento Sci Terra A Desio, Milan, Italy	Sapienza University Rome; University of Witwatersrand; University of Cambridge; Sapienza University Rome; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); University of North Carolina; University of North Carolina Chapel Hill; Universita di Modena e Reggio Emilia; University of Milan	di Lernia, S (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Antichita, Rome, Italy.	savino.dilernia@uniroma1.it	Tafuri, Mary Anne/I-7145-2017; Mercuri, Anna Maria/G-2085-2011; di Lernia, Savino/AAI-4535-2020; Gallinaro, Marina/E-4142-2019	Tafuri, Mary Anne/0000-0002-2913-7225; Mercuri, Anna Maria/0000-0001-6138-4165; Gallinaro, Marina/0000-0003-2683-8170; ALHAIQUE, Francesca/0000-0003-4085-1523; zerboni, andrea/0000-0002-6844-8528	Sapienza University of Rome (Grandi Scavi di Ateneo); Italian Minister of Foreign Affairs (DGSP); Eni North Africa (The Messak Project); MIUR; Marie Curie IEF	Sapienza University of Rome (Grandi Scavi di Ateneo); Italian Minister of Foreign Affairs (DGSP); Eni North Africa (The Messak Project); MIUR(Ministry of Education, Universities and Research (MIUR)); Marie Curie IEF(European Commission)	Funds come from: Sapienza University of Rome (Grandi Scavi di Ateneo); Italian Minister of Foreign Affairs (DGSP); Eni North Africa (The Messak Project), entrusted to Savino di Lernia. Additional funds come from MIUR and Marie Curie IEF, entrusted to Mary Anne Tafuri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-zbek M, 2001, AM J PHYS ANTHROPOL, V115, P238; Ambrose S.H., 2005, ANTHROPOZOOLOGICA, V40, P147; Anag G., 2002, AFR ARCHAEOL REV, V19, P67, DOI DOI 10.1023/A:1015473709731; Anag G., 2007, EDEYEN MURZUQ ARCHAE; Applegate A., 2001, HOLOCENE SETTLEMENT, P468; BEKURE S, 1991, ILCA SYST S, V4, P1; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Biagetti S., 2003, SAHARA, V14, P7; Blench R, 2000, ORIGINS DEV AFRICAN; Bocherens H, 2001, CR ACAD SCI II A, V332, P67, DOI 10.1016/S1251-8050(00)01488-9; Boulos L., 2000, FLORA EGYPT; Bunting MJ, 2001, J ARCHAEOLOGICAL SCI, V28; Cancellieri E, MIDDLE STON IN PRESS; Caneva I., 1987, BRIT ARCHAEOLOGICAL, VS368, p[1978, 231]; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Chaix L, 2001, ANIMALS MAN ESSAYS H, P364; Clark J.D., 2008, ADRAR BOUS ARCHAEOLO, P355; CLARK JD, 2008, ADRAR BOUS ARCHAEOLO; Clutton-Brock J., 1989, WALKING LARDER PATTE; Corridi C., 1998, WADI TESHUINAT PALAE, P89; Cremaschi M., 1999, AFR ARCHAEOL REV, V16, P211, DOI DOI 10.1023/A:1021609623737; Cremaschi M, 2000, LASMO N FC 174 CONCE; Cremaschi M, 1997, PROCESSING QUARTZITE, P225; Cremaschi M, 2010, LANDSCAPES AND SOCIETIES: SELECTED CASES, P67, DOI 10.1007/978-90-481-9413-1_5; DANSGAARD W, 1964, TELLUS, V16, P436; de Lernia S, OXFORD HDB IN PRESS; di Lernia S, 2002, DROUGHTS FOOD CULTUR, P225; di Lernia S., 2008, MEMORIA ARTE PITTURE; di Lernia S, 2006, QUATERN INT, V151, P50, DOI 10.1016/j.quaint.2006.01.014; di Lernia S, 2010, ANTIQUITY, V84, P954, DOI 10.1017/S0003598X00067016; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; Dupire Marguerite, 1962, PEULS NOMADES ETUDE; Evans-Pritchard E.E., 1940, NUER DESCRIPTION MOD; Florenzano A, 2012, GEOARCHAEOLOGY, V27, P34, DOI 10.1002/gea.21390; Galaty J. G., 1989, WALKING LARDER PATTE, P215; Gallin A, 2008, CAHIERS AARS, V12, P71; Gallinaro M, 2012, MESSAK PROJECT CULTU; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Gauthier Y., 2004, CAHIERS AARS, V9, P45; Gifford-Gonzalez D., 2008, ADRAR BOUS ARCHAEOLO, P313; Gifford-Gonzalez D., 2000, AFR ARCHAEOL REV; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Giraudi C, 2012, HOLOCENE PALAEOCLIMA; Graziosi P, 1942, ARTE RUPESTRE LIBIA; HASSAN FA, 2002, DROUGHTS FOOD CULTUR; Herskovits MJ, 1926, AM ANTHROPOL, V28, P230, DOI 10.1525/aa.1926.28.1.02a00050; Hildebrand EA, 2011, J FIELD ARCHAEOL, V36, P181, DOI 10.1179/009346911X12991472411088; Jelinek J., 2004, SAHARA HIST ART RUPE; Jelinek J., 2003, CAHIERS AARS, V8, P41; Kobusiewicz M, 2009, BURIAL PRACTICES FIN, P147; Lane P., PATH VERSUS IN PRESS; LE QuELLEC J.-L., 1998, ART RUPESTRE PREHIST; Lezine A. -M., 2007, ENCY QUATERNARY SCI, V4, P2682; Lhote Henri, 1959, SEARCH TASSILI FRESC; Lienhardt Ronald Godfrey, 1961, DIVINITY EXPERIENCE; Lutz R., 1995, SECRET DESERT ROCK A; Marshall F, 2002, J WORLD PREHIST, V16, P99, DOI 10.1023/A:1019954903395; Mercuri AM, 2008, J ARID ENVIRON, V72, P1950, DOI 10.1016/j.jaridenv.2008.04.008; Mercuri AM, GOBERO NO R IN PRESS; Mercuri AM, 2008, J ARCHAEOL SCI, V35, P1619, DOI 10.1016/j.jas.2007.11.003; Ozenda P., 2000, FLORE VEGETATION SAH; Paris F., 2000, ORIGINS DEV AFRICAN, P111; Perego A, 2011, J MAPS, V7, P464, DOI 10.4113/jom.2011.1207; Poland M, 2003, ABUNDANT HERBS CELEB; Ponti R., 2003, SAHARA, V14, P161; Ponti R., 2001, SAHARA, V13, P132; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Roset JP, 1987, INT J FRENCH QUATERN, V32, P203; Silvermann BW, 1986, MONOGRAPHS STAT APPL; SMEDLEY MP, 1991, OECOLOGIA, V85, P314, DOI 10.1007/BF00320605; Smith AB, 2005, AFRICAN HERDERS EMER; Stenning Derrick J., 1959, SAVANNAH NOMADS STUD; Tafuri MA, J ANTHR ARC IN PRESS; Tafuri MA, 2006, J ANTHROPOL ARCHAEOL, V25, P390, DOI 10.1016/j.jaa.2006.01.002; Tauveron M, 2009, PALAEOECO A, V29, P179; Trevisan Grandi G., 1998, WADI TESHUINAT PALAE, P95; Van Albada A., 2000, MONTAGNE HOMMES CHIE; Watrin J, 2009, CR GEOSCI, V341, P656, DOI 10.1016/j.crte.2009.06.007; Wendorf F, 1998, J ANTHROPOL ARCHAEOL, V17, P97, DOI 10.1006/jaar.1998.0319; Wendorf F., 2001, HOLOCENE SETTLEMENT; Wendorf F., 1997, DYNAMICS POPULATIONS, P90; White F., 1983, VEGETATION AFRICA DE; Zerboni A, 2011, GEOMORPHOLOGY, V125, P319, DOI 10.1016/j.geomorph.2010.10.015; Zerboni A, 2008, GEOMORPHOLOGY, V102, P640, DOI 10.1016/j.geomorph.2008.06.010	84	53	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56879	10.1371/journal.pone.0056879	http://dx.doi.org/10.1371/journal.pone.0056879			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	093IE	23437260	gold, Green Published			2022-12-27	WOS:000315184200176
J	Fang, HS; Liu, AD; Sun, J; Kitz, A; Dirsch, O; Dahmen, U				Fang, Haoshu; Liu, Anding; Sun, Jian; Kitz, Alexandra; Dirsch, Olaf; Dahmen, Uta			Granulocyte Colony Stimulating Factor Induces Lipopolysaccharide (LPS) Sensitization via Upregulation of LPS Binding Protein in Rat	PLOS ONE			English	Article							INDUCED LIVER-INJURY; HEMORRHAGIC-SHOCK; G-CSF; ENDOTOXIN; MICE; INFECTION; RESPONSES; SEPSIS; LBP; ANTIBODIES	Liver is the main organ for lipopolysaccharide (LPS) clearance. Sensitization to LPS is associated with the upregulation of LPS-binding protein (LBP) in animal models. Therefore, we hypothesized that LBP could induce LPS sensitization through enhancing hepatic uptake of LPS. In this study, we examined the role of LBP in pathogenesis of LPS induced systemic inflammatory response syndrome (SIRS). LBP expression was upregulated after granulocyte colony stimulating (G-CSF) pretreatment. The effect of LBP was further confirmed by blockade of LBP using LBP blocking peptide - LBPK95A. After G-CSF pretreatment, upregulation of LBP was observed in bone marrow cells and liver. The G-CSF induced LBP upregulation caused LPS hypersensitization in rats as indicated by higher mortality and severer liver damage. Of note, LBP blockade increased the survival rate and attenuated the liver injury. The LBP induced LPS hypersensitization was associated with increased hepatic uptake of LPS and augmented hepatic expression of LPS receptors, such as toll-like receptor (TLR)-4. Furthermore, LBP mediated early neutrophil infiltration, which led to increased monocyte recruitment in liver after LPS administration. In conclusion, G-CSF induced LBP expression could serve as a new model for investigation of LPS sensitization. We demonstrated the crucial role of LBP upregulation in pathogenesis of LPS induced SIRS.	[Fang, Haoshu; Liu, Anding; Sun, Jian; Dahmen, Uta] Univ Hosp Jena, Jena, Germany; [Liu, Anding] Huazhong Univ Sci & Technol, Ctr Med Expt, Tongji Hosp, Wuhan 430074, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Dept Hepatobiliopancreat Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Kitz, Alexandra] Univ Gottingen, Inst Neuroimmunol, D-37073 Gottingen, Germany; [Dirsch, Olaf] Univ Hosp Jena, Inst Pathol, Jena, Germany	Friedrich Schiller University of Jena; Huazhong University of Science & Technology; Sun Yat Sen University; University of Gottingen; Friedrich Schiller University of Jena	Dahmen, U (corresponding author), Univ Hosp Jena, Jena, Germany.	uta.dahmen@med.uni-jena.de	Liu, Anding/AAU-2477-2020		German Federal Ministry for Education and Research (BMBF) Virtual Liver Network	German Federal Ministry for Education and Research (BMBF) Virtual Liver Network(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry for Education and Research (BMBF) Virtual Liver Network. URL: http://www.virtual-liver.de/ and Center for Sepsis Control and Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arana MD, 2003, J ENDOTOXIN RES, V9, P281, DOI 10.1177/09680519030090050301; Bo LL, 2011, CRIT CARE, V15, DOI 10.1186/cc10031; Cornelie S, 2002, INTENS CARE MED, V28, P1340, DOI 10.1007/s00134-002-1418-z; Cotroneo TM, 2012, INNATE IMMUN; FERLUGA J, 1978, LANCET, V2, P610; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; GALLAY P, 1994, P NATL ACAD SCI USA, V91, P7922, DOI 10.1073/pnas.91.17.7922; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Ji Y, 2009, J INVEST SURG, V22, P167, DOI 10.1080/08941930802713027; Le Roy D, 1999, J IMMUNOL, V162, P7454; LEDER LD, 1970, BLUT, V21, P1, DOI 10.1007/BF01633225; Lehnert M, 2006, AM J PHYSIOL-GASTR L, V291, pG456, DOI 10.1152/ajpgi.00480.2005; Liu AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035379; Lundblad R, 1996, CRIT CARE MED, V24, P820, DOI 10.1097/00003246-199605000-00016; MILESKI WJ, 1992, J APPL PHYSIOL, V73, P1146, DOI 10.1152/jappl.1992.73.3.1146; Minter RM, 2009, AM J PHYSIOL-GASTR L, V296, pG45, DOI 10.1152/ajpgi.00041.2008; MOORE MAS, 1991, ANNU REV IMMUNOL, V9, P159; Pollmacher T, 1996, BLOOD, V87, P900, DOI 10.1182/blood.V87.3.900.bloodjournal873900; PRINS JM, 1994, ANTIMICROB AGENTS CH, V38, P1211, DOI 10.1128/AAC.38.6.1211; Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Schumann RR, 1999, CLIN CHEM LAB MED, V37, P271, DOI 10.1515/CCLM.1999.047; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Scott MJ, 2009, HEPATOLOGY, V49, P1695, DOI 10.1002/hep.22839; Su GL, 2005, HEPATOLOGY, V41, P187, DOI 10.1002/hep.20533; SUTER E, 1962, J IMMUNOL, V89, P377; van OOsten M, 2001, J ENDOTOXIN RES, V7, P381, DOI 10.1177/09680519010070050601; Vollmer T, 2009, CLIN CHEM, V55, P295, DOI 10.1373/clinchem.2008.106195; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051; Yang KK, 2002, J IMMUNOL, V169, P4475, DOI 10.4049/jimmunol.169.8.4475; Yano R, 2010, J ANDROL, V31, P201, DOI 10.2164/jandrol.109.007880; Yasui M, 1995, HEPATO-GASTROENTEROL, V42, P683	35	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56654	10.1371/journal.pone.0056654	http://dx.doi.org/10.1371/journal.pone.0056654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437199	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200129
J	Othman, A; Ahmad, S; Megyerdi, S; Mussell, R; Choksi, K; Maddipati, KR; Elmarakby, A; Rizk, N; Al-Shabrawey, M				Othman, Amira; Ahmad, Saif; Megyerdi, Sylvia; Mussell, Rene; Choksi, Karishma; Maddipati, Krishna Rao; Elmarakby, Ahmed; Rizk, Nasser; Al-Shabrawey, Mohamed			12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; VASCULAR NAD(P)H OXIDASE; DIABETIC-RETINOPATHY; GROWTH-FACTOR; ADHESION MOLECULES; OXIDATIVE STRESS; ANGIOTENSIN-II; MOUSE MODEL; EXPRESSION; KINASE	The purpose of the current study was to evaluate the effect of 12/15-lipoxygenase (12/15-LOX) metabolites on retinal endothelial cell (REC) barrier function. FITC-dextran flux across the REC monolayers and electrical cell-substrate impedance sensing (ECIS) were used to evaluate the effect of 12- and 15-hydroxyeicosatetreanoic acids (HETE) on REC permeability and transcellular electrical resistance (TER). Effect of 12- or 15-HETE on the levels of zonula occludens protein 1 (ZO-1), reactive oxygen species (ROS), NOX2, pVEGF-R2 and pSHP1 was examined in the presence or absence of inhibitors of NADPH oxidase. In vivo studies were performed using Ins2(Akita) mice treated with or without the 12/15-LOX inhibitor baicalein. Levels of HETE and inflammatory mediators were examined by LC/MS and Multiplex Immunoassay respectively. ROS generation and NOX2 expression were also measured in mice retinas. 12- and 15-HETE significantly increased permeability and reduced TER and ZO-1expression in REC. VEGF-R2 inhibitor reduced the permeability effect of 12-HETE. Treatment of REC with HETE also increased ROS generation and expression of NOX2 and pVEGF-R2 and decreased pSHP1 expression. Treatment of diabetic mice with baicalein significantly decreased retinal HETE, ICAM-1, VCAM-1, IL-6, ROS generation, and NOX2 expression. Baicalein also reduced pVEGF-R2 while restored pSHP1 levels in diabetic retina. Our findings suggest that 12/15-LOX contributes to vascular hyperpermeability during DR via NADPH oxidase dependent mechanism which involves suppression of protein tyrosine phosphatase and activation of VEGF-R2 signal pathway.	[Othman, Amira; Megyerdi, Sylvia; Mussell, Rene; Choksi, Karishma; Elmarakby, Ahmed; Al-Shabrawey, Mohamed] GRU, Coll Dent Med, Dept Oral Biol Anat, Augusta, GA USA; [Othman, Amira; Al-Shabrawey, Mohamed] Mansoura Univ, Dept Anat, Mansoura, Egypt; [Ahmad, Saif; Al-Shabrawey, Mohamed] GRU, Med Coll Georgia, Dept Ophthalmol, Augusta, GA USA; [Ahmad, Saif; Al-Shabrawey, Mohamed] GRU, Med Coll Georgia, Vis Discovery Inst, Augusta, GA USA; [Maddipati, Krishna Rao] Wayne States Univ, Dept Pathol, Detroit, MI USA; [Elmarakby, Ahmed; Al-Shabrawey, Mohamed] GRU, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA; [Rizk, Nasser] Qatar Univ, Coll Sci, Dept Hlth Sci, Doha, Qatar	University System of Georgia; Augusta University; Egyptian Knowledge Bank (EKB); Mansoura University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Qatar University	Al-Shabrawey, M (corresponding author), GRU, Coll Dent Med, Dept Oral Biol Anat, Augusta, GA USA.	malshabrawey@gru.edu	Rizk, Nasser/AAE-4660-2022; Maddipati, Krishna Rao/H-3569-2019; Rizk, Nasser M/C-5174-2015; Maddipati, Krishna Rao/G-1859-2011; Elmarakby, Ahmed/ABF-5055-2021; Ahmad, Saif/K-5075-2013; Al-Shabrawey, Mohamed/P-9570-2018	Rizk, Nasser/0000-0002-6288-3609; Maddipati, Krishna Rao/0000-0003-1445-791X; Rizk, Nasser M/0000-0002-6288-3609; Maddipati, Krishna Rao/0000-0003-1445-791X; Othman, Amira/0000-0002-2437-8564; Al-Shabrawey, Mohamed/0000-0001-5362-7972; Rizk, Nasser/0000-0001-7629-1332	Qatar National Research Fund [NPRP 4 - 1046 - 3 " 284]; American Heart Association [AHA00104]; Vision Discovery Institute [VDI002010]; Bridge Fund from the Georgia Health Sciences University [BFP00018]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027926] Funding Source: NIH RePORTER	Qatar National Research Fund(Qatar National Research Fund (QNRF)); American Heart Association(American Heart Association); Vision Discovery Institute; Bridge Fund from the Georgia Health Sciences University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Qatar National Research Fund (NPRP 4 - 1046 - 3 " 284), American Heart Association (AHA00104) and Vision Discovery Institute (VDI002010) and Bridge Fund (BFP00018) from the Georgia Health Sciences University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3231, DOI 10.1167/iovs.08-1754; Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008; Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Behzadian MA, 1998, GLIA, V24, P216, DOI 10.1002/(SICI)1098-1136(199810)24:2<216::AID-GLIA6>3.3.CO;2-D; Bhatia S, 2003, CLIN BIOCHEM, V36, P557, DOI 10.1016/S0009-9120(03)00094-8; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Chen WQ, 2003, INVEST OPHTH VIS SCI, V44, P5016, DOI 10.1167/iovs.03-0418; CHEN XS, 1994, J BIOL CHEM, V269, P13979; Cheung CMG, 2012, MOL VIS, V18, P830; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Cui LL, 2010, PHARMACOL BIOCHEM BE, V96, P469, DOI 10.1016/j.pbb.2010.07.007; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6; Endo A, 2003, J RECEPT SIG TRANSD, V23, P239, DOI 10.1081/RRS-120025567; Funk CD, 1996, J BIOL CHEM, V271, P23338, DOI 10.1074/jbc.271.38.23338; GAITS F, 1995, BIOCHEM J, V311, P97, DOI 10.1042/bj3110097; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Guo DQ, 2000, J BIOL CHEM, V275, P11216, DOI 10.1074/jbc.275.15.11216; Haneda M, 1997, DIABETES, V46, P847, DOI 10.2337/diabetes.46.5.847; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Inoguchi T, 2003, CURR MED CHEM, V10, P1759, DOI 10.2174/0929867033457133; Kang SW, 2003, J AM SOC NEPHROL, V14, P3178, DOI 10.1097/01.ASN.0000099702.16315.DE; Khalfaoui T, 2008, J MOL HISTOL, V39, P243, DOI 10.1007/s10735-007-9159-5; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Ma J, 2005, PROSTAG LEUKOTR ESS, V72, P13, DOI 10.1016/j.plefa.2004.06.004; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Nardi M, 2004, J CLIN INVEST, V113, P973, DOI 10.1172/JCI200420726; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Natarajan R, 2003, FRONT BIOSCI-LANDMRK, V8, pS783, DOI 10.2741/1144; NOZAWA K, 1990, AM J PHYSIOL, V259, pH1774, DOI 10.1152/ajpheart.1990.259.6.H1774; Rojas M, 2010, INVEST OPHTH VIS SCI, V51, P1709, DOI 10.1167/iovs.09-3375; Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001; Tabet F, 2008, CIRC RES, V103, P149, DOI 10.1161/CIRCRESAHA.108.178608; Talahalli R, 2010, INVEST OPHTH VIS SCI, V51, P1699, DOI 10.1167/iovs.09-3557; Tawfik A, 2009, INVEST OPHTH VIS SCI, V50, P878, DOI 10.1167/iovs.08-2005; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Wen YH, 2008, AM J PHYSIOL-HEART C, V294, pH1933, DOI 10.1152/ajpheart.00260.2007; Whittles CE, 2002, MICROCIRCULATION, V9, P513, DOI 10.1038/sj.mn.7800164; Woo CH, 2000, BIOCHEM J, V348, P525, DOI 10.1042/0264-6021:3480525; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; Young BA, 2003, AM J PHYSIOL-LUNG C, V285, pL63, DOI 10.1152/ajplung.00423.2002; Zarbock A, 2009, J IMMUNOL, V183, P4715, DOI 10.4049/jimmunol.0802592	56	67	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57254	10.1371/journal.pone.0057254	http://dx.doi.org/10.1371/journal.pone.0057254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437353	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200231
J	Su, TH; Liu, CJ; Tseng, TC; Liu, CH; Yang, HC; Chen, CL; Chen, PJ; Kao, JH; Chen, DS				Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Chi-Ling; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn			Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; SURFACE-ANTIGEN LEVELS; VIRUS-INFECTION; NATURAL-HISTORY; ISOLATED ANTIBODY; CORE ANTIGEN; HBV DNA; QUANTIFICATION; CARRIERS; SEROCONVERTERS	Background & Aims: Quantitative HBsAg has been recognized to assist in the management of chronic hepatitis B virus (HBV) infection. However, its role in disease monitoring of HBeAg-negative patients remains unclear. We aimed to investigate the longitudinal HBsAg change in HBeAg-negative carriers with HBV genotype B or C infection. Methods: This is a retrospective cohort study conducted in a university hospital. Treatment-naive HBeAg-negative carriers followed for more than 3 years were recruited. Their hepatitis activities were categorized by longitudinal HBV-DNA levels into high viral-load (HVL: HBV-DNA >/=2000 IU/mL persistently), low viral-load (LVL: HBV-DNA <2000 IU/mL persistently) and fluctuated viral-load (FVL: HBV-DNA between HVL and LVL). The baseline and end-of-follow-up (EOF) HBsAg levels were quantified for analyses. Results: We recruited 187 patients with a median follow-up of 8 years. LVL patients had a significantly lower HBsAg at baseline and EOF and a significantly greater annualized HBsAg decline compared with the FVL and HVL. The longitudinal HBsAg change was independent of genotype B or C. The lower baseline HBsAg level predicted the HBsAg decline and HBsAg loss, whereas the higher baseline HBV-DNA predicted the hepatitis flare. A baseline HBsAg <50 IU/mL predicted subsequent HBsAg loss with a sensitivity of 82% and specificity of 67%. The annualized HBsAg decline appeared non-linear, and accelerated as the HBsAg level lowered (0.054, 0.091, 0.126 log(10) IU/mL in patients with baseline HBsAg >1000, 100-999, <100 IU/mL, respectively, P for trend = .014). Conclusions: In genotype B or C HBeAg-negative carriers, baseline HBsAg levels correlate with future disease activities and help to predict HBsAg decline or loss. Inactive carriers with lower baseline HBsAg levels have a greater and accelerating HBsAg decline over time, regardless of HBV genotypes.	[Su, Tung-Hung; Liu, Chun-Jen; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Liu, Chen-Hua; Chen, Chi-Ling; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Su, Tung-Hung; Liu, Chun-Jen; Liu, Chen-Hua; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei 100, Taiwan; [Tseng, Tai-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Yang, Hung-Chih] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital; National Taiwan University	Kao, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	kaojh@ntu.edu.tw	Kao, Jia-Horng/AAB-8947-2019; Liu, Chen-Hua/F-6608-2018; CHEN, DING-SHINN/T-4395-2019	Kao, Jia-Horng/0000-0002-2442-7952; Liu, Chen-Hua/0000-0003-3622-9707; YANG, HUNG-CHIH/0000-0003-3864-9895; LIU, CHUN-JEN/0000-0002-6202-0993; CHEN, DING-SHINN/0000-0001-7791-6154; Chen, Pei-Jer/0000-0001-8316-3785; SU, TUNG-HUNG/0000-0002-6747-7941	National Taiwan University Hospital [NTUH 100-S1914]; Department of Health; National Science Council, Executive Yuan, Taiwan	National Taiwan University Hospital(National Taiwan University); Department of Health; National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Taiwan University Hospital (NTUH 100-S1914), the Department of Health, and the National Science Council, Executive Yuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Brunetto MR, 2010, J HEPATOL, V52, P475, DOI 10.1016/j.jhep.2009.12.020; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Chan HLY, 2010, ALIMENT PHARM THER, V32, P1323, DOI 10.1111/j.1365-2036.2010.04474.x; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chan HLY, 2011, J INFECT DIS, V204, P408, DOI 10.1093/infdis/jir283; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Chen YC, 2012, CLIN GASTROENTEROL H, V10, P297, DOI 10.1016/j.cgh.2011.08.029; Chu CM, 2009, AM J GASTROENTEROL, V104, P1693, DOI 10.1038/ajg.2009.187; Chulanov VP, 2003, J MED VIROL, V69, P313, DOI 10.1002/jmv.10291; Feld JJ, 2007, HEPATOLOGY, V46, P1057, DOI 10.1002/hep.21811; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Kabir A, 2008, HUM VACCINES, V4, P379, DOI 10.4161/hv.4.5.6010; Kao JH, 2002, J CLIN MICROBIOL, V40, P1207, DOI 10.1128/JCM.40.4.1207-1209.2002; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2000, J HEPATOL, V33, P998, DOI 10.1016/S0168-8278(00)80135-X; Kao JH, 2004, J MED VIROL, V72, P363, DOI 10.1002/jmv.10534; Liaw YF, 2011, HEPATOLOGY, V53, P2121, DOI 10.1002/hep.24364; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu CJ, 2005, LIVER INT, V25, P1097, DOI 10.1111/j.1478-3231.2005.01177.x; LOK ASF, 1988, HEPATOLOGY, V8, P766, DOI 10.1002/hep.1840080411; Moucari R, 2009, ANTIVIR THER, V14, P1183, DOI 10.3851/IMP1458; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Pei SN, 2012, ANN HEMATOL, V91, P1007, DOI 10.1007/s00277-012-1405-6; Reijnders JGP, 2011, J HEPATOL, V54, P449, DOI 10.1016/j.jhep.2010.07.046; Su TH, 2010, ANTIVIR THER, V15, P1133, DOI 10.3851/IMP1696; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Taheri H, 2011, HEPAT MON, V11, P119; Tseng KC, 2003, HEPATO-GASTROENTEROL, V50, P1474; Tseng TC, 2012, HEPATOLOGY, V55, P68, DOI 10.1002/hep.24615; Tseng TC, 2012, J INFECT DIS, V205, P54, DOI 10.1093/infdis/jir687; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031	36	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55916	10.1371/journal.pone.0055916	http://dx.doi.org/10.1371/journal.pone.0055916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437072	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200030
J	Xue, ZH; Feng, C; Liu, WL; Tan, SM				Xue, Zhi-Hong; Feng, Chen; Liu, Wei-Ling; Tan, Suet-Mien			A Role of Kindlin-3 in Integrin alpha M beta 2 Outside-In Signaling and the Syk-Vav1-Rac1/Cdc42 Signaling Axis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP1; ADHESION DEFICIENCY-III; LEUKOCYTE ADHESION; DOWN-REGULATION; RHO GTPASES; MONOCYTE DIFFERENTIATION; MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; TYROSINE KINASE; FOCAL ADHESIONS	Integrins mediate cell-cell and cell-extracellular matrix attachments. Integrins are signaling receptors because their cytoplasmic tails are docking sites for cytoskeletal and signaling proteins. Kindlins are a family of band 4.1-ezrin-radixin-moesin-containing intracellular proteins. Apart from regulating integrin ligand-binding affinity, recent evidence suggests that kindlins are involved in integrin outside-in signaling. Kindlin-3 is expressed in platelets, hematopoietic cells and endothelial cells. In humans, loss of kindlin-3 expression accounts for the rare autosomal disease leukocyte adhesion deficiency (LAD) type III that is characterized by bleeding disorders and defective recruitment of leukocytes into sites of infection. Studies have shown that the loss of kindlin-3 expression leads to poor ligand-binding properties of beta 1, beta 2 and beta 3 integrin subfamilies. The leukocyte-restricted beta 2 integrin subfamily comprises four members, namely alpha L beta 2, alpha M beta 2, alpha X beta 2 and alpha D beta 2. Integrin alpha M beta 2 mediates leukocyte adhesion, phagocytosis, degranulation and it is involved in the maintenance of immune tolerance. Here we provide further evidence that kindlin-3 is required for integrin alpha M beta 2-mediated cell adhesion and spreading using transfected K562 cells that expressed endogenous kindlin-3 but not beta 2 integrins. K562 stable cell line expressing si-RNA targeting kindlin-3, but not control-si-RNA, and transfected with constitutively activated integrin alpha M beta 2N329S adhered and spread poorly on iC3b. We also show that kindlin-3 is required for the integrin alpha M beta 2-Syk-Vav1 signaling axis that regulates Rac1 and Cdc42 activities. These findings reinforce a role for kindlin-3 in integrin outside-in signaling.	[Xue, Zhi-Hong; Feng, Chen; Liu, Wei-Ling; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	smtan@ntu.edu.sg	Tan, Suet/A-2224-2011; Xue, Zhihong/T-8848-2019	Tan, Suet-Mien/0000-0003-2371-8739	Singapore Ministry of Education grant [2010-T2-2-014]; Singapore Agency for Science, Technology, and Research Biomedical Research Council grant [10/1/22/19/654]	Singapore Ministry of Education grant(Ministry of Education, Singapore); Singapore Agency for Science, Technology, and Research Biomedical Research Council grant	This work was supported by Singapore Ministry of Education grant 2010-T2-2-014 and Singapore Agency for Science, Technology, and Research Biomedical Research Council grant 10/1/22/19/654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; ARNAOUT MA, 1983, J CLIN INVEST, V72, P171, DOI 10.1172/JCI110955; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Bouaouina M, 2011, CURR BIOL, V21, pR99, DOI 10.1016/j.cub.2010.12.002; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Butler B, 2003, J BIOL CHEM, V278, P5264, DOI 10.1074/jbc.M206997200; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Ding ZM, 1999, J IMMUNOL, V163, P5029; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Graff JC, 2007, J LEUKOCYTE BIOL, V82, P603, DOI 10.1189/jlb.0207125; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jung GY, 2011, J CELL BIOCHEM, V112, P2541, DOI 10.1002/jcb.23178; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Manevich-Mendelson E, 2009, BLOOD, V114, P2344, DOI 10.1182/blood-2009-04-218636; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; McEver RP, 2007, NAT IMMUNOL, V8, P1035, DOI 10.1038/ni1007-1035; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miao H, 2002, J CELL SCI, V115, P2199; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shaw JM, 2001, CLIN EXP IMMUNOL, V126, P311, DOI 10.1046/j.1365-2249.2001.01661.x; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Stephens P, 1995, CELL ADHES COMMUN, V3, P375, DOI 10.3109/15419069509081292; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Tang ML, 2006, BIOCHEM BIOPH RES CO, V348, P1184, DOI 10.1016/j.bbrc.2006.07.179; Tang XY, 2008, J IMMUNOL, V180, P4793, DOI 10.4049/jimmunol.180.7.4793; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Xue ZH, 2010, J IMMUNOL, V184, P3697, DOI 10.4049/jimmunol.0903316; Yan SR, 1997, J IMMUNOL, V158, P1902; Yu Y, 2012, EMBO REP, V13, P750, DOI 10.1038/embor.2012.88	80	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56911	10.1371/journal.pone.0056911	http://dx.doi.org/10.1371/journal.pone.0056911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437269	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200183
J	Zhang, YF; Anderson, SJ; French, SL; Sikes, ML; Viktorovskaya, OV; Huband, J; Holcomb, K; Hartman, JL; Beyer, AL; Schneider, DA				Zhang, Yinfeng; Anderson, Susan J.; French, Sarah L.; Sikes, Martha L.; Viktorovskaya, Olga V.; Huband, Jacalyn; Holcomb, Katherine; Hartman, John L.; Beyer, Ann L.; Schneider, David A.			The SWI/SNF Chromatin Remodeling Complex Influences Transcription by RNA Polymerase I in Saccharomyces cerevisiae	PLOS ONE			English	Article							RIBOSOMAL-RNA; HISTONE ACETYLTRANSFERASE; REPRESSES TRANSCRIPTION; GENE-EXPRESSION; MULTIPLE STEPS; YEAST; ELONGATION; RECRUITMENT; ACTIVATION; DNA	SWI/SNF is a chromatin remodeling complex that affects transcription initiation and elongation by RNA polymerase II. Here we report that SWI/SNF also plays a role in transcription by RNA polymerase I (Pol I) in Saccharomyces cerevisiae. Deletion of the genes encoding the Snf6p or Snf5p subunits of SWI/SNF was lethal in combination with mutations that impair Pol I transcription initiation and elongation. SWI/SNF physically associated with ribosomal DNA ( rDNA) within the coding region, with an apparent peak near the 59 end of the gene. In snf6 Delta cells there was a similar to 2.5-fold reduction in rRNA synthesis rate compared to WT, but there was no change in average polymerase occupancy per gene, the number of rDNA gene repeats, or the percentage of transcriptionally active rDNA genes. However, both ChIP and EM analyses showed a small but reproducible increase in Pol I density in a region near the 59 end of the gene. Based on these data, we conclude that SWI/SNF plays a positive role in Pol I transcription, potentially by modifying chromatin structure in the rDNA repeats. Our findings demonstrate that SWI/SNF influences the most robust transcription machinery in proliferating cells.	[Zhang, Yinfeng; Anderson, Susan J.; Viktorovskaya, Olga V.; Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [French, Sarah L.; Sikes, Martha L.; Beyer, Ann L.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Hartman, John L.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Huband, Jacalyn; Holcomb, Katherine] Univ Virginia, Alliance Computat Sci & Engn, Charlottesville, VA USA	University of Alabama System; University of Alabama Birmingham; University of Virginia; University of Alabama System; University of Alabama Birmingham; University of Virginia	Schneider, DA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091; Hartman, John/0000-0003-1176-6469	NIH [GM63952, GM84946]; Howard Hughes Medical Institute [P/S ECA 57005927]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946, R01GM063952] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM63952 to ALB; NIH GM84946 to DAS; Howard Hughes Medical Institute P/S ECA 57005927 to JLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert B, 2012, GENET RES INT, V2012, DOI 10.1155/2012/276948; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson SJ, 2011, J BIOL CHEM, V286, P18816, DOI 10.1074/jbc.M110.202101; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; CARLSON M, 1981, GENETICS, V98, P25; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Ferreira ME, 2009, FEBS J, V276, P2557, DOI 10.1111/j.1742-4658.2009.06979.x; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Gunawardena RW, 2007, J BIOL CHEM, V282, P20116, DOI 10.1074/jbc.M701406200; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jones HS, 2007, NAT STRUCT MOL BIOL, V14, P123, DOI 10.1038/nsmb1199; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; NEIGEBORN L, 1984, GENETICS, V108, P845; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Schneider DA, 2012, GENE, V493, P176, DOI 10.1016/j.gene.2011.08.006; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Singh I, 2009, GENETICS, V181, P289, DOI 10.1534/genetics.108.092981; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Thomson E, 2010, MOL CELL BIOL, V30, P976, DOI 10.1128/MCB.01359-09; Tong A, 2005, YEAST PROTOCOLS METH, P171; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Zhang Y, 2010, J BIOL CHEM, V108, P6079; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	57	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56793	10.1371/journal.pone.0056793	http://dx.doi.org/10.1371/journal.pone.0056793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437238	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200162
J	Pancera, M; Yang, YP; Louder, MK; Gorman, J; Lu, G; McLellan, JS; Stuckey, J; Zhu, J; Burton, DR; Koff, WC; Mascola, JR; Kwong, PD				Pancera, Marie; Yang, Yongping; Louder, Mark K.; Gorman, Jason; Lu, Gabriel; McLellan, Jason S.; Stuckey, Jonathan; Zhu, Jiang; Burton, Dennis R.; Koff, Wayne C.; Mascola, John R.; Kwong, Peter D.			N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; CD4 BINDING; POTENT; GP120; SEQUENCE; SITE; GP41; ASSOCIATION; PREDICTION	Dozens of broadly neutralizing HIV-1 antibodies have been isolated in the last few years from the sera of HIV-1-infected individuals. Only a limited number of regions on the HIV-1 spike, however, are recognized by these antibodies. One of these regions (N332) is characterized by an N-linked glycan at residue 332 on HIV-1 gp120 and is recognized by antibody 2G12 and by the recently reported antibodies PGT121-137, the latter isolated from three donors. To investigate the diversity in mode of antibody recognition at the N332 site, we used functional complementation between antibody heavy and light chains as a means of assessing similarity in mode of recognition. We examined a matrix of 12 PGT-heavy chains with each of 12 PGT-light chains. Expression in 96-well format for the 144 antibodies (132 chimeric and 12 wild-type) was generally consistent (58+/-10 mu g/ml). In contrast, recognition of HIV-1 gp120 was bimodal: when the source of heavy and light chains was from the same donor, recognition was good; when sources of heavy and light chains were from different donors, recognition was poor. Moreover, neutralization of HIV-1 strains SF162.LS and TRO.11 generally followed patterns of gp120 recognition. These results are consistent with published sequence, mutational, and structural findings, all of which indicate that N332-directed neutralizing antibodies from different donors utilize different modes of recognition, and provide support for a correlation between functional complementation of antibody heavy and light chains and similarity in antibody mode of recognition. Overall, our results add to the growing body of evidence that the human immune system is capable of recognizing the N332-region of HIV-1 gp120 in diverse ways.	[Pancera, Marie; Yang, Yongping; Louder, Mark K.; Gorman, Jason; Lu, Gabriel; McLellan, Jason S.; Zhu, Jiang; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Burton, Dennis R.] Harvard Univ, Cambridge, MA 02138 USA; [Koff, Wayne C.] Int AIDS Vaccine Initiat IAVI, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; International AIDS Vaccine Initiative	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Mascola, John/AAI-7193-2021; Gorman, Jason/AGG-9417-2022	McLellan, Jason/0000-0003-3991-542X; Gorman, Jason/0000-0002-3775-6560	National Institutes of Health (NIH); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005022] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the National Institutes of Health (NIH) and by the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinandan KR, 2010, PROTEIN ENG DES SEL, V23, P689, DOI 10.1093/protein/gzq043; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chailyan A, 2011, FEBS J, V278, P2858, DOI 10.1111/j.1742-4658.2011.08207.x; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen Yunjia, 2008, V426, P209, DOI 10.1007/978-1-60327-058-8_13; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Jayaram N, 2012, PROTEIN ENG DES SEL, V25, P523, DOI 10.1093/protein/gzs043; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Kwong PD, 2009, CELL HOST MICROBE, V6, P292, DOI 10.1016/j.chom.2009.09.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Moore PL, 2011, AIDS RES HUM RETROV, V27, pA29; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Mouquet H, 2012, P NATL ACAD SCI US; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Noonan Daniel J, 2004, Methods Mol Biol, V284, P51; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	41	29	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55701	10.1371/journal.pone.0055701	http://dx.doi.org/10.1371/journal.pone.0055701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431362	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800005
J	Perony, N; Townsend, SW				Perony, Nicolas; Townsend, Simon W.			Why Did the Meerkat Cross the Road? Flexible Adaptation of Phylogenetically-Old Behavioural Strategies to Modern-Day Threats	PLOS ONE			English	Article							SELFISH HERD; PROGRESSIONS	Risk-sensitive adaptive spatial organisation during group movement has been shown to efficiently minimise the risks associated with external ecological threats. Whether animals can draw on such behaviours when confronted with man-made threats is generally less clear. We studied road-crossing in a wild, but habituated, population of meerkats living in the Kalahari Desert, South Africa. We found that dominant females, the core member in meerkat social systems, led groups to the road significantly more often than subordinates, yet were consistently less likely to cross first. Our results suggest that a reshuffling occurs in progression order when meerkat groups reach the road. By employing a simple model of collective movement, we have shown that risk aversion alone may be sufficient to explain this reshuffling, but that the risk aversion of dominant females toward road crossing is significantly higher than that of subordinates. It seems that by not crossing first, dominant females avoid occupying the most risky, exposed locations, such as at the front of the group - a potential selfish strategy that also promotes the long-term stability and hence reproductive output of their family groups. We argue that our findings support the idea that animals can flexibly apply phylogenetically-old behavioural strategies to deal with emerging modern-day problems.	[Perony, Nicolas] Swiss Fed Inst Technol, Chair Syst Design, Zurich, Switzerland; [Townsend, Simon W.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Townsend, Simon W.] Kuruman River Reserve, Kalahari Meerkat Project, No Cape, South Africa	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Townsend, SW (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	simon.townsend@ieu.uzh.ch		Perony, Nicolas/0000-0002-2918-163X	University of Zurich; ETH Zurich; NERC [NE/H004912/1] Funding Source: UKRI; Natural Environment Research Council [NE/H004912/1] Funding Source: researchfish	University of Zurich; ETH Zurich(ETH Zurich); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by University of Zurich and ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN SA, 1979, ANIM BEHAV, V27, P46, DOI 10.1016/0003-3472(79)90128-3; Clutton-Brock TH, 2005, ANIM BEHAV, V69, P1273, DOI 10.1016/j.anbehav.2004.10.006; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Quinn JL, 2006, P R SOC B, V273, P2521, DOI 10.1098/rspb.2006.3612; RHINE RJ, 1985, INT J PRIMATOL, V6, P115, DOI 10.1007/BF02693649; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Viscido SV, 2002, ANIM BEHAV, V63, P735, DOI 10.1006/anbe.2001.1935	14	6	6	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e52834	10.1371/journal.pone.0052834	http://dx.doi.org/10.1371/journal.pone.0052834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441144	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000315159200002
J	Shields, RC; Mokhtar, N; Ford, M; Hall, MJ; Burgess, JG; ElBadawey, MR; Jakubovics, NS				Shields, Robert C.; Mokhtar, Norehan; Ford, Michael; Hall, Michael J.; Burgess, J. Grant; ElBadawey, Mohamed Reda; Jakubovics, Nicholas S.			Efficacy of a Marine Bacterial Nuclease against Biofilm Forming Microorganisms Isolated from Chronic Rhinosinusitis	PLOS ONE			English	Article							EXTRACELLULAR DNA; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; CHRONIC SINUSITIS; IDENTIFICATION; EPIDEMIOLOGY; DIAGNOSIS; SURGERY; MUCOSA; MATRIX	Background: The persistent colonization of paranasal sinus mucosa by microbial biofilms is a major factor in the pathogenesis of chronic rhinosinusitis (CRS). Control of microorganisms within biofilms is hampered by the presence of viscous extracellular polymers of host or microbial origin, including nucleic acids. The aim of this study was to investigate the role of extracellular DNA in biofilm formation by bacteria associated with CRS. Methods/Principal Findings: Obstructive mucin was collected from patients during functional endoscopic sinus surgery. Examination of the mucous by transmission electron microscopy revealed an acellular matrix punctuated occasionally with host cells in varying states of degradation. Bacteria were observed in biofilms on mucosal biopsies, and between two and six different species were isolated from each of 20 different patient samples. In total, 16 different bacterial genera were isolated, of which the most commonly identified organisms were coagulase-negative staphylococci, Staphylococcus aureus and alpha-haemolytic streptococci. Twenty-four fresh clinical isolates were selected for investigation of biofilm formation in vitro using a microplate model system. Biofilms formed by 14 strains, including all 9 extracellular nuclease-producing bacteria, were significantly disrupted by treatment with a novel bacterial deoxyribonuclease, NucB, isolated from a marine strain of Bacillus licheniformis. Extracellular biofilm matrix was observed in untreated samples but not in those treated with NucB and extracellular DNA was purified from in vitro biofilms. Conclusion/Significance: Our data demonstrate that bacteria associated with CRS form robust biofilms which can be reduced by treatment with matrix-degrading enzymes such as NucB. The dispersal of bacterial biofilms with NucB may offer an additional therapeutic target for CRS sufferers.	[Shields, Robert C.; Mokhtar, Norehan; Jakubovics, Nicholas S.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mokhtar, Norehan] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia; [Ford, Michael] Freeman Rd Hosp, Dept Microbiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Hall, Michael J.] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Burgess, J. Grant] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [ElBadawey, Mohamed Reda] Freeman Rd Hosp, Dept Otolaryngol & Head & Neck Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [ElBadawey, Mohamed Reda] Tanta Univ, Dept Otolaryngol, Tanta, Egypt	Newcastle University - UK; Universiti Sains Malaysia; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Egyptian Knowledge Bank (EKB); Tanta University	Jakubovics, NS (corresponding author), Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	nick.jakubovics@ncl.ac.uk	Jakubovics, Nicholas S/B-1938-2010; Hall, Michael/N-2458-2019; Hall, Michael J/A-4126-2012; Shields, Robert C./I-7890-2019	Jakubovics, Nicholas S/0000-0001-6667-0515; Hall, Michael/0000-0001-6475-9161; Hall, Michael J/0000-0001-6475-9161; Shields, Robert C./0000-0002-8823-9504; Mokhtar, Norehan/0000-0002-8851-1539	NERC [NE/I01523X/1]; Centre for Oral Health Research at Newcastle University	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Centre for Oral Health Research at Newcastle University	This study was supported by an NERC follow-on-fund grant NE/I01523X/1 awarded to JGB, and by a PhD studentship to RS from the Centre for Oral Health Research at Newcastle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Araujo Elisabeth, 2007, Braz J Otorhinolaryngol, V73, P549; Bassiouni A, 2012, LARYNGOSCOPE, V122, P460, DOI 10.1002/lary.22461; Beenken KE, 2012, INFECT IMMU IN PRESS; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Benninger MS, 2003, OTOLARYNG HEAD NECK, V129, pS1, DOI 10.1016/S0194-5998(03)01397-4; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Brook I, 2005, J CLIN MICROBIOL, V43, P3479, DOI 10.1128/JCM.43.7.3479-3480.2005; Brook I, 2006, ARCH OTOLARYNGOL, V132, P1099, DOI 10.1001/archotol.132.10.1099; CATLIN BW, 1956, SCIENCE, V124, P441, DOI 10.1126/science.124.3219.441; Cerqueira L, 2008, INT J MOL SCI, V9, P1944, DOI 10.3390/ijms9101944; Chakrabarti A, 2009, MED MYCOL, V47, pS299, DOI 10.1080/13693780802213357; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Diez-Garcia M, 2012, FOOD MICROBIOL, V31, P173, DOI 10.1016/j.fm.2012.03.012; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dominiak DM, 2011, ENVIRON MICROBIOL, V13, P710, DOI 10.1111/j.1462-2920.2010.02375.x; DOYLE PW, 1991, J CLIN MICROBIOL, V29, P2396, DOI 10.1128/JCM.29.11.2396-2400.1991; Feazel LM, 2012, LARYNGOSCOPE, V122, P467, DOI 10.1002/lary.22398; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Foreman A, 2012, CURR ALLERGY ASTHM R, V12, P127, DOI 10.1007/s11882-012-0246-7; Gilbert P, 1997, Adv Dent Res, V11, P160; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Healy DY, 2008, OTOLARYNG HEAD NECK, V138, P641, DOI 10.1016/j.otohns.2008.02.002; Hochstim CJ, 2010, OTOLARYNG HEAD NECK, V143, P697, DOI 10.1016/j.otohns.2010.07.017; JOUSIMIESSOMER HR, 1989, J CLIN MICROBIOL, V27, P2736, DOI 10.1128/JCM.27.12.2736-2743.1989; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113; Khalil HS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004458.pub2; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lara JF, 2001, ARCH PATHOL LAB MED, V125, P1442; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lim M, 2008, AM J RHINOL, V22, P381, DOI 10.2500/ajr.2008.22.3189; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Martins M, 2010, MYCOPATHOLOGIA, V169, P323, DOI 10.1007/s11046-009-9264-y; Matthews PC, 2011, J CLIN MICROBIOL, V49, P2740, DOI 10.1128/JCM.00722-11; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032; Palmer LJ, 2012, J PERIODONTAL RES, V47, P439, DOI 10.1111/j.1600-0765.2011.01451.x; Pimenta P, 2008, LETT APPL MICROBIOL, V46, P307, DOI 10.1111/j.1472-765X.2007.02310.x; Piromchai P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008233.pub2; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Prince AA, 2008, AM J RHINOL, V22, P239, DOI 10.2500/ajr.2008.22.3180; Ramadan HH, 2005, OTOLARYNG HEAD NECK, V132, P414, DOI 10.1016/j.otohns.2004.11.011; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seper A, 2011, MOL MICROBIOL, V82, P1015, DOI 10.1111/j.1365-2958.2011.07867.x; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; SYED SA, 1972, APPL MICROBIOL, V24, P638, DOI 10.1128/AEM.24.4.638-644.1972; Taylor MJ, 2002, OTOLARYNG HEAD NECK, V127, P377, DOI 10.1067/mhn.2002.128896; Tetz VV, 2010, DNA CELL BIOL, V29, P399, DOI 10.1089/dna.2009.1011; Thompson GR, 2012, J ALLERGY CLIN IMMUN, V129, P321, DOI 10.1016/j.jaci.2011.11.039; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Zhang Z, 2011, OTOLARYNG HEAD NECK, V144, P457, DOI 10.1177/0194599810394302	64	55	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55339	10.1371/journal.pone.0055339	http://dx.doi.org/10.1371/journal.pone.0055339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441151	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200009
J	Brereton, MF; Wareing, M; Jones, RL; Greenwood, SL				Brereton, Melissa F.; Wareing, Mark; Jones, Rebecca L.; Greenwood, Susan L.			Characterisation of K+ Channels in Human Fetoplacental Vascular Smooth Muscle Cells	PLOS ONE			English	Article							HUMAN PLACENTAL ARTERIES; POTASSIUM CHANNELS; NITRIC-OXIDE; CURRENTS; EXPRESSION; VASOCONSTRICTION; INVOLVEMENT; ACTIVATION; DIVERSITY; CONDUIT	Adequate blood flow through placental chorionic plate resistance arteries (CPAs) is necessary for oxygen and nutrient transfer to the fetus and a successful pregnancy. In non-placental vascular smooth muscle cells (SMCs), K+ channels regulate contraction, vascular tone and blood flow. Previous studies showed that K+ channel modulators alter CPA tone, but did not distinguish between effects on K+ channels in endothelial cells and SMCs. In this study, we developed a preparation of freshly isolated CPASMCs of normal pregnancy and investigated K+ channel expression and function. CPASMCs were isolated from normal human term placentas using enzymatic digestion. Purity and phenotype was confirmed with immunocytochemistry. Whole-cell patch clamp was used to assess K+ channel currents, and mRNA and protein expression was determined in intact CPAs and isolated SMCs with RT-PCR and immunostaining. Isolated SMCs expressed alpha-actin but not CD31, a marker of endothelial cells. CPASMCs and intact CPAs expressed h-caldesmon and non-muscle myosin heavy chain-2; phenotypic markers of contractile and synthetic SMCs respectively. Whole-cell currents were inhibited by 4-AP, TEA, charybdotoxin and iberiotoxin implicating functional K-v and BKCa channels. 1-EBIO enhanced whole cell currents which were abolished by TRAM-34 and reduced by apamin indicating activation of IKCa and SKCa respectively. BKCa, IKCa and SK(Ca)3 mRNA and/or protein were expressed in CPASMCs and intact CPAs. This study provides the first direct evidence for functional K-v, BKCa, IKCa and SKCa channels in CPASMCs. These cells display a mixed phenotype implicating a dual role for CPASMCs in controlling both fetoplacental vascular resistance and vasculogenesis.	[Brereton, Melissa F.; Wareing, Mark; Jones, Rebecca L.; Greenwood, Susan L.] Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr,Inst Human Dev, Manchester M13 0JH, Lancs, England	University of Manchester	Brereton, MF (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	melissa.brereton@dpag.ox.ac.uk	Jones, Rebecca/E-4481-2011; Wareing, Mark/J-6396-2015	Jones, Rebecca/0000-0002-8871-0589; Wareing, Mark/0000-0002-1333-0899; Greenwood, Susan/0000-0003-2867-4368	University of Manchester Medical Research Council Doctoral Training Grant [G0800127]; Tommy's the baby charity	University of Manchester Medical Research Council Doctoral Training Grant; Tommy's the baby charity	This work was supported by University of Manchester 2008-2012 Medical Research Council Doctoral Training Grant (G0800127), Tommy's the baby charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 1996, CIRC RES, V78, P431, DOI 10.1161/01.RES.78.3.431; Beech DJ, 2007, BIOCHEM SOC T, V35, P890, DOI 10.1042/BST0350890; Beech DJ, 2006, J PHYSIOL-LONDON, V570, P1, DOI 10.1113/jphysiol.2005.101873; BEECH DJ, 1989, J PHYSIOL-LONDON, V418, P293, DOI 10.1113/jphysiol.1989.sp017841; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; CLAPP LH, 1991, EXP PHYSIOL, V76, P677, DOI 10.1113/expphysiol.1991.sp003535; Corcoran J, 2008, HYPERTENS PREGNANCY, V27, P75, DOI 10.1080/10641950701826158; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Fyfe GK, 2012, J OBSTET GYNAECOL, V32, P624, DOI 10.3109/01443615.2012.709288; Gardener MJ, 1999, BRIT J PHARMACOL, V128, P1064, DOI 10.1038/sj.bjp.0702916; Garland C.J., 2010, BR J PHARM; Gollasch M, 1996, CIRC RES, V78, P676, DOI 10.1161/01.RES.78.4.676; Guiet-Bara A, 1999, BIOELECTROCH BIOENER, V48, P407, DOI 10.1016/S0302-4598(99)00020-3; Halliday FC, 1995, BRIT J PHARMACOL, V116, P3139, DOI 10.1111/j.1476-5381.1995.tb15116.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hampl V, 2002, AM J PHYSIOL-HEART C, V283, pH2440, DOI 10.1152/ajpheart.01033.2001; Ibrahim B, 1998, BIOELECTROCH BIOENER, V45, P131, DOI 10.1016/S0302-4598(97)00105-0; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jackson WF, 2000, HYPERTENSION, V35, P173, DOI 10.1161/01.HYP.35.1.173; Jewsbury S, 2007, EUR J CLIN INVEST, V37, P65, DOI 10.1111/j.1365-2362.2007.01749.x; Kiernan MF, 2010, PLACENTA, V31, P553, DOI 10.1016/j.placenta.2010.03.009; Ko EA, 2007, AM J PHYSIOL-CELL PH, V293, pC928, DOI 10.1152/ajpcell.00101.2007; MAIGAARD S, 1986, ACTA PHYSIOL SCAND, V128, P23, DOI 10.1111/j.1748-1716.1986.tb07945.x; McNeish AJ, 2006, STROKE, V37, P1277, DOI 10.1161/01.STR.0000217307.71231.43; Mills TA, 2009, REPROD SCI A, V163A; MYATT L, 1991, AM J OBSTET GYNECOL, V164, P687, DOI 10.1016/S0002-9378(11)80047-5; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Neylon CB, 2002, VASC PHARMACOL, V38, P35, DOI 10.1016/S1537-1891(02)00124-6; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Platoshyn O, 2004, AM J PHYSIOL-LUNG C, V287, pL226, DOI 10.1152/ajplung.00438.2003; Reeve HL, 1998, AM J PHYSIOL-LUNG C, V275, pL1019, DOI 10.1152/ajplung.1998.275.6.L1019; Rhodes MT, 2001, AM J PHYSIOL-LUNG C, V280, pL1250, DOI 10.1152/ajplung.2001.280.6.L1250; Sampson U, 2010, P PHYSL SOC, V20, pPC4; Sand A, 2006, PLACENTA, V27, P181, DOI 10.1016/j.placenta.2004.12.013; SMIRNOV SV, 1992, J PHYSIOL-LONDON, V457, P431, DOI 10.1113/jphysiol.1992.sp019386; Smirnov SV, 2002, J PHYSIOL-LONDON, V538, P867, DOI 10.1113/jphysiol.2001.013003; Snetkov VA, 1998, PEDIATR RES, V43, P548, DOI 10.1203/00006450-199804000-00019; Sones WR, 2009, BRIT J PHARMACOL, V158, P521, DOI 10.1111/j.1476-5381.2009.00332.x; Standen NB, 1998, ACTA PHYSIOL SCAND, V164, P549; Sweeney M, 2006, PLACENTA, V27, P635, DOI 10.1016/j.placenta.2005.05.010; Wareing M, 2006, PLACENTA, V27, P660, DOI 10.1016/j.placenta.2005.05.012; Wareing M, 2011, PLACENTA, V32, pS203, DOI 10.1016/j.placenta.2010.12.022; Wareing M, 2002, PLACENTA, V23, P400, DOI 10.1053/plac.2002.0825; Wareing M, 2006, AM J PHYSIOL-REG I, V291, pR437, DOI 10.1152/ajpregu.00040.2006	45	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57451	10.1371/journal.pone.0057451	http://dx.doi.org/10.1371/journal.pone.0057451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437391	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000105
J	Costa, PR; Acencio, ML; Lemke, N				Costa, Pedro Rafael; Acencio, Marcio Luis; Lemke, Ney			Cooperative RNA Polymerase Molecules Behavior on a Stochastic Sequence-Dependent Model for Transcription Elongation	PLOS ONE			English	Article							TERMINATION; PARAMETERS; STABILITY	The transcription process is crucial to life and the enzyme RNA polymerase (RNAP) is the major component of the transcription machinery. The development of single-molecule techniques, such as magnetic and optical tweezers, atomic-force microscopy and single-molecule fluorescence, increased our understanding of the transcription process and complements traditional biochemical studies. Based on these studies, theoretical models have been proposed to explain and predict the kinetics of the RNAP during the polymerization, highlighting the results achieved by models based on the thermodynamic stability of the transcription elongation complex. However, experiments showed that if more than one RNAP initiates from the same promoter, the transcription behavior slightly changes and new phenomenona are observed. We proposed and implemented a theoretical model that considers collisions between RNAPs and predicts their cooperative behavior during multi-round transcription generalizing the Bai et al. stochastic sequence-dependent model. In our approach, collisions between elongating enzymes modify their transcription rate values. We performed the simulations in Mathematica (R) and compared the results of the single and the multiple-molecule transcription with experimental results and other theoretical models. Our multi-round approach can recover several expected behaviors, showing that the transcription process for the studied sequences can be accelerated up to 48% when collisions are allowed: the dwell times on pause sites are reduced as well as the distance that the RNAPs backtracked from backtracking sites.	[Costa, Pedro Rafael; Acencio, Marcio Luis; Lemke, Ney] UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Fis & Biofis, Sao Paulo, Brazil	Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista	Costa, PR (corresponding author), UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Fis & Biofis, Sao Paulo, Brazil.	costapr@ibb.unesp.br	Acencio, Marcio L/D-9264-2012; Lemke, Ney/A-8213-2008; Costa, Pedro R/J-7460-2012; Acencio, Marcio Luis/ABH-1930-2020; Lemke, Ney/L-6761-2019	Acencio, Marcio L/0000-0002-8278-240X; Lemke, Ney/0000-0001-7463-4303; Acencio, Marcio Luis/0000-0002-8278-240X; Lemke, Ney/0000-0001-7463-4303	FAPESP (The State of Sao Paulo Research Foundation) [2010/03338-4, 2010/20684-3, 2009/10382-2]; CAPES (Coordination of Improvement of Higher Education Personnel) [PNPD 2897/2011]	FAPESP (The State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to thank FAPESP (The State of Sao Paulo Research Foundation) for the financial support through the FAPESP research grants 2010/03338-4, 2010/20684-3 and 2009/10382-2 and CAPES (Coordination of Improvement of Higher Education Personnel) research grant PNPD 2897/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bai L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068103; Bai L, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12007; BORER PN, 1974, J MOL BIOL, V86, P843, DOI 10.1016/0022-2836(74)90357-X; Ehrenberg M, 2010, BIOCHIMIE, V92, P12, DOI 10.1016/j.biochi.2009.10.002; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; FOE VE, 1977, COLD SPRING HARB SYM, V42, P723, DOI 10.1101/SQB.1978.042.01.074; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; HAMMING J, 1981, NUCLEIC ACIDS RES, V9, P1339, DOI 10.1093/nar/9.6.1339; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Klumpp S, 2011, J STAT PHYS, V142, P1252, DOI 10.1007/s10955-011-0120-3; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P18159, DOI 10.1073/pnas.0806084105; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; Rajala T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000704; Sahoo M, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/60004; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Shapiro BE, 2003, BIOINFORMATICS, V19, P677, DOI 10.1093/bioinformatics/btg042; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Tripathi T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011921; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032	26	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57328	10.1371/journal.pone.0057328	http://dx.doi.org/10.1371/journal.pone.0057328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437369	Green Published, gold			2022-12-27	WOS:000315186000096
J	Faheem, M; Rehman, MT; Danishuddin, M; Khan, AU				Faheem, Mohammad; Rehman, Md Tabish; Danishuddin, Mohd; Khan, Asad U.			Biochemical Characterization of CTX-M-15 from Enterobacter cloacae and Designing a Novel Non-beta-Lactam-beta-Lactamase Inhibitor	PLOS ONE			English	Article							ESCHERICHIA-COLI; DRUG-RESISTANCE; TEM-1; CLAVULANATE; HYPERPRODUCTION; SUSCEPTIBILITY; IDENTIFICATION; EPIDEMIOLOGY; CEFOTAXIMASE; CEFTAZIDIME	The worldwide dissemination of CTX-M type beta-lactamases is a threat to human health. Previously, we have reported the spread of bla(CTX-M-15) gene in different clinical strains of Enterobacteriaceae from the hospital settings of Aligarh in north India. In view of the varying resistance pattern against cephalosporins and other beta-lactam antibiotics, we intended to understand the correlation between MICs and catalytic activity of CTX-M-15. In this study, steady-state kinetic parameters and MICs were determined on E. coli DH5 alpha transformed with bla(CTX-M-15) gene that was cloned from Enterobacter cloacae (EC-15) strain of clinical background. The effect of conventional beta-lactamase inhibitors (clavulanic acid, sulbactam and tazobactam) on CTX-M-15 was also studied. We have found that tazobactam is the best among these inhibitors against CTX-M-15. The inhibition characteristic of tazobactam is defined by its very low IC50 value (6 nM), high affinity (K-i = 0.017 mu M) and better acylation efficiency (k(+2)/K' = 0.44 mu M-1 s(-1)). It forms an acyl-enzyme covalent complex, which is quite stable (k(+3) = 0.0057 s(-1)). Since increasing resistance has been reported against conventional b-lactam antibiotic-inhibitor combinations, we aspire to design a non-beta-lactam core containing beta-lactamase inhibitor. For this, we screened ZINC database and performed molecular docking to identify a potential non-beta-lactam based inhibitor (ZINC03787097). The MICs of cephalosporin antibiotics in combination with this inhibitor gave promising results. Steady-state kinetics and molecular docking studies showed that ZINC03787097 is a reversible inhibitor which binds non-covalently to the active site of the enzyme through hydrogen bonds and hydrophobic interactions. Though, it's IC50 (180 nM) is much higher than tazobactam, it has good affinity for CTX-M-15 (K-i = 0.388 mu M). This study concludes that ZINC03787097 compound can be used as seed molecule to design more efficient non-b-lactam containing b-lactamase inhibitor that could evade pre-existing bacterial resistance mechanisms.	[Faheem, Mohammad; Rehman, Md Tabish; Danishuddin, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	REHMAN, TABISH/H-8471-2012; Rehman, Md Tabish/AAC-8512-2019; Khan, Asad U/K-8157-2013	REHMAN, TABISH/0000-0003-2341-900X; Rehman, Md Tabish/0000-0003-2341-900X; Khan, Asad U/0000-0001-9191-9423	Department of Biotechnology, Government of India [BT/PR12553/BID/07/296/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by Department of Biotechnology, Government of India grant no. BT/PR12553/BID/07/296/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; BAUERNFEIND A, 1992, INFECTION, V20, P158, DOI 10.1007/BF01704610; BENNETT PM, 1993, ANTIMICROB AGENTS CH, V37, P153, DOI 10.1128/AAC.37.2.153; Bethel CR, 2011, ANTIMICROB AGENTS CH, V55, P3465, DOI 10.1128/AAC.00089-11; Bonnet R, 2003, J ANTIMICROB CHEMOTH, V52, P29, DOI 10.1093/jac/dkg256; Bonnet R, 2000, ANTIMICROB AGENTS CH, V44, P1936, DOI 10.1128/AAC.44.7.1936-1942.2000; Bonnet R, 2001, ANTIMICROB AGENTS CH, V45, P2269, DOI 10.1128/AAC.45.8.2269-2275.2001; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 1999, CURR PHARM DESIGN, V5, P839; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Celenza G, 2008, J ANTIMICROB CHEMOTH, V62, P991, DOI 10.1093/jac/dkn339; Chambers HF, 1999, J INFECT DIS, V179, pS353, DOI 10.1086/513854; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Coque TM, 2008, EURO SURVEILL, V13; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Djamdjian L, 2011, ANTIMICROB AGENTS CH, V55, P1861, DOI 10.1128/AAC.01656-10; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Essack SY, 2001, PHARM RES-DORDR, V18, P1391, DOI 10.1023/A:1012272403776; GALLENI M, 1994, ANTIMICROB AGENTS CH, V38, P1608, DOI 10.1128/AAC.38.7.1608; Gniadkowski M, 1998, ANTIMICROB AGENTS CH, V42, P827, DOI 10.1128/AAC.42.4.827; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Hasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040319; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; ISHII Y, 1995, ANTIMICROB AGENTS CH, V39, P2269, DOI 10.1128/AAC.39.10.2269; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Perez-Llarena FJ, 2011, ANTIMICROB AGENTS CH, V55, P4361, DOI 10.1128/AAC.00298-11; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; MARTINEZ JL, 1989, ANTIMICROB AGENTS CH, V33, P595, DOI 10.1128/AAC.33.4.595-a; MARTINEZ JL, 1987, LANCET, V2, P1473; MATAGNE A, 1993, BIOCHEM J, V295, P705, DOI 10.1042/bj2950705; Meroueh SO, 2002, J AM CHEM SOC, V124, P9422, DOI 10.1021/ja026547q; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Poirel L, 2002, J ANTIMICROB CHEMOTH, V50, P1031, DOI 10.1093/jac/dkf240; Power RA, 2002, STRUCTURE, V10, P1012; Powers RA, 1999, PROTEIN SCI, V8, P2330; Rehman MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017159; Rice LB, 2000, DRUG RESIST UPDATE, V3, P178, DOI 10.1054/drup.2000.0144; SANDERS CC, 1988, ANTIMICROB AGENTS CH, V32, P1365, DOI 10.1128/AAC.32.9.1365; Shakil S, 2010, J MED MICROBIOL, V59, P948, DOI 10.1099/jmm.0.020214-0; Shakil S, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-2; Stachyra T, 2010, ANTIMICROB AGENTS CH, V54, P5132, DOI 10.1128/AAC.00568-10; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Sun T, 2004, BIOCHEMISTRY-US, V43, P14111, DOI 10.1021/bi0487903; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Tondi D, 2005, J AM CHEM SOC, V127, P4632, DOI 10.1021/ja042984o; Vilar M, 2001, ANTIMICROB AGENTS CH, V45, P2215, DOI 10.1128/AAC.45.8.2215-2223.2001; Waley SG, 1992, CHEM BLACTAMS, P198; WILLIAMS H, 1988, LANCET, V1, P304; WU PJ, 1994, ANTIMICROB AGENTS CH, V38, P494, DOI 10.1128/AAC.38.3.494; Wu PJ, 1995, J ANTIMICROB CHEMOTH, V36, P927, DOI 10.1093/jac/36.6.927	57	48	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56926	10.1371/journal.pone.0056926	http://dx.doi.org/10.1371/journal.pone.0056926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437273	gold, Green Submitted, Green Published			2022-12-27	WOS:000315186000057
J	Hemmatzadeh, F; Sumarningsih, S; Tarigan, S; Indriani, R; Dharmayanti, NLPI; Ebrahimie, E; Igniatovic, J				Hemmatzadeh, Farhid; Sumarningsih, Sumarningsih; Tarigan, Simson; Indriani, Risa; Dharmayanti, N. L. P. Indi; Ebrahimie, Esmaeil; Igniatovic, Jagoda			Recombinant M2e Protein-Based ELISA: A Novel and Inexpensive Approach for Differentiating Avian Influenza Infected Chickens from Vaccinated Ones	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CONJUGATE VACCINES; ANIMALS STRATEGY; A VACCINE; VIRUS; DIVA; IMMUNOGENICITY; GENETICS; POULTRY; PEPTIDE	Available avian influenza (AIV) serological diagnostic tests cannot distinguish vaccinated from naturally infected birds. Differentiation of vaccinated from infected animals (DIVA) is currently advocated as a means of achieving the full control of H5N1. In this study, for the first time, recombinant ectodomain of M2 protein (M2e) of avian influenza virus (H5N1 strain) was used for the DIVA serology test. M2e was cloned into pMAL-P4X vector and expressed in E. coli cells. We used Western blot to recognize the expressed M2e-MBP protein by chicken antisera produced against live H5N1 virus. Also, the specificity of M2e-MBP protein was compared to the M2e synthetic peptide via ELISA. In M2e-MBP ELISA, all sera raised against the live avian influenza viruses were positive for M2e antibodies, whereas sera from killed virus vaccination were negative. Furthermore, M2e-MBP ELISA of the field sera obtained from vaccinated and non-vaccinated chickens showed negative results, while challenged vaccinated chickens demonstrated strong positive reactions. H5N1-originated recombinant M2e protein induced broad-spectrum response and successfully reacted with antibodies against other AIV strains such as H5N2, H9N2, H7N7, and H11N6. The application of the recombinant protein instead of synthetic peptide has the advantages of continues access to an inexpensive reagent for performing a large scale screening. Moreover, recombinant proteins provide the possibility of testing the DIVA results with an additional technique such a Western blotting which is not possible in the case of synthetic proteins. All together, the results of the present investigation show that recombinant M2e-MBP can be used as a robust and inexpensive solution for DIVA test.	[Hemmatzadeh, Farhid] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Sumarningsih, Sumarningsih; Igniatovic, Jagoda] Univ Melbourne, Sch Vet Sci, Melbourne, Vic, Australia; [Tarigan, Simson; Indriani, Risa; Dharmayanti, N. L. P. Indi] Indonesian Res Ctr Vet Sci, Bogor, Indonesia; [Ebrahimie, Esmaeil] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide; University of Melbourne; University of Adelaide	Hemmatzadeh, F (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	farhid.hemmatzadeh@adelaide.edu.au	Ebrahimi, Mansour/AAO-9096-2021; Ebrahimie, Esmaeil/AAN-2611-2020	Ebrahimi, Mansour/0000-0001-7011-2567; Ebrahimie, Esmaeil/0000-0002-4431-2861; Hemmatzadeh, Farhid/0000-0002-4572-8869	Australian Centre for International Agricultural Research (ACIAR) fund [AH/2006/050]	Australian Centre for International Agricultural Research (ACIAR) fund(Australian Ctr Intl Agr Res)	This work was supported by Australian Centre for International Agricultural Research (ACIAR) fund (project number AH/2006/050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Bouma A, 2008, REV SCI TECH OIE, V27, P633, DOI 10.20506/rst.27.3.1823; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Capua I, 2004, DEV BIOLOGICALS, V119, P229; Capua I., 2003, VVolume 114, P213; Capua I, 2003, AVIAN PATHOL, V32, P47, DOI 10.1080/0307945021000070714; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Greiner M, 1996, J IMMUNOL METHODS, V191, P93, DOI 10.1016/0022-1759(96)00013-0; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Intharathep P, 2008, J MOL GRAPH MODEL, V27, P342, DOI 10.1016/j.jmgm.2008.06.002; Kim MC, 2010, CLIN VACCINE IMMUNOL, V17, P1977, DOI 10.1128/CVI.00191-10; Kitikoon P, 2009, VACCINE, V28, P523, DOI 10.1016/j.vaccine.2009.09.130; Kollerova E, 2007, Acta Virol, V51, P119; Kolocouris A, 2008, BIOORG MED CHEM LETT, V18, P6156, DOI 10.1016/j.bmcl.2008.10.003; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Lambrecht B, 2007, AVIAN DIS, V51, P221, DOI 10.1637/7589-040206R.1; Layton SL, 2009, POULTRY SCI, V88, P2244, DOI 10.3382/ps.2009-00251; Lee CW, 2004, VACCINE, V22, P3175, DOI 10.1016/j.vaccine.2004.01.055; Marangon S, 2004, DEV BIOLOGICALS, V119, P155; Mettenleiter T, 2009, REV SCI TECH OIE, V28, P15, DOI 10.20506/rst.28.1.1873; Pasick John, 2004, Animal Health Research Reviews, V5, P257, DOI 10.1079/AHR200479; Sambrook J., 2001, MOL CLONING LAB MANU; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Tumpey TM, 2005, J CLIN MICROBIOL, V43, P676, DOI 10.1128/JCM.43.2.676-683.2005; van den Berg T, 2008, COMP IMMUNOL MICROB, V31, P121, DOI 10.1016/j.cimid.2007.07.004	32	28	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56801	10.1371/journal.pone.0056801	http://dx.doi.org/10.1371/journal.pone.0056801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437243	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000046
J	Zhang, RX; Marshall, D; Bryan, GJ; Hornyik, C				Zhang, Runxuan; Marshall, David; Bryan, Glenn J.; Hornyik, Csaba			Identification and Characterization of miRNA Transcriptome in Potato by High-Throughput Sequencing	PLOS ONE			English	Article							PLANT SMALL RNAS; STRESS RESPONSES; SIRNA BIOGENESIS; GENOME SEQUENCE; MICRORNAS; GENES; ARABIDOPSIS; EVOLUTION; ROLES; EXPRESSION	Micro RNAs (miRNAs) represent a class of short, non-coding, endogenous RNAs which play important roles in post-transcriptional regulation of gene expression. While the diverse functions of miRNAs in model plants have been well studied, the impact of miRNAs in crop plant biology is poorly understood. Here we used high-throughput sequencing and bioinformatics analysis to analyze miRNAs in the tuber bearing crop potato (Solanum tuberosum). Small RNAs were analysed from leaf and stolon tissues. 28 conserved miRNA families were found and potato-specific miRNAs were identified and validated by RNA gel blot hybridization. The size, origin and predicted targets of conserved and potato specific miRNAs are described. The large number of miRNAs and complex population of small RNAs in potato suggest important roles for these non-coding RNAs in diverse physiological and metabolic pathways.	[Zhang, Runxuan; Marshall, David; Bryan, Glenn J.; Hornyik, Csaba] James Hutton Inst, Dundee, Scotland	James Hutton Institute	Hornyik, C (corresponding author), James Hutton Inst, Dundee, Scotland.	csaba.hornyik@hutton.ac.uk	Hornyik, Csaba/G-6279-2012; Zhang, Runxuan/F-2236-2013	Zhang, Runxuan/0000-0001-7558-765X; Bryan, Glenn/0000-0002-7752-5740; Hornyik, Csaba/0000-0003-3692-2413; Marshall, David/0000-0001-9309-2570	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); BBSRC [BB/J017213/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017213/1] Funding Source: researchfish	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelenda JA, 2011, CURR OPIN BIOTECH, V22, P287, DOI 10.1016/j.copbio.2010.11.013; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen X, 2012, CURR OPIN GENET DEV; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Jiao YP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-141; Kim HJ, 2011, GENOME, V54, P91, DOI 10.1139/G10-104; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lelandais-Briere C, 2010, CURR GENOMICS, V11, P14, DOI 10.2174/138920210790217918; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meng YJ, 2011, PLANT PHYSIOL, V157, P1583, DOI 10.1104/pp.111.187088; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang WZ, 2010, MOL BIOL REP, V37, P3081, DOI 10.1007/s11033-009-9881-z; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	81	301	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57233	10.1371/journal.pone.0057233	http://dx.doi.org/10.1371/journal.pone.0057233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437348	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000089
J	Bond, AE; Bodger, O; Skibinski, DOF; Jones, DH; Restall, CJ; Dudley, E; van Keulen, G				Bond, A. Elizabeth; Bodger, Owen; Skibinski, David O. F.; Jones, D. Hugh; Restall, Colin J.; Dudley, Edward; van Keulen, Geertje			Negatively-Marked MCQ Assessments That Reward Partial Knowledge Do Not Introduce Gender Bias Yet Increase Student Performance and Satisfaction and Reduce Anxiety	PLOS ONE			English	Article							MULTIPLE-CHOICE TESTS	Multiple-choice question (MCQ) examinations are increasingly used as the assessment method of theoretical knowledge in large class-size modules in many life science degrees. MCQ-tests can be used to objectively measure factual knowledge, ability and high-level learning outcomes, but may also introduce gender bias in performance dependent on topic, instruction, scoring and difficulty. The 'Single Answer' (SA) test is often used in which students choose one correct answer, in which they are unable to demonstrate partial knowledge. Negatively marking eliminates the chance element of guessing but may be considered unfair. Elimination testing (ET) is an alternative form of MCQ, which discriminates between all levels of knowledge, while rewarding demonstration of partial knowledge. Comparisons of performance and gender bias in negatively marked SA and ET tests have not yet been performed in the life sciences. Our results show that life science students were significantly advantaged by answering the MCQ test in elimination format compared to single answer format under negative marking conditions by rewarding partial knowledge of topics. Importantly, we found no significant difference in performance between genders in either cohort for either MCQ test under negative marking conditions. Surveys showed that students generally preferred ET-style MCQ testing over SA-style testing. Students reported feeling more relaxed taking ET MCQ and more stressed when sitting SA tests, while disagreeing with being distracted by thinking about best tactics for scoring high. Students agreed ET testing improved their critical thinking skills. We conclude that appropriately-designed MCQ tests do not systematically discriminate between genders. We recommend careful consideration in choosing the type of MCQ test, and propose to apply negative scoring conditions to each test type to avoid the introduction of gender bias. The student experience could be improved through the incorporation of the elimination answering methods in MCQ tests via rewarding partial and full knowledge.	[Bond, A. Elizabeth; Bodger, Owen; Skibinski, David O. F.; Jones, D. Hugh; Restall, Colin J.; Dudley, Edward; van Keulen, Geertje] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Bond, A. Elizabeth] Swansea Univ, Coll Sci, Inst Life Sci, Swansea, W Glam, Wales	Swansea University; Swansea University	van Keulen, G (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	g.van.keulen@swansea.ac.uk		SKIBINSKI, David/0000-0003-4077-6236; Bodger, Owen/0000-0002-4022-9964	Higher Education Academy's Centre for Bioscience under the Departmental Teaching Enhancement Scheme	Higher Education Academy's Centre for Bioscience under the Departmental Teaching Enhancement Scheme	This work was part-funded through a grant to GVK from the Higher Education Academy's Centre for Bioscience under the Departmental Teaching Enhancement Scheme (http://www.bioscience.heacademy.ac.uk/funding/currentprojects/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BenSimon A, 1997, APPL PSYCH MEAS, V21, P65, DOI 10.1177/0146621697211006; Bradbard DA, 2004, DECISION SCI J INNOV, V2, P11, DOI [10.1111/dsji.2004.2.issue-1, DOI 10.1111/DSJI.2004.2.ISSUE-1, 10.1111/j.0011-7315.2004.00016.x]; Chang SH, 2007, EDUC TECHNOL SOC, V10, P95; Cole, 1997, ETS GENDER STUDY FEM; COOMBS CH, 1956, EDUC PSYCHOL MEAS, V16, P13, DOI 10.1177/001316445601600102; Deepak K. K., 2011, Al Ameen Journal of Medical Sciences, V4, P123; Dressel PL, 1953, EDUC PSYCHOL MEAS, V13, P574, DOI 10.1177/001316445301300404; Grundy S, 2008, UK CTR BIOSCIENCE B, V23, P2; HASSMEN P, 1994, J EDUC MEAS, V31, P149, DOI 10.1111/j.1745-3984.1994.tb00440.x; Jennings S, 2006, PRACTICAL ASSESSMENT, V11, P1; Kelly S, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-32; McKendree J, 2002, COMPUTER ASSISTED AS; Murphy P, 2009, P0910623 SWANS U; Ng AWY, 2009, AIP CONF PROC, V1174, P236, DOI 10.1063/1.3256252; Ng AWY, 2009, DIFFERENT METHODS MU; Prieto G, 1999, PERS INDIV DIFFER, V27, P1067, DOI 10.1016/S0191-8869(99)00049-5; Ricketts C, 2010, ADV HEALTH SCI EDUC, V15, P265, DOI 10.1007/s10459-009-9197-8; Scott J, 2007, BIOSCIENCE ED, V10, pc2; Scott J, 2012, P STEM ANN C 2012; Stratford B, 2009, P0910987 SWANS U	20	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55956	10.1371/journal.pone.0055956	http://dx.doi.org/10.1371/journal.pone.0055956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437081	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200036
J	Fan, CJ; Ma, JM; Guo, QR; Li, XT; Wang, H; Lu, MZ				Fan, Chunjie; Ma, Jinmin; Guo, Qirong; Li, Xiaotie; Wang, Hui; Lu, Mengzhu			Selection of Reference Genes for Quantitative Real-Time PCR in Bamboo (Phyllostachys edulis)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INTERNAL CONTROL; RT-PCR; EXPRESSION; NORMALIZATION; ARABIDOPSIS; ORGAN	Background: The Moso bamboo (Phyllostachys edulis) is one of the most important forestry resources and plays essential ecological roles in southern China. A draft nuclear genome sequence is expected to be publicly available in the near future; an explosion of gene expression data related to the unique traits of Moso bamboo will undoubtedly follow. Reverse transcription quantitative real-time PCR ((RT-)qPCR) is a widely used method for gene expression analysis. A necessary prerequisite of exact and reliable data is the accurate choice of reference genes. Result: In this study, 14 candidate reference genes were chosen, and their expression levels were assessed by (RT-)qPCR in a set of six tissue samples (root, stem, mature stem, leaf, flower, and leaf sheath) and at two developmental stages (before and after flowering) in bamboo specimens obtained in three locations. The stability and suitability of the candidate reference genes were validated using the geNorm, NormFinder and BestKeeper programs. The results showed that TIP41 and NTB were suitable reference genes across all the tissues and at the different developmental stages examined in this study. While the expression of the NTB, TIP41 and UBQ were the mostly stable in different plant tissues samples, the expression of the TIP41, NTB and CAC were ranked the most stable in bamboo plants at various developmental stages. AP2-like gene was further assessed by using the reference genes TIP41 and NTB in comparison to ACT. Significant difference of the expression profile of AP2-like demonstrated the importance of choosing adequate reference genes in bamboo. Conclusion: TIP41 and NTB were found to be homogeneously expressed and were adequate for normalization purposes, showing equivalent transcript levels in different samples. They are therefore the recommended reference genes for measuring gene expression in P. edulis.	[Fan, Chunjie; Wang, Hui; Lu, Mengzhu] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Fan, Chunjie] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Ma, Jinmin; Wang, Hui] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Guo, Qirong] Int Ctr Bamboo & Rattan, Beijing, Peoples R China; [Li, Xiaotie] Guilin Res Inst Forestry, Guilin, Peoples R China; [Wang, Hui] NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF; Beijing Genomics Institute (BGI); International Centre for Bamboo & Rattan; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Wang, H (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	huw@ceh.ac.uk; lumz@caf.ac.cn	Ma, Jinmin/L-8470-2019; Wang, Hui/E-6764-2012; Lu, Meng-Zhu/AAN-9710-2020	Ma, Jinmin/0000-0002-7993-7001; 	National Natural Science Foundation of China (China) [31028004]; Ministry of Science and Technology of the Peoples Republic of China (China) [S2012ZR0137]; Natural Environment Research Council (United Kingdom) [NE/I000593/1]; NERC [NE/I000593/1] Funding Source: UKRI; Natural Environment Research Council [NE/I000593/1, CEH010021] Funding Source: researchfish	National Natural Science Foundation of China (China)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the Peoples Republic of China (China); Natural Environment Research Council (United Kingdom)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding provided by the National Natural Science Foundation of China (China, grant no. 31028004), Ministry of Science and Technology of the Peoples Republic of China (China, grant no. S2012ZR0137) and Natural Environment Research Council (United Kingdom, grant no. NE/I000593/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gui YJ, 2007, SCI CHINA SER C, V50, P700, DOI 10.1007/s11427-007-0081-6; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Han JG, 2009, MICROB ECOL, V58, P363, DOI 10.1007/s00248-009-9491-2; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Isagiks Y, 2004, MOL ECOL, V13, P5; Janzen DH, 1976, ANN REV ECOLOGY SYST, P7; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Z, 2002, BAMBOO RATTAN WORLD; Krogan NT, 2012, DEVELOPMENT, V139, P4180, DOI 10.1242/dev.085407; Li R, 1997, ACTA PHYTOECOLOGICA, V21, P7; Li XB, 2007, J TROP FOR SCI, V19, P6; Luo HL, 2010, ANAL BIOCHEM, V404, P100, DOI 10.1016/j.ab.2010.05.002; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rai V, 2012, GENE, V497, P243, DOI 10.1016/j.gene.2012.01.018; Rai V, 2011, GENE, V478, P19, DOI 10.1016/j.gene.2011.01.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xu H, 2010, BIOTECHNOL LETT, V32, P1961, DOI 10.1007/s10529-010-0362-1; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	39	203	248	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56573	10.1371/journal.pone.0056573	http://dx.doi.org/10.1371/journal.pone.0056573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437174	Green Published, Green Accepted, gold			2022-12-27	WOS:000315184200110
J	Hardy, R; Cooper, R; Sayer, AA; Ben-Shlomo, Y; Cooper, C; Deary, IJ; Demakakos, P; Gallacher, J; Martin, RM; McNeill, G; Starr, JM; Steptoe, A; Syddall, H; Kuh, D				Hardy, Rebecca; Cooper, Rachel; Sayer, Avan Aihie; Ben-Shlomo, Yoav; Cooper, Cyrus; Deary, Ian J.; Demakakos, Panayotes; Gallacher, John; Martin, Richard M.; McNeill, Geraldine; Starr, John M.; Steptoe, Andrew; Syddall, Holly; Kuh, Diana		HALCyon Study Team	Body Mass Index, Muscle Strength and Physical Performance in Older Adults from Eight Cohort Studies: The HALCyon Programme	PLOS ONE			English	Article							GRIP STRENGTH; FUNCTIONAL DECLINE; BIRTH COHORT; FOLLOW-UP; OBESITY; HEALTH; PROFILE; WOMEN; DISABILITY; PERCENTAGE	Objective: To investigate the associations of body mass index (BMI) and grip strength with objective measures of physical performance (chair rise time, walking speed and balance) including an assessment of sex differences and non-linearity. Methods: Cross-sectional data from eight UK cohort studies (total N = 16 444) participating in the Healthy Ageing across the Life Course (HALCyon) research programme, ranging in age from 50 to 90+ years at the time of physical capability assessment, were used. Regression models were fitted within each study and meta-analysis methods used to pool regression coefficients across studies and to assess the extent of heterogeneity between studies. Results: Higher BMI was associated with poorer performance on chair rise (N = 10 773), walking speed (N = 9 761) and standing balance (N = 13 921) tests. Higher BMI was associated with stronger grip strength in men only. Stronger grip strength was associated with better performance on all tests with a tendency for the associations to be stronger in women than men; for example, walking speed was higher by 0.43 cm/s (0.14, 0.71) more per kg in women than men. Both BMI and grip strength remained independently related with performance after mutual adjustment, but there was no evidence of effect modification. Both BMI and grip strength exhibited non-linear relations with performance; those in the lowest fifth of grip strength and highest fifth of BMI having particularly poor performance. Findings were similar when waist circumference was examined in place of BMI. Conclusion: Older men and women with weak muscle strength and high BMI have considerably poorer performance than others and associations were observed even in the youngest cohort (age 53). Although causality cannot be inferred from observational cross-sectional studies, our findings suggest the likely benefit of early assessment and interventions to reduce fat mass and improve muscle strength in the prevention of future functional limitations.	[Hardy, Rebecca; Cooper, Rachel; Kuh, Diana] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Hardy, Rebecca; Cooper, Rachel; Kuh, Diana] UCL, Inst Epidemiol & Hlth Care, London, England; [Sayer, Avan Aihie; Cooper, Cyrus; Syddall, Holly] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Ben-Shlomo, Yoav; Martin, Richard M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Cooper, Cyrus] Univ Oxford, Natl Inst Hlth & Res, Musculoskeletal Biomed Res Unit, Oxford, England; [Deary, Ian J.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Demakakos, Panayotes; Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, London, England; [Gallacher, John] Cardiff Univ, Dept Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [McNeill, Geraldine] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Starr, John M.] Western Gen Hosp, Geriatr Med Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of London; University College London; University of London; University College London; University of Southampton; University of Bristol; University of Oxford; University of Edinburgh; University of London; University College London; Cardiff University; University of Aberdeen; University of Edinburgh	Hardy, R (corresponding author), UCL, MRC, Unit Lifelong Hlth & Ageing, London, England.	r.hardy@nshd.mrc.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Steptoe, Andrew/Y-2440-2019; Cooper, Rachel/ABE-3768-2021; Hardy, Rebecca/AFR-1989-2022; Deary, Ian J/C-6297-2009; Kuh, Diana/L-6019-2014	Ben-Shlomo, Yoav/0000-0001-6648-3007; Cooper, Rachel/0000-0003-3370-5720; Deary, Ian J/0000-0002-1733-263X; Kuh, Diana/0000-0001-7386-2857; Aihie Sayer, Avan/0000-0003-1283-6457; von Zglinicki, Thomas/0000-0002-5939-0248; Cooper, Cyrus/0000-0003-3510-0709; Steptoe, Andrew/0000-0001-7808-4943; Demakakos, Panayotes/0000-0002-7663-2122; Martin, Richard/0000-0002-7992-7719; Shiels, Paul/0000-0002-7577-9843; Hardy, Rebecca/0000-0001-9949-0799; Martin-Ruiz, Carmen/0000-0002-3361-6974; McNeill, Geraldine/0000-0003-0373-650X	New Dynamics of Ageing [RES-353-25-0001]; UK Medical Research Council; Biological Sciences Research Council; Alzheimer Research Trust; Medical Research Council; World Cancer Research Fund; Research into Ageing; United Kingdom Survivors; Economic and Social Research Council; Wellcome Trust; British Heart Foundation; Alzheimer's society; National Institute of Aging in the United States; Arthritis Research UK; University of Southampton; Biotechnology and Biological Sciences Research Council; Royal Society-Wolfson Research Merit Award; Chief Scientist Office of the Scottish Government; Engineering and Physical Sciences Research Council; ESRC [ES/G00773X/1] Funding Source: UKRI; MRC [MC_U123092724, MC_U147585827, G0601333, MC_UP_A620_1015, G0400491, MC_U123092721, MC_U123092720, MC_U147585819, MC_UU_12011/2, G0700704] Funding Source: UKRI; Economic and Social Research Council [ES/G00773X/1] Funding Source: researchfish; Medical Research Council [G0400491, MC_U123092720, U1475000002, MC_U147585819, MC_U147585824, MC_U123092721, MC_UP_A620_1014, G0601333, MC_U123092724, G0700704, U1475000001, MC_U147585827, MC_UP_A620_1015, MC_UU_12011/1, MR/K026992/1, MC_UU_12011/2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [ETM/55] Funding Source: researchfish	New Dynamics of Ageing; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Research into Ageing; United Kingdom Survivors; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Alzheimer's society; National Institute of Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arthritis Research UK(Versus Arthritis); University of Southampton; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society-Wolfson Research Merit Award(Royal Society of London); Chief Scientist Office of the Scottish Government; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	HALCyon is funded by the New Dynamics of Ageing (RES-353-25-0001) and R. C. received support from this grant. D. K., A. A. S. and R. H. were supported by the UK Medical Research Council. The Aberdeen Birth Cohort 1936 data collection was funded by the Biological Sciences Research Council (wave 1) and the Alzheimer Research Trust. Boyd Orr cohort has received funding from the Medical Research Council, the World Cancer Research Fund, Research into Ageing, United Kingdom Survivors, the Economic and Social Research Council, the Wellcome Trust, and the British Heart Foundation. The Caerphilly Prospective Study was undertaken by the former Medical Research Council Epidemiology Unit (South Wales), and the School of Social and Community Based Medicine, University of Bristol, acts as the data custodian. The phase V follow-up was funded by the Alzheimer's society. The ELSA was developed by a team of researchers based at University College London, the National Centre for Social Research, and the Institute for Fiscal Studies. The funding is provided by the National Institute of Aging in the United States, and a consortium of UK government departments co-ordinated by the Office for National Statistics. The Hertfordshire Ageing Study and the Hertfordshire Cohort Study were funded by the UK Medical Research Council, the Wellcome Trust, Arthritis Research UK and the University of Southampton. The LBC1921 data were collected by grants from the Biotechnology and Biological Sciences Research Council (wave 1), a Royal Society-Wolfson Research Merit Award to IJD (wave 2), and the Chief Scientist Office of the Scottish Government (wave 3). LBC1921 has been undertaken within The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council and Medical Research Council is gratefully acknowledged. The NSHD is funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard DR, 2009, OBESITY, V17, P2082, DOI 10.1038/oby.2009.109; Brach JS, 2004, PREV MED, V39, P74, DOI 10.1016/j.ypmed.2004.02.044; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; COOPER R, 2011, PLOS ONE, V0006; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Davison KK, 2002, J AM GERIATR SOC, V50, P1802, DOI 10.1046/j.1532-5415.2002.50508.x; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding JZ, 2007, AM J CLIN NUTR, V85, P405; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1102, DOI 10.1111/j.1532-5415.2000.tb04787.x; Forrest KYZ, 2006, J GERONTOL A-BIOL, V61, P1194, DOI 10.1093/gerona/61.11.1194; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houston DK, 2007, INT J OBESITY, V31, P1680, DOI 10.1038/sj.ijo.0803652; Jensen GL, 2005, CLIN GERIATR MED, V21, P677, DOI 10.1016/j.cger.2005.06.007; Jensen GL, 2002, J AM GERIATR SOC, V50, P918, DOI 10.1046/j.1532-5415.2002.50220.x; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Kuh D, 2006, AM J EPIDEMIOL, V164, P110, DOI 10.1093/aje/kwj193; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Li L, 2008, AM J EPIDEMIOL, V168, P1008, DOI 10.1093/aje/kwn227; Lobstein T., 2007, FORESIGHT TACKLING O; Martin RM, 2005, INT J EPIDEMIOL, V34, P742, DOI 10.1093/ije/dyi124; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rossner S, 2002, INT J OBES RELAT S4, V26, pS4; Sergi G, 2007, J AM GERIATR SOC, V55, P2023, DOI 10.1111/j.1532-5415.2007.01460.x; Shin Hyehyung, 2011, J Aging Res, V2011, P191896, DOI 10.4061/2011/191896; Stenholm S, 2009, INT J OBESITY, V33, P634; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Steptoe A, 2012, INT J EPIDEMIOL; Syddall HE, 2010, INT J EPIDEMIOL, V39, P36, DOI 10.1093/ije/dyn275; Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127; Tolea MI, 2010, J GERONTOL B-PSYCHOL, V65, P174, DOI 10.1093/geronb/gbp130; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Woo J, 2007, OBESITY, V15, P1886, DOI 10.1038/oby.2007.223; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	40	103	106	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56483	10.1371/journal.pone.0056483	http://dx.doi.org/10.1371/journal.pone.0056483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437142	Green Published, gold, Green Accepted			2022-12-27	WOS:000315184200081
J	Marthin, JK; Nielsen, KG				Marthin, June Kehlet; Nielsen, Kim Gjerum			Hand-Held Tidal Breathing Nasal Nitric Oxide Measurement - A Promising Targeted Case-Finding Tool for the Diagnosis of Primary Ciliary Dyskinesia	PLOS ONE			English	Article							CLINICAL-PRACTICE; CHILDREN	Background: Nasal nitric oxide (nNO) measurement is an established first line test in the work-up for primary ciliary dyskinesia (PCD). Tidal breathing nNO (TB-nNO) measurements require minimal cooperation and are potentially useful even in young children. Hand-held NO devices are becoming increasingly widespread for asthma management. Therefore, we chose to assess whether hand-held TB-nNO measurements reliably discriminate between PCD, and Healthy Subjects (HS) and included Cystic Fibrosis (CF) patients as a disease control group known to have intermediate nNO levels. Methods: In this cross sectional, single centre, single occasion, proof-of-concept study in children and adults with PCD and CF, and in HS we compared feasibility, success rates, discriminatory capacity, repeatability and agreement between a hand-held electrochemical device equipped with a nNO software application sampling at flow rates 2 ml/s or 5 ml/s, and two stationary chemiluminescence devices, applying both tidal breathing and velum closure techniques. Results: Measurements were done in 16 PCD patients, 21 patients with CF and 20 HS aged between 3.8 and 60.9 years. Hand-held TB-nNO showed high success rate (96.5-100%) vs. velum closure nNO techniques (70.2-89.5%). Hand-held TB-nNO sampling at flow rate 5 ml/s showed equally high discriminative power (PCD vs. HS [p<0.0001] and PCD vs. CF [p<0.0001]) and reaching close to 100% sensitivity and specificity, superior repeatability (CV% = 10%) and equal limits of agreement compared to TB-nNO by stationary devices and even compared to velum closure sampling. Conclusion: Hand-held TB-nNO discriminates significantly between PCD, CF and HS and shows promising potential as a widespread targeted case-finding tool for PCD, although further studies are warranted before implementation.	[Marthin, June Kehlet; Nielsen, Kim Gjerum] Rigshosp, Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, Pediat Pulm Serv, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Nielsen, KG (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, Pediat Pulm Serv, DK-2100 Copenhagen, Denmark.	kgn@dadlnet.dk	Nielsen, KG/AAE-6575-2020	Nielsen, KG/0000-0001-5906-9449				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P912; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Corbelli R, 2004, CHEST, V126, P1054, DOI 10.1378/chest.126.4.1054; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Hogg C, 2009, PAEDIATR RESPIR REV, V10, P44, DOI 10.1016/j.prrv.2008.10.001; Karadag B, 1999, EUR RESPIR J, V13, P1402, DOI 10.1034/j.1399-3003.1999.13f28.x; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; Maniscalco M, 2008, EUR J CLIN INVEST, V38, P197, DOI 10.1111/j.1365-2362.2008.01907.x; Marthin JK, 2011, EUR RESPIR J, V37, P559, DOI 10.1183/09031936.00032610; Marthin JK, 2010, AM J RESP CRIT CARE, V181, P1262, DOI 10.1164/rccm.200811-1731OC; Marthin JK, 2007, CHEST, V132, P966, DOI 10.1378/chest.06-2951; Mateos-Corral D, 2011, J PEDIATR-US, V159, P420, DOI 10.1016/j.jpeds.2011.03.007; Menzies D, 2007, CHEST, V131, P410, DOI 10.1378/chest.06-1335; Montella S, 2011, EUR J CLIN INVEST, V41, P1063, DOI 10.1111/j.1365-2362.2011.02501.x; Narang I, 2002, THORAX, V57, P586, DOI 10.1136/thorax.57.7.586; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Santamaria F, 2008, MED SCI MONITOR, V14, pCR80; Strippoli MPF, 2012, EUR RESPIR J, V39, P1482, DOI 10.1183/09031936.00073911	19	43	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57262	10.1371/journal.pone.0057262	http://dx.doi.org/10.1371/journal.pone.0057262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437356	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200234
J	Saito, A; Suzuki, HI; Horie, M; Ohshima, M; Morishita, Y; Abiko, Y; Nagase, T				Saito, Akira; Suzuki, Hiroshi I.; Horie, Masafumi; Ohshima, Mitsuhiro; Morishita, Yasuyuki; Abiko, Yoshimitsu; Nagase, Takahide			An Integrated Expression Profiling Reveals Target Genes of TGF-beta and TNF-alpha Possibly Mediated by MicroRNAs in Lung Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; NF-KAPPA-B; UP-REGULATION; DIFFERENTIAL REGULATION; ADENOCARCINOMA CELLS; CARCINOMA CELLS; E-CADHERIN; PROGRESSION; PROMOTES	EMT (epithelial-mesenchymal transition) is crucial for cancer cells to acquire invasive phenotypes. In A549 lung adenocarcinoma cells, TGF-beta elicited EMT in Smad-dependent manner and TNF-alpha accelerated this process, as confirmed by cell morphology, expression of EMT markers, capacity of gelatin lysis and cell invasion. TNF-alpha stimulated the phosphorylation of Smad2 linker region, and this effect was attenuated by inhibiting MEK or JNK pathway. Comprehensive expression analysis unraveled genes differentially regulated by TGF-beta and TNF-alpha, such as cytokines, chemokines, growth factors and ECM (extracellular matrices), suggesting the drastic change in autocrine/paracrine signals as well as cell-to-ECM interactions. Integrated analysis of microRNA signature enabled us to identify a subset of genes, potentially regulated by microRNAs. Among them, we confirmed TGF-beta-mediated induction of miR-23a in lung epithelial cell lines, target genes of which were further identified by gene expression profiling. Combined with in silico approaches, we determined HMGN2 as a downstream target of miR-23a. These findings provide a line of evidence that the effects of TGF-beta and TNF-alpha were partially mediated by microRNAs, and shed light on the complexity of molecular events elicited by TGF-beta and TNF-alpha.	[Saito, Akira; Horie, Masafumi; Nagase, Takahide] Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Saito, Akira] Univ Tokyo, Div Hlth Serv Promot, Bunkyo Ku, Tokyo, Japan; [Suzuki, Hiroshi I.; Morishita, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo, Japan; [Ohshima, Mitsuhiro] Ohu Univ, Dept Biochem, Sch Pharmaceut Sci, Koriyama, Fukushima, Japan; [Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Matsudo, Chiba, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Nihon University	Saito, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.	asaitou-tky@umin.ac.jp		Suzuki, Hiroshi/0000-0003-4682-5086	KAKENHI Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour and Welfare of Japan	KAKENHI Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by KAKENHI (Grants-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Borthwick LA, 2012, CANCER MICROENVIRON, V5, P45, DOI 10.1007/s12307-011-0080-9; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Deng LX, 2011, FEBS J, V278, P2152, DOI 10.1111/j.1742-4658.2011.08132.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gerlitz G, 2010, BBA-GENE REGUL MECH, V1799, P80, DOI 10.1016/j.bbagrm.2009.10.007; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamitani S, 2011, INT ARCH ALLERGY IMM, V155, P119, DOI 10.1159/000318854; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Lehtonen S, 2001, DIFFERENTIATION, V67, P154, DOI 10.1046/j.1432-0436.2001.670407.x; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Meng XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018715; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Papadimitriou E, 2012, ONCOGENE, V31, P2862, DOI 10.1038/onc.2011.457; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Saito RA, 2010, CANCER RES, V70, P2644, DOI 10.1158/0008-5472.CAN-09-3644; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yamauchi Y, 2010, EXP LUNG RES, V36, P12, DOI 10.3109/01902140903042589; Zhang YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020319; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	44	53	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56587	10.1371/journal.pone.0056587	http://dx.doi.org/10.1371/journal.pone.0056587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437179	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200115
J	Starmans, LWE; Burdinski, D; Haex, NPM; Moonen, RPM; Strijkers, GJ; Nicolay, K; Grull, H				Starmans, Lucas W. E.; Burdinski, Dirk; Haex, Nicole P. M.; Moonen, Rik P. M.; Strijkers, Gustav J.; Nicolay, Klaas; Grull, Holger			Iron Oxide Nanoparticle-Micelles (ION-Micelles) for Sensitive (Molecular) Magnetic Particle Imaging and Magnetic Resonance Imaging	PLOS ONE			English	Article							IN-VIVO DETECTION; CONTRAST; SIZE	Background: Iron oxide nanoparticles (IONs) are a promising nanoplatform for contrast-enhanced MRI. Recently, magnetic particle imaging (MPI) was introduced as a new imaging modality, which is able to directly visualize magnetic particles and could serve as a more sensitive and quantitative alternative to MRI. However, MPI requires magnetic particles with specific magnetic properties for optimal use. Current commercially available iron oxide formulations perform suboptimal in MPI, which is triggering research into optimized synthesis strategies. Most synthesis procedures aim at size control of iron oxide nanoparticles rather than control over the magnetic properties. In this study, we report on the synthesis, characterization and application of a novel ION platform for sensitive MPI and MRI. Methods and Results: IONs were synthesized using a thermal-decomposition method and subsequently phase-transferred by encapsulation into lipidic micelles (ION-Micelles). Next, the material and magnetic properties of the ION-Micelles were analyzed. Most notably, vibrating sample magnetometry measurements showed that the effective magnetic core size of the IONs is 16 nm. In addition, magnetic particle spectrometry (MPS) measurements were performed. MPS is essentially zero-dimensional MPI and therefore allows to probe the potential of iron oxide formulations for MPI. ION-Micelles induced up to 200 times higher signal in MPS measurements than commercially available iron oxide formulations (Endorem, Resovist and Sinerem) and thus likely allow for significantly more sensitive MPI. In addition, the potential of the ION-Micelle platform for molecular MPI and MRI was showcased by MPS and MRI measurements of fibrin-binding peptide functionalized ION-Micelles (FibPep-ION-Micelles) bound to blood clots. Conclusions: The presented data underlines the potential of the ION-Micelle nanoplatform for sensitive (molecular) MPI and warrants further investigation of the FibPep-ION-Micelle platform for in vivo, non-invasive imaging of fibrin in preclinical disease models of thrombus-related pathologies and atherosclerosis.	[Starmans, Lucas W. E.; Moonen, Rik P. M.; Strijkers, Gustav J.; Nicolay, Klaas; Grull, Holger] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Burdinski, Dirk; Haex, Nicole P. M.; Grull, Holger] Philips Res Eindhoven, Dept Minimally Invas Healthcare, Eindhoven, Netherlands	Eindhoven University of Technology; Philips; Philips Research	Grull, H (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	h.gruell@tue.nl		Starmans, Luc/0000-0003-4569-1725; Strijkers, Gustav/0000-0001-6700-5058; Moonen, Rik/0000-0002-2294-0226; Nicolay, Klaas/0000-0002-4179-616X; Grull, Holger/0000-0002-0993-9300	Center for Translational Molecular Medicine; Netherlands Heart Foundation PARISK [01C-202]	Center for Translational Molecular Medicine; Netherlands Heart Foundation PARISK(Netherlands Heart Foundation)	This research was supported by the Center for Translational Molecular Medicine (http://www.ctmm.nl) and the Netherlands Heart Foundation (www.hartstichting.nl): PARISK, grant 01C-202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Biederer S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/20/205007; Briley-Saebo KC, 2011, J AM COLL CARDIOL, V57, P337, DOI 10.1016/j.jacc.2010.09.023; Burdinski D, 2012, Synthesis of high-performance iron oxide particle tracers for magnetic particle imaging (MPI), Patent No. [WO 2012/001579 A1, 2012001579]; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; Chen DX, 2009, J APPL PHYS, V106, DOI 10.1063/1.3211307; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Dash R, 2011, MAGN RESON MED, V66, P1152, DOI 10.1002/mrm.22876; DIAS MHM, 1986, MAGNET RESON MED, V3, P328, DOI 10.1002/mrm.1910030218; Ferguson RM, 2011, MED PHYS, V38, P1619, DOI 10.1118/1.3554646; Ferguson RM, 2009, J MAGN MAGN MATER, V321, P1548, DOI 10.1016/j.jmmm.2009.02.083; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s; Jayapaul J, 2011, BIOMATERIALS, V32, P5863, DOI 10.1016/j.biomaterials.2011.04.056; Luigjes B, 2011, J PHYS CHEM C, V115, P14598, DOI 10.1021/jp203373f; Marinelli E., 2008, Fibrin Binding Peptide Conjugates for Diagnostic and Therapeutic Applications, Patent No. [WO 2008/071679 A1, 2008071679]; Markov DE, 2010, PHYS MED BIOL, V55, P6461, DOI 10.1088/0031-9155/55/21/008; McAteer MA, 2008, ARTERIOSCL THROM VAS, V28, P77, DOI 10.1161/ATVBAHA.107.145466; Muja N, 2011, MAGN RESON MED, V65, P1738, DOI 10.1002/mrm.22757; Mulder WJM, 2009, ANGIOGENESIS, V12, P17, DOI 10.1007/s10456-008-9124-2; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Radermacher KA, 2009, INVEST RADIOL, V44, P398, DOI 10.1097/RLI.0b013e3181a49639; REIMER P, 1995, RADIOLOGY, V195, P489, DOI 10.1148/radiology.195.2.7724772; Starmans LWE, 2011, CONTRAST MEDIA MOL I, V6, P100, DOI 10.1002/cmmi.411; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; von zur Muhlen C, 2008, CIRCULATION, V118, P258, DOI 10.1161/CIRCULATIONAHA.107.753657; Weizenecker J, 2007, PHYS MED BIOL, V52, P6363, DOI 10.1088/0031-9155/52/21/001; Weizenecker J, 2009, PHYS MED BIOL, V54, pL1, DOI 10.1088/0031-9155/54/5/L01; Wescot C. R., 2002, Fibrin Binding Moieties Useful as Imaging Agents, Patent No. [WO 02/055544 A2, 02055544]; Xu CJ, 2009, DALTON T, P5583, DOI 10.1039/b900272n; Yu WW, 2004, CHEM COMMUN, P2306, DOI 10.1039/b409601k	33	47	50	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57335	10.1371/journal.pone.0057335	http://dx.doi.org/10.1371/journal.pone.0057335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437371	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200245
J	Wilhelm, M; Dahl, E; Alexander, H; Brahler, E; Stobel-Richter, Y				Wilhelm, Miriam; Dahl, Edgar; Alexander, Henry; Braehler, Elmar; Stoebel-Richter, Yve			Ethical Attitudes of German Specialists in Reproductive Medicine and Legal Regulation of Preimplantation Sex Selection in Germany	PLOS ONE			English	Article							GENETIC DIAGNOSIS; GENDER SELECTION; ISSUES; CELL; COMMITTEE; SOCIETY; CHOICE; THREAT	Background: Because of its ethical and social implications, preimplantation sex selection is frequently the subject of debates. Methods: In 2006, we surveyed specialists in reproductive medicine in Germany using an anonymous questionnaire, including sociodemographic data and questions regarding ethical problems occurring in the practice of reproductive medicine. Most questions focused on preimplantation sex selection, including 10 case vignettes, since these enabled us to describe the most difficult and ethically controversial situations. This is the first survey among specialists in reproductive medicine regarding this topic in Germany. Results: 114 specialists in reproductive medicine participated, 72 males (63%) and 42 females (37%), average age was 48 years (age range 29-67 years). The majority of respondents (79%) favoured a regulation that limits the use of preimplantation sex selection only for medical reasons, such as X-linked diseases (including 18%: summoning an ethics commission for every case). A minority of 18% approved of the use of sex selection for non-medical reasons (4% generally and further 14% for family balancing). 90% had received obvious requests from patients. The highest approval (46%) got the counselling guideline against a preimplantation sex selection and advising a normal pregnancy, if preimplantation sex selection would be allowed in Germany. The majority (67%) was opposed the personal use of preimplantation sex selection for non-medical reasons, but would think about it in medical cases. In opposite to woman, 14% of the men were in favour of personal use for non-medical reasons (p = 0,043). 25% of specialists in reproductive medicine feared that an allowance of preimplantation sex selection would cause a shift in the sex ratio. Conclusions: The majority of German specialists in reproductive medicine opposes preimplantation sex selection for non-medical reasons while recommending preimplantation sex selection for medical reasons, e. g. X-linked diseases like haemophilia.	[Wilhelm, Miriam] Olga Hosp, Klinikum Stuttgart, Stuttgart, Germany; [Dahl, Edgar] Univ Munster, Inst Eth Med, D-48149 Munster, Germany; [Alexander, Henry] Univ Leipzig, Dept Obstet & Gynaecol, D-04109 Leipzig, Germany; [Braehler, Elmar; Stoebel-Richter, Yve] Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany	General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; University of Munster; Leipzig University; Leipzig University	Wilhelm, M (corresponding author), Olga Hosp, Klinikum Stuttgart, Stuttgart, Germany.	Miriam.Wilhelm@olgahospital-stuttgart.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728	Department of Medical Psychology and Medical Sociology, University of Leipzig	Department of Medical Psychology and Medical Sociology, University of Leipzig	This work was supported by the Department of Medical Psychology and Medical Sociology, University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benagiano G, 1999, HUM REPROD, V14, P868, DOI 10.1093/humrep/14.4.868; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Berlin-Institut, 2007, UNG KIND WAS KANN MO; Boyle RJ, 2001, BMJ-BRIT MED J, V323, P1240, DOI 10.1136/bmj.323.7323.1240; Brahler E, 2004, UNVEROFFENT IN PRESS; Buhler K, 2011, J REPRODUKTIONSMED E, V8, P253; Bundesarztekammer, 2006, DTSCH ARZTEBL, V103, P1392; Combelles CMH, 2008, HUM REPROD, V23, P493, DOI 10.1093/humrep/dem396; Committee on Ethics American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V109, P475; Dahl E, 2005, REPROD BIOMED ONLINE, V10, P116, DOI 10.1016/S1472-6483(10)62218-3; Dahl E, 2004, REPROD BIOMED ONLINE, V9, P600, DOI 10.1016/S1472-6483(10)61767-1; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Dickens BM, 2005, INT J GYNECOL OBSTET, V90, P171, DOI 10.1016/j.ijgo.2005.05.001; Gianaroli L, 2010, HUM REPROD, V25, P2933, DOI 10.1093/humrep/deq331; Gleicher N, 2007, HUM REPROD, V22, P3038, DOI 10.1093/humrep/dem227; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Harper JC, 2012, HUM REPROD UPDATE, V18, P234, DOI 10.1093/humupd/dmr052; Harris LH, 2011, OBSTET GYNECOL, V118, P905, DOI 10.1097/AOG.0b013e31822f12b7; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Himmel W, 2008, REPROD BIOMED ONLINE, V16, P18, DOI 10.1016/S1472-6483(10)60395-1; Hollingsworth LD, 2005, HEALTH SOC WORK, V30, P126, DOI 10.1093/hsw/30.2.126; Human Fertilisation and Embryology Authority, 2003, SEX SEL OPT REG REP; Human Fertilisation and Embryology Authority, 2002, SEX SEL CHOIC RESP H; Jylha ME, 2010, SCAND J PUBLIC HEALT, V38, P756, DOI 10.1177/1403494810377680; Klinkhammer G, 2012, DTSCH ARZTEBL, V109, P737; Klinkhammer G, 2007, DTSCH ARZTEBL, V9, P458; Klinkhammer G, 2010, DTSCH ARZTEBL, V107, P1215; Klinkhammer G, 2012, DTSCH ARZTEBL, V109, P1902; Kovacs GT, 2003, MED J AUSTRALIA, V178, P127, DOI 10.5694/j.1326-5377.2003.tb05103.x; Levy N, 2007, SOUTH MED J, V100, P107, DOI 10.1097/SMJ.0b013e31802e6138; Liao SM, 2005, J MED ETHICS, V31, P116, DOI 10.1136/jme.2003.005983; MARTEAU TM, 1993, BRIT MED J, V306, P1704, DOI 10.1136/bmj.306.6894.1704; Martinhago CD, 2010, REPROD BIOMED ONLINE, V20, P75, DOI 10.1016/j.rbmo.2009.10.008; Meister U, 2005, HUM REPROD, V20, P231, DOI 10.1093/humrep/deh548; Morey Celine, 2010, Ann N Y Acad Sci, V1214, pE18, DOI 10.1111/j.1749-6632.2010.05943.x; Nippert I, 2006, PRAIMPLANTATIONSDIAG; Nippert I, 2005, BIOPOLITIK, P201; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Pennings G, 1996, HUM REPROD, V11, P2339; Ratzel Rudolf, 2002, Z Arztl Fortbild Qualitatssich, V96, P413; Richter-Kuhlmann, 2011, DTSCH ARZTEBL, V108, P1322; Robertson JA, 2003, HUM REPROD, V18, P465, DOI 10.1093/humrep/deg100; Savulescu J, 2000, HUM REPROD, V15, P1879, DOI 10.1093/humrep/15.9.1879; Schulman JD, 2005, REPROD BIOMED ONLINE, V10, P111, DOI 10.1016/S1472-6483(10)62217-1; Statz A, 2000, BZGA FORUM, V1, P6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van Balen F, 2005, J PSYCHOSOM OBST GYN, V26, P229, DOI 10.1080/01674820500392224; Wertz D., 2004, GENETICS ETHICS GLOB, DOI [10.1007/978-94-007-0981-2, DOI 10.1007/978-94-007-0981-2]; Wertz DC, 1998, SOC SCI MED, V46, P255, DOI 10.1016/S0277-9536(97)00159-7; Wertz DC, 2001, GENOMEXPRESS, V2, P15; Zachia S, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-21; 2009, BGBI, V50, P2529	53	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56390	10.1371/journal.pone.0056390	http://dx.doi.org/10.1371/journal.pone.0056390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437121	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200065
J	Yang, TY; Eissler, CL; Hall, MC; Parker, LL				Yang, Tzu-Yi; Eissler, Christie L.; Hall, Mark C.; Parker, Laurie L.			A Multiple Reaction Monitoring (MRM) Method to Detect Bcr-Abl Kinase Activity in CML Using a Peptide Biosensor	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; MASS-SPECTROMETRY; PHOSPHORYLATION; IMATINIB; ASSAY; QUANTIFICATION; STOICHIOMETRY; INHIBITION; ACTIVATION; CELLS	The protein kinase Bcr-Abl plays a major role in the pathogenesis of chronic myelogenous leukemia (CML), and is the target of the breakthrough drug imatinib (Gleevec (TM)). While most patients respond well to imatinib, approximately 30% never achieve remission or develop resistance within 1-5 years of starting imatinib treatment. Evidence from clinical studies suggests that achieving at least 50% inhibition of a patient's Bcr-Abl kinase activity (relative to their level at diagnosis) is associated with improved patient outcomes, including reduced occurrence of resistance and longer maintenance of remission. Accordingly, sensitive assays for detecting Bcr-Abl kinase activity compatible with small amounts of patient material are desirable as potential companion diagnostics for imatinib. Here we report the detection of Bcr-Abl activity and inhibition by imatinib in the human CML cell line K562 using a cell-penetrating peptide biosensor and multiple reaction monitoring (MRM) on a triple quadrupole mass spectrometer. MRM enabled reproducible, selective detection of the peptide biosensor at fmol levels from aliquots of cell lysate equivalent to similar to 15,000 cells. This degree of sensitivity will facilitate the miniaturization of the entire assay procedure down to cell numbers approaching 15,000, making it practical for translational applications in patient cells in which the limited amount of available patient material often presents a major challenge.	[Yang, Tzu-Yi; Parker, Laurie L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Eissler, Christie L.; Hall, Mark C.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Yang, Tzu-Yi; Eissler, Christie L.; Hall, Mark C.; Parker, Laurie L.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Parker, LL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	llparker@purdue.edu	Hall, Mark C./D-1698-2011; Parker, Laurie L/C-1510-2010	Parker, Laurie L/0000-0002-6234-3346; Hall, Mark/0000-0001-6429-2506	National Institutes of Health [R00CA127161, R21CA160129]; Project Development Team within the ICTSI NIH/NCRR Grant [TR000006]; NATIONAL CANCER INSTITUTE [R21CA160129, R00CA127161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project Development Team within the ICTSI NIH/NCRR Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support and funding for this work from the National Institutes of Health through the following grants to LLP: Howard Temin Pathway to Independence Award R00CA127161, R21CA160129; and by a Project Development Team within the ICTSI NIH/NCRR Grant Number TR000006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea MP, 2012, MOL CELL PROTEOMICS, V11, P453, DOI 10.1074/mcp.M112.017483; [Anonymous], 2012, WORLD MARKET CANC TH; Balasubramaniam D, 2010, PROTEOMICS, V10, P4301, DOI 10.1002/pmic.201000232; Blagosklonny MV, 2003, CANCER BIOL THER, V2, P137, DOI 10.4161/cbt.2.2.286; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Disis M, 2004, ASSAY VALIDATION VAC; Domanski D, 2010, ANAL CHEM, V82, P5610, DOI 10.1021/ac1005553; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Eissler CL, 2011, ANAL BIOCHEM, V418, P267, DOI 10.1016/j.ab.2011.07.015; Houseman BT, 2002, NAT BIOTECHNOL, V20, P270, DOI 10.1038/nbt0302-270; Lee AG, 2012, BIOMED MICRODEVICES, V14, P247, DOI 10.1007/s10544-011-9602-y; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Placzek EA, 2010, ANAL BIOCHEM, V397, P73, DOI 10.1016/j.ab.2009.09.048; Pratz KW, 2009, BLOOD, V113, P3938, DOI 10.1182/blood-2008-09-177030; Proctor A, 2012, ANAL CHEM, V84, P7195, DOI 10.1021/ac301489d; Proctor A, 2012, ANALYST, V137, P3028, DOI 10.1039/c2an16162a; Schmidt C, 2011, NAT BIOTECHNOL, V29, P955, DOI 10.1038/nbt1111-955; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Storey S, 2009, NAT REV DRUG DISCOV, V8, P447, DOI [10.1038/nrd2908, 10.1038/nrd2873]; Sylvester JE, 2010, MOL CANCER THER, V9, P1469, DOI 10.1158/1535-7163.MCT-10-0157; Tang JB, 2012, CHEMBIOCHEM, V13, P665, DOI 10.1002/cbic.201100763; White D, 2007, J CLIN ONCOL, V25, P4445, DOI 10.1200/JCO.2006.09.9499; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wu D, 2005, ANAL BIOCHEM, V347, P67, DOI 10.1016/j.ab.2005.09.001; Wu D, 2008, ANAL BIOCHEM, V375, P18, DOI 10.1016/j.ab.2007.12.023; Zhang Y, 2008, CHINESE J CHEM, V26, P1863, DOI 10.1002/cjoc.200890336; Zhou GC, 2011, ANAL BIOCHEM, V408, P5, DOI 10.1016/j.ab.2010.08.034	29	16	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56627	10.1371/journal.pone.0056627	http://dx.doi.org/10.1371/journal.pone.0056627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437189	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200122
J	Yue, XP; Li, R; Xie, WM; Xu, P; Chang, TC; Liu, L; Cheng, F; Zhang, RF; Lan, XY; Chen, H; Lei, CZ				Yue, Xiang-Peng; Li, Ran; Xie, Wen-Mei; Xu, Ping; Chang, Ti-Cheng; Liu, Li; Cheng, Feng; Zhang, Run-Feng; Lan, Xian-Yong; Chen, Hong; Lei, Chu-Zhao			Phylogeography and Domestication of Chinese Swamp Buffalo	PLOS ONE			English	Article							DNA D-LOOP; GENETIC DIVERSITY; WATER-BUFFALO; BUBALUS-BUBALIS; MITOCHONDRIAL-DNA; MATERNAL ORIGIN; RIVER; SEQUENCES; DIFFERENTIATION; POPULATIONS	To further probe into whether swamp buffaloes were domesticated once or multiple times in China, this survey examined the mitochondrial DNA (mtDNA) Control Region (D-loop) diversity of 471 individuals representing 22 populations of 455 Chinese swamp buffaloes and 16 river buffaloes. Phylogenetic analysis revealed that Chinese swamp buffaloes could be divided into two distinct lineages, A and B, which were defined previously. Of the two lineages, lineage A was predominant across all populations. For predominant lineage A, Southwestern buffalo populations possess the highest genetic diversity among the three hypothesized domestication centers (Southeastern, Central, and Southwestern China), suggesting Southwestern China as the most likely location for the domestication of lineage A. However, a complex pattern of diversity is detected for the lineage B, preventing the unambiguous pinpointing of the exact place of domestication center and suggesting the presence of a long-term, strong gene flow among swamp buffalo populations caused by extensive migrations of buffaloes and frequent human movements along the Yangtze River throughout history. Our current study suggests that Southwestern China is the most likely domestication center for lineage A, and may have been a primary center of swamp buffalo domestication. More archaeological and genetic evidence is needed to show the process of domestication.	[Yue, Xiang-Peng; Li, Ran; Xu, Ping; Lan, Xian-Yong; Chen, Hong; Lei, Chu-Zhao] NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Xie, Wen-Mei] Pingliang Med Coll, Dept Basic Med, Pingliang, Gansu, Peoples R China; [Chang, Ti-Cheng] Penn State Univ, Dept Dairy & Anim Sci, Ctr Reprod Biol & Hlth, Coll Agr Sci, University Pk, PA 16802 USA; [Liu, Li] Stanford Univ, Dept E Asian Languages & Cultures, Stanford, CA 94305 USA; [Cheng, Feng] Xinyang Agr Coll, Dept Anim Sci, Xinyang, Henan, Peoples R China; [Zhang, Run-Feng] Hubei Normal Univ, Coll Life Sci, Huangshi, Hubei, Peoples R China	Northwest A&F University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Hubei Normal University	Lei, CZ (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	leichuzhao1118@126.com	Chang, Ti-Cheng/N-3252-2018; Zhang, RF/GXZ-8547-2022; Chang, Ti-Cheng/HHS-7370-2022		National Natural Science Foundation of China [31272399, 31072001]; Agricultural Science & Technology Project of Shaanxi Province [2012K02-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science & Technology Project of Shaanxi Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31272399, 31072001) and Agricultural Science & Technology Project of Shaanxi Province (No.2012K02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO T, 1994, ANIM GENET, V25, P29, DOI 10.1111/j.1365-2052.1994.tb00400.x; [Anonymous], KAOGU; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barker JSF, 1997, ANIM GENET, V28, P1, DOI 10.1111/j.1365-2052.1997.00036.x; Barker JSF, 1997, ANIM GENET, V28, P103, DOI 10.1111/j.1365-2052.1997.00085.x; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Chen SY, 2006, GENE, V376, P216, DOI 10.1016/j.gene.2006.03.009; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; Chen Y.C., 1989, Buffalo Journal, V5, P51; COCKRILL WR, 1981, BRIT VET J, V137, P8, DOI 10.1016/S0007-1935(17)31782-7; DEJONG PED, 1965, J ASIAN STUD, V24, P283, DOI 10.2307/2050566; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ge J, 1997, MIGRATION HIST CHINA; Groves CP, 1996, Z SAUGETIERKD, V61, P327; Guo SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-73; HIGHAM CFW, 1981, J ARCHAEOL SCI, V8, P353, DOI 10.1016/0305-4403(81)90035-2; Higham Charles, 1989, ARCHAEOLOGY MAINLAND; Hu WP, 1997, BIOCHEM GENET, V35, P225, DOI 10.1023/A:1021892915368; Jiang Y, 1995, GUDIA XINAN SICHOU Z; Kierstein G, 2004, MOL PHYLOGENET EVOL, V30, P308, DOI 10.1016/S1055-7903(03)00221-5; Kikkawa Y, 1997, ANIM GENET, V28, P195, DOI 10.1111/j.1365-2052.1997.00101.x; Kumar S, 2007, ANIM GENET, V38, P227, DOI 10.1111/j.1365-2052.2007.01602.x; Kumar S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-186; Lau CH, 1998, ANIM GENET, V29, P253, DOI 10.1046/j.1365-2052.1998.00309.x; Legendre P, 2002, SYST BIOL, V51, P199, DOI 10.1080/10635150252899725; Lei CZ, 2007, ANIM GENET, V38, P97, DOI 10.1111/j.1365-2052.2007.01567.x; Lei CZ, 2011, ANIM GENET, V42, P432, DOI 10.1111/j.1365-2052.2011.02174.x; Lei CZ, 2007, ASIAN AUSTRAL J ANIM, V20, P645, DOI 10.5713/ajas.2007.645; Lei CZ, 2007, ASIAN AUSTRAL J ANIM, V20, P471, DOI 10.5713/ajas.2007.471; Liu Li, 2006, KAOGU XUEBAO, V2, P141; Liu RY, 2007, ASIAN AUSTRAL J ANIM, V20, P178; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Mason I.L., 1974, HUSBANDRY HLTH DOMES, P1; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Mudar K., 2007, ASIAN PERSPECT, V46, P298, DOI DOI 10.1353/ASI.2007.0013; Nanda Amarjit Singh, 2003, Animal Science Journal, V74, P443, DOI 10.1046/j.1344-3941.2003.00138.x; Navani N, 2002, ANIM GENET, V33, P149, DOI 10.1046/j.1365-2052.2002.00823.x; O'Reilly Dougald J.W., 2006, Asian Perspectives, V45, P188, DOI 10.1353/asi.2006.0024; Patel Ajita, 1998, ARC PUBLICATIES, V18, P180; Patel Ajita, 1998, S ASIAN ARCHAEOLOGY, P101; QIU H, 1986, BOVINE BREEDS CHINA; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka K, 1996, BIOCHEM GENET, V34, P443, DOI 10.1007/BF00570125; TANAKA K, 1995, BIOCHEM GENET, V33, P137, DOI 10.1007/BF00554726; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tong E, 1983, WENWU, V9, P73; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Xiaochen Li, 2000, GUJIZHUI DONGWU XUEB, V38, P218; Yunnan Museum, 1995, KAOGU, V9, P775; Zhang Y, 2007, ANIM GENET, V38, P569, DOI 10.1111/j.1365-2052.2007.01648.x; Zhang Y, 2011, ANIM GENET, V42, P366, DOI 10.1111/j.1365-2052.2010.02166.x; Zhu FY, 2005, JIEMI WASHAN DECODIN; Zong Guanfu, 1985, SHIQIAN YANJIU, V4, P46; [No title captured]	58	24	27	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56552	10.1371/journal.pone.0056552	http://dx.doi.org/10.1371/journal.pone.0056552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437167	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200104
J	Moren, J; Shibata, T; Doya, K				Moren, Jan; Shibata, Tomohiro; Doya, Kenji			The Mechanism of Saccade Motor Pattern Generation Investigated by a Large-Scale Spiking Neuron Model of the Superior Colliculus	PLOS ONE			English	Article							MESENCEPHALIC RETICULAR-FORMATION; INTERMEDIATE GRAY LAYER; FRONTAL EYE FIELD; BRAIN-STEM; REVERSIBLE INACTIVATION; IN-VITRO; MONKEY; MOVEMENTS; CONNECTIONS; PRIMATE	The subcortical saccade-generating system consists of the retina, superior colliculus, cerebellum and brainstem motoneuron areas. The superior colliculus is the site of sensory-motor convergence within this basic visuomotor loop preserved throughout the vertebrates. While the system has been extensively studied, there are still several outstanding questions regarding how and where the saccade eye movement profile is generated and the contribution of respective parts within this system. Here we construct a spiking neuron model of the whole intermediate layer of the superior colliculus based on the latest anatomy and physiology data. The model consists of conductance-based spiking neurons with quasi-visual, burst, buildup, local inhibitory, and deep layer inhibitory neurons. The visual input is given from the superficial superior colliculus and the burst neurons send the output to the brainstem oculomotor nuclei. Gating input from the basal ganglia and an integral feedback from the reticular formation are also included. We implement the model in the NEST simulator and show that the activity profile of bursting neurons can be reproduced by a combination of NMDA-type and cholinergic excitatory synaptic inputs and integrative inhibitory feedback. The model shows that the spreading neural activity observed in vivo can keep track of the collicular output over time and reset the system at the end of a saccade through activation of deep layer inhibitory neurons. We identify the model parameters according to neural recording data and show that the resulting model recreates the saccade size-velocity curves known as the saccadic main sequence in behavioral studies. The present model is consistent with theories that the superior colliculus takes a principal role in generating the temporal profiles of saccadic eye movements, rather than just specifying the end points of eye movements.	[Moren, Jan] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Shibata, Tomohiro] Nara Inst Sci & Technol, Math Informat Lab, Nara, Japan; [Doya, Kenji] Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan	Kyoto University; Nara Institute of Science & Technology; Okinawa Institute of Science & Technology Graduate University	Moren, J (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	jan.moren@gmail.com	Doya, Kenji/B-5841-2015	Doya, Kenji/0000-0002-2446-6820; Shibata, Tomohiro/0000-0002-8766-4250	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [06060246]; Next Generation Supercomputing Project; MEXT (Ministry of of Education, Culture, Sports, Science, and Technology) in Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Next Generation Supercomputing Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of of Education, Culture, Sports, Science, and Technology) in Japan	This study was funded by the Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, grant number 06060246 (http://www.csrp.riken.jp/index_e.html and http://www.nsc.riken.jp/index-eng.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to the Riken Integrated Cluster of Clusters (RICC) at RIKEN for supplying the computing resources, and to the Next Generation Supercomputing Project and MEXT (Ministry of of Education, Culture, Sports, Science, and Technology) in Japan for the support. We also thank Drs. Yasushi Kobayashi, Tadashi Ogawa and Kae Nakamura for very productive discussions.	Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Aizawa H, 1999, J NEUROPHYSIOL, V82, P1642, DOI 10.1152/jn.1999.82.3.1642; Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; BALOH RW, 1975, NEUROLOGY, V25, P1065, DOI 10.1212/WNL.25.11.1065; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Choi WY, 2009, J NEUROSCI, V29, P7166, DOI 10.1523/JNEUROSCI.5038-08.2009; Cromer JA, 2007, J NEUROPHYSIOL, V98, P835, DOI 10.1152/jn.00308.2007; Cui H, 2003, J NEUROPHYSIOL, V89, P3128, DOI 10.1152/jn.01067.2002; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; FUCHS AF, 1967, J PHYSIOL-LONDON, V191, P609, DOI 10.1113/jphysiol.1967.sp008271; Gandhi NJ, 2008, EXP BRAIN RES, V189, P35, DOI 10.1007/s00221-008-1401-1; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI DOI 10.4249/SCH0LARPEDIA.1430; Girard B, 2005, PROG NEUROBIOL, V77, P215, DOI 10.1016/j.pneurobio.2005.11.001; Gisbergen J, 1985, EXPT BRAIN RES, V57; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; Grantyn AA, 2004, METH NE FRO NEUROSCI, P107; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Harris CM, 2006, BIOL CYBERN, V95, P21, DOI 10.1007/s00422-006-0064-x; Helms MC, 2004, J NEUROPHYSIOL, V91, P1706, DOI 10.1152/jn.00705.2003; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Isa T, 2002, PROG NEUROBIOL, V66, P205, DOI 10.1016/S0301-0082(02)00006-0; Isa T, 2009, J NEUROPHYSIOL, V102, P2581, DOI 10.1152/jn.00498.2009; Isoda M, 2008, J NEUROPHYSIOL, V100, P1332, DOI 10.1152/jn.90275.2008; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; Keller EL, 2004, METH NE FRO NEUROSCI, P277; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Lee P, 2006, J NEUROSCI, V26, P4763, DOI 10.1523/JNEUROSCI.0724-06.2006; LEFEVRE P, 1992, NEURAL NETWORKS, V5, P871, DOI 10.1016/S0893-6080(05)80084-X; Marino RA, 2008, J NEUROPHYSIOL, V100, P2564, DOI 10.1152/jn.90688.2008; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Meredith MA, 1998, J NEUROPHYSIOL, V79, P1597, DOI 10.1152/jn.1998.79.3.1597; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1991, SCIENCE, V251, P1358, DOI 10.1126/science.2003221; Nakahara H, 2006, J NEUROPHYSIOL, V96, P765, DOI 10.1152/jn.01372.2005; OTTES FP, 1986, VISION RES, V26, P857, DOI 10.1016/0042-6989(86)90144-6; Pettit DL, 1999, J NEUROPHYSIOL, V81, P1424, DOI 10.1152/jn.1999.81.3.1424; Port NL, 2000, J NEUROPHYSIOL, V84, P344, DOI 10.1152/jn.2000.84.1.344; Saito Y, 2005, J NEUROPHYSIOL, V93, P2898, DOI 10.1152/jn.01051.2004; Saito Y, 2003, J NEUROSCI, V23, P5854; Saito Y, 1999, J NEUROPHYSIOL, V82, P754, DOI 10.1152/jn.1999.82.2.754; SCHILLER PH, 1979, SCIENCE, V206, P590, DOI 10.1126/science.115091; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P679, DOI 10.1152/jn.00886.2000; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P2778, DOI 10.1152/jn.2002.87.6.2778; SPARKS DL, 1978, BRAIN RES, V156, P1, DOI 10.1016/0006-8993(78)90075-6; SPARKS DL, 1980, BRAIN RES, V190, P39, DOI 10.1016/0006-8993(80)91158-0; Tabareau N, 2007, BIOL CYBERN, V97, P279, DOI 10.1007/s00422-007-0172-2; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Takahashi M, 2010, J NEUROPHYSIOL, V104, P3146, DOI 10.1152/jn.00554.2010; van Opstal AJ, 2008, BIOL CYBERN, V98, P561, DOI 10.1007/s00422-008-0219-z; Waitzman DM, 2000, J NEUROPHYSIOL, V83, P2260, DOI 10.1152/jn.2000.83.4.2260; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Zhou L, 2008, EXP BRAIN RES, V189, P485, DOI 10.1007/s00221-008-1444-3; Zhu JJ, 2000, J PHYSIOL-LONDON, V523, P731, DOI 10.1111/j.1469-7793.2000.00731.x	57	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57134	10.1371/journal.pone.0057134	http://dx.doi.org/10.1371/journal.pone.0057134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431402	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800045
J	Cromer, D; Best, SE; Engwerda, C; Haque, A; Davenport, M				Cromer, Deborah; Best, Shannon E.; Engwerda, Christian; Haque, Ashraful; Davenport, Miles			Where Have All the Parasites Gone? Modelling Early Malaria Parasite Sequestration Dynamics	PLOS ONE			English	Article							CEREBRAL MALARIA; T-CELLS; IN-VIVO; HOST; BLOOD; STAGE; INFECTIONS; PATHOLOGY	Traditional approaches to measuring the level of malaria infection involve counting the proportion of parasite-infected red blood cells (iRBC) in circulating blood, known as parasitaemia. However, iRBC can also accumulate within the microvasculature of tissues and organs, a process called sequestration. Thus measurements of parasitemia do not necessarily reflect the total parasite burden (TPB). Recent experimental advances have allowed TPB measurements to be made in humans and experimental models. TPB is particularly important because it is the best current predictor of malaria disease severity and death in humans. Understanding the relationship between freely circulating iRBC versus tissue-sequestered iRBC is an important question in infection dynamics. The recent ability to experimentally measure the dynamics of iRBC in blood and tissue during murine malaria provides an exciting potential window into sequestration, but new modeling approaches are clearly required to understand these interactions. We present a model of malaria dynamics during early infection that incorporates iRBC that both circulate in the blood and sequester in tissue microvasculature. We explore the effect that perturbations to the system have on the ratio of the number of iRBC between these compartments, and consider which changes are most consistent with experimental data from mice. Using this model we predict an increase in the clearance rate of sequestered iRBCs around the time when mild symptoms become apparent, but a more pronounced increase in the rate of sequestration of iRBCs associated with the onset of severe malaria symptoms.	[Cromer, Deborah; Davenport, Miles] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Kensington, NSW 2033, Australia; [Best, Shannon E.; Engwerda, Christian; Haque, Ashraful] Queensland Inst Med Res, Immunol & Infect Lab, Brisbane, Qld 4006, Australia	University of New South Wales Sydney; QIMR Berghofer Medical Research Institute	Cromer, D (corresponding author), Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, POB 1, Kensington, NSW 2033, Australia.	d.cromer@unsw.edu.au	Haque, Ashraful/H-8697-2014; Engwerda, Christian/I-3072-2015	Haque, Ashraful/0000-0003-2260-0026; Davenport, Miles/0000-0002-4751-1831; Engwerda, Christian/0000-0003-2813-4804; Cromer, Deborah/0000-0002-5276-5094	Australian NHMRC Project Grant [613702]; NHMRC; Australian Centre for Vaccine Development	Australian NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for Vaccine Development	DC is an UNSW Vice-Chancellor's Post-Doctoral Fellow, SEB is funded by an Australian NHMRC Project Grant (Grant Number 613702), CE is a NHMRC Senior Research Fellow, AH is an Australian NHMRC Career Development Fellow and MPD is a NHMRC Senior Research Fellow. The work was funded by the NHMRC and Australian Centre for Vaccine Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426; Antia R, 2008, P ROY SOC B-BIOL SCI, V275, P1449, DOI 10.1098/rspb.2008.0198; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Cromer D, 2006, INT J PARASITOL, V36, P1389, DOI 10.1016/j.ijpara.2006.07.009; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Fonager J, 2011, J EXPT MED; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Gravenor MB, 1998, P NATL ACAD SCI USA, V95, P7620, DOI 10.1073/pnas.95.13.7620; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; HELLRIEGEL B, 1992, P ROY SOC B-BIOL SCI, V250, P249, DOI 10.1098/rspb.1992.0156; Hetzel C, 1996, PARASITOLOGY, V113, P25, DOI 10.1017/S0031182000066245; Hoshen MB, 2000, PARASITOLOGY, V121, P227, DOI 10.1017/S0031182099006368; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; Lovegrove FE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000068; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Mideo N, 2008, AM NAT, V172, pE214, DOI 10.1086/591684; Miller MR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000946; MONS B, 1985, PARASITOLOGY, V91, P423, DOI 10.1017/S0031182000062673; NEILL AL, 1992, PARASITOLOGY, V105, P165, DOI 10.1017/S0031182000074072; Newton CRJC, 2000, J NEUROL NEUROSUR PS, V69, P433, DOI 10.1136/jnnp.69.4.433; Ochola LB, 2005, PARASITOLOGY, V131, P449, DOI 10.1017/S0031182005008085; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Phillips AN, 1996, SCIENCE, V271, P497, DOI 10.1126/science.271.5248.497; SILAMUT K, 1993, T ROY SOC TROP MED H, V87, P436, DOI 10.1016/0035-9203(93)90028-O; Smith T, 2004, PARASITOLOGY, V129, P289, DOI 10.1017/S003118200400575X; WHITE NJ, 1992, T ROY SOC TROP MED H, V86, P590, DOI 10.1016/0035-9203(92)90141-X; WHO, 2010, GUID TREATM MAL, V2nd	35	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55961	10.1371/journal.pone.0055961	http://dx.doi.org/10.1371/journal.pone.0055961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441158	gold, Green Published			2022-12-27	WOS:000315159200015
J	Chen, JJ; Rosas, HD; Salat, DH				Chen, J. Jean; Rosas, H. Diana; Salat, David H.			The Relationship between Cortical Blood Flow and Sub-Cortical White-Matter Health across the Adult Age Span	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VASCULAR RISK-FACTORS; DIFFUSION TENSOR; ALZHEIMERS-DISEASE; NEUROVASCULAR MECHANISMS; CEREBRAL PERFUSION; CORPUS-CALLOSUM; OLDER-ADULTS; RANDOM-FIELD; INTEGRITY	Degeneration of cerebral white matter is commonly observed in aging, and the associated degradation in neural connectivity contributes to cognitive decline in older adults. Vascular dysfunction has been implicated as a potential mechanism for general age-related neural tissue deterioration; however, no prior study has examined the direct relationship between cortical vascular health and subcortical white-matter integrity. In this work, we aimed to determine whether blood supply to the brain is associated with microstructural integrity of connective tissue, and whether such associations are regionally specific and mainly accounted for by aging. We examined the association between cerebral blood flow (CBF) in the cortical mantle, measured using arterial spin labeling (ASL), and subcortical white-matter integrity, measured using diffusion tensor imaging (DTI), in a group of healthy adults spanning early to late adulthood. We found cortical CBF to be significantly associated with white-matter integrity throughout the brain. In addition, these associations were only partially tied to aging, as they remained even when statistically controlling for age, and when restricting the analyses to a young subset of the sample. Furthermore, vascular risk was not a prominent determinant of these effects. These findings suggest that the overall blood supply to the brain is an important indicator of white-matter health in the normal range of variations amongst adults, and that the decline in CBF with advancing age may potentially exacerbate deterioration of the connective anatomy of the brain.	[Chen, J. Jean] Univ Toronto, Rotman Res Inst, Baycrest Ctr Geriatr Care, Toronto, ON, Canada; [Chen, J. Jean; Rosas, H. Diana; Salat, David H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Chen, J. Jean; Salat, David H.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Rosas, H. Diana] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA USA	University of Toronto; University Toronto Affiliates; Baycrest; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Chen, JJ (corresponding author), Univ Toronto, Rotman Res Inst, Baycrest Ctr Geriatr Care, Toronto, ON, Canada.	jchen@rotman-baycrest.on.ca	Chen, Jean/A-2846-2013	Chen, Jean/0000-0001-5469-7542	National Institutes of Health [R01NR010827, NS042861, P41RR14075]; Canadian Institutes of Health Research; Athinoula A. Martinos Center for Biomedical Imaging; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Athinoula A. Martinos Center for Biomedical Imaging; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by National Institutes of Health grants R01NR010827, NS042861, and P41RR14075, as well as by fellowship funding from the Canadian Institutes of Health Research (to JJC) and the Athinoula A. Martinos Center for Biomedical Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, NMR BIOMED, V23, P446, DOI 10.1002/nbm.1479; Aslan S, 2011, NEUROIMAGE, V56, P1145, DOI 10.1016/j.neuroimage.2011.02.082; Avants BB, 2010, NEUROIMAGE, V50, P1004, DOI 10.1016/j.neuroimage.2010.01.041; Barodka VM, 2011, ANESTH ANALG, V112, P1048, DOI 10.1213/ANE.0b013e3182147e3c; Bastin ME, 2010, NEUROIMAGE, V51, P1, DOI 10.1016/j.neuroimage.2010.02.036; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Brown WR, 2007, J NEUROL SCI, V257, P62, DOI 10.1016/j.jns.2007.01.015; Brown WR, 2002, J NEUROL SCI, V203, P159, DOI 10.1016/S0022-510X(02)00283-6; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Caroli A, 2007, J NEUROL, V254, P1698, DOI 10.1007/s00415-007-0631-7; Cavusoglu M, 2009, MAGN RESON IMAGING, V27, P1039, DOI 10.1016/j.mri.2009.04.002; Chen JJ, 2012, NEUROIMAGE, V59, P1043, DOI 10.1016/j.neuroimage.2011.08.112; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; de la Torre JC, 2005, ANN NEUROL, V57, P783, DOI 10.1002/ana.20516; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franc DT, 2011, DIABETES, V60, P315, DOI 10.2337/db10-0598; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Henskens LH, 2009, J HYPERTENS, V27, P846, DOI 10.1097/HJH.0b013e3283232c96; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; HUGHES CCW, 1987, J NEUROL SCI, V79, P101, DOI 10.1016/0022-510X(87)90264-4; Jacobs HIL, 2013, HUM BRAIN MAPP, V34, P77, DOI 10.1002/hbm.21412; Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85; Kakou M, 1998, NEUROCHIRURGIE, V44, P31; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Kennedy KM, 2009, BRAIN RES, V1297, P41, DOI 10.1016/j.brainres.2009.08.058; KERTESZ A, 1990, ARCH NEUROL-CHICAGO, V47, P387, DOI 10.1001/archneur.1990.00530040029015; Keymel S, 2011, AM J CARDIOVASC DIS, V1, P68; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; KOBARI M, 1990, AM J NEURORADIOL, V11, P273; Korf ESC, 2005, DEMENT GERIATR COGN, V20, P331, DOI 10.1159/000088464; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Leoni RF, 2011, NEUROIMAGE, V58, P75, DOI 10.1016/j.neuroimage.2011.06.030; Leritz EC, 2011, NEUROIMAGE, V54, P2659, DOI 10.1016/j.neuroimage.2010.10.050; Leritz EC, 2010, NEUROPSYCHOLOGY, V24, P199, DOI 10.1037/a0018108; Lu HZ, 2006, MAGN RESON MED, V56, P546, DOI 10.1002/mrm.20976; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; MATSUSHITA K, 1994, HYPERTENSION, V23, P565, DOI 10.1161/01.HYP.23.5.565; Ni JM, 2010, EUR J RADIOL, V75, P134, DOI 10.1016/j.ejrad.2009.04.028; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reshef S, 2011, J GERONTOL A-BIOL, V66, P74, DOI 10.1093/gerona/glq166; Rosso C, 2011, NEURORADIOLOGY, V53, P763, DOI 10.1007/s00234-011-0916-5; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sachdev PS, 1999, MED J AUSTRALIA, V170, P81, DOI 10.5694/j.1326-5377.1999.tb126889.x; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Salat DH, 2006, STROKE, V37, P1759, DOI 10.1161/01.STR.0000227328.86353.a7; Salat DH, 2012, NEUROIMAGE, V59, P181, DOI 10.1016/j.neuroimage.2011.07.033; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Salat DH, 2005, ANN NY ACAD SCI, V1064, P37, DOI 10.1196/annals.1340.009; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sullivan EV, 2003, EUR J RADIOL, V45, P244, DOI 10.1016/S0720-048X(02)00313-3; Sydykova D, 2007, CEREB CORTEX, V17, P2276, DOI 10.1093/cercor/bhl136; Tarumi T, 2011, AM J HYPERTENS, V24, P1108, DOI 10.1038/ajh.2011.101; TELL GS, 1994, HYPERTENSION, V23, P59, DOI 10.1161/01.HYP.23.1.59; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; van Elderen SGC, 2011, DIABETES CARE, V34, P459, DOI 10.2337/dc10-1446; van Norden AGW, 2008, NEUROLOGY, V71, P1152, DOI 10.1212/01.wnl.0000327564.44819.49; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	85	29	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56733	10.1371/journal.pone.0056733	http://dx.doi.org/10.1371/journal.pone.0056733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437228	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000042
J	Delaney, C; Garg, SK; Fernandes, C; Hoeltzel, M; Allen, RH; Stabler, S; Yung, R				Delaney, Colin; Garg, Sanjay K.; Fernandes, Chris; Hoeltzel, Mark; Allen, Robert H.; Stabler, Sally; Yung, Raymond			Maternal Diet Supplemented with Methyl-Donors Protects against Atherosclerosis in F1 ApoE(-/-) Mice	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC MODIFICATION; CARDIOVASCULAR-DISEASE; LIVER; GENE; DEFICIENCY; EXPRESSION; SERUM; INFLAMMATION; CHOLESTEROL	Atherosclerosis is an inflammatory condition of the arterial wall mediated by cells of both innate and adaptive immunity. T lymphocytes play an important role in orchestrating the pathogenic immune response involved in the acceleration of atherosclerosis. Previously, we have shown that a prenatal methyl-donor supplementation diet (MS), when fed to dams during pregnancy and lactation, decreased the T cell-mediated pro-inflammatory cytokine and chemokine response in F1 mice. In the current study, we report feeding Apolipoprotein E (ApoE(-/-)) deficient dams with the MS diet during pregnancy reduces atherosclerotic plaques in F1 mice that were fed high fat diet (HFD) after weaning. F1 mice from dams on the MS diet exhibited increased global T cell DNA methylation. T-cell chemokines and their receptors (in particular CCR2, CCR5, and CXCR3) play important roles in the inflammatory cell recruitment to vascular lesions. MS diet significantly reduced Ccr2 mRNA and protein expression in CD3+ T cells but not in CD11b+ monocytes in MS F1 mice relative to controls. F1 litter size, HFD consumption, body weight, and body fat were similar between control and MS diet groups. Moreover, serum thiol metabolite levels were similar between the two groups. However, MS diet is associated with significantly higher serum HDL and lower LDL+VLDL levels in comparison to F1 mice from dams on the control diet. Inflammatory cytokines (IL-17, TNF-alpha, IL-6) were also lower in MS F1 mice serum and conditioned media from T-cell culture. Altogether, these data suggest that the MS diet ameliorates development of atherosclerosis by inhibiting the T-cell Ccr2 expression, reducing inflammatory cytokines production and increasing serum HDL:LDL ratio.	[Delaney, Colin; Garg, Sanjay K.; Fernandes, Chris; Yung, Raymond] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hoeltzel, Mark] Childrens Mercy Hosp & Clin, Dept Pediat, Kansas City, MO USA; [Allen, Robert H.; Stabler, Sally] Univ Colorado, Sch Med, Aurora, CO USA	University of Michigan System; University of Michigan; Children's Mercy Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus	Yung, R (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	ryung@umich.edu		Delaney, Colin E/0000-0001-6880-6973	National Institutes of Health National Institute on Aging [AG020628, AG028268, AG013283, AG024824]; National Institute of Environmental Health Sciences [ES017885]; Michigan Diabetes Research and Training Center; VA Ann Arbor Geriatrics Research, Education and Clinical Care Center (GRECC); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020628, P30AG024824, R56AG020628, R01AG028268, P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Michigan Diabetes Research and Training Center; VA Ann Arbor Geriatrics Research, Education and Clinical Care Center (GRECC); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by National Institutes of Health National Institute on Aging (AG020628, AG028268, AG013283, AG024824), National Institute of Environmental Health Sciences (ES017885), Michigan Diabetes Research and Training Center, VA Ann Arbor Geriatrics Research, Education and Clinical Care Center (GRECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; Ballestar E, 2006, J IMMUNOL, V176, P7143, DOI 10.4049/jimmunol.176.12.7143; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Brooks WH, 2010, J AUTOIMMUN, V34, pJ207, DOI 10.1016/j.jaut.2009.12.006; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; Delaney C, 2012, J NUTR, V142, P1329, DOI 10.3945/jn.111.155903; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feingold KR, 1998, ATHEROSCLEROSIS, V139, P307, DOI 10.1016/S0021-9150(98)00084-7; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Garg S, 2006, J BIOL CHEM, V281, P38712, DOI 10.1074/jbc.M606235200; HANSSON GK, 1988, CIRC RES, V63, P712, DOI 10.1161/01.RES.63.4.712; Hoekstra M, 2005, J HEPATOL, V42, P400, DOI 10.1016/j.jhep.2004.11.032; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Khateeb J, 2010, ATHEROSCLEROSIS, V208, P119, DOI 10.1016/j.atherosclerosis.2009.08.051; Kim J, 2007, BBA-MOL BASIS DIS, V1772, P72, DOI 10.1016/j.bbadis.2006.10.004; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P170; Libby P, 2000, BBA-MOL CELL BIOL L, V1529, P299, DOI 10.1016/S1388-1981(00)00161-X; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; STABLER SP, 1993, BLOOD, V81, P3404; Suarez-Alvarez B, 2012, TRENDS GENET; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889	47	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56253	10.1371/journal.pone.0056253	http://dx.doi.org/10.1371/journal.pone.0056253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437105	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000021
J	Poce, G; Bates, RH; Alfonso, S; Cocozza, M; Porretta, GC; Ballell, L; Rullas, J; Ortega, F; De Logu, A; Agus, E; La Rosa, V; Pasca, MR; De Rossi, E; Wae, BJ; Franzblau, SG; Manetti, F; Botta, M; Biava, M				Poce, Giovanna; Bates, Robert H.; Alfonso, Salvatore; Cocozza, Martina; Porretta, Giulio Cesare; Ballell, Lluis; Rullas, Joaquin; Ortega, Fatima; De Logu, Alessandro; Agus, Emanuela; La Rosa, Valentina; Pasca, Maria Rosalia; De Rossi, Edda; Wae, Baojie; Franzblau, Scott G.; Manetti, Fabrizio; Botta, Maurizio; Biava, Mariangela			Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG DISCOVERY; ANTIMYCOBACTERIAL; IDENTIFICATION; STREPTOMYCIN; DERIVATIVES; ASSAY	1,5-Diphenyl pyrroles were previously identified as a class of compounds endowed with high in vitro efficacy against M. tuberculosis. To improve the physical chemical properties and drug-like parameters of this class of compounds, a medicinal chemistry effort was undertaken. By selecting the optimal substitution patterns for the phenyl rings at N1 and C5 and by replacing the thiomorpholine moiety with a morpholine one, a new series of compounds was produced. The replacement of the sulfur with oxygen gave compounds with lower lipophilicity and improved in vitro microsomal stability. Moreover, since the parent compound of this family has been shown to target MmpL3, mycobacterial mutants resistant to two compounds have been isolated and characterized by sequencing the mmpL3 gene; all the mutants showed point mutations in this gene. The best compound identified to date was progressed to dose-response studies in an acute murine TB infection model. The resulting ED99 of 49 mg/Kg is within the range of commonly employed tuberculosis drugs, demonstrating the potential of this chemical series. The in vitro and in vivo target validation evidence presented here adds further weight to MmpL3 as a druggable target of interest for anti-tubercular drug discovery.	[Poce, Giovanna; Alfonso, Salvatore; Cocozza, Martina; Porretta, Giulio Cesare; Biava, Mariangela] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Bates, Robert H.; Ballell, Lluis; Rullas, Joaquin; Ortega, Fatima] GlaxoSmithKline, Dis Dev World, Madrid, Spain; [De Logu, Alessandro; Agus, Emanuela] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [La Rosa, Valentina; Pasca, Maria Rosalia; De Rossi, Edda] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Wae, Baojie; Franzblau, Scott G.] Univ Illinois, Inst TB Res, Chicago, IL USA; [Manetti, Fabrizio; Botta, Maurizio] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; GlaxoSmithKline; University of Cagliari; University of Pavia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Siena	Poce, G (corresponding author), Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, Rome, Italy.	giovanna.poce@uniroma1.it; mariangela.biava@uniroma1.it	Manetti, Fabrizio/Q-9412-2019; Pasca, Maria Rosalia/J-8752-2016	Manetti, Fabrizio/0000-0002-9598-2339; Pasca, Maria Rosalia/0000-0002-8906-4937; Franzblau, Scott/0000-0002-8698-0243; poce, giovanna/0000-0001-7466-8861; biava, mariangela/0000-0002-5409-807X; Ballell, Lluis/0000-0002-3029-1860	Istituto Pasteur Fondazione Cenci-Bolognetti (Italy); MIUR-PRIN (Italy); MIUR (Progetti di Ricerca di Ateneo) (Italy); Tres Cantos Open Lab Foundation; European Union's 7th framework programme (FP7) [261378]	Istituto Pasteur Fondazione Cenci-Bolognetti (Italy)(Istituto Pasteur Italia Fondazione Cenci Bolognetti); MIUR-PRIN (Italy)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); MIUR (Progetti di Ricerca di Ateneo) (Italy)(Ministry of Education, Universities and Research (MIUR)); Tres Cantos Open Lab Foundation; European Union's 7th framework programme (FP7)	This work was supported by Istituto Pasteur Fondazione Cenci-Bolognetti (Italy), MIUR-PRIN 2008 (Italy), MIUR 2011 (Progetti di Ricerca di Ateneo) (Italy) and Tres Cantos Open Lab Foundation. The research leading to these results also received funding from the European Union's 7th framework programme (FP7-2007-2013) under grant agreement no 261378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biava M, 1997, MED CHEM RES, V7, P228; Biava M, 2006, J MED CHEM, V49, P4946, DOI 10.1021/jm0602662; Biava M, 2011, CHEMMEDCHEM, V6, P593, DOI 10.1002/cmdc.201000526; Biava M, 2010, BIOORGAN MED CHEM, V18, P8076, DOI 10.1016/j.bmc.2010.09.006; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Deidda D, 1998, ANTIMICROB AGENTS CH, V42, P3035, DOI 10.1128/AAC.42.11.3035; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Fioravanti R, 1996, FARMACO, V51, P643; Fioravanti R, 1997, MED CHEM RES, V7, P87; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Rullas J, 2010, ANTIMICROB AGENTS CH, V54, P2262, DOI 10.1128/AAC.01423-09; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; World Health Organization, WHOHTMTB201116; World Health Organization, WHOHTMTB2009420, V4th; World Health Organization, 2010, WHOHTMTB20103; Zhang M, 2012, ANTIMICROB AGENTS CH, V56, P5782, DOI 10.1128/AAC.01125-12	20	76	79	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56980	10.1371/journal.pone.0056980	http://dx.doi.org/10.1371/journal.pone.0056980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437287	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000063
J	Zhao, Y; Zhang, DH; Wang, S; Tao, L; Wang, AY; Chen, WX; Zhu, ZJ; Zheng, SZ; Gao, X; Lu, Y				Zhao, Yang; Zhang, Daohai; Wang, Sheng; Tao, Li; Wang, Aiyun; Chen, Wenxing; Zhu, Zhijie; Zheng, Shizhong; Gao, Xiang; Lu, Yin			Holothurian Glycosaminoglycan Inhibits Metastasis and Thrombosis via Targeting of Nuclear Factor-kappa B/Tissue Factor/Factor Xa Pathway in Melanoma B16F10 Cells	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; BREAST-CANCER; PROCOAGULANT ACTIVITY; GCMA PHOSPHORYLATION; SIGNALING PATHWAYS; MOLECULAR-WEIGHT; TUMOR-GROWTH; COAGULATION; INVASION; INVOLVEMENT	Holothurian glycosaminoglycan (hGAG) is a high-molecular-weight form of fucosylated chondroitin sulfate and has an antithrombotic effect. Our previous studies demonstrated that hGAG efficiently inhibited tumor cell metastasis. The interplays between thrombosis and tumor progression may have a major impact on hematogenous metastasis. In this study, we demonstrated that the mouse melanoma B16F10 cells treated with hGAG displayed a significant reduction of metastasis and coagulation capacity in vitro and in vivo. Mechanistic studies revealed that hGAG treatment in B16F10 cells remarkably inhibited the formation of fibrin through attenuating the generation of activated Factor Xa (FXa), without affecting the expression of urokinase (uPA) and plasminogen activator inhibitor 1 (PAI-1) that involved in fibrinolysis. Moreover, hGAG treatment downregulated the transcription and protein expression of tissue factor (TF). Promoter deletions, site mutations and functional studies identified that the nuclear transcription factor NF-kappa B binding region is responsible for hGAG-induced inhibition of TF expression. While the hGAG treatment of B16F10 cells was unable to inhibit NF-kappa B expression and phosphorylation, hGAG significantly prevented nuclear translocation of NF-kappa B from the cytosol, a potential mechanism underlying the transcriptional suppression of TF. Moreover, hGAG markedly suppressed the activation of p38MAPK and ERK1/2 signaling pathways, the central regulators for the expression of metastasis-related matrix metalloproteinases (MMPs). Consequently, hGAG exerts a dual function in the inhibition of metastasis and coagulation activity in mouse melanoma B16F10 cells. Our studies suggest hGAG to be a promising therapeutic agent for metastatic cancer treatment.	[Zhao, Yang; Wang, Sheng; Tao, Li; Wang, Aiyun; Chen, Wenxing; Zhu, Zhijie; Zheng, Shizhong; Lu, Yin] Nanjing Univ Chinese Med, Coll Pharm, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China; [Zhang, Daohai] Univ Sydney, Sch Med Sci, Dept Pathol, Sydney, NSW 2006, Australia; [Zheng, Shizhong; Lu, Yin] Nanjing Univ Chinese Med, Jiangsu Key Lab Efficacy & Safety Evaluat Tradit, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; University of Sydney; Nanjing University of Chinese Medicine; Nanjing University	Lu, Y (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China.	profyinlu@163.com	Chen, Wenxing/GSI-9910-2022; Tao, Li/AAF-4654-2021	Chen, Wenxing/0000-0003-4571-7622	National Natural Science Foundation of China [81173174, 30772766]; Natural Science Foundation of Jiangsu Province [BK2010085, 2010562]; Educational Commission of Jiangsu Province [09KJA360002]; Jiangsu College Graduate Research and Innovation Projects [2010-469, 2010-471]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Supporting Jiangsu Provincial Talents in Six Fields [06-B-023, 08-A-012]; Jiangsu Administration of Traditional Chinese Medicine [LZ09022]; Open Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica [P09013]; Program of Jiangsu International Cooperation [SBZ200900175]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Educational Commission of Jiangsu Province; Jiangsu College Graduate Research and Innovation Projects; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Supporting Jiangsu Provincial Talents in Six Fields; Jiangsu Administration of Traditional Chinese Medicine; Open Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica; Program of Jiangsu International Cooperation	This work was supported by research funds/projects from National Natural Science Foundation of China (81173174,30772766); Natural Science Foundation of Jiangsu Province (BK2010085, 2010562); Educational Commission of Jiangsu Province (09KJA360002); Jiangsu College Graduate Research and Innovation Projects (2010-469 and 2010-471); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Supporting Jiangsu Provincial Talents in Six Fields (06-B-023 and 08-A-012); Jiangsu Administration of Traditional Chinese Medicine (LZ09022); Open Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica (P09013); and Program of Jiangsu International Cooperation (SBZ200900175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Babykutty S, 2012, MOL CARCINOGEN, V51, P475, DOI 10.1002/mc.20812; Bambang IF, 2009, LAB INVEST, V89, P1229, DOI 10.1038/labinvest.2009.87; Barrowcliffe TW, 2002, THROMB HAEMOSTASIS, V87, P442; Bastarache JA, 2007, THORAX, V62, P608, DOI 10.1136/thx.2006.063305; Blom JW, 2004, J THROMB HAEMOST, V2, P1760, DOI 10.1111/j.1538-7836.2004.00928.x; Buyue Y, 2009, BLOOD, V114, P3092, DOI 10.1182/blood-2009-02-203661; de Vicente JC, 2012, HEAD NECK-J SCI SPEC, V17, P2303; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Gomez K, 2006, FRONT BIOSCI-LANDMRK, V11, P1349, DOI 10.2741/1888; Gomez-Pina V, 2012, J LEUKOCYTE BIOL, V91, P933, DOI 10.1189/jlb.0711340; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035901; Imanari T, 1999, THROMB RES, V93, P129, DOI 10.1016/S0049-3848(98)00171-6; Ingles-Esteve J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038347; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Ko HS, 2012, J AGR FOOD CHEM, V60, P4083, DOI 10.1021/jf205171g; Lee BJ, 2011, ONCOL REP, V26, P665, DOI 10.3892/or.2011.1314; Lee SO, 2008, BIOCHEM BIOPH RES CO, V366, P1019, DOI 10.1016/j.bbrc.2007.12.068; Li H, 2010, ENDOCRINOLOGY, V151, P63, DOI 10.1210/en.2009-0833; Lim W, 2012, PHOTOCHEM PHOTOBIOL, V14, P1751; Lin KL, 2012, LIFE SCI, V90, P54, DOI 10.1016/j.lfs.2011.10.020; Ludwig RJ, 2004, CANCER RES, V64, P2743, DOI 10.1158/0008-5472.CAN-03-1054; Mandal SK, 2007, BLOOD, V110, P161, DOI 10.1182/blood-2006-10-050476; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Mousa SA, 2009, THROMB HAEMOSTASIS, V102, P258, DOI 10.1160/TH08-12-0832; Nicolini A, 2009, MED RES REV, V29, P436, DOI 10.1002/med.20143; Otero LL, 2011, BIOMARKERS, V16, P58, DOI 10.3109/1354750X.2010.533282; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Pickering W, 2004, J THROMB HAEMOST, V2, P459, DOI 10.1111/j.1538-7836.2004.00607.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Riddel JP, 2007, J PEDIATR ONCOL NURS, V24, P123, DOI 10.1177/1043454206298693; Rizoli SB, 2011, J TRAUMA, V71, pS427, DOI 10.1097/TA.0b013e318232e5ab; Rong Y, 2005, CANCER RES, V65, P1406, DOI 10.1158/0008-5472.CAN-04-3376; Satou R, 2012, FASEB J, V26, P1821, DOI 10.1096/fj.11-195198; Schoots IG, 2004, THROMB HAEMOSTASIS, V91, P497, DOI 10.1160/TH03-08-0529; Sheehan JP, 2006, BLOOD, V107, P3876, DOI 10.1182/blood-2005-07-3043; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; Shum MSY, 2011, FASEB J, V25, P4423, DOI 10.1096/fj.11-185447; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Stenina OI, 2005, NAT MED, V11, P376, DOI 10.1038/nm0405-376; Sudha T, 2012, CLIN EXP METASTAS, V29, P431, DOI 10.1007/s10585-012-9461-9; Switzer CH, 2012, CANCER RES, V72, P2394, DOI 10.1158/0008-5472.CAN-11-3115; Takada H, 2010, CANCER GENET CYTOGEN, V197, P16, DOI 10.1016/j.cancergencyto.2009.11.004; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Terasaka N, 2005, FEBS J, V272, P1546, DOI 10.1111/j.1742-4658.2005.04599.x; Tian ML, 2011, CANCER BIOL THER, V12, P896, DOI 10.4161/cbt.12.10.17679; Tormoen GW, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066005; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Welsh J, 2012, INT J LAB HEMATOL, V34, P396, DOI 10.1111/j.1751-553X.2012.01409.x; Yang J, 2008, J BIOMED MATER RES B, V84B, P131, DOI 10.1002/jbm.b.30853; Yasui Y, 2012, BIOMED RES-TOKYO, V33, P217, DOI 10.2220/biomedres.33.217; Yasui Y, 2012, BIOCHEM BIOPH RES CO, V417, P1127, DOI 10.1016/j.bbrc.2011.12.059; Yates KR, 2011, BLOOD COAGUL FIBRIN, V22, P680, DOI 10.1097/MBC.0b013e32834ad7bc; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; Yokota N, 2009, BRIT J CANCER, V101, P2023, DOI 10.1038/sj.bjc.6605406; Zhang WW, 2009, CANCER BIOL THER, V8, P1489, DOI 10.4161/cbt.8.15.8948; Zheng S, 2009, CANCER SCI, V100, P859, DOI 10.1111/j.1349-7006.2009.01115.x; Zubair A, 2012, CURR ALLERGY ASTHM R, V6, P234	65	30	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56557	10.1371/journal.pone.0056557	http://dx.doi.org/10.1371/journal.pone.0056557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437168	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000032
J	Blain, A; Greally, E; Laval, S; Blamire, A; Straub, V; MacGowan, GA				Blain, Alison; Greally, Elizabeth; Laval, Steve; Blamire, Andrew; Straub, Volker; MacGowan, Guy A.			Beta-Blockers, Left and Right Ventricular Function, and In-Vivo Calcium Influx in Muscular Dystrophy Cardiomyopathy	PLOS ONE			English	Article							HEART-FAILURE; MOUSE MODEL; DILATED CARDIOMYOPATHY; MICE; INVOLVEMENT; SURVIVAL	Beta-blockers are used to treat acquired heart failure in adults, though their role in early muscular dystrophy cardiomyopathy is unclear. We treated 2 different dystrophic mouse models which have an associated cardiomyopathy (mdx: model for Duchenne Muscular Dystrophy, and Sgcd-/-: model for limb girdle muscular dystrophy type 2F) and wild type controls (C57 Bl10) with the beta blocker metoprolol or placebo for 8 weeks at an early stage in the development of the cardiomyopathy. Left and right ventricular function was assessed with cardiac magnetic resonance imaging (MRI) and in-vivo myocardial calcium influx with manganese enhanced MRI. In the mdx mice at baseline there was reduced stroke volume, cardiac index, and end-diastolic volume with preserved left ventricular ejection fraction. These abnormalities were no longer evident after treatment with beta-blockers. Right ventricular ejection fraction was reduced and right ventricular end-systolic volume increased in the mdx mice. With metoprolol there was an increase in right ventricular end-diastolic and end-systolic volumes. Left and right ventricular function was normal in the Sgcd-/- mice. Metroprolol had no significant effects on left and right ventricular function in these mice, though heart/body weight ratios increased after treatment. In-vivo myocardial calcium influx with MEMRI was significantly elevated in both models, though metoprolol had no significant effects on either. In conclusion, metoprolol treatment at an early stage in the development of cardiomyopathy has deleterious effects on right ventricular function in mdx mice and in both models no effect on increased in- vivo calcium influx. This suggests that clinical trials need to carefully monitor not just left ventricular function but also right ventricular function and other aspects of myocardial metabolism.	[Blain, Alison; Greally, Elizabeth; Laval, Steve; Straub, Volker; MacGowan, Guy A.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Blamire, Andrew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Blamire, Andrew] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [MacGowan, Guy A.] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	MacGowan, GA (corresponding author), Newcastle Univ, Int Ctr Life, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	guy.macgowan@nuth.nhs.uk	Blamire, Andrew/AAU-6100-2021	Oliver, Alison/0000-0002-4564-9984; Straub, Volker/0000-0001-9046-3540; Blamire, Andrew/0000-0002-8749-1257	Heart Research UK grant [RG 2585]; British Heart Foundation Clinical Leave Research Fellowship [FS/11/89/29162]; British Heart Foundation [FS/11/89/29162] Funding Source: researchfish; Medical Research Council [MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	Heart Research UK grant; British Heart Foundation Clinical Leave Research Fellowship; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded in part by Heart Research UK grant RG 2585 and British Heart Foundation Clinical Leave Research Fellowship FS/11/89/29162 (both to GMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer R, 2008, CARDIOVASC RES, V79, P652, DOI 10.1093/cvr/cvn131; Bauer R, 2010, EUR J HEART FAIL, V12, P1163, DOI 10.1093/eurjhf/hfq129; Bauer R, 2010, NEUROMUSCULAR DISORD, V20, P21, DOI 10.1016/j.nmd.2009.10.003; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Bushby K, 2003, 107 ENMC INT WORKSH, V13, P166; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Fraysse B, 2010, AM J PHYSIOL-CELL PH, V299, pC706, DOI 10.1152/ajpcell.00545.2009; Greally E, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-4; Hu TCC, 2001, MAGNET RESON MED, V46, P884, DOI 10.1002/mrm.1273; Jacoby C, 2006, BASIC RES CARDIOL, V101, P87, DOI 10.1007/s00395-005-0542-7; Jefferies JL, 2005, CIRCULATION, V112, P2799, DOI 10.1161/CIRCULATIONAHA.104.528281; MacGowan GA, 2005, J APPL PHYSIOL, V98, P1163, DOI 10.1152/japplphysiol.00959.2004; MacGowan GA, 2012, CURR OPIN CARDIOL, V27, P296, DOI 10.1097/HCO.0b013e3283511e60; Melacini P, 1996, CIRCULATION, V94, P3168, DOI 10.1161/01.CIR.94.12.3168; MELACINI P, 1993, J AM COLL CARDIOL, V22, P1927, DOI 10.1016/0735-1097(93)90781-U; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; Stuckey DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028569; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Williams IA, 2007, AM J PHYSIOL-HEART C, V292, pH846, DOI 10.1152/ajpheart.00688.2006; Winter EM, 2008, ACTA PHYSIOL, V194, P111, DOI 10.1111/j.1748-1716.2008.01863.x; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844	24	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57260	10.1371/journal.pone.0057260	http://dx.doi.org/10.1371/journal.pone.0057260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437355	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200233
J	Curlik, DM; Maeng, LY; Agarwal, PR; Shors, TJ				Curlik, Daniel M., II; Maeng, Lisa Y.; Agarwal, Prateek R.; Shors, Tracey J.			Physical Skill Training Increases the Number of Surviving New Cells in the Adult Hippocampus	PLOS ONE			English	Article							LEARNING INCREASES; NEUROGENESIS; MOTOR; CEREBELLAR; ACQUISITION; PERFORMANCE; AMNESIA; NEURONS; LESIONS; TIME	The dentate gyrus is a major site of plasticity in the adult brain, giving rise to thousands of new neurons every day, through the process of adult neurogenesis. Although the majority of these cells die within two weeks of their birth, they can be rescued from death by various forms of learning. Successful acquisition of select types of associative and spatial memories increases the number of these cells that survive. Here, we investigated the possibility that an entirely different form of learning, physical skill learning, could rescue new hippocampal cells from death. To test this possibility, rats were trained with a physically-demanding and technically-difficult version of a rotarod procedure. Acquisition of the physical skill greatly increased the number of new hippocampal cells that survived. The number of surviving cells positively correlated with performance on the task. Only animals that successfully mastered the task retained the cells that would have otherwise died. Animals that failed to learn, and those that did not learn well did not retain any more cells than those that were untrained. Importantly, acute voluntary exercise in activity wheels did not increase the number of surviving cells. These data suggest that acquisition of a physical skill can increase the number of surviving hippocampal cells. Moreover, learning an easier version of the task did not increase cell survival. These results are consistent with previous reports revealing that learning only rescues new neurons from death when acquisition is sufficiently difficult to achieve. Finally, complete hippocampal lesions did not disrupt acquisition of this physical skill. Therefore, physical skill training that does not depend on the hippocampus can effectively increase the number of surviving cells in the adult hippocampus, the vast majority of which become mature neurons.	[Shors, Tracey J.] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shors, TJ (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.	shors@rutgers.edu			National Institutes of Health [MH-59970, ARRA-3R01MH059970-10S1]; National Science Foundation [IOB-0444364, IOS-0914386]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (grant nos. MH-59970 and ARRA-3R01MH059970-10S1) and the National Science Foundation (grant nos. IOB-0444364 and IOS-0914386) to TJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta P, 2009, BEHAV NEUROSCI, V123, P1036, DOI 10.1037/a0016870; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anderson ML, 2011, EUR J NEUROSCI, V33, P175, DOI 10.1111/j.1460-9568.2010.07486.x; Bangasser DA, 2005, BEHAV NEUROSCI, V119, P1459, DOI 10.1037/0735-7044.119.6.1459; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Bizon Jennifer L, 2005, Sci Aging Knowledge Environ, V2005, pre2, DOI 10.1126/sageke.2005.7.re2; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Curlik DM, 2011, J COGNITIVE NEUROSCI, V23, P2159, DOI 10.1162/jocn.2010.21597; Dalla C, 2007, NEUROBIOL LEARN MEM, V88, P143, DOI 10.1016/j.nlm.2007.02.003; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gasbarri A, 2003, NEUROSCIENCE, V116, P1131, DOI 10.1016/S0306-4522(02)00780-7; Goddyn H, 2006, BEHAV BRAIN RES, V173, P138, DOI 10.1016/j.bbr.2006.06.016; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; KARNI A, 1995, NATURE, V377, P155; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; NEWMAN PP, 1979, J PHYSIOL-LONDON, V287, P405, DOI 10.1113/jphysiol.1979.sp012667; Nokia MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031375; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Shors TJ, 2012, BEHAV BRAIN RES, V227, P450, DOI 10.1016/j.bbr.2011.04.023; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Snyder JS, 2009, HIPPOCAMPUS, V19, P898, DOI 10.1002/hipo.20552; SOLOMON PR, 1983, SCIENCE, V220, P329, DOI 10.1126/science.6836277; Song YN, 2006, NEUROSCIENCE, V140, P33, DOI 10.1016/j.neuroscience.2006.01.045; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; TEITELBAUM H, 1963, J COMP PHYSIOL PSYCH, V56, P284, DOI 10.1037/h0047052; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Waddell J, 2008, EUR J NEUROSCI, V27, P3020, DOI 10.1111/j.1460-9568.2008.06222.x; Waddell J, 2011, NEUROBIOL LEARN MEM, V95, P159, DOI 10.1016/j.nlm.2010.09.012	41	40	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55850	10.1371/journal.pone.0055850	http://dx.doi.org/10.1371/journal.pone.0055850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437067	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200026
J	Liu, K; Zhang, L; Lin, XL; Chen, LL; Shi, HB; Magaye, R; Zou, BB; Zhao, JS				Liu, Kui; Zhang, Lu; Lin, Xialu; Chen, Liangliang; Shi, Hongbo; Magaye, Ruth; Zou, Baobo; Zhao, Jinshun			Association of GST Genetic Polymorphisms with the Susceptibility to Hepatocellular Carcinoma (HCC) in Chinese Population Evaluated by an Updated Systematic Meta-Analysis	PLOS ONE			English	Article							S-TRANSFERASE M1; HEPATITIS-B CARRIERS; NULL GENOTYPES; AFLATOXIN; RISK; HETEROGENEITY; PATHOGENESIS; GUANGXI; BREAST; XRCC1	Background: Due to the possible involvement of Glutathione S-transferase Mu-1 (GSTM1) and Glutathione S-transferase theta-1 (GSTT1) in the detoxification of environmental carcinogens, environmental toxins, and oxidative stress products, genetic polymorphisms of these two genes may play important roles in the susceptibility of human being to hepatocellular carcinoma. However, the existing research results are not conclusive. Methods: A systematic literature search using databases (PubMed, Scopus, Embase, Chinese Biomedical Database, Chinese National Knowledge Infrastructure, Wanfang Data, etc.) for the eligible studies meeting the inclusion criteria including case-control studies or cohort studies is evaluated using an updated systematic meta-analysis. Results: Significant increase in the risk of HCC in the Chinese population is found in GSTM1 null genotype (OR = 1.47, 95% CI: 1.21 to 1.79, P<0.001) and GSTT1 null genotype (OR = 1.38, 95% CI: 1.14 to 1.65, P<0.001). Analysis using the random-effects model found an increased risk of HCC in GSTM1-GSTT1 dual null population (OR = 1.79, 95% CI: 1.26 to 2.53, P<0.001). In addition, subgroup analyses showed a significant increase in the association of GST genetic polymorphisms (GSTM1, GSTT1, and GSTM1-GSTT1) with HCC in southeast and central China mainland. However, available data collected by this study fail to show an association between GST genetic polymorphisms and HCC in people from the Taiwan region (for GSTM1: OR = 0.78, 95% CI: 0.60 to 1.01, P = 0.06; for GSTT1: OR = 0.94, 95% CI: 0.78 to 1.14, P = 0.546; for GSTM1-GSTT1: OR = 1.04, 95% CI: 0.81 to 1.32, P = 0.77). Sensitivity analysis and publication bias diagnostics confirmed the reliability and stability of this meta-analysis. Conclusions: Our results indicate that both GSTM1 and GSTT1 null genotypes are associated with an increased HCC risk in Chinese population. Peoples with dual null genotypes of GSTM1-GSTT1 are more susceptible to developing HCC. In conclusion, GST genetic polymorphisms play vital roles in the development of HCC in the Chinese population.	[Liu, Kui; Lin, Xialu; Shi, Hongbo; Magaye, Ruth; Zou, Baobo; Zhao, Jinshun] Ningbo Univ, Sch Med, Dept Preventat Med, Ningbo 315211, Zhejiang, Peoples R China; [Liu, Kui; Lin, Xialu; Shi, Hongbo; Magaye, Ruth; Zou, Baobo; Zhao, Jinshun] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathol & Physiol Technol, Ningbo 315211, Zhejiang, Peoples R China; [Zhang, Lu] Anhui Med Univ, Sch Hlth Management, Hefei, Anhui, Peoples R China; [Chen, Liangliang] Ningbo Univ, Yinzhou Peoples Hosp, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University; Anhui Medical University; Ningbo University	Zhao, JS (corresponding author), Ningbo Univ, Sch Med, Dept Preventat Med, Ningbo 315211, Zhejiang, Peoples R China.	zhaojinshun@nbu.edu.cn			National Nature Science Foundation of China [81273111]; Foundations of Innovative Research Team of Educational Commission of Zhejiang Province [T200907]; Nature Science Foundation of Ningbo city [2012A610185]; Ningbo Scientific Projects [2012C5019, SZX11073]; Scientific Innovation Team Project of Ningbo [2011B82014]; Innovative Research Team of Ningbo [2009B21002]; K. C. Wong Magna Fund in Ningbo University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundations of Innovative Research Team of Educational Commission of Zhejiang Province; Nature Science Foundation of Ningbo city; Ningbo Scientific Projects; Scientific Innovation Team Project of Ningbo; Innovative Research Team of Ningbo; K. C. Wong Magna Fund in Ningbo University	Funding provided by grant number: the National Nature Science Foundation of China (Grant No. 81273111), the Foundations of Innovative Research Team of Educational Commission of Zhejiang Province (T200907), the Nature Science Foundation of Ningbo city (Grant No. 2012A610185), the Ningbo Scientific Projects (2012C5019 and SZX11073), the Scientific Innovation Team Project of Ningbo (No. 2011B82014), Innovative Research Team of Ningbo (2009B21002). This work was partly supported by K. C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghemo A, 2012, HEPATOCELLULAR CARCI, P1; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; BEASLEY RP, 1981, LANCET, V2, P1129; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bian J, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P171; Bian JC, 2000, WORLD J GASTROENTERO, V6, P228; Bian JC, 1996, CHINESE J MED GENET, V13, P353; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Cabibbo G, 2012, CAUSES PREVENTION ST, P374; Chen CC, 2005, INT J EPIDEMIOL, V34, P1310, DOI 10.1093/ije/dyi191; Chen CJ, 1996, AM J HUM GENET, V59, P128; Chen JM, 2012, COMM COM INF SC, V346, P1; Deng CH, 1997, CHINESE J PUBLIC HLT, V16, P141; Deng ZL, 2005, WORLD J GASTROENTERO, V11, P272, DOI 10.3748/wjg.v11.i2.272; Deng Zhuolin, 2001, Zhonghua Zhongliu Zazhi, V23, P477; Dong CH, 1998, SHIJIE HUAREN XIAOHU, V6, P463; Dong CH, 1997, ZHONG LIU FANG ZHI Y, V24, P327; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; French SW, 2012, J GASTROINTEST ONCOL, V3, P174, DOI 10.3978/j.issn.2078-6891.2012.025; Guo HY, 2005, ZHONGLIU, V25, P58; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; [贺菽嘉 HE Shujia], 2007, [基础医学与临床, Basic & Clinical Medicine], V27, P666; He SJ, 2008, J GUANGXI MED U, V25; He SJ, 2005, GUANGXI YIKE DAXUE X, V22, P875; HE SJ, 2004, PRACT J CANC, V19, P460; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Helzlsouer KJ, 1998, J NATL CANCER I, V90, P512, DOI 10.1093/jnci/90.7.512; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsieh LL, 1996, CANCER LETT, V103, P171, DOI 10.1016/0304-3835(96)04209-7; Hu Y, 1997, CHINESE J MED GENET, V14, P76; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kao CC, 2010, J SURG ONCOL, V102, P301, DOI 10.1002/jso.21643; Katoh T, 1996, CARCINOGENESIS, V17, P1855, DOI 10.1093/carcin/17.9.1855; Li CG, 2012, ASIAN PAC J CANCER P, V13, P3247, DOI 10.7314/APJCP.2012.13.7.3247; Li SP, 2004, PRACT J CANC, V19, P229; LIU CZ, 2002, CHINA PUBLIC HLTH, V18, P935; Liu ZG, 2003, J GUANGXI MED U, V2, P002; Long XD, 2006, HEPATOL RES, V36, P48, DOI 10.1016/j.hepres.2006.06.004; Long Xi-dai, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P777; Long Xi-dai, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P668; Ma DL, 2005, GUANGXI YI XUE, V27, P656; MCGLYNN KA, 1995, P NATL ACAD SCI USA, V92, P2384, DOI 10.1073/pnas.92.6.2384; McGlynn KA, 2003, CANCER RES, V63, P4594; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Sun CA, 2002, BRIT J CANCER, V87, P966, DOI 10.1038/sj.bjc.6600584; Sun CA, 2001, CARCINOGENESIS, V22, P1289, DOI 10.1093/carcin/22.8.1289; Tang YT, 2012, CHIN J LAB DIAGN, P16; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Udomsinprasert R, 2005, BIOCHEM J, V388, P763, DOI 10.1042/BJ20042015; Wang B, 2010, J HEPATOL, V53, P508, DOI 10.1016/j.jhep.2010.03.026; Wang JW, 2003, CANCER LETT, V201, P185, DOI 10.1016/S0304-3835(03)00480-4; Wei YiPing, 2010, Cancer Research on Prevention and Treatment, V37, P1162; Wei YP, 2012, CHIN GERMAN J CLIN O, V11, P138, DOI DOI 10.1007/S10330-011-0945-X; Wei YP, 2004, TUMOR, V23, P464; Wu HL, 2000, PRACT J CANC, V15, P463; Yang ZG, 2009, ZHONGHUA ZHONGLIU FA, V16, P970; Yu L, 2011, WORLD J GASTROENTERO, V17, P3248, DOI 10.3748/wjg.v17.i27.3248; Yu MW, 1999, AM J EPIDEMIOL, V149, P621, DOI 10.1093/oxfordjournals.aje.a009862; YU MW, 1995, GASTROENTEROLOGY, V109, P1266, DOI 10.1016/0016-5085(95)90587-1; Yu MW, 2003, J NATL CANCER I, V95, P1485, DOI 10.1093/jnci/djg051; Yu MW, 1997, J HEPATOL, V27, P320, DOI 10.1016/S0168-8278(97)80178-X; Zhang YC, 2005, J WENZHOU MED COLL, V35, P464; ZHONG S, 1993, CARCINOGENESIS, V14, P1821, DOI 10.1093/carcin/14.9.1821; Zhu Man-hua, 2005, Zhejiang Da Xue Xue Bao Yi Xue Ban, V34, P126; Zhu WC, 2001, ZHONG LIU FANG ZHI Y, V8, P572; 马韵, 2001, Chinese Journal of Cancer Research, V13, P176, DOI 10.1007/BF02983879	70	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57043	10.1371/journal.pone.0057043	http://dx.doi.org/10.1371/journal.pone.0057043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437305	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200205
J	Liu, ME; Huang, CC; Yang, AC; Tu, PC; Yeh, HL; Hong, CJ; Chen, JF; Liou, YJ; Lin, CP; Tsai, SJ				Liu, Mu-En; Huang, Chu-Chung; Yang, Albert C.; Tu, Pei-Chi; Yeh, Heng-Liang; Hong, Chen-Jee; Chen, Jin-Fan; Liou, Ying-Jay; Lin, Ching-Po; Tsai, Shih-Jen			Effect of Bcl-2 rs956572 Polymorphism on Age-Related Gray Matter Volume Changes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-DEATH; ALZHEIMERS-DISEASE; BRAIN MORPHOLOGY; TRANSGENIC MICE; PSYCHIATRIC-DISORDERS; VAL66MET POLYMORPHISM; COGNITIVE IMPAIRMENT; PROTEIN EXPRESSION; OXIDATIVE-STRESS	The anti-apoptotic protein B-cell CLL/lymphoma 2 (Bcl-2) gene is a major regulator of neural plasticity and cellular resilience. Recently, the Bcl-2 rs956572 single nucleotide polymorphism was proposed to be a functional allelic variant that modulates cellular vulnerability to apoptosis. Our cross-sectional study investigated the genetic effect of this Bcl-2 polymorphism on age-related decreases in gray matter (GM) volume across the adult lifespan. Our sample comprised 330 healthy volunteers (191 male, 139 female) with a mean age of 56.2 +/- 22.0 years (range: 21-92). Magnetic resonance imaging and genotyping of the Bcl-2 rs956572 were performed for each participant. The differences in regional GM volumes between G homozygotes and A-allele carriers were tested using optimized voxel-based morphometry. The association between the Bcl-2 rs956572 polymorphism and age was a predictor of regional GM volumes in the right cerebellum, bilateral lingual gyrus, right middle temporal gyrus, and right parahippocampal gyrus. We found that the volume of these five regions decreased with increasing age (all P<.001). Moreover, the downward slope was steeper among the Bcl-2 rs956572 A-allele carriers than in the G-homozygous participants. Our data provide convergent evidence for the genetic effect of the Bcl-2 functional allelic variant in brain aging. The rs956572 G-allele, which is associated with significantly higher Bcl-2 protein expression and diminished cellular sensitivity to stress-induced apoptosis, conferred a protective effect against age-related changes in brain GM volume, particularly in the cerebellum.	[Liu, Mu-En] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Huang, Chu-Chung; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Albert C.; Tu, Pei-Chi; Hong, Chen-Jee; Liou, Ying-Jay; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.; Hong, Chen-Jee; Liou, Ying-Jay; Tsai, Shih-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Yeh, Heng-Liang] Taipei Vet Home, New Taipei City, Taiwan; [Chen, Jin-Fan] Tao Yuan Vet Hosp, Dept Pathol, Tao Yuan, Tao Yuan County, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lin, CP (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	chingpolin@gmail.com; tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Yang, Albert Chih-Chieh/0000-0003-2794-9649; Huang, Chu-Chung/0000-0002-9096-9610	Taipei Veterans General Hospital, Taiwan [V101C-006, VGHUST101-G1-1-1, VGHUST102-G1-2-1]; Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 101-2911-I-008-001]; National Science Council Grant, Taiwan [NSC 101-2911-I-008-001, NSC 101-2314-B-075-040]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; National Science Council Grant, Taiwan	This work was supported by grants V101C-006, VGHUST101-G1-1-1, VGHUST102-G1-2-1 from Taipei Veterans General Hospital, Taiwan, grant NSC 101-2911-I-008-001 (the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan) and grants NSC 101-2314-B-075-040, NSC 101-2911-I-008-001 from National Science Council Grant, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Baldacara L, 2008, REV BRAS PSIQUIATR, V30, P281, DOI 10.1590/S1516-44462008000300016; Berridge MJ, 2011, NEUROCHEM RES, V36, P1149, DOI 10.1007/s11064-010-0371-4; Caraci F, 2005, BRAIN RES, V1047, P30, DOI 10.1016/j.brainres.2005.04.004; Cardozo-Pelaez F, 1999, MOVEMENT DISORD, V14, P972, DOI 10.1002/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0; Chan WY, 1998, ANAT RECORD, V252, P165; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chen G, 2006, CURR OPIN PSYCHIATR, V19, P313, DOI 10.1097/01.yco.0000218604.63463.cd; Crivello F, 2010, NEUROIMAGE, V53, P1064, DOI 10.1016/j.neuroimage.2009.12.116; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Engidawork E, 2001, NEUROSCI LETT, V303, P79, DOI 10.1016/S0304-3940(01)01618-4; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hochman A, 1998, J NEUROCHEM, V71, P741; Jarskog LF, 2000, BIOL PSYCHIAT, V48, P641, DOI 10.1016/S0006-3223(00)00988-4; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Jonas E, 2006, MOL INTERV, V6, P208, DOI 10.1124/mi.6.4.7; Kaufmann JA, 2001, J NEUROCHEM, V76, P1099, DOI 10.1046/j.1471-4159.2001.00118.x; Kawamoto EM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00061; Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047; Liu ME, 2011, AGE DORDR; Machado-Vieira R, 2011, BIOL PSYCHIAT, V69, P344, DOI 10.1016/j.biopsych.2010.10.019; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Marshall KA, 1997, BIOCHEM BIOPH RES CO, V240, P84, DOI 10.1006/bbrc.1997.7604; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MERRY DE, 1994, DEVELOPMENT, V120, P301; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Nemoto K, 2006, NEUROSCI LETT, V397, P25, DOI 10.1016/j.neulet.2005.11.067; Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22682, DOI 10.1073/pnas.1012651108; Passot JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032560; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pfefferbaum A, 2004, NEUROBIOL AGING, V25, P175, DOI 10.1016/S0197-4580(03)00045-9; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Salvadore G, 2009, BIOL PSYCHIAT, V66, P804, DOI 10.1016/j.biopsych.2009.05.025; SATOU T, 1995, BRAIN RES, V697, P35, DOI 10.1016/0006-8993(95)00748-F; SCHMAHMANN JD, 1992, J COMP NEUROL, V326, P159, DOI 10.1002/cne.903260202; Shacka JJ, 2005, CNS NEUROL DISORD-DR, V4, P25, DOI 10.2174/1568007053005127; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sublette ME, 2008, PROG NEURO-PSYCHOPH, V32, P1652, DOI 10.1016/j.pnpbp.2008.06.009; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Sultana R, 2010, J NEUROSCI RES, V88, P469, DOI 10.1002/jnr.22227; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanabe H, 1997, EUR J NEUROSCI, V9, P848, DOI 10.1111/j.1460-9568.1997.tb01434.x; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Toman J, 2011, J BIOENERG BIOMEMBR, V43, P3, DOI 10.1007/s10863-011-9337-8; Uemura T, 2011, BIPOLAR DISORD, V13, P41, DOI 10.1111/j.1399-5618.2011.00897.x; van Haren NEM, 2008, BIOL PSYCHIAT, V63, P106, DOI 10.1016/j.biopsych.2007.01.004; Vinet J, 2002, NEUROSCI RES, V42, P269, DOI 10.1016/S0168-0102(02)00004-4; Warsh JJ, 2004, CLIN NEUROSCI RES, V4, P201, DOI 10.1016/j.cnr.2004.09.012; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581	59	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56663	10.1371/journal.pone.0056663	http://dx.doi.org/10.1371/journal.pone.0056663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437205	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200135
J	Ramraj, C; Sadeghi, L; Lawrence, HP; Dempster, L; Quinonez, C				Ramraj, Chantel; Sadeghi, Laleh; Lawrence, Herenia P.; Dempster, Laura; Quinonez, Carlos			Is Accessing Dental Care Becoming More Difficult? Evidence from Canada's Middle-Income Population	PLOS ONE			English	Article							INSURANCE; VISITS; POLICY	Objective: To explore trends in access to dental care among middle-income Canadians. Methods: A secondary data analysis of six Canadian surveys that collected information on dental insurance coverage, cost-barriers to dental care, and out-of-pocket expenditures for dental care was conducted for select years from 1978 to 2009. Descriptive analyses were used to outline and compare trends among middle-income Canadians with other levels of income as well as national averages. Results: By 2009, middle-income Canadians had the lowest levels of dental insurance coverage (48.7%) compared to all other income groups. They reported the greatest increase in cost-barriers to dental care, from 12.6% in 1996 to 34.1% by 2009. Middle-income Canadians had the largest rise in out-of-pocket expenditures for dental care since 1978. Conclusions: This study suggests that affordability issues in accessing dental care are no longer just a problem for the lowest income groups in Canada, but are now impacting middle-income earners as a consequence of their lack of, or decreased access to, comprehensive dental insurance.	[Ramraj, Chantel; Sadeghi, Laleh; Lawrence, Herenia P.; Dempster, Laura; Quinonez, Carlos] Univ Toronto, Fac Dent, Discipline Dent Publ Hlth, Toronto, ON, Canada	University of Toronto	Ramraj, C (corresponding author), Univ Toronto, Fac Dent, Discipline Dent Publ Hlth, Toronto, ON, Canada.	chantel.ramraj@utoronto.ca	Lawrence, Herenia P/U-6600-2018	Lawrence, Herenia/0000-0002-2340-2307	Population Health Improvement Research Network (PHIRN) of the Applied Health Research Network Initiative (AHRNI), of the Government of Ontario	Population Health Improvement Research Network (PHIRN) of the Applied Health Research Network Initiative (AHRNI), of the Government of Ontario	The authors would like to thank the funders of this project, the Population Health Improvement Research Network (PHIRN) of the Applied Health Research Network Initiative (AHRNI), of the Government of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arison P, 1996, Ont Dent, V73, P35; Bedos C, 2004, REV EPIDEMIOL SANTE, V52, P261, DOI 10.1016/S0398-7620(04)99051-7; Bhatti T, 2007, J CAN DENT ASSOC, V73, P57; Blumberg LJ, 2004, CHANGES INSURED COVE; Chen WH, 2012, URBAN STUD, V49, P877, DOI 10.1177/0042098011408142; Leake JL, 2008, COMMUNITY DENT ORAL, V36, P287, DOI 10.1111/j.1600-0528.2008.00438.x; Locker D, 2011, J PUBLIC HEALTH DENT, V71, P327, DOI 10.1111/j.1752-7325.2011.00277.x; Manski RJ, 2004, AM J PUBLIC HEALTH, V94, P759, DOI 10.2105/AJPH.94.5.759; Marshall Katherine, 2003, PERSPECTIVES LABOUR, V4, P5; Millar W J, 1999, Health Rep, V11, P55; Muirhead VE, 2009, COMMUNITY DENT ORAL, V37, P199, DOI 10.1111/j.1600-0528.2009.00471.x; Muirhead V, 2009, COMMUNITY DENT ORAL, V37, P294, DOI 10.1111/j.1600-0528.2009.00479.x; Organization for Economic Co-operation and Development (OECD), 2008, OECD IND ED GLANC 20; Porter J, 1999, HEALTH SERV RES, V34, P901; Quinonez C, 2006, ENV SCAN PROVINCIAL; Quinonez C, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-14; Quinonez C, 2010, CAN J PUBLIC HEALTH, V101, P481, DOI 10.1007/BF03403968; Quinonez CR, 2009, THESIS U TORONTO TOR; Ramraj C, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-46; Reesor M, 1998, W982E APPL RES BRANC; Statistics Canada, 2011, AN CONC; Statistics Canada, 2008, CAN COMM HLTH SURV A; Thompson B, 2012, COST BARRIERS DENT C; Wall TP, 2003, J AM DENT ASSOC, V134, P621, DOI 10.14219/jada.archive.2003.0231; Zeytinoglu IU, 2005, RELAT IND-IND RELAT, V60, P29, DOI 10.7202/011538ar	26	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57377	10.1371/journal.pone.0057377	http://dx.doi.org/10.1371/journal.pone.0057377			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437378	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200250
J	Reinius, B; Kanduri, C				Reinius, Bjorn; Kanduri, Chandrasekhar			Elevated Expression of H19 and Igf2 in the Female Mouse Eye	PLOS ONE			English	Article							SEX-DIFFERENCES; BLADDER-CARCINOMA; GENE-EXPRESSION; X-CHROMOSOME; METHYLATION; CANCER; BRAIN; CTCF; ASSOCIATION; BINDING	The catalogue of genes expressed at different levels in the two sexes is growing, and the mechanisms underlying sex differences in regulation of the mammalian transcriptomes are being explored. Here we report that the expression of the imprinted non-protein-coding maternally expressed gene H19 was female-biased specifically in the female mouse eye (1.9-fold, p = 3.0E-6) while not being sex-biased in other somatic tissues. The female-to-male expression fold-change of H19 fell in the range expected from an effect of biallelic versus monoallelic expression. Recently, the possibility of sex-specific parent-of-origin allelic expression has been debated. This led us to hypothesize that H19 might express biallelically in the female mouse eye, thus escape its silencing imprint on the paternal allele specifically in this tissue. We therefore performed a sex-specific imprinting assay of H19 in female and male eye derived from a cross between Mus musculus and Mus spretus. However, this analysis demonstrated that H19 was exclusively expressed from the maternal gene copy, disproving the escape hypothesis. Instead, this supports that the female-biased expression of H19 is the result of upregulation of the single maternal. Furthermore, if H19 would have been expressed from both gene copies in the female eye, an associated downregulation of Insulin-like growth factor 2 (Igf2) was expected, since H19 and Igf2 compete for a common enhancer element located in the H19/Igf2 imprinted domain. On the contrary we found that also Igf2 was significantly upregulated in its expression in the female eye (1.2-fold, p = 6.1E-3), in further agreement with the conclusion that H19 is monoallelically elevated in females. The female-biased expression of H19 and Igf2 specifically in the eye may contribute to our understanding of sex differences in normal as well as abnormal eye physiology and processes.	[Reinius, Bjorn; Kanduri, Chandrasekhar] Univ Gothenburg, Inst Biomed, Dept Med & Clin Genet, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Reinius, B (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	bjorn.reinius@licr.ki.se		Kanduri, Chandrasekhar/0000-0001-6271-9078; Reinius, Bjorn/0000-0002-7021-5248	Swedish Cancer Research foundation (Cancerfonden) [100422]; Swedish Research Council [VR-M: K2011-66X-20781-04-3, VR-NT: 621-2011-4996]; Barncancerfonden [PROJ11/067]	Swedish Cancer Research foundation (Cancerfonden)(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Barncancerfonden	This work was supported by the grants from the Swedish Cancer Research foundation (Cancerfonden: Kontrakt no. 100422), Swedish Research Council (VR-M: K2011-66X-20781-04-3; VR-NT: 621-2011-4996), and Barncancerfonden (PROJ11/067) to C.K. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Ariel I, 2000, J CLIN PATHOL-MOL PA, V53, P320, DOI 10.1136/mp.53.6.320; ARIEL I, 1995, UROLOGY, V45, P335, DOI 10.1016/0090-4295(95)80030-1; Arnold AP, 2012, ENDOCRINOLOGY, V153, P2551, DOI 10.1210/en.2011-2134; Aubin-Horth N, 2009, MOL ECOL, V18, P3763, DOI 10.1111/j.1365-294X.2009.04313.x; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; Dean W, 1998, DEVELOPMENT, V125, P2273; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Durcova-Hills G, 2004, DEV BIOL, V268, P105, DOI 10.1016/j.ydbio.2003.12.018; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Hager R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-303; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hibi K, 1996, CANCER RES, V56, P480; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Ober C, 2011, TRENDS GENET, V27, P107, DOI 10.1016/j.tig.2010.12.004; Razeghinejad MR, 2005, MED HYPOTHESES, V64, P572, DOI 10.1016/j.mehy.2004.07.035; Reinius B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000100; Reinius B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-607; Reinius B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-614; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Talebizadeh Z, 2006, GENOMICS, V88, P675, DOI 10.1016/j.ygeno.2006.07.016; Tanos V, 2004, INT J GYNECOL CANCER, V14, P521, DOI 10.1111/j.1048-891x.2004.014314.x; Wagner Heidi, 2008, Optometry, V79, P636, DOI 10.1016/j.optm.2008.01.024; Weth O, 2011, BIOCHEM CELL BIOL, V89, P459, DOI [10.1139/O11-033, 10.1139/o11-033]; Wijchers PJ, 2010, DEV CELL, V19, P477, DOI 10.1016/j.devcel.2010.08.005; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	37	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56611	10.1371/journal.pone.0056611	http://dx.doi.org/10.1371/journal.pone.0056611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437185	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200119
J	Tannetta, DS; Dragovic, RA; Gardiner, C; Redman, CW; Sargent, IL				Tannetta, Dionne S.; Dragovic, Rebecca A.; Gardiner, Chris; Redman, Christopher W.; Sargent, Ian L.			Characterisation of Syncytiotrophoblast Vesicles in Normal Pregnancy and Pre-Eclampsia: Expression of Flt-1 and Endoglin	PLOS ONE			English	Article							PLACENTAL ALKALINE-PHOSPHATASE; MICROVILLOUS MEMBRANES; ENDOTHELIAL-CELLS; SOLUBLE ENDOGLIN; MATERNAL CIRCULATION; FLOW CYTOMETER; GROWTH-FACTOR; IN-VITRO; MICROPARTICLES; EXOSOMES	Background: The placental syncytiotrophoblast releases micro and nanovesicles (STBM), into the maternal circulation in normal pregnancy and in increased amounts in pre-eclampsia (PE), which have proinflammatory and antiangiogenic activity and are implicated in PE pathophysiology. Better characterisation of STBM is essential to understand their role in PE. Methods and Results: STBM prepared by placental lobe dual perfusion (pSTBM) and mechanical disruption (mSTBM) were analysed by four colour flow cytometry (4CFC), nanoparticle tracking analysis (NTA) and Western blotting to determine vesicle size, purity and Flt-1 and endoglin (Eng) expression. Biological activity of STBM associated Flt-1 and endoglin was assessed by the ability of VEGF, PIGF and TGF beta to bind to mSTBM and inhibit mSTBM induced endothelial monolayer disruption. STBM content was consistently high (similar to 87-95%) across the different preparations. However, surface antigen intensities differed, with significantly lower placental alkaline phosphatase (P<0.05) and Eng (P<0.05) expression on mSTBM, and Flt-1 (P<0.05) expression on pSTBM. For PE placenta derived preparations, pSTBM contained lower Eng positive STBM (P<0.05) and mSTBM Eng expression was increased (P<0.05). Western blotting revealed increased Flt-1/sFlt-1 (P<0.02) and decreased placental alkaline phosphatase (P = 0.0002) content of PE placenta pSTBM. Using NTA, perfused PE placentas released significantly larger MV (P<0.001). Finally, VEGF, PlGF and TGFb bound to mSTBM at physiologically relevant concentrations and inhibited mSTBM induced endothelial disruption (P<0.05-P<0.001). Conclusions: This study has found differences in physical and antigenic characteristics of normal and PE placenta STBM preparations produced by placental perfusion or mechanical disruption. We have also demonstrated that large quantities of biologically active STBM associated endoglin and Flt-1/sFlt-1 could contribute to the increased circulating levels measured in PE patients and add to the perturbation of the maternal vascular endothelium, normally attributed to non-membrane bound sFlt-1 and sEndoglin.	[Tannetta, Dionne S.; Dragovic, Rebecca A.; Gardiner, Chris; Redman, Christopher W.; Sargent, Ian L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Tannetta, DS (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	dionne.tannetta@obs-gyn.ox.ac.uk	Gardiner, Chris/F-1178-2011	Gardiner, Chris/0000-0002-2318-0062; Dragovic, Rebecca/0000-0002-4634-5165	Wellcome Trust Programme Grant [GR079862MA]; Wellcome Trust Technology Development Grant [GR087730]; MRC Programme Grant [MR/J003360/1]; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres; MRC [MR/J003360/1] Funding Source: UKRI; Medical Research Council [MR/J003360/1] Funding Source: researchfish	Wellcome Trust Programme Grant(Wellcome Trust); Wellcome Trust Technology Development Grant(Wellcome Trust); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Programme Grant (ref GR079862MA), Wellcome Trust Technology Development Grant (ref GR087730), MRC Programme Grant MR/J003360/1 and by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENIYI FA, 1984, BRIT J OBSTET GYNAEC, V91, P857, DOI 10.1111/j.1471-0528.1984.tb03697.x; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Aly AS, 2004, AM J OBSTET GYNECOL, V190, P252, DOI 10.1016/j.ajog.2003.07.003; Aras O, 2004, BLOOD, V103, P4545, DOI 10.1182/blood-2003-03-0713; ARKWRIGHT PD, 1994, GLYCOBIOLOGY, V4, P39, DOI 10.1093/glycob/4.1.39; ARKWRIGHT PD, 1991, PLACENTA, V12, P637, DOI 10.1016/0143-4004(91)90498-5; Ayers L, 2011, THROMB RES, V127, P370, DOI 10.1016/j.thromres.2010.12.014; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; DAVIES JO, 1985, J ROY SOC MED, V78, P899, DOI 10.1177/014107688507801104; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Enjeti AK, 2007, SEMIN THROMB HEMOST, V33, P771, DOI 10.1055/s-2007-1000369; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Gardiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026313; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gilbert JS, 2010, HYPERTENSION, V55, P380, DOI 10.1161/HYPERTENSIONAHA.109.141937; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2005, PLACENTA, V26, P59, DOI 10.1016/j.placenta.2004.04.004; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Holder BS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097014; HOLMGREN PA, 1979, OBSTET GYNECOL, V54, P631; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Kaitu'u-Lino TJ, 2012, AM J PATHOL, V180, P888, DOI 10.1016/j.ajpath.2011.11.014; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Sadallah S, 2011, CLIN EXP IMMUNOL, V163, P26, DOI 10.1111/j.1365-2249.2010.04271.x; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Schneider H, 1985, Contrib Gynecol Obstet, V13, P40; SMARASON AK, 1993, BRIT J OBSTET GYNAEC, V100, P943, DOI 10.1111/j.1471-0528.1993.tb15114.x; SMITH NC, 1974, NATURE, V252, P302, DOI 10.1038/252302b0; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Tannetta DS, 2003, J CLIN ENDOCR METAB, V88, P5995, DOI 10.1210/jc.2002-021924; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Yu T, 2012, J CONTROLLE IN PRESS; Zhao S, 2010, PLACENTA, V31, P512, DOI 10.1016/j.placenta.2010.03.014	50	127	133	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56754	10.1371/journal.pone.0056754	http://dx.doi.org/10.1371/journal.pone.0056754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437230	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200156
J	Teferedegne, B; Lewis, AM; Peden, K; Murata, H				Teferedegne, Belete; Lewis, Andrew M., Jr.; Peden, Keith; Murata, Haruhiko			Development of a Neutralization Assay for Influenza Virus Using an Endpoint Assessment Based on Quantitative Reverse-Transcription PCR	PLOS ONE			English	Article							HEMAGGLUTINATION-INHIBITING ANTIBODY; SEROLOGIC ASSAYS; MEDIATED NEUTRALIZATION; PARVOVIRUS B19; INFECTION; SERUM; VACCINATION; PROTECTION; CHALLENGE; DIAGNOSIS	A microneutralization assay using an ELISA-based endpoint assessment (ELISA-MN) is widely used to measure the serological response to influenza virus infection and vaccination. We have developed an alternative microneutralization assay for influenza virus using a quantitative reverse transcription PCR-based endpoint assessment (qPCR-MN) in order to improve upon technical limitations associated with ELISA-MN. For qPCR-MN, infected MDCK-London cells in 96-well cell-culture plates are processed with minimal steps such that resulting samples are amenable to high-throughput analysis by downstream one-step quantitative reverse transcription PCR (qRT-PCR; SYBR Green chemistry with primers targeting a conserved region of the M1 gene of influenza A viruses). The growth curves of three recent vaccine strains demonstrated that the qRT-PCR signal detected at 6 hours post-infection reflected an amplification of at least 100-fold over input. Using ferret antisera, we have established the feasibility of measuring virus neutralization at 6 hours post-infection, a duration likely confined to a single virus-replication cycle. The neutralization titer for qPCR-MN was defined as the highest reciprocal serum dilution necessary to achieve a 90% inhibition of the qRT-PCR signal; this endpoint was found to be in agreement with ELISA-MN using the same critical reagents in each assay. qPCR-MN was robust with respect to assay duration (6 hours vs. 12 hours). In addition, qPCR-MN appeared to be compliant with the Percentage Law (i.e., virus neutralization results appear to be consistent over an input virus dose ranging from 500 to 12,000 TCID50). Compared with ELISA-MN, qPCR-MN might have inherent properties conducive to reducing intra-and inter-laboratory variability while affording suitability for automation and high-throughput uses. Finally, our qRT-PCR-based approach may be broadly applicable to the development of neutralization assays for a wide variety of viruses.	[Teferedegne, Belete; Lewis, Andrew M., Jr.; Peden, Keith; Murata, Haruhiko] US FDA, Lab DNA Viruses, Div Viral Prod, Off Vaccines Res & Review,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Murata, H (corresponding author), US FDA, Lab DNA Viruses, Div Viral Prod, Off Vaccines Res & Review,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	haruhiko.murata@fda.hhs.gov			Division of Microbiology and Infectious Diseases, NIAID, NIH [YI-AI-4893-02NIAID]	Division of Microbiology and Infectious Diseases, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a contract from the Division of Microbiology and Infectious Diseases, NIAID, NIH (YI-AI-4893-02NIAID; http://www.niaid.nih.gov/about/organization/dmid/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini I, 2009, VACCINE, V27, P5998, DOI 10.1016/j.vaccine.2009.07.079; Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Grund S, 2011, J VIROL METHODS, V171, P369, DOI 10.1016/j.jviromet.2010.11.024; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Kramski M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-139; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Murata H, 2009, J VIROL METHODS, V162, P236, DOI 10.1016/j.jviromet.2009.08.012; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Saito T, 2003, J VIROL METHODS, V107, P81, DOI 10.1016/S0166-0934(02)00195-7; Seitz C, 2012, APPL MICROBIOL BIOT, V93, P601, DOI 10.1007/s00253-011-3569-8; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Stephenson I, 2007, VACCINE, V25, P4056, DOI 10.1016/j.vaccine.2007.02.039; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; van Santen VL, 2004, J VIROL METHODS, V115, P123, DOI 10.1016/j.jviromet.2003.09.022; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wang W, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002081; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Wong S, 2006, J CLIN VIROL, V35, P407, DOI 10.1016/j.jcv.2005.12.008; Wood JM, 2012, VACCINE, V30, P210, DOI 10.1016/j.vaccine.2011.11.019; World Health Organization, MAN LAB DIAGN VIR SU; Yuan L, 2007, J VIROL METHODS, V146, P96, DOI 10.1016/j.jviromet.2007.06.009	35	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56023	10.1371/journal.pone.0056023	http://dx.doi.org/10.1371/journal.pone.0056023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437084	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200038
J	Wendel, SK; Mullis, CE; Eshleman, SH; Blankson, JN; Moore, RD; Keruly, JC; Brookmeyer, R; Quinn, TC; Laeyendecker, O				Wendel, Sarah K.; Mullis, Caroline E.; Eshleman, Susan H.; Blankson, Joel N.; Moore, Richard D.; Keruly, Jeanne C.; Brookmeyer, Ron; Quinn, Thomas C.; Laeyendecker, Oliver			Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENZYME-IMMUNOASSAY; ASSAYS	Background: Viral suppression and viral breakthrough impact the humoral immune response to HIV infection. We evaluated the impact of viral suppression and viral breakthrough on results obtained with two cross-sectional HIV incidence assays. Methods: All samples were collected from adults in the US who were HIV infected for >2 years. Samples were tested with the BED capture enzyme immunoassay (BED-CEIA) which measures the proportion of IgG that is HIV-specific, and with an antibody avidity assay based on the Genetic Systems 1/2+ O ELISA. We tested 281 samples: (1) 30 samples from 18 patients with natural control of HIV-1 infection known as elite controllers or suppressors (2) 72 samples from 18 adults on antiretroviral therapy (ART), with 1 sample before and 2-6 samples after ART initiation, and (3) 179 samples from 20 virally-suppressed adults who had evidence of viral breakthrough receiving ART (>400 copies/ml HIV RNA) and with subsequent viral suppression. Results: For elite suppressors, 10/18 had BED-CEIA values <0.8 normalized optical density units (OD-n) and these values did not change significantly over time. For patients receiving ART, 14/18 had BED-CEIA values that decreased over time, with a median decrease of 0.42 OD-n (range 0.10 to 0.63)/time point receiving ART. Three patterns of BED-CEIA values were observed during viral breakthrough: (1) values that increased then returned to pre-breakthrough values when viral suppression was re-established, (2) values that increased after viral breakthrough, and (3) values that did not change with viral breakthrough. Conclusions: Viral suppression and viral breakthrough were associated with changes in BED-CEIA values, reflecting changes in the proportion of HIV-specific IgG. These changes can result in misclassification of patients with long-term HIV infection as recently infected using the BED-CEIA, thereby influencing a falsely high value for cross-sectional incidence estimates.	[Wendel, Sarah K.; Quinn, Thomas C.; Laeyendecker, Oliver] NIAID, Div Intramural Res, NIH, Baltimore, MD USA; [Mullis, Caroline E.; Blankson, Joel N.; Moore, Richard D.; Keruly, Jeanne C.; Quinn, Thomas C.; Laeyendecker, Oliver] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Brookmeyer, Ron] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles	Laeyendecker, O (corresponding author), NIAID, Div Intramural Res, NIH, Baltimore, MD USA.	olaeyen1@jhmi.edu	Laeyendecker, Oliver B/B-9331-2009	Laeyendecker, Oliver/0000-0002-6429-4760	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); HIV Prevention Trials Network; NIAID [R01-AI-80328, R24-AI-067039]; National Institutes of Child Health and Human Development; National Institute on Drug Abuse (NIDA) [R01-DA-11602]; National Institute of Mental Health; Office of AIDS Research, of the NIH, Department of Health and Human Services [UM1-AI068613]; National Institute on Alcohol Abuse and Alcoholism [R01-AA16893]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613, UM1AI068613, ZIAAI000361, R01AI095068, R24AI067039, R01AI080328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HIV Prevention Trials Network; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the NIH, Department of Health and Human Services; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Additional support was provided by the HIV Prevention Trials Network sponsored by NIAID, National Institutes of Child Health and Human Development, National Institute on Drug Abuse (NIDA), National Institute of Mental Health, and Office of AIDS Research, of the NIH, Department of Health and Human Services (UM1-AI068613). The Johns Hopkins HIV Clinical Practice Cohort was supported by NIDA (R01-DA-11602), National Institute on Alcohol Abuse and Alcoholism (R01-AA16893), NIAID (R01-AI-80328) and NIAID (R24-AI-067039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Bailey JR, 2009, J VIROL, V83, P88, DOI 10.1128/JVI.01958-08; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Carr JK, 2010, JAIDS-J ACQ IMM DEF, V54, P297, DOI 10.1097/QAI.0b013e3181e0c3b3; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kahle E, 2012, 15 18 APR INT MICR C; Kassutto S, 2005, CLIN INFECT DIS, V40, P868, DOI 10.1086/428127; LAEYENDECKER O, 2010, 17 C RETR OPP INF SA; Laeyendecker O, 2011, AIDS RES HUM RETROVI, V27; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Masciotra S, 2010, 17 C RETR OPP INF SA; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Murphy G, 2008, EURO SURVEILL, V13; Nelson KE, 2002, AM J EPIDEMIOL, V156, P641, DOI 10.1093/aje/kwf086; Orrell C, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/469127; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Taha TE, 2011, AIDS, V25, P1357, DOI 10.1097/QAD.0b013e3283489d45; Truong HHM, 2009, JAIDS-J ACQ IMM DEF, V51, P502, DOI 10.1097/QAI.0b013e3181a25383; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; Zhang C, 2012, THER DRUG MONIT, V34, P481, DOI 10.1097/FTD.0b013e31825c6067	30	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55525	10.1371/journal.pone.0055525	http://dx.doi.org/10.1371/journal.pone.0055525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437058	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200020
J	Fanning, LB; Buckley, CC; Xing, W; Breslow, RG; Katz, HR				Fanning, Laura B.; Buckley, Carolyn C.; Xing, Wei; Breslow, Rebecca G.; Katz, Howard R.			Downregulation of Key Early Events in the Mobilization of Antigen-bearing Dendritic Cells by Leukocyte Immunoglobulin-like Receptor B4 in a Mouse Model of Allergic Pulmonary Inflammation	PLOS ONE			English	Article							T-CELLS; AIRWAY INFLAMMATION; ENDOTHELIAL-CELLS; INHALED ANTIGEN; LYMPH-NODES; IN-VIVO; DIFFERENTIAL REGULATION; CUTTING EDGE; EXPRESSION; ASTHMA	Leukocyte Immunoglobulin-like Receptor B4 (LILRB4) null mice have an exacerbated T helper cell type 2 (Th2) immune response and pulmonary inflammation compared with Lilrb4(+/+) animals when sensitized intranasally with ovalbumin (OVA) and low-dose lipopolysaccharide (LPS) followed by challenge with OVA. Moreover, OVA-challenged Lilrb4(-/-) mice exhibit greater migration of antigen (Ag)-bearing dendritic cells (DCs) to lymph nodes and accumulation of interleukin 4- and interleukin 5-producing lymph node lymphocytes. The main objective of this study was to determine how the absence of LILRB4 leads to a greater number of DCs in the lymph nodes of Ag-challenged mice and increased lung Th2 inflammation. Mice were sensitized intranasally with PBS alone or containing OVA and LPS; additional cohorts were subsequently challenged with OVA. Expression of chemokine (C-C motif) ligand 21 (CCL21) in the lung was assessed immunohistologically. OVA ingestion and expression of LILRB4 and chemokine (C-C motif) receptor 7 (CCR7) were quantified by flow cytometry. Inhalation of OVA and LPS induced upregulation of LILRB4 selectively on lung Ag-bearing DCs. After sensitization and challenge, the lung lymphatic vessels of Lilrb4(-/-) mice expressed more CCL21, a chemokine that directs the migration of DCs from peripheral tissue to draining lymph nodes, compared with Lilrb4(+/+) mice. In addition, lung DCs of challenged Lilrb4(-/-) mice expressed more CCR7, the CCL21 receptor. The lungs of challenged Lilrb4(-/-) mice also contained significantly greater numbers of CD4+ cells expressing interleukin-4 or interleukin-5, consistent with the greater number of Ag-bearing DCs and Th2 cells in lymph nodes and the attendant exacerbated Th2 lung pathology. Our data establish a new mechanism by which LILRB4 can downregulate the development of pathologic allergic inflammation: reduced upregulation of key molecules needed for DC migration leading to decreases in Th2 cells in lymph nodes and their target tissue.	[Katz, Howard R.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Katz, HR (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	hkatz@rics.bwh.harvard.edu			National Institutes of Health [AI07306, AI41144, HL36110]; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007306, R01AI041144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI07306, AI41144, and HL36110 from the National Institutes of Health; and a Senior Research Training Fellowship from the American Lung Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis NE, 2004, J ALLERGY CLIN IMMUN, V114, P1325, DOI 10.1016/j.jaci.2004.09.002; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Breslow RG, 2010, J IMMUNOL, V184, P1003, DOI 10.4049/jimmunol.0900877; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Chang CC, 2009, J IMMUNOL, V182, P5208, DOI 10.4049/jimmunol.0804048; Daheshia M, 2001, J EXP MED, V194, P227, DOI 10.1084/jem.194.2.227; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Feldweg AM, 2003, EUR J IMMUNOL, V33, P2262, DOI 10.1002/eji.200323978; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hintzen G, 2006, J IMMUNOL, V177, P7346, DOI 10.4049/jimmunol.177.10.7346; Huh JC, 2003, J EXP MED, V198, P19, DOI 10.1084/jem.20021328; Itakura M, 2001, J IMMUNOL, V166, P2071, DOI 10.4049/jimmunol.166.3.2071; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Koya T, 2006, AM J RESP CRIT CARE, V173, P42, DOI 10.1164/rccm.200505-783OC; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Morandi F, 2011, BLOOD, V118, P5840, DOI 10.1182/blood-2011-05-352393; Morandi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011763; Ogata M, 1999, BLOOD, V93, P3225, DOI 10.1182/blood.V93.10.3225.410k25_3225_3232; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Ritter U, 2004, J LEUKOCYTE BIOL, V76, P472, DOI 10.1189/jlb.0104037; Saeki H, 1999, J IMMUNOL, V162, P2472; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schaumann F, 2008, AM J RESP CRIT CARE, V177, P1307, DOI 10.1164/rccm.200706-870OC; Sozzani S, 1998, J IMMUNOL, V161, P1083; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Sugaya M, 2006, J IMMUNOL, V177, P7665, DOI 10.4049/jimmunol.177.11.7665; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; van Rijt LS, 2002, BLOOD, V100, P3663, DOI 10.1182/blood-2002-03-0673; Vermaelen K, 2003, AM J RESP CELL MOL, V29, P405, DOI 10.1165/rcmb.2003-0008OC; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; von Garnier C, 2007, J IMMUNOL, V179, P5748, DOI 10.4049/jimmunol.179.9.5748; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391; Zhou JS, 2005, EUR J IMMUNOL, V35, P1530, DOI 10.1002/eji.200425895; Zhou JS, 2003, J EXP MED, V198, P1243, DOI 10.1084/jem.20030906	51	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57007	10.1371/journal.pone.0057007	http://dx.doi.org/10.1371/journal.pone.0057007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431396	Green Published, gold, Green Submitted			2022-12-27	WOS:000315182800039
J	Abed, M; Balasaheb, S; Towhid, ST; Daniel, C; Amann, K; Lang, F				Abed, Majed; Balasaheb, Siraskar; Towhid, Syeda Tasneem; Daniel, Christoph; Amann, Kerstin; Lang, Florian			Adhesion of Annexin 7 Deficient Erythrocytes to Endothelial Cells	PLOS ONE			English	Article							RED-BLOOD-CELLS; BERGHEI-INFECTED MICE; ACUTE KIDNEY INJURY; SUICIDAL DEATH; PHOSPHATIDYLSERINE EXPOSURE; CATION CHANNELS; CA2+ ENTRY; IN-VITRO; ERYPTOTIC ERYTHROCYTES; APOPTOTIC DEATH	Annexin 7 deficiency has previously been shown to foster suicidal death of erythrocytes or eryptosis, which is triggered by increase of intracellular Ca2+ concentration ([Ca2+](i)) and characterized by cell shrinkage and cell membrane scrambling with subsequent phosphatidylserine exposure at the cell surface. Eryptosis following increase of [Ca2+](i) by Ca2+ ionophore ionomycin, osmotic shock or energy depletion was more pronounced in erythrocytes from annexinA7-deficient mice (anxA7(-/-)) than in erythrocytes from wild type mice (anxA7(+/+)). As phosphatidylserine exposure is considered to mediate adhesion of erythrocytes to the vascular wall, the present study explored adhesion of erythrocytes from anx7(-/-) and anx7(+/+)-mice following increase of [Ca2+](i) by Ca2+ ionophore ionomycin (1 mu M for 30 min), hyperosmotic shock (addition of 550 mM sucrose for 2 hours) or energy depletion (removal of glucose for 12 hours). Phosphatidylserine exposing erythrocytes were identified by annexin V binding, cell volume estimated from forward scatter in FACS analysis and adhesion to human umbilical vein endothelial cells (HUVEC) utilizing a flow chamber. As a result, ionomycin, sucrose addition and glucose removal all triggered phosphatidylserine-exposure, decreased forward scatter and enhanced adhesion of erythrocytes to human umbilical vein endothelial cells (HUVEC), effects significantly more pronounced in anx7(-/-) than in anx7(+/+)-erythrocytes. Following ischemia, morphological renal injury was significantly higher in anx7(-/-) than in anx7(+/+)-mice. The present observations demonstrate that enhanced eryptosis of annexin7 deficient cells is paralleled by increased adhesion of erythrocytes to the vascular wall, an effect, which may impact on microcirculation during ischemia.	[Abed, Majed; Balasaheb, Siraskar; Towhid, Syeda Tasneem; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Abed, Majed] Al Furat Univ, Dept Physiol, Fac Med, Deir Ezzor, Syria; [Daniel, Christoph; Amann, Kerstin] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany	Eberhard Karls University of Tubingen; University of Erlangen Nuremberg	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Daniel, Christoph/AAK-2136-2021	Daniel, Christoph/0000-0002-6803-4755	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2012, TOXICOLOGY, V302, P123, DOI 10.1016/j.tox.2012.10.006; Abed M, 2012, AM J PHYSIOL-CELL PH, V303, pC991, DOI 10.1152/ajpcell.00239.2012; Andrews D A, 1999, Curr Opin Hematol, V6, P76, DOI 10.1097/00062752-199903000-00004; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; Bernhardt I, 2007, CELL PHYSIOL BIOCHEM, V20, P601, DOI 10.1159/000107543; Bhavsar SK, 2011, CELL PHYSIOL BIOCHEM, V27, P547, DOI 10.1159/000329956; Birka C, 2004, PFLUG ARCH EUR J PHY, V448, P471, DOI 10.1007/s00424-004-1289-y; Bobbala D, 2010, CELL PHYSIOL BIOCHEM, V26, P355, DOI 10.1159/000320559; Bottger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033774; Bookchin R M, 1987, Prog Clin Biol Res, V240, P193; Borst O, 2012, AM J PHYSIOL-CELL PH, V302, pC644, DOI 10.1152/ajpcell.00340.2011; Brand VB, 2003, CELL PHYSIOL BIOCHEM, V13, P347, DOI 10.1159/000075122; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; BRUGNARA C, 1993, J CLIN INVEST, V92, P520, DOI 10.1172/JCI116597; Clemen CS, 1999, J MUSCLE RES CELL M, V20, P669, DOI 10.1023/A:1005524623337; Clemen CS, 2003, EXP CELL RES, V291, P406, DOI 10.1016/j.yexcr.2003.07.012; Closse C, 1999, BRIT J HAEMATOL, V107, P300, DOI 10.1046/j.1365-2141.1999.01718.x; Duranton C, 2003, CELL PHYSIOL BIOCHEM, V13, P189, DOI 10.1159/000072421; Duranton C, 2002, J PHYSIOL-LONDON, V539, P847, DOI 10.1113/jphysiol.2001.013040; Felder KM, 2011, CELL PHYSIOL BIOCHEM, V27, P557, DOI 10.1159/000329957; Firat U, 2012, EXP DIABETES RES, DOI 10.1155/2012/316384; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; Foller M, 2008, CELL PHYSIOL BIOCHEM, V21, P183, DOI 10.1159/000113760; Foller M, 2009, CELL PHYSIOL BIOCHEM, V24, P133, DOI 10.1159/000233238; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Gallagher PG, 2003, BLOOD, V101, P4625, DOI 10.1182/blood-2001-12-0329; Ganesan S, 2012, TOXICOLOGY, V294, P54, DOI 10.1016/j.tox.2012.01.015; Gao MH, 2012, ARCH TOXICOL, V86, P741, DOI 10.1007/s00204-012-0808-4; Gatidis S, 2011, CELL PHYSIOL BIOCHEM, V28, P1279, DOI 10.1159/000335859; Ghashghaeinia M, 2012, BRIT J HAEMATOL, V157, P606, DOI 10.1111/j.1365-2141.2012.09100.x; Ghashghaeinia M, 2011, CELL PHYSIOL BIOCHEM, V27, P45, DOI 10.1159/000325204; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Grenz A, 2007, AM J PHYSIOL-RENAL, V292, pF475, DOI 10.1152/ajprenal.00275.2006; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Herr C, 2001, MOL CELL BIOL, V21, P4119, DOI 10.1128/MCB.21.13.4119-4128.2001; Heyman SN, 2011, CONTRIB NEPHROL, V169, P286, DOI 10.1159/000313957; Hung CH, 1996, P NATL ACAD SCI USA, V93, P10797, DOI 10.1073/pnas.93.20.10797; Jilani K, 2012, KIDNEY BLOOD PRESS R, V36, P107, DOI 10.1159/000341488; Jilani K, 2013, TOXICOL IN VITRO, V27, P52, DOI 10.1016/j.tiv.2012.09.004; Kaestner L, 2000, BIOELECTROCHEMISTRY, V52, P117, DOI 10.1016/S0302-4598(00)00110-0; Kaestner L, 2002, BIOELECTROCHEMISTRY, V55, P71, DOI 10.1016/S1567-5394(01)00164-5; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; Kempe DS, 2006, FASEB J, V20, P368, DOI 10.1096/fj.05-4872fje; Koka S, 2009, CELL PHYSIOL BIOCHEM, V23, P191, DOI 10.1159/000204107; Kucherenko Y, 2012, CELL PHYSIOL BIOCHEM, V30, P407, DOI 10.1159/000339034; Kucherenko YV, 2012, CELL PHYSIOL BIOCHEM, V30, P863, DOI 10.1159/000341464; KUIJPERS GAJ, 1992, CELL TISSUE RES, V269, P323, DOI 10.1007/BF00319624; Lang E, 2012, BASIC CLIN PHARMACOL, V111, P348, DOI 10.1111/j.1742-7843.2012.00915.x; Lang E, 2012, INT J BIOCHEM CELL B, V44, P1236, DOI 10.1016/j.biocel.2012.04.019; Lang E, 2011, CELL PHYSIOL BIOCHEM, V28, P347, DOI 10.1159/000331751; Lang E, 2010, PFLUG ARCH EUR J PHY, V460, P667, DOI 10.1007/s00424-010-0829-x; Lang F, 2012, BLOOD PURIFICAT, V33, P125, DOI 10.1159/000334163; Lang F, 2008, CELL PHYSIOL BIOCHEM, V22, P373, DOI 10.1159/000185448; Lang KS, 2004, AM J PHYSIOL-RENAL, V286, pF1046, DOI 10.1152/ajprenal.00263.2003; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang PA, 2005, CELL DEATH DIFFER, V12, P415, DOI 10.1038/sj.cdd.4401561; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; Lang PA, 2006, J MOL MED, V84, P378, DOI 10.1007/s00109-006-0058-0; Lang PA, 2009, CELL PHYSIOL BIOCHEM, V24, P415, DOI 10.1159/000257529; Lindoso RS, 2011, CELL PHYSIOL BIOCHEM, V28, P267, DOI 10.1159/000331739; Linkermann A, 2012, NEPHROL DIAL TRANSPL, V27, P3412, DOI 10.1093/ndt/gfs373; Liu Y, 2012, KIDNEY BLOOD PRESS R, V35, P373, DOI 10.1159/000336171; Lupescu A, 2012, J NAT PROD; Lupescu A, 2012, CELL PHYSIOL BIOCHEM, V30, P876, DOI 10.1159/000341465; Lupescu A, 2012, CELL PHYSIOL BIOCHEM, V30, P428, DOI 10.1159/000339036; Lupescu A, 2012, BIOMETALS, V25, P309, DOI 10.1007/s10534-011-9507-5; MASON J, 1986, RENAL PHYSIOL BIOCH, V9, P129; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Nogueira BV, 2012, CELL PHYSIOL BIOCHEM, V29, P143, DOI 10.1159/000337595; Pandolfi A, 2007, J CELL PHYSIOL, V213, P699, DOI 10.1002/jcp.21138; Polak-Jonkisz D, 2012, BLOOD PURIFICAT, V34, P209, DOI 10.1159/000341627; Qadri SM, 2011, CELL PHYSIOL BIOCHEM, V28, P857, DOI 10.1159/000335800; Qadri SM, 2011, CELL PHYSIOL BIOCHEM, V28, P339, DOI 10.1159/000331750; Qadri SM, 2011, TOXICOLOGY, V283, P24, DOI 10.1016/j.tox.2011.01.023; Qian EW, 2012, J NAT PROD, V75, P531, DOI 10.1021/np200555s; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rodriguez F, 2012, CURR PHARM DES; Sauvant C, 2009, CELL PHYSIOL BIOCHEM, V24, P567, DOI 10.1159/000257513; Shaik N, 2012, CELL PHYSIOL BIOCHEM, V30, P678, DOI 10.1159/000341448; Shaik N, 2012, CELL PHYSIOL BIOCHEM, V30, P512, DOI 10.1159/000341434; Shimaoka T, 2007, J IMMUNOL, V179, P8172, DOI 10.4049/jimmunol.179.12.8172; Siraskar B, 2010, CELL PHYSIOL BIOCHEM, V26, P347, DOI 10.1159/000320558; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vota D.M., 2012, CELL BIOCH BIOPHYS; Weiss E, 2012, CELL CALCIUM, V51, P51, DOI 10.1016/j.ceca.2011.10.005; Wood BL, 1996, BLOOD, V88, P1873; Zappulla Donatella, 2008, J Cardiometab Syndr, V3, P30, DOI 10.1111/j.1559-4572.2008.07263.x; Zbidah M., 2012, BASIC CLIN PHARM TOX; Zbidah M, 2012, TOXICOLOGY, V302, P101, DOI 10.1016/j.tox.2012.09.010; Zelenak C, 2012, CELL PHYSIOL BIOCHEM, V30, P282, DOI 10.1159/000339064; Zelenak C, 2012, CELL PHYSIOL BIOCHEM, V29, P171, DOI 10.1159/000337598; Zelenak C, 2011, J PROTEOME RES, V10, P1690, DOI 10.1021/pr101004j	95	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56650	10.1371/journal.pone.0056650	http://dx.doi.org/10.1371/journal.pone.0056650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437197	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200128
J	Avasarala, S; Zhang, FF; Liu, GL; Wang, RX; London, SD; London, L				Avasarala, Sreedevi; Zhang, Fangfang; Liu, Guangliang; Wang, Ruixue; London, Steven D.; London, Lucille			Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; OBLITERANS ORGANIZING PNEUMONIA; REOVIRUS 1/L INDUCTION; INDUCED PULMONARY-FIBROSIS; ACTIVATED PROTEIN-KINASE; HEPATIC STELLATE CELLS; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX GENES; DIFFUSE ALVEOLAR DAMAGE	Acute Respiratory Distress Syndrome (ARDS) is a clinical syndrome characterized by diffuse alveolar damage usually secondary to an intense host inflammatory response of the lung to a pulmonary or extrapulmonary infectious or noninfectious insult often leading to the development of intra-alveolar and interstitial fibrosis. Curcumin, the principal curcumoid of the popular Indian spice turmeric, has been demonstrated as an anti-oxidant and anti-inflammatory agent in a broad spectrum of diseases. Using our well-established model of reovirus 1/L-induced acute viral pneumonia, which displays many of the characteristics of the human ALI/ARDS, we evaluated the anti-inflammatory and anti-fibrotic effects of curcumin. Female CBA/J mice were treated with curcumin (50 mg/kg) 5 days prior to intranasal inoculation with 10(7) PFU reovirus 1/L and daily, thereafter. Mice were evaluated for key features associated with ALI/ARDS. Administration of curcumin significantly modulated inflammation and fibrosis, as revealed by histological and biochemical analysis. The expression of IL-6, IL-10, IFN gamma, and MCP-1, key chemokines/cytokines implicated in the development of ALI/ARDS, from both the inflammatory infiltrate and whole lung tissue were modulated by curcumin potentially through a reduction in the phosphorylated form of NF kappa B p65. While the expression of TGF beta 1 was not modulated by curcumin, TGF beta Receptor II, which is required for TGF beta signaling, was significantly reduced. In addition, curcumin also significantly inhibited the expression of alpha-smooth muscle actin and Tenascin-C, key markers of myofibroblast activation. This data strongly supports a role for curcumin in modulating the pathogenesis of viral-induced ALI/ARDS in a pre-clinical model potentially manifested through the alteration of inflammation and myofibroblast differentiation.	[Avasarala, Sreedevi; Zhang, Fangfang; Liu, Guangliang; Wang, Ruixue; London, Steven D.; London, Lucille] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, L (corresponding author), SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA.	lucille.london@stonybrook.edu	Liu, Guangliang/I-8173-2013; Zhang, Fang/HHN-2153-2022	Liu, Guangliang/0000-0001-8158-5749; 	U.S. Public Health Service grant [NCCAM 5R21AT003824]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003824] Funding Source: NIH RePORTER	U.S. Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a U.S. Public Health Service grant NCCAM 5R21AT003824 (LL)(http://nccam.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CURCUMIN DERIVED TUR, P350; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Amin K, 2000, AM J RESP CRIT CARE, V162, P2295, DOI 10.1164/ajrccm.162.6.9912001; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bansal S, 2010, J MED MICROBIOL, V59, P429, DOI 10.1099/jmm.0.016873-0; Bellum SC, 1997, AM J PATHOL, V150, P2243; Biswas SK, 2005, ANTIOXID REDOX SIGN, V7, P32, DOI 10.1089/ars.2005.7.32; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Budinger GRS, 2005, INTENS CARE MED, V31, P121, DOI 10.1007/s00134-004-2503-2; Chen Bi, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P257; Creagh-Brown BC, 2009, CRIT CARE, V13, DOI 10.1186/cc7734; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Del Sorbo L, 2011, CURR OPIN CRIT CARE, V17, P1, DOI 10.1097/MCC.0b013e3283427295; Dhainaut JF, 2003, CRIT CARE MED, V31, pS258, DOI 10.1097/01.CCM.0000057901.92381.75; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Gaedeke J, 2004, KIDNEY INT, V66, P112, DOI 10.1111/j.1523-1755.2004.00713.x; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Guzel A, 2009, PEDIATR SURG INT, V25, P83, DOI 10.1007/s00383-008-2282-x; Han W, 2009, AM J PHYSIOL-LUNG C, V296, pL320, DOI 10.1152/ajplung.90485.2008; Hsu YC, 2010, ARCH DERMATOL RES, V302, P717, DOI 10.1007/s00403-010-1075-y; Hu MW, 2005, CRIT CARE MED, V33, P2571, DOI 10.1097/01.CCM.0000186760.20502.C7; Jiang Zhen-you, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P399; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kaarteenaho-Wiik R, 2000, J HISTOCHEM CYTOCHEM, V48, P1257, DOI 10.1177/002215540004800909; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023756; Lee PJ, 2005, CRIT CARE MED, V33, P2703, DOI 10.1097/01.CCM.0000183162.61584.43; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Literat A, 2001, LIFE SCI, V70, P253, DOI 10.1016/S0024-3205(01)01398-4; Liu K, 2012, J CARDIOVASC PHARM T, V17, P395, DOI 10.1177/1074248412442002; Liu K, 2012, J SURG RES, V174, P73, DOI 10.1016/j.jss.2010.12.002; London L, 2002, EXP MOL PATHOL, V72, P24, DOI 10.1006/exmp.2001.2414; London L, 2002, CLIN IMMUNOL, V103, P284, DOI 10.1006/clim.2002.5214; Lopez AD, 2009, J IMMUNOL, V183, P8244, DOI 10.4049/jimmunol.0901958; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Majeski EI, 2003, AM J PATHOL, V163, P1467, DOI 10.1016/S0002-9440(10)63504-3; Majeski EI, 2003, AM J RESP CELL MOL, V28, P208, DOI 10.1165/rcmb.4891; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Meier M, 2007, J AM SOC NEPHROL, V18, P1190, DOI 10.1681/ASN.2005070694; Moine P, 2000, SHOCK, V13, P85, DOI 10.1097/00024382-200013020-00001; Morris GF, 2010, AM J PATHOL, V176, P2595, DOI 10.2353/ajpath.2010.100272; Nahra R, 2008, CURR OPIN ANESTHESIO, V21, P98, DOI 10.1097/ACO.0b013e3282f5335c; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; Oh SW, 2011, J ETHNOPHARMACOL, V136, P414, DOI 10.1016/j.jep.2010.07.026; Paakko P, 2000, AM J RESP CRIT CARE, V161, P967; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Punithavathi D, 2000, BRIT J PHARMACOL, V131, P169, DOI 10.1038/sj.bjp.0703578; Punithavathi D, 2003, BRIT J PHARMACOL, V139, P1342, DOI 10.1038/sj.bjp.0705362; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Smith MR, 2010, AM J PHYSIOL-LUNG C, V298, pL616, DOI 10.1152/ajplung.00002.2009; Song KM, 2011, BIOCHEM BIOPH RES CO, V411, P821, DOI 10.1016/j.bbrc.2011.07.044; SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x; Stengler M, 2002, NATURAL PHYS HEALING, P444; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Suresh MV, 2012, AM J RESP CELL MOL, V47, P280, DOI 10.1165/rcmb.2011-0175OC; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tham CL, 2011, EUR J PHARMACOL, V652, P136, DOI 10.1016/j.ejphar.2010.10.092; Thiemermann C, 2006, CRIT CARE MED, V34, P2009, DOI 10.1097/01.CCM.0000224230.63684.06; Thresiamma K. C., 1996, Indian Journal of Experimental Biology, V34, P845; Tourkina E, 2004, AM J RESP CELL MOL, V31, P28, DOI 10.1165/rcmb.2003-0354OC; Tourkina E, 2001, ARTHRITIS RHEUM-US, V44, P1370, DOI 10.1002/1529-0131(200106)44:6<1370::AID-ART230>3.0.CO;2-2; Tully JE, 2012, AM J RESP CELL MOL, V47, P497, DOI 10.1165/rcmb.2012-0014OC; Vachharajani V, 2010, MICROCIRCULATION, V17, P407, DOI 10.1111/j.1549-8719.2010.00039.x; VENKATESAN N, 1995, MOL CELL BIOCHEM, V142, P79, DOI 10.1007/BF00928916; Venkatesan N, 1997, LIFE SCI, V61, pPL51; Venkatesan N, 1999, LIFE SCI, V66, pPL21, DOI 10.1016/S0024-3205(99)00576-7; Wang Y, 2011, MOL CELL BIOCHEM, V357, P83, DOI 10.1007/s11010-011-0878-2; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xu M, 2007, J ETHNOPHARMACOL, V112, P292, DOI 10.1016/j.jep.2007.03.011; Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC; Zhang De-ping, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P197; Zheng SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG113, DOI 10.1152/ajpgi.00200.2006; Zheng SZ, 2006, AM J PHYSIOL-GASTR L, V290, pG883, DOI 10.1152/ajpgi.00450.2005; Zheng SZ, 2004, BIOCHEM J, V384, P149, DOI 10.1042/BJ20040928; Zhu Rui-fang, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2141	87	80	86	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57285	10.1371/journal.pone.0057285	http://dx.doi.org/10.1371/journal.pone.0057285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437361	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200237
J	Glorvigen, P; Andreassen, HP; Ims, RA				Glorvigen, Petter; Andreassen, Harry P.; Ims, Rolf A.			Local and Regional Determinants of Colonisation-Extinction Dynamics of a Riparian Mainland-Island Root Vole Metapopulation	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; SPACE-USE RESPONSES; HABITAT FRAGMENTATION; MICROTUS-OECONOMUS; POPULATION-SIZE; PATCH QUALITY; CONNECTIVITY; AREA; PATTERNS; RATES	The role of local habitat geometry (habitat area and isolation) in predicting species distribution has become an increasingly more important issue, because habitat loss and fragmentation cause species range contraction and extinction. However, it has also become clear that other factors, in particular regional factors (environmental stochasticity and regional population dynamics), should be taken into account when predicting colonisation and extinction. In a live trapping study of a mainland-island metapopulation of the root vole (Microtus oeconomus) we found extensive occupancy dynamics across 15 riparian islands, but yet an overall balance between colonisation and extinction over 4 years. The 54 live trapping surveys conducted over 13 seasons revealed imperfect detection and proxies of population density had to be included in robust design, multi-season occupancy models to achieve unbiased rate estimates. Island colonisation probability was parsimoniously predicted by the multi-annual density fluctuations of the regional mainland population and local island habitat quality, while extinction probability was predicted by island population density and the level of the recent flooding events (the latter being the main regionalized disturbance regime in the study system). Island size and isolation had no additional predictive power and thus such local geometric habitat characteristics may be overrated as predictors of vole habitat occupancy relative to measures of local habitat quality. Our results suggest also that dynamic features of the larger region and/or the metapopulation as a whole, owing to spatially correlated environmental stochasticity and/or biotic interactions, may rule the colonisation - extinction dynamics of boreal vole metapopulations. Due to high capacities for dispersal and habitat tracking voles originating from large source populations can rapidly colonise remote and small high quality habitat patches and re-establish populations that have gone extinct due to demographic (small population size) and environmental stochasticity (e.g. extreme climate events).	[Glorvigen, Petter; Andreassen, Harry P.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Koppang, Norway; [Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	Inland Norway University of Applied Sciences; UiT The Arctic University of Tromso	Glorvigen, P (corresponding author), Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Koppang, Norway.	petter.glorvigen@hihm.no			Research Council of Norway [182612]	Research Council of Norway(Research Council of Norway)	Funding was provided by the Research Council of Norway (project 182612). (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars J, 2002, ECOLOGY, V83, P3449, DOI 10.1890/0012-9658(2002)083[3449:IACDOP]2.0.CO;2; Aars J, 1999, OIKOS, V85, P204, DOI 10.2307/3546487; Andreassen HP, 1998, ECOLOGY, V79, P1223, DOI 10.1890/0012-9658(1998)079[1223:SURTHF]2.0.CO;2; Baguette M, 2004, BASIC APPL ECOL, V5, P213, DOI 10.1016/j.baae.2004.03.001; Barrett GW, 1999, LANDSCAPE ECOLOGY SM; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Crone EE, 2001, ECOLOGY, V82, P831; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Franken RJ, 2004, J ANIM ECOL, V73, P889, DOI 10.1111/j.0021-8790.2004.00865.x; Franzen M, 2010, P ROY SOC B-BIOL SCI, V277, P79, DOI 10.1098/rspb.2009.1584; GILBERT FS, 1980, J BIOGEOGR, V7, P209, DOI 10.2307/2844629; HANSKI I, 1993, ECOGRAPHY, V16, P372, DOI 10.1111/j.1600-0587.1993.tb00227.x; HANSKI I, 1988, OIKOS, V51, P105, DOI 10.2307/3565813; Hanski I., 1999, METAPOPULATION ECOLO; HANSSON L, 1977, OIKOS, V29, P539, DOI 10.2307/3543592; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Henden JA, 2011, POLAR BIOL, V34, P533, DOI 10.1007/s00300-010-0908-7; Hines JE., 2006, PRESENCESOFTWARE EST; IMS RA, 1993, BIOL CONSERV, V63, P261, DOI 10.1016/0006-3207(93)90722-D; IMS RA, 1989, NATURE, V342, P21; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; LOFGREN O, 1995, OIKOS, V72, P29, DOI 10.2307/3546034; MAC ARTHUR ROBERT H., 1967; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MARGULES C, 1982, BIOL CONSERV, V24, P115, DOI 10.1016/0006-3207(82)90063-5; Mauritzen M, 1999, J APPL ECOL, V36, P409, DOI 10.1046/j.1365-2664.1999.00414.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Pellet J, 2007, BIOL CONSERV, V136, P483, DOI 10.1016/j.biocon.2006.12.020; PELTONEN A, 1991, ECOLOGY, V72, P1698, DOI 10.2307/1940969; POKKI J, 1981, ACTA ZOOL FENN, V164, P1, DOI DOI 10.1007/S00248-004-0240-2; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Robles H, 2012, CONSERV BIOL, V26, P284, DOI 10.1111/j.1523-1739.2011.01816.x; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; STEEN H, 1995, OIKOS, V73, P65, DOI 10.2307/3545726; Stenseth N.C., 1992, ANIMAL DISPERSAL SMA; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Tanadini LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028244; TAST JOHAN, 1966, ANN ZOOL FENNICI, V3, P127; THOMAS CD, 1994, CONSERV BIOL, V8, P373, DOI 10.1046/j.1523-1739.1994.08020373.x; Thomas L, 2010, USERS GUIDE DISTANCE; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931	47	12	12	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56462	10.1371/journal.pone.0056462	http://dx.doi.org/10.1371/journal.pone.0056462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437137	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200078
J	Gumieiro, DN; Rafacho, BPM; Goncalves, AF; Santos, PP; Azevedo, PS; Zornoff, LAM; Pereira, GJC; Matsubara, LS; Paiva, SAR; Minicucci, MF				Gumieiro, David N.; Rafacho, Bruna P. M.; Goncalves, Andrea F.; Santos, Priscila P.; Azevedo, Paula S.; Zornoff, Leonardo A. M.; Pereira, Gilberto J. C.; Matsubara, Luiz S.; Paiva, Sergio A. R.; Minicucci, Marcos F.			Serum Metalloproteinases 2 and 9 as Predictors of Gait Status, Pressure Ulcer and Mortality after Hip Fracture	PLOS ONE			English	Article							WOUND FLUIDS; INHIBITORS; SURGERY	Introduction: The aim of this study is to evaluate the serum activity of metalloproteinases (MMPs) -2 and -9 as predictors of pressure ulcer (PU), gait status and mortality 6 months after hip fracture. Methods: Eighty-seven patients over the age of 65 admitted to the orthopedic unit from January to December 2010 with hip fracture were prospectively evaluated. Upon admission, patient demographic information, including age, gender and concomitant diseases, was recorded. Blood samples were taken for analysis of MMP -2 and -9 activity by gel zymography and for biochemical examination within the first 72 hours of the patient's admission, after clinical stabilization. The fracture pattern (neck, trochanteric or subtrochanteric), time from admission to surgery, surgery duration and length of hospital stay were also recorded. Results: Two patients were excluded due to the presence of pathological fractures (related to cancer), and three patients were excluded due to the presence of PU before admission. Eighty-two patients, with a mean age of 80.4 +/- 6 7.3 years, were included in the analysis. Among these patients, 75.6% were female, 59.8% had PU, and 13.4% died 6 months after hip fracture. All patients underwent hip fracture repair. In a univariate analysis, there were no differences in serum MMP activity between hip fracture patients with or without PU. In addition, the multiple logistic regression analysis models, which were adjusted by age, gender, length of hospital stay and C-reactive protein, showed that the pro-MMP-9 complexed with neutrophil gelatinase-associated lipocalin form (130 kDa) was associated with gait status recovery 6 months after hip fracture. Conclusions: In conclusion, serum pro-MMP-9 is a predictor of gait status recovery 6 months after hip fracture.	[Gumieiro, David N.; Pereira, Gilberto J. C.] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Surg & Orthoped Dept, Botucatu, SP, Brazil; [Rafacho, Bruna P. M.; Goncalves, Andrea F.; Santos, Priscila P.; Azevedo, Paula S.; Zornoff, Leonardo A. M.; Matsubara, Luiz S.; Paiva, Sergio A. R.; Minicucci, Marcos F.] Univ Estadual Paulista, UNESP, Dept Internal Med, Botucatu Med Sch, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Minicucci, MF (corresponding author), Univ Estadual Paulista, UNESP, Dept Internal Med, Botucatu Med Sch, Botucatu, SP, Brazil.	minicucci@fmb.unesp.br	Paiva, Sergio AR/A-5101-2008; Zornoff, Leonardo/A-5612-2008; Rafacho, Bruna Paola Murino/B-5460-2013; Rafacho, Bruna Paola Murino/AGW-5794-2022; Minicucci, Marcos F/A-9094-2008; Azevedo, Paula Schmidt/S-1597-2019; Azevedo, Paula S/F-2701-2012; dos Santos, Priscila Portugal/U-5345-2018	Paiva, Sergio AR/0000-0003-4412-1990; Zornoff, Leonardo/0000-0002-9831-8820; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Minicucci, Marcos F/0000-0002-5980-4367; Azevedo, Paula Schmidt/0000-0002-5843-6232; Azevedo, Paula S/0000-0002-5843-6232; dos Santos, Priscila Portugal/0000-0003-1159-5030	Botucatu Medical School	Botucatu Medical School	This work was supported by Botucatu Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Baumgarten M, 2003, WOUND REPAIR REGEN, V11, P96, DOI 10.1046/j.1524-475X.2003.11204.x; Beloosesky Y, 2004, GERONTOLOGY, V50, P216, DOI 10.1159/000078350; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Dunbar MJ, 2009, J BONE JOINT SURG AM, V91A, P2276, DOI 10.2106/JBJS.H.01521; European Pressure Ulcer Advisory Panel (EPUAP), 1999, EPUAP REV, V1, P31; Gumieiro DN, 2012, NUTRITION, V28, P874, DOI 10.1016/j.nut.2011.11.010; GUO S, 2010, INJURY, V89, P219, DOI DOI 10.1177/0022034509359125; Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015; Hu FK, 2012, INJURY, V43, P676, DOI 10.1016/j.injury.2011.05.017; Kurtinaitis J, 2012, MEDICINA KAUNAS, V48, P145; Ladwig GP, 2002, WOUND REPAIR REGEN, V10, P26, DOI 10.1046/j.1524-475X.2002.10903.x; Lauhio A, 2011, PHARM RES, V64, P590; Lefaivre KA, 2009, J BONE JOINT SURG BR, V91B, P922, DOI 10.1302/0301-620X.91B7.22446; Lindholm C, 2008, INT WOUND J, V5, P315, DOI 10.1111/j.1742-481X.2008.00452.x; Ma GF, 2006, RISK, V54, P2928; Ngbanda AR, 2012, OSTEOPOROS INT, DOI 0.1007/s00198-012-2061-3; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Shoda N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000416; SHODA N, 2012, J DENT RES, DOI DOI 10.1177/0022034509359125; TYAGI SC, 1993, CLIN BIOCHEM, V26, P191, DOI 10.1016/0009-9120(93)90025-2; UTZ ER, 2010, PLOS ONE, V159, P633, DOI DOI 10.1016/J.JSS.2009.08.021; Utz ER, 2010, RISK, V159, P633; Vidal EI, 2012, OSTEOPOROS INT, V23, P2847; Wysocki AB, 1993, RISK, V101, P64; WYSOCKI AB, 1993, PATHOL ONCOL RES, V101, P64; Yager DR, 1996, J INVEST DERMATOL, V107, P743, DOI 10.1111/1523-1747.ep12365637; Yokohama Y, 1995, RISK, V73, P899	28	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57424	10.1371/journal.pone.0057424	http://dx.doi.org/10.1371/journal.pone.0057424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437384	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200254
J	Madsen, JM; Zimmermann, NG; Timmons, J; Tablante, NL				Madsen, Jennifer M.; Zimmermann, Nickolas G.; Timmons, Jennifer; Tablante, Nathaniel L.			Avian Influenza Seroprevalence and Biosecurity Risk Factors in Maryland Backyard Poultry: A Cross-Sectional Study	PLOS ONE			English	Article							MANAGEMENT-PRACTICES; VIRUS	Major implications on a country's economy, food source, and public health. With recent concern over the highly pathogenic avian influenza outbreaks around the world, government agencies are carefully monitoring and inspecting live bird markets, commercial flocks, and migratory bird populations. However, there remains limited surveillance of non-commercial poultry. Therefore, a cross-sectional study was conducted in backyard poultry flocks using a convenience sampling method across three regions of Maryland from July 2011 to August 2011. The objective of this study was to develop a better understanding of the ecology and epidemiology of avian influenza by investigating the prevalence and seroprevalence in this potentially vulnerable population and by evaluating biosecurity risk factors associated with positive findings. Serum, tracheal, and cloacal swabs were randomly collected from 262 birds among 39 registered premises. Analysis indicated bird and flock seroprevalence as 4.2% (11/262) and 23.1% (9/39), respectively. Based on RT-qPCR analysis, none of the samples were found to be positive for AI RNA and evidence of AI hemagglutinin subtypes H5, H7, or H9 were not detected. Although no statistically significant biosecurity associations were identified (p <= 0.05), AI seroprevalence was positively associated with exposure to waterfowl, pest control, and location. AI seropositive flocks exposed to waterfowl were 3.14 times as likely to be AI seropositive than those not exposed (p = 0.15). AI seropositive flocks that did not use pest control were 2.5 times as likely to be AI seropositive compared to those that did and AI seropositive flocks located in the Northern region of Maryland were 2.8 times as likely to be AI seropositive than those that were located elsewhere.	[Madsen, Jennifer M.; Tablante, Nathaniel L.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Zimmermann, Nickolas G.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Timmons, Jennifer] Univ Maryland Extens, Lower Eastern Shore Res & Educ Ctr, Salisbury, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Tablante, NL (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	nlt@umd.edu			Maryland Agricultural Experiment Station Competitive Grants Program	Maryland Agricultural Experiment Station Competitive Grants Program	This project was funded by the Maryland Agricultural Experiment Station Competitive Grants Program (FY 2011-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Beard CW, 2000, IT IS LIKE TICKING B, P4; Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Brooks J, 2005, P 39 NAT M POULTR HL, P17; Brown VL, 2012, BIOL LETTERS, V8, P1036, DOI 10.1098/rsbl.2012.0635; Cardona C, 2009, POULTRY SCI, V88, P856, DOI 10.3382/ps.2008-00338; CDC, 2005, INFL VIR; CDC, 2006, AV INFL OUTBR; FAO, 2011, ANIMAL PRODUCTION HL, P14; FAOSTAT, 2010, FOOD AGR COMM; Friend M., 1999, FIELD MANUAL WILDLIF, P181; Halvorson DA, 2009, REV SCI TECH OIE, V28, P359, DOI 10.20506/rst.28.1.1866; Hanson BA, 2003, THESIS U GEORGIA GEO; Killian Mary Lea, 2008, V436, P7, DOI 10.1007/978-1-59745-279-3_2; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; PALMER DF, 1975, IMMUNOLOGY SERIES, V6, P51; Pascua A, 2006, THESIS U MARYLAND CO; Slemons RD, 2003, AVIAN DIS, V47, P1107, DOI 10.1637/0005-2086-47.s3.1107; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Spackman Erica, 2008, V436, P13, DOI 10.1007/978-1-59745-279-3_3; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Swayne D.E., 2008, DIS POULTRY, P153; Swayne DE, 2005, WAG UR FRON, V8, P113; USDA, 2012, POULTR PROD VAL 2011; USDA, 2007, NAT AV INFL SURV PLA; WHO, 2012, CUM NUMB CONF HUM CA; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Wunderwald C, 2002, AVIAN PATHOL, V31, P157, DOI 10.1080/03079450120118649; Yendell SJ, 2012, ZOONOSES PUBLIC HLTH, V59, P139, DOI 10.1111/j.1863-2378.2011.01427.x; Zheng T, 2010, NEW ZEAL VET J, V58, P74, DOI 10.1080/00480169.2010.65086	31	21	21	16	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56851	10.1371/journal.pone.0056851	http://dx.doi.org/10.1371/journal.pone.0056851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437257	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200173
J	North, CR; Wild, TC; Zwaigenbaum, L; Colman, I				North, C. Rebecca; Wild, T. Cam; Zwaigenbaum, Lonnie; Colman, Ian			Early Neurodevelopment and Self-Reported Adolescent Symptoms of Depression and Anxiety in a National Canadian Cohort Study	PLOS ONE			English	Article							YOUNG-CHILDREN; BIRTH COHORT; DEVELOPMENTAL MILESTONES; BEHAVIORAL-PROBLEMS; DISORDERS; CHILDHOOD; MOTHERS; RISK; EMERGENCE; ATTENTION	Objective: Little is known about the mental health outcomes of young children who experience developmental delay. The objective of this study was to assess whether delay in attaining developmental milestones was related to depressive and anxious symptoms in adolescence. Method: The sample included 3508 Canadian children who participated in a nationally representative prospective cohort study. The person most knowledgeable about the child reported on attainment of developmental milestones spanning several developmental domains at ages 2-3. The children were followed into adolescence and self-reported depressive and anxious symptoms were used from adolescents ages 12-13. An overall assessment of developmental milestones as well as a supplementary analysis of specific categories of developmental milestones was conducted. Results: Cohort members who displayed delayed developmental milestones in early childhood were more likely to experience higher levels of depressive and anxious symptoms as adolescents. However, there was no interaction between delayed developmental milestones and stressful life events. In the supplementary analysis, two developmental domains (self-care and speech/communication) were associated with higher levels of depressive and anxious symptoms in adolescence. Conclusion: Delay in attainment of early developmental milestones is significantly associated with adolescent depressive and anxious symptoms.	[North, C. Rebecca; Wild, T. Cam; Colman, Ian] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Colman, Ian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Alberta; University of Alberta; University of Ottawa	Colman, I (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	icolman@uottawa.ca		Colman, Ian/0000-0001-5924-0277	SickKids Foundation; Canadian Institutes of Health Research [SKF 116328]; Canada Research Chairs program	SickKids Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This research was supported by a grant from the SickKids Foundation and the Canadian Institutes of Health Research (grant number SKF 116328; www.sickkidsfoundation.com). This research was undertaken, in part, thanks to funding from the Canada Research Chairs program (www.chairs-chaires.gc.ca) for IC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MW, 2011, EUR CHILD ADOLES PSY, V20, P599, DOI 10.1007/s00787-011-0220-2; ACHENBACH TM, 1981, MONOGR SOC RES CHILD, V46, P1, DOI 10.2307/1165983; American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ayuso-Mateos JL, 2010, BRIT J PSYCHIAT, V196, P365, DOI 10.1192/bjp.bp.109.071191; Baker P., 1993, NLSY CHILD HDB REVIS; BARRY H, 1957, J ABNORM SOC PSYCH, V55, P327, DOI 10.1037/h0041178; BOYLE MH, 1987, ARCH GEN PSYCHIAT, V44, P826; COHLER BJ, 1977, J CHILD PSYCHOL PSYC, V18, P115, DOI 10.1111/j.1469-7610.1977.tb00424.x; Colman I, 2007, BIOL PSYCHIAT, V62, P1265, DOI 10.1016/j.biopsych.2007.05.012; Colman I, 2012, CAN J PSYCHIAT, V57, P422, DOI 10.1177/070674371205700705; Cotton C, 2001, RECENT DEV LOW INCOM; Crnic K, 2004, INFANT YOUNG CHILD, V17, P223, DOI 10.1097/00001163-200407000-00004; Gale CR, 2008, EVID-BASED MENT HEAL, V11, P30, DOI 10.1136/ebmh.11.1.30; Glaser B, 2011, PSYCHOL MED, V41, P333, DOI 10.1017/S0033291710000814; GRUNEBAUM H, 1978, CHILD PSYCHIAT HUM D, V8, P219, DOI 10.1007/BF01463553; Hatch SL, 2007, SOC SCI MED, V64, P2285, DOI 10.1016/j.socscimed.2007.02.027; Inaba A, 2005, SOC SCI MED, V61, P2280, DOI 10.1016/j.socscimed.2005.07.014; Kendler KS, 1999, AM J PSYCHIAT, P159; Klimes-Dougan B, 2006, BIOL PSYCHIAT, V60, P957, DOI 10.1016/j.biopsych.2006.03.031; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Kovacs M, 1997, J AM ACAD CHILD PSY, V36, P777, DOI 10.1097/00004583-199706000-00014; Liu XC, 2000, J AM ACAD CHILD PSY, V39, P1557, DOI 10.1097/00004583-200012000-00020; Liu XC, 2005, J AFFECT DISORDERS, V87, P281, DOI 10.1016/j.jad.2005.05.010; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mannie ZN, 2009, PSYCHOL MED, V39, P757, DOI 10.1017/S0033291708004248; Micco JA, 2009, DEPRESS ANXIETY, V26, P780, DOI 10.1002/da.20573; Murray GK, 2007, ANN NEUROL, V62, P128, DOI 10.1002/ana.21120; Naicker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033422; Peterson JL, 1987, 8703 CHILD TRENDS IN; RODGERS B, 1990, J CHILD PSYCHOL PSYC, V31, P393, DOI 10.1111/j.1469-7610.1990.tb01577.x; Shea SE, 2012, PEDIATR REV, V33, P110, DOI 10.1542/pir.33-3-110; Spencer T, 1999, PEDIATR CLIN N AM, V46, P915, DOI 10.1016/S0031-3955(05)70163-2; Statistics Canada, 1992, GROW CAN NAT LONG SU; Statistics Canada, 2005, MICR US GUID NAT LON; Statistics Canada, 2007, MICR US GUID NAT LON; Statistics Canada, 1997, MICR US GUID NAT LON; Statistics Canada, 1995, MICR US GUID NAT LON; Storksen I, 2006, SCAND J PSYCHOL, V47, P75, DOI 10.1111/j.1467-9450.2006.00494.x; Tervo RC, 2007, CLIN PEDIATR, V46, P530, DOI 10.1177/0009922806299154; To T, 2004, ARCH PEDIAT ADOL MED, V158, P643, DOI 10.1001/archpedi.158.7.643; Toppelberg CO, 2000, J AM ACAD CHILD PSY, V39, P143, DOI 10.1097/00004583-200002000-00011; vanOs J, 1997, ARCH GEN PSYCHIAT, V54, P625; Wade TJ, 2002, J AM ACAD CHILD PSY, V41, P190, DOI 10.1097/00004583-200202000-00013; Wilks T, 2010, PEDIATR REV, V31, P364, DOI 10.1542/pir.31-9-364	44	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56804	10.1371/journal.pone.0056804	http://dx.doi.org/10.1371/journal.pone.0056804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437245	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200168
J	Wang, HX; Zhou, Y; Tang, CX; He, YH; Wu, JG; Chen, Y; Jiang, QW				Wang, Hexing; Zhou, Ying; Tang, Chuanxi; He, Yanhong; Wu, Jingui; Chen, Yue; Jiang, Qingwu			Urinary Phthalate Metabolites Are Associated with Body Mass Index and Waist Circumference in Chinese School Children	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE; ENDOCRINE DISRUPTORS; TEMPORAL VARIABILITY; US POPULATION; EXPOSURE; OBESITY; HEALTH; TOXICITY; PHENOLS; ESTERS	Background: Lab studies have suggested that ubiquitous phthalate exposures are related to obesity, but relevant epidemiological studies are scarce, especially for children. Objective: To investigate the association of phthalate exposures with body mass index (BMI) and waist circumference (WC) in Chinese school children. Methods: A cross-sectional study was conducted in three primary and three middle schools randomly selected from Changning District of Shanghai City of China in 2011-2012. According to the physical examination data in October, 2011, 124 normal weight, 53 overweight, and 82 obese students 8-15 years of age were randomly chosen from these schools on the basis of BMI-based age- and sex-specific criterion. First morning urine was collected in January, 2012, and fourteen urine phthalate metabolites (free plus conjugated) were determined by ultra-performance liquid chromatography coupled to tandem mass spectrometry. Multiple linear regression was used to explore the associations between naturally log-transformed urine phthalate metabolites and BMI or WC. Results: The urine specific gravity-corrected concentrations of nine urine phthalate metabolites and five molar sums were positively associated with BMI or WC in Chinese school children after adjustment for age and sex. However, when other urine phthalate metabolites were included in the models together with age and sex as covariables, most of these significant associations disappeared except for mono (2-ethylhexyl) phthalate (MEHP) and monoethyl phthalate (MEP). Additionally, some associations showed sex- or age- specific differences. Conclusions: Some phthalate exposures were associated with BMI or WC in Chinese school children. Given the cross-sectional nature of this study and lack of some important obesity-related covariables, further studies are needed to confirm the associations.	[Wang, Hexing; Zhou, Ying; Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Tang, Chuanxi; Wu, Jingui] Ctr Dis Control & Prevent Changning Dist, Shanghai, Peoples R China; [He, Yanhong] Anting Hosp, Dept Lab Med, Shanghai, Peoples R China; [Chen, Yue] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Fudan University; Shanghai Center for Disease Control & Prevention; University of Ottawa	Zhou, Y (corresponding author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.	yingchou@fudan.edu.cn		Jiang, Qingwu/0000-0001-8921-3317; Wang, Hexing/0000-0002-8456-8888	Ministry of Education of China [EZF201001]; National Health Research Program from the State Ministry of Health of China [201202012]	Ministry of Education of China(Ministry of Education, China); National Health Research Program from the State Ministry of Health of China	This study was supported by project of 985 innovation platform for superiority subject of Ministry of Education of China (No. EZF201001) and grants of the National Health Research Program from the State Ministry of Health of China (No. 201202012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward LL, 2012, J EXPO SCI ENV EPID, V22, P398, DOI 10.1038/jes.2012.35; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; CAMERON N, 1978, HUMAN GROWTH, V2, P35, DOI DOI 10.1007/978-1-4684-2622-9_3; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012; Centers for Disease Control and Prevention, 2012, 4 CDCP; Clark K, 2003, HANDB ENVIRON CHEM, V3, P227; Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Guo Y, 2012, J AGR FOOD CHEM; Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m; Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Kitahara CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034979; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0; Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231; Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917, DOI 10.1289/ehp.02110917; Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Shen OX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019159; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Takeuchi S, 2005, TOXICOLOGY, V210, P223, DOI 10.1016/j.tox.2005.02.002; Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006; Wang HX, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-79; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002; Zhou Y, 2011, LANCET, V378, pE4, DOI 10.1016/S0140-6736(11)61700-5	57	91	91	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56800	10.1371/journal.pone.0056800	http://dx.doi.org/10.1371/journal.pone.0056800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437242	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200166
J	Chang, YY; Huang, HL; Lai, CH; Hsu, JT; Shieh, TM; Wu, AYJ; Chen, CL				Chang, Yin-Yu; Huang, Heng-Li; Lai, Chih-Ho; Hsu, Jui-Ting; Shieh, Tzong-Ming; Wu, Aaron Yu-Jen; Chen, Chao-Ling			Analyses of Antibacterial Activity and Cell Compatibility of Titanium Coated with a Zr-C-N Film	PLOS ONE			English	Article							DENTAL IMPLANTS; STAPHYLOCOCCUS-AUREUS; COATINGS; ADHESION; BIOFILM	Objective: The purpose of this study was to verify the antibacterial performance and cell proliferation activity of zirconium (Zr)-carbon (C)-nitride (N) coatings on commercially pure titanium (Ti) with different C contents. Materials and Methods: Reactive nitrogen gas (N-2) with and without acetylene (C2H2) was activated by Zr plasma in a cathodic-arc evaporation system to deposit either a zirconium nitride (ZrN) or a Zr-C-N coating onto Ti plates. The bacterial activity of the coatings was evaluated against Staphylococcus aureus with the aid of SYTO9 nucleic acid staining and scanning electron microscopy (SEM). Cell compatibility, mRNA expression, and morphology related to human gingival fibroblasts (HGFs) on the coated samples were also determined by using the MTT assay, reverse transcriptase-polymerase chain reaction, and SEM. Results: The Zr-C-N coating with the highest C content (21.7 at%) exhibited the lowest bacterial preservation (P<0.001). Biological responses including proliferation, gene expression, and attachment of HGF cells to ZrN and Zr-C-N coatings were comparable to those of the uncoated Ti plate. Conclusions: High-C-content Zr-C-N coatings not only provide short-term antibacterial activity against S. aureus but are also biocompatible with HGF cells.	[Chang, Yin-Yu] Natl Formosa Univ, Dept Mech & Comp Aided Engn, Yunlin, Taiwan; [Huang, Heng-Li; Hsu, Jui-Ting] China Med Univ, Sch Dent, Taichung, Taiwan; [Lai, Chih-Ho] China Med Univ, Sch Med, Taichung, Taiwan; [Shieh, Tzong-Ming] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Wu, Aaron Yu-Jen] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Kaohsiung, Taiwan; [Chen, Chao-Ling] China Med Univ, Sch Pharm, Taichung, Taiwan	National Formosa University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan	Huang, HL (corresponding author), China Med Univ, Sch Dent, Taichung, Taiwan.	henleyh@gmail.com	Hsu, Jui-Ting/I-8224-2012; Lai, Chih-Ho/M-2433-2013	Lai, Chih-Ho/0000-0001-9229-818X	Government Organization-National Science Council in Taiwan [NSC 101-2314-B-039-022-MY3]	Government Organization-National Science Council in Taiwan	This research was supported by the Government Organization-National Science Council (NSC 101-2314-B-039-022-MY3) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguer-Flores A, 2009, DIAM RELAT MATER, V18, P1179, DOI 10.1016/j.diamond.2009.03.003; BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2; BECKER W, 1990, International Journal of Oral and Maxillofacial Implants, V5, P31; Chang YY, 2012, CLIN ORAL INVEST, V16, P95, DOI 10.1007/s00784-010-0504-9; Chaudhari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024186; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Esteban-Tejeda L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033135; Grainger DW, 2004, EXPERT OPIN BIOL TH, V4, P1029, DOI 10.1517/14712598.4.7.1029; Groessner-Schreiber B, 2004, EUR J ORAL SCI, V112, P516, DOI 10.1111/j.1600-0722.2004.00171.x; Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x; Grossner-Schreiber B, 2009, CLIN ORAL IMPLAN RES, V20, P817, DOI 10.1111/j.1600-0501.2009.01729.x; Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb; Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003; Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036; Heydenrijk K, 2002, INT J ORAL MAX IMPL, V17, P829; Hoyle B D, 1991, Prog Drug Res, V37, P91; Huang HL, 2010, SURF COAT TECH, V205, P1636, DOI 10.1016/j.surfcoat.2010.07.096; Isidor F, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2006.01360.x; Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r; Kelly PJ, 2010, SURF COAT TECH, V205, P1606, DOI 10.1016/j.surfcoat.2010.07.029; Kertzman Z, 2008, J BIOMED MATER RES A, V84A, P1061, DOI 10.1002/jbm.a.31533; Koerner RJ, 2002, BIOMATERIALS, V23, P2835, DOI 10.1016/S0142-9612(01)00404-5; Kronstrom M, 2001, INT J ORAL MAX IMPL, V16, P201; Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x; MEYERSIEGLER K, 1992, CARCINOGENESIS, V13, P2127, DOI 10.1093/carcin/13.11.2127; Narayan RJ, 2005, MAT SCI ENG C-BIO S, V25, P405, DOI 10.1016/j.msec.2005.01.026; Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7; Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152; Pae A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025005; Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tian XB, 2007, SURF COAT TECH, V201, P8606, DOI 10.1016/j.surfcoat.2006.09.322; Wang GC, 2010, MATERIALS, V3, P3994, DOI 10.3390/ma3073994; Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046; Watzak G, 2005, CLIN ORAL IMPLAN RES, V16, P408, DOI 10.1111/j.1600-0501.2005.01155.x; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zhou H, 2008, DIAM RELAT MATER, V17, P1416, DOI 10.1016/j.diamond.2008.01.047	37	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56771	10.1371/journal.pone.0056771	http://dx.doi.org/10.1371/journal.pone.0056771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431391	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800034
J	Han, XY; Luo, YY; Zhang, XY; Lv, C; Sun, XQ; Zhang, XM; Zhou, XH; Cai, XL; Ren, Q; Ji, LN				Han, Xueyao; Luo, Yingying; Zhang, Xiuying; Lv, Chao; Sun, Xiuqin; Zhang, Xiaomei; Zhou, Xianghai; Cai, Xiaoling; Ren, Qian; Ji, Linong			Rs4074134 Near BDNF Gene Is Associated with Type 2 Diabetes Mellitus in Chinese Han Population Independently of Body Mass Index	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NEUROTROPHIC FACTOR BDNF; BETA-CELL FUNCTION; COMMON VARIANTS; FTO GENE; FAT MASS; OBESITY; SUSCEPTIBILITY; EXPRESSION; CHILDHOOD	Obesity and family history are the most important predictors for type 2 diabetes mellitus(T2DM) in the Chinese Han population. However, it is not known whether the genetic loci related to obesity are associated with the risk of developing T2DM in this population. The present case-control study evaluated the associations between five genetic loci for obesity and the pathogenesis of T2DM. The study included 1117 Chinese Han patients with T2DM, 1629 patients with pre-diabetes (impaired fasting glucose and impaired glucose tolerance, IFG/IGT) and 1113 control subjects residing in Beijing. Five genetic loci including rs2815752 near NEGR1, rs10938397 near GNPDA2, rs4074134 near BDNF, rs17782313 near MC4R and rs1084753 near KCTD15 were genotyped. The results showed an association between rs4074134-BDNF minor allele and T2DM irrespective of age, gender and body mass index (BMI) (OR = 0.87; 95% CI: 0.77-0.99, P = 0.04). This SNP was also associated with pre-diabetes (OR = 0.87; 95% CI: 0.77-0.97, P = 0.01) independently of age, gender and BMI. No associations were found between diabetes or pre-diabetes and any of the other SNP loci studied. Genotype-phenotype association analysis (adjusting for age and gender) showed rs4074134-BDNF to be associated with BMI, waist circumference, fasting and postprandial plasma glucose, fasting serum insulin, and HOMA-IR in subjects without T2DM. However, fasting and postprandial plasma glucose were the only significant factors after adjusting for BMI. These results suggest that the common variation of BDNF (rs4074134) is associated with T2DM independently of obesity in Chinese Han population. This variant also has an effect on plasma glucose concentration, BMI and insulin sensitivity.	[Han, Xueyao; Luo, Yingying; Zhang, Xiuying; Lv, Chao; Sun, Xiuqin; Zhang, Xiaomei; Zhou, Xianghai; Cai, Xiaoling; Ren, Qian; Ji, Linong] Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020	Cai, Xiaoling/0000-0002-7881-0543	National High Technology Research and Development Program (863 program) [2006AA02A409, 2012AA02A509]; Beijing Science&Technology Committee [D0905003040131, D090507046410012]; National Basic Research Program of China [2011CB504001]; National Natural Science Foundation of China [30771031]	National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Beijing Science&Technology Committee; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National High Technology Research and Development Program (863 program, 2006AA02A409,2012AA02A509), Beijing Science&Technology Committee(D0905003040131 and D090507046410012), the National Basic Research Program of China (2011CB504001) and the National Natural Science Foundation of China (30771031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gray J, 2006, DANCING TIMES, V96, P55; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Loos RJF, 2003, J INTERN MED, V254, P401, DOI 10.1046/j.1365-2796.2003.01242.x; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mousavi K, 2006, J NEUROSCI, V26, P5739, DOI 10.1523/JNEUROSCI.5398-05.2006; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Nonomura T, 2001, Int J Exp Diabetes Res, V2, P201, DOI 10.1155/EDR.2001.201; Ong CJ, 2010, OBESITY, V18, pS61; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Robiou-du-Pont S, 2013, INT J OBESITY, V37, P980, DOI 10.1038/ijo.2012.175; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Torrens JI, 2004, DIABETES CARE, V27, P354, DOI 10.2337/diacare.27.2.354; Ukropec Jozef, 2008, Archives of Physiology and Biochemistry, V114, P357, DOI 10.1080/13813450802535812 ; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	41	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56898	10.1371/journal.pone.0056898	http://dx.doi.org/10.1371/journal.pone.0056898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431394	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800037
J	Lodi, A; Tiziani, S; Khanim, FL; Gunther, UL; Viant, MR; Morgan, GJ; Bunce, CM; Drayson, MT				Lodi, Alessia; Tiziani, Stefano; Khanim, Farhat L.; Guenther, Ulrich L.; Viant, Mark R.; Morgan, Gareth J.; Bunce, Christopher M.; Drayson, Mark T.			Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; L-CARNITINE; IN-VITRO; APOPTOSIS; SPECTROSCOPY; METABOLOMICS; CHEMOTHERAPY; PATHOGENESIS	Background: Biomarker identification is becoming increasingly important for the development of personalized or stratified therapies. Metabolomics yields biomarkers indicative of phenotype that can be used to characterize transitions between health and disease, disease progression and therapeutic responses. The desire to reproducibly detect ever greater numbers of metabolites at ever diminishing levels has naturally nurtured advances in best practice for sample procurement, storage and analysis. Reciprocally, since many of the available extensive clinical archives were established prior to the metabolomics era and were not processed in such an 'ideal' fashion, considerable scepticism has arisen as to their value for metabolomic analysis. Here we have challenged that paradigm. Methods: We performed proton nuclear magnetic resonance spectroscopy-based metabolomics on blood serum and urine samples from 32 patients representative of a total cohort of 1970 multiple myeloma patients entered into the United Kingdom Medical Research Council Myeloma IX trial. Findings: Using serial paired blood and urine samples we detected metabolite profiles that associated with diagnosis, post-treatment remission and disease progression. These studies identified carnitine and acetylcarnitine as novel potential biomarkers of active disease both at diagnosis and relapse and as a mediator of disease associated pathologies. Conclusions: These findings show that samples conventionally processed and archived can provide useful metabolomic information that has important implications for understanding the biology of myeloma, discovering new therapies and identifying biomarkers potentially useful in deciding the choice and application of therapy.	[Lodi, Alessia; Tiziani, Stefano; Guenther, Ulrich L.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Lodi, Alessia; Tiziani, Stefano] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Tiziani, Stefano] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA; [Khanim, Farhat L.; Viant, Mark R.; Bunce, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Morgan, Gareth J.] Royal Marsden NHS Fdn Trust, Inst Canc Res, London, England; [Drayson, Mark T.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Birmingham	Lodi, A (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England.	alessia@austin.utexas.edu; m.t.drayson@bham.ac.uk	Viant, Mark R/B-6339-2009; Bunce, Chris/D-4579-2015	Viant, Mark R/0000-0001-5898-4119; morgan, gareth/0000-0002-4271-6360; Bunce, Chris/0000-0003-4084-8973; Drayson, Mark/0000-0002-1528-7564	EU Marie Currie grants MOTET; EU-NMR EU; Leukaemia & Lymphoma Research Specialist Programme; University of Birmingham's System Science for Health initiative	EU Marie Currie grants MOTET; EU-NMR EU; Leukaemia & Lymphoma Research Specialist Programme; University of Birmingham's System Science for Health initiative	A.L. and S.T. were supported by EU Marie Currie grants MOTET & EU-NMR EU. F. L. K. is supported by a Leukaemia & Lymphoma Research Specialist Programme awarded to CMB and MTD. The Myeloma IX trial was supported by the Medical Research Council UK. This study was in part supported by the University of Birmingham's System Science for Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanassakis I, 2001, INT IMMUNOPHARMACOL, V1, P1813, DOI 10.1016/S1567-5769(01)00105-9; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Barton RH, 2008, INT J EPIDEMIOL, V37, P31, DOI 10.1093/ije/dym284; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; Bryce AH, 2009, HAEMATOL-HEMATOL J, V94, P380, DOI 10.3324/haematol.13369; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Colucci S, 2005, CALCIFIED TISSUE INT, V76, P458, DOI 10.1007/s00223-004-0147-4; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dimopoulos MA, 2010, J CLIN ONCOL, V28, P4976, DOI 10.1200/JCO.2010.30.8791; Drayson M, 2006, BLOOD, V108, P2013, DOI 10.1182/blood-2006-03-008953; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Hamed EA, 2010, J PEDIAT HEMATOL ONC, V32, P267, DOI 10.1097/MPH.0b013e3181d419d6; Hersey P, 2009, CLIN CANCER RES, V15, P6490, DOI 10.1158/1078-0432.CCR-09-0251; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; HOLUB BJ, 1986, ANNU REV NUTR, V6, P563, DOI 10.1146/annurev.nu.06.070186.003023; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Khoo SHG, 2009, METAB ENG, V11, P199, DOI 10.1016/j.ymben.2009.02.001; KULISZKIEWICZJANUS M, 1995, NMR BIOMED, V8, P127, DOI 10.1002/nbm.1940080308; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2010, CURR HEMATOL MALIG R, V5, P62, DOI 10.1007/s11899-010-0047-9; Lazarus HM, 2008, J CLIN ONCOL, V26, P2240, DOI 10.1200/JCO.2007.14.7827; Lemaire M, 2011, ADV CANCER RES, V110, P19, DOI 10.1016/B978-0-12-386469-7.00002-5; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Ludwig C, 2009, MAGN RESON CHEM, V47, pS68, DOI 10.1002/mrc.2519; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; Minter AR, 2011, SEMIN HEMATOL, V48, P55, DOI 10.1053/j.seminhematol.2010.11.001; Mitsiades CS, 2011, J CLIN ONCOL, V29, P1916, DOI 10.1200/JCO.2010.34.0760; Morgan GJ, 2012, BLOOD, V119, P7, DOI 10.1182/blood-2011-06-357038; Morgan GJ, 2011, BLOOD, V118, P1231, DOI 10.1182/blood-2011-02-338665; Odunsi K, 2005, INT J CANCER, V113, P782, DOI 10.1002/ijc.20651; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; SILIPRANDI N, 1989, CLIN CHIM ACTA, V183, P3, DOI 10.1016/0009-8981(89)90267-2; Tiziani S, 2008, ANAL BIOCHEM, V377, P16, DOI 10.1016/j.ab.2008.01.037; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; van de Donk NWCJ, 2011, CANCER TREAT REV, V37, P266, DOI 10.1016/j.ctrv.2010.08.008; Wang J, 2006, APOPTOSIS, V11, P2043, DOI 10.1007/s10495-006-0191-9; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Whitehead TL, 2005, PROG NUCL MAG RES SP, V47, P165, DOI 10.1016/j.pnmrs.2005.09.001; Xie H, 2008, AMINO ACIDS, V35, P419, DOI 10.1007/s00726-007-0598-9	52	35	36	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56422	10.1371/journal.pone.0056422	http://dx.doi.org/10.1371/journal.pone.0056422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431376	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800018
J	Oishi, M; Iizumi, Y; Taniguchi, T; Goi, W; Miki, T; Sakai, T				Oishi, Masakatsu; Iizumi, Yosuke; Taniguchi, Tomoyuki; Goi, Wakana; Miki, Tsuneharu; Sakai, Toshiyuki			Apigenin Sensitizes Prostate Cancer Cells to Apo2L/TRAIL by Targeting Adenine Nucleotide Translocase-2	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; UP-REGULATION; DOWN-REGULATION; C-FLIP; TUMOR; RESISTANCE; RECEPTOR; PROTEIN; SUSCEPTIBILITY; MITOXANTRONE	Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent. Recombinant human Apo2L/TRAIL has been under clinical trials, whereas various kinds of malignant tumors have resistance to Apo2L/TRAIL. We and others have shown that several anticancer agents and flavonoids overcome resistance to Apo2L/TRAIL by upregulating death receptor 5 (DR5) in malignant tumor cells. However, the mechanisms by which these compounds induce DR5 expression remain unknown. Here we show that the dietary flavonoid apigenin binds and inhibits adenine nucleotide translocase-2 (ANT2), resulting in enhancement of Apo2L/TRAIL-induced apoptosis by upregulation of DR5. Apigenin and genistein, which are major flavonoids, enhanced Apo2L/TRAIL-induced apoptosis in cancer cells. Apigenin induced DR5 expression, but genistein did not. Using our method identifying the direct targets of flavonoids, we compared the binding proteins of apigenin with those of genistein. We discovered that ANT2 was a target of apigenin, but not genistein. Similarly to apigenin, knockdown of ANT2 enhanced Apo2L/TRAIL-induced apoptosis by upregulating DR5 expression at the post-transcriptional level. Moreover, silencing of ANT2 attenuated the enhancement of Apo2L/TRAIL-induced apoptosis by apigenin. These results suggest that apigenin upregulates DR5 and enhances Apo2L/TRAIL-induced apoptosis by binding and inhibiting ANT2. We propose that ANT2 inhibitors may contribute to Apo2L/TRAIL therapy.	[Oishi, Masakatsu; Iizumi, Yosuke; Taniguchi, Tomoyuki; Goi, Wakana; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto, Japan; [Oishi, Masakatsu; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kamigyo Ku, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Sakai, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto, Japan.	tsakai@koto.kpu-m.ac.jp			Japan Society for the Promotion of Science (JSPS) [21890223, 20533178]; Grants-in-Aid for Scientific Research [23659335] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (Start-up,21890223) and (A,20533178) from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzacq AS, 2002, BIOCHIMIE, V84, P167, DOI 10.1016/S0300-9084(02)01366-4; Bracarda S, 2011, BJU INT, V107, P13, DOI 10.1111/j.1464-410X.2010.10036.x; Budhraja A, 2012, MOL CANCER THER, V11, P132, DOI 10.1158/1535-7163.MCT-11-0343; Chan LP, 2012, BBA-GEN SUBJECTS, V1820, P1081, DOI 10.1016/j.bbagen.2012.04.013; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; Ding J, 2012, J BIOL CHEM, V287, P641, DOI 10.1074/jbc.M111.286526; el Dein OS, 2011, CURR DRUG TARGETS, V12, P894, DOI 10.2174/138945011795529047; Hellebrand EE, 2010, DRUG DISCOV THER, V4, P54; Horinaka M, 2006, MOL CANCER THER, V5, P945, DOI 10.1158/1535-7163.MCT-05-0431; Horinaka M, 2005, ONCOGENE, V24, P7180, DOI 10.1038/sj.onc.1208874; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jang JY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1857; Jang JY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-262; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin CY, 2007, CANCER LETT, V257, P56, DOI 10.1016/j.canlet.2007.06.019; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kantoff PW, 1999, J CLIN ONCOL, V17, P2506, DOI 10.1200/JCO.1999.17.8.2506; Le Bras M, 2006, CANCER RES, V66, P9143, DOI 10.1158/0008-5472.CAN-05-4407; Sakamoto S, 2009, CHEM REC, V9, P66, DOI 10.1002/tcr.20170; Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Szliszka E, 2008, INT J MOL SCI, V9, P56, DOI 10.3390/ijms9010056; Szliszka E, 2011, EUR J CANCER PREV, V20, P63, DOI 10.1097/CEJ.0b013e32833ecc48; Taniguchi H, 2008, CANCER RES, V68, P8918, DOI 10.1158/0008-5472.CAN-08-1120; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Torkin R, 2005, MOL CANCER THER, V4, P1; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Urusova DV, 2011, CANCER PREV RES, V4, P1366, DOI 10.1158/1940-6207.CAPR-11-0301; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Xu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029169; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	32	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55922	10.1371/journal.pone.0055922	http://dx.doi.org/10.1371/journal.pone.0055922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431365	Green Submitted, Green Published, gold			2022-12-27	WOS:000315182800007
J	Lee, SJ; Kang, JH; Choi, SY; Suk, KT; Kim, DJ; Kwon, OS				Lee, Su Jin; Kang, Jeong Han; Choi, Soo Young; Suk, Ki Tae; Kim, Dong Joon; Kwon, Oh-Shin			PKC delta as a Regulator for TGF beta 1-Induced alpha-SMA Production in a Murine Nonalcoholic Steatohepatitis Model	PLOS ONE			English	Article							KINASE-C-DELTA; FATTY LIVER-DISEASE; NF-KAPPA-B; TGF-BETA; HEPATIC-FIBROSIS; STELLATE CELLS; GROWTH-FACTOR; PROTEIN; EXPRESSION; MICE	The precise mechanism of TGF beta 1 signaling in the progression of non-alcoholic steatohepatitis (NASH) has remained unclear. In particular, a potential regulatory mechanism by which PKC delta affects profibrogenic gene expression had never been explored. In this study, therefore, the role of PKC delta in TGF beta 1 mediated alpha-SMA expression was investigated using NASH model mice. In preparation of the NASH model, male C57BL6/J mice were fed a methionine-choline-deficient (MCD) diet for 3 weeks, after which time they were intraperitoneally injected with lipopolysaccharide (LPS). In addition, Tlr4(Lps-d) (CH3/HeJ) mice were used to demonstrate the TGF beta 1 signaling's dependency on TLR4 induction. Liver histology and hepatic hepatitis markers were investigated, and hepatic gene expression levels were determined by real-time PCR. Acute liver injury by LPS injection specifically elevated not only alpha-SMA expression but also phospho-PKC delta in this model. In contrast, Tlr4(Lps-d) (CH3/HeJ) and blockade of TGF beta 1 receptor by SB431542 resulted in a significant reduction of PKC delta activation and alpha-SMA expression. Moreover, the TGF beta 1-induced alpha-SMA production was significantly reduced by a specific PKC delta inhibitor. These findings suggested that PKC delta plays a critical role in TGF beta 1-induced alpha-SMA production in a NASH model. Thus, this was the first demonstration of the involvement of PKC delta in the regulation of alpha-SMA expression in NASH liver tissues, and the impaired induction of PKC delta phosphorylation by LPS in a steatohepatitis condition. Interestingly, treatment by PKC delta inhibitor caused dramatic reduction of myofibroblast activation, indicating that PKC delta represents a promising target for treating NASH.	[Lee, Su Jin; Kwon, Oh-Shin] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu, South Korea; [Kang, Jeong Han] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Choi, Soo Young] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Choi, Soo Young] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon, South Korea; [Suk, Ki Tae; Kim, Dong Joon] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea	Kyungpook National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hallym University; Hallym University; Hallym University	Kwon, OS (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu, South Korea.	oskwon@knu.ac.kr	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696	Basic Science Research Program through the National Research Foundation of Korea (NRF); Korean Ministry of Education, Science and Technology [2011-0014420]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korean Ministry of Education, Science and Technology (2011-0014420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; Brunt EM, 2005, FRONT BIOSCI-LANDMRK, V10, P1475; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dina OA, 2001, NEUROSCIENCE, V108, P507, DOI 10.1016/S0306-4522(01)00425-0; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gore-Hyer E, 2003, ARTHRITIS RHEUM-US, V48, P798, DOI 10.1002/art.10953; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Kucich U, 2000, ARCH BIOCHEM BIOPHYS, V374, P313, DOI 10.1006/abbi.1999.1625; Lee MC, 2008, J LEUKOCYTE BIOL, V84, P835, DOI 10.1189/jlb.1007691; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Su GL, 2000, HEPATOLOGY, V31, P932, DOI 10.1053/he.2000.5634; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Vallee S, 2004, EXP CELL RES, V297, P165, DOI 10.1016/j.yexcr.2004.03.007; Wermuth PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027110; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Yue JB, 2000, METH MOL B, V142, P125	32	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55979	10.1371/journal.pone.0055979	http://dx.doi.org/10.1371/journal.pone.0055979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441159	gold, Green Submitted, Green Published			2022-12-27	WOS:000315159200016
J	Mukaro, VR; Bylund, J; Hodge, G; Holmes, M; Jersmann, H; Reynolds, PN; Hodge, S				Mukaro, Violet R.; Bylund, Johan; Hodge, Greg; Holmes, Mark; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra			Lectins Offer New Perspectives in the Development of Macrophage-Targeted Therapies for COPD/Emphysema	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MANNOSE-BINDING LECTIN; T-CELL APOPTOSIS; ALVEOLAR MACROPHAGES; GALECTIN-3; EXPRESSION; AIRWAY; EFFEROCYTOSIS; PHAGOCYTOSIS; RECOGNITION	We have previously shown that the defective ability of alveolar macrophages (AM) to phagocytose apoptotic cells ('efferocytosis') in chronic obstructive pulmonary disease/emphysema (COPD) could be therapeutically improved using the C-type lectin, mannose binding lectin (MBL), although the exact mechanisms underlying this effect are unknown. An S-type lectin, galectin-3, is also known to regulate macrophage phenotype and function, via interaction with its receptor CD98. We hypothesized that defective expression of galectin/CD98 would be associated with defective efferocytosis in COPD and that mechanisms would include effects on cytoskeletal remodeling and macrophage phenotype and glutathione (GSH) availability. Galectin-3 was measured by ELISA in BAL from controls, smokers and current/ex-smokers with COPD. CD98 was measured on AM using flow cytometry. We assessed the effects of galectin-3 on efferocytosis, CD98, GSH, actin polymerisation, rac activation, and the involvement of PI3K (using beta-actin probing and wortmannin inhibition) in vitro using human AM and/or MH-S macrophage cell line. Significant decreases in BAL galectin-3 and AM CD98 were observed in BAL from both current- and ex-smoker COPD subjects vs controls. Galectin 3 increased efferocytosis via an increase in active GTP bound Rac1. This was confirmed with beta-actin probing and the role of PI3K was confirmed using wortmannin inhibition. The increased efferocytosis was associated with increases in available glutathione and expression of CD98. We provide evidence for a role of airway lectins in the failed efferocytosis in COPD, supporting their further investigation as potential macrophage-targeted therapies.	[Mukaro, Violet R.; Hodge, Greg; Holmes, Mark; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia; [Mukaro, Violet R.; Hodge, Greg; Holmes, Mark; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Hanson Inst, Lung Res Lab, Adelaide, SA, Australia; [Bylund, Johan] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Hodge, Greg; Holmes, Mark; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia	Royal Adelaide Hospital; Hanson Institute; University of Gothenburg; University of Adelaide	Hodge, S (corresponding author), Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia.	sandra.hodge@health.sa.gov.au	Jersmann, Hubertus/ABC-5287-2020	Jersmann, Hubertus/0000-0003-1763-2736; Mukaro, Violet/0000-0002-3968-6551	National Health and Medical Research Council Project Grant; Career Development Award; Practitioner Fellowship	National Health and Medical Research Council Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Career Development Award; Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Supported by a National Health and Medical Research Council Project Grant and Career Development Award and Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNAI S, 1986, J BIOL CHEM, V261, P2256; Beatty WL, 2002, CELL MICROBIOL, V4, P167, DOI 10.1046/j.1462-5822.2002.00183.x; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; Dobashi K, 2001, CLIN EXP IMMUNOL, V124, P290, DOI 10.1046/j.1365-2249.2001.01535.x; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Fukumori T, 2003, CANCER RES, V63, P8302; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2012, RESPIROLOGY, V17, P802, DOI 10.1111/j.1440-1843.2012.02135.x; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2011, J HEART LUNG TRANSPL, V30, P589, DOI 10.1016/j.healun.2011.01.710; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Krzeslak A, 2004, CELL MOL BIOL LETT, V9, P305; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Matthews GM, 2007, CANCER BIOL THER, V6, P1051, DOI 10.4161/cbt.6.7.4318; Pilette C, 2007, EUR RESPIR J, V29, P914, DOI 10.1183/09031936.00073005; Rimaniol AC, 2001, AM J PHYSIOL-CELL PH, V281, pC1964, DOI 10.1152/ajpcell.2001.281.6.C1964; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Stuart LM, 2005, J IMMUNOL, V174, P3220, DOI 10.4049/jimmunol.174.6.3220; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Theakston F, 2008, WORLD HLTH STAT; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737	31	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56147	10.1371/journal.pone.0056147	http://dx.doi.org/10.1371/journal.pone.0056147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441163	Green Published, gold			2022-12-27	WOS:000315159200020
J	Espina, L; Gelaw, TK; de Lamo-Castellvi, S; Pagan, R; Garcia-Gonzalo, D				Espina, Laura; Gelaw, Tilahun K.; de Lamo-Castellvi, Silvia; Pagan, Rafael; Garcia-Gonzalo, Diego			Mechanism of Bacterial Inactivation by (+)-Limonene and Its Potential Use in Food Preservation Combined Processes	PLOS ONE			English	Article							ALTERNATIVE SIGMA-FACTORS; ESCHERICHIA-COLI O157/H7; ESSENTIAL OILS; OUTER-MEMBRANE; STRESS-RESPONSE; ANTIMICROBIAL ACTIVITY; HEAT-RESISTANCE; FTIR SPECTROSCOPY; GENOME SEQUENCE; RPOS	This work explores the bactericidal effect of (+)-limonene, the major constituent of citrus fruits' essential oils, against E. coli. The degree of E. coli BJ4 inactivation achieved by (+)-limonene was influenced by the pH of the treatment medium, being more bactericidal at pH 4.0 than at pH 7.0. Deletion of rpoS and exposure to a sub-lethal heat or an acid shock did not modify E. coli BJ4 resistance to (+)-limonene. However, exposure to a sub-lethal cold shock decreased its resistance to (+)-limonene. Although no sub-lethal injury was detected in the cell envelopes after exposure to (+)-limonene by the selective-plating technique, the uptake of propidium iodide by inactivated E. coli BJ4 cells pointed out these structures as important targets in the mechanism of action. Attenuated Total Reflectance Infrared Microspectroscopy (ATR-IRMS) allowed identification of altered E. coli BJ4 structures after (+)-limonene treatments as a function of the treatment pH: beta-sheet proteins at pH 4.0 and phosphodiester bonds at pH 7.0. The increased sensitivity to (+)-limonene observed at pH 4.0 in an E. coli MC4100 lptD4213 mutant with an increased outer membrane permeability along with the identification of altered beta-sheet proteins by ATR-IRMS indicated the importance of this structure in the mechanism of action of (+)-limonene. The study of mechanism of inactivation by (+)-limonene led to the design of a synergistic combined process with heat for the inactivation of the pathogen E. coli O157:H7 in fruit juices. These results show the potential of (+)-limonene in food preservation, either acting alone or in combination with lethal heat treatments.	[Espina, Laura; Pagan, Rafael; Garcia-Gonzalo, Diego] Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain; [Gelaw, Tilahun K.; de Lamo-Castellvi, Silvia] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain	University of Zaragoza; Universitat Rovira i Virgili	Garcia-Gonzalo, D (corresponding author), Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain.	Diego.Garcia@unizar.es	Gonzalo, Diego Garcia/AAE-8947-2021; Gonzalo, Diego Garcia/A-2766-2012; Pagan, Rafael/H-4401-2011; de Lamo Castellví, Sílvia/L-8233-2014	Gonzalo, Diego Garcia/0000-0002-7629-8101; Gonzalo, Diego Garcia/0000-0002-7629-8101; Pagan, Rafael/0000-0002-0238-6328; de Lamo Castellví, Sílvia/0000-0002-5261-6806; Espina, Laura/0000-0002-3170-9755	Comison Interministerial de Ciencia y Tecnologia (CICYT) [AGL2009-11660, AGL2012-32165]; Gobierno de Aragon; European Social Fund; Departament Quimica of Universitat Rovira i Virgili; Spanish Ministerio de Ciencia e Innovacion	Comison Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Gobierno de Aragon(Gobierno de Aragon); European Social Fund(European Social Fund (ESF)); Departament Quimica of Universitat Rovira i Virgili; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was financially supported by the Comison Interministerial de Ciencia y Tecnologia (CICYT) (Projects AGL2009-11660 and AGL2012-32165), Gobierno de Aragon, European Social Fund and Departament Quimica of Universitat Rovira i Virgili. Spanish Ministerio de Ciencia e Innovacion provided LE with a grant to carry out this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 1999, INT J FOOD MICROBIOL, V50, P65, DOI 10.1016/S0168-1605(99)00078-1; Ait-Ouazzou A, 2012, INT J FOOD MICROBIOL, V153, P358, DOI 10.1016/j.ijfoodmicro.2011.11.027; Ait-Ouazzou A, 2011, INNOV FOOD SCI EMERG, V12, P320, DOI 10.1016/j.ifset.2011.04.004; Alvarez-Ordonez A, 2011, J MICROBIOL METH, V84, P369, DOI 10.1016/j.mimet.2011.01.009; Arroyo C, 2010, LETT APPL MICROBIOL, V51, P525, DOI 10.1111/j.1472-765X.2010.02931.x; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Belfer S, 2005, DESALINATION, V184, P13, DOI 10.1016/j.desal.2005.04.035; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; CHAPMAN PA, 1993, EPIDEMIOL INFECT, V111, P439, DOI 10.1017/S0950268800057162; Chee Hee Youn, 2009, Mycobiology, V37, P243, DOI 10.4489/MYCO.2009.37.3.243; Chung HJ, 2006, COMPR REV FOOD SCI F, V5, P52, DOI 10.1111/j.1541-4337.2006.00002.x; Condon S, 1996, LETT APPL MICROBIOL, V22, P149, DOI 10.1111/j.1472-765X.1996.tb01130.x; Dambolena JS, 2008, TOXICON, V51, P37, DOI 10.1016/j.toxicon.2007.07.005; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Dunn W.J., 1995, CHEMOMETRIC METHODS, P179; Espina L, 2010, J FOOD PROTECT, V73, P2189, DOI 10.4315/0362-028X-73.12.2189; Espina L, 2012, INT J FOOD MICROBIOL, V159, P9, DOI 10.1016/j.ijfoodmicro.2012.07.020; Espina L, 2011, FOOD CONTROL, V22, P896, DOI 10.1016/j.foodcont.2010.11.021; FDA, 2001, FED REGISTER, V66, P6137; Fisher K, 2008, TRENDS FOOD SCI TECH, V19, P156, DOI 10.1016/j.tifs.2007.11.006; FULCO AJ, 1974, ANNU REV BIOCHEM, V43, P215, DOI 10.1146/annurev.bi.43.070174.001243; Garcia D, 2005, INNOV FOOD SCI EMERG, V6, P388, DOI 10.1016/j.ifset.2005.04.003; GIBSON AM, 1988, INT J FOOD MICROBIOL, V6, P155, DOI [10.1016/0168-1605(88)90051-7, 10.1016/S0168-1605(00)00395-0]; GMEINER J, 1980, ARCH MICROBIOL, V127, P81, DOI 10.1007/BF00428010; Gould GW, 1989, MECH ACTION FOOD PRE, P11; Grasso EM, 2009, J AGR FOOD CHEM, V57, P10670, DOI 10.1021/jf902371j; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hruschka WR, 2001, NEAR INFRARED TECHNO, P39; Hucl T, 2007, CELL CYCLE, V6, P1336, DOI 10.4161/cc.6.11.4359; Jaroenkit P., 2011, International Journal of Medicinal and Aromatic Plants, V1, P234; JUVEN BJ, 1994, J APPL BACTERIOL, V76, P626, DOI 10.1111/j.1365-2672.1994.tb01661.x; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Krogfelt KA, 2000, INFECT IMMUN, V68, P2518, DOI 10.1128/IAI.68.5.2518-2524.2000; LEGAL JM, 1991, J MOL STRUCT, V242, P397, DOI 10.1016/0022-2860(91)87150-G; LEISTNER L, 1995, TRENDS FOOD SCI TECH, V6, P41, DOI 10.1016/S0924-2244(00)88941-4; Mackey B. M., 2000, MICROBIOLOGICAL SAFE, VI, P315; MACKEY BM, 1982, J APPL BACTERIOL, V53, P243, DOI 10.1111/j.1365-2672.1982.tb04683.x; Manas P, 2005, J APPL MICROBIOL, V98, P1387, DOI 10.1111/j.1365-2672.2005.02561.x; Mourey A, 2002, FOOD CONTROL, V13, P289, DOI 10.1016/S0956-7135(02)00026-9; Pagan R, 2000, APPL ENVIRON MICROB, V66, P2829, DOI 10.1128/AEM.66.7.2829-2834.2000; Parikh SJ, 2006, LANGMUIR, V22, P8492, DOI 10.1021/la061359p; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rota C, 2004, J FOOD PROTECT, V67, P1252, DOI 10.4315/0362-028X-67.6.1252; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SAMPSON BA, 1989, GENETICS, V122, P491; Shin JK, 1997, J FOOD SCI, V62, P163, DOI 10.1111/j.1365-2621.1997.tb04391.x; SIKKEMA J, 1994, J BIOL CHEM, V269, P8022; Silhavy TJ, 2010, COLD SPRING HARB PER, P2; Somolinos M, 2008, INT J FOOD MICROBIOL, V124, P260, DOI 10.1016/j.ijfoodmicro.2008.03.021; Somolinos M, 2010, INT J FOOD MICROBIOL, V141, P32, DOI 10.1016/j.ijfoodmicro.2010.04.023; Somolinos M, 2010, J APPL MICROBIOL, V108, P1928, DOI 10.1111/j.1365-2672.2009.04597.x; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Van Vuuren SF, 2007, FLAVOUR FRAG J, V22, P540, DOI 10.1002/ffj.1843; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193; Yu CX, 2005, BIOPOLYMERS, V77, P368, DOI 10.1002/bip.20247; ZUKERMAN I, 1951, NATURE, V168, P517, DOI 10.1038/168517a0	63	87	91	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56769	10.1371/journal.pone.0056769	http://dx.doi.org/10.1371/journal.pone.0056769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424676	gold, Green Published			2022-12-27	WOS:000315965100064
J	Jones, JJ; Bond, RM; Fariss, CJ; Settle, JE; Kramer, ADI; Marlow, C; Fowler, JH				Jones, Jason J.; Bond, Robert M.; Fariss, Christopher J.; Settle, Jaime E.; Kramer, Adam D. I.; Marlow, Cameron; Fowler, James H.			Yahtzee: An Anonymized Group Level Matching Procedure	PLOS ONE			English	Article							RANDOMIZED-RESPONSE; SOCIAL-INFLUENCE	Researchers often face the problem of needing to protect the privacy of subjects while also needing to integrate data that contains personal information from diverse data sources. The advent of computational social science and the enormous amount of data about people that is being collected makes protecting the privacy of research subjects ever more important. However, strict privacy procedures can hinder the process of joining diverse sources of data that contain information about specific individual behaviors. In this paper we present a procedure to keep information about specific individuals from being "leaked'' or shared in either direction between two sources of data without need of a trusted third party. To achieve this goal, we randomly assign individuals to anonymous groups before combining the anonymized information between the two sources of data. We refer to this method as the Yahtzee procedure, and show that it performs as predicted by theoretical analysis when we apply it to data from Facebook and public voter records.	[Jones, Jason J.; Bond, Robert M.; Fariss, Christopher J.; Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Jones, Jason J.; Fowler, James H.] Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA; [Settle, Jaime E.] Coll William & Mary, Dept Govt, Williamsburg, VA USA; [Kramer, Adam D. I.; Marlow, Cameron] Facebook Inc, Data Sci, Palo Alto, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; William & Mary; Facebook Inc	Fowler, JH (corresponding author), Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA.	jhfowler@ucsd.edu	Jones, Jason J/I-3350-2012; Fariss, Christopher/A-2244-2010; Fowler, James H/C-2750-2008; Fariss, Christopher/AAN-9494-2020; Fariss, Christopher J/AAG-9477-2021; Bond, Robert Meade/A-1561-2014	Jones, Jason J/0000-0002-4140-0268; Fowler, James H/0000-0001-7795-1638; Fariss, Christopher J/0000-0001-9837-186X; 	James S. McDonnell Foundation; University of Notre Dame; John Templeton Foundation	James S. McDonnell Foundation; University of Notre Dame; John Templeton Foundation	This work was supported in part by the James S. McDonnell Foundation and the University of Notre Dame and the John Templeton Foundation as part of the Science of Generosity Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK PA, 1982, AM POLIT SCI REV, V76, P94, DOI 10.2307/1960445; Blair G, 2012, POLIT ANAL, V20, P47, DOI 10.1093/pan/mpr048; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Campbell Angus., 1954, VOTER DECIDES; Cioffi-Revilla C, 2010, WIRES COMPUT STAT, V2, P259, DOI 10.1002/wics.95; Fowler J. H., 2005, SOCIAL LOGIC POLITIC; Fowler JH, 2011, AM POLIT RES, V39, P437, DOI 10.1177/1532673X10396310; Freedman MJ, 2004, LECT NOTES COMPUT SC, V3027, P1; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; GLASER WA, 1959, PUBLIC OPIN QUART, V23, P563, DOI 10.1086/266911; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Goldreich O, 2003, DISTRIB COMPUT, V16, P177, DOI 10.1007/s00446-002-0077-1; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GREENBERG BG, 1969, J AM STAT ASSOC, V64, P520, DOI 10.2307/2283636; Huckfeldt R.R., 1995, CITIZENS POLITICS SO; Imai K, 2011, J AM STAT ASSOC, V106, P407, DOI 10.1198/jasa.2011.ap10415; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052168; KENNY C, 1993, AM POLIT QUART, V21, P223, DOI 10.1177/1532673X9302100204; KENNY CB, 1992, AM J POLIT SCI, V36, P259, DOI 10.2307/2111432; Knack S., 1992, RATION SOC, V4, P133, DOI [10.1177/1043463192004002002, DOI 10.1177/1043463192004002002]; Lazarsfeld P. F., 1948, PEOPLES CHOICE VOTER, V2nd; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lindell Y., 2008, J PRIVACY CONFIDENT, V2008, P197, DOI DOI 10.29012/JPC.V1I1.566; Mutz DC, 1998, ANN M MIDW POL SCI A; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Rosenquist J., 2021, P INT AAAI C WEB SOC, V5, P554; Settle JE, 2011, AM POLIT RES, V39, P239, DOI 10.1177/1532673X10382195; STRAITS BC, 1991, PUBLIC OPIN QUART, V55, P432, DOI 10.1086/269272; Vitak J, 2011, CYBERPSYCH BEH SOC N, V14, P107, DOI 10.1089/cyber.2009.0226; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137	31	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55760	10.1371/journal.pone.0055760	http://dx.doi.org/10.1371/journal.pone.0055760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086NV	23441156	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800055
J	Menon, VK; George, S; Aladin, F; Nawaz, S; Sarkar, R; Lopman, B; Gray, JJ; Gomara, MI; Kang, G				Menon, Vipin Kumar; George, Santosh; Aladin, Farah; Nawaz, Sameena; Sarkar, Rajiv; Lopman, Ben; Gray, James J.; Gomara, Miren Iturriza; Kang, Gagandeep			Comparison of Age-Stratified Seroprevalence of Antibodies against Norovirus GII in India and the United Kingdom	PLOS ONE			English	Article							LINKED IMMUNOSORBENT ASSAYS; MEXICO VIRUS-INFECTIONS; NORWALK VIRUS; HUMAN CALICIVIRUSES; ACUTE GASTROENTERITIS; CAPSID ANTIGEN; PREVALENCE; CHILDREN; SOUTH; SEROEPIDEMIOLOGY	Noroviruses are a common cause of gastroenteritis worldwide, but outbreaks appear to be more common in industrialized countries than in developing countries, possibly reflecting differences in exposure and immunity. In this study, age-stratified sera from India and UK populations were analysed for the presence of norovirus-genogroup II specific IgG by a time resolved immunofluorescence assay and relative levels of antibodies in the two populations were compared. Antibody levels were higher among all age groups in India than in UK and increased with age in India, whereas in the UK, levels of antibody decreased in adulthood. These results indicate different patterns of exposure to noroviruses in the two countries.	[Menon, Vipin Kumar; George, Santosh; Sarkar, Rajiv; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Aladin, Farah; Nawaz, Sameena] Hlth Protect Agcy, Virus Reference Dept, Ctr Infect, London, England; [Lopman, Ben] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Gray, James J.] Norfolk & Norwich Univ Hosp Specialist Virol Ctr, Dept Microbiol, NRP Innovat Ctr, Norwich, Norfolk, England; [Gomara, Miren Iturriza] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	Christian Medical College & Hospital (CMCH) Vellore; Health Protection Agency; Centers for Disease Control & Prevention - USA; University of Liverpool	Kang, G (corresponding author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India.	gkang@cmcvellore.ac.in	Menon, Vipin Kumar/J-7451-2019; George, Santosh/F-2054-2018; Sarkar, Rajiv/AAU-7203-2021; George, Santosh/AAX-4797-2021; Gomara, Miren Iturriza/B-4351-2013	George, Santosh/0000-0003-0886-9766; Sarkar, Rajiv/0000-0003-0616-3129; Gomara, Miren Iturriza/0000-0001-5816-6423; Kang, Gagandeep/0000-0002-3656-564X; Menon, Vipin/0000-0001-7404-678X	British Council [SA08-040]; FOGARTY INTERNATIONAL CENTER [D43TW007392] Funding Source: NIH RePORTER	British Council(The British Council in India); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by British Council, with grant number SA08-040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-150; Atmar RL, 2010, FOOD ENVIRON VIROL, V2, P117, DOI 10.1007/s12560-010-9038-1; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Cannon JL, 2009, J VIROL, V83, P5363, DOI 10.1128/JVI.02518-08; Chhabra P, 2008, J CLIN VIROL, V42, P429, DOI 10.1016/j.jcv.2008.03.014; Chhabra P, 2009, J MED VIROL, V81, P922, DOI 10.1002/jmv.21458; Cubitt WD, 1998, J MED VIROL, V54, P135, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;135::AID-JMV11&gt;3.0.CO;2-I; Dai YC, 2004, J CLIN MICROBIOL, V42, P4615, DOI 10.1128/JCM.42.10.4615-4619.2004; Garcia C, 2006, J CLIN MICROBIOL, V44, P2997, DOI 10.1128/JCM.00065-06; Girish R, 2002, J MED VIROL, V67, P603, DOI 10.1002/jmv.10145; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; GRAY JJ, 1993, J CLIN MICROBIOL, V31, P1022, DOI 10.1128/JCM.31.4.1022-1025.1993; GREEN KY, 1993, J CLIN MICROBIOL, V31, P2185, DOI 10.1128/JCM.31.8.2185-2191.1993; Honma S, 1998, J CLIN MICROBIOL, V36, P2481, DOI 10.1128/JCM.36.9.2481-2484.1998; Jing Y, 2000, J MED VIROL, V60, P97, DOI 10.1002/(SICI)1096-9071(200001)60:1&lt;97::AID-JMV16&gt;3.0.CO;2-D; JOHNSON PC, 1990, J INFECT DIS, V161, P18, DOI 10.1093/infdis/161.1.18; Kang G, 2005, NATL MED J INDIA, V18, P15; Koopmans M, 2008, CURR OPIN INFECT DIS, V21, P544, DOI 10.1097/QCO.0b013e3283108965; Monica B, 2007, J MED VIROL, V79, P544, DOI 10.1002/jmv.20862; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Mukhopadhya I, 2010, EPIDEMIOL INFECT, V138, P442, DOI 10.1017/S0950268809990732; Nayak MK, 2009, J CLIN VIROL, V45, P223, DOI 10.1016/j.jcv.2009.04.018; Nicollier-Jamot B, 2003, J CLIN MICROBIOL, V41, P3901, DOI 10.1128/JCM.41.8.3901-3904.2003; O'Ryan ML, 1998, CLIN INFECT DIS, V27, P789, DOI 10.1086/514949; Parashar UD, 2004, J INFECT DIS, V190, P1088, DOI 10.1086/423324; PARKER S, 1993, J MED VIROL, V41, P179, DOI 10.1002/jmv.1890410302; Pelosi E, 1999, J MED VIROL, V58, P93, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;93::AID-JMV15&gt;3.0.CO;2-P; Smit TK, 1997, J CLIN MICROBIOL, V35, P2381, DOI 10.1128/JCM.35.9.2381-2385.1997; Smit TK, 1999, J MED VIROL, V59, P227, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;227::AID-JMV17&gt;3.0.CO;2-8; Smith DR, 2001, CLIN DIAGN LAB IMMUN, V8, P1070, DOI 10.1128/CDLI.8.6.1070-1075.2001; Vipond IB, 2004, J CLIN VIROL, V30, P243, DOI 10.1016/j.jcv.2003.11.011; Widdowson MA, 2005, J MED VIROL, V76, P119, DOI 10.1002/jmv.20333	32	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56239	10.1371/journal.pone.0056239	http://dx.doi.org/10.1371/journal.pone.0056239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437102	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000019
J	Persson, M; Gullberg, M; Tolf, C; Lindberg, AM; Mansson, A; Kocer, A				Persson, Malin; Gullberg, Maria; Tolf, Conny; Lindberg, A. Michael; Mansson, Alf; Kocer, Armagan			Transportation of Nanoscale Cargoes by Myosin Propelled Actin Filaments	PLOS ONE			English	Article							IN-VITRO; F-ACTIN; MOTOR PROTEINS; ACTOMYOSIN FUNCTION; MOLECULAR SHUTTLES; SLIDING MOVEMENT; DNA-MOLECULES; DRIVEN; GELSOLIN; DYNAMICS	Myosin II propelled actin filaments move ten times faster than kinesin driven microtubules and are thus attractive candidates as cargo-transporting shuttles in motor driven lab-on-a-chip devices. In addition, actomyosin-based transportation of nanoparticles is useful in various fundamental studies. However, it is poorly understood how actomyosin function is affected by different number of nanoscale cargoes, by cargo size, and by the mode of cargo-attachment to the actin filament. This is studied here using biotin/fluorophores, streptavidin, streptavidin-coated quantum dots, and liposomes as model cargoes attached to monomers along the actin filaments ("side-attached") or to the trailing filament end via the plus end capping protein CapZ. Long-distance transportation (> 100 mu m) could be seen for all cargoes independently of attachment mode but the fraction of motile filaments decreased with increasing number of side-attached cargoes, a reduction that occurred within a range of 10-50 streptavidin molecules, 1-10 quantum dots or with just 1 liposome. However, as observed by monitoring these motile filaments with the attached cargo, the velocity was little affected. This also applied for end-attached cargoes where the attachment was mediated by CapZ. The results with side-attached cargoes argue against certain models for chemomechanical energy transduction in actomyosin and give important insights of relevance for effective exploitation of actomyosin-based cargo-transportation in molecular diagnostics and other nanotechnological applications. The attachment of quantum dots via CapZ, without appreciable modulation of actomyosin function, is useful in fundamental studies as exemplified here by tracking with nanometer accuracy.	[Persson, Malin; Gullberg, Maria; Tolf, Conny; Lindberg, A. Michael; Mansson, Alf] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Kocer, Armagan] Univ Groningen, Dept Biochem, Groningen, Netherlands	Linnaeus University; University of Groningen	Mansson, A (corresponding author), Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden.	alf.mansson@lnu.se; a.kocer@rug.nl	Kocer, A/M-6371-2013; Mansson, Alf/ABC-6271-2021; Persson, Malin/K-6133-2017	Mansson, Alf/0000-0002-5889-7792; Persson, Malin/0000-0003-2819-3046; kocer, Armagan/0000-0001-7343-3139	Carl Trygger Foundation; European Union [228971]; Swedish Research Council [621-2007-6137, 621-210-5146]; Faculty of Natural Sciences and Engineering at Linnaeus University; Netherlands Organisation for Scientific Research [700.57.427]	Carl Trygger Foundation; European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Natural Sciences and Engineering at Linnaeus University; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Carl Trygger Foundation, the European Union Seventh Framework Programme (FP7/2007-2011) under grant agreement number 228971 (MONAD), the Swedish Research Council (Project #621-2007-6137 and #621-210-5146), the Faculty of Natural Sciences and Engineering at Linnaeus University and the Netherlands Organisation for Scientific Research (NWO-VIDI Grant 700.57.427 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, PROG POLYM SCI, V35, P252, DOI 10.1016/j.progpolymsci.2009.10.007; Albet-Torres N, 2007, LANGMUIR, V23, P11147, DOI 10.1021/la7008682; Albet-Torres N, 2011, LANGMUIR, V27, P7108, DOI 10.1021/la201081w; Albet-Torres N, 2010, SOFT MATTER, V6, P3211, DOI 10.1039/c0sm00019a; Bachand GD, 2004, NANO LETT, V4, P817, DOI 10.1021/nl049811h; Bachand GD, 2006, SMALL, V2, P381, DOI 10.1002/smll.200500262; Bakewell DJG, 2007, AUST J CHEM, V60, P314, DOI 10.1071/CH06456; Balaz M, 2005, ANAL BIOCHEM, V338, P224, DOI 10.1016/j.ab.2004.12.012; Balaz M, 2007, BIOCHEMISTRY-US, V46, P7233, DOI 10.1021/bi700211u; Banos FGD, 1996, BIOPHYS J, V71, P576, DOI 10.1016/S0006-3495(96)79292-5; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Brunner C, 2007, LAB CHIP, V7, P1263, DOI 10.1039/b707301a; CASELLA JF, 1991, METHOD ENZYMOL, V196, P140; Chase PB, 2000, AM J PHYSIOL-CELL PH, V278, pC1088, DOI 10.1152/ajpcell.2000.278.6.C1088; Chen Y, 2011, NANOTECHNOLOGY, V22; Clemmens J, 2004, LAB CHIP, V4, P83, DOI 10.1039/b317059d; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Diez S, 2003, NANO LETT, V3, P1251, DOI 10.1021/nl034504h; Dinu CZ, 2006, SMALL, V2, P1090, DOI 10.1002/smll.200600112; Esaki S, 2007, BIOSYSTEMS, V88, P293, DOI 10.1016/j.biosystems.2006.03.013; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Fischer T, 2009, NAT NANOTECHNOL, V4, P162, DOI [10.1038/nnano.2008.393, 10.1038/NNANO.2008.393]; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Goel A, 2008, NAT NANOTECHNOL, V3, P465, DOI 10.1038/nnano.2008.190; Hess H, 2001, NANO LETT, V1, P235, DOI 10.1021/nl015521e; Hess H, 2005, NANO LETT, V5, P629, DOI 10.1021/nl0478427; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Hiratsuka Y, 2001, BIOPHYS J, V81, P1555, DOI 10.1016/S0006-3495(01)75809-2; Hiyama S, 2010, LAB CHIP, V10, P2741, DOI 10.1039/c004615a; Holohan S.-J. P., 2005, IEE Proceedings Nanobiotechnology, V152, P113, DOI 10.1049/ip-nbt:20045003; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Howard J., 2001, MECH MOTOR PROTEINS; Huang YM, 2007, BIOMED MICRODEVICES, V9, P175, DOI 10.1007/s10544-006-9019-1; Hutchins BM, 2007, SMALL, V3, P126, DOI 10.1002/smll.200600410; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Iwabuchi S, 2012, BIOCHEM BIOPH RES CO, V422, P164, DOI 10.1016/j.bbrc.2012.04.130; Jia LL, 2004, BIOMED MICRODEVICES, V6, P67, DOI 10.1023/B:BMMD.0000013368.89455.8d; Kaur H, 2010, J BIOMED NANOTECHNOL, V6, P279, DOI 10.1166/jbn.2010.1124; Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484; Kim T, 2009, LAB CHIP, V9, P1282, DOI 10.1039/b900753a; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Klinth J, 2003, J MUSCLE RES CELL M, V24, P15, DOI 10.1023/A:1024894130989; Kocer A, 2007, NAT PROTOC, V2, P1426, DOI 10.1038/nprot.2007.196; Korten T, 2008, LAB CHIP, V8, P1441, DOI 10.1039/b803585g; Korten T, 2010, CURR OPIN BIOTECH, V21, P477, DOI 10.1016/j.copbio.2010.05.001; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Kumar S, 2011, 2 INT C BIOS TECHN A; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046298; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Mansson A, 2005, IEEE T ADV PACKAGING, V28, P547, DOI 10.1109/TADVP.2005.858309; Mansson A, 2004, BIOCHEM BIOPH RES CO, V314, P529, DOI 10.1016/j.bbrc.2003.12.133; Mansson A, 2003, ANAL BIOCHEM, V314, P281, DOI 10.1016/S0003-2697(02)00610-3; Mansson A, 2008, FRONT BIOSCI-LANDMRK, V13, P5732; Mansson A, 2012, J MUSCLE RES CELL M, V33, P219, DOI 10.1007/s10974-012-9298-5; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Nakayama H, 1998, BIOCHEM BIOPH RES CO, V246, P261, DOI 10.1006/bbrc.1998.8594; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PATERNOSTRE MT, 1988, BIOCHEMISTRY-US, V27, P2668, DOI 10.1021/bi00408a006; Patolsky F, 2004, NAT MATER, V3, P692, DOI 10.1038/nmat1205; Persson M, 2010, LANGMUIR, V26, P9927, DOI 10.1021/la100395a; POPE B, 1991, FEBS LETT, V280, P70, DOI 10.1016/0014-5793(91)80206-I; Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435; Ramachandran S, 2006, SMALL, V2, P330, DOI 10.1002/smll.200500265; Rios L, 2009, LAB CHIP, V9, P1005, DOI 10.1039/b816444d; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Schmidt C, 2012, NANO LETT, V12, P3466, DOI 10.1021/nl300936j; Sheehan PE, 2005, NANO LETT, V5, P803, DOI 10.1021/nl050298x; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; Soto CM, 2008, ANAL CHEM, V80, P5433, DOI 10.1021/ac800541x; Sundberg M, 2003, ANAL BIOCHEM, V323, P127, DOI 10.1016/j.ab.2003.07.022; Sundberg M, 2006, LANGMUIR, V22, P7302, DOI 10.1021/la060365i; Sundberg M, 2006, LANGMUIR, V22, P7286, DOI 10.1021/la060854i; Suzuki N, 1996, BIOPHYS J, V70, P401, DOI 10.1016/S0006-3495(96)79583-8; Taira S, 2008, BIOTECHNOL BIOENG, V99, P734, DOI 10.1002/bit.21618; Taira S, 2006, BIOTECHNOL BIOENG, V95, P533, DOI 10.1002/bit.21055; Takatsuki H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245101; Takatsuki H, 2010, SMALL, V6, P452, DOI 10.1002/smll.200901369; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; Vikhorev PG, 2008, LANGMUIR, V24, P13509, DOI 10.1021/la8016112; Vikhoreva NN, 2008, EUR MUSCL C OXF SEPT; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Xu JY, 1999, CELL MOTIL CYTOSKEL, V42, P73, DOI 10.1002/(SICI)1097-0169(1999)42:1<73::AID-CM7>3.0.CO;2-Z; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912; YU FX, 1991, J BIOL CHEM, V266, P19269	91	24	24	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55931	10.1371/journal.pone.0055931	http://dx.doi.org/10.1371/journal.pone.0055931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437074	gold, Green Published			2022-12-27	WOS:000315186000012
J	Schmidt, S; Fleischmann, R; Bathe-Peters, R; Irlbacher, K; Brandt, SA				Schmidt, Sein; Fleischmann, Robert; Bathe-Peters, Rouven; Irlbacher, Kerstin; Brandt, Stephan A.			Evolution of Premotor Cortical Excitability after Cathodal Inhibition of the Primary Motor Cortex: A Sham-Controlled Serial Navigated TMS Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL EXCITABILITY; DC-STIMULATION; FRONTAL-LOBE; HUMAN BRAIN; STROKE; AREAS; REORGANIZATION; HAND; OUTPUT	Background: Premotor cortical regions (PMC) play an important role in the orchestration of motor function, yet their role in compensatory mechanisms in a disturbed motor system is largely unclear. Previous studies are consistent in describing pronounced anatomical and functional connectivity between the PMC and the primary motor cortex (M1). Lesion studies consistently show compensatory adaptive changes in PMC neural activity following an M1 lesion. Non-invasive brain modification of PMC neural activity has shown compensatory neurophysiological aftereffects in M1. These studies have contributed to our understanding of how M1 responds to changes in PMC neural activity. Yet, the way in which the PMC responds to artificial inhibition of M1 neural activity is unclear. Here we investigate the neurophysiological consequences in the PMC and the behavioral consequences for motor performance of stimulation mediated M1 inhibition by cathodal transcranial direct current stimulation (tDCS). Purpose: The primary goal was to determine how electrophysiological measures of PMC excitability change in order to compensate for inhibited M1 neural excitability and attenuated motor performance. Hypothesis: Cathodal inhibition of M1 excitability leads to a compensatory increase of ipsilateral PMC excitability. Methods: We enrolled 16 healthy participants in this randomized, double-blind, sham-controlled, crossover design study. All participants underwent navigated transcranial magnetic stimulation (nTMS) to identify PMC and M1 corticospinal projections as well as to evaluate electrophysiological measures of cortical, intracortical and interhemispheric excitability. Cortical M1 excitability was inhibited using cathodal tDCS. Finger-tapping speeds were used to examine motor function. Results: Cathodal tDCS successfully reduced M1 excitability and motor performance speed. PMC excitability was increased for longer and was the only significant predictor of motor performance. Conclusion: The PMC compensates for attenuated M1 excitability and contributes to motor performance maintenance.	[Schmidt, Sein; Fleischmann, Robert; Bathe-Peters, Rouven; Irlbacher, Kerstin; Brandt, Stephan A.] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brandt, SA (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	stephan.brandt@charite.de	Schmidt, Sein/AFR-1244-2022; Schmidt, Sein/AAT-2308-2021	Bathe-Peters, Rouven/0000-0001-5425-0273; Fleischmann, Robert/0000-0001-8159-2658	DFG [IR 48/1-1]; Bernstein Center for Computational Neuroscience Berlin (BCCN)	DFG(German Research Foundation (DFG)); Bernstein Center for Computational Neuroscience Berlin (BCCN)	Supported by the DFG grant IR 48/1-1 and the Bernstein Center for Computational Neuroscience Berlin (BCCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; BRASILNETO JP, 1992, ELECTROEN CLIN NEURO, V85, P9, DOI 10.1016/0168-5597(92)90095-S; Brocke J, 2005, CLIN NEUROPHYSIOL, V116, P2748, DOI 10.1016/j.clinph.2005.08.015; Calautti C, 2010, NEUROIMAGE, V50, P1, DOI 10.1016/j.neuroimage.2009.12.012; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; Civardi C, 2001, NEUROIMAGE, V14, P1444, DOI 10.1006/nimg.2001.0918; Dancause N, 2006, NEUROSCIENTIST, V12, P489, DOI 10.1177/1073858406292782; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 2010, CLIN NEUROPHYSIOL, V121, P464, DOI 10.1016/j.clinph.2009.11.007; DUM RP, 1991, J NEUROSCI, V11, P667; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; FREUND HJ, 1985, BRAIN, V108, P697, DOI 10.1093/brain/108.3.697; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; Gerschlager W, 2001, NEUROLOGY, V57, P449, DOI 10.1212/WNL.57.3.449; Groppa S, 2012, HUM BRAIN MAPP, V33, P419, DOI 10.1002/hbm.21221; Huber R, 2013, CEREB CORTEX, V23, P1, DOI 10.1093/cercor/bhs014; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; Jalinous R, 2002, HDB TRANSCRANIAL MAG, P30; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Kantak SS, 2012, EUR J NEUROSCI, V36, P2710, DOI 10.1111/j.1460-9568.2012.08175.x; Kimura J, 2001, ELECTRODIAGNOSIS DIS; Kirimoto H, 2011, CLIN NEUROPHYSIOL, V122, P777, DOI 10.1016/j.clinph.2010.09.025; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Kukaswadia S, 2005, J PHYSIOL-LONDON, V563, P915, DOI 10.1113/jphysiol.2004.080010; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Liu Y, 1999, EXP BRAIN RES, V128, P149, DOI 10.1007/s002210050830; Miranda PC, 2009, CLINNEURO; Munchau A, 2002, J NEUROSCI, V22, P554, DOI 10.1523/JNEUROSCI.22-02-00554.2002; Nelles G, 1999, ANN NEUROL, V46, P901, DOI 10.1002/1531-8249(199912)46:6<901::AID-ANA13>3.0.CO;2-7; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Picht T, 2009, NEUROSURGERY, V65, P93, DOI 10.1227/01.NEU.0000348009.22750.59; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Rehme AK, 2011, NEUROIMAGE, V55, P1147, DOI 10.1016/j.neuroimage.2011.01.014; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rizzo V, 2004, J PHYSIOL-LONDON, V554, P483, DOI 10.1113/jphysiol.2003.048777; Ruohonen J, 1999, EEG CL N SU, P30; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Schmidt S, 2009, CLIN NEUROPHYSIOL, V120, P987, DOI 10.1016/j.clinph.2009.02.164; Seitz RJ, 2005, ACT NEUR S, V93, P65; Spangenberg P, 2012, KLIN NEUROPHYSIOL, V43, P139; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Takeuchi N, 2007, STROKE, V38, P1551, DOI 10.1161/STROKEAHA.106.470187; Taubert M, 2010, CLIN NEUROPHYSIOL, V121, P408, DOI 10.1016/j.clinph.2009.11.011; Teitti S, 2008, NEUROIMAGE, V40, P1243, DOI 10.1016/j.neuroimage.2007.12.065; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Thielscher A, 2002, NEUROIMAGE, V17, P1117, DOI 10.1006/nimg.2002.1282; Toschi N, 2008, J PSYCHIATR RES, V43, P255, DOI 10.1016/j.jpsychires.2008.04.008; Vaalto S, 2011, HUM BRAIN MAPP, V32, P1692, DOI 10.1002/hbm.21137; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Ward NS, 2004, ANN NEUROL, V55, P829, DOI 10.1002/ana.20099; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001	60	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57425	10.1371/journal.pone.0057425	http://dx.doi.org/10.1371/journal.pone.0057425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437385	gold, Green Submitted, Green Published			2022-12-27	WOS:000315186000101
J	Wang, Y; Chen, L; Huang, GC; He, DM; He, J; Xu, W; Zou, CY; Zong, F; Li, Y; Chen, B; Wu, SS; Zhao, WH; Wu, JQ				Wang, Yan; Chen, Lei; Huang, Guochang; He, Dongmei; He, Juan; Xu, Wei; Zou, Chunying; Zong, Feng; Li, Yan; Chen, Bo; Wu, Shuanshuan; Zhao, Weihong; Wu, Jianqing			Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway	PLOS ONE			English	Article							HUMAN OVARIAN-CANCER; HUMAN BREAST-CANCER; TUMOR-SUPPRESSOR; AKT; RESISTANCE; APOPTOSIS; SURVIVAL; PROTEIN; GENE; EXPRESSION	Klotho was first identified in 1997 and has been considered as an anti-aging gene. Emerging evidence demonstrates that klotho has a close relationship with cancers, including lung cancer, breast cancer, etc, by inhibiting the proliferation and promoting apoptosis of cancer cells. Cisplatin has been the most widely used drug in the first-line chemotherapy. However, the increase in cisplatin-resistant cancer cells has become a major obstacle in clinical management of cancers. In our study, we for the first time demonstrated that klotho could attenuate the resistance of lung cancer to cisplatin based chemotherapy and the apoptosis of the resistant cells with klotho overexpression was markedly increased. However, klotho knockdown cells showed enhanced resistance to chemotherapy. Further analysis showed that inhibition of PI3K/Akt pathway with specific inhibitor (LY294002) attenuated the promotive effects on cancer growth following interfering with klotho shRNA. Moreover, we demonstrated that klotho modulated the resistance to cisplatin in a xenograft nude mice model. These observations suggested that klotho could improve the resistance of lung cancer cells to chemotherapy and may serve as a potential target for the gene therapy of lung cancers resistant to cisplatin based chemotherapy.	[Wang, Yan; Chen, Lei; He, Juan; Xu, Wei; Zou, Chunying; Zong, Feng; Li, Yan; Chen, Bo; Wu, Shuanshuan; Zhao, Weihong; Wu, Jianqing] Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Huang, Guochang] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [He, Dongmei] Nanjing Univ, Nanjing Stomatol Hosp, Dept Orthodont, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Memorial Sloan Kettering Cancer Center; Nanjing University	Wu, JQ (corresponding author), Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	jwuny@njmu.edu.cn			National Natural Science Foundation of China [30971320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 30971320). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz L, 2011, CLIN CANCER RES, V17, P4254, DOI 10.1158/1078-0432.CCR-10-2749; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chen B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-99; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eastman A, 1991, Cancer Treat Res, V57, P233; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Galluzzi L., 2011, ONCOGENE; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Hayakawa J, 2000, CANCER RES, V60, P5988; He XH, 2004, CELL RES, V14, P487, DOI 10.1038/sj.cr.7290252; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hennenlotter J, 2011, ANTICANCER RES, V31, P3783; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Milane L, 2011, J CONTROL RELEASE, V155, P237, DOI 10.1016/j.jconrel.2011.03.032; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Olaussen KA, 2007, CURR OPIN PULM MED, V13, P284, DOI 10.1097/MCP.0b013e32816b5c63; Pan J, 2011, TUMOR BIOL, V32, P729, DOI 10.1007/s13277-011-0174-5; Poh TW, 2005, CANCER RES, V65, P6264, DOI 10.1158/0008-5472.CAN-05-0152; Reed E, 2005, CLIN CANCER RES, V11, P6100, DOI 10.1158/1078-0432.CCR-05-1083; Rubinek T, 2011, BREAST CANC RES TREA; Shibata T, 2009, CANCER LETT, V283, P203, DOI 10.1016/j.canlet.2009.03.038; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Yuan Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020586; Zhao ZW, 2012, BIOCHEM J, V444, P291, DOI 10.1042/BJ20111855	39	46	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57391	10.1371/journal.pone.0057391	http://dx.doi.org/10.1371/journal.pone.0057391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437382	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000100
J	Zhu, T; Wang, DX; Zhang, W; Liao, XQ; Guan, X; Bo, H; Sun, JY; Huang, NW; He, J; Zhang, YK; Tong, J; Li, CY				Zhu, Tao; Wang, Dao-xin; Zhang, Wei; Liao, Xiu-qing; Guan, Xian; Bo, Hong; Sun, Jia-yang; Huang, Ni-wen; He, Jing; Zhang, Yun-kun; Tong, Jing; Li, Chang-yi			Andrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-kappa B	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PI-3K/AKT-NF-KAPPA-B SIGNALING PATHWAY; EPITHELIAL SODIUM-CHANNEL; ALVEOLAR FLUID CLEARANCE; INDUCED MITOGENIC FACTOR; IN-VITRO; EXPRESSION; PANICULATA; INHIBITION; ACTIVATION	Background: Nuclear factor-kappa B (NF-kappa B) is a central transcriptional factor and a pleiotropic regulator of many genes involved in acute lung injury. Andrographolide is found in the plant of Andrographis paniculata and widely used in Traditional Chinese Medicine, exhibiting potently anti-inflammatory property by inhibiting NF-kappa B activity. The purpose of our investigation was designed to reveal the effect of andrographolide on various aspects of LPS induced inflammation in vivo and in vitro. Methods and Results: In vivo, BALB/C mice were subjected to LPS injection with or without andrographolide treatments to induce ALI model. In vitro, MLE-12 cells were stimulated with LPS in the presence and absence of andrographolide. In vivo, pulmonary inflammation, pulmonary edema, ultrastructure changes of type II alveolar epithelial cells, MPO activity, total cells, neutrophils, macrophages, TNF-alpha, IL-6 and IL-1 beta in BALF, along with the expression of VCAM-1 and VEGF were dose-dependently attenuated by andrographolide. Meanwhile, in vitro, the expression of VCAM-1 and VEGF was also reduced by andrographolide. Moreover, our data showed that andrographolide significantly inhibited the ratios of phospho-IKK beta/total IKK beta, phospho-I kappa B alpha/total I kappa B alpha and phospho-NF-kappa B p65/total NF-kappa B p65, and NF-kappa B p65 DNA binding activities, both in vivo and in vitro. Conclusions: These results indicate that andrographolide dose-dependently suppressed the severity of LPS-induced ALI, more likely by virtue of andrographolide-mediated NF-kappa B inhibition at the level of IKK beta activation. These results suggest andrographolide may be considered as an effective and safe drug for the potential treatment of ALI.	[Zhu, Tao; Wang, Dao-xin; Guan, Xian; He, Jing; Zhang, Yun-kun; Tong, Jing; Li, Chang-yi] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Zhang, Wei] Chengdu Med Coll, Affiliated Hosp 1, Chengdu, Peoples R China; [Liao, Xiu-qing] Chongqing Fuling Cent Hosp, Chongqing, Peoples R China; [Bo, Hong] Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China; [Sun, Jia-yang; Huang, Ni-wen] Guiyang Med Coll, Affiliated Hosp, Guiyang, Peoples R China	Chongqing Medical University; Chengdu Medical College; Sichuan University; Guizhou Medical University	Wang, DX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China.	wangdaoxin2011@sina.com	Li, Changyi/GVS-6654-2022		National Natural Science Foundation of China [30971303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 30971303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghefreh AA, 2009, INT IMMUNOPHARMACOL, V9, P313, DOI 10.1016/j.intimp.2008.12.002; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amroyan E, 1999, PHYTOMEDICINE, V6, P27, DOI 10.1016/S0944-7113(99)80031-2; Bao Z, 2009, AM J RESP CRIT CARE, V179, P657, DOI 10.1164/rccm.200809-1516OC; Batkhuu J, 2002, BIOL PHARM BULL, V25, P1169, DOI 10.1248/bpb.25.1169; Burgos RA, 2009, CLIN RHEUMATOL, V28, P931, DOI 10.1007/s10067-009-1180-5; Christofidou-Solomidou M, 2002, AM J PATHOL, V160, P1155, DOI 10.1016/S0002-9440(10)64935-8; Deng J, 2012, RESP PHYSIOL NEUROBI, V181, P53, DOI 10.1016/j.resp.2011.11.009; Deng W, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-29; Deng W, 2011, CHINESE MED J-PEKING, V124, P1551, DOI 10.3760/cma.j.issn.0366-6999.2011.10.021; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hidalgo MA, 2005, BRIT J PHARMACOL, V144, P680, DOI 10.1038/sj.bjp.0706105; Ito K, 2005, INJURY, V36, P387, DOI 10.1016/j.injury.2004.06.018; KAPIL A, 1993, BIOCHEM PHARMACOL, V46, P182, DOI 10.1016/0006-2952(93)90364-3; Lee L, 2012, J SURG RES, V174, P24, DOI 10.1016/j.jss.2011.06.022; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Liu S, 2008, EUR J PHARMACOL, V584, P159, DOI 10.1016/j.ejphar.2008.02.009; Medford ARL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-27; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; Moine P, 2000, SHOCK, V13, P85, DOI 10.1097/00024382-200013020-00001; Parsey MV, 1998, J IMMUNOL, V160, P1007; PURI A, 1993, J NAT PROD, V56, P995, DOI 10.1021/np50097a002; Shen YC, 2000, PLANTA MED, V66, P314, DOI 10.1055/s-2000-8537; Shen YC, 2002, BRIT J PHARMACOL, V135, P399, DOI 10.1038/sj.bjp.0704493; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; Tong QS, 2006, AM J RESP CELL MOL, V35, P444, DOI 10.1165/rcmb.2005-0424OC; Tong QS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-37; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Xu T, 2009, EUR RESPIR J, V33, P852, DOI 10.1183/09031936.00130507; Zhang X, 2005, INJURY, V36, P387; Zhu T, 2012, INJURY, V43, P1277, DOI 10.1016/j.injury.2012.04.004	36	196	215	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56407	10.1371/journal.pone.0056407	http://dx.doi.org/10.1371/journal.pone.0056407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437127	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000026
J	Gale, HB; Rodriguez, MD; Hoffman, HJ; Benator, DA; Gordin, FM; Labriola, AM; Kan, VL				Gale, Howard B.; Rodriguez, Manuel D.; Hoffman, Heather J.; Benator, Debra A.; Gordin, Fred M.; Labriola, Ann M.; Kan, Virginia L.			Progress Realized: Trends in HIV-1 Viral Load and CD4 Cell Count in a Tertiary-Care Center from 1999 through 2011	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HEALTH-CARE; HEPATITIS-C; ALCOHOL-USE; VIRUS; VETERANS; RNA; COMORBIDITIES; PREDICTORS; DISORDERS	Background: HIV-1 RNA and CD4 cell counts are important parameters for HIV care. The objective of this study was to assess the overall trends in HIV-1 viral load and CD4 cell counts within our clinic. Methods: Patients with at least one of each test performed by the Infectious Diseases Laboratory from 1999 through 2011 were included in this analysis. By adapting a novel statistical model, log(10) HIV-1 RNA means were estimated by month, and log(10)-transformed HIV-1 RNA means were estimated by calendar year. Geometric means were calculated for CD4 cell counts by month and calendar year. Log(10) HIV-1 RNA and CD4 cell count monthly means were also examined with polynomial regression. Results: There were 1,814 individuals with approximately 25,000 paired tests over the 13-year observation period. Based on each patient's final value of the year, the percentage of patients with viral loads below the lower limit of quantitation rose from 29% in 1999 to 72% in 2011, while the percentage with CD4 counts <200 cells/mu L fell from 31% to 11%. On average annually, the mean HIV-1 RNA decreased by 86 copies/mL and the mean CD4 counts increased by 16 cells/mu L. For the monthly means, the correlations (R-2) from second-order polynomial regressions were 0.944 for log(10) HIV-1 RNA and 0.840 for CD4 cell counts. Conclusions: Marked improvements in HIV-1 RNA suppression and CD4 cell counts were achieved in a large inner-city population from 1999 through 2011. This success demonstrates that sustained viral control with improved immunologic status can be a realistic goal for most individuals in clinical care.	[Gale, Howard B.; Rodriguez, Manuel D.; Benator, Debra A.; Gordin, Fred M.; Labriola, Ann M.; Kan, Virginia L.] Vet Affairs Med Ctr, Med Serv, Infect Dis Sect, Washington, DC 20422 USA; [Rodriguez, Manuel D.; Benator, Debra A.; Gordin, Fred M.; Labriola, Ann M.; Kan, Virginia L.] George Washington Univ, Div Infect Dis, Washington, DC USA; [Hoffman, Heather J.] George Washington Univ, Dept Epidemiol & Biostat, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); George Washington University; George Washington University	Gale, HB (corresponding author), Vet Affairs Med Ctr, Med Serv, Infect Dis Sect, 50 Irving St NW, Washington, DC 20422 USA.	howard.gale@va.gov	Hoffman, Heather/AAF-6429-2020		District of Columbia Developmental Center for AIDS Research [P30AI087714/NIAID/NIH]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714] Funding Source: NIH RePORTER	District of Columbia Developmental Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the staff of the Infectious Diseases Clinic and our volunteer clinicians for their dedication to the HIV care of our patients and Karen Rexroth and Rebecca Shinol for their performance of CD4 counts and HIV-1 RNA viral loads in the Infectious Diseases Laboratory. This work was IRB-exempt and reviewed and approved by the R&D Committee at this VA Medical Center. The views expressed are those of the authors and do not reflect the views or policies of the Department of Veterans Affairs. Statistical support for our work was provided by The District of Columbia Developmental Center for AIDS Research (P30AI087714/NIAID/NIH). Presented in part at the XIX International AIDS Conference, Washington, DC, July 22-27, 2012 (Abstract THPE061).	Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Backus LI, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000192065.09281.01; Box G.E.P., 2008, TIMES SERIES ANAL FO; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Conigliaro J, 2003, JAIDS-J ACQ IMM DEF, V33, P521, DOI 10.1097/00126334-200308010-00014; Conigliaro J, 2006, MED CARE, V44, pS1, DOI 10.1097/01.mlr.0000223659.36369.cf; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; Folker GK, 2012, JAMA-J AM MED ASSOC, V304, P350; Frick P, 2006, AIDS PATIENT CARE ST, V20, P511, DOI 10.1089/apc.2006.20.511; Fuller BE, 2009, CURR OPIN PSYCHIATR, V22, P401, DOI 10.1097/YCO.0b013e32832cadb9; Gale HB, 2008, J MOL DIAGN, V10, P586; GALE HB, 1992, CYTOMETRY, V13, P175, DOI 10.1002/cyto.990130211; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Gordon AJ, 2006, MED CARE, V44, pS37, DOI 10.1097/01.mlr.0000223705.00175.3d; Goulet JL, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000192077.11067.e5; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hoang T, 2009, MED CARE, V47, P560, DOI 10.1097/MLR.0b013e31819432a0; Justice Amy C, 2006, Top HIV Med, V14, P159; Kilbourne AM, 2002, J GEN INTERN MED, V17, P512, DOI 10.1046/j.1525-1497.2002.10803.x; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Ma A, 2010, AIDS CARE, V22, P1189, DOI 10.1080/09540121003668102; MADDALA GS, 1983, LIMITED DEPENDENT QU; Mavandadi S, 2009, JAIDS-J ACQ IMM DEF, V51, P91, DOI 10.1097/QAI.0b013e318199069b; Moore RD, 2011, CLIN INFECT DIS, V53, P600, DOI 10.1093/cid/cir467; Mrus JM, 2006, J GEN INTERN MED, V21, pS39, DOI 10.1111/j.1525-1497.2006.00644.x; Nurutdinova D, 2012, AIDS, V26, P229, DOI 10.1097/QAD.0b013e32834e1404; Sherer R, 2002, AIDS CARE, V14, pS31, DOI 10.1080/09540120220149975; Sullivan G, 2006, COMMUNITY MENT HLT J, V42, P345, DOI 10.1007/s10597-006-9053-8; Zaragoza-Macias E, 2010, AIDS RES HUM RETROV, V26, P133, DOI 10.1089/aid.2009.0001	35	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56845	10.1371/journal.pone.0056845	http://dx.doi.org/10.1371/journal.pone.0056845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437255	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200171
J	Hou, Y; Zheng, JH; Wang, YK; Yu, M; Vembar, M; Guo, QY				Hou, Yang; Zheng, Jiahe; Wang, Yuke; Yu, Mei; Vembar, Mani; Guo, Qiyong			Optimizing Radiation Dose Levels in Prospectively Electrocardiogram-Triggered Coronary Computed Tomography Angiography Using Iterative Reconstruction Techniques: A Phantom and Patient Study	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; DUAL-SOURCE CT; IMAGE QUALITY; ACCURACY; NOISE; ALGORITHM; CHEST	Aim: To investigate the potential of reducing the radiation dose in prospectively electrocardiogram-triggered coronary computed tomography angiography (CCTA) while maintaining diagnostic image quality using an iterative reconstruction technique (IRT). Methods and Materials: Prospectively-gated CCTA were first performed on a phantom using 256-slice multi-detector CT scanner at 120 kVp, with the tube output gradually reduced from 210 mAs (Group A) to 125, 105, 84, and 63 mAs (Group B-E). All scans were reconstructed using filtered back projection (FBP) algorithm and five IRT levels (L2-6), image quality (IQ) assessment was performed. Based on the IQ assessment, Group D(120 kVp, 84 mAs) reconstructed with L5 was found to provide IQ comparable to that of Group A with FBP. In the patient study, 21 patients underwent CCTA using 120 kV, 210 mAs with FBP reconstruction (Group 1) followed by 36 patients scanned with 120 kV, 84 mAs with IRT L5 (Group 2). Subjective and objective IQ and effective radiation dose were compared between two groups. Results: In the phantom scans, there were no significant differences in image noise, contrast-to-noise ratio (CNR) and modulation transfer function (MTF) curves between Group A and the 84 mAs, 63 mAs groups (Groups D and E). Group D (120 kV, 84 mAs and L5) provided an optimum balance, producing equivalent image quality to Group A, at the lowest possible radiation dose. In the patient study, there were no significant difference in image noise, signal-to-noise ratio (SNR) and CNR between Group 1 and Group 2 (p = 0.71, 0.31, 0.5, respectively). The effective radiation dose in Group 2 was 1.21+/-0.14 mSv compared to 3.20+/-0.58 mSv (Group 1), reflecting dose savings of 62.5% (p < 0.05). Conclusion: iterative reconstruction technique used in prospectively ECG-triggered 256-slice coronary CTA can provide radiation dose reductions of up to 62.5% with acceptable image quality.	[Hou, Yang; Zheng, Jiahe; Wang, Yuke; Yu, Mei; Guo, Qiyong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China; [Vembar, Mani] CT Clin Sci Philips Healthcare, Cleveland, OH USA	China Medical University; Philips; Philips Healthcare	Guo, QY (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China.	guoqy@vip.sina.com	Yang, Aliza/HGU-3681-2022	Hou, Yang/0000-0002-9184-5441	two provincial government funds-Innovative Research Team of Liaoning Educational Committee [LT2010105]; Science and Technique Foundation of Shenyang [F12-193-9-35]	two provincial government funds-Innovative Research Team of Liaoning Educational Committee; Science and Technique Foundation of Shenyang	This work was supported by two provincial government funds-Innovative Research Team of Liaoning Educational Committee (LT2010105) and Science and Technique Foundation of Shenyang(F12-193-9-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkadhi H, 2010, HEART, V96, P933, DOI 10.1136/hrt.2009.189100; d'Othee BJ, 2008, EUR J RADIOL, V65, P449, DOI 10.1016/j.ejrad.2007.05.003; Feuchtner GM, 2010, EUR J RADIOL, V75, pE51, DOI 10.1016/j.ejrad.2009.07.012; Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94; Gutstein Ariel, 2008, J Cardiovasc Comput Tomogr, V2, P311, DOI 10.1016/j.jcct.2008.07.003; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Hosch W, 2012, EUR J RADIOL, V81, P3568, DOI 10.1016/j.ejrad.2011.06.055; Hosch W, 2011, EUR J RADIOL, V80, P127, DOI 10.1016/j.ejrad.2010.07.011; Hou Y, 2012, AM J ROENTGENOL, V199, P588, DOI 10.2214/AJR.11.7557; Hou Y, 2012, INT J CARDIOVAS IMAG, V28, P153, DOI 10.1007/s10554-010-9760-7; Hu XH, 2011, CLIN RADIOL, V66, P1023, DOI 10.1016/j.crad.2011.04.008; Kambadakone AR, 2011, AM J ROENTGENOL, V196, pW743, DOI 10.2214/AJR.10.5303; Kerl JM, 2011, EUR RADIOL, V21, P1895, DOI 10.1007/s00330-011-2134-2; Klass O, 2010, EUR RADIOL, V20, P1124, DOI 10.1007/s00330-009-1652-7; Law WY, 2011, ACAD RADIOL, V18, P31, DOI 10.1016/j.acra.2010.07.013; Leipsic J, 2010, AM J ROENTGENOL, V195, P655, DOI 10.2214/AJR.10.4288; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; Leschka S, 2008, EUR RADIOL, V18, P1809, DOI 10.1007/s00330-008-0966-1; Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9; Marwan M, 2012, INT J CARDIOVASC IMA; McCollough C., 2008, 96 AM ASS PHYS MED; Mitsumori LM, 2012, EUR RADIOL, V22, P138, DOI 10.1007/s00330-011-2186-3; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Park EA, 2012, INT J CARDIOVASC IMA; Pflederer T, 2009, AM J ROENTGENOL, V192, P1045, DOI 10.2214/AJR.08.1025; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec; Raff GL, 2010, J CARDIOVASC COMPUT, V4, P365, DOI 10.1016/j.jcct.2010.09.002; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Wang R, 2012, EUR J RADIOL	32	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56295	10.1371/journal.pone.0056295	http://dx.doi.org/10.1371/journal.pone.0056295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437110	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200056
J	Malinowska, IA; Lee, N; Kumar, V; Thiele, EA; Franz, DN; Ashwal, S; Sagalowsky, A; DiMario, FJ; Cutler, D; Krueger, D; Camposano, S; Paolini, J; Dabora, SL				Malinowska, Izabela A.; Lee, Nancy; Kumar, Vidhya; Thiele, Elizabeth A.; Franz, David Neal; Ashwal, Stephen; Sagalowsky, Arthur; DiMario, Francis J., Jr.; Cutler, Drew; Krueger, Darcy; Camposano, Susana; Paolini, Jan; Dabora, Sandra L.			Similar Trends in Serum VEGF-D Levels and Kidney Angiomyolipoma Responses with Longer Duration Sirolimus Treatment in Adults with Tuberous Sclerosis	PLOS ONE			English	Article							GROWTH FACTOR-D; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; SOLID TUMORS; COMPLEX; TSC2; WOMEN; HETEROZYGOSITY; MUTATIONS; GENE	Context: We have previously shown that serum VEGF-D is elevated at baseline, correlates with kidney angiomyolipoma size at baseline and 12 months, and decreases with sirolimus treatment in adults with tuberous sclerosis complex (TSC). To further investigate the utility of serum VEGF-D for longer term monitoring of TSC kidney disease, we present VEGF-D level results with 24 month follow-up. Objective: To compare 24 month VEGF-D levels in two subgroups of sirolimus treated patients (OFF SIROLIMUS AFTER 12 MONTHS or ON SIROLIMUS AFTER 12 MONTHS). Design and Intervention(s): Serum VEGF-D was measured in samples collected from subjects enrolled in a phase 2 multicenter trial evaluating sirolimus for the treatment of kidney angiomyolipomas associated with TSC or TSC/LAM. All participants were treated with sirolimus from 0-12 months. During months 12-24, sirolimus was discontinued in one subgroup. The other subgroup was treated with additional sirolimus. Setting: Adult TSC participants were recruited from six clinical sites in the United States (comprehensive TSC clinics, 5; urology clinic, 1). Patients: There were 28 TSC patients who completed all 24 months of the study and serum samples were available at 24 months from 18/28 patients. Main Outcome Measure(s): We compared the percent change in VEGF-D levels (baseline to 24 months) in patients from the two treatment subgroups. Results: At 24 months, VEGF-D levels decreased by 67% compared with baseline (to 787+/-426 pg/ml) in the ON SIROLIMUS AFTER 12 MONTHS group versus a 13% decrease (to 2971+/-4014 pg/ml) in the OFF SIROLIMUS AFTER 12 MONTHS group (p = 0.013, Mann-Whitney test). A similar trend was observed in kidney angiomyolipoma size but not in pulmonary function tests. Conclusions Serum VEGF-D may be useful for monitoring response to treatment with sirolimus and kidney angiomyolipoma size in patients with TSC, but confirmation is needed.	[Malinowska, Izabela A.; Lee, Nancy; Kumar, Vidhya; Dabora, Sandra L.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Thiele, Elizabeth A.; Camposano, Susana; Paolini, Jan] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Franz, David Neal; Krueger, Darcy] Childrens Med Ctr, Dept Pediat, Cincinnati, OH USA; [Ashwal, Stephen] Loma Linda Univ, Dept Neurol, Loma Linda, CA 92350 USA; [Sagalowsky, Arthur] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [DiMario, Francis J., Jr.] Connecticut Childrens Med Ctr, Dept Pediat Neurol, Hartford, CT USA; [Cutler, Drew] Loma Linda Univ, Loma Linda, CA 92350 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Loma Linda University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Connecticut Children's Medical Center; Loma Linda University	Dabora, SL (corresponding author), East Boston Neighborhood Hlth Ctr, Boston, MA USA.	sandy.dabora@gmail.com	Malinowska, Izabela/A-4816-2013	Krueger, Darcy/0000-0002-7250-7391	NIH/National Cancer Institute [R01CA107164]; Tuberous Sclerosis Alliance planning and supplement grants; Brigham and Women's Hospital Research Institute Bridge Funding award; NATIONAL CANCER INSTITUTE [R01CA107164] Funding Source: NIH RePORTER	NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tuberous Sclerosis Alliance planning and supplement grants; Brigham and Women's Hospital Research Institute Bridge Funding award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the following grants to S. Dabora: NIH/National Cancer Institute (R01CA107164), Tuberous Sclerosis Alliance planning and supplement grants, and the Brigham and Women's Hospital Research Institute Bridge Funding award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dabora SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023379; Davies DM, 2011, CLIN CANCER RES, V17, P4071, DOI 10.1158/1078-0432.CCR-11-0445; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Glasgow CG, 2009, CHEST, V135, P1293, DOI 10.1378/chest.08-1160; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Henske EP, 1996, AM J HUM GENET, V59, P400; HENSKE EP, 1995, GENE CHROMOSOME CANC, V13, P295, DOI 10.1002/gcc.2870130411; Hirama M, 2007, INTERNAL MED, V46, P1593, DOI 10.2169/internalmedicine.46.0225; Issaka RB, 2009, AM J PATHOL, V175, P1410, DOI 10.2353/ajpath.2009.080830; Juvet SC, 2007, AM J RESP CELL MOL, V36, P398, DOI 10.1165/rcmb.2006-0372TR; Klatte T, 2009, CANCER EPIDEM BIOMAR, V18, P894, DOI 10.1158/1055-9965.EPI-08-0786; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Marcotte L, 2006, NEUROMOL MED, V8, P531, DOI 10.1385/NMM:8:4:531; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Motulsky H, 2003, PRACTICAL GUIDE CURV; Petrova TV, 2008, CANCER CELL, V13, P554, DOI 10.1016/j.ccr.2008.04.022; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Seyama Kuniaki, 2006, Lymphatic Research and Biology, V4, P143, DOI 10.1089/lrb.2006.4.143; Seyama K, 2010, AM J PATHOL, V176, P2051, DOI 10.2353/ajpath.2010.091239; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Young LR, 2008, NEW ENGL J MED, V358, P199, DOI 10.1056/NEJMc0707517; Young LR, 2010, CHEST, V138, P674, DOI 10.1378/chest.10-0573	29	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56199	10.1371/journal.pone.0056199	http://dx.doi.org/10.1371/journal.pone.0056199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437092	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200045
J	Mizokami, A; Yasutake, Y; Gao, J; Matsuda, M; Takahashi, I; Takeuchi, H; Hirata, M				Mizokami, Akiko; Yasutake, Yu; Gao, Jing; Matsuda, Miho; Takahashi, Ichiro; Takeuchi, Hiroshi; Hirata, Masato			Osteocalcin Induces Release of Glucagon-Like Peptide-1 and Thereby Stimulates Insulin Secretion in Mice	PLOS ONE			English	Article							COLLAGEN-SYNTHESIS; BETA-CELL; METABOLISM; EXENDIN-4; RECEPTOR; CYCLINS; BIOLOGY; SYSTEM	The uncarboxylated form (ucOC), but not the gamma-carboxylated form (GlaOC), of the bone-derived protein osteocalcin stimulates insulin secretion and regulates energy metabolism in insulin target tissues. Glucagon-like peptide-1 (GLP-1) is an insulin secretagogue that is released from the gut in response to food intake. We have now found that Gprc6a, a putative ucOC receptor, is expressed in epithelial cells of the mouse small intestine as well as in STC-1 enteroendocrine cells. Secretion of GLP-1 by STC-1 cells was stimulated by ucOC but not by GlaOC. The serum GLP-1 concentration in mice was increased by intraperitoneal or oral administration of ucOC, whereas GlaOC was effective in this regard only after oral application. Serum insulin levels were also increased by ucOC, and this effect was potentiated by an inhibitor of dipeptidyl peptidase IV and blocked by a GLP-1 receptor antagonist. Intravenous injection of ucOC in mice increased the serum GLP-1 concentration, and also increased the serum level of insulin. Our results suggest that ucOC acts via Gprc6a to induce GLP-1 release from the gut, and that the stimulatory effect of ucOC on insulin secretion is largely mediated by GLP-1.	[Mizokami, Akiko; Yasutake, Yu; Gao, Jing; Matsuda, Miho; Takeuchi, Hiroshi; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 812, Japan; [Yasutake, Yu; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Orthodont, Fukuoka 812, Japan; [Takeuchi, Hiroshi] Kyushu Dent Coll, Div Appl Pharmacol, Kitakyushu, Fukuoka 803, Japan	Kyushu University; Kyushu University; Kyushu Dental University	Hirata, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 812, Japan.	hirata1@dent.kyushu-u.ac.jp	Mizokami, Akiko/ABC-5448-2021; Takeuchi, Hiroshi/I-8849-2019; Mizokami, Akiko/AAY-2193-2020	Takeuchi, Hiroshi/0000-0003-0033-2913; Mizokami, Akiko/0000-0002-7490-5190	KAKENHI from Japan Society for Promotion of Science [24229009, 23792127, 24592805, 24592804]	KAKENHI from Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI from Japan Society for Promotion of Science to MH (24229009), JG (23792127), HT (24592805) and MM (24592804). AM is a Research Fellow (RPD program) of Japan Society for the Promotion of Science. The Uehara Memorial Foundation (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; ENG J, 1992, J BIOL CHEM, V267, P7402; ENGELKE JA, 1991, BIOCHIM BIOPHYS ACTA, V1078, P31, DOI 10.1016/0167-4838(91)90088-H; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2012, BONE, V50, P568, DOI 10.1016/j.bone.2011.04.017; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; GOKE R, 1993, J BIOL CHEM, V268, P19650; Green BD, 2005, J ENDOCRINOL, V185, P307, DOI 10.1677/joe.1.05876; Hauschka PV, 1989, PHYSIOL REV, V130, P287; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Humphrey MJ, 1986, DELIVERY SYSTEMS PEP; ITUARTE EA, 1989, CALCIFIED TISSUE INT, V45, P27, DOI 10.1007/BF02556657; Karsenty G, 2012, ANNU REV PHYSIOL, V74, P87, DOI 10.1146/annurev-physiol-020911-153233; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; KREAM BE, 1985, ENDOCRINOLOGY, V116, P296, DOI 10.1210/endo-116-1-296; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lim GE, 2006, DIABETES, V55, pS70, DOI 10.2337/db06-S020; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; ROSEN DM, 1983, ENDOCRINOLOGY, V112, P992, DOI 10.1210/endo-112-3-992; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Yang RY, 2006, CELL CYCLE, V5, P180, DOI 10.4161/cc.5.2.2306	30	105	114	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57375	10.1371/journal.pone.0057375	http://dx.doi.org/10.1371/journal.pone.0057375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437377	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200249
J	Tashyreva, D; Elster, J; Billi, D				Tashyreva, Daria; Elster, Josef; Billi, Daniela			A Novel Staining Protocol for Multiparameter Assessment of Cell Heterogeneity in Phormidium Populations (Cyanobacteria) Employing Fluorescent Dyes	PLOS ONE			English	Article							5-CYANO-2,3-DITOLYL TETRAZOLIUM CHLORIDE; FLOW-CYTOMETRY; ESCHERICHIA-COLI; CHLOROPHYLL FLUORESCENCE; MICROBIAL-POPULATIONS; RESPIRATORY ACTIVITY; RESPIRING BACTERIA; VIABILITY; PHYCOBILISOMES; MEMBRANE	Bacterial populations display high heterogeneity in viability and physiological activity at the single-cell level, especially under stressful conditions. We demonstrate a novel staining protocol for multiparameter assessment of individual cells in physiologically heterogeneous populations of cyanobacteria. The protocol employs fluorescent probes, i.e., redox dye 5-cyano-2,3-ditolyl tetrazolium chloride, 'dead cell' nucleic acid stain SYTOX Green, and DNA-specific fluorochrome 4',6-diamidino-2-phenylindole, combined with microscopy image analysis. Our method allows simultaneous estimates of cellular respiration activity, membrane and nucleoid integrity, and allows the detection of photosynthetic pigments fluorescence along with morphological observations. The staining protocol has been adjusted for, both, laboratory and natural populations of the genus Phormidium (Oscillatoriales), and tested on 4 field-collected samples and 12 laboratory strains of cyanobacteria. Based on the mentioned cellular functions we suggest classification of cells in cyanobacterial populations into four categories: (i) active and intact; (ii) injured but active; (iii) metabolically inactive but intact; (iv) inactive and injured, or dead.	[Tashyreva, Daria; Elster, Josef] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Elster, Josef] Acad Sci Czech Republ, Inst Bot, Ctr Phycol, Trebon, Czech Republic; [Billi, Daniela] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Rome Tor Vergata	Tashyreva, D (corresponding author), Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic.	tashyreva@butbn.cas.cz	Billi, Daniela/AAT-6690-2021; Elster, Josef/B-1031-2008; Tashyreva, Daria/Q-6880-2016; Tashyreva, Daria/AAD-6325-2021	Tashyreva, Daria/0000-0002-1280-4095; BILLI, DANIELA/0000-0002-9363-2415	Ministery of Education of the Czech Republic [Kontakt ME 934, Ingo LA 341]; Czech Polar Project [LM 2010009]; GAJU Grant (Czech Republic) [138/2010/P]	Ministery of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Polar Project; GAJU Grant (Czech Republic)	This work was funded by Kontakt ME 934, Ingo LA 341 (Ministery of Education of the Czech Republic); LM 2010009 (Czech Polar Project); GAJU Grant 138/2010/P (Czech Republic); microscopy analyses were partially paid from PNRA, PEA2009 to DB (previously to Patrizia Albertano dagger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernas T, 2000, ARCH BIOCHEM BIOPHYS, V380, P108, DOI 10.1006/abbi.2000.1907; Billi D, 2009, EXTREMOPHILES, V13, P49, DOI 10.1007/s00792-008-0196-0; Bodemer U, 2004, J PLANKTON RES, V26, P1147, DOI 10.1093/plankt/fbh105; Breeuwer P, 2000, INT J FOOD MICROBIOL, V55, P193, DOI 10.1016/S0168-1605(00)00163-X; BROWN JS, 1969, BIOPHYS J, V9, P1542, DOI 10.1016/S0006-3495(69)86469-6; BRYANT DA, 1982, J GEN MICROBIOL, V128, P835; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; CARON GNV, 1995, J MICROSC-OXFORD, V179, P55, DOI 10.1111/j.1365-2818.1995.tb03612.x; Davey Hazel M., 2003, Current Issues in Molecular Biology, V5, P9; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; FRENCH CS, 1956, PLANT PHYSIOL, V31, P369, DOI 10.1104/pp.31.5.369; GANTT E, 1979, PLANT PHYSIOL, V63, P615, DOI 10.1104/pp.63.4.615; Hatzinger PB, 2003, J MICROBIOL METH, V52, P47, DOI 10.1016/S0167-7012(02)00132-X; Hernlem B, 2010, CURR MICROBIOL, V61, P57, DOI 10.1007/s00284-009-9576-7; KAPRELYANTS AS, 1993, J MICROBIOL METH, V17, P115, DOI 10.1016/0167-7012(93)90004-2; Karner M, 1997, APPL ENVIRON MICROB, V63, P1208, DOI 10.1128/AEM.63.4.1208-1213.1997; Kell DB, 2000, CURR OPIN MICROBIOL, V3, P238, DOI 10.1016/S1369-5274(00)00082-5; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, V2, P243, DOI DOI 10.1002/9780470281840.CH8; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; LopezAmoros R, 1997, CYTOMETRY, V29, P298, DOI 10.1002/(SICI)1097-0320(19971201)29:4<298::AID-CYTO6>3.0.CO;2-6; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MCFETERS GA, 1995, J MICROBIOL METH, V21, P1, DOI 10.1016/0167-7012(94)00027-5; Mimuro M, 1999, CONCEPTS IN PHOTOBIOLOGY, P104; Muller S, 2010, FEMS MICROBIOL REV, V34, P554, DOI 10.1111/j.1574-6976.2010.00214.x; Nebe-von Caron G, 1998, J APPL MICROBIOL, V84, P988, DOI 10.1046/j.1365-2672.1998.00436.x; PORTER J, 1995, J APPL BACTERIOL, V79, P399, DOI 10.1111/j.1365-2672.1995.tb03154.x; RIGBI M, 1980, P NATL ACAD SCI-BIOL, V77, P1961, DOI 10.1073/pnas.77.4.1961; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801, DOI 10.1128/AEM.58.6.1801-1808.1992; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; SCHAULE G, 1993, APPL ENVIRON MICROB, V59, P3850, DOI 10.1128/AEM.59.11.3850-3857.1993; Schumann R, 2003, AQUAT MICROB ECOL, V32, P137, DOI 10.3354/ame032137; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; SIEGELMAN HW, 1982, PLANT PHYSIOL, V70, P887, DOI 10.1104/pp.70.3.887; Smith JJ, 1997, J MICROBIOL METH, V29, P161, DOI 10.1016/S0167-7012(97)00036-5; Strunecky O, 2012, POLISH POLA IN PRESS; Tachon S, 2009, MICROBIOL-SGM, V155, P2941, DOI 10.1099/mic.0.029678-0; TEALE FWJ, 1970, BIOCHEM J, V116, P161, DOI 10.1042/bj1160161; Veldhuis MJW, 2001, EUR J PHYCOL, V36, P167, DOI 10.1080/09670260110001735318; Ying LM, 1998, J PHYS CHEM B, V102, P10399, DOI 10.1021/jp983227d; YU W, 1995, APPL ENVIRON MICROB, V61, P3367, DOI 10.1128/AEM.61.9.3367-3372.1995; ZIMMERMANN R, 1978, APPL ENVIRON MICROB, V36, P926, DOI 10.1128/AEM.36.6.926-935.1978; ZWEIFEL UL, 1995, APPL ENVIRON MICROB, V61, P2180, DOI 10.1128/AEM.61.6.2180-2185.1995	44	30	31	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55283	10.1371/journal.pone.0055283	http://dx.doi.org/10.1371/journal.pone.0055283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437052	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200014
J	Todorova, N; Yeung, L; Hung, A; Yarovsky, I				Todorova, Nevena; Yeung, Levi; Hung, Andrew; Yarovsky, Irene			"Janus" Cyclic Peptides: A New Approach to Amyloid Fibril Inhibition?	PLOS ONE			English	Article							APOLIPOPROTEIN-C-II; SIMULATIONS; LIPIDS	Cyclic peptides are increasingly being shown as powerful inhibitors of fibril formation, and have the potential to be therapeutic agents for combating many debilitating amyloid-related diseases. One such example is a cyclic peptide derivative from the human apolipoprotein C-II, which has the ability to inhibit fibril formation by the fibrillogenic peptide apoC-II(60-70). Using classical molecular dynamics and electronic structure calculations, we were able to provide insight into the interaction between the amyloidogenic peptide apoC-II(60-70) and its cyclic derivative, cyc(60-70). Our results showed that cyc(60-70) induced increased flexibility in apoC-II(60-70), suggesting that one mechanism by which cyc(60-70) inhibits fibrillisation is by destabilising apoC-II(60-70) structure, rendering it incapable of adopting fibril favouring conformations. In contrast, cyc(60-70) shows less flexibility upon binding to apoC-II(60-70), which is predominantly mediated by hydrophobic interactions between the aromatic rings of the peptides. This effectively creates a cap around the fibril-forming region of apoC-II(60-70) and generates an outer hydrophilic shell that discourages further apoC-II(60-70) peptide self-association. We showed that apoC-II(60-70) exhibited stronger binding affinity for the hydrophobic face of cyc(60-70) and weakest binding affinity for the hydrophilic side. This suggests that cyc(60-70) can be an effective fibril inhibitor due to its amphipathic character, like that of the "Janus"-type particles. This property can be exploited in the design of specific inhibitors of amyloid fibril formation.	[Todorova, Nevena; Yarovsky, Irene] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia; [Yeung, Levi; Hung, Andrew] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Todorova, Nevena; Hung, Andrew; Yarovsky, Irene] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Yarovsky, I (corresponding author), RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia.	irene.yarovsky@rmit.edu.au	Todorova, Nevena/L-5190-2016	Todorova, Nevena/0000-0001-6358-2974; Yarovsky, Irene/0000-0002-4033-5150; Hung, Andrew/0000-0003-3569-2951	Australian Research Council under the Discovery Project Scheme [DP0984565]	Australian Research Council under the Discovery Project Scheme(Australian Research Council)	The authors acknowledge financial support from the Australian Research Council under the Discovery Project Scheme (DP0984565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen HJC, 1991, TRANSPORT PROPERTIES; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cole DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002096; Elstner M, 2001, J CHEM PHYS, V114, P5149, DOI 10.1063/1.1329889; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gazit E, 2005, FEBS J, V272, P5971, DOI 10.1111/j.1742-4658.2005.05022.x; Griffin MDW, 2012, J MOL BIOL, V416, P642, DOI 10.1016/j.jmb.2011.12.059; Hatters DM, 2003, BIOPHYS J, V85, P3979, DOI 10.1016/S0006-3495(03)74812-7; Hill Q, 2009, P ROY SOC A-MATH PHY, V465, P669, DOI 10.1098/rspa.2008.0398; Hine NDM, 2009, COMPUT PHYS COMMUN, V180, P1041, DOI 10.1016/j.cpc.2008.12.023; Hung A, 2008, EUR BIOPHYS J BIOPHY, V38, P99, DOI 10.1007/s00249-008-0363-3; Hung A, 2011, J MOL GRAPH MODEL, V29, P597, DOI 10.1016/j.jmgm.2010.11.001; Hung A, 2009, J PHYS CHEM B, V113, P9447, DOI 10.1021/jp901051n; Kapurniotu A, 2003, CHEM BIOL, V10, P149, DOI 10.1016/S1074-5521(03)00022-X; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Skylaris CK, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839852; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Teoh CL, 2011, J MOL BIOL, V405, P1246, DOI 10.1016/j.jmb.2010.12.006; Todorova N, 2010, PHYS CHEM CHEM PHYS, V12, P14762, DOI 10.1039/c0cp00299b; Todorova N, 2010, J PHYS CHEM B, V114, P7974, DOI 10.1021/jp102142x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Zheng J, 2011, J AM CHEM SOC, V133, P3144, DOI 10.1021/ja110545h	29	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57437	10.1371/journal.pone.0057437	http://dx.doi.org/10.1371/journal.pone.0057437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437387	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200255
J	Bagci, U; Yao, JH; Miller-Jaster, K; Chen, XJ; Mollura, DJ				Bagci, Ulas; Yao, Jianhua; Miller-Jaster, Kirsten; Chen, Xinjian; Mollura, Daniel J.			Predicting Future Morphological Changes of Lesions from Radiotracer Uptake in 18F-FDG-PET Images	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; F-18-FDG PET; SEGMENTATION; TEXTURE; HETEROGENEITY; VOLUMES	We introduce a novel computational framework to enable automated identification of texture and shape features of lesions on F-18-FDG-PET images through a graph-based image segmentation method. The proposed framework predicts future morphological changes of lesions with high accuracy. The presented methodology has several benefits over conventional qualitative and semi-quantitative methods, due to its fully quantitative nature and high accuracy in each step of (i) detection, (ii) segmentation, and (iii) feature extraction. To evaluate our proposed computational framework, thirty patients received 2 F-18-FDG-PET scans (60 scans total), at two different time points. Metastatic papillary renal cell carcinoma, cerebellar hemongioblastoma, non-small cell lung cancer, neurofibroma, lymphomatoid granulomatosis, lung neoplasm, neuroendocrine tumor, soft tissue thoracic mass, nonnecrotizing granulomatous inflammation, renal cell carcinoma with papillary and cystic features, diffuse large B-cell lymphoma, metastatic alveolar soft part sarcoma, and small cell lung cancer were included in this analysis. The radiotracer accumulation in patients' scans was automatically detected and segmented by the proposed segmentation algorithm. Delineated regions were used to extract shape and textural features, with the proposed adaptive feature extraction framework, as well as standardized uptake values (SUV) of uptake regions, to conduct a broad quantitative analysis. Evaluation of segmentation results indicates that our proposed segmentation algorithm has a mean dice similarity coefficient of 85.75 +/- 1.75%. We found that 28 of 68 extracted imaging features were correlated well with SUVmax (p<0.05), and some of the textural features (such as entropy and maximum probability) were superior in predicting morphological changes of radiotracer uptake regions longitudinally, compared to single intensity feature such as SUVmax. We also found that integrating textural features with SUV measurements significantly improves the prediction accuracy of morphological changes (Spearman correlation coefficient = 0.8715, p<e-16).	[Bagci, Ulas; Miller-Jaster, Kirsten; Mollura, Daniel J.] NIH, Ctr Infect Dis Imaging, Bethesda, MD 20892 USA; [Bagci, Ulas; Yao, Jianhua; Miller-Jaster, Kirsten; Mollura, Daniel J.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Chen, Xinjian] Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Soochow University - China	Bagci, U (corresponding author), NIH, Ctr Infect Dis Imaging, Bldg 10, Bethesda, MD 20892 USA.	ulas.bagci@nih.gov	Chen, Xinjian/E-8592-2016; Bagci, Ulas/A-4225-2012; Yao, Jianhua/GQZ-6627-2022	Bagci, Ulas/0000-0001-7379-6829; Yao, Jianhua/0000-0001-9157-9596; Chen, Xinjian/0000-0002-0871-293X	Imaging Sciences Training Program (ISTP); Center for Infectious Disease Imaging (CIDI); Intramural Program of the National Institutes of Allergy and Infectious Diseases; Intramural Research Program of the National Institutes of Bio-imaging and Bioengineering at the National Institutes of Health (NIH); CLINICAL CENTER [ZIACL090018, ZIDCL040016] Funding Source: NIH RePORTER	Imaging Sciences Training Program (ISTP); Center for Infectious Disease Imaging (CIDI); Intramural Program of the National Institutes of Allergy and Infectious Diseases; Intramural Research Program of the National Institutes of Bio-imaging and Bioengineering at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This research is supported by the Imaging Sciences Training Program (ISTP), the Center for Infectious Disease Imaging (CIDI), the Intramural Program of the National Institutes of Allergy and Infectious Diseases, and the Intramural Research Program of the National Institutes of Bio-imaging and Bioengineering at the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kadi OS, 2010, PATTERN RECOGN, V43, P2043, DOI 10.1016/j.patcog.2010.01.005; Bagci U, 2012, LECT NOTES COMPUT SC, V7512, P459, DOI 10.1007/978-3-642-33454-2_57; Bagci U, 2011, IEEE ENG MED BIO, P8479, DOI 10.1109/IEMBS.2011.6092092; Bagci U, 2012, COMPUT MED IMAG GRAP, V36, P72, DOI 10.1016/j.compmedimag.2011.06.002; BESAG J, 1986, J R STAT SOC B, V48, P259; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Bouaynaya N, 2008, IEEE T PATTERN ANAL, V30, P823, DOI 10.1109/TPAMI.2007.70754; Catana C, 2008, P NATL ACAD SCI USA, V105, P3705, DOI 10.1073/pnas.0711622105; Chen XJ, 2011, MED PHYS, V38, P4610, DOI 10.1118/1.3602070; Cignoni P, 1998, COMPUT GRAPH FORUM, V17, P167, DOI 10.1111/1467-8659.00236; COGGINS JM, 1985, PATTERN RECOGN LETT, V3, P195, DOI 10.1016/0167-8655(85)90053-4; CROSS GR, 1983, IEEE T PATTERN ANAL, V5, P25, DOI 10.1109/TPAMI.1983.4767341; Day E, 2009, MED PHYS, V36, P4349, DOI 10.1118/1.3213099; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Erdi YE, 1997, CANCER, V80, P2505, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.3.CO;2-B; EVERITT B, 1980, QUAL QUANT, V14, P75, DOI 10.1007/BF00154794; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; HALL P, 1993, BIOMETRIKA, V80, P246, DOI 10.2307/2336774; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2011, J NUCL MED, V52, P1690, DOI 10.2967/jnumed.111.092767; Hatt M, 2009, IEEE T MED IMAGING, V28, P881, DOI 10.1109/TMI.2008.2012036; INGLIS J, 1975, TECHNOMETRICS, V17, P513, DOI 10.2307/1268442; Jentzen W, 2007, J NUCL MED, V48, P108; Komodakis N, 2011, IEEE T PATTERN ANAL, V33, P531, DOI 10.1109/TPAMI.2010.108; MARKOWSKI CA, 1990, AM STAT, V44, P322, DOI 10.2307/2684360; Montgomery DWG, 2007, MED PHYS, V34, P722, DOI 10.1118/1.2432404; O'Sullivan F, 2005, BIOSTATISTICS, V6, P293, DOI 10.1093/biostatistics/kxi010; O'Sullivan F, 2003, BIOSTATISTICS, V4, P433, DOI 10.1093/biostatistics/4.3.433; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rosenfeld A, 1975, TR361 U MAR COMP SCI; Shankar LK, 2006, J NUCL MED, V47, P1059; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SWARTZLA EE, 1974, IEEE T SYST MAN CYB, VMC 4, P238; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Zhu SC, 2000, IEEE T PATTERN ANAL, V22, P554, DOI 10.1109/34.862195	37	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57105	10.1371/journal.pone.0057105	http://dx.doi.org/10.1371/journal.pone.0057105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431398	Green Submitted, gold, Green Published			2022-12-27	WOS:000315182800041
J	Costamagna, AC; McCornack, BP; Ragsdale, DW				Costamagna, Alejandro C.; McCornack, Brian P.; Ragsdale, David W.			Within-Plant Bottom-Up Effects Mediate Non-Consumptive Impacts of Top-Down Control of Soybean Aphids	PLOS ONE			English	Article							POPULATION-GROWTH; GLYCINES MATSUMURA; GENERALIST PREDATORS; BIOLOGICAL-CONTROL; TROPHIC CASCADES; NATURAL ENEMIES; SUGAR-BEET; PEA APHIDS; MANAGEMENT; QUALITY	There is increasing evidence that top-down controls have strong non-consumptive effects on herbivore populations. However, little is known about how these non-consumptive effects relate to bottom-up influences. Using a series of field trials, we tested how changes in top-down and bottom-up controls at the within-plant scale interact to increase herbivore suppression. In the first experiment, we manipulated access of natural populations of predators (primarily lady beetles) to controlled numbers of A. glycines on upper (i.e. vigorous-growing) versus lower (i.e. slow-growing) soybean nodes and under contrasting plant ages. In a second experiment, we measured aphid dispersion in response to predation. Bottom-up and top-down controls had additive effects on A. glycines population growth. Plant age and within-plant quality had significant bottom-up effects on aphid size and population growth. However, top-down control was the dominant force suppressing aphid population growth, and completely counteracted bottom-up effects at the plant and within-plant scales. The intensity of predation was higher on upper than lower soybean nodes, and resulted in a non-consumptive reduction in aphid population growth because most of the surviving aphids were located on lower plant nodes, where rates of increase were reduced. No effects of predation on aphid dispersal among plants were detected, suggesting an absence of predator avoidance behavior by A. glycines. Our results revealed significant non-consumptive predator impacts on aphids due to the asymmetric intensity of predation at the within-plant scale, suggesting that low numbers of predators are highly effective at suppressing aphid populations.	[Costamagna, Alejandro C.; McCornack, Brian P.; Ragsdale, David W.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Costamagna, AC (corresponding author), Univ Manitoba, Dept Entomol, Winnipeg, MB R3T 2N2, Canada.	Ale_Costamagna@umanitoba.ca	Costamagna, Alejandro/B-1750-2009	Costamagna, Alejandro/0000-0002-7301-2534	North Central Soybean Research Program; Minnesota Soybean Research and Promotion Council; Minnesota Agricultural Experiment Station; College of Food, Agricultural, and Natural Resource Sciences Rapid Agricultural Response Fund	North Central Soybean Research Program; Minnesota Soybean Research and Promotion Council; Minnesota Agricultural Experiment Station; College of Food, Agricultural, and Natural Resource Sciences Rapid Agricultural Response Fund	Funding for this research was provided by the North Central Soybean Research Program; the Minnesota Soybean Research and Promotion Council; the Minnesota Agricultural Experiment Station; and the College of Food, Agricultural, and Natural Resource Sciences Rapid Agricultural Response Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awmack CS, 2007, APHIDS AS CROP PESTS, P135, DOI 10.1079/9780851998190.0135; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Berryman AA, 2006, OIKOS, V115, P192, DOI 10.1111/j.0030-1299.2006.15188.x; Blaauw BR, 2012, ECOL ENTOMOL, V37, P386, DOI 10.1111/j.1365-2311.2012.01376.x; Brosius TR, 2007, J ECON ENTOMOL, V100, P1268, DOI 10.1603/0022-0493(2007)100[1268:PDOSAA]2.0.CO;2; Butler CD, 2006, ANN ENTOMOL SOC AM, V99, P317, DOI 10.1603/0013-8746(2006)099[0317:DROSAH]2.0.CO;2; Case T. J, 2000, ILLUSTRATED GUIDE TH; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; Costamagna AC, 2007, AGR FOREST ENTOMOL, V9, P297, DOI 10.1111/j.1461-9563.2007.00348.x; Costamagna AC, 2013, J APPL ENTOMOL, V137, P317, DOI 10.1111/j.1439-0418.2012.01730.x; Costamagna AC, 2008, BIOL CONTROL, V45, P368, DOI 10.1016/j.biocontrol.2008.01.018; Costamagna AC, 2007, BIOL CONTROL, V42, P16, DOI 10.1016/j.biocontrol.2007.04.001; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; Costamagna AC, 2011, BIOL CONTROL, V57, P184, DOI 10.1016/j.biocontrol.2011.03.006; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Donaldson JR, 2007, BIOL CONTROL, V43, P111, DOI 10.1016/j.biocontrol.2007.06.004; Dyer LA, 2003, BASIC APPL ECOL, V4, P423, DOI 10.1078/1439-1791-00191; Fox TB, 2004, ENVIRON ENTOMOL, V33, P608, DOI 10.1603/0046-225X-33.3.608; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; HACKER SD, 1995, AM NAT, V145, P192, DOI 10.1086/285736; Hodek I., 1996, Series Entomologica (Dordrecht), V54, P143; Hodgson EW, 2005, ENVIRON ENTOMOL, V34, P1456, DOI 10.1603/0046-225X-34.6.1456; Kift NB, 1998, ENTOMOL EXP APPL, V88, P155, DOI 10.1023/A:1003445427935; Landis DA, 1997, ENTOMOPHAGA, V42, P499, DOI 10.1007/BF02769810; Lin LA, 2003, ECOL ENTOMOL, V28, P542, DOI 10.1046/j.1365-2311.2003.00536.x; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; McCornack BP, 2008, J ECON ENTOMOL, V101, P1488, DOI 10.1603/0022-0493(2008)101[1488:WDOSAH]2.0.CO;2; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Meihls LN, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14104; Moon DC, 2006, ECOL ENTOMOL, V31, P236, DOI 10.1111/j.1365-2311.2006.00785.x; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rhainds M, 2007, CAN ENTOMOL, V139, P728, DOI 10.4039/N06-095; Ritchie SW, 1994, 53 IOW STAT U IOW ST; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; *SAS I INC, 2001, SAS STAT US MAN VERS; Schmidt NP, 2007, ENVIRON ENTOMOL, V36, P416, DOI 10.1603/0046-225X(2007)36[416:ALMABC]2.0.CO;2; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Thaler JS, 2008, ENTOMOL EXP APPL, V128, P34, DOI 10.1111/j.1570-7458.2008.00737.x; TURCHIN P, 1989, ECOLOGY, V70, P1008, DOI 10.2307/1941369; VandenBerg H, 1997, J APPL ECOL, V34, P971, DOI 10.2307/2405287; Von Ende CN., 2001, DESIGN ANAL ECOLOGIC, P134; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Walter AJ, 2007, ENVIRON ENTOMOL, V36, P26, DOI 10.1603/0046-225X(2007)36[26:SPDASP]2.0.CO;2; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; White TCR, 2009, OIKOS, V118, P807, DOI 10.1111/j.1600-0706.2009.17495.x; Williams CT, 1995, B ENTOMOL RES, V85, P557, DOI 10.1017/S000748530003306X; Woltz JM, 2012, AGR ECOSYST ENVIRON, V152, P40, DOI 10.1016/j.agee.2012.02.008; Xia JY, 2003, ENVIRON ENTOMOL, V32, P151, DOI 10.1603/0046-225X-32.1.151	55	16	16	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56394	10.1371/journal.pone.0056394	http://dx.doi.org/10.1371/journal.pone.0056394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431373	Green Submitted, Green Published, gold			2022-12-27	WOS:000315182800015
J	Radke, J; Bortolussi, G; Pagenstecher, A				Radke, Josefine; Bortolussi, Ginette; Pagenstecher, Axel			Akt and c-Myc Induce Stem-Cell Markers in Mature Primary p53(-/-) Astrocytes and Render These Cells Gliomagenic in the Brain of Immunocompetent Mice	PLOS ONE			English	Article							IN-VITRO; GLIOBLASTOMA-MULTIFORME; ANAPLASTIC ASTROCYTOMA; PATHWAY ACTIVATION; SELF-RENEWAL; MOUSE MODELS; P53; CANCER; EXPRESSION; DIFFERENTIATION	Astrocytomas and their most malignant variant glioblastoma multiforme (GBM) represent the vast majority of primary brain tumors. Despite the current progress in neurosurgery, radiation therapy and chemotherapy, most astrocytomas remain fatal disorders. Although brain tumor biology is a matter of intense research, the cell-of-origin and the complete astrocytoma-inducing signaling pathway remain unknown. To further identify the mechanisms leading to gliomagenesis, we transduced primary astrocytes on a p53(-/-) background with c-Myc, constitutively active myr-Akt or both, myr-Akt and c-Myc. Transduced astrocytes showed oncogene-specific alterations of morphology, proliferation and differentiation. Following prolonged periods of cultivation, oncogene-transduced astrocytes expressed several stem-cell markers. Furthermore, astrocytes coexpressing c-Myc and Akt were tumorigenic when implanted into the brain of immunocompetent C57BL/6 mice. Our results reveal that the loss of p53 combined with oncogene overexpression in mature astrocytes simulates pivotal features of glioma pathogenesis, providing a good model for assessing the development of secondary glioblastomas.	[Radke, Josefine; Bortolussi, Ginette; Pagenstecher, Axel] Univ Marburg, Dept Neuropathol, Marburg, Germany	Philipps University Marburg	Pagenstecher, A (corresponding author), Univ Marburg, Dept Neuropathol, Marburg, Germany.	pagenste@med.uni-marburg.de	Radke, Josefine/GQH-8274-2022	Radke, Josefine/0000-0001-9860-2007; Pagenstecher, Axel/0000-0001-9627-6439	University Hospital (UKGM); University of Marburg	University Hospital (UKGM); University of Marburg	This study was funded by an in-house grant according to the cooperation agreement between the University Hospital (UKGM) and the University of Marburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff GEM, 2010, AM J PATHOL, V177, P840, DOI 10.2353/ajpath.2010.090918; Bello MJ, 2006, CANCER GENET CYTOGEN, V164, P172, DOI 10.1016/j.cancergencyto.2005.07.002; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bogler O, 1999, CELL GROWTH DIFFER, V10, P73; BOGLER O, 1995, CANCER RES, V55, P2746; Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Bourseau-Guilmain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025515; CBTRUS, 2012, STAT REP PRIM BRAIN; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Fatoo A, 2011, J NEURO-ONCOL, V103, P397, DOI 10.1007/s11060-010-0406-3; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Fischer U, 2010, INT J CANCER, V126, P2594, DOI 10.1002/ijc.24971; Friedl G, 2004, J VIROL, V78, P1212, DOI 10.1128/JVI.78.3.1212-1218.2004; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Hadjipanayis CG, 2009, TRENDS MOL MED, V15, P519, DOI 10.1016/j.molmed.2009.09.003; Hambardzumyan D, 2011, GLIA, V59, P1155, DOI 10.1002/glia.21142; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Jao SW, 2012, ANN SURG ONCOL, V19, P3432, DOI 10.1245/s10434-012-2394-3; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Ke RH, 2009, NEUROSCI RES, V65, P280, DOI 10.1016/j.neures.2009.08.002; Kim YH, 2011, BRAIN PATHOL, V21, P645, DOI 10.1111/j.1750-3639.2011.00492.x; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Ksendzovsky A, 2009, J NEURO-ONCOL, V93, P107, DOI 10.1007/s11060-009-9884-6; Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249; Lee JS, 2008, BIOCHEM BIOPH RES CO, V365, P496, DOI 10.1016/j.bbrc.2007.11.005; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Moliterno JA, 2012, CANCER J, V18, P20, DOI 10.1097/PPO.0b013e3183243f6e3; Munoz DM, 2011, ONCOTARGET, V2, P590; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nozaki M, 1999, Neuro Oncol, V1, P124, DOI 10.1093/neuonc/1.2.124; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Ruano Y, 2008, CANCER-AM CANCER SOC, V112, P1575, DOI 10.1002/cncr.23338; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schmidt KF, 2004, J NEURO-ONCOL, V68, P207, DOI 10.1023/B:NEON.0000033364.43142.bf; Siebzehnrubl FA, 2011, GLIA, V59, P1135, DOI 10.1002/glia.21143; Sonoda Y, 2001, CANCER RES, V61, P4956; Sonoda Y, 2001, CANCER RES, V61, P6674; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Stalder A K, 1999, Methods Mol Med, V22, P53, DOI 10.1385/0-89603-612-X:53; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tabatabai G, 2011, CELL TISSUE RES, V343, P459, DOI 10.1007/s00441-010-1123-0; Varley JM, 1997, BRIT J CANCER, V76, P1, DOI 10.1038/bjc.1997.328; Vetter M, 2009, J NEUROPATH EXP NEUR, V68, P525, DOI 10.1097/NEN.0b013e3181a2afa0; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang YY, 2012, J NEURO-ONCOL, V106, P217, DOI 10.1007/s11060-011-0679-1; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Weller M, 2012, CANCER J, V18, P40, DOI 10.1097/PPO.0b013e318243f6c9; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; YAHANDA AM, 1995, MOL CELL BIOL, V15, P4249; Zheng H, 2008, COLD SH Q B, V73, P427, DOI 10.1101/sqb.2008.73.047; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	60	28	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56691	10.1371/journal.pone.0056691	http://dx.doi.org/10.1371/journal.pone.0056691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424671	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100059
J	Aridgides, D; Salvador, R; PereiraPerrin, M				Aridgides, Daniel; Salvador, Ryan; PereiraPerrin, Mercio			Cardiomyocyte Death by Activating Nerve Growth Factor Receptor TrkA	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; TRANS-SIALIDASE; CARDIAC FIBROBLASTS; NEUROTROPHIC FACTOR; IN-VITRO; CELLS; DIFFERENTIATION; IDENTIFICATION; SURVIVAL; ANGIOGENESIS	Rationale: Cardiomyocytes neurotrophin receptor TrkA that promotes survival following nerve growth factor (NGF) ligation. Whether TrkA also resides in cardiac fibroblasts (CFs) and underlies cardioprotection is unknown. Objective: To test whether CFs express TrkA that conveys paracrine signals to neighbor cardiomyocytes using, as probe, the Chagas disease parasite Trypanosoma cruzi, which expresses a TrkA-binding neurotrophin mimetic, named PDNF. T cruzi targets the heart, causing chronic debilitating cardiomyopathy in, similar to 30% patients. Methods and Results: Basal levels of TrkA and TrkC in primary CFs are comparable to those in cardiomyocytes. However, in the myocardium, TrkA expression is significantly lower in fibroblasts than myocytes, and vice versa for TrkC. Yet T cruzi recognition of TrkA on fibroblasts, preferentially over cardiomyocytes, triggers a sharp and sustained increase in NGF, including in the heart of infected mice or of mice administered PDNF intravenously, as early as 3-h post-administration. Further, NGF-containing T cruzi-or PDNF-induced fibroblast-conditioned medium averts cardiomyocyte damage by H2O2, in agreement with the previously recognized cardioprotective role of NGF. Conclusions: TrkA residing in CFs induces an exuberant NGF production in response to T cruzi infection, enabling, in a paracrine fashion, myocytes to resist oxidative stress, a leading Chagas cardiomyopathy trigger. Thus, PDNF-TrkA interaction on CFs may be a mechanism orchestrated by T cruzi to protect its heart habitat, in concert with the long-term (decades) asymptomatic heart parasitism that characterizes Chagas disease. Moreover, as a potent booster of cardioprotective NGF in vivo, PDNF may offer a novel therapeutic opportunity against cardiomyopathies.	[Aridgides, Daniel; Salvador, Ryan; PereiraPerrin, Mercio] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA; [Aridgides, Daniel; Salvador, Ryan; PereiraPerrin, Mercio] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts University; Tufts University	PereiraPerrin, M (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA.	Mercio.perrin@tufts.edu			NIH [NS40574, NS42960]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042960, R01NS040574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS40574 and NS42960. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; BASHEY RI, 1992, J MOL CELL CARDIOL, V24, P691, DOI 10.1016/0022-2828(92)93383-U; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Cai DQ, 2006, PHYSIOL GENOMICS, V24, P191, DOI 10.1152/physiolgenomics.00165.2005; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Caradonna K, 2009, INFECT IMMUN, V77, P1349, DOI 10.1128/IAI.01434-08; Chuenkova M, 1999, BIOCHEM BIOPH RES CO, V262, P549, DOI 10.1006/bbrc.1999.1154; Chuenkova MV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000374; Chuenkova MV, 2004, J NEUROCHEM, V91, P385, DOI 10.1111/j.1471-4159.2004.02724.x; Chuenkova MV, 2005, BIOCHEMISTRY-US, V44, P15685, DOI 10.1021/bi0512039; Chuenkova MV, 2000, MOL BIOL CELL, V11, P1487, DOI 10.1091/mbc.11.4.1487; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; de Melo-Jorge M, 2007, CELL HOST MICROBE, V1, P251, DOI 10.1016/j.chom.2007.05.006; Donovan MJ, 1996, NAT GENET, V14, P210, DOI 10.1038/ng1096-210; EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ieda M, 2006, CIRCULATION, V114, P2351, DOI 10.1161/CIRCULATIONAHA.106.627588; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kane NM, 2012, STEM CELLS, V30, P643, DOI 10.1002/stem.1026; KATWA LC, 1993, CARDIOVASC RES, V27, P2125, DOI 10.1093/cvr/27.12.2125; Kawaguchi-Manabe H, 2007, LIFE SCI, V81, P385, DOI 10.1016/j.lfs.2007.05.024; Manque PA, 2011, INFECT IMMUN, V79, P1855, DOI 10.1128/IAI.00643-10; Martinelli PM, 2006, AUTON NEUROSCI-BASIC, V130, P32, DOI 10.1016/j.autneu.2006.05.004; Meloni M, 2012, DIABETES, V61, P229, DOI 10.2337/db11-0763; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Ottaviano FG, 2011, J CARDIOVASC PHARM, V57, P513, DOI 10.1097/FJC.0b013e31821209ee; PEREIRA MEA, 1983, SCIENCE, V219, P1444, DOI 10.1126/science.6338592; PEREIRA MEA, 1991, J EXP MED, V174, P179, DOI 10.1084/jem.174.1.179; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567; SCUDDER P, 1993, J BIOL CHEM, V268, P9886; Skaper S, 2001, METHODS MOL BIOL, V846, P1; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Weinkauf C, 2009, INFECT IMMUN, V77, P1368, DOI 10.1128/IAI.01450-08; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	50	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57450	10.1371/journal.pone.0057450	http://dx.doi.org/10.1371/journal.pone.0057450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437390	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000104
J	Chan, AA; Hertsenberg, AJ; Funderburgh, ML; Mann, MM; Du, YQ; Davoli, KA; Mich-Basso, JD; Yang, L; Funderburgh, JL				Chan, Audrey A.; Hertsenberg, Andrew J.; Funderburgh, Martha L.; Mann, Mary M.; Du, Yiqin; Davoli, Katherine A.; Mich-Basso, Jocelyn Danielle; Yang, Lei; Funderburgh, James L.			Differentiation of Human Embryonic Stem Cells into Cells with Corneal Keratocyte Phenotype	PLOS ONE			English	Article							NEURAL CREST CELLS; IN-VITRO; KERATAN SULFATE; COLLAGEN LAMELLAE; PROGENITOR CELLS; EXPRESSION; TISSUE; STROMA; FIBROBLASTS; GENERATION	Corneal transparency depends on a unique extracellular matrix secreted by stromal keratocytes, mesenchymal cells of neural crest lineage. Derivation of keratocytes from human embryonic stem (hES) cells could elucidate the keratocyte developmental pathway and open a potential for cell-based therapy for corneal blindness. This study seeks to identify conditions inducing differentiation of pluripotent hES cells to the keratocyte lineage. Neural differentiation of hES cell line WA01(H1) was induced by co-culture with mouse PA6 fibroblasts. After 6 days of co-culture, hES cells expressing cell-surface NGFR protein (CD271, p75NTR) were isolated by immunoaffinity adsorption, and cultured as a monolayer for one week. Keratocyte phenotype was induced by substratum-independent pellet culture in serum-free medium containing ascorbate. Gene expression, examined by quantitative RT-PCR, found hES cells co-cultured with PA6 cells for 6 days to upregulate expression of neural crest genes including NGFR, SNAI1, NTRK3, SOX9, and MSX1. Isolated NGFR-expressing cells were free of PA6 feeder cells. After expansion as a monolayer, mRNAs typifying adult stromal stem cells were detected, including BMI1, KIT, NES, NOTCH1, and SIX2. When these cells were cultured as substratum-free pellets keratocyte markers AQP1, B3GNT7, PTDGS, and ALDH3A1 were upregulated. mRNA for keratocan (KERA), a cornea-specific proteoglycan, was upregulated more than 10,000 fold. Culture medium from pellets contained high molecular weight keratocan modified with keratan sulfate, a unique molecular component of corneal stroma. These results show hES cells can be induced to differentiate into keratocytes in vitro. Pluripotent stem cells, therefore, may provide a renewable source of material for development of treatment of corneal stromal opacities.	[Chan, Audrey A.; Hertsenberg, Andrew J.; Funderburgh, Martha L.; Mann, Mary M.; Du, Yiqin; Davoli, Katherine A.; Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Mich-Basso, Jocelyn Danielle; Yang, Lei] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Funderburgh, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	jlfunder@pitt.edu	DU, YIQIN/AAO-1566-2020; Yang, Lei/D-7462-2015; Du, Yiqin/A-7727-2018	DU, YIQIN/0000-0002-4330-0957; Hertsenberg, Andrew/0000-0002-9058-1595; Davoli, Katherine/0000-0001-7681-245X	National Institutes of Health [EY016415, EY009368, P30-EY008098]; Research to Prevent Blindness Inc; Eye and Ear Foundation of Pittsburgh; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009368, P30EY008098, R01EY016415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Inc(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grants EY016415 (JLF), EY009368 (JLF), P30-EY008098, Research to Prevent Blindness Inc, and the Eye and Ear Foundation of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2012, CELL BIOL INT, V36, P927, DOI 10.1042/CBI20110506; Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Cox G, 2012, BONE, V50, P510, DOI 10.1016/j.bone.2011.07.016; Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764, DOI 10.1177/039139880302600810; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2007, INVEST OPHTH VIS SCI, V48, P5038, DOI 10.1167/iovs.07-0587; Du YQ, 2012, INVEST OPHTH VIS SCI, V53, P1566, DOI 10.1167/iovs.11-9134; Du YQ, 2010, MOL VIS, V16, P2680; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Funderburgh ML, 2008, MOL VIS, V14, P308; Funderburgh ML, 2005, FASEB J, V19, P1371, DOI 10.1096/fj.04-2770fje; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Lambiase A, 2005, P NATL ACAD SCI USA, V102, P16795, DOI 10.1073/pnas.0508516102; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Liu H, 2011, J CELL MOL MED; Long CJ, 2000, J BIOL CHEM, V275, P13918, DOI 10.1074/jbc.275.18.13918; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657; Pinnamaneni N, 2012, STEM CELLS; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Qi H, 2008, EXP EYE RES, V86, P34, DOI 10.1016/j.exer.2007.09.003; Qi H, 2007, MOL VIS, V13, P1934; Ren SW, 2010, MOL VIS, V16, P1076; Roh DS, 2011, INVEST OPHTH VIS SCI, V52, P5174, DOI 10.1167/iovs.11-7272; Torbet J, 2007, P ANN INT IEEE EMBS, P6400; Turksen K, 2006, HUMAN EMBRYONIC STEM; Vaculik C, 2012, J INVEST DERMATOL, V132, P563, DOI 10.1038/jid.2011.355; Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599; Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055	35	66	69	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56831	10.1371/journal.pone.0056831	http://dx.doi.org/10.1371/journal.pone.0056831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437251	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000315186000051
J	Cillo, U; Vitale, A; Dupuis, D; Corso, S; Neri, D; D'Amico, F; Gringeri, E; Farinati, F; Vincenzi, V; Zanus, G				Cillo, Umberto; Vitale, Alessandro; Dupuis, Davide; Corso, Stefano; Neri, Daniele; D'Amico, Francesco; Gringeri, Enrico; Farinati, Fabio; Vincenzi, Valter; Zanus, Giacomo			Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; MICROWAVE COAGULATION; LOCAL RECURRENCE; MILAN CRITERIA; TRANSPLANTATION; CHEMOEMBOLIZATION; SURVIVAL; THERAPY; TUMORS; HCC	The aim of this study was to demonstrate the safety and efficacy of laparoscopic ablation for cirrhotic HCC patients. Between January 2004 and December 2009, laparoscopic ablation was applied prospectively in 169 consecutive HCC patients (median age 62 years, 43% hepatitis C positive) considered ineligible for liver resection and/or percutaneous ablation. There was clinically relevant portal hypertension in 72% of cases. A significant proportion of subjects (50%) had multinodular tumors or nodules larger than 25 mm. The main ablation techniques used were radiofrequency in 103 patients (61%), microwave ablation in 8 (5%), and ethanol injection in 58 (34%). The primary endpoint was 3-year survival. There was no perioperative mortality. The overall morbidity rate was 25%. The median postoperative hospital stay was 3 days (range 1-19 days). Patients survived a median 33 months with a 3-year survival rate of 47%. Cox's multivariate analysis identified patient age, presence of diabetes, albumin <= 37 g/l, and alpha-fetoprotein >400 mu g/l as significant preoperative predictors of survival, while the chance to undergo liver transplantation and postoperative ascites were the only independent postoperative predictor of survival. Laparoscopic ablation is a safe and effective therapeutic option for selected HCC patients ineligible for liver resection and/or percutaneous ablation.	[Cillo, Umberto; Vitale, Alessandro; Dupuis, Davide; Corso, Stefano; Neri, Daniele; D'Amico, Francesco; Gringeri, Enrico; Zanus, Giacomo] Univ Padua, Azienda Osped, Unita Chirurg Epatobiliare & Trapianto Epat, Padua, Italy; [Farinati, Fabio] Univ Padua, Azienda Osped, Div Gastroenterol, Padua, Italy; [Vincenzi, Valter] Osped San Martino, Unita Med Gen, Belluno, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; ULSS 1 Dolomiti; Ospedale di Belluno	Vitale, A (corresponding author), Univ Padua, Azienda Osped, Unita Chirurg Epatobiliare & Trapianto Epat, Padua, Italy.	alessandro.vitale@unipd.it	Farinati, Fabio/A-8267-2012; Gringeri, Enrico/K-4199-2018; GRINGERI, ENRICO/AAB-9315-2019; Cillo, Umberto/AAC-2591-2019; Vitale, Alessandro/AAA-9182-2021; Zanus, Giacomo/AIB-1093-2022	Farinati, Fabio/0000-0002-2944-1374; GRINGERI, ENRICO/0000-0002-3459-7306; Cillo, Umberto/0000-0002-2310-0245; Vitale, Alessandro/0000-0002-4548-8308				Asahina Y, 2009, DIGEST ENDOSC, V21, P67, DOI 10.1111/j.1443-1661.2009.00844.x; Ballem N, 2008, HPB, V10, P315, DOI 10.1080/13651820802247102; Belghiti J, 2009, J GASTROENTEROL, V44, P132, DOI 10.1007/s00535-008-2250-1; Belli G, 2007, SURG LAPARO ENDO PER, V17, P331, DOI 10.1097/SLE.0b013e31806d9c65; Berber E, 2007, SURG ENDOSC, V21, P613, DOI 10.1007/s00464-006-9139-y; Berber E, 2008, ANN SURG ONCOL, V15, P2757, DOI 10.1245/s10434-008-0043-7; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Buell JF, 2008, ANN SURG, V248, P475, DOI 10.1097/SLA.0b013e318185e647; Casaccia M, 2008, J LAPAROENDOSC ADV S, V18, P797, DOI 10.1089/lap.2008.0039; Cassera MA, 2011, SURG ENDOSC, V25, P1088, DOI 10.1007/s00464-010-1322-5; Cillo U, 2007, AM J TRANSPLANT, V7, P972, DOI 10.1111/j.1600-6143.2006.01719.x; Golfieri R, 2011, HEPATOLOGY, V53, P1580, DOI 10.1002/hep.24246; Ho MC, 2009, ANN SURG ONCOL, V16, P848, DOI 10.1245/s10434-008-0282-7; Hsieh CB, 2004, WORLD J GASTROENTERO, V10, P505, DOI 10.3748/wjg.v10.i4.505; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Kawamoto C, 2005, CANCER-AM CANCER SOC, V103, P985, DOI 10.1002/cncr.20880; Kurokohchi K, 2008, WORLD J GASTROENTERO, V14, P2037, DOI 10.3748/wjg.14.2037; Lam VWT, 2008, J AM COLL SURGEONS, V207, P20, DOI 10.1016/j.jamcollsurg.2008.01.020; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Minami Y, 2010, WORLD J RADIOL, V2, P417, DOI 10.4329/wjr.v2.i11.417; Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217; N'Kontchou G, 2012, J HEPATOL, V56, P160, DOI 10.1016/j.jhep.2011.03.026; Pelletier SJ, 2009, LIVER TRANSPLANT, V15, P859, DOI 10.1002/lt.21778; Perrone F, 2000, HEPATOLOGY, V31, P840; Ramsey DE, 2002, J VASC INTERV RADIOL, V13, pS211, DOI 10.1016/S1051-0443(07)61789-8; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Santambrogio R, 2003, SURG ENDOSC, V17, P1826, DOI 10.1007/s00464-002-8960-1; Santambrogio R, 2009, ANN SURG ONCOL, V16, P3289, DOI 10.1245/s10434-009-0678-z; Seki S, 2005, ENDOSCOPY, V37, P1220, DOI 10.1055/s-2005-921035; Tanaka S, 2009, HEPATO-GASTROENTEROL, V56, P1169; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Tesche LJ, 2010, SURG LAPARO ENDO PER, V20, P404, DOI 10.1097/SLE.0b013e3181fd619b; Vitale A, 2011, LANCET ONCOL, V12, P654, DOI 10.1016/S1470-2045(11)70144-9; Vitale A, 2010, ANN SURG ONCOL, V17, P2290, DOI 10.1245/s10434-010-0993-4; Volk ML, 2008, AM J TRANSPLANT, V8, P839, DOI 10.1111/j.1600-6143.2007.02138.x	40	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57249	10.1371/journal.pone.0057249	http://dx.doi.org/10.1371/journal.pone.0057249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437351	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000091
J	Zhang, Y; Lu, TL; Yan, H; Ruan, YY; Wang, LF; Zhang, D; Yue, WH; Lu, L				Zhang, Yang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Wang, Lifang; Zhang, Dai; Yue, Weihua; Lu, Lin			Replication of Association between Schizophrenia and Chromosome 6p21-6p22.1 Polymorphisms in Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY GENE; JAPANESE PATIENTS; LINKAGE ANALYSES; COMMON VARIANTS; SCAN DOMAIN; LOCUS; 6P; RISK; HLA	Chromosome 6p21-p22.1, spanning the extended major histocompatibility complex (MHC) region, is a highly polymorphic, gene-dense region. It has been identified as a susceptibility locus of schizophrenia in Europeans, Japanese, and Chinese. In our previous two-stage genome-wide association study (GWAS), polymorphisms of zinc finger with KRAB and SCAN domains 4 (ZKSCAN4), nuclear factor-kappa B-activating protein-like (NKAPL), and piggyBac transposable element derived 1 (PGBD1), localized to chromosome 6p21-p22.1, were strongly associated with schizophrenia. To further investigate the association between polymorphisms at this locus and schizophrenia in the Chinese Han population, we selected eight other single-nucleotide polymorphisms (SNPs) distributed in or near these genes for a case-control association study in an independent sample of 902 cases and 1,091 healthy controls in an attempt to replicate the GWAS results. Four of these eight SNPs (rs12214383, rs1150724, rs3800324, and rs1997660) displayed a nominal difference in allele frequencies between the case and control groups. The association between two of these SNPs and schizophrenia were significant even after Bonferroni correction (rs12000: allele A. G, P = 2.50E-04, odds ratio [OR] = 1.27, 95% confidence interval [CI] = 1.12-1.45; rs1150722: allele C. T, P = 4.28E-05, OR = 0.55, 95% CI = 0.41-0.73). Haplotype ATTGACGC, comprising these eight SNPs (rs2235359, rs2185955, rs12214383, rs12000, rs1150724, rs1150722, rs3800324, and rs1997660), was significantly associated with schizophrenia (P = 6.60E-05). We also performed a combined study of this replication sample and the first-stage GWAS sample. The combined study revealed that rs12000 and rs1150722 were still strongly associated with schizophrenia (rs12000: allele G. A, P-combined = 0.0019, OR = 0.81; rs1150722: allele G. A, P-combined = 3.00E-04, OR = 0.61). These results support our findings that locus 6p21-p22.1 is significantly associated with schizophrenia in the Chinese Han population and encourage further studies of the functions of these genetic factors.	[Zhang, Yang; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Zhang, Yang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Zhang, Yang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Key Lab Mental Hlth, Minist Hlth, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Yue, WH (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	dryue@bjmu.edu.cn; linlu@bjmu.edu.cn	Yan, Hao/U-1330-2017	Yan, Hao/0000-0003-0376-9037; Zhang, Yang/0000-0001-6898-346X	National Natural Science Foundation of China [81071087, 81071088]; International Science & Technology Cooperation Program of China [2010DFB30820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by grants from the National Natural Science Foundation of China (81071087 and 81071088; http://www.nsfc.gov.cn/) and International Science & Technology Cooperation Program of China (2010DFB30820; http://www.istcp.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 2011, BIOL PSYCHIAT, V70, P696, DOI 10.1016/j.biopsych.2011.02.034; Alkelai A, 2012, INT J NEUROPSYCHOPH, V15, P459, DOI 10.1017/S1461145711000903; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Belbin O, 2011, HUM GENET, V129, P273, DOI 10.1007/s00439-010-0924-2; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Czerski PM, 2008, NEUROPSYCHOBIOLOGY, V57, P88, DOI 10.1159/000135642; Daniels JK, 1997, AM J MED GENET, V74, P319, DOI 10.1002/(SICI)1096-8628(19970531)74:3<319::AID-AJMG14>3.0.CO;2-R; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Garner C, 1996, AM J MED GENET, V67, P595, DOI 10.1002/(SICI)1096-8628(19961122)67:6<595::AID-AJMG12>3.3.CO;2-D; Gibson S, 1999, AM J MED GENET, V88, P416, DOI 10.1002/(SICI)1096-8628(19990820)88:4<416::AID-AJMG21>3.0.CO;2-S; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hsu FC, 2011, J EXP MED, V208, P1291, DOI 10.1084/jem.20101874; Ikeda M, 2013, MOL PSYCHIATR, V18, P636, DOI 10.1038/mp.2012.74; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Ivanov D, 2005, MOL CELL, V17, P137, DOI 10.1016/j.molcel.2004.12.015; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Kim JJ, 2008, EUR ARCH PSY CLIN N, V258, P239, DOI 10.1007/s00406-007-0791-6; Kitazawa M, 2012, AM J MED GENET B, V159B, P456, DOI 10.1002/ajmg.b.32049; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li T, 2005, MOL PSYCHIATR, V10, P1037, DOI 10.1038/sj.mp.4001718; Li T, 2010, BIOL PSYCHIAT, V68, P671, DOI 10.1016/j.biopsych.2010.06.014; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Ma L, 2013, MOL PSYCHIATR, V18, P638, DOI 10.1038/mp.2012.63; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsumoto S, 2002, AM J MED GENET, V114, P42, DOI 10.1002/ajmg.1629; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Morar B, 2007, AM J MED GENET B, V144B, P318, DOI 10.1002/ajmg.b.30451; Mowry BJ, 2012, MOL PSYCHIAT; Pae CU, 2009, NEUROPSYCHOBIOLOGY, V59, P135, DOI 10.1159/000218075; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Peterson FC, 2006, J MOL BIOL, V363, P137, DOI 10.1016/j.jmb.2006.07.063; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Riley BP, 1996, PSYCHIATR GENET, V6, P41, DOI 10.1097/00041444-199622000-00003; Rogers DP, 2009, EXPERT REV NEUROTHER, V9, P47, DOI 10.1586/14737175.9.1.47; Roig B, 2007, MOL PSYCHIATR, V12, P833, DOI 10.1038/sj.mp.4001995; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Shao LS, 2011, P NATL ACAD SCI USA, V108, P18831, DOI 10.1073/pnas.1114569108; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shirts BH, 2007, SCHIZOPHR RES, V94, P342, DOI 10.1016/j.schres.2007.04.021; Singh B, 2011, PSYCHIAT RES, V189, P215, DOI 10.1016/j.psychres.2011.03.010; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Tochigi M, 2007, AM J MED GENET B, V144B, P305, DOI 10.1002/ajmg.b.30441; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	52	82	89	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56732	10.1371/journal.pone.0056732	http://dx.doi.org/10.1371/journal.pone.0056732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437227	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000041
J	Kenny, LC; Lavender, T; McNamee, R; O'Neill, SM; Mills, T; Khashan, AS				Kenny, Louise C.; Lavender, Tina; McNamee, Roseanne; O'Neill, Sinead M.; Mills, Tracey; Khashan, Ali S.			Advanced Maternal Age and Adverse Pregnancy Outcome: Evidence from a Large Contemporary Cohort	PLOS ONE			English	Article							CESAREAN-SECTION RATES; DELAYED CHILDBEARING; FETAL-DEATH; STILLBIRTH; RISK; POPULATION; WOMEN; IMPACT; OLDER	Background: Recent decades have witnessed an increase in mean maternal age at childbirth in most high-resourced countries. Advanced maternal age has been associated with several adverse maternal and perinatal outcomes. Although there are many studies on this topic, data from large contemporary population-based cohorts that controls for demographic variables known to influence perinatal outcomes is limited. Methods: We performed a population-based cohort study using data on all singleton births in 2004-2008 from the North Western Perinatal Survey based at The University of Manchester, UK. We compared pregnancy outcomes in women aged 30-34, 35-39 and >= 40 years with women aged 20-29 years using log-linear binomial regression. Models were adjusted for parity, ethnicity, social deprivation score and body mass index. Results: The final study cohort consisted of 215,344 births; 122,307 mothers (54.19%) were aged 20-29 years, 62,371(27.63%) were aged 30-34 years, 33,966(15.05%) were aged 35-39 years and 7,066(3.13%) were aged >= 40 years. Women aged 40+ at delivery were at increased risk of stillbirth (RR = 1.83, [95% CI 1.37-2.43]), pre-term (RR = 1.25, [95% CI: 1.14-1.36]) and very pre-term birth (RR = 1.29, [95% CI: 1.08-1.55]), Macrosomia (RR = 1.31, [95% CI: 1.12-1.54]), extremely large for gestational age (RR = 1.40, [95% CI: 1.25-1.58]) and Caesarean delivery (RR = 1.83, [95% CI: 1.77-1.90]). Conclusions: Advanced maternal age is associated with a range of adverse pregnancy outcomes. These risks are independent of parity and remain after adjusting for the ameliorating effects of higher socioeconomic status. The data from this large contemporary cohort will be of interest to healthcare providers and women and will facilitate evidence based counselling of older expectant mothers.	[Kenny, Louise C.; Khashan, Ali S.] Cork Univ, Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol,Anu Res Ctr, Cork, Ireland; [Lavender, Tina; Mills, Tracey] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [McNamee, Roseanne] Univ Manchester, Biostat Grp, Sch Community Based Med, Manchester, Lancs, England; [O'Neill, Sinead M.] Cork Univ, Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol,Anu Res Ctr,NPEC, Cork, Ireland; [Khashan, Ali S.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England	University College Cork; University of Manchester; University of Manchester; University College Cork; University of Manchester	Khashan, AS (corresponding author), Cork Univ, Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol,Anu Res Ctr, Cork, Ireland.	a.khashan@ucc.ie	Mills, Tracey A/F-6748-2014; Kenny, Louise/X-6329-2019; Lavender, Tina/B-1211-2011; Kenny, Louise C/G-1112-2011	Mills, Tracey A/0000-0002-2183-7999; Kenny, Louise/0000-0002-9011-759X; Lavender, Tina/0000-0003-1473-4956; Kenny, Louise C/0000-0002-9011-759X; O Neill, Sinead/0000-0001-9787-4609				ALES KL, 1990, SURG GYNECOL OBSTET, V171, P209; Aliyu MH, 2008, ARCH GYNECOL OBSTET, V278, P39, DOI 10.1007/s00404-007-0529-8; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; [Anonymous], NATL VITAL STAT REPO; Bahtiyar MO, 2008, AM J PERINAT, V25, P301, DOI 10.1055/s-2008-1076605; Bell JS, 2001, BRIT MED J, V322, P894, DOI 10.1136/bmj.322.7291.894; BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P659, DOI 10.1056/NEJM199003083221004; Carolan M, 2003, JOGNN-J OBST GYN NEO, V32, P19, DOI 10.1177/0884217502239797; Carolan M, 2011, MIDWIFERY, V27, P793, DOI 10.1016/j.midw.2010.07.006; Chan BCP, 2008, INT J GYNECOL OBSTET, V102, P237, DOI 10.1016/j.ijgo.2008.05.004; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; CNATTINGIUS S, 1992, Journal of the American Medical Association, V268, P886, DOI 10.1001/jama.268.7.886; Delbaere I, 2007, EUR J OBSTET GYN R B, V135, P41, DOI 10.1016/j.ejogrb.2006.10.030; European Commission, FERT STAT; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Hoffman MC, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.862; Huang L, 2008, CAN MED ASSOC J, V178, P165, DOI 10.1503/cmaj.070150; Janssens S, 2008, AUST NZ J OBSTET GYN, V48, P564, DOI 10.1111/j.1479-828X.2008.00920.x; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; Khashan AS, 2009, EUR J EPIDEMIOL, V24, P697, DOI 10.1007/s10654-009-9375-2; Khashan AS, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-36; Martin JA, 2011, NATL VITAL STAT REPO, V60; Mathews T, 2002, NATL VITAL STAT REPO, V50; O'Leary CM, 2007, PAEDIATR PERINAT EP, V21, P541, DOI 10.1111/j.1365-3016.2007.00849.x; Office for National Statistics, 2011, FREQ ASK QUEST BIRTH; Office of the deputy Prime Minsiter, 2004, ENGL IND DEPR; Silver RM, 2007, OBSTET GYNECOL, V109, P153, DOI 10.1097/01.AOG.0000248537.89739.96; Wang Y, 2011, ARCH GYNECOL OBSTET, V284, P31, DOI 10.1007/s00404-010-1587-x; Wildschut HIJ, 1999, HIGH RISK PREGNANCY, P39	31	313	329	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56583	10.1371/journal.pone.0056583	http://dx.doi.org/10.1371/journal.pone.0056583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437176	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200112
J	Kim, J; Heindl, JE; Fuqua, C				Kim, Jinwoo; Heindl, Jason E.; Fuqua, Clay			Coordination of Division and Development Influences Complex Multicellular Behavior in Agrobacterium tumefaciens	PLOS ONE			English	Article							BACTERIAL RESPONSE REGULATOR; CELL-CYCLE REGULATION; RHIZOBIUM-MELILOTI; HISTIDINE KINASES; BIOFILM FORMATION; TI PLASMID; PROTEINS; TRANSFORMATION; MUTANTS; LOCALIZATION	The alpha-Proteobacterium Agrobacterium tumefaciens has proteins homologous to known regulators that govern cell division and development in Caulobacter crescentus, many of which are also conserved among diverse alpha-Proteobacteria. In light of recent work demonstrating similarity between the division cycle of C. crescentus and that of A. tumefaciens, the functional conservation for this presumptive control pathway was examined. In C. crescentus the CtrA response regulator serves as the master regulator of cell cycle progression and cell division. CtrA activity is controlled by an integrated pair of multi-component phosphorelays: PleC/DivJ-DivK and CckA-ChpT-CtrA. Although several of the conserved orthologues appear to be essential in A. tumefaciens, deletions in pleC or divK were isolated and resulted in cell division defects, diminished swimming motility, and a decrease in biofilm formation. A. tumefaciens also has two additional pleC/divJ homologue sensor kinases called pdhS1 and pdhS2, absent in C. crescentus. Deletion of pdhS1 phenocopied the Delta pleC and Delta divK mutants. Cells lacking pdhS2 morphologically resembled wild-type bacteria, but were decreased in swimming motility and elevated for biofilm formation, suggesting that pdhS2 may serve to regulate the motile to non-motile switch in A. tumefaciens. Genetic analysis suggests that the PleC/DivJ-DivK and CckA-ChpT-CtrA phosphorelays in A. tumefaciens are vertically-integrated, as in C. crescentus. A gain-of-function mutation in CckA (Y674D) was identified as a spontaneous suppressor of the Delta pleC motility phenotype. Thus, although the core architecture of the A. tumefaciens pathway resembles that of C. crescentus there are specific differences including additional regulators, divergent pathway architecture, and distinct target functions.	[Kim, Jinwoo; Heindl, Jason E.; Fuqua, Clay] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Fuqua, C (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	cfuqua@indiana.edu	Kim, Jinwoo/AAP-8786-2020	Kim, Jinwoo/0000-0003-1104-8088; Heindl, Jason/0000-0003-3919-8045	United States National Institutes of Health (NIH) grant [GM080546]; National Research Foundation of Korea grant [NRF-2007-357-F00002]; Ruth L. Kirschstein National Research Service Award [1 F32 GM100601-01A1]; Indiana University METACyt program; Lilly Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100601, R01GM080546] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH) grant; National Research Foundation of Korea grant(National Research Foundation of Korea); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University METACyt program; Lilly Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by United States National Institutes of Health (NIH) grant GM080546 (CF), National Research Foundation of Korea grant NRF-2007-357-F00002 (JK), Ruth L. Kirschstein National Research Service Award 1 F32 GM100601-01A1 (JEH), and through a grant from the Indiana University METACyt program funded in part by a major endowment from the Lilly Foundation (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; AMEMURA A, 1984, AGR BIOL CHEM TOKYO, V48, P1809, DOI 10.1080/00021369.1984.10866397; ANAND VK, 1977, AM J BOT, V64, P153, DOI 10.2307/2442102; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5; Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09; Chesnokova O, 1997, MOL MICROBIOL, V23, P579, DOI 10.1046/j.1365-2958.1997.d01-1875.x; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DOHERTY D, 1988, J BACTERIOL, V170, P4249, DOI 10.1128/jb.170.9.4249-4256.1988; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Dworkin J, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003368; Dworkin M, 2007, CURR OPIN MICROBIOL, V10, P588, DOI 10.1016/j.mib.2007.10.007; ELY B, 1984, GENETICS, V108, P523; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; FUKUDA A, 1977, J BACTERIOL, V131, P280, DOI 10.1128/JB.131.1.280-287.1977; Gibson KE, 2007, J BACTERIOL, V189, P3591, DOI 10.1128/JB.01834-06; Gibson KE, 2006, J BACTERIOL, V188, P4508, DOI 10.1128/JB.01923-05; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Hallez R, 2004, TRENDS MICROBIOL, V12, P361, DOI 10.1016/j.tim.2004.06.002; Hallez R, 2007, EMBO J, V26, P1444, DOI 10.1038/sj.emboj.7601577; Iniesta AA, 2010, P NATL ACAD SCI USA, V107, P7012, DOI 10.1073/pnas.1001767107; Janakiraman A, 2004, TRENDS MICROBIOL, V12, P518, DOI 10.1016/j.tim.2004.09.003; Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kirkpatrick C. L, 2011, COLD SPRING HARB PER, V3; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MATTHYSSE AG, 1981, J BACTERIOL, V145, P583, DOI 10.1128/JB.145.1.583-595.1981; MAYFIELD CI, 1977, CAN J MICROBIOL, V23, P1311, DOI 10.1139/m77-198; Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07; MERSEREAU M, 1990, GENE, V90, P149, DOI 10.1016/0378-1119(90)90452-W; Mignolet J, 2010, J BACTERIOL, V192, P3235, DOI 10.1128/JB.00066-10; Morton E.R., 2012, CURR PROTOC MICROBIO, V24; Morton Elise R, 2012, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03d02s25; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Pierce DL, 2006, J BACTERIOL, V188, P2473, DOI 10.1128/JB.188.7.2473-2482.2006; Piers KL, 1996, P NATL ACAD SCI USA, V93, P1613, DOI 10.1073/pnas.93.4.1613; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Ramey BE, 2004, MOL MICROBIOL, V52, P1495, DOI 10.1111/j.1365-2958.2004.04079.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; TEMPE J, 1977, P NATL ACAD SCI USA, V74, P2848, DOI 10.1073/pnas.74.7.2848; Tomlinson AD, 2010, MICROBIOL-SGM, V156, P2670, DOI 10.1099/mic.0.039032-0; Tomlinson AD, 2009, CURR OPIN MICROBIOL, V12, P708, DOI 10.1016/j.mib.2009.09.014; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; WATSON B, 1975, J BACTERIOL, V123, P255, DOI 10.1128/JB.123.1.255-264.1975; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; White CE, 2007, PHILOS T R SOC B, V362, P1135, DOI 10.1098/rstb.2007.2040; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443; Xu J, 2012, RES MICROBIOL, V163, P674, DOI 10.1016/j.resmic.2012.10.013; ZEVENHUIZEN LPTM, 1986, A VAN LEEUW J MICROB, V52, P381, DOI 10.1007/BF00393465; Zhang HT, 2011, J IND MICROBIOL BIOT, V38, P667, DOI 10.1007/s10295-010-0810-x	71	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56682	10.1371/journal.pone.0056682	http://dx.doi.org/10.1371/journal.pone.0056682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437210	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200140
J	Spring, KJ; Pham, S; Zufall, RA				Spring, Kevin J.; Pham, Stephanie; Zufall, Rebecca A.			Chromosome Copy Number Variation and Control in the Ciliate Chilodonella uncinata	PLOS ONE			English	Article							STRUCTURAL VARIATION; TUBULIN GENES; EXPRESSION; EVOLUTION; GENOME; DNA; AMPLIFICATION; MICRONUCLEAR; SEGREGATION; PROTEIN	Copy number variations are widespread in eukaryotes. The unusual genome architecture of ciliates, in particular, with its process of amitosis in macronuclear division, provides a valuable model in which to study copy number variation. The current model of amitosis envisions stochastic distribution of macronuclear chromosomes during asexual reproduction. This suggests that amitosis is likely to result in high levels of copy number variation in ciliates, as dividing daughter cells can have variable copy numbers of chromosomes if chromosomal distribution during amitosis is a stochastic process. We examined chromosomal distribution during amitosis in Chilodonella uncinata, a ciliate with gene-size macronuclear chromosomes. We quantified 4 chromosomes in evolving populations of C. uncinata and modeled the amitotic distribution process. We found that macronuclear chromosomes differ in copy number from one another but that copy number does not change as expected under a stochastic process. The chromosome carrying SSU increased in copy number, which is consistent with selection to increase abundance; however, two other studied chromosomes displayed much lower than expected among-line variance. Our models suggest that balancing selection is sufficient to explain the observed maintenance of chromosome copy during asexual reproduction.	[Spring, Kevin J.; Pham, Stephanie; Zufall, Rebecca A.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA	University of Houston System; University of Houston	Spring, KJ (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	kevinjspring@gmail.com			University of Houston GEAR; Sigma Xi	University of Houston GEAR; Sigma Xi	This work was supported in part by the University of Houston GEAR and Sigma Xi Grant-in-Aid of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PS, 2006, REAL TIME PCR, P40; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Auer H, 2008, CYTOGENET GENOME RES, V123, P278, DOI 10.1159/000184718; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2011, LANGUAGE DATA SETS F; BAIRD SE, 1991, J PROTOZOOL, V38, P136, DOI 10.1111/j.1550-7408.1991.tb06033.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bell G., 1988, SEX DEATH PROTOZOA H; Bellec L, 2012, GENE, V504, P303, DOI 10.1016/j.gene.2012.04.067; BLACKBURN EH, 1986, ANNU REV GENET, V20, P501; Canty A, 2012, BOOT BOOTSTRAP R S P; Davison AC, 1997, BOOTSTRAP METHODS TH; Ding CM, 2004, J BIOCHEM MOL BIOL, V37, P1; DOERDER FP, 1992, DEV GENET, V13, P126, DOI 10.1002/dvg.1020130206; Drummond AJ, 2008, GENEIOUS V4 0 4; Duerr HP, 2004, PROTIST, V155, P45, DOI 10.1078/1434461000163; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Force A, 1999, GENETICS, V151, P1531; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Infante JJ, 2003, GENETICS, V165, P1745; Israel RL, 2002, EVOLUTION, V56, P1110; Katz LA, 2003, GENE, V315, P15, DOI 10.1016/j.gene.2003.08.003; Katz LA, 2001, INT J SYST EVOL MICR, V51, P1587, DOI 10.1099/00207713-51-4-1587; KAUFMANN J, 1992, NUCLEIC ACIDS RES, V20, P4445, DOI 10.1093/nar/20.17.4445; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; LATERZA A, 1995, DEV GENET, V17, P272, DOI 10.1002/dvg.1020170312; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Nowacki M, 2010, P NATL ACAD SCI USA, V107, P22140, DOI 10.1073/pnas.1012236107; ORIAS E, 1992, DEV GENET, V13, P87, DOI 10.1002/dvg.1020130114; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; PREER JR, 1976, GENET RES, V27, P227, DOI 10.1017/S0016672300016426; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson T, 2007, MOL BIOL EVOL, V24, P2495, DOI 10.1093/molbev/msm203; Roff DA, 2010, MODELING EVOLUTION I, P223; Rozen S, 2000, Methods Mol Biol, V132, P365; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; SCHENSTED IV, 1958, AM NAT, V92, P161, DOI 10.1086/282023; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Xu K, 2012, GENE, V505, P75, DOI 10.1016/j.gene.2012.05.045; Zufall RA, 2007, J EUKARYOT MICROBIOL, V54, P275, DOI 10.1111/j.1550-7408.2007.00267.x	50	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56413	10.1371/journal.pone.0056413	http://dx.doi.org/10.1371/journal.pone.0056413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437129	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200071
J	Teng, GG; Wang, WH; Dai, Y; Wang, SJ; Chu, YX; Li, J				Teng, Gui-gen; Wang, Wei-hong; Dai, Yun; Wang, Shu-jun; Chu, Yun-xiang; Li, Jiang			Let-7b Is Involved in the Inflammation and Immune Responses Associated with Helicobacter pylori Infection by Targeting Toll-Like Receptor 4	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; NF-KAPPA-B; SIGNALING PATHWAY; GENE-EXPRESSION; MICRORNA FAMILY; CANCER; LIPOPOLYSACCHARIDE; INTERLEUKIN-8; ACTIVATION; INDUCTION	Objectives: Toll-like receptors (TLRs) are important initiators in native immune responses to microbial infections. TLR4 is up-regulated in response to H. pylori infection in gastric epithelial cells. However, the regulatory mechanisms for the expression of TLR4 in H. pylori infection have not been clearly defined. The aims of this study are to present the evidence that microRNA let-7b directly regulates TLR4 expression in human gastric epithelial cells, and subsequently influences the activation of NF-kappa B and the expression of the downstream genes in H. pylori infection. Methods: The expression of let-7b was determined in gastric mucosa specimens and in two gastric epithelial cell lines using quantitative RT-PCR. The expression of TLR4 was determined by immunohistochemistry staining and RT-PCR. The potential target of let-7b was identified by luciferase reporter assay and Western blot. Let-7b mimics and inhibitors were used to examine the effects of let-7b on NF-kappa B activity. The expression of the downstream genes of NF-kappa B was also determined in cells infected with H. pylori 26695. Results: Let-7b was significantly decreased in gastric mucosa specimens and in gastric epithelial cell lines (AGS, GES-1) infected with H. pylori 26695 (cagA+). Let-7b was complementary to the 3'-UTR of TLR4 mRNA and regulated TLR4 expression via post-transcriptional suppression in gastric epithelium. Infection of H. pylori induced the expression of TLR4 and activated NF-kappa B in AGS and GES-1 cells. Overexpression of let-7b by mimics downregulated TLR4, and subsequently attenuated NF-kappa B, MyD88, NF-kappa B1/p50, RelA/p65. The expression of IL-8, COX-2 and CyclinD1 was inhibited in H. pylori infected cells with let-7b overexpression. Both TAK-242 (TLR4 inhibitor) and SN50 (NF-kappa B inhibitor) significantly inhibited the H. pylori induced downregulation of let-7b. Conclusions: Let-7b targets at TLR4 mRNA, and regulates the activation of NF-kappa B and the expression of the downstream genes related to the inflammation and immune responses in H. pylori infection.	[Teng, Gui-gen; Wang, Wei-hong; Dai, Yun; Wang, Shu-jun; Chu, Yun-xiang; Li, Jiang] Peking Univ, Dept Gastroenterol, Hosp 1, Beijing 100871, Peoples R China	Peking University	Wang, WH (corresponding author), Peking Univ, Dept Gastroenterol, Hosp 1, Beijing 100871, Peoples R China.	wangweihong@medmail.com.cn			Beijing Natural Science Foundation [7123232]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by a grant from the Beijing Natural Science Foundation (No. 7123232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Heikham R, 2010, J BIOSCIENCES, V35, P105, DOI 10.1007/s12038-010-0013-7; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda S, 2000, GASTROENTEROLOGY, V119, P97, DOI 10.1053/gast.2000.8540; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Motoyama K, 2008, CLIN CANCER RES, V14, P2334, DOI 10.1158/1078-0432.CCR-07-4667; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pimentel-Nunes P, 2011, PATHOL ONCOL RES, V17, P677, DOI 10.1007/s12253-011-9368-9; Satoh M, 2012, IMMUNOBIOLOGY, V217, P533, DOI 10.1016/j.imbio.2011.08.005; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Sharma SA, 1998, J IMMUNOL, V160, P2401; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Strober W, 2004, NAT MED, V10, P898, DOI 10.1038/nm0904-898; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takenaka R, 2004, MICROBIOL-SGM, V150, P3913, DOI 10.1099/mic.0.27527-0; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; Wang BL, 2006, WORLD J GASTROENTERO, V12, P966, DOI 10.3748/wjg.v12.i6.966; Wang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031240; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883	46	107	114	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56709	10.1371/journal.pone.0056709	http://dx.doi.org/10.1371/journal.pone.0056709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437218	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200148
J	Gadan, K; Sandtro, A; Marjara, IS; Santi, N; Munang'andu, HM; Evensen, O				Gadan, Koestan; Sandtro, Ane; Marjara, Inderjit S.; Santi, Nina; Munang'andu, Hetron M.; Evensen, Oystein			Stress-Induced Reversion to Virulence of Infectious Pancreatic Necrosis Virus in Naive Fry of Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; POLYOMAVIRUS VP1; RAINBOW-TROUT; CARRIER STATE; POST-SMOLTS; CELL-LINE; IN-VITRO; A VIRUS; REPLICATION; IPNV	We have studied stress-induced reversion to virulence of infectious pancreatic necrosis virus (IPNV) in persistently infected Atlantic salmon (Salmo salar L.) fry. Naive fry were persistently infected with a virulent strain (T(217)A(221) of major structural virus protein 2, VP2) or a low virulent (T217T221) variant of IPNV. The fry were infected prior to immunocompetence as documented by lack of recombination activating gene-1, T-cell receptor and B-cell receptor mRNA expression at time of challenge. The fish were followed over 6 months and monitored monthly for presence of virus and viral genome mutations. No mutation was identified in the TA or TT group over the 6 months period post infection. Six months post infection TA and TT infected groups were subject to daily stress for 7 days and then sampled weekly for an additional period of 28 days post stress. Stress-responses were documented by down-regulation of mRNA expression of IFN-alpha 1 and concomitant increase of replication levels of T217T221 infected fish at day 1 post stress. By 28 days post stress a T221A reversion was found in 3 of 6 fish in the T217T221 infected group. Sequencing of reverted isolates showed single nucleotide peaks on chromatograms for residue 221 for all three isolates and no mix of TA and TT strains. Replication fitness of reverted (TA) and non-reverted (TT) variants was studied in vitro under an antiviral state induced by recombinant IFN-alpha 1. The T(217)A(221) reverted variant replicated to levels 23-fold higher than the T217T221 strain in IFN-alpha 1 treated cells. Finally, reverted TA strains were virulent when tested in an in vivo trial in susceptible salmon fry. In conclusion, these results indicate that stress plays a key role in viral replication in vivo and can facilitate conditions that will allow reversion from attenuated virus variants of IPNV.	[Gadan, Koestan; Sandtro, Ane; Marjara, Inderjit S.; Munang'andu, Hetron M.; Evensen, Oystein] Norwegian Sch Vet Sci, Oslo, Norway; [Santi, Nina] Aqua Gen AS, Trondheim, Norway	Norwegian University of Life Sciences	Evensen, O (corresponding author), Norwegian Sch Vet Sci, Oslo, Norway.	oystein.evensen@nvh.no	Munang'andu, Hetron Mweemba/C-5926-2014; Evensen, Øystein/O-3011-2015	Munang'andu, Hetron Mweemba/0000-0002-1021-6396; Evensen, Øystein/0000-0002-4856-3043	Research Council of Norway [172508]; European Union [501984]	Research Council of Norway(Research Council of Norway); European Union(European Commission)	Funding was received from the Research Council of Norway (project number 172508) and the European Union under the 6th Framework program (project number 501984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; BAUER PH, 1995, J VIROL, V69, P7925, DOI 10.1128/JVI.69.12.7925-7931.1995; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; BOOTLAND LM, 1991, DIS AQUAT ORGAN, V10, P13, DOI 10.3354/dao010013; Brower-Sinning R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r18; Collet B, 2007, FISH SHELLFISH IMMUN, V22, P44, DOI 10.1016/j.fsi.2006.03.011; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Coulibaly F, 2010, J VIROL, V84, P1792, DOI 10.1128/JVI.01536-09; Evensen O., 2008, ENCY VIROLOGY, P83, DOI DOI 10.1016/B978-012374410-4.00772-X; Fishman SL, 2009, CLIN CANCER RES, V15, P3205, DOI 10.1158/1078-0432.CCR-08-2418; FREUND R, 1991, J VIROL, V65, P350, DOI 10.1128/JVI.65.1.350-355.1991; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109; HEDRICK RP, 1978, J FISH DIS, V1, P297, DOI 10.1111/j.1365-2761.1978.tb00034.x; JARP J, 1995, J FISH DIS, V18, P67, DOI 10.1111/j.1365-2761.1995.tb01267.x; JOHANSEN LH, 1995, J FISH DIS, V18, P147, DOI 10.1111/j.1365-2761.1995.tb00272.x; Karber G, 1931, ARCH EXP PATHOL PH, V162, P761; KNOTT RM, 1986, VET IMMUNOL IMMUNOP, V12, P359, DOI 10.1016/0165-2427(86)90141-8; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Larsen R, 2004, J VIROL, V78, P7938, DOI 10.1128/JVI.78.15.7938-7944.2004; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Lockhart K, 2004, FISH SHELLFISH IMMUN, V17, P245, DOI 10.1016/j.fsi.2004.03.008; Lodish H, 2000, MOL CELL BIOL; MANGUNWIRYO H, 1988, J FISH DIS, V11, P125, DOI 10.1111/j.1365-2761.1988.tb00532.x; Moreno-Gonzalez E, 2003, TRANSPLANT P, V35, P1863, DOI 10.1016/S0041-1345(03)00595-5; Murray AG, 2003, EMERG INFECT DIS, V9, P455; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Roberts RJ, 2005, J FISH DIS, V28, P383, DOI 10.1111/j.1365-2761.2005.00642.x; Sadasiv Eileen C., 1995, Annual Review of Fish Diseases, V5, P209, DOI 10.1016/0959-8030(95)00001-1; Santi N, 2005, VIROLOGY, V342, P13, DOI 10.1016/j.virol.2005.07.028; Santi N, 2005, J VIROL, V79, P9206, DOI 10.1128/JVI.79.14.9206-9216.2005; Santi N, 2004, VIROLOGY, V322, P31, DOI 10.1016/j.virol.2003.12.016; Schvoerer E, 2006, PATHOL BIOL, V54, P556, DOI 10.1016/j.patbio.2006.07.027; Skjesol A, 2009, VIRUS RES, V143, P53, DOI 10.1016/j.virusres.2009.03.004; Song HC, 2005, J VIROL, V79, P10289, DOI 10.1128/JVI.79.16.10289-10299.2005; Taksdal T, 1998, J FISH DIS, V21, P193, DOI 10.1046/j.1365-2761.1998.00092.x; THUVANDER A, 1990, DEV COMP IMMUNOL, V14, P415, DOI 10.1016/0145-305X(90)90034-C; Verani A, 2005, MOL IMMUNOL, V42, P195, DOI 10.1016/j.molimm.2004.06.020; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183; Xu C, 2010, J VIROL, V84, P8903, DOI 10.1128/JVI.00851-10; Yao K, 1998, J VIROL, V72, P8913, DOI 10.1128/JVI.72.11.8913-8920.1998	42	32	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e54656	10.1371/journal.pone.0054656	http://dx.doi.org/10.1371/journal.pone.0054656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431359	Green Submitted, gold, Green Published			2022-12-27	WOS:000315182800002
J	Gao, YH; Yechikov, S; Vazquez, AE; Chen, DY; Nie, LP				Gao, Yanhong; Yechikov, Sergey; Vazquez, Ana E.; Chen, Dongyang; Nie, Liping			Distinct Roles of Molecular Chaperones HSP90 alpha and HSP90 beta in the Biogenesis of KCNQ4 Channels	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; OUTER HAIR-CELLS; POTASSIUM CHANNELS; CYSTIC-FIBROSIS; CLIENT PROTEINS; HERG CHANNEL; PORE-REGION; HOT-SPOT; MUTATION; GENE	Loss-of-function mutations in the KCNQ4 channel cause DFNA2, a subtype of autosomal dominant non-syndromic deafness that is characterized by progressive sensorineural hearing loss. Previous studies have demonstrated that the majority of the pathogenic KCNQ4 mutations lead to trafficking deficiency and loss of KCNQ4 currents. Over the last two decades, various strategies have been developed to rescue trafficking deficiency of pathogenic mutants; the most exciting advances have been made by manipulating activities of molecular chaperones involved in the biogenesis and quality control of the target protein. However, such strategies have not been established for KCNQ4 mutants and little is known about the molecular chaperones governing the KCNQ4 biogenesis. To identify KCNQ4-associated molecular chaperones, a proteomic approach was used in this study. As a result, two major molecular chaperones, HSP70 and HSP90, were identified and then confirmed by reciprocal co-immunoprecipitation assays, suggesting that the HSP90 chaperone pathway might be involved in the KCNQ4 biogenesis. Manipulating chaperone expression further revealed that two different isoforms of HSP90, the inducible HSP90 alpha and the constitutive HSP90 beta, had opposite effects on the cellular level of the KCNQ4 channel; that HSP40, HSP70, and HOP, three key components of the HSP90 chaperone pathway, were crucial in facilitating KCNQ4 biogenesis. In contrast, CHIP, a major E3 ubiquitin ligase, had an opposite effect. Collectively, our data suggest that HSP90 alpha and HSP90 beta play key roles in controlling KCNQ4 homeostasis via the HSP40-HSP70-HOP-HSP90 chaperone pathway and the ubiquitin-proteasome pathway. Most importantly, we found that over-expression of HSP90 beta significantly improved cell surface expression of the trafficking-deficient, pathogenic KCNQ4 mutants L274H and W276S. KCNQ4 surface expression was restored by HSP90 beta in cells mimicking heterozygous conditions of the DFNA2 patients, even though it was not sufficient to rescue the function of KCNQ4 channels.	[Gao, Yanhong; Yechikov, Sergey; Vazquez, Ana E.; Chen, Dongyang; Nie, Liping] Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA	University of California System; University of California Davis	Vazquez, AE (corresponding author), Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA.	avazquez@ucdavis.edu; lnie@ucdavis.edu			National Institutes of Health, USA [DC008649]; American Hearing Research Foundation; National Science Foundation, USA [0920802]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008649] Funding Source: NIH RePORTER; Direct For Biological Sciences [0920802] Funding Source: National Science Foundation	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearing Research Foundation; National Science Foundation, USA(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Institutes of Health, USA (DC008649) and a research award from the American Hearing Research Foundation to L.N., and a grant from the National Science Foundation, USA (0920802 to A.E.V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita J, 2001, J HUM GENET, V46, P355, DOI 10.1007/s100380170053; Aridon P, 2011, NEURODEGENER DIS, V8, P155, DOI 10.1159/000321548; Arnett J, 2011, ARCH OTOLARYNGOL, V137, P54, DOI 10.1001/archoto.2010.234; Baek JI, 2011, BBA-MOL BASIS DIS, V1812, P536, DOI 10.1016/j.bbadis.2010.09.001; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; de Heer AMR, 2011, ANN OTO RHINOL LARYN, V120, P243, DOI 10.1177/000348941112000405; Dennis A, 2007, BIOCHEM SOC T, V35, P1060, DOI 10.1042/BST0351060; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Guo J, 2012, BIOCHEM BIOPH RES CO, V422, P305, DOI 10.1016/j.bbrc.2012.04.153; Hahn JS, 2009, BMB REP, V42, P623, DOI 10.5483/BMBRep.2009.42.10.623; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hildebrand MS, 2008, GENET MED, V10, P297, DOI 10.1097/GIM.0b013e318187e106; Hinzpeter A, 2006, AM J PHYSIOL-CELL PH, V290, pC45, DOI 10.1152/ajpcell.00209.2005; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Kamada F, 2006, J HUM GENET, V51, P455, DOI 10.1007/s10038-006-0384-7; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Namba Kazunori, 2012, BMC Res Notes, V5, P145, DOI 10.1186/1756-0500-5-145; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nie LP, 2008, CURR OPIN OTOLARYNGO, V16, P441, DOI 10.1097/MOO.0b013e32830f4aa3; Oliver D, 2003, J NEUROSCI, V23, P2141; Peterson LB, 2012, MOL PHARMACEUT, V9, P1841, DOI 10.1021/mp300138n; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Smith RJ., 1993, GENEREVIEWS; Su CC, 2007, AUDIOL NEURO-OTOL, V12, P20, DOI 10.1159/000096154; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Talebizadeh Z, 1999, HUM MUTAT, V14, P493, DOI 10.1002/(SICI)1098-1004(199912)14:6<493::AID-HUMU8>3.0.CO;2-P; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Topsakal V, 2005, OTOL NEUROTOL, V26, P52, DOI 10.1097/00129492-200501000-00009; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Van Camp G, 2002, HUM MUTAT, V20, P15, DOI 10.1002/humu.10096; Van Hauwe P, 2000, AM J MED GENET, V93, P184, DOI 10.1002/1096-8628(20000731)93:3<184::AID-AJMG4>3.0.CO;2-5; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Whitesell L, 2012, CURR MOL MED; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yang BX, 2009, FASEB J, V23, P503, DOI 10.1096/fj.08-118422; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	53	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57282	10.1371/journal.pone.0057282	http://dx.doi.org/10.1371/journal.pone.0057282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431407	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800050
J	Cornett, EM; O'Steen, MR; Kolpashchikov, DM				Cornett, Evan M.; O'Steen, Martin R.; Kolpashchikov, Dmitry M.			Operating Cooperatively (OC) Sensor for Highly Specific Recognition of Nucleic Acids	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MOLECULAR BEACONS; MESSENGER-RNA; SNP ANALYSIS; DNA; PROBES; HYBRIDIZATION; DIAGNOSTICS; MUTATIONS; SEQUENCE	Molecular Beacon (MB) probes have been extensively used for nucleic acid analysis because of their ability to produce fluorescent signal in solution instantly after hybridization. The indirect binding of MB probe to a target analyte offers several advantages, including: improved genotyping accuracy and the possibility to analyse folded nucleic acids. Here we report on a new design for MB-based sensor, called 'Operating Cooperatively' (OC), which takes advantage of indirect binding of MB probe to a target analyte. The sensor consists of two unmodified DNA strands, which hybridize to a universal MB probe and a nucleic acid analyte to form a fluorescent complex. OC sensors were designed to analyze two human SNPs and E.coli 16S rRNA. High specificity of the approach was demonstrated by the detection of true analyte in over 100 times excess amount of single base substituted analytes. Taking into account the flexibility in the design and the simplicity in optimization, we conclude that OC sensors may become versatile and efficient tools for instant DNA and RNA analysis in homogeneous solution.	[Cornett, Evan M.; Kolpashchikov, Dmitry M.] Univ Cent Florida, Dept Chem, Coll Sci, Orlando, FL 32816 USA; [Cornett, Evan M.; O'Steen, Martin R.; Kolpashchikov, Dmitry M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Kolpashchikov, DM (corresponding author), Univ Cent Florida, Dept Chem, Coll Sci, Orlando, FL 32816 USA.	dmk2111@gmail.com	Kolpashchuikov, Dmitry M./AAE-2085-2019; Kolpashchikov, Dmitry/AAO-2777-2020; Cornett, Evan/M-1989-2019	Kolpashchuikov, Dmitry M./0000-0002-8682-6553; Cornett, Evan/0000-0003-1468-4506	NIHGRI [R21 HG004060]; NSF CCF [1117205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004060] Funding Source: NIH RePORTER	NIHGRI; NSF CCF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by NIHGRI (R21 HG004060) and NSF CCF (1117205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2012, HUM GENET, V131, P1541, DOI 10.1007/s00439-012-1213-z; Asanuma H, 2012, CHEM COMMUN, V48, P1760, DOI 10.1039/c2cc16812j; Balasingham SV, 2009, MOL DIAGN THER, V13, P137, DOI 10.2165/01250444-200913030-00001; Browne KA, 2005, J AM CHEM SOC, V127, P1989, DOI 10.1021/ja046369w; Chandler DP, 2003, APPL ENVIRON MICROB, V69, P2950, DOI 10.1128/AEM.69.5.2950-2958.2003; Cornett EM, 2012, ANGEW CHEM INT EDIT, V51, P9075, DOI 10.1002/anie.201203708; Demidov VV, 2004, TRENDS BIOCHEM SCI, V29, P62, DOI 10.1016/j.tibs.2003.12.007; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Gerasimova YV, 2013, BIOSENS BIOELECTRON, V41, P386, DOI 10.1016/j.bios.2012.08.058; Gerasimova YV, 2010, CHEMBIOCHEM, V11, P1762, DOI 10.1002/cbic.201000287; Grimes J, 2010, ANGEW CHEM INT EDIT, V49, P8950, DOI 10.1002/anie.201004475; Hiyari Sarah, 2011, J Dent Hyg, V85, P256; Hopkins JF, 2005, NUCLEIC ACIDS RES, V33, P5763, DOI 10.1093/nar/gki877; Huang KW, 2012, ANAL BIOANAL CHEM, V402, P3091, DOI 10.1007/s00216-011-5570-6; Kam Y, 2012, MOL PHARMACEUT, V9, P685, DOI 10.1021/mp200505k; Kim Y, 2007, NUCLEIC ACIDS RES, V35, P7279, DOI 10.1093/nar/gkm771; Kolpashchikov DM, 2006, J AM CHEM SOC, V128, P10625, DOI 10.1021/ja0628093; Kolpashchikov DM, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/928783; Kolpashchikov DM, 2011, CHEMBIOCHEM, V12, P2564, DOI 10.1002/cbic.201100545; Lane S, 2004, BIOSENS BIOELECTRON, V20, P728, DOI 10.1016/j.bios.2004.04.014; Li J, 2012, BIOSENS BIOELECTRON, V36, P142, DOI 10.1016/j.bios.2012.04.003; Li YQ, 2011, BIOSENS BIOELECTRON, V26, P2317, DOI 10.1016/j.bios.2010.10.002; Liang XW, 2012, SCI CHINA LIFE SCI, V55, P670, DOI 10.1007/s11427-012-4354-3; Lin YH, 2012, CHEM COMMUN, V48, P6262, DOI 10.1039/c2cc31382k; Liu AL, 2012, ANAL BIOANAL CHEM, V402, P805, DOI 10.1007/s00216-011-5480-7; Marras SAE, 2006, CLIN CHIM ACTA, V363, P48, DOI 10.1016/j.cccn.2005.04.037; Moschioni M, 2010, MICROB BIOTECHNOL, V3, P370, DOI 10.1111/j.1751-7915.2009.00138.x; Nagy C, 2012, EPIGENOMICS-UK, V4, P445, DOI [10.2217/EPI.12.37, 10.2217/epi.12.37]; Nguyen C, 2011, CHEM-EUR J, V17, P13052, DOI 10.1002/chem.201101987; Nogueira da Costa A, 2012, MOL ONCOL; Phillips C, 2012, TRANSFUS MED HEMOTH, V39, P202, DOI 10.1159/000338857; Qiao GM, 2011, CHEM-EUR J, V17, P11210, DOI 10.1002/chem.201100658; Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Santangelo P, 2006, ANN BIOMED ENG, V34, P39, DOI 10.1007/s10439-005-9003-6; Shen ZL, 2012, CHEM COMMUN, V48, P7580, DOI 10.1039/c2cc33280a; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Slodkowska Janina, 2012, Stud Health Technol Inform, V179, P143; Starke EM, 2007, ANN NY ACAD SCI, V1098, P345, DOI 10.1196/annals.1384.007; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Wang JH, 2009, MOL BIOL REP, V36, P1903, DOI 10.1007/s11033-008-9397-y; Wang KM, 2009, ANGEW CHEM INT EDIT, V48, P856, DOI 10.1002/anie.200800370; Yang CN, 2012, CHEM COMMUN, V48, P112, DOI [10.1039/c1cc14518e, 10.3778/j.issn.1002-8331.2012.30.024]; Yoshinaga H, 2012, ANAL SCI, V28, P939, DOI 10.2116/analsci.28.939; Yu M, 2012, ADV CLIN CHEM, V57, P99, DOI 10.1016/B978-0-12-394384-2.00004-8	45	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55919	10.1371/journal.pone.0055919	http://dx.doi.org/10.1371/journal.pone.0055919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441157	Green Published, gold			2022-12-27	WOS:000315159200014
J	Fu, D; Cong, XL; Ma, YS; Cai, HD; Cai, MX; Li, D; Lv, ML; Yuan, XY; Huang, YH; Lv, ZW				Fu, Da; Cong, Xianling; Ma, Yushui; Cai, Haidong; Cai, Mingxiang; Li, Dan; Lv, Mingli; Yuan, Xueyu; Huang, Yinghui; Lv, Zhongwei			Genetic Polymorphism of Glucokinase on the Risk of Type 2 Diabetes and Impaired Glucose Regulation: Evidence Based on 298, 468 Subjects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FASTING GLUCOSE; COMMON VARIANTS; SUSCEPTIBILITY LOCI; YOUNG GENES; POPULATION; PROMOTER; MELLITUS; HYPERGLYCEMIA; HYPOGLYCEMIA	Background: Glucokinase (GCK) is the key glucose phosphorylation enzyme which has attracted considerable attention as a candidate gene for type 2 diabetes (T2D) based on its enzyme function as the first rate-limiting step in the glycolysis pathway and regulates glucose-stimulated insulin secretion. In the past decade, the relationship between GCK and T2D has been reported in various ethnic groups. To derive a more precise estimation of the relationship and the effect of factors that might modify the risk, we performed this meta-analysis. Methods: Databases including Pubmed, EMBASE, Web of Science and China National Knowledge Infrastructure (CNKI) were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. Results: A total of 24 articles involving 88, 229 cases and 210, 239 controls were included. An overall random-effects per-allele OR of 1.06 (95% CI: 1.03-1.09; P<10(-4)) was found for the GCK -30G>A polymorphism. Significant results were also observed using dominant or recessive genetic models. In the subgroup analyses by ethnicity, significant results were found in Caucasians; whereas no significant associations were found among Asians. In addition, we found that the -30G>A polymorphism is a risk factor associated with increased impaired glucose regulation susceptibility. Besides, -30G>A homozygous was found to be significantly associated with increased fasting plasma glucose level with weighted mean difference (WMD) of 0.15 (95%: 0.05-0.24, P = 0.001) compared with G/G genotype. Conclusions: This meta-analysis demonstrated that the -30G>A polymorphism of GCK is a risk factor associated with increased T2D susceptibility, but these associations vary in different ethnic populations.	[Fu, Da; Ma, Yushui; Cai, Haidong; Cai, Mingxiang; Li, Dan; Lv, Mingli; Yuan, Xueyu; Lv, Zhongwei] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China; [Cong, Xianling; Huang, Yinghui] Jilin Univ, China Japan Union Hosp, Changchun 130023, Peoples R China	Tongji University; Jilin University	Huang, YH (corresponding author), Jilin Univ, China Japan Union Hosp, Changchun 130023, Peoples R China.	yinghui_huang@163.com; zhongwei_lv01@126.com	lyu, Minfli/GVU-4023-2022; Fu, Da/GXF-2656-2022; Fu, Da/F-1763-2013; ma, yushui/HGC-6206-2022		National Nature Scientific Foundation of China [81201535, 81071662]; Nature Scientific Foundation of Shanghai [12ZR1436000]; Scientific Research Foundation of Jilin Province [200905169, 20100945, 2011756]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP203]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Scientific Foundation of Shanghai; Scientific Research Foundation of Jilin Province; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This study was supported by National Nature Scientific Foundation of China (81201535, 81071662), Nature Scientific Foundation of Shanghai (12ZR1436000), Scientific Research Foundation of Jilin Province (200905169, 20100945, 2011756), the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Cauchi S, 2012, DIABETES METAB, V38, P316, DOI 10.1016/j.diabet.2012.02.003; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; CHIU KC, 1994, DIABETOLOGIA, V37, P104; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ezzidi I, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-33; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; Holmkvist J, 2008, DIABETES, V57, P1738, DOI 10.2337/db06-1464; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lotfi K, 1997, DIABETOLOGIA, V40, P959, DOI 10.1007/s001250050774; Ma YC, 2009, ZHONGGUO XIAN DAI YI, V19, P513; Marz W, 2004, CIRCULATION, V109, P2844, DOI 10.1161/01.CIR.0000129306.44085.C4; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Murad AS, 2010, INT J MOL EPIDEMIOL, V1, P175; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Panzer C, 2002, DIABETES, V51, P803, DOI 10.2337/diabetes.51.3.803; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Rissanen J, 1998, DIABETES CARE, V21, P1194, DOI 10.2337/diacare.21.7.1194; Rose CS, 2005, DIABETES, V54, P3026, DOI 10.2337/diabetes.54.10.3026; SHIMOKAWA K, 1994, J CLIN ENDOCR METAB, V79, P883, DOI 10.1210/jc.79.3.883; Stone LM, 1996, DIABETES, V45, P422, DOI 10.2337/diabetes.45.4.422; Tam CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011428; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yamada K, 1997, DIABETES CARE, V20, P1159, DOI 10.2337/diacare.20.7.1159; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	44	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55727	10.1371/journal.pone.0055727	http://dx.doi.org/10.1371/journal.pone.0055727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441155	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200013
J	Hawken, ER; Delva, NJ; Beninger, RJ				Hawken, Emily R.; Delva, Nicholas J.; Beninger, Richard J.			Increased Drinking following Social Isolation Rearing: Implications for Polydipsia Associated with Schizophrenia	PLOS ONE			English	Article							SCHEDULE-INDUCED-POLYDIPSIA; OBSESSIVE-COMPULSIVE SYMPTOMS; INDIVIDUAL-DIFFERENCES; WATER-INTOXICATION; HIPPOCAMPAL-FORMATION; LOCOMOTOR-ACTIVITY; ANIMAL-MODEL; DOPAMINE; RATS; DETERMINANTS	Primary polydipsia, excessive drinking without known medical cause, is especially associated with a diagnosis of schizophrenia. We used animal models of schizophrenia-like symptoms to examine the effects on schedule-induced polydipsia: post-weaning social isolation rearing, subchronic MK-801 treatment (an NMDA-receptor antagonist) or the two combined. Male, Sprague-Dawley rats reared in groups or in isolation beginning at postnatal day 21 were further divided to receive subchronic MK-801 (0.5 mg/kg twice daily) or saline for 7 days beginning on postnatal day 62. Following a 4-day withdrawal period, all groups were trained on a schedule-induced polydipsia paradigm. Under food-restriction, animals reared in isolation and receiving food pellets at 1-min intervals developed significantly more drinking behavior than those reared with others. The addition of subchronic MK-801 treatment did not significantly augment the amount of water consumed. These findings suggest a predisposition to polydipsia is a schizophrenia-like behavioral effect of post-weaning social isolation.	[Hawken, Emily R.; Beninger, Richard J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Hawken, Emily R.; Delva, Nicholas J.; Beninger, Richard J.] Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada; [Delva, Nicholas J.] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Beninger, Richard J.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada; Dalhousie University; Queens University - Canada	Beninger, RJ (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.	beninger@queensu.ca	Beninger, Richard/AAR-1584-2021		Ontario Ministry of Mental Health; H. Lundbeck A/S; Institut de Recherche Pierre Fabre (Boulogne, France)	Ontario Ministry of Mental Health; H. Lundbeck A/S; Institut de Recherche Pierre Fabre (Boulogne, France)	This work was funded by the Ontario Ministry of Mental Health, Type B Grant (no grant number assigned). [http://www.omhf.on.ca/home/] The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.; E.R. Hawken declares no competing interest exist. N.J. Delva has read the journal's policy and has the following conflict: he has received funding (ending in late 2009) from H. Lundbeck A/S for research unrelated to this study. R.J. Beninger has read the journal's policy and has the following conflicts: he has been compenstated as an expert witness by Kenyon and Kenyon LLP (New York, New York, USA) acting for defendants Teva Pharmaceuticals Industries Ltd. Teva Pharmaceuticals USA Inc., and has carried out research under contract for Institut de Recherche Pierre Fabre (Boulogne, France). This does not alter the author's adherence to all the PLOS ONE policies on sharing data and materials.	Alquicer G, 2008, J CHEM NEUROANAT, V35, P179, DOI 10.1016/j.jchemneu.2007.10.001; Ashby DM, 2010, BEHAV BRAIN RES, V212, P64, DOI 10.1016/j.bbr.2010.03.041; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Beninger RJ, 2009, PHARMACOL BIOCHEM BE, V91, P495, DOI 10.1016/j.pbb.2008.09.003; Braun I, 2007, SCHIZOPHR RES, V97, P254, DOI 10.1016/j.schres.2007.05.005; Byerly M, 2005, SCHIZOPHR RES, V76, P309, DOI 10.1016/j.schres.2005.02.004; Cassano GB, 1998, J CLIN PSYCHIAT, V59, P60, DOI 10.4088/JCP.v59n0204; Cunill R, 2009, J CLIN PSYCHIAT, V70, P70, DOI 10.4088/JCP.07r03618; Dawe GS, 2009, ANN ACAD MED SINGAP, V38, P425; DELEON J, 1994, BIOL PSYCHIAT, V35, P408, DOI 10.1016/0006-3223(94)90008-6; EINON DF, 1977, DEV PSYCHOBIOL, V10, P123, DOI 10.1002/dev.420100205; EINON DF, 1978, Q J EXP PSYCHOL, V30, P151, DOI 10.1080/14640747808400663; Escher T, 2006, PSYCHOPHARMACOLOGY, V187, P424, DOI 10.1007/s00213-006-0465-5; Fabricius K, 2010, NEUROSCI LETT, V482, P117, DOI 10.1016/j.neulet.2010.07.014; FALK JL, 1966, J EXP ANAL BEHAV, V9, P37, DOI 10.1901/jeab.1966.9-37; FALK JL, 1971, PHYSIOL BEHAV, V6, P577, DOI 10.1016/0031-9384(71)90209-5; FLORES P, 1995, BEHAV PHARMACOL, V6, P16; Flory RK, 1971, LEARN MOTIV, V2, P215, DOI [10.1016/0023-9690(71)90022-1, DOI 10.1016/0023-9690(71)90022-1]; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Goldman MB, 2007, HIPPOCAMPUS, V17, P554, DOI 10.1002/hipo.20292; Goldman MB, 2004, SCHIZOPHRENIA BULL, V30, P367, DOI 10.1093/oxfordjournals.schbul.a007086; Goldman MB, 2007, J CLIN ENDOCR METAB, V92, P698, DOI 10.1210/jc.2006-1131; Goldman MB, 2011, BEHAV BRAIN RES, V218, P106, DOI 10.1016/j.bbr.2010.11.025; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Harte MK, 2007, J NEURAL TRANSM, V114, P893, DOI 10.1007/s00702-007-0627-6; Hawken ER, 2011, SCHIZOPHR RES, V125, P93, DOI 10.1016/j.schres.2010.07.022; Hawken ER, 2009, SCHIZOPHR RES, V107, P128, DOI 10.1016/j.schres.2008.09.029; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hickey AJ, 2012, PHARMACOL BIOCHEM BE, V101, P231, DOI 10.1016/j.pbb.2012.01.015; Hong SZ, 2012, PHYSIOL BEHAV, V105, P269, DOI 10.1016/j.physbeh.2011.08.036; HOOKS MS, 1994, BEHAV BRAIN RES, V60, P199, DOI 10.1016/0166-4328(94)90148-1; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; JONES GH, 1989, PHYSIOL BEHAV, V45, P71, DOI 10.1016/0031-9384(89)90167-4; Lapiz M D S, 2003, Neurosci Behav Physiol, V33, P13, DOI 10.1023/A:1021171129766; Lodge DJ, 2008, NEUROTOX RES, V14, P97, DOI 10.1007/BF03033801; Lopez-Grancha M, 2008, PSYCHOPHARMACOLOGY, V197, P487, DOI 10.1007/s00213-007-1059-6; LUCHINS DJ, 1992, SCHIZOPHR RES, V8, P119, DOI 10.1016/0920-9964(92)90027-3; Lysaker PH, 2009, EXPERT REV NEUROTHER, V9, P99, DOI 10.1586/14737175.9.1.99; Mercier-Guidez E, 2000, EUR PSYCHIAT, V15, P306, DOI 10.1016/S0924-9338(00)00399-0; MITTLEMAN G, 1994, J PHARMACOL EXP THER, V271, P638; Moreno M, 2012, PSYCHOPHARMACOLOGY, V219, P647, DOI 10.1007/s00213-011-2570-3; Nettles KW, 2000, BRAIN RES, V858, P181, DOI 10.1016/S0006-8993(99)02281-7; Pellon R, 2011, BEHAV BRAIN RES, V217, P195, DOI 10.1016/j.bbr.2010.10.010; Platt B., 2008, CURR PROTOC NEUROSCI, V43, P1, DOI [DOI 10.1002/0471142301.NS0927S43, 10.1002/0471142301.ns0927-43, DOI 10.1002/0471142301.NS0927-43]; Poirier S, 2010, SCHIZOPHR RES, V118, P285, DOI 10.1016/j.schres.2009.12.036; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Poyurovsky M, 1999, AM J PSYCHIAT, V156, P1998; Simpson SM, 2010, PHARMACOL BIOCHEM BE, V95, P72, DOI 10.1016/j.pbb.2009.12.008; Torres IJ, 2009, NEUROPSYCHOLOGY, V23, P307, DOI 10.1037/a0014481; UMBRICHT D, 1994, BIOL PSYCHIAT, V36, P709, DOI 10.1016/0006-3223(94)91183-5; van den Heuvel OA, 2010, J NEUROL SCI, V289, P55, DOI 10.1016/j.jns.2009.08.043; WALLACE M, 1976, PHARMACOL BIOCHEM BE, V5, P483, DOI 10.1016/0091-3057(76)90114-3; WILKINSON LS, 1994, NEUROPSYCHOPHARMACOL, V10, P61, DOI 10.1038/npp.1994.8; WOODS A, 1993, PSYCHOPHARMACOLOGY, V112, P195, DOI 10.1007/BF02244910	55	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56105	10.1371/journal.pone.0056105	http://dx.doi.org/10.1371/journal.pone.0056105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441161	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200018
J	Lenna, S; Chrobak, I; Farina, GA; Rodriguez-Pascual, F; Lamas, S; Lafyatis, R; Scorza, R; Trojanowska, M				Lenna, Stefania; Chrobak, Izabela; Farina, G. Alessandra; Rodriguez-Pascual, Fernando; Lamas, Santiago; Lafyatis, Robert; Scorza, Raffaella; Trojanowska, Maria			HLA-B35 and dsRNA Induce Endothelin-1 via Activation of ATF4 in Human Microvascular Endothelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; ENDOPLASMIC-RETICULUM STRESS; PULMONARY ARTERIAL-HYPERTENSION; INNATE IMMUNE-RESPONSES; TRANSCRIPTION FACTOR; SYSTEMIC-SCLEROSIS; INTERFERON; EXPRESSION; MODULATORS; FACTOR-4	Endothelin 1 (ET-1) is a key regulator of vascular homeostasis. We have recently reported that the presence of Human antigen class I, HLA-B35, contributes to human dermal microvascular endothelial cell (HDMEC) dysfunction by upregulating ET-1 and proinflammatory genes. Likewise, a Toll-like receptor 3 (TLR3) ligand, Poly(I:C), was shown to induce ET-1 expression in HDMECs. The goal of this study was to determine the molecular mechanism of ET-1 induction by these two agonists. Because HLA-B35 expression correlated with induction of Binding Immunoglobulin Protein (BiP/GRP78) and several heat shock proteins, we first focused on ER stress and unfolded protein response (UPR) as possible mediators of this response. ER stress inducer, Thapsigargin (TG), HLA-B35, and Poly(I:C) induced ET-1 expression with similar potency in HDMECs. TG and HLA-B35 activated the PERK/eIF2 alpha/ATF4 branch of the UPR and modestly increased the spliced variant of XBP1, but did not affect the ATF6 pathway. Poly(I:C) also activated eIF2 alpha/ATF4 in a protein kinase R (PKR)-dependent manner. Depletion of ATF4 decreased basal expression levels of ET-1 mRNA and protein, and completely prevented upregulation of ET-1 by all three agonists. Additional experiments have demonstrated that the JNK and NF-kappa B pathways are also required for ET-1 upregulation by these agonists. Formation of the ATF4/c-JUN complex, but not the ATF4/NF-kappa B complex was increased in the agonist treated cells. The functional role of c-JUN in responses to HLA-B35 and Poly(I:C) was further confirmed in ET-1 promoter assays. This study identified ATF4 as a novel activator of the ET-1 gene. The ER stress/UPR and TLR3 pathways converge on eIF2 alpha/ATF4 during activation of endothelial cells.	[Lenna, Stefania; Chrobak, Izabela; Farina, G. Alessandra; Lafyatis, Robert; Trojanowska, Maria] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA; [Rodriguez-Pascual, Fernando; Lamas, Santiago] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Scorza, Raffaella] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Referral Ctr Syst Autoimmune Dis, Milan, Italy; [Scorza, Raffaella] Univ Milan, Milan, Italy	Boston University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Trojanowska, M (corresponding author), Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA.	trojanme@bu.edu	Lamas, Santiago/G-7308-2015; Rodríguez-Pascual, Fernando/Q-5100-2019	Lamas, Santiago/0000-0001-5166-4155; Rodríguez-Pascual, Fernando/0000-0002-9765-9578; Lafyatis, Robert/0000-0002-9398-5034; Trojanowska, Maria/0000-0001-9550-7178	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [P50 AR060780]; Scleroderma Foundation; Gruppo Italiano per la Lotta alla Sclerodermia (GILS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051089, P50AR060780, R03AR062721] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Scleroderma Foundation; Gruppo Italiano per la Lotta alla Sclerodermia (GILS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR060780 to MT and RL, Scleroderma Foundation grants to MT and AF, and by a grant from Gruppo Italiano per la Lotta alla Sclerodermia (GILS) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3221; Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Arnett FC, 1996, ARTHRITIS RHEUM, V39, P1362, DOI 10.1002/art.1780390814; Caselli E, 2012, ARCH VIROL, V157, P63, DOI 10.1007/s00705-011-1144-3; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; DOUKAS J, 1994, AM J PATHOL, V145, P137; Farina G, 2011, ANN RHEUM DIS, V70, P544, DOI 10.1136/ard.2010.132464; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Kato Y, 1999, MOL CELL ENDOCRINOL, V154, P151, DOI 10.1016/S0303-7207(99)00078-7; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; Lenna S, J IMMUNOL, V184, P4654; Lenna S, 2010, J IMMUNOL, V184, P4654, DOI 10.4049/jimmunol.0903188; Malabanan KP, 2008, CIRC RES, V103, P378, DOI 10.1161/CIRCRESAHA.107.168682; Malabanan KP, 2010, J MOL MED, V88, P545, DOI 10.1007/s00109-010-0615-4; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Rath E, 2011, EUR J NUTR, V50, P219, DOI 10.1007/s00394-011-0197-0; Rodriguez-Pascual F, 2003, CIRC RES, V92, P1288, DOI 10.1161/01.RES.0000078491.79697.7F; Rodriguez-Pascual F, 2011, PHARMACOL RES, V63, P463, DOI 10.1016/j.phrs.2011.01.014; Santaniello A, 2006, TISSUE ANTIGENS, V68, P239, DOI 10.1111/j.1399-0039.2006.00657.x; Scorza R, 2002, ANN NY ACAD SCI, V966, P238, DOI 10.1111/j.1749-6632.2002.tb04221.x; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shibamiya A, 2009, BLOOD, V113, P714, DOI 10.1182/blood-2008-02-137901; Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612; Sulli A, 2009, J RHEUMATOL, V36, P1235, DOI 10.3899/jrheum.081030; Tsui JC, 2011, PHARMACOL RES, V63, P473, DOI 10.1016/j.phrs.2011.02.012; van Bon L, 2011, CURR OPIN RHEUMATOL, V23, P505, DOI 10.1097/BOR.0b013e32834b0dac; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	33	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56123	10.1371/journal.pone.0056123	http://dx.doi.org/10.1371/journal.pone.0056123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441162	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200019
J	Osmancik, P; Teringova, E; Tousek, P; Paulu, P; Widimsky, P				Osmancik, Pavel; Teringova, Elena; Tousek, Petr; Paulu, Petra; Widimsky, Petr			Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; HUMAN ENDOTHELIAL-CELLS; HEART-FAILURE; TROPONIN-T; RECEPTORS 1; INTERVENTION; INHIBITION; EXPRESSION; MORTALITY	Background: Apoptosis plays an important role in the development of heart failure. The aim of the prospectively designed study was to assess whether the concentration of apoptotic markers apoptosis-stimulating fragment (Fas, CD95/APO-1) and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) can predict prognosis in patients with acute coronary syndromes. Methods: The concentrations of soluble Fas and TRAIL were determined in 295 patients with acute coronary syndromes. The status of all patients was evaluated at 6 months. The primary goal was a composite end-point of death and hospitalization for heart failure. The secondary end-points were re-MI, death alone and stroke alone. Results: During the median follow-up of 6 months, 26 patients experienced the composite end-point. Using multivariate logistic regression, the concentration of TRAIL was the strongest significant and independent predictor of composite endpoint (OR 0.11 (95% CI 0.03-0.45), p = 0.002). Low concentration was associated with poor prognosis of patients. Other significant predictors of composite end-point were serum creatinine (OR 7.7 (95% CI 1.1-54.5, p = 0.041) and complete revascularization (OR 0.19 (95% CI 0.05-0.78, p = 0.02). Independent significant predictors of death in the multivariate analysis were the concentration of TRAIL (OR 0.053 (95% CI 0.004-0.744), p = 0.029), older age (OR 1.20 (95% CI 1.02-1.41, p = 0.026) and serum creatinine (OR 15.1 (95% CI 1.56-145.2), p = 0.0193). Re-MI or stroke could not be predicted by any combination of obtained parameters. Conclusions: Low concentrations of soluble TRAIL represent a strong predictor of a poor prognosis in patients with acute coronary syndrome. The predictive value of TRAIL concentration is independent of age, ejection fraction, index peak troponin level, concentration of BNP or serum creatinine.	[Osmancik, Pavel] Charles Univ Prague, Med Sch 3, Dept Cardiol, Cardioctr, Prague, Czech Republic; Univ Hosp Kralovske Vinohrady, Prague, Czech Republic	Charles University Prague; University Hospital Vinohrady	Osmancik, P (corresponding author), Charles Univ Prague, Med Sch 3, Dept Cardiol, Cardioctr, Prague, Czech Republic.	pavel.osmancik@gmail.com	Widimsky, Petr/P-8088-2016; Tousek, Petr/P-3455-2016	Widimsky, Petr/0000-0001-5686-7752; Tousek, Petr/0000-0002-2598-3635	Third Faculty of Medicine, Charles University Prague [PRVOUK P35]	Third Faculty of Medicine, Charles University Prague	Third Faculty of Medicine, Charles University Prague, research project PRVOUK P35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2003, J AM COLL CARDIOL, V41, P753, DOI 10.1016/S0735-1097(02)02959-5; Byrne RA, 2010, AM J CARDIOL, V106, P1212, DOI 10.1016/j.amjcard.2010.06.050; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Filippatos G, 2003, CURR PHARM DESIGN, V9, P707, DOI 10.2174/1381612033455477; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Goussev A, 1998, AM J PHYSIOL-HEART C, V275, pH626, DOI 10.1152/ajpheart.1998.275.2.H626; Guidez T, 2012, EMERG MED J, V29, P274, DOI 10.1136/emj.2010.104422; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jayasankar V, 2005, J CARDIAC SURG, V20, P93, DOI 10.1111/j.0886-0440.2005.200373.x; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Landmesser U, 2005, NAT CLIN PRACT CARD, V2, P628, DOI 10.1038/ncpcardio0371; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Mueller M, 2012, CLIN RES CARDIOL, V101, P837, DOI 10.1007/s00392-012-0469-6; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Oemrawsingh RM, 2011, HEART, V97, P1061, DOI 10.1136/hrt.2010.197392; Rossig L, 2004, EUR HEART J, V25, P1620, DOI 10.1016/j.ehj.2004.06.036; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2010, ATHEROSCLEROSIS, V210, P274, DOI 10.1016/j.atherosclerosis.2009.11.005; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Suzuki G, 2002, CIRCULATION, V106, P2967, DOI 10.1161/01.CIR.0000039104.56479.42; Toffoli B, 2012, INVEST NEW DRUGS; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zauli G, 2003, CIRC RES, V92, P732, DOI 10.1161/01.RES.0000067928.83455.9C; Zhao L, 2009, J INVASIVE CARDIOL, V21, P493	32	37	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e53860	10.1371/journal.pone.0053860	http://dx.doi.org/10.1371/journal.pone.0053860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441146	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200004
J	Carey, AL; Siebel, AL; Reddy-Luthmoodoo, M; Natoli, AK; D'Souza, W; Meikle, PJ; Sviridov, D; Drew, BG; Kingwell, BA				Carey, Andrew L.; Siebel, Andrew L.; Reddy-Luthmoodoo, Medini; Natoli, Alaina K.; D'Souza, Wilissa; Meikle, Peter J.; Sviridov, Dmitri; Drew, Brian G.; Kingwell, Bronwyn A.			Skeletal Muscle Insulin Resistance Associated with Cholesterol-Induced Activation of Macrophages Is Prevented by High Density Lipoprotein	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FATTY-ACID OXIDATION; GLUCOSE-UPTAKE; AMP-KINASE; ABCA1; INFLAMMATION; EFFLUX; ACCUMULATION; MECHANISMS; SALSALATE	Background: Emerging evidence suggests that high density lipoprotein (HDL) may modulate glucose metabolism through multiple mechanisms including pancreatic insulin secretion as well as insulin-independent glucose uptake into muscle. We hypothesized that HDL may also increase skeletal muscle insulin sensitivity via cholesterol removal and anti-inflammatory actions in macrophages associated with excess adiposity and ectopic lipid deposition. Methods: Human primary and THP-1 macrophages were treated with vehicle (PBS) or acetylated low density lipoprotein (acLDL) with or without HDL for 18 hours. Treatments were then removed, and macrophages were incubated with fresh media for 4 hours. This conditioned media was then applied to primary human skeletal myotubes derived from vastus lateralis biopsies taken from patients with type 2 diabetes to examine insulin-stimulated glucose uptake. Results: Conditioned media from acLDL-treated primary and THP-1 macrophages reduced insulin-stimulated glucose uptake in primary human skeletal myotubes compared with vehicle (primary macrophages, 168 +/- 21% of basal uptake to 104 +/- 19%; THP-1 macrophages, 142 +/- 8% of basal uptake to 108 +/- 6%; P<0.05). This was restored by co-treatment of macrophages with HDL. While acLDL increased total intracellular cholesterol content, phosphorylation of c-jun N-terminal kinase and secretion of pro- and anti-inflammatory cytokines from macrophages, none were altered by co-incubation with HDL. Insulin-stimulated Akt phosphorylation in human skeletal myotubes exposed to conditioned media was unaltered by either treatment condition. Conclusion: Inhibition of insulin-stimulated glucose uptake in primary human skeletal myotubes by conditioned media from macrophages pre-incubated with acLDL was restored by co-treatment with HDL. However, these actions were not linked to modulation of common pro- or anti-inflammatory mediators or insulin signaling via Akt.	[Carey, Andrew L.; Siebel, Andrew L.; Reddy-Luthmoodoo, Medini; Natoli, Alaina K.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Res Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia; [D'Souza, Wilissa; Sviridov, Dmitri] Baker IDI Heart & Diabet Res Inst, Lipoprot & Atherosclerosis Lab, Melbourne, Vic, Australia; [Meikle, Peter J.] Baker IDI Heart & Diabet Res Inst, Metabol Lab, Melbourne, Vic, Australia; [Drew, Brian G.] Univ Calif Los Angeles, Div Endocrinol Diabet & Hypertens, Los Angeles, CA USA	University of California System; University of California Los Angeles	Kingwell, BA (corresponding author), Baker IDI Heart & Diabet Res Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia.	bronwyn.kingwell@bakeridi.edu.au	Sviridov, Dmitri/E-7943-2010; Kingwell, Bronwyn A/B-1183-2009; Meikle, Peter J/B-4023-2009; Siebel, Andrew L/B-3203-2013	Siebel, Andrew L/0000-0002-9230-9042; Carey, Andrew/0000-0003-3452-1501; Meikle, Peter/0000-0002-2593-4665	National Health and Medical Research Council of Australia; Operational Infrastructure Support (OIS) Scheme of the Victorian State Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support (OIS) Scheme of the Victorian State Government	This study was supported by the National Health and Medical Research Council of Australia and the Operational Infrastructure Support (OIS) Scheme of the Victorian State Government. BAK and DS are fellows of the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter PJ, 2011, CIRCULATION, V124, P555, DOI 10.1161/CIRCULATIONAHA.111.018259; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen MB, 2005, J CLIN ENDOCR METAB, V90, P3665, DOI 10.1210/jc.2004-1980; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Drew BG, 2012, NAT REV ENDOCRINOL, V8, P237, DOI 10.1038/nrendo.2011.235; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Elmendorf JS, 2004, MOL BIOTECHNOL, V27, P127, DOI 10.1385/MB:27:2:127; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hoang A, 2012, EUR HEART J, V33, P657, DOI 10.1093/eurheartj/ehr103; Hoffman NJ, 2011, TRENDS ENDOCRIN MET, V22, P110, DOI 10.1016/j.tem.2010.12.001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Kruit JK, 2010, DIABETOLOGIA, V53, P1110, DOI 10.1007/s00125-010-1691-2; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Singh I, 2008, EUR J NUTR, V47, P387, DOI 10.1007/s00394-008-0739-2; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	36	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56601	10.1371/journal.pone.0056601	http://dx.doi.org/10.1371/journal.pone.0056601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437184	gold, Green Published			2022-12-27	WOS:000315186000034
J	Green-Mitchell, SM; Tersey, SA; Cole, BK; Ma, KW; Kuhn, NS; Cunningham, TD; Maybee, NA; Chakrabarti, SK; McDuffie, M; Taylor-Fishwick, DA; Mirmira, RG; Nadler, JL; Morris, MA				Green-Mitchell, Shamina M.; Tersey, Sarah A.; Cole, Banumathi K.; Ma, Kaiwen; Kuhn, Norine S.; Cunningham, Tina Duong; Maybee, Nelly A.; Chakrabarti, Swarup K.; McDuffie, Marcia; Taylor-Fishwick, David A.; Mirmira, Raghavendra G.; Nadler, Jerry L.; Morris, Margaret A.			Deletion of 12/15-Lipoxygenase Alters Macrophage and Islet Function in NOD-Alox15(null) Mice, Leading to Protection against Type 1 Diabetes Development	PLOS ONE			English	Article							NOD MICE; INSULIN-SECRETION; IL-12 PRODUCTION; MOUSE MODEL; T-CELLS; BETA; INFLAMMATION; 12-LIPOXYGENASE; ACTIVATION; TRANSCRIPTION	Aims: Type 1 diabetes (T1D) is characterized by autoimmune depletion of insulin-producing pancreatic beta cells. We showed previously that deletion of the 12/15-lipoxygenase enzyme (12/15-LO, Alox15 gene) in NOD mice leads to nearly 100 percent protection from T1D. In this study, we test the hypothesis that cytokines involved in the IL-12/12/15-LO axis affect both macrophage and islet function, which contributes to the development of T1D. Methods: 12/15-LO expression was clarified in immune cells by qRT-PCR, and timing of expression was tested in islets using qRT-PCR and Western blotting. Expression of key proinflammatory cytokines and pancreatic transcription factors was studied in NOD and NOD-Alox15(null) macrophages and islets using qRT-PCR. The two mouse strains were also assessed for the ability of splenocytes to transfer diabetes in an adoptive transfer model, and beta cell mass. Results: 12/15-LO is expressed in macrophages, but not B and T cells of NOD mice. In macrophages, 12/15-LO deletion leads to decreased proinflammatory cytokine mRNA and protein levels. Furthermore, splenocytes from NOD-Alox15(null) mice are unable to transfer diabetes in an adoptive transfer model. In islets, expression of 12/15-LO in NOD mice peaks at a crucial time during insulitis development. The absence of 12/15-LO results in maintenance of islet health with respect to measurements of islet-specific transcription factors, markers of islet health, proinflammatory cytokines, and beta cell mass. Conclusions: These results suggest that 12/15-LO affects islet and macrophage function, causing inflammation, and leading to autoimmunity and reduced beta cell mass.	[Green-Mitchell, Shamina M.; Cole, Banumathi K.; Ma, Kaiwen; Kuhn, Norine S.; Chakrabarti, Swarup K.; Taylor-Fishwick, David A.; Nadler, Jerry L.; Morris, Margaret A.] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA; [Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Cunningham, Tina Duong] Eastern Virginia Med Sch, Grad Program Publ Hlth, Norfolk, VA 23501 USA; [McDuffie, Marcia] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Maybee, Nelly A.; McDuffie, Marcia; Nadler, Jerry L.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Taylor-Fishwick, David A.; Morris, Margaret A.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Eastern Virginia Medical School; University of Virginia; University of Virginia; Eastern Virginia Medical School	Morris, MA (corresponding author), Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA.	morrisma@evms.edu	Taylor, David/S-5508-2019; Mirmira, Raghavendra G/AAD-7592-2020	Taylor, David/0000-0002-6720-7482; Mirmira, Raghavendra G/0000-0002-5013-6075; Tersey, Sarah/0000-0003-0667-2361	Juvenile Diabetes Research Foundation [40-2009-711]; American Diabetes Association [7-11-JF-33]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association)	This work was funded by grants from the Juvenile Diabetes Research Foundation (www.jdrf.org, 40-2009-711), and the American Diabetes Association (www.diabetes.org, 7-11-JF-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Bleich D, 1998, INT J MOL MED, V1, P265; Boyton RJ, 2005, INT IMMUNOL, V17, P1157, DOI 10.1093/intimm/dxh293; Carrington EM, 2011, EUR J IMMUNOL, V41, P2238, DOI 10.1002/eji.201141476; Cetkovic-Cvrlje M, 2005, CLIN IMMUNOL, V114, P299, DOI 10.1016/j.clim.2004.11.001; Chakrabarti SK, 2011, AM J PHYSIOL-ENDOC M, V300, pE175, DOI 10.1152/ajpendo.00203.2010; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chen M, 2005, DIABETOLOGIA, V48, P486, DOI 10.1007/s00125-005-1673-y; Cole BK, 2012, AM J PHYSIOL-ENDOC M, V302, pE654, DOI 10.1152/ajpendo.00373.2011; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Estil les E, 2009, J ENDOCRINOL, V203, P55, DOI [10.1677/JOE-09-0047, DOI 10.1677/JOE-09-0047]; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; GUEST PC, 1989, BIOCHEM J, V257, P431, DOI 10.1042/bj2570431; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Kim HS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4048; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Li L, 2009, J IMMUNOL, V183, P7585, DOI 10.4049/jimmunol.0901587; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Middleton MK, 2006, J IMMUNOL, V176, P265, DOI 10.4049/jimmunol.176.1.265; Morris MA, 2011, AUTOIMMUNITY, V44, P115, DOI 10.3109/08916934.2010.499885; SOBERMAN RJ, 1985, J BIOL CHEM, V260, P4508; Taylor-Fishwick D.A., 2012, DIABETOLOGIA; Tersey SA, 2011, DIAB 71 SCI SESS, P117; Tersey SA, DIABETES IN PRESS; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Wen YH, 2008, AM J PHYSIOL-HEART C, V294, pH1933, DOI 10.1152/ajpheart.00260.2007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Yang ZD, 2003, ANN NY ACAD SCI, V1005, P409, DOI 10.1196/annals.1288.069; Yang ZD, 2004, J AUTOIMMUN, V22, P191, DOI 10.1016/j.jaut.2003.08.006; Zhao L, 2002, J BIOL CHEM, V277, P35350, DOI 10.1074/jbc.M205738200; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	41	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56763	10.1371/journal.pone.0056763	http://dx.doi.org/10.1371/journal.pone.0056763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437231	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000043
J	Kwon, N; Pyo, J; Lee, SJ; Je, JH				Kwon, Namseop; Pyo, Jaeyeon; Lee, Seung-Jae; Je, Jung Ho			3-D Worm Tracker for Freely Moving C. elegans	PLOS ONE			English	Article							NEMATODE; BEHAVIOR; SYSTEM	The manner in which the nervous system regulates animal behaviors in natural environments is a fundamental issue in biology. To address this question, C. elegans has been widely used as a model animal for the analysis of various animal behaviors. Previous behavioral assays have been limited to two-dimensional (2-D) environments, confining the worm motion to a planar substrate that does not reflect three-dimensional (3-D) natural environments such as rotting fruits or soil. Here, we develop a 3-D worm tracker (3DWT) for freely moving C. elegans in 3-D environments, based on a stereoscopic configuration. The 3DWT provides us with a quantitative trajectory, including the position and movement direction of the worm in 3-D. The 3DWT is also capable of recording and visualizing postures of the moving worm in 3-D, which are more complex than those in 2-D. Our 3DWT affords new opportunities for understanding the nervous system function that regulates animal behaviors in natural 3-D environments.	[Kwon, Namseop; Pyo, Jaeyeon; Je, Jung Ho] Pohang Univ Sci & Technol, Xray Imaging Ctr, Pohang, South Korea; [Kwon, Namseop; Lee, Seung-Jae; Je, Jung Ho] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Pyo, Jaeyeon; Je, Jung Ho] Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Pohang, South Korea; [Lee, Seung-Jae] Pohang Univ Sci & Technol, Dept Mol & Life Sci, Pohang, South Korea; [Lee, Seung-Jae] Pohang Univ Sci & Technol, World Class Univ Informat Technol Convergence Eng, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	seungjaelee@postech.ac.kr; jhje@postech.ac.kr	Lee, Seung Jae V/E-2468-2019	Lee, Seung-Jae/0000-0002-6103-156X	Creative Research Initiatives (Functional X-ray Imaging) of MEST/NRF (Ministry of Education, Science and Technology/National Research Foundation)	Creative Research Initiatives (Functional X-ray Imaging) of MEST/NRF (Ministry of Education, Science and Technology/National Research Foundation)	This research was supported by the Creative Research Initiatives (Functional X-ray Imaging) of MEST/NRF (Ministry of Education, Science and Technology/National Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Buckingham SD, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-84; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; Cronin Christopher J., 2006, V351, P241; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; GUO ZC, 1989, COMMUN ACM, V32, P359, DOI 10.1145/62065.62074; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Ronkko M, 2008, J THEOR BIOL, V253, P316, DOI 10.1016/j.jtbi.2008.03.028; Sengupta P, 2009, CURR OPIN NEUROBIOL, V19, P637, DOI 10.1016/j.conb.2009.09.009; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	14	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57484	10.1371/journal.pone.0057484	http://dx.doi.org/10.1371/journal.pone.0057484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437394	gold, Green Submitted, Green Published			2022-12-27	WOS:000315186000107
J	Smitz, N; Berthouly, C; Cornelis, D; Heller, R; Van Hooft, P; Chardonnet, P; Caron, A; Prins, H; van Vuuren, BJ; De Iongh, H; Michaux, J				Smitz, Nathalie; Berthouly, Cecile; Cornelis, Daniel; Heller, Rasmus; Van Hooft, Pim; Chardonnet, Philippe; Caron, Alexandre; Prins, Herbert; van Vuuren, Bettine Jansen; De Iongh, Hans; Michaux, Johan			Pan-African Genetic Structure in the African Buffalo (Syncerus caffer): Investigating Intraspecific Divergence	PLOS ONE			English	Article							MITOCHONDRIAL CONTROL REGION; POPULATION-STRUCTURE; FOREST BUFFALO; NATIONAL-PARK; CAPE BUFFALO; MICROSATELLITE ANALYSIS; EVOLUTIONARY HISTORY; SABLE ANTELOPE; DNA VARIATION; D-LOOP	The African buffalo (Syncerus caffer) exhibits extreme morphological variability, which has led to controversies about the validity and taxonomic status of the various recognized subspecies. The present study aims to clarify these by inferring the pan-African spatial distribution of genetic diversity, using a comprehensive set of mitochondrial D-loop sequences from across the entire range of the species. All analyses converged on the existence of two distinct lineages, corresponding to a group encompassing West and Central African populations and a group encompassing East and Southern African populations. The former is currently assigned to two to three subspecies (S. c. nanus, S. c. brachyceros, S. c. aequinoctialis) and the latter to a separate subspecies (S. c. caffer). Forty-two per cent of the total amount of genetic diversity is explained by the between-lineage component, with one to seventeen female migrants per generation inferred as consistent with the isolation-with-migration model. The two lineages diverged between 145 000 to 449 000 years ago, with strong indications for a population expansion in both lineages, as revealed by coalescent-based analyses, summary statistics and a star-like topology of the haplotype network for the S. c. caffer lineage. A Bayesian analysis identified the most probable historical migration routes, with the Cape buffalo undertaking successive colonization events from Eastern toward Southern Africa. Furthermore, our analyses indicate that, in the West- Central African lineage, the forest ecophenotype may be a derived form of the savanna ecophenotype and not vice versa, as has previously been proposed. The African buffalo most likely expanded and diverged in the late to middle Pleistocene from an ancestral population located around the current-day Central African Republic, adapting morphologically to colonize new habitats, hence developing the variety of ecophenotypes observed today.	[Smitz, Nathalie; Michaux, Johan] Univ Liege, Dept Life Sci Conservat Genet, Liege, Belgium; [Berthouly, Cecile; Cornelis, Daniel; Caron, Alexandre] Ctr Cooperat Int Rech Agron Dev CIRAD, Montferrier Le Lez, France; [Heller, Rasmus] Univ Copenhagen, Dept Biol Bioinformat, Copenhagen, Denmark; [Van Hooft, Pim] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Chardonnet, Philippe] Int Fdn Conservat Wildlife IGF, Paris, France; [Caron, Alexandre] Univ Zimbabwe, Dept Environm & Soc, Ctr Cooperat Int Rech Agron Dev CIRAD, Harare, Zimbabwe; [Caron, Alexandre] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Prins, Herbert] Wageningen Univ, Trop Nat Conservat & Vertebrate Ecol Grp, NL-6700 AP Wageningen, Netherlands; [van Vuuren, Bettine Jansen] Univ Johannesburg, Dept Zool, Ctr Invas Biol, Johannesburg, South Africa; [De Iongh, Hans] Leiden Univ, Inst Environm Sci, Leiden, Netherlands; [Michaux, Johan] Ctr Biol & Gest Populat CBGP, Montferrier Le Lez, France	University of Liege; CIRAD; University of Copenhagen; Wageningen University & Research; CIRAD; University of Zimbabwe; University of Pretoria; Wageningen University & Research; University of Johannesburg; Leiden University; Leiden University - Excl LUMC	Smitz, N (corresponding author), Univ Liege, Dept Life Sci Conservat Genet, Liege, Belgium.	nsmitz@student.ulg.ac.be	Berthouly-Salazar, Cecile/J-3204-2016; Jansen van Vuuren, Bettine/E-6227-2013; Caron, Alexandre/F-8969-2010; de Iongh, Hendrik/K-6694-2013; Heller, Rasmus/M-2580-2014	Berthouly-Salazar, Cecile/0000-0002-0685-6745; Jansen van Vuuren, Bettine/0000-0002-5334-5358; Caron, Alexandre/0000-0002-5213-3273; Heller, Rasmus/0000-0001-6583-6923; Smitz, Nathalie/0000-0001-5155-0801; Prins, Herbert/0000-0003-1131-5107	FRS-FNRS of Belgium (Fond National pour la Recherche Scientifique) [A5/5-MCF/BIC-11561, F3/5/5-MCF/ROI/BC-20.003]; French National Research Agency (ANR Mobility program)	FRS-FNRS of Belgium (Fond National pour la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); French National Research Agency (ANR Mobility program)(French National Research Agency (ANR))	This study is supported by research grants from the FRS-FNRS of Belgium (Fond National pour la Recherche Scientifique) provided to J.R. Michaux (A5/5-MCF/BIC-11561) and N.M.R. Smitz (F3/5/5- MCF/ROI/BC-20.003) (http://www1.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; West African buffalo tissue samples came from a study funded by the French National Research Agency (ANR Mobility program). Special thanks go to M. Pellerin from the IGF of Paris (Fondation Internationale pour la Gestion de la Faune), K.L. Kanapeckas for the samples from the Hluhluwe-Imfolozi National Park, P. Bouche, M. de Garine-Wichatitsky (Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement), F. Jori (Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement), R. Godinho, D. Mathieu, R. Barrat, E. Turquin, P. Dumesnil, Y. Penet, R. Michael, R. Paolucci, D. Stromberg, M. Pariente, E. Jan, Y. Forestier, J.F. Herrera, R. Garza, P. Leveau, P. Augais, Basson, R. Buij, B. Croes and Jayet for all other samples of tissue, dung or blood of the African buffalo. We also thank the CIRAD RP-PCP platform of Harare for providing samples from Southern Africa. Further thanks to M. Melletti and E.S. Vrba for personal comments and investigation into the interpretation of the results.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALDEN P, 1995, NATL AUDUBON SOC FIE; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; [Anonymous], CHROM; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; AQUADRO CF, 1983, GENETICS, V103, P287; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Arctander P, 1996, HEREDITY, V76, P465, DOI 10.1038/hdy.1996.69; Arctander P, 1996, MOL GENETICS CONSERV; Bekhuis PDBM, 2008, AFR J ECOL, V46, P668, DOI 10.1111/j.1365-2028.2008.00956.x; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Birungi J, 2000, MOL ECOL, V9, P1997, DOI 10.1046/j.1365-294X.2000.01107.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Buchholtz C, 1990, GRZIMEKS ENCY MAMMAL, V5, P360; Cohen AS, 2007, P NATL ACAD SCI USA, V104, P16422, DOI 10.1073/pnas.0703873104; Corson PJ, 2002, BUFFLE AFRIQUE BIOL; CRANDALL KA, 1993, GENETICS, V134, P959; CRIBIU EP, 1980, ANN GENET SEL ANIM, V12, P291, DOI 10.1186/1297-9686-12-3-291; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Douzery E, 1997, MOL BIOL EVOL, V14, P1154, DOI 10.1093/oxfordjournals.molbev.a025725; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupont LM, 2000, PALAEOGEOGR PALAEOCL, V155, P95, DOI 10.1016/S0031-0182(99)00095-4; DUPONT LM, 1992, VEG HIST ARCHAEOBOT, V1, P163; East R., 1999, AFRICAN ANTELOPE DAT, V21; Endler J.A., 1977, Monographs in Population Biology, pi; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang M, 2006, ANIM GENET, V37, P459, DOI 10.1111/j.1365-2052.2006.01498.x; Finlay EK, 2007, BIOLOGY LETT, V3, P449, DOI 10.1098/rsbl.2007.0146; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Fritz H, 1997, ECOGRAPHY, V20, P417, DOI 10.1111/j.1600-0587.1997.tb00387.x; Fu YX, 1997, GENETICS, V147, P915; Gentry A.W., 1978, P540; GIRMAN DJ, 1993, J HERED, V84, P450, DOI 10.1093/oxfordjournals.jhered.a111371; Greyling BJ, 2008, AFR J BIOTECHNOL, V7, P655; Groves C, 2011, UNGULATE TAXONOMY; Groves Colin P., 1992, Archaeology in Oceania, V27, P153; GRUBB P, 1972, Zeitschrift fuer Saeugetierkunde, V37, P121; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heller R, 2008, MOL ECOL, V17, P4845, DOI 10.1111/j.1365-294X.2008.03961.x; Heller R, 2010, MOL ECOL, V19, P1324, DOI 10.1111/j.1365-294X.2010.04589.x; Heller R, 2012, MOL ECOL, V21, P3947, DOI 10.1111/j.1365-294X.2012.05671.x; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hsu T. C., 1970, ATLAS MAMMALIAN CHRO, V4; Joly S, 2007, SYST BIOL, V56, P857, DOI 10.1080/10635150701633153; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kingdon J., 1982, E AFRICAN MAMMALS AT, V3; Klein R. G., 1988, AFR ARCHAEOL REV, V6, P3, DOI [10.1007/BF01117110., DOI 10.1007/BF01117110]; Klein R. G., 1995, QUATERNARY EXTINCTIO, P553; Korte LM, 2008, J ZOOL, V275, P229, DOI 10.1111/j.1469-7998.2008.00430.x; Korte LM, 2008, J MAMMAL, V89, P115, DOI 10.1644/06-MAMM-A-423.1; Kraus RH, 2011, JOVE-J VIS EXP, V54; Kraus Robert H. S., 2009, Wildfowl, P215; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Lorenzen ED, 2006, J HERED, V97, P119, DOI 10.1093/jhered/esj012; Lorenzen ED, 2004, MOL ECOL, V13, P3007, DOI 10.1111/j.1365-294X.2004.02308.x; Lorenzen ED, 2007, MOL ECOL, V16, P3241, DOI 10.1111/j.1365-294X.2007.03382.x; Lorenzen ED, 2006, MOL ECOL, V15, P3787, DOI 10.1111/j.1365-294X.2006.03059.x; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Melletti M, 2007, J MAMMAL, V88, P1312, DOI 10.1644/06-MAMM-A-240R1.1; Moodley Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000454; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Nei M., 1987, MOL EVOLUTIONARY GEN; Nersting LG, 2001, MOL ECOL, V10, P711, DOI 10.1046/j.1365-294x.2001.01205.x; Nowak RM, 1991, WALKERS MAMMALS WORL; Nyakaana S, 1999, MOL ECOL, V8, P1105, DOI 10.1046/j.1365-294x.1999.00661.x; Nyakaana S, 2002, HEREDITY, V89, P90, DOI 10.1038/sj.hdy.6800110; O'Ryan C, 1998, ANIM CONSERV, V1, P85, DOI 10.1111/j.1469-1795.1998.tb00015.x; Okello JBA, 2005, HEREDITY, V95, P206, DOI 10.1038/sj.hdy.6800711; Pitra C, 2002, MOL ECOL, V11, P1197, DOI 10.1046/j.1365-294X.2002.01516.x; Pitra C, 2006, EUR J WILDLIFE RES, V52, P145, DOI 10.1007/s10344-005-0026-y; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Prins HHT, 1996, WILDLIFE ECOLOGY BEH, V1; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Simonsen B. T., 1997, THESIS U COPENHAGEN; Simonsen BT, 1998, MOL ECOL, V7, P225, DOI 10.1046/j.1365-294x.1998.00343.x; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; STARK MA, 1986, AFR J ECOL, V24, P255, DOI 10.1111/j.1365-2028.1986.tb00369.x; Templeton A. R., 1996, CONSERVATION GENETIC; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Hooft P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-106; van Hooft P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001086; van Hooft WF, 2003, CONSERV GENET, V4, P467, DOI 10.1023/A:1024719231545; Van Hooft WF, 2002, MOL ECOL, V11, P267, DOI 10.1046/j.1365-294X.2002.01429.x; van Hooft WF, 2000, MOL ECOL, V9, P2017, DOI 10.1046/j.1365-294X.2000.01101.x; van Vuuren BJ, 2010, S AFR J WILDL RES, V40, P35, DOI 10.3957/056.040.0114; Villagomez DAF, 2008, CYTOGENET GENOME RES, V120, P69, DOI 10.1159/000118742; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; Wenink PW, 1998, MOL ECOL, V7, P1315, DOI 10.1046/j.1365-294x.1998.00463.x; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WURSTER DH, 1968, CHROMOSOMA, V25, P152, DOI 10.1007/BF00327175	102	35	35	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56235	10.1371/journal.pone.0056235	http://dx.doi.org/10.1371/journal.pone.0056235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437100	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000018
J	Walsh, SD; Molcho, M; Craig, W; Harel-Fisch, Y; Huynh, Q; Kukaswadia, A; Aasvee, K; Varnai, D; Ottova, V; Ravens-Sieberer, U; Pickett, W				Walsh, Sophie D.; Molcho, Michal; Craig, Wendy; Harel-Fisch, Yossi; Quynh Huynh; Kukaswadia, Atif; Aasvee, Katrin; Varnai, Dora; Ottova, Veronika; Ravens-Sieberer, Ulrike; Pickett, William			Physical and Emotional Health Problems Experienced by Youth Engaged in Physical Fighting and Weapon Carrying	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; PROBLEM BEHAVIOR-THEORY; MULTIPLE RISK BEHAVIOR; UNITED-STATES; COMMUNITY VIOLENCE; MEXICAN-AMERICAN; SUBSTANCE USE; ADOLESCENCE; COMPLAINTS; ASSOCIATION	Then aims of the current study were 1) to provide cross-national estimates of the prevalence of physical fighting and weapon carrying among adolescents aged 11-15 years; (2) To examine the possible effects of physical fighting and weapon carrying on the occurrence of physical (medically treated injuries) and emotional health outcomes (multiple health complaints) among adolescents within the theoretical framework of Problem Behaviour Theory. 20,125 adolescents aged 11-15 in five countries (Belgium, Israel, USA, Canada, FYR Macedonia) were surveyed via the 2006 Health Behaviour in School Aged Children survey. Prevalence was calculated for physical fighting and weapon carrying along with physical and emotional measures that potentially result from violence. Regression analyses were used to quantify associations between violence/weapon carrying and the potential health consequences within each country. Large variations in fighting and weapon carrying were observed across countries. Boys reported more frequent episodes of fighting/weapon carrying and medically attended injuries in every country, while girls reported more emotional symptoms. Although there were some notable variations in findings between different participating countries, increased weapon carrying and physical fighting were both independently and consistently associated with more frequent reports of the potential health outcomes. Adolescents engaging in fighting and weapon carrying are also at risk for physical and emotional health outcomes. Involvement in fighting and weapon carrying can be seen as part of a constellation of risk behaviours with obvious health implications. Our findings also highlight the importance of the cultural context when examining the nature of violent behaviour for adolescents.	[Walsh, Sophie D.] Bar Ilan Univ, Dept Criminol, Ramat Gan, Israel; [Molcho, Michal] Natl Univ Ireland, Sch Hlth Sci, Galway, Ireland; [Craig, Wendy] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Harel-Fisch, Yossi] Bar Ilan Univ, Sch Educ, Ramat Gan, Israel; [Quynh Huynh; Pickett, William] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Kukaswadia, Atif; Pickett, William] Queens Univ, Social Program Evaluat Grp, Kingston, ON, Canada; [Aasvee, Katrin] Natl Inst Hlth Dev, Dept Chron Dis, Tallinn, Estonia; [Varnai, Dora] Natl Inst Child Hlth, Budapest, Hungary; [Ottova, Veronika; Ravens-Sieberer, Ulrike] Univ Med Ctr Hamburg Eppendorf, Res Unit Child Publ Hlth, Hamburg, Germany	Bar Ilan University; Ollscoil na Gaillimhe-University of Galway; Queens University - Canada; Bar Ilan University; Queens University - Canada; Queens University - Canada; National Institute for Health Development - Estonia; University of Hamburg; University Medical Center Hamburg-Eppendorf	Walsh, SD (corresponding author), Bar Ilan Univ, Dept Criminol, Ramat Gan, Israel.	sophiewalsh@gmail.com			Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation (HSF) (CIHR Grant) [MOP 97962]; Heart and Stroke Foundation (HSF) (CIHR/HSF Grant) [PCR 101415]; Public Health Agency of Canada; ministries of health and education of the Israeli government; Israeli HBSC survey	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (HSF) (CIHR Grant)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (HSF) (CIHR/HSF Grant)(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; ministries of health and education of the Israeli government; Israeli HBSC survey	Partial support for this analysis included operating grants from the Canadian Institutes of Health Research (CIHR) and Heart and Stroke Foundation (HSF) (CIHR Grant MOP 97962; CIHR/HSF Grant PCR 101415) and the Public Health Agency of Canada. It was also supported by a joint grant from the ministries of health and education of the Israeli government that co-funded the Israeli HBSC survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SCH VIOLENCE EMBEDDE; Aspy CB, 2004, J COUNS DEV, V82, P268, DOI 10.1002/j.1556-6678.2004.tb00310.x; Barnekow V., 2008, INEQUALITIES YOUNG P; Chivvis CS, 2008, SURVIVAL, V50, P141, DOI 10.1080/00396330802034275; Cook PJ, 2004, CRIMINOLOGY, V42, P27, DOI 10.1111/j.1745-9125.2004.tb00512.x; Currie C., 2012, SOCIAL DETERMINANTS; Currie C., 2004, WHO POLICY SERIES HL; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; de Looze M, 2012, J EARLY ADOLESCENCE, V32, P104, DOI 10.1177/0272431611414062; DONOVAN JE, 1993, J HEALTH SOC BEHAV, V34, P346, DOI 10.2307/2137372; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P21; DuRant RH, 1997, ARCH PEDIAT ADOL MED, V151, P360, DOI 10.1001/archpedi.1997.02170410034004; Evans WP, 2001, J INTERPERS VIOLENCE, V16, P1330, DOI 10.1177/088626001016012006; Ferguson CJ, 2010, PSYCHIAT QUART, V81, P293, DOI 10.1007/s11126-010-9138-y; Ferguson CJ, 2009, J PEDIAT, V155; GARRISON CZ, 1993, AM J PUBLIC HEALTH, V83, P179, DOI 10.2105/AJPH.83.2.179; Grossman DC, 1997, JAMA-J AM MED ASSOC, V277, P1605, DOI 10.1001/jama.277.20.1605; Grunbaum JA, 2002, J SCHOOL HEALTH, V72, P313, DOI 10.1111/j.1746-1561.2002.tb07917.x; Harel-Fisch Y, 2012, YOUTH ISRAEL RESULTS; Harel-Fisch Y, 2010, CHILD ABUSE NEGLECT, V34, P623, DOI 10.1016/j.chiabu.2009.12.007; Haugland S, 2001, EUR J PUBLIC HEALTH, V11, P4, DOI 10.1093/eurpub/11.1.4; Hetland J, 2002, SCAND J PUBLIC HEALT, V30, P223, DOI 10.1080/140349402320290953; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hyder AA, 2009, LANCET, V373, P102, DOI 10.1016/S0140-6736(08)61736-5; JESSOR R, 1992, DEV REV, V12, P374, DOI 10.1016/0273-2297(92)90014-S; Jessor R., 1977, PROBLEM BEHAV PSYCHO; Khoury-Kassabri M, 2007, HEALTH EDUC BEHAV, V34, P453, DOI 10.1177/1090198106291966; Koven R, 2005, PREV MED, V41, P240, DOI 10.1016/j.ypmed.2004.11.009; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Laufer A., 2006, J SCH VIOLENCE, V5, P71, DOI DOI 10.1300/J202V05N03_06; Lim LL, 2009, INT J PSYCHOL, V44, P71, DOI 10.1080/00207590701656168; Muula Adamson S, 2008, Ann Gen Psychiatry, V7, P8, DOI 10.1186/1744-859X-7-8; Nickerson AB, 2009, SCHOOL PSYCHOL REV, V38, P218; O'Donnell DA, 2006, DEV PSYCHOPATHOL, V18, P215, DOI 10.1017/S0954579406060123; ORPINAS PK, 1995, J ADOLESCENT HEALTH, V16, P216, DOI 10.1016/1054-139X(94)00067-O; Parker H, 2002, SOCIOLOGY, V36, P941, DOI 10.1177/003803850203600408; Parker H, 2005, ADDICT RES THEORY, V13, P205, DOI 10.1080/16066350500053703; Parsai M, 2009, YOUTH SOC, V40, P353, DOI 10.1177/0044118X08318117; Pepler D, 2011, INT J BEHAV DEV, V35, P389, DOI 10.1177/0165025411407455; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Pickett W, 2004, YOUNG PEOPLES HLTH C, P145; Pickett W, PEDIATRICS IN PRESS; Pickett W, 2009, J SCHOOL HEALTH, V79, P160, DOI 10.1111/j.1746-1561.2009.00385.x; Prince S, 2009, FORENSIC MENTAL HLTH, P67; Ravens-Sieberer U, 2008, EUR J PUBLIC HEALTH, V18, P294, DOI 10.1093/eurpub/ckn001; Roberts C, 2007, J PUBLIC HEALTH-HEID, V15, P179, DOI 10.1007/s10389-007-0100-x; Roche KM, 2008, SOC SCI MED, V66, P2023, DOI 10.1016/j.socscimed.2008.01.009; SCHEIDT PC, 1995, AM J PUBLIC HEALTH, V85, P932, DOI 10.2105/AJPH.85.7.932; Sethi D, 2008, PROGR PREVENTING INJ; Shetgiri R, 2010, ACAD PEDIATR, V10, P323, DOI 10.1016/j.acap.2010.06.004; Shields N, 2006, NATL RESPONSES PREVE; Simon TR, 1999, J ADOLESCENT HEALTH, V24, P340, DOI 10.1016/S1054-139X(98)00121-9; SOSIN DM, 1995, J ADOLESCENT HEALTH, V16, P209, DOI 10.1016/1054-139X(94)00093-T; Thomas EM, 2004, AGGRESSIVE BEHAV OUT; Torsheim T, 2001, J ADOLESCENT RES, V16, P293, DOI 10.1177/0743558401163003; Tschann JM, 2005, J ADOLESCENT HEALTH, V37, P11, DOI 10.1016/j.jadohealth.2004.07.009; Udry J. R., 1998, NEW PERSPECTIVES ADO, P241, DOI [10.1017/CBO9780511571138.009, DOI 10.1017/CBO9780511571138.009]; Valois R.F., 2006, J CHILD FAM STUD, V15, P695, DOI [10.1007/s10826-006-9043-z, DOI 10.1007/S10826-006-9043-Z]; Vazsonyi AT, 2010, DEV PSYCHOL, V46, P1779, DOI 10.1037/a0020682; Vazsonyi AT, 2008, J ADOLESCENT HEALTH, V43, P555, DOI 10.1016/j.jadohealth.2008.06.013; WAXWEILER RJ, 1993, PUBLIC HEALTH REP, V108, P11; Wilcox P, 2001, JUSTICE Q, V18, P509, DOI 10.1080/07418820100095001; World Health Organization (WHO), 2009, CHANG CULT SOC NORMS	63	54	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56403	10.1371/journal.pone.0056403	http://dx.doi.org/10.1371/journal.pone.0056403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437126	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000025
J	Wang, Q; Li, B; Tsang, AKL; Yi, Y; Woo, PCY; Liu, CH				Wang, Qi; Li, Bin; Tsang, Alan K. L.; Yi, Yong; Woo, Patrick C. Y.; Liu, Cui Hua			Genotypic Analysis of Klebsiella pneumoniae Isolates in a Beijing Hospital Reveals High Genetic Diversity and Clonal Population Structure of Drug-Resistant Isolates	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; RISK-FACTORS; TEL-AVIV; STRAINS; SPREAD; CARE; DISSEMINATION; CIPROFLOXACIN; INFECTION	Background: The genetic diversity and the clinical relevance of the drug-resistant Klebsiella pneumoniae isolates from hospital settings are largely unknown. We thus conducted this prospective study to analyze the molecular epidemiology of K. pneumoniae isolates from patients being treated in the 306 Hospital in Beijing, China for the period of November 1, 2010-October 31, 2011. Methodology/Principal Findings: Antibiotic susceptibility testing, PCR amplification and sequencing of the drug resistance-associated genes, and multilocus sequence typing (MLST) were conducted. A total of 163 isolates were analyzed. The percentage of MDR, XDR and PDR isolates were 63.8% (104), 20.9 (34), and 1.8% (3), respectively. MLST results showed that 60 sequence types (STs) were identified, which were further separated by eBURST into 13 clonal complexes and 18 singletons. The most dominant ST was ST15 (10.4%). Seven new alleles and 24 new STs were first identified in this study. Multiple logistic regression analysis revealed that certain clinical characteristics were associated with those prevalent STs such as: from ICU, from medical ward, from community acquired infection, from patients without heart disease, from patients with treatment success, susceptible to extended spectrum cephalosporin, susceptible to cephamycins, susceptible to fluoroquinolones, and with MDR. Conclusions/Significance: Our data indicate that certain drug-resistant K. pneumoniae clones are highly prevalent and are associated with certain clinical characteristics in hospital settings. Our study provides evidence demonstrating that intensive nosocomial infection control measures are urgently needed.	[Wang, Qi; Li, Bin; Liu, Cui Hua] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Tsang, Alan K. L.; Woo, Patrick C. Y.] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Yi, Yong] 306 Hosp, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Hong Kong	Woo, PCY (corresponding author), Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	pcywoo@hkucc.hku.hk; liucuihua@im.ac.cn	Woo, Patrick Chiu Yat/AAJ-6112-2020	Woo, Patrick Chiu Yat/0000-0001-9401-1832	National Basic Research Program of China [2012CB518700]; National Natural Science Foundation of China (NSFC) [30700975]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-6]; Merieux Research Grant program; Chinese Academy of Sciences; Merieux Research Grant	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Merieux Research Grant program; Chinese Academy of Sciences(Chinese Academy of Sciences); Merieux Research Grant	This study was supported by a grant from the National Basic Research Program of China (grant number 2012CB518700); a grant from National Natural Science Foundation of China (NSFC) (grant No. 30700975); a grant from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6); and the Merieux Research Grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was largely supported by research grants from National Natural Science Foundation of China and Chinese Academy of Sciences, while the Merieux Research Grant acknowledged in this manuscript only partially contributed to this study. In addition, no competing interests and any other relevant declarations relating to employment, consultancy, patents, products in development or marketed products etc. are associated with this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; [Anonymous], 2011, PERF STAND ANT SUS S; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Breurec S, 2013, CLIN MICROBIOL INFEC, V19, P349, DOI 10.1111/j.1469-0691.2012.03805.x; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; Chmelnitsky I, 2009, J ANTIMICROB CHEMOTH, V64, P718, DOI 10.1093/jac/dkp272; Chudackova E, 2010, FEMS MICROBIOL LETT, V309, P62, DOI 10.1111/j.1574-6968.2010.02016.x; Chung DR, 2012, EUR J CLIN MICROBIOL, V31, P481, DOI 10.1007/s10096-011-1334-7; Chung HC, 2012, ANTIMICROB AGENTS CH, V56, P618, DOI 10.1128/AAC.05753-11; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Damjanova I, 2008, J ANTIMICROB CHEMOTH, V62, P978, DOI 10.1093/jac/dkn287; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hammerum AM, 2010, LANCET INFECT DIS, V10, P829, DOI 10.1016/S1473-3099(10)70276-0; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Jemima SA, 2008, INDIAN J MED MICROBI, V26, P365, DOI 10.4103/0255-0857.43581; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Kohlenberg A, 2012, EPIDEMIOL INFECT, V140, P528, DOI 10.1017/S0950268811000781; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Li B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042280; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Nagano N, 2012, J ANTIMICROB CHEMOTH, V67, P849, DOI 10.1093/jac/dkr546; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Orsi GB, 2006, J HOSP INFECT, V64, P23, DOI 10.1016/j.jhin.2006.02.022; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Rotariu O, 2010, EPIDEMIOL INFECT, V138, P1744, DOI 10.1017/S0950268810001457; Sanchez-Romero I, 2012, ANTIMICROB AGENTS CH, V56, P420, DOI 10.1128/AAC.05036-11; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Siu LK, 2011, J CLIN MICROBIOL, V49, P3761, DOI 10.1128/JCM.00977-11; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Zhang R, 2011, J MED MICROBIOL, V60, P977, DOI 10.1099/jmm.0.015826-0; Zimhony O, 2006, ANTIMICROB AGENTS CH, V50, P3179, DOI 10.1128/AAC.00218-06	41	27	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57091	10.1371/journal.pone.0057091	http://dx.doi.org/10.1371/journal.pone.0057091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437318	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000075
J	Dargent, F; Torres-Dowdall, J; Scott, ME; Ramnarine, I; Fussmann, GF				Dargent, Felipe; Torres-Dowdall, Julian; Scott, Marilyn E.; Ramnarine, Indar; Fussmann, Gregor F.			Can Mixed-Species Groups Reduce Individual Parasite Load? A Field Test with Two Closely Related Poeciliid Fishes (Poecilia reticulata and Poecilia picta)	PLOS ONE			English	Article							GYRODACTYLUS-BULLATARUDIS; EXPERIMENTAL INFECTIONS; JUVENILE STICKLEBACKS; TRINIDADIAN GUPPIES; HOST DIVERSITY; HERD-IMMUNITY; LIFE-HISTORY; POPULATIONS; DISEASE; SIZE	Predation and parasitism are two of the most important sources of mortality in nature. By forming groups, individuals can gain protection against predators but may increase their risk of being infected with contagious parasites. Animals might resolve this conflict by forming mixed-species groups thereby reducing the costs associated with parasites through a relative decrease in available hosts. We tested this hypothesis in a system with two closely related poeciliid fishes (Poecilia reticulata and Poecilia picta) and their host-specific monogenean ectoparasites (Gyrodactylus spp.) in Trinidad. Fish from three different rivers were sampled from single and mixed-species groups, measured and scanned for Gyrodactylus. The presence and abundance of Gyrodactylus were lower when fish of both species were part of mixed-species groups relative to single-species groups. This is consistent with the hypothesis that mixed-species groups provide a level of protection against contagious parasites. We discuss the importance of potentially confounding factors such as salinity and individual fish size.	[Dargent, Felipe; Fussmann, Gregor F.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Torres-Dowdall, Julian] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Scott, Marilyn E.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Ramnarine, Indar] Univ W Indies, Dept Life Sci, St Augustine, Piarco Tunapuna, Trinidad Tobago	McGill University; Colorado State University; McGill University; University West Indies Mona Jamaica; University West Indies Saint Augustine	Dargent, F (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	felipe.dargent@mail.mcgill.ca	Scott, Marilyn E/L-5347-2015; Dargent, Felipe/F-8749-2012	Dargent, Felipe/0000-0002-4510-0086; Fussmann, Gregor/0000-0001-9576-0122; Torres-Dowdall, Julian/0000-0003-2729-6246	Natural Sciences and Engineering Research Council of Canada (NSERC) Special Research Opportunity grant [SRO 356373-07]; Vanier CGS; Richard H Tomlinson Fellowship; McGill-STRI NEO	Natural Sciences and Engineering Research Council of Canada (NSERC) Special Research Opportunity grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier CGS; Richard H Tomlinson Fellowship; McGill-STRI NEO	This study was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Special Research Opportunity grant (SRO 356373-07) awarded to GF Fussmann (PI), ME Scott, AP Hendry and P Bentzen; and by a Vanier CGS, a Richard H Tomlinson Fellowship and a McGill-STRI NEO grant-in-aid awarded to F Dargent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Barber I, 1998, J FISH BIOL, V53, P1365, DOI 10.1111/j.1095-8649.1998.tb00256.x; Bates D, 2012, LINEAR MIXED EFFECTS; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2005, SYST PARASITOL, V60, P159, DOI 10.1007/s11230-004-6348-4; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; DUGATKIN LA, 1994, ENVIRON BIOL FISH, V39, P215, DOI 10.1007/BF00004940; FREELAND WJ, 1983, AM NAT, V121, P223, DOI 10.1086/284052; Goncalves G, 2008, EXPERT REV VACCINES, V7, P1493, DOI 10.1586/14760584.7.10.1493; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HARRIS PD, 1992, J PARASITOL, V78, P912, DOI 10.2307/3283329; Hino T, 2000, J AVIAN BIOL, V31, P441, DOI 10.1034/j.1600-048X.2000.310402.x; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; Huizinga M, 2009, J EVOLUTION BIOL, V22, P1860, DOI 10.1111/j.1420-9101.2009.01799.x; Johnson PTJ, 2012, ECOLOGY, V93, P56, DOI 10.1890/11-0636.1; KEARN GC, 1994, INT J PARASITOL, V24, P1227, DOI 10.1016/0020-7519(94)90193-7; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; King TA, 2007, INT J PARASITOL, V37, P663, DOI 10.1016/j.ijpara.2006.11.015; King TA, 2009, PARASITOL INT, V58, P249, DOI 10.1016/j.parint.2009.04.005; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; KRAUSE J, 1994, ETHOLOGY, V98, P128; Krause J, 2002, LIVING GROUPS; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Magurran AE, 2001, BIOL J LINN SOC, V73, P1, DOI [10.1006/bijl.2000.0519, 10.1111/j.1095-8312.2001.tb01342.x]; MIKHEEV VN, 2009, J ICHTHYOL, V49, P1032, DOI DOI 10.1134/S0032945209110034; MOLLER AP, 1993, ADV STUD BEHAV, V22, P65, DOI 10.1016/S0065-3454(08)60405-2; Moore SM, 2012, ECOLOGY, V93, P1095, DOI 10.1890/11-0086.1; Poulin R, 1999, ETHOLOGY, V105, P959, DOI 10.1046/j.1439-0310.1999.00491.x; Poulin R, 1997, OECOLOGIA, V110, P278, DOI 10.1007/s004420050160; POULIN R, 1991, CONDOR, V93, P418, DOI 10.2307/1368958; POULIN R, 1989, BEHAV ECOL SOCIOBIOL, V24, P251, DOI 10.1007/BF00295205; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; REZNICK DN, 1992, COPEIA, P782, DOI 10.2307/1446155; Roche B, 2012, PHILOS T R SOC B, V367, P2807, DOI 10.1098/rstb.2011.0364; Russell ST, 2006, BIOL J LINN SOC, V88, P397, DOI 10.1111/j.1095-8312.2006.00628.x; SASVARI L, 1992, ANIM BEHAV, V43, P289, DOI 10.1016/S0003-3472(05)80224-6; Schelkle B, 2011, AQUACULTURE, V311, P74, DOI 10.1016/j.aquaculture.2010.11.036; SCOTT ME, 1984, PARASITOLOGY, V89, P159, DOI 10.1017/S0031182000001207; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Stumbo AD, 2012, J ANIM ECOL; Tadiri CP, 2012, PARASITOLOGY FIRSTVI, V140, P1, DOI [10.1017/S0031182000055207, DOI 10.1017/S0031182000055207]; TERBORGH J, 1990, AM J PRIMATOL, V21, P87, DOI 10.1002/ajp.1350210203; Thieltges DW, 2008, PARASITOLOGY, V135, P407, DOI 10.1017/S0031182007000248; Tosh CR, 2007, P ROY SOC B-BIOL SCI, V274, P827, DOI 10.1098/rspb.2006.3760; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; WOLF NG, 1985, BEHAV ECOL SOCIOBIOL, V17, P47, DOI 10.1007/BF00299428	50	7	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56789	10.1371/journal.pone.0056789	http://dx.doi.org/10.1371/journal.pone.0056789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437237	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200161
J	Jackson, CJ; Waller, RF				Jackson, Christopher J.; Waller, Ross F.			A Widespread and Unusual RNA Trans-Splicing Type in Dinoflagellate Mitochondria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GENOME; TRANSCRIPTS; EXPRESSION; EVOLUTION; OXYRRHIS; INTRONS; GENES	Cytochrome oxidase subunit 3 (Cox3) is a mitochondrion-encoded core membrane protein of complex IV of the mitochondrial respiratory chain, and consists of seven trans-membrane helices. Here we show that in diverse later-branching dinoflagellates, cox3 is consistently split into two exons in the mitochondrial genome between helices six and seven. Gene exons are transcribed as two discrete oligoadenylated precursor RNAs, and these are subsequently trans-spliced to form a complete coding mRNA. This trans-splicing is highly unusual in that some of the oligoadenylated tail is incorporated at the splice site, such that a short string of adenosines links the two coding exons. This feature is consistently represented in diverse dinoflagellates, however the number of adenosines added varies according to the size of the coding gap between the two exons. Thus we observed between zero (Amphidinium carterae) and 10 (Symbiodinium sp.) adenosines added in different taxa, but the final coding sequence length is identical with the reading frame maintained. Northern analyses show that precursor cox3 transcripts are approximately equally abundant as mature cox3 mRNAs, suggesting a slow or regulated maturation process. These data indicate that the splicing mechanism in dinoflagellate mitochondria is tolerant of variations in the length of the precursor coding sequence, and implicates the use of a splicing template, or guide molecule, during splicing that controls mature mRNA length.	[Jackson, Christopher J.; Waller, Ross F.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	University of Melbourne	Waller, RF (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia.	r.waller@unimelb.edu.au	Waller, Ross F/D-5761-2016	Waller, Ross F/0000-0001-6961-9344	Australian Research Council Discovery [DP0663590]; University of Melbourne Science Faculty Scholarship	Australian Research Council Discovery(Australian Research Council); University of Melbourne Science Faculty Scholarship	This work was supported by an Australian Research Council Discovery grant (DP0663590), and C.J.J. was supported by the University of Melbourne Science Faculty Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbrook AC, 2010, PHILOS T R SOC B, V365, P785, DOI 10.1098/rstb.2009.0250; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; Chaput H, 2002, PROTIST, V153, P111, DOI 10.1078/1434-4610-00090; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Dorrell RG, 2012, P NATL ACAD SCI USA, V109, P18879, DOI 10.1073/pnas.1212270109; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Galvis MLE, 1998, CURR GENET, V33, P320, DOI 10.1007/s002940050343; Gillespie DE, 1999, NUCLEIC ACIDS RES, V27, P2416, DOI 10.1093/nar/27.11.2416; Gornik SG, 2012, CURR BIOL IN PRESS; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Imanian B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-172; Jackson CJ, 2012, GENOME BIOL EVOL, V4, P59, DOI 10.1093/gbe/evr122; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; Kamikawa R, 2011, CURR BIOL, V21, P311, DOI 10.1016/j.cub.2011.01.025; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kiethega GN, 2011, MOL BIOL EVOL, V28, P2425, DOI 10.1093/molbev/msr075; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Lin S., 2008, RNA DNA EDITING MOL, P280, DOI DOI 10.1002/9780470262269.CH13; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; Moreira S, 2012, WIRES RNA, V3, P213, DOI 10.1002/wrna.1106; Nash EA, 2008, TRENDS GENET, V24, P328, DOI 10.1016/j.tig.2008.04.001; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; Rehkopf DH, 2000, MOL BIOCHEM PARASIT, V105, P91, DOI 10.1016/S0166-6851(99)00170-X; Roy SW, 2012, MOL BIOL EVOL, V29, P43, DOI 10.1093/molbev/msr063; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vlcek C, 2011, NUCLEIC ACIDS RES, V39, P979, DOI 10.1093/nar/gkq883; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; Wang YL, 2006, NUCLEIC ACIDS RES, V34, P613, DOI 10.1093/nar/gkj438; Zhang H, 2008, J PHYCOL, V44, P703, DOI 10.1111/j.1529-8817.2008.00521.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang HA, 2011, PROTIST, V162, P154, DOI 10.1016/j.protis.2010.03.003	42	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56777	10.1371/journal.pone.0056777	http://dx.doi.org/10.1371/journal.pone.0056777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437234	gold, Green Published			2022-12-27	WOS:000315184200158
J	Ntshoe, GM; McAnerney, JM; Archer, BN; Smit, SB; Harris, BN; Tempia, S; Mashele, M; Singh, B; Thomas, J; Cengimbo, A; Blumberg, LH; Puren, A; Moyes, J; van den Heever, J; Schoub, BD; Cohen, C				Ntshoe, Genevie M.; McAnerney, Johanna M.; Archer, Brett N.; Smit, Sheilagh B.; Harris, Bernice N.; Tempia, Stefano; Mashele, Mirriam; Singh, Beverley; Thomas, Juno; Cengimbo, Ayanda; Blumberg, Lucille H.; Puren, Adrian; Moyes, Jocelyn; van den Heever, Johann; Schoub, Barry D.; Cohen, Cheryl			Measles Outbreak in South Africa: Epidemiology of Laboratory-Confirmed Measles Cases and Assessment of Intervention, 2009-2011	PLOS ONE			English	Article							PLACENTAL-TRANSFER; ANTIBODIES; IMMUNITY; VIRUS; INFECTION; VACCINE; INFANTS	Background: Since 1995, measles vaccination at nine and 18 months has been routine in South Africa; however, coverage seldom reached >95%. We describe the epidemiology of laboratory-confirmed measles case-patients and assess the impact of the nationwide mass vaccination campaign during the 2009 to 2011 measles outbreak in South Africa. Methods: Serum specimens collected from patients with suspected-measles were tested for measles-specific IgM antibodies using an enzyme-linked immunosorbent assay and genotypes of a subset were determined. To estimate the impact of the nationwide mass vaccination campaign, we compared incidence in the seven months pre-(1 September 2009-11 April 2010) and seven months post-vaccination campaign (24 May 2010-31 December 2010) periods in seven provinces of South Africa. Results: A total of 18,431 laboratory-confirmed measles case-patients were reported from all nine provinces of South Africa (cumulative incidence 37 per 100,000 population). The highest cumulative incidence per 100,000 population was in children aged <1 year (603), distributed as follows: <6 months (302/100,000), 6 to 8 months (1083/100,000) and 9 to 11 months (724/100,000). Forty eight percent of case-patients were >= 5 years (cumulative incidence 54/100,000). Cumulative incidence decreased with increasing age to 2/100,000 in persons >= 40 years. A single strain of measles virus (genotype B3) circulated throughout the outbreak. Prior to the vaccination campaign, cumulative incidence in the targeted vs. non-targeted age group was 5.9-fold higher, decreasing to 1.7 fold following the campaign (P<0.001) and an estimated 1,380 laboratory-confirmed measles case-patients were prevented. Conclusion: We observed a reduction in measles incidence following the nationwide mass vaccination campaign even though it was conducted approximately one year after the outbreak started. A booster dose at school entry may be of value given the high incidence in persons >5 years.	[Ntshoe, Genevie M.; Smit, Sheilagh B.; Mashele, Mirriam; Puren, Adrian; Schoub, Barry D.] NHLS, NICD, Ctr Vaccines & Immunol, Johannesburg, South Africa; [McAnerney, Johanna M.; Moyes, Jocelyn; Cohen, Cheryl] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Archer, Brett N.; Thomas, Juno; Cengimbo, Ayanda; Blumberg, Lucille H.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Harris, Bernice N.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa; [Tempia, Stefano] NICD NHLS, US Ctr Dis Control & Prevent CDC, Johannesburg, South Africa; [Singh, Beverley] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa; [van den Heever, Johann] Dept Hlth, Expanded Programme Immunisat S Africa EPI SA, Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Ntshoe, GM (corresponding author), NHLS, NICD, Ctr Vaccines & Immunol, Johannesburg, South Africa.	genevien@nicd.ac.za; cherylc@nicd.ac.za	Harris, Bernice N/AAN-6197-2021; Archer, Brett Nicholas/A-5610-2012; Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018; Moyes, Jocelyn/AAF-7882-2019	Harris, Bernice N/0000-0002-0924-3178; Archer, Brett Nicholas/0000-0002-4144-1094; Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Cohen, Cheryl/0000-0003-0376-2302; Thomas, Juno/0000-0002-8986-1135				[Anonymous], 2009, Wkly Epidemiol Rec, V84, P397; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P129; Aylward RB, 1997, INT J EPIDEMIOL, V26, P662, DOI 10.1093/ije/26.3.662; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P585; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Department of Health, 1998, EPI DIS SURV FIELD G; Dubray C, 2006, VACCINE, V24, P3984, DOI 10.1016/j.vaccine.2006.01.049; EMBREE JE, 1992, J INFECT DIS, V165, P262, DOI 10.1093/infdis/165.2.262; European Center for Disease Prevention and Control, 2011, EP UPD MEASL EU EEA; EUVAC.NET, 2010, SURV COMM NETW VACC; Goodson JL, 2009, VACCINE, V27, P5870, DOI 10.1016/j.vaccine.2009.07.057; Heymann DL, 2004, CONTROL COMMUNICABLE, P347; HULL HF, 1983, LANCET, V1, P972; LEPAGE P, 1992, AM J DIS CHILD, V146, P550, DOI 10.1001/archpedi.1992.02160170030011; Leuridan E, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1626; McAnerney J, 2008, COMMUNICABLE DIS SUR, V6, P2; McAnerney J, 2009, COMMUNICABLE DIS SUR, V7, P2; McMorrow ML, 2009, SAMJ S AFR MED J, V99, P314; National Department of Health South Africa, 2010, GUID MAN HIV CHILDR; PABST HF, 1992, PEDIATR INFECT DIS J, V11, P525, DOI 10.1097/00006454-199207000-00004; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Scott S, 2007, CLIN INFECT DIS, V45, P1417, DOI 10.1086/522989; Smit S, 2007, COMMUNICABLE DIS SUR, V5, P1; Statistics South Africa, 2010, STAT REL P0302 MID P; WHO, WHO UNICEF JOINT STA; World Health Organisation, 1990, WHOEPIGEN947; World Health Organisation Regional Office for Africa, MEASL PREEL; World Health Organization, 2009, MEASL; World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P469; World Health Organization, 1999, WHOCDSCSRISR991; World Health Organization, 2009, RESP COVID 19 HLTH S	31	33	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55682	10.1371/journal.pone.0055682	http://dx.doi.org/10.1371/journal.pone.0055682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437059	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200021
J	Ohta, S; Fukui, N; Sakai, KL				Ohta, Shinri; Fukui, Naoki; Sakai, Kuniyoshi L.			Syntactic Computation in the Human Brain: The Degree of Merger as a Key Factor	PLOS ONE			English	Article							LEFT PREFRONTAL CORTEX; SUPERIOR TEMPORAL CORTEX; SENTENCE COMPREHENSION; BROCAS AREA; LANGUAGE; JAPANESE; DORSAL; HONORIFICATION; SPECIALIZATION; ACQUISITION	Our goal of this study is to characterize the functions of language areas in most precise terms. Previous neuroimaging studies have reported that more complex sentences elicit larger activations in the left inferior frontal gyrus (L.F3op/F3t), although the most critical factor still remains to be identified. We hypothesize that pseudowords with grammatical particles and morphosyntactic information alone impose a construction of syntactic structures, just like normal sentences, and that "the Degree of Merger" (DoM) in recursively merged sentences parametrically modulates neural activations. Using jabberwocky sentences with distinct constructions, we fitted various parametric models of syntactic, other linguistic, and nonlinguistic factors to activations measured with functional magnetic resonance imaging. We demonstrated that the models of DoM and "DoM+ number of Search (searching syntactic features)" were the best to explain activations in the L. F3op/F3t and supramarginal gyrus (L. SMG), respectively. We further introduced letter strings, which had neither lexical associations nor grammatical particles, but retained both matching orders and symbol orders of sentences. By directly contrasting jabberwocky sentences with letter strings, localized activations in L. F3op/F3t and L. SMG were indeed independent of matching orders and symbol orders. Moreover, by using dynamic causal modeling, we found that the model with a inhibitory modulatory effect for the bottom-up connectivity from L. SMG to L. F3op/F3t was the best one. For this best model, the top-down connection from L. F3op/F3t to L. SMG was significantly positive. By using diffusion-tensor imaging, we confirmed that the left dorsal pathway of the superior longitudinal and arcuate fasciculi consistently connected these regions. Lastly, we established that nonlinguistic order-related and error-related factors significantly activated the right (R.) lateral premotor cortex and R. F3op/F3t, respectively. These results indicate that the identified network of L. F3op/F3t and L. SMG subserves the calculation of DoM in recursively merged sentences.	[Ohta, Shinri; Sakai, Kuniyoshi L.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Ohta, Shinri] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Fukui, Naoki] Sophia Univ, Dept Linguist, Chiyoda Ku, Tokyo 102, Japan; [Fukui, Naoki; Sakai, Kuniyoshi L.] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Sakai, Kuniyoshi L.] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science; Sophia University; Japan Science & Technology Agency (JST); University of Tokyo	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.	sakai@mind.c.u-tokyo.ac.jp	Ohta, Shinri/D-9919-2019	Ohta, Shinri/0000-0003-3240-0028	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan [20220005, 22222001]; Japan Society for the Promotion of Science (JSPS) [24N8931]; Grants-in-Aid for Scientific Research [12J08931] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST), by a Grant-in-Aid for Scientific Research (S) (Nos. 20220005 and 22222001) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by a Grant-in-Aid for JSPS Fellows (No. 24N8931) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2011, NAT NEUROSCI, V14, P1067, DOI 10.1038/nn.2869; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2007, HUM BRAIN MAPP, V28, P940, DOI 10.1002/hbm.20318; Beckers GJL, 2012, NEUROREPORT, V23, P139, DOI 10.1097/WNR.0b013e32834f1765; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Chomsky N., 1957, SYNTACTIC STRUCTURES; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Chomsky Noam, 2004, STRUCTURES CARTOGRAP, P104; Corballis MC, 2007, COGNITIVE SCI, V31, P697, DOI 10.1080/15326900701399947; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; den Ouden DB, 2012, NEUROIMAGE, V59, P815, DOI 10.1016/j.neuroimage.2011.07.057; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friederici AD, 2009, NEUROREPORT, V20, P563, DOI 10.1097/WNR.0b013e3283297dee; Friston KJ, 2006, NEUROIMAGE, V30, P1097, DOI 10.1016/j.neuroimage.2006.02.007; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fukui N, 2003, LINGUA, V113, P321, DOI 10.1016/S0024-3841(02)00080-3; Fukui Naoki., 2011, OXFORD HDB LINGUISTI, P73; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Griffiths JD, 2013, CEREB CORTEX, V23, P139, DOI 10.1093/cercor/bhr386; Gunji T., 1987, JAPANESE PHRASE STRU; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Homae F, 2003, NEUROIMAGE, V20, P578, DOI 10.1016/S1053-8119(03)00272-6; Hopcroft J. E., 1979, INTRO AUTOMATA THEOR; Iijima K, 2009, NEUROIMAGE, V44, P1387, DOI 10.1016/j.neuroimage.2008.10.041; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; Ivana A, 2007, J EAST ASIAN LINGUIS, V16, P171, DOI 10.1007/s10831-007-9011-7; Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Lewis R. L., 2002, SENTENCE PROCESSING, P85; Momo K, 2008, BRAIN LANG, V107, P81, DOI 10.1016/j.bandl.2007.12.003; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; O'Grady W., 2010, CONT LINGUISTICS INT, V6th ed.; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Pattamadilok C, 2010, J NEUROSCI, V30, P8435, DOI 10.1523/JNEUROSCI.5791-09.2010; Petersson KM, 2004, COGNITIVE SCI, V28, P383, DOI 10.1016/j.cogsci.2003.12.003; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Saito M, 1998, LINGUIST INQ, V29, P439, DOI 10.1162/002438998553815; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Santi A, 2010, NEUROIMAGE, V51, P1285, DOI 10.1016/j.neuroimage.2010.03.034; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Tatsuno Y, 2005, J NEUROSCI, V25, P1637, DOI 10.1523/JNEUROSCI.3978-04.2005; Tsujimura Natsuko., 2007, INTRO JAPANESE LINGU; Wilson SM, 2011, NEURON, V72, P397, DOI 10.1016/j.neuron.2011.09.014; Wong FCK, 2011, J NEUROSCI, V31, P8780, DOI 10.1523/JNEUROSCI.0999-11.2011; YNGVE VICTOR H., 1960, PROC AMER PHIL SOC, V104, P444	53	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56230	10.1371/journal.pone.0056230	http://dx.doi.org/10.1371/journal.pone.0056230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437097	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200048
J	Paupy, C; Makanga, B; Ollomo, B; Rahola, N; Durand, P; Magnus, J; Willaume, E; Renaud, F; Fontenille, D; Prugnolle, F				Paupy, Christophe; Makanga, Boris; Ollomo, Benjamin; Rahola, Nil; Durand, Patrick; Magnus, Julie; Willaume, Eric; Renaud, Francois; Fontenille, Didier; Prugnolle, Franck			Anopheles moucheti and Anopheles vinckei Are Candidate Vectors of Ape Plasmodium Parasites, Including Plasmodium praefalciparum in Gabon	PLOS ONE			English	Article							HUMAN MALARIA; FALCIPARUM; ORIGIN; MOSQUITOS; COMPLEX; AFRICA	During the last four years, knowledge about the diversity of Plasmodium species in African great apes has considerably increased. Several new species were described in chimpanzees and gorillas, and some species that were previously considered as strictly of human interest were found to be infecting African apes. The description in gorillas of P. praefalciparum, the closest relative of P. falciparum which is the main malignant agent of human malaria, definitively changed the way we understand the evolution and origin of P. falciparum. This parasite is now considered to have appeared recently, following a cross-species transfer from gorillas to humans. However, the Plasmodium vector mosquito species that have served as bridge between these two host species remain unknown. In order to identify the vectors that ensure ape Plasmodium transmission and evaluate the risk of transfer of these parasites to humans, we carried out a field study in Gabon to capture Anopheles in areas where wild and semi-wild ape populations live. We collected 1070 Anopheles females belonging to 15 species, among which An. carnevalei, An. moucheti and An. marshallii were the most common species. Using mtDNA-based PCR tools, we discovered that An. moucheti, a major human malaria vector in Central Africa, could also ensure the natural transmission of P. praefalciparum among great apes. We also showed that, together with An. vinckei, An. moucheti was infected with P. vivax-like parasites. An. moucheti constitutes, therefore, a major candidate for the transfer of Plasmodium parasites from apes to humans.	[Paupy, Christophe; Rahola, Nil; Durand, Patrick; Renaud, Francois; Fontenille, Didier; Prugnolle, Franck] IRD Montpellier, Lab MIVEGEC, UMR CNRS IRD UM1 UM2 224 5290, Montpellier, France; [Paupy, Christophe; Makanga, Boris; Ollomo, Benjamin; Rahola, Nil; Magnus, Julie; Prugnolle, Franck] CIRMF, Franceville, Gabon; [Makanga, Boris] Inst Rech Ecol Trop, Libreville, Gabon; [Willaume, Eric] ERMAET COMILOG, Bakoumba, Gabon	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Paupy, C (corresponding author), IRD Montpellier, Lab MIVEGEC, UMR CNRS IRD UM1 UM2 224 5290, Montpellier, France.	christophe.paupy@ird.fr; franck.prugnolle@ird.fr	Paupy, Christophe/I-4847-2017; MAKANGA, Boris Kevin MBK/E-5239-2019; RAHOLA, Nil/G-2397-2019; FONTENILLE, didier/G-4091-2013	Paupy, Christophe/0000-0002-7122-2079; MAKANGA, Boris Kevin MBK/0000-0003-1172-6109; RAHOLA, Nil/0000-0003-4067-6438; Prugnolle, Franck/0000-0001-8519-1253; FONTENILLE, didier/0000-0002-0544-3885	CIRMF (Centre International de Recherches Medicales de Franceville); CNRS (Centre National de la Recherche Scientifique); IRD (Institut de Recherche pour le Developpement) through the program PPR FTH-AC (Programme Pilote Regional "Changements globaux, Biodiversite et Sante dans les Forets Tropicales Humides d' Afrique Centrale"); Agence Nationale pour la Recherche (ANR) through the project ORIGIN (Programme Jeunes Chercheurs-Jeunes Chercheuses,Sciences de la Vie, de la Sante et des Ecosystemes) [JCJC-SVSE 7-2012]	CIRMF (Centre International de Recherches Medicales de Franceville); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); IRD (Institut de Recherche pour le Developpement) through the program PPR FTH-AC (Programme Pilote Regional "Changements globaux, Biodiversite et Sante dans les Forets Tropicales Humides d' Afrique Centrale"); Agence Nationale pour la Recherche (ANR) through the project ORIGIN (Programme Jeunes Chercheurs-Jeunes Chercheuses,Sciences de la Vie, de la Sante et des Ecosystemes)(French National Research Agency (ANR))	This work was jointly funded by CIRMF (Centre International de Recherches Medicales de Franceville), CNRS (Centre National de la Recherche Scientifique), IRD (Institut de Recherche pour le Developpement) through the program PPR FTH-AC (Programme Pilote Regional "Changements globaux, Biodiversite et Sante dans les Forets Tropicales Humides d' Afrique Centrale"), and by Agence Nationale pour la Recherche (ANR) through the project ORIGIN JCJC-SVSE 7-2012 (Programme Jeunes Chercheurs-Jeunes Chercheuses,Sciences de la Vie, de la Sante et des Ecosystemes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, ANOPHELINAE AFR S SA; Antonio-Nkondjio C, 2009, ACTA TROP, V112, P270, DOI 10.1016/j.actatropica.2009.08.009; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Gautret P, 2001, ACTA TROP, V78, P177, DOI 10.1016/S0001-706X(00)00181-9; Gillies M, 1987, ANOPHELINAE AFRICA S; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kaiser M, 2010, EMERG INFECT DIS, V16, P1956, DOI 10.3201/eid1612.100424; Kengne P, 2007, MED VET ENTOMOL, V21, P177, DOI 10.1111/j.1365-2915.2007.00681.x; Kengne P, 2003, MED VET ENTOMOL, V7, P1; Krief S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-116; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2011, P NATL ACAD SCI USA, V108, P11948, DOI 10.1073/pnas.1109368108; Prugnolle F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001283; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Verhulst NO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00197	26	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57294	10.1371/journal.pone.0057294	http://dx.doi.org/10.1371/journal.pone.0057294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437363	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200238
J	Vila, M; Carrillo-Gavilan, A; Vayreda, J; Bugmann, H; Fridman, J; Grodzki, W; Haase, J; Kunstler, G; Schelhaas, M; Trasobares, A				Vila, Montserrat; Carrillo-Gavilan, Amparo; Vayreda, Jordi; Bugmann, Harald; Fridman, Jonas; Grodzki, Wojciech; Haase, Josephine; Kunstler, Georges; Schelhaas, MartJan; Trasobares, Antoni			Disentangling Biodiversity and Climatic Determinants of Wood Production	PLOS ONE			English	Article							SPECIES RICHNESS; ECOSYSTEM FUNCTION; FOREST DIVERSITY; METAANALYSIS; SENSITIVITY; PATTERNS; INCREASE; BIOMASS; GROWTH; SCALE	Background: Despite empirical support for an increase in ecosystem productivity with species diversity in synthetic systems, there is ample evidence that this relationship is dependent on environmental characteristics, especially in structurally more complex natural systems. Empirical support for this relationship in forests is urgently needed, as these ecosystems play an important role in carbon sequestration. Methodology/Principal Findings: We tested whether tree wood production is positively related to tree species richness while controlling for climatic factors, by analyzing 55265 forest inventory plots in 11 forest types across five European countries. On average, wood production was 24% higher in mixed than in monospecific forests. Taken alone, wood production was enhanced with increasing tree species richness in almost all forest types. In some forests, wood production was also greater with increasing numbers of tree types. Structural Equation Modeling indicated that the increase in wood production with tree species richness was largely mediated by a positive association between stand basal area and tree species richness. Mean annual temperature and mean annual precipitation affected wood production and species richness directly. However, the direction and magnitude of the influence of climatic variables on wood production and species richness was not consistent, and vary dependent on forest type. Conclusions: Our analysis is the first to find a local scale positive relationship between tree species richness and tree wood production occurring across a continent. Our results strongly support incorporating the role of biodiversity in management and policy plans for forest carbon sequestration.	[Vila, Montserrat; Carrillo-Gavilan, Amparo] Estn Biol Donana EBD CSIC, Seville, Spain; [Vayreda, Jordi] Ctr Recerca Ecol & Aplicac Forestals, Barcelona, Spain; [Bugmann, Harald; Trasobares, Antoni] ETH, Dept Environm Sci, Inst Terr Ecosyst, Zurich, Switzerland; [Fridman, Jonas] Swedish Univ Agr Sci, Dept Forest Resource Management, Swedish Natl Forest Inventory, S-90183 Umea, Sweden; [Grodzki, Wojciech] Dept Forest Management Mt Reg, Forest Res Inst, Krakow, Poland; [Haase, Josephine] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Kunstler, Georges] UR Ecosyst Montagnards, Irstea, St Martin Dheres, France; [Schelhaas, MartJan] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swedish University of Agricultural Sciences; Agricultural University Krakow; Forest Research Institute; University of Freiburg; INRAE; Wageningen University & Research	Vila, M (corresponding author), Estn Biol Donana EBD CSIC, Seville, Spain.	montse.vila@ebd.csic.es	Kunstler, Georges/F-9179-2012; Grodzki, Wojciech/R-8170-2018; Bugmann, Harald/A-1252-2008; Schelhaas, Mart-Jan/I-4731-2012; Vila, Montserrat/D-9339-2013; Trasobares, Antoni/J-8882-2017; Vayreda, Jordi/U-8172-2017	Kunstler, Georges/0000-0002-2544-1940; Grodzki, Wojciech/0000-0003-0623-752X; Vila, Montserrat/0000-0003-3171-8261; Trasobares, Antoni/0000-0002-8123-9405; Vayreda, Jordi/0000-0002-9538-7361; Schelhaas, Mart-Jan/0000-0003-4525-2677; Bugmann, Harald/0000-0003-4233-0094	EU project BACCARA [226299]; Spanish Ministerio de Ciencia e Innovacion project Consolider-Ingenio MONTES [CSD2008-00040]	EU project BACCARA; Spanish Ministerio de Ciencia e Innovacion project Consolider-Ingenio MONTES	The authors thank the National Forest Inventory Services of France, The Netherlands, Spain, Sweden and Switzerland for their long term effort in collecting forest data. The authors thank A. Sala and two anonymous referees for constructive comments on a previous version of this manuscript. Research has been partially funded by the EU project BACCARA (FP7/2007-2013 project No 226299), http://www.baccara-project.eu/) and the Spanish Ministerio de Ciencia e Innovacion project Consolider-Ingenio MONTES (CSD2008-00040), http://www.creaf.uab.es/montes/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2006, SAS MIXED MODELS; Arbuckle JL, 2003, AMOS 18; BABAKUS E, 1987, J MARKETING RES, V24, P222, DOI 10.2307/3151512; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Baraloto C, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009110; Belote RT, 2011, FOREST ECOL MANAG, V261, P1315, DOI 10.1016/j.foreco.2011.01.010; Burger JA, 2009, FOREST ECOL MANAG, V258, P2335, DOI 10.1016/j.foreco.2009.03.015; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Caspersen JP, 2001, ECOL RES, V16, P895, DOI 10.1046/j.1440-1703.2001.00455.x; Chytry M, 2003, J VEG SCI, V14, P563, DOI 10.1111/j.1654-1103.2003.tb02183.x; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; Costanza R, 2007, ECOL ECON, V61, P478, DOI 10.1016/j.ecolecon.2006.03.021; Diaz S., 2009, BIODIVERSITY ECOSYST, P149; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Firn J, 2007, OECOLOGIA, V154, P521, DOI 10.1007/s00442-007-0850-8; Healy C, 2008, J ECOL, V96, P903, DOI 10.1111/j.1365-2745.2008.01419.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Iriondo JM, 2003, BIOL CONSERV, V113, P367, DOI 10.1016/S0006-3207(03)00129-0; Legendre L., 1983, DEV ENV MODELLING; Liang JJ, 2007, FOREST ECOL MANAG, V243, P116, DOI 10.1016/j.foreco.2007.02.028; Liira J, 2010, PLANT BIOSYST, V144, P211, DOI 10.1080/11263500903560868; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Luyssaert S, 2010, GLOBAL CHANGE BIOL, V16, P1429, DOI 10.1111/j.1365-2486.2009.02056.x; Milla R, 2009, ANN BOT-LONDON, V103, P1279, DOI 10.1093/aob/mcp068; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Paquette A, 2009, ECOL SOC, V14; Piotto D, 2008, FOREST ECOL MANAG, V255, P781, DOI 10.1016/j.foreco.2007.09.065; Potvin C, 2008, ECOL LETT, V11, P217, DOI 10.1111/j.1461-0248.2007.01148.x; Pretzsch H, 2005, ECOL STUD-ANAL SYNTH, V176, P41; Robert N, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P207, DOI 10.1007/978-90-481-3233-1_12; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Scherer-Lorenzen M, 2005, ECOL STUD-ANAL SYNTH, V176, P347; Scherer-Lorenzen M, 2007, PERSPECT PLANT ECOL, V9, P53, DOI 10.1016/j.ppees.2007.08.002; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Szwagrzyk J, 2007, J VEG SCI, V18, P555, DOI 10.1111/j.1654-1103.2007.tb02569.x; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P1, DOI 10.1007/978-90-481-3233-1; Vallet P, 2011, J VEG SCI, V22, P932, DOI 10.1111/j.1654-1103.2011.01288.x; Vayreda J, 2012, GLOBAL CHANGE BIOL, V18, P1028, DOI 10.1111/j.1365-2486.2011.02606.x; Vehvilainen H, 2006, ECOGRAPHY, V29, P497, DOI 10.1111/j.0906-7590.2006.04457.x; Vila M, 2005, ECOL STU AN, V176, P65; Vila M, 2007, ECOL LETT, V10, P241, DOI 10.1111/j.1461-0248.2007.01016.x; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Wu M.L, 2010, STRUCTURAL EQUATION; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	53	152	158	3	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e53530	10.1371/journal.pone.0053530	http://dx.doi.org/10.1371/journal.pone.0053530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437038	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200005
J	Andorf, CM; Honavar, V; Sen, TZ				Andorf, Carson M.; Honavar, Vasant; Sen, Taner Z.			Predicting the Binding Patterns of Hub Proteins: A Study Using Yeast Protein Interaction Networks	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; SACCHAROMYCES-CEREVISIAE; INTERACTION MAP; FAMILIES DATABASE; EVOLUTIONARY RATE; SCOP DATABASE; GENOME; MODULARITY; SEQUENCE; DESIGN	Background: Protein-protein interactions are critical to elucidating the role played by individual proteins in important biological pathways. Of particular interest are hub proteins that can interact with large numbers of partners and often play essential roles in cellular control. Depending on the number of binding sites, protein hubs can be classified at a structural level as singlish-interface hubs (SIH) with one or two binding sites, or multiple-interface hubs (MIH) with three or more binding sites. In terms of kinetics, hub proteins can be classified as date hubs (i.e., interact with different partners at different times or locations) or party hubs (i.e., simultaneously interact with multiple partners). Methodology: Our approach works in 3 phases: Phase I classifies if a protein is likely to bind with another protein. Phase II determines if a protein-binding (PB) protein is a hub. Phase III classifies PB proteins as singlish-interface versus multiple-interface hubs and date versus party hubs. At each stage, we use sequence-based predictors trained using several standard machine learning techniques. Conclusions: Our method is able to predict whether a protein is a protein-binding protein with an accuracy of 94% and a correlation coefficient of 0.87; identify hubs from non-hubs with 100% accuracy for 30% of the data; distinguish date hubs/party hubs with 69% accuracy and area under ROC curve of 0.68; and SIH/MIH with 89% accuracy and area under ROC curve of 0.84. Because our method is based on sequence information alone, it can be used even in settings where reliable protein-protein interaction data or structures of protein-protein complexes are unavailable to obtain useful insights into the functional and evolutionary characteristics of proteins and their interactions. Availability: We provide a web server for our three-phase approach: http://hybsvm.gdcb.iastate.edu.	[Andorf, Carson M.; Honavar, Vasant] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Honavar, Vasant; Sen, Taner Z.] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Sen, Taner Z.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Sen, Taner Z.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Iowa State University	Sen, TZ (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA.	taner@iastate.edu	Honavar, Vasant G/K-9835-2015	Honavar, Vasant G/0000-0001-5399-3489; Sen, Taner/0000-0002-5553-6190; Andorf, Carson/0000-0003-2380-6704	National Institute of Health [GM066387]; Integrative Graduate Education and Research Training award [0504304]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM066387, R33GM066387] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Graduate Education and Research Training award; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institute of Health grant GM066387 to VH. The work of CMA was supported in part by a graduate fellowship funded by an Integrative Graduate Education and Research Training award 0504304. The work of VH while working at the National Science Foundation was supported by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi T.H., 2011, AMINO ACIDS; Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andorf C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-284; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Baker M, 2012, NATURE, V484, P271, DOI 10.1038/484271a; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Cukuroglu E, 2010, ANN BIOMED ENG, V38, P2068, DOI 10.1007/s10439-010-0048-9; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fong JH, 2010, MOL BIOSYST, V6, P1821, DOI 10.1039/c005144f; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Gursoy A, 2008, BIOCHEM SOC T, V36, P1398, DOI 10.1042/BST0361398; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hsing M, 2009, BIOINFORMATION, V4, P164, DOI 10.6026/97320630004164; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Ignatev A, 2008, J BIOL CHEM, V283, P18377, DOI 10.1074/jbc.M709718200; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207; Kahali B, 2009, GENE, V429, P18, DOI 10.1016/j.gene.2008.09.032; Kar G, 2012, CURR PHARM DES; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kuzu G, 2012, CURR OPIN STRUCT BIO; Latha AB, 2011, BIOINFORMATION, V7, P163; Liu CH, 2012, HUMAN PROTEIN PROTEI; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Manna B, 2009, GENE, V434, P50, DOI 10.1016/j.gene.2008.12.013; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McCallum A., 1998, P AAAI 98 WORKSH LEA, P41; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mirzarezaee M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-172; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Mitchell T.M, 2003, MACH LEARN; Nair MTaAS, 2009, INT J BIOINFORMATICS, V1, P70; Nash R, 2007, NUCLEIC ACIDS RES, V35, pD468, DOI 10.1093/nar/gkl931; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Pang KF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-179; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Platt J C, 1999, ADV KERNEL METHODS S; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rosenblatt F, 1962, PRINCIPLES NEURODYNA; Liu S, 2007, P NATL ACAD SCI USA, V104, P5330, DOI 10.1073/pnas.0606198104; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vapnik V., 1998, STAT LEARNING THEORY; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xue LC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-244; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	82	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56833	10.1371/journal.pone.0056833	http://dx.doi.org/10.1371/journal.pone.0056833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431393	Green Published, gold, Green Submitted			2022-12-27	WOS:000315182800036
J	Garske, AK; Lawyer, CR; Peterson, BM; Illig, KR				Garske, Anna K.; Lawyer, Chloe R.; Peterson, Brittni M.; Illig, Kurt R.			Adolescent Changes in Dopamine D1 Receptor Expression in Orbitofrontal Cortex and Piriform Cortex Accompany an Associative Learning Deficit	PLOS ONE			English	Article							ORBITAL PREFRONTAL CORTEX; LATERAL OLFACTORY TRACT; BASOLATERAL AMYGDALA; NEURONAL-ACTIVITY; PRESYNAPTIC INHIBITION; POSTNATAL-DEVELOPMENT; TASK-PERFORMANCE; RAT FOREBRAIN; BEHAVIOR; MEMORY	The orbitofrontal cortex (OFC) and piriform cortex are involved in encoding the predictive value of olfactory stimuli in rats, and neural responses to olfactory stimuli in these areas change as associations are learned. This experience-dependent plasticity mirrors task-related changes previously observed in mesocortical dopamine neurons, which have been implicated in learning the predictive value of cues. Although forms of associative learning can be found at all ages, cortical dopamine projections do not mature until after postnatal day 35 in the rat. We hypothesized that these changes in dopamine circuitry during the juvenile and adolescent periods would result in age-dependent differences in learning the predictive value of environmental cues. Using an odor-guided associative learning task, we found that adolescent rats learn the association between an odor and a palatable reward significantly more slowly than either juvenile or adult rats. Further, adolescent rats displayed greater distractibility during the task than either juvenile or adult rats. Using real-time quantitative PCR and immunohistochemical methods, we observed that the behavioral deficit in adolescence coincides with a significant increase in D1 dopamine receptor expression compared to juvenile rats in both the OFC and piriform cortex. Further, we found that both the slower learning and increased distractibility exhibited in adolescence could be alleviated by experience with the association task as a juvenile, or by an acute administration of a low dose of either the dopamine D1 receptor agonist SKF-38393 or the D2 receptor antagonist eticlopride. These results suggest that dopaminergic modulation of cortical function may be important for learning the predictive value of environmental stimuli, and that developmental changes in cortical dopaminergic circuitry may underlie age-related differences in associative learning.	[Illig, Kurt R.] Univ St Thomas, Dept Biol, St Paul, MN 55105 USA; Univ St Thomas, Program Neurosci, St Paul, MN USA	University of St Thomas Minnesota; University of St Thomas Minnesota	Illig, KR (corresponding author), Univ St Thomas, Dept Biol, St Paul, MN 55105 USA.	krillig@stthomas.edu		Illig, Kurt/0000-0002-6373-9625				Anker JJ, 2010, PSYCHOPHARMACOLOGY, V208, P211, DOI 10.1007/s00213-009-1721-2; Bohn I, 2003, BEHAV BRAIN RES, V143, P49, DOI 10.1016/S0166-4328(03)00008-1; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; Brenhouse HC, 2008, BEHAV NEUROSCI, V122, P460, DOI 10.1037/0735-7044.122.2.460; Brenhouse HC, 2008, J NEUROSCI, V28, P2375, DOI 10.1523/JNEUROSCI.5064-07.2008; Calu DJ, 2007, CEREB CORTEX, V17, P1342, DOI 10.1093/cercor/bhl045; Campbell KM, 1999, J NEUROSCI, V19, P5044; CHIODO LA, 1984, NEUROSCIENCE, V12, P1, DOI 10.1016/0306-4522(84)90133-7; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Dang LC, 2012, J NEUROSCI, V32, P9582, DOI 10.1523/JNEUROSCI.0909-12.2012; DIOP L, 1988, SYNAPSE, V2, P395, DOI 10.1002/syn.890020406; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Ekstrand JJ, 2001, J COMP NEUROL, V434, P308; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Galef B.G. Jr, 1981, P211; GELLMAN RL, 1993, BRAIN RES, V600, P63, DOI 10.1016/0006-8993(93)90402-9; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Illig KR, 2005, J COMP NEUROL, V488, P224, DOI 10.1002/cne.20595; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEADORWOODRUFF JH, 1989, P NATL ACAD SCI USA, V86, P7625, DOI 10.1073/pnas.86.19.7625; Meyer EA, 2006, J COMP NEUROL, V498, P786, DOI 10.1002/cne.21077; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moriceau S, 2005, DEV PSYCHOBIOL, V47, P230, DOI 10.1002/dev.20093; Moriceau S, 2004, J NEUROSCI, V24, P1182, DOI 10.1523/JNEUROSCI.4578-03.2004; Pirez N, 2008, J NEUROSCI, V28, P6360, DOI 10.1523/JNEUROSCI.0793-08.2008; Richards JB, 1999, PSYCHOPHARMACOLOGY, V146, P432, DOI 10.1007/PL00005488; Roesch MR, 2007, CEREB CORTEX, V17, P643, DOI 10.1093/cercor/bhk009; Schoenbaum G, 2003, BEHAV BRAIN RES, V146, P19, DOI 10.1016/j.bbr.2003.09.013; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1999, NEWS PHYSIOL SCI, V14, P249; SCHWOB JE, 1984, J COMP NEUROL, V223, P223, DOI 10.1002/cne.902230206; SCHWOB JE, 1984, J COMP NEUROL, V223, P203, DOI 10.1002/cne.902230205; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stanwood GD, 1997, NEUROSCI LETT, V223, P13, DOI 10.1016/S0304-3940(97)13396-1; Sullivan RM, 2000, BEHAV NEUROSCI, V114, P957, DOI 10.1037/0735-7044.114.5.957; Tarazi FI, 1998, DEV BRAIN RES, V110, P227, DOI 10.1016/S0165-3806(98)00111-4; Tarazi FI, 2000, INT J DEV NEUROSCI, V18, P29, DOI 10.1016/S0736-5748(99)00108-2; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Walz A, 2006, J NEUROBIOL, V66, P835, DOI 10.1002/neu.20266; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Ward AS, 1997, EXP CLIN PSYCHOPHARM, V5, P130, DOI 10.1037/1064-1297.5.2.130; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 1997, BEHAV NEURAL BIOL, V61, P1; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2007, ANN NY ACAD SCI, V1121, P639, DOI 10.1196/annals.1401.024; Winstanley CA, 2007, J NEUROSCI, V27, P10497, DOI 10.1523/JNEUROSCI.2566-07.2007; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	63	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56191	10.1371/journal.pone.0056191	http://dx.doi.org/10.1371/journal.pone.0056191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437091	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000015
J	Huang, SW; Zhang, HY				Huang, Shengwei; Zhang, Hongyu			The Impact of Environmental Heterogeneity and Life Stage on the Hindgut Microbiota of Holotrichia parallela Larvae (Coleoptera: Scarabaeidae)	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; PACHNODA-EPHIPPIATA COLEOPTERA; HUMUS-FEEDING LARVA; GUT BACTERIA; COMMUNITY STRUCTURE; MANAGEMENT REGIME; AEDES-ALBOPICTUS; DIVERSITY; TEMPERATURE; VECTOR	Gut microbiota has diverse ecological and evolutionary effects on its hosts. However, the ways in which it responds to environmental heterogeneity and host physiology remain poorly understood. To this end, we surveyed intestinal microbiota of Holotrichia parallela larvae at different instars and from different geographic regions. Bacterial 16S rRNA gene clone libraries were constructed and clones were subsequently screened by DGGE and sequenced. Firmicutes and Proteobacteria were the major phyla, and bacteria belonging to Ruminococcaceae, Lachnospiraceae, Enterobacteriaceae, Desulfovibrionaceae and Rhodocyclaceae families were commonly found in all natural populations. However, bacterial diversity (Chao1 and Shannon indices) and community structure varied across host populations, and the observed variation can be explained by soil pH, organic carbon and total nitrogen, and the climate factors (e.g., mean annual temperature) of the locations where the populations were sampled. Furthermore, increases in the species richness and diversity of gut microbiota were observed during larval growth. Bacteroidetes comprised the dominant group in the first instar; however, Firmicutes composed the majority of the hindgut microbiota during the second and third instars. Our results suggest that the gut's bacterial community changes in response to environmental heterogeneity and host's physiology, possibly to meet the host's ecological needs or physiological demands.	[Huang, Shengwei; Zhang, Hongyu] Huazhong Agr Univ, Inst Urban & Hort Pests, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Huang, Shengwei; Zhang, Hongyu] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zhang, HY (corresponding author), Huazhong Agr Univ, Inst Urban & Hort Pests, State Key Lab Agr Microbiol, Wuhan, Peoples R China.; Zhang, HY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	hongyu.zhang@mail.hzau.edu.cn			National Natural Science Foundation of China [30671404, 31272378]; Special Fund for Agro-Scientific Research of the Public Interest [201003025]; earmarked fund for Modern Agro-industry Technology Research System of China [CARS-27]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200805040010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research of the Public Interest; earmarked fund for Modern Agro-industry Technology Research System of China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work is partly supported by National Natural Science Foundation of China (No. 30671404 and No. 31272378), the Special Fund for Agro-Scientific Research of the Public Interest (No. 201003025), the earmarked fund for Modern Agro-industry Technology Research System of China (No. CARS-27), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 200805040010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; BAYON C, 1980, J INSECT PHYSIOL, V26, P819, DOI 10.1016/0022-1910(80)90098-0; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Behar A, 2008, ISR J ECOL EVOL, V54, P181, DOI 10.1080/15659801.2008.10639612; Bell C, 2008, MICROB ECOL, V56, P153, DOI 10.1007/s00248-007-9333-z; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; CAYLEY GR, 1980, PESTIC SCI, V11, P9, DOI 10.1002/ps.2780110103; Cazemier AE, 2003, ANTON LEEUW INT J G, V83, P135, DOI 10.1023/A:1023325817663; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Clark J, 2009, MICROB ECOL, V57, P248, DOI 10.1007/s00248-008-9475-7; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Barros HP, 2003, AQUACULTURE, V216, P165, DOI 10.1016/S0044-8486(02)00505-7; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; de Vries EJ, 2004, P ROY SOC B-BIOL SCI, V271, P2171, DOI 10.1098/rspb.2004.2817; de Vries EJ, 2001, J INVERTEBR PATHOL, V77, P120, DOI 10.1006/jipa.2001.5009; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 2002, J APPL MICROBIOL, V92, P759, DOI 10.1046/j.1365-2672.2002.01581.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; DOWD PF, 1992, J IND MICROBIOL, V9, P149, DOI 10.1007/BF01569619; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Ghiglione JF, 2008, BIOGEOSCIENCES, V5, P1751, DOI 10.5194/bg-5-1751-2008; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kirk JL, 2005, ENVIRON POLLUT, V133, P455, DOI 10.1016/j.envpol.2004.06.002; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Lemke T, 2003, APPL ENVIRON MICROB, V69, P6650, DOI 10.1128/AEM.69.11.6650-6658.2003; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Liu WT, 2002, J BIOSCI BIOENG, V93, P101, DOI 10.1263/jbb.93.101; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakatsu CH, 2000, SOIL SCI SOC AM J, V64, P1382, DOI 10.2136/sssaj2000.6441382x; Nubel U, 1996, J BACTERIOL, V178, P5636; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Panikkar P, 2002, INDIAN J FISH, V49, P29; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Penders J, 2006, CLIN EXP ALLERGY, V36, P1602, DOI 10.1111/j.1365-2222.2006.02599.x; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Pittman GW, 2008, APPL ENVIRON MICROB, V74, P762, DOI 10.1128/AEM.01831-07; Prado SS, 2010, APPL ENVIRON MICROB, V76, P1261, DOI 10.1128/AEM.02034-09; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Salles JF, 2006, MICROB ECOL, V52, P267, DOI 10.1007/s00248-006-9048-6; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Toth EM, 2006, MICROB ECOL, V51, P13, DOI 10.1007/s00248-005-0090-6; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Visotto LE, 2009, J INSECT PHYSIOL, V55, P185, DOI 10.1016/j.jinsphys.2008.10.017; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Yang H, 2005, ENVIRON MICROBIOL, V7, P916, DOI 10.1111/j.1462-2920.2005.00760.x; Zhang H, 2008, J APPL MICROBIOL, V105, P1277, DOI 10.1111/j.1365-2672.2008.03867.x; Zhou Li-Mei, 2009, Acta Entomologica Sinica, V52, P121; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	77	31	37	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57169	10.1371/journal.pone.0057169	http://dx.doi.org/10.1371/journal.pone.0057169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437336	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000081
J	Presser, LD; McRae, S; Waris, G				Presser, Lance D.; McRae, Steven; Waris, Gulam			RETRACTED: Activation of TGF-beta 1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-beta 1 in Hepatic Stellate Cell Activation and Invasion (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							GROWTH-FACTOR-BETA; NF-KAPPA-B; LIVER FIBROSIS; CORE PROTEIN; LIPID DROPLETS; TRANSCRIPTIONAL REGULATION; OXIDATIVE STRESS; UP-REGULATION; ER STRESS; TGF-BETA	Our previous studies have shown the induction and maturation of transforming growth factor-beta 1 (TGF-beta 1) in HCV-infected human hepatoma cells. In this study, we have investigated the molecular mechanism of TGF-beta 1 gene expression in response to HCV infection. We demonstrate that HCV-induced transcription factors AP-1, Sp1, NF-kappa B and STAT-3 are involved in TGF-beta 1 gene expression. Using chromatin immunoprecipitation (ChIP) assay, we further show that AP-1 and Sp1 interact with TGF-b1 promoter in vivo in HCV-infected cells. In addition, we demonstrate that HCV-induced TGF-beta 1 gene expression is mediated by the activation of cellular kinases such as p38 MAPK, Src, JNK, and MEK1/2. Next, we determined the role of secreted bioactive TGF-beta 1 in human hepatic stellate cells (HSCs) activation and invasion. Using siRNA approach, we show that HCV-induced bioactive TGF-beta 1 is critical for the induction of alpha smooth muscle actin (alpha-SMA) and type 1 collagen, the markers of HSCs activation and proliferation. We further demonstrate the potential role of HCV-induced bioactive TGF-beta 1 in HSCs invasion/cell migration using a transwell Boyden chamber. Our results also suggest the role of HCV-induced TGF-beta 1 in HCV replication and release. Collectively, these observations provide insight into the mechanism of TGF-beta 1 promoter activation, as well as HSCs activation and invasion, which likely manifests in liver fibrosis associated with HCV infection.	[Presser, Lance D.; McRae, Steven; Waris, Gulam] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, Chicago Med Sch, HM Bligh Canc Res Labs, Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Waris, G (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, Chicago Med Sch, HM Bligh Canc Res Labs, Chicago, IL 60064 USA.	gulam.waris@rosalindfranklin.edu			American Cancer Society; Illinois Division, Inc. [09-14]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R21:A1078532]; Rosalind Franklin University of Medicine and Science-H.M Bligh Cancer Research Fund	American Cancer Society(American Cancer Society); Illinois Division, Inc.(American Cancer Society); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rosalind Franklin University of Medicine and Science-H.M Bligh Cancer Research Fund	This work was supported in part by the American Cancer Society, Illinois Division, Inc., 09-14, National Institutes of Health/National Institute of Allergy and Infectious Diseases grant R21:A1078532, and by the Rosalind Franklin University of Medicine and Science-H.M. Bligh Cancer Research Fund to G. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2000, BEST PRACT RES CL GA, V14, P241, DOI 10.1053/bega.1999.0073; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2002, MED CLIN-BARCELONA, V118, P339, DOI 10.1016/S0025-7753(02)72380-4; Bauer M, 2001, FEBS LETT, V502, P1, DOI 10.1016/S0014-5793(01)02655-2; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Burdette D, 2012, J GEN VIROL, V93, P235, DOI 10.1099/vir.0.034033-0; Burdette D, 2010, J GEN VIROL, V91, P681, DOI 10.1099/vir.0.014340-0; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gao CF, 1996, J CELL PHYSIOL, V167, P394, DOI 10.1002/(SICI)1097-4652(199606)167:3<394::AID-JCP3>3.0.CO;2-K; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Grungreiff K, 1999, CYTOKINE, V11, P1076, DOI 10.1006/cyto.1999.0504; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Hui Alex Y., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005684; Ikeda K, 1999, HEPATOLOGY, V29, P1760, DOI 10.1002/hep.510290640; Jeong WI, 2004, LIVER INT, V24, P658, DOI 10.1111/j.1478-3231.2004.0961.x; Johnson CL, 2007, J BIOL CHEM, V282, P10792, DOI 10.1074/jbc.M610361200; Kim KS, 2008, J KOREAN MED SCI, V23, P870, DOI 10.3346/jkms.2008.23.5.870; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Lin YL, 2008, PHYTOTHER RES, V22, P69, DOI 10.1002/ptr.2265; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McCann KL, 2007, J VIROL, V81, P2880, DOI 10.1128/JVI.02583-06; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Peralta-Zaragoza O, 2006, VIRAL IMMUNOL, V19, P468, DOI 10.1089/vim.2006.19.468; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Presser LD, 2011, VIROLOGY, V412, P284, DOI 10.1016/j.virol.2010.12.051; Qadri I, 2004, BIOCHEM J, V378, P919, DOI 10.1042/BJ20031587; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Ravichandran V, 2007, J VIROL, V81, P6412, DOI 10.1128/JVI.02658-06; Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551; Rossmanith W, 2001, MICROSC RES TECHNIQ, V52, P430, DOI 10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO;2-3; Sancho-Bru P, 2010, LIVER INT, V30, P31, DOI 10.1111/j.1478-3231.2009.02161.x; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Shi YF, 2006, BBA-GEN SUBJECTS, V1760, P1587, DOI 10.1016/j.bbagen.2006.09.012; Shin JY, 2005, EXP MOL MED, V37, P138, DOI 10.1038/emm.2005.19; Siagris D, 2006, J VIRAL HEPATITIS, V13, P56, DOI 10.1111/j.1365-2893.2005.00655.x; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Taniguchi H, 2004, J MED VIROL, V72, P52, DOI 10.1002/jmv.10545; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Waris G, 2002, BIOCHEM PHARMACOL, V64, P1425, DOI 10.1016/S0006-2952(02)01300-X; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Weigert C, 2004, J BIOL CHEM, V279, P15908, DOI 10.1074/jbc.M313524200; Weigert C, 2002, DIABETOLOGIA, V45, P890, DOI 10.1007/s00125-002-0843-4; Weigert C, 2000, J AM SOC NEPHROL, V11, P2007, DOI 10.1681/ASN.V11112007; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091; Xiang ZH, 2010, BIOCHEM BIOPH RES CO, V402, P549, DOI 10.1016/j.bbrc.2010.10.081; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yoo YD, 1996, J VIROL, V70, P7062, DOI 10.1128/JVI.70.10.7062-7070.1996; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	71	68	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56367	10.1371/journal.pone.0056367	http://dx.doi.org/10.1371/journal.pone.0056367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437118	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000024
J	Schnettler, S				Schnettler, Sebastian			Revisiting a Sample of US Billionaires: How Sample Selection and Timing of Maternal Condition Influence Findings on the Trivers-Willard Effect	PLOS ONE			English	Article							SEX-BIASED INVESTMENT; REPRODUCTIVE STRATEGIES; PARENTAL INVESTMENT; RATIO; BIRTH; HYPOTHESIS; DAUGHTERS; SUCCESS	Based on evolutionary theory, Trivers & Willard (TW) predicted the existence of mechanisms that lead parents with high levels of resources to bias offspring sex composition to favor sons and parents with low levels of resources to favor daughters. This hypothesis has been tested in samples of wealthy individuals but with mixed results. Here, I argue that both sample selection due to a high number of missing cases and a lacking specification of the timing of wealth accumulation contribute to this equivocal pattern. This study improves on both issues: First, analyses are based on a data set of U.S. billionaires with near-complete information on the sex of offspring. Second, subgroups of billionaires are distinguished according to the timing when they acquired their wealth. Informed by recent insights on the timing of a potential TW effect in animal studies, I state two hypotheses. First, billionaires have a higher share of male offspring than the general population. Second, this effect is larger for heirs and heiresses who are wealthy at the time of conception of all of their children than for self-made billionaires who acquired their wealth during their adult lives, that is, after some or all of their children have already been conceived. Results do not support the first hypothesis for all subgroups of billionaires. But for males, results are weakly consistent with the second hypothesis: Heirs but not self-made billionaires have a higher share of male offspring than the U.S. population. Heiresses, on the other hand, have a much lower share of male offspring than the U.S. average. This hints to a possible interplay of at least two mechanisms affecting sex composition. Implications for future research that would allow disentangling the distinct mechanisms are discussed.	Univ Konstanz, Dept Sociol, Constance, Germany	University of Konstanz	Schnettler, S (corresponding author), Univ Konstanz, Dept Sociol, Constance, Germany.	sebastian.schnettler@uni-konstanz.de						Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; Almond D, 2011, AM ECON J-APPL ECON, V3, P56, DOI 10.1257/app.3.4.56; [Anonymous], 2009, FORBES; [Anonymous], 2009, FORBES MAGAZINE; Bereczkei T, 1997, P ROY SOC B-BIOL SCI, V264, P17, DOI 10.1098/rspb.1997.0003; BETZIG L, 1995, POLIT LIFE SCI, V14, P61, DOI 10.1017/S0730938400011771; Brown GR, 2001, ANIM BEHAV, V61, P683, DOI 10.1006/anbe.2000.1659; Bruckner TA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-273; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; ChaconPuignau GC, 1996, SOC BIOL, V43, P257; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P162; CRAN, 2013, PACK MULTC; ESSOCKVITALE SM, 1984, ETHOL SOCIOBIOL, V5, P45, DOI 10.1016/0162-3095(84)90034-7; FestaBianchet M, 1996, ECOSCIENCE, V3, P42, DOI 10.1080/11956860.1996.11682313; Freese J, 2001, AM J SOCIOL, V106, P1776, DOI 10.1086/321304; Freese J, 1999, AM J SOCIOL, V104, P1704, DOI 10.1086/210221; Gelman AB, 2009, AM SCI; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Grant VJ, 2007, J THEOR BIOL, V246, P708, DOI 10.1016/j.jtbi.2007.02.005; Grant VJ, 2010, REPRODUCTION, V140, P425, DOI 10.1530/REP-10-0137; Grant VJ, 2005, J EXP ZOOL PART A, V303A, P1120, DOI 10.1002/jez.a.233; Hansen D, 1999, BRIT MED J, V319, P548, DOI 10.1136/bmj.319.7209.548; Hopcroft RL, 2005, SOC FORCES, V83, P1111, DOI 10.1353/sof.2005.0035; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; James WH, 2012, J THEOR BIOL, V310, P183, DOI 10.1016/j.jtbi.2012.06.038; James WH, 2009, J THEOR BIOL, V257, P116, DOI 10.1016/j.jtbi.2008.09.028; Keller MC, 2001, EVOL HUM BEHAV, V22, P343, DOI 10.1016/S1090-5138(01)00075-7; KLINDWORTH H, 1995, HUM NATURE-INT BIOS, V6, P221, DOI 10.1007/BF02734140; Kolk M, 2013, J BIOSOC SCI, V45, P683, DOI 10.1017/S0021932012000557; Lazarus J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P287, DOI 10.1017/CBO9780511542053.015; LOW BS, 1992, ETHOL SOCIOBIOL, V13, P463, DOI 10.1016/0162-3095(92)90013-T; MACKEY WC, 1987, ETHOL SOCIOBIOL, V8, P49, DOI 10.1016/0162-3095(87)90057-4; Mathews T J, 2005, Natl Vital Stat Rep, V53, P1; MEALEY L, 1990, ETHOL SOCIOBIOL, V11, P83, DOI 10.1016/0162-3095(90)90030-A; Neuhauser M, 2004, ENVIRON ECOL STAT, V11, P295, DOI 10.1023/B:EEST.0000038017.58293.c0; Norberg K, 2004, P ROY SOC B-BIOL SCI, V271, P2403, DOI 10.1098/rspb.2004.2857; ROSKAFT E, 1992, ETHOL SOCIOBIOL, V13, P443, DOI 10.1016/0162-3095(92)90012-S; Ruckstuhl KE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-269; Ryan M.K., 2009, GLASS CEILING 21 CEN, P153; Scott S, 1999, HUM NATURE-INT BIOS, V10, P85, DOI 10.1007/s12110-999-1002-0; Shackelford TK, 2005, PERS INDIV DIFFER, V39, P447, DOI 10.1016/j.paid.2005.01.023; Trivers R., 2002, NATURAL SELECTION SO; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; VOLAND E, 1995, HUMAN REPRODUCTIVE DECISIONS, P137; Woods FA, 1939, J HERED, V30, P313, DOI 10.1093/oxfordjournals.jhered.a104752; Zilko CEM, 2010, HUM REPROD UPDATE, V16, P445, DOI 10.1093/humupd/dmp059	47	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57446	10.1371/journal.pone.0057446	http://dx.doi.org/10.1371/journal.pone.0057446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437389	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000103
J	Wang, MJ; Yin, BN; Matsueda, S; Deng, LJ; Li, Y; Zhao, W; Zou, J; Li, QT; Loo, C; Wang, RF; Wang, HY				Wang, Mingjun; Yin, Bingnan; Matsueda, Satoko; Deng, Lijuan; Li, Ying; Zhao, Wei; Zou, Jia; Li, Qingtian; Loo, Christopher; Wang, Rong-Fu; Wang, Helen Y.			Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8(+) T Cells: Implication for Cancer Immunotherapy	PLOS ONE			English	Article							REED-STERNBERG CELLS; GENOME-WIDE; HODGKINS LYMPHOMA; IMMUNE SELECTION; PROSTATE-CANCER; GENE-EXPRESSION; GASTRIC-CANCER; UP-REGULATION; SATB1; MELANOMA	Background: A large number of human tumor-associated antigens that are recognized by CD8(+) T cells in a human leukocyte antigen class I (HLA-I)-restricted fashion have been identified. Special AT-rich sequence binding protein 1 (SATB1) is highly expressed in many types of human cancers as part of their neoplastic phenotype, and up-regulation of SATB1 expression is essential for tumor survival and metastasis, thus this protein may serve as a rational target for cancer vaccines. Methodology/Principal Findings: Twelve SATB1-derived peptides were predicted by an immuno-informatics approach based on the HLA-A*02 binding motif. These peptides were examined for their ability to induce peptide-specific T cell responses in peripheral blood mononuclear cells (PBMCs) obtained from HLA-A*02(+) healthy donors and/or HLA-A*02(+) cancer patients. The recognition of HLA-A*02(+) SATB1-expressing cancer cells was also tested. Among the twelve SATB1-derived peptides, SATB1(565-574) frequently induced peptide-specific T cell responses in PBMCs from both healthy donors and cancer patients. Importantly, SATB1(565-574)-specific T cells recognized and killed HLA-A*02(+) SATB1(+) cancer cells in an HLA-I-restricted manner. Conclusions/Significance: We have identified a novel HLA-A*02-restricted SATB1-derived peptide epitope recognized by CD8(+) T cells, which, in turn, recognizes and kills HLA-A*02(+) SATB1(+) tumor cells. The SATB1-derived epitope identified may be used as a diagnostic marker as well as an immune target for development of cancer vaccines.	[Wang, Mingjun; Yin, Bingnan; Deng, Lijuan; Zhao, Wei; Zou, Jia; Li, Qingtian; Loo, Christopher; Wang, Rong-Fu; Wang, Helen Y.] Methodist Hosp Res Inst, Ctr Inflammat & Epigenet, Houston, TX USA; [Wang, Mingjun; Matsueda, Satoko; Li, Ying; Wang, Rong-Fu; Wang, Helen Y.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Baylor College of Medicine	Wang, HY (corresponding author), Methodist Hosp Res Inst, Ctr Inflammat & Epigenet, Houston, TX USA.	ywang4@tmhs.org		WANG, MINGJUN/0000-0002-5848-0444	National Cancer Institute; Methodist Hospital Research Institute; National Institutes of Health and Cancer Research Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Methodist Hospital Research Institute; National Institutes of Health and Cancer Research Institute	This work was in part supported by grants from National Cancer Institute, National Institutes of Health and Cancer Research Institute, and The Methodist Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Andersen MH, 2007, CLIN CANCER RES, V13, P5991, DOI 10.1158/1078-0432.CCR-07-0686; Beatty GL, 2008, EXPERT REV VACCINES, V7, P881, DOI 10.1586/14760584.7.7.881; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; Campoli M, 2002, VACCINE, V20, pA40, DOI 10.1016/S0264-410X(02)00386-9; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Chu SH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-149; Di Lorenzo G, 2011, NAT REV CLIN ONCOL, V8, P551, DOI 10.1038/nrclinonc.2011.72; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Fogh J, 1975, NEW HUMAN TUMOR CELL; Hammond AS, 2005, CLIN EXP IMMUNOL, V140, P109, DOI 10.1111/j.1365-2249.2005.02751.x; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kanzler H, 1996, BLOOD, V87, P3429, DOI 10.1182/blood.V87.8.3429.bloodjournal8783429; Kohwi-Shigematsu T, 2012, SEMINARS CANC BIOL; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Matsueda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045756; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Mir R, 2012, CURRENT DRUG TARGETS; Mokhtar NM, 2012, CANCER INVEST, V30, P156, DOI 10.3109/07357907.2011.633290; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Riker A, 1999, SURGERY, V126, P112, DOI 10.1067/msy.1999.98739; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Straten PT, 2010, ONCOTARGET, V1, P239; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; VandenEynde BJ, 1997, INT J CLIN LAB RES, V27, P81, DOI 10.1007/BF02912440; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Weng JS, 2005, J CELL BIOCHEM, V96, P1034, DOI 10.1002/jcb.20600; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Xiang JD, 2012, ONCOL LETT, V3, P865, DOI 10.3892/ol.2012.571; Yamayoshi A, 2011, OLIGONUCLEOTIDES, V21, P115, DOI 10.1089/oli.2010.0277; Zeng G, 2001, P NATL ACAD SCI USA, V98, P3964, DOI 10.1073/pnas.061507398; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534	47	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56730	10.1371/journal.pone.0056730	http://dx.doi.org/10.1371/journal.pone.0056730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437226	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000040
J	Cui, LQ; Wang, Y; Li, Y; He, T; Schwarz, S; Ding, YJ; Shen, JZ; Lv, Y				Cui, Lanqing; Wang, Yang; Li, Yun; He, Tao; Schwarz, Stefan; Ding, Yujing; Shen, Jianzhong; Lv, Yuan			Cfr-Mediated Linezolid-Resistance among Methicillin-Resistant Coagulase-Negative Staphylococci from Infections of Humans	PLOS ONE			English	Article							1ST REPORT; GENE CFR; CHLORAMPHENICOL; OXAZOLIDINONES; MUTATIONS	Four methicillin-resistant coagulase-negative staphylococci (MRCoNS), one Staphylococcus haemolyticus and three Staphylococcus cohnii, from infections of humans collected via the Ministry of Health National Antimicrobial Resistance Surveillance Net (Mohnarin) program in China were identified as linezolid-resistant. These four isolates were negative for the 23S rRNA mutations, but positive for the gene cfr. Mutations in the gene for the ribosomal protein L3, which resulted in the amino acid exchanges Gly152Asp and Tyr158Phe, were identified in S. haemolyticus 09D279 and S. cohnii NDM113, respectively. In each isolate, the cfr gene was located on a plasmid of ca. 35.4 kb, as shown by S1 nuclease pulsed-field gel electrophoresis and Southern blotting experiments. This plasmid was indistinguishable from the previously described plasmid pSS-02 by its size, restriction pattern, and a sequenced 14-kb cfr-carrying segment. Plasmid pSS-02 was originally identified in staphylococci isolated from pigs. This is the first time that a cfr-carrying plasmid has been detected in MRCoNS obtained from intensive care patients in China. Based on the similarities to the cfr-carrying plasmid pSS-02 from porcine coagulase-negative staphylococci, a transmission of this cfr-carrying plasmid between staphylococci from pigs and humans appears to be likely.	[Cui, Lanqing; Li, Yun; Ding, Yujing; Lv, Yuan] Peking Univ, Peking Univ Hosp 1, Inst Clin Pharmacol, Beijing 100871, Peoples R China; [Wang, Yang; He, Tao; Shen, Jianzhong] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Schwarz, Stefan] FLI, Inst Farm Anim Genet, Neustadt, Germany	Peking University; China Agricultural University; Friedrich Loeffler Institute	Shen, JZ (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	sjz@cau.edu.cn; lyzx5857@sina.com	Wang, Yang/ABD-5983-2021; Shen, Jianzhong/AAH-8184-2019	Wang, Yang/0000-0002-5928-9377; 	National Science and Technology Major Project [2012ZX09303005-003]; National Natural Science Foundation of China [31001087]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science and Technology Major Project (No. 2012ZX09303005-003) and National Natural Science Foundation of China (No. 31001087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bongiorno D, 2010, J ANTIMICROB CHEMOTH, V65, P2336, DOI 10.1093/jac/dkq344; Bosling J, 2003, ANTIMICROB AGENTS CH, V47, P2892, DOI 10.1128/AAC.47.9.2892-2896.2003; Cai JC, 2012, J MED MICROBIOL, V61, P1568, DOI 10.1099/jmm.0.043729-0; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; Hong T, 2007, J CLIN MICROBIOL, V45, P3277, DOI 10.1128/JCM.02048-06; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Kosowska-Shick K, 2010, DIAGN MICR INFEC DIS, V68, P34, DOI 10.1016/j.diagmicrobio.2010.05.007; Leach KL, 2011, ANN NY ACAD SCI, V1222, P49, DOI 10.1111/j.1749-6632.2011.05962.x; Liakopoulos A, 2009, J ANTIMICROB CHEMOTH, V64, P206, DOI 10.1093/jac/dkp167; Locke JB, 2009, ANTIMICROB AGENTS CH, V53, P5265, DOI 10.1128/AAC.00871-09; Locke JB, 2009, ANTIMICROB AGENTS CH, V53, P5275, DOI 10.1128/AAC.01032-09; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Long KS, 2012, ANTIMICROB AGENTS CH, V56, P603, DOI 10.1128/AAC.05702-11; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P2244, DOI 10.1128/AAC.00231-08; Mendes RE, 2010, J ANTIMICROB CHEMOTH, V65, P2329, DOI 10.1093/jac/dkq331; Mendes RE, 2010, J CLIN MICROBIOL, V48, P3041, DOI 10.1128/JCM.00880-10; Miller K, 2008, ANTIMICROB AGENTS CH, V52, P1737, DOI 10.1128/AAC.01015-07; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; de Gopegui ER, 2012, ANTIMICROB AGENTS CH, V56, P2139, DOI 10.1128/AAC.06042-11; Garcia MS, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI 10.1001/jama.2010.757; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SERAL C, 2011, J MED MICROBIOL, V301, P354, DOI DOI 10.1016/J.IJMM.2010.11.001; Shore AC, 2010, ANTIMICROB AGENTS CH, V54, P4978, DOI 10.1128/AAC.01113-10; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Wang Y, 2012, ANTIMICROB AGENTS CH, V56, P1485, DOI 10.1128/AAC.05827-11; Wolter N, 2005, ANTIMICROB AGENTS CH, V49, P3554, DOI 10.1128/AAC.49.8.3554-3557.2005	26	39	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57096	10.1371/journal.pone.0057096	http://dx.doi.org/10.1371/journal.pone.0057096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437319	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200213
J	Kaushik, S; Mutt, E; Chellappan, A; Sankaran, S; Srinivasan, N; Sowdhamini, R				Kaushik, Swati; Mutt, Eshita; Chellappan, Ajithavalli; Sankaran, Sandhya; Srinivasan, Narayanaswamy; Sowdhamini, Ramanathan			Improved Detection of Remote Homologues Using Cascade PSI-BLAST: Influence of Neighbouring Protein Families on Sequence Coverage	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; TOMATO SUBTILASE 3; INTERMEDIATE SEQUENCE; FOLD RECOGNITION; PLANT PROTEASES; DATABASE; SEARCH; DOMAIN; PROTEOLYSIS; CLASSIFICATION	Background: Development of sensitive sequence search procedures for the detection of distant relationships between proteins at superfamily/fold level is still a big challenge. The intermediate sequence search approach is the most frequently employed manner of identifying remote homologues effectively. In this study, examination of serine proteases of prolyl oligopeptidase, rhomboid and subtilisin protein families were carried out using plant serine proteases as queries from two genomes including A. thaliana and O. sativa and 13 other families of unrelated folds to identify the distant homologues which could not be obtained using PSI-BLAST. Methodology/Principal Findings: We have proposed to start with multiple queries of classical serine protease members to identify remote homologues in families, using a rigorous approach like Cascade PSI-BLAST. We found that classical sequence based approaches, like PSI-BLAST, showed very low sequence coverage in identifying plant serine proteases. The algorithm was applied on enriched sequence database of homologous domains and we obtained overall average coverage of 88% at family, 77% at superfamily or fold level along with specificity of similar to 100% and Mathew's correlation coefficient of 0.91. Similar approach was also implemented on 13 other protein families representing every structural class in SCOP database. Further investigation with statistical tests, like jackknifing, helped us to better understand the influence of neighbouring protein families. Conclusions/Significance: Our study suggests that employment of multiple queries of a family for the Cascade PSI-BLAST searches is useful for predicting distant relationships effectively even at superfamily level. We have proposed a generalized strategy to cover all the distant members of a particular family using multiple query sequences. Our findings reveal that prior selection of sequences as query and the presence of neighbouring families can be important for covering the search space effectively in minimal computational time. This study also provides an understanding of the 'bridging' role of related families.	[Kaushik, Swati; Mutt, Eshita; Chellappan, Ajithavalli; Sowdhamini, Ramanathan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Chellappan, Ajithavalli] Shanmugha Arts Sci Technol & Res Acad, Sch Chem & Biotechnol, Thanjavur, Tamil Nadu, India; [Sankaran, Sandhya; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Indian Institute of Science (IISC) - Bangalore	Srinivasan, N (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in; mini@ncbs.res.in	Kaushik, Swati/AAR-6954-2020	Kaushik, Swati/0000-0002-3562-8522; Mutt, Eshita/0000-0003-3225-4761; Sandhya, Sankaran/0000-0003-0055-302X	Department of Biotechnology (DBT); DBT-BINC (Bioinformatics National Certification); NCBS-TIFR; DBT through Centre of Excellence Project [BT/01/COE/09/01]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT-BINC (Bioinformatics National Certification); NCBS-TIFR; DBT through Centre of Excellence Project	SK thanks Department of Biotechnology (DBT) for financial support. EM thanks DBT-BINC (Bioinformatics National Certification) for financial support. RS thanks NCBS-TIFR for financial and infrastructural support. RS and NS also thank DBT for funding through Centre of Excellence Project (Grant number BT/01/COE/09/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abola E. E., 1984, PROTEIN DATA BANK; Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Aroul-Selvam R, 2004, J MOL BIOL, V338, P633, DOI 10.1016/j.jmb.2004.03.039; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben-Hur A, 2003, BIOINFORMATICS, V19, pi26, DOI 10.1093/bioinformatics/btg1002; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fariselli P, 2007, BRIEF BIOINFORM, V8, P78, DOI 10.1093/bib/bbl032; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; Freeman M, 2003, CURR BIOL, V13, pR586, DOI 10.1016/S0960-9822(03)00519-0; Gerstein M, 1998, BIOINFORMATICS, V14, P707, DOI 10.1093/bioinformatics/14.8.707; Gowri VS, 2007, PROTEINS, V67, P789, DOI 10.1002/prot.21356; Gowri VS, 2003, NUCLEIC ACIDS RES, V31, P486, DOI 10.1093/nar/gkg063; Handstad T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-23; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Li WZ, 2000, BIOINFORMATICS, V16, P1105, DOI 10.1093/bioinformatics/16.12.1105; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palma JM, 2002, PLANT PHYSIOL BIOCH, V40, P521, DOI 10.1016/S0981-9428(02)01404-3; Park J, 1997, J MOL BIOL, V273, P349, DOI 10.1006/jmbi.1997.1288; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Salamov AA, 1999, PROTEIN ENG, V12, P95, DOI 10.1093/protein/12.2.95; Sandhya S, 2005, J BIOMOL STRUCT DYN, V23, P283, DOI 10.1080/07391102.2005.10507066; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Teichmann SA, 2000, BIOINFORMATICS, V16, P117, DOI 10.1093/bioinformatics/16.2.117; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wallqvist A, 2000, BIOINFORMATICS, V16, P988, DOI 10.1093/bioinformatics/16.11.988; Wang G, 2005, PROTEINS, V61, P46, DOI 10.1002/prot.20721; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957; YI TM, 1994, PROTEIN SCI, V3, P1315, DOI 10.1002/pro.5560030818	46	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56449	10.1371/journal.pone.0056449	http://dx.doi.org/10.1371/journal.pone.0056449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437136	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000315184200077
J	Letcher, PM; Lopez, S; Schmieder, R; Lee, PA; Behnke, C; Powell, MJ; McBride, RC				Letcher, Peter M.; Lopez, Salvador; Schmieder, Robert; Lee, Philip A.; Behnke, Craig; Powell, Martha J.; McBride, Robert C.			Characterization of Amoeboaphelidium protococcarum, an Algal Parasite New to the Cryptomycota Isolated from an Outdoor Algal Pond Used for the Production of Biofuel	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHYTRID ROZELLA-ALLOMYCIS; PSEUDAPHELIDIUM DREBESII; FINE-STRUCTURE; BIOMASS; MUSCLE	Mass culture of algae for the production of biofuels is a developing technology designed to offset the depletion of fossil fuel reserves. However, large scale culture of algae in open ponds can be challenging because of incidences of infestation with algal parasites. Without knowledge of the identity of the specific parasite and how to control these pests, algal-based biofuel production will be limited. We have characterized a eukaryotic parasite of Scenedesmus dimorphus growing in outdoor ponds used for biofuel production. We demonstrated that as the genomic DNA of parasite FD01 increases, the concentration of S. dimorphus cells decreases; consequently, this is a highly destructive pathogen. Techniques for culture of the parasite and host were developed, and the endoparasite was identified as the Aphelidea, Amoeboaphelidium protococcarum. Phylogenetic analysis of ribosomal sequences revealed that parasite FD01 placed within the recently described Cryptomycota, a poorly known phylum based on two species of Rozella and environmental samples. Transmission electron microscopy demonstrated that aplanospores of the parasite produced filose pseudopodia, which contained fine fibers the diameter of actin microfilaments. Multiple lipid globules clustered and were associated with microbodies, mitochondria and a membrane cisternae, an arrangement characteristic of the microbody-lipid globule complex of chytrid zoospores. After encystment and attachment to the host cells, the parasite injected its protoplast into the host between the host cell wall and plasma membrane. At maturity the unwalled parasite occupied the entire host cell. After cleavage of the protoplast into aplanospores, a vacuole and lipids remained in the host cell. Amoeboaphelidium protococcarum isolate FD01 is characteristic of the original description of this species and is different from strain X-5 recently characterized. Our results help put a face on the Cryptomycota, revealing that the phylum is more diverse than previously understood and include some of the Aphelidea as well as Rozella species and potentially Microsporidia.	[Letcher, Peter M.; Powell, Martha J.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Lopez, Salvador; Lee, Philip A.; Behnke, Craig; McBride, Robert C.] Sapphire Energy Inc, Crop Protect Grp, San Diego, CA USA; [Schmieder, Robert] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Schmieder, Robert] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA	University of Alabama System; University of Alabama Tuscaloosa; California State University System; San Diego State University; California State University System; San Diego State University	Letcher, PM (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	letch006@bama.ua.edu		Behnke, Craig/0000-0001-6949-7957	PL: NSF AFTOL [DEB-0732599]	PL: NSF AFTOL	PL: NSF AFTOL Grant DEB-0732599, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Davis R, 2011, APPL ENERG, V88, P3524, DOI 10.1016/j.apenergy.2011.04.018; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fott B, 1957, U CAROL BIOL, V3, P229; Freeman KR, 2009, P NATL ACAD SCI USA, V106, P18315, DOI 10.1073/pnas.0907303106; Gao YH, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-S1-S1; GROMOV B. V., 1966, MIKROBIOLOGIYA, V35, P1073; GROMOV B V, 1968, Acta Protozoologica, V6, P221; GROMOV BV, 1970, ARCH HYDROBIOL, V67, P452; Gromov BV, 2000, ZOOL ZH, V79, P517; Gromov BV, 1969, PHYCOLOGIA, V7, P19; Gromov BV, 1969, 3 INT C PROT, P96; Gromov BV, 1969, VESTN LENINGRAD U  B, V9, P140; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hase R, 2000, J BIOSCI BIOENG, V89, P157, DOI 10.1016/S1389-1723(00)88730-7; HELD AA, 1973, CAN J BOT, V51, P1825, DOI 10.1139/b73-234; HELD AA, 1973, B TORREY BOT CLUB, V100, P203, DOI 10.2307/2484798; HELD AA, 1974, ARCH MICROBIOL, V95, P97, DOI 10.1007/BF02451752; Jones MDM, 2011, IMA FUNGUS, V2, P173, DOI 10.5598/imafungus.2011.02.02.08; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Karpov SA, 2013, PROTIST, V164, P195, DOI 10.1016/j.protis.2012.08.001; Kirk PM., 2008, DICT FUNGI, V10th ed; Kozhenkova EV, 1999, INT J ALGAE, V1, P46; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Mamkaeva K. A., 1969, NAUCHNYE DOKL VYSSHE, V8, P112; Pinevich A, 1997, CURR MICROBIOL, V34, P122, DOI 10.1007/s002849900155; POWELL MJ, 1984, MYCOLOGIA, V76, P1039, DOI 10.2307/3793019; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scherffel A., 1925, Archiv fuer Protistenkunde Jena, V52, P1; SCHNEPF E, 1971, ARCH MIKROBIOL, V75, P230, DOI 10.1007/BF00408984; Schweikert M, 1996, ARCH PROTISTENKD, V147, P11; Schweikert M, 1997, PROTOPLASMA, V199, P113, DOI 10.1007/BF01294500; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens E, 2010, TRENDS PLANT SCI, V15, P554, DOI 10.1016/j.tplants.2010.06.003; Ugwu CU, 2008, BIORESOURCE TECHNOL, V99, P4021, DOI 10.1016/j.biortech.2007.01.046; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zhu CJ, 1997, J APPL PHYCOL, V9, P189, DOI 10.1023/A:1007914806640; Zopf W, 1885, ENCYKLOPAEDIE NATURW	42	104	113	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56232	10.1371/journal.pone.0056232	http://dx.doi.org/10.1371/journal.pone.0056232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437098	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200049
J	Liu, K; Guo, TL; Hait, NC; Allegood, J; Parikh, HI; Xu, WF; Kellogg, GE; Grant, S; Spiegel, S; Zhang, SJ				Liu, Kai; Guo, Tai L.; Hait, Nitai C.; Allegood, Jeremy; Parikh, Hardik I.; Xu, Wenfang; Kellogg, Glen E.; Grant, Steven; Spiegel, Sarah; Zhang, Shijun			Biological Characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a Selective Sphingosine Kinase-2 Inhibitor and Anticancer Agent	PLOS ONE			English	Article							BREAST-CANCER; FUNCTIONAL-CHARACTERIZATION; PROTEASOMAL-DEGRADATION; ANTITUMOR-ACTIVITY; MOLECULAR-CLONING; PROTEIN; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; SURVIVAL; ANALOGS	In our effort to develop selective sphingosine kinase-2 (SphK2) inhibitors as pharmacological tools, a thiazolidine-2,4-dione analogue, 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145), was synthesized and biologically characterized. Biochemical assay results indicate that K145 is a selective SphK2 inhibitor. Molecular modeling studies also support this notion. In vitro studies using human leukemia U937 cells demonstrated that K145 accumulates in U937 cells, suppresses the S1P level, and inhibits SphK2. K145 also exhibited inhibitory effects on the growth of U937 cells as well as apoptotic effects in U937 cells, and that these effects may be through the inhibition of down-stream ERK and Akt signaling pathways. K145 also significantly inhibited the growth of U937 tumors in nude mice by both intraperitoneal and oral administration, thus demonstrating its in vivo efficacy as a potential lead anticancer agent. The antitumor activity of K145 was also confirmed in a syngeneic mouse model by implanting murine breast cancer JC cells in BALB/c mice. Collectively, these results strongly encourage further optimization of K145 as a novel lead compound for development of more potent and selective SphK2 inhibitors.	[Liu, Kai; Parikh, Hardik I.; Kellogg, Glen E.; Zhang, Shijun] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Guo, Tai L.] Virginia Commonwealth Univ, Dept Pharmacol, Richmond, VA 23298 USA; [Guo, Tai L.] Virginia Commonwealth Univ, Dept Toxicol, Richmond, VA 23298 USA; [Hait, Nitai C.; Allegood, Jeremy; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Xu, Wenfang] Shandong Univ, Sch Pharmaceut Sci, Jinan, Shandong, Peoples R China	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Shandong University	Zhang, SJ (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA.	szhang2@vcu.edu	Parikh, Hardik/AAG-4963-2021	Kellogg, Glen/0000-0002-6282-6794; Parikh, Hardik/0000-0002-5621-7343	National Institutes of Health [P30CA16059]; Multi-School AD William Fund from Virginia Commonwealth University; NIGMS [R37GM043880]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multi-School AD William Fund from Virginia Commonwealth University; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Flow cytometry was supported in part by National Institutes of Health Grant P30CA16059 awarded to Massey Cancer Center, VCU. This work was supported in part by the Multi-School AD William Fund from Virginia Commonwealth University (SZ) and NIGMS Grant R37GM043880 (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 2001, BLOOD, V98, P2828, DOI 10.1182/blood.V98.9.2828; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Gault CR, 2011, CRIT REV BIOCHEM MOL, V46, P342, DOI 10.3109/10409238.2011.597737; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hamada Y, 1993, Patent, Patent No. [US5214202, 5214202]; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Kennedy AJ, 2011, J MED CHEM, V54, P3524, DOI 10.1021/jm2001053; Kharel Y, 2012, BIOCHEM J, V447, P149, DOI 10.1042/BJ20120609; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee BD, 2003, ONCOL RES, V14, P49, DOI 10.3727/000000003108748603; Li Q, 2009, MICRO NANO LETT, V4, P1, DOI 10.1049/mnl:20080036; Lim KG, 2011, J BIOL CHEM, V286, P18633, DOI 10.1074/jbc.M111.220756; Lim KG, 2011, CELL SIGNAL, V23, P1590, DOI 10.1016/j.cellsig.2011.05.010; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Liu K, 2012, EUR J MED CHEM, V47, P125, DOI 10.1016/j.ejmech.2011.10.031; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mendgen T, 2012, J MED CHEM, V55, P743, DOI 10.1021/jm201243p; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Pyne S, 2011, CANCER RES, V71, P6576, DOI 10.1158/0008-5472.CAN-11-2364; Raje MR, 2012, BIOORGAN MED CHEM, V20, P183, DOI 10.1016/j.bmc.2011.11.011; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Siow D, 2011, CRIT REV BIOCHEM MOL, V46, P365, DOI 10.3109/10409238.2011.580097; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tomasic T, 2009, CURR MED CHEM, V16, P1596, DOI 10.2174/092986709788186200; Tonelli F, 2010, CELL SIGNAL, V22, P1536, DOI 10.1016/j.cellsig.2010.05.022; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Yokota S, 2004, FEBS LETT, V578, P106, DOI 10.1016/j.febslet.2004.10.081	57	65	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56471	10.1371/journal.pone.0056471	http://dx.doi.org/10.1371/journal.pone.0056471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437140	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200080
J	Nambu, I; Ebisawa, M; Kogure, M; Yano, S; Hokari, H; Wada, Y				Nambu, Isao; Ebisawa, Masashi; Kogure, Masumi; Yano, Shohei; Hokari, Haruhide; Wada, Yasuhiro			Estimating the Intended Sound Direction of the User: Toward an Auditory Brain-Computer Interface Using Out-of-Head Sound Localization	PLOS ONE			English	Article							P300 SPELLING SYSTEM; MENTAL PROSTHESIS	The auditory Brain-Computer Interface (BCI) using electroencephalograms (EEG) is a subject of intensive study. As a cue, auditory BCIs can deal with many of the characteristics of stimuli such as tone, pitch, and voices. Spatial information on auditory stimuli also provides useful information for a BCI. However, in a portable system, virtual auditory stimuli have to be presented spatially through earphones or headphones, instead of loudspeakers. We investigated the possibility of an auditory BCI using the out-of-head sound localization technique, which enables us to present virtual auditory stimuli to users from any direction, through earphones. The feasibility of a BCI using this technique was evaluated in an EEG oddball experiment and offline analysis. A virtual auditory stimulus was presented to the subject from one of six directions. Using a support vector machine, we were able to classify whether the subject attended the direction of a presented stimulus from EEG signals. The mean accuracy across subjects was 70.0% in the single-trial classification. When we used trial-averaged EEG signals as inputs to the classifier, the mean accuracy across seven subjects reached 89.5% (for 10-trial averaging). Further analysis showed that the P300 event-related potential responses from 200 to 500 ms in central and posterior regions of the brain contributed to the classification. In comparison with the results obtained from a loudspeaker experiment, we confirmed that stimulus presentation by out-of-head sound localization achieved similar event-related potential responses and classification performances. These results suggest that out-of-head sound localization enables us to provide a high-performance and loudspeaker-less portable BCI system.	[Nambu, Isao; Ebisawa, Masashi; Kogure, Masumi; Hokari, Haruhide; Wada, Yasuhiro] Nagaoka Univ Technol, Nagaoka, Niigata 94021, Japan; [Yano, Shohei] Nagaoka Natl Coll Technol, Nagaoka, Niigata, Japan	Nagaoka University of Technology	Wada, Y (corresponding author), Nagaoka Univ Technol, Nagaoka, Niigata 94021, Japan.	ywada@nagaokaut.ac.jp	Isao, Nambu/S-5963-2018; Wada, Yasuhiro/D-2587-2011	Isao, Nambu/0000-0002-1705-6268; Ebisawa, Motohiro/0000-0003-4117-558X; Wada, Yasuhiro/0000-0003-0268-8921	Japan Society for the Promotion of Science (JSPS) KAKENHI [21240013, 24650104, 24300051]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (Grants in Aid for Scientific Research) grants number 21240013, 24650104, 24300051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algazi VR, 2001, IEEE WORKSH APPL SIG, V2001, P99, DOI [DOI 10.1109/ASPAA.2001.969552, 10.1155/S1463924601000141]; Bishop C. M, 2006, PATTERN RECOGNITION; Blauert J., 1997, SPATIAL HEARING PSYC, DOI [10.7551/mitpress/6391.001.0001, DOI 10.7551/MITPRESS/6391.001.0001]; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cecotti H, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/016001; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Gao HY, 2011, IEEE ENG MED BIO, P4568, DOI 10.1109/IEMBS.2011.6091131; GARDNER WG, 1995, J ACOUST SOC AM, V97, P3907, DOI 10.1121/1.412407; Guo J, 2010, IEEE T NEUR SYS REH, V18, P230, DOI 10.1109/TNSRE.2010.2047604; Halder S, 2010, CLIN NEUROPHYSIOL, V121, P516, DOI 10.1016/j.clinph.2009.11.087; Hill NJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026011; Hohne J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045003; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Jrad N, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056004; Kanoh Shin'ichiro, 2010, Journal of Biomechanical Science and Engineering, V5, P32, DOI 10.1299/jbse.5.32; Kim DW, 2011, J NEUROSCI METH, V197, P180, DOI 10.1016/j.jneumeth.2011.02.007; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Kubler A, 2009, ANN NY ACAD SCI, V1157, P90, DOI 10.1111/j.1749-6632.2008.04122.x; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Morioka S, 2012, LECT NOTES COMPUT SC, V7666, P423, DOI 10.1007/978-3-642-34478-7_52; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Schreuder M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00112; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Sellers EW, 2006, IEEE T NEUR SYS REH, V14, P221, DOI 10.1109/TNSRE.2006.875580; Shimada S, 1995, ACTA ACUST UNITED AC, V81, P267; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yano S, 2000, IEICE T FUND ELECTR, VE83A, P877	37	21	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57174	10.1371/journal.pone.0057174	http://dx.doi.org/10.1371/journal.pone.0057174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437338	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200225
J	Oliveira, AB; Moura, CFH; Gomes, E; Marco, CA; Urban, L; Miranda, MRA				Oliveira, Aurelice B.; Moura, Carlos F. H.; Gomes-Filho, Eneas; Marco, Claudia A.; Urban, Laurent; Miranda, Maria Raquel A.			The Impact of Organic Farming on Quality of Tomatoes Is Associated to Increased Oxidative Stress during Fruit Development	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; ANTIOXIDANT ACTIVITY; PHENOLIC CONTENT; TEMPERATURE; POLYPHENOLS; BENEFITS; PLANTS; GENES	This study was conducted with the objective of testing the hypothesis that tomato fruits from organic farming accumulate more nutritional compounds, such as phenolics and vitamin C as a consequence of the stressing conditions associated with farming system. Growth was reduced in fruits from organic farming while titratable acidity, the soluble solids content and the concentrations in vitamin C were respectively +29%, +57% and +55% higher at the stage of commercial maturity. At that time, the total phenolic content was +139% higher than in the fruits from conventional farming which seems consistent with the more than two times higher activity of phenylalanine ammonia lyase (PAL) we observed throughout fruit development in fruits from organic farming. Cell membrane lipid peroxidation (LPO) degree was 60% higher in organic tomatoes. SOD activity was also dramatically higher in the fruits from organic farming. Taken together, our observations suggest that tomato fruits from organic farming experienced stressing conditions that resulted in oxidative stress and the accumulation of higher concentrations of soluble solids as sugars and other compounds contributing to fruit nutritional quality such as vitamin C and phenolic compounds.	[Oliveira, Aurelice B.; Gomes-Filho, Eneas; Miranda, Maria Raquel A.] Univ Fed Ceara, Depto Bioquim & Biol Mol, Fortaleza, CE, Brazil; [Moura, Carlos F. H.] Embrapa Agroind Trop, Fortaleza, CE, Brazil; [Marco, Claudia A.] Univ Fed Ceara, Juazeiro Do N, CE, Brazil; [Urban, Laurent] Univ Avignon & Pays de Vaucluse, Avignon, France	Universidade Federal do Ceara; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Ceara; Avignon Universite	Miranda, MRA (corresponding author), Univ Fed Ceara, Depto Bioquim & Biol Mol, Fortaleza, CE, Brazil.	rmiranda@ufc.br	Gomes-Filho, Enéas/AAG-2144-2020; Gomes-Filho, Enéas/F-4191-2010; de Miranda, Maria Raquel Alcântara/N-1942-2016	Gomes-Filho, Enéas/0000-0001-5945-6596; Gomes-Filho, Enéas/0000-0001-5945-6596; de Miranda, Maria Raquel Alcântara/0000-0003-0069-7242	BNB-Fundeci; CAPES-REUNI; CNPq/INCT Frutos Tropicais	BNB-Fundeci; CAPES-REUNI(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/INCT Frutos Tropicais	Funding was provided by BNB-Fundeci, CAPES-REUNI, and CNPq/INCT Frutos Tropicais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ANTIOXID REDOX SIGN, DOI DOI 10.1038/nrm3270; ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTRY, 2005, OFF METH AN ASS OFF; Basu A, 2007, EUR J CLIN NUTR, V61, P295, DOI 10.1038/sj.ejcn.1602510; BEERS RF, 1952, J BIOL CHEM, V195, P133; Beno-Moualem D, 2000, PHYTOPATHOLOGY, V90, P553, DOI 10.1094/PHYTO.2000.90.5.553; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bouvier F, 1998, J BIOL CHEM, V273, P30651, DOI 10.1074/jbc.273.46.30651; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caris-Veyrat C, 2004, J AGR FOOD CHEM, V52, P6503, DOI 10.1021/jf0346861; Chang A, 2008, J BIOL CHEM, V283, P33591, DOI 10.1074/jbc.M804428200; Chassy AW, 2006, J AGR FOOD CHEM, V54, P8244, DOI 10.1021/jf060950p; Chun OK, 2004, FOOD RES INT, V37, P337, DOI 10.1016/j.foodres.2004.02.001; Cunningham FX, 2002, PURE APPL CHEM, V74, P1409, DOI 10.1351/pac200274081409; El-Mergawi RA, 2010, J FOOD AGRIC ENVIRON, V8, P253; El-Shora HM, 2002, PLANT SCI, V162, P1, DOI 10.1016/S0168-9452(01)00471-X; Francis F. J., 1982, ANTHOCYANINS FOOD CO, P181, DOI [DOI 10.1016/B978-0-12-472550-8.50011-1, 10.1016/B978-0-12-472550-8.50011-1]; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Guo J, 2010, PLANT GROWTH REGUL, V62, P1, DOI 10.1007/s10725-010-9472-y; Hafiz IM, 2011, INT J MOL SCI, V12, P5238; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Jin P, 2011, FOOD CHEM, V124, P262, DOI 10.1016/j.foodchem.2010.06.029; Kuntz M, 1998, PLANT J, V13, P351, DOI 10.1046/j.1365-313X.1998.00032.x; Kuskoski E. Marta, 2005, Food Sci. Technol (Campinas), V25, P726, DOI 10.1590/S0101-20612005000400016; Larrauri JA, 1997, J AGR FOOD CHEM, V45, P1390, DOI 10.1021/jf960282f; Lima VLAG, 2005, FOOD CHEM, V90, P565, DOI 10.1016/j.foodchem.2004.04.014; LORIO PL, 1986, FOREST ECOL MANAG, V14, P259, DOI 10.1016/0378-1127(86)90172-6; Luthria D, 2010, FOOD CHEM, V121, P406, DOI 10.1016/j.foodchem.2009.12.055; LUXMOORE RJ, 1991, TREE PHYSIOL, V9, P267, DOI 10.1093/treephys/9.1-2.267; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mitchell AE, 2007, J AGR FOOD CHEM, V55, P6154, DOI 10.1021/jf070344+; Mori T, 2001, PLANT SCI, V160, P355, DOI 10.1016/S0168-9452(00)00399-X; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Obanda M, 1997, J SCI FOOD AGR, V74, P209, DOI [10.1002/(SICI)1097-0010(199706)74:2<209::AID-JSFA789>3.3.CO;2-W, 10.1002/(SICI)1097-0010(199706)74:2&lt;209::AID-JSFA789&gt;3.0.CO;2-4]; Olsson ME, 2006, J AGR FOOD CHEM, V54, P1248, DOI 10.1021/jf0524776; Poiroux-Gonord F, 2012, J SCI FOOD AGR, V92, P2076, DOI 10.1002/jsfa.5584; Poiroux-Gonord F, 2010, J AGR FOOD CHEM, V58, P12065, DOI 10.1021/jf1037745; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Strohecker R., 1967, ANALISIS VITAMINAS M; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Urban L, 2008, C DINABIO MONTP; Vallverdu-Queralt A, 2012, FOOD CHEM, V130, P222, DOI 10.1016/j.foodchem.2011.07.017; Zhu SH, 2008, J SCI FOOD AGR, V88, P2324, DOI 10.1002/jsfa.3353; Zushi K, 2009, SCI HORTIC-AMSTERDAM, V122, P362, DOI 10.1016/j.scienta.2009.06.001	45	85	89	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56354	10.1371/journal.pone.0056354	http://dx.doi.org/10.1371/journal.pone.0056354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437115	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200060
J	Rehn, T; McGowan, RTS; Keeling, LJ				Rehn, Therese; McGowan, Ragen T. S.; Keeling, Linda J.			Evaluating the Strange Situation Procedure (SSP) to Assess the Bond between Dogs and Humans	PLOS ONE			English	Article							ATTACHMENT BEHAVIOR; CANIS-FAMILIARIS; MOTHER ATTACHMENT; GUIDE DOGS; VALIDATION; SEPARATION; RESPONSES	The Strange Situation Procedure (SSP) is increasingly being used to study attachment between dogs and humans. It has been developed from the Ainsworth Strange Situation Procedure, which is used extensively to investigate attachment between children and their parents. In this experiment, 12 female beagle dogs were tested in two treatments to identify possible order effects in the test, a potential weakness in the SSP. In one treatment (FS), dogs participated together with a 'familiar person' and a 'stranger'. In a control treatment (SS), the same dogs participated together with two unfamiliar people, 'stranger A' and 'stranger B'. Comparisons were made between episodes within as well as between treatments. As predicted in FS, dogs explored more in the presence of the familiar person than the stranger. Importantly, they also explored more in the presence of stranger A (who appeared in the same order as the familiar person and followed the same procedure) than stranger B in SS. Furthermore, comparisons between treatments, where a familiar person was present in FS and stranger A was present in SS, showed no differences in exploration. In combination, these results indicate that the effect of a familiar person on dogs' exploratory behaviour, a key feature when assessing secure attachment styles, could not be tested reliably due to the order in which the familiar person and the stranger appear. It is proposed that in the future only counterbalanced versions of the SSP are used. Alternatively, since dogs reliably initiated more contact with the familiar person compared to the strangers, it is suggested that future studies on attachment in dogs towards humans should focus either on the behaviour of the dog in those episodes of the SSP when the person returns, or on reunion behaviour in other studies, specially designed to address dog-human interactions at this time.	[Rehn, Therese; McGowan, Ragen T. S.; Keeling, Linda J.] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden	Swedish University of Agricultural Sciences	Rehn, T (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden.	Therese.Rehn@slu.se	Rehn, Therese/C-5980-2014; Keeling, Linda J/K-6542-2012	Rehn, Therese/0000-0002-5687-1521; Keeling, Linda J/0000-0003-2629-0117	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [221-2009-1633]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	Funding was contributed by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, grant number: 221-2009-1633 (URL:http://www.formas.se/en/About-Sustainability-Formas-Research-Council/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORT.MD, 1970, CHILD DEV, V41, P49, DOI 10.2307/1127388; Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT, P45; BOWLBY J, 1958, INT J PSYCHOANAL, V39, P350; Bowlby J, 1969, ATTACHMENT LOSS SEPA; BRETHERTON I, 1992, DEV PSYCHOL, V28, P759, DOI 10.1037/0012-1649.28.5.759; Burman O, 2011, APPL ANIM BEHAV SCI, V132, P160, DOI 10.1016/j.applanim.2011.04.001; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; CASSIDY J, 1988, CHILD DEV, V59, P121, DOI 10.2307/1130394; Cassidy J., 1999, HDB ATTACHMENT THEOR; Fallani G, 2007, PHYSIOL BEHAV, V90, P648, DOI 10.1016/j.physbeh.2006.12.001; Fallani G, 2006, APPL ANIM BEHAV SCI, V100, P241, DOI 10.1016/j.applanim.2005.12.005; FELDMAN SS, 1975, CHILD DEV, V46, P319, DOI 10.2307/1128124; Gacsi M, 2001, J COMP PSYCHOL, V115, P423, DOI 10.1037/0735-7036.115.4.423; GOLDBERG S, 1991, CAN J PSYCHIAT, V36, P393, DOI 10.1177/070674379103600603; Keller H, 2008, INTEGR PSYCHOL BEHAV, V42, P406, DOI 10.1007/s12124-008-9080-9; Koren-Karie N, 2009, J CHILD PSYCHOL PSYC, V50, P643, DOI 10.1111/j.1469-7610.2008.02043.x; Kubinyi E, 2003, J COMP PSYCHOL, V117, P156, DOI 10.1037/0735-7036.117.2.156; LAMB ME, 1984, BEHAV BRAIN SCI, V7, P127, DOI 10.1017/S0140525X00026522; MACCOBY EE, 1972, MONOGR SOC RES CHILD, V37, P1, DOI 10.2307/1165693; McGowan RTS, 2010, P 44 C ISAE, P59; Palestrini C, 2005, APPL ANIM BEHAV SCI, V94, P75, DOI 10.1016/j.applanim.2005.02.005; Palmer R, 2008, APPL ANIM BEHAV SCI, V109, P306, DOI 10.1016/j.applanim.2007.04.002; Pederson DR, 1999, J FAM PSYCHOL, V13, P496, DOI 10.1037/0893-3200.13.4.496; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Rehn T, 2011, APPL ANIM BEHAV SCI, V129, P129, DOI 10.1016/j.applanim.2010.11.015; Serpell JA, 2003, SOC ANIM, V11, P83, DOI 10.1163/156853003321618864; SHILLER VM, 1986, DEV PSYCHOL, V22, P378, DOI 10.1037/0012-1649.22.3.378; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Valsecchi P, 2010, APPL ANIM BEHAV SCI, V123, P43, DOI 10.1016/j.applanim.2009.12.012; VAUGHN B, 1979, CHILD DEV, V50, P971, DOI 10.2307/1129321; WATERS E, 1975, CHILD DEV, V46, P348, DOI 10.2307/1128127	32	44	44	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56938	10.1371/journal.pone.0056938	http://dx.doi.org/10.1371/journal.pone.0056938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437277	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200189
J	Zhang, JK; Yang, L; Meng, GL; Yuan, Z; Fan, J; Li, D; Chen, JZ; Shi, TY; Hu, HM; Wei, BY; Luo, ZJ; Liu, J				Zhang, Jin-Kang; Yang, Liu; Meng, Guo-Lin; Yuan, Zhi; Fan, Jing; Li, Dan; Chen, Jian-Zong; Shi, Tian-Yao; Hu, Hui-Min; Wei, Bo-Yuan; Luo, Zhuo-Jing; Liu, Jian			Protection by Salidroside against Bone Loss via Inhibition of Oxidative Stress and Bone-Resorbing Mediators	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-PEROXIDE; OSTEOBLASTIC DIFFERENTIATION; POSTMENOPAUSAL OSTEOPOROSIS; OSTEOCLAST FORMATION; MECHANICAL-PROPERTIES; ANTIOXIDANT SYSTEM; LIPID-PEROXIDATION; MC3T3-E1 CELLS; STROMAL CELLS	Oxidative stress is a pivotal pathogenic factor for bone loss in mouse model. Salidroside, a phenylpropanoid glycoside extracted from Rhodiola rosea L, exhibits potent antioxidative effects. In the present study, we used an in vitro oxidative stress model induced by hydrogen peroxide (H2O2) in MC3T3-E1 cells and a murine ovariectomized (OVX) osteoporosis model to investigate the protective effects of salidroside on bone loss and the related mechanisms. We demonstrated that salidroside caused a significant (P < 0.05) elevation of cell survival, alkaline phosphatase (ALP) staining and activity, calcium deposition, and the transcriptional expression of Alp, Col1a1 and Osteocalcin (Ocn) in the presence of H2O2. Moreover, salidroside decreased the production of intracellular reactive oxygen species (ROS), and osteoclast differentiation inducing factors such as receptor activator of nuclear factor-kB ligand (RANKL) and IL-6 induced by H2O2. In vivo studies further demonstrated that salidroside supplementation for 3 months caused a decrease in malondialdehyde (MDA) and an increase in reduced glutathione (GSH) concentration in blood of ovariectomized mouse (P < 0.05), it also improved trabecular bone microarchitecture and bone mineral density in the fourth lumbar vertebra and distal femur. Our study indicated that the protection provided by salidroside in alleviating bone loss was mediated, at least in part, via inhibition of the release of bone-resorbing mediators and oxidative damage to bone-forming cells, suggesting that salidroside can be used as an effective remedy in the treatment or prevention of osteoporosis.	[Zhang, Jin-Kang; Yang, Liu; Meng, Guo-Lin; Yuan, Zhi; Fan, Jing; Li, Dan; Hu, Hui-Min; Wei, Bo-Yuan; Luo, Zhuo-Jing; Liu, Jian] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China; [Chen, Jian-Zong] Fourth Mil Med Univ, Xijing Hosp, Res Ctr Tradit Chinese Med, Xian 710032, Peoples R China; [Shi, Tian-Yao] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Luo, ZJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China.	zjluo@fmmu.edu.cn; zjk1271984@21cn.com			Ministry of Science and Technology of China [2011CB964703]; National High Technology Research and Development Program 863 [2012AA020502]; China Postdoctoral Science Foundation [20100480093]; National Natural Science Foundation of China [30901504]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China (2011CB964703), National High Technology Research and Development Program 863 (2012AA020502), China Postdoctoral Science Foundation (20100480093) and National Natural Science Foundation of China (30901504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Baek KH, 2010, CALCIFIED TISSUE INT, V87, P226, DOI 10.1007/s00223-010-9393-9; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Fatokun AA, 2008, EUR J PHARMACOL, V587, P35, DOI 10.1016/j.ejphar.2008.03.024; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; GIRASOLE G, 1992, J CLIN INVEST, V89, P883, DOI 10.1172/JCI115668; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Isomura H, 2004, TOXICOLOGY, V197, P93, DOI 10.1016/j.tox.2003.12.006; Kazakia GJ, 2006, REV ENDOCR METAB DIS, V7, P67, DOI 10.1007/s11154-006-9004-2; Kinov P, 2006, J ORTHOP RES, V24, P55, DOI 10.1002/jor.20013; KITAZAWA R, 1994, J CLIN INVEST, V94, P2397, DOI 10.1172/JCI117606; KURIHARA N, 1990, J IMMUNOL, V144, P4226; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Li Y, 2012, J BIOMED MAT RES B; Li Yongming, 2010, BMC Res Notes, V3, P309, DOI 10.1186/1756-0500-3-309; Liu AL, 2004, CELL BIOL INT, V28, P905, DOI 10.1016/j.cellbi.2004.09.004; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; Nielsen F, 1997, CLIN CHEM, V43, P1209; Ning J, 2000, TOXICOL IN VITRO, V14, P329, DOI 10.1016/S0887-2333(00)00024-2; Ozgocmen S, 2007, ARCH MED RES, V38, P196, DOI 10.1016/j.arcmed.2006.09.010; Ozgocmen S, 2007, MOL CELL BIOCHEM, V295, P45, DOI 10.1007/s11010-006-9270-z; Papanicolaou DA, 2000, J CLIN ENDOCR METAB, V85, P1331, DOI 10.1210/jc.85.3.1331; Peng ZQ, 1997, BONE, V20, P207, DOI 10.1016/S8756-3282(96)00369-9; Qian EW, 2012, J NAT PROD, V75, P531, DOI 10.1021/np200555s; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sendur OF, 2009, JOINT BONE SPINE, V76, P514, DOI 10.1016/j.jbspin.2009.02.005; Shi TY, 2012, NEUROTOX RES, V21, P358, DOI 10.1007/s12640-011-9290-7; Skopinska-Rozewska E, 2008, POL J VET SCI, V11, P97; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Teo JCM, 2006, CLIN BIOMECH, V21, P235, DOI 10.1016/j.clinbiomech.2005.11.001; Wiegant FAC, 2009, BIOGERONTOLOGY, V10, P27, DOI 10.1007/s10522-008-9151-9; Yang P, 2007, J TOXICOL ENV HEAL A, V70, P976, DOI 10.1080/15287390701290832; Yu PZ, 2007, CHEM BIODIVERS, V4, P508, DOI 10.1002/cbdv.200790043; Yu S, 2008, CELL MOL NEUROBIOL, V28, P1067, DOI 10.1007/s10571-008-9284-z; Zhu Y, 2011, DNA CELL BIOL, V30, P809, DOI 10.1089/dna.2010.1183; 2001, JAMA, V285, P785	45	66	74	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57251	10.1371/journal.pone.0057251	http://dx.doi.org/10.1371/journal.pone.0057251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437352	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200230
J	Hu, YJ; Shao, ZY; Wang, Q; Jiang, YT; Ma, R; Tang, ZS; Liu, Z; Liang, JP; Huang, ZW				Hu, Yue-jian; Shao, Zi-yang; Wang, Qian; Jiang, Yun-tao; Ma, Rui; Tang, Zi-sheng; Liu, Zheng; Liang, Jing-ping; Huang, Zheng-wei			Exploring the Dynamic Core Microbiome of Plaque Microbiota during Head-and-Neck Radiotherapy Using Pyrosequencing	PLOS ONE			English	Article							ORAL MICROFLORA	Radiotherapy is the primary treatment modality used for patients with head-and-neck cancers, but inevitably causes microorganism-related oral complications. This study aims to explore the dynamic core microbiome of oral microbiota in supragingival plaque during the course of head-and-neck radiotherapy. Eight subjects aged 26 to 70 were recruited. Dental plaque samples were collected (over seven sampling time points for each patient) before and during radiotherapy. The V1-V3 hypervariable regions of bacterial 16S rRNA genes were amplified, and the high-throughput pyrosequencing was performed. A total of 140 genera belonging to 13 phyla were found. Four phyla (Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria) and 11 genera (Streptococcus, Actinomyces, Veillonella, Capnocytophaga, Derxia, Neisseria, Rothia, Prevotella, Granulicatella, Luteococcus, and Gemella) were found in all subjects, supporting the concept of a core microbiome. Temporal variation of these major cores in relative abundance were observed, as well as a negative correlation between the number of OTUs and radiation dose. Moreover, an optimized conceptual framework was proposed for defining a dynamic core microbiome in extreme conditions such as radiotherapy. This study presents a theoretical foundation for exploring a core microbiome of communities from time series data, and may help predict community responses to perturbation as caused by exposure to ionizing radiation.	[Hu, Yue-jian; Wang, Qian; Jiang, Yun-tao; Ma, Rui; Tang, Zi-sheng; Liu, Zheng; Liang, Jing-ping; Huang, Zheng-wei] Shanghai Jiao Tong Univ, Dept Endodont, Sch Med, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China; [Shao, Zi-yang] Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Sch Med, Div Radiat Oncol,Peoples Hosp 9, Shanghai 200030, Peoples R China; [Hu, Yue-jian] Tongji Univ, Dept Endodont, Affiliated Stomatol Hosp, Sch Stomatol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Liang, JP (corresponding author), Shanghai Jiao Tong Univ, Dept Endodont, Sch Med, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China.	liangjp123@yahoo.com.cn; huangzhengwei@shsmu.edu.cn	Hu, Yue/HGE-1673-2022		National Natural Science Foundation (NSFC) [81070826/30872886]; Shanghai Rising-Star Program [12QH1401400]; Shanghai Jiaotong University [YG2011MS67]	National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Jiaotong University	This work was supported by a grant from the National Natural Science Foundation (NSFC) No. 81070826/30872886 and partly sponsored by Shanghai Rising-Star Program No. 12QH1401400. Patient enrollment was funded by the Shanghai Jiaotong University grant (YG2011MS67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAmri OD, 2012, ENVIRON POLLUT, V168, P107, DOI 10.1016/j.envpol.2012.04.015; Almstahl A, 1999, J DENT RES, V78, P1410, DOI 10.1177/00220345990780080601; Alvarado Yesid, 2002, Hematology, V7, P281, DOI 10.1080/1024533021000037216; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Farah CS, 2001, ORAL MICROBIOL IMMUN, V16, P358, DOI 10.1034/j.1399-302X.2001.160607.x; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Junior GD, 2006, CURR OPIN ONCOL, V18, P266; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; MACFARLANE TW, 1974, J CLIN PATHOL, V27, P416, DOI 10.1136/jcp.27.5.416; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nederfors T, 2000, Adv Dent Res, V14, P48; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schuurhuis JM, 2011, RADIOTHER ONCOL, V101, P403, DOI 10.1016/j.radonc.2011.09.018; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shao ZY, 2011, J RADIAT RES, V52, P834, DOI 10.1269/jrr.11085; Shih A, 2003, CANCER NURS, V26, P222, DOI 10.1097/00002820-200306000-00008; Siqueira Jose F Jr, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10743; Tong HC, 2003, CARIES RES, V37, P261, DOI 10.1159/000070868; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	24	38	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56343	10.1371/journal.pone.0056343	http://dx.doi.org/10.1371/journal.pone.0056343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437114	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000023
J	Kumar, S; Mazumder, M; Dharavath, S; Gourinath, S				Kumar, Sudhir; Mazumder, Mohit; Dharavath, Sudhaker; Gourinath, S.			Single Residue Mutation in Active Site of Serine Acetyltransferase Isoform 3 from Entamoeba histolytica Assists in Partial Regaining of Feedback Inhibition by Cysteine	PLOS ONE			English	Article							ESCHERICHIA-COLI; L-CYSTINE; BIOSYNTHESIS; OVERPRODUCTION; SULFHYDRYLASE; MUTAGENESIS; COMPLEX; MUTANT; GENE	The cysteine biosynthetic pathway is essential for survival of the protist pathogen Entamoeba histolytica, and functions by producing cysteine for countering oxidative attack during infection in human hosts. Serine acetyltransferase ( SAT) and O-acetylserine sulfhydrylase (OASS) are involved in cysteine biosynthesis and are present in three isoforms each. While EhSAT1 and EhSAT2 are feedback inhibited by end product cysteine, EhSAT3 is nearly insensitive to such inhibition. The active site residues of EhSAT1 and of EhSAT3 are identical except for position 208, which is a histidine residue in EhSAT1 and a serine residue in EhSAT3. A combination of comparative modeling, multiple molecular dynamics simulations and free energy calculation studies showed a difference in binding energies of native EhSAT3 and of a S208H-EhSAT3 mutant for cysteine. Mutants have also been generated in vitro, replacing serine with histidine at position 208 in EhSAT3 and replacing histidine 208 with serine in EhSAT1. These mutants showed decreased affinity for substrate serine, as indicated by K-m, compared to the native enzymes. Inhibition kinetics in the presence of physiological concentrations of serine show that IC50 of EhSAT1 increases by about 18 folds from 9.59 mu M for native to 169.88 mu M for H208S-EhSAT1 mutant. Similar measurements with EhSAT3 confirm it to be insensitive to cysteine inhibition while its mutant (S208H-EhSAT3) shows a gain of cysteine inhibition by 36% and the IC50 of 3.5 mM. Histidine 208 appears to be one of the important residues that distinguish the serine substrate from the cysteine inhibitor.	[Kumar, Sudhir; Mazumder, Mohit; Dharavath, Sudhaker; Gourinath, S.] Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India	Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India.	sgourinath@mail.jnu.ac.in	Kumar, Sudhir/AAE-3615-2020	Kumar, Sudhir/0000-0001-9673-5842; dharavath, Sudhaker/0000-0002-5973-0214; mazumder, mohit/0000-0002-2593-725X	University Grants Commission (UGC); DBT; Department of Biotechnology; Council of Scientific and Industrial research, Government of India; UGC resource networking; Department of Science and Technology; UGC; ICMR; DST-FIST	University Grants Commission (UGC)(University Grants Commission, India); DBT(Department of Biotechnology (DBT) India); Department of Biotechnology; Council of Scientific and Industrial research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC resource networking; Department of Science and Technology(Department of Science & Technology (India)); UGC(University Grants Commission, India); ICMR(Indian Council of Medical Research (ICMR)); DST-FIST(Department of Science & Technology (India))	SK and MM thank University Grants Commission (UGC) and DBT for fellowship respectively. The authors thank Programme support on Molecular Parasitology by Department of Biotechnology, and Council of Scientific and Industrial research, Government of India. The authors thank UGC resource networking and Department of Science and Technology-Fund for Improvement of S&T Infrastructure in Higher Educational Institutions funding for departmental central facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.K, M.M, S. D thanks UGC, DBT and ICMR for fellowship respectively. We thank UGC resource networking and DST-FIST funding for departmental central facility. We thank Dean, School of Biotechnology, JNU, New Delhi for granting access to Central Instrumentation Facility. We also thank Dr. Rajesh Pujari for his help in enzyme assays.	BAKKERGRUNWALD T, 1995, J EUKARYOT MICROBIOL, V42, P346, DOI 10.1111/j.1550-7408.1995.tb01592.x; Cheatham TE, 2011, AMBER 11; Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; DENK D, 1987, J GEN MICROBIOL, V133, P515; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Guan R, 2008, BIOCHEMISTRY-US, V47, P6322, DOI 10.1021/bi800075c; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hussain S, 2009, MOL BIOCHEM PARASIT, V163, P39, DOI 10.1016/j.molbiopara.2008.09.006; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kumar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197376; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Na GN, 2011, J BIOL CHEM, V286, P40423, DOI 10.1074/jbc.M111.247411; Nakamori S, 1998, APPL ENVIRON MICROB, V64, P1607; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raj I, 2012, ACTA CRYSTALLOGRAP D, V68; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SMITH IK, 1971, BIOCHIM BIOPHYS ACTA, V227, P288, DOI 10.1016/0005-2744(71)90061-1; Takagi H, 1999, FEBS LETT, V452, P323, DOI 10.1016/S0014-5793(99)00679-1; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	26	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55932	10.1371/journal.pone.0055932	http://dx.doi.org/10.1371/journal.pone.0055932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437075	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000013
J	Moncunill, G; Mayor, A; Jimenez, A; Nhabomba, A; Puyol, L; Manaca, MN; Barrios, D; Cistero, P; Guinovart, C; Aguilar, R; Bardaji, A; Pinazo, MJ; Angov, E; Dutta, S; Chitnis, CE; Munoz, J; Gascon, J; Dobano, C				Moncunill, Gemma; Mayor, Alfredo; Jimenez, Alfons; Nhabomba, Augusto; Puyol, Laura; Manaca, Maria N.; Barrios, Diana; Cistero, Pau; Guinovart, Caterina; Aguilar, Ruth; Bardaji, Azucena; Pinazo, Maria-Jesus; Angov, Evelina; Dutta, Sheetij; Chitnis, Chetan E.; Munoz, Jose; Gascon, Joaquim; Dobano, Carlota			Cytokine and Antibody Responses to Plasmodium falciparum in Naive Individuals during a First Malaria Episode: Effect of Age and Malaria Exposure	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; INFECTED ERYTHROCYTES; ACQUIRED-IMMUNITY; CLINICAL MALARIA; BLOOD-STAGE; PROTECTION; INTERFERON; ANTIGENS; ACQUISITION; TOLERANCE	Age- and exposure-dependent immune responses during a malaria episode may be key to understanding the role of these factors in the acquisition of immunity to malaria. Plasma/serum samples collected from naive Mozambican children (n = 48), European adults (naive travelers, n = 22; expatriates with few prior malaria exposures, n = 15) and Mozambican adults with long-life malaria exposure (n = 99) during and after a malaria episode were analyzed for IgG against merozoite proteins by Luminex and against infected erythrocytes by flow cytometry. Cytokines and chemokines were analyzed in plasmas/sera by suspension array technology. No differences were detected between children and adults with a primary infection, with the exception of higher IgG levels against 3D7 MSP-1(42) (P = 0.030) and a P. falciparum isolate (P = 0.002), as well as higher IL-12 (P = 0.020) in children compared to other groups. Compared to malaria-exposed adults, children, travelers and expatriates had higher concentrations of IFN-gamma (P <= 0.0090), IL-2 (P <= 0.0379) and IL-8 (P <= 0.0233). Children also had higher IL-12 (P = 0.0001), IL-4 (P = 0.003), IL-1 beta (P = 0.024) and TNF (P = 0.006) levels compared to malaria-exposed adults. Although IL-12 was elevated in children, overall the data do not support a role of age in immune responses to a first malaria episode. A T(H)1/pro-inflammatory response was the hallmark of non-immune subjects.	[Moncunill, Gemma; Mayor, Alfredo; Jimenez, Alfons; Puyol, Laura; Barrios, Diana; Cistero, Pau; Guinovart, Caterina; Aguilar, Ruth; Bardaji, Azucena; Pinazo, Maria-Jesus; Munoz, Jose; Gascon, Joaquim; Dobano, Carlota] Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, CRESIB, Barcelona, Spain; [Mayor, Alfredo; Nhabomba, Augusto; Manaca, Maria N.; Guinovart, Caterina; Aguilar, Ruth; Dobano, Carlota] Ctr Invest Saude Manhica, Maputo, Mozambique; [Angov, Evelina; Dutta, Sheetij] Walter Reed Army Inst Res, Silver Spring, MD USA; [Chitnis, Chetan E.] Int Ctr Genet Engn & Biotechnol, New Delhi, India	ISGlobal; CRESIB; University of Barcelona; Centro de Investigacao em Saude de Manhica; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Moncunill, G (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, CRESIB, Barcelona, Spain.	gemma.moncunil@cresib.cat	Alonso, Azucena Bardají/V-5978-2018; Gutiérrez, José/GSJ-1846-2022; Gutiérrez, Jose Muñoz/X-5917-2018; Delgado, Maria Jesús Pinazo/X-6093-2018; JIMENEZ, ALFONS/L-2106-2019; Gascon, Joaquim/M-3598-2015; Mayor, Alfredo/H-7488-2017; Barrios-Rodríguez, Diana/D-3910-2018; Guinovart, Caterina/ABH-2981-2020; Cisteró, Pau/H-2468-2017; Aguilar, Ruth/D-2147-2018; Gutierrez, Jose Muñoz/AAH-6954-2020; Moncunill, Gemma/B-7989-2011; Bardají, Azucena/AAE-9145-2019; Dobaño, Carlota/N-4119-2014	Alonso, Azucena Bardají/0000-0002-5135-0540; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Delgado, Maria Jesús Pinazo/0000-0002-4237-1075; JIMENEZ, ALFONS/0000-0003-0301-3344; Gascon, Joaquim/0000-0002-5045-1585; Mayor, Alfredo/0000-0003-3890-2897; Barrios-Rodríguez, Diana/0000-0001-9929-5707; Cisteró, Pau/0000-0001-7225-4331; Aguilar, Ruth/0000-0003-3277-3107; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Moncunill, Gemma/0000-0001-5105-9836; Dobaño, Carlota/0000-0002-6751-4060; Puyol, Laura/0000-0003-2840-7753; Fernandez, Ivette/0000-0001-5179-0477; Chitnis, Chetan/0000-0002-8773-9865	Ministerio de Ciencia e Innovacion [SAF2008-00743, SAF2005-25642-E, RYC-2008-02631]; Instituto de Salud Carlos III [PI050275, A107190024, PS0901113, CD10/00156, CP-4/00220, CM04/00028]; EU FP6 [LSHP-CT-2005-18902]; Fundacion Ramon Areces	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); EU FP6(European Commission); Fundacion Ramon Areces	The study received financial support from the Ministerio de Ciencia e Innovacion (SAF2008-00743, SAF2005-25642-E, salary support RYC-2008-02631 to CD); the Instituto de Salud Carlos III (PI050275, A107190024, PS0901113, salary support CD10/00156 to GM, CP-4/00220 to AM, and CM04/00028 to CG), the EU FP6 (LSHP-CT-2005-18902), and the Fundacion Ramon Areces. The Centro de Investigacao em Saude de Manhica receives core support from the Spanish Agency for International Cooperation and Development (AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR JC, 1992, AM J TROP MED HYG, V47, P621; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; BAIRD JK, 1991, AM J TROP MED HYG, V45, P65, DOI 10.4269/ajtmh.1991.45.65; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Broad A, 2007, IMMUNOLOGY, V120, P103, DOI 10.1111/j.1365-2567.2006.02485.x; Campo JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025779; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Cook PC, 2012, P NATL ACAD SCI USA, V109, P9977, DOI 10.1073/pnas.1121231109; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Dobano C, 2012, CLIN VACCINE IMMUNOL, V19, P157, DOI 10.1128/CVI.05523-11; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Elliott SR, 2007, AM J TROP MED HYG, V76, P860, DOI 10.4269/ajtmh.2007.76.860; Gigley JP, 2012, TRENDS PARASITOL, V28, P377, DOI 10.1016/j.pt.2012.07.001; Guinovart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032362; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Hoffman SL, 1997, NAT MED, V3, P80, DOI 10.1038/nm0197-80; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Keenihan SNH, 2003, AM J TROP MED HYG, V69, P36; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Mackintosh CL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-155; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Mayor A, 2012, CLIN INFECT DIS, V54, P1561, DOI 10.1093/cid/cis236; Mayor A, 2011, INFECT IMMUN, V79, P1654, DOI 10.1128/IAI.01000-10; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; Metenou S, 2007, J IMMUNOL, V178, P2770, DOI 10.4049/jimmunol.178.5.2770; Nielsen MA, 2004, INFECT IMMUN, V72, P3531, DOI 10.1128/IAI.72.6.3531-3535.2004; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Perkins DJ, 2000, J INFECT DIS, V182, P988, DOI 10.1086/315762; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Reeder JC, 1997, ACTA TROP, V65, P163, DOI 10.1016/S0001-706X(97)00661-X; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Rovira-Vallbona E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-181; Rovira-Vallbona E, 2011, J INFECT DIS, V204, P27, DOI 10.1093/infdis/jir217; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Salvado E, 2008, ENFERM INFEC MICR CL, V26, P282, DOI 10.1157/13120415; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P10700, DOI 10.1073/pnas.91.22.10700; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stevenson MM, 2006, PARASITE IMMUNOL, V28, P5, DOI 10.1111/j.1365-3024.2006.00772.x; Torre D, 2009, CLIN INFECT DIS, V48, P1481, DOI 10.1086/598508; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WHO, 2011, WORLD MALARIA REPORT 2011, P1	57	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55756	10.1371/journal.pone.0055756	http://dx.doi.org/10.1371/journal.pone.0055756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437061	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000008
J	Chen, CC; Er, TK; Liu, YY; Hwang, JK; Barrio, MJ; Rodrigo, M; Garcia-Toro, E; Herreros-Villanueva, M				Chen, Chih-Chieh; Er, Tze-Kiong; Liu, Yen-Yi; Hwang, Jenn-Kang; Jesus Barrio, Maria; Rodrigo, Maximiliano; Garcia-Toro, Enrique; Herreros-Villanueva, Marta			Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations	PLOS ONE			English	Article							K-RAS MUTATIONS; COLORECTAL-CANCER; GROWTH; GENE; CETUXIMAB; ONCOGENE; CODON-13; EGFR; PROTOONCOGENE; ACTIVATION	Background: The issue of whether patients diagnosed with metastatic colorectal cancer who harbor KRAS codon 13 mutations could benefit from the addition of anti-epidermal growth factor receptor therapy remains under debate. The aim of the current study was to perform computational analysis to investigate the structural implications of the underlying mutations caused by c.38G>A (p.G13D) on protein conformation. Methods: Molecular dynamics (MD) simulations were performed to understand the plausible structural and dynamical implications caused by c.35G>A (p.G12D) and c.38G>A (p.G13D). The potential of mean force (PMF) simulations were carried out to determine the free energy profiles of the binding processes of GTP interacting with wild-type (WT) KRAS and its mutants (MT). Results: Using MD simulations, we observed that the root mean square deviation (RMSD) increased as a function of time for the MT c.35G>A (p.G12D) and MT c.38G>A (p.G13D) when compared with the WT. We also observed that the GTP-binding pocket in the c.35G>A (p.G12D) mutant is more open than that of the WT and the c.38G>A (p.G13D) proteins. Intriguingly, the analysis of atomic fluctuations and free energy profiles revealed that the mutation of c.35G>A (p.G12D) may induce additional fluctuations in the sensitive sites (P-loop, switch I and II regions). Such fluctuations may promote instability in these protein regions and hamper GTP binding. Conclusions: Taken together with the results obtained from MD and PMF simulations, the present findings implicate fluctuations at the sensitive sites (P-loop, switch I and II regions). Our findings revealed that KRAS mutations in codon 13 have similar behavior as KRAS WT. To gain a better insight into why patients with metastatic colorectal cancer (mCRC) and the KRAS c.38G>A (p.G13D) mutation appear to benefit from anti-EGFR therapy, the role of the KRAS c.38G>A (p.G13D) mutation in mCRC needs to be further investigated.	[Chen, Chih-Chieh; Liu, Yen-Yi; Hwang, Jenn-Kang] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Er, Tze-Kiong] Kaohsiung Med Univ Hosp, Dept Lab Med, Div Mol Diagnost, Kaohsiung, Taiwan; [Er, Tze-Kiong] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Er, Tze-Kiong] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Jesus Barrio, Maria] Hosp Gen Yague, Serv Oncol, Burgos, Spain; [Rodrigo, Maximiliano; Garcia-Toro, Enrique] Hosp Gen Yague, Serv Anat Patol, Burgos, Spain; [Herreros-Villanueva, Marta] Hosp Gen Yague, Unidad Invest, Burgos, Spain	National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Hospital General Yague; Hospital General Yague; Hospital General Yague	Herreros-Villanueva, M (corresponding author), Hosp Gen Yague, Unidad Invest, Burgos, Spain.	martahvh1978@hotmail.com	ER, TZE/AFN-4587-2022; , Herreros-Villanueva/M-5702-2016	ER, TZE/0000-0002-7068-1652; , Herreros-Villanueva/0000-0002-6905-0693; Liu, Yen-Yi/0000-0001-8386-4418	Kaohsiung Medical University Research Foundation [KMUH101-1M68]	Kaohsiung Medical University Research Foundation	This study was supported by a grant from the Kaohsiung Medical University Research Foundation (KMUH101-1M68). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 1999, J PATHOL, V187, P433, DOI 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; American Cancer Society, 2009, CANC FACTS FIG 2009; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; [Anonymous], 2009, STRATEGIC COMMENTS, V14, P1; Baselga J, 2008, J CLIN ONCOL, V26, P1582, DOI 10.1200/JCO.2007.15.3700; Bazan V, 2002, ANN ONCOL, V13, P1438, DOI 10.1093/annonc/mdf226; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Chang DZ, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-18; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Chen J, 2012, CANC CHEMOTHER PHARM; Chen YL, 2009, J CHROMATOGR A, V1216, P5147, DOI 10.1016/j.chroma.2009.04.083; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Edkins S, 2006, CANCER BIOL THER, V5, P928, DOI 10.4161/cbt.5.8.3251; Er TK, 2010, CLIN LAB, V56, P175; Futatsugi N, 2001, BIOPHYS J, V81, P3483, DOI 10.1016/S0006-3495(01)75979-6; Gajate P, 2012, CLIN COLORECTAL CANC; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Guerrero S, 2000, CANCER RES, V60, P6750; Herreros-Villanueva M, 2011, MOL BIOL REP, V38, P1315, DOI 10.1007/s11033-010-0232-x; Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33; Imamura Y, 2012, CLIN CANC RES OFFICI; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mao C, 2012, CANCER; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; Messner I, 2012, J CANC RES CLIN ONCO; Modest DP, 2011, ANTI-CANCER DRUG, V22, P913, DOI 10.1097/CAD.0b013e3283493160; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Park JH, 2004, CLIN CHEM, V50, P1688, DOI 10.1373/clinchem.2004.034017; Parthasarathy S, 2000, PROTEIN ENG, V13, P9, DOI 10.1093/protein/13.1.9; Roux B., 1995, Computer Physics Communications, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SLOAN SR, 1990, MOL CELL BIOL, V10, P405, DOI 10.1128/MCB.10.1.405; Tejpar S, 2012, J CLIN ONCOLOGY OFFI; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tveit KM, 2012, J CLIN ONCOLOGY OFFI; US Food and Drug Administration, 2004, FDA APPR ERB COL CAN; US Food and Drug Administration, 2007, FDA APPR VECT PAN TR; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Ward RL, 1997, CANCER, V79, P1106, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1106::AID-CNCR8>3.0.CO;2-D; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035	61	50	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55793	10.1371/journal.pone.0055793	http://dx.doi.org/10.1371/journal.pone.0055793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437064	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200023
J	Colin, SP; Costello, JH; Katija, K; Seymour, J; Kiefer, K				Colin, Sean P.; Costello, John H.; Katija, Kakani; Seymour, Jamie; Kiefer, Kristen			Propulsion in Cubomedusae: Mechanisms and Utility	PLOS ONE			English	Article							JELLYFISH TRIPEDALIA-CYSTOPHORA; AUSTRALIAN BOX JELLYFISH; CHIRONEX-FLECKERI; SWIMMING PERFORMANCE; AURELIA-AURITA; FLOW PATTERNS; PREY SIZE; BEHAVIOR; MORPHOLOGY; PREDATION	Evolutionary constraints which limit the forces produced during bell contractions of medusae affect the overall medusan morphospace such that jet propulsion is limited to only small medusae. Cubomedusae, which often possess large prolate bells and are thought to swim via jet propulsion, appear to violate the theoretical constraints which determine the medusan morphospace. To examine propulsion by cubomedusae, we quantified size related changes in wake dynamics, bell shape, swimming and turning kinematics of two species of cubomedusae, Chironex fleckeri and Chiropsella bronzie. During growth, these cubomedusae transitioned from using jet propulsion at smaller sizes to a rowing-jetting hybrid mode of propulsion at larger sizes. Simple modifications in the flexibility and kinematics of their velarium appeared to be sufficient to alter their propulsive mode. Turning occurs during both bell contraction and expansion and is achieved by generating asymmetric vortex structures during both stages of the swimming cycle. Swimming characteristics were considered in conjunction with the unique foraging strategy used by cubomedusae.	[Colin, Sean P.; Kiefer, Kristen] Roger Williams Univ, Bristol, RI 02809 USA; [Colin, Sean P.; Costello, John H.] Marine Biol Labs, Whitman Ctr, Woods Hole, MA USA; [Costello, John H.] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Katija, Kakani] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Seymour, Jamie] James Cook Univ, Queensland Trop Hlth Alliance, Cairns, Australia	Marine Biological Laboratory - Woods Hole; Providence College; Woods Hole Oceanographic Institution; James Cook University	Colin, SP (corresponding author), Roger Williams Univ, Bristol, RI 02809 USA.	scolin@rwu.edu	Seymour, Jamie E/C-9748-2013; Katija, Kakani/R-4935-2019	Seymour, Jamie E/0000-0002-4805-3289; Colin, Sean/0000-0003-4463-5588	ONR MURI [N000140810654]; National Science Foundation [OCE 0623508]; Roger Williams University Foundation; Office of Integrative Activities [1004057] Funding Source: National Science Foundation	ONR MURI(MURIOffice of Naval Research); National Science Foundation(National Science Foundation (NSF)); Roger Williams University Foundation; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by an ONR MURI award (N000140810654) and National Science Foundation grant OCE 0623508 to JHC, SPC, JOD. And the work was supported by the Roger Williams University Foundation to Promote Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER EH, 1969, TOXICON, V7, P195, DOI 10.1016/0041-0101(69)90006-3; Blough T, 2011, BIOL BULL-US, V220, P6, DOI 10.1086/BBLv220n1p6; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Chang-yu L, 2010, ECOLOGICAL STUDY BOX; Coates MM, 2006, J EXP BIOL, V209, P3758, DOI 10.1242/jeb.02431; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; Colin SP, 2007, J EXP MAR BIOL ECOL, V351, P114, DOI 10.1016/j.jembe.2007.06.033; Colin SP, 2003, MAR ECOL PROG SER, V253, P305, DOI 10.3354/meps253305; Colin SP, 2002, J EXP BIOL, V205, P427; Conant F. S., 1898, CUBOMEDUSAE; Costello JH, 2002, LIMNOL OCEANOGR, V47, P934, DOI 10.4319/lo.2002.47.4.0934; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Costello JH, 1995, MAR BIOL, V124, P399, DOI 10.1007/BF00363913; Costello JH, 2008, INVERTEBR BIOL, V127, P265, DOI 10.1111/j.1744-7410.2008.00126.x; Dabiri JO, 2010, J EXP BIOL, V213, P1217, DOI 10.1242/jeb.034660; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Dabiri JO, 2007, J EXP BIOL, V210, P1868, DOI 10.1242/jeb.003772; Dabiri JO, 2006, J EXP BIOL, V209, P2025, DOI 10.1242/jeb.02242; Ford MD, 2000, SCI MAR, V64, P47; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2011, CURR BIOL, V21, P798, DOI 10.1016/j.cub.2011.03.054; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Gershwin LA, 2008, BIOL BULL-US, V215, P57, DOI 10.2307/25470683; GLADFELTER WB, 1972, HELGOLAND WISS MEER, V23, P38, DOI 10.1007/BF01616310; GLADFELTER WG, 1973, HELGOLAND WISS MEER, V25, P228, DOI 10.1007/BF01611199; Gordon M, 1998, ECOPHYSIOLOGY TROPIC; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; Hoerner SF., 1958, FLUID DYNAMIC DRAG P; Katija K, 2011, MAR ECOL PROG SER, V435, P111, DOI 10.3354/meps09212; Kintner AH, 2005, TOXICON, V46, P699, DOI 10.1016/j.toxicon.2005.07.015; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Majdalani J., 2006, VISCOUS FLUID FLOW, V3; Matanoski JC, 2001, MAR BIOL, V139, P191; Matsumoto GI, 1995, MAR FRESHW BEHAV PHY, V26, P139, DOI 10.1080/10236249509378935; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Nogueira M, 2008, BRAZ J OCEANOGR, V56, P157, DOI 10.1590/S1679-87592008000300001; OLESEN NJ, 1995, MAR ECOL PROG SER, V124, P63, DOI 10.3354/meps124063; Petie R, 2011, J EXP BIOL, V214, P2809, DOI 10.1242/jeb.057190; Purcell J.E., 1988, P463; Rakow KC, 2006, LIMNOL OCEANOGR, V51, P1097, DOI 10.4319/lo.2006.51.2.1097; Regula C, 2009, MAR ECOL PROG SER, V374, P135, DOI 10.3354/meps07756; Sahin M, 2009, J EXP BIOL, V212, P2656, DOI 10.1242/jeb.025536; Satterlie RA, 2005, BIOL BULL-US, V209, P154, DOI 10.2307/3593133; Seymour JE, 2004, MED J AUSTRALIA, V181, P707, DOI 10.5694/j.1326-5377.2004.tb06529.x; Shorten M, 2005, J ZOOL, V267, P371, DOI 10.1017/S0952836905007600; Stewart SE, 1996, MAR FRESHW BEHAV PHY, V27, P175, DOI 10.1080/10236249609378963; Suchman CL, 2000, J PLANKTON RES, V22, P2289, DOI 10.1093/plankt/22.12.2289; Suchman CL, 1998, MAR BIOL, V132, P237, DOI 10.1007/s002270050389; Weston J, 2009, MAR ECOL PROG SER, V374, P127, DOI 10.3354/meps07762	52	22	23	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56393	10.1371/journal.pone.0056393	http://dx.doi.org/10.1371/journal.pone.0056393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437122	gold, Green Published, Green Accepted			2022-12-27	WOS:000315184200066
J	Ferguson, PM; Feindel, KW; Slocombe, A; MacKay, M; Wignall, T; Delahunt, B; Tilley, RD; Hermans, IF				Ferguson, Peter M.; Feindel, Kirk W.; Slocombe, Angela; MacKay, Matthew; Wignall, Trudy; Delahunt, Brett; Tilley, Richard D.; Hermans, Ian F.			Strongly Magnetic Iron Nanoparticles Improve the Diagnosis of Small Tumours in the Reticuloendothelial System by Magnetic Resonance Imaging	PLOS ONE			English	Article							LYMPH-NODE METASTASES; OXIDE CORE/SHELL NANOPARTICLES; CONTRAST AGENT; PROSTATE-CANCER; BREAST-CANCER; MRI	Despite advances in non-invasive medical imaging, accurate nodal staging of malignancy continues to rely on surgery. Superparamagnetic iron oxide nanoparticles (IONP) with lymphotropic qualities have shown some promise as contrast agents for MRI of the lymph nodes, but recent large-scale studies failed to show consistent detection of tumours below 5 mm. Herein we compare imaging of splenic and lymph node tissue using iron/iron oxide core/shell nanoparticles (Fe NP) that have superior magnetic qualities to IONP, to determine whether improved negative contrast in T-2-weighted MRI can enhance the diagnosis of small tumours in the reticuloendothelial system. To provide an in vivo pre-clinical model of human lymph node micrometastases, breast cancer cells were injected into the spleens of mice, providing localised areas of tumour growth. MR images of groups of tumour-bearing and sham-treated animals were generated using a 1.5 T imaging system and analysed by two independent, blinded radiologists. Fe NP improved the sensitivity and specificity of MRI when compared to IONP, enabling accurate detection of tumours as small as 1-3 mm. The use of Fe NP as contrast agents have the potential to improve the diagnostic accuracy of MRI in cancer patients, leading to more rapid and effective treatment.	[Ferguson, Peter M.; Hermans, Ian F.] Victoria Univ Wellington, Malaghan Inst Med Res, Wellington, New Zealand; [Ferguson, Peter M.; Hermans, Ian F.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Ferguson, Peter M.; Delahunt, Brett] Univ Otago, Dept Pathol Mol Med, Wellington Sch Med & Hlth Sci, Wellington, New Zealand; [Feindel, Kirk W.] Natl Res Council Inst Biodiagnost Atlantic, Halifax, NS, Canada; [Slocombe, Angela; MacKay, Matthew; Wignall, Trudy] Wellington Hosp, Dept Radiol, Wellington, New Zealand; [Tilley, Richard D.] Victoria Univ Wellington, Sch Chem & Phys Sci, MacDiarmid Inst Adv Mat & Nanotechnol, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; Victoria University Wellington; University of Otago; National Research Council Canada; Victoria University Wellington	Ferguson, PM (corresponding author), Victoria Univ Wellington, Malaghan Inst Med Res, Wellington, New Zealand.	pferguson@malaghan.org.nz	Delahunt, Brett/AAG-2382-2019; Tilley, Richard/AAN-5610-2020; Hermans, Ian/I-3961-2013; Feindel, Kirk/H-9772-2014	Feindel, Kirk/0000-0002-4402-0180; Ferguson, Peter M./0000-0002-8335-0406; Hermans, Ian/0000-0002-7584-887X; Tilley, Richard/0000-0003-2097-063X	New Zealand Ministry of Science and Innovation [PROJ-13733-NMTS]; New Zealand Health Research Council; Wellington Medical Research Foundation; Natural Sciences and Engineering Research Council of Canada	New Zealand Ministry of Science and Innovation; New Zealand Health Research Council(Health Research Council of New Zealand); Wellington Medical Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by the New Zealand Ministry of Science and Innovation (www.msi.govt.nz) through grant PROJ-13733-NMTS. P.F. was supported by the New Zealand Health Research Council (www.hrc.govt.nz) and the Wellington Medical Research Foundation (www.wmrf.co.nz/). K.W.F. was supported by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellin MF, 2002, ABDOM IMAGING, V28, P155, DOI 10.1007/s00261-001-0182-9; Bittencourt LK, 2012, EUR RADIOL, V22, P468, DOI 10.1007/s00330-011-2269-1; Cheong S, 2012, CHEMPLUSCHEM, V77, P135, DOI 10.1002/cplu.201100074; Cheong S, 2011, ANGEW CHEM INT EDIT, V50, P4206, DOI 10.1002/anie.201100562; European Medicines Authority, 2008, EMEACHMP115272008 EM; Fauconnier N, 1997, J COLLOID INTERF SCI, V194, P427, DOI 10.1006/jcis.1997.5125; Harisinghani MG, 2006, AM J ROENTGENOL, V186, P144, DOI 10.2214/AJR.04.1287; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Heesakkers RAM, 2008, LANCET ONCOL, V9, P850, DOI 10.1016/S1470-2045(08)70203-1; Herman DAJ, 2011, CHEM COMMUN, V47, P9221, DOI 10.1039/c1cc13416g; Johnson PM, 2006, J CLIN ONCOL, V24, P3570, DOI 10.1200/JCO.2006.06.8866; Klumpp BD, 2012, ABDOM IMAGING, V37, P834, DOI 10.1007/s00261-011-9825-7; Kroon BK, 2005, J UROLOGY, V173, P816, DOI 10.1097/01.ju.0000154565.37397.4d; Motomura K, 2011, ANN SURG ONCOL, V18, P3422, DOI 10.1245/s10434-011-1710-7; Nakagawa T, 2007, CLIN CANCER RES, V13, P4105, DOI 10.1158/1078-0432.CCR-07-0419; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Saksena MA, 2006, EUR J RADIOL, V58, P367, DOI 10.1016/j.ejrad.2005.12.041; Tiefenauer LX, 1996, MAGN RESON IMAGING, V14, P391, DOI 10.1016/0730-725X(95)02106-4; Tudorica LA, 2012, MAGN RESON IMAGING, V30, P1257, DOI 10.1016/j.mri.2012.04.009; van den Brekel MWM, 1998, AM J NEURORADIOL, V19, P695; WEISSLEDER R, 1990, RADIOLOGY, V175, P494, DOI 10.1148/radiology.175.2.2326475; Willinek WA, 2008, EUR J RADIOL, V65, P2, DOI 10.1016/j.ejrad.2007.11.006; Wu LC, 2011, EUR J RADIOL, V80, P582, DOI 10.1016/j.ejrad.2009.11.027	23	9	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56572	10.1371/journal.pone.0056572	http://dx.doi.org/10.1371/journal.pone.0056572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437173	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200109
J	Hardy, GAD; Sieg, S; Rodriguez, B; Anthony, D; Asaad, R; Jiang, W; Mudd, J; Schacker, T; Funderburg, NT; Pilch-Cooper, HA; Debernardo, R; Rabin, RL; Lederman, MM; Harding, CV				Hardy, Gareth A. D.; Sieg, Scott; Rodriguez, Benigno; Anthony, Donald; Asaad, Robert; Jiang, Wei; Mudd, Joseph; Schacker, Timothy; Funderburg, Nicholas T.; Pilch-Cooper, Heather A.; Debernardo, Robert; Rabin, Ronald L.; Lederman, Michael M.; Harding, Clifford V.			Interferon-alpha Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MYELOID DENDRITIC CELLS; ADAPTIVE IMMUNITY; T-CELLS; HIV-1-INFECTED PATIENTS; SIV INFECTION; EXPRESSION; INNATE; BLOOD; MATURATION	Type-I interferon (IFN-I) has been increasingly implicated in HIV-1 pathogenesis. Various studies have shown elevated IFN-I and an IFN-I-induced gene and protein expression signature in HIV-1 infection, yet the elevated IFN-I species has not been conclusively identified, its source remains obscure and its role in driving HIV-1 pathogenesis is controversial. We assessed IFN-I species in plasma by ELISAs and bioassay, and we investigated potential sources of IFN-I in blood and lymph node tissue by qRT-PCR. Furthermore, we measured the effect of therapeutic administration of IFN alpha in HCV-infected subjects to model the effect of IFN alpha on chronic immune activation. IFN-I bioactivity was significantly increased in plasma of untreated HIV-1-infected subjects relative to uninfected subjects (p = 0.012), and IFN alpha was the predominant IFN-I subtype correlating with IFN-I bioactivity (r = 0.658, p<0.001). IFN alpha was not detectable in plasma of subjects receiving anti-retroviral therapy. Elevated expression of IFN alpha mRNA was limited to lymph node tissue cells, suggesting that peripheral blood leukocytes are not a major source of IFN alpha in untreated chronic HIV-1 infection. Plasma IFN-I levels correlated inversely with CD4 T cell count (p = 0.003) and positively with levels of plasma HIV-1 RNA and CD38 expression on CD8 T cells (p = 0.009). In hepatitis C virus-infected subjects, treatment with IFN-I and ribavirin increased expression of CD38 on CD8 T cells (p = 0.003). These studies identify IFN alpha derived from lymph nodes, rather than blood leukocytes, as a possible source of the IFN-I signature that contributes to immune activation in HIV-1 infection.	[Hardy, Gareth A. D.; Mudd, Joseph; Lederman, Michael M.; Harding, Clifford V.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Hardy, Gareth A. D.; Sieg, Scott; Rodriguez, Benigno; Anthony, Donald; Asaad, Robert; Jiang, Wei; Mudd, Joseph; Funderburg, Nicholas T.; Pilch-Cooper, Heather A.; Debernardo, Robert; Lederman, Michael M.; Harding, Clifford V.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Sieg, Scott; Rodriguez, Benigno; Anthony, Donald; Asaad, Robert; Jiang, Wei; Mudd, Joseph; Funderburg, Nicholas T.; Pilch-Cooper, Heather A.; Lederman, Michael M.; Harding, Clifford V.] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Hardy, Gareth A. D.; Sieg, Scott; Rodriguez, Benigno; Anthony, Donald; Asaad, Robert; Jiang, Wei; Lederman, Michael M.; Harding, Clifford V.] Case Western Reserve Univ, Ctr AIDS Res, Cleveland, OH 44106 USA; [Anthony, Donald] Cleveland Vet Adm Med Ctr, Cleveland, OH USA; [Schacker, Timothy] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Debernardo, Robert] Case Western Reserve Univ, Dept Obstet & Gynecol, Cleveland, OH 44106 USA; [Rabin, Ronald L.] US FDA, Ctr Biol Evaluat & Res, Lab Immunobiochem, Bethesda, MD 20014 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University; US Food & Drug Administration (FDA)	Harding, CV (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	cvh3@cwru.edu	Sieg, Scott/AAV-2429-2021; Funderburg, Nicholas/L-8022-2013; Rodriguez, Benigno/C-3365-2009	Rodriguez, Benigno/0000-0001-9736-7957; Rabin, Ronald/0000-0003-3496-0504; Funderburg, Nicholas/0000-0003-3113-1217	National Institutes of Health (NIH) [AI034343, AI069085]; Case Western Reserve University Center for AIDS Research (NIH) [AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI069085, T32AI089474, R01AI034343] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University Center for AIDS Research (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI034343 and AI069085 to CVH and by core facilities of the Case Western Reserve University Center for AIDS Research (NIH grant AI036219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Benito JM, 2005, J INFECT DIS, V192, P2142, DOI 10.1086/498168; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; DESTEFANO E, 1982, J INFECT DIS, V146, P451, DOI 10.1093/infdis/146.4.451; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hardy GAD, 2009, BLOOD, V113, P5497, DOI 10.1182/blood-2008-11-190231; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jones GJ, 2001, AIDS, V15, P1657, DOI 10.1097/00002030-200109070-00008; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kadowaki N, 2002, HUM IMMUNOL, V63, P1126, DOI 10.1016/S0198-8859(02)00751-6; KONTSEK P, 1991, VIROLOGY, V181, P416, DOI 10.1016/0042-6822(91)90517-F; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; MINAGAWA T, 1989, LIFE SCI, V45, pR3, DOI 10.1016/0024-3205(89)90147-1; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Rodriguez B, 2006, AIDS, V20, P1379, DOI 10.1097/01.aids.0000233571.51899.ab; Santini SM, 2002, J INTERF CYTOK RES, V22, P1071, DOI 10.1089/10799900260442494; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375	36	111	113	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56527	10.1371/journal.pone.0056527	http://dx.doi.org/10.1371/journal.pone.0056527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437155	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200093
J	Iwata, T; Chiku, K; Amano, K; Kusumoto, M; Ohnishi-Kameyama, M; Ono, H; Akiba, M				Iwata, Taketoshi; Chiku, Kazuhiro; Amano, Ken-ichi; Kusumoto, Masahiro; Ohnishi-Kameyama, Mayumi; Ono, Hiroshi; Akiba, Masato			Effects of Lipooligosaccharide Inner Core Truncation on Bile Resistance and Chick Colonization by Campylobacter jejuni	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; NATURAL TRANSFORMATION; GANGLIOSIDE MIMICRY; ACID; LIPOPOLYSACCHARIDE; POLYSACCHARIDE; BACTERIA; REVEALS; CMEABC; GENE	Campylobacter jejuni is the most common bacterium that causes diarrhea worldwide, and chickens are considered the main reservoir of this pathogen. This study investigated the effects of serial truncation of lipooligosaccharide (LOS), a major component of the outer membrane of C. jejuni, on its bile resistance and intestinal colonization ability in chickens. Genes encoding manno-heptose synthetases or glycosyltransferases were inactivated to generate isogenic mutants. Serial truncation of the LOS core oligosaccharide caused a stepwise increase in susceptibilities of two C. jejuni strains, NCTC 11168 and 81-176, to bile acids. Inactivation of hldE, hldD, or waaC caused severe truncation of the core oligosaccharide, which greatly increased the susceptibility to bile acids. Both wild-type strains grew normally in chicken intestinal extracts, whereas the mutants with severe oligosaccharide truncation were not detected 12 h after inoculation. These mutants attained viable bacterial counts in the bile acid-free extracts 24 h after inoculation. The wild-type strain 11-164 was present in the cecal contents at >10(7) CFU/g on 5 days after challenge infection and after this time period, whereas its hldD mutant was present at <10(3) CFU/g throughout the experimental period. Trans- complementation of the hldD mutant with the wild-type hldD allele completely restored the in vivo colonization level to that of the wild-type strain. Mutants with a shorter LOS had higher hydrophobicities. Thus, the length of the LOS core oligosaccharide affected the surface hydrophobicity and bile resistance of C. jejuni as well as its ability to colonize chicken intestines.	[Iwata, Taketoshi; Kusumoto, Masahiro; Akiba, Masato] Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 305, Japan; [Chiku, Kazuhiro; Ohnishi-Kameyama, Mayumi; Ono, Hiroshi] Natl Food Res Inst, Analyt Sci Div, Tsukuba, Ibaraki 305, Japan; [Amano, Ken-ichi] Akita Univ, Biosci Res Educ Ctr, Akita 010, Japan; [Akiba, Masato] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Akita University; Osaka Metropolitan University	Akiba, M (corresponding author), Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 305, Japan.	akiba@affrc.go.jp	Kusumoto, Masahiro/B-9616-2014; Chiku, Kazuhiro/O-3055-2018	Chiku, Kazuhiro/0000-0001-6857-8894	Ministry of Agriculture, Forestry, and Fisheries of Japan (Research project for ensuring food safety from farm to table) [DI-5101]	Ministry of Agriculture, Forestry, and Fisheries of Japan (Research project for ensuring food safety from farm to table)	This work was supported in part by a Grant-in-Aid from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Research project for ensuring food safety from farm to table DI-5101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akiba M, 2006, J ANTIMICROB CHEMOTH, V57, P52, DOI 10.1093/jac/dki419; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Baker J, 1999, AUST VET J, V77, P662, DOI 10.1111/j.1751-0813.1999.tb13159.x; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Buswell CM, 1998, APPL ENVIRON MICROB, V64, P733; Buzby JC, 1997, J INFECT DIS, V176, pS192, DOI 10.1086/513785; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; COLEMAN WG, 1983, J BIOL CHEM, V258, P1985; Edwards AD, 2009, VACCINE, V27, P3897, DOI 10.1016/j.vaccine.2009.04.006; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Fernandez-Cruz A, 2010, MEDICINE, V89, P319, DOI 10.1097/MD.0b013e3181f2638d; GREEN J, 1987, POULTRY SCI, V66, P535, DOI 10.3382/ps.0660535; Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Hansen CR, 2007, LETT APPL MICROBIOL, V45, P599, DOI 10.1111/j.1472-765X.2007.02232.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Horrocks SM, 2009, ANAEROBE, V15, P18, DOI 10.1016/j.anaerobe.2008.09.001; Inzana TJ, 2002, INFECT IMMUN, V70, P4870, DOI 10.1128/IAI.70.9.4870-4879.2002; Javed MA, 2012, INFECT IMMUN, V80, P2361, DOI 10.1128/IAI.00151-12; Jeon B, 2009, J ANTIMICROB CHEMOTH, V63, P462, DOI 10.1093/jac/dkn529; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Louis Petra, 2010, Science Progress, V93, P7, DOI 10.3184/003685009X12605525292307; Marsden GL, 2009, J BACTERIOL, V191, P2392, DOI 10.1128/JB.01397-08; MEINERSMANN RJ, 1991, AM J VET RES, V52, P1518; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Nesper J, 2002, INFECT IMMUN, V70, P5990, DOI 10.1128/IAI.70.11.5990-5996.2002; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Nichols WA, 1997, INFECT IMMUN, V65, P1377, DOI 10.1128/IAI.65.4.1377-1386.1997; Oakland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020084; Oldfield NJ, 2002, J BACTERIOL, V184, P2100, DOI 10.1128/JB.184.8.2100-2107.2002; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PENNER J L, 1988, Clinical Microbiology Reviews, V1, P157; PICKEN RN, 1977, J GEN MICROBIOL, V102, P319, DOI 10.1099/00221287-102-2-319; Pigrau C, 1997, CLIN INFECT DIS, V25, P1414, DOI 10.1086/516127; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Sahm D.H., 1991, MANUAL CLIN MICROBIO; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Smith DP, 2005, J FOOD PROTECT, V68, P1340, DOI 10.4315/0362-028X-68.7.1340; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Therisod H, 2001, ANAL CHEM, V73, P3804, DOI 10.1021/ac010313s; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; YORK WS, 1985, CARBOHYD RES, V138, P109, DOI 10.1016/0008-6215(85)85228-9; Yuki N, 2005, CURR OPIN NEUROL, V18, P557, DOI 10.1097/01.wco.0000174604.42272.2d	55	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56900	10.1371/journal.pone.0056900	http://dx.doi.org/10.1371/journal.pone.0056900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437265	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200180
J	Jang, S; Morris, S; Lukacs, NW				Jang, Sihyug; Morris, Susan; Lukacs, Nicholas W.			TSLP Promotes Induction of Th2 Differentiation but Is Not Necessary during Established Allergen-Induced Pulmonary Disease	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; T-CELL DIFFERENTIATION; IMMUNE-RESPONSES; DENDRITIC CELLS; AIRWAY HYPERREACTIVITY; HELMINTH INFECTION; INFLAMMATION; EXPRESSION; ASTHMA; MICE	Thymic stromal lymphopoietin (TSLP) has been implicated in the development of allergic inflammation by promoting Th2-type responses and has become a potential therapeutic target. Using in vitro T cell differentiation cultures we were able to validate that TSLP played a more critical role in the early development of Th2 immune responses with less significant enhancement of already developed Th2 responses. Adoptive transfer of naive DO11.10 ovalbumin-specific T cells followed by airway exposure to ovalbumin showed an early impairment of Th2 immune response in TSLP-/- mice compared to wild type mice during the development of a Th2 response. In contrast, transfer of already differentiated Th2 cells into TSLP-/- mice did not change lung pathology or Th2 cytokine production upon ovalbumin challenge compared to transfer into wild type mice. An allergen-induced Th2 airway model demonstrated that there was only a difference in gob5 expression (a mucus-associated gene) between wild type and TSLP-/- mice. Furthermore, when allergic animals with established disease were treated with a neutralizing anti-TSLP antibody there was no change in airway hyperreponsiveness (AHR) or Th2 cytokine production compared to the control antibody treated animals, whereas a change in gob5 gene expression was also observed similar to the TSLP-/- mouse studies. In contrast, when animals were treated with anti-TSLP during the initial stages of allergen sensitization there was a significant change in Th2 cytokines during the final allergen challenge. Collectively, these studies suggest that in mice TSLP has an important role during the early development of Th2 immune responses, whereas its role at later stages of allergic disease may not be as critical for maintaining the Th2-driven allergic disease.	[Jang, Sihyug; Morris, Susan; Lukacs, Nicholas W.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lukacs, NW (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	nlukacs@umich.edu	Lukacs, Nicholas W/ABH-5583-2020		NIH [AI032302]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a NIH grant AI032302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Berlin AA, 2006, LAB INVEST, V86, P557, DOI 10.1038/labinvest.3700419; Besin G, 2008, DIABETES, V57, P2107, DOI 10.2337/db08-0171; Blazquez AB, 2010, GASTROENTEROLOGY, V139, P1301, DOI 10.1053/j.gastro.2010.06.055; Campbell EM, 1999, J IMMUNOL, V163, P2160; Campbell EM, 1998, J IMMUNOL, V161, P7047; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Dolgachev V, 2009, J IMMUNOL, V183, P5705, DOI 10.4049/jimmunol.0901666; Ebner S, 2007, J ALLERGY CLIN IMMUN, V119, P982, DOI 10.1016/j.jaci.2007.01.003; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Han J, 2012, J ALLERGY CLIN IMMUN, V130, p[1175, e1179]; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Iwasaki M, 2002, J INVEST DERMATOL, V119, P609, DOI 10.1046/j.1523-1747.2002.01862.x; Jariwala S, 2011, CLIN EXP ALLERGY; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kim S, 2010, J IMMUNOL, V184, P1143, DOI 10.4049/jimmunol.0902447; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Leonard WJ, 2002, NAT IMMUNOL, V3, P605, DOI 10.1038/ni0702-605; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; Miyata M, 2009, EUR J IMMUNOL, V39, P3078, DOI 10.1002/eji.200939302; Nguyen Khoa D, 2010, Allergy Asthma Clin Immunol, V6, P4, DOI 10.1186/1710-1492-6-4; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Okayama Y, 2009, EUR RESPIR J, V34, P425, DOI 10.1183/09031936.00121008; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Qiao JO, 2011, IMMUNOL CELL BIOL, V89, P231, DOI 10.1038/icb.2010.85; Ramalingam TR, 2009, J IMMUNOL, V182, P6452, DOI 10.4049/jimmunol.0900181; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Smith K, 2009, J ASTHMA, V46, P234, DOI 10.1080/02770900802627294; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spadoni I, 2012, MUCOSAL IMMUNOL, V5, P184, DOI 10.1038/mi.2011.64; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Tekkanat KK, 2001, J IMMUNOL, V166, P3542, DOI 10.4049/jimmunol.166.5.3542; Wang YH, 2009, CLIN EXP ALLERGY, V39, P798, DOI 10.1111/j.1365-2222.2009.03241.x; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang F, 2011, CLIN EXP IMMUNOL, V164, P256, DOI 10.1111/j.1365-2249.2011.04328.x; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	61	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56433	10.1371/journal.pone.0056433	http://dx.doi.org/10.1371/journal.pone.0056433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437132	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200073
J	Park, K; Nakagawa, Y; Kumagai, Y; Nagahara, M				Park, Kaechang; Nakagawa, Yoshinori; Kumagai, Yasuhiko; Nagahara, Mitsuhiro			Leukoaraiosis, a Common Brain Magnetic Resonance Imaging Finding, as a Predictor of Traffic Crashes	PLOS ONE			English	Article							CEREBRAL WHITE-MATTER; DIFFUSION TENSOR MRI; METABOLIC SYNDROME; HYPERINTENSITIES; DECLINE; LESIONS	Background: There are no reported studies on the relationship between traffic crashes and brain tissue changes in healthy drivers. The relationship between traffic crashes and leukoaraiosis, a common magnetic resonance imaging finding, was investigated in this study. Methods: A total of 3,930 automobile drivers (2,037 men and 1,893 women; age, 21-87 years) who underwent brain magnetic resonance imaging as part of total health check-ups and answered a road traffic questionnaire were examined to determine whether asymptomatic leukoaraiosis was associated with various types of traffic crashes. Multiple logistic regression analysis was performed to elucidate the relationship between leukoaraiosis and various types of traffic crashes. Results: Subcortical leukoaraiosis was diagnosed in 28.52% of all subjects, whereas periventricular leukoaraiosis was diagnosed in 9.57% of all subjects. Adjusted odds ratios for involvement in all types of traffic crashes were not significant for subjects with periventricular leukoaraiosis; however, they were significant for subjects with multiple and large multiple subcortical leukoaraiosis. Adjusted odds ratios for involvement in crashes at crossroads were 1.09 (95% confidence interval [CI], 0.60-2.00) for subjects with single subcortical leukoaraiosis, 3.35 (95% CI, 2.36-4.77) for subjects with multiple subcortical leukoaraiosis, and 2.45 (95% CI, 2.36-4.98) for subjects with large multiple subcortical leukoaraiosis. Periventricular leukoaraiosis was not significantly associated with crossroad crashes. Involvement in crashes of any type, parking lot crashes, and rear-end collisions showed no significant association with either subcortical or periventricular leukoaraiosis. Conclusions: Multiple subcortical leukoaraiosis, but not periventricular leukoaraiosis, is significantly associated with traffic crashes, in particular, crossroad crashes. This association is independent of sex, age, and driving exposure. To our knowledge, this is the first evidence describing the relationship between brain tissue changes and traffic crashes.	[Park, Kaechang] Kochi Univ Technol, Res Org Reg Alliance, Traff Med Lab, Kami, Kochi, Japan; [Nakagawa, Yoshinori] Kochi Univ Technol, Res Org Reg Alliance, Dept Management, Kami, Kochi, Japan; [Kumagai, Yasuhiko; Nagahara, Mitsuhiro] Kochi Univ Technol, Res Org Reg Alliance, Reg ITS Social Lab, Kami, Kochi, Japan	Kochi University Technology; Kochi University Technology; Kochi University Technology	Park, K (corresponding author), Kochi Univ Technol, Res Org Reg Alliance, Traff Med Lab, Kami, Kochi, Japan.	park.kaechang@kochi-tech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [22656114]	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant (No. 22656114) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, CATEGORICAL DATA ANA; [Anonymous], 2004, WORLD REP ROAD TRAFF; Bao S, 2009, ACCIDENT ANAL PREV, V41, P146, DOI 10.1016/j.aap.2008.10.007; Bokura H, 2008, STROKE, V39, P1607, DOI 10.1161/STROKEAHA.107.508630; Brodal P., 1998, CENTRAL NERVOUS SYST; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; de Groot JC, 2002, ANN NEUROL, V52, P335, DOI 10.1002/ana.10294; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044; Filley CM, 1998, NEUROLOGY, V50, P1535, DOI 10.1212/WNL.50.6.1535; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Maltz M, 1999, HUM FACTORS, V41, P15, DOI 10.1518/001872099779577282; Moody DM, 2004, RADIOLOGY, V233, P883, DOI 10.1148/radiol.2333020981; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Park K, 2007, NEUROLOGY, V69, P974, DOI 10.1212/01.wnl.0000266562.54684.bf; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Sasaki M, 2008, NEURORADIOLOGY, V249, P624; Schmidt R, 2007, STROKE, V38, P2619, DOI 10.1161/STROKEAHA.107.489112; Shinohara Y, 2007, CEREBROVASC DIS, V24, P202, DOI 10.1159/000104478; van den Heuvel DMJ, 2006, J NEUROL NEUROSUR PS, V77, P149, DOI 10.1136/jnnp.2005.070193	21	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57255	10.1371/journal.pone.0057255	http://dx.doi.org/10.1371/journal.pone.0057255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437354	Green Published, gold			2022-12-27	WOS:000315184200232
J	Pedersen, R; Ingerslev, HC; Sturek, M; Alloosh, M; Cirera, S; Christoffersen, BO; Moesgaard, SG; Larsen, N; Boye, M				Pedersen, Rebecca; Ingerslev, Hans-Christian; Sturek, Michael; Alloosh, Mouhamad; Cirera, Susanna; Christoffersen, Berit O.; Moesgaard, Sophia G.; Larsen, Niels; Boye, Mette			Characterisation of Gut Microbiota in Ossabaw and Gottingen Minipigs as Models of Obesity and Metabolic Syndrome	PLOS ONE			English	Article							HIGH-FAT-DIET; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; DISTAL GUT; TIME; PCR; MICROFLORA; INCREASES; GLUCOSE	Background: Recent evidence suggests that the gut microbiota is an important contributing factor to obesity and obesity related metabolic disorders, known as the metabolic syndrome. The aim of this study was to characterise the intestinal microbiota in two pig models of obesity namely Gottingen minipigs and the Ossabaw minipigs. Methods and Findings: The cecal, ileal and colonic microbiota from lean and obese Osabaw and Gottingen minipigs were investigated by Illumina-based sequencing and by high throughput qPCR, targeting the 16S rRNA gene in different phylogenetic groups of bacteria. The weight gain through the study was significant in obese Gottingen and Ossabaw minipigs. The lean Gottingen minipigs' cecal microbiota contained significantly higher abundance of Firmicutes (P<0.006), Akkermensia (P<0.01) and Methanovibribacter (P<0.01) than obese Gottingen minipigs. The obese Gottingen cecum had higher abundances of the phyla Spirochaetes (P<0.03), Tenericutes (P<0.004), Verrucomicrobia (P<0.005) and the genus Bacteroides (P<0.001) compared to lean minipigs. The relative proportion of Clostridium cluster XIV was 7.6-fold higher in cecal microbiota of obese Gottingen minipigs as compared to lean. Obese Ossabaw minipigs had a higher abundance of Firmicutes in terminal ileum and lower abundance of Gottingen in colon than lean Ossabaw minipigs (P<0.01). Obese Ossabaws had significantly lower abundances of the genera Prevotella and Lactobacillus and higher abundance of Clostridium in their colon than the lean Ossabaws. Overall, the Gottingen and Ossabaw minipigs displayed different microbial communities in response to diet-induced obesity in the different sections of their intestine. Conclusion: Obesity-related changes in the composition of the gut microbiota were found in lean versus obese Gottingen and Ossabaw minipigs. In both pig models diet seems to be the defining factor that shapes the gut microbiota as observed by changes in different bacteria divisions between lean and obese minipigs.	[Pedersen, Rebecca; Ingerslev, Hans-Christian; Boye, Mette] Tech Univ Denmark, Natl Vet Inst, Dept Bacteriol Pathol & Parasitol, Frederiksberg C, Denmark; [Sturek, Michael; Alloosh, Mouhamad] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Cirera, Susanna] Tech Univ Denmark, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg C, Denmark; [Christoffersen, Berit O.; Moesgaard, Sophia G.] Novo Nordisk AS, Malov, Denmark; [Larsen, Niels] Danish Genome Inst, Aarhus C, Denmark	Technical University of Denmark; Indiana University System; Indiana University Bloomington; Technical University of Denmark; Novo Nordisk	Boye, M (corresponding author), Tech Univ Denmark, Natl Vet Inst, Dept Bacteriol Pathol & Parasitol, Frederiksberg C, Denmark.	mboy@vet.dtu.dk	Ingerslev, Hans-Christian/AAP-6079-2020; Cirera, Susanna/K-8540-2017; Sturek, Michael/CAH-2948-2022	Cirera, Susanna/0000-0001-8105-1579; Ingerslev, Hans-Christian/0000-0002-9761-7474	SHARE Foundation; Danielsen's Foundation; United States National Institutes of Health [HL062552]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062552] Funding Source: NIH RePORTER	SHARE Foundation; Danielsen's Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The lean Gottingen minipigs were funded by the SHARE Foundation and Danielsen's Foundation. Ossabaw minipig studies were funded by the United States National Institutes of Health grant HL062552. The characterization of Gottingen minipigs and Ossabaw minipigs has only been possible due to collaborations between research groups at Copenhagen University, Novo Nordisk A/S and Indiana University School of Medicine. The study sponsors have no involvement in the publication of this article. The funders of our study had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Cirera S, 2012, IMMUNITY UNPUB; Cleophas TJ., 2011, STAT ANAL CLIN DATA, pp. 41; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Guo XL, 2008, ANAEROBE, V14, P224, DOI 10.1016/j.anaerobe.2008.04.001; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Johansen T, 2001, COMPARATIVE MED, V51, P150; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Larsen MO, 2005, AM J PHYSIOL-ENDOC M, V288, pE412, DOI 10.1152/ajpendo.00352.2004; Larsen MO, 2002, ANN NY ACAD SCI, V967, P414; Larsen N, 2012, BION META 16S UNPUB; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Litten-Brown JC, 2010, ANIMAL, V4, P899, DOI 10.1017/S1751731110000200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McKight P.E., 2010, CORSINI ENCY PSYCHOL, DOI 10.1002/9780470479216; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; World Health Organization, 2022, OB OV	41	84	89	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56612	10.1371/journal.pone.0056612	http://dx.doi.org/10.1371/journal.pone.0056612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437186	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200120
J	Rinnan, R; Michelsen, A; Baath, E				Rinnan, Riikka; Michelsen, Anders; Baath, Erland			Fungi Benefit from Two Decades of Increased Nutrient Availability in Tundra Heath Soil	PLOS ONE			English	Article							CLIMATE-CHANGE; ENVIRONMENTAL PERTURBATIONS; CARBON TURNOVER; FATTY-ACIDS; NITROGEN; RESPONSES; ECOSYSTEM; PLANTS; MINERALIZATION; COMMUNITY	If microbial degradation of carbon substrates in arctic soil is stimulated by climatic warming, this would be a significant positive feedback on global change. With data from a climate change experiment in Northern Sweden we show that warming and enhanced soil nutrient availability, which is a predicted long-term consequence of climatic warming and mimicked by fertilization, both increase soil microbial biomass. However, while fertilization increased the relative abundance of fungi, warming caused only a minimal shift in the microbial community composition based on the phospholipid fatty acid (PLFA) and neutral lipid fatty acid (NLFA) profiles. The function of the microbial community was also differently affected, as indicated by stable isotope probing of PLFA and NLFA. We demonstrate that two decades of fertilization have favored fungi relative to bacteria, and increased the turnover of complex organic compounds such as vanillin, while warming has had no such effects. Furthermore, the NLFA-to-PLFA ratio for C-13-incorporation from acetate increased in warmed plots but not in fertilized ones. Thus, fertilization cannot be used as a proxy for effects on warming in arctic tundra soils. Furthermore, the different functional responses suggest that the biomass increase found in both fertilized and warmed plots was mediated via different mechanisms.	[Rinnan, Riikka; Baath, Erland] Lund Univ, Dept Biol, Lund, Sweden; [Rinnan, Riikka; Michelsen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Rinnan, Riikka; Michelsen, Anders] Univ Copenhagen, Ctr Permafrost CENPERM, Copenhagen, Denmark	Lund University; University of Copenhagen; University of Copenhagen	Baath, E (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	erland.baath@biol.lu.se	Michelsen, Anders/L-5279-2014; Rinnan, Riikka/AAB-8552-2019; Rinnan, Riikka/C-9771-2010	Michelsen, Anders/0000-0002-9541-8658; Rinnan, Riikka/0000-0001-7222-700X; Rinnan, Riikka/0000-0001-7222-700X; Baath, Erland/0000-0002-2616-1342	Academy of Finland [108277]; European Commission [MEIF-CT-20065-024364]; Swedish Research Council [621-2009-4503]; Danish Council for Independent Research/Nature and Universe [10-084285]; Danish National Research Foundation	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Council for Independent Research/Nature and Universe(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond)	RR was supported by the Academy of Finland (decision no. 108277) and the European Commission (MEIF-CT-20065-024364). EB was supported by the Swedish Research Council (grant 621-2009-4503). AM was supported by the Danish Council for Independent Research/Nature and Universe (grant 10-084285). This work was part of LUCCI (Lund University Centre for Studies of Carbon Cycle and Climate Interactions) and the Center for Permafrost (CENPERM) funded by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WR, 1998, APPL ENVIRON MICROB, V64, P4202; Andresen LC, 2008, PLANT SOIL, V313, P283, DOI 10.1007/s11104-008-9700-7; [Anonymous], 1997, INTRO SOIL MICROBIOL; Baath E, 2003, MICROBIAL ECOL, V45, P373, DOI 10.1007/s00248-003-2002-y; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; BOSCHKER H. T. S., 2004, MOL MICROBIAL ECOLOG, P1673; Campioli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034842; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Deslippe JR, 2011, GLOBAL CHANGE BIOL, V17, P1625, DOI 10.1111/j.1365-2486.2010.02318.x; Edwards IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020421; FLAIG W, 1964, GEOCHIM COSMOCHIM AC, V28, P1523, DOI 10.1016/0016-7037(64)90003-1; Forsius M, 2010, AMBIO, V39, P136, DOI 10.1007/s13280-010-0022-7; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Graglia E, 2001, ECOGRAPHY, V24, P5, DOI 10.1034/j.1600-0587.2001.240102.x; Hansen AH, 2006, OECOLOGIA, V147, P1, DOI 10.1007/s00442-005-0233-y; HAVSTROM M, 1993, OIKOS, V66, P389, DOI 10.2307/3544933; IPCC, 2007, CONTRIBUTION WORKING; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; Jonasson S, 2006, SOIL BIOL BIOCHEM, V38, P526, DOI 10.1016/j.soilbio.2005.05.024; Jonasson S, 2001, GLOBAL BIOGEOCHEMICA, P139; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Michelsen A, 1996, OECOLOGIA, V105, P1, DOI 10.1007/BF00328785; Michelsen A, 2012, AMBIO, V41, P218, DOI 10.1007/s13280-012-0303-4; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Olsson PA, 2005, APPL ENVIRON MICROB, V71, P2592, DOI 10.1128/AEM.71.5.2592-2599.2005; Rinnan R, 2007, SOIL BIOL BIOCHEM, V39, P3014, DOI 10.1016/j.soilbio.2007.05.035; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rinnan R, 2009, APPL ENVIRON MICROB, V75, P3611, DOI 10.1128/AEM.02865-08; Ruess L, 1999, PLANT SOIL, V212, P63, DOI 10.1023/A:1004567816355; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schmidt IK, 1999, APPL SOIL ECOL, V11, P147, DOI 10.1016/S0929-1393(98)00147-4; Sorensen LI, 2006, POLAR BIOL, V29, P189, DOI 10.1007/s00300-005-0038-9; Sorensen PL, 2012, PLANT ECOL, V213, P695, DOI 10.1007/s11258-012-0034-4; Sorensen PL, 2008, ECOSYSTEMS, V11, P1223, DOI 10.1007/s10021-008-9204-6; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; Waldrop MP, 2006, ECOSYSTEMS, V9, P921, DOI 10.1007/s10021-004-0149-0; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Wardle D.A, 2002, MG POP BIOL, V34, P1, DOI 10.1515/9781400847297; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016	47	15	15	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56532	10.1371/journal.pone.0056532	http://dx.doi.org/10.1371/journal.pone.0056532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437159	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200097
J	Roedder, S; Kimura, N; Okamura, H; Hsieh, SC; Gong, YQ; Sarwal, MM				Roedder, Silke; Kimura, Naoyuki; Okamura, Homare; Hsieh, Szu-Chuan; Gong, Yongquan; Sarwal, Minnie M.			Significance and Suppression of Redundant IL17 Responses in Acute Allograft Rejection by Bioinformatics Based Drug Repositioning of Fenofibrate	PLOS ONE			English	Article							EXPRESSION PROFILES; CARDIAC ALLOGRAFTS; RENAL-ALLOGRAFTS; TH17 CELLS; T-CELLS; INTERLEUKIN-17; IL-17; MICE; TRANSPLANTATION; INFLAMMATION	Despite advanced immunosuppression, redundancy in the molecular diversity of acute rejection (AR) often results in incomplete resolution of the injury response. We present a bioinformatics based approach for identification of these redundant molecular pathways in AR and a drug repositioning approach to suppress these using FDA approved drugs currently available for non-transplant indications. Two independent microarray data-sets from human renal allograft biopsies (n = 101) from patients on majorly Th1/IFN-y immune response targeted immunosuppression, with and without AR, were profiled. Using gene-set analysis across 3305 biological pathways, significant enrichment was found for the IL17 pathway in AR in both data-sets. Recent evidence suggests IL17 pathway as an important escape mechanism when Th1/IFN-y mediated responses are suppressed. As current immunosuppressions do not specifically target the IL17 axis, 7200 molecular compounds were interrogated for FDA approved drugs with specific inhibition of this axis. A combined IL17/IFN-y suppressive role was predicted for the antilipidemic drug Fenofibrate. To assess the immunregulatory action of Fenofibrate, we conducted in-vitro treatment of anti-CD3/CD28 stimulated human peripheral blood cells (PBMC), and, as predicted, Fenofibrate reduced IL17 and IFN-gamma gene expression in stimulated PMBC. In-vivo Fenofibrate treatment of an experimental rodent model of cardiac AR reduced infiltration of total leukocytes, reduced expression of IL17/IFN-y and their pathway related genes in allografts and recipients' spleens, and extended graft survival by 21 days (p < 0.007). In conclusion, this study provides important proof of concept that meta-analyses of genomic data and drug databases can provide new insights into the redundancy of the rejection response and presents an economic methodology to reposition FDA approved drugs in organ transplantation.	[Roedder, Silke; Hsieh, Szu-Chuan; Sarwal, Minnie M.] Calif Pacific Med Ctr, Transplant Res Program Sutter Hlth Care, San Francisco, CA 94118 USA; [Kimura, Naoyuki; Okamura, Homare; Gong, Yongquan] Stanford Univ, Dept Cardiothorac Surg, Sch Med, Stanford, CA 94305 USA	California Pacific Medical Center; Stanford University	Sarwal, MM (corresponding author), Calif Pacific Med Ctr, Transplant Res Program Sutter Hlth Care, San Francisco, CA 94118 USA.	Msarwal@psg.ucsf.edu			Beta-Sigma Phi Northern California Chapter	Beta-Sigma Phi Northern California Chapter	This work was supported by Beta-Sigma Phi Northern California Chapter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslibekyan S, 2012, PHARMACOGENET GENOM, V22, P191, DOI 10.1097/FPC.0b013e32834fdd41; Belfort R, 2010, J CLIN ENDOCR METAB, V95, P829, DOI 10.1210/jc.2009-1487; Billingham M, 2005, J HEART LUNG TRANSPL, V24, P1709, DOI 10.1016/j.healun.2005.03.018; Burrell BE, 2008, J IMMUNOL, V181, P3906, DOI 10.4049/jimmunol.181.6.3906; Corry R, 1973, NEW POSSIBILITIES OR, P279; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Duez H, 2002, J BIOL CHEM, V277, P48051, DOI 10.1074/jbc.M206966200; Fabrega E, 2009, LIVER TRANSPLANT, V15, P629, DOI 10.1002/lt.21724; Fischbein MP, 2000, J IMMUNOL, V165, P7316, DOI 10.4049/jimmunol.165.12.7316; Gorbacheva V, 2010, AM J PATHOL, V177, P1265, DOI 10.2353/ajpath.2010.091106; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Itoh S, 2011, CIRCULATION, V124, pS187, DOI 10.1161/CIRCULATIONAHA.110.014852; Kish DD, 2009, J IMMUNOL, V182, P5949, DOI 10.4049/jimmunol.0802830; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuri Aruro Dib, 2008, Rev Med Inst Mex Seguro Soc, V46, P581; Lee JW, 2007, GASTROENTEROLOGY, V133, P108, DOI 10.1053/j.gastro.2007.03.113; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Loverre A, 2011, AM J TRANSPLANT, V11, P1248, DOI 10.1111/j.1600-6143.2011.03529.x; Ma SG, 2006, BIOMETRICS, V62, P555, DOI 10.1111/j.1541-0420.2005.00452.x; Nagai S, 2001, INT IMMUNOL, V13, P367, DOI 10.1093/intimm/13.3.367; Oikawa M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-168; Olson N Eric, 2006, NeuroRx, V3, P373; Racusen Lorraine C, 2004, Am J Transplant, V4, P1562, DOI 10.1111/j.1600-6143.2004.00585.x; Rodriguez ER, 2003, J HEART LUNG TRANSPL, V22, P3, DOI 10.1016/S1053-2498(02)00575-2; Rodder S, 2010, AM J TRANSPLANT, V10, P286, DOI 10.1111/j.1600-6143.2009.02928.x; Rodder S, 2009, AM J TRANSPLANT, V9, P517, DOI 10.1111/j.1600-6143.2008.02512.x; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Shahbaba B, 2011, J R STAT SOC C-APPL, V60, P541, DOI 10.1111/j.1467-9876.2011.00765.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stadlbauer THW, 2008, CARDIOVASC RES, V79, P698, DOI 10.1093/cvr/cvn135; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka M, 2005, J HEART LUNG TRANSPL, V24, P446, DOI 10.1016/j.healun.2004.01.022; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vanaudenaerde BM, 2008, AM J TRANSPLANT, V8, P1911, DOI 10.1111/j.1600-6143.2008.02321.x; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; World Medical Association, 2009, J INDIAN MED ASSOC, V107, P403; Yapici U, 2011, TRANSPL INT, V24, P1008, DOI 10.1111/j.1432-2277.2011.01302.x; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937; Zhao X, 2012, AM J TRANSPLANT, V12, P90, DOI 10.1111/j.1600-6143.2011.03770.x; Zhou Z, 2012, PPAR RES, V2012, DOI [10.1155/2012/145654, DOI 10.1155/2012/145654]	42	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56657	10.1371/journal.pone.0056657	http://dx.doi.org/10.1371/journal.pone.0056657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437201	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200131
J	Zhao, XD; Zhang, W; Liang, HJ; Ji, WY				Zhao, Xu-dong; Zhang, Wei; Liang, Hong-jun; Ji, Wen-yue			Overexpression of miR-155 Promotes Proliferation and Invasion of Human Laryngeal Squamous Cell Carcinoma via Targeting SOCS1 and STAT3	PLOS ONE			English	Article							BREAST-CANCER CELLS; EXPRESSION; ACTIVATION; CYTOKINE; TUMOR; GENE; INHIBITOR; GROWTH	MicroRNA155 plays an important role in many solid malignancies. Expression and function of miR-155 in laryngeal carcinoma have not been fully understood. This study aims to investigate the expression and function of miR-155 in laryngeal squamous cell carcinoma (LSCC), the relationship between miR-155 and its downstream target suppressor of cytokine signaling 1 (SOCS1)-STAT3 pathway, and the related clinicopathological factors. Sixty-three samples of laryngeal squamous cell carcinoma and twenty-one samples of control mucosa obtained from total laryngectomy cases were analyzed using Western blot analysis and real-time PCR. Hep-2 cells were cultured and transfected with miR-155 mimic and ASO. Cell proliferation, migration and invasion assays were used to determine the role of miR-155 in regulation of LSCC growth, migration, and invasion, respectively. The expression levels of miR-155 in LSCC were significantly higher than those in the control mucosa tissues. Downregulation of SOCS1 expression and elevated expression of STAT3 were also observed in LSCC. The relevance of the three factors were statistically significant. Moreover, knockdown of miR-155 elevated SOCS1expression level, suppressed STAT3 expression, and inhibited hep-2 cells growth, migration and invasion. Whereas overexpression of miR-155 inhibited SOCS1expression, elevated STAT3 expression, and promoted hep-2 cells growth, migration and invasion. Furthermore, the miR-155 levels in T-3 T-4 stages, and poor/moderate cell differentiation were significantly higher than those in T-2 stage and higher degree of cell differentiation. The STAT3 protein in poor/moderate cell differentiation was significantly higher than those in higher degree of cell differentiation. We firstly demonstrated the aberrant expression and function of miR-155 and its downstream targets in LSCC. The current findings suggest that miR-155 play promotingrole during the development of LSCC, and miR-155 may be a useful marker for the prognosis and assessment of therapeutic effects.	[Zhao, Xu-dong; Ji, Wen-yue] China Med Univ, Shengjing Hosp, Dept Otorhinolaryngol, Shenyang, Peoples R China; [Zhang, Wei] China Med Univ, Shengjing Hosp, Dept Endocrinol, Shenyang, Peoples R China; [Liang, Hong-jun] China Med Univ, Educ Adm Off, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Ji, WY (corresponding author), China Med Univ, Shengjing Hosp, Dept Otorhinolaryngol, Shenyang, Peoples R China.	jiwenyue@yahoo.cn			Liaoning Province Science Found Subject, "Laryngeal cancer surgical genetic diagnosis and treatment''	Liaoning Province Science Found Subject, "Laryngeal cancer surgical genetic diagnosis and treatment''	The funding of this work is Liaoning Province Science Found Subject, "Laryngeal cancer surgical genetic diagnosis and treatment.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Bakirtzi K, 2011, GASTROENTEROLOGY, V141, P1749, DOI 10.1053/j.gastro.2011.07.038; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chu PY, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13065; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Dunlop EA, 2007, STEM CELLS, V25, P380, DOI 10.1634/stemcells.2006-0452; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Evans MK, 2007, ONCOGENE, V26, P1941, DOI 10.1038/sj.onc.1209993; Genden EM, 2007, ORAL ONCOL, V43, P431, DOI 10.1016/j.oraloncology.2006.08.007; Huang FJ, 2008, CANCER RES, V68, P9634, DOI 10.1158/0008-5472.CAN-08-1429; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kim BH, 2011, EXP MOL MED, V43, P313, DOI [10.3858/emm.2011.43.5.035, 10.3858/emm.2011.43.2.035]; Kluge A, 2011, MOL ONCOL, V5, P256, DOI 10.1016/j.molonc.2011.03.004; Komazaki T, 2004, JPN J CLIN ONCOL, V34, P191, DOI 10.1093/jjco/hyh035; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Ling Hui, 2011, Chin J Cancer, V30, P739, DOI 10.5732/cjc.011.10243; Liu B, 2008, LARYNGOSCOPE, V118, P1976, DOI 10.1097/MLG.0b013e31817fd3fa; Liu J, 2011, INT J CANC; Liu Y, 2011, CANCER PREV RES, V4, P1296, DOI 10.1158/1940-6207.CAPR-10-0317; O Flowers L, 2005, ONCOGENE, V24, P2114, DOI 10.1038/sj.onc.1208437; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Starska K, 2009, FOLIA HISTOCHEM CYTO, V47, P401, DOI 10.2478/v10042-009-0075-2; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Xie Q, 2011, CANCER; Xiong H, 2011, MOL CARCINOGENESIS	28	43	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56395	10.1371/journal.pone.0056395	http://dx.doi.org/10.1371/journal.pone.0056395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437123	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200067
J	Arias, SCA; Valente, CP; Machado, FG; Fanelli, C; Origassa, CST; de Brito, T; Camara, NOS; Malheiros, DMAC; Zatz, R; Fujihara, CK				Alarcon Arias, Simone Costa; Valente, Carla Perez; Machado, Flavia Gomes; Fanelli, Camilla; Taemi Origassa, Clarice Silvia; de Brito, Thales; Saraiva Camara, Niels Olsen; Avancini Costa Malheiros, Denise Maria; Zatz, Roberto; Fujihara, Clarice Kazue			Regression of Albuminuria and Hypertension and Arrest of Severe Renal Injury by a Losartan-Hydrochlorothiazide Association in a Model of Very Advanced Nephropathy	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITOR; RENIN-ANGIOTENSIN SYSTEM; LIMITS GLOMERULAR INJURY; LIPID-LOWERING TREATMENT; REMNANT KIDNEY MODEL; ATTACK TRIAL ALLHAT; MYCOPHENOLATE-MOFETIL; DIABETIC-NEPHROPATHY; NEPHRECTOMIZED RATS; METABOLIC SYNDROME	Treatments that effectively prevent chronic kidney disease (CKD) when initiated early often yield disappointing results when started at more advanced phases. We examined the long-term evolution of renal injury in the 5/6 nephrectomy model (Nx) and the effect of an association between an AT-1 receptor blocker, losartan (L), and hydrochlorothiazide (H), shown previously to be effective when started one month after Nx. Adult male Munich-Wistar rats underwent Nx, being divided into four groups: Nx+V, no treatment; Nx+L, receiving L monotherapy; Nx+LH, receiving the L+H association (LH), and Nx+AHHz, treated with the calcium channel blocker, amlodipine, the vascular relaxant, hydralazine, and H. This latter group served to assess the effect of lowering blood pressure (BP). Rats undergoing sham nephrectomy (S) were also studied. In a first protocol, treatments were initiated 60 days after Nx, when CKD is at a relatively early stage. In a second protocol, treatments were started 120 days after Nx, when glomerulosclerosis and interstitial fibrosis are already advanced. In both protocols, L treatment promoted only partial renoprotection, whereas LH brought BP, albuminuria, tubulointerstitial cell proliferation and plasma aldosterone below pretreatment levels, and completely detained progression of renal injury. Despite normalizing BP, the AHHz association failed to prevent renal damage, indicating that the renoprotective effect of LH was not due to a systemic hemodynamic action. These findings are inconsistent with the contention that thiazides are innocuous in advanced CKD. In Nx, LH promotes effective renoprotection even at advanced stages by mechanisms that may involve anti-inflammatory and intrarenal hemodynamic effects, but seem not to require BP normalization.	[Alarcon Arias, Simone Costa; Valente, Carla Perez; Machado, Flavia Gomes; Fanelli, Camilla; Avancini Costa Malheiros, Denise Maria; Zatz, Roberto; Fujihara, Clarice Kazue] Univ Sao Paulo, Fac Med, Dept Clin Med, Renal Div,Lab Renal Pathophysiol LIM 16, Sao Paulo, Brazil; [de Brito, Thales] Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil; [Taemi Origassa, Clarice Silvia; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Fac Med, Immunol Lab, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Zatz, R (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Renal Div,Lab Renal Pathophysiol LIM 16, Sao Paulo, Brazil.	r.zatz@uol.com.br	Origassa, Clarice/C-2676-2012; Fanelli, Camilla/D-6287-2012; Zatz, Roberto/D-5716-2012; Camara, Niels OS/G-8336-2011; MALHEIROS, DENISE MAC/L-7382-2017; camara, niels olsen saraiva/AAX-3269-2020; De Brito, Thales/L-2865-2017	Fanelli, Camilla/0000-0003-4425-7708; Camara, Niels OS/0000-0001-5436-1248; MALHEIROS, DENISE MAC/0000-0002-0409-816X; camara, niels olsen saraiva/0000-0001-5436-1248; De Brito, Thales/0000-0003-1106-7254	State of Sao Paulo Foundation for Research Support (FAPESP) [2008/55047-3]; Brazilian Council of Scientific and Technologic Development (CNPq) [304657/2007-7]	State of Sao Paulo Foundation for Research Support (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council of Scientific and Technologic Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grant 2008/55047-3 from the State of Sao Paulo Foundation for Research Support (FAPESP). RZ is the recipient of a Research Award (No. 304657/2007-7) from the Brazilian Council of Scientific and Technologic Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldigier JC, 2005, J AM SOC NEPHROL, V16, P3306, DOI 10.1681/asn.2004090804; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013; Bidani AK, 2000, KIDNEY INT, V57, P1651, DOI 10.1046/j.1523-1755.2000.00009.x; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Dussol B, 2005, NEPHROL DIAL TRANSPL, V20, P349, DOI 10.1093/ndt/gfh650; Dussol B, 2012, J CLIN HYPERTENS, V14, P32, DOI 10.1111/j.1751-7176.2011.00564.x; FLOEGE J, 1992, KIDNEY INT, V41, P297, DOI 10.1038/ki.1992.42; Fujihara CK, 2006, AM J PHYSIOL-RENAL, V290, pF632, DOI 10.1152/ajprenal.00259.2005; Fujihara CK, 2005, KIDNEY INT, V67, P1913, DOI 10.1111/j.1523-1755.2005.00290.x; Fujihara CK, 1998, KIDNEY INT, V54, P1510, DOI 10.1046/j.1523-1755.1998.00138.x; Fujihara CK, 2001, HYPERTENSION, V37, P170, DOI 10.1161/01.HYP.37.1.170; Fujihara CK, 2000, J AM SOC NEPHROL, V11, P283, DOI 10.1681/ASN.V112283; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006; Fujihara CK, 2010, AM J NEPHROL, V32, P95, DOI 10.1159/000315137; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Goncalves ARR, 2004, AM J PHYSIOL-RENAL, V286, pF945, DOI 10.1152/ajprenal.00238.2003; Greene EL, 1996, J CLIN INVEST, V98, P1063, DOI 10.1172/JCI118867; HANING R, 1970, Endocrinology, V87, P1147; HARRIS RC, 1992, LAB INVEST, V66, P548; JEPSEN FL, 1979, VIRCHOWS ARCH A, V383, P265, DOI 10.1007/BF00430245; LAFAYETTE RA, 1992, J CLIN INVEST, V90, P766, DOI 10.1172/JCI115949; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; MEYER TW, 1987, KIDNEY INT, V31, P752, DOI 10.1038/ki.1987.62; Nagai Y, 2005, HYPERTENSION, V46, P1039, DOI 10.1161/01.HYP.0000174593.88899.68; Noda M, 1999, KIDNEY INT, V56, P898, DOI 10.1046/j.1523-1755.1999.00614.x; Piecha G, 2008, AM J PHYSIOL-RENAL, V295, pF137, DOI 10.1152/ajprenal.00065.2008; REUBI FC, 1961, CIRCULATION, V23, P200, DOI 10.1161/01.CIR.23.2.200; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Riser BL, 1996, AM J PATHOL, V148, P1915; Riser BL, 2001, AM J PATHOL, V158, P11, DOI 10.1016/S0002-9440(10)63938-7; Romero F, 1999, KIDNEY INT, V55, P945, DOI 10.1046/j.1523-1755.1999.055003945.x; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Soto K, 2004, KIDNEY INT, V65, P811, DOI 10.1111/j.1523-1755.2004.00455.x; STANTON BA, 1988, AM J PHYSIOL, V255, pF1269, DOI 10.1152/ajprenal.1988.255.6.F1269; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; Takase O, 2005, KIDNEY INT, V68, P464, DOI 10.1111/j.1523-1755.2005.00424.x; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Teles F, 2009, KIDNEY INT, V75, P72, DOI 10.1038/ki.2008.528; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wright JT, 2008, ARCH INTERN MED, V168, P207, DOI 10.1001/archinternmed.2007.66; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Yamamoto M, 1997, J CLIN LAB ANAL, V11, P53, DOI 10.1002/(SICI)1098-2825(1997)11:1<53::AID-JCLA9>3.0.CO;2-L	45	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56215	10.1371/journal.pone.0056215	http://dx.doi.org/10.1371/journal.pone.0056215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431367	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800009
J	Delli Pizzi, S; Rossi, C; Di Matteo, V; Esposito, E; Guarnieri, S; Mariggio, MA; Franciotti, R; Caulo, M; Thomas, A; Onofrj, M; Tartaro, A; Bonanni, L				Delli Pizzi, Stefano; Rossi, Cosmo; Di Matteo, Vincenzo; Esposito, Ennio; Guarnieri, Simone; Mariggio, Maria Addolorata; Franciotti, Raffaella; Caulo, Massimo; Thomas, Astrid; Onofrj, Marco; Tartaro, Armando; Bonanni, Laura			Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; ALPHA-SYNUCLEIN; MODEL; DEGENERATION; BRAIN; QUANTIFICATION	Systemic administration of a Synthetic Proteasome Inihibitor (PSI) in rats has been described as able to provide a model of Parkinson's disease (PD), characterized by behavioral and biochemical modifications, including loss of dopaminergic neurons in the substantia nigra (SN), as assessed by post-mortem studies. With the present study we aimed to assess in-vivo by Magnetic Resonance (MR) possible morphological and metabolic changes in the nigro-striatal pathway of PSI-treated rats. 10 animals were subcutaneously injected with PSI 6.0 mg/kg dissolved in DMSO 100%. Injections were made thrice weekly over the course of two weeks. 5 more animals injected with DMSO 100% with the same protocol served as controls. The animals underwent MR sessions before and at four weeks after the end of treatment with either PSI or vehicle. MR Imaging was performed to measure SN volume and Proton MR Spectroscopy (H-1-MRS) was performed to measure metabolites changes at the striatum. Animals were also assessed for motor function at baseline and at 4 and 6 weeks after treatment. Dopamine and dopamine metabolite levels were measured in the striata at 6 weeks after treatment. PSI-treated animals showed volumetric reduction of the SN (p<0.02) at 4 weeks after treatment as compared to baseline. Immunofluorescence analysis confirmed MRI changes in SN showing a reduction of tyrosine hydroxylase expression as compared to neuron-specific enolase expression. A reduction of N-acetyl-aspartate/total creatine ratio (p = 0.05) and an increase of glutamate-glutamine-gamma amminobutirrate/total creatine were found at spectroscopy (p = 0.03). At 6 weeks after treatment, PSI-treated rats also showed motor dysfunction compared to baseline (p = 0.02), accompanied by dopamine level reduction in the striatum (p = 0.02). Treatment with PSI produced morphological and metabolic modifications of the nigro-striatal pathway, accompanied by motor dysfunction. MR demonstrated to be a powerful mean to assess in-vivo the nigro-striatal pathway morphology and metabolism in the PSI-based PD animal model.	[Delli Pizzi, Stefano; Franciotti, Raffaella; Caulo, Massimo; Tartaro, Armando] Univ G DAnnunzio, ITAB, Chieti, Italy; [Rossi, Cosmo] Gabriele dAnnunzio Univ Fdn, CeSI, Aging Res Ctr, Chieti, Italy; [Di Matteo, Vincenzo; Esposito, Ennio] Consorzio Mario Negri Sud, Ist Ric Farmacol Mario Negri, Neurophysiol Lab, Chieti, Italy; [Delli Pizzi, Stefano; Guarnieri, Simone; Mariggio, Maria Addolorata; Caulo, Massimo; Thomas, Astrid; Onofrj, Marco; Tartaro, Armando; Bonanni, Laura] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Delli Pizzi, Stefano; Guarnieri, Simone; Mariggio, Maria Addolorata; Caulo, Massimo; Thomas, Astrid; Onofrj, Marco; Tartaro, Armando; Bonanni, Laura] Univ G dAnnunzio, CESI Aging Res Ctr, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Bonanni, L (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy.	l.bonanni@unich.it	Mariggiò, Maria Addolorata/T-9047-2017; Guarnieri, Simone/AAA-5921-2020; Franciotti, Raffaella/AAC-2664-2022; Bonanni, Laura/K-3868-2016; tartaro, armando at/K-2184-2016; onofrj, marco/K-7710-2016; Pizzi, Stefano Delli/J-3935-2016; THOMAS, Astrid Maria/K-7727-2016	Mariggiò, Maria Addolorata/0000-0001-5306-7143; Bonanni, Laura/0000-0001-7443-9233; tartaro, armando at/0000-0003-0095-2792; onofrj, marco/0000-0002-0480-2495; Pizzi, Stefano Delli/0000-0003-4075-0132; Guarnieri, Simone/0000-0002-2916-2965; THOMAS, Astrid Maria/0000-0003-3853-2996; Mariggio, Maria Addolorata/0000-0002-3508-8706	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work has been supported by the Italian Ministry of Health, Grant Young Researchers 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bove J, 2006, ANN NEUROL, V60, P260, DOI 10.1002/ana.20937; BRAFFMAN BH, 1989, AM J ROENTGENOL, V152, P159, DOI 10.2214/ajr.152.1.159; Brownell AL, 1998, NAT MED, V4, P1308, DOI 10.1038/3300; Bukhatwa S, 2010, BRAIN RES, V1354, P236, DOI 10.1016/j.brainres.2010.07.060; Cabanes E, 2001, J MAGN RESON, V150, P116, DOI 10.1006/jmre.2001.2318; Chassain C, 2008, J NEUROCHEM, V105, P874, DOI 10.1111/j.1471-4159.2007.05185.x; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Delli Pizzi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044752; Gerlach M, 2006, J NEURAL TRANSM-SUPP, P133; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffith HR, 2008, NMR BIOMED, V21, P381, DOI 10.1002/nbm.1203; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Kickler N, 2009, NMR BIOMED, V22, P207, DOI 10.1002/nbm.1305; Kickler N, 2007, NMR BIOMED, V20, P757, DOI 10.1002/nbm.1141; Kordower JH, 2006, ANN NEUROL, V60, P264, DOI 10.1002/ana.20935; Landau AM, 2007, MOVEMENT DISORD, V22, P403, DOI 10.1002/mds.21306; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Manning-Bog AB, 2006, ANN NEUROL, V60, P256, DOI 10.1002/ana.20938; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; MILETICH RS, 1994, ANN NEUROL, V35, P689, DOI 10.1002/ana.410350609; Minati L, 2007, AM J NEURORADIOL, V28, P309; Modrego PJ, 2011, ACAD RADIOL, V18, P235, DOI 10.1016/j.acra.2010.09.022; MOKRY J, 1995, PHYSIOL RES, V44, P143; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Niu CS, 2009, STEREOT FUNCT NEUROS, V87, P69, DOI 10.1159/000202972; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PUJOL J, 1992, ARCH NEUROL-CHICAGO, V49, P1119, DOI 10.1001/archneur.1992.00530350033015; Romero-Granados R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028927; Schapira AHV, 2006, ANN NEUROL, V60, P253, DOI 10.1002/ana.20934; Shin M, 2011, NEUROBIOL AGING, V32, P2100, DOI 10.1016/j.neurobiolaging.2009.11.015; Stefanova N, 2012, ACTA NEUROPATHOL, V124, P51, DOI 10.1007/s00401-012-0977-5; Torriani M, 2005, RADIOLOGY, V236, P609, DOI 10.1148/radiol.2362041661; van Vlieta SAM, 2008, BRAIN RES, V1189, P219, DOI 10.1016/j.brainres.2007.10.059; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vernon AC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-1; Zeng BY, 2006, ANN NEUROL, V60, P248, DOI 10.1002/ana.20932	39	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56501	10.1371/journal.pone.0056501	http://dx.doi.org/10.1371/journal.pone.0056501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431380	Green Submitted, Green Published, gold			2022-12-27	WOS:000315182800022
J	Suyatin, DB; Wallman, L; Thelin, J; Prinz, CN; Jorntell, H; Samuelson, L; Montelius, L; Schouenborg, J				Suyatin, Dmitry B.; Wallman, Lars; Thelin, Jonas; Prinz, Christelle N.; Jorntell, Henrik; Samuelson, Lars; Montelius, Lars; Schouenborg, Jens			Nanowire-Based Electrode for Acute In Vivo Neural Recordings in the Brain	PLOS ONE			English	Article							SILICON NANOWIRES; ARRAYS; INTERFACES; PLATFORM; TISSUE; BIOMOLECULES; PERFORMANCE; POTENTIALS; SUBSTRATE; COMPUTER	We present an electrode, based on structurally controlled nanowires, as a first step towards developing a useful nanostructured device for neurophysiological measurements in vivo. The sensing part of the electrode is made of a metal film deposited on top of an array of epitaxially grown gallium phosphide nanowires. We achieved the first functional testing of the nanowire-based electrode by performing acute in vivo recordings in the rat cerebral cortex and withstanding multiple brain implantations. Due to the controllable geometry of the nanowires, this type of electrode can be used as a model system for further analysis of the functional properties of nanostructured neuronal interfaces in vivo.	[Suyatin, Dmitry B.; Prinz, Christelle N.; Samuelson, Lars; Montelius, Lars] Lund Univ, Div Solid State Phys, Lund, Sweden; [Suyatin, Dmitry B.; Prinz, Christelle N.; Samuelson, Lars; Montelius, Lars] Lund Univ, Nanometer Struct Consortium, Lund, Sweden; [Suyatin, Dmitry B.; Wallman, Lars; Thelin, Jonas; Prinz, Christelle N.; Jorntell, Henrik; Samuelson, Lars; Montelius, Lars; Schouenborg, Jens] Lund Univ, Fac Med, Neuronano Res Ctr, Lund, Sweden; [Wallman, Lars] Lund Univ, Dept Measurement Technol & Ind Elect Engn, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Schouenborg, J (corresponding author), Lund Univ, Fac Med, Neuronano Res Ctr, Lund, Sweden.	Jens.Schouenborg@med.lu.se	Samuelson, Lars/A-2171-2010; Suyatin, Dmitry B./A-4075-2010; Montelius, Lars/B-9071-2008	Samuelson, Lars/0000-0003-1971-9894; Suyatin, Dmitry B./0000-0002-6342-1449; Prinz, Christelle/0000-0002-1726-3275; Thelin, Jonas/0000-0002-6452-1476; Schouenborg, Jens/0000-0002-2815-6918; Montelius, Lars/0000-0001-9563-2307	Swedish Research Council (VR) [80658701, 621-2009-3266]; Knut and Alice Wallenberg Foundation [KAW 2004.0119]	Swedish Research Council (VR)(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council (VR) Linnaeus grant No. 80658701 and VR project No. 621-2009-3266 and The Knut and Alice Wallenberg Foundation project No. KAW 2004.0119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist BD, 2010, P NATL ACAD SCI USA, V107, P5815, DOI 10.1073/pnas.0909250107; Ansaldo A, 2011, ACS NANO, V5, P2206, DOI 10.1021/nn103445d; Benabid AL, 2007, EXPERT REV MED DEVIC, V4, P895, DOI 10.1586/17434440.4.6.895; Berthing T, 2011, SMALL, V7, P640, DOI 10.1002/smll.201001642; Bruggemann D, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265104; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; DRAKE KL, 1988, IEEE T BIO-MED ENG, V35, P719, DOI 10.1109/10.7273; Duan XJ, 2012, NAT NANOTECHNOL, V7, P174, DOI [10.1038/nnano.2011.223, 10.1038/NNANO.2011.223]; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Fromherz P., 2003, NANOELECTRONICS INFO, P781; Hai A, 2010, NAT METHODS, V7, P200, DOI [10.1038/nmeth.1420, 10.1038/NMETH.1420]; Hallstrom W, 2007, NANO LETT, V7, P2960, DOI 10.1021/nl070728e; Hallstrom W, 2010, NANO LETT, V10, P782, DOI 10.1021/nl902675h; Hallstrom W, 2009, LANGMUIR, V25, P4343, DOI 10.1021/la900436e; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Kawano T, 2010, BIOSENS BIOELECTRON, V25, P1809, DOI 10.1016/j.bios.2009.12.037; Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Kipke DR, 2003, IEEE T NEUR SYS REH, V11, P151, DOI 10.1109/TNSRE.2003.814443; KOHLER P, 2009, FLEXIBLE MULTIELECTR, P536; Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984; Lehew Gary, 2008, P1; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lieber CM, 2011, MRS BULL, V36, P1052, DOI 10.1557/mrs.2011.269; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Linsmeier CE, 2008, BIOMATERIALS, V29, P4598, DOI 10.1016/j.biomaterials.2008.08.028; Linsmeier CE, 2009, NANO LETT, V9, P4184, DOI 10.1021/nl902413x; Martin DC, 2010, POLYM REV, V50, P340, DOI 10.1080/15583724.2010.495440; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prinz C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/34/345101; ROBINSON DA, 1968, PR INST ELECTR ELECT, V56, P1065, DOI 10.1109/PROC.1968.6458; Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427; SCHOUENBORG J, 1986, BRAIN RES, V397, P86, DOI 10.1016/0006-8993(86)91371-5; Schouenborg J, 2011, PROG BRAIN RES, V194, P61, DOI 10.1016/B978-0-444-53815-4.00017-0; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Suyatin DB, 2009, J VAC SCI TECHNOL B, V27, P3092, DOI 10.1116/1.3264665; Takei K, 2010, BIOMED MICRODEVICES, V12, P41, DOI 10.1007/s10544-009-9356-y; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Timko BP, 2010, IEEE T NANOTECHNOL, V9, P269, DOI 10.1109/TNANO.2009.2031807; Vaadia E, 2009, FRONT NEUROSCI-SWITZ, V3, P151, DOI 10.3389/neuro.01.015.2009; Voge CM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/011001; Wernersson LE, 2010, P IEEE, V98, P2047, DOI 10.1109/JPROC.2010.2065211; Witteveen JA, 2010, J VAC SCI TECHNOL B, V28, pC6K13, DOI 10.1116/1.3498764; Xie C, 2012, NAT NANOTECHNOL, V7, P185, DOI [10.1038/nnano.2012.8, 10.1038/NNANO.2012.8]; Xie C, 2010, NANO LETT, V10, P4020, DOI 10.1021/nl101950x; Yang PD, 2010, NANO LETT, V10, P1529, DOI 10.1021/nl100665r	53	63	64	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56673	10.1371/journal.pone.0056673	http://dx.doi.org/10.1371/journal.pone.0056673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431387	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800030
J	Seltmann, KC; Penzes, Z; Yoder, MJ; Bertone, MA; Deans, AR				Seltmann, Katja C.; Penzes, Zsolt; Yoder, Matthew J.; Bertone, Matthew A.; Deans, Andrew R.			Utilizing Descriptive Statements from the Biodiversity Heritage Library to Expand the Hymenoptera Anatomy Ontology	PLOS ONE			English	Article								Hymenoptera, the insect order that includes sawflies, bees, wasps, and ants, exhibits an incredible diversity of phenotypes, with over 145,000 species described in a corpus of textual knowledge since Carolus Linnaeus. In the absence of specialized training, often spanning decades, however, these articles can be challenging to decipher. Much of the vocabulary is domain-specific (e.g., Hymenoptera biology), historically without a comprehensive glossary, and contains much homonymous and synonymous terminology. The Hymenoptera Anatomy Ontology was developed to surmount this challenge and to aid future communication related to hymenopteran anatomy, as well as provide support for domain experts so they may actively benefit from the anatomy ontology development. As part of HAO development, an active learning, dictionary-based, natural language recognition tool was implemented to facilitate Hymenoptera anatomy term discovery in literature. We present this tool, referred to as the 'Proofer', as part of an iterative approach to growing phenotype-relevant ontologies, regardless of domain. The process of ontology development results in a critical mass of terms that is applied as a filter to the source collection of articles in order to reveal term occurrence and biases in natural language species descriptions. Our results indicate that taxonomists use domain-specific terminology that follows taxonomic specialization, particularly at superfamily and family level groupings and that the developed Proofer tool is effective for term discovery, facilitating ontology construction.	[Seltmann, Katja C.] Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA; [Penzes, Zsolt] Univ Szeged, Dept Ecol, Szeged, Csongrad, Hungary; [Yoder, Matthew J.] Prairie Res Inst, Champaign, IL USA; [Bertone, Matthew A.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Deans, Andrew R.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	American Museum of Natural History (AMNH); Szeged University; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Seltmann, KC (corresponding author), Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA.	enicospilus@gmail.com	Pénzes, Zsolt/M-1395-2018; Seltmann, Katja/AAC-9120-2020; Deans, Andrew R./AAG-4166-2021	Pénzes, Zsolt/0000-0003-0447-5997; Seltmann, Katja/0000-0001-5354-6048; Deans, Andrew R./0000-0002-2119-4663; Bertone, Matt/0000-0001-7985-1913	NSF [BDI-0446224, EF-0337220, DEB-0328922, DBI-0850223];  [TAMOP-4.2/B-09/1/KONV-2010-0005];  [KTIA-OTKA CNK 80140];  [HURO/0901/205/2.2.2]; Div Of Biological Infrastructure [1321620] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ; ; ; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Hymenoptera Anatomy Ontology was initially funded in part by NSF grants BDI-0446224, EF-0337220, and DEB-0328922. Primary funding for this project was from NSF DBI-0850223 (http://www.nsf.gov/awardsearch/showAward?AWD_ID = 0850223). Additional support for Zsolt Penzes TAMOP-4.2/B-09/1/KONV-2010-0005, KTIA-OTKA CNK 80140, and HURO/0901/205/2.2.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti Donat, 2009, BMC Res Notes, V2, P53, DOI 10.1186/1756-0500-2-53; Akella LM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-211; Bodenreider O., 2006, TEXT MINING BIOL BIO, P43; Catapano T, 2011, COMMUNICATION; Cui H, 2012, J AM SOC INF SCI TEC, V63, P738, DOI 10.1002/asi.22618; Dahdul WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010708; Day David, 1997, P 5 C APPL NAT LANG, P348, DOI [DOI 10.3115/974557.974608, 10.3115/974557.974608]; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Jensen LJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000374; Jurasinski G., 2012, COLLECTION FUNCTIONS; Kaufman L., 1990, FINDING GROUPS DATA, DOI [10.1002/9780470316801, DOI 10.1002/9780470316801]; Klingenberg C, 2012, GOLDENGATE XML MARKU; Leary PR, 2007, BIOINFORMATICS, V23, P1434, DOI 10.1093/bioinformatics/btm109; Legendre P., 2012, NUMERICAL ECOLOGY; Mullins PL, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.223.3572; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Development Core Team, 2010, LANG ENV STAT COMP; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sautter G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P391; Seltmann KC, 2012, J HYMENOPT RES, V27, P67, DOI 10.3897/JHR.27.2961; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Vogt L, 2010, CLADISTICS, V26, P301, DOI 10.1111/j.1096-0031.2009.00286.x; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	25	7	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55674	10.1371/journal.pone.0055674	http://dx.doi.org/10.1371/journal.pone.0055674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441153	gold, Green Submitted, Green Published			2022-12-27	WOS:000315159200011
J	Thriemer, K; Katuala, Y; Batoko, B; Alworonga, JP; Devlieger, H; Van Geet, C; Ngbonda, D; Jacobs, J				Thriemer, Kamala; Katuala, Yves; Batoko, Bibi; Alworonga, Jean-Pierre; Devlieger, Hugo; Van Geet, Christel; Ngbonda, Dauly; Jacobs, Jan			Antibiotic Prescribing in DR Congo: A Knowledge, Attitude and Practice Survey among Medical Doctors and Students	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; PERCEPTIONS; EXPECTATIONS; PHYSICIANS; BELIEFS	Objectives: Antibiotic resistance (ABR) particularly hits resource poor countries, and is fuelled by irrational antibiotic (AB) prescribing. We surveyed knowledge, attitudes and practices of AB prescribing among medical students and doctors in Kisangani, DR Congo. Methods: Self-administered questionnaires. Results: A total of 184 questionnaires were completed (response rate 94.4%). Knowledge about AB was low (mean score 4.9/8 points), as was the estimation of local resistance rates of S. Typhi and Klebsiella spp.(correct by 42.5% and 6.9% of respondents respectively). ABR was recognized as a problem though less in their own practice (67.4%) than nation- or worldwide (92.9% and 85.5%, p<.0001). Confidence in AB prescribing was high (88.6%) and students consulted more frequently colleagues than medical doctors when prescribing (25.4% versus 11.6%, p = 0.19). Sources of AB prescribing included pharmaceutical companies (73.9%), antibiotic guidelines (66.3%), university courses (63.6%), internet-sites (45.7%) and WHO guidelines (26.6%). Only 30.4% and 16.3% respondents perceived AB procured through the central procurement and local pharmacies as of good quality. Local AB guidelines and courses about AB prescribing are welcomed (73.4% and 98.8% respectively). Conclusions: This data shows the need for interventions that support rational AB prescribing.	[Thriemer, Kamala; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Katuala, Yves; Batoko, Bibi; Alworonga, Jean-Pierre; Ngbonda, Dauly] Univ Hosp Kisangani, Dept Pediat, Kisangani, DEM REP CONGO; [Devlieger, Hugo; Van Geet, Christel] Katholieke Univ Leuven Hosp, Dept Pediat, Louvain, Belgium	Institute of Tropical Medicine (ITM); Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Thriemer, K (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	kthriemer@itg.be	Jacobs, Jan/GRX-7316-2022	Thriemer, Kamala/0000-0001-7536-7497	Flemish Interuniversity Council [ZRDC2009EIN6]	Flemish Interuniversity Council	This study was sponsored by the Flemish Interuniversity Council Project ZRDC2009EIN6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda CMA, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P491, DOI 10.1007/978-0-387-89370-9_28; Britten N, 1997, BRIT MED J, V315, P1506, DOI 10.1136/bmj.315.7121.1506; Garcia Coralith, 2011, BMC Clin Pharmacol, V11, P18, DOI 10.1186/1472-6904-11-18; Gaudiano MC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-22; Giblin TB, 2004, ARCH INTERN MED, V164, P1662, DOI 10.1001/archinte.164.15.1662; Guerra CM, 2007, INFECT CONT HOSP EP, V28, P1411, DOI 10.1086/523278; Karras DJ, 2003, ANN EMERG MED, V42, P835, DOI 10.1016/S0196-0644(03)00602-4; Kinshasa Ud, 2009, ANN AFRICAINES MED; Lunguya Octavie, 2012, PLoS Negl Trop Dis, V6, pe1921, DOI 10.1371/journal.pntd.0001921; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; MULLER C, 1972, SCIENCE, V176, P488, DOI 10.1126/science.176.4034.488; Okeke IN, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P27, DOI 10.1007/978-0-387-89370-9_3; Olivier C, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P505, DOI 10.1007/978-0-387-89370-9_29; Pulcini C, 2011, CLIN MICROBIOL INFEC, V17, P80, DOI 10.1111/j.1469-0691.2010.03179.x; Srinivasan A, 2004, ARCH INTERN MED, V164, P1451, DOI 10.1001/archinte.164.13.1451; Vlieghe E, 2009, INT J ANTIMICROB AG, V34, P295, DOI 10.1016/j.ijantimicag.2009.04.015; Wester CW, 2002, ARCH INTERN MED, V162, P2210, DOI 10.1001/archinte.162.19.2210; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	19	97	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55495	10.1371/journal.pone.0055495	http://dx.doi.org/10.1371/journal.pone.0055495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441152	gold, Green Published			2022-12-27	WOS:000315159200010
J	Felli, N; Felicetti, F; Lustri, AM; Errico, MC; Bottero, L; Cannistraci, A; De Feo, A; Petrini, M; Pedini, F; Biffoni, M; Alvino, E; Negrini, M; Ferracin, M; Mattia, G; Care, A				Felli, Nadia; Felicetti, Federica; Lustri, Anna Maria; Errico, M. Cristina; Bottero, Lisabianca; Cannistraci, Alessio; De Feo, Alessandra; Petrini, Marina; Pedini, Francesca; Biffoni, Mauro; Alvino, Ester; Negrini, Massimo; Ferracin, Manuela; Mattia, Gianfranco; Care, Alessandra			miR-126&126*Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma	PLOS ONE			English	Article							MATRILYSIN MATRIX METALLOPROTEINASE-7; GROWTH-FACTOR; TERMINAL FRAGMENT; CANCER-THERAPY; MIR-126; CELLS; EGF; OSTEOPONTIN; GENE; METASTASIS	The abnormal expression of several microRNAs has a causal role in tumorigenesis with either antineoplastic or oncogenic functions. Here we demonstrated that miR-126 and miR-126* play a tumor suppressor role in human melanoma through the direct or indirect repression of several key oncogenic molecules. The expression levels of miR-126&126* were elevated in normal melanocytes and primary melanoma cell lines, whereas they markedly declined in metastatic cells. Indeed, the restored expression of miR-126&126* in two advanced melanoma cell lines was accompanied by a significant reduction of proliferation, invasion and chemotaxis in vitro as well as of growth and dissemination in vivo. In accordance, the reverse functional effects were obtained by knocking down miR-126&126* by transfecting antisense LNA oligonucleotides in melanoma cells. Looking for the effectors of these antineoplastic functions, we identified ADAM9 and MMP7, two metalloproteases playing a pivotal role in melanoma progression, as direct targets of miR-126&126*. In addition, as ADAM9 and MMP7 share a role in the proteolytic cleavage of the HB-EGF precursor, we looked for the effectiveness of this regulatory pathway in melanoma, confirming the decrease of HB-EGF activation as a consequence of miR-126&126*-dependent downmodulation of ADAM9 and MMP7. Finally, gene profile analyses showed that miR-126&126* reexpression was sufficient to inactivate other key signaling pathways involved in the oncogenic transformation, as PI3K/AKT and MAPK, and to restore melanogenesis, as indicated by KIT/MITF/TYR induction. In view of this miR-126&126* wide-ranging action, we believe that the replacement of these microRNAs might be considered a promising therapeutic approach.	[Felli, Nadia; Felicetti, Federica; Lustri, Anna Maria; Errico, M. Cristina; Bottero, Lisabianca; Cannistraci, Alessio; De Feo, Alessandra; Petrini, Marina; Pedini, Francesca; Biffoni, Mauro; Mattia, Gianfranco; Care, Alessandra] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Negrini, Massimo; Ferracin, Manuela] Univ Ferrara, LTTA, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Alvino, Ester] CNR, Inst Translat Pharmacol, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Care, A (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	alessandra.care@iss.it	Negrini, Massimo/J-2377-2016; De Feo, Alessandra/C-7030-2019; Pedini, Francesca/N-5677-2017; Felicetti, Federica/N-7077-2017; Biffoni, Mauro/J-8318-2016; Ferracin, Manuela/K-2097-2016; Alvino, Ester/J-8148-2012; De Feo, Alessandra/ABI-1458-2020; Errico, Maria Cristina/K-3971-2016; CARE', Alessandra/H-5090-2016; Mattia, Gianfranco/K-5194-2016; Felli, Nadia/G-2088-2012	Negrini, Massimo/0000-0002-0007-1920; De Feo, Alessandra/0000-0002-9805-1361; Pedini, Francesca/0000-0002-3454-6162; Felicetti, Federica/0000-0003-4628-0696; Biffoni, Mauro/0000-0002-1304-9060; Ferracin, Manuela/0000-0002-1595-6887; Alvino, Ester/0000-0001-9467-7634; De Feo, Alessandra/0000-0002-9805-1361; Errico, Maria Cristina/0000-0003-3014-2643; CARE', Alessandra/0000-0003-4106-3342; Mattia, Gianfranco/0000-0001-7047-6360; Felli, Nadia/0000-0001-6763-3361; petrini, marina/0000-0003-4891-3389	Italian Ministry of Health; Italy-USA Program; Italian Association for Cancer Research (AIRC)	Italian Ministry of Health(Ministry of Health, Italy); Italy-USA Program; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Italian Ministry of Health, the Italy-USA Program and the Italian Association for Cancer Research (AIRC) to A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; ALBINI A, 1987, CANCER RES, V47, P3239; Alvino E, 2002, J INVEST DERMATOL, V118, P79, DOI 10.1046/j.0022-202x.2001.01611.x; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Buback F, 2009, EXP DERMATOL, V18, P750, DOI 10.1111/j.1600-0625.2009.00926.x; Cara L B, 2007, MOL CARCINOGEN, V46, P671; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Duffy MJ, 2004, CLIN PROTEOMICS, V8, P9; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Felli N, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-85; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kawasaki K, 2007, BRIT J DERMATOL, V156, P613, DOI 10.1111/j.1365-2133.2006.07678.x; Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x; Ko JM, 2011, J PATHOL, V223, P241, DOI 10.1002/path.2804; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Miko E, 2011, FEBS LETT, V585, P1191, DOI 10.1016/j.febslet.2011.03.039; Mochizuki S, 2004, BIOCHEM BIOPH RES CO, V315, P79, DOI 10.1016/j.bbrc.2004.01.022; Mongaret C, 2011, INT J CANCER, V129, P791, DOI 10.1002/ijc.25746; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Nanba D, 2008, J CELL PHYSIOL, V214, P465, DOI 10.1002/jcp.21233; Niu J, 2002, INT J CANCER, V99, P529, DOI 10.1002/ijc.10397; Ohashi S, 2011, CANCER BIOL THER, V11, P184, DOI 10.4161/cbt.11.2.14140; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Schmidt Maike, 2007, Novartis Found Symp, V283, P18; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Shimura T, 2008, CLIN CANCER RES, V14, P3956, DOI 10.1158/1078-0432.CCR-07-4794; Slack FJ, 2013, CLIN CHEM, V59, P325, DOI 10.1373/clinchem.2011.181016; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Terzian T, 2011, J PATHOL, V224, P540, DOI 10.1002/path.2891; Toki F, 2005, J CELL PHYSIOL, V202, P839, DOI 10.1002/jcp.20175; Tomasetti M, 2012, CLIN BIOCHEM, V45, P575, DOI 10.1016/j.clinbiochem.2012.02.009; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Wielockx B, 2004, CYTOKINE GROWTH F R, V15, P111, DOI 10.1016/j.cytogfr.2003.12.001; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7; Zigrino P, 2005, INT J CANCER, V116, P853, DOI 10.1002/ijc.21087	53	76	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56824	10.1371/journal.pone.0056824	http://dx.doi.org/10.1371/journal.pone.0056824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437250	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000050
J	Ronchi, G; Gambarotta, G; Di Scipio, F; Salamone, P; Sprio, AE; Cavallo, F; Perroteau, I; Berta, GN; Geuna, S				Ronchi, Giulia; Gambarotta, Giovanna; Di Scipio, Federica; Salamone, Paolina; Sprio, Andrea E.; Cavallo, Federica; Perroteau, Isabelle; Berta, Giovanni N.; Geuna, Stefano			ErbB2 Receptor Over-Expression Improves Post-Traumatic Peripheral Nerve Regeneration in Adult Mice	PLOS ONE			English	Article							SCHWANN-CELLS; NEUREGULIN-1; PROLIFERATION; SYSTEM; CARCINOGENESIS; TRASTUZUMAB; LAPATINIB; DISECTOR; RESCUE; BREAST	In a transgenic mice (BALB-neuT) over-expressing ErbB2 receptor, we investigated the adult mouse median nerve in physiological and pathological conditions. Results showed that, in physiological conditions, the grip function controlled by the median nerve in BALB-neuT mice was similar to wild-type (BALB/c). Stereological assessment of ErbB2-overexpressing intact nerves revealed no difference in number and size of myelinated fibers compared to wild-type mice. By contrast, after a nerve crush injury, the motor recovery was significantly faster in BALB-neuT compared to BALB/c mice. Moreover, stereological assessment revealed a significant higher number of regenerated myelinated fibers with a thinner axon and fiber diameter and myelin thickness in BALB-neuT mice. At day-2 post-injury, the level of the mRNAs coding for all the ErbB receptors and for the transmembrane (type III) Neuregulin 1 (NRG1) isoforms significantly decreased in both BALB/c and BALB-neuT mice, as shown by quantitative real time PCR. On the other hand, the level of the mRNAs coding for soluble NRG1 isoforms (type I/II, alpha and beta) increased at the same post-traumatic time point though, intriguingly, this response was significantly higher in BALB-neuT mice with respect to BALB/c mice. Altogether, these results suggest that constitutive ErbB2 receptor over-expression does not influence the physiological development of peripheral nerves, while it improves nerve regeneration following traumatic injury, possibly through the up-regulation of soluble NRG1 isoforms.	[Ronchi, Giulia; Gambarotta, Giovanna; Di Scipio, Federica; Salamone, Paolina; Sprio, Andrea E.; Cavallo, Federica; Perroteau, Isabelle; Berta, Giovanni N.; Geuna, Stefano] Univ Turin, Dept Clin & Biol Sci, Orbassano, TO, Italy; [Ronchi, Giulia; Geuna, Stefano] Univ Turin, Neurosci Inst Cavalieri Ottolenghi Fdn NICO, Orbassano, TO, Italy; [Cavallo, Federica] Univ Turin, Ctr Mol Biotechnol, Turin, Italy	University of Turin; University of Turin; University of Turin	Geuna, S (corresponding author), Univ Turin, Dept Clin & Biol Sci, Orbassano, TO, Italy.	stefano.geuna@unito.it	Gambarotta, Giovanna/I-8473-2012; Berta, Giovanni N./D-4418-2018; Ronchi, Giulia/J-4785-2018; Cavallo, Federica/C-5666-2011; Sprio, Andrea Elio/B-9370-2012	Gambarotta, Giovanna/0000-0002-8380-5925; Berta, Giovanni N./0000-0002-3263-9349; Ronchi, Giulia/0000-0002-4795-7024; Geuna, Stefano/0000-0002-6962-831X; Cavallo, Federica/0000-0003-4571-1060; Sprio, Andrea Elio/0000-0001-5891-871X; Perroteau, Isabelle/0000-0001-9797-2276	MIUR; Compagnia di San Paolo (MOVAG); Regione Piemonte (Progetto Ricerca Sanitaria Finalizzata); AIRC [IG 5377]	MIUR(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo (MOVAG)(Compagnia di San Paolo); Regione Piemonte (Progetto Ricerca Sanitaria Finalizzata)(Regione Piemonte); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from MIUR, Compagnia di San Paolo (MOVAG), Regione Piemonte (Progetto Ricerca Sanitaria Finalizzata) and AIRC (IG 5377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino E, 2006, CANCER RES, V66, P7734, DOI 10.1158/0008-5472.CAN-06-1432; Atanasoski S, 2006, J NEUROSCI, V26, P2124, DOI 10.1523/JNEUROSCI.4594-05.2006; Audisio C, 2008, NEUROREPORT, V19, P1605, DOI 10.1097/WNR.0b013e32831313ef; Audisio C, 2009, J NEUROSCI METH, V185, P89, DOI 10.1016/j.jneumeth.2009.09.021; Bangaru ML, 2011, J MOL NEUROSCI; Beer GM, 2001, J RECONSTR MICROSURG, V17, P531, DOI 10.1055/s-2001-17755; Berta GN, 2011, CANCER PREV RES, V4, P994, DOI 10.1158/1940-6207.CAPR-10-0301; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Carroll SL, 1997, J NEUROSCI, V17, P1642; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Di Scipio F, 2008, MICROSC RES TECHNIQ, V71, P497, DOI 10.1002/jemt.20577; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Gambarotta G, 2004, J BIOL CHEM, V279, P48808, DOI 10.1074/jbc.M408374200; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Geuna S, 2000, J COMP NEUROL, V427, P333; Geuna S, 2000, ANN ANAT, V182, P23, DOI 10.1016/S0940-9602(00)80117-X; Geuna S, 2005, MICROSC RES TECHNIQ, V66, P270, DOI 10.1002/jemt.20167; Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Khademi B, 2002, CANCER LETT, V184, P223, DOI 10.1016/S0304-3835(02)00242-2; Larsen JO, 1998, J NEUROSCI METH, V85, P107, DOI 10.1016/S0165-0270(98)00129-0; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Magill C, 2008, NEUROL RES, V30, P1023, DOI 10.1179/174313208X362497; de Albornoz PM, 2011, BRIT MED BULL, V100, P73, DOI 10.1093/bmb/ldr005; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meyer D, 1997, DEVELOPMENT, V124, P3575; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Moy B, 2007, ONCOLOGIST, V12, P756, DOI 10.1634/theoncologist.12-7-756; NADIM W, 1990, NEUROPATH APPL NEURO, V16, P411, DOI 10.1111/j.1365-2990.1990.tb01277.x; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Oh YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023894; Ronchi G, 2010, J NEUROSCI METH, V188, P71, DOI 10.1016/j.jneumeth.2010.01.024; Ronchi G, 2009, J NEUROSCI METH, V179, P51, DOI 10.1016/j.jneumeth.2009.01.011; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; Schmitz C, 1998, ANAT EMBRYOL, V198, P371, DOI 10.1007/s004290050191; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Syed Neeraja, 2010, Mol Cell Pharmacol, V2, P161; Syed N, 2010, J NEUROSCI, V30, P6122, DOI 10.1523/JNEUROSCI.1681-09.2010; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Tos P, 2008, J NEUROSCI METH, V169, P119, DOI 10.1016/j.jneumeth.2007.11.030; Tos P, 2007, MICROSURG, V27, P48, DOI 10.1002/micr.20306; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; Treekitkarnmongkol W, 2010, WORLD J GASTROENTERO, V16, P4047, DOI 10.3748/wjg.v16.i32.4047; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wadugu B, 2012, AM J PHYSIOL-HEART C, V302, pH2139, DOI 10.1152/ajpheart.00063.2012; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	57	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56282	10.1371/journal.pone.0056282	http://dx.doi.org/10.1371/journal.pone.0056282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437108	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000022
J	Wu, CW; Dong, YJ; Liang, QY; He, XQ; Ng, SSM; Chan, FKL; Sung, JJY; Yu, J				Wu, Chung-Wah; Dong, Yu-Juan; Liang, Qiao-Yi; He, Xin-Qi; Ng, Simon S. M.; Chan, Francis K. L.; Sung, Joseph J. Y.; Yu, Jun			MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer	PLOS ONE			English	Article							MIR-17-92 CLUSTER; ATM; 5-FLUOROURACIL	Background: miR-18a is one of the most up-regulated miRNAs in colorectal cancers (CRC) based on miRNA profiling. In this study, we examined the functional significance of miR-18a in CRC. Methods: Expression of miR-18a was investigated in 45 CRC patients. Potential target genes of miR-18a were predicted by in silico search and confirmed by luciferase activity assay and Western blot. DNA damage was measured by comet assay. Gene function was measured by cell viability, colony formation and apoptosis assays. Results: The up-regulation of miR-18a was validated and confirmed in 45 primary CRC tumors compared with adjacent normal tissues (p<0.0001). Through in silico search, the 3'UTR of Ataxia telangiectasia mutated (ATM) contains a conserved miR-18a binding site. Expression of ATM was down-regulated in CRC tumors (p<0.0001) and inversely correlated with miR-18a expression (r = -0.4562, p<0.01). Over-expression of miR-18a in colon cancer cells significantly reduced the luciferase activity of the construct with wild-type ATM 39UTR but not that with mutant ATM 39UTR, inferring a direct interaction of miR-18a with ATM 39UTR. This was further confirmed by the down-regulation of ATM protein by miR-18a. As ATM is a key enzyme in DNA damage repair, we evaluated the effect of miR-18a on DNA double-strand breaks. Ectopic expression of miR-18a significantly inhibited the repair of DNA damage induced by etoposide (p<0.001), leading to accumulation of DNA damage, increase in cell apoptosis and poor clonogenic survival. Conclusion: miR-18a attenuates cellular repair of DNA double-strand breaks by directly suppressing ATM, a key enzyme in DNA damage repair.	[Wu, Chung-Wah; Liang, Qiao-Yi; He, Xin-Qi; Chan, Francis K. L.; Sung, Joseph J. Y.; Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Wu, Chung-Wah; Liang, Qiao-Yi; He, Xin-Qi; Chan, Francis K. L.; Sung, Joseph J. Y.; Yu, Jun] Chinese Univ Hong Kong, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Wu, Chung-Wah; Liang, Qiao-Yi; Chan, Francis K. L.; Sung, Joseph J. Y.; Yu, Jun] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Shenzhen, Peoples R China; [Dong, Yu-Juan; Ng, Simon S. M.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [He, Xin-Qi] Hebei Med Univ, Affiliated Hosp 1, Dept Surg, Shijiazhuang, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Hebei Medical University	Yu, J (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk	Chan, Francis K. L./F-4851-2010; Dong, Yujuan/AAS-3467-2021; Sung, Joseph J. Y./R-3203-2018; Ng, Simon S. M./M-1219-2018; Liang, Qiaoyi Jessie/G-9612-2019; Yu, Jun/D-8569-2015	Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199; Ng, Simon S. M./0000-0002-5389-9297; Liang, Qiaoyi Jessie/0000-0001-8496-3442; Yu, Jun/0000-0001-5008-2153	National Natural Science Foundation of China (NSFC) [81101488]; China 863 program [2012AA02A506]; Hong Kong ITF fund [ITS/276/11]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China 863 program(National High Technology Research and Development Program of China); Hong Kong ITF fund	This project was supported by a National Natural Science Foundation of China (NSFC) (Project code 81101488), a China 863 program (2012AA02A506) and Hong Kong ITF fund (ITS/276/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsen BL, 2011, INT J ONCOL, V39, P673, DOI 10.3892/ijo.2011.1080; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bandres E, 2007, ORAL ONCOL, V43, P713, DOI 10.1016/j.oraloncology.2006.09.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BODER E, 1958, PEDIATRICS, V21, P526; Brennecke J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-228; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2004, GENETICS, V168, P1827, DOI 10.1534/genetics.104.032888; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huehls AM, 2011, CANCER RES, V71, P4944, DOI 10.1158/0008-5472.CAN-11-0814; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kastan MB, 2000, COLD SPRING HARB SYM, V65, P521, DOI 10.1101/sqb.2000.65.521; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Roossink F, 2012, INT J CANCER, V131, P2056, DOI 10.1002/ijc.27488; SONG BJ, 1987, MOL ENDOCRINOL, V1, P542, DOI 10.1210/mend-1-8-542; Tamakawa RA, 2010, CANCER RES, V70, P8684, DOI 10.1158/0008-5472.CAN-10-2227; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Wang CL, 2006, P NATL ACAD SCI USA, V103, P18680, DOI 10.1073/pnas.0609030103; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Wu CW, 2011, GASTROENTEROLOGY, V140, pS73	32	81	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57036	10.1371/journal.pone.0057036	http://dx.doi.org/10.1371/journal.pone.0057036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437304	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000069
J	Li, Y; Xue, WJ; Liu, HB; Fan, P; Wang, XH; Ding, XM; Tian, XH; Feng, XS; Pan, XM; Zheng, J; Tian, PX; Ding, CG; Fan, XH				Li, Yang; Xue, Wujun; Liu, Hongbao; Fan, Ping; Wang, Xiaohong; Ding, Xiaoming; Tian, Xiaohui; Feng, Xinshun; Pan, Xiaoming; Zheng, Jin; Tian, Puxun; Ding, Chenguang; Fan, Xiaohu			Combined Strategy of Endothelial Cells Coating, Sertoli Cells Coculture and Infusion Improves Vascularization and Rejection Protection of Islet Graft	PLOS ONE			English	Article							GROWTH-FACTOR; HEME OXYGENASE-1; DIABETIC-RATS; TRANSPLANTATION; BETA; LANGERHANS; EXPRESSION; APOPTOSIS; SURVIVAL; ANGIOGENESIS	Improving islet graft revascularization and inhibiting rejection become crucial tasks for prolonging islet graft survival. Endothelial cells (ECs) are the basis of islet vascularization and Sertoli cells (SCs) have the talent to provide nutritional support and exert immunosuppressive effects. We construct a combined strategy of ECs coating in the presence of nutritious and immune factors supplied by SCs in a co-culture system to investigate the effect of vascularization and rejection inhibition for islet graft. In vivo, the combined strategy improved the survival and vascularization as well as inhibited lymphocytes and inflammatory cytokines. In vitro, we found the combinatorial strategy improved the function of islets and the effect of ECs-coating on islets. Combined strategy treated islets revealed higher levels of anti-apoptotic signal molecules (Bcl-2 and HSP-32), survival and function related molecules (PDX-1, Ki-67, ERK1/2 and Akt) and demonstrated increased vascular endothelial growth factor receptor 2 (KDR) and angiogenesis signal molecules (FAk and PLC-gamma). SCs effectively inhibited the activation of lymphocyte stimulated by islets and ECs. Predominantly immunosuppressive cytokines could be detected in culture supernatants of the SCs coculture group. These results suggest that ECs-coating and Sertoli cells co-culture or infusion synergistically enhance islet survival and function after transplantation.	[Li, Yang; Xue, Wujun; Wang, Xiaohong; Ding, Xiaoming; Tian, Xiaohui; Feng, Xinshun; Pan, Xiaoming; Zheng, Jin; Tian, Puxun; Ding, Chenguang] Xi An Jiao Tong Univ, Hosp Nephrol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China; [Liu, Hongbao] Fourth Mil Med Univ, Dept Nephrol, Xijing Hosp, Xian 710032, Peoples R China; [Fan, Ping] Xi An Jiao Tong Univ, Dept Rheumatism & Immunol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China; [Fan, Xiaohu] Univ Alberta, Edmonton, AB, Canada	Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University; University of Alberta	Li, Y (corresponding author), Xi An Jiao Tong Univ, Hosp Nephrol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China.	leon4344@126.com; xwujun@126.com	Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022; Li, Yang/GWM-7879-2022	Liu, Hongbao/0000-0002-1283-4956	National Nature Science Foundation of China [81270548]; nation "973" project [2009CB522400]; Science and technology project of Shaanxi [2012K16-09-02]; Youth Foundation of the First Affiliated Hospital, Medical College, Xi'an Jiaotong University [2011YK.20]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); nation "973" project; Science and technology project of Shaanxi; Youth Foundation of the First Affiliated Hospital, Medical College, Xi'an Jiaotong University	This work was supported by grants from National Nature Science Foundation of China (Nos. 81270548), the nation "973" project (2009CB522400), Science and technology project of Shaanxi (2012K16-09-02), Youth Foundation of the First Affiliated Hospital, Medical College, Xi'an Jiaotong University (2011YK.20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ahn YO, 2009, J IMMUNOL, V182, P6114, DOI 10.4049/jimmunol.0803725; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Chen C, 2011, AM J TRANSPLANT, V11, P215, DOI 10.1111/j.1600-6143.2010.03390.x; Dalle S, 2004, J BIOL CHEM, V279, P20345, DOI 10.1074/jbc.M312483200; Fan P, 2011, BIOCHEM BIOPH RES CO, V404, P829, DOI 10.1016/j.bbrc.2010.12.068; Fiorina P, 2003, TRANSPLANTATION, V75, P1296, DOI 10.1097/01.TP.0000061788.32639.D9; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hering BJ, 2005, TRANSPLANTATION, V79, P1296, DOI 10.1097/01.TP.0000157321.55375.86; Ichii H, 2007, AM J TRANSPLANT, V7, P1010, DOI 10.1111/j.1600-6143.2006.01687.x; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Johansson U, 2005, AM J TRANSPLANT, V5, P2632, DOI 10.1111/j.1600-6143.2005.01076.x; Johansson U, 2003, BIOCHEM BIOPH RES CO, V308, P474, DOI 10.1016/S0006-291X(03)01392-5; Kilani RT, 2003, PLACENTA, V24, P826, DOI 10.1016/S0143-4004(03)00129-2; KUTTY RK, 1994, J CELL PHYSIOL, V159, P371; Lee DY, 2006, AM J TRANSPLANT, V6, P1820, DOI 10.1111/j.1600-6143.2006.01414.x; Li Y, 2011, ARTIF ORGANS, V35, P634, DOI 10.1111/j.1525-1594.2010.01155.x; Li Y, 2010, TRANSPLANTATION, V89, P1430, DOI 10.1097/TP.0b013e3181da607e; Li Y, 2009, J ZHEJIANG UNIV-SC B, V10, P820, DOI 10.1631/jzus.B0920115; Li Zhao-Lun, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P1147; Linn T, 2003, FASEB J, V17, P881, DOI 10.1096/fj.02-0615fje; Matsumoto T, 2006, J ATHEROSCLER THROMB, V13, P130, DOI 10.5551/jat.13.130; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Meng ZX, 2006, DIABETOLOGIA, V49, P2959, DOI 10.1007/s00125-006-0447-5; MENGER MD, 1989, DIABETES, V38, P199, DOI 10.2337/diab.38.1.S199; Mottram PL, 1998, TRANSPLANTATION, V66, P1510, DOI 10.1097/00007890-199812150-00015; Muruve DA, 1997, HUM GENE THER, V8, P955, DOI 10.1089/hum.1997.8.8-955; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Pan XM, 2011, TRANSPLANTATION, V92, P1208, DOI 10.1097/TP.0b013e3182356ca7; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rodriguez AI, 2003, NEUROTOX RES, V5, P443, DOI 10.1007/BF03033174; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Shapiro AMJ, 2005, TRANSPLANTATION, V79, P1304, DOI 10.1097/01.TP.0000157300.53976.2A; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; Song HJ, 2010, TRANSPL P, V42, P2662, DOI 10.1016/j.transproceed.2010.06.003; STAGNER JI, 1990, TRANSPLANT P, V22, P824; Tajik N, 2008, INT J IMMUNOGENET, V35, P9, DOI 10.1111/j.1744-313X.2007.00727.x; VAJKOCZY P, 1995, TRANSPLANTATION, V60, P123, DOI 10.1097/00007890-199507270-00002; [王于蓝 WANG Yulan], 2006, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V26, P877; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963; Zhu GQ, 2004, CLIN J CONSERV, V16, P371	42	10	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56696	10.1371/journal.pone.0056696	http://dx.doi.org/10.1371/journal.pone.0056696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437215	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200145
J	Meckenhauser, G; Hennig, RM; Nawrot, MP				Meckenhaeuser, Gundula; Hennig, R. Matthias; Nawrot, Martin P.			Critical Song Features for Auditory Pattern Recognition in Crickets	PLOS ONE			English	Article							CALLING-SONG; FEMALE CRICKETS; GRYLLUS; NEURONS; BEHAVIOR; GRASSHOPPER; SIGNALS; WALKING; ORTHOPTERA; PHONOTAXIS	Many different invertebrate and vertebrate species use acoustic communication for pair formation. In the cricket Gryllus bimaculatus, females recognize their species-specific calling song and localize singing males by positive phonotaxis. The song pattern of males has a clear structure consisting of brief and regular pulses that are grouped into repetitive chirps. Information is thus present on a short and a long time scale. Here, we ask which structural features of the song critically determine the phonotactic performance. To this end we employed artificial neural networks to analyze a large body of behavioral data that measured females' phonotactic behavior under systematic variation of artificially generated song patterns. In a first step we used four non-redundant descriptive temporal features to predict the female response. The model prediction showed a high correlation with the experimental results. We used this behavioral model to explore the integration of the two different time scales. Our result suggested that only an attractive pulse structure in combination with an attractive chirp structure reliably induced phonotactic behavior to signals. In a further step we investigated all feature sets, each one consisting of a different combination of eight proposed temporal features. We identified feature sets of size two, three, and four that achieve highest prediction power by using the pulse period from the short time scale plus additional information from the long time scale.	[Meckenhaeuser, Gundula; Nawrot, Martin P.] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hennig, R. Matthias] Humboldt Univ, Dept Biol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin	Meckenhauser, G (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	gundula.meckenhaeuser@fu-berlin.de	Nawrot, Martin Paul/AAO-5523-2020	Nawrot, Martin Paul/0000-0003-4133-6419	Deutsche Forschungsgemeinschaft (DFG) within the collaborative research center 'Theoretical Biology' [SFB 618]	Deutsche Forschungsgemeinschaft (DFG) within the collaborative research center 'Theoretical Biology'(German Research Foundation (DFG))	This work is supported by the Deutsche Forschungsgemeinschaft (DFG) within the collaborative research center 'Theoretical Biology' (SFB 618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; Beckers OM, 2011, ANIM BEHAV, V81, P519, DOI 10.1016/j.anbehav.2010.11.022; Benda J, 2008, J COMPUT NEUROSCI, V24, P113, DOI 10.1007/s10827-007-0044-8; Bishop C. M, 2006, PATTERN RECOGNITION; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P173, DOI 10.1046/j.1463-6409.2003.00107.x; DOHERTY JA, 1985, J COMP PHYSIOL A, V156, P787, DOI 10.1007/BF00610831; Duchamp-Viret P, 2003, EUR J NEUROSCI, V18, P2690, DOI 10.1111/j.1460-9568.2003.03001.x; Grobe B, 2012, J EXP BIOL, V215, P1681, DOI 10.1242/jeb.065466; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; Hedwig B, 2006, J COMP PHYSIOL A, V192, P677, DOI 10.1007/s00359-006-0115-8; Hennig RM, 2009, J COMP PHYSIOL A, V195, P971, DOI 10.1007/s00359-009-0473-0; Huber F., 1989, CRICKET BEHAV NEUROB; Kastenhuber E, 2011, CURR BIOL, V21, pR986, DOI 10.1016/j.cub.2011.10.048; Klappert K, 2003, ANIM BEHAV, V65, P225, DOI 10.1006/anbe.2002.2034; Kostarakos K, 2012, J NEUROSCI, V32, P9601, DOI 10.1523/JNEUROSCI.1170-12.2012; Mhatre N, 2007, J EXP BIOL, V210, P3661, DOI 10.1242/jeb.003764; Nissen S., 2003, REPORT, V3, P54; Pollack G, 2000, CURR OPIN NEUROBIOL, V10, P763, DOI 10.1016/S0959-4388(00)00161-6; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; SCHILDBERGER K, 1986, J COMP PHYSIOL A, V158, P291, DOI 10.1007/BF00603613; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; Schneider E, 2012, J COMP PHYSIOL A, V198, P181, DOI 10.1007/s00359-011-0698-6; Schul J, 1998, J COMP PHYSIOL A, V183, P401, DOI 10.1007/s003590050266; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; von Helversen D., 1983, P95; von Helversen D, 1998, BIOL CYBERN, V79, P467, DOI 10.1007/s004220050496; von Helversen Otto, 1994, Progress in Zoology, V39, P253; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Webb B, 1995, ROBOT AUTON SYST, V16, P117, DOI 10.1016/0921-8890(95)00044-5; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weiss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045057; Wittmann JP, 2011, J COMPUT NEUROSCI, V31, P105, DOI 10.1007/s10827-010-0299-3; WOHLERS DW, 1982, J COMP PHYSIOL, V146, P161, DOI 10.1007/BF00610234; Woolley SC, 2004, PHYSIOL BEHAV, V83, P347, DOI 10.1016/j.physbeh.2004.08.021; Zorovic M, 2011, J NEUROPHYSIOL, V105, P2181, DOI 10.1152/jn.00416.2010	35	7	7	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55349	10.1371/journal.pone.0055349	http://dx.doi.org/10.1371/journal.pone.0055349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437054	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200016
J	Proctor, E; Waghray, M; Lee, CJ; Heidt, DG; Yalamanchili, M; Li, CW; Bednar, F; Simeone, DM				Proctor, Erica; Waghray, Meghna; Lee, Cheong Jun; Heidt, David G.; Yalamanchili, Malica; Li, Chenwei; Bednar, Filip; Simeone, Diane M.			Bmi1 Enhances Tumorigenicity and Cancer Stem Cell Function in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							SELF-RENEWAL; MESENCHYMAL TRANSITION; EXPRESSION; OVEREXPRESSION; ONCOPROTEIN; MYC; IDENTIFICATION; TRANSFORMATION; PROLIFERATION; SENESCENCE	Background: Bmi1 is an integral component of the Polycomb Repressive Complex 1 (PRC1) and is involved in the pathogenesis of multiple cancers. It also plays a key role in the functioning of endogenous stem cells and cancer stem cells. Previous work implicated a role for cancer stem cells in the pathogenesis of pancreatic cancer. We hypothesized that Bmi1 plays an integral role in enhancing pancreatic tumorigenicity and the function of cancer stem cells in pancreatic ductal adenocarcinoma. Methods: We measured endogenous Bmi1 levels in primary human pancreatic ductal adenocarcinomas, pancreatic intraepithelial neoplasias (PanINs) and normal pancreas by immunohistochemistry and Western blotting. The function of Bmi1 in pancreatic cancer was assessed by alteration of Bmi1 expression in several cell model systems by measuring cell proliferation, cell apoptosis, in vitro invasion, chemotherapy resistance, and in vivo growth and metastasis in an orthotopic model of pancreatic cancer. We also assessed the cancer stem cell frequency, tumorsphere formation, and in vivo growth of human pancreatic cancer xenografts after Bmi1 silencing. Results: Bmi1 was overexpressed in human PanINs, pancreatic cancers, and in several pancreatic cancer cell lines. Overexpression of Bmi1 in MiaPaCa2 cells resulted in increased proliferation, in vitro invasion, larger in vivo tumors, more metastases, and gemcitabine resistance while opposite results were seen when Bmi1 was silenced in Panc-1 cells. Bmi1 was overexpressed in the cancer stem cell compartment of primary human pancreatic cancer xenografts. Pancreatic tumorspheres also demonstrated high levels of Bmi1. Silencing of Bmi1 inhibited secondary and tertiary tumorsphere formation, decreased primary pancreatic xenograft growth, and lowered the proportion of cancer stem cells in the xenograft tissue. Conclusions: Our results implicate Bmi1 in the invasiveness and growth of pancreatic cancer and demonstrate its key role in the regulation of pancreatic cancer stem cells.	[Proctor, Erica; Waghray, Meghna; Lee, Cheong Jun; Heidt, David G.; Yalamanchili, Malica; Li, Chenwei; Bednar, Filip; Simeone, Diane M.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Simeone, Diane M.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Simeone, Diane M.] Univ Michigan, Sch Med, Translat Oncol Program, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simeone, DM (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	simeone@med.umich.edu	Lee, Cheong/AAD-1346-2019	Lee, Cheong/0000-0003-1439-5659	National Institutes of Health [R01 CA131045]; Rich Rogel Family Fund for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA131045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rich Rogel Family Fund for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health R01 CA131045 and the Rich Rogel Family Fund for Pancreatic Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bea S, 2001, CANCER RES, V61, P2409; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chen H, 2011, ORAL ONCOL, V47, P472, DOI 10.1016/j.oraloncology.2011.03.016; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dimri GP, 2002, CANCER RES, V62, P4736; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fukuda A, 2012, GASTROENTEROLOGY, V143, P821, DOI 10.1053/j.gastro.2012.05.009; HAUPT Y, 1993, ONCOGENE, V8, P3161; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lindstrom MS, 2001, ONCOGENE, V20, P2171, DOI 10.1038/sj.onc.1204303; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Martinez-Romero C, 2009, J PATHOL, V219, P205, DOI 10.1002/path.2585; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Nakauchi H, 2005, E SCHERING RES FDN W, V54, P85; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Reinisch CM, 2007, J CUTAN PATHOL, V34, P174, DOI 10.1111/j.1600-0560.2006.00587.x; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Song WJ, 2010, CANCER SCI, V101, P1754, DOI 10.1111/j.1349-7006.2010.01577.x; Tateishi K, 2006, CLIN CANCER RES, V12, P6960, DOI 10.1158/1078-0432.CCR-06-0449; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791	40	82	83	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55820	10.1371/journal.pone.0055820	http://dx.doi.org/10.1371/journal.pone.0055820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437065	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200024
J	Williams, JJ; Mayurasakorn, K; Vannucci, SJ; Mastropietro, C; Bazan, NG; Ten, VS; Deckelbaum, RJ				Williams, Jill J.; Mayurasakorn, Korapat; Vannucci, Susan J.; Mastropietro, Christopher; Bazan, Nicolas G.; Ten, Vadim S.; Deckelbaum, Richard J.			N-3 Fatty Acid Rich Triglyceride Emulsions Are Neuroprotective after Cerebral Hypoxic-Ischemic Injury in Neonatal Mice	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; LIPID EMULSIONS; BLOOD CLEARANCE; PARTICLE-SIZE; BRAIN-INJURY; MODEL; STROKE; OMEGA-3-FATTY-ACIDS; NEUROINFLAMMATION	We questioned if acute administration of n-3 fatty acids (FA) carried in n-3 rich triglyceride (TG) emulsions provides neuroprotection in neonatal mice subjected to hypoxic-ischemic (H/I) brain injury. We examined specificity of FA, optimal doses, and therapeutic windows for neuroprotection after H/I. H/I insult was induced in C57BL/6J 10-day-old mice by right carotid artery ligation followed by exposure to 8% O-2 for 15 minutes at 37 degrees C. Intraperitoneal injection with n-3-rich TG emulsions, n-6 rich TG emulsions or saline for control was administered at different time points before and/or after H/I. In separate experiments, dose responses were determined with TG containing only docosahexaenoic acid (Tri-DHA) or eicosapentaenoic acid (Tri-EPA) with a range of 0.1-0.375 g n-3 TG/kg, administered immediately after H/I insult. Infarct volume and cerebral blood flow (CBF) were measured. Treatment with n-3 TG emulsions both before-and after-H/I significantly reduced total infarct volume by a mean of 43% when administered 90 min prior to H/I and by 47% when administered immediately after H/I. In post-H/I experiments Tri-DHA, but not Tri-EPA exhibited neuroprotective effects with both low and high doses (p<0.05). Moreover, delayed post-H/I treatment with Tri-DHA significantly decreased total infarct volume by a mean of 51% when administered at 0 hr, by 46% at 1 hr, and by 51% at 2 hr after H/I insult. No protective effect occurred with Tri-DHA injection at 4 hr after H/I. There were no n-3 TG related differences in CBF. A significant reduction in brain tissue death was maintained after Tri-DHA injection at 8 wk after the initial brain injury. Thus, n-3 TG, specifically containing DHA, is protective against H/I induced brain infarction when administered up to 2 hr after H/I injury. Acute administration of TG-rich DHA may prove effective for treatment of stroke in humans.	[Williams, Jill J.; Mayurasakorn, Korapat; Deckelbaum, Richard J.] Columbia Univ, Inst Human Nutr, Dept Pediat, Coll Phys & Surg, New York, NY 10032 USA; [Vannucci, Susan J.] Cornell Univ, Dept Pediat, Weill Cornell Med Coll, New York, NY 10021 USA; [Mastropietro, Christopher] Childrens Hosp Michigan, Dept Pediat, Detroit, MI USA; [Mastropietro, Christopher] Wayne State Univ, Detroit, MI 48202 USA; [Bazan, Nicolas G.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA USA; [Ten, Vadim S.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA	Columbia University; Cornell University; Children's Hospital of Michigan; Wayne State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Columbia University	Deckelbaum, RJ (corresponding author), Columbia Univ, Inst Human Nutr, Dept Pediat, Coll Phys & Surg, New York, NY 10032 USA.	rjd20@columbia.edu	Bazan, Nicolas/AAN-4121-2020; Mastropietro, Christopher/V-9078-2019	Bazan, Nicolas/0000-0002-9243-5444; Mastropietro, Christopher/0000-0002-7409-7664; Mayurasakorn, Korapat/0000-0003-3816-6463	National Institutes of Health [R01 HL040404, NS 056146, NS 046741]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046741, R01NS056146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 HL040404, NS 056146 and NS 046741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph M, 1999, ANN NUTR METAB, V43, P1, DOI 10.1159/000012761; Agustin L, 2000, INT PEDIAT, V15, P143; Bazan NG, 2012, MOL NEUROBIOL, V46, P221, DOI 10.1007/s12035-012-8322-5; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Berman DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.020; Blaxter K, 1989, ENERGY METABOLISM AN; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Callaway JK, 2001, CLIN EXP PHARMACOL P, V28, P913, DOI 10.1046/j.1440-1681.2001.03547.x; Caspersen CS, 2008, DEV NEUROSCI-BASEL, V30, P319, DOI 10.1159/000121416; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; GRANOT E, 1994, BIOCHEMISTRY-US, V33, P15190, DOI 10.1021/bi00254a030; Grimsgaard S, 1997, AM J CLIN NUTR, V66, P649, DOI 10.1093/ajcn/66.3.649; Huang J, 2000, STROKE, V31, P3054, DOI 10.1161/01.STR.31.12.3054; Khairallah RJ, 2010, BBA-BIOENERGETICS, V1797, P1555, DOI 10.1016/j.bbabio.2010.05.007; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lewandowski C, 2001, ANN EMERG MED, V37, P202, DOI 10.1067/mem.2001.111573; Lim SN, 2010, PROSTAG LEUKOTR ESS, V83, P193, DOI 10.1016/j.plefa.2010.08.003; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mayurasakorn K, 2011, FASEB J, V25; Mayurasakorn K, 2011, CURR OPIN CLIN NUTR, V14, P158, DOI 10.1097/MCO.0b013e328342cba5; Miller AT, 1986, ENERGY METABOLISM; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Oliveira FLC, 1997, JPEN-PARENTER ENTER, V21, P224, DOI 10.1177/0148607197021004224; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pavlakis SG, 2006, PEDIATR NEUROL, V34, P433, DOI 10.1016/j.pediatrneurol.2005.09.009; Perlman JM, 2007, J PERINATOL, V27, pS39, DOI 10.1038/sj.jp.7211716; Qi KM, 2006, J NUTR, V136, P2766, DOI 10.1093/jn/136.11.2766; Qi KM, 2003, JPEN-PARENTER ENTER, V27, P58, DOI 10.1177/014860710302700158; Qi KM, 2002, BIOCHEMISTRY-US, V41, P3119, DOI 10.1021/bi015770h; Raju TNK, 2007, PEDIATRICS, V120, P609, DOI 10.1542/peds.2007-0336; SCHWIEGELSHOHN B, 1995, J BIOL CHEM, V270, P1761, DOI 10.1074/jbc.270.4.1761; Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004; Singh A K, 1989, J Exp Pathol, V4, P9; Stanley WC, 2012, CURR OPIN CLIN NUTR, V15, P122, DOI 10.1097/MCO.0b013e32834fdaf7; Ten VS, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/542976; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Terpstra AHM, 2001, J NUTR, V131, P2067, DOI 10.1093/jn/131.7.2067; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Williams JJ, 2009, FASEB J, V23; Williams JJ, 2011, FASEB J, V25	53	44	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56233	10.1371/journal.pone.0056233	http://dx.doi.org/10.1371/journal.pone.0056233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437099	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200050
J	Chinnakannan, SK; Nanda, SK; Baron, MD				Chinnakannan, Senthil K.; Nanda, Sambit K.; Baron, Michael D.			Morbillivirus V Proteins Exhibit Multiple Mechanisms to Block Type 1 and Type 2 Interferon Signalling Pathways	PLOS ONE			English	Article							NIPAH-VIRUS-V; DES-PETITS-RUMINANTS; ALPHA-INTERFERON; PREVENTING STAT1; INHIBIT STAT1; C-PROTEIN; RINDERPEST; PARAMYXOVIRUS; PHOSPHORYLATION; CELLS	Morbilliviruses form a closely related group of pathogenic viruses which encode three non-structural proteins V, W and C in their P gene. Previous studies with rinderpest virus (RPV) and measles virus (MeV) have demonstrated that these nonstructural proteins play a crucial role in blocking type I (IFN alpha/beta) and type II (IFN gamma) interferon action, and various mechanisms have been proposed for these effects. We have directly compared four important morbilliviruses, rinderpest (RPV), measles virus (MeV), peste des petits ruminants virus (PPRV) and canine distemper virus (CDV). These viruses and their V proteins could all block type I IFN action. However, the viruses and their V proteins had varying abilities to block type II IFN action. The ability to block type II IFN-induced gene transcription correlated with co-precipitation of STAT1 with the respective V protein, but there was no correlation between co-precipitation of either STAT1 or STAT2 and the abilities of the V proteins to block type I IFN-induced gene transcription or the creation of the antiviral state. Further study revealed that the V proteins of RPV, MeV, PPRV and CDV could all interfere with phosphorylation of the interferon-receptor-associated kinase Tyk2, and the V protein of highly virulent RPV could also block the phosphorylation of another such kinase, Jak1. Co-precipitation studies showed that morbillivirus V proteins all form a complex containing Tyk2 and Jak1. This study highlights the ability of morbillivirus V proteins to target multiple components of the IFN signalling pathways to control both type I and type II IFN action.	[Chinnakannan, Senthil K.; Nanda, Sambit K.; Baron, Michael D.] Pirbright Inst, Pirbright, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Baron, MD (corresponding author), Pirbright Inst, Pirbright, Surrey, England.	michael.baron@pirbright.ac.uk	Chinnakannan, Senthil/AAP-9369-2020	Chinnakannan, Senthil/0000-0002-4404-0229	Pirbright Institute; United Kingdom Biotechnology and Biological Sciences Research Council; United Kingdom Department for International Development; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001433, BBS/E/I/00001719, BBS/E/I/00001368] Funding Source: researchfish; BBSRC [BBS/E/I/00001719, BBS/E/I/00001433, BBS/E/I/00001368] Funding Source: UKRI	Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Department for International Development; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SKC and SKN received PhD studentships from the Institute for Animal Health (now known as The Pirbright Institute, www.pirbright.ac.uk). The laboratory of MDB receives funding from the United Kingdom Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) and the United Kingdom Department for International Development (www.dfid.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson J, 2011, VET REC, V169, P10, DOI 10.1136/vr.d4011; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Bailey D, 2007, VIRUS RES, V126, P250, DOI 10.1016/j.virusres.2007.01.015; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; BELLINI WJ, 1985, J VIROL, V53, P908, DOI 10.1128/JVI.53.3.908-919.1985; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Bonami F, 2007, J VIROL, V81, P12066, DOI 10.1128/JVI.00818-07; Bousse T, 2006, VIRUS RES, V121, P23, DOI 10.1016/j.virusres.2006.03.012; Boxer EL, 2009, VIROLOGY, V385, P134, DOI 10.1016/j.virol.2008.11.022; Caignard G, 2009, VIROLOGY, V383, P112, DOI 10.1016/j.virol.2008.10.014; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Devaux P, 2008, J VIROL, V82, P5359, DOI 10.1128/JVI.00169-08; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; Devaux P, 2011, J VIROL, V85, P348, DOI 10.1128/JVI.00802-10; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Fauquet C.M., 1999, 8 INT COMM TAX VIR, P1730, DOI 10.1006/rwvi.1999.0277; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; Fontana JM, 2008, VIROLOGY, V374, P71, DOI 10.1016/j.virol.2007.12.031; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Gotoh B, 2002, REV MED VIROL, V12, P337, DOI 10.1002/rmv.357; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Holzer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028594; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Horvath CM, 2004, CYTOKINE GROWTH F R, V15, P117, DOI 10.1016/j.cytogfr.2004.02.003; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; HUBER M, 1991, VIROLOGY, V185, P299, DOI 10.1016/0042-6822(91)90777-9; Kaushik R, 2004, J GEN VIROL, V85, P687, DOI 10.1099/vir.0.19702-0; Komatsu T, 2000, J VIROL, V74, P2477, DOI 10.1128/JVI.74.5.2477-2480.2000; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Malur AG, 2005, J VIROL, V79, P7877, DOI 10.1128/JVI.79.12.7877-7882.2005; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Nanda SK, 2009, VIROLOGY, V395, P223, DOI 10.1016/j.virol.2009.09.031; Ohno S, 2004, J GEN VIROL, V85, P2991, DOI 10.1099/vir.0.80308-0; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ramachandran A, 2009, J INTERF CYTOK RES, V29, P531, DOI 10.1089/jir.2009.0070; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rarnachandran A, 2008, J VIROL, V82, P8330, DOI 10.1128/JVI.00831-08; Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Roeder PL, 2011, PREV VET MED, V102, P98, DOI 10.1016/j.prevetmed.2011.04.004; Rothlisberger A, 2010, J VIROL, V84, P6328, DOI 10.1128/JVI.01878-09; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Sleeman K, 2005, VIROLOGY, V332, P225, DOI 10.1016/j.virol.2004.11.020; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; Takeuchi K, 2003, VIRUS RES, V94, P11, DOI 10.1016/S0168-1702(03)00117-5; Taylor W P, 1986, Rev Sci Tech, V5, P407, DOI 10.20506/rst.5.2.250; Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; WOHLSEIN P, 1993, VET PATHOL, V30, P544, DOI 10.1177/030098589303000608; WOHLSEIN P, 1995, VET MICROBIOL, V44, P141, DOI 10.1016/0378-1135(95)00007-W; Yokota S, 2003, VIROLOGY, V306, P135, DOI 10.1016/S0042-6822(02)00026-0	65	45	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57063	10.1371/journal.pone.0057063	http://dx.doi.org/10.1371/journal.pone.0057063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431397	Green Published, gold, Green Submitted			2022-12-27	WOS:000315182800040
J	Levin, E; Roll, U; Dolev, A; Yom-Tov, Y; Kronfeld-Shcor, N				Levin, Eran; Roll, Uri; Dolev, Amit; Yom-Tov, Yoram; Kronfeld-Shcor, Noga			Bats of a Gender Flock Together: Sexual Segregation in a Subtropical Bat	PLOS ONE			English	Article							HABITAT USE; THERMOREGULATION; HYPOTHESES; DIMORPHISM; SOCIALITY; SELECTION; SIZE	Competition has long been assumed to be a major driver in regulating ecological communities. Intra-specific competition is considered to be maximal as members of the same species use the same ecological niches in a similar way. Many species of animals exhibit great physiological, behavioral, and morphological differences between sexes (sexual dimorphism). Here we report an extreme geographical segregation between the sexes in the greater mouse-tailed bat (Rhinopoma microphyllum). To gain insight into the driving mechanisms of sexual segregation outside the mating season, we collected and integrated environmental, behavioral, physiological, and spatial information. We found that both sexes choose roosts with similar characteristics and the same food type, but use different habitats for different durations. Males forage around cliffs at higher and cooler elevations while females forage in lowlands around a river delta. We suggest that it is their different physiological and social needs, and not competition, that drives sexual segregation in this species.	[Levin, Eran; Roll, Uri; Yom-Tov, Yoram; Kronfeld-Shcor, Noga] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Dolev, Amit] INPA, Megido, Israel	Tel Aviv University	Levin, E (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	levineran1@gmail.com	Levin, Eran/GPF-5345-2022; Roll, Uri/AAE-7137-2019	Levin, Eran/0000-0002-9972-7028; Roll, Uri/0000-0002-5418-1164	Israel Science Foundation [232/08]; Adams Fellowship Program of the Israel Academy of Sciences and Humanities	Israel Science Foundation(Israel Science Foundation); Adams Fellowship Program of the Israel Academy of Sciences and Humanities	This research was supported by The Israel Science Foundation (grant No. 232/08). UR is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham John D., 2005, P280; Amichai E, 2012, MAMMALIAN BIOL; [Anonymous], 1999, WALKERS MAMMALS WORL; BEIER P, 1987, J MAMMAL, V68, P323, DOI 10.2307/1381471; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; BRADBURY JW, 1977, BEHAV ECOL SOCIOBIOL, V2, P1, DOI 10.1007/BF00299284; Cristol Daniel A., 1999, Current Ornithology, V15, P33; Cryan PM, 2000, J MAMMAL, V81, P719, DOI 10.1644/1545-1542(2000)081<0719:EOEODO>2.3.CO;2; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Darwin C, 1859, ORIGIN SPECIES MEANS; DAYAN T, 1989, ECOLOGY, V70, P1526, DOI 10.2307/1938210; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Encarnacao JA, 2012, J ETHOL, V30, P271, DOI 10.1007/s10164-011-0323-8; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillen J, 2011, ANN ZOOL FENN, V48, P180, DOI 10.5735/086.048.0306; Humphries MM, 2011, INTEGR COMP BIOL, V51, P419, DOI 10.1093/icb/icr059; Jenkins EV, 1998, ANIM BEHAV, V56, P909, DOI 10.1006/anbe.1998.0858; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Kaciuba-Uscilko H, 2001, CURR OPIN CLIN NUTR, V4, P533, DOI 10.1097/00075197-200111000-00012; KALCOUNIS MC, 1995, CAN J ZOOL, V73, P89, DOI 10.1139/z95-011; Kazial KA, 2008, ETHOLOGY, V114, P469, DOI 10.1111/j.1439-0310.2008.01483.x; Komar O, 2005, AUK, V122, P938, DOI 10.1642/0004-8038(2005)122[0938:EOLSSA]2.0.CO;2; Kunz TH, 2003, BAT ECOLOGY, P3; Levin E, 2012, J COMP PHYSIOL B, P1; Levin Eran, 2012, P167; Levin E, 2008, ACTA CHIROPTEROL, V10, P207, DOI 10.3161/150811008X414791; Levin E, 2009, NATURWISSENSCHAFTEN, V96, P477, DOI 10.1007/s00114-008-0496-3; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; Martinez JJI, 2008, VIE MILIEU, V58, P233; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; Ruckstuhl KE, 2002, ANIM BEHAV, V64, P909, DOI 10.1006/anbe.2002.2015; Safi K, 2007, AM NAT, V170, P465, DOI 10.1086/520116; Safi K, 2007, BIOL CONSERV, V137, P28, DOI 10.1016/j.biocon.2007.01.011; Safi K, 2008, J MAMMAL, V89, P1342, DOI 10.1644/08-MAMM-S-058.1; Schlitter Duane A., 1996, Mammalian Species, V0, P1; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Terrien J, 2010, PHYSIOL BEHAV, V101, P469, DOI 10.1016/j.physbeh.2010.07.012; Wallace AR, 1889, DARWINISM; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000400	46	28	28	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e54987	10.1371/journal.pone.0054987	http://dx.doi.org/10.1371/journal.pone.0054987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441148	Green Published, gold			2022-12-27	WOS:000315159200006
J	Chu, JJ; Zhang, HX; Huang, XQ; Lin, YJ; Shen, T; Chen, BD; Man, Y; Wang, S; Li, J				Chu, Jiaojiao; Zhang, Hangxiang; Huang, Xiuqing; Lin, Yajun; Shen, Tao; Chen, Beidong; Man, Yong; Wang, Shu; Li, Jian			Apelin Ameliorates TNF-alpha-Induced Reduction of Glycogen Synthesis in the Hepatocytes through G Protein-Coupled Receptor APJ	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; MIDDLE-AGED MEN; INSULIN-RESISTANCE; METABOLIC SYNDROME; PEPTIDE APELIN; EXPRESSION; LIGAND; OBESITY; MICE; ADIPOCYTES	Apelin, a novel adipokine, is the specific endogenous ligand of G protein-coupled receptor APJ. Consistent with its putative role as an adipokine, apelin has been linked to states of insulin resistance. However, the function of apelin in hepatic insulin resistance, a vital part of insulin resistance, and its underlying mechanisms still remains unclear. Here we define the impacts of apelin on TNF-alpha-induced reduction of glycogen synthesis in the hepatocytes. Our studies indicate that apelin reversed TNF-alpha-induced reduction of glycogen synthesis in HepG2 cells, mouse primary hepatocytes and liver tissues of C57BL/6J mice by improving JNK-IRS1-AKT-GSK pathway. Moreover, Western blot revealed that APJ, but not apelin, expressed in the hepatocytes and liver tissues of mice. We found that F13A, a competitive antagonist for G protein- coupled receptor APJ, suppressed the effects of apelin on TNF-alpha-induced reduction of glycogen synthesis in the hepatocytes, suggesting APJ is involved in the function of apelin. In conclusion, we show novel evidence suggesting that apelin ameliorates TNF-alpha-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ. Apelin appears as a beneficial adipokine with anti-insulin resistance properties, and thus as a promising therapeutic target in metabolic disorders.	[Chu, Jiaojiao; Zhang, Hangxiang; Huang, Xiuqing; Lin, Yajun; Shen, Tao; Chen, Beidong; Man, Yong; Wang, Shu; Li, Jian] Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China; [Chu, Jiaojiao; Zhang, Hangxiang; Huang, Xiuqing; Lin, Yajun; Shen, Tao; Chen, Beidong; Man, Yong; Wang, Shu; Li, Jian] Beijing Hosp, Minist Hlth, Beijing, Peoples R China; [Zhang, Hangxiang] Fourth Mil Med Univ, Xi Jing Hosp, Dept Gerontol, Xian 710032, Peoples R China; [Chu, Jiaojiao] Zhejiang Hosp, Hangzhou, Zhejiang, Peoples R China	Beijing Hospital; Air Force Military Medical University	Wang, S (corresponding author), Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China.	ws3704@yahoo.com.cn; lijian@bjhmoh.cn		Shen, Tao/0000-0001-5856-0818	National Basic Research Program of China [2012CB517502]; National Natural Science Foundation of China [81070634, 81270887, 81270495]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (2012CB517502) and National Natural Science Foundation of China (81070634, 81270887, 81270495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Casciano DA, 2000, DRUG METAB REV, V32, P1, DOI 10.1081/DMR-100100561; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Devic E, 1999, MECH DEVELOP, V84, P199, DOI 10.1016/S0925-4773(99)00081-7; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Erdem G, 2008, EXP CLIN ENDOCR DIAB, V116, P289, DOI 10.1055/s-2007-1004564; Falcao-Pires I, 2010, EXPERT OPIN THER TAR, V14, P633, DOI 10.1517/14728221003752743; Foussal C, 2010, FEBS LETT, V584, P2363, DOI 10.1016/j.febslet.2010.04.025; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Glassford AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1590, DOI 10.1152/ajpendo.00490.2007; Goldstein BJ, 2002, AM J CARDIOL, V90, p3G; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hung WW, 2011, CARDIOVASC DRUG THER, V25, P3, DOI 10.1007/s10557-010-6274-4; Ingelsson E, 2006, HEART, V92, P1409, DOI 10.1136/hrt.2006.089011; Kadoglou NPE, 2010, METABOLISM, V59, P373, DOI 10.1016/j.metabol.2009.08.005; Katakam AK, 2005, J ENDOCRINOL, V187, P237, DOI 10.1677/joe.1.06411; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Li L, 2006, EXP CLIN ENDOCR DIAB, V114, P544, DOI 10.1055/s-2006-948309; Li LF, 2010, FEBS LETT, V584, P995, DOI 10.1016/j.febslet.2010.01.044; Liang HF, 2008, ENDOCRINOLOGY, V149, P2943, DOI 10.1210/en.2007-0978; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Mlinar B, 2007, CLIN CHIM ACTA, V375, P20, DOI 10.1016/j.cca.2006.07.005; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Winzell MS, 2005, REGUL PEPTIDES, V131, P12, DOI 10.1016/j.regpep.2005.05.004; Xu SM, 2011, J DIABETES, V3, P225, DOI 10.1111/j.1753-0407.2011.00132.x; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; Zhang Yu, 2009, Diabetes Care, V32, pe150, DOI 10.2337/dc09-1146	41	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57231	10.1371/journal.pone.0057231	http://dx.doi.org/10.1371/journal.pone.0057231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437347	gold, Green Submitted, Green Published			2022-12-27	WOS:000315186000088
J	Fryer, RA; Graham, TJ; Smith, EM; Walker-Samuel, S; Morgan, GJ; Robinson, SP; Davies, FE				Fryer, Rosemary A.; Graham, Timothy J.; Smith, Emma M.; Walker-Samuel, Simon; Morgan, Gareth J.; Robinson, Simon P.; Davies, Faith E.			Characterization of a Novel Mouse Model of Multiple Myeloma and Its Use in Preclinical Therapeutic Assessment	PLOS ONE			English	Article							SCID MICE; CELLS; TRANSPLANTATION; PLASMACYTOMA; PATHOGENESIS; INHIBITION; STRATEGY; LEUKEMIA; CLONE; MYC	To aid preclinical development of novel therapeutics for myeloma, an in vivo model which recapitulates the human condition is required. An important feature of such a model is the interaction of myeloma cells with the bone marrow microenvironment, as this interaction modulates tumour activity and protects against drug-induced apoptosis. Therefore NOD/SCID gamma C-null mice were injected intra-tibially with luciferase-tagged myeloma cells. Disease progression was monitored by weekly bioluminescent imaging (BLI) and measurement of paraprotein levels. Results were compared with magnetic resonance imaging (MRI) and histology. Assessment of model suitability for preclinical drug testing was investigated using bortezomib, melphalan and two novel agents. Cells engrafted at week 3, with a significant increase in BLI radiance occurring between weeks 5 and 7. This was accompanied by an increase in paraprotein secretion, MRI-derived tumour volume and CD138 positive cells within the bone marrow. Treatment with known anti-myeloma agents or novel agents significantly attenuated the increase in all disease markers. In addition, intra-tibial implantation of primary patient plasma cells resulted in development of myeloma within bone marrow. In conclusion, using both myeloma cell lines and primary patient cells, we have developed a model which recapitulates human myeloma by ensuring the key interaction of tumour cells with the microenvironment.	[Fryer, Rosemary A.; Smith, Emma M.; Morgan, Gareth J.; Davies, Faith E.] Inst Canc Res, Haematooncol Res Unit, London SW3 6JB, England; [Graham, Timothy J.; Robinson, Simon P.] Canc Res UK, London, England; [Graham, Timothy J.; Robinson, Simon P.] Inst Canc Res, EPSRC Canc Imaging Ctr, London SW3 6JB, England; [Walker-Samuel, Simon] UCL, Ctr Adv Biomed Imaging, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; University of London; University College London	Davies, FE (corresponding author), Inst Canc Res, Haematooncol Res Unit, London SW3 6JB, England.	faith.davies@icr.ac.uk		Robinson, Simon/0000-0003-4101-7274; Davies, Faith/0000-0002-3971-2393; morgan, gareth/0000-0002-4271-6360	Cancer Research UK [C20826/A12103]; Myeloma UK and Kay Kendall Leukaemia Fund; Institute of Cancer Research; Cancer Research UK; Engineering and Physical Sciences Research Council Cancer Imaging Centre; Medical Research Council and Department of Health (England) [C1060/A10334]; National Health Service; MRC [G0701533] Funding Source: UKRI; Cancer Research UK [16464, 12103] Funding Source: researchfish; Medical Research Council [G0701533] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Myeloma UK and Kay Kendall Leukaemia Fund; Institute of Cancer Research; Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council and Department of Health (England)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Service; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Cancer Research UK (FD is a Cancer Research UK Senior Fellow, grant number: C20826/A12103), Myeloma UK and Kay Kendall Leukaemia Fund. The authors acknowledge the support received for The Institute of Cancer Research, Cancer Research UK, and Engineering and Physical Sciences Research Council Cancer Imaging Centre, in association with the Medical Research Council and Department of Health (England), grant C1060/A10334, and National Health Service funding to the National Institute for Health Research Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boylan KLM, 2007, CANCER RES, V67, P4069, DOI 10.1158/0008-5472.CAN-06-3699; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Edinger Matthias, 1999, Neoplasia (New York), V1, P303, DOI 10.1038/sj.neo.7900048; Gado K, 2001, HAEMATOLOGICA, V86, P227; Groen RW, 2010, BLOOD, V116; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lowenberg B, 2010, J CLIN ONCOL, V28, P4333, DOI 10.1200/JCO.2009.27.6295; Mitsiades CS, 2003, CANCER RES, V63, P6689; Miyakawa Y, 2004, BIOCHEM BIOPH RES CO, V313, P258, DOI 10.1016/j.bbrc.2003.11.120; Moore HE, 2009, MOL CANCER THER, V8, P762, DOI 10.1158/1535-7163.MCT-08-0735; Morito N, 2011, CANCER RES, V71, P339, DOI 10.1158/0008-5472.CAN-10-1057; Pattengale PK, 1997, AM J PATHOL, V151, P647; Podar K, 2007, BEST PRACT RES CL HA, V20, P597, DOI 10.1016/j.beha.2007.08.002; RADL J, 1979, J IMMUNOL, V122, P609; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; TONG AW, 1993, ANTICANCER RES, V13, P593; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513	21	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57641	10.1371/journal.pone.0057641	http://dx.doi.org/10.1371/journal.pone.0057641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437401	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000114
J	He, YQ; Chen, J; Lu, XJ; Shi, YH				He, Yu-Qing; Chen, Jiong; Lu, Xin-Jiang; Shi, Yu-Hong			Characterization of P2X7R and Its Function in the Macrophages of ayu, Plecoglossus altivelis	PLOS ONE			English	Article							SCAVENGER RECEPTOR; APOPTOTIC CELLS; ATP; P2X(7); MYOSIN; LIPOPOLYSACCHARIDE; ZEBRAFISH; MECHANISM; MONOCYTES; BACTERIA	P2X purinoceptor 7 (P2X7R), an ATP-gated ion channel, plays an important role during the innate immune response in mammals. However, relatively little is known about the role of P2X7R in the fish immune system. Here, we cloned a cDNA sequence encoding ayu (Plecoglossus altivelis) P2X7R (aP2X7R). The predicted protein was composed of 574 amino acid residues with a P2X family signature, two transmembrane domains, and a long C-terminal. aP2X7R transcripts were mainly distributed in ayu immune tissues and significantly increased in all tested tissues and in macrophages after Listonella anguillarum infection. The aP2X7R protein was upregulated significantly in macrophages upon bacterial challenge. An antibody against the ectodomain of aP2X7R (aEPAb) and an antagonist (oATP) were used to block aP2X7R. aP2X7R siRNA was also used to knockdown the receptor expression in ayu macrophages. Cell death induced by ATP was significantly inhibited in ayu macrophages after aEPAb, oATP, or siRNA treatment. Moreover, aP2X7R ablation also resulted in suppression of phagocytic activity and ATP-induced bacterial killing in ayu macrophages. Our results indicated that aP2X7R was upregulated after infection and mediated cell death, phagocytosis, and bacterial killing of ayu macrophages.	[He, Yu-Qing; Chen, Jiong; Lu, Xin-Jiang; Shi, Yu-Hong] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University	Chen, J (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	jchen1975@163.com	He, Yuqing/GRR-5357-2022	He, Yuqing/0000-0002-7633-9188	Program for the National Natural Science Foundation of China [31201970]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201119291]; Research Fund for the Doctoral Program of Higher Education of China [20113305120001]; Discipline Project of Ningbo University [szx11069, xkc11004]; KC Wong Magna Fund in Ningbo University	Program for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Zhejiang Provincial Education Department; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Discipline Project of Ningbo University; KC Wong Magna Fund in Ningbo University	The project was supported by the Program for the National Natural Science Foundation of China (31201970), the Scientific Research Fund of Zhejiang Provincial Education Department (Y201119291), the Research Fund for the Doctoral Program of Higher Education of China (20113305120001), the Discipline Project of Ningbo University (szx11069, xkc11004) and the KC Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; BRAUNNESJE R, 1981, J FISH DIS, V4, P141, DOI 10.1111/j.1365-2761.1981.tb01118.x; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chaves SP, 2009, MICROBES INFECT, V11, P842, DOI 10.1016/j.micinf.2009.05.001; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Gu BJ, 2011, J IMMUNOL, V187, P2365, DOI 10.4049/jimmunol.1101178; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Kawano A, 2012, BIOCHEM BIOPH RES CO, V419, P374, DOI 10.1016/j.bbrc.2012.01.156; Kucenas S, 2003, NEUROSCIENCE, V121, P935, DOI 10.1016/S0306-4522(03)00566-9; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Li Changhong, 2009, Weishengwu Xuebao, V49, P931; Lopez-Castejon G, 2007, MOL IMMUNOL, V44, P1286, DOI 10.1016/j.molimm.2006.05.015; Lu XJ, 2011, FISH SHELLFISH IMMUN, V31, P52, DOI 10.1016/j.fsi.2011.03.005; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Nishimori E, 2000, INT J SYST EVOL MICR, V50, P83, DOI 10.1099/00207713-50-1-83; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Smith RA, 2001, VET IMMUNOL IMMUNOP, V78, P249, DOI 10.1016/S0165-2427(01)00245-8; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Watters JJ, 2001, DRUG DEVELOP RES, V53, P91, DOI 10.1002/ddr.1176; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wiley JS, 2012, PURINERG SIGNAL, V8, P579, DOI 10.1007/s11302-012-9308-5	39	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57505	10.1371/journal.pone.0057505	http://dx.doi.org/10.1371/journal.pone.0057505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437395	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000108
J	Hill, MF; Patel, AV; Murphy, A; Smith, HM; Galindo, CL; Pentassuglia, L; Peng, XY; Lenneman, CG; Odiete, O; Friedman, DB; Kronenberg, MW; Zheng, SY; Zhao, ZM; Song, YN; Harrell, FE; Srinivas, M; Ganguly, A; Iaci, J; Parry, TJ; Caggiano, AO; Sawyer, DB				Hill, Michael F.; Patel, Amish V.; Murphy, Abigail; Smith, Holly M.; Galindo, Cristi L.; Pentassuglia, Laura; Peng, Xuyang; Lenneman, Carrie G.; Odiete, Oghenerukevwe; Friedman, David B.; Kronenberg, Marvin W.; Zheng, Siyuen; Zhao, Zhongming; Song, Yanna; Harrell, Frank E., Jr.; Srinivas, Maya; Ganguly, Anindita; Iaci, Jennifer; Parry, Tom J.; Caggiano, Anthony O.; Sawyer, Douglas B.			Intravenous Glial Growth Factor 2 (GGF2) Isoform of Neuregulin-1 beta Improves Left Ventricular Function, Gene and Protein Expression in Rats after Myocardial Infarction	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; RECOMBINANT HUMAN NEUREGULIN-1; CHRONIC HEART-FAILURE; CARDIAC MYOCYTES; MITOCHONDRIAL DYSFUNCTION; ERBB2; CARDIOMYOPATHY; INHIBITION; STANDARD; SURVIVAL	Aims: Recombinant Neuregulin (NRG)-1 beta has multiple beneficial effects on cardiac myocytes in culture, and has potential as a clinical therapy for heart failure (HF). A number of factors may influence the effect of NRG-1 beta on cardiac function via ErbB receptor coupling and expression. We examined the effect of the NRG-1 beta isoform, glial growth factor 2 (GGF2), in rats with myocardial infarction (MI) and determined the impact of high-fat diet as well as chronicity of disease on GGF2 induced improvement in left ventricular systolic function. Potential mechanisms for GGF2 effects on the remote myocardium were explored using microarray and proteomic analysis. Methods and Results: Rats with MI were randomized to receive vehicle, 0.625 mg/kg, or 3.25 mg/kg GGF2 in the presence and absence of high-fat feeding beginning at day 7 post-MI and continuing for 4 weeks. Residual left ventricular (LV) function was improved in both of the GGF2 treatment groups compared with the vehicle treated MI group at 4 weeks of treatment as assessed by echocardiography. High-fat diet did not prevent the effects of high dose GGF2. In experiments where treatment was delayed until 8 weeks after MI, high but not low dose GGF2 treatment was associated with improved systolic function. mRNA and protein expression analysis of remote left ventricular tissue revealed a number of changes in myocardial gene and protein expression altered by MI that were normalized by GGF2 treatment, many of which are involved in energy production. Conclusions: This study demonstrates that in rats with MI induced systolic dysfunction, GGF2 treatment improves cardiac function. There are differences in sensitivity of the myocardium to GGF2 effects when administered early vs. late post-MI that may be important to consider in the development of GGF2 in humans.	[Hill, Michael F.; Patel, Amish V.; Murphy, Abigail; Smith, Holly M.; Galindo, Cristi L.; Pentassuglia, Laura; Peng, Xuyang; Lenneman, Carrie G.; Odiete, Oghenerukevwe; Kronenberg, Marvin W.; Sawyer, Douglas B.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37203 USA; [Friedman, David B.] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA; [Zheng, Siyuen; Zhao, Zhongming] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Song, Yanna; Harrell, Frank E., Jr.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Srinivas, Maya; Ganguly, Anindita; Iaci, Jennifer; Parry, Tom J.; Caggiano, Anthony O.] Acorda Therapeut Inc, Hawthorne, NY USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Sawyer, DB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37203 USA.	douglas.b.sawyer@Vanderbilt.Edu			National Institutes of Health [P20 HL101425, U01 HL100398]; Acorda Therapeutics, Inc.; NIH [DK59637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100398, R01HL068144, P20HL101425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, U2CDK059637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Acorda Therapeutics, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (P20 HL101425, U01 HL100398) and Acorda Therapeutics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Several authors are employed by Acorda Therapeutics. These authors participated in study design and preparation of the manuscript.; Douglas Sawyer has received research support from Acorda Therapeutics, Inc. that helped to fund parts of this study. Several authors as noted on the title page are employees of Acorda Therapeutics, Inc., a company that is developing GGF2 for the treatment of cardiovascular and neurodegenerative disease. The authors note that these competing interests do not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.; We thank Lian Li and Zhizhang Wang for technical assistance with animal surgery and echocardiography. We thank Todd Peterson and the Vanderbilt University Insititute for Imaging Sciences for conducting Positron Emission Tomography imaging studies. Cardiac surgery and echocardiography were conducted in the Mouse Metabolic Phenotyping Center which is supported by NIH Grant DK59637.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; [Anonymous], NHLBI PROGR GEN APPL; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Colak D, 2009, GENOMICS, V94, P20, DOI 10.1016/j.ygeno.2009.03.003; Friedman David B, 2007, Methods Mol Biol, V367, P219; Friedman DB, 2004, PROTEOMICS, V4, P793, DOI 10.1002/pmic.200300635; Ganguly A, 2008, CIRC RES, V103, pE51; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; Grazette LP, 2004, J AM COLL CARDIOL, V44, P2231, DOI 10.1016/j.jacc.2004.08.066; Guo YF, 2012, CHINESE MED J-PEKING, V125, P807, DOI 10.3760/cma.j.issn.0366-6999.2012.05.015; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; Kuramochi Y, 2006, J MOL CELL CARDIOL, V41, P228, DOI 10.1016/j.yjmcc.2006.04.007; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Miller TA, 2009, BIOCHEM BIOPH RES CO, V379, P32, DOI 10.1016/j.bbrc.2008.11.150; Morgan EE, 2006, AM J PHYSIOL-HEART C, V290, pH1899, DOI 10.1152/ajpheart.01014.2005; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Peng XY, 2005, J BIOL CHEM, V280, P13148, DOI 10.1074/jbc.M410838200; Pentassuglia L, 2009, EXP CELL RES, V315, P1302, DOI 10.1016/j.yexcr.2009.02.001; Rennison JH, 2007, AM J PHYSIOL-HEART C, V292, pH1498, DOI 10.1152/ajpheart.01021.2006; Rohrbach S, 1999, CIRCULATION, V100, P407, DOI 10.1161/01.CIR.100.4.407; Sawyer DB, 2002, CIRCULATION, V105, P1551, DOI 10.1161/01.CIR.0000013839.41224.1C; Sawyer DB, 2011, J MOL CELL CARDIOL, V51, P501, DOI 10.1016/j.yjmcc.2011.06.016; Trivedi CM, 2011, J MOL CELL CARDIOL, V50, P1056, DOI 10.1016/j.yjmcc.2011.02.015; Udelson JE, 2002, J CARD FAIL, V8, pS465, DOI 10.1054/jcaf.2002.129289; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	31	29	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55741	10.1371/journal.pone.0055741	http://dx.doi.org/10.1371/journal.pone.0055741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437060	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000007
J	Huang, SX; Wu, FX; Luo, M; Ma, L; Gao, KF; Li, J; Wu, WJ; Huang, S; Yang, Q; Liu, K; Zhao, YN; Li, LQ				Huang, Sheng-xin; Wu, Fei-xiang; Luo, Min; Ma, Liang; Gao, Ke-feng; Li, Jian; Wu, Wen-juan; Huang, Shan; Yang, Qi; Liu, Ke; Zhao, Yin-nong; Li, Le-qun			The Glutathione S-Transferase P1 341C > T Polymorphism and Cancer Risk: A Meta-Analysis of 28 Case-Control Studies	PLOS ONE			English	Article							METABOLISM GENE POLYMORPHISMS; LUNG-CANCER; PHASE-I; COMPREHENSIVE ANALYSIS; GSTP1 POLYMORPHISMS; BARRETTS-ESOPHAGUS; BLADDER-CANCER; NULL-GENOTYPE; GSTM1; GSTT1	Background: GSTP1, which is one major group of the glutathione S-transferase family, plays an important role in the metabolism of carcinogens and toxins, reducing damage of DNA as a suppressor of carcinogenesis. The 341C>T polymorphism of the GSTP1 has been implicated in cancer risk through cutting down its metabolic detoxification activities. However, results from previous studies remain conflicting rather than conclusive. To clarify the correlation and provide more statistical evidence for detecting the significance of 341C>T, a meta-analysis was conducted. Methodology/Principal Findings: The relevant studies were identified through searching of PubMed, Embase, ISI Web of Knowledge and China National Knowledge Infrastructure in August 2012, and selected based on the established inclusion criteria for publications, then a meta-analysis was performed to quantitatively summarize the association of GSTP1 341C>T polymorphism with cancer susceptibility. Stratified analyses were employed to identify the source of heterogeneity. Publication bias was evaluated as well as sensitivity analysis. Based on 28 case-control studies with 13249 cases and 16798 controls, the pooled results indicated that the variant genotypes significantly increased the risk of cancer in homozygote comparison (TT versus CC: P = 0.012, OR = 1.40, 95% CI: 1.08-1.81, P-het. = 0.575), and recessive model (TT versus CT/CC: P = 0.012, OR = 1.40, 95% CI: 1.08-1.81, P-het. = 0.562). This was confirmed when stratified analyses were conducted according to ethnicity, source of control, matched control, quality score and cancer types. Moreover, significantly increased risk of cancer was also found in lung cancer (heterozygote comparison and dominant model). The stability of these observations was confirmed by a sensitivity analysis. Begger's funnel plot and Egger's test did not reveal any publication bias. Conclusions/Significance: This meta-analysis suggests that the GSTP1 341C>T polymorphism may contribute to genetic susceptibility to cancer, especially to lung cancer, and in Asian population. Nevertheless, additional well-designed studies focusing on different ethnicity and cancer types are needed to provide a more exact and comprehensive conclusion.	[Huang, Sheng-xin; Wu, Fei-xiang; Ma, Liang; Li, Jian; Huang, Shan; Yang, Qi; Liu, Ke; Zhao, Yin-nong; Li, Le-qun] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China; [Luo, Min] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Expt, Nanning, Peoples R China; [Gao, Ke-feng] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Thorac Surg, Nanning, Peoples R China; [Wu, Wen-juan] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China.	wufxiang@yahoo.com.cn	Wu, wenjuan/GPX-6968-2022					Al-Dayel F, 2008, LEUKEMIA LYMPHOMA, V49, P122, DOI 10.1080/10428190701704605; AliOsman F, 1997, J BIOL CHEM, V272, P10004; Barnette P, 2004, CANCER EPIDEM BIOMAR, V13, P304, DOI 10.1158/1055-9965.EPI-03-0178; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bull LM, 2009, DIS ESOPHAGUS, V22, P571, DOI 10.1111/j.1442-2050.2009.00947.x; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Canova C, 2009, CANCER RES, V69, P2956, DOI 10.1158/0008-5472.CAN-08-2604; Chan EC, 2005, CANCER GENET CYTOGEN, V162, P10, DOI 10.1016/j.cancergencyto.2005.03.008; Chang-Claude J, 2010, BREAST CANCER RES TR, V119, P463, DOI 10.1007/s10549-009-0407-0; Das P, 2009, LEUKEMIA LYMPHOMA, V50, P1345, DOI 10.1080/10428190903003236; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Ebrahimkhani S, 2012, PATHOL ONCOL RES, V18, P651, DOI 10.1007/s12253-011-9490-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Harris MJ, 1998, PHARMACOGENETICS, V8, P27, DOI 10.1097/00008571-199802000-00004; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Ibarrola-Villava M, 2012, BR J DERMATOL; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao L, 2007, CANCER-AM CANCER SOC, V109, P840, DOI 10.1002/cncr.22468; Kellen E, 2007, AM J EPIDEMIOL, V165, P1221, DOI 10.1093/aje/kwm003; Kim JY, 2007, MOVEMENT DISORD, V22, P1922, DOI 10.1002/mds.21628; Kury S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-326; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Landi S, 2007, INT J CANCER, V120, P2739, DOI 10.1002/ijc.22590; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu GY, 2011, ARCH MED RES, V42, P149, DOI 10.1016/j.arcmed.2011.02.002; Marciniak Pawel, 2006, Endokrynol Pol, V57, P509; Medeiros R, 2004, PROSTATE, V58, P414, DOI 10.1002/pros.10348; Moore LE, 2005, CANCER EPIDEM BIOMAR, V14, P1823, DOI 10.1158/1055-9965.EPI-05-0037; MOSCOW JA, 1989, CANCER RES, V49, P1422; Murphy SJ, 2007, CARCINOGENESIS, V28, P1323, DOI 10.1093/carcin/bgm007; Northwood EL, 2010, PHARMACOGENET GENOM, V20, P315, DOI 10.1097/FPC.0b013e3283395c6a; Saarikoski ST, 1998, INT J CANCER, V77, P516, DOI 10.1002/(SICI)1097-0215(19980812)77:4<516::AID-IJC7>3.0.CO;2-X; Sergentanis TN, 2010, BREAST CANCER RES TR, V121, P195, DOI 10.1007/s10549-009-0520-0; Siraj AK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-61; Sorensen M, 2004, INT J CANCER, V110, P219, DOI 10.1002/ijc.20075; Strange R C, 1999, IARC Sci Publ, P231; TERRIER P, 1990, AM J PATHOL, V137, P845; Van Emburgh BO, 2008, ONCOL REP, V19, P1311; Wadelius M, 1999, PHARMACOGENETICS, V9, P333, DOI 10.1097/00008571-199906000-00008; Wang JW, 2011, CANCER EPIDEMIOL, V35, P66, DOI 10.1016/j.canep.2010.07.003; Wang YF, 2003, LUNG CANCER, V40, P25, DOI 10.1016/S0169-5002(02)00537-8; Yang P, 2004, CARCINOGENESIS, V25, P1935, DOI 10.1093/carcin/bgh203; Zienolddiny S, 2008, CARCINOGENESIS, V29, P1164, DOI 10.1093/carcin/bgn020	46	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56722	10.1371/journal.pone.0056722	http://dx.doi.org/10.1371/journal.pone.0056722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437223	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000039
J	Malda, J; de Grauw, JC; Benders, KEM; Kik, MJL; van de Lest, CHA; Creemers, LB; Dhert, WJA; van Weeren, PR				Malda, Jos; de Grauw, Janny C.; Benders, Kim E. M.; Kik, Marja J. L.; van de Lest, Chris H. A.; Creemers, Laura B.; Dhert, Wouter J. A.; van Weeren, P. Rene			Of Mice, Men and Elephants: The Relation between Articular Cartilage Thickness and Body Mass	PLOS ONE			English	Article							IN-VITRO; TOPOGRAPHICAL VARIATION; KNEE-JOINT; EQUINE; TISSUE; PROTEOGLYCAN; REGENERATION; ORGANIZATION; ALLOMETRY; STIFFNESS	Mammalian articular cartilage serves diverse functions, including shock absorption, force transmission and enabling low-friction joint motion. These challenging requirements are met by the tissue's thickness combined with its highly specific extracellular matrix, consisting of a glycosaminoglycan-interspersed collagen fiber network that provides a unique combination of resilience and high compressive and shear resistance. It is unknown how this critical tissue deals with the challenges posed by increases in body mass. For this study, osteochondral cores were harvested post-mortem from the central sites of both medial and lateral femoral condyles of 58 different mammalian species ranging from 25 g (mouse) to 4000 kg (African elephant). Joint size and cartilage thickness were measured and biochemical composition (glycosaminoclycan, collagen and DNA content) and collagen cross-links densities were analyzed. Here, we show that cartilage thickness at the femoral condyle in the mammalian species investigated varies between 90 mm and 3000 mm and bears a negative allometric relationship to body mass, unlike the isometric scaling of the skeleton. Cellular density (as determined by DNA content) decreases with increasing body mass, but gross biochemical composition is remarkably constant. This however need not affect life-long performance of the tissue in heavier mammals, due to relatively constant static compressive stresses, the zonal organization of the tissue and additional compensation by joint congruence, posture and activity pattern of larger mammals. These findings provide insight in the scaling of articular cartilage thickness with body weight, as well as in cartilage biochemical composition and cellularity across mammalian species. They underscore the need for the use of appropriate in vivo models in translational research aiming at human applications.	[Malda, Jos; Benders, Kim E. M.; Creemers, Laura B.; Dhert, Wouter J. A.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Malda, Jos] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Malda, Jos; de Grauw, Janny C.; van de Lest, Chris H. A.; Dhert, Wouter J. A.; van Weeren, P. Rene] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Kik, Marja J. L.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [van de Lest, Chris H. A.] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Queensland University of Technology (QUT); Utrecht University; Utrecht University; Utrecht University	Malda, J (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.malda@umcutrecht.nl	Malda, Jos/ABA-9685-2021; Creemers, Laura B/AAS-2424-2020	Dhert, Wouter/0000-0001-9150-6143; Malda, Jos/0000-0002-9241-7676; Creemers, Laura/0000-0002-1585-3052; van de Lest, Chris H.A./0000-0003-2143-2825	Dutch Arthritis Foundation; Alexandre Suerman Fellowship	Dutch Arthritis Foundation; Alexandre Suerman Fellowship	JM is supported by the Dutch Arthritis Foundation (www.reumafonds.nl). KB is supported by an Alexandre Suerman Fellowship (www.umcutrecht.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG SJ, 1995, OSTEOARTHR CARTILAGE, V3, P25, DOI 10.1016/S1063-4584(05)80035-4; ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304; Benninghoff A., 1925, CELL TISSUE RES, V2, P783, DOI [10.1007/bf00583443, DOI 10.1007/BF00583443, 10.1007/BF00583443]; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Brama PAJ, 2009, EQUINE VET J, V41, P557, DOI 10.2746/042516409X424162; Brama PAJ, 1999, AM J VET RES, V60, P341; Brama PAJ, 2000, EQUINE VET J, V32, P19, DOI 10.2746/042516400777612062; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Brommer H, 2005, EQUINE VET J, V37, P148, DOI 10.2746/0425164054223769; Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021; Buckwalter JA, 1989, T ORTHOP RES SOC, V14, P155; Christiansen P, 2002, J MORPHOL, V251, P195, DOI 10.1002/jmor.1083; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Doube M, 2011, P BIOL SCI; Esquisatto MAM, 1997, ANN ANAT, V179, P433, DOI 10.1016/S0940-9602(97)80044-1; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Frisbie DD, 2006, VET COMP ORTHOPAED, V19, P142, DOI 10.1055/s-0038-1632990; Galilei Linceo G, 1683, DISCORZSI DEMOSTRAZI; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Han E, 2011, BIOPHYS J, V101, P916, DOI 10.1016/j.bpj.2011.07.006; Hayes AJ, 2007, J HISTOCHEM CYTOCHEM, V55, P853, DOI 10.1369/jhc.7A7210.2007; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; KEMPSON GE, 1970, BIOCHIM BIOPHYS ACTA, V215, P70, DOI 10.1016/0304-4165(70)90388-0; KIVIRANTA I, 1987, ARTHRITIS RHEUM, V30, P801, DOI 10.1002/art.1780300710; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Malda J, 2012, OSTEOARTHR CARTILAGE, V20, P1147, DOI 10.1016/j.joca.2012.06.005; Malda J, 2010, TISSUE ENG PT A, V16, P897, DOI 10.1089/ten.TEA.2009.0376; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794; McIlwraith CW, 2011, CARTILAGE, V2, P317, DOI 10.1177/1947603511406531; McLure SWD, 2012, P I MECH ENG H, V226, P652, DOI 10.1177/0954411912447158; Rasanen T, 1996, J BIOMED MATER RES, V31, P519; REYNOLDS WW, 1977, HYDROBIOLOGIA, V56, P35, DOI 10.1007/BF00023283; Rogers BA, 2006, J BONE JOINT SURG BR, V88B, P1670, DOI 10.1302/0301-620X.88B12.18132; Schinagl RM, 1996, ANN BIOMED ENG, V24, P500, DOI 10.1007/BF02648112; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Schuurman W, 2009, AM J SPORT MED, V37, p97S, DOI 10.1177/0363546509350978; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305; Souza MV, 2010, EQUINE VET J, V42, P611, DOI 10.1111/j.2042-3306.2010.0089.x; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; STOCKWELL RA, 1971, J ANAT, V109, P411	44	81	82	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57683	10.1371/journal.pone.0057683	http://dx.doi.org/10.1371/journal.pone.0057683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437402	Green Published, gold			2022-12-27	WOS:000315186000115
J	Binagwaho, A; Pegurri, E; Drobac, PC; Mugwaneza, P; Stulac, SN; Wagner, CM; Karema, C; Tsague, L				Binagwaho, Agnes; Pegurri, Elisabetta; Drobac, Peter C.; Mugwaneza, Placidie; Stulac, Sara N.; Wagner, Claire M.; Karema, Corine; Tsague, Landry			Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; FORMULA-FED INFANTS; HIV-1-INFECTED WOMEN; TREATMENT PROGRAM; INFECTED WOMEN; FREE SURVIVAL; MORTALITY; ZIDOVUDINE; THERAPY; MORBIDITY	Background: Rwanda's National PMTCT program aims to achieve elimination of new HIV infections in children by 2015. In November 2010, Rwanda adopted the WHO 2010 ARV guidelines for PMTCT recommending Option B (HAART) for all HIV-positive pregnant women extended throughout breastfeeding and discontinued (short course-HAART) only for those not eligible for life treatment. The current study aims to assess the cost-effectiveness of this policy choice. Methods: Based on a cohort of HIV-infected pregnant women in Rwanda, we modelled the cost-effectiveness of six regimens: dual ARV prophylaxis with either 12 months breastfeeding or replacement feeding; short course HAART (Sc-HAART) prophylaxis with either 6 months breastfeeding, 12 months breastfeeding, or 18 months breastfeeding; and Sc-HAART prophylaxis with replacement feeding. Direct costs were modelled based on all inputs in each scenario and related unit costs. Effectiveness was evaluated by measuring HIV-free survival at 18 months. Savings correspond to the lifetime costs of HIV treatment and care avoided as a result of all vertical HIV infections averted. Results: All PMTCT scenarios considered are cost saving compared to "no intervention." Sc-HAART with 12 months breastfeeding or 6 months breastfeeding dominate all other scenarios. Sc-HAART with 12 months breastfeeding allows for more children to be alive and HIV-uninfected by 18 months than Sc-HAART with 6 months breastfeeding for an incremental cost per child alive and uninfected of 11,882 USD. This conclusion is sensitive to changes in the relative risk of mortality by 18 months for exposed HIV-uninfected children on replacement feeding from birth and those who were breastfed for only 6 months compared to those breastfeeding for 12 months or more. Conclusion: Our findings support the earlier decision by Rwanda to adopt WHO Option B and could inform alternatives for breastfeeding duration. Local contexts and existing care delivery models should be part of national policy decisions.	[Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Binagwaho, Agnes; Drobac, Peter C.; Stulac, Sara N.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Pegurri, Elisabetta] UNAIDS Ethiopia, Addis Ababa, Ethiopia; [Drobac, Peter C.] Partners Hlth Inshuti Mu Buzima, Kigali, Rwanda; [Drobac, Peter C.; Mugwaneza, Placidie; Karema, Corine] Rwanda Biomed Ctr, Kigali, Rwanda; [Stulac, Sara N.] Partners Hlth, Boston, MA USA; [Wagner, Claire M.] Global Hlth Delivery Partnership, Boston, MA USA; [Tsague, Landry] UNICEF Zambia, Lusaka, Zambia	Harvard University; Brigham & Women's Hospital; Rwanda Biomedical Center; Partners Healthcare System	Binagwaho, A (corresponding author), Minist Hlth, Kigali, Rwanda.	abinagwaho@gmail.com						Arrive E, 2008, INT J EPIDEMIOL, V37, P474, DOI 10.1093/ije/dym216; Banerjee T, 2010, ANN TROP PAEDIATR, V30, P27, DOI 10.1179/146532810X12637745451915; Becquet R, 2007, PLOS MED, V4, P139, DOI 10.1371/journal.pmed.0040017; Carter RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P404, DOI 10.1097/QAI.0b013e3181e73f4b; Center for Treatment and Research on AIDS Malaria Tuberculosis and Other Epidemics (TRAC-Plus) & Rwanda Ministry of Health, 2010, NAT STAND GUID CLIN; Center for Treatment and Research on AIDS Malaria Tuberculosis and Other Epidemics (TRAC-Plus) & Rwanda Ministry of Health, 2010, RWAND NAT GUID PREV; Center for Treatment and Research on AIDS Malaria Tuberculosis and Other Epidemics (TRAC-Plus) & Rwanda National AIDS Control Commission, 2010, HIV AIDS RWAND 2010; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Clinton Health Access Initiative, 2010, ANT ARV PRIC LIST VE; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Dabis F, 2005, AIDS, V19, P309; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Franke MF, 2011, PEDIATR INFECT DIS J, V30, P614, DOI 10.1097/INF.0b013e31820a599e; Homsy J, 2010, JAIDS-J ACQ IMM DEF, V53, P28, DOI 10.1097/QAI.0b013e3181bdf65a; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Ivers LC, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-37; Kagaayi J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003877; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2010, CLIN PERINATOL, V37, P843, DOI 10.1016/j.clp.2010.08.011; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; National Bank of Rwanda, 2009, EXCH RAT RWF USD; National Institute of Statistics of Rwanda World Food Programme UNICEF World Vision, 2009, RWAND COMPR FOOD SEC; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Omes C, 2004, 15 INT AIDS C BANGK; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3; Rollins N, 2006, HIV TRANSMISSION MOR; Rwanda Ministry of Health, 2010, FIN REC; Rwanda Ministry of Health, 2007, SURV INF VIH SIT SEN; Rwanda Ministry of Health, 2011, DEM HLTH SURV 2010 P; Rwanda Ministry of Health, 2001, NAT STRAT APPL NSA B; Rwanda National AIDS Control Commission, 2007, DAT EST AM FIN RES N; Rwanda National AIDS Control Commission, 2008, UN GEN ASS SPEC SESS; Rwanda National AIDS Control Commission, 2009, RWAND NAT STRAT PLAN; Rwanda National Institute of Statistics & ORC Macro, 2008, RWAND INT DEM HLTH S; Rwanda National Institute of Statistics & ORC Macro, 2006, RWAND DEM HLTH SURV; Scotland GS, 2003, AIDS, V17, P1045, DOI 10.1097/00002030-200305020-00014; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Soderlund N, 1999, BRIT MED J, V318, P1650, DOI 10.1136/bmj.318.7199.1650; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Stringer JSA, 2000, J ACQ IMMUN DEF SYND, V24, P369, DOI 10.1097/00126334-200008010-00012; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Teerawattananon Y, 2005, COST EFFECTIVENESS R, V3; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; *UNAIDS, 2009, AIDS EP UPD; UNAIDS & WHO, 2009, UNAIDS REP GLOB AIDS; Universite de Bordeaux Institut de Sante Publique dEedDIIU UNICEF, 2010, PMCT PED HIV AIDS CA; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2006, ANT DRUGS TREAT PREG; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2010, PMTCT STRAT VIS 2010; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, GUID HIV INF FEED 20; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	66	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54180	10.1371/journal.pone.0054180	http://dx.doi.org/10.1371/journal.pone.0054180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437040	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200007
J	Chen, FH; Sarabipour, S; Hristova, K				Chen, Fenghao; Sarabipour, Sarvenaz; Hristova, Kalina			Multiple Consequences of a Single Amino Acid Pathogenic RTK Mutation: The A391E Mutation in FGFR3	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; MUENKE CRANIOSYNOSTOSIS; THANATOPHORIC DYSPLASIA; TRANSMEMBRANE MUTATION; ACANTHOSIS NIGRICANS; STRUCTURAL BASIS; CROUZON-SYNDROME; HEPARAN-SULFATE; POINT MUTATION	The A391E mutation in fibroblast growth factor receptor 3 (FGFR3) is the genetic cause for Crouzon syndrome with Acanthosis Nigricans. Here we investigate the effect of this mutation on FGFR3 activation in HEK 293 T cells over a wide range of fibroblast growth factor 1 concentrations using a physical-chemical approach that deconvolutes the effects of the mutation on dimerization, ligand binding, and efficiency of phosphorylation. It is believed that the mutation increases FGFR3 dimerization, and our results verify this. However, our results also demonstrate that the increase in dimerization is not the sole effect of the mutation, as the mutation also facilitates the phosphorylation of critical tyrosines in the activation loop of FGFR3. The activation of mutant FGFR3 is substantially increased due to a combination of these two effects. The low expression of the mutant, however, attenuates its signaling and may explain the mild phenotype in Crouzon syndrome with Acanthosis Nigricans. The results presented here provide new knowledge about the physical basis behind growth disorders and highlight the fact that a single RTK mutation may affect multiple steps in RTK activation.	[Chen, Fenghao; Sarabipour, Sarvenaz; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	kh@jhu.edu	Hristova, Kalina/A-3326-2010; Sarabipour, Sarvenaz/H-2992-2015	Sarabipour, Sarvenaz/0000-0001-5097-5509	United States National Institutes of Health (NIH) [GM068619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by United States National Institutes of Health (NIH) GM068619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Chen FH, 2011, BIOCHEMISTRY-US, V50, P8576, DOI 10.1021/bi200986f; Chen FH, 2011, BBA-BIOMEMBRANES, V1808, P2045, DOI 10.1016/j.bbamem.2011.04.007; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FANGER BO, 1989, FASEB J, V3, P71, DOI 10.1096/fasebj.3.1.2783412; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; He LJ, 2011, J BIOL CHEM, V286, P13272, DOI 10.1074/jbc.M110.205583; He LJ, 2011, BBA-BIOMEMBRANES, V1808, P253, DOI 10.1016/j.bbamem.2010.08.007; He LJ, 2010, J BIOL CHEM, V285, P30103, DOI 10.1074/jbc.M109.094086; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Khnykin D, 2006, GROWTH FACTORS, V24, P111, DOI 10.1080/08977190600621388; L'Horte CGM, 2005, EXP CELL RES, V304, P417; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; PERDUE JF, 1970, BIOCHIM BIOPHYS ACTA, V196, P125, DOI 10.1016/0005-2736(70)90001-5; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	45	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56521	10.1371/journal.pone.0056521	http://dx.doi.org/10.1371/journal.pone.0056521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437153	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200091
J	Dong, XB; Zhang, YJ; Zhang, ZD				Dong, Xiaobao; Zhang, Yong-Jun; Zhang, Ziding			Using Weakly Conserved Motifs Hidden in Secretion Signals to Identify Type-III Effectors from Bacterial Pathogen Genomes	PLOS ONE			English	Article							COMPUTATIONAL PREDICTION; VIRULENCE EFFECTORS; PROTEIN; SEQUENCE; IDENTIFICATION; COLLOCATION; DOMAINS; SITES; YOPE	Background: As one of the most important virulence factor types in gram-negative pathogenic bacteria, type-III effectors (TTEs) play a crucial role in pathogen-host interactions by directly influencing immune signaling pathways within host cells. Based on the hypothesis that type-III secretion signals may be comprised of some weakly conserved sequence motifs, here we used profile-based amino acid pair information to develop an accurate TTE predictor. Results: For a TTE or non-TTE, we first used a hidden Markov model-based sequence searching method (i.e., HHblits) to detect its weakly homologous sequences and extracted the profile-based k-spaced amino acid pair composition (HH-CKSAAP) from the N-terminal sequences. In the next step, the feature vector HH-CKSAAP was used to train a linear support vector machine model, which we designate as BEAN (Bacterial Effector ANalyzer). We compared our method with four existing TTE predictors through an independent test set, and our method revealed improved performance. Furthermore, we listed the most predictive amino acid pairs according to their weights in the established classification model. Evolutionary analysis shows that predictive amino acid pairs tend to be more conserved. Some predictive amino acid pairs also show significantly different position distributions between TTEs and non-TTEs. These analyses confirmed that some weakly conserved sequence motifs may play important roles in type-III secretion signals. Finally, we also used BEAN to scan one plant pathogen genome and showed that BEAN can be used for genome-wide TTE identification. The webserver and stand-alone version of BEAN are available at http://protein.cau.edu.cn:8080/bean/.	[Dong, Xiaobao; Zhang, Ziding] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhang, Yong-Jun] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, ZD (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	zidingzhang@cau.edu.cn	, zidingzhang/E-9320-2011	, zidingzhang/0000-0002-9296-571X; Dong, Xiaobao/0000-0003-1652-117X	National Natural Science Foundation of China [31271414, 31070259]; National Key Basic Research Program of China [2009CB918802, 2012CB114104]; Chinese Universities Scientific Fund [2012QJ146]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Chinese Universities Scientific Fund	This work was supported by grants from the National Natural Science Foundation of China (31271414 and 31070259), the National Key Basic Research Program of China (2009CB918802 and 2012CB114104), and the Chinese Universities Scientific Fund (2012QJ146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Buchko GW, 2010, MOL BIOSYST, V6, P2448, DOI 10.1039/c0mb00097c; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Costa SCP, 2012, MBIO, V3, DOI 10.1128/mBio.00243-11; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; McDermott JE, 2011, INFECT IMMUN, V79, P23, DOI 10.1128/IAI.00537-10; Muschiol S, 2011, INFECT IMMUN, V79, P571, DOI 10.1128/IAI.00825-10; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Sato Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-442; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036038; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Tay DMM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S4; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47	42	37	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56632	10.1371/journal.pone.0056632	http://dx.doi.org/10.1371/journal.pone.0056632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437191	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200123
J	Jorgenson, AK; Clark, B				Jorgenson, Andrew K.; Clark, Brett			The Relationship between National-Level Carbon Dioxide Emissions and Population Size: An Assessment of Regional and Temporal Variation, 1960-2005	PLOS ONE			English	Article							ECOLOGICALLY UNEQUAL EXCHANGE; LESS-DEVELOPED-COUNTRIES; KUZNETS CURVE; PANEL	This study examines the regional and temporal differences in the statistical relationship between national-level carbon dioxide emissions and national-level population size. The authors analyze panel data from 1960 to 2005 for a diverse sample of nations, and employ descriptive statistics and rigorous panel regression modeling techniques. Initial descriptive analyses indicate that all regions experienced overall increases in carbon emissions and population size during the 45-year period of investigation, but with notable differences. For carbon emissions, the sample of countries in Asia experienced the largest percent increase, followed by countries in Latin America, Africa, and lastly the sample of relatively affluent countries in Europe, North America, and Oceania combined. For population size, the sample of countries in Africa experienced the largest percent increase, followed countries in Latin America, Asia, and the combined sample of countries in Europe, North America, and Oceania. Findings for two-way fixed effects panel regression elasticity models of national-level carbon emissions indicate that the estimated elasticity coefficient for population size is much smaller for nations in Africa than for nations in other regions of the world. Regarding potential temporal changes, from 1960 to 2005 the estimated elasticity coefficient for population size decreased by 25% for the sample of Africa countries, 14% for the sample of Asia countries, 6.5% for the sample of Latin America countries, but remained the same in size for the sample of countries in Europe, North America, and Oceania. Overall, while population size continues to be the primary driver of total national-level anthropogenic carbon dioxide emissions, the findings for this study highlight the need for future research and policies to recognize that the actual impacts of population size on national-level carbon emissions differ across both time and region.	[Jorgenson, Andrew K.; Clark, Brett] Univ Utah, Dept Sociol, Salt Lake City, UT 84112 USA; [Clark, Brett] Univ Utah, Environm & Sustainabil Studies Program, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jorgenson, AK (corresponding author), Univ Utah, Dept Sociol, Salt Lake City, UT 84112 USA.	andrew.jorgenson@soc.utah.edu		Jorgenson, Andrew/0000-0002-5902-3704				Allison PD, 2009, FIXED EFFECT REGRESS; Baum C.F., 2006, INTRO MODERN ECONOME; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Brady D, 2007, STUD COMP INT DEV, V42, P1, DOI 10.1007/s12116-007-9003-7; Cohen J. E., 1995, MANY PEOPLE CAN EART; Dietz T., 2003, INT J SOCIOLOGY SOCI, V23, P31, DOI DOI 10.1108/01443330310790291; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Firebaugh G., 2018, 7 RULES SOCIAL RES, DOI [10.1515/9780691190433, DOI 10.1515/9780691190433]; Fox Jr J., 2015, APPL REGRESSION ANAL; Hsiao Cheng., 2003, ANAL PANEL DATA, VSecond; IPCC [Intergovernmental Panel on Climate Change], 2007, CONTR WORK GROUP 3 4; Jorgenson A, 2012, URBAN STUD, V49, P3495, DOI 10.1177/0042098012440124; Jorgenson A, 2010, ECOL ECON, V69, P2634, DOI 10.1016/j.ecolecon.2010.08.008; Jorgenson AK, 2012, SOC NATUR RESOUR, V25, P1182, DOI 10.1080/08941920.2012.656186; Jorgenson AK, 2012, AM J SOCIOL, V118, P1, DOI 10.1086/665990; Jorgenson AK, 2012, SOC SCI RES, V41, P242, DOI 10.1016/j.ssresearch.2011.11.011; Jorgenson AK, 2011, HUM ECOL REV, V18, P105; Jorgenson AK, 2011, SOC SCI RES, V40, P226, DOI 10.1016/j.ssresearch.2010.09.004; Jorgenson AK, 2010, POPUL ENVIRON, V32, P27, DOI 10.1007/s11111-010-0117-x; McKibbin W, 1993, COSTS IMPACTS BENEFI, P247; McKibbin WJ, 1999, ECON MODEL, V16, P123, DOI 10.1016/S0264-9993(98)00035-2; Onozaki K, 2009, J HEALTH SCI, V55, P125, DOI 10.1248/jhs.55.125; Rosa EA, 2004, AMBIO, V33, P509, DOI 10.1639/0044-7447(2004)033[0509:TTADOE]2.0.CO;2; Rosa EA., 2010, HUMAN FOOTPRINTS GLO; Rosa EA, 2012, NAT CLIM CHANGE, V2, P581, DOI 10.1038/NCLIMATE1506; Rudel T., 2005, TROPICAL FORESTS REG; Sanglimsuwan K., 2012, INT RES J FINANCE EC, V82, P89; Schofer E, 2005, AM SOCIOL REV, V70, P898, DOI 10.1177/000312240507000602; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; The Royal Society Science Policy Centre, 2012, PEOPL PLAN; United Nations Development Program, 2011, HUM DEV REP SUST EQ; US National Research Council, 2010, ADV SCI CLIM CHANG; Wagner M, 2008, RESOUR ENERGY ECON, V30, P388, DOI 10.1016/j.reseneeco.2007.11.001; Wooldridge J.M., 2006, INTRO ECONOMETRICS M; World Bank, WORLD DEV IND; York R, 2007, SOC SCI RES, V36, P855, DOI 10.1016/j.ssresearch.2006.06.007; York R, 2012, NAT CLIM CHANGE, V2, P762, DOI 10.1038/nclimate1699; Zhou M, 2010, SOC FORCES, V88, P1619	38	39	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57107	10.1371/journal.pone.0057107	http://dx.doi.org/10.1371/journal.pone.0057107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437323	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200216
J	Lee, D; Oka, T; Hunter, B; Robinson, A; Papp, S; Nakamura, K; Srisakuldee, W; Nickel, BE; Light, PE; Dyck, JRB; Lopaschuk, GD; Kardami, E; Opas, M; Michalak, M				Lee, Dukgyu; Oka, Tatsujiro; Hunter, Beth; Robinson, Alison; Papp, Sylvia; Nakamura, Kimitoshi; Srisakuldee, Wattamon; Nickel, Barbara E.; Light, Peter E.; Dyck, Jason R. B.; Lopaschuk, Gary D.; Kardami, Elissavet; Opas, Michal; Michalak, Marek			Calreticulin Induces Dilated Cardiomyopathy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; TRANSGENIC MICE; GENE-EXPRESSION; CALCIUM-RELEASE; HUMAN HEART; CALSEQUESTRIN; MODULATION; HYPERTROPHY	Background: Calreticulin, a Ca2+-buffering chaperone of the endoplasmic reticulum, is highly expressed in the heart and is essential for cardiac development. After birth, the calreticulin gene is sharply down regulated in the heart, thus, adult hearts have negligible levels of calreticulin. In this study we tested the role of calreticulin in the adult heart. Methodology/Principal Findings: We generated an inducible transgenic mouse in which calreticulin is targeted to cardiac tissue using a Cre/loxP system and can be up-regulated in adult hearts. Echocardiography analysis of hearts transgenic mice expressing calreticulin revealed impaired left ventricular systolic and diastolic function and impaired valve function. There was altered expression of Ca2+ signaling molecules and the gap junction proteins, Connexin 43 and Sarcoplasmic reticulum associated Ca2+-handling proteins (including the cardiac ryanodine receptor, sarco/reticulum Ca2+-ATPase, and cardiac calsequestrin) were down-regulated in the transgenic hearts with increased of calreticulin. Conclusions/Significance: We show that in adult heart, up-regulated expression of calreticulin induces cardiomyopathy vivo leading to heart failure. This is due to an alternation in changes in a subset of Ca2+ handling genes, gap components and left ventricle remodeling.	[Lee, Dukgyu; Robinson, Alison; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Oka, Tatsujiro; Dyck, Jason R. B.; Lopaschuk, Gary D.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Hunter, Beth; Light, Peter E.; Lopaschuk, Gary D.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Papp, Sylvia; Opas, Michal] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Nakamura, Kimitoshi] Kumamoto Univ, Sch Med, Dept Pediat, Kumamoto 860, Japan; [Srisakuldee, Wattamon; Nickel, Barbara E.; Kardami, Elissavet] Univ Manitoba, St Boniface Res Ctr, Dept Human Anat & Cell Sci & Physiol, Winnipeg, MB, Canada; [Srisakuldee, Wattamon; Nickel, Barbara E.; Kardami, Elissavet] Univ Manitoba, St Boniface Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Toronto; Kumamoto University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	marek.michalak@ualberta.ca		, Kimitoshi/0000-0003-4903-2428; Dyck, Jason/0000-0002-7045-2884; Kardami, Elissavet/0000-0002-3198-8432	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2005, CIRCULATION, V112, P3140, DOI 10.1161/CIRCULATIONAHA.105.550806; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bao M, 2011, CHANNELS, V5, P489, DOI 10.4161/chan.5.6.18523; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Dupont E, 2001, CIRCULATION, V103, P842, DOI 10.1161/01.CIR.103.6.842; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo A, 2012, J BIOL CHEM, V287, P16670, DOI 10.1074/jbc.M112.340927; Guo L, 2001, J BIOL CHEM, V276, P2797, DOI 10.1074/jbc.C000822200; Gutstein WH, 2004, TRENDS CARDIOVAS MED, V14, P257, DOI 10.1016/S1050-1738(04)00112-4; Gyorke S, 2004, BIOL RES, V37, P603, DOI 10.4067/s0716-97602004000400014; Hasenfuss G, 1997, BASIC RES CARDIOL, V92, P87, DOI 10.1007/BF00794072; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Li J, 2002, J CELL BIOL, V158; Lynch J, 2005, J CELL BIOL, V170, P37, DOI 10.1083/jcb.200412156; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Mery A, 2005, MOL BIOL CELL, V16, P2414, DOI 10.1091/mbc.E04-10-0883; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Miquerol L, 2003, Novartis Found Symp, V250, P80; Miquerol L., 2003, NOVART FDN SYMP, V250, P98; Miquerol L., 2003, NOVART FDN SYMP, V250, P276; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nakamura K, 2001, J CLIN INVEST, V107, P1245, DOI 10.1172/JCI12412; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; PATTON WF, 1995, J BIOL CHEM, V270, P21404, DOI 10.1074/jbc.270.36.21404; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Srisakuldee W, 2009, CARDIOVASC RES, V83, P672, DOI 10.1093/cvr/cvp142; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Terentyev D, 2008, BIOPHYS J, V95, P2037, DOI 10.1529/biophysj.107.128249; Terentyev D, 2007, J PHYSIOL-LONDON, V583, P71, DOI 10.1113/jphysiol.2007.136879; Tsutsui H, 1997, AM J PHYSIOL-HEART C, V272, pH168, DOI 10.1152/ajpheart.1997.272.1.H168; van Veen TAB, 2006, ADV CARDIOL, V42, P18, DOI 10.1159/000092560; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200	50	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56387	10.1371/journal.pone.0056387	http://dx.doi.org/10.1371/journal.pone.0056387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437120	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200064
J	O'Quin, KE; Yoshizawa, M; Doshi, P; Jeffery, WR				O'Quin, Kelly E.; Yoshizawa, Masato; Doshi, Pooja; Jeffery, William R.			Quantitative Genetic Analysis of Retinal Degeneration in the Blind Cavefish Astyanax mexicanus	PLOS ONE			English	Article							HOMEOBOX GENE; REGRESSIVE EVOLUTION; EYE DEGENERATION; AMACRINE CELLS; USHER-SYNDROME; OPSIN GENE; EXPRESSION; LENS; GANGLION; FISH	The retina is the light-sensitive tissue of the eye that facilitates vision. Mutations within genes affecting eye development and retinal function cause a host of degenerative visual diseases, including retinitis pigmentosa and anophthalmia/microphthalmia. The characin fish Astyanax mexicanus includes both eyed (surface fish) and eyeless (cavefish) morphs that initially develop eyes with normal retina; however, early in development, the eyes of cavefish degenerate. Since both surface and cave morphs are members of the same species, they serve as excellent evolutionary mutant models with which to identify genes causing retinal degeneration. In this study, we crossed the eyed and eyeless forms of A. mexicanus and quantified the thickness of individual retinal layers among 115 F-2 hybrid progeny. We used next generation sequencing (RAD-seq) and microsatellite mapping to construct a dense genetic map of the Astyanax genome, scan for quantitative trait loci (QTL) affecting retinal thickness, and identify candidate genes within these QTL regions. The map we constructed for Astyanax includes nearly 700 markers assembled into 25 linkage groups. Based on our scans with this map, we identified four QTL, one each associated with the thickness of the ganglion, inner nuclear, outer plexiform, and outer nuclear layers of the retina. For all but one QTL, cavefish alleles resulted in a clear reduction in the thickness of the affected layer. Comparative mapping of genetic markers within each QTL revealed that each QTL corresponds to an approximately 35 Mb region of the zebrafish genome. Within each region, we identified several candidate genes associated with the function of each affected retinal layer. Our study is the first to examine Astyanax retinal degeneration in the context of QTL mapping. The regions we identify serve as a starting point for future studies on the genetics of retinal degeneration and eye disease using the evolutionary mutant model Astyanax.	[O'Quin, Kelly E.; Yoshizawa, Masato; Doshi, Pooja; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	O'Quin, KE (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	koquin@umd.edu	Yoshizawa, Masato/AAE-9415-2022; Yoshizawa, Masato/D-6276-2013; Yoshizawa, Masato/AFD-8467-2022	Yoshizawa, Masato/0000-0001-8455-8252; Yoshizawa, Masato/0000-0001-9488-2283; Yoshizawa, Masato/0000-0001-8455-8252	Japan Society for the Promotion of Science; NSF [IBN-05384]; NIH [R01-EY014619]; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science to MY, and NSF (IBN-05384) and NIH (R01-EY014619) grants to WRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alunni A, 2007, J COMP NEUROL, V505, P221, DOI 10.1002/cne.21488; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; Bem D, 2011, AM J HUM GENET, V88, P499, DOI 10.1016/j.ajhg.2011.03.012; Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Borowsky R, 2008, CURR BIOL, V18, pR23, DOI 10.1016/j.cub.2007.11.023; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2010, GENETIC MAP CONSTRUC; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Collery RF, 2010, ADV EXP MED BIOL, V664, P55, DOI 10.1007/978-1-4419-1399-9_7; de Melo J, 2005, DEVELOPMENT, V132, P311, DOI 10.1242/dev.01560; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Dowling JE, 2011, RETINA APPROACHABLE; Elicker KS, 2007, GENE, V403, P60, DOI 10.1016/j.gene.2007.08.003; Epting D, 2007, GENE EXPR PATTERNS, V7, P389, DOI 10.1016/j.modgep.2006.11.010; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Gallardo ME, 2004, AM J MED GENET A, V129A, P92, DOI 10.1002/ajmg.a.30126; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gordon A., 2011, FASTX TOOLKIT; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Grossman GH, 2009, INVEST OPHTH VIS SCI, V50, P3074, DOI 10.1167/iovs.08-3190; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P2706; Jeffery G, 1997, TRENDS NEUROSCI, V20, P165, DOI 10.1016/S0166-2236(96)10080-1; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; KIRBY RF, 1977, COPEIA, P578; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; LANGECKER TG, 1993, CELL TISSUE RES, V273, P183, DOI 10.1007/BF00304625; Lin-Jones J, 2007, INVEST OPHTH VIS SCI, V48, P1380, DOI 10.1167/iovs.06-0763; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Manichaikul A, 2009, GENETICS, V181, P1077, DOI 10.1534/genetics.108.094565; MITCHELL RW, 1977, SPECIAL PUBLICATIONS, V12; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; O'Quin KE, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-251; Oetting WS, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9318; Porter FD, 1997, DEVELOPMENT, V124, P2935; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Scheer N, 2001, DEVELOPMENT, V128, P1099; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; Shen YC, 2004, DEV BIOL, V269, P237, DOI 10.1016/j.ydbio.2004.01.037; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Slavotinek AM, 2011, MOL GENET METAB, V104, P448, DOI 10.1016/j.ymgme.2011.09.029; Strickler AG, 2001, DEV GENES EVOL, V211, P138, DOI 10.1007/s004270000123; Strickler AG, 2007, DEV BIOL, V311, P512, DOI 10.1016/j.ydbio.2007.08.050; Strickler AG, 2009, INTEGR ZOOL, V4, P99, DOI 10.1111/j.1749-4877.2008.00139.x; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; WILKENS H, 1971, EVOLUTION, V25, P530, DOI 10.1111/j.1558-5646.1971.tb01913.x; WILKENS H, 1988, EVOL BIOL, V23, P271; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631; YOKOYAMA S, 1995, MOL BIOL EVOL, V12, P527; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108	63	64	65	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57281	10.1371/journal.pone.0057281	http://dx.doi.org/10.1371/journal.pone.0057281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437360	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200236
J	Shah, NK; Tyagi, P; Sharma, SK				Shah, Naman K.; Tyagi, Prajesh; Sharma, Surya K.			The Impact of Artemisinin Combination Therapy and Long-Lasting Insecticidal Nets on Forest Malaria Incidence in Tribal Villages of India, 2006-2011	PLOS ONE			English	Article							VECTORS ANOPHELES-CULICIFACIES; PLASMODIUM-FALCIPARUM; FIELD-EVALUATION; ORISSA; EPIDEMIOLOGY; TRANSMISSION; FLUVIATILIS; RESISTANCE; AREA; IMMUNITY	Introduction: New tools for malaria control, artemisinin combination therapy (ACT) and long-lasting insecticidal nets (LLINs) were recently introduced across India. We estimated the impact of universal coverage of ACT and ACT plus LLINs in a setting of hyperendemic, forest malaria transmission. Methods: We reviewed data collected through active and passive case detection in a vaccine trial cohort of 2,204 tribal people residing in Sundargarh district, Odisha between 2006 and 2011. We compared measures of transmission at the village and individual level in 2006-2009 versus 2010-2011 after ACT (in all villages) and LLINs (in three villages) were implemented. Results: During 2006-2009 malaria incidence per village ranged from 156-512 per 1000 persons per year and slide prevalence ranged from 28-53%. Routine indoor residual spray did not prevent seasonal peaks of malaria. Post-intervention impact in 2010-2011 was dramatic with ranges of 14-71 per 1000 persons per year and 6-16% respectively. When adjusted for village, ACT alone decreased the incidence of malaria by 83% (IRR 0.17, 95%CI: 0.10, 0.27) and areas using ACT and LLINs decreased the incidence of malaria by 86% (IRR 0.14, 95% CI: 0.05, 0.38). After intervention, the age of malaria cases, their parasite density, and proportion with fever at the time of screening increased. Conclusions: ACT, and LLINs along with ACT, effectively reduced malaria incidence in a closely monitored population living in a forest ecotype. It is unclear whether LLINs were impactful when prompt and quality antimalarial treatment was available. In spite of universal coverage, substantial malaria burden remained.	[Shah, Naman K.; Tyagi, Prajesh; Sharma, Surya K.] Natl Inst Malaria Res, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Sharma, SK (corresponding author), Natl Inst Malaria Res, New Delhi, India.	suryaksharma@gmail.com						Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Greenwood BM, 1997, ANN TROP MED PARASIT, V91, P763, DOI 10.1080/00034989760518; JASWANT SINGH, 1953, Indian Journal of Malariology, V7, P267; Kondrashin A. V., 1992, Indian Journal of Malariology, V29, P129; Nanda N, 2000, J AM MOSQUITO CONTR, V16, P199; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Revised National Drug Policy, 2010, J INDIAN MED ASSOC, V108, P844; Shah NK, 2011, LANCET INFECT DIS, V11, P57, DOI 10.1016/S1473-3099(10)70214-0; Sharma SK, 2009, J MED ENTOMOL, V46, P342, DOI 10.1603/033.046.0220; Sharma SK, 2004, AM J TROP MED HYG, V71, P457, DOI 10.4269/ajtmh.2004.71.457; Sharma SK, 2004, ANN TROP MED PARASIT, V98, P459, DOI 10.1179/000349804225003569; Sharma SK, 2006, T ROY SOC TROP MED H, V100, P917, DOI 10.1016/j.trstmh.2006.01.007; Sharma SK, 2012, INDIAN J MED RES, V135, P382; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Sharma VP, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P349; Singh N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-93; Sonal G S, 2010, J Indian Med Assoc, V108, P840; Valecha N, 2009, ACTA TROP, V111, P21, DOI 10.1016/j.actatropica.2009.01.013; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	23	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56740	10.1371/journal.pone.0056740	http://dx.doi.org/10.1371/journal.pone.0056740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437229	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200155
J	Tesli, M; Skatun, KC; Ousdal, OT; Brown, AA; Thoresen, C; Agartz, I; Melle, I; Djurovic, S; Jensen, J; Andreassen, OA				Tesli, Martin; Skatun, Kristina C.; Ousdal, Olga Therese; Brown, Andrew Anand; Thoresen, Christian; Agartz, Ingrid; Melle, Ingrid; Djurovic, Srdjan; Jensen, Jimmy; Andreassen, Ole A.			CACNA1C Risk Variant and Amygdala Activity in Bipolar Disorder, Schizophrenia and Healthy Controls	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; RELEVANCE DETECTION; GENE POLYMORPHISM; FMRI; SYSTEM; SCALE; TASK; SET	Objectives: Several genetic studies have implicated the CACNA1C SNP rs1006737 in bipolar disorder (BD) and schizophrenia (SZ) pathology. This polymorphism was recently found associated with increased amygdala activity in healthy controls and patients with BD. We performed a functional Magnetic Resonance Imaging (fMRI) study in a sample of BD and SZ cases and healthy controls to test for altered amygdala activity in carriers of the rs1006737 risk allele (AA/AG), and to investigate if there were differences across the diagnostic groups. Methods: Rs1006737 was genotyped in 250 individuals (N = 66 BD, 61 SZ and 123 healthy controls), all of Northern European origin, who underwent an fMRI negative faces matching task. Statistical tests were performed with a model correcting for sex, age, diagnostic category and medication status in the total sample, and then in each diagnostic group. Results: In the total sample, carriers of the risk allele had increased activation in the left amygdala. Group-wise analyses showed that this effect was significant in the BD group, but not in the other diagnostic groups. However, there was no significant interaction effect for the risk allele between BD and the other groups. Conclusions: These results indicate that CACNA1C SNP rs1006737 affects amygdala activity during emotional processing across all diagnostic groups. The current findings add to the growing body of knowledge of the pleiotropic effect of this polymorphism, and further support that ion channel dysregulation is involved in the underlying mechanisms of BD and SZ.	[Tesli, Martin; Ousdal, Olga Therese; Agartz, Ingrid; Melle, Ingrid; Djurovic, Srdjan; Jensen, Jimmy; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Tesli, Martin; Skatun, Kristina C.; Ousdal, Olga Therese; Brown, Andrew Anand; Thoresen, Christian; Melle, Ingrid; Djurovic, Srdjan; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Melle, Ingrid] Karolinska Hosp & Inst, Dept Clin Neurosci, Psychiat Sect, HUBIN Project, Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Jensen, Jimmy] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Brown, Andrew Anand] Wellcome Trust Sanger Inst, Hinxton, England	University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska University Hospital; Diakonhjemmet Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Wellcome Trust Sanger Institute	Tesli, M (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	m.s.tesli@medisin.uio.no	Jensen, Jimmy/H-7517-2014; Melle, Ingrid S/B-4858-2011; Andreassen, Ole A./AAY-7531-2020	Jensen, Jimmy/0000-0001-6841-1808; Melle, Ingrid S/0000-0002-9783-548X; Andreassen, Ole A./0000-0002-4461-3568; Djurovic, Srdjan/0000-0002-8140-8061; Agartz, Ingrid/0000-0002-9839-5391; Brown, Andrew/0000-0002-8087-3033	University of Oslo; Research Council of Norway [167153/V50, 163070/V50]; SouthEast Norway Health Authority [2004123, 2008-080]	University of Oslo; Research Council of Norway(Research Council of Norway); SouthEast Norway Health Authority	The study was supported by grants to the TOP study group from the University of Oslo (http://www.uio.no/english/), the Research Council of Norway (http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1177315753906&p=1177315753906&pagename=ForskningsradetEngels%2FHovedsidemal) (#167153/V50, #163070/V50) and the SouthEast Norway Health Authority (http://www.helse-sorost.no/omoss/english/Sider/page.aspx) (#2004123, #2008-080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Blond BN, 2012, BIPOLAR DISORD, V14, P340, DOI 10.1111/j.1399-5618.2012.01015.x; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Hallahan B, 2011, BIOL PSYCHIAT, V69, P326, DOI 10.1016/j.biopsych.2010.08.029; Hamshere ML, 2011, BRIT J PSYCHIAT, V198, P284, DOI 10.1192/bjp.bp.110.087866; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Jogia J, 2011, MOL PSYCHIATR, V16, P1070, DOI 10.1038/mp.2011.49; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Ousdal OT, 2008, NEUROSCIENCE, V156, P450, DOI 10.1016/j.neuroscience.2008.07.066; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Simonsen C, 2011, SCHIZOPHRENIA BULL, V37, P73, DOI 10.1093/schbul/sbp034; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Welander-Vatn AS, 2009, BIPOLAR DISORD, V11, P270, DOI 10.1111/j.1399-5618.2009.00680.x; Wessa M, 2010, MOL PSYCHIATR, V15, P1126, DOI 10.1038/mp.2009.103; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zhang QM, 2012, NEUROPSYCHOPHARMACOL, V37, P677, DOI 10.1038/npp.2011.242; Zuccotti A, 2011, TRENDS PHARMACOL SCI, V32, P366, DOI 10.1016/j.tips.2011.02.012	34	56	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56970	10.1371/journal.pone.0056970	http://dx.doi.org/10.1371/journal.pone.0056970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437284	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200193
J	Vilstrup, JT; Seguin-Orlando, A; Stiller, M; Ginolhac, A; Raghavan, M; Nielsen, SCA; Weinstock, J; Froese, D; Vasiliev, SK; Ovodov, ND; Clary, J; Helgen, KM; Fleischer, RC; Cooper, A; Shapiro, B; Orlando, L				Vilstrup, Julia T.; Seguin-Orlando, Andaine; Stiller, Mathias; Ginolhac, Aurelien; Raghavan, Maanasa; Nielsen, Sandra C. A.; Weinstock, Jacobo; Froese, Duane; Vasiliev, Sergei K.; Ovodov, Nikolai D.; Clary, Joel; Helgen, Kristofer M.; Fleischer, Robert C.; Cooper, Alan; Shapiro, Beth; Orlando, Ludovic			Mitochondrial Phylogenomics of Modern and Ancient Equids	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; EVOLUTIONARY HISTORY; FOSSIL HORSES; GENUS EQUUS; PERISSODACTYLA; SEQUENCE; MAMMALIA; ACCURATE; GENOME; QUAGGA	The genus Equus is richly represented in the fossil record, yet our understanding of taxonomic relationships within this genus remains limited. To estimate the phylogenetic relationships among modern horses, zebras, asses and donkeys, we generated the first data set including complete mitochondrial sequences from all seven extant lineages within the genus Equus. Bayesian and Maximum Likelihood phylogenetic inference confirms that zebras are monophyletic within the genus, and the Plains and Grevy's zebras form a well-supported monophyletic group. Using ancient DNA techniques, we further characterize the complete mitochondrial genomes of three extinct equid lineages (the New World stilt-legged horses, NWSLH; the subgenus Sussemionus; and the Quagga, Equus quagga quagga). Comparisons with extant taxa confirm the NWSLH as being part of the caballines, and the Quagga and Plains zebras as being conspecific. However, the evolutionary relationships among the non-caballine lineages, including the now-extinct subgenus Sussemionus, remain unresolved, most likely due to extremely rapid radiation within this group. The closest living outgroups (rhinos and tapirs) were found to be too phylogenetically distant to calibrate reliable molecular clocks. Additional mitochondrial genome sequence data, including radiocarbon dated ancient equids, will be required before revisiting the exact timing of the lineage radiation leading up to modern equids, which for now were found to have possibly shared a common ancestor as far as up to 4 Million years ago (Mya).	[Vilstrup, Julia T.; Seguin-Orlando, Andaine; Ginolhac, Aurelien; Raghavan, Maanasa; Nielsen, Sandra C. A.; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Stiller, Mathias; Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Weinstock, Jacobo] Univ Southampton, Fac Humanities, Southampton, Hants, England; [Froese, Duane] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2M7, Canada; [Vasiliev, Sergei K.] Russian Acad Sci, Inst Archaeol & Ethnog, Novosibirsk, Russia; [Ovodov, Nikolai D.] Russian Acad Sci, Inst Archaeol & Ethnog, Lab Archaeol & Paleogeog Cent Siberia, Novosibirsk, Russia; [Clary, Joel] Musee Confluences, Ctr Conservat & Etud Collect, Lyon, France; [Helgen, Kristofer M.] Smithsonian Inst, Div Mammals, Natl Museum Nat Hist, Washington, DC 20560 USA; [Fleischer, Robert C.] Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Washington, DC 20008 USA; [Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia	University of Copenhagen; University of California System; University of California Santa Cruz; University of Southampton; University of Alberta; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Adelaide	Orlando, L (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	lorlando@snm.ku.dk	Vilstrup Mouatt, Julia T./N-4553-2017; Cooper, Alan/E-8171-2012; Helgen, Kristofer M./AAB-8348-2019; Orlando, Ludovic/A-8932-2013	Vilstrup Mouatt, Julia T./0000-0001-6534-8452; Cooper, Alan/0000-0002-7738-7851; Helgen, Kristofer M./0000-0002-8776-4040; Orlando, Ludovic/0000-0003-3936-1850; Shapiro, Beth/0000-0002-2733-7776; Raghavan, Maanasa/0000-0003-1997-0739	Danish National Research foundation; Marie Curie Intra European Fellowship [FP7-IEF-299176]; Marie-Curie Career Integration Grant [FP7-CIG-293845]; Australian Research Council; US National Science Foundation ARC [0909456]; Searle Scholars Program; David and Lucille Packard Foundation	Danish National Research foundation(Danmarks Grundforskningsfond); Marie Curie Intra European Fellowship(European Commission); Marie-Curie Career Integration Grant; Australian Research Council(Australian Research Council); US National Science Foundation ARC; Searle Scholars Program; David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	Julia Vilstrup is supported by a PhD grant from The Danish National Research foundation; Aurelien Ginolhac is supported by a Marie Curie Intra European Fellowship (FP7-IEF-299176); this research was also funded by one Marie-Curie Career Integration Grant (FP7-CIG-293845); Alan Cooper is supported by the Australian Research Council; Mathias Stiller and Beth Shapiro are supported by the US National Science Foundation ARC 0909456, the Searle Scholars Program, and by the David and Lucille Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bell CJ, 2004, LATE CRETACEOUS CENO; BENNETT DK, 1980, SYST ZOOL, V29, P272, DOI 10.2307/2412662; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EISENMANN V, 1979, CR ACAD SCI D NAT, V288, P497; Eisenmann V., 1980, CHEVAUX EQUUS SENSU; Eisenmann V, 1979, THESIS U P M CURIE P, VVI, P1; Eisenmann V, 2011, GEODIVERSITAS, V33, P519, DOI 10.5252/g2011n3a5; Eisenmann V, 2010, CR BIOL, V333, P235, DOI 10.1016/j.crvi.2009.12.013; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Geigl EM, 2012, ANN ANAT, V194, P88, DOI 10.1016/j.aanat.2011.06.002; GEORGE M, 1986, MOL BIOL EVOL, V3, P535; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Goto H, 2011, GENOME BIOL EVOL, V3, P1096, DOI 10.1093/gbe/evr067; Groves C, 2011, UNGULATE TAXONOMY; GROVES COLIN P., 1967, Z SAUGETIERK, V32, P321; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HOELZER GA, 1994, TRENDS ECOL EVOL, V9, P104, DOI 10.1016/0169-5347(94)90207-0; Jiang QY, 2011, MOL BIOL REP, V38, P593, DOI 10.1007/s11033-010-0145-8; KAMINSKI M, 1979, COMP BIOCHEM PHYS B, V63, P175, DOI 10.1016/0305-0491(79)90025-7; Kampmann ML, 2011, J VIROL METHODS, V178, P243, DOI 10.1016/j.jviromet.2011.09.001; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Kruger K, 2005, J ANIM BREED GENET, V122, P78, DOI 10.1111/j.1439-0388.2005.00505.x; Leonard JA, 2005, BIOL LETTERS, V1, P291, DOI 10.1098/rsbl.2005.0323; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lorenzen ED, 2008, MOL ECOL, V17, P2812, DOI 10.1111/j.1365-294X.2008.03781.x; LOWENSTEIN JM, 1985, EXPERIENTIA, V41, P1192, DOI 10.1007/BF01951724; Luo Y, 2011, MITOCHONDR DNA, V22, P6, DOI 10.3109/19401736.2011.588221; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; MACFADDEN BJ, 1986, PALEOBIOLOGY, V12, P355, DOI 10.1017/S0094837300003109; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; McCue ME, 2012, PLOS GENETICS, V8; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Musilova P, 2009, CHROMOSOME RES, V17, P783, DOI 10.1007/s10577-009-9069-3; Oakenfull E. Ann, 2000, Conservation Genetics, V1, P341, DOI 10.1023/A:1011559200897; Oakenfull EA, 1998, J MOL EVOL, V47, P772, DOI 10.1007/PL00006436; Oakenfull EA, 1998, ANIM GENET, V29, P456, DOI 10.1046/j.1365-2052.1998.296380.x; Orlando L, 2003, J MOL EVOL, V57, pS29, DOI 10.1007/s00239-003-0005-4; Orlando L, 2006, MOL ECOL, V15, P2083, DOI 10.1111/j.1365-294X.2006.02922.x; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price Samantha A., 2009, Zoosystematics and Evolution, V85, P277, DOI 10.1002/zoos.200900005; Prothero DR, 1989, EVOLUTION PERISSODAC; Rambaut A, 2009, TRACER V1 5 MCMC TRA; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Soubrier J, 2012, MOL BIOL EVOLUTION; Steiner CC, 2012, MOL PHYLOGENETICS EV; Steiner CC, 2011, ZOOL J LINN SOC-LOND, V163, P1289, DOI 10.1111/j.1096-3642.2011.00752.x; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Wallner B, 2003, ANIM GENET, V34, P453, DOI 10.1046/j.0268-9146.2003.01044.x; Walsh HE, 1999, EVOLUTION, V53, P932, DOI 10.1111/j.1558-5646.1999.tb05386.x; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	76	93	96	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55950	10.1371/journal.pone.0055950	http://dx.doi.org/10.1371/journal.pone.0055950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437078	Green Accepted, gold, Green Published			2022-12-27	WOS:000315184200033
J	Xi, XY; Zhang, XY; Wang, B; Wang, T; Wang, J; Huang, H; Wang, JW; Jin, Q; Zhao, ZD				Xi, Xueyan; Zhang, Xiaoyan; Wang, Bei; Wang, Tao; Wang, Ji; Huang, He; Wang, Jianwei; Jin, Qi; Zhao, Zhendong			The Interplays between Autophagy and Apoptosis Induced by Enterovirus 71	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MOUTH-DISEASE; INHIBITION; ACTIVATION; MACROAUTOPHAGY; RESISTANCE; INFECTION; 3-KINASE; HEALTH; HAND	Background: Enterovirus 71 (EV71) is the causative agent of human diseases with distinct severity, from mild hand, foot and mouth disease to severe neurological syndromes, such as encephalitis and meningitis. The lack of understanding of viral pathogenesis as well as lack of efficient vaccine and drugs against this virus impedes the control of EV71 infection. EV71 virus induces autophagy and apoptosis; however, the relationship between EV71-induced autophagy and apoptosis as well as the influence of autophagy and apoptosis on virus virulence remains unclear. Methodology/Principal Findings: In this study, it was observed that the Anhui strain of EV71 induced autophagy and apoptosis in human rhabdomyosarcoma (RD-A) cells. Additionally, by either applying chemical inhibitors or knocking down single essential autophagic or apoptotic genes, inhibition of EV71 induced autophagy inhibited the apoptosis both at the autophagosome formation stage and autophagy execution stage. However, inhibition of autophagy at the stage of autophagosome and lysosome fusion promoted apoptosis. In reverse, the inhibition of EV71-induced apoptosis contributed to the conversion of microtubule-associated protein 1 light chain 3-I (LC3-I) to LC3-II and degradation of sequestosome 1 (SQSTM1/P62). Furthermore, the inhibition of autophagy in the autophagsome formation stage or apoptosis decreased the release of EV71 viral particles. Conclusions/Significance: In conclusion, the results of this study not only revealed novel aspect of the interplay between autophagy and apoptosis in EV71 infection, but also provided a new insight to control EV71 infection.	[Xi, Xueyan; Zhang, Xiaoyan; Wang, Bei; Wang, Tao; Wang, Ji; Huang, He; Wang, Jianwei; Jin, Qi; Zhao, Zhendong] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Xi, Xueyan; Zhang, Xiaoyan; Wang, Bei; Wang, Tao; Wang, Ji; Huang, He; Wang, Jianwei; Jin, Qi; Zhao, Zhendong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Xiaoyan] Shanxi Med Univ, Fengyang Coll, Dept Med Lab Sci, Fengyang, Shanxi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanxi Medical University	Zhao, ZD (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	timjszzd@163.com	Wang, Jianwei/AAW-9499-2020; huang, he/GLT-7903-2022; Wang, Jianwei/W-5916-2019	Wang, Jianwei/0000-0002-1116-4559; 	National Natural Science Foundation of China [NSFC 31270200]; National Basic Research Program of China (973 Project) [2011CB504903]; Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' [2009ZX10004-303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases''	This work was supported by grants from National Natural Science Foundation of China (NSFC 31270200), National Basic Research Program of China (973 Project, 2011CB504903), Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' (2009ZX10004-303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2003, INTERVIROLOGY, V46, P245, DOI 10.1159/000072435; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Chen TC, 2007, CELL MICROBIOL, V9, P2676, DOI 10.1111/j.1462-5822.2007.00988.x; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kirschke H., 1987, CHEM LYSOSOMAL PROTE, P193; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Lamparska-Przybysz M, 2005, J Physiol Pharmacol, V56 Suppl 3, P159; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang CC, 2004, J MED VIROL, V74, P597, DOI 10.1002/jmv.20216; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sirois I, 2012, AUTOPHAGY, V8, P927, DOI 10.4161/auto.19768; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; UENO T, 1991, BIOMED BIOCHIM ACTA, V50, P365; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Ya-Feng W, 2009, ANTIVIR RES, V84, P150, DOI 10.1016/j.antiviral.2009.08.004; Yin XC, 2011, AUTOPHAGY, V7, P1242, DOI 10.4161/auto.7.10.16507; Yin XC, 2011, EMBO REP, V12, P727, DOI 10.1038/embor.2011.79; Yoon YH, 2011, INVEST OPHTH VIS SCI, V51, P11; Zalckvar E, 2010, CELL DEATH DIFFER, V17, P1244, DOI 10.1038/cdd.2010.7; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang N, 2011, AUTOPHAGY, V7, P1, DOI DOI 10.4161/AUT0.7.6.15103; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	43	57	66	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56966	10.1371/journal.pone.0056966	http://dx.doi.org/10.1371/journal.pone.0056966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437282	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200191
J	Zhang, P; Liu, P; Dou, HW; Chen, L; Chen, LX; Lin, L; Tan, P; Vajta, G; Gao, JF; Du, YT; Ma, RLZ				Zhang, Peng; Liu, Peng; Dou, Hongwei; Chen, Lei; Chen, Longxin; Lin, Lin; Tan, Pingping; Vajta, Gabor; Gao, Jianfeng; Du, Yutao; Ma, Runlin Z.			Handmade Cloned Transgenic Sheep Rich in Omega-3 Fatty Acids	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; HIGH-EFFICIENCY; CLONING; DESATURASE; FAT-1; GENE; IDENTIFICATION; EXPRESSION; GENERATION; EMBRYOS	Technology of somatic cell nuclear transfer (SCNT) has been adapted worldwide to generate transgenic animals, although the traditional procedure relies largely on instrumental micromanipulation. In this study, we used the modified handmade cloning (HMC) established in cattle and pig to produce transgenic sheep with elevated levels of omega-3 (n-3) fatty acids. Codon-optimized nematode mfat-1 was inserted into a eukaryotic expression vector and was transferred into the genome of primary ovine fibroblast cells from a male Chinese merino sheep. Reverse transcriptase PCR, gas chromatography, and chromosome analyses were performed to select nuclear donor cells capable of converting omega-6 (n-6) into n-3 fatty acids. Blastocysts developed after 7 days of in vitro culture were surgically transplanted into the uterus of female ovine recipients of a local sheep breed in Xinjiang. For the HMC, approximately 8.9% (n = 925) of reconstructed embryos developed to the blastocyst stage. Four recipients became pregnant after 53 blastocysts were transplanted into 29 naturally cycling females, and a total of 3 live transgenic lambs were produced. Detailed analyses on one of the transgenic lambs revealed a single integration of the modified nematode mfat-1 gene at sheep chromosome 5. The transgenic sheep expressed functional n-3 fatty acid desaturase, accompanied by more than 2-folds reduction of n-6/n-3 ratio in the muscle (p<0.01) and other major organs/tissues (p<0.05). To our knowledge, this is the first report of transgenic sheep produced by the HMC. Compared to the traditional SCNT method, HMC showed an equivalent efficiency but proved cheaper and easier in operation.	[Zhang, Peng; Chen, Lei; Chen, Longxin; Tan, Pingping; Ma, Runlin Z.] Chinese Acad Sci, State Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Liu, Peng; Dou, Hongwei; Lin, Lin; Vajta, Gabor; Du, Yutao] BGI ARK Biotechnol Co Ltd, Shenzhen, Peoples R China; [Vajta, Gabor] Cent Queensland Univ, IRIS, Rockhampton, Qld 4702, Australia; [Gao, Jianfeng] Shihezi Univ, Sch Life Sci, Shihezi, Peoples R China; [Du, Yutao] BGI Shenzhen, Shenzhen, Peoples R China; [Ma, Runlin Z.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Central Queensland University; Shihezi University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Du, YT (corresponding author), BGI ARK Biotechnol Co Ltd, Shenzhen, Peoples R China.	duyt@genomics.cn; rlma@genetics.ac.cn	Chen, Longxin/HGD-3900-2022; Vajta, Gabor/I-3672-2016; Zhang, Peng/T-8441-2019; Zhang, Peng/T-8334-2019	Zhang, Peng/0000-0002-3394-6922; Lin, Lin/0000-0002-7546-4948	China Ministry of Agriculture [2009ZX08008-005B]; Chinese Academy of Sciences [KSZD-EW-005]	China Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by the research grants from the China Ministry of Agriculture (2009ZX08008-005B) and the Chinese Academy of Sciences (KSZD-EW-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhojwani S, 2005, J REPROD DEVELOP, V51, P465, DOI 10.1262/jrd.17025; Chen L, 2012, J GENET GENOMICS, V39, P181, DOI 10.1016/j.jgg.2012.03.002; Du Y, 2007, THERIOGENOLOGY, V68, P1104, DOI 10.1016/j.theriogenology.2007.07.021; Duan B, 2012, THERIOGENOLOGY, V78, P793, DOI 10.1016/j.theriogenology.2012.03.027; Feltrin C., 2006, Reproduction Fertility and Development, V18, P126, DOI 10.1071/RDv18n2Ab35; Hiendleder S, 2005, REPROD FERT DEVELOP, V17, P69, DOI 10.1071/RD04115; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kang JX, 2005, J MEMBRANE BIOL, V206, P165, DOI 10.1007/s00232-005-0790-3; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kragh PM, 2004, REPROD FERT DEVELOP, V16, P315, DOI 10.1071/RD04007; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lee JH, 2010, CELL REPROGRAM, V12, P347, DOI 10.1089/cell.2009.0096; Luo YL, 2011, TRANSGENIC RES, V20, P975, DOI 10.1007/s11248-010-9472-8; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Pan DK, 2010, SCI CHINA LIFE SCI, V53, P517, DOI 10.1007/s11427-010-0080-x; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Vajta G, 2004, THERIOGENOLOGY, V62, P1465, DOI 10.1016/j.theriogenology.2004.02.010; Vajta G, 2001, Cloning, V3, P89, DOI 10.1089/15204550152475590; Vajta G, 2003, BIOL REPROD, V68, P571, DOI 10.1095/biolreprod.102.008771; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu XJ, 2012, TRANSGENIC RES, V21, P1359, DOI 10.1007/s11248-012-9612-4; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Zhang P, 2012, CELL REPROGRAM, V14, P258, DOI 10.1089/cell.2011.0073; Zhang Peng, 2007, Journal of Northwest A & F University - Natural Science Edition, V35, P24; Zhu GM, 2008, TRANSGENIC RES, V17, P717, DOI 10.1007/s11248-008-9171-x	32	27	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55941	10.1371/journal.pone.0055941	http://dx.doi.org/10.1371/journal.pone.0055941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437077	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200032
J	Kutar, BMRNS; Rajpara, N; Upadhyay, H; Ramamurthy, T; Bhardwaj, AK				Kutar, Braj M. R. N. S.; Rajpara, Neha; Upadhyay, Hardik; Ramamurthy, Thandavarayan; Bhardwaj, Ashima K.			Clinical Isolates of Vibrio cholerae O1 El Tor Ogawa of 2009 from Kolkata, India: Preponderance of SXT Element and Presence of Haitian ctxB Variant	PLOS ONE			English	Article							RESISTANCE; BIOTYPE; ORIGIN; FLUVIALIS; VIRULENCE; PLASMIDS; STRAINS; NON-O1; GENE	Background: Increase in the number of multidrug resistant pathogens and the accompanied rise in case fatality rates has hampered the treatment of many infectious diseases including cholera. Unraveling the mechanisms responsible for multidrug resistance in the clinical isolates of Vibrio cholerae would help in understanding evolution of these pathogenic bacteria and their epidemic potential. This study was carried out to identify genetic factors responsible for multiple drug resistance in clinical isolates of Vibrio cholerae O1, serotype Ogawa, biotype El Tor isolated from the patients admitted to the Infectious Diseases Hospital, Kolkata, India, in 2009. Methodology/Principal Findings: One hundred and nineteen clinical isolates of V. cholerae were analysed for their antibiotic resistance phenotypes. Antibiogram analysis revealed that majority of the isolates showed resistance to cotrimoxazole, nalidixic acid, polymixin B and streptomycin. In PCR, SXT integrase was detected in 117 isolates and its sequence showed 99% identity notably to ICEVchInd5 from Sevagram, India, ICEVchBan5 from Bangladesh and VC1786ICE sequence from Haiti outbreak among others. Antibiotic resistance traits corresponding to SXT element were transferred from the parent Vibrio isolate to the recipient E. coli XL-1 Blue cells during conjugation. Double-mismatch-amplification mutation assay (DMAMA) revealed the presence of Haitian type ctxB allele of genotype 7 in 55 isolates and the classical ctxB allele of genotype 1 in 59 isolates. Analysis of topoisomerase sequences revealed the presence of mutation Ser83 -> Ile in gyrA and Ser85 -> Leu in parC. This clearly showed the circulation of SXT-containing V. cholerae as causative agent for cholera in Kolkata. Conclusions: There was predominance of SXT element in these clinical isolates from Kolkata region which also accounted for their antibiotic resistance phenotype typical of this element. DMAMA PCR showed them to be a mixture of isolates with different ctxB alleles like classical, El Tor and Haitian variants.	[Kutar, Braj M. R. N. S.; Rajpara, Neha; Upadhyay, Hardik; Bhardwaj, Ashima K.] Indian Inst Adv Res, Koba Inst Area, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India; [Ramamurthy, Thandavarayan] Natl Inst Cholera & Enter Dis, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Bhardwaj, AK (corresponding author), Indian Inst Adv Res, Koba Inst Area, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India.	ashima.bhardwaj@gmail.com			Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR/11634/INF/22/104/2008]; Puri Foundation for Education in India; Council of Scientific and Industrial Research, India [09/988(0003)/2010-EMR-I]; Indian Council of Medical Research, New Delhi, India [AMR/49/11-ECDI]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Puri Foundation for Education in India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by the grant from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [Grant number BT/PR/11634/INF/22/104/2008]. The authors thankfully acknowledge the partial funding received from The Puri Foundation for Education in India. BMRNSK is a recipient of Junior Research Fellowship [Fellowship number 09/988(0003)/2010-EMR-I] from the Council of Scientific and Industrial Research, India. NR is a recipient of Senior Research Fellowship [Grant number AMR/49/11-ECDI] from Indian Council of Medical Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj Ashima K, 2012, Recent Pat Antiinfect Drug Discov, V7, P73; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Ceccarelli D, 2011, LANCET INFECT DIS, V11, P262, DOI 10.1016/S1473-3099(11)70078-0; Ceccarelli D, 2011, INT J MED MICROBIOL, V301, P318, DOI 10.1016/j.ijmm.2010.11.005; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chowdhury G, 2011, INT J ANTIMICROB AG, V38, P169, DOI 10.1016/j.ijantimicag.2011.04.013; CLSI, 2010, PERF STAND ANT SUS S; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Frerichs RR, 2012, CLIN MICROBIOL INFEC, V18, pE158, DOI 10.1111/j.1469-0691.2012.03841.x; Ghosh A, 2011, INDIAN J MED RES, V133, P225; Goel AK, 2010, INFECT GENET EVOL, V10, P815, DOI 10.1016/j.meegid.2009.06.022; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kumar P, 2010, FEMS MICROBIOL LETT, V303, P132, DOI 10.1111/j.1574-6968.2009.01868.x; Mekalanos JJ, 2012, P NATL ACAD SCI USA, V109, pE3206, DOI 10.1073/pnas.1212443109; Mohanty P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035752; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Naha A, 2012, J CLIN MICROBIOL, V50, P1733, DOI 10.1128/JCM.00387-12; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Pande K, 2012, INDIAN J MED RES, V135, P346; Pun SB, 2011, MBIO, V2, DOI 10.1128/mBio.00219-11; Rajpara N, 2009, INT J ANTIMICROB AG, V34, P220, DOI 10.1016/j.ijantimicag.2009.03.020; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Singh R, 2012, J MED MICROBIOL, V61, P369, DOI 10.1099/jmm.0.037226-0; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786	30	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56477	10.1371/journal.pone.0056477	http://dx.doi.org/10.1371/journal.pone.0056477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431378	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800020
J	Lavoue, S; Miya, M; Musikasinthorn, P; Chen, WJ; Nishida, M				Lavoue, Sebastien; Miya, Masaki; Musikasinthorn, Prachya; Chen, Wei-Jen; Nishida, Mutsumi			Mitogenomic Evidence for an Indo-West Pacific Origin of the Clupeoidei (Teleostei: Clupeiformes)	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURES; DISPERSAL-VICARIANCE ANALYSIS; PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY HISTORY; MOLECULAR PHYLOGENY; DIVERSITY PATTERNS; GEOGRAPHIC RANGE; FOSSIL RECORD; CLUPEID FISH; GENUS	The clupeoid fishes are distributed worldwide, with marine, freshwater and euryhaline species living in either tropical or temperate environments. Regional endemism is important at the species and genus levels, and the highest species diversity is found in the tropical marine Indo-West Pacific region. The clupeoid distribution follows two general pattern of species richness, the longitudinal and latitudinal gradients. To test historical hypotheses explaining the formation of these two gradients, we have examined the early biogeography of the Clupeoidei in reconstructing the evolution of their habitat preferences along with their ancestral range distributions on a time-calibrated mitogenomic phylogeny. The phylogenetic results support the distinction of nine main lineages within the Clupeoidei, five of them new. We infer several independent transitions from a marine to freshwater environment and from a tropical to temperate environment that occurred after the initial diversification period of the Clupeoidei. These results combined with our ancestral range reconstruction hypothesis suggest that the probable region of origin and diversification of the Clupeoidei during the Cretaceous period was the tropical marine precursor to the present Indo-West Pacific region. Thus, our study favors the hypotheses of "Region of origin" and "Tropical conservatism" to explain the origins of the longitudinal and latitudinal gradients of clupeoid species richness, respectively. Additional geological and paleontological evidence further define the tropical marine paleo-region of origin as the eastern Tethys Sea region. The Cretaceous fossil record of the Clupeoidei is partially incongruent with the results here as it contains taxa found outside this region. We discuss three possible causes of conflict between our biogeographical hypothesis and the distributions of the Cretaceous clupeoid fossils: regional extinction, incomplete taxonomic sampling and incorrect timescale estimation.	[Lavoue, Sebastien; Chen, Wei-Jen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Lavoue, Sebastien; Nishida, Mutsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Miya, Masaki] Nat Hist Museum & Inst, Chiba, Japan; [Musikasinthorn, Prachya] Kasetsart Univ, Fac Fisheries, Bangkok, Thailand	National Taiwan University; University of Tokyo; Kasetsart University	Lavoue, S (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	microceb@hotmail.com	Lavoue, Sebastien/H-7118-2012; Miya, Masaki/O-2664-2019; CHEN, Wei-Jen/A-2605-2008	Lavoue, Sebastien/0000-0003-4798-6666; CHEN, Wei-Jen/0000-0003-4751-7632; Miya, Masaki/0000-0002-9791-9886	Japan Society for the Promotion of Science [16570082, 15380131, 19207007, 23370041]; University of Tokyo; National Science Council of Taiwan [NSC100-2811-M-002-069, NSC101-2811-M-002-069-071, NSC 99-2611-M-002-001-MY2]; Systematics Research Fund grant	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Tokyo; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Systematics Research Fund grant	This study was funded by Research Grants Nos 16570082, 15380131, 19207007 and 23370041 from the Japan Society for the Promotion of Science. SL was supported by postdoctoral fellowships of The University of Tokyo and the National Science Council of Taiwan (NSC100-2811-M-002-069 and NSC101-2811-M-002-069-071). Fieldwork in Thailand in 2011 was supported by a Systematics Research Fund grant awarded to SL. PM acknowledges Nagao Natural Environment Foundation (NEF) that permitted his fieldwork. WJC' research is supported by a Research Grant (NSC 99-2611-M-002-001-MY2) from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Amaral CRL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037247; Anderson JD, 2007, FISH B-NOAA, V105, P368; Arratia Gloria, 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P137; Arratia Gloria, 1997, Palaeo Ichthyologica, V7, P5; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Benton Michael J., 2009, P35; Blaber SJM, 1999, ESTUAR COAST SHELF S, V49, P689, DOI 10.1006/ecss.1999.0545; Bloom DD, 2012, J EVOLUTION BIOL, V25, P701, DOI 10.1111/j.1420-9101.2012.02464.x; Borsa P, 2004, CR BIOL, V327, P1113, DOI 10.1016/j.crvi.2004.09.003; Bowen BR, 2008, J FISH BIOL, V72, P1188, DOI 10.1111/j.1095-8649.2007.01785.x; Bowen BW, 1997, EVOLUTION, V51, P1601, DOI 10.1111/j.1558-5646.1997.tb01483.x; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; Briggs JC, 2007, DIVERS DISTRIB, V13, P544, DOI 10.1111/j.1472-4642.2007.00362.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Britz Ralf, 1999, Ichthyological Exploration of Freshwaters, V10, P337; Carpenter KE, 2011, J MAR BIOL, V2011, pe1; CASTRO-AGUIRRE J L, 1990, Anales de la Escuela Nacional de Ciencias Biologicas Mexico, V33, P135; Castro-Aguirre Jose Luis, 2002, Bulletin Southern California Academy of Sciences, V101, P1; Crame J. Alistair, 2001, Diversity and Distributions, V7, P175, DOI 10.1111/j.1472-4642.2001.00106.x; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; De Figueiredo FJ, 2009, J VERTEBR PALEONTOL, V29, P993, DOI 10.1671/039.029.0402; De Figueiredo FJ, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2164.1.2; Di Dario F, 2002, COPEIA, P496; Di Dario F, 2009, ZOOL J LINN SOC-LOND, V156, P363, DOI 10.1111/j.1096-3642.2008.00472.x; Dibattista JD, 2012, CYBIUM, V36, P447; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eschmeyer W. N., 2012, CATALOG FISHES ELECT; Eschmeyer William N., 2011, Zootaxa, V3148, P26; Fara E, 2010, SER TELEOST FISH BIO, P173, DOI 10.1201/b10194-7; Faria R, 2006, MOL PHYLOGENET EVOL, V40, P298, DOI 10.1016/j.ympev.2006.02.008; Filleul A, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)455<0001:ROSDOC>2.0.CO;2; Forey PL, 2003, J SYST PALAEONTOL, V1, P227, DOI 10.1017/S147720190300107X; Frey MA, 2008, MOL PHYLOGENET EVOL, V48, P1067, DOI 10.1016/j.ympev.2008.05.009; Garcia G, 2011, INT J FISH AQUA, V2, P41; Garcia G, 2008, MAR BIOL, V155, P325, DOI 10.1007/s00227-008-1030-z; Giersch S, 2011, SWISS J GEOSCI, V104, pS73, DOI 10.1007/s00015-011-0079-8; GOURENE G, 1988, Cybium, V12, P357; Gourene Germain, 1994, Journal of African Zoology, V108, P77; Grande L., 1982, American Museum Novitates, P1; GRANDE L, 1985, American Museum Novitates, P1; GRANDE L, 1985, B AM MUS NAT HIST, V181, P235; Grant WS, 2010, J BIOGEOGR, V37, P1352, DOI 10.1111/j.1365-2699.2010.02291.x; Grant WS, 2005, J FISH BIOL, V67, P1242, DOI 10.1111/j.1095-8649.2005.00820.x; Guiraud R, 2001, PALAEOTECTONIC ATLAS; HALLAM A, 1985, J GEOL SOC LONDON, V142, P433, DOI 10.1144/gsjgs.142.3.0433; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue JG, 2009, MOL PHYLOGENET EVOL, V51, P486, DOI 10.1016/j.ympev.2009.01.020; Ishiguro NB, 2005, J FISH BIOL, V67, P561, DOI 10.1111/j.0022-1112.2005.00746.x; Jerome M, 2003, J AGR FOOD CHEM, V51, P7326, DOI 10.1021/jf034652t; JERZMANSKA A, 1979, Acta Palaeontologica Polonica, V24, P65; JOKIEL P, 1992, J BIOGEOGR, V19, P449, DOI 10.2307/2845572; Jolly MT, 2012, MAR BIOL, V159, P675, DOI 10.1007/s00227-011-1845-x; Jurkovsek B, 2007, NEUES JAHRB GEOL P-A, V245, P83, DOI 10.1127/0077-7749/2007/0245-0083; Kimura S, 2009, ICHTHYOL RES, V56, P292, DOI 10.1007/s10228-009-0103-4; Lavoue S, 2005, MOL PHYLOGENET EVOL, V37, P165, DOI 10.1016/j.ympev.2005.03.024; Lavoue S, 2008, ICHTHYOL RES, V55, P328, DOI 10.1007/s10228-008-0044-3; Lavoue S, 2007, MOL PHYLOGENET EVOL, V43, P1096, DOI 10.1016/j.ympev.2006.09.018; Lavoue S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036287; Lavoue S, 2010, MOL PHYLOGENET EVOL, V56, P480, DOI 10.1016/j.ympev.2009.11.022; Li C, 2007, GENOME SCALE APPROAC; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Lieberman BS, 2003, ANNU REV ECOL EVOL S, V34, P51, DOI 10.1146/annurev.ecolsys.34.121101.153549; Lieberman BS, 2002, PALAEOGEOGR PALAEOCL, V178, P39, DOI 10.1016/S0031-0182(01)00367-4; Loeb MV, 2012, NEOTROP ICHTHYOL, V10, P13, DOI 10.1590/S1679-62252012000100002; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Maddison WP, 2019, MESQUITE MODULAR SYS; Menezes NA, 2000, P BIOL SOC WASH, V113, P238; Milton DA, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P325, DOI 10.1007/978-90-481-2406-0_9; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Miyashita T, 2010, ICHTHYOL RES, V57, P121, DOI 10.1007/s10228-009-0132-z; Murray AM, 2005, J VERTEBR PALEONTOL, V25, P300, DOI 10.1671/0272-4634(2005)025[0300:ANCFCF]2.0.CO;2; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; NELSON G, 1973, Bulletin of the American Museum of Natural History, V150, P131; NELSON G, 1984, COPEIA, P422, DOI 10.2307/1445200; NELSON G, 1995, JPN J ICHTHYOL, V41, P379; Nelson G. J., 1970, Am. Mus. Novit., VNo. 2410, P1; NELSON G J, 1970, Japanese Journal of Ichthyology, V17, P131; NELSON GJ, 1967, COPEIA, P389; Neraudeau D, 2000, PALAEOGEOGR PALAEOCL, V156, P71, DOI 10.1016/S0031-0182(99)00132-7; Norris RD, 1998, GEOLOGY, V26, P823, DOI 10.1130/0091-7613(1998)026<0823:LLSSTF>2.3.CO;2; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Palkovacs EP, 2008, MOL ECOL, V17, P582, DOI 10.1111/j.1365-294X.2007.03593.x; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Peng Y., 1988, Journal of Fisheries of China, V12, P355; RANDALL JE, 1994, RAFFLES B ZOOL, V42, P893; Randall JE, 2012, PAC SCI, V66, P97, DOI 10.2984/66.1.6; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Roberts T.R., 1972, Breviora, VNo. 382, P1; ROBERTS T R, 1981, Proceedings of the California Academy of Sciences, V42, P295; Roberts TR, 2008, RAFFLES B ZOOL, V56, P125; Rocha LA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-157; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; ROSEN BR, 1988, HELGOLANDER MEERESUN, V42, P269, DOI 10.1007/BF02366046; Saitoh K, 2011, ZOOL J LINN SOC-LOND, V161, P633, DOI 10.1111/j.1096-3642.2010.00651.x; Salisbury BA, 2001, SYST BIOL, V50, P557, DOI 10.1080/106351501750435103; Samonte IE, 2000, J HERED, V91, P247, DOI 10.1093/jhered/91.3.247; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Schouten S, 2003, GEOLOGY, V31, P1069, DOI 10.1130/G19876.1; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Siebert Darrell J., 1997, Bulletin of the Natural History Museum Zoology Series, V63, P13; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens RR, 1996, COPEIA, P475; Stiassny MLJ, 2002, COPEIA, P67, DOI 10.1643/0045-8511(2002)002[0067:ROSBCP]2.0.CO;2; Streelman JT, 2002, EVOLUTION, V56, P961; Takashima R., 2006, OCEANOGRAPHY, V19, P82, DOI DOI 10.5670/OCEANOG.2006.07; Tarduno JA, 1998, SCIENCE, V282, P2241, DOI 10.1126/science.282.5397.2241; TAVERNE L, 1977, Revue de Zoologie Africaine, V91, P330; Taverne L, 1997, BELG J ZOOL, V127, P75; Taverne L, 1997, OSTEOLOGIE POSITION, V1997, P203; Taverne Louis, 2011, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V35, P3; Taverne Louis, 2007, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V31, P37; Taverne Louis, 2007, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V31, P21; Taverne Louis, 2004, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V28, P17; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Whitehead P.J.P., 1988, FAO FISH SYNOP, P305; Whitehead P.J.P., 1985, FAO FISH, V125, P1; WHITEHEAD PJ, 1968, J NAT HIST, V2, P477, DOI 10.1080/00222936800770971; WHITEHEAD PJP, 1985, CAN J FISH AQUAT SCI, V42, P3; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilson AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001979; WILSON MVH, 1992, J PALEONTOL, V66, P839, DOI 10.1017/S0022336000020849; WONGRATANA T, 1987, P BIOL SOC WASH, V100, P104; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	137	58	59	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56485	10.1371/journal.pone.0056485	http://dx.doi.org/10.1371/journal.pone.0056485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431379	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800021
J	Pais, SV; Milho, C; Almeida, F; Mota, LJ				Pais, Sara V.; Milho, Catarina; Almeida, Filipe; Mota, Luis Jaime			Identification of Novel Type III Secretion Chaperone-Substrate Complexes of Chlamydia trachomatis	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; YERSINIA-ENTEROCOLITICA; TRANSLOCATED PROTEIN; EFFECTOR PROTEIN; GENOME SEQUENCE; VIRULENCE; SYSTEM; FAMILY; EXPORT; CELLS	Chlamydia trachomatis is an obligate intracellular bacterial pathogen of humans that uses a type III secretion (T3S) system to manipulate host cells through the delivery of effector proteins into their cytosol and membranes. The function of T3S systems depends on small bacterial cytosolic chaperone-like proteins, which bind T3S substrates and ensure their appropriate secretion. To find novel T3S chaperone-substrate complexes of C. trachomatis we first searched its genome for genes encoding proteins with features of T3S chaperones. We then systematically tested for interactions between candidate chaperones and chlamydial T3S substrates by bacterial two-hybrid. This revealed interactions between Slc1 (a known T3S chaperone) or CT584 and several T3S substrates. Co-immunoprecipation after protein expression in Yersinia enterocolitica and protein overlay binding assays indicated that Slc1 interacted with the N-terminal region of the known T3S substrates Tarp (a previously described substrate of Slc1), CT694, and CT695, and that CT584 interacted with a central region of CT082, which we identified as a C. trachomatis T3S substrate using Y. enterocolitica as a heterologous system. Further T3S assays in Yersinia indicated that Slc1 or CT584 increased the amount of secreted Tarp, CT694, and CT695, or CT082, respectively. Expression of CT584 increased the intra-bacterial stability of CT082, while Slc1 did not affect the stability of its substrates. Overall, this indicated that in C. trachomatis Slc1 is a chaperone of multiple T3S substrates and that CT584 is a chaperone of the newly identified T3S substrate CT082.	[Pais, Sara V.; Milho, Catarina; Almeida, Filipe; Mota, Luis Jaime] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Infect Biol Lab, Oeiras, Portugal; [Mota, Luis Jaime] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, Caparica, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	Mota, LJ (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Infect Biol Lab, Oeiras, Portugal.	jmota@itqb.unl.pt	Almeida, Filipe/O-2871-2015; Mota, Luis/B-9497-2008; Milho, Catarina/AAD-7116-2021; Pais, Sara/O-3327-2015; da Silva Almeida, Filipe Manuel Baeta/AAP-5315-2021; Milho, Catarina/Q-4744-2018	Almeida, Filipe/0000-0001-5114-7721; Mota, Luis/0000-0002-5592-8397; Pais, Sara/0000-0003-2392-0451; da Silva Almeida, Filipe Manuel Baeta/0000-0001-5114-7721; Milho, Catarina/0000-0002-9074-8498; Milho, Catarina/0000-0002-4176-765X	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011, PTDC/SAU-MII/099623/2008, ERA-PTG/0005/2010]; European Commission [PERG03-GA-2008-230954]; European Society for Clinical Microbiology and Infectious Diseases (ESCMID); FCT [SFRH/BD/73545/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); European Society for Clinical Microbiology and Infectious Diseases (ESCMID); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) through grants PEst-OE/EQB/LA0004/2011, PTDC/SAU-MII/099623/2008, and ERA-PTG/0005/2010 (in the frame of ERA-NET PathoGenoMics), by the European Commission through a Marie Curie European Re-integration Grant (PERG03-GA-2008-230954), and by a European Society for Clinical Microbiology and Infectious Diseases (ESCMID) research grant. FA holds PhD fellowship SFRH/BD/73545/2010 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Almeida F, 2012, J BACTERIOL, V194, P6574, DOI 10.1128/JB.01428-12; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Binet R, 2009, P NATL ACAD SCI USA, V106, P292, DOI 10.1073/pnas.0806768106; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000; Brinkworth AJ, 2011, MOL MICROBIOL, V82, P131, DOI 10.1111/j.1365-2958.2011.07802.x; Bullock HD, 2012, J BIOL CHEM, V287, P28078, DOI 10.1074/jbc.M112.386904; Chellas-Gery B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costa SCP, 2012, MBIO, V3, DOI 10.1128/mBio.00243-11; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Fling SP, 2001, P NATL ACAD SCI USA, V98, P1160, DOI 10.1073/pnas.98.3.1160; Ho TD, 2005, INFECT IMMUN, V73, P905, DOI 10.1128/IAI.73.2.905-911.2005; Hobolt-Pedersen AS, 2009, FEMS IMMUNOL MED MIC, V57, P46, DOI 10.1111/j.1574-695X.2009.00581.x; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kurushima J, 2012, FEMS MICROBIOL LETT, V331, P144, DOI 10.1111/j.1574-6968.2012.02561.x; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; Markham AP, 2009, BIOCHEMISTRY-US, V48, P10353, DOI 10.1021/bi901200y; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Munera D, 2010, J BACTERIOL, V192, P3534, DOI 10.1128/JB.00046-10; Muschiol S, 2011, INFECT IMMUN, V79, P571, DOI 10.1128/IAI.00825-10; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Sambrook J., 2001, MOL CLONING LAB MANU; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Silva-Herzog E, 2011, J BACTERIOL, V193, P3490, DOI 10.1128/JB.00203-11; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Stainier I, 1997, MOL MICROBIOL, V26, P833, DOI 10.1046/j.1365-2958.1997.6281995.x; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stone CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030220; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Thomas NA, 2012, J BACTERIOL, V194, P3767, DOI 10.1128/JB.00406-12; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879; Zurawski DV, 2004, MICROBIOL-SGM, V150, P2055, DOI 10.1099/mic.0.26997-0	75	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56292	10.1371/journal.pone.0056292	http://dx.doi.org/10.1371/journal.pone.0056292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431368	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800010
J	Paz, S; Malkinson, D; Green, MS; Tsioni, G; Papa, A; Danis, K; Sirbu, A; Ceianu, C; Katalin, K; Ferenczi, E; Zeller, H; Semenza, JC				Paz, Shlomit; Malkinson, Dan; Green, Manfred S.; Tsioni, Gil; Papa, Anna; Danis, Kostas; Sirbu, Anca; Ceianu, Cornelia; Katalin, Krisztalovics; Ferenczi, Emoke; Zeller, Herve; Semenza, Jan C.			Permissive Summer Temperatures of the 2010 European West Nile Fever Upsurge	PLOS ONE			English	Article							CULEX-PIPIENS DIPTERA; VECTOR COMPETENCE; ENVIRONMENTAL-TEMPERATURE; VIRUS TRANSMISSION; CLIMATE-CHANGE; CULICIDAE; OUTBREAK; INCUBATION; MOSQUITOS; EPIDEMIC	Background: In the summer of 2010, Europe experienced outbreaks of West Nile Fever (WNF) in humans, which was preceded by hot spells. The objective of this study was to identify potential drivers of these outbreaks, such as spring and summer temperatures, relative humidity (RH), and precipitation. Methods: Pearson and lag correlations, binary and multinomial logistic regressions were used to assess the relationship between the climatic parameters and these outbreaks. Results: For human morbidity, significant (<0.05) positive correlations were observed between a number of WNF cases and temperature, with a geographic latitude gradient: northern ("colder") countries displayed strong correlations with a lag of up to four weeks, in contrast to southern ("warmer") countries, where the response was immediate. The correlations with RH were weaker, while the association with precipitation was not consistent. Horse morbidity started three weeks later than in humans where integrated surveillance was conducted, and no significant associations with temperature or RH were found for lags of 0 to 4 weeks. Conclusions: Significant temperature deviations during summer months might be considered environmental precursors of WNF outbreaks in humans, particularly at more northern latitudes. These insights can guide vector abatement strategies by health practitioners in areas at risk for persistent transmission cycles.	[Paz, Shlomit; Malkinson, Dan; Tsioni, Gil] Univ Haifa, Dept Geog & Environm Studies, IL-31999 Haifa, Israel; [Green, Manfred S.] Univ Haifa, Sch Publ Hlth, IL-31999 Haifa, Israel; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, GR-54006 Thessaloniki, Greece; [Danis, Kostas] Hellen Ctr Dis Prevent & Control, Athens, Greece; [Sirbu, Anca] Natl Ctr Surveillance & Control Communicable Dis, Bucharest, Romania; [Ceianu, Cornelia] Cantacuzino Natl Inst Res & Dev Microbiol & Immun, Bucharest, Romania; [Katalin, Krisztalovics; Ferenczi, Emoke] Natl Ctr Epidemiol, Budapest, Hungary; [Zeller, Herve; Semenza, Jan C.] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden	University of Haifa; University of Haifa; Aristotle University of Thessaloniki; Cantacuzino Institute Bucharest; European Centre for Disease Prevention & Control	Semenza, JC (corresponding author), European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.	Jan.Semenza@ecdc.europa.eu	Danis, Kostas/ABD-7357-2020; Ceianu, Cornelia-Svetlana/A-7423-2018	Ceianu, Cornelia Svetlana/0000-0001-6222-0752; Green, Manfred S./0000-0002-9753-5612; Malkinson, Dan/0000-0001-6172-0253	European Centre for Disease Prevention and Control (ECDC); ECDC Specific Contract (Health impact assessment: Climate, weather and West Nile Virus in Europe) [OJ/01/14/2011-PROC/2011/008]; University of Haifa, Israel	European Centre for Disease Prevention and Control (ECDC); ECDC Specific Contract (Health impact assessment: Climate, weather and West Nile Virus in Europe); University of Haifa, Israel	Research under this project was funded by the European Centre for Disease Prevention and Control (ECDC) and performed under an ECDC Specific Contract (Health impact assessment: Climate, weather and West Nile Virus in Europe) Number OJ/01/14/2011-PROC/2011/008 - January 2011, with University of Haifa, Israel. ECDC staff specified the terms of reference for the project, collected the data and were involved in study design, data analysis and interpretation, and writing of the manuscript.	Amante C, 2009, NGDC24 NESDIS CIRES; Andrade CC, 2011, J GEN VIROL, V92, P2523, DOI 10.1099/vir.0.032318-0; [Anonymous], 2001, GLOBAL CHANGE HUM HL, DOI DOI 10.1023/A:1015089901425; CDC Division of vector-born infectious diseases, 2007, W NIL VIR VERT EC TR; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; CORNEL AJ, 1993, J MED ENTOMOL, V30, P449, DOI 10.1093/jmedent/30.2.449; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; Dauphin G, 2004, COMP IMMUNOL MICROB, V27, P343, DOI 10.1016/j.cimid.2004.03.009; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Dohm DJ, 2001, J MED ENTOMOL, V38, P462, DOI 10.1603/0022-2585-38.3.462; ECDC, 2011, ANN EP REP 2011 REP; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Epstein PR, 2001, J URBAN HEALTH, V78, P367, DOI 10.1093/jurban/78.2.367; European Centre for Disease Prevention and Control, 2011, EXP CONS W NIL VIR I; Garcia-Bocanegra I, 2011, EMERG INFECT DIS, V17, P2397, DOI 10.3201/eid1712.110651; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Korukluoglu G, 2011, W NILE VIRUS INFECT; Leshem Y, BIRD MIGRATION VIA M; McLean RG, 2001, ANN NY ACAD SCI, V951, P54; Ministry of Health Israel, 2011, W NIL FEV REFR GUID; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; National Oceanic and Atmospheric Administration USA, 2011, NNDC CLIM DAT ONL; NOAA, 2012, HEAT IND; Owen J, 2006, ECOHEALTH, V3, P79, DOI 10.1007/s10393-006-0025-9; Papa A, 2010, EUROSURVEILLANCE, V15; Patz J.A., 2003, CLIM CHANG HUM HLTH, V2, P103; Paz S, 2006, INT J ENVIRON HEAL R, V16, P1, DOI 10.1080/09603120500392400; Paz S, 2008, ECOHEALTH, V5, P40, DOI 10.1007/s10393-007-0150-0; Peterson AT, 2003, VECTOR-BORNE ZOONOT, V3, P27, DOI 10.1089/153036603765627433; Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5633; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Salkind N., 2007, ENCY MEASUREMENT STA; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Sirbu A., 2011, EUROSURVEILLANCE, V16; Tibbetts J, 2007, ENVIRON HEALTH PERSP, V115, pA196, DOI 10.1289/ehp.115-a196; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Uejio CK, 2012, VECTOR-BORNE ZOONOT, V12, P117, DOI 10.1089/vbz.2011.0655; Victorov D, 2010, W NILE FEVER OUTBREA; Weinberger M, 2001, EMERG INFECT DIS, V7, P686, DOI 10.3201/eid0704.010416; World Organisation for Animal Health (OIE), 2012, WORLD AN HLTH INF DA	51	76	79	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56398	10.1371/journal.pone.0056398	http://dx.doi.org/10.1371/journal.pone.0056398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431374	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800016
J	Yu, QG; Chow, EMC; McCaw, SE; Hu, NJ; Byrd, D; Amet, T; Hu, SS; Ostrowski, MA; Gray-Owen, SD				Yu, Qigui; Chow, Edith M. C.; McCaw, Shannon E.; Hu, Ningjie; Byrd, Daniel; Amet, Tohti; Hu, Sishun; Ostrowski, Mario A.; Gray-Owen, Scott D.			Association of Neisseria gonorrhoeae Opa(CEA) with Dendritic Cells Suppresses Their Ability to Elicit an HIV-1-Specific T Cell Memory Response	PLOS ONE			English	Article							GONOCOCCAL OPACITY PROTEINS; HERPES-SIMPLEX-VIRUS; DC-SIGN CD209; CARCINOEMBRYONIC ANTIGEN FAMILY; HUMAN-IMMUNODEFICIENCY-VIRUS; SEROVAR-SPECIFIC IMMUNITY; EPITHELIAL-CELLS; OPA PROTEINS; ADHESION MOLECULE-1; CD40 LIGAND	Infection with Neisseria gonorrhoeae (N. gonorrhoeae) can trigger an intense local inflammatory response at the site of infection, yet there is little specific immune response or development of immune memory. Gonococcal surface epitopes are known to undergo antigenic variation; however, this is unlikely to explain the weak immune response to infection since individuals can be re-infected by the same serotype. Previous studies have demonstrated that the colony opacity-associated (Opa) proteins on the N. gonorrhoeae surface can bind human carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) on CD4(+) T cells to suppress T cell activation and proliferation. Interesting in this regard, N. gonorrhoeae infection is associated with impaired HIV-1 (human immunodeficiency virus type 1)-specific cytotoxic T-lymphocyte (CTL) responses and with transient increases in plasma viremia in HIV-1-infected patients, suggesting that N. gonorrhoeae may also subvert immune responses to co-pathogens. Since dendritic cells (DCs) are professional antigen presenting cells (APCs) that play a key role in the induction of an adaptive immune response, we investigated the effects of N. gonorrhoeae Opa proteins on human DC activation and function. While morphological changes reminiscent of DC maturation were evident upon N. gonorrhoeae infection, we observed a marked downregulation of DC maturation marker CD83 when the gonococci expressing CEACAM1-specific Opa(CEA), but not other Opa variants. Consistent with a gonococcal-induced defect in maturation, Opa(CEA) binding to CEACAM1 reduced the DCs' capacity to stimulate an allogeneic T cell proliferative response. Moreover, Opa(CEA)-expressing N. gonorrhoeae showed the potential to impair DC-dependent development of specific adaptive immunity, since infection with Opa(CEA)-positive gonococci suppressed the ability of DCs to stimulate HIV-1-specific memory CTL responses. These results reveal a novel mechanism to explain why infection of N. gonorrhoeae fails to trigger an effective specific immune response or develop immune memory, and may affect the potent synergy between gonorrhea and HIV-1 infection.	[Yu, Qigui; Hu, Ningjie; Byrd, Daniel; Amet, Tohti; Hu, Sishun] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46204 USA; [Chow, Edith M. C.; McCaw, Shannon E.; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; Univ Toronto, Div Clin Sci, Toronto, ON, Canada	Indiana University System; Indiana University Bloomington; University of Toronto; University of Toronto	Yu, QG (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46204 USA.	andyu@iupui.edu; scott.gray.owen@utoronto.ca	Gray-Owen, Scott/AAG-7337-2022; Gray-Owen, Scott/AFL-7380-2022	Gray-Owen, Scott D./0000-0002-1477-3616	Grand Challenges Explorations (GCE) Phase II grant through the Bill & Melinda Gates Foundation [OPP1035237]; Showalter Research Trust Fund; United States National Institutes of Health (NIH) [T32 AI060519]; Research Facilities Improvement Program from the National Center for Research Resources, NIH [C06 RR015481-01]; Canadian Institutes for Health Research [MOP-15499, HET-85518]; Ontario HIV Treatment Network; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER	Grand Challenges Explorations (GCE) Phase II grant through the Bill & Melinda Gates Foundation; Showalter Research Trust Fund; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program from the National Center for Research Resources, NIH; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Grand Challenges Explorations (GCE) Phase II grant through the Bill & Melinda Gates Foundation (OPP1035237 to QY), Showalter Research Trust Fund (QY), United States National Institutes of Health (NIH) T32 AI060519 (DB), the Research Facilities Improvement Program Grant Number C06 RR015481-01 from the National Center for Research Resources, NIH to Indiana University School of Medicine, the Canadian Institutes for Health Research grants MOP-15499 (SDG) and HET-85518 (SDG and MAO), and support from the Ontario HIV Treatment Network (SDG and MAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1988, J EXP MED, V168, P507, DOI 10.1084/jem.168.2.507; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; [Anonymous], 2002, AIDS ALERT, V17, P63; Anzala AO, 2000, J INFECT DIS, V182, P459, DOI 10.1086/315733; Bamberger AM, 2006, CARCINOGENESIS, V27, P483, DOI 10.1093/carcin/bgi275; Beauchemin N, 1999, EXP CELL RES, V252, P243; BHAT KS, 1992, MOL MICROBIOL, V6, P1073, DOI 10.1111/j.1365-2958.1992.tb02172.x; Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Botling J, 1995, LEUKEMIA, V9, P2034; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chen A, 2003, AIDS, V17, P625, DOI 10.1097/00002030-200303070-00019; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Ciesielski Carol A., 2003, Curr Infect Dis Rep, V5, P145, DOI 10.1007/s11908-003-0051-5; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Ferreira VH, 2011, J INFECT DIS, V204, P299, DOI 10.1093/infdis/jir260; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Freissler E, 2000, CELL MICROBIOL, V2, P69, DOI 10.1046/j.1462-5822.2000.00036.x; Geijtenbeek TBH, 2003, APMIS, V111, P698, DOI 10.1034/j.1600-0463.2003.11107803.x; Geijtenbeek TBH, 2001, PLACENTA, V22, pS19, DOI 10.1053/plac.2001.0674; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Granucci F, 2003, CURR OPIN MICROBIOL, V6, P72, DOI 10.1016/S1369-5274(03)00007-9; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; JAMES JF, 1978, INFECT IMMUN, V19, P332, DOI 10.1128/IAI.19.1.332-340.1978; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kaufmann SHE, 2003, J EXP MED, V197, P1, DOI 10.1084/jem.20021964; Kaul R, 2001, J CLIN INVEST, V107, P341, DOI 10.1172/JCI10714; Knight SC, 1997, ANNU REV IMMUNOL, V15, P593, DOI 10.1146/annurev.immunol.15.1.593; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kummer M, 2007, J VIROL, V81, P6326, DOI 10.1128/JVI.02327-06; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Lechmann M, 2005, BIOCHEM BIOPH RES CO, V329, P132, DOI 10.1016/j.bbrc.2005.01.114; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Lee HSW, 2007, INFECT IMMUN, V75, P4449, DOI 10.1128/IAI.00222-07; Levine D, 2008, AM J PUBLIC HEALTH, V98, P393, DOI 10.2105/AJPH.2007.110767; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Muenzner P, 2001, J BIOL CHEM, V276, P24331, DOI 10.1074/jbc.M006883200; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; NASSIF X, 1995, CLIN MICROBIOL REV, V8, P376, DOI 10.1128/CMR.8.3.376; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Ostrowski MA, 2000, J IMMUNOL, V165, P6133, DOI 10.4049/jimmunol.165.11.6133; Pieper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023290; PLUMMER FA, 1989, J CLIN INVEST, V83, P1472, DOI 10.1172/JCI114040; PLUMMER FA, 1987, REV INFECT DIS, V9, P846; PLUMMER FA, 1994, J CLIN INVEST, V93, P1748, DOI 10.1172/JCI117159; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schmidt KA, 2000, SEX TRANSM DIS, V27, P278, DOI 10.1097/00007435-200005000-00008; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Winter AJ, 1999, SEX TRANSM INFECT, V75, P261, DOI 10.1136/sti.75.4.261; Yu QG, 2006, J IMMUNOL, V176, P2486, DOI 10.4049/jimmunol.176.4.2486; Yu QG, 2003, J IMMUNOL, V170, P1797, DOI 10.4049/jimmunol.170.4.1797; Yu QG, 2004, J IMMUNOL, V172, P6047, DOI 10.4049/jimmunol.172.10.6047; Yu QG, 2006, J BIOL CHEM, V281, P39179, DOI 10.1074/jbc.M608864200; Zhang JZ, 2005, J IMMUNOL, V174, P7995, DOI 10.4049/jimmunol.174.12.7995; Zhang P, 2006, J LEUKOCYTE BIOL, V79, P731, DOI 10.1189/jlb.0405184	87	8	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56705	10.1371/journal.pone.0056705	http://dx.doi.org/10.1371/journal.pone.0056705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424672	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100060
J	Liaw, HH; Lin, CC; Juan, HF; Huang, HC				Liaw, Hao-Han; Lin, Chen-Ching; Juan, Hsueh-Fen; Huang, Hsuan-Cheng			Differential MicroRNA Regulation Correlates with Alternative Polyadenylation Pattern between Breast Cancer and Normal Cells	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNAS; SITE; TRANSCRIPTION; TERMINATION; EXPRESSION; GENOMICS; CLEAVAGE	Alternative polyadenylation (APA) could result in mRNA isoforms with variable lengths of 39 UTRs. Gain of microRNA target sites in the 39 UTR of a long mRNA isoform may cause different regulation from the corresponding short isoform. It has been known that cancer cells globally exhibit a lower ratio of long and short isoforms (LSR); that is, they tend to express larger amounts of short isoforms. The objective of this study is to illustrate the relationship between microRNA differential regulation and LSR. We retrieved public APA annotations and isoform expression profiles of breast cancer and normal cells from a high-throughput sequencing method study specific for the mRNA 39 end. Combining microRNA expression profiles, we performed statistical analysis to reveal and estimate microRNA regulation on APA patterns in a global scale. First, we found that the amount of microRNA target sites in the alternative UTR (aUTR), the region only present in long isoforms, could affect the LSR of the target genes. Second, we observed that the genes whose aUTRs were targeted by up-regulated microRNAs in cancer cells had an overall lower LSR. Furthermore, the target sites of up-regulated microRNAs tended to appear in aUTRs. Finally, we demonstrated that the amount of target sites for up-regulated microRNAs in aUTRs correlated with the LSR change between cancer and normal cells. The results indicate that up-regulation of microRNAs might cause lower LSRs of target genes in cancer cells through degradation of their long isoforms. Our findings provide evidence of how microRNAs might play a crucial role in APA pattern shifts from normal to cancerous or proliferative states.	[Liaw, Hao-Han; Huang, Hsuan-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Inst Biomed Informat, Taipei 112, Taiwan; [Lin, Chen-Ching; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University	Juan, HF (corresponding author), Natl Taiwan Univ, Dept Life Sci, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	yukijuan@ntu.edu.tw; hsuancheng@ym.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council of Taiwan [99-2621-B-010-001-MY3, 99-2621-B-002-005-MY3]; National Taiwan University Cutting-Edge Steering Research Project [10R70602C3]; National Health Research Institutes [NHRI-EX101-9819PI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project; National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by grants from the National Science Council of Taiwan (99-2621-B-010-001-MY3 and 99-2621-B-002-005-MY3), the National Taiwan University Cutting-Edge Steering Research Project (10R70602C3), and National Health Research Institutes (NHRI-EX101-9819PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Ulitsky I, 2012, GENOME RES; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WHITELAW E, 1986, EMBO J, V5, P2915, DOI 10.1002/j.1460-2075.1986.tb04587.x; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	30	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56958	10.1371/journal.pone.0056958	http://dx.doi.org/10.1371/journal.pone.0056958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437281	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000060
J	Okoh, VO; Felty, Q; Parkash, J; Poppiti, R; Roy, D				Okoh, Victor O.; Felty, Quentin; Parkash, Jai; Poppiti, Robert; Roy, Deodutta			Reactive Oxygen Species via Redox Signaling to PI3K/AKT Pathway Contribute to the Malignant Growth of 4-Hydroxy Estradiol-Transformed Mammary Epithelial Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER CELLS; ANCHORAGE-INDEPENDENT GROWTH; SUPEROXIDE-DISMUTASE GENE; MALE SYRIAN-HAMSTERS; PROTEIN-KINASE; OXIDATIVE STRESS; CARCINOMA-CELLS; NEOPLASTIC TRANSFORMATION; AKT ACTIVATION	The purpose of this study was to investigate the effects of 17-beta-estradiol (E2)-induced reactive oxygen species (ROS) on the induction of mammary tumorigenesis. We found that ROS-induced by repeated exposures to 4-hydroxy-estradiol (4-OH-E2), a predominant catechol metabolite of E2, caused transformation of normal human mammary epithelial MCF-10A cells with malignant growth in nude mice. This was evident from inhibition of estrogen-induced breast tumor formation in the xenograft model by both overexpression of catalase as well as by co-treatment with Ebselen. To understand how 4-OH-E2 induces this malignant phenotype through ROS, we investigated the effects of 4-OH-E2 on redox-sensitive signal transduction pathways. During the malignant transformation process we observed that 4-OH-E2 treatment increased AKT phosphorylation through PI3K activation. The PI3K-mediated phosphorylation of AKT in 4-OH-E2-treated cells was inhibited by ROS modifiers as well as by silencing of AKT expression. RNA interference of AKT markedly inhibited 4-OH-E2-induced in vitro tumor formation. The expression of cell cycle genes, cdc2, PRC1 and PCNA and one of transcription factors that control the expression of these genes - nuclear respiratory factor-1 (NRF-1) was significantly up-regulated during the 4-OH-E2-mediated malignant transformation process. The increased expression of these genes was inhibited by ROS modifiers as well as by silencing of AKT expression. These results indicate that 4-OH-E2-induced cell transformation may be mediated, in part, through redox-sensitive AKT signal transduction pathways by up-regulating the expression of cell cycle genes cdc2, PRC1 and PCNA, and the transcription factor - NRF-1. In summary, our study has demonstrated that: (i) 4-OH-E2 is one of the main estrogen metabolites that induce mammary tumorigenesis and (ii) ROS-mediated signaling leading to the activation of PI3K/AKT pathway plays an important role in the generation of 4-OH-E2-induced malignant phenotype of breast epithelial cells. In conclusion, ROS are important signaling molecules in the development of estrogen-induced malignant breast lesions.	[Okoh, Victor O.; Felty, Quentin; Parkash, Jai; Roy, Deodutta] Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA; [Poppiti, Robert] Florida Int Univ, Dept Pathol, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Roy, D (corresponding author), Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA.	Droy@fiu.edu		Felty, Quentin/0000-0002-7151-0441	Department of Defense (CDMRP) [W81XWH-06-1-0468]; Veterans Affairs [I01BX001463] Funding Source: NIH RePORTER	Department of Defense (CDMRP)(United States Department of Defense); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Department of Defense (CDMRP) grant W81XWH-06-1-0468 to DR. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 1999, BIOCHEM PHARMACOL, V58, P425, DOI 10.1016/S0006-2952(99)00125-2; Ambrosone CB, 1999, CANCER RES, V59, P602; Arteaga E, 2003, MENOPAUSE, V10, P142, DOI 10.1097/00042192-200310020-00005; Ball P, 1983, ACTA ENDOCRINOL-COP, V93, P1; Banerjee S, 2003, BIOCHEM BIOPH RES CO, V300, P209, DOI 10.1016/S0006-291X(02)02830-9; BARNEA ER, 1983, STEROIDS, V41, P643, DOI 10.1016/0039-128X(83)90030-2; Barnett SF, 2005, CURR TOP MED CHEM, V5, P109, DOI 10.2174/1568026053507714; Bocchinfuso WP, 1999, CANCER RES, V59, P1869; Burdick AD, 2003, CANCER RES, V63, P7825; Cai QY, 2004, BREAST CANCER RES, V6, pR647, DOI 10.1186/bcr929; Castagnetta L, 2004, ANN NY ACAD SCI, V1028, P233, DOI 10.1196/annals.1321.028; Castagnetta LAM, 2002, CLIN CANCER RES, V8, P3146; Cejas P, 2004, CANCER CAUSE CONTROL, V15, P707, DOI 10.1023/B:CACO.0000036189.61607.52; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Covey TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013545; Cuendet M, 2004, MUTAT RES-FUND MOL M, V550, P109, DOI 10.1016/j.mrfmmm.2004.02.005; Das SK, 2000, J BIOL CHEM, V275, P28834, DOI 10.1074/jbc.M003827200; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Devanesan P, 2001, CARCINOGENESIS, V22, P1573, DOI 10.1093/carcin/22.9.1573; Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006; Embrechts J, 2003, J AM SOC MASS SPECTR, V14, P482, DOI 10.1016/S1044-0305(03)00130-2; Felty Q, 2005, BIOCHEMISTRY-US, V44, P6900, DOI 10.1021/bi047629p; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; Fernandez SV, 2006, INT J CANCER, V118, P1862, DOI 10.1002/ijc.21590; GALEOTTI T, 1983, BIOCHEM PHARMACOL, V32, P3285, DOI 10.1016/0006-2952(83)90352-0; Gao N, 2004, TOXICOL APPL PHARM, V196, P124, DOI 10.1016/j.taap.2003.12.002; HENDERSON BE, 1988, CANCER RES, V48, P246; HOLLAND MB, 1995, CARCINOGENESIS, V16, P1955, DOI 10.1093/carcin/16.8.1955; Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; *IARC, 1979, IARC MON, V21, P139; IARC, 2007, IARC MON EV CARC RIS, V91; *IARC, 1999, IARC MON EV CARC RIS, V72, P399; Jin J, 2005, ONCOGENE, V24, P5459, DOI 10.1038/sj.onc.1208704; Kim MS, 2003, CANCER RES, V63, P5454; Lam EWN, 1997, CANCER RES, V57, P5550; Lareef MH, 2005, INT J ONCOL, V26, P423; Lee YR, 2005, BIOCHEM BIOPH RES CO, V336, P1221, DOI 10.1016/j.bbrc.2005.08.256; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Li JJ, 2002, MOL CARCINOGEN, V33, P56, DOI 10.1002/mc.10022; LI JJ, 1987, FED PROC, V46, P1858; LI JJ, 1995, ONCOGENE, V10, P1989; Liehr JG, 1996, P NATL ACAD SCI USA, V93, P3294, DOI 10.1073/pnas.93.8.3294; LIEHR JG, 1989, CARCINOGENESIS, V10, P1983, DOI 10.1093/carcin/10.11.1983; Liu Suling, 2004, Breast J, V10, P514, DOI 10.1111/j.1075-122X.2004.21410.x; Maggiolini M, 2004, J MOL ENDOCRINOL, V32, P777, DOI 10.1677/jme.0.0320777; Markides CSA, 2005, J ENDOCRINOL, V185, P235, DOI 10.1677/joe.1.06014; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mirza AM, 2000, CELL GROWTH DIFFER, V11, P279; Mitrunen K, 2001, CARCINOGENESIS, V22, P827, DOI 10.1093/carcin/22.5.827; Moon R. C., 1981, Banbury Report, V8, P353; National Toxicology Program, 2002, FED REGISTER, V67, P77283; NCI, 2003, US HORM MEN; Niwa K, 2003, ANTIOXID REDOX SIGN, V5, P713, DOI 10.1089/152308603770380016; OBERLEY LW, 1988, MOL CELL BIOCHEM, V84, P147, DOI 10.1007/BF00421049; OBERLEY LW, 1984, J THEOR BIOL, V106, P403, DOI 10.1016/0022-5193(84)90038-9; Okoh V, 2011, BBA-REV CANCER, V1815, P115, DOI 10.1016/j.bbcan.2010.10.005; Park SA, 2009, CANCER RES, V69, P2416, DOI 10.1158/0008-5472.CAN-08-2177; Parkash J, 2006, BIOCHEMISTRY-US, V45, P2872, DOI 10.1021/bi051855x; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; ROEDERER M, 1990, P NATL ACAD SCI USA, V87, P4884, DOI 10.1073/pnas.87.12.4884; Rogan EG, 2003, CARCINOGENESIS, V24, P697, DOI 10.1093/carcin/bgg004; Roy D, 2004, CURR GENOMICS, V5, P245, DOI 10.2174/1389202043349471; ROY D, 1988, J BIOL CHEM, V263, P3646; ROY D, 1990, CARCINOGENESIS, V11, P567, DOI 10.1093/carcin/11.4.567; Roy D., 1997, J TOXICOL ENV HLTH, V49, P101; Roy D, 1998, FRONT BIOSCI-LANDMRK, V3, P913; Russo J, 2002, ENVIRON MOL MUTAGEN, V39, P254, DOI 10.1002/em.10052; Russo J, 2002, J STEROID BIOCHEM, V80, P149, DOI 10.1016/S0960-0760(01)00183-2; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Soini Y, 2001, J PATHOL, V195, P156, DOI 10.1002/path.946; Son YO, 2012, TOXICOL APPL PHARM, V264, P153, DOI 10.1016/j.taap.2012.07.028; Stauffer Frederic, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P449, DOI 10.2174/1568011054866937; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Sun M, 2001, CANCER RES, V61, P5985; THOMAS RD, 1995, CARCINOGENESIS, V16, P891, DOI 10.1093/carcin/16.4.891; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; WEISZ J, 1992, ENDOCRINOLOGY, V131, P655, DOI 10.1210/en.131.2.655; Wilson AM, 2001, CARCINOGENESIS, V22, P257, DOI 10.1093/carcin/22.2.257; Xie B, 1999, CARCINOGENESIS, V20, P1069, DOI 10.1093/carcin/20.6.1069; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Yusuf R, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-30; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200	86	77	83	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e54206	10.1371/journal.pone.0054206	http://dx.doi.org/10.1371/journal.pone.0054206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437041	gold, Green Submitted, Green Published			2022-12-27	WOS:000315186000002
J	Fujikawa, T; Miyata, SI; Iwanami, T				Fujikawa, Takashi; Miyata, Shin-Ichi; Iwanami, Toru			Convenient Detection of the Citrus Greening (Huanglongbing) Bacterium 'Candidatus Liberibacter asiaticus' by Direct PCR from the Midrib Extract	PLOS ONE			English	Article							SAO-PAULO STATE; DNA AMPLIFICATION; DISEASE; IDENTIFICATION; AMERICANUS; PATHOGEN; BRAZIL; CELLS; TREE	A phloem-limited bacterium, 'Candidatus Liberibacter asiaticus' (Las) is a major pathogen of citrus greening (huanglongbing), one of the most destructive citrus diseases worldwide. The rapid identification and culling of infected trees and budwoods in quarantine are the most important control measures. DNA amplification including conventional polymerase chain reaction (PCR) has commonly been used for rapid detection and identification. However, long and laborious procedures for DNA extraction have greatly reduced the applicability of this method. In this study, we found that the Las bacterial cells in the midribs of infected leaves were extracted rapidly and easily by pulverization and centrifugation with mini homogenization tubes. We also found that the Las bacterial cells in the midrib extract were suitable for highly sensitive direct PCR. The performance of direct PCR using this extraction method was not inferior to that of conventional PCR. Thus, the direct PCR method described herein is characterized by its simplicity, sensitivity, and robustness, and is applicable to quarantine testing.	[Fujikawa, Takashi; Miyata, Shin-Ichi; Iwanami, Toru] Natl Inst Fruit Tree Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan	Iwanami, T (corresponding author), Natl Inst Fruit Tree Sci, Tsukuba, Ibaraki, Japan.	tiwsw37@affrc.go.jp	Fujikawa, Takashi/V-8150-2019	Fujikawa, Takashi/0000-0001-5659-0407	Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported in part by a Grant-in-Aid for Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries from the Ministry of Agriculture, Forestry and Fisheries of Japan. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Bove JM, 2006, J PLANT PATHOL, V88, P7; Committee on the strategic planning for the Florida citrus industry: addressing citrus greening disease (huanglongbing); National Research Council, 2010, STRATEGIC PLANNING F; Ding F, 2005, J PLANT PATHOL, V87, P207; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Fujikawa T, 2012, MOL CELL PROBE, V26, P194, DOI 10.1016/j.mcp.2012.06.001; Furuya N, 2010, J GEN PLANT PATHOL, V76, P122, DOI 10.1007/s10327-010-0223-8; Garnier M, 2000, INT J SYST EVOL MICR, V50, P2119, DOI 10.1099/00207713-50-6-2119; Garnier M, 1996, P 13 C INT ORG CITR, P388; Glockner FO, 1996, APPL ENVIRON MICROB, V65, P3721; Halbert SE., 2005, PROC 2 INT CITRUS CA, pH3; Hocquellet A, 1999, MOL CELL PROBE, V13, P373, DOI 10.1006/mcpr.1999.0263; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Karner M, 1997, APPL ENVIRON MICROB, V63, P1208, DOI 10.1128/AEM.63.4.1208-1213.1997; Li WB, 2007, PLANT DIS, V91, P51, DOI 10.1094/PD-91-0051; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Roche Applied Science, 2002, DIG APPLICATION MANU; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Teixeira DC, 2008, MOL CELL PROBE, V22, P139, DOI 10.1016/j.mcp.2007.12.006; Tomimura K, 2010, JARQ-JPN AGR RES Q, V44, P151, DOI 10.6090/jarq.44.151; Wang Z, 2006, PLANT PATHOL, V55, P630, DOI 10.1111/j.1365-3059.2006.01438.x; ZARDA B, 1991, J GEN MICROBIOL, V137, P2823, DOI 10.1099/00221287-137-12-2823	27	26	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57011	10.1371/journal.pone.0057011	http://dx.doi.org/10.1371/journal.pone.0057011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437295	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200198
J	Ito, TY; Lhagvasuren, B; Tsunekawa, A; Shinoda, M; Takatsuki, S; Buuveibaatar, B; Chimeddorj, B				Ito, Takehiko Y.; Lhagvasuren, Badamjav; Tsunekawa, Atsushi; Shinoda, Masato; Takatsuki, Seiki; Buuveibaatar, Bayarbaatar; Chimeddorj, Buyanaa			Fragmentation of the Habitat of Wild Ungulates by Anthropogenic Barriers in Mongolia	PLOS ONE			English	Article							GAZELLES PROCAPRA-GUTTUROSA; INTERANNUAL VARIATIONS; MIGRATION; UNDERPASSES; RAILROAD; SELECTION; SEARCH; EQUIDS	Habitat loss and habitat fragmentation caused by anthropogenic activities are the main factors that constrain long-distance movement of ungulates. Mongolian gazelles (Procapra gutturosa) and Asiatic wild asses (Equus hemionus) in Mongolia are facing habitat fragmentation and loss. To better understand how their movements respond to potential anthropogenic and natural barriers, we tracked 24 Mongolian gazelles and 12 wild asses near the Ulaanbaatar-Beijing Railroad and the fenced international border between Mongolia and China between 2002 and 2012. None of the tracked gazelles crossed the railroad, even though gazelles were captured on both sides of the tracks at the start of the study. Similarly, we did not observe cross-border movements between Mongolia and China for either species, even though some animals used areas adjacent to the border. The both species used close areas to the anthropogenic barriers more frequently during winter than summer. These results suggest strong impacts by the artificial barriers. The construction of new railroads and roads to permit mining and other resource development therefore creates the threat of further habitat fragmentation, because the planned routes will divide the remaining non-fragmented habitats of the ungulates into smaller pieces. To conserve long-distance movement of the ungulates in this area, it will be necessary to remove or mitigate the barrier effects of the existing and planned roads and railroads and to adopt a landscape-level approach to allow access by ungulates to wide ranges throughout their distribution.	[Ito, Takehiko Y.; Tsunekawa, Atsushi; Shinoda, Masato] Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan; [Lhagvasuren, Badamjav; Buuveibaatar, Bayarbaatar; Chimeddorj, Buyanaa] Mongolian Acad Sci, Inst Biol, Ulaanbaatar, Mongolia; [Lhagvasuren, Badamjav; Chimeddorj, Buyanaa] World Wide Fund Nat WWF Mongolia, Ulaanbaatar, Mongolia; [Takatsuki, Seiki] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan; [Buuveibaatar, Bayarbaatar] WCS, Mongolia Program, Ulaanbaatar, Mongolia	Tottori University; Mongolian Academy of Sciences; Azabu University	Ito, TY (corresponding author), Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan.	ito@alrc.tottori-u.ac.jp	Bayarbaatar, Buuveibaatar/AAS-5963-2020; Shinoda, Masato/F-2830-2014; Buuveibaatar, Bayarbaatar/AAY-9092-2020; Tsunekawa, Atsushi/L-8526-2013; Ito, Takehiko Y/M-7221-2015	Tsunekawa, Atsushi/0000-0002-7690-0633; Ito, Takehiko Y/0000-0003-3203-9770; Bayarbaatar, Buuveibaatar/0000-0003-1803-0745	Japan Ministry of Education, Culture, Sports, Science, and Technology [14405039, 18255002, 20255001]; Ministry's 21st Century COE (Centers of Excellence) Program; Ministry's 21st Century Global COE program	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry's 21st Century COE (Centers of Excellence) Program; Ministry's 21st Century Global COE program	This research was supported by the Japan Ministry of Education, Culture, Sports, Science, and Technology's Grants-in-Aid for Scientific Research (B) 14405039, (A) 18255002, and (A) 20255001, and by the Ministry's 21st Century COE (Centers of Excellence) Program and Global COE program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bolger DT, 2008, ECOL LETT, V11, P63; Collecte Localisation Satellites (CLS), 2007, ARG US MAN WORLDW TR; Dodd NL, 2011, WILDLIFE SOC B, V35, P270, DOI 10.1002/wsb.31; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Ito TY, 2006, J ZOOL, V269, P291, DOI 10.1111/j.1469-7998.2006.00077.x; Ito TY, 2013, J ARID ENVIRON, V91, P61, DOI 10.1016/j.jaridenv.2012.12.008; Ito TY, 2008, J WILDLIFE MANAGE, V72, P940, DOI 10.2193/2007-188; Ito TY, 2005, CONSERV BIOL, V19, P945, DOI 10.1111/j.1523-1739.2005.004364.x; Jiang Zhaowen, 1998, Mammal Study, V23, P63, DOI 10.3106/mammalstudy.23.63; Kaczensky P, 2008, J APPL ECOL, V45, P1762, DOI 10.1111/j.1365-2664.2008.01565.x; Kaczensky Petra, 2010, Wildlife Biology in Practice, V6, P108; Kaczensky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028057; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Leimgruber P, 2001, BIOL CONSERV, V102, P205, DOI 10.1016/S0006-3207(01)00041-6; Lhagvasuren B, 1997, ORYX, V31, P127, DOI 10.1046/j.1365-3008.1997.d01-6.x; Mallon D. P., 2008, IUCN 2012 IUCN RED L; Mallon DP, 2009, J APPL ECOL, V46, P516, DOI 10.1111/j.1365-2664.2009.01654.x; McCollister MF, 2010, J WILDLIFE MANAGE, V74, P1722, DOI 10.2193/2009-535; Moehlman PD, 2008, IUCN 2012 IUCN RED L; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Nandintsetseg B, 2011, INT J CLIMATOL, V31, P1143, DOI 10.1002/joc.2134; Okada Ayumi, 2012, Mongolian Journal of Biological Sciences, V10, P59; Olson K.A., 2009, MONGOLIAN J BIOL S, V7, P45; Olson KA, 2011, CONSERV LETT, V4, P304, DOI 10.1111/j.1755-263X.2011.00180.x; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Olson KA, 2009, ORYX, V43, P149, DOI 10.1017/S0030605307002293; Sawyer H, 2012, WILDLIFE SOC B, V36, P492, DOI 10.1002/wsb.166; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Singh NJ, 2011, ORYX, V45, P38, DOI 10.1017/S0030605310000839; Sorokin P.A., 2005, DOKL AKAD NAUK, V41, P1345, DOI [DOI 10.1134/S0012496606040120, 10.1134/S0012496606040120]; Sorokin PA, 2005, RUSS J GENET+, V41, P1101, DOI 10.1007/s11177-005-0206-6; Walzer Chris, 2006, Mongolian Journal of Biological Sciences, V4, P19; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Xia L, 2007, ORYX, V41, P352, DOI 10.1017/S0030605307000116; Yu F, 2004, INT J REMOTE SENS, V25, P327, DOI 10.1080/0143116031000084297; Yu FF, 2003, REMOTE SENS ENVIRON, V87, P42, DOI 10.1016/S0034-4257(03)00144-5	39	62	66	9	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56995	10.1371/journal.pone.0056995	http://dx.doi.org/10.1371/journal.pone.0056995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437291	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200195
J	Pazoki, R; de Jong, JSSG; Marsman, RF; Bruinsma, N; Dekker, LRC; Wilde, AAM; Bezzina, CR; Tanck, MWT				Pazoki, Raha; de Jong, Jonas S. S. G.; Marsman, Roos F.; Bruinsma, Nienke; Dekker, Lukas R. C.; Wilde, Arthur A. M.; Bezzina, Connie R.; Tanck, Michael W. T.			SNPs Identified as Modulators of ECG Traits in the General Population Do Not Markedly Affect ECG Traits during Acute Myocardial Infarction nor Ventricular Fibrillation Risk in This Condition	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QT INTERVAL DURATION; COMMON GENETIC-VARIATION; SUDDEN CARDIAC DEATH; HEART-RATE; QRS DURATION; PR INTERVAL; VARIANTS; LOCI; REPOLARIZATION	Background: Ventricular fibrillation (VF) in the setting of acute ST elevation myocardial infarction (STEMI) is a leading cause of mortality. Although the risk of VF has a genetic component, the underlying genetic factors are largely unknown. Since heart rate and ECG intervals of conduction and repolarization during acute STEMI differ between patients who do and patients who do not develop VF, we investigated whether SNPs known to modulate these ECG indices in the general population also impact on the respective ECG indices during STEMI and on the risk of VF. Methods and Results: The study population consisted of participants of the Arrhythmia Genetics in the NEtherlandS (AGNES) study, which enrols patients with a first STEMI that develop VF (cases) and patients that do not develop VF (controls). SNPs known to impact on RR interval, PR interval, QRS duration or QTc interval in the general population were tested for effects on the respective STEMI ECG indices (stage 1). Only those showing a (suggestive) significant association were tested for association with VF (stage 2). On average, VF cases had a shorter RR and a longer QTc interval compared to non-VF controls. Eight SNPs showed a trend for association with the respective STEMI ECG indices. Of these, three were also suggestively associated with VF. Conclusions: RR interval and ECG indices of conduction and repolarization during acute STEMI differ between patients who develop VF and patients who do not. Although the effects of the SNPs on ECG indices during an acute STEMI seem to be similar in magnitude and direction as those found in the general population, the effects, at least in isolation, are too small to explain the differences in ECGs between cases and controls and to determine risk of VF.	[Pazoki, Raha; Tanck, Michael W. T.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Pazoki, Raha; de Jong, Jonas S. S. G.; Marsman, Roos F.; Bruinsma, Nienke; Wilde, Arthur A. M.; Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Clin & Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Dekker, Lukas R. C.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Catharina Hospital	Bezzina, CR (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Clin & Expt Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.r.bezzina@amc.uva.nl; m.w.tanck@amc.uva.nl		Tanck, Michael/0000-0001-9828-4459; Pazoki, Raha/0000-0002-5142-2348; Bezzina, Connie/0000-0002-0633-3514	Netherlands Heart Foundation [2001D019, 2003T302, 2007B202]; Leducq Foundation [05-CVD]; Netherlands Heart Institute (ICIN) [27]; Established Investigator of the Netherlands Heart Foundation [2005T024]	Netherlands Heart Foundation(Netherlands Heart Foundation); Leducq Foundation(Leducq Foundation); Netherlands Heart Institute (ICIN); Established Investigator of the Netherlands Heart Foundation	The authors are supported by research grants from the Netherlands Heart Foundation (grants 2001D019, 2003T302 and 2007B202), the Leducq Foundation (grant 05-CVD) and the Netherlands Heart Institute (ICIN project 27). CRB is an Established Investigator of the Netherlands Heart Foundation (grant 2005T024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; HAVLIK RJ, 1980, J ELECTROCARDIOL, V13, P45, DOI 10.1016/S0022-0736(80)80008-2; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Kaikkonen KS, 2006, CIRCULATION, V114, P1462, DOI 10.1161/CIRCULATIONAHA.106.624593; Kolder ICRM, 2012, J MOL CELL CARDIOL, V52, P620, DOI 10.1016/j.yjmcc.2011.12.014; Lemmert ME, 2008, HEART RHYTHM, V5, P71, DOI 10.1016/j.hrthm.2007.09.011; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Myerburg R, 2007, BRAUNWALDS HEART DIS; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nolte IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006138; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Postema PG, 2008, HEART RHYTHM, V5, P1015, DOI 10.1016/j.hrthm.2008.03.037; Russell MW, 1997, J ELECTROCARDIOL, V30, P64, DOI 10.1016/S0022-0736(98)80034-4; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; ZAREBA W, 1994, AM J CARDIOL, V74, P550, DOI 10.1016/0002-9149(94)90742-0	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57216	10.1371/journal.pone.0057216	http://dx.doi.org/10.1371/journal.pone.0057216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437344	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200228
J	Thompson, D; Batterham, AM				Thompson, Dylan; Batterham, Alan M.			Towards Integrated Physical Activity Profiling	PLOS ONE			English	Article							MEASURED SEDENTARY TIME; ENERGY-EXPENDITURE; ACTIVITY THERMOGENESIS; SPRINT INTERVAL; PUBLIC-HEALTH; HEART-RATE; EXERCISE; ADULTS; RECOMMENDATION; OBESITY	Recently, there has been some discussion of whether it is possible to score highly in one dimension of physical activity behaviour (e. g., moderate intensity exercise) whilst also scoring poorly in another (e. g., sedentary time). Interestingly, direct empirical observations to support these proposals are lacking. New technologies now enable the capture of physical activity thermogenesis on a minute-by-minute basis and over a sustained period. We used one of the best available technologies to explore whether individuals can score differently in various physiologically-important physical activity dimensions. We determined minute-by-minute physical activity energy expenditure over 7 days in 100 men aged 28+/-9 years. We used combined accelerometry and heart rate with branched equation modelling to estimate energy expenditure and extracted data for key physical activity outcomes and descriptors. Although some physical activity outcomes were tightly correlated, the attainment of one threshold for a given physical activity dimension did not automatically predict how well an individual scored in another dimension (with bivariate correlations ranging from 0.05 to 0.96). In one illustrative example of this heterogeneity, although 41 men showed a relatively low Physical Activity Level (total energy expenditure/resting energy expenditure <= 1.75), only 17% (n = 7) of these men showed consistently low physical activity across other dimensions (moderate intensity activity, vigorous intensity activity, and sedentary time). Thus, physical activity is highly heterogeneous and there is no single outcome measure that captures all the relevant information about a given individual. We propose that future studies need to capture (rather than ignore) the different physiologically-important dimensions of physical activity via generation of integrated, multidimensional physical activity 'profiles'.	[Thompson, Dylan] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Batterham, Alan M.] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England	University of Bath; University of Teesside	Thompson, D (corresponding author), Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England.	d.thompson@bath.ac.uk		BATTERHAM, ALAN/0000-0002-7865-7227; Thompson, Dylan/0000-0002-6312-1518	National Preventative Research Initiative (NPRI); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council; Stroke Association; Wellcome Trust; Welsh Assembly Government; World Cancer Research Fund; Medical Research Council [MR/J00040X/1] Funding Source: researchfish; MRC [MR/J00040X/1] Funding Source: UKRI	National Preventative Research Initiative (NPRI); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Wellcome Trust(Wellcome Trust); Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the project was provided by the National Preventative Research Initiative (NPRI; http://www.npri.org.uk). Funding partners are: Alzheimer's Research Trust, Alzheimer's Society, Biotechnology and Biological Sciences Research Council, British Heart Foundation; Cancer Research UK; Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council; The Stroke Association; Wellcome Trust; Welsh Assembly Government and World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanck HM, 2007, OBESITY, V15, P1578, DOI 10.1038/oby.2007.187; Boule NG, 2005, DIABETES CARE, V28, P108, DOI 10.2337/diacare.28.1.108; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brooks GA, 2004, AM J CLIN NUTR, V79, P921; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Centers for Disease Control and Prevention, 2008, PHYS ACT EV MUCH PHY; Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003; Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766; Department of Health, 2004, LEAST 5 WEEK EV IMP; Department of Health, 2011, UK PHYS ACT GUID; Department of Health Physical Activity Health Improvement and Protection, 2011, START ACT STAY ACT R, P1; Eaton SB, 2003, COMP BIOCHEM PHYS A, V136, P153, DOI 10.1016/S1095-6433(03)00208-3; Gibala Martin J, 2007, Curr Sports Med Rep, V6, P211, DOI 10.1007/s11932-007-0033-8; Guiraud T, 2011, MED SCI SPORT EXER, V43, P211, DOI 10.1249/MSS.0b013e3181ebc5de; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Institute of Medicine, 2005, DIET REF INT EN CARB; Lee SMC, 2010, AVIAT SPACE ENVIR MD, V81, P52, DOI 10.3357/ASEM.2474.2010; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Rakobowchuk M, 2008, AM J PHYSIOL-REG I, V295, pR236, DOI 10.1152/ajpregu.00069.2008; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Thompson D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004337; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; World Health Organization, 2000, WHO EUR SER, V91	39	25	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56427	10.1371/journal.pone.0056427	http://dx.doi.org/10.1371/journal.pone.0056427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437131	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200072
J	Bekada, A; Fregel, R; Cabrera, VM; Larruga, JM; Pestano, J; Benhamamouch, S; Gonzalez, AM				Bekada, Asmahan; Fregel, Rosa; Cabrera, Vicente M.; Larruga, Jose M.; Pestano, Jose; Benhamamouch, Soraya; Gonzalez, Ana M.			Introducing the Algerian Mitochondrial DNA and Y-Chromosome Profiles into the North African Landscape	PLOS ONE			English	Article							HIGH-RESOLUTION ANALYSIS; MTDNA HAPLOGROUP-H; SUB-SAHARAN AFRICA; NEAR-EASTERN; GENETIC-STRUCTURE; MOLECULAR DISSECTION; POPULATION-STRUCTURE; PHYLOGENETIC TREE; WESTERN; SEQUENCE	North Africa is considered a distinct geographic and ethnic entity within Africa. Although modern humans originated in this Continent, studies of mitochondrial DNA (mtDNA) and Y-chromosome genealogical markers provide evidence that the North African gene pool has been shaped by the back-migration of several Eurasian lineages in Paleolithic and Neolithic times. More recent influences from sub-Saharan Africa and Mediterranean Europe are also evident. The presence of East-West and North-South haplogroup frequency gradients strongly reinforces the genetic complexity of this region. However, this genetic scenario is beset with a notable gap, which is the lack of consistent information for Algeria, the largest country in the Maghreb. To fill this gap, we analyzed a sample of 240 unrelated subjects from a northwest Algeria cosmopolitan population using mtDNA sequences and Y-chromosome biallelic polymorphisms, focusing on the fine dissection of haplogroups E and R, which are the most prevalent in North Africa and Europe respectively. The Eurasian component in Algeria reached 80% for mtDNA and 90% for Y-chromosome. However, within them, the North African genetic component for mtDNA (U6 and M1; 20%) is significantly smaller than the paternal (E-M81 and E-V65; 70%). The unexpected presence of the European-derived Y-chromosome lineages R-M412, R-S116, R-U152 and R-M529 in Algeria and the rest of the Maghreb could be the counterparts of the mtDNA H1, H3 and V subgroups, pointing to direct maritime contacts between the European and North African sides of the western Mediterranean. Female influx of sub-Saharan Africans into Algeria (20%) is also significantly greater than the male (10%). In spite of these sexual asymmetries, the Algerian uniparental profiles faithfully correlate between each other and with the geography.	[Bekada, Asmahan; Benhamamouch, Soraya] Univ Oran, Fac Sci, Dept Biotechnol, Oran, Algeria; [Fregel, Rosa; Cabrera, Vicente M.; Larruga, Jose M.; Gonzalez, Ana M.] Univ La Laguna, Fac Biol, Dept Genet, Tenerife, Spain; [Fregel, Rosa; Pestano, Jose] Univ Las Palmas Gran Canaria, Fac Med, Dept Genet, Las Palmas Gran Canaria, Spain; [Fregel, Rosa; Pestano, Jose] Inst Legal Med Las Palmas, Forens Genet Lab, Las Palmas Gran Canaria, Spain	Universite d'Oran; Universidad de la Laguna; Universidad de Las Palmas de Gran Canaria	Gonzalez, AM (corresponding author), Univ La Laguna, Fac Biol, Dept Genet, Tenerife, Spain.	amglez@ull.es	Pestano, Jose/A-9640-2017; Fregel, Rosa/H-4942-2015	Pestano, Jose/0000-0001-6454-4785; Fregel, Rosa/0000-0002-2951-6508	Spanish Ministerio de Ciencia e Innovacion [CGL2010-16195]; University of La Laguna; Algerian grant	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); University of La Laguna; Algerian grant	This research was supported by Grant no. CGL2010-16195 from the Spanish Ministerio de Ciencia e Innovacion to AMG and JML, by grant "Ayuda para el mantenimiento de grupos de investigacion consolidados 2012" from the University of La Laguna to AMG, and by Algerian grant to BA "programme boursier de formation a l'etranger au titre de l'annee universitaire 2010-2011 pour la categorie PNE." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brakez Z, 2001, ANN HUM BIOL, V28, P295, DOI 10.1080/030144601300119106; Capelli C, 2006, ANN HUM GENET, V70, P207, DOI 10.1111/j.1529-8817.2005.00224.x; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Casas MJ, 2006, AM J PHYS ANTHROPOL, V131, P539, DOI 10.1002/ajpa.20463; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Cherni L, 2005, HUM BIOL, V77, P61, DOI 10.1353/hub.2005.0028; Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Cruciani F, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9445; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Egyed B, 2007, FORENSIC SCI INT-GEN, V1, P158, DOI 10.1016/j.fsigen.2007.03.001; Ennafaa H, 2011, J HUM GENET, V56, P734, DOI 10.1038/jhg.2011.92; Ennafaa H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-8; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V146, P271, DOI 10.1002/ajpa.21581; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V145, P107, DOI 10.1002/ajpa.21472; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; Fentress Elizabeth, 1996, BERBERS; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Flores C, 2005, J HUM GENET, V50, P435, DOI 10.1007/s10038-005-0274-4; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Fregel R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-181; Garcia O, 2011, HEREDITY, V106, P37, DOI 10.1038/hdy.2010.47; Gonzalez AM, 2006, ANN HUM GENET, V70, P631, DOI 10.1111/j.1469-1809.2006.00259.x; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Gonzalez AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-223; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Grignani P, 2006, INT J LEGAL MED, V120, P151, DOI 10.1007/s00414-005-0059-5; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kefi R, 2005, ANTHROPOL-INT J HUM, V43, P1; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Loueslati BY, 2006, AM J HUM BIOL, V18, P149, DOI 10.1002/ajhb.20473; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Murdock G.P., 1959, AFRICA ITS PEOPLES T; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nei N, 1987, MOL EVOLUTIONARY GEN; Newman JL., 1995, PEOPLING AFRICA GEOG; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Ottoni C, 2011, AM J PHYS ANTHROPOL, V145, P118, DOI 10.1002/ajpa.21473; Ottoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013378; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Rhouda T, 2009, MITOCHONDRION, V9, P402, DOI 10.1016/j.mito.2009.07.003; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Robino C, 2008, INT J LEGAL MED, V122, P251, DOI 10.1007/s00414-007-0203-5; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tofanelli S, 2009, EUR J HUM GENET, V17, P1520, DOI 10.1038/ejhg.2009.58; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wendorf F, 1994, J RADIOCARBON ASS AM, P147	91	42	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56775	10.1371/journal.pone.0056775	http://dx.doi.org/10.1371/journal.pone.0056775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093HR	23431392	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800035
J	Coelho, JR; Carrico, JA; Knight, D; Martinez, JL; Morrissey, I; Oggioni, MR; Freitas, AT				Coelho, Joana Rosado; Carrico, Joao Andre; Knight, Daniel; Martinez, Jose-Luis; Morrissey, Ian; Oggioni, Marco Rinaldo; Freitas, Ana Teresa			The Use of Machine Learning Methodologies to Analyse Antibiotic and Biocide Susceptibility in Staphylococcus aureus	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BACTERIAL-RESISTANCE; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; CLINICAL STRAINS; TRICLOSAN; EXPOSURE; EFFLUX; TYPHIMURIUM; BREAKPOINTS	Background: The rise of antibiotic resistance in pathogenic bacteria is a significant problem for the treatment of infectious diseases. Resistance is usually selected by the antibiotic itself; however, biocides might also co-select for resistance to antibiotics. Although resistance to biocides is poorly defined, different in vitro studies have shown that mutants presenting low susceptibility to biocides also have reduced susceptibility to antibiotics. However, studies with natural bacterial isolates are more limited and there are no clear conclusions as to whether the use of biocides results in the development of multidrug resistant bacteria. Methods: The main goal is to perform an unbiased blind-based evaluation of the relationship between antibiotic and biocide reduced susceptibility in natural isolates of Staphylococcus aureus. One of the largest data sets ever studied comprising 1632 human clinical isolates of S. aureus originated worldwide was analysed. The phenotypic characterization of 13 antibiotics and 4 biocides was performed for all the strains. Complex links between reduced susceptibility to biocides and antibiotics are difficult to elucidate using the standard statistical approaches in phenotypic data. Therefore, machine learning techniques were applied to explore the data. Results: In this pioneer study, we demonstrated that reduced susceptibility to two common biocides, chlorhexidine and benzalkonium chloride, which belong to different structural families, is associated to multidrug resistance. We have consistently found that a minimum inhibitory concentration greater than 2 mg/L for both biocides is related to antibiotic non-susceptibility in S. aureus. Conclusions: Two important results emerged from our work, one methodological and one other with relevance in the field of antibiotic resistance. We could not conclude on whether the use of antibiotics selects for biocide resistance or vice versa. However, the observation of association between multiple resistance and two biocides commonly used may be of concern for the treatment of infectious diseases in the future.	[Coelho, Joana Rosado; Carrico, Joao Andre; Freitas, Ana Teresa] Univ Tecn Lisboa, INESC ID IST, Lisbon, Portugal; [Carrico, Joao Andre] Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal; [Knight, Daniel; Morrissey, Ian] Quotient Biores, Fordham, England; [Knight, Daniel] Univ Western Australia, Queen Elizabeth II Med Ctr, Nedlands, WA 6009, Australia; [Martinez, Jose-Luis] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain; [Morrissey, Ian] IHMA Europe Sarl, Epalinges, Switzerland; [Oggioni, Marco Rinaldo] Univ Siena, Dipartimento Biotecnol, I-53100 Siena, Italy	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Quotient; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); IHMA Europe Sarl; University of Siena	Coelho, JR (corresponding author), Univ Tecn Lisboa, INESC ID IST, Lisbon, Portugal.	jrcoelho@kdbio.inesc-id.pt	Oggioni, Marco Rinaldo/K-3839-2016; Coelho, Joana Rosado/I-7008-2015; Carriço, Joao André/A-7367-2008; Freitas, Ana Teresa/C-3647-2008; Knight, Daniel R./F-2522-2014; Martinez, Jose L/A-4725-2013	Oggioni, Marco Rinaldo/0000-0003-4117-793X; Coelho, Joana Rosado/0000-0002-2827-7031; Carriço, Joao André/0000-0002-5274-2722; Freitas, Ana Teresa/0000-0002-2997-5990; Knight, Daniel R./0000-0002-9480-4733; Martinez, Jose L/0000-0001-8813-7607; Morrissey, Ian/0000-0001-8254-9651	FCT [PEst-OE/EEI/LA0021/2011]; FP7 Cooperation Work Programme: Food, Agriculture and Fisheries, and Biotechnologies (BIOHYPO project) [KBBE-227258]; European Union; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/33719/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FP7 Cooperation Work Programme: Food, Agriculture and Fisheries, and Biotechnologies (BIOHYPO project); European Union(European Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT (INESC-ID multiannual funding) through the PIDDAC Program funds and under project PEst-OE/EEI/LA0021/2011 and the FP7 Cooperation Work Programme: Food, Agriculture and Fisheries, and Biotechnologies, KBBE-227258 (BIOHYPO project). Quotient Bioresearch received part-funding from the European Union in the scope of BIOHYPO project. The work of J. R. Coelho was supported by the PhD grant SFRH/BD/33719/2009 from Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase B, 2000, INT J FOOD MICROBIOL, V62, P57, DOI 10.1016/S0168-1605(00)00357-3; Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Adriaans P., 1997, DATA MINING; Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Ambrose PG, 2006, PHARMACOTHERAPY, V26, P129, DOI 10.1592/phco.2006.26.1.129; Anunciacao O, 2010, ADV INTEL SOFT COMPU, V74, P43, DOI 10.1007/978-3-642-13214-8_6; Bailey AM, 2009, J ANTIMICROB CHEMOTH, V64, P973, DOI 10.1093/jac/dkp320; Beier RC, 2005, B ENVIRON CONTAM TOX, V75, P835, DOI 10.1007/s00128-005-0826-5; Beier RC, 2011, FOODBORNE PATHOG DIS, V8, P593, DOI 10.1089/fpd.2010.0702; Birosova L, 2009, J MED MICROBIOL, V58, P436, DOI 10.1099/jmm.0.003657-0; Chapman JS, 1998, INT BIODETER BIODEGR, V41, P241, DOI 10.1016/S0964-8305(98)00025-0; Chuanchuen R, 2002, J BACTERIOL, V184, P5036, DOI 10.1128/JB.184.18.5036-5044.2002; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021; *CLIN LAB STAND I, 2011, M100S21 CLSI; Clinical and Laboratory Standards Institute, 1999, METHODS DETERMINING; CLSI, 2018, METHODS DILUTION ANT; Copitch JL, 2010, INT J ANTIMICROB AG, V36, P247, DOI 10.1016/j.ijantimicag.2010.04.012; EARSS, 2005, ANN REP EUR ANT RES; Espigares E, 2006, INT J HYG ENVIR HEAL, V209, P103, DOI 10.1016/j.ijheh.2005.08.006; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Ferber D, 2000, SCIENCE, V288, P792, DOI 10.1126/science.288.5467.792; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Hernandez A, 2011, PLOS PATHOG, V7, P12; Hesterberg T, 2003, BOOTSTRAP METHODS PE, V47, P1; Hochberg Y., 1987, MULTIPLE COMP PROCED; Hugard L, 1994, MED AFRIQUE NOIRE, V41, P31; Jansen WTM, 2006, DRUG RESIST UPDATE, V9, P123, DOI 10.1016/j.drup.2006.06.002; Kraskov A, 2008, EUROPHYSICS LETT, P70; Lambert RJW, 2004, J APPL MICROBIOL, V97, P699, DOI 10.1111/j.1365-2672.2004.02345.x; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Lucey B, 2000, EMERG INFECT DIS, V6, P50; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; MacGowan AP, 2001, J ANTIMICROB CHEMOTH, V48, P17, DOI 10.1093/jac/48.suppl_1.17; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maillard JY, 2009, CHIM OGGI, V27, P26; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Mitchell T.M, 2003, MACH LEARN; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Parikh SL, 2000, BIOCHEMISTRY-US, V39, P7645, DOI 10.1021/bi0008940; PAULSEN IT, 1993, ANTIMICROB AGENTS CH, V37, P761, DOI 10.1128/AAC.37.4.761; Rouillon S, 2006, PATHOL BIOL, V54, P325, DOI 10.1016/j.patbio.2006.01.011; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Russell AD, 2002, J APPL MICROBIOL, V92, p1S, DOI 10.1046/j.1365-2672.92.5s1.14.x; Rutala WA, 2001, J HOSP INFECT, V48, pS64, DOI 10.1016/S0195-6701(01)90017-9; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; SCCS, 2010, OP TRICL ANT RES EUR; Soumet C, 2005, LETT APPL MICROBIOL, V41, P291, DOI 10.1111/j.1472-765X.2005.01763.x; Tankovic J, 1997, MED MALADIES INFECT, V27, P207, DOI 10.1016/S0399-077X(97)80022-4; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; THABAUT A, 1983, MED MALADIES INFECT, V13, P128, DOI 10.1016/S0399-077X(83)80110-3; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; Weisstein EW, 2012, FISHERS EXACT TEST; WHO, 2007, WORLD HLTH REP A SAF	59	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55582	10.1371/journal.pone.0055582	http://dx.doi.org/10.1371/journal.pone.0055582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431361	gold, Green Published			2022-12-27	WOS:000315182800004
J	Ben-Ari, M; Inbar, M				Ben-Ari, Matan; Inbar, Moshe			When Herbivores Eat Predators: Predatory Insects Effectively Avoid Incidental Ingestion by Mammalian Herbivores	PLOS ONE			English	Article							IMPACT; PLANT; COCCINELLIDAE; ECOLOGY; ARTHROPODS; COLEOPTERA; DEFENSE; PREY; DEER; SIZE	The direct trophic links between mammalian herbivores and plant-dwelling insects have been practically ignored. Insects are ubiquitous on plants consumed by mammalian herbivores and are thus likely to face the danger of being incidentally ingested by a grazing mammal. A few studies have shown that some herbivorous hemipterans are able to avoid this peril by dropping to the ground upon detecting the heat and humidity on the mammal's breath. We hypothesized that if this risk affects the entire plant-dwelling insect community, other insects that share this habitat are expected to develop similar escape mechanisms. We assessed the ability of three species (adults and larvae) of coccinellid beetles, important aphid predators, to avoid incidental ingestion. Both larvae and adults were able to avoid incidental ingestion effectively by goats by dropping to the ground, demonstrating the importance of this behavior in grazed habitats. Remarkably, all adult beetles escaped by dropping off the plant and none used their functional wings to fly away. In controlled laboratory experiments, we found that human breath caused 60-80% of the beetles to drop. The most important component of mammalian herbivore breath in inducing adult beetles and larvae to drop was the combination of heat and humidity. The fact that the mechanism of dropping in response to mammalian breath developed in distinct insect orders and disparate life stages accentuates the importance of the direct influence of mammalian herbivores on plant-dwelling insects. This direct interaction should be given its due place when discussing trophic interactions.	[Ben-Ari, Matan; Inbar, Moshe] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	University of Haifa	Inbar, M (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	minbar@research.haifa.ac.il		Inbar, Moshe/0000-0002-4707-9508	Israel Science Foundation [940/08]	Israel Science Foundation(Israel Science Foundation)	This work was partly supported by The Israel Science Foundation (Grant Number 940/08). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1980, J THEOR BIOL, V82, P283, DOI 10.1016/0022-5193(80)90104-6; Barrozo RB, 2004, J INSECT PHYSIOL, V50, P249, DOI 10.1016/j.jinsphys.2004.01.001; Begon M., 1996, ECOLOGY; Bravo SP, 1998, AM J PRIMATOL, V45, P411, DOI 10.1002/(SICI)1098-2345(1998)45:4<411::AID-AJP7>3.0.CO;2-Z; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; DIXON AFG, 1977, ANNU REV ECOL SYST, V8, P329, DOI 10.1146/annurev.es.08.110177.001553; GIBSON CWD, 1992, ECOGRAPHY, V15, P166, DOI 10.1111/j.1600-0587.1992.tb00020.x; Gish M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032706; Gish M, 2011, NATURWISSENSCHAFTEN, V98, P731, DOI 10.1007/s00114-011-0819-7; Gish M, 2010, CURR BIOL, V20, pR628, DOI 10.1016/j.cub.2010.06.065; Gomez Jose M., 2007, P104, DOI 10.1017/CBO9780511542701.006; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Hodek I, 2012, ECOLOGY BEHAV LADYBI, DOI DOI 10.1002/9781118223208; KING KL, 1983, AUST J ECOL, V8, P245, DOI 10.1111/j.1442-9993.1983.tb01322.x; Kleijn D, 2002, J ECOL, V90, P360, DOI 10.1046/j.1365-2745.2001.00676.x; Latham DR, 2009, ENVIRON ENTOMOL, V38, P1117, DOI 10.1603/022.038.0419; Laubertie E, 2006, J INSECT BEHAV, V19, P231, DOI 10.1007/s10905-006-9018-3; Lucas E, 1997, ENTOMOPHAGA, V42, P3, DOI 10.1007/BF02769874; Lucas E, 1998, ECOLOGY, V79, P1084, DOI 10.1890/0012-9658(1998)079[1084:IPAAPC]2.0.CO;2; Martinsen GD, 1998, ECOLOGY, V79, P192, DOI 10.1890/0012-9658(1998)079[0192:IIMBCP]2.0.CO;2; Mathisen KM, 2011, THESIS U AGR SCI UME; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Minoretti N, 2000, EUR J ENTOMOL, V97, P475, DOI 10.14411/eje.2000.073; Moretti M, 2009, ECOGRAPHY, V32, P299, DOI 10.1111/j.1600-0587.2008.05524.x; Morris MG, 2000, BIOL CONSERV, V95, P129, DOI 10.1016/S0006-3207(00)00028-8; Nunamaker RA, 2003, J MED ENTOMOL, V40, P957, DOI 10.1603/0022-2585-40.6.957; Obrycki JJ, 1998, ANNU REV ENTOMOL, V43, P295, DOI 10.1146/annurev.ento.43.1.295; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Ohno T, 2007, P R SOC B, V274, P555, DOI 10.1098/rspb.2006.3750; POLLARD E, 1994, BIOL CONSERV, V70, P189, DOI 10.1016/0006-3207(94)90287-9; Rambo JL, 1999, CONSERV BIOL, V13, P1047, DOI 10.1046/j.1523-1739.1999.98504.x; Ribak G, 2013, CURR BIOL IN PRESS; Roeder K.D., 1974, P CAN SOC ZOOL ANN M, P71; Sato S, 2005, ECOL ENTOMOL, V30, P220, DOI 10.1111/j.0307-6946.2005.00688.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; SPANGLER HG, 1988, ANNU REV ENTOMOL, V33, P59, DOI 10.1146/annurev.en.33.010188.000423; STAMP NE, 1988, OECOLOGIA, V75, P619, DOI 10.1007/BF00776428; Stewart AJA, 2001, FORESTRY, V74, P259, DOI 10.1093/forestry/74.3.259; Tscharntke T, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P277; van Noordwijk CGE, 2012, J INSECT CONSERV, V16, P909, DOI 10.1007/s10841-012-9478-z; van Wieren Spike E., 2008, V195, P263; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; ZAMORA R, 1993, OIKOS, V66, P223, DOI 10.2307/3544808	45	14	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56748	10.1371/journal.pone.0056748	http://dx.doi.org/10.1371/journal.pone.0056748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424674	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100062
J	Hopton, A; Thomas, K; MacPherson, H				Hopton, Ann; Thomas, Kate; MacPherson, Hugh			The Acceptability of Acupuncture for Low Back Pain: A Qualitative Study of Patient's Experiences Nested within a Randomised Controlled Trial	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; EXPECTATIONS; OUTCOMES; PLACEBO; CARE	Introduction: The National Institute for Health and Clinical Excellence guidelines recommend acupuncture as a clinically effective treatment for chronic back pain. However, there is insufficient knowledge of what factors contribute to patients' positive and negative experiences of acupuncture, and how those factors interact in terms of the acceptability of treatment. This study used patient interviews following acupuncture treatment for back pain to identify, understand and describe the elements that contribute or detract from acceptability of treatment. Methods: The study used semi-structured interviews. Twelve patients were interviewed using an interview schedule as a sub-study nested within a randomised controlled trial of acupuncture for chronic back pain. The interviews were analysed using thematic analysis. Results and Discussion: Three over-arching themes emerged from the analysis. The first entitled facilitators of acceptability contained five subthemes; experience of pain relief, improvements in physical activity, relaxation, psychological benefit, reduced reliance on medication. The second over-arching theme identified barriers to acceptability, which included needle-related discomfort and temporary worsening of symptoms, pressure to continue treatment and financial cost. The third over-arching theme comprised mediators of acceptability, which included pre-treatment mediators such as expectation and previous experience, and treatment-related mediators of time, therapeutic alliance, lifestyle advice and the patient's active involvement in recovery. These themes inform our understanding of the acceptability of acupuncture to patients with low back pain. Conclusion: The acceptability of acupuncture treatment for low back pain is complex and multifaceted. The therapeutic relationship between the practitioner and patient emerged as a strong driver for acceptability, and as a useful vehicle to develop the patients' self-efficacy in pain management in the longer term. Unpleasant treatment related effects do not necessarily detract from patients' overall perception of acceptability.	[Hopton, Ann; MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Thomas, Kate] Univ Sheffield, Hlth Serv Res Unit, Sheffield, S Yorkshire, England	University of York - UK; University of Sheffield	Hopton, A (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	ann.hopton@york.ac.uk		Hopton, Ann/0000-0002-2505-1176; MacPherson, Hugh/0000-0003-4255-4768	National Institute for Health Research (NIHR) Health Technology Assessment programme; NIHR Career Scientist Award [PAS/03/07/CSA/008]	National Institute for Health Research (NIHR) Health Technology Assessment programme(National Institute for Health Research (NIHR)); NIHR Career Scientist Award	This research was supported by the National Institute for Health Research (NIHR) Health Technology Assessment programme and in part by a NIHR Career Scientist Award, grant number PAS/03/07/CSA/008 awarded to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NICE GUID 88, V1, P61; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Breen A, 2007, EUR J PAIN, V11, P21, DOI 10.1016/j.ejpain.2005.12.006; Cedraschi C, 2005, BEST PRACT RES CL RH, V19, P577, DOI 10.1016/j.berh.2005.03.002; Corbett M, 2009, FAM PRACT, V26, P359, DOI 10.1093/fampra/cmp042; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Evans M, 2011, J ALTERN COMPLEM MED, V17, P519, DOI 10.1089/acm.2010.0749; Foster NE, 2010, PAIN, V148, P398, DOI 10.1016/j.pain.2009.11.002; Hopton AK, 2010, ACUPUNCT MED, V28, P185, DOI 10.1136/aim.2010.002279; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; MacPherson H, 2004, COMPLEMENT THER MED, V12, P136, DOI 10.1016/j.ctim.2004.07.043; MacPherson H, 2006, J ALTERN COMPLEM MED, V12, P873, DOI 10.1089/acm.2006.12.873; Newcomer KL, 2010, PM&R, V2, P514, DOI 10.1016/j.pmrj.2010.03.034; Nicholas MK, 2007, EUR J PAIN, V11, P153, DOI 10.1016/j.ejpain.2005.12.008; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Ratcliffe J, 2006, BRIT MED J, V333, P626, DOI 10.1136/bmj.38932.806134.7C; So DW, 2002, AM J PUBLIC HEALTH, V92, P1662, DOI 10.2105/AJPH.92.10.1662; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Thomas K. J., 2005, HEALTH TECHNOL ASSES, V9, P1, DOI DOI 10.3310/hta9320; Toye Francine, 2012, Prim Health Care Res Dev, V13, P72, DOI 10.1017/S1463423611000387; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Wasan AD, 2010, J PAIN, V11, P555, DOI 10.1016/j.jpain.2009.09.013; Webb R, 2003, SPINE, V28, P1195, DOI 10.1097/00007632-200306010-00021; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007	24	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56806	10.1371/journal.pone.0056806	http://dx.doi.org/10.1371/journal.pone.0056806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437246	Green Published, gold, Green Accepted			2022-12-27	WOS:000315186000047
J	Ma, YB; Kubicek, J; Labahn, J				Ma, Yanbin; Kubicek, Jan; Labahn, Joerg			Expression and Purification of Functional Human Mu Opioid Receptor from E.coli	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; INFECTED INSECT CELLS; RAT NEUROTENSIN RECEPTOR; LARGE-SCALE PRODUCTION; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; PICHIA-PASTORIS; OVEREXPRESSION; SOLUBILIZATION; SEQUENCE	N-terminally his-tagged human mu opioid receptor, a G protein-coupled receptor was produced in E. coli employing synthetic codon-usage optimized constructs. The receptor was expressed in inclusion bodies and membrane- inserted in different E. coli strains. By optimizing the expression conditions the expression level for the membrane-integrated receptor was raised to 0.3- 0.5 mg per liter of culture. Milligram quantities of receptor could be enriched by affinity chromatography from IPTG induced cultures grown at 18 degrees C. By size exclusion chromatography the protein fraction with the fraction of alpha- helical secondary structure expected for a 7-TM receptor was isolated, by CD-spectroscopy an alpha-helical content of ca. 45% was found for protein solubilised in the detergent Fos-12. Receptor in Fos-12 micelles was shown to bind endomorphin-1 with a K-D of 61 nM. A final yield of 0.17 mg functional protein per liter of culture was obtained.	[Ma, Yanbin; Kubicek, Jan; Labahn, Joerg] Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Kubicek, Jan] QIAGEN GmbH, Hilden, Germany	Helmholtz Association; Research Center Julich; QIAGEN GmbH	Labahn, J (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany.	j.labahn@fz-juelich.de	Labahn, Jörg/G-9593-2013	Labahn, Jörg/0000-0002-0648-8145				Akermoun M, 2005, PROTEIN EXPRES PURIF, V44, P65, DOI 10.1016/j.pep.2005.04.016; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Chaturvedi K, 2000, MOL BRAIN RES, V76, P64, DOI 10.1016/S0169-328X(99)00332-0; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Corin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023036; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Grunewald S, 2004, RECEPTOR CHANNEL, V10, P37, DOI 10.1080/10606820490279466; Hassaine G, 2006, PROTEIN EXPRES PURIF, V45, P343, DOI 10.1016/j.pep.2005.06.007; Kaiser L, 2008, P NATL ACAD SCI USA, V105, P15726, DOI 10.1073/pnas.0804766105; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Maggio R, 2005, FEBS J, V272, P2939, DOI 10.1111/j.1742-4658.2005.04729.x; Magnusdottir A, 2009, NAT METHODS, V6, P477, DOI 10.1038/nmeth0709-477; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Massotte D, 1999, J BIOTECHNOL, V69, P39, DOI 10.1016/S0168-1656(98)00209-0; Massotte D, 1997, J BIOL CHEM, V272, P19987, DOI 10.1074/jbc.272.32.19987; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Sarramegna V, 2002, PROTEIN EXPRES PURIF, V24, P212, DOI 10.1006/prep.2001.1564; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Singh VK, 1997, NEUROIMMUNOMODULAT, V4, P285, DOI 10.1159/000097349; Stanasila L, 1999, EUR J BIOCHEM, V260, P430, DOI 10.1046/j.1432-1327.1999.00187.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Tyndall JDA, 2005, MED CHEM, V1, P405, DOI 10.2174/1573406054368675; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Wang XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023076; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	41	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56500	10.1371/journal.pone.0056500	http://dx.doi.org/10.1371/journal.pone.0056500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437147	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000030
J	Mertins, SD; Scudiero, DA; Hollingshead, MG; Divelbiss, RD; Alley, MC; Monks, A; Covell, DG; Hite, KM; Salomon, DS; Niederhuber, JE				Mertins, Susan D.; Scudiero, Dominic A.; Hollingshead, Melinda G.; Divelbiss, Raymond D., Jr.; Alley, Michael C.; Monks, Anne; Covell, David G.; Hite, Karen M.; Salomon, David S.; Niederhuber, John E.			A Small Molecule (Pluripotin) as a Tool for Studying Cancer Stem Cell Biology: Proof of Concept	PLOS ONE			English	Article							PROSPECTIVE IDENTIFICATION; GENE-EXPRESSION; TUMOR; DIFFERENTIATION; REVEALS; PATHWAY; GROWTH; MODEL; RSK	Background: Cancer stem cells (CSC) are thought to be responsible for tumor maintenance and heterogeneity. Bona fide CSC purified from tumor biopsies are limited in supply and this hampers study of CSC biology. Furthermore, purified stem-like CSC subpopulations from existing tumor lines are unstable in culture. Finding a means to overcome these technical challenges would be a useful goal. In a first effort towards this, we examined whether a chemical probe that promotes survival of murine embryonic stem cells without added exogenous factors can alter functional characteristics in extant tumor lines in a fashion consistent with a CSC phenotype. Methodology/Principal Findings: The seven tumor lines of the NCI60 colon subpanel were exposed to SC-1 (pluripotin), a dual kinase and GTPase inhibitor that promotes self-renewal, and then examined for tumorigenicity under limiting dilution conditions and clonogenic activity in soft agar. A statistically significant increase in tumor formation following SC-1 treatment was observed (p<0.04). Cloning efficiencies and expression of putative CSC surface antigens (CD133 and CD44) were also increased. SC-1 treatment led to sphere formation in some colon tumor lines. Finally, SC-1 inhibited in vitro kinase activity of RSK2, and another RSK2 inhibitor increased colony formation implicating a role for this kinase in eliciting a CSC phenotype. Conclusions/Significance: These findings validate a proof of concept study exposure of extant tumor lines to a small molecule may provide a tractable in vitro model for understanding CSC biology.	[Mertins, Susan D.; Alley, Michael C.; Covell, David G.] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA; [Scudiero, Dominic A.; Monks, Anne; Hite, Karen M.] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Hollingshead, Melinda G.; Divelbiss, Raymond D., Jr.] NCI, Biol Testing Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA; [Salomon, David S.] NCI, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Niederhuber, John E.] NCI, Cell & Canc Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mertins, SD (corresponding author), NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA.	smertins@mail.nih.gov			Division for Cancer Diagnosis and Treatment; Center for Cancer Research at the National Cancer Institute; NCI Contract [HHSN261200800001E]	Division for Cancer Diagnosis and Treatment; Center for Cancer Research at the National Cancer Institute; NCI Contract	This study was supported by the Division for Cancer Diagnosis and Treatment and Center for Cancer Research at the National Cancer Institute and partially funded by NCI Contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alkatout I, 2008, BIOL CHEM, V389, P799, DOI 10.1515/BC.2008.094; ALLEY MC, 1991, CANCER RES, V51, P1247; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gamelin E, 1999, J UROLOGY, V162, P217, DOI 10.1097/00005392-199907000-00071; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Horiuchi KY, 2006, J BIOMOL SCREEN, V11, P48, DOI 10.1177/1087057105282097; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; Huang RL, 2006, MOL CANCER THER, V5, P2417, DOI 10.1158/1535-7163.MCT-06-0239; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Hurt EM, 2010, STEM CELLS, V28, P390, DOI 10.1002/stem.271; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kirkland SC, 2008, J BIOL CHEM, V283, P27612, DOI 10.1074/jbc.M802932200; Leder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014366; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Nguyen TL, 2006, BIOORGAN MED CHEM, V14, P6097, DOI 10.1016/j.bmc.2006.05.001; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Plowman J, 1997, HUMAN TUMOR XENOGRAF; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rappa G, 2008, EXP CELL RES, V314, P2110, DOI 10.1016/j.yexcr.2008.03.008; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Smith JA, 2005, CANCER RES, V65, P1027; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; TASWELL C, 1981, J IMMUNOL, V126, P1614; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57099	10.1371/journal.pone.0057099	http://dx.doi.org/10.1371/journal.pone.0057099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437320	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000076
J	Rai, A; Tzvetkov, N; Manstein, DJ				Rai, Amrita; Tzvetkov, Nikolay; Manstein, Dietmar J.			Functional Dissection of the Dictyostelium discoideum Dynamin B Mitochondrial Targeting Sequence	PLOS ONE			English	Article							PROTEIN IMPORT; PROCESSING PEPTIDASE; PRECURSOR PROTEINS; CRYSTAL-STRUCTURE; FUSION; CLEAVAGE; PREDICTION; REQUIRES; IDENTIFICATION; TRANSLOCATION	Most mitochondrial proteins are nuclear encoded and synthesized in the cytosol with an N-terminal mitochondrial targeting sequence or presequence for subsequent import into mitochondria. Here, we describe the proteolytic processing and inner membrane potential-dependent translocation of a dynamin family member by the Dictyostelium discoideum mitochondrial import system. Our results show that the unusual D. discoideum dynamin B presequence is removed through a processing mechanism that is common for mitochondrial matrix proteins. We identified a minimal segment of the dynamin B presequence containing seven lysine residues. This 47-residue region is, in combination with consensus matrix protease cleavage sites, necessary and sufficient for mitochondrial targeting. The correct positioning of these lysine residues plays a critical role for the proper processing and mitochondrial import of dynamin B in D. discoideum. Fluorescent proteins tagged with the dynamin B presequence or presequence regions supporting mitochondrial import in D. discoideum are imported with similar efficiency into the mitochondrial matrix of mammalian cells, indicating that the basic mechanisms underlying mitochondrial protein import are highly conserved from amoebozoa to mammalia.	[Rai, Amrita; Tzvetkov, Nikolay; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, Hannover, Germany	Hannover Medical School	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Hannover, Germany.	manstein.dietmar@mh-hannover.de	Manstein, Dietmar J. J/M-1034-2013; Manstein, Dietmar J./AAG-2640-2019; Tzvetkov, Nikolay/N-2872-2014	Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147; Rai, Amrita/0000-0002-5471-5250	state of Lower-Saxony; German Research Council (DFG); NICHD	state of Lower-Saxony; German Research Council (DFG)(German Research Foundation (DFG)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by the state of Lower-Saxony and the German Research Council (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Anurag Kumar Singh for help and stimulating discussions. The monoclonal anti-mitoporin antibody 70-100-1 developed by G. Gerisch and co-workers was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Ahmed AU, 2006, EUKARYOT CELL, V5, P1314, DOI 10.1128/EC.00386-05; Barth C, 2007, INT REV CYTOL, V263, P207, DOI 10.1016/S0074-7696(07)63005-8; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; GELI V, 1990, J BIOL CHEM, V265, P19216; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; HAUCKE V, 1995, J BIOL CHEM, V270, P5565, DOI 10.1074/jbc.270.10.5565; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Insall R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-222; ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; Knetsch MLW, 2002, J MUSCLE RES CELL M, V23, P605, DOI 10.1023/A:1024498805771; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rai A, 2011, CELL MOL LIFE SCI, V68, P2751, DOI 10.1007/s00018-010-0590-5; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; TROLL H, 1992, J BIOL CHEM, V267, P21072; Tzvetkov N, 2006, BIOTECHNIQUES, V40, P145, DOI 10.2144/000112113; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56975	10.1371/journal.pone.0056975	http://dx.doi.org/10.1371/journal.pone.0056975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437285	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000061
J	Shi, L; Shi, L; Wang, L; Duan, YH; Lei, W; Wang, Z; Li, J; Fan, XL; Li, XK; Li, SJ; Guo, Z				Shi, Lei; Shi, Lei; Wang, Ling; Duan, Yonghong; Lei, Wei; Wang, Zhen; Li, Jing; Fan, Xiangli; Li, Xiaokang; Li, Shujun; Guo, Zheng			The Improved Biological Performance of a Novel Low Elastic Modulus Implant	PLOS ONE			English	Article							IN-VIVO; BIOMECHANICAL CHARACTERIZATION; SHAPE-MEMORY; BONE LOSS; TITANIUM; TISSUE; MICROMOTION; MODEL; OSSEOINTEGRATION; DIFFERENTIATION	Background: The mismatch of the elastic modulus between implants and bone tissue can lead to stress shielding, bone resorption and poor osseointegration. Compared with normal bone tissue, this problem is much more serious in osteoporosis. The purpose of this study was designed to find out whether the novel Ti-24Nb-4Zr-7.9Sn (TNZS) implant with low elastic modulus and high strength was suitable for biomedical material, especially in osteoporosis. Methodology: In vitro study, the viability and Alkaline phosphatase (ALP) activity of osteoblasts on the TNZS and Ti-6V-4V (TAV) were observed. In vivo study, 30 adult female New Zealand rabbits were selected and divided randomly into two groups: sham-operation (SHAM, n = 6) and ovariectomised in combination with methylprednisolone treatment (OVX+MP, n = 24). Two implants were then placed in the tibia of each OVX + MP group rabbit, one in each side (left: TAV; right: TNZS). The OVX + MP group rabbits were sacrificed at 4 and 12 weeks after the implantation. The osteoporotic bone responses to the TNZS and TAV implants were evaluated by pull-out test, Micro-CT analyses and histological observation. Principal Findings: Compared with the TAV group, the TNZS group showed a significant increase (P<0.05) in cell viability and ALP activity, new bone formation and pull-out force. Conclusions: The novel TNZS implants show good biological performance both in vitro and in vivo, which suggests that the alloys are suitable for biomedical applications, especially in osteoporosis.	[Shi, Lei; Duan, Yonghong; Lei, Wei; Wang, Zhen; Li, Jing; Fan, Xiangli; Li, Xiaokang; Guo, Zheng] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China; [Shi, Lei] Fourth Mil Med Univ, Inst Implantat, Stomatol Hosp, Xian 710032, Peoples R China; [Wang, Ling] Fourth Mil Med Univ, Inst Hlth Stat, Xian 710032, Peoples R China; [Li, Shujun] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese Academy of Sciences; Institute of Metal Research, CAS	Guo, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China.	guozheng@fmmu.edu.cn		Lei, Wei/0000-0002-7346-6915	National Natural Science Foundation of China [30471754]; 863 Program of China [2007AA03Z431]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program of China(National High Technology Research and Development Program of China)	This work was supported financially in part by the National Natural Science Foundation of China (grant 30471754) and 863 Program of China (No. 2007AA03Z431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Branemark R, 1998, J ORTHOPAED RES, V16, P61, DOI 10.1002/jor.1100160111; Branemark R, 1998, MED ENG PHYS, V20, P216, DOI 10.1016/S1350-4533(98)00023-X; Cao T, 2004, J PERIODONTAL RES, V39, P37, DOI 10.1111/j.1600-0765.2004.00703.x; Cao T, 2001, CLIN ORAL IMPLAN RES, V12, P604, DOI 10.1034/j.1600-0501.2001.120608.x; Cao XY, 2006, BIOMED MATER, V1, pL16, DOI 10.1088/1748-6041/1/4/L02; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Castaneda S, 2008, J BONE MINER METAB, V26, P53, DOI 10.1007/s00774-007-0797-1; Chaudhari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024186; COOK SD, 1983, J BIOMED MATER RES, V17, P519, DOI 10.1002/jbm.820170311; DHERT WJ, 2000, MECH TESTING BONE BO; Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003; Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021; Ferrandini PL, 2007, J ALLOY COMPD, V433, P207, DOI 10.1016/j.jallcom.2006.06.094; Fu J, 2008, APPL SURF SCI, V255, P286, DOI 10.1016/j.apsusc.2008.06.064; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Gibson L.J., 1997, CELLULAR SOLIDS; GRARDEL B, 1994, OSTEOPOROSIS INT, V4, P204, DOI 10.1007/BF01623240; Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018; Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002; Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192; He FM, 2009, INT J ORAL MAX SURG, V38, P677, DOI 10.1016/j.ijom.2009.03.716; HEAD WC, 1995, CLIN ORTHOP RELAT R, P85; Hedia HS, 2002, BIO-MED MATER ENG, V12, P111; Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512; Inamura T, 2005, MAT SCI ENG C-BIO S, V25, P426, DOI 10.1016/j.msec.2005.01.025; Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010; Jonsson AK, 2002, THIN SOLID FILMS, V402, P242, DOI 10.1016/S0040-6090(01)01715-1; Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008; Li BF, 2010, ACTA ORTHOP, V81, P396, DOI 10.3109/17453674.2010.483986; Lin DJ, 2007, BIOMATERIALS, V28, P2582, DOI 10.1016/j.biomaterials.2007.02.005; Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054; Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2; Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002; Park CH, 2007, J PERIODONTOL, V78, P273, DOI 10.1902/jop.2007.060252; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Sanden B, 2001, EUR SPINE J, V10, P334, DOI 10.1007/s005860100291; Simon U, 2003, J BIOMECH, V36, P1079, DOI 10.1016/S0021-9290(03)00114-3; Southard TE, 2000, ORAL SURG ORAL MED O, V89, P244, DOI 10.1067/moe.2000.102223; Spoerke ED, 2008, J BIOMED MATER RES A, V84A, P402, DOI 10.1002/jbm.a.31317; Stoppie N, 2009, J BIOMED MATER RES A, V90A, P792, DOI 10.1002/jbm.a.32145; Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y; Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K; Takeuchi K, 2005, J BIOMED MATER RES A, V72A, P296, DOI 10.1002/jbm.a.30227; Thompson GJ, 1996, BIOMATERIALS, V17, P1949, DOI 10.1016/0142-9612(96)00009-9; Turner A. Simon, 2001, European Cells & Materials, V1, P66; Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8; Wolff J, 1892, GESETZ TRANSFORMATIO	50	52	53	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55015	10.1371/journal.pone.0055015	http://dx.doi.org/10.1371/journal.pone.0055015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437048	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000005
J	Vreven, T; Hwang, H; Weng, ZP				Vreven, Thom; Hwang, Howook; Weng, Zhiping			Exploring Angular Distance in Protein-Protein Docking Algorithms	PLOS ONE			English	Article							SHAPE COMPLEMENTARITY; GEOMETRIC FIT; PREDICTION; ELECTROSTATICS; RECOGNITION; PERFORMANCE; POTENTIALS; COMPLEXES; ZRANK; ZDOCK	We present a two-stage hybrid-resolution approach for rigid-body protein-protein docking. The first stage is carried out at low-resolution (15 degrees) angular sampling. In the second stage, we sample promising regions from the first stage at a higher resolution of 6 degrees. The hybrid-resolution approach produces the same results as a 6 degrees uniform sampling docking run, but uses only 17% of the computational time. We also show that the angular distance can be used successfully in clustering and pruning algorithms, as well as the characterization of energy funnels. Traditionally the root-mean-square-distance is used in these algorithms, but the evaluation is computationally expensive as it depends on both the rotational and translational parameters of the docking solutions. In contrast, the angular distances only depend on the rotational parameters, which are generally fixed for all docking runs. Hence the angular distances can be pre-computed, and do not add computational time to the post-processing of rigid-body docking results.	[Vreven, Thom; Hwang, Howook; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.	Zhiping.Weng@umassmed.edu			National Institutes of Health [R01 GM084884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant R01 GM084884 awarded to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; Bajaj C, 2011, IEEE ACM T COMPUT BI, V8, P45, DOI 10.1109/TCBB.2009.57; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hwang H, 2011, PROTEINS, V79, P2467, DOI 10.1002/prot.23070; Hwang H, 2010, PROTEINS, V78, P3104, DOI 10.1002/prot.22764; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; London N, 2008, STRUCTURE, V16, P269, DOI 10.1016/j.str.2007.11.013; London N, 2008, BIOCHEM SOC T, V36, P1418, DOI 10.1042/BST0361418; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Mitchell JC, 2008, SIAM J SCI COMPUT, V30, P525, DOI 10.1137/030601879; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NOREL R, 1995, J MOL BIOL, V252, P263, DOI 10.1006/jmbi.1995.0493; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Ravikant DVS, 2010, PROTEINS, V78, P400, DOI 10.1002/prot.22550; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Shen Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000191; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Vreven T, 2012, PROTEIN SCI, V21, P396, DOI 10.1002/pro.2027; Vreven T, 2011, PROTEIN SCI, V20, P1576, DOI 10.1002/pro.687; Yershova A, INT J ROBOT RES, V29, P801; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56645	10.1371/journal.pone.0056645	http://dx.doi.org/10.1371/journal.pone.0056645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437194	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000037
J	Ebrahimpour, M; Putnins, TJ; Berryman, MJ; Allison, A; Ng, BWH; Abbott, D				Ebrahimpour, Maryam; Putnins, Talis J.; Berryman, Matthew J.; Allison, Andrew; Ng, Brian W. -H.; Abbott, Derek			Automated Authorship Attribution Using Advanced Signal Classification Techniques	PLOS ONE			English	Article								In this paper, we develop two automated authorship attribution schemes, one based on Multiple Discriminant Analysis (MDA) and the other based on a Support Vector Machine (SVM). The classification features we exploit are based on word frequencies in the text. We adopt an approach of preprocessing each text by stripping it of all characters except a-z and space. This is in order to increase the portability of the software to different types of texts. We test the methodology on a corpus of undisputed English texts, and use leave-one-out cross validation to demonstrate classification accuracies in excess of 90%. We further test our methods on the Federalist Papers, which have a partly disputed authorship and a fair degree of scholarly consensus. And finally, we apply our methodology to the question of the authorship of the Letter to the Hebrews by comparing it against a number of original Greek texts of known authorship. These tests identify where some of the limitations lie, motivating a number of open questions for future work. An open source implementation of our methodology is freely available for use at https://github.com/matthewberryman/author-detection.	[Ebrahimpour, Maryam; Putnins, Talis J.; Berryman, Matthew J.; Allison, Andrew; Ng, Brian W. -H.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Putnins, Talis J.] Stockholm Sch Econ Riga, Riga, Latvia; [Putnins, Talis J.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Berryman, Matthew J.] Univ Wollongong, SMART Infrastruct Facil, Wollongong, NSW, Australia	University of Adelaide; University of Technology Sydney; University of Wollongong	Abbott, D (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	derek.abbott@adelaide.edu.au	Allison, Andrew/AAG-8356-2019; Abbott, Derek/E-8352-2011; Ng, Brian W.-H./D-3700-2018	Allison, Andrew/0000-0003-3865-511X; Abbott, Derek/0000-0002-0945-2674; Ng, Brian W.-H./0000-0002-8316-4996; Putnins, Talis/0000-0001-5731-499X				Adair D., 1944, WILLIAM MARY Q, V1, P235, DOI DOI 10.2307/1923729; Alviar JJ, 2008, NEW TESTAMENT STUD, V54, P139, DOI 10.1017/S0028688508000088; Ayat NE, 2005, PATTERN RECOGN, V38, P1733, DOI 10.1016/j.patcog.2005.03.011; Baayen H., 2002, 6 JADT, V1, P69; Berryman MJ, 2003, FLUCT NOISE LETT, V3, pL1, DOI 10.1142/S021947750300104X; Bosch RA, 1998, AM MATH MON, V105, P601, DOI 10.2307/2589242; CANNON RL, 1986, IEEE T PATTERN ANAL, V8, P248, DOI 10.1109/TPAMI.1986.4767778; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Diederich J, 2003, APPL INTELL, V19, P109, DOI 10.1023/A:1023824908771; Dunn J.C., 1973, J CYBERNETICS, V3, P32, DOI [10.1080/01969727308546046, DOI 10.1080/01969727308546046]; Estival D, 2008, J SCI VIETNAM NATL U, V1, P1; Eusebius, 1890, CHURCH HIST; Fung G., 2003, P 2003 C DIV COMP, P42; Gray D, 1998, 4 INT C OPT TECHN AP, P891; Gray D, 1998, WORKSH COMM GDR ISIS; Green S. B., 2005, USING SPSS WINDOWS M, V4th; Hirst G, 2012, ENGL STUD, V93, P357, DOI 10.1080/0013838X.2012.668789; Holmes D. I., 1995, LIT LINGUIST COMPUT, V10, P111, DOI DOI 10.1093/LLC/10.2.111; Hsu C. W., 2010, TECHNICAL REPORT; Iqbal F, 2008, DIGIT INVEST, V5, pS42, DOI 10.1016/j.diin.2008.05.001; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Juola P, 2012, ENGL STUD, V93, P275, DOI 10.1080/0013838X.2012.668792; Koppel M, 2012, ENGL STUD, V93, P284, DOI 10.1080/0013838X.2012.668794; Krieg M, 2001, DEFENCE APPL SIGNAL, P126; Lewicki P, 2005, STAT METHODS APPL; Luyckx K., 2008, P 22 INT C COMP LING, P513; Mosteller F, 1964, INFERENCE DISPUTED A; Mustafa Tareef Kamil, 2010, Journal of Computer Sciences, V6, P235, DOI 10.3844/jcssp.2010.235.243; Ortuno M, 2002, EUROPHYS LETT, V57, P759, DOI 10.1209/epl/i2002-00528-3; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Putnins TJ, 2005, P SPIE COMPLEX SYSTE, V6039, P1; Sabordo M, 2004, P SPIE SMART STRUCTU, P513; Savoy J, 2013, INFORM PROCESS MANAG, V49, P341, DOI 10.1016/j.ipm.2012.06.003; Sayoud H, 2012, LIT LINGUISTIC COMPU, V1, P1; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Tsimboukakis N, 2010, NEURAL COMPUT APPL, V19, P573, DOI 10.1007/s00521-009-0314-7; Tweedie FJ, 1996, COMPUT HUMANITIES, V30, P1, DOI 10.1007/BF00054024; Wallace DB, 2000, HEBREWS INTRO ARGUME; Xiaoling Chen, 2011, Machine Learning and Data Mining in Pattern Recognition. Proceedings 7th International Conference, MLDM 2011, P375, DOI 10.1007/978-3-642-23199-5_28; Zhao Y, 2005, LECT NOTES COMPUT SC, V3689, P174	42	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54998	10.1371/journal.pone.0054998	http://dx.doi.org/10.1371/journal.pone.0054998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437047	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200011
J	Garske, T; Ferguson, NM; Ghani, AC				Garske, Tini; Ferguson, Neil M.; Ghani, Azra C.			Estimating Air Temperature and Its Influence on Malaria Transmission across Africa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANOPHELES-GAMBIAE; CLIMATE-CHANGE; LAND-COVER; AQUATIC STAGES; MODEL; RISK; DYNAMICS; WEST; POPULATION	Malaria transmission is strongly influenced by climatic conditions which determine the abundance and seasonal dynamics of the Anopheles vector. In particular, water temperature influences larval development rates whereas air temperature determines adult longevity as well as the rate of parasite development within the adult mosquito. Although data on land surface temperature exist at a spatial resolution of approximately 1 km globally with four time steps per day, comparable data are not currently available for air temperature. In order to address this gap and demonstrate the importance of using the right type of temperature data, we fitted simple models of the relationship between land-surface and air temperature at lower resolution to obtain a high resolution estimate of air temperature across Africa. We then used these estimates to calculate some crucial malaria transmission parameters that strongly depend on air temperatures. Our results demonstrate substantial differences between air and surface temperatures that impact temperature-based maps of areas suitable for transmission. We present high resolution maps of the malaria transmission parameters driven by air temperature and their seasonal variation. The fitted air temperature datasets are made publicly available alongside this publication.	[Garske, Tini; Ferguson, Neil M.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England	Imperial College London	Garske, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England.	t.garske@imperial.ac.uk	Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Ghani, Azra/0000-0002-0007-4910	Medical Research Council; Bill and Melinda Gates Foundation; National Institute of General Medical Sciences (NIGMS) Models of Infectious Disease Agent Study (MIDAS) initiative; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [G0600719B, MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of General Medical Sciences (NIGMS) Models of Infectious Disease Agent Study (MIDAS) initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Medical Research Council (http://www.mrc.ac.uk), the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org) and the National Institute of General Medical Sciences (NIGMS) Models of Infectious Disease Agent Study (MIDAS) initiative (http://www.nigms.nih.gov/Research/FeaturedPrograms/MIDAS) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; [Anonymous], 1990, ALMANAC COMPUTERS; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Bounoua L, 2002, CLIMATIC CHANGE, V52, P29, DOI 10.1023/A:1013051420309; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; DETINOVA T. S., 1964, BULL WORLD HEALTH ORGAN, V30, P23; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; European Centre for Medium-Range Weather Forecasts, ECMWF DAT SERV; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Githeko A.K., 2001, GLOB CHANGE HUM HLTH, V2, P54, DOI [10.1023/A:1011943131643, DOI 10.1023/A:1011943131643]; Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287; Gosoniu L, 2009, COMPUT STAT DATA AN, V53, P3358, DOI 10.1016/j.csda.2009.02.022; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Ikemoto T, 2008, J MED ENTOMOL, V45, P963, DOI 10.1603/0022-2585(2008)45[963:TMDNMH]2.0.CO;2; Isaaks E.H., 1989, ISA; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kleinschmidt I, 2001, AM J EPIDEMIOL, V153, P1213, DOI 10.1093/aje/153.12.1213; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Loveland TR, 1997, INT J REMOTE SENS, V18, P3291, DOI 10.1080/014311697217099; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558; Munga S, 2009, AM J TROP MED HYG, V81, P1079, DOI 10.4269/ajtmh.2009.09-0156; Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Press W. H., 1992, ART SCI COMPUTING; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shanks GD, 2002, EMERG INFECT DIS, V8, P1404, DOI 10.3201/eid0812.020077; Snijders AB, 1999, MULTILEVEL ANAL INTR; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Thomas MB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001262; van Lieshout M, 2004, GLOBAL ENVIRON CHANG, V14, P87, DOI 10.1016/j.gloenvcha.2003.10.009; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537	61	41	41	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56487	10.1371/journal.pone.0056487	http://dx.doi.org/10.1371/journal.pone.0056487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437143	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200082
J	Ismail, Y; Lee, H; Riordan, SM; Grimm, MC; Zhang, L				Ismail, Yazan; Lee, Hoyul; Riordan, Stephen M.; Grimm, Michael C.; Zhang, Li			The Effects of Oral and Enteric Campylobacter concisus Strains on Expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; IDENTIFICATION; HELICOBACTER; RESPONSIVENESS; STIMULATION; TOLERANCE; APOPTOSIS	Campylobacter concisus, a Gram-negative bacterium that colonizes the human oral cavity, has been shown to be associated with inflammatory bowel diseases (IBD). The effects of different C. concisus strains on intestinal epithelial expression of Toll like receptors (TLR) have not been investigated. This study examined the effects of C. concisus strains isolated from patients with IBD and controls on expression of TLR4, its co-receptor myeloid differentiation factor (MD)-2; TLR2, TLR5, cyclooxygenase-2 (COX-2) and interleukin (IL)-8 in HT-29 cells. Fourteen oral and enteric C. concisus strains isolated from patients with IBD and healthy controls were co-incubated with HT-29 cells. Expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 cells in response to C. concisus infection was examined by Western blot, flow cytometry analysis and immunofluorescent staining visualized by confocal microscope. Production of IL-8 was evaluated by enzyme-linked immunosorbent assay. Both oral and enteric C. concisus strains upregulated expression of TLR4 in HT-29 cells. The levels of glycosylated TLR4 (Gly-TLR4) and surface TLR4 induced by C. concisus strains isolated from patients with IBD were significantly higher than those induced by C. concisus strains isolated from the healthy controls. Four C. concisus strains isolated from patients with IBD induced more than two-fold increase of surface expression of MD-2. C. concisus did not affect expression of TLR2 and TLR5. All C. concisus strains induced production of IL-8 and COX-2 in HT-29 cells. This study shows that some C. concisus strains, most from patients with IBD, upregulate surface expression of TLR4 and MD-2 in HT-29 cells. These data suggest that a potential role of specific C. concisus strains in modulating the intestinal epithelial responses to bacterial LPS needs to be investigated.	[Ismail, Yazan; Lee, Hoyul; Zhang, Li] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Riordan, Stephen M.] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Riordan, Stephen M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Grimm, Michael C.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Zhang, L (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	L.Zhang@unsw.edu.au		Grimm, Michael/0000-0001-9426-3917; Zhang, Li/0000-0001-7506-8278; Ismail, Yazan/0000-0002-7020-3642	Broad Medical Research Program of the Broad Foundation [IBD0273-R]; faculty research grant from the University of New South Wales; Al-Balaq' Applied University, Jordan	Broad Medical Research Program of the Broad Foundation; faculty research grant from the University of New South Wales; Al-Balaq' Applied University, Jordan	This work was supported by the Broad Medical Research Program of the Broad Foundation (Grant no: IBD0273-R) and a faculty research grant from the University of New South Wales. Yazan Ismail is supported by a PhD scholarship from Al-Balaq' Applied University, Jordan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; BASTYNS K, 1995, MOL CELL PROBE, V9, P247, DOI 10.1016/S0890-8508(95)90114-0; Bertelsen LS, 2003, INFECT IMMUN, V71, P2102, DOI 10.1128/IAI.71.4.2102-2109.2003; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291, DOI 10.1111/j.1365-2249.1995.tb03667.x; Ismail Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038217; Jones NL, 1999, INFECT IMMUN, V67, P4237, DOI 10.1128/IAI.67.8.4237-4242.1999; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim JM, 2006, EUR J IMMUNOL, V36, P2446, DOI 10.1002/eji.200535808; Lastovica AJ, 2009, J CLIN MICROBIOL, V47, P2360, DOI 10.1128/JCM.00568-09; Lynch OA, 2011, INT J FOOD MICROBIOL, V150, P171, DOI 10.1016/j.ijfoodmicro.2011.07.037; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Matsheka MI, 2001, J CLIN MICROBIOL, V39, P3684, DOI 10.1128/JCM.39.10.3684-3689.2001; Mukhopadhya I, 2011, PLOS ONE, V6; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nielsen HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023858; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Petersen RF, 2007, J APPL MICROBIOL, V103, P2601, DOI 10.1111/j.1365-2672.2007.03515.x; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Seksik P, 2010, INNATE IMMUN-LONDON, V16, P381, DOI 10.1177/1753425909357076; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Smith K, 2003, POETRY REV, V93, P5; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Vamadevan AS, 2010, INNATE IMMUN-LONDON, V16, P93, DOI 10.1177/1753425909339231; VANDAMME P, 1989, J CLIN MICROBIOL, V27, P1775, DOI 10.1128/JCM.27.8.1775-1781.1989; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Veltkamp C, 2001, GASTROENTEROLOGY, V120, P900, DOI 10.1053/gast.2001.22547; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	50	21	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56888	10.1371/journal.pone.0056888	http://dx.doi.org/10.1371/journal.pone.0056888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437263	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200178
J	MacGregor-Fors, I; Payton, ME				MacGregor-Fors, Ian; Payton, Mark E.			Contrasting Diversity Values: Statistical Inferences Based on Overlapping Confidence Intervals	PLOS ONE			English	Article							BIODIVERSITY	Ecologists often contrast diversity (species richness and abundances) using tests for comparing means or indices. However, many popular software applications do not support performing standard inferential statistics for estimates of species richness and/or density. In this study we simulated the behavior of asymmetric log-normal confidence intervals and determined an interval level that mimics statistical tests with P(alpha) = 0.05 when confidence intervals from two distributions do not overlap. Our results show that 84% confidence intervals robustly mimic 0.05 statistical tests for asymmetric confidence intervals, as has been demonstrated for symmetric ones in the past. Finally, we provide detailed user-guides for calculating 84% confidence intervals in two of the most robust and highly-used freeware related to diversity measurements for wildlife (i.e., EstimateS, Distance).	[MacGregor-Fors, Ian] Inst Ecol, AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Payton, Mark E.] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA	Instituto de Ecologia - Mexico; Oklahoma State University System; Oklahoma State University - Stillwater	MacGregor-Fors, I (corresponding author), Inst Ecol, AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico.	ian.macgregor@inecol.edu.mx	MacGregor-Fors, Ian/P-1455-2014	MacGregor-Fors, Ian/0000-0003-3198-7322				Buckland ST, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00186.1; Colwell R.K., 2011, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Fernandez-Juricic E, 2001, BIODIVERS CONSERV, V10, P1303, DOI 10.1023/A:1016614625675; Gaines WL, 2007, RESTOR ECOL, V15, P670, DOI 10.1111/j.1526-100X.2007.00279.x; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hubbell Stephen P., 2001, V32, pi; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran AE, 2011, BIOL DIVERSITY; Moreno C., 2001, THESIS SEA; Moreno CE, 2010, OECOLOGIA, V163, P279, DOI 10.1007/s00442-010-1591-7; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; SAS, 2008, PC SAS VERS 9 2; Sokal R.R., 2012, BIOMETRY; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x	17	156	164	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56794	10.1371/journal.pone.0056794	http://dx.doi.org/10.1371/journal.pone.0056794			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437239	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200163
J	Migita, K; Agematsu, K; Masumoto, J; Ida, H; Honda, S; Jiuchi, Y; Izumi, Y; Maeda, Y; Uehara, R; Nakamura, Y; Koga, T; Kawakami, A; Nakashima, M; Fujieda, Y; Nonaka, F; Eguchi, K; Furukawa, H; Nakamura, T; Nakamura, M; Yasunami, M				Migita, Kiyoshi; Agematsu, Kazunaga; Masumoto, Junya; Ida, Hiroaki; Honda, Seiyo; Jiuchi, Yuka; Izumi, Yasumori; Maeda, Yumi; Uehara, Ritei; Nakamura, Yoshikazu; Koga, Tomohiro; Kawakami, Atsushi; Nakashima, Munetoshi; Fujieda, Yuichiro; Nonaka, Fumiaki; Eguchi, Katsumi; Furukawa, Hiroshi; Nakamura, Tadashi; Nakamura, Minoru; Yasunami, Michio			The Contribution of SAA1 Polymorphisms to Familial Mediterranean Fever Susceptibility in the Japanese Population	PLOS ONE			English	Article							SERUM AMYLOID A1; GENE POLYMORPHISMS; RHEUMATOID-ARTHRITIS; FMF PATIENTS; SECONDARY; DISEASE; INTERLEUKIN-1-BETA; INFLAMMASOME; ALLELES; MEFV	Background/Aims: Familial Mediterranean Fever (FMF) has traditionally been considered to be an autosomal-recessive disease, however, it has been observed that substantial numbers of patients with FMF possess only 1 demonstrable MEFV mutation. The clinical profile of familial Mediterranean fever (FMF) may be influenced by MEFV allelic heterogeneity and other genetic and/or environmental factors. Methodology/Principal Findings: In view of the inflammatory nature of FMF, we investigated whether serum amyloid A (SAA) and interleukin-1 beta (IL-1b) gene polymorphisms may affect the susceptibility of Japanese patients with FMF. The genotypes of the -13C/T SNP in the 5'-flanking region of the SAA1 gene and the two SNPs within exon 3 of SAA1 (2995C/T and 3010C/T polymorphisms) were determined in 83 Japanese patients with FMF and 200 healthy controls. The same samples were genotyped for IL-1 beta-511 (C/T) and IL-1 receptor antagonist (IL-1Ra) variable number of tandem repeat (VNTR) polymorphisms. There were no significant differences between FMF patients and healthy subjects in the genotypic distribution of IL-1 beta -511 (C/T), IL-1Ra VNTR and SAA2 polymorphisms. The frequencies of SAA1.1 allele were significantly lower (21.7% versus 34.0%), and inversely the frequencies of SAA1.3 allele were higher (48.8% versus 37.5%) in FMF patients compared with healthy subjects. The frequency of -13T alleles, associated with the SAA1.3 allele in the Japanese population, was significantly higher (56.0% versus 41.0%, p = 0.001) in FMF patients compared with healthy subjects. Conclusions/Significance: Our data indicate that SAA1 gene polymorphisms, consisting of -13T/C SNP in the 5'-flanking region and SNPs within exon 3 (2995C/T and 3010C/T polymorphisms) of SAA1 gene, are associated with susceptibility to FMF in the Japanese population.	[Migita, Kiyoshi; Jiuchi, Yuka; Izumi, Yasumori; Maeda, Yumi; Nakamura, Minoru] Clin Res Ctr, Dept Gen Internal Med, Omura, Japan; [Migita, Kiyoshi; Jiuchi, Yuka; Izumi, Yasumori; Maeda, Yumi; Nakamura, Minoru] NHO Nagasaki Med Ctr, Omura, Japan; [Agematsu, Kazunaga] Shinshu Univ, Grad Sch Med, Dept Infect & Host Def, Asahi Ku, Matsumoto, Nagano, Japan; [Masumoto, Junya] Ehime Univ, Grad Sch Med, Dept Pathogenom, Toone City, Ehime, Japan; [Ida, Hiroaki; Honda, Seiyo] Kurume Univ, Sch Med, Dept Rheumatol, Kurume, Fukuoka 830, Japan; [Uehara, Ritei; Nakamura, Yoshikazu] Jichi Med Univ, Dept Publ Hlth, Mibu, Tochigi, Japan; [Koga, Tomohiro; Kawakami, Atsushi] Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki, Japan; [Nakashima, Munetoshi] Red Cross Nagasaki Atom Bomb Hosp, Dept Rheumatol, Mori, Nagasaki, Japan; [Fujieda, Yuichiro] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan; [Nonaka, Fumiaki; Eguchi, Katsumi] Sasebo City Gen Hosp, Dept Rheumatol, Sasebo, Japan; [Furukawa, Hiroshi] NHO Sagamihara Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Nakamura, Tadashi] NTT W JAPAN Kyushu Hosp, Dept Rheumatol, Kumamoto, Japan; [Yasunami, Michio] Nagasaki Univ, Ctr Int Collaborat Res CICORN, Nagasaki 852, Japan; [Yasunami, Michio] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan	Shinshu University; Ehime University; Kurume University; Jichi Medical University; Nagasaki University; Hokkaido University; Nagasaki University; Nagasaki University	Migita, K (corresponding author), Clin Res Ctr, Dept Gen Internal Med, Omura, Japan.	migita@nmc.hosp.go.jp	Furukawa, Hidemitsu/F-3478-2018; Koga, Tomohiro/V-9397-2019; Koga, Tomohiro/AAU-9697-2020; 藤枝, 雄一郎/AAG-1610-2020	Furukawa, Hidemitsu/0000-0002-0778-3330; 藤枝, 雄一郎/0000-0003-4705-341X; Koga, Tomohiro/0000-0003-2077-4428	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Research on intractable diseases from Ministry of Health, Labour and Welfare of Japan, "Study group of national-wide survey for Familial Mediterranean fever in Japan". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro Junya, 2006, Mod Rheumatol, V16, P294; Akar N, 2003, AMYLOID, V10, P12, DOI 10.3109/13506120308995251; Akar N, 2006, J NEPHROL, V19, P318; Aksentijevich I, 1997, CELL, V90, P797; Bakkaloglu A, 2004, J RHEUMATOL, V31, P1139; Balci-Peynircioglu B, 2008, CLIN EXP RHEUMATOL, V26, pS99; Ben-Chetrit E, 1998, LANCET, V351, P659, DOI 10.1016/S0140-6736(97)09408-7; Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Cazeneuve C, 2000, AM J HUM GENET, V67, P1136, DOI 10.1016/S0002-9297(07)62944-9; Chae JJ, 2009, BRIT J HAEMATOL, V146, P467, DOI 10.1111/j.1365-2141.2009.07733.x; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; El-Shanti H, 2006, LANCET, V367, P1016, DOI 10.1016/S0140-6736(06)68430-4; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gershoni-Baruch R, 2003, ARTHRITIS RHEUM, V48, P1149, DOI 10.1002/art.10944; Gershoni-Baruch R, 2003, J RHEUMATOL, V30, P308; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Jeru I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007676; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; MARHAUG G, 1994, BAILLIERE CLIN RHEUM, V8, P553, DOI 10.1016/S0950-3579(05)80115-3; Mavragani CP, 2007, AMYLOID, V14, P271, DOI 10.1080/13506120701614008; Migita K, 2007, J HEPATOL, V46, P381, DOI 10.1016/j.jhep.2006.09.015; Moriguchi M, 2005, AMYLOID, V12, P26, DOI 10.1080/13506120500032394; Moriguchi M, 2001, ARTHRITIS RHEUM, V44, P1266, DOI 10.1002/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3; Nakamura T, 2006, RHEUMATOLOGY, V45, P43, DOI 10.1093/rheumatology/kei112; Nakamura T, 2011, CLIN EXP RHEUMATOL, V29, P850; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Ozen S, 2003, J RHEUMATOL, V30, P2014; Ozen S, 2006, J RHEUMATOL, V33, P2498; Ozen S, 2009, ARTHRITIS RHEUM, V60, P1575, DOI 10.1002/art.24565; Savic S, 2012, CURR OPIN RHEUMATOL, V24, P103, DOI 10.1097/BOR.0b013e32834dd2d5; Speletas M, 2009, HUM IMMUNOL, V70, P750, DOI 10.1016/j.humimm.2009.05.004; Tanaka M, 2007, CLIN EXP RHEUMATOL, V25, P792; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; van der Hilst JCH, 2008, RHEUMATOLOGY, V47, P1651, DOI 10.1093/rheumatology/ken371; YAKAR S, 1995, SEMIN ARTHRITIS RHEU, V24, P255, DOI 10.1016/S0049-0172(95)80035-2; Yamada T, 2003, AMYLOID, V10, P7, DOI 10.3109/13506120308995250; Yilmaz E, 2003, TURKISH J PEDIATR, V45, P198	40	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55227	10.1371/journal.pone.0055227	http://dx.doi.org/10.1371/journal.pone.0055227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437051	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200013
J	Shen, RX; Xie, F; Shen, H; Liu, Q; Zheng, T; Kou, XR; Wang, DX; Yang, JM				Shen, Rongxi; Xie, Feng; Shen, Hui; Liu, Qu; Zheng, Tao; Kou, Xingrui; Wang, Dexian; Yang, Jiamei			Negative Correlation of LIV-1 and E-Cadherin Expression in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ZINC TRANSPORTER LIV-1; MESENCHYMAL TRANSITION; PROGRESSION; ESTROGEN; PROTEIN	LIV-1, a zinc transporter, is a mediator downstream of STAT3 both in zebrafish and mammalian cells, and is involved in epithelial-mesenchymal transition (EMT). Despite LIV-1 participates in cancer growth and metastasis, little is known about the association of LIV-1 with human liver cancer development. Therefore, the expression of LIV-1 mRNA was analyzed by reverse transcriptase polymerase chain reaction (RT-PCR) in 4 cultured cell lines (3 carcinoma and 1 normal liver cell lines), and the localization of LIV-1 protein was investigated by immunohistochemistry. Expression of LIV-1 protein was analyzed by Western blot both in 4 cultured cell lines and 120 liver tissues (100 carcinoma and 20 histologically normal tissues), and the relationship between its expression and clinicopathological finding was investigated in 100 hepatocellular carcinoma(HCC) tissues. Then stable siRNA expressing Hep-G2 cells were generated to assess the function of LIV-1 in liver cancer cells. We found that LIV-1 mRNA was more highly expressed in liver cancer cell lines compared to normal liver cell line. Western blot showed the expression of LIV-1 was higher in 61% liver carcinoma tissues than that in normal liver tissues. Down-regulated LIV-1 cells showed significant inhibition of proliferation in vitro and reduction of tumor growth in vivo. Furthermore, E-cadherin expression increased in LIV-1 siRNA expressing Hep-G2. These findings indicated that LIV-1 may induce the EMT in HCC cells.	[Shen, Rongxi; Xie, Feng; Liu, Qu; Zheng, Tao; Wang, Dexian; Yang, Jiamei] Second Mil Med Univ, Dept Special Treatment, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Shen, Hui] Second Mil Med Univ, Dept Mil Hyg, Shanghai, Peoples R China; [Kou, Xingrui] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Yang, JM (corresponding author), Second Mil Med Univ, Dept Special Treatment, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	jiameiyang@gmail.com			China Postdoctoral Science Fund [20100470107]; China Postdoctoral Science Special Fund [201104750]; CSCO Fund [Y-B2011-006]; Ministry of Science and Technology of China [2008ZX10002-018]	China Postdoctoral Science Fund(China Postdoctoral Science Foundation); China Postdoctoral Science Special Fund; CSCO Fund; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported in part by grants from the China Postdoctoral Science Fund (20100470107), China Postdoctoral Science Special Fund (201104750), CSCO Fund (Y-B2011-006) and the Fund of the Ministry of Science and Technology of China (2008ZX10002-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y; Cousins RJ, 1998, P NUTR SOC, V57, P307, DOI 10.1079/PNS19980045; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kasper G, 2005, INT J CANCER, V117, P961, DOI 10.1002/ijc.21235; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; MANNING DL, 1994, EUR J CANCER, V30A, P675, DOI 10.1016/0959-8049(94)90543-6; MANNING DL, 1988, MOL CELL ENDOCRINOL, V59, P205, DOI 10.1016/0303-7207(88)90105-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Shen H, 2009, MOL BIOL REP, V36, P653, DOI 10.1007/s11033-008-9225-4; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Taylor KM, 2004, TRENDS ENDOCRIN MET, V15, P461, DOI 10.1016/j.tem.2004.10.003; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127; Zhao Le, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1590	20	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56542	10.1371/journal.pone.0056542	http://dx.doi.org/10.1371/journal.pone.0056542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437163	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200101
J	Wang, SH; Chen, WJ; Chuang, LM; Hsiao, PC; Liu, PH; Hsiao, CK				Wang, Shi-Heng; Chen, Wei J.; Chuang, Lee-Ming; Hsiao, Po-Chang; Liu, Pi-Hua; Hsiao, Chuhsing K.			Inference of Cross-Level Interaction between Genes and Contextual Factors in a Matched Case-Control Metabolic Syndrome Study: A Bayesian Approach	PLOS ONE			English	Article							BODY-MASS INDEX; ENVIRONMENT INTERACTION; PHYSICAL-ACTIVITY; PPAR-GAMMA; MULTILEVEL ANALYSIS; POLYMORPHISM; ASSOCIATION; GENOTYPE; EXERCISE; EPIDEMIOLOGY	Genes, environment, and the interaction between them are each known to play an important role in the risk for developing complex diseases such as metabolic syndrome. For environmental factors, most studies focused on the measurements observed at the individual level, and therefore can only consider the gene-environment interaction at the same individual scale. Indeed the group-level (called contextual) environmental variables, such as community factors and the degree of local area development, may modify the genetic effect as well. To examine such cross-level interaction between genes and contextual factors, a flexible statistical model quantifying the variability of the genetic effects across different categories of the contextual variable is in need. With a Bayesian generalized linear mixed-effects model with an unconditional likelihood, we investigate whether the individual genetic effect is modified by the group-level residential environment factor in a matched case-control metabolic syndrome study. Such cross-level interaction is evaluated by examining the heterogeneity in allelic effects under various contextual categories, based on posterior samples from Markov chain Monte Carlo methods. The Bayesian analysis indicates that the effect of rs1801282 on metabolic syndrome development is modified by the contextual environmental factor. That is, even among individuals with the same genetic component of PPARG_Pro12Ala, living in a residential area with low availability of exercise facilities may result in higher risk. The modification of the group-level environment factors on the individual genetic attributes can be essential, and this Bayesian model is able to provide a quantitative assessment for such cross-level interaction. The Bayesian inference based on the full likelihood is flexible with any phenotype, and easy to implement computationally. This model has a wide applicability and may help unravel the complexity in development of complex diseases.	[Wang, Shi-Heng; Chen, Wei J.; Hsiao, Po-Chang; Hsiao, Chuhsing K.] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Wei J.; Hsiao, Po-Chang] Natl Taiwan Univ, Genet Epidemiol Core Lab, Ctr Genom Med, Taipei 10764, Taiwan; [Chen, Wei J.; Hsiao, Chuhsing K.] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Liu, Pi-Hua] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Guishan, Taiwan; [Hsiao, Chuhsing K.] Natl Taiwan Univ, Bioinformat & Biostat Core, Ctr Genom Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung University; National Taiwan University	Hsiao, CK (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	ckhsiao@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019	Chen, Wei Jen/0000-0001-5899-5870; Hsiao, Po-Chang/0000-0002-5813-3389; Liu, Pi-Hua/0000-0002-7165-6248; CHUANG, LEE-MING/0000-0003-0978-2662; hsiao, chuhsing kate/0000-0003-4905-8484	NSC [100-2314-B-002-107-MY3, NSC 97-2314-B-002-040-MY3]; DOH [94-TD-G-111-036, 94HDI002]; National Taiwan University Center of Genomic Medicine; Research Center for Genes, Environment and Human Health in College of Public Health, National Taiwan University	NSC(Ministry of Science and Technology, Taiwan); DOH; National Taiwan University Center of Genomic Medicine; Research Center for Genes, Environment and Human Health in College of Public Health, National Taiwan University	This research was supported in part by NSC 100-2314-B-002-107-MY3, NSC 97-2314-B-002-040-MY3, DOH 94-TD-G-111-036, 94HDI002, and National Taiwan University Center of Genomic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WJC and CKH thank the support of Research Center for Genes, Environment and Human Health in College of Public Health, National Taiwan University.	Adamo KB, 2005, DIABETOLOGIA, V48, P1503, DOI 10.1007/s00125-005-1827-y; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Aragaki CC, 1997, CANCER EPIDEM BIOMAR, V6, P307; Beamer BA, 1998, DIABETES, V47, P1806, DOI 10.2337/diabetes.47.11.1806; Bianchi G, 2008, QJM-INT J MED, V101, P713, DOI 10.1093/qjmed/hcn084; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P367, DOI 10.1136/jech.54.5.367; Cardona F, 2006, CLIN CHEM, V52, P1920, DOI 10.1373/clinchem.2006.069690; Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Franks PW, 2004, METABOLISM, V53, P11, DOI 10.1016/j.metabol.2003.08.005; Greenland S, 2001, INT J EPIDEMIOL, V30, P1343, DOI 10.1093/ije/30.6.1343; Greenland S, 2009, EPIDEMIOLOGY, V20, P14, DOI 10.1097/EDE.0b013e318193e7b5; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Hung RJ, 2004, CANCER EPIDEM BIOMAR, V13, P1013; Jiang Y, 2004, AM J HUM GENET, V75, P220, DOI 10.1086/422699; Kahara T, 2003, METABOLISM, V52, P209, DOI 10.1053/meta.2003.50038; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Rice K, 2008, J AM STAT ASSOC, V103, P385, DOI 10.1198/016214507000001463; Robert SA, 2004, SOC SCI MED, V59, P2421, DOI 10.1016/j.socscimed.2004.03.034; Ross NA, 2007, AM J PUBLIC HEALTH, V97, P500, DOI 10.2105/AJPH.2004.060954; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Roux AVD, 2004, SOC SCI MED, V58, P1953, DOI 10.1016/S0277-9536(03)00414-3; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Rutter M, 2008, J ABNORM CHILD PSYCH, V36, P969, DOI 10.1007/s10802-008-9256-2; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Stephens JW, 2008, ATHEROSCLEROSIS, V200, P229, DOI 10.1016/j.atherosclerosis.2008.04.003; Thapar A, 2007, DEV PSYCHOPATHOL, V19, P989, DOI 10.1017/S0954579407000491; Wakefield J, 2010, GENET EPIDEMIOL, V34, P16, DOI 10.1002/gepi.20429; Wang SH, 2011, PREV MED, DOI [10.1016/j.ypmed.2011.1004.1017, DOI 10.1016/J.YPMED.2011.1004.1017]; Weiss EP, 2005, METABOLISM, V54, P97, DOI 10.1016/j.metabol.2004.08.006; Yu K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002482; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	41	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56693	10.1371/journal.pone.0056693	http://dx.doi.org/10.1371/journal.pone.0056693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437214	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200144
J	Warimwe, GM; Murungi, LM; Kamuyu, G; Nyangweso, GM; Wambua, J; Naranbhai, V; Fletcher, HA; Hill, AVS; Bejon, P; Osier, FHA; Marsh, K				Warimwe, George M.; Murungi, Linda M.; Kamuyu, Gathoni; Nyangweso, George M.; Wambua, Juliana; Naranbhai, Vivek; Fletcher, Helen A.; Hill, Adrian V. S.; Bejon, Philip; Osier, Faith H. A.; Marsh, Kevin			The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ACQUIRED-IMMUNITY; SURFACE-ANTIGENS; KILIFI DISTRICT; PROTECTION; ANTIBODIES; MORTALITY; RESPONSES	Background: Plasmodium falciparum malaria remains a major cause of illness and death in sub-Saharan Africa. Young children bear the brunt of the disease and though older children and adults suffer relatively fewer clinical attacks, they remain susceptible to asymptomatic P. falciparum infection. A better understanding of the host factors associated with immunity to clinical malaria and the ability to sustain asymptomatic P. falciparum infection will aid the development of improved strategies for disease prevention. Methods and Findings: Here we investigate whether full differential blood counts can predict susceptibility to clinical malaria among Kenyan children sampled at five annual cross-sectional surveys. We find that the ratio of monocytes to lymphocytes, measured in peripheral blood at the time of survey, directly correlates with risk of clinical malaria during follow-up. This association is evident among children with asymptomatic P. falciparum infection at the time the cell counts are measured (Hazard ratio (HR) = 2.7 (95% CI 1.42, 5.01, P = 0.002) but not in those without detectable parasitaemia (HR = 1.0 (95% CI 0.74, 1.42, P = 0.9). Conclusions: We propose that the monocyte to lymphocyte ratio, which is easily derived from routine full differential blood counts, reflects an individual's capacity to mount an effective immune response to P. falciparum infection.	[Warimwe, George M.; Fletcher, Helen A.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Murungi, Linda M.; Kamuyu, Gathoni; Nyangweso, George M.; Wambua, Juliana; Bejon, Philip; Osier, Faith H. A.; Marsh, Kevin] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Naranbhai, Vivek] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bejon, Philip; Marsh, Kevin] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	University of Oxford; Jenner Institute; Kenya Medical Research Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Warimwe, GM (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	george.warimwe@ndm.ox.ac.uk		Fletcher, Helen/0000-0002-0435-1006; Naranbhai, Vivek/0000-0003-4281-8882; Osier, Faith/0000-0001-7133-5375	Wellcome Trust grant [092741/Z/10/Z]; Medical Research Council [G1002624] Funding Source: researchfish; MRC [G1002624] Funding Source: UKRI	Wellcome Trust grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded through a Wellcome Trust grant (092741/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Dunachie SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012557; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hanscheid T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-109; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; LINES J, 1992, PARASITOL TODAY, V8, P381, DOI 10.1016/0169-4758(92)90176-3; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mackintosh CL, 2008, INT J PARASITOL, V38, P1445, DOI 10.1016/j.ijpara.2008.03.009; Maina RN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S4; Manning L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048701; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1992, PARASITOLOGY, V104, pS53, DOI 10.1017/S0031182000075247; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Olliaro P, 2011, AM J TROP MED HYG, V85, P619, DOI 10.4269/ajtmh.2011.11-0154; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Rhee MSM, 2001, CLIN EXP IMMUNOL, V126, P503, DOI 10.1046/j.1365-2249.2001.01681.x; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660	28	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57320	10.1371/journal.pone.0057320	http://dx.doi.org/10.1371/journal.pone.0057320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437368	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000315184200243
J	Kong, DR; Zhang, C; Zhang, L; Wang, JG; Xiong, Z; Li, P; Xu, JM				Kong, De-Run; Zhang, Chao; Zhang, Lei; Wang, Jing-Guang; Xiong, Zhuang; Li, Pan; Xu, Jian-Ming			Measurement of Variceal Pressure with a Computerized Endoscopic Manometry: Validation and Effect of Propranolol Therapy in Cirrhotic Patients	PLOS ONE			English	Article							ESOPHAGEAL-VARICES; HEMORRHAGE; PUNCTURE	Background and Purpose: Recently, we invented a computerized endoscopic balloon manometry (CEBM) to measure variceal pressure (VP) in cirrhotic patient. The purpose of this study was to evaluate the reliability and feasibility of this method, and whether this technique provided further information to pharmacological therapy. Patients and Methods: VP measurements were performed in 83 cirrhotic patients and compared with HVPG as well as endoscopic bleeding risk parameters. Furthermore, VP was assessed before and during propranolol therapy in 30 patients without previous bleeding. Results: VP measurements were successful in 96% (83/86) of all patients. Of the 83 patients, the VP correlated closely with the HVPG (P < 0.001). The presence of red colour signs and the size of varices were strongly associated with VP. Patients with previous bleeding had higher VP than those who had not yet experienced bleeding. In univariate analysis, the level of VP, the size of varices, and red color signs predicted a higher risk of bleeding. The multiple logistic regression model revealed that VP was the major risk factor for bleeding. In 30 patients receiving propranolol, VP significantly decreased from 21.1 +/- 3.5 mmHg before therapy to 18.1 +/- 3.3 mmHg after 3 months and to 16.3 +/- 4.0 mmHg after 6 months. Comparing the mean decrease in VP with that in hepatic venous pressure gradient (HVPG), the decrease in VP was more obvious than HVPG response to propranolol. Conclusions: This study showed that CEBM is safe and practical to assess VP in cirrhotic patient. It has the potential to be used as a clinical method to assess the risk of variceal bleeding and the effects of pharmacological therapy.	[Kong, De-Run; Zhang, Lei; Wang, Jing-Guang; Li, Pan; Xu, Jian-Ming] Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei, Anhui, Peoples R China; [Zhang, Chao] Anhui Med Univ, Affiliated Hosp 1, Dept Surg, Hefei, Anhui, Peoples R China; [Xiong, Zhuang] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Xu, JM (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei, Anhui, Peoples R China.	xjm1017@yahoo.com.cn			Anhui Provincial Educational and Health Department [KJ2010A158, KJ2012Z189, 2010B018]; National Natural Science Foundation of China [81070337, 81271736]	Anhui Provincial Educational and Health Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by a grant (KJ2010A158, KJ2012Z189, 2010B018) from Anhui Provincial Educational and Health Department and in part by the grants (81070337, 81271736) from the General Program of National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSCH J, 1986, HEPATOLOGY, V6, P667, DOI 10.1002/hep.1840060421; El Atti EA, 1999, GUT, V45, P618, DOI 10.1136/gut.45.4.618; Escorsell A, 2000, HEPATOLOGY, V31, P1061, DOI 10.1053/he.2000.6779; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; GERTSCH P, 1987, GUT, V28, P1162, DOI 10.1136/gut.28.9.1162; Japanese Research Society for portal hypertension, 2010, DIGEST ENDOSC, V22, P1; KLEBER G, 1989, GUT, V30, P228, DOI 10.1136/gut.30.2.228; Kong DR, 2009, ENDOSCOPY, V41, P415, DOI 10.1055/s-0029-1214602; Lay CS, 2006, J GASTROEN HEPATOL, V21, P413, DOI 10.1111/j.1440-1746.2005.04071.x; Miller LS, 2004, AM J GASTROENTEROL, V99, P1267, DOI 10.1111/j.1572-0241.2004.30177.x; Nevens F, 1998, HEPATOLOGY, V27, P15, DOI 10.1002/hep.510270104; Pontes JM, 2002, ENDOSCOPY, V34, P966, DOI 10.1055/s-2002-35840; Vegesna AK, 2009, GASTROINTEST ENDOSC, V70, P407, DOI 10.1016/j.gie.2008.11.033	13	1	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56332	10.1371/journal.pone.0056332	http://dx.doi.org/10.1371/journal.pone.0056332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431369	Green Published, gold, Green Submitted			2022-12-27	WOS:000315182800011
J	Sheng, Q; Cao, DG; Zhou, Y; Lei, QX; Han, HX; Li, FW; Lu, Y; Wang, CF				Sheng, Qian; Cao, Dingguo; Zhou, Yan; Lei, Qiuxia; Han, Haixia; Li, Fuwei; Lu, Yan; Wang, Cunfang			Detection of SNPs in the Cathepsin D Gene and Their Association with Yolk Traits in Chickens	PLOS ONE			English	Article							EGG-PRODUCTION; MOLECULAR-CLONING; QUALITY TRAITS; MESSENGER-RNA; EXPRESSION; IDENTIFICATION; PROTEIN; ENZYME	CTSD (Cathepsin D) is a key enzyme in yolk formation, and it primarily affects egg yolk weight and egg weight. However, recent research has mostly focused on the genomic structure of the CTSD gene and the enzyme's role in pathology, and less is known about the enzyme's functions in chickens. In this paper, the correlations between CTSD polymorphisms and egg quality traits were analyzed in local Shandong chicken breeds. CTSD polymorphisms were investigated by PCR-SSCP (polymerase chain reaction single strand conformation polymorphism) and sequencing analysis. Two variants were found to be associated with egg quality traits. One variant (2614T>C), located in exon 3, was novel. Another variant (5274G>T), located in intron 4, was previously referred to as rs16469410. Overall, our results indicated that CTSD would be a useful candidate gene in selection programs for improving yolk traits.	[Sheng, Qian; Wang, Cunfang] Shandong Polytech Univ, Shandong Prov Key Lab Microbiol Engn, Jinan, Shandong, Peoples R China; [Sheng, Qian; Cao, Dingguo; Zhou, Yan; Lei, Qiuxia; Han, Haixia; Li, Fuwei; Lu, Yan] Acad Agr Sci Shandong Prov, Inst Poultry Sci, Jinan, Shandong, Peoples R China; [Cao, Dingguo; Zhou, Yan; Lei, Qiuxia; Han, Haixia; Li, Fuwei; Lu, Yan] Poultry Breeding Engn Technol Ctr Shandong Prov, Jinan, Shandong, Peoples R China	Qilu University of Technology; Shandong Academy of Agricultural Sciences	Lu, Y (corresponding author), Acad Agr Sci Shandong Prov, Inst Poultry Sci, Jinan, Shandong, Peoples R China.	luyan1957@163.com; cunfangwang@163.com	WANG, CUNFANG/P-4640-2014	WANG, CUNFANG/0000-0001-7992-6524	Natural Science Foundation of Shandong Province [ZR2010CQ005]; Thoroughbred project of Shandong Province [2008LZ015]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Thoroughbred project of Shandong Province	This work was supported by the Natural Science Foundation of Shandong Province (ZR2010CQ005) and the Thoroughbred project of Shandong Province (2008LZ015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya TK, 2011, ANIM BIOTECHNOL, V22, P71, DOI 10.1080/10495398.2011.555680; Boruszewska K, 2009, POULTRY SCI, V88, P932, DOI 10.3382/ps.2008-00445; Bourin M, 2012, POULTRY SCI, V91, P2288, DOI 10.3382/ps.2011-01910; Chai Y, 2012, ARCH GYNECOL OBSTET, V286, P465, DOI 10.1007/s00404-012-2318-2; Chen L, 2011, CARCINOGENESIS, V32, P986, DOI 10.1093/carcin/bgr065; De Stasio R, 1999, MOL REPROD DEV, V52, P126; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Down CF, 2012, BBA-GENE REGUL MECH, V1819, P855, DOI 10.1016/j.bbagrm.2012.03.008; Fan CF, 2012, TUMOR BIOL, V33, P1045, DOI 10.1007/s13277-012-0338-y; Fulton JE, 2012, ANIM GENET, V43, P102, DOI 10.1111/j.1365-2052.2012.02384.x; Gao M, 2010, J CELL BIOCHEM, V109, P1264, DOI 10.1002/jcb.22509; Hah YS, 2012, CANCER LETT, V323, P208, DOI 10.1016/j.canlet.2012.04.012; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; Ribeca C, 2012, ANIM GENET; Schreiweis MA, 2006, ANIM GENET, V37, P106, DOI 10.1111/j.1365-2052.2005.01394.x; Shubin AV, 2010, BIOMARKERS, V15, P608, DOI 10.3109/1354750X.2010.504310; Williford A, 2012, MOL BIOL EVOL, V29, P3755, DOI 10.1093/molbev/mss184; Yao JF, 2010, POULTRY SCI, V89, P883, DOI 10.3382/ps.2009-00613; Zelazowska M, 2009, CELL TISSUE RES, V335, P585, DOI 10.1007/s00441-007-0459-6; Zhang LC, 2005, POULTRY SCI, V84, P1209, DOI 10.1093/ps/84.8.1209	22	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56656	10.1371/journal.pone.0056656	http://dx.doi.org/10.1371/journal.pone.0056656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431385	Green Submitted, Green Published, gold			2022-12-27	WOS:000315182800028
J	Andreu-Fernandez, V; Genoves, A; Messeguer, A; Orzaez, M; Sancho, M; Perez-Paya, E				Andreu-Fernandez, Vicente; Genoves, Ainhoa; Messeguer, Angel; Orzaez, Mar; Sancho, Monica; Perez-Paya, Enrique			BH3-Mimetics- and Cisplatin-Induced Cell Death Proceeds through Different Pathways Depending on the Availability of Death-Related Cellular Components	PLOS ONE			English	Article							APAF-1 LEVELS; CYTOCHROME-C; APOPTOSIS; MODULATION; RESISTANCE; INHIBITORS; AUTOPHAGY; PROTEINS; CED-4; MCL-1	Background: Owing to their important function in regulating cell death, pharmacological inhibition of Bcl-2 proteins by dubbed BH3-mimetics is a promising strategy for apoptosis induction or sensitization to chemotherapy. However, the role of Apaf-1, the main protein constituent of the apoptosome, in the process has yet not been analyzed. Furthermore as new chemotherapeutics develop, the possible chemotherapy-induced toxicity to rapidly dividing normal cells, especially sensitive differentiated cells, has to be considered. Such undesirable effects would probably be ameliorated by selectively and locally inhibiting apoptosis in defined sensitive cells. Methodology and Principal Findings: Mouse embryonic fibroblasts (MEFS) from Apaf-1 knock out mouse (MEFS KO Apaf-1) and Bax/Bak double KO (MEFS KO Bax/Bak), MEFS from wild-type mouse (MEFS wt) and human cervix adenocarcinoma (HeLa) cells were used to comparatively investigate the signaling cell death-induced pathways of BH3-mimetics, like ABT737 and GX15-070, with DNA damage-inducing agent cisplatin (cis-diammineplatinum(II) dichloride, CDDP). The study was performed in the absence or presence of apoptosis inhibitors namely, caspase inhibitors or apoptosome inhibitors. BH3-mimetic ABT737 required of Apaf-1 to exert its apoptosis-inducing effect. In contrast, BH3-mimetic GX15-070 and DNA damage-inducing CDDP induced cell death in the absence of both Bax/Bak and Apaf-1. GX15-070 induced autophagy-based cell death in all the cell lines analyzed. MEFS wt cells were protected from the cytotoxic effects of ABT737 and CDDP by chemical inhibition of the apoptosome through QM31, but not by using general caspase inhibitors. Conclusions: BH3-mimetic ABT737 not only requires Bax/Bak to exert its apoptosis-inducing effect, but also Apaf-1, while GX15-070 and CDDP induce different modalities of cell death in the absence of Bax/Bak or Apaf-1. Inclusion of specific Apaf-1 inhibitors in topical and well-localized administrations, but not in systemic ones, to avoid interferences with chemotherapeutics would be of interest to prevent chemotherapeutic-induced unwanted cell death which could improve cancer patient care.	[Andreu-Fernandez, Vicente; Genoves, Ainhoa; Orzaez, Mar; Sancho, Monica; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, Valencia, Spain; [Messeguer, Angel] Inst Quim Avanzada Cataluna CSIC, Dept Chem & Biomol Nanotechnol, Barcelona, Spain; [Perez-Paya, Enrique] IBV CSIC, Inst Biomed Valencia, Valencia, Spain	Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Perez-Paya, E (corresponding author), Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, Valencia, Spain.	eperez@cipf.es	Medina, Mónica Sancho/L-4660-2014; Orzaez, Mar/B-4992-2014	Medina, Mónica Sancho/0000-0003-3707-062X; Orzaez, Mar/0000-0003-3231-5835; Messeguer, Angel/0000-0002-8358-9425; Andreu Fernandez, Vicente/0000-0001-7183-8706	Spanish Ministry of Science and Innovation (MICINN) [BIO2007-60066, SAF2010-15512, SAF2011-30542-C02-01, CSD2008-00005C]; Generalitat Valenciana Prometeo [2010/005]; ERDF	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana Prometeo(Center for Forestry Research & Experimentation (CIEF)); ERDF(European Commission)	This work was supported by grants from the Spanish Ministry of Science and Innovation (MICINN - BIO2007-60066, SAF2010-15512, SAF2011-30542-C02-01 and CSD2008-00005C) and Generalitat Valenciana Prometeo 2010/005 (partially funded with ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Heidari N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.53; Hellwig CT, 2012, MOL CANCER THER, V11, P3, DOI 10.1158/1535-7163.MCT-11-0434; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Johnson CE, 2007, P NATL ACAD SCI USA, V104, P20820, DOI 10.1073/pnas.0709101105; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Linton SD, 2005, CURR TOP MED CHEM, V5, P1697, DOI 10.2174/156802605775009720; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; McCoy F, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.86; Mondragon L, 2008, J MED CHEM, V51, P521, DOI 10.1021/jm701195j; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Moure A, 2011, CHEM-EUR J, V17, P7927, DOI 10.1002/chem.201100216; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Perez-Paya E, 2011, MED RES REV, V31, P649, DOI 10.1002/med.20198; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Slattery EL, 2010, J NEUROSCI, V30, P3473, DOI 10.1523/JNEUROSCI.4316-09.2010; Soengas MS, 2006, CELL DEATH DIFFER, V13, P352, DOI 10.1038/sj.cdd.4401755; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Trueb RM, 2009, SEMIN CUTAN MED SURG, V28, P11, DOI 10.1016/j.sder.2008.12.001; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	29	14	14	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56881	10.1371/journal.pone.0056881	http://dx.doi.org/10.1371/journal.pone.0056881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437261	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000054
J	Brochu, C; Cabrita, MA; Melanson, BD; Hamill, JD; Lau, R; Pratt, MAC; Mckay, BC				Brochu, Christian; Cabrita, Miguel A.; Melanson, Brian D.; Hamill, Jeffrey D.; Lau, Rosanna; Pratt, M. A. Christine; McKay, Bruce C.			NF-kappa B-Dependent Role for Cold-Inducible RNA Binding Protein in Regulating Interleukin 1 beta	PLOS ONE			English	Article							HIGHLY SELECTIVE INHIBITOR; GENE-EXPRESSION; DNA DAMAGE; TRANSCRIPTIONAL REGULATION; ACTIVATION; KINASE; CELLS; RICH; CIRP; IDENTIFICATION	The cold inducible RNA binding protein (CIRBP) responds to a wide array of cellular stresses, including short wavelength ultraviolet light (UVC), at the transcriptional and post-translational level. CIRBP can bind the 3'untranslated region of specific transcripts to stabilize them and facilitate their transport to ribosomes for translation. Here we used RNA interference and oligonucleotide microarrays to identify potential downstream targets of CIRBP induced in response to UVC. Twenty eight transcripts were statistically increased in response to UVC and these exhibited a typical UVC response. Only 5 of the 28 UVC-induced transcripts exhibited a CIRBP-dependent pattern of expression. Surprisingly, 3 of the 5 transcripts (IL1B, IL8 and TNFAIP6) encoded proteins important in inflammation with IL-1 beta apparently contributing to IL8 and TNFAIP6 expression in an autocrine fashion. UVC-induced IL1B expression could be inhibited by pharmacological inhibition of NF kappa B suggesting that CIRBP was affecting NF-kappa B signaling as opposed to IL1B mRNA stability directly. Bacterial lipopolysaccharide (LPS) was used as an activator of NF-kappa B to further study the potential link between CIRBP and NF kappa B. Transfection of siRNAs against CIRBP reduced the extent of the LPS-induced phosphorylation of I kappa B alpha, NF-kappa B DNA binding activity and IL-1 beta expression. The present work firmly establishes a novel link between CIRBP and NF-kappa B signaling in response to agents with diverse modes of action. These results have potential implications for disease states associated with inflammation.	[Brochu, Christian; Cabrita, Miguel A.; Melanson, Brian D.; Hamill, Jeffrey D.; McKay, Bruce C.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [Cabrita, Miguel A.; Melanson, Brian D.; Lau, Rosanna; Pratt, M. A. Christine; McKay, Bruce C.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [McKay, Bruce C.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Carleton University	Mckay, BC (corresponding author), Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada.	bruce_mckay@carleton.ca	McKay, Bruce C/I-4081-2013	McKay, Bruce C/0000-0002-7921-1331	Canadian Institutes of Health Research; Ottawa Regional Cancer Foundation; Cancer Research Society Fellowship; Ontario Graduate Scholarship in Science and Technology; National Cancer Institute of Canada; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa Regional Cancer Foundation; Cancer Research Society Fellowship; Ontario Graduate Scholarship in Science and Technology; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by the Canadian Institutes of Health Research to B.C.M. and M.A.C.P. and funds from the Ottawa Regional Cancer Foundation. C.B. was a recipient of a Cancer Research Society Fellowship, B.D.M. held an Ontario Graduate Scholarship in Science and Technology and B.C.M. was supported with a Research Scientist Award from the National Cancer Institute of Canada supported with funds provided by the Canadian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cao SQ, 2006, CELL MOL BIOL LETT, V11, P526, DOI 10.2478/s11658-006-0042-2; CARRIER F, 1994, P NATL ACAD SCI USA, V91, P1554, DOI 10.1073/pnas.91.4.1554; Chang NB, 2010, INT J HYG ENVIR HEAL, V213, P359, DOI 10.1016/j.ijheh.2010.06.006; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; FENTON MJ, 1987, J IMMUNOL, V138, P3972; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Guo X, 2010, MOL CARCINOGEN, V49, P130, DOI 10.1002/mc.20582; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hong JK, 2007, METAB ENG, V9, P208, DOI 10.1016/j.ymben.2006.11.003; Huss JW, 2010, NUCLEIC ACIDS RES, V38, pD633, DOI 10.1093/nar/gkp760; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Katdare M, 2007, INT J ONCOL, V31, P1519; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Lau R, 2012, CELL CYCLE, V11, P4009, DOI 10.4161/cc.22223; LEE TH, 1993, J BIOL CHEM, V268, P6154; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Liu AJ, 2010, BRAIN RES, V1347, P104, DOI 10.1016/j.brainres.2010.05.029; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P142, DOI 10.3390/ijms13010142; Masuda T, 2012, P NATL ACAD SCI USA, V109, P10885, DOI 10.1073/pnas.1121524109; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; O'Hagan HM, 2004, EXP CELL RES, V297, P548, DOI 10.1016/j.yexcr.2004.03.051; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rossi M, 2005, REPRODUCTION, V130, P721, DOI 10.1530/rep.1.00688; Ryan JC, 2005, NEUROSCIENCE, V136, P1121, DOI 10.1016/j.neuroscience.2005.08.047; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sheikh MS, 1997, J BIOL CHEM, V272, P26720, DOI 10.1074/jbc.272.42.26720; SIBGHATULLAH, 1989, NUCLEIC ACIDS RES, V17, P4471, DOI 10.1093/nar/17.12.4471; Smith JM, 2007, NEOPLASIA, V9, P1057, DOI 10.1593/neo.07688; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; VANNOCKER S, 1993, PLANT MOL BIOL, V21, P695, DOI 10.1007/BF00014552; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang RQ, 2006, NUCLEIC ACIDS RES, V34, P1224, DOI 10.1093/nar/gkj519; Yang RQ, 2010, J BIOL CHEM, V285, P8887, DOI 10.1074/jbc.M109.013128; YOUNG PR, 1988, J CELL BIOL, V107, P447, DOI 10.1083/jcb.107.2.447	53	35	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57426	10.1371/journal.pone.0057426	http://dx.doi.org/10.1371/journal.pone.0057426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437386	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000102
J	Ferenci, T; Benyo, B; Kovacs, L; Fisk, L; Shaw, GM; Chase, JG				Ferenci, Tamas; Benyo, Balazs; Kovacs, Levente; Fisk, Liam; Shaw, Geoffrey M.; Chase, J. Geoffrey			Daily Evolution of Insulin Sensitivity Variability with Respect to Diagnosis in the Critically Ill	PLOS ONE			English	Article							MORTALITY; ASSOCIATION; THERAPY; IMPACT	Introduction: This study examines the likelihood and evolution of overall and hypoglycemia-inducing variability of insulin sensitivity in ICU patients based on diagnosis and day of stay. Materials and Methods: An analysis of model-based insulin sensitivity for n = 390 patients in a medical ICU (Christchurch, New Zealand). Two metrics are defined to measure the variability of a patient's insulin sensitivity relative to predictions of a stochastic model created from the same data for all patients over all days of stay. The first selectively captures large increases related to the risk of hypoglycemia. The second captures overall variability. Distributions of per-patient variability scores were evaluated over different ICU days of stay and for different diagnosis groups based on APACHE III: operative and non-operative cardiac, gastric, all other. Linear and generalized linear mixed effects models assess the statistical significance of differences between groups and over days. Results: Variability defined by the two metrics was not substantially different. Variability was highest on day 1, and decreased over time (p < 0.0001) in every diagnosis group. There were significant differences between some diagnosis groups: non-operative gastric patients were the least variable, while cardiac (operative and non-operative) patients exhibited the highest variability. Conclusions: This study characterizes the variability and evolution of insulin sensitivity in critically ill patients, and may help inform the clinical management of metabolic dysfunction in critical care.	[Ferenci, Tamas; Benyo, Balazs; Kovacs, Levente] Budapest Univ Technol & Econ, Fac Elect Engn & Informat, Dept Control Engn & Informat Technol, Budapest, Hungary; [Fisk, Liam; Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Ctr Bioengn, Christchurch 1, New Zealand; [Shaw, Geoffrey M.] Univ Otago, Christchurch Sch Med, Christchurch Hosp, Dept Intens Care, Christchurch, New Zealand	Budapest University of Technology & Economics; University of Canterbury; Christchurch Hospital New Zealand; University of Otago	Kovacs, L (corresponding author), Budapest Univ Technol & Econ, Fac Elect Engn & Informat, Dept Control Engn & Informat Technol, Budapest, Hungary.	lkovacs@iit.bme.hu	Kovacs, Levente/AAA-1781-2019; Benyó, Balázs/AAR-4275-2021; Ferenci, Tamás/H-4682-2012; Benyó, Balázs/H-6208-2012; Chase, James G/B-1584-2012; Kovacs, Levente/A-7539-2015	Kovacs, Levente/0000-0002-3188-0800; Benyó, Balázs/0000-0003-2770-9127; Ferenci, Tamás/0000-0001-6791-3080; Benyó, Balázs/0000-0003-2770-9127; Chase, James G/0000-0001-9989-4849; Kovacs, Levente/0000-0002-3188-0800	Hungarian National Scientific Research Foundation [CK80316, K82066]; New Hungary Development Plan [TAMOP-4.2.1/B-09/1/KMR-2010-0002]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	Hungarian National Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New Hungary Development Plan; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This research work was supported by the Hungarian National Scientific Research Foundation (http://www.otka.hu/), Grants No. CK80316 and K82066, and it is connected to the scientific program of the "Development of quality-oriented and harmonized R+D+I strategy and functional model at BME" project, supported by the New Hungary Development Plan (Project ID: TAMOP-4.2.1/B-09/1/KMR-2010-0002). Levente Kovacs is supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7921; Bates D, 2012, LME4 LINEAR MIXED EF; Brown, 2006, APPL MIXED MODELS ME; Chase JG, 2008, CRIT CARE, V12, DOI 10.1186/cc6868; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Fox J., 2019, R COMPANION APPL REG, V.; Fritzmaurice GM, 2004, APPL LONGITUDINAL AN; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hsu J., 1996, MULTIPLE COMP THEORY; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Langouche L, 2007, J CLIN ENDOCR METAB, V92, P3890, DOI 10.1210/jc.2007-0813; Lin J, 2008, COMPUT METH PROG BIO, V89, P141, DOI 10.1016/j.cmpb.2007.04.006; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Pinheiro J, 2001, MIXED EFFECTS MODELS; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Pretty C, 2011, COMPUT METH PROG BIO, V102, P172, DOI 10.1016/j.cmpb.2010.08.004; R Core Team, 2012, R LANG ENV STAT COMP; Sarkar D., 2019, NLME LINEAR NONLINEA; Suhaimi Fatanah, 2010, J Diabetes Sci Technol, V4, P284	23	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57119	10.1371/journal.pone.0057119	http://dx.doi.org/10.1371/journal.pone.0057119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437328	Green Published, Green Accepted, gold			2022-12-27	WOS:000315186000077
J	Murphy, MK; Huey, DJ; Reimer, AJ; Hu, JC; Athanasiou, KA				Murphy, Meghan K.; Huey, Daniel J.; Reimer, Andrew J.; Hu, Jerry C.; Athanasiou, Kyriacos A.			Enhancing Post-Expansion Chondrogenic Potential of Costochondral Cells in Self-Assembled Neocartilage	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; IN-VITRO; SEEDING DENSITY; CARTILAGINOUS TISSUE; ENGINEERED CARTILAGE; CONDYLAR CARTILAGE; SOX9 EXPRESSION; COLLAGEN; GROWTH; HYDROXYPROLINE	The insufficient healing capacity of articular cartilage necessitates mechanically functional biologic tissue replacements. Using cells to form biomimetic cartilage implants is met with the challenges of cell scarcity and donor site morbidity, requiring expanded cells that possess the ability to generate robust neocartilage. To address this, this study assesses the effects of expansion medium supplementation (bFGF, TFP, FBS) and self-assembled construct seeding density (2, 3, 4 million cells/5 mm dia. construct) on the ability of costochondral cells to generate biochemically and biomechanically robust neocartilage. Results show TFP (1 ng/mL TGF-beta 1, 5 ng/mL bFGF, 10 ng/mL PDGF) supplementation of serum-free chondrogenic expansion medium enhances the post-expansion chondrogenic potential of costochondral cells, evidenced by increased glycosaminoglycan content, decreased type I/II collagen ratio, and enhanced compressive properties. Low density (2 million cells/construct) enhances matrix synthesis and tensile and compressive mechanical properties. Combined, TFP and Low density interact to further enhance construct properties. That is, with TFP, Low density increases type II collagen content by over 100%, tensile stiffness by over 300%, and compressive moduli by over 140%, compared with High density. In conclusion, the interaction of TFP and Low density seeding enhances construct material properties, allowing for a mechanically functional, biomimetic cartilage to be formed using clinically relevant costochondral cells.	[Murphy, Meghan K.; Huey, Daniel J.; Reimer, Andrew J.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Athanasiou, KA (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	athanasiou@ucdavis.edu	Hu, Jerry/E-7385-2013	Hu, Jerry/0000-0003-0651-1461	National Science Foundation Graduate Research Fellowship [DGE-1148897]; National Institutes of Health [R01DE015038, R01DE019666]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019666, R01DE015038] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1148897 (http://www.nsf.gov). Additionally, the authors acknowledge funding support from R01DE015038 and R01DE019666 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012; Anderson DEJ, 2008, ANN BIOMED ENG, V36, P1992, DOI 10.1007/s10439-008-9572-2; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bernstein P, 2009, J BIOMED MATER RES A, V91A, P910, DOI 10.1002/jbm.a.32308; Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; DESHMUKH K, 1973, BIOCHEM J, V133, P615, DOI 10.1042/bj1330615; DOLWICK MF, 1994, BRIT J ORAL MAX SURG, V32, P307, DOI 10.1016/0266-4356(94)90052-3; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Farrar W B, 1979, J Ala Dent Assoc, V63, P19; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; Giannoni P, 2005, OSTEOARTHR CARTILAGE, V13, P589, DOI 10.1016/j.joca.2005.02.015; Hagandora CK, 2012, TISSUE ENG A; HENRY CH, 1993, J ORAL MAXIL SURG, V51, P352, DOI 10.1016/S0278-2391(10)80343-X; Hsieh-Bonassera ND, 2009, TISSUE ENG PT A, V15, P3513, DOI [10.1089/ten.tea.2008.0628, 10.1089/ten.TEA.2008.0628]; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; Huang AH, 2008, OSTEOARTHR CARTILAGE, V16, P1074, DOI 10.1016/j.joca.2008.02.005; Huey DJ, 2013, CELLS TISSU IN PRESS; Huey DJ, 2012, CELL TRANSPLANTATION; Jadin KD, 2005, J HISTOCHEM CYTOCHEM, V53, P1109, DOI 10.1369/jhc.4A6511.2005; Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J; Kobayashi S, 2008, J ORTHOP RES, V26, P493, DOI 10.1002/jor.20507; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Lu XL, 2009, J DENT RES, V88, P244, DOI 10.1177/0022034508330432; MACINTOSH RB, 1977, J MAXILLOFAC SURG, V5, P257, DOI 10.1016/S0301-0503(77)80120-3; Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708; Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676; NIMNI ME, 1983, SEMIN ARTHRITIS RHEU, V13, P1, DOI 10.1016/0049-0172(83)90024-0; OBEID G, 1988, J ORAL MAXIL SURG, V46, P177, DOI 10.1016/0278-2391(88)90079-1; PAL S, 1981, COLLAGEN REL RES, V1, P151; POSWILLO D, 1974, International Journal of Oral Surgery, V3, P400, DOI 10.1016/S0300-9785(74)80005-0; PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Revell CM, 2008, ANN BIOMED ENG, V36, P1441, DOI 10.1007/s10439-008-9524-x; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Stewart MC, 2000, J BONE MINER RES, V15, P166, DOI 10.1359/jbmr.2000.15.1.166; Tallheden T, 2005, ARTHRITIS RES THER, V7, pR560, DOI 10.1186/ar1709; Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027; Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572; Teramoto M, 2003, J BONE MINER METAB, V21, P276, DOI 10.1007/s00774-003-0421-y; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Weinand C, 2006, ARCH ORTHOP TRAUM SU, V126, P599, DOI 10.1007/s00402-005-0100-7; Williams GM, 2005, ACTA BIOMATER, V1, P625, DOI 10.1016/j.actbio.2005.07.009; Williamson AK, 2003, TISSUE ENG, V9, P625, DOI 10.1089/107632703768247322; Wolford Larry M, 2006, Proc (Bayl Univ Med Cent), V19, P232; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Yan D, 2009, BIOMATERIALS, V30, P814, DOI 10.1016/j.biomaterials.2008.10.042	52	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56983	10.1371/journal.pone.0056983	http://dx.doi.org/10.1371/journal.pone.0056983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437288	Green Published, gold			2022-12-27	WOS:000315186000064
J	Rogers, SL; Fay, N; Maybery, M				Rogers, Shane L.; Fay, Nicolas; Maybery, Murray			Audience Design through Social Interaction during Group Discussion	PLOS ONE			English	Article							PERSPECTIVE-TAKING; COMMUNICATION; COMPREHENSION; ADDRESSEES; KNOWLEDGE; DIALOGUE; SYSTEMS	This paper contrasts two accounts of audience design during multiparty communication: audience design as a strategic individual-level message adjustment or as a non-strategic interaction-level message adjustment. Using a non-interactive communication task, Experiment 1 showed that people distinguish between messages designed for oneself and messages designed for another person; consistent with strategic message design, messages designed for another person/s were longer (number of words) than those designed for oneself. However, audience size did not affect message length (messages designed for different sized audiences were similar in length). Using an interactive communication task Experiment 2 showed that as group size increased so too did communicative effort (number of words exchanged between interlocutors). Consistent with a non-strategic account, as group members were added more social interaction was necessary to coordinate the group's collective situation model. Experiment 3 validates and extends the production measures used in Experiment 1 and 2 using a comprehension task. Taken together, our results indicate that audience design arises as a non-strategic outcome of social interaction during group discussion.	[Rogers, Shane L.; Fay, Nicolas; Maybery, Murray] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia	University of Western Australia	Fay, N (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia.	nicolas.fay@gmail.com	Rogers, Shane L./I-8562-2019; Maybery, Murray/H-5390-2014	Rogers, Shane L./0000-0002-6869-3400; Fay, Nicolas/0000-0001-9866-2800; Maybery, Murray/0000-0002-3760-1382	ARC Discovery grant [DP120104237]	ARC Discovery grant(Australian Research Council)	Funding provided by an ARC Discovery grant DP120104237 (http://www.arc.gov.au/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AH, 2006, DISCOURSE PROCESS, V41, P251, DOI 10.1207/s15326950dp4103_2; Barr D. J., 2012, LANGUAGE COGNITIVE P; BELL A, 1984, LANG SOC, V13, P145, DOI 10.1017/S004740450001037X; Branigan HP, 2011, COGNITION, V121, P41, DOI 10.1016/j.cognition.2011.05.011; Branigan HP, 2011, LANG COGNITIVE PROC, V26, P1667, DOI 10.1080/01690965.2010.524765; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brennan SE, 2009, TOP COGN SCI, V1, P274, DOI 10.1111/j.1756-8765.2009.01019.x; CLARK HH, 1982, LANGUAGE, V58, P332, DOI 10.2307/414102; Duff MC, 2011, HIPPOCAMPUS, V21, P1; Epley N, 2004, J EXP SOC PSYCHOL, V40, P760, DOI 10.1016/j.jesp.2004.02.002; Fay N, 2000, PSYCHOL SCI, V11, P481, DOI 10.1111/1467-9280.00292; Fay N, 2010, COGNITIVE SCI, V34, P351, DOI 10.1111/j.1551-6709.2009.01090.x; FUSSELL SR, 1989, EUR J SOC PSYCHOL, V19, P509, DOI 10.1002/ejsp.2420190603; FUSSELL SR, 1989, J EXP SOC PSYCHOL, V25, P203, DOI 10.1016/0022-1031(89)90019-X; Garrod S, 2007, COGNITIVE SCI, V31, P961, DOI 10.1080/03640210701703659; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Horton WS, 2002, J MEM LANG, V47, P589, DOI 10.1016/S0749-596X(02)00019-0; Kahneman D, 2011, THINKING FAS SLOW; Keysar B, 2007, INTERCULT PRAGMAT, V4, DOI [10.1515/IP.2007.004, DOI 10.1515/IP.2007.004]; Kingsbury D, 1968, THESIS HARVARD U; Krauss R. M., 1996, SOCIAL PSYCHOL HDB B, P655; KRAUSS RM, 1991, SOC COGNITION, V9, P2, DOI 10.1521/soco.1991.9.1.2; KRAUSS RM, 1964, PSYCHON SCI, V1, P113, DOI 10.3758/BF03342817; Levelt W., 1989, SPEAKING INTENTION A; Nuckles M, 2005, J EXP PSYCHOL-APPL, V11, P219, DOI 10.1037/1076-898X.11.4.219; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Sacks H, 1974, LANGUAGE, V50; SCHOBER MF, 1989, COGNITIVE PSYCHOL, V21, P211, DOI 10.1016/0010-0285(89)90008-X; Steiner I. D, 1972, GROUP PROCESSES PROD; Tree JEF, 2008, DISCOURSE PROCESS, V45, P160, DOI 10.1080/01638530701792867; Tree JEF, 1999, DISCOURSE PROCESS, V27, P35, DOI 10.1080/01638539909545049	33	15	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57211	10.1371/journal.pone.0057211	http://dx.doi.org/10.1371/journal.pone.0057211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437343	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000085
J	Crutzen, R; Cyr, D; Larios, H; Ruiter, RAC; de Vries, NK				Crutzen, Rik; Cyr, Dianne; Larios, Hector; Ruiter, Robert A. C.; de Vries, Nanne K.			Social Presence and Use of Internet-Delivered Interventions: A Multi-Method Approach	PLOS ONE			English	Article							VISUAL COMPLEXITY; WEB INTERFACE; ATTENTION; EXPOSURE; ADOLESCENTS; INFORMATION; INTENTION; PROMOTION; COMMERCE; WEBSITES	Objective: Internet-delivered interventions can effectively change health risk behaviors and their determinants, but adherence to intervention websites once they are accessed is very low. This study tests whether and how social presence elements can increase website use. Methods: A website about Hepatitis A, B, and C virus infections was used in a preparatory lab-based eye-tracking study assessing whether social presence elements attract participants' attention, because this is a prerequisite for affecting website use. In the following field study, 482 participants representative of the Dutch population were randomized to either a website with or a website without social presence elements. Participants completed a questionnaire of validated measures regarding user perceptions immediately after exposure to the website. Server registrations were used to assess website use. Results: Participants in the experimental condition focused on the social presence elements, both in terms of frequency (F(1, 98) = 40.34, p<.001) and duration (F(1, 88) = 39.99, p<.001), but did not differ in website use in comparison with the control condition; neither in terms of the number of pages visited (t(456) = 1.44, p = .15), nor in terms of time on the website (t(456) = 0.01, p = .99). Conclusions: Adding social presence elements did not affect actual use of an intervention website within a public health context. Possible reasons are limited attention for these elements in comparison with the main text and the utilitarian value of intervention websites.	[Crutzen, Rik; de Vries, Nanne K.] Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands; [Cyr, Dianne] Simon Fraser Univ, Beedie Sch Business, Vancouver, BC, Canada; [Larios, Hector] Simon Fraser Univ, Sch Interact Arts & Technol, Vancouver, BC, Canada; [Ruiter, Robert A. C.] Maastricht Univ, Dept Work & Social Psychol, Maastricht, Netherlands	Maastricht University; Simon Fraser University; Simon Fraser University; Maastricht University	Crutzen, R (corresponding author), Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands.	rik.crutzen@maastrichtuniversity.nl			Innovational Research Incentives Scheme Veni from NWO-MaGW (Netherlands Organisation for Scientific Research - Division for the Social Sciences)	Innovational Research Incentives Scheme Veni from NWO-MaGW (Netherlands Organisation for Scientific Research - Division for the Social Sciences)	This study was supported by the Innovational Research Incentives Scheme Veni from NWO-MaGW (Netherlands Organisation for Scientific Research - Division for the Social Sciences; www.nwo.nl) accredited to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley M, 2002, J EDUC PSYCHOL, V94, P545, DOI 10.1037//0022-0663.94.3.545; [Anonymous], 2006, EXPLORING PSYCHOL IN; Ballantine PW, 2005, INT J RETAIL DISTRIB, V33, P461, DOI 10.1108/09590550510600870; Benbasat I, 2007, J ASSOC INF SYST, V8, P211, DOI 10.17705/1jais.00126; Bennett GG, 2009, ANNU REV PUBL HEALTH, V30, P273, DOI 10.1146/annurev.publhealth.031308.100235; Binks Martin, 2010, J Med Internet Res, V12, pe9, DOI 10.2196/jmir.1347; Brouwer W, 2011, J MED INTERNET RES, V13, P23, DOI 10.2196/jmir.1639; Brouwer W, 2010, HEALTH EDUC RES, V25, P585, DOI 10.1093/her/cyp063; Chen A, 2001, BRIT J EDUC PSYCHOL, V71, P383, DOI 10.1348/000709901158578; Crutzen R, 2008, J HEALTH PSYCHOL, V13, P906, DOI 10.1177/1359105308095064; Crutzen R, 2012, INTERACT STUD, V13, P469, DOI 10.1075/is.13.3.07cru; Crutzen Rik, 2012, J Infect Public Health, V5, P195, DOI 10.1016/j.jiph.2011.12.001; Crutzen R, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1922; Crutzen R, 2011, ARCH SEX BEHAV, V40, P1105, DOI 10.1007/s10508-011-9833-2; Crutzen R, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1837; Crutzen R, 2011, ADDICTION, V106, P1871, DOI 10.1111/j.1360-0443.2011.03539.x; Crutzen R, 2011, HEALTH EDUC BEHAV, V38, P49, DOI 10.1177/1090198110372878; Crutzen R, 2011, J ADOLESCENT HEALTH, V48, P514, DOI 10.1016/j.jadohealth.2010.09.002; Crutzen R, 2009, HEALTH PROMOT INT, V24, P277, DOI 10.1093/heapro/dap018; Cugelman B, 2009, COMMUN ASSOC INF SYS, V24, P455; Cyr D, 2007, INTERACT COMPUT, V19, P43, DOI 10.1016/j.intcom.2006.07.010; Cyr D, 2009, INT J HUM-COMPUT ST, V67, P850, DOI 10.1016/j.ijhcs.2009.07.004; Cyr D, 2009, MIS QUART, V33, P539; Cyr Dianne, 2008, SIGHCI 2008 P, V17, P35; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Gefen D., 2003, E SERVICE, V2, P7, DOI [DOI 10.2979/ESJ.2003.2.2.7, 10.2979/esj.2003.2.2.7]; Geissler GL, 2006, J ADVERTISING, V35, P69, DOI 10.1080/00913367.2006.10639232; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Hartmann J, 2008, ACM T COMPUT-HUM INT, V15, DOI 10.1145/1460355.1460357; Hassanein K, 2005, INT J ELECTRON COMM, V10, P31, DOI 10.2753/JEC1086-4415100202; Hassanein Khaled, 2009, International Journal of Electronic Business, V7, P625, DOI 10.1504/IJEB.2009.029050; Hassanein K, 2007, INT J HUM-COMPUT ST, V65, P689, DOI 10.1016/j.ijhcs.2006.11.018; Hawkins RP, 2008, HEALTH EDUC RES, V23, P454, DOI 10.1093/her/cyn004; Hermans D, 1999, COGNITION EMOTION, V13, P419, DOI 10.1080/026999399379249; Hofstede G., 1991, BUILDING GLOBAL BUSI; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Izard C.E., 2000, HDB EMOTIONS, V2, P253; Keeney RL, 1999, MANAGE SCI, V45, P533, DOI 10.1287/mnsc.45.4.533; Kline RB, 2005, PRINCIPLES PRACTICE; Komiak SYX, 2008, J ASSOC INF SYST, V9, P727, DOI 10.17705/1jais.00180; Krebs P, 2010, PREV MED, V51, P214, DOI 10.1016/j.ypmed.2010.06.004; Lindgaard G, 2006, BEHAV INFORM TECHNOL, V25, P115, DOI 10.1080/01449290500330448; Mazaheri E, 2011, J BUS RES, V64, P958, DOI 10.1016/j.jbusres.2010.11.018; Nusair K., 2008, Information Technology and Tourism, V10, P75, DOI 10.3727/109830508785058977; Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014; Qiu LY, 2010, INT J HUM-COMPUT ST, V68, P669, DOI 10.1016/j.ijhcs.2010.05.005; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [DOI 10.1080/14792772143000003, 10.1080/14792772143000003]; Smerecnik CMR, 2010, RISK ANAL, V30, P1387, DOI 10.1111/j.1539-6924.2010.01435.x; Sun YQ, 2011, COMPUT HUM BEHAV, V27, P1033, DOI 10.1016/j.chb.2010.12.007; Thielsch MT, 2010, ERGONOMICS, V53, P972, DOI 10.1080/00140139.2010.489970; Tuch AN, 2009, INT J HUM-COMPUT ST, V67, P703, DOI 10.1016/j.ijhcs.2009.04.002; Turner SA, 2006, EMOTION, V6, P670, DOI 10.1037/1528-3542.6.4.670; van der Heijden H, 2003, INFORM MANAGE-AMSTER, V40, P541, DOI 10.1016/S0378-7206(02)00079-4; Van't Riet J, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1345; Weisberg J, 2011, INTERNET RES, V21, P82, DOI 10.1108/10662241111104893; Yoo Y, 2001, MIS QUART, V25, P371, DOI 10.2307/3250922	59	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57067	10.1371/journal.pone.0057067	http://dx.doi.org/10.1371/journal.pone.0057067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437310	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200208
J	Fry, EL; Manning, P; Allen, DGP; Hurst, A; Everwand, G; Rimmler, M; Power, SA				Fry, Ellen L.; Manning, Pete; Allen, David G. P.; Hurst, Alex; Everwand, Georg; Rimmler, Martin; Power, Sally A.			Plant Functional Group Composition Modifies the Effects of Precipitation Change on Grassland Ecosystem Function	PLOS ONE			English	Article							EXPERIMENTAL MANIPULATIONS; COMMUNITY DYNAMICS; SPECIES RICHNESS; SOIL; DIVERSITY; BIODIVERSITY; RESPONSES; TRAITS; DROUGHT; STABILITY	Temperate grassland ecosystems face a future of precipitation change, which can alter community composition and ecosystem functions through reduced soil moisture and waterlogging. There is evidence that functionally diverse plant communities contain a wider range of water use and resource capture strategies, resulting in greater resistance of ecosystem function to precipitation change. To investigate this interaction between composition and precipitation change we performed a field experiment for three years in successional grassland in southern England. This consisted of two treatments. The first, precipitation change, simulated end of century predictions, and consisted of a summer drought phase alongside winter rainfall addition. The second, functional group identity, divided the plant community into three groups based on their functional traits- broadly described as perennials, caespitose grasses and annuals- and removed these groups in a factorial design. Ecosystem functions related to C, N and water cycling were measured regularly. Effects of functional groupidentity were apparent, with the dominant trend being that process rates were higher under control conditions where a range of perennial species were present. E.g. litter decomposition rates were significantly higher in plots containing several perennial species, the group with the highest average leaf N content. Process rates were also very strongly affected by the precipitation change treatmentwhen perennial plant species were dominant, but not where the community contained a high abundance of annual species and caespitose grasses. This contrasting response could be attributable to differing rooting patterns (shallower structures under annual plants, and deeper roots under perennials) and faster nutrient uptake in annuals compared to perennials. Our results indicate that precipitation change will have a smaller effect on key process rates in grasslandscontaining a range of perennial and annual species, and that maintaining the presence of key functional groups should be a crucial consideration in future grassland management.	[Fry, Ellen L.; Manning, Pete; Allen, David G. P.; Hurst, Alex; Everwand, Georg; Rimmler, Martin; Power, Sally A.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Fry, Ellen L.] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London, England; [Manning, Pete] Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Everwand, Georg] Univ Gottingen, D-37073 Gottingen, Germany; [Rimmler, Martin] Univ Bayreuth, Dept Ecol Modelling, Bayreuth, Germany; [Power, Sally A.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia	Imperial College London; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Gottingen; University of Bayreuth; Western Sydney University	Fry, EL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England.	ellen.l.fry@gmail.com	Power, Sally/I-2923-2012; Fry, Ellen/S-7483-2018; Manning, Peter/I-6523-2012	Power, Sally/0000-0002-2723-8671; Fry, Ellen/0000-0001-7513-2006; Manning, Peter/0000-0002-7940-2023	Grantham Institute for Climate Change at Imperial College; UK POPnet; Centre for Population Biology; UK Big Lottery Fund	Grantham Institute for Climate Change at Imperial College; UK POPnet; Centre for Population Biology; UK Big Lottery Fund	EF was supported by a PhD studentship funded by the Grantham Institute for Climate Change at Imperial College, URL http://www3.imperial.ac.uk/climatechange. The work was further supported by UK POPnet, Centre for Population Biology and the UK Big Lottery Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanderud ZT, 2011, ECOSYSTEMS, V14, P156, DOI 10.1007/s10021-010-9401-y; Allen SE, 1989, CHEM ANAL ECOLOGICAL, P46; [Anonymous], 2005, MILLENNIUM ECOSYSTEM; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Carey P.D., 2008, COUNTRYSIDE SURVEY U; Chimner RA, 2010, ECOHYDROLOGY, V3, P284, DOI 10.1002/eco.106; Chimner RA, 2005, BIOGEOCHEMISTRY, V73, P257, DOI 10.1007/s10533-004-1989-6; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Craine JM, 2011, OECOLOGIA, V165, P1109, DOI 10.1007/s00442-011-1938-8; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Debinski DM, 2010, ECOLOGY, V91, P1672, DOI 10.1890/09-0567.1; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Edwards GR, 2000, J APPL ECOL, V37, P321, DOI 10.1046/j.1365-2664.2000.00495.x; Fay PA, 2011, BIOGEOSCIENCES DISCU, V8, P6859; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP, 1985, POPULATION STRUCTURE, V3, P503, DOI DOI 10.1007/978-94-009-5500-4_21; Haddad NM, 2002, ECOL LETT, V5, P110, DOI 10.1046/j.1461-0248.2002.00293.x; Hector A, 2000, OIKOS, V90, P357, DOI 10.1034/j.1600-0706.2000.900217.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hooper D, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P329; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Lamb EG, 2011, PLANT SOIL, V338, P483, DOI 10.1007/s11104-010-0560-6; Laporte Michael F, 2002, BMC Ecol, V2, P10, DOI 10.1186/1472-6785-2-10; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lee M, 2010, PHILOS T R SOC B, V365, P2047, DOI 10.1098/rstb.2010.0028; LEPS J, 1982, VEGETATIO, V50, P53, DOI 10.1007/BF00120678; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Markham JH, 2009, ECOL RES, V24, P93, DOI 10.1007/s11284-008-0485-1; McCulley RL, 2004, OECOLOGIA, V141, P620, DOI 10.1007/s00442-004-1687-z; Met Office, 2011, REGIONAL CLIMATE VAL; Minns A, 2001, OUTLOOK AGR, V30, P179, DOI 10.5367/000000001101293634; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mokany K, 2008, J VEG SCI, V19, P119, DOI 10.3170/2007-8-18340; Morecroft MD, 2004, FUNCT ECOL, V18, P648, DOI 10.1111/j.0269-8463.2004.00896.x; Murphy J.M, 2009, UK CLIMATE PROJECTIO; Murphy K., 2009, STATISTICAL POWER AN; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; Pang JY, 2011, CROP PASTURE SCI, V62, P992, DOI 10.1071/CP11229; R Core Team, 2020, R LANG ENV STAT COMP; Roscher C, 2011, J ECOL, V99, P1460, DOI 10.1111/j.1365-2745.2011.01875.x; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; RYSER P, 1995, PLANT SOIL, V170, P251, DOI 10.1007/BF00010478; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Signarbieux C, 2011, ENVIRON EXP BOT, V71, P192, DOI 10.1016/j.envexpbot.2010.12.003; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Sternberg M, 1999, PLANT ECOL, V143, P29, DOI 10.1023/A:1009812024996; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Turner LR, 2012, GRASS FORAGE SCI, V67, P507, DOI 10.1111/j.1365-2494.2012.00866.x; USDA NRCS, 2010, THE PLANTS DATABASE; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; Volaire F, 1998, NEW PHYTOL, V140, P439, DOI [10.1046/j.1469-8137.1998.00288.x, 10.1111/j.1469-8137.1998.00288.x]; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Walter J, 2011, ENVIRON EXP BOT, V71, P34, DOI 10.1016/j.envexpbot.2010.10.020; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yahdjian L, 2006, ECOLOGY, V87, P952, DOI 10.1890/0012-9658(2006)87[952:VSCPPR]2.0.CO;2; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643; Zhang L, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001504	72	57	59	4	198	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57027	10.1371/journal.pone.0057027	http://dx.doi.org/10.1371/journal.pone.0057027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437300	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200203
J	Horta, A; Nobrega, C; Amorim-Machado, P; Coutinho-Teixeira, V; Barreira-Silva, P; Boavida, S; Costa, P; Sarmento-Castro, R; Castro, AG; Correia-Neves, M				Horta, Ana; Nobrega, Claudia; Amorim-Machado, Pedro; Coutinho-Teixeira, Vitor; Barreira-Silva, Palmira; Boavida, Susana; Costa, Patricio; Sarmento-Castro, Rui; Castro, Antonio Gil; Correia-Neves, Margarida			Poor Immune Reconstitution in HIV-Infected Patients Associates with High Percentage of Regulatory CD4(+) T Cells	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD; COUNT RECOVERY; VIRAL LOAD; ACTIVATION; FOXP3; INDUCTION; DISEASE; REPOPULATION	CD4(+) regulatory T cells (Tregs) are essential for the maintenance of the immune system's equilibrium, by dampening the activation of potential auto-reactive T cells and avoiding excessive immune activation. To correctly perform their function, Tregs must be maintained at the right proportion with respect to effector T cells. Since this equilibrium is frequently disrupted in individuals infected with the human immunodeficiency virus (HIV), we hypothesize that its deregulation could hamper immune reconstitution in patients with poor CD4(+) T cell recovery under highly active antiretroviral therapy (HAART). We analysed Tregs percentages amongst CD4(+) T cells in 53 HIV-infected patients under HAART, with suppression of viral replication and distinct levels of immune reconstitution. As controls, 51 healthy individuals were also analysed. We observed that amongst the patients with Nadir values (the lowest CD4(+) T cell counts achieved) <200 cells/mu L, the individuals with high Tregs percentages (>= 10% of total CD4(+) T cells) had the worse CD4(+) T cell reconstitution. In accordance, the well-described direct correlation between the Nadir value and CD4(+) T cell reconstitution is clearly more evident in individuals with high Tregs proportions. Furthermore, we observed a strong negative correlation between Tregs percentages and CD4(+) T cell recovery among immunological non-responder HIV+ individuals. All together, this work shows that high Tregs frequency is an important factor associated with sub-optimal CD4(+) T cell recovery. This is particularly relevant for immunological non-responders with low Nadir values. Our results suggest that the Tregs proportion might be of clinical relevance to define cut-offs for HAART initiation.	[Horta, Ana; Nobrega, Claudia; Amorim-Machado, Pedro; Coutinho-Teixeira, Vitor; Barreira-Silva, Palmira; Costa, Patricio; Sarmento-Castro, Rui; Castro, Antonio Gil; Correia-Neves, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Horta, Ana; Nobrega, Claudia; Amorim-Machado, Pedro; Coutinho-Teixeira, Vitor; Barreira-Silva, Palmira; Costa, Patricio; Sarmento-Castro, Rui; Castro, Antonio Gil; Correia-Neves, Margarida] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Horta, Ana; Boavida, Susana; Sarmento-Castro, Rui] Hosp Joaquim Urbano Unit, Ctr Hosp Porto, Infect Dis Serv, Oporto, Portugal	Universidade do Minho	Correia-Neves, M (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	mcorreianeves@ecsaude.uminho.pt	Correia-Neves, Margarida/C-9122-2009; Claudia, Nobrega/D-7537-2014; Barreira-Silva, Palmira/T-5360-2018; Costa, Patrício/A-3072-2013; Castro, Gil/T-7584-2018; Nóbrega, Cláudia/T-6430-2018; Correia-Neves, Margarida/AAH-4636-2020	Correia-Neves, Margarida/0000-0002-2202-5431; Claudia, Nobrega/0000-0002-0282-9619; Barreira-Silva, Palmira/0000-0002-8070-1856; Costa, Patrício/0000-0002-1201-9177; Castro, Gil/0000-0002-4684-4183; Nóbrega, Cláudia/0000-0002-0282-9619; Correia-Neves, Margarida/0000-0002-2202-5431; Horta, Ana/0000-0003-3342-9762	Portuguese Foundation for Science and Technology (FCT) [PIC/IC/83313/2007]; FCT [SFRH/BPD/65380/2009, SFRH/BD/73544/2010]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT; PIC/IC/83313/2007; http://www.fct.pt/apoios/projectos/consulta/vglobal_projecto.phtml.en?idProjecto = 83313&idElemConcurso = 1689). CN and PB-S received a fellowship from FCT (SFRH/BPD/65380/2009 and SFRH/BD/73544/2010, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fehervari Z, 2004, CURR OPIN IMMUNOL, V16, P203, DOI 10.1016/j.coi.2004.01.004; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Franco JM, 2002, BLOOD, V99, P3702, DOI 10.1182/blood.V99.10.3702; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Guihot A, 2011, TRENDS IMMUNOL, V32, P131, DOI 10.1016/j.it.2010.12.002; Guihot A, 2010, AIDS, V24, P614, DOI 10.1097/QAD.0b013e32833556f3; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Jiao YM, 2009, IMMUNOLOGY, V128, pe366, DOI 10.1111/j.1365-2567.2008.02978.x; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kolte L, 2009, CLIN EXP IMMUNOL, V155, P44, DOI 10.1111/j.1365-2249.2008.03803.x; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Le Moing V, 2007, HIV MED, V8, P156, DOI 10.1111/j.1468-1293.2007.00446.x; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Long SA, 2011, J IMMUNOL, V187, P3511, DOI 10.4049/jimmunol.1003880; Mendez-Lagares G, 2012, J INFECT DIS, V205, P1501, DOI 10.1093/infdis/jis230; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Nasi M, 2005, IMMUNOGENETICS, V57, P628, DOI 10.1007/s00251-005-0031-z; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Rubio A, 2002, CLIN EXP IMMUNOL, V130, P121, DOI 10.1046/j.1365-2249.2002.01950.x; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Simonetta F, 2012, J INFECT DIS, V205, P1510, DOI 10.1093/infdis/jis235; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365	54	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57336	10.1371/journal.pone.0057336	http://dx.doi.org/10.1371/journal.pone.0057336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437372	Green Published, gold			2022-12-27	WOS:000315184200246
J	La Riviere, M; Roumagnac, M; Garrabou, J; Bally, M				La Riviere, Marie; Roumagnac, Marie; Garrabou, Joaquim; Bally, Marc			Transient Shifts in Bacterial Communities Associated with the Temperate Gorgonian Paramuricea clavata in the Northwestern Mediterranean Sea	PLOS ONE			English	Article							CORAL POCILLOPORA-DAMICORNIS; MASS MORTALITY EVENTS; T-RFLP ANALYSIS; MICROBIAL COMMUNITIES; GENETIC DIVERSITY; LENGTH; SEAWATER; MUCUS; ASSEMBLAGES; POPULATIONS	Background: Bacterial communities that are associated with tropical reef-forming corals are being increasingly recognized for their role in host physiology and health. However, little is known about the microbial diversity of the communities associated with temperate gorgonian corals, even though these communities are key structural components of the ecosystem. In the Northwestern Mediterranean Sea, gorgonians undergo recurrent mass mortalities, but the potential relationship between these events and the structure of the associated bacterial communities remains unexplored. Because microbial assemblages may contribute to the overall health and disease resistance of their host, a detailed baseline of the associated bacterial diversity is required to better understand the functioning of the gorgonian holobiont. Methodology/Principal Findings: The bacterial diversity associated with the gorgonian Paramuricea clavata was determined using denaturing gradient gel electrophoresis, terminal-restriction fragment length polymorphism and the construction of clone libraries of the bacterial 16S ribosomal DNA. Three study sites were monitored for 4 years to assess the variability of communities associated with healthy colonies. Bacterial assemblages were highly dominated by one Hahellaceae-related ribotype and exhibited low diversity. While this pattern was mostly conserved through space and time, in summer 2007, a deep shift in microbiota structure toward increased bacterial diversity and the transient disappearance of Hahellaceae was observed. Conclusion/Significance: This is the first spatiotemporal study to investigate the bacterial diversity associated with a temperate shallow gorgonian. Our data revealed an established relationship between P. clavata and a specific bacterial group within the Oceanospirillales. These results suggest a potential symbiotic role of Hahellaceae in the host-microbe association, as recently suggested for tropical corals. However, a transient imbalance in bacterial associations can be tolerated by the holobiont without apparent symptoms of disease. The subsequent restoration of the Hahellaceae-dominated community is indicative of the specificity and resilience of the bacteria associated with the gorgonian host.	[La Riviere, Marie; Roumagnac, Marie; Garrabou, Joaquim; Bally, Marc] Univ Sud Toulon Var, Aix Marseille Univ, IRD, CNRS INSU,Mediterranean Inst Oceanog MIO UM 110, Marseille, France; [Garrabou, Joaquim] CSIC, ICM, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Bally, M (corresponding author), Univ Sud Toulon Var, Aix Marseille Univ, IRD, CNRS INSU,Mediterranean Inst Oceanog MIO UM 110, Marseille, France.	marc.bally@univ-amu.fr			French National Agency for Research (ANR); Total Foundation	French National Agency for Research (ANR)(French National Research Agency (ANR)); Total Foundation(Total SA)	This work was supported by the French National Agency for Research (ANR; http://www.agence-nationale-recherche.fr/en/) (MEDCHANGE ANR Project) and the Total Foundation (http://fondation.total.com/) (MAGIC3 Project; http://www.magic3-project.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2009, AQUAT BIOL, V4, P289, DOI 10.3354/ab00102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves N, 2010, ENV MICROBIOL REP, V2, P90, DOI 10.1111/j.1758-2229.2009.00101.x; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bruck TB, 2007, MAR BIOTECHNOL, V9, P561, DOI 10.1007/s10126-007-9009-1; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; CHAO A, 1984, SCAND J STAT, V11, P265; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Crisci C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023814; Dahllof I, 2000, APPL ENVIRON MICROB, V66, P3376, DOI 10.1128/AEM.66.8.3376-3380.2000; de Castro AP, 2010, MICROB ECOL, V59, P658, DOI 10.1007/s00248-010-9646-1; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fischer EM, 2009, CLIM DYNAM, V33, P917, DOI 10.1007/s00382-008-0473-8; Fox J., 2019, R COMPANION APPL REG, V.; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Garren M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007319; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Gray MA, 2011, FEMS MICROBIOL ECOL, V76, P109, DOI 10.1111/j.1574-6941.2010.01033.x; Hall-Spencer JM, 2007, DIS AQUAT ORGAN, V76, P87, DOI 10.3354/dao076087; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Hennig C, 2012, FPC FLEXIBLE PROCEDU; Hewson I, 2012, CORAL REEFS, V31, P487, DOI 10.1007/s00338-011-0864-x; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Ji NN, 2004, J MICROBIOL METH, V57, P409, DOI 10.1016/j.mimet.2004.02.010; Klaus JS, 2007, ENVIRON MICROBIOL, V9, P1291, DOI 10.1111/j.1462-2920.2007.01249.x; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lampert Y, 2008, FEMS MICROBIOL ECOL, V64, P187, DOI 10.1111/j.1574-6941.2008.00458.x; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Martin Y, 2002, WATER RES, V36, P779, DOI 10.1016/S0043-1354(01)00251-2; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muyzer G., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P743; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Osborne CA, 2006, APPL ENVIRON MICROB, V72, P1270, DOI 10.1128/AEM.72.2.1270-1278.2006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodolfo-Metalpa R, 2005, ITAL J ZOOL, V72, P271, DOI 10.1080/11250000509356685; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shannon CE, 1949, MATH THEORY COMMUNIC, P125; Sharp KH, 2012, BIOL BULL-US, V223, P66, DOI 10.1086/BBLv223n1p66; SOUTHERN EM, 1979, ANAL BIOCHEM, V100, P319, DOI 10.1016/0003-2697(79)90235-5; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57	67	54	55	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57385	10.1371/journal.pone.0057385	http://dx.doi.org/10.1371/journal.pone.0057385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437379	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200251
J	Lo, WC; Lee, ME; Narayan, M; Chou, CS; Park, HO				Lo, Wing-Cheong; Lee, Mid Eum; Narayan, Monisha; Chou, Ching-Shan; Park, Hay-Oak			Polarization of Diploid Daughter Cells Directed by Spatial Cues and GTP Hydrolysis of Cdc42 in Budding Yeast	PLOS ONE			English	Article							BUD-SITE-SELECTION; SACCHAROMYCES-CEREVISIAE; ACTIVATING PROTEIN; SYMMETRY-BREAKING; POLARITY; GENE; GROWTH; MORPHOGENESIS; ESTABLISHMENT; PATTERN	Cell polarization occurs along a single axis that is generally determined by a spatial cue. Cells of the budding yeast exhibit a characteristic pattern of budding, which depends on cell-type-specific cortical markers, reflecting a genetic programming for the site of cell polarization. The Cdc42 GTPase plays a key role in cell polarization in various cell types. Although previous studies in budding yeast suggested positive feedback loops whereby Cdc42 becomes polarized, these mechanisms do not include spatial cues, neglecting the normal patterns of budding. Here we combine live-cell imaging and mathematical modeling to understand how diploid daughter cells establish polarity preferentially at the pole distal to the previous division site. Live-cell imaging shows that daughter cells of diploids exhibit dynamic polarization of Cdc42-GTP, which localizes to the bud tip until the M phase, to the division site at cytokinesis, and then to the distal pole in the next G1 phase. The strong bias toward distal budding of daughter cells requires the distal-pole tag Bud8 and Rga1, a GTPase activating protein for Cdc42, which inhibits budding at the cytokinesis site. Unexpectedly, we also find that over 50% of daughter cells lacking Rga1 exhibit persistent Cdc42-GTP polarization at the bud tip and the distal pole, revealing an additional role of Rga1 in spatiotemporal regulation of Cdc42 and thus in the pattern of polarized growth. Mathematical modeling indeed reveals robust Cdc42-GTP clustering at the distal pole in diploid daughter cells despite random perturbation of the landmark cues. Moreover, modeling predicts different dynamics of Cdc42-GTP polarization when the landmark level and the initial level of Cdc42-GTP at the division site are perturbed by noise added in the model.	[Lo, Wing-Cheong; Chou, Ching-Shan] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Lee, Mid Eum; Park, Hay-Oak] Ohio State Univ, Mol Cellular Dev Biol Program, Columbus, OH 43210 USA; [Narayan, Monisha; Chou, Ching-Shan] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Park, Hay-Oak] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Park, HO (corresponding author), Ohio State Univ, Mol Cellular Dev Biol Program, Columbus, OH 43210 USA.	park.294@osu.edu		LO, Wing Cheong/0000-0001-7771-5213; Park, Hay-Oak/0000-0001-5782-2257	Mathematical Biosciences Institute and National Science Foundation (NSF) grant [DMS 0931642]; NSF grant [DMS-1020625]; National Institutes of Health/National Institute of General Medical Sciences grant [GM076375]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076375] Funding Source: NIH RePORTER	Mathematical Biosciences Institute and National Science Foundation (NSF) grant; NSF grant(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Mathematical Biosciences Institute and National Science Foundation (NSF) grant DMS 0931642 (to WCL and CSC), NSF grant DMS-1020625 (to CSC), and National Institutes of Health/National Institute of General Medical Sciences grant GM076375 (to HOP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Arkowitz RA, 2011, SEMIN CELL DEV BIOL, V22, P806, DOI 10.1016/j.semcdb.2011.08.010; Ausubel F., 1999, CURRENT PROTOCOLS MO; BACON JSD, 1966, BIOCHEM J, V101, pC36, DOI 10.1042/bj1010036C; BENDER A, 1993, P NATL ACAD SCI USA, V90, P9926, DOI 10.1073/pnas.90.21.9926; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen GC, 1996, MOL CELL BIOL, V16, P1376; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; FREIFELDER D, 1960, J BACTERIOL, V80, P567, DOI 10.1128/JB.80.4.567-568.1960; Frydlova I, 2009, EUKARYOT CELL, V8, P586, DOI 10.1128/EC.00376-08; Fujita A, 2004, GENE, V327, P161, DOI 10.1016/j.gene.2003.11.021; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Guthrie C, 1991, GUIDE YEAST GENETICS; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; HICKS JB, 1977, GENETICS, V85, P395; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Kang PJ, 2004, MOL BIOL CELL, V15, P5145, DOI 10.1091/mbc.E04-07-0600; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Kozminski KG, 2003, MOL BIOL CELL, V14, P4958, DOI 10.1091/mbc.E03-06-0426; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Marquitz AR, 2002, EMBO J, V21, P4012, DOI 10.1093/emboj/cdf416; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; POWERS S, 1991, CELL, V65, P1225, DOI 10.1016/0092-8674(91)90017-S; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Schenkman LR, 2002, J CELL BIOL, V156, P829, DOI 10.1083/jcb.200107041; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Smith GR, 2002, EUKARYOT CELL, V1, P469, DOI 10.1128/EC.1.3.469-480.2002; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; STEVENSON BJ, 1995, GENE DEV, V9, P2949, DOI 10.1101/gad.9.23.2949; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; Watanabe M, 2009, CURR GENET, V55, P365, DOI 10.1007/s00294-009-0251-0; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Yang S, 1997, J CELL BIOL, V136, P111, DOI 10.1083/jcb.136.1.111; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; ZHENG Y, 1994, J BIOL CHEM, V269, P2369; ZHENG Y, 1993, J BIOL CHEM, V268, P24629	54	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56665	10.1371/journal.pone.0056665	http://dx.doi.org/10.1371/journal.pone.0056665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437206	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200136
J	Muller, KAL; Muller, I; Kramer, U; Kandolf, R; Gawaz, M; Bauer, A; Zuern, CS				Mueller, Karin A. L.; Mueller, Iris; Kramer, Ulrich; Kandolf, Reinhard; Gawaz, Meinrad; Bauer, Axel; Zuern, Christine S.			Prognostic Value of Contrast-enhanced Cardiac Magnetic Resonance Imaging in Patients with Newly Diagnosed Non-Ischemic Cardiomyopathy: Cohort Study	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; HEART-FAILURE; HYPERTROPHIC CARDIOMYOPATHY; POSTINFARCTION PATIENTS; DILATED CARDIOMYOPATHY; INTERNATIONAL SOCIETY; MYOCARDIAL-INFARCTION; DELAYED ENHANCEMENT; QRS DURATION; MORTALITY	Background: Owing to its variable course from asymptomatic cases to sudden death risk stratification is of paramount importance in newly diagnosed non-ischemic cardiomyopathy. We tested whether late gadolinium enhancement (LGE) assessed by cardiac magnetic resonance (CMR) imaging is a prognostic marker in consecutive patients with newly diagnosed non-ischemic cardiomyopathy. Methods: We enrolled 185 patients who presented for evaluation of newly diagnosed non-ischemic cardiomyopathy. Coronary artery disease was excluded by coronary angiography. Following risk markers were additionally assessed: NYHA functional class (>= II), brain natriuretic peptide (>100 ng/l), troponin I (Tnl, >= 0.03 mu g/l), left ventricular ejection fraction (LVEF, <= 40%), left ventricular enddiastolic diameter (>55 mm) and QRS duration (>98 ms). Endpoint of the study was the composite of all-cause mortality, heart transplantation, aborted sudden death, sustained ventricular tachycardia or hospitalization due to decompensated heart failure within three years of follow-up. Results: During median follow-up of 21 months, 54 patients (29.2%) reached the composite endpoint. Ninety-four of the 185 patients (50.8%) were judged LGE-positive. Prognosis of LGE-positive patients was significantly worse than that of LGE-negative patients (cumulative 3-year event rates of 67.4% in LGE-positive and 27.2% in LGE-negative patients, respectively; p = 0.021). However, in multivariable analysis, presence of LGE was not an independent predictor of outcome. Only LVEF <= 40% and Tnl >= 0.03 mu g/l were independent risk predictors of the composite endpoint yielding relative risks of 3.9 (95% CI 1.9-8.1; p<0.0001) and 2.2 (95% CI 1.2-4.0; p = 0.014), respectively. Conclusions: In consecutive patients presenting with newly diagnosed non-ischemic cardiomyopathy, LGE-positive patients had worse prognosis. However, only traditional risk parameters like left ventricular performance and cardiac biomarkers but not presence of LGE were independent risk predictors.	[Mueller, Karin A. L.; Mueller, Iris; Gawaz, Meinrad; Bauer, Axel; Zuern, Christine S.] Univ Tubingen, Med Klin 3, Tubingen, Germany; [Kramer, Ulrich] Univ Tubingen, Radiol Univ Klin, Tubingen, Germany; [Kandolf, Reinhard] Univ Tubingen, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Zuern, CS (corresponding author), Univ Tubingen, Med Klin 3, Tubingen, Germany.	christine.zuern@med.uni-tuebingen.de		Zuern, Christine/0000-0001-6625-284X; Bauer, Axel/0000-0001-9201-8555	Deutsche Forschungsgemeinschaft [Transregio-SFB-19]; Klinische Forschergruppe [KFO 274]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klinische Forschergruppe	The study was supported by the Deutsche Forschungsgemeinschaft - Transregio-SFB-19 "Inflammatory Cardiomyopathy" and the Klinische Forschergruppe KFO 274 "Platelets-Molecular Mechanisms and Translational Implications". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the Deutsche Forschungsgemeinschaft Transregio-SFB-19 "Inflammatory Cardiomyopathy" and the Klinische Forschergruppe KFO 274 "Platelets-Molecular Mechanisms and Translational Implications".	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Appelbaum E, 2012, CIRC-CARDIOVASC IMAG, V5, P78, DOI 10.1161/CIRCIMAGING.111.963819; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Bauer A, 2006, EUR HEART J, V27, P427, DOI 10.1093/eurheartj/ehi683; Bauer A, 2008, J AM COLL CARDIOL, V52, P1353, DOI 10.1016/j.jacc.2008.07.041; Bauer A, 2009, EUR HEART J, V30, P576, DOI 10.1093/eurheartj/ehn540; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Bello D, 2005, J AM COLL CARDIOL, V45, P1104, DOI 10.1016/j.jacc.2004.12.057; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Camici PG, 2008, CIRCULATION, V117, P103, DOI 10.1161/CIRCULATIONAHA.107.702993; Camm AJ, 1996, EUR HEART J, V17, P354; Choi KA, 2001, CIRCULATION, V104, P1101, DOI 10.1161/hc3501.096798; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; D'Ambrosio A, 2001, HEART, V85, P499, DOI 10.1136/heart.85.5.499; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Geisler T, 2011, EUROPEAN J RADIOLOGY; Gruen S, 2012, J AM COLL CARDIOL, V59, P1604, DOI 10.1016/j.jacc.2012.01.007; Hsia HH, 2002, PACE, V25, P1114, DOI 10.1046/j.1460-9592.2002.01114.x; Ingkanisorn WP, 2004, J AM COLL CARDIOL, V43, P2253, DOI 10.1016/j.jacc.2004.02.046; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; KWONG RY, 2006, CIRCULATION, V113, P2733, DOI DOI 10.1161/CIRCULATIONHA.105.570648; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Michels VV, 2003, HEART, V89, P757, DOI 10.1136/heart.89.7.757; Miller WL, 2007, CLIN CARDIOL, V30, P245, DOI 10.1002/clc.20075; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Ordovas KG, 2011, RADIOLOGY, V261, P358, DOI 10.1148/radiol.11091882; Ramani K, 1998, CIRCULATION, V98, P2687, DOI 10.1161/01.CIR.98.24.2687; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Wang NC, 2008, JAMA-J AM MED ASSOC, V299, P2656, DOI 10.1001/jama.299.22.2656; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018; Yan AT, 2006, CIRCULATION, V114, P32, DOI 10.1161/CIRCULATIONAHA.106.613414	37	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57077	10.1371/journal.pone.0057077	http://dx.doi.org/10.1371/journal.pone.0057077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437315	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200211
J	Prior, T; Wild, M; Mullins, E; Bennett, P; Kumar, S				Prior, Tomas; Wild, Marianne; Mullins, Edward; Bennett, Phillip; Kumar, Sailesh			Sex Specific Differences in Fetal Middle Cerebral Artery and Umbilical Venous Doppler	PLOS ONE			English	Article							BLOOD-FLOW VELOCITY; PLACENTAL DYSFUNCTION; HUMAN-FETUS; WAVE-FORMS; GROWTH; RATIO; REDISTRIBUTION; AGE	Background: The incidence of several adverse pregnancy outcomes including fetal growth restriction are higher in pregnancies where the fetus is male, leading to suggestions that placental insufficiency is more common in these fetuses. Placental insufficiency associated with fetal growth restriction may be identified by multi-vessel Doppler assessment, but little evidence exists regarding sex specific differences in these Doppler indices or placental function. This study aims to investigate sex specific differences in fetal and placental perfusion and to correlate these changes with intra-partum outcome. Methods and Findings: This is a prospective cohort study. We measured Doppler indices of 388 term pregnancies immediately prior to the onset of active labour (<= 3 cm dilatation). Fetal sex was unknown at the time of the ultrasound assessment. Information from the ultrasound scan was not made available to clinical staff. Case notes and electronic records were reviewed following delivery. We report significantly lower Middle Cerebral artery pulsatility index (1.34 vs. 1.43, p = 0.004), Middle Cerebral artery peak velocity (53.47 cm/s vs. 58.10 cm/s, p = <0.001), and Umbilical venous flow/kg (56 ml/min/kg vs. 61 ml/min/kg, p = 0.02) in male fetuses. These differences however, were not associated with significant differences in intra-partum outcome. Conclusion: Sex specific differences in feto-placental perfusion indices exist. Whilst the physiological relevance of these is currently unknown, the identification of these differences adds to our knowledge of the physiology of male and female fetuses in utero. A number of disease processes have now been shown to have an association with changes in fetal haemodynamics in-utero, as well as having a sex bias, making further investigation of the sex specific differences present during fetal life important. Whilst the clinical application of these findings is currently limited, the results from this study do provide further insight into the gender specific circulatory differences present in the fetal period.	[Prior, Tomas; Wild, Marianne; Mullins, Edward; Bennett, Phillip; Kumar, Sailesh] Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, London W6 0XG, England; [Prior, Tomas; Mullins, Edward; Bennett, Phillip; Kumar, Sailesh] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England	Imperial College London; Imperial College London	Kumar, S (corresponding author), Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, London W6 0XG, England.	Sailesh.Kumar@imperial.ac.uk	Kumar, Sailesh/M-3207-2014; Wild, Marianne Alexia/AFS-1683-2022	Kumar, Sailesh/0000-0003-0832-4811; Wild, Marianne Alexia/0000-0002-8440-2087; Bennett, Phillip/0000-0002-6253-4919; Mullins, Edward/0000-0003-1886-6358	Moonbeam Trust, a small charity funding research in Fetal Medicine	Moonbeam Trust, a small charity funding research in Fetal Medicine	This research was funded by the Moonbeam Trust, a small charity funding research in Fetal Medicine (http://www.moonbeamtrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera A, 1999, AM J OBSTET GYNECOL, V181, P174, DOI 10.1016/S0002-9378(99)70456-4; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Bekedam DJ, 2002, AM J OBSTET GYNECOL, V187, P1605, DOI 10.1067/mob.2002.127379; Benders MJNL, 2013, NEONATOLOGY, V103, P21, DOI 10.1159/000342336; BERKOWITZ GS, 1988, AM J OBSTET GYNECOL, V158, P1149, DOI 10.1016/0002-9378(88)90243-8; BYRNE J, 1987, AM J MED GENET, V26, P605, DOI 10.1002/ajmg.1320260315; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Edwards A, 2000, LANCET, V355, P203, DOI 10.1016/S0140-6736(99)05061-8; Eixarch E, 2008, ULTRASOUND OBST GYN, V32, P894, DOI 10.1002/uog.6249; GRAMELLINI D, 1992, OBSTET GYNECOL, V79, P416, DOI 10.1097/00006250-199203000-00018; JAKOBOVITS AA, 1991, EUR J OBSTET GYN R B, V40, P211, DOI 10.1016/0028-2243(91)90119-6; JAMES WH, 1995, HUM REPROD, V10, P1403, DOI 10.1093/HUMREP/10.6.1403; Lieberman E, 1997, AM J OBSTET GYNECOL, V176, P667, DOI 10.1016/S0002-9378(97)70567-2; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; Munne S, 1993, ZYGOTE, V1, P155, DOI 10.1017/S0967199400001416; Murji A, 2012, AM J MED GENET A, V158A, P779, DOI 10.1002/ajmg.a.35250; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; Piazze J, 2005, INT J GYNECOL OBSTET, V91, P233, DOI 10.1016/j.ijgo.2005.08.015; Rigano S, 2001, AM J OBSTET GYNECOL, V185, P834, DOI 10.1067/mob.2001.117356; Roza SJ, 2008, AM J EPIDEMIOL, V168, P1145, DOI 10.1093/aje/kwn233; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; VYAS S, 1990, BRIT J OBSTET GYNAEC, V97, P797, DOI 10.1111/j.1471-0528.1990.tb02573.x; Whitehouse AJO, 2012, J CHILD PSYCHOL PSYC, V53, P726, DOI 10.1111/j.1469-7610.2011.02523.x; WLADIMIROFF JW, 1987, OBSTET GYNECOL, V69, P705; WLADIMIROFF JW, 1986, BRIT J OBSTET GYNAEC, V93, P471, DOI 10.1111/j.1471-0528.1986.tb08656.x	25	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56933	10.1371/journal.pone.0056933	http://dx.doi.org/10.1371/journal.pone.0056933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437275	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200187
J	Sonde, L; Johnell, K				Sonde, Lars; Johnell, Kristina			Is Drug Treatment for Dementia Followed Up in Primary Care? A Swedish Study of Dementia Clinics and Referring Primary Care Centres	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; MEMANTINE; DONEPEZIL	Purpose: It is largely unknown how the medical treatment of patients diagnosed with dementia is followed up in primary care. Therefore, we studied patient medical records from two dementia clinics and from the referring primary care centres. Methods: A retrospective study of 241 patients was conducted from April to October 2011 in north west Stockholm, Sweden. Over half (51.5%) of the patients had Alzheimer's disease (AD), the remainder had mixed AD/vascular dementia (VaD). Eighty-four medical reports from primary care (35% of the study group) were analysed at follow-up 18 months after diagnosis. Results: All four dementia drugs available on the Swedish market (three cholinesterase inhibitors [donepezil, rivastigmine and galantamine] and memantine) were prescribed at the two dementia clinics. The most commonly used dementia drug was galantamine. There were differences between the two dementia clinics in preference and combination of drugs and of treatment given to male and female patients. At follow-up, 84% were still on dementia medication. Drug use was followed up by the general practitioners (GPs) in two-thirds of the cases. Eighteen per cent of the GPs' medical records made no reference to the patient's dementia or treatment even though dementia drugs were included in the list of medications prescribed. Conclusions: The results indicate that the Swedish guidelines for treatment of cognitive symptoms in AD are being followed in primary care. However, documentation of follow-up of drug treatment was sometimes insufficient, which calls for development of guidelines for complete medical records and medication lists.	[Sonde, Lars] FOU Nu Res & Dev Ctr, Stockholm, Sweden; [Sonde, Lars; Johnell, Kristina] Stockholm Gerontol Res Ctr, Stockholm, Sweden; [Johnell, Kristina] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Johnell, Kristina] Stockholm Univ, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University	Sonde, L (corresponding author), FOU Nu Res & Dev Ctr, Stockholm, Sweden.	lars.sonde@aldrecentrum.se			Stockholm County Council; Swedish Research Council	Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported financially by the Stockholm County Council and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Burns A, 2009, LANCET NEUROL, V8, P39, DOI 10.1016/S1474-4422(08)70261-8; Christensen DD, 2007, J FAM PRACTICE, V56, P17; Geldmacher David S., 2003, Prim Care Companion J Clin Psychiatry, V5, P251; Hardie JA, 2003, SCAND J PUBLIC HEALT, V31, P411, DOI 10.1177/140349480303100603; Herrmann N, 2011, EXPERT OPIN PHARMACO, V12, P787, DOI 10.1517/14656566.2011.558006; Jedenius E, 2011, SCAND J PRIM HEALTH, V29, P181, DOI 10.3109/02813432.2011.585277; Jelic V, 2008, DEMENT GERIATR COGN, V26, P458, DOI 10.1159/000167267; Johnell K, 2008, DEMENT GERIATR COGN, V25, P54, DOI 10.1159/000111534; Kavirajan H, 2007, LANCET NEUROL, V6, P782, DOI 10.1016/S1474-4422(07)70195-3; Krebs EE, 2010, J GEN INTERN MED, V25, P194, DOI 10.1007/s11606-009-1194-3; Miyamoto M, 2009, J CLIN NEUROSCI, V16, P270, DOI 10.1016/j.jocn.2008.03.007; Purandare N, 2006, INT J GERIATR PSYCH, V21, P961, DOI 10.1002/gps.1591; Religa D, 2003, ACTA NEUROBIOL EXP, V63, P393; Rodda J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2986; Santoro A, 2010, CNS DRUGS, V24, P163, DOI 10.2165/11310960-000000000-00000; The Swedish National Board of Health and Welfare, 2010, GUID DEM CAR; Thompson Sarah, 2004, Expert Opin Drug Saf, V3, P425, DOI 10.1517/14740338.3.5.425; Winblad B, 2001, INT J GERIATR PSYCH, V16, P653, DOI 10.1002/gps.496	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57161	10.1371/journal.pone.0057161	http://dx.doi.org/10.1371/journal.pone.0057161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437334	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200223
J	Shen, YY; Chen, X; Murphy, RW				Shen, Yong-Yi; Chen, Xiao; Murphy, Robert W.			Assessing DNA Barcoding as a Tool for Species Identification and Data Quality Control	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; TURTLE PHYLOGENY; AMPHIBIANS; TAXONOMY; CODE	In recent years, the number of sequences of diverse species submitted to GenBank has grown explosively and not infrequently the data contain errors. This problem is extensively recognized but not for invalid or incorrectly identified species, sample mixed-up, and contamination. DNA barcoding is a powerful tool for identifying and confirming species and one very important application involves forensics. In this study, we use DNA barcoding to detect erroneous sequences in GenBank by evaluating deep intraspecific and shallow interspecific divergences to discover possible taxonomic problems and other sources of error. We use the mitochondrial DNA gene encoding cytochrome b (Cytb) from turtles to test the utility of barcoding for pinpointing potential errors. This gene is widely used in phylogenetic studies of the speciose group. Intraspecific variation is usually less than 2.0% and in most cases it is less than 1.0%. In comparison, most species differ by more than 10.0% in our dataset. Overlapping intra-and interspecific percentages of variation mainly involve problematic identifications of species and outdated taxonomies. Further, we detect identical problems in Cytb from Insectivora and Chiroptera. Upon applying this strategy to 47,524 mammalian CoxI sequences, we resolve a suite of potentially problematic sequences. Our study reveals that erroneous sequences are not rare in GenBank and that the DNA barcoding can serve to confirm sequencing accuracy and discover problems such as misidentified species, inaccurate taxonomies, contamination, and potential errors in sequencing.	[Shen, Yong-Yi] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Chen, Xiao] Zhejiang Mariculture Res Inst, Wenzhou, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	Xiamen University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum	Shen, YY (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.	shen_yongyi@yahoo.com.cn	Shen, Yongyi/GWU-8031-2022	Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China [31172080]; Key Program of West Light Foundation; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Engineering Research Council [3148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of West Light Foundation; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Engineering Research Council	The authors thank National Natural Science Foundation of China (31172080), Key Program of West Light Foundation (2011), Youth Innovation Promotion Association of the Chinese Academy of Sciences, and Engineering Research Council (Discovery Grant 3148) for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Cox JPL, 2001, ANALYST, V126, P545, DOI 10.1039/b101850g; Forster R, 2003, ANN HUM GENET, V67, P2, DOI 10.1046/j.1469-1809.2003.00002.x; Fritz U, 2005, ZOOL SCR, V34, P351, DOI 10.1111/j.1463-6409.2005.00188.x; Fujita MK, 2004, MOL PHYLOGENET EVOL, V31, P1031, DOI 10.1016/j.ympev.2003.09.016; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Krenz JG, 2005, MOL PHYLOGENET EVOL, V37, P178, DOI 10.1016/j.ympev.2005.04.027; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Min XJ, 2007, MOL ECOL NOTES, V7, P365, DOI 10.1111/j.1471-8286.2007.01698.x; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; Murphy RW, 2011, ZOOKEYS, P39, DOI 10.3897/zookeys.113.1353; Nagy V, 2007, APPL ENVIRON MICROB, V73, P7048, DOI 10.1128/AEM.00995-07; Nicolas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036586; Parham JF, 2001, ASIAN HERPETOL RES, V9, P71; Pennisi E, 2003, SCIENCE, V300, P1692, DOI 10.1126/science.300.5626.1692; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Spinks PQ, 2004, MOL PHYLOGENET EVOL, V32, P164, DOI 10.1016/j.ympev.2003.12.015; Stoeckle M, 2003, BIOSCIENCE, V53, P796, DOI 10.1641/0006-3568(2003)053[0796:TDATBC]2.0.CO;2; Stuart BL, 2004, MOL PHYLOGENET EVOL, V31, P164, DOI 10.1016/S1055-7903(03)00258-6; Stuart BL, 2007, CONSERV GENET, V8, P169, DOI 10.1007/s10592-006-9159-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wink Michael, 2001, Zoologische Abhandlungen (Dresden), V51, P41; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia Y, 2012, MOL ECOL RESOUR, V12, P48, DOI 10.1111/j.1755-0998.2011.03055.x; Yao YG, 2003, AM J HUM GENET, V72, P1341, DOI 10.1086/375119; Yao YG, 2004, FORENSIC SCI INT, V141, P1, DOI 10.1016/j.forsciint.2003.12.004	48	83	96	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57125	10.1371/journal.pone.0057125	http://dx.doi.org/10.1371/journal.pone.0057125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431400	gold, Green Published			2022-12-27	WOS:000315182800043
J	Wang, XM; Li, J; Yan, MX; Liu, L; Jia, DS; Geng, Q; Lin, HC; He, XH; Li, JJ; Yao, M				Wang, Xiao-Min; Li, Jing; Yan, Ming-Xia; Liu, Lei; Jia, De-Shui; Geng, Qin; Lin, He-Chun; He, Xiang-Huo; Li, Jin-Jun; Yao, Ming			Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer	PLOS ONE			English	Article							CELL-MIGRATION; EXPRESSION; MODEL; ADHESION; GROWTH; TOOL	Objective: To explore the key regulatory genes associated with lung cancer in order to reduce its occurrence and progress through silencing these key genes. Methods: To identify the key regulatory genes involved in lung cancer, we performed a combination of gene array and bioinformatics analyses to compare gene transcription profiles in 3 monoclonal cell strains with high, medium or low metastatic abilities, which were separated from the SPC-A-1sci and SPC-A-1 cell lines by limiting dilution monoclone assay. We then analyzed those genes' biological activities by knocking down their expression in SPC-A-1sci cells using siRNA and lenti-viral shRNA vectors, followed by determinations of the invasion and migration capabilities of the resulting cell lines in vitro as well as their potential for inducing occurrence and metastasis of lung cancer in vivo. To examine the clinical relevance of these findings, we analyzed the expression levels of the identified genes in human lung cancer tissues (n = 135) and matched adjacent normal tissues by immunohistochemical (IHC) staining. Results: Three monoclonal cell strains characterized with high, medium or low metastatic abilities were successfully selected. Gene array and bioinformatics analyses implied that osteopontin, LAMB3 and ITGB1 were key genes involved in lung cancer. Knockdown of these genes suppressed human lung cancer cell invasion and metastasis in vitro and in vivo. Clinical sample analyses indicated that osteopontin, LAMB3 and ITGB1 protein expression levels were higher in lung cancer patients, compared to non-cancerous adjacent tissues, and correlated with lymphatic metastasis. Conclusions: We confirmed that osteopontin, LAMB3 and ITGB1 played important roles in the occurrence and metastasis of lung cancer, thus provided important clues to understanding the molecular mechanism of metastasis and contributing to the therapeutic treatment of lung cancer.	[Wang, Xiao-Min; Li, Jing; Yan, Ming-Xia; Liu, Lei; Jia, De-Shui; Geng, Qin; Lin, He-Chun; He, Xiang-Huo; Li, Jin-Jun; Yao, Ming] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yao, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200030, Peoples R China.	myao@shsci.org	He, Xianghuo/I-1497-2014; Jia, Deshui/U-9732-2019	He, Xianghuo/0000-0001-8872-668X; 	National Key Basic Research Program of China [2009CB521803]; "action plan to innovation'' of the Shanghai Science and Technology fund [10140902400]	National Key Basic Research Program of China(National Basic Research Program of China); "action plan to innovation'' of the Shanghai Science and Technology fund	This work was supported by grants from the National Key Basic Research Program of China (2009CB521803), and "action plan to innovation'' of the Shanghai Science and Technology fund (10140902400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Calaluce R, 2004, NEOPLASIA, V6, P468, DOI 10.1593/neo.03499; Chung H, 2011, J BIOL CHEM, V286, P13438, DOI 10.1074/jbc.M110.166751; Courter D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009633; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; Cui R, 2007, LUNG CANCER, V57, P302, DOI 10.1016/j.lungcan.2007.03.019; Dai JX, 2010, CANCER IMMUNOL IMMUN, V59, P355, DOI 10.1007/s00262-009-0754-z; Donati V, 2005, CLIN CANCER RES, V11, P6459, DOI 10.1158/1078-0432.CCR-05-0541; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; Fong YC, 2009, LUNG CANCER, V64, P263, DOI 10.1016/j.lungcan.2008.09.003; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Griffin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023404; Hu Z, 2005, CLIN CANCER RES, V11, P4646, DOI 10.1158/1078-0432.CCR-04-2013; Ii M, 2011, INT J ONCOL, V39, P593, DOI 10.3892/ijo.2011.1048; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-364; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Luo JH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-428; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Mason CK, 2008, MOL CANCER THER, V7, P548, DOI 10.1158/1535-7163.MCT-07-2251; Mierke CT, 2008, EUR J CELL BIOL, V87, P669, DOI 10.1016/j.ejcb.2008.01.002; Nguyen DX, 2011, J PATHOL, V223, P195, DOI 10.1002/path.2801; Oikawa Y, 2011, EXP CELL RES, V317, P1119, DOI 10.1016/j.yexcr.2010.12.019; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Takahashi M, 2008, CLIN EXP METASTAS, V25, P517, DOI 10.1007/s10585-008-9163-5; Tarin D, 2012, CANCER MICROENVIRON, V5, P95, DOI 10.1007/s12307-012-0099-6; Tripathi M, 2008, J BIOL CHEM, V283, P30576, DOI 10.1074/jbc.M802312200; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wu SF, 1980, SCI CHINA, P913; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Young AL, 2011, EUR J DERMATOL, V21, P401, DOI 10.1684/ejd.2011.1360; Zhang R, 2011, PLOS ONE, V8	41	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55714	10.1371/journal.pone.0055714	http://dx.doi.org/10.1371/journal.pone.0055714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441154	gold, Green Published, Green Submitted			2022-12-27	WOS:000315159200012
J	Arias-Goeta, C; Mousson, L; Rougeon, F; Failloux, AB				Arias-Goeta, Camilo; Mousson, Laurence; Rougeon, Francois; Failloux, Anna-Bella			Dissemination and Transmission of the E1-226V Variant of Chikungunya Virus in Aedes albopictus Are Controlled at the Midgut Barrier Level	PLOS ONE			English	Article							MOSQUITO; VECTORS; ARBOVIRUSES; INFECTION; EMERGENCE; CULICIDAE; EPIDEMIC; OUTBREAK; PATTERNS; DIPTERA	Emergence of arboviruses could result from their ability to exploit new environments, for example a new host. This ability is facilitated by the high mutation rate occurring during viral genome replication. The last emergence of chikungunya in the Indian Ocean region corroborates this statement since a single viral mutation at the position 226 on the E1 glycoprotein (E1-A226V) was associated with enhanced transmission by the mosquito Aedes albopictus in regions where the major mosquito vector, Aedes aegypti, is absent. We used direct competition assays in vivo to dissect out the mechanisms underlying the selection of E1-226V by Ae. albopictus. When the original variant E1-226A and the newly emerged E1-226V were provided in the same blood-meal at equal titers to both species of mosquitoes, we found that the proportion of both variants was drastically different in the two mosquito species. Following ingestion of the infectious blood-meal, the E1-226V variant was preferentially selected in Ae. albopictus, whereas the E1-226A variant was sometimes favored in Ae. aegypti. Interestingly, when the two variants were introduced into the mosquitoes by intrathoracic inoculations, E1-226V was no longer favored for dissemination and transmission in Ae. albopictus, showing that the midgut barrier plays a key role in E1-226V selection. This study sheds light on the role of the midgut barrier in the selection of novel arbovirus emerging variants. We also bring new insight into how the pre-existing variant E1-226V was selected among other viral variants including E1-226A. Indeed the E1-226V variant present at low levels in natural viral populations could rapidly emerge after being selected in Ae. albopictus at the midgut barrier level.	[Arias-Goeta, Camilo; Mousson, Laurence; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France; [Arias-Goeta, Camilo] Univ Paris 06, Cellule Pasteur, Paris, France; [Rougeon, Francois] Inst Pasteur, CNRS, URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Failloux, AB (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.	anna-bella.failloux@pasteur.fr			Institut Pasteur (ACIP) [A-10-2009]; European Commission Framework Program Seven Award "InfraVec'' [228421]; French Ministry of Superior Education and Research	Institut Pasteur (ACIP); European Commission Framework Program Seven Award "InfraVec''; French Ministry of Superior Education and Research	This work was funded by the Institut Pasteur (ACIP grant A-10-2009) and the European Commission Framework Program Seven Award "InfraVec'' (no228421). CAG was supported by the French Ministry of Superior Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Bagny L, 2009, J MED ENTOMOL, V46, P1541, DOI 10.1603/033.046.0644; Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; Sang RC, 2008, AM J TROP MED HYG, V78, P77; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011; Tsetsarkin KA, 2009, THESIS U TEXAS MED B; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168	27	57	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57548	10.1371/journal.pone.0057548	http://dx.doi.org/10.1371/journal.pone.0057548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437397	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000110
J	Biffi, S; Dal Monego, S; Dullin, C; Garrovo, C; Bosnjak, B; Licha, K; Welker, P; Epstein, MM; Alves, F				Biffi, Stefania; Dal Monego, Simeone; Dullin, Christian; Garrovo, Chiara; Bosnjak, Berislav; Licha, Kai; Welker, Pia; Epstein, Michelle M.; Alves, Frauke			Dendritic Polyglycerolsulfate Near Infrared Fluorescent (NIRF) Dye Conjugate for Non-Invasively Monitoring of Inflammation in an Allergic Asthma Mouse Model	PLOS ONE			English	Article							L-SELECTIN; PULMONARY INFLAMMATION; AIRWAY INFLAMMATION; MICE; SULFATES; INHIBITORS; VOLUME	Background: Non-invasive in vivo imaging strategies are of high demand for longitudinal monitoring of inflammation during disease progression. In this study we present an imaging approach using near infrared fluorescence (NIRF) imaging in combination with a polyanionic macromolecular conjugate as a dedicated probe, known to target L- and P-selectin and C3/C5 complement factors. Methodology/Principal Findings: We investigated the suitability of dendritic polyglycerol sulfates (dPGS), conjugated with a hydrophilic version of the indocyanine green label with 6 sulfonate groups (6S-ICG) to monitor sites of inflammation using an experimental mouse model of allergic asthma. Accumulation of the NIRF-conjugated dPGS (dPGS-NIRF) in the inflamed lungs was analyzed in and ex vivo in comparison with the free NIRF dye using optical imaging. Commercially available smart probes activated by matrix metalloproteinase's (MMP) and cathepsins were used as a comparative control. The fluorescence intensity ratio between lung areas of asthmatic and healthy mice was four times higher for the dPGS in comparison to the free dye in vivo at four hrs post intravenous administration. No significant difference in fluorescence intensity between healthy and asthmatic mice was observed 24 hrs post injection for dPGS-NIRF. At this time point ex-vivo scans of asthmatic mice confirmed that the fluorescence within the lungs was reduced to approximately 30% of the intensity observed at 4 hrs post injection. Conclusions/Significance: Compared with smart-probes resulting in a high fluorescence level at 24 hrs post injection optical imaging with dPGS-NIRF conjugates is characterized by fast uptake of the probe at inflammatory sites and represents a novel approach to monitor lung inflammation as demonstrated in mice with allergic asthma.	[Biffi, Stefania; Garrovo, Chiara] Cluster Biomed CBM Scrl, Opt Imaging Lab, Trieste, Italy; [Biffi, Stefania; Garrovo, Chiara] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Dal Monego, Simeone] Cluster Biomed CBM Scrl, Bioinformat, Trieste, Italy; [Dullin, Christian] Univ Med Ctr Gottingen, Dept Diagnost Radiol, Gottingen, Germany; [Bosnjak, Berislav; Epstein, Michelle M.] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria; [Licha, Kai; Welker, Pia] Mivenion GmbH, Berlin, Germany; [Alves, Frauke] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany	IRCCS Burlo Garofolo; University of Gottingen; Medical University of Vienna; University of Gottingen	Biffi, S (corresponding author), Cluster Biomed CBM Scrl, Opt Imaging Lab, Trieste, Italy.	stefania.biffi@cbm.fvg.it	Biffi, Stefania/C-6652-2015; Bošnjak, Berislav/H-7370-2019	Biffi, Stefania/0000-0003-2257-2053; Bošnjak, Berislav/0000-0003-3374-7488; Dullin, Christian/0000-0003-4297-8077; Garrovo, Chiara/0000-0003-1432-0147; Epstein, Michelle/0000-0002-4755-0224	European Commission through an FP7- IAPP Marie Curie Action [GA 230739]	European Commission through an FP7- IAPP Marie Curie Action	The funders (European Commission through an FP7- IAPP Marie Curie Action - (GA 230739)) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis C, 2011, BLOOD, V118, P4231, DOI 10.1182/blood-2011-01-333617; Banerjee ER, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-19; Biffi S, 2008, MOL IMAGING, V7, P272, DOI 10.2310/7290.2008.00028; Clapper ML, 2011, NEOPLASIA, V13, P685, DOI 10.1593/neo.11400; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; Dernedde J, 2010, P NATL ACAD SCI USA, V107, P19679, DOI 10.1073/pnas.1003103107; Dullin C, 2009, MOL IMAGING, V8, P2, DOI 10.2310/7290.2009.00001; Epstein MM, 2004, INT ARCH ALLERGY IMM, V133, P84, DOI 10.1159/000076131; GOOTZ TD, 1988, ANTIMICROB AGENTS CH, V32, P159, DOI 10.1128/AAC.32.2.159; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007; Hammer O, 2001, PAST PALEONTOLOGICAL, P22; Hutteman M, 2011, ANN SURG ONCOL, V18, P1006, DOI 10.1245/s10434-010-1426-0; Jannasch K., 2009, DRUG DISCOV TODAY, V6, P129, DOI DOI 10.1016/J.DDMOD.2009.12.003; Keramidaris E, 2001, J ALLERGY CLIN IMMUN, V107, P734, DOI 10.1067/mai.2001.114050; Licha K, 2011, BIOCONJUGATE CHEM, V22, P2453, DOI 10.1021/bc2002727; Ma GB, 2007, APPL OPTICS, V46, P1650, DOI 10.1364/AO.46.001650; Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065; Napp J, 2011, PEDIATR RADIOL, V41, P161, DOI 10.1007/s00247-010-1907-0; Ntziachristos Vasilis, 2009, Proc Am Thorac Soc, V6, P416, DOI 10.1513/pats.200901-003AW; Reichert S, 2011, SMALL, V7, P820, DOI 10.1002/smll.201002220; Royce SG, 2010, J ASTHMA ALLERGY, V3, P9; Tang MLK, 2001, PULM PHARMACOL THER, V14, P203, DOI 10.1006/pupt.2001.0293; Turk H, 2004, BIOCONJUGATE CHEM, V15, P162, DOI 10.1021/bc034044j; Ushiki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011114; Weinhart M, 2011, BIOMACROMOLECULES, V12, P2502, DOI 10.1021/bm200250f	26	34	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57150	10.1371/journal.pone.0057150	http://dx.doi.org/10.1371/journal.pone.0057150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437332	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000079
J	Deng, T; Huang, Y; Yu, SC; Gu, J; Huang, CR; Xiao, GX; Hao, YT				Deng, Te; Huang, Yong; Yu, Shicheng; Gu, Jing; Huang, Cunrui; Xiao, Gexin; Hao, Yuantao			Spatial-Temporal Clusters and Risk Factors of Hand, Foot, and Mouth Disease at the District Level in Guangdong Province, China	PLOS ONE			English	Article							ENTEROVIRUS 71; EPIDEMIOLOGY; OUTBREAK; HERPANGINA; MALARIA; CANCER; JAPAN; A6	Objective: Hand, foot, and mouth disease (HFMD) has posed a great threat to the health of children and become a public health priority in China. This study aims to investigate the epidemiological characteristics, spatial-temporal patterns, and risk factors of HFMD in Guangdong Province, China, and to provide scientific information for public health responses and interventions. Methods: HFMD surveillance data from May 2008 to December 2011were provided by the Chinese Center for Disease Control and Prevention. We firstly conducted a descriptive analysis to evaluate the epidemic characteristics of HFMD. Then, Kulldorff scan statistic based on a discrete Poisson model was used to detect spatial-temporal clusters. Finally, a spatial paneled model was applied to identify the risk factors. Results: A total of 641,318 HFMD cases were reported in Guangdong Province during the study period (total population incidence: 17.51 per 10,000). Male incidence was higher than female incidence for all age groups, and approximately 90% of the cases were children <= 5 years old. Spatial-temporal cluster analysis detected four most likely clusters and several secondary clusters (P<0.001) with the maximum cluster size 50% and 20% respectively during 2008-2011. Monthly average temperature, relative humidity, the proportion of population <= 5 years, male-to-female ratio, and total sunshine were demonstrated to be the risk factors for HFMD. Conclusion: Children <= 5 years old, especially boys, were more susceptible to HFMD and we should take care of their vulnerability. Provincial capital city Guangzhou and the Pearl River Delta regions had always been the spatial-temporal clusters and future public health planning and resource allocation should be focused on these areas. Furthermore, our findings showed a strong association between HFMD and meteorological factors, which may assist in predicting HFMD incidence.	[Deng, Te; Huang, Yong; Gu, Jing; Hao, Yuantao] Sun Yat Sen Univ, Dept Med Stat, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Te; Huang, Yong; Gu, Jing; Hao, Yuantao] Sun Yat Sen Univ, Epidemiol & Hlth Informat Res Ctr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Shicheng; Xiao, Gexin] Chinese Ctr Dis Control & Prevent, Ctr Publ Hlth Surveillance & Informat Serv, Beijing, Peoples R China; [Huang, Cunrui] Griffith Univ, Sch Environm, Ctr Environm & Populat Hlth, Brisbane, Qld 4111, Australia	Sun Yat Sen University; Sun Yat Sen University; Chinese Center for Disease Control & Prevention; Griffith University	Hao, YT (corresponding author), Sun Yat Sen Univ, Dept Med Stat, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China.	haoyt@mail.sysu.edu.cn	Huang, Cunrui/ABI-3312-2020	Huang, Yong/0000-0001-7973-4039				Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [Anonymous], 2011, SATSCAN USER GUIDE V; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L., 2008, ECONOMETRICS PANEL D, P625, DOI 10.1007/978-3-540-75892-1_19; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chinese Center for Disease Control and Prevention(China CDC), 2008, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2011, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2010, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2009, NAT INC DEATH CAS NO; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Elhorst J. P., 2010, HDB APPL SPATIAL ANA, P377, DOI DOI 10.1007/978-3-642-03647-7_19; Elhorst J P, 2010, MATLAB SOFTWARE SPAT; Elhorst JP, 2003, INT REGIONAL SCI REV, V26, P244, DOI 10.1177/0160017603253791; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Ji Z, 2012, MICROBES ENV; Kleinman KP, 2005, EPIDEMIOL INFECT, V133, P409, DOI 10.1017/S0950268804003528; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Lv H, 2011, ZHEJIANG PREV MED, V23, P29; Ma E, 2010, JPN J INFECT DIS, V63, P422; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Momoki TS, 2009, JPN J INFECT DIS, V62, P471; Openshaw, 1984, CONCEPTS TECHNIQUES, V38; Ruan F, 2011, PEDIATRICS, V127, pE898, DOI 10.1542/peds.2010-1497; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; The Ministry of Health of the People's Republic of China, 2008, CAP J PUBLIC HLTH, P146; The Ministry of Health of The People's Republic of China, 2009, GAZETTE MINIST HLTH, P65; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Xu W, 2011, ASIA PAC J PUBLIC HL; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang WY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-206; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	41	99	111	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56943	10.1371/journal.pone.0056943	http://dx.doi.org/10.1371/journal.pone.0056943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437278	Green Published, gold			2022-12-27	WOS:000315186000058
J	Knaepen, L; Rayen, I; Charlier, TD; Fillet, M; Houbart, V; van Kleef, M; Steinbusch, HW; Patijn, J; Tibboel, D; Joosten, EA; Pawluski, JL				Knaepen, Liesbeth; Rayen, Ine; Charlier, Thierry D.; Fillet, Marianne; Houbart, Virginie; van Kleef, Maarten; Steinbusch, Harry W.; Patijn, Jacob; Tibboel, Dick; Joosten, Elbert A.; Pawluski, Jodi L.			Developmental Fluoxetine Exposure Normalizes the Long-Term Effects of Maternal Stress on Post-Operative Pain in Sprague-Dawley Rat Offspring	PLOS ONE			English	Article							DEPRESSION-LIKE BEHAVIOR; PITUITARY-ADRENAL AXIS; MONTHS CORRECTED AGE; GLUCOCORTICOID-RECEPTOR; MEDICATION EXPOSURE; PLACENTAL-TRANSFER; BINDING GLOBULIN; CORTISOL-LEVELS; SPINAL-CORD; ANTIDEPRESSANTS	Early life events can significantly alter the development of the nociceptive circuit. In fact, clinical work has shown that maternal adversity, in the form of depression, and concomitant selective serotonin reuptake inhibitor (SSRI) treatment influence nociception in infants. The combined effects of maternal adversity and SSRI exposure on offspring nociception may be due to their effects on the developing hypothalamic-pituitary-adrenal (HPA) system. Therefore, the present study investigated long-term effects of maternal adversity and/or SSRI medication use on nociception of adult Sprague-Dawley rat offspring, taking into account involvement of the HPA system. Dams were subject to stress during gestation and were treated with fluoxetine (26/5 mg/kg/day) prior to parturition and throughout lactation. Four groups of adult male offspring were used: 1. Control+Vehicle, 2. Control+Fluoxetine, 3. Prenatal Stress+Vehicle, 4. Prenatal Stress+Fluoxetine. Results show that post-operative pain, measured as hypersensitivity to mechanical stimuli after hind paw incision, was decreased in adult offspring subject to prenatal stress alone and increased in offspring developmentally exposed to fluoxetine alone. Moreover, post-operative pain was normalized in prenatally stressed offspring exposed to fluoxetine. This was paralleled by a decrease in corticosteroid binding globulin (CBG) levels in prenatally stressed offspring and a normalization of serum CBG levels in prenatally stressed offspring developmentally exposed to fluoxetine. Thus, developmental fluoxetine exposure normalizes the long-term effects of maternal adversity on post-operative pain in offspring and these effects may be due, in part, to the involvement of the HPA system.	[Knaepen, Liesbeth; van Kleef, Maarten; Patijn, Jacob; Joosten, Elbert A.] Maastricht Univ, Med Ctr, Dept Anesthesiol Pain Management, Univ Pain Ctr Maastricht, Maastricht, Netherlands; [Rayen, Ine; Steinbusch, Harry W.; Pawluski, Jodi L.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Charlier, Thierry D.; Tibboel, Dick; Pawluski, Jodi L.] Univ Liege, GIGA Neurosci, Liege, Belgium; [Fillet, Marianne; Houbart, Virginie] Univ Liege, Dept Pharm, CIRM, Lab Analyt Pharmaceut Chem, Liege, Belgium; Erasmus MC Sophia, Rotterdam, Netherlands; Erasmus MC Sophia, Dept Pediat Surg, Rotterdam, Netherlands	Maastricht University; Maastricht University; University of Liege; University of Liege; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pawluski, JL (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	j.pawluski@ulg.ac.be	Charlier, Thierry/J-4668-2015; Pawluski, Jodi L/K-5801-2015; Steinbusch, Heinrich/L-6950-2017	Pawluski, Jodi L/0000-0002-8240-8178; Fillet, Marianne/0000-0002-1453-6282	Fonds de la Recherche Scientifique-FNRS, Belgium; Pain Knowledge Centers of Maastricht and Rotterdam	Fonds de la Recherche Scientifique-FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); Pain Knowledge Centers of Maastricht and Rotterdam	This research was funded by a Charge de recherche and Apirant grants from Fonds de la Recherche Scientifique-FNRS, Belgium (to JLP and VH) and by the Pain Knowledge Centers of Maastricht and Rotterdam (to LK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2007, NEUROSCI RES, V59, P145, DOI 10.1016/j.neures.2007.06.1465; Andrews MH, 2004, STRESS, V7, P15, DOI 10.1080/10253890310001650277; BARDEN N, 1995, TRENDS NEUROSCI, V18, P6, DOI 10.1016/0166-2236(95)93942-Q; Benedetti M, 2012, EUR J PAIN, V16, P803, DOI 10.1002/j.1532-2149.2011.00066.x; Berguer R, 1998, SURG ENDOSC-ULTRAS, V12, P236, DOI 10.1007/s004649900642; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Brummelte S, 2011, DEV PSYCHOBIOL, V53, P184, DOI 10.1002/dev.20511; Butkevich I, 2011, PHYSIOL BEHAV, V102, P137, DOI 10.1016/j.physbeh.2010.10.023; Butkevich IP, 2007, EUR J PAIN, V11, P888, DOI 10.1016/j.ejpain.2007.02.001; CINTRA A, 1994, NEUROSCIENCE, V62, P843, DOI 10.1016/0306-4522(94)90481-2; CINTRA A, 1993, BRAIN RES, V632, P334, DOI 10.1016/0006-8993(93)91172-O; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; FUXE K, 1985, NEUROSCI LETT, V60, P1, DOI 10.1016/0304-3940(85)90372-6; Goodin BR, 2012, BIOL PSYCHOL; Green MK, 2011, NEUROSCIENCE, V192, P438, DOI 10.1016/j.neuroscience.2011.06.041; Green PG, 2011, PAIN, V152, P2549, DOI 10.1016/j.pain.2011.07.021; Grunau RE, 2010, CLIN J PAIN, V26, P698, DOI 10.1097/AJP.0b013e3181e5bb00; Hamalainen MM, 2009, J PAIN, V10, P637, DOI 10.1016/j.jpain.2009.01.003; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; Helgeland H, 2010, J PSYCHOSOM RES, V68, P359, DOI 10.1016/j.jpsychores.2009.10.010; Houbart V, 2012, ELECTROPHORESIS, V33, P3370, DOI 10.1002/elps.201200168; Knaepen L, 2013, DEV NEUROBIOL, V73, P85, DOI 10.1002/dneu.22047; Kotani N, 2001, ANESTHESIOLOGY, V95, P349, DOI 10.1097/00000542-200108000-00015; Laplante P, 2002, DEV BRAIN RES, V139, P199, DOI 10.1016/S0165-3806(02)00550-3; Lee LJ, 2009, NEUROTOX RES, V15, P212, DOI 10.1007/s12640-009-9022-4; Leung BMY, 2009, J AM DIET ASSOC, V109, P1566, DOI 10.1016/j.jada.2009.06.368; Lisboa SFS, 2007, PHARMACOLOGY, V80, P49, DOI 10.1159/000103097; McLean SA, 2005, ARTHRITIS RHEUM-US, V52, P3660, DOI 10.1002/art.21372; Moloney RD, 2012, NEUROSCI LETT, V512, P99, DOI 10.1016/j.neulet.2012.01.066; Motamed S, 1998, ANESTHESIOLOGY, V88, P1211, DOI 10.1097/00000542-199805000-00011; O'Connor TG, 2012, DEV PSYCHOBIOL; O'Mahony SM, 2006, NEUROIMMUNOMODULAT, V13, P82, DOI 10.1159/000096090; Oberlander TF, 2005, PEDIATRICS, V115, P411, DOI 10.1542/peds.2004-0420; Oberlander TF, 2002, PEDIATR RES, V51, P443, DOI 10.1203/00006450-200204000-00008; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Panchaud A, 2011, CLIN PHARMACOL THER, V89, P830, DOI 10.1038/clpt.2011.23; Pawluski JL, 2012, NEUROSCIENCE, V220, P131, DOI 10.1016/j.neuroscience.2012.06.034; Pawluski JL, 2012, PSYCHONEUROENDOCRINO, V37, P1019, DOI 10.1016/j.psyneuen.2011.11.011; Pawluski JL, 2012, BEHAV BRAIN RES, V228, P159, DOI 10.1016/j.bbr.2011.11.043; Pawluski JL, 2009, PHYSIOL BEHAV, V96, P108, DOI 10.1016/j.physbeh.2008.09.004; POHLAND RC, 1989, TOXICOL APPL PHARM, V98, P198, DOI 10.1016/0041-008X(89)90225-1; Powers BE, 2006, TOXICOL SCI, V89, P415, DOI 10.1093/toxsci/kfj051; Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Smith JW, 2004, PSYCHONEUROENDOCRINO, V29, P227, DOI 10.1016/S0306-4530(03)00025-8; Tsang SW, 2011, EUR J PAIN; Van den Hove DLA, 2005, DEV NEUROSCI-BASEL, V27, P313, DOI 10.1159/000086711; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; WARD IL, 1984, ENDOCRINOLOGY, V114, P1635, DOI 10.1210/endo-114-5-1635; Wolff N, 2010, J PEDIATR PSYCHOL, V35, P306, DOI 10.1093/jpepsy/jsp058	55	42	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57608	10.1371/journal.pone.0057608	http://dx.doi.org/10.1371/journal.pone.0057608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437400	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000113
J	Lee, ST; Wong, PF; He, H; Hooper, JD; Mustafa, MR				Lee, Sui-Ting; Wong, Pooi-Fong; He, Hui; Hooper, John David; Mustafa, Mohd Rais			Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B Signaling	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; ACTIVATION; INHIBITION; EXPRESSION; INVASION; SURVIVAL; AGENTS; LIVER	Background: Nuclear factor-kappa B (NF-kappa B) plays a role in prostate cancer and agents that suppress its activation may inhibit development or progression of this malignancy. Alpha (alpha)-tomatine is the major saponin present in tomato ( Lycopersicon esculentum) and we have previously reported that it suppresses tumor necrosis factor-alpha (TNF-alpha)-induced nuclear translocation of nuclear factor-kappa B (NF-k beta) in androgen-independent prostate cancer PC-3 cells and also potently induces apoptosis of these cells. However, the precise mechanism by which alpha-tomatine suppresses NF-kappa B nuclear translocation is yet to be elucidated and the anti-tumor activity of this agent in vivo has not been examined. Methodology/Principal Findings: In the present study we show that suppression of NF-kappa B activation by alpha-tomatine occurs through inhibition of I kappa B alpha (I kappa B alpha) kinase activity, leading to sequential suppression of IkBa phosphorylation, I kappa B alpha degradation, NF-kappa B/p65 phosphorylation, and NF-kappa B p50/p65 nuclear translocation. Consistent with its ability to induce apoptosis, alpha-tomatine reduced TNF-alpha induced activation of the pro-survival mediator Akt and its inhibition of NF-kappa B activation was accompanied by significant reduction in the expression of NF-kappa B-dependent anti-apoptotic (c-IAP1, c-IAP2, Bcl-2, Bcl-xL, XIAP and survivin) proteins. We also evaluated the antitumor activity of alpha-tomatine against PC-3 cell tumors grown subcutaneously and orthotopically in mice. Our data indicate that intraperitoneal administration of alpha-tomatine significantly attenuates the growth of PC-3 cell tumors grown at both sites. Analysis of tumor material indicates that the tumor suppressing effects of alpha-tomatine were accompanied by increased apoptosis and lower proliferation of tumor cells as well as reduced nuclear translocation of the p50 and p65 components of NF-kappa B. Conclusion/Significance: Our study provides first evidence for in vivo antitumor efficacy of alpha-tomatine against the human androgen-independent prostate cancer. The potential usefulness of alpha-tomatine in prostate cancer prevention and therapy requires further investigation.	[Lee, Sui-Ting; Wong, Pooi-Fong; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [He, Hui; Hooper, John David] Mater Med Res Inst, Brisbane, Qld, Australia	Universiti Malaya; Mater Research	Mustafa, MR (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	rais@um.edu.my	WONG, POOI-FONG PF/B-5234-2010; Mustafa, Mohamed R/B-1647-2009; Hooper, John/C-1481-2016	WONG, POOI-FONG PF/0000-0002-6705-2521; Mustafa, Mohamed R/0000-0002-7864-5189; Hooper, John/0000-0003-1054-8486	Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG) [E000002-20001]; University Malaya Research Grant (UMRG) [RG161/09HTM]	Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG); University Malaya Research Grant (UMRG)	This work was funded by Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG) E000002-20001 and University Malaya Research Grant (UMRG) RG161/09HTM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal Bharat B., 2004, Indian Journal of Experimental Biology, V42, P341; Akimoto T, 2001, INT J RADIAT ONCOL, V50, P195, DOI 10.1016/S0360-3016(00)01560-1; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bracarda S, 2005, CRIT REV ONCOL HEMAT, V56, P379, DOI 10.1016/j.critrevonc.2005.03.010; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Dagher R, 2004, CLIN CANCER RES, V10, P8147, DOI 10.1158/1078-0432.CCR-04-1402; Das KC, 1997, J BIOL CHEM, V272, P14914, DOI 10.1074/jbc.272.23.14914; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Estrada AC, 2010, MOL PHARMACOL, V77, P378, DOI 10.1124/mol.109.060475; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Friedman M, 2005, J AGR FOOD CHEM, V53, P6162, DOI 10.1021/jf050620p; Friedman M, 2007, MOL NUTR FOOD RES, V51, P1485, DOI 10.1002/mnfr.200700176; Friedman M, 2009, J AGR FOOD CHEM, V57, P5727, DOI 10.1021/jf900364j; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; Gasparian AV, 2002, J CELL SCI, V115, P141; Gill C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-39; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Husain K, 2011, MOL CANCER THER, V10, P2363, DOI 10.1158/1535-7163.MCT-11-0424; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Khan N, 2010, ENDOCR-RELAT CANCER, V17, pR39, DOI 10.1677/ERC-09-0262; Komatsu K, 1997, CANCER LETT, V112, P135, DOI 10.1016/S0304-3835(96)04555-7; Kunnumakkara AB, 2009, INT J CANCER, V125, P2187, DOI 10.1002/ijc.24593; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604; Luk SU, 2011, INT J CANCER, V128, P2182, DOI 10.1002/ijc.25546; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Morrow WJW, 2004, VACCINE, V22, P2380, DOI 10.1016/j.vaccine.2004.03.022; Nobili S, 2009, PHARMACOL RES, V59, P365, DOI 10.1016/j.phrs.2009.01.017; Ozes ON, 1999, NATURE, V401, P82; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Plymate SR, 2003, ONCOGENE, V22, P1024, DOI 10.1038/sj.onc.1206210; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sandur SK, 2009, INT J RADIAT ONCOL, V75, P534, DOI 10.1016/j.ijrobp.2009.06.034; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shieh JM, 2011, CELL BIOCHEM BIOPHYS, V60, P297, DOI 10.1007/s12013-011-9152-1; Shih YW, 2009, FOOD CHEM TOXICOL, V47, P1985, DOI 10.1016/j.fct.2009.05.011; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tang YX, 2011, NEOPLASIA, V13, P108, DOI 10.1593/neo.101092; Uetsuka H, 2003, EXP CELL RES, V289, P27, DOI 10.1016/S0014-4827(03)00223-4; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yemelyanov A, 2006, ONCOGENE, V25, P387, DOI 10.1038/sj.onc.1209066; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhu L, 2001, FEBS LETT, V508, P369, DOI 10.1016/S0014-5793(01)03084-8; Zoberi I, 2002, CANCER LETT, V175, P165, DOI 10.1016/S0304-3835(01)00719-4	57	126	129	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57708	10.1371/journal.pone.0057708	http://dx.doi.org/10.1371/journal.pone.0057708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437404	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315186000117
J	Stoppin-Mellet, V; Fache, V; Portran, D; Martiel, JL; Vantard, M				Stoppin-Mellet, Virginie; Fache, Vincent; Portran, Didier; Martiel, Jean-Louis; Vantard, Marylin			MAP65 Coordinate Microtubule Growth during Bundle Formation	PLOS ONE			English	Article							DYNAMIC INSTABILITY; CROSS-LINKING; PROTEIN; BINDING; ARRAYS; PRC1; INTERPHASE; GENERATION; REVEALS; ASE1P	Microtubules (MTs) are highly dynamical structures that play a crucial role in cell physiology. In cooperation with microtubule-associated proteins (MAPs), MTs form bundles endowing cells with specific mechanisms to control their shape or generate forces. Whether the dynamics of MTs is affected by the lateral connections that MAPs make between MTs during bundle formation is still under debate. Using in vitro reconstitution of MT bundling, we analyzed the dynamics of MT bundles generated by two plant MAP65 (MAP65-1/4), MAP65-1 being the plant ortholog of vertebrate PRC1 and yeast Ase1. MAP65-1/4 limit the amplitude of MT bundle depolymerization and increase the elongation phases. The subsequent sustained elongation of bundles is governed by the coordination of MT growth, so that MT ends come in close vicinity. We develop a model based on the assumption that both MAP65-1/4 block MT depolymerization. Model simulations reveal that rescue frequencies are higher between parallel than between anti-parallel MTs. In consequence the polarity of bundled MTs by MAP65 controls the amplitude of bundle's growth. Our results illustrate how MAP-induced MT-bundling, which is finely tuned by MT polarity, robustly coordinates MT elongation within bundles.	[Stoppin-Mellet, Virginie; Fache, Vincent; Portran, Didier; Martiel, Jean-Louis; Vantard, Marylin] Univ Grenoble 1, Physiol Cellulaire Vegetale Lab, Inst Rech Technol & Sci Vivant iRTSV,CNRS,INRA, Commissariat Energie Atom & Energies Alternat,CEA, Grenoble, France	INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Stoppin-Mellet, V (corresponding author), Univ Grenoble 1, Physiol Cellulaire Vegetale Lab, Inst Rech Technol & Sci Vivant iRTSV,CNRS,INRA, Commissariat Energie Atom & Energies Alternat,CEA, Grenoble, France.	virginie.stoppin-mellet@cea.fr; marylin.vantard@cea.fr	Martiel, Jean-Louis/N-5250-2018; Martiel, Jean-Louis/M-7181-2014; stoppin-mellet, Virginie/I-9883-2017	Martiel, Jean-Louis/0000-0001-8638-7207; stoppin-mellet, Virginie/0000-0002-1958-1306; Portran, Didier/0000-0002-0356-398X	CNRS; CEA; French Research Ministry	CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); French Research Ministry(Ministry of Research, France)	This work was funded by grants from the CNRS, the CEA and from the French Research Ministry (D.P and V.F). We also thank the Agence Nationale de la Recherche (ANR-08-Syscom_013, J-L.M.) and the Institute of Complex Systems IXXI-Rhone-Alpes (J-L.M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Barton DA, 2008, PLANT CELL, V20, P982, DOI 10.1105/tpc.108.058503; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bratman SV, 2008, TRENDS CELL BIOL, V18, P580, DOI 10.1016/j.tcb.2008.09.004; Brun L, 2009, P NATL ACAD SCI USA, V106, P21173, DOI 10.1073/pnas.0910774106; Caillaud MC, 2008, PLANT CELL, V20, P423, DOI 10.1105/tpc.107.057422; Dhonukshe P, 2012, CELL, V149, P383, DOI 10.1016/j.cell.2012.02.051; Fache V, 2010, PLANT CELL, V22, P3804, DOI 10.1105/tpc.110.080606; Gaillard J, 2008, MOL BIOL CELL, V19, P4534, DOI 10.1091/mbc.E08-04-0341; HARDHAM AR, 1978, J CELL BIOL, V77, P14, DOI 10.1083/jcb.77.1.14; Hussey PJ, 2002, PLANT MOL BIOL, V50, P915, DOI 10.1023/A:1021236307508; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kiris E, 2010, METHOD CELL BIOL, V95, P481, DOI 10.1016/S0091-679X(10)95024-3; Laan L, 2008, P NATL ACAD SCI USA, V105, P8920, DOI 10.1073/pnas.0710311105; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Lucas JR, 2011, PLANT CELL, V23, P1889, DOI 10.1105/tpc.111.084970; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Muller S, 2004, CURR BIOL, V14, P412, DOI 10.1016/j.cub.2004.02.032; SCHULZE E, 1986, J CELL BIOL, V102, P1020, DOI 10.1083/jcb.102.3.1020; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Shaw SL, 2011, CYTOSKELETON, V68, P56, DOI 10.1002/cm.20495; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Smertenko AP, 2004, PLANT CELL, V16, P2035, DOI 10.1105/tpc.104.023937; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Tulin A, 2012, BIOPHYS J, V102, P802, DOI 10.1016/j.bpj.2012.01.008; Van Damme D, 2004, PLANT PHYSIOL, V136, P3956, DOI 10.1104/pp.104.051623; VANTARD M, 1994, EUR J BIOCHEM, V220, P847, DOI 10.1111/j.1432-1033.1994.tb18687.x; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wicker-Planquart C, 2004, PLANT J, V39, P126, DOI 10.1111/j.1365-313X.2004.02115.x	33	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56808	10.1371/journal.pone.0056808	http://dx.doi.org/10.1371/journal.pone.0056808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437247	Green Published, gold			2022-12-27	WOS:000315186000048
J	Weisberg, E; Liu, QS; Zhang, X; Nelson, E; Sattler, M; Liu, FY; Nicolais, M; Zhang, JM; Mitsiades, C; Smith, RW; Stone, R; Galinsky, I; Nonami, A; Griffin, JD; Gray, N				Weisberg, Ellen; Liu, Qingsong; Zhang, Xin; Nelson, Erik; Sattler, Martin; Liu, Feiyang; Nicolais, Maria; Zhang, Jianming; Mitsiades, Constantine; Smith, Robert W.; Stone, Richard; Galinsky, Ilene; Nonami, Atsushi; Griffin, James D.; Gray, Nathanael			Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells	PLOS ONE			English	Article							LYMPHOBLASTIC-LEUKEMIA CELLS; CONSTITUTIVE ACTIVATION; FLT3 INHIBITORS; APOPTOSIS; MUTATIONS; SURVIVAL; RESISTANCE; THERAPIES; PATHWAYS; CONTACT	Objectives: Tyrosine kinase inhibitor (TKI)-treated acute myeloid leukemia (AML) patients commonly show rapid and significant peripheral blood blast cell reduction, however a marginal decrease in bone marrow blasts. This suggests a protective environment and highlights the demand for a better understanding of stromal: leukemia cell communication. As a strategy to improve clinical efficacy, we searched for novel agents capable of potentiating the stroma-diminished effects of TKI treatment of mutant FLT3-expressing cells. Methods: We designed a combinatorial high throughput drug screen using well-characterized kinase inhibitor-focused libraries to identify novel kinase inhibitors capable of overriding stromal-mediated resistance to TKIs, such as PKC412 and AC220. Standard liquid culture proliferation assays, cell cycle and apoptosis analysis, and immunoblotting were carried out with cell lines or primary AML to validate putative candidates from the screen and characterize the mechanism(s) underlying observed synergy. Results and Conclusions: Our study led to the observation of synergy between selective Akt inhibitors and FLT3 inhibitors against mutant FLT3-positive AML in either the absence or presence of stroma. Our findings are consistent with evidence that Akt activation is characteristic of mutant FLT3-transformed cells, as well as observed residual Akt activity following FLT3 inhibitor treatment. In conclusion, our study highlights the potential importance of Akt as a signaling factor in leukemia survival, and supports the use of the co-culture chemical screen to identify agents able to potentiate TKI anti-leukemia activity in a cytoprotective microenvironment.	[Weisberg, Ellen; Nelson, Erik; Sattler, Martin; Nicolais, Maria; Mitsiades, Constantine; Smith, Robert W.; Stone, Richard; Galinsky, Ilene; Nonami, Atsushi; Griffin, James D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liu, Qingsong; Zhang, Xin; Zhang, Jianming; Gray, Nathanael] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Liu, Feiyang] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Weisberg, E (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	ellen_weisberg@dfci.harvard.edu; james_griffin@dfci.harvard.edu	刘, 青松/AEM-1932-2022; Liu, Qingsong/AFS-0714-2022	刘, 青松/0000-0002-7829-2547; Liu, Qingsong/0000-0002-7829-2547; Zhang, Jianming/0000-0001-6326-3906	National Institutes of Health (NIH) Library of Integrated Network-Based Cellular Signatures (LINCS) grant [HG006097]; Chinese Academy of Science High Magnetic Field Laboratory training grant; NIH grant [CA66996]; CAS; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Library of Integrated Network-Based Cellular Signatures (LINCS) grant; Chinese Academy of Science High Magnetic Field Laboratory training grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grant Support: QL and NG are supported by National Institutes of Health (NIH) Library of Integrated Network-Based Cellular Signatures (LINCS) grant HG006097. FL is supported by a Chinese Academy of Science High Magnetic Field Laboratory training grant. JDG is supported by NIH grant CA66996. FL is supported by CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; BENDALL LJ, 1994, EXP HEMATOL, V22, P1252; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Feldhahn N, 2012, ONCOIMMUNOLOGY, V1, P618, DOI 10.4161/onci.20249; Garrido SM, 2001, EXP HEMATOL, V29, P448, DOI 10.1016/S0301-472X(01)00612-9; Gaundar SS, 2009, CELL CYCLE, V8, P2975; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019169; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kimbrel EA, 2009, MOL IMAGING, V8, P140, DOI 10.2310/7290.2009.00007; Kumagai MA, 1996, J CLIN INVEST, V97, P755, DOI 10.1172/JCI118474; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Piloto O, 2007, BLOOD, V109, P1643, DOI 10.1182/blood-2006-05-023804; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Ringshausen I, 2004, LEUKEMIA, V18, P1964, DOI 10.1038/sj.leu.2403544; Siendones E, 2007, HEMATOL ONCOL, V25, P30, DOI 10.1002/hon.805; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Weisberg E, 2012, LEUKEMIA, V26, P2233, DOI 10.1038/leu.2012.96; Weisberg E, 2012, LEUKEMIA, V26, P985, DOI 10.1038/leu.2011.360; Weisberg E, 2010, LEUKEMIA, V24, P2100, DOI 10.1038/leu.2010.212; Weisberg E, 2008, MOL CANCER THER, V7, P1121, DOI 10.1158/1535-7163.MCT-07-2331; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; Zeng ZH, 2006, CANCER RES, V66, P3737, DOI 10.1158/0008-5472.CAN-05-1278	29	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56473	10.1371/journal.pone.0056473	http://dx.doi.org/10.1371/journal.pone.0056473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000029
J	Branch, TA				Branch, Trevor A.			Citation Patterns of a Controversial and High-Impact Paper: Worm et al. (2006) "Impacts of Biodiversity Loss on Ocean Ecosystem Services''	PLOS ONE			English	Article							FISHERIES; CONSERVATION	Citation patterns were examined for Worm et al. 2006 (Science 314:787-790), a high-impact paper that focused on relationships between marine biodiversity and ecosystem services. This paper sparked much controversy through its projection, highlighted in the press release, that all marine fisheries would be collapsed by 2048. Analysis of 664 citing papers revealed that only a small percentage (11%) referred to the 2048 projection, while 39% referred to fisheries collapse in general, and 40% to biodiversity and ecosystem services. The 2048 projection was mentioned more often in papers published soon after the original paper, in low-impact journals, and in journals outside of fields that would be expected to focus on biodiversity. Citing papers also mentioned the 2048 projection more often if they had few authors (28% of single-author papers vs. 2% of papers with 10 or more authors). These factors suggest that the more knowledgeable the authors of citing papers were about the controversy over the 2048 projection, the less likely they were to refer to it. A noteworthy finding was that if the original authors were also involved in the citing papers, they rarely (1 of 55 papers, 2%) mentioned the 2048 projection. Thus the original authors have emphasized the broader concerns about biodiversity loss, rather than the 2048 projection, as the key result of their study.	Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Branch, TA (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	tbranch@uw.edu						Banobi JA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00142.1; Baron N, 2010, NATURE, V468, P1032, DOI 10.1038/4681032a; Bernton H, 2006, SEATTLE TIMES   1103; Branch TA, 2012, BOOKS PAPERS; Branch TA, 2008, MAR POLICY, V32, P38, DOI 10.1016/j.marpol.2007.04.001; Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Branch TA, 2010, CAN J FISH AQUAT SCI, V67, P886, DOI 10.1139/F10-032; Briggs JC, 2007, SCIENCE, V316, P1282; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Gutierrez NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043765; Hilborn R, 2007, ECOSYSTEMS, V10, P1362, DOI 10.1007/s10021-007-9100-5; Hilborn R, 2007, AMBIO, V36, P296, DOI 10.1579/0044-7447(2007)36[296:MTSBLF]2.0.CO;2; Hilborn R, 2006, FISHERIES, V31, P554; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Hilborn R, 2012, CONSERV BIOL, V26, DOI 10.1111/j.1523-1739.2011.01800.x; Holker F, 2007, SCIENCE, V316, P1285, DOI 10.1126/science.1139114; Jaenike J, 2007, SCIENCE, V316, DOI 10.1126/science.1137730; Jensen OP, 2012, THEOR ECOL-NETH, V5, P3, DOI 10.1007/s12080-011-0146-9; Longhurst A, 2007, FISH RES, V86, P1, DOI 10.1016/j.fishres.2007.02.004; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Murawski S, 2007, SCIENCE, V316, P1281; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; R Development Core Team, 2012, R LANG ENV STAT COMP; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Stokstad E, 2009, SCIENCE, V324, P170, DOI 10.1126/science.324.5924.170; Wilberg MJ, 2007, SCIENCE, V316, DOI 10.1126/science.1137946; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	31	10	10	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56723	10.1371/journal.pone.0056723	http://dx.doi.org/10.1371/journal.pone.0056723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437224	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200153
J	Evans, K; Moore, R; Harris, S				Evans, Kate; Moore, Randall; Harris, Stephen			The Social and Ecological Integration of Captive-Raised Adolescent Male African Elephants (Loxodonta africana) into a Wild Population	PLOS ONE			English	Article							DOG LYCAON-PICTUS; NATIONAL-PARK; CONSERVATION; REINTRODUCTION; TRANSLOCATION; SURVIVAL; CHIMPANZEES; MOVEMENTS; PROGRAMS; RELEASE	Background: A rapid rise in the number of captive African elephants (Loxodonta africana) used in the tourism industry in southern Africa and orphaned elephants in human care has led to concerns about their long-term management, particularly males. One solution is to release them into the wild at adolescence, when young males naturally leave their herd. However, this raises significant welfare concerns: little is known about how well released elephants integrate into wild populations and whether they pose a greater threat to humans than wild elephants. We document the release of three captive-raised adolescent male African elephants in the Okavango Delta, Botswana. Methodology/Principal Findings: Despite having been part of a herd of working elephants for at least eight years, the three males progressively integrated into the complex fission-fusion society of wild bull elephants. In the three years following release, they showed no tendency to be closer to human habitation, and there were no significant differences between wild and captive-raised adolescent males in the total number of social interactions, size of ranges and habitat use. However, the captive-raised elephants sparred less and vocalised more, and spent more time alone and in smaller social groups. Thereafter the released elephants continued to expand their ranges and interact with both mixed-sex herds and males. One male was shot by farmers 94 months after release, along with ten wild elephants, on a ranch outside the protected area. Conclusions/Significance: We show that captive-raised adolescent male elephants can integrate into a wild population. Long-term studies are required to determine the longevity, breeding success, and eventual fate of released male elephants, but we identified no significant short-term welfare problems for the released elephants or recipient population. Release of captive-raised mammals with complex social systems is a husbandry option that should be explored further.	[Evans, Kate; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Evans, Kate] Elephants Africa, Maun, Botswana; [Moore, Randall] Elephant Back Safaris, Maun, Botswana	University of Bristol	Evans, K (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Kate@ElephantsForAfrica.org	Evans, Kate/AAY-9703-2021		Elephant Back Safaris (Plc) Ltd; Whitley Wildlife Conservation Fund; Dulverton Trust	Elephant Back Safaris (Plc) Ltd; Whitley Wildlife Conservation Fund; Dulverton Trust	The work was funded by Elephant Back Safaris (Plc) Ltd, The Whitley Wildlife Conservation Fund and the Dulverton Trust. Elephant Back Safaris (Plc), through Randall Moore, contributed to the study design and final editing of the manuscript but played no role in data collection and analysis, decision to publish, or preparation of the manuscript. The Whitley Wildlife Conservation Fund and the Dulverton Trust funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer N.J., 1992, P285; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; BECK B, 1993, J ZOO WILDLIFE MED, V24, P394; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; BLANCHARD BM, 1995, J WILDLIFE MANAGE, V59, P560, DOI 10.2307/3802463; Carter Scott, 2010, P263; CHENEY DL, 1986, ANIM BEHAV, V34, P1722, DOI 10.1016/S0003-3472(86)80259-7; Crawley M.J., 2007, R BOOK; Crawley M. J, 2002, STAT COMPUTING INTRO; Croze H., 1972, East African Wildlife Journal, V10, P91; Custance DM, 2002, INT J PRIMATOL, V23, P479, DOI 10.1023/A:1014961415219; Dietz J. M., 1994, P32; Dublin H.T., 2003, IUCNSSC AFESG GUIDEL; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; FRITTS SH, 1984, J WILDLIFE MANAGE, V48, P709, DOI 10.2307/3801418; Garai Marion E., 2001, Pachyderm, V31, P52; Garai Marion E., 2004, Pachyderm, V37, P28; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Goossens B, 2005, BIOL CONSERV, V123, P461, DOI 10.1016/j.biocon.2005.01.008; Goossens B, 2002, ANIM CONSERV, V5, P225, DOI 10.1017/S1367943002002275; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Griffiths CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039395; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; Hanks J., 1972, East African Wildlife Journal, V10, P251; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Ishida Y, 2013, EVOL APPL, V6, P253, DOI 10.1111/j.1752-4571.2012.00286.x; Jellema A., 2002, VEGETATION MAP UNPUB; Kleiman D.G., 1991, Symposia of the Zoological Society of London, P125; Kruger SC, 1999, J ZOOL, V248, P543, DOI 10.1111/j.1469-7998.1999.tb01054.x; Lahiri-Choudhury D. K., 1993, Oryx, V27, P53; LEE PC, 1995, J ZOOL, V236, P29, DOI 10.1111/j.1469-7998.1995.tb01782.x; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; Lee Phyllis C., 1999, Symposia of the Zoological Society of London, V72, P102; Lee Phyllis C., 2011, P74; Lee Phyllis C., 2011, P260; Mendelsohn J, 2004, COMMUNAL LANDS E NAM; Mendelsohn J.M., 2010, OKAVANGO DELTA FLOOD; Moehrenschlager A, 2003, ANIM CONSERV, V6, P199, DOI 10.1017/S1367943003251; Moore RJ, 2000, ELEPHANTS AFRICA; Mosillo M, 1999, J WILDLIFE MANAGE, V63, P278, DOI 10.2307/3802510; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Pinter-Wollman N, 2009, BEHAVIOUR, V146, P1171, DOI 10.1163/156853909X413105; Poole J., 1982, THESIS U CAMBRIDGE C; Poole J. H., 1982, THESIS U CAMBRIDGE; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Slotow R., 2001, Koedoe, V44, P85; Slotow Rob, 2001, Pachyderm, V31, P14; Spalton JA, 1999, ORYX, V33, P168, DOI 10.1046/j.1365-3008.1999.00062.x; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Strier KB, 2000, PRIMATE MALES, P72; Stuart S.N., 1991, Symposia of the Zoological Society of London, P27; Sullivan BK, 2004, BIOL CONSERV, V117, P235, DOI 10.1016/j.biocon.2003.07.002; Tutin CEG, 2001, CONSERV BIOL, V15, P1247, DOI 10.1046/j.1523-1739.2001.00046.x; WESTERN D, 1983, J WILDLIFE MANAGE, V47, P1192, DOI 10.2307/3808191; Whitehouse AM, 2002, ORYX, V36, P243, DOI 10.1017/S0030605302000455; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x; Woodroffe R, 1999, ORYX, V33, P143, DOI 10.1046/j.1365-3008.1999.00053.x; Yeager CP, 1997, CONSERV BIOL, V11, P802, DOI 10.1046/j.1523-1739.1997.95500.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; [No title captured]; [No title captured]	63	22	23	3	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55933	10.1371/journal.pone.0055933	http://dx.doi.org/10.1371/journal.pone.0055933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437076	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200031
J	Godel, M; Ostendorf, BN; Baumer, J; Weber, K; Huber, TB				Goedel, Markus; Ostendorf, Benjamin N.; Baumer, Jessica; Weber, Katrin; Huber, Tobias B.			A Novel Domain Regulating Degradation of the Glomerular Slit Diaphragm Protein Podocin in Cell Culture Systems	PLOS ONE			English	Article							NEPHROTIC SYNDROME; NEPHRIN; NPHS2; EXPRESSION; MUTATIONS; MICRODOMAINS; ENDOCYTOSIS; PODOCYTES; PLATFORM; PATHWAY	Mutations in the gene NPHS2 are the most common cause of hereditary steroid-resistant nephrotic syndrome. Its gene product, the stomatin family member protein podocin represents a core component of the slit diaphragm, a unique structure that bridges the space between adjacent podocyte foot processes in the kidney glomerulus. Dislocation and misexpression of slit diaphragm components have been described in the pathogenesis of acquired and hereditary nephrotic syndrome. However, little is known about mechanisms regulating cellular trafficking and turnover of podocin. Here, we discover a three amino acids-comprising motif regulating intracellular localization of podocin in cell culture systems. Mutations of this motif led to markedly reduced degradation of podocin. These findings give novel insight into the molecular biology of the slit diaphragm protein podocin, enabling future research to establish the biological relevance of podocin turnover and localization.	[Goedel, Markus; Ostendorf, Benjamin N.; Baumer, Jessica; Weber, Katrin; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Huber, TB (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de	Ostendorf, Benjamin Nils/AAA-2109-2022	Ostendorf, Benjamin Nils/0000-0003-4492-9252; Huber, Tobias B./0000-0001-7175-5062	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft; Excellence Initiative of the German Federal and State Governments [EXC 294]; Deutsche Gesellschaft fur Nephrologie	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Deutsche Gesellschaft fur Nephrologie	This study was supported by Else Kroner-Fresenius-Stiftung (http://www.ekfs.de/, TBH), Deutsche Forschungsgemeinschaft (http://www.dfg.de/,TBH), the Excellence Initiative of the German Federal and State Governments EXC 294 (http://www.bioss.uni-freiburg.de/, TBH) and Deutsche Gesellschaft fur Nephrologie (http://dgfn.eu/, MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Caridi G, 2010, PEDIATR NEPHROL, V25, P241, DOI 10.1007/s00467-008-1051-3; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hosoyamada M, 2005, J PHARMACOL SCI, V97, P234, DOI 10.1254/jphs.FP0040802; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kawachi H, 2003, J AM SOC NEPHROL, V14, P46, DOI 10.1097/01.ASN.0000037401.02391.76; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; McCarthy HJ, 2011, NEPHRON EXP NEPHROL, V118, pE1, DOI 10.1159/000320878; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Nickel C, 2002, J CLIN INVEST, V109, P481, DOI 10.1172/JC1200212867; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Relle M, 2011, MODERN PATHOL, V24, P1101, DOI 10.1038/modpathol.2011.58; Roselli S, 2004, TRAFFIC, V5, P37, DOI 10.1046/j.1600-0854.2003.00148.x; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Tossidou I, 2010, J BIOL CHEM, V285, P25285, DOI 10.1074/jbc.M109.087239; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Waters AM, 2012, J AM SOC NEPHROL, V23, P27, DOI 10.1681/ASN.2011010027	36	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57078	10.1371/journal.pone.0057078	http://dx.doi.org/10.1371/journal.pone.0057078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437316	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200212
J	Gupta, R; Bhatty, M; Swiatlo, E; Nanduri, B				Gupta, Radha; Bhatty, Minny; Swiatlo, Edwin; Nanduri, Bindu			Role of an Iron-Dependent Transcriptional Regulator in the Pathogenesis and Host Response to Infection with Streptococcus pneumoniae	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; ANTIINFLAMMATORY CYTOKINE; PNEUMOCOCCAL PNEUMONIA; INFLAMMATORY MARKERS; ESCHERICHIA-COLI; IMMUNE-RESPONSES; ABC TRANSPORTER; STRESS-RESPONSE; PROTECTS MICE	Iron is a critical cofactor for many enzymes and is known to regulate gene expression in many bacterial pathogens. Streptococcus pneumoniae normally inhabits the upper respiratory mucosa but can also invade and replicate in lungs and blood. These anatomic sites vary considerably in both the quantity and form of available iron. The genome of serotype 4 pneumococcal strain TIGR4 encodes a putative iron-dependent transcriptional regulator (IDTR). A mutant deleted at idtr (Delta idtr) exhibited growth kinetics similar to parent strain TIGR4 in vitro and in mouse blood for up to 48 hours following infection. However, Delta idtr was significantly attenuated in a murine model of sepsis. IDTR down-regulates the expression of ten characterized and putative virulence genes in nasopharyngeal colonization and pneumonia. The host cytokine response was significantly suppressed in sepsis with Delta idtr. Since an exaggerated inflammatory response is associated with a poor prognosis in sepsis, the decreased inflammatory response could explain the increased survival with Delta idtr. Our results suggest that IDTR, which is dispensable for pneumococcal growth in vitro, is associated with regulation of pneumococcal virulence in specific host environments. Additionally, IDTR ultimately modulates the host cytokine response and systemic inflammation that contributes to morbidity and mortality of invasive pneumococcal disease.	[Gupta, Radha; Swiatlo, Edwin] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Bhatty, Minny; Nanduri, Bindu] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Swiatlo, Edwin] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; Mississippi State University; University of Mississippi; University of Mississippi Medical Center	Swiatlo, E (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	eswiatlo@umc.edu	gupta, radha/GQQ-2292-2022		Mississippi INBRE grant from the National Institutes of Health	Mississippi INBRE grant from the National Institutes of Health	This work was funded by the Mississippi INBRE grant from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparartion of the manuscript.	Adrian PV, 2000, ANTIMICROB AGENTS CH, V44, P355, DOI 10.1128/AAC.44.2.355-361.2000; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; Bernatoniene J, 2008, J INFECT DIS, V198, P1823, DOI 10.1086/593177; Biffl WL, 1996, J TRAUMA, V40, P575, DOI 10.1097/00005373-199604000-00009; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brett PJ, 2008, MOL MICROBIOL, V70, P396, DOI 10.1111/j.1365-2958.2008.06418.x; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Ferreira DM, 2009, CLIN VACCINE IMMUNOL, V16, P636, DOI 10.1128/CVI.00395-08; FISS EH, 1994, MOL MICROBIOL, V14, P557, DOI 10.1111/j.1365-2958.1994.tb02189.x; GOLDBERG MB, 1990, J BACTERIOL, V172, P6863, DOI 10.1128/jb.172.12.6863-6870.1990; GUNTERSEEBOTH K, 1995, GENE, V166, P117, DOI 10.1016/0378-1119(95)00628-7; Gupta R, 2009, MICROB PATHOGENESIS, V47, P101, DOI 10.1016/j.micpath.2009.05.003; Hill PJ, 1998, INFECT IMMUN, V66, P4123; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Khan AQ, 2002, INFECT IMMUN, V70, P749, DOI 10.1128/IAI.70.2.749-761.2002; Knapp S, 2004, J INFECT DIS, V189, P1506, DOI 10.1086/382962; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LITWIN CM, 1993, J BACTERIOL, V175, P706, DOI 10.1128/JB.175.3.706-715.1993; Ness TL, 2004, J IMMUNOL, V173, P6938, DOI 10.4049/jimmunol.173.11.6938; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; PRINCE RW, 1993, J BACTERIOL, V175, P2589, DOI 10.1128/JB.175.9.2589-2598.1993; Quin LR, 2008, INFECT IMMUN, V76, P1122, DOI 10.1128/IAI.01066-07; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; STAGGS TM, 1992, MOL MICROBIOL, V6, P2507; TAI SS, 1993, INFECT IMMUN, V61, P5401, DOI 10.1128/IAI.61.12.5401-5405.1993; Tamayo E, 2011, EUR CYTOKINE NETW, V22, P82, DOI 10.1684/ecn.2011.0281; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THOMAS CE, 1994, MOL MICROBIOL, V11, P725, DOI 10.1111/j.1365-2958.1994.tb00350.x; TILG H, 1994, BLOOD, V83, P113; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; vanderPoll T, 1997, J INFECT DIS, V175, P118, DOI 10.1093/infdis/175.1.118; Wu HP, 2011, CRIT CARE, V15, DOI 10.1186/cc10464; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062	45	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55157	10.1371/journal.pone.0055157	http://dx.doi.org/10.1371/journal.pone.0055157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437050	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200012
J	Katiyar, S; Kufareva, I; Behera, R; Thomas, SM; Ogata, Y; Pollastri, M; Abagyan, R; Mensa-Wilmot, K				Katiyar, Samiksha; Kufareva, Irina; Behera, Ranjan; Thomas, Sarah M.; Ogata, Yuko; Pollastri, Michael; Abagyan, Ruben; Mensa-Wilmot, Kojo			Lapatinib-Binding Protein Kinases in the African Trypanosome: Identification of Cellular Targets for Kinase-Directed Chemical Scaffolds	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; BLOOD-STREAM FORM; TYROSINE KINASE; GROWTH-FACTOR; ONCOGENE ADDICTION; DUAL INHIBITOR; DESIGN; EGFR; TRANSFERRIN; GW572016	Human African trypanosomiasis is caused by the eukaryotic microbe Trypanosoma brucei. To discover new drugs against the disease, one may use drugs in the clinic for other indications whose chemical scaffolds can be optimized via a medicinal chemistry campaign to achieve greater potency against the trypanosome. Towards this goal, we tested inhibitors of human EGFR and/or VEGFR as possible anti-trypanosome compounds. The 4-anilinoquinazolines canertinib and lapatinib, and the pyrrolopyrimidine AEE788 killed bloodstream T. brucei in vitro with GI(50) in the low micromolar range. Curiously, the genome of T. brucei does not encode EGFR or VEGFR, indicating that the drugs recognize alternate proteins. To discover these novel targets, a trypanosome lysate was adsorbed to an ATP-sepharose matrix and washed with a high salt solution followed by nicotinamide adenine dinucleotide (NAD+). Proteins that remained bound to the column were eluted with drugs, and identified by mass spectrometry/bioinformatics. Lapatinib bound to Tb927.4.5180 (termed T. brucei lapatinib-binding protein kinase-1 (TbLBPK1)) while AEE788 bound Tb927.5.800 (TbLBPK2). When the NAD+ wash was omitted from the protocol, AEE788, canertinib and lapatinib eluted TbLBPK1, TbLBPK2, and Tb927.3.1570 (TbLBPK3). In addition, both canertinib and lapatinib eluted Tb10.60.3140 (TbLBPK4), whereas only canertinib desorbed Tb10.61.1880 (TbCBPK1). Lapatinib binds to a unique conformation of protein kinases. To gain insight into the structural basis for lapatinib interaction with TbLBPKs, we constructed three-dimensional models of lapatinib center dot TbLBPK complexes, which confirmed that TbLBPKs can adopt lapatinib-compatible conformations. Further, lapatinib, AEE788, and canertinib were docked to TbLBPKs with favorable scores. Our studies (a) present novel targets of kinase-directed drugs in the trypanosome, and (b) offer the 4-anilinoquinazoline and pyrrolopyrimidines as scaffolds worthy of medicinal chemistry and structural biology campaigns to develop them into anti-trypanosome drugs.	[Katiyar, Samiksha; Behera, Ranjan; Thomas, Sarah M.; Mensa-Wilmot, Kojo] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Kufareva, Irina; Abagyan, Ruben] UCSD Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Pollastri, Michael] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Ogata, Yuko] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98104 USA	University System of Georgia; University of Georgia; Northeastern University; Fred Hutchinson Cancer Center	Abagyan, R (corresponding author), UCSD Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	rabagyan@ucsd.edu; mensawil@uga.edu	pollastri, Michael/AAR-5790-2020; Bansal, Reema/AAH-6896-2019	pollastri, Michael/0000-0001-9943-7197; Kufareva, Irina/0000-0001-9083-7039	National Institutes of Health [AI076647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health AI076647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barbarroja N, 2010, EXP HEMATOL; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Brehmer D, 2005, CANCER RES, V65, P379; Brun R, 2006, CURR OPIN INFECT DIS, V19, P415, DOI 10.1097/01.qco.0000244045.93016.b1; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Calvo E, 2004, CLIN CANCER RES, V10, P7112, DOI 10.1158/1078-0432.CCR-04-1187; Chen R, 2006, CANCER RES, V66, P10959, DOI 10.1158/0008-5472.CAN-06-1216; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Duncan JS, 2012, METHODS MOL BIOL, V795, P119, DOI 10.1007/978-1-61779-337-0_8; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Gafken Philip R., 2009, V527, P159, DOI 10.1007/978-1-60327-834-8_12; Goldammer T, 2006, CYTOGENET GENOME RES, V112, p341C, DOI 10.1159/000089893; Hamadien M, 2000, PARASITOLOGY, V120, P281, DOI 10.1017/S0031182099005521; Haystead TAJ, 2006, CURR TOP MED CHEM, V6, P1117; Heymach JV, 2006, CLIN CANCER RES, V12, p4441S, DOI 10.1158/1078-0432.CCR-06-0286; Higdon R, 2007, OMICS, V11, P351, DOI 10.1089/omi.2007.0040; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Hubbard RD, 2008, BIOORG MED CHEM LETT, V18, P5738, DOI 10.1016/j.bmcl.2008.09.090; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Kaouass M, 1997, MOL CELL BIOL, V17, P2994, DOI 10.1128/MCB.17.6.2994; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim JW, 2008, CANCER LETT, V272, P296, DOI 10.1016/j.canlet.2008.07.018; Kufareva I, 2011, STRUCTURE IN PRESS; Lackey KE, 2006, CURR TOP MED CHEM, V6, P435, DOI 10.2174/156802606776743156; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LETWIN K, 1992, EMBO J, V11, P3521, DOI 10.1002/j.1460-2075.1992.tb05435.x; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Lu C, 2007, CLIN CANCER RES, V13, P4209, DOI 10.1158/1078-0432.ccr-07-0197; MYERS T, 2007, CURR PROTOC BIOINFOR, pCH13; Nett IR, 2009, MOL CELL PROTEOMICS; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Ojo KK, 2008, ANTIMICROB AGENTS CH, V52, P3710, DOI 10.1128/AAC.00364-08; Olaussen KA, 2009, ONCOGENE, V28, P4249, DOI 10.1038/onc.2009.277; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Park YW, 2005, CLIN CANCER RES, V11, P1963, DOI 10.1158/1078-0432.CCR-04-1665; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rixe O, 2009, CANCER CHEMOTH PHARM, V64, P1139, DOI 10.1007/s00280-009-0975-z; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; SCHELL D, 1991, PARASITOL RES, V77, P558, DOI 10.1007/BF00931012; Sessa G, 1996, PLANT CELL, V8, P2223, DOI 10.1105/tpc.8.12.2223; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Slichenmyer WJ, 2001, SEMIN ONCOL, V28, P80, DOI 10.1016/S0093-7754(01)90285-4; Smaill JB, 2001, J MED CHEM, V44, P429, DOI 10.1021/jm000372i; Subramanya S, 2009, BIOCHEM J, V417, P685, DOI 10.1042/BJ20080167; Subramanya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008538; Traxler P, 2004, CANCER RES, V64, P4931, DOI 10.1158/0008-5472.CAN-03-3681; Trinks C, 2010, BIOCHEM BIOPH RES CO, V393, P6, DOI 10.1016/j.bbrc.2010.01.055; Urbaniak MD, 2009, MOL BIOCHEM PARASIT, V166, P183, DOI 10.1016/j.molbiopara.2009.03.001; Vema A, 2003, BIOORGAN MED CHEM, V11, P4643, DOI 10.1016/S0968-0896(03)00482-6; Walter SA, 2003, J BIOL CHEM, V278, P18221, DOI 10.1074/jbc.M212556200; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; WHEELERALM E, 1992, J PROTOZOOL, V39, P413, DOI 10.1111/j.1550-7408.1992.tb01473.x; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	73	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56150	10.1371/journal.pone.0056150	http://dx.doi.org/10.1371/journal.pone.0056150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437089	Green Published, gold			2022-12-27	WOS:000315184200043
J	Leach, G; Adidharma, W; Yan, L				Leach, Greg; Adidharma, Widya; Yan, Lily			Depression-Like Responses Induced by Daytime Light Deficiency in the Diurnal Grass Rat (Arvicanthis niloticus)	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; SEASONAL AFFECTIVE-DISORDER; ANXIETY-LIKE BEHAVIORS; FAT SAND RAT; BRIGHT LIGHT; TRYPTOPHAN DEPLETION; RETINAL PROJECTION; SHORT DAYLIGHT; MODEL; MOOD	Seasonal Affective Disorder (SAD) is one of the most common mood disorders with depressive symptoms recurring in winter when there is less sunlight. The fact that light is the most salient factor entraining circadian rhythms leads to the phase-shifting hypothesis, which suggests that the depressive episodes of SAD are caused by misalignments between the circadian rhythms and the habitual sleep times. However, how changes in environmental lighting conditions lead to the fluctuations in mood is largely unknown. The objective of this study is to develop an animal model for some of the features/symptoms of SAD using the diurnal grass rats Arvichantis niloticus and to explore the neural mechanisms underlying the light associated mood changes. Animals were housed in either a 12:12 hr bright light:dark (1000lux, BLD) or dim light: dark (50lux, DLD) condition. The depression-like behaviors were assessed by sweet-taste Saccharin solution preference (SSP) and forced swimming test (FST). Animals in the DLD group showed higher levels of depression-like behaviors compared to those in BLD. The anxiety-like behaviors were assessed in open field and light/dark box test, however no significant differences were observed between the two groups. The involvement of the circadian system on depression-like behaviors was investigated as well. Analysis of locomotor activity revealed no major differences in daily rhythms that could possibly contribute to the depression-like behaviors. To explore the neural substrates associated with the depression-like behaviors, the brain tissues from these animals were analyzed using immunocytochemistry. Attenuated indices of 5-HT signaling were observed in DLD compared to the BLD group. The results lay the groundwork for establishing a novel animal model and a novel experimental paradigm for SAD. The results also provide insights into the neural mechanisms underlying light-dependent mood changes.	[Leach, Greg; Adidharma, Widya; Yan, Lily] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Yan, Lily] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Yan, L (corresponding author), Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA.	yanl@msu.edu	Yan, Lily/AAU-2005-2021	Yan, Lily/0000-0002-6261-2542	National Institute of Mental Health [R03MH093760]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH093760] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by grant number R03MH093760 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; Adidharma W, 2012, NEUROSCIENCE, V220, P201, DOI 10.1016/j.neuroscience.2012.06.020; Ashkenazy T, 2009, BEHAV BRAIN RES, V201, P343, DOI 10.1016/j.bbr.2009.03.005; Ashkenazy T, 2009, INT J NEUROPSYCHOPH, V12, P83, DOI 10.1017/S1461145708009115; Ashkenazy-Frolinger T, 2010, J NEUROSCI METH, V186, P165, DOI 10.1016/j.jneumeth.2009.11.013; Bennett MR, 2011, PROG NEUROBIOL, V93, P468, DOI 10.1016/j.pneurobio.2011.01.006; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; Einat H, 2006, BEHAV BRAIN RES, V173, P153, DOI 10.1016/j.bbr.2006.06.006; Fite KV, 1999, J COMP NEUROL, V414, P469, DOI 10.1002/(SICI)1096-9861(19991129)414:4<469::AID-CNE4>3.0.CO;2-P; Fite KV, 2001, BRAIN RES, V895, P139, DOI 10.1016/S0006-8993(01)02061-3; Flaisher-Grinberg S, 2011, BEHAV PHARMACOL, V22, P23, DOI 10.1097/FBP.0b013e3283425012; Fonken LK, 2012, J BIOL RHYTHM, V27, P319, DOI 10.1177/0748730412448324; Graeff FG, 2004, NEUROSCI BIOBEHAV R, V28, P239, DOI 10.1016/j.neubiorev.2003.12.004; Hale MW, 2011, PSYCHOPHARMACOLOGY, V213, P243, DOI 10.1007/s00213-010-2089-z; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hebert M, 1998, CHRONOBIOL INT, V15, P59; Janusonis S, 2001, J COMP NEUROL, V440, P31, DOI 10.1002/cne.1368; Kawano H, 1996, NEUROSCI LETT, V212, P143, DOI 10.1016/0304-3940(96)12795-6; Krivisky K, 2012, J NEURAL TRANSM, V119, P1241, DOI 10.1007/s00702-012-0783-1; Krivisky K, 2011, NEUROPSYCHOBIOLOGY, V63, P191, DOI 10.1159/000321805; Kronfeld-Schor N, 2012, NEUROPHARMACOLOGY, V62, P101, DOI 10.1016/j.neuropharm.2011.08.020; Lam RW, 1996, ARCH GEN PSYCHIAT, V53, P41; Lam RW, 2006, AM J PSYCHIAT, V163, P805, DOI 10.1176/appi.ajp.163.5.805; Leach G, 2013, NEUROSCIENCE; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Levitan Robert D, 2007, Dialogues Clin Neurosci, V9, P315; Lewy Alfred J, 2007, Dialogues Clin Neurosci, V9, P291; Lewy AJ, 2009, CURR PSYCHIAT REP, V11, P459, DOI 10.1007/s11920-009-0070-5; Michelsen KA, 2007, BRAIN RES REV, V55, P329, DOI 10.1016/j.brainresrev.2007.01.002; Neumeister A, 1997, ARCH GEN PSYCHIAT, V54, P133; Neumeister A, 2001, INT J NEUROPSYCHOPH, V4, P409, DOI 10.1017/S1461145701002644; Nixon JP, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-28; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peyron C, 1998, J NEUROSCI, V18, P9996; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prendergast BJ, 2005, PSYCHONEUROENDOCRINO, V30, P438, DOI 10.1016/j.psyneuen.2004.08.008; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Ruhrmann S, 1998, PSYCHOL MED, V28, P923, DOI 10.1017/S0033291798006813; SHEN H, 1994, BRAIN RES, V635, P159, DOI 10.1016/0006-8993(94)91435-4; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; Stephenson KM, 2012, SLEEP MED REV, V16, P445, DOI 10.1016/j.smrv.2011.09.002; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; Turner PL, 2010, SLEEP MED REV, V14, P269, DOI 10.1016/j.smrv.2009.11.002; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WIRZJUSTICE A, 1992, INT CLIN PSYCHOPHARM, V7, P109, DOI 10.1097/00004850-199211000-00008; Workman JL, 2011, NEUROSCI BIOBEHAV R, V35, P669, DOI 10.1016/j.neubiorev.2010.08.005; Yan L, 2011, NEUROSCIENCE, V183, P99, DOI 10.1016/j.neuroscience.2011.03.041; Yan L, 2010, J BIOL RHYTHM, V25, P19, DOI 10.1177/0748730409352054	50	55	59	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57115	10.1371/journal.pone.0057115	http://dx.doi.org/10.1371/journal.pone.0057115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437327	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200220
J	Makonde, HM; Boga, HI; Osiemo, Z; Mwirichia, R; Stielow, JB; Goker, M; Klenk, HP				Makonde, Huxley M.; Boga, Hamadi I.; Osiemo, Zipporah; Mwirichia, Romano; Stielow, J. Benjamin; Goeker, Markus; Klenk, Hans-Peter			Diversity of Termitomyces Associated with Fungus-Farming Termites Assessed by Cultural and Culture-Independent Methods	PLOS ONE			English	Article							GROWING TERMITES; ODONTOTERMES-FORMOSANUS; HOST-SPECIFICITY; TRANSMISSION; SYMBIONTS; GUT; INFORMATION; ANTIFUNGAL; STABILIZES; CHARACTERS	Background: Fungus-cultivating termites make use of an obligate mutualism with fungi from the genus Termitomyces, which are acquired through either vertical transmission via reproductive alates or horizontally transmitted during the formation of new mounds. Termitomyces taxonomy, and thus estimating diversity and host specificity of these fungi, is challenging because fruiting bodies are rarely found. Molecular techniques can be applied but need not necessarily yield the same outcome than morphological identification. Methodology: Culture-dependent and culture-independent methods were used to comprehensively assess host specificity and gut fungal diversity. Termites were identified using mitochondrial cytochrome oxidase II (COII) genes. Twenty-three Termitomyces cultures were isolated from fungal combs. Internal transcribed spacer (ITS) clone libraries were constructed from termite guts. Presence of Termitomyces was confirmed using specific and universal primers. Termitomyces species boundaries were estimated by cross-comparison of macromorphological and sequence features, and ITS clustering parameters accordingly optimized. The overall trends in coverage of Termitomyces diversity and host associations were estimated using Genbank data. Results and Conclusion: Results indicate a monoculture of Termitomyces in the guts as well as the isolation sources (fungal combs). However, cases of more than one Termitomyces strains per mound were observed since mounds can contain different termite colonies. The newly found cultures, as well as the clustering analysis of GenBank data indicate that there are on average between one and two host genera per Termitomyces species. Saturation does not appear to have been reached, neither for the total number of known Termitomyces species nor for the number of Termitomyces species per host taxon, nor for the number of known hosts per Termitomyces species. Considering the rarity of Termitomyces fruiting bodies, it is suggested to base the future taxonomy of the group mainly on well-characterized and publicly accessible cultures.	[Makonde, Huxley M.; Goeker, Markus; Klenk, Hans-Peter] German Collect Microorganisms & Cell Cultures Gmb, Leibniz Inst DSMZ, Braunschweig, Germany; [Makonde, Huxley M.; Mwirichia, Romano] Jomo Kenyatta Univ Agr & Technol, Biotechnol Res Inst, Nairobi, Kenya; [Boga, Hamadi I.; Osiemo, Zipporah] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Stielow, J. Benjamin] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Jomo Kenyatta University of Agriculture & Technology; Jomo Kenyatta University of Agriculture & Technology; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Goker, M (corresponding author), German Collect Microorganisms & Cell Cultures Gmb, Leibniz Inst DSMZ, Braunschweig, Germany.	markus.goeker@dsmz.de	Göker, Markus/AAX-6258-2021	Göker, Markus/0000-0002-5144-6200; Mwirichia, Romano/0000-0002-4198-5593; Boga, Hamadi/0000-0003-1930-5413	Deutscher Akademischer Austauschdienst (DAAD); Kenya National Council for Science and Technology (NCST) [NCST/5/003/PG/224]	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Kenya National Council for Science and Technology (NCST)	This work was supported by the Deutscher Akademischer Austauschdienst (DAAD) within a Ph.D. scholarship (sandwich model) and a grant (NCST/5/003/PG/224) to HMM from the Kenya National Council for Science and Technology (NCST). The DSMZ supported this study via the employment of JBS, MG and HPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Aanen DK, 2006, BIOL LETT-UK, V2, P209, DOI 10.1098/rsbl.2005.0424; Aanen DK, 2009, SCIENCE, V326, P1103, DOI 10.1126/science.1173462; Aanen DK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-115; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Austin JW, 2004, ANN ENTOMOL SOC AM, V97, P548, DOI 10.1603/0013-8746(2004)097[0548:PAOTST]2.0.CO;2; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Baker RH, 1998, MOL PHYLOGENET EVOL, V9, P427, DOI 10.1006/mpev.1998.0519; BOTHA WJ, 1991, MYCOL RES, V95, P435, DOI 10.1016/S0953-7562(09)80843-5; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; FARRIS JS, 1979, SYST ZOOL, V28, P483, DOI 10.2307/2412562; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fuller CA, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.1401; Gams W, 2012, MYCOTAXON, V119, P495, DOI DOI 10.5248/119.495; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Guedegbe HJ, 2009, MYCOLOGIA, V101, P686, DOI 10.3852/08-182; Hawksworth DL, 2011, IMA FUNGUS, V2, P105, DOI 10.5598/imafungus.2011.02.01.14; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Ju YM, 2007, MYCOLOGIA, V99, P936, DOI 10.3852/mycologia.99.6.936; Katoh H, 2002, MOL ECOL, V11, P1565, DOI 10.1046/j.1365-294X.2002.01535.x; Kendrick B, 2011, GENERA HYPHOMYCETES; Kirk PM., 2008, DICT FUNGI, V10th ed; Kone NA, 2011, INSECT SOC, V58, P371, DOI 10.1007/s00040-011-0154-1; Korb J, 2003, BEHAV ECOL SOCIOBIOL, V53, P65, DOI 10.1007/s00265-002-0559-y; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Legendre P., 2012, NUMERICAL ECOLOGY; Licht HHF, 2006, MOL ECOL, V15, P3131, DOI 10.1111/j.1365-294X.2006.03008.x; Long YH, 2010, INSECT SCI, V17, P265, DOI 10.1111/j.1744-7917.2010.01327.x; Mathew GM, 2012, FEMS MICROBIOL ECOL, V79, P504, DOI 10.1111/j.1574-6941.2011.01232.x; MORIYA S, 2005, MICROBES ENVIRON, V20, P243, DOI DOI 10.1264/JSME2.20.243; NAKAMURA S, 1993, APPL ENVIRON MICROB, V59, P2311, DOI 10.1128/AEM.59.7.2311-2316.1993; Nobre T, 2010, P ROY SOC B-BIOL SCI, V277, P359, DOI 10.1098/rspb.2009.1373; Nobre T, 2011, MOL ECOL, V20, P2023, DOI 10.1111/j.1365-294X.2011.05064.x; Okane Izumi, 2007, Mycoscience, V48, P240, DOI 10.1007/s10267-007-0361-9; Osiemo ZB, 2010, INSECT SOC, V57, P351, DOI 10.1007/s00040-010-0092-3; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pattengale ND, 2009, LECT NOTES COMPUT SC, V5541, P184, DOI 10.1007/978-3-642-02008-7_13; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rouland-Lefevre C, 2002, MOL PHYLOGENET EVOL, V22, P423, DOI 10.1006/mpev.2001.1071; Ruijssenaars HJ, 2001, APPL MICROBIOL BIOT, V55, P143, DOI 10.1007/s002530000477; Sands W. L, 1969, BIOL TERMITES, P495; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6018, DOI 10.1128/AEM.69.10.6018-6024.2003; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Setaro SD, 2012, BIODIVERS CONSERV, V21, P2269, DOI 10.1007/s10531-011-0205-y; Shinzato N, 2005, ZOOL SCI, V22, P917, DOI 10.2108/zsj.22.917; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stielow B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015614; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; THOMAS R, 1985, T BRIT MYCOL SOC, V84, P519, DOI 10.1016/S0007-1536(85)80014-0; VANDERWESTHUIZEN GCA, 1990, MYCOL RES, V94, P923, DOI 10.1016/S0953-7562(09)81306-3; Visser AA, 2009, MOL ECOL, V18, P553, DOI 10.1111/j.1365-294X.2008.04036.x; Visser AA, 2012, MICROB ECOL, V63, P975, DOI 10.1007/s00248-011-9987-4; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiley EO, 2011, PHYLOGENETICS THEORY; Wood T.G., 1978, International Biological Programme, P245; Zantinge JL, 2003, ENZYME MICROB TECH, V32, P224, DOI 10.1016/S0141-0229(02)00249-1; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	60	20	26	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56464	10.1371/journal.pone.0056464	http://dx.doi.org/10.1371/journal.pone.0056464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437139	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200079
J	Milstein, JA; Elnabawi, A; Vinish, M; Swanson, T; Enos, JK; Bailey, AM; Kolb, B; Frost, DO				Milstein, Jean A.; Elnabawi, Ahmed; Vinish, Monika; Swanson, Thomas; Enos, Jennifer K.; Bailey, Aileen M.; Kolb, Bryan; Frost, Douglas O.			Olanzapine Treatment of Adolescent Rats Causes Enduring Specific Memory Impairments and Alters Cortical Development and Function	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; AMPHETAMINE-INDUCED CHANGES; PRENATAL COCAINE EXPOSURE; DOPAMINE-RECEPTORS; ATYPICAL ANTIPSYCHOTICS; BASOLATERAL AMYGDALA; PROJECTION NEURONS; NUCLEUS-ACCUMBENS; PYRAMIDAL NEURONS	Antipsychotic drugs are increasingly used in children and adolescents to treat a variety of psychiatric disorders. However, little is known about the long-term effects of early life antipsychotic drug treatment. Most antipsychotic drugs are potent antagonists or partial agonists of dopamine D2 receptors; atypical antipsychotic drugs also antagonize type 2A serotonin receptors. Dopamine and serotonin regulate many neurodevelopmental processes. Thus, early life antipsychotic drug treatment can, potentially, perturb these processes, causing long- term behavioral- and neurobiological impairments. Here, we treated adolescent, male rats with olanzapine on post-natal days 28-49. As adults, they exhibited impaired working memory, but normal spatial memory, as compared to vehicle-treated control rats. They also showed a deficit in extinction of fear conditioning. Measures of motor activity and skill, habituation to an open field, and affect were normal. In the orbital- and medial prefrontal cortices, parietal cortex, nucleus accumbens core and dentate gyrus, adolescent olanzapine treatment altered the developmental dynamics and mature values of dendritic spine density in a region-specific manner. Measures of motor activity and skill, habituation to an open field, and affect were normal. In the orbital- and medial prefrontal cortices, D1 binding was reduced and binding of GABA(A) receptors with open Cl- channels was increased. In medial prefrontal cortex, D2 binding was also increased. The persistence of these changes underscores the importance of improved understanding of the enduring sequelae of pediatric APD treatment as a basis for weighing the benefits and risks of adolescent antipsychotic drug therapy, especially prophylactic treatment in high risk, asymptomatic patients. The long- term changes in neurotransmitter receptor binding and neural circuitry induced by adolescent APD treatment may also cause enduring changes in behavioral- and neurobiological responses to other therapeutic- or illicit psychotropic drugs.	[Milstein, Jean A.; Vinish, Monika; Swanson, Thomas; Enos, Jennifer K.; Frost, Douglas O.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Elnabawi, Ahmed] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Bailey, Aileen M.] St Marys Coll Maryland, Dept Psychol, St Marys, MD USA; [Kolb, Bryan] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Frost, Douglas O.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Frost, Douglas O.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Lethbridge; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Frost, DO (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.	dfrost@umaryland.edu	Burne, Thomas/C-5656-2009	Burne, Thomas/0000-0003-3502-9789	NIMH grant [MH07083]; CIHR grant; Eli Lilly Co.; NINDS training grant [T32 NS007375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER	NIMH grant; CIHR grant(Canadian Institutes of Health Research (CIHR)); Eli Lilly Co.(Eli Lilly); NINDS training grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by: NIMH grant MH07083 to DOF (http://www.nih.gov/); a CIHR grant to BK (http://www.cihr-irsc.gc.ca); olanzapine from Eli Lilly & Co. and NIMH. JM was partially supported by NINDS training grant T32 NS007375 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Andersen SL, 2004, NEUROPSYCHOPHARMACOL, V29, P1988, DOI 10.1038/sj.npp.1300528; Andersen SL, 2008, EUR J NEUROSCI, V27, P2962, DOI 10.1111/j.1460-9568.2008.06254.x; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P485; BARON JC, 1989, PSYCHOPHARMACOLOGY, V99, P463, DOI 10.1007/BF00589893; BARTOLINI L, 1992, PHARMACOL BIOCHEM BE, V43, P1161, DOI 10.1016/0091-3057(92)90497-4; Beduin AS, 2010, PSYCHOPHARMACOL BULL, V43, P45; Benes FM, 2000, CEREB CORTEX, V10, P1014, DOI 10.1093/cercor/10.10.1014; Bourgeois JP, 1996, EUR J NEUROSCI, V8, P942, DOI 10.1111/j.1460-9568.1996.tb01581.x; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Brenhouse HC, 2010, NEUROSCIENCE, V169, P628, DOI 10.1016/j.neuroscience.2010.05.063; Brenhouse HC, 2008, J NEUROSCI, V28, P2375, DOI 10.1523/JNEUROSCI.5064-07.2008; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Chen LG, 2011, TOXICOL APPL PHARM, V250, P221, DOI 10.1016/j.taap.2010.11.010; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Chen YC, 2005, J NEUROBIOL, V64, P4, DOI 10.1002/neu.20150; Cheng-Shannon J, 2004, J CHILD ADOL PSYCHOP, V14, P372, DOI 10.1089/1044546042389037; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; El-Nabawi A, 2000, TOXICOL APPL PHARM, V169, P84, DOI 10.1006/taap.2000.9042; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; FOOTE SL, 1987, CURR TOP DEV BIOL, V21, P391; Frankfurt M, 2009, DEV NEUROSCI-BASEL, V31, P71, DOI 10.1159/000207495; Frost DO, 2000, BRAIN RES REV, V34, P103, DOI 10.1016/S0165-0173(00)00042-4; Frost DO, 2010, SYNAPSE, V64, P191, DOI 10.1002/syn.20715; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Ginovart N, 2009, NEUROPSYCHOPHARMACOL, V34, P662, DOI 10.1038/npp.2008.116; Halliwell C, 2009, DEV NEUROREHABIL, V12, P269, DOI 10.3109/17518420903087715; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Heijtz RD, 2003, EUR J NEUROSCI, V18, P3394, DOI 10.1046/j.1460-9568.2003.03067.x; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Jones LB, 2000, J NEUROSCI, V20, P4606, DOI 10.1523/JNEUROSCI.20-12-04606.2000; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; KOESTER SE, 1992, J NEUROSCI, V12, P1382; KOLB B, 1994, CEREB CORTEX, V4, P664, DOI 10.1093/cercor/4.6.664; KOLB B, 1981, J COMP PHYSIOL PSYCH, V95, P863, DOI 10.1037/h0077849; Kolb B, 2008, ABSTRACT VIEWER ITIN; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; LEYSEN JE, 1988, J PHARMACOL EXP THER, V247, P661; Li YL, 2003, NEUROPSYCHOPHARMACOL, V28, P1082, DOI 10.1038/sj.npp.1300115; Llorente-Berzal A., 2011, NEUROPHARMACOLOGY; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McCracken JT, 2008, J CHILD ADOL PSYCHOP, V18, P501, DOI 10.1089/cap.2007.135; McKnight RF, 2010, EUR EAT DISORD REV, V18, P10, DOI 10.1002/erv.988; Meyer U, 2010, SCHIZOPHRENIA BULL, V36, P607, DOI 10.1093/schbul/sbn131; Moran-Gates T, 2006, SYNAPSE, V59, P92, DOI 10.1002/syn.20220; Moran-Gates T, 2007, EUR NEUROPSYCHOPHARM, V17, P448, DOI 10.1016/j.euroneuro.2006.10.004; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Morrow BA, 2005, SYNAPSE, V56, P1, DOI 10.1002/syn.20121; Morrow BA, 2007, SYNAPSE, V61, P862, DOI 10.1002/syn.20430; Muhammad A, 2012, SYNAPSE, V66, P950, DOI 10.1002/syn.21589; Mukda S, 2009, DEV NEUROSCI-BASEL, V31, P193, DOI 10.1159/000193395; Mychasiuk R, 2012, BRAIN RES IN PRESS; Nader K, 1999, BEHAV NEUROSCI, V113, P152, DOI 10.1037/0735-7044.113.1.152; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Pappadopulos E, 2003, J AM ACAD CHILD PSY, V42, P145, DOI 10.1097/00004583-200302000-00008; Pappadopulos E, 2011, J CHILD ADOL PSYCHOP, V21, P505, DOI 10.1089/cap.2010.0128; Perez-Costas E, 2008, J NEURAL TRANSM, V115, P745, DOI 10.1007/s00702-007-0004-5; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Piontkewitz Y, 2011, SCHIZOPHRENIA BULL, V37, P1257, DOI 10.1093/schbul/sbq040; Piontkewitz Y, 2012, NEUROPHARMACOLOGY, V62, P1273, DOI 10.1016/j.neuropharm.2011.04.019; Piontkewitz Y, 2009, BIOL PSYCHIAT, V66, P1038, DOI 10.1016/j.biopsych.2009.07.005; PRIBRAM KH, 1961, EXP NEUROL, V3, P432, DOI 10.1016/0014-4886(61)90021-8; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Redmond L, 2008, NEUROSIGNALS, V16, P194, DOI 10.1159/000111563; Remington G, 2010, SCHIZOPHRENIA BULL, V36, P900, DOI 10.1093/schbul/sbq083; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Robinson TE, 1997, J NEUROSCI, V17, P8491; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Rosenkranz JA, 2001, J NEUROSCI, V21, P4090, DOI 10.1523/JNEUROSCI.21-11-04090.2001; Samaha AN, 2007, J NEUROSCI, V27, P2979, DOI 10.1523/JNEUROSCI.5416-06.2007; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Sikich L, 2008, J CLIN PSYCHIAT, V69, P21; Silvestri S, 2000, PSYCHOPHARMACOLOGY, V152, P174, DOI 10.1007/s002130000532; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stanwood GD, 2005, J COMP NEUROL, V487, P270, DOI 10.1002/cne.20548; Stanwood GD, 2001, CEREB CORTEX, V11, P430, DOI 10.1093/cercor/11.5.430; Stanwood GD, 2001, NEUROSCIENCE, V106, P5, DOI 10.1016/S0306-4522(01)00256-1; Strawn JR, 2008, EXPERT OPIN PHARMACO, V9, P467, DOI [10.1517/14656566.9.3.467, 10.1517/14656566.9.3.467 ]; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; Suzuki M, 2001, SYNAPSE, V41, P285, DOI 10.1002/syn.1085; Tarazi FI, 2001, J PHARMACOL EXP THER, V297, P711; Terry AV, 2008, NEUROSCIENCE, V156, P1005, DOI 10.1016/j.neuroscience.2008.08.030; Thomas T, 2011, PEDIATR CLIN N AM, V58, pxii; Thomas T, 2011, PEDIATR CLIN N AM, V58, P173, DOI 10.1016/j.pcl.2010.10.001; Tseng KY, 2007, SYNAPSE, V61, P843, DOI 10.1002/syn.20432; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Tseng KY, 2005, CEREB CORTEX, V15, P49, DOI 10.1093/cercor/bhh107; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vasconcelos SMM, 2003, BEHAV PROCESS, V63, P45, DOI 10.1016/S0376-6357(03)00028-7; Vinish M, 2012, INT J NEURO IN PRESS; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Weller EB, 2009, CURR PSYCHIAT REP, V11, P95, DOI 10.1007/s11920-009-0015-z; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; WHISHAW IQ, 1991, BEHAV BRAIN RES, V42, P77, DOI 10.1016/S0166-4328(05)80042-7; Yadav PN, 2011, NEUROPSYCHOPHARMACOL, V36, P638, DOI 10.1038/npp.2010.195; Zilles K., 1985, CORTEX RAT STEREOTAX; Zuddas A, 2011, EUR NEUROPSYCHOPHARM	115	40	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57308	10.1371/journal.pone.0057308	http://dx.doi.org/10.1371/journal.pone.0057308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437365	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200240
J	Min, Y; Jin, XG; Ge, Y; Chang, J				Min, Yong; Jin, Xiaogang; Ge, Ying; Chang, Jie			The Role of Community Mixing Styles in Shaping Epidemic Behaviors in Weighted Networks	PLOS ONE			English	Article							TRANSPORTATION NETWORK; COMPLEX NETWORKS; DYNAMICS; DISEASE	The dynamics of infectious diseases that are spread through direct contact have been proven to depend on the strength of community structure or modularity within the underlying network. It has been recently shown that weighted networks with similar modularity values may exhibit different mixing styles regarding the number of connections among communities and their respective weights. However, the effect of mixing style on epidemic behavior was still unclear. In this paper, we simulate the spread of disease within networks with different mixing styles: a dense-weak style (i.e., many edges among the communities with small weights) and a sparse-strong style (i.e., a few edges among the communities with large weights). Simulation results show that, with the same modularity: 1) the mixing style significantly influences the epidemic size, speed, pattern and immunization strategy; 2) the increase of the number of communities amplifies the effect of the mixing style; 3) when the mixing style changes from sparse-strong to dense-weak, there is a 'saturation point', after which the epidemic size and pattern become stable. We also provide a mean-field solution of the epidemic threshold and size on weighted community networks with arbitrary external and internal degree distribution. The solution explains the effect of the second moment of the degree distribution, and a symmetric effect of internal and external connections (incl. degree distribution and weight). Our study has both potential significance for designing more accurate metrics for the community structure and exploring diffusion dynamics on metapopulation networks.	[Min, Yong] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Min, Yong; Ge, Ying; Chang, Jie] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Xiaogang] Zhejiang Univ, Coll Comp Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; Zhejiang University; Zhejiang University	Chang, J (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	jchang@zju.edu.cn			China Postdoctoral Science Foundation [2012M510202]; National Science Foundation of China [30970281, 31170305, 60873033]; Natural Science Foundation of Zhejiang Province, China [R1090569, LZ12F02003, LY12F02018]; State Key Laboratory of Software Development Environment Open Fund [SKLSDE-2012KF-05]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); State Key Laboratory of Software Development Environment Open Fund	Funding provided by China Postdoctoral Science Foundation (2012M510202), National Science Foundation of China (30970281, 31170305, and 60873033), and Natural Science Foundation of Zhejiang Province, China (R1090569, LZ12F02003, and LY12F02018), and the State Key Laboratory of Software Development Environment Open Fund (SKLSDE-2012KF-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Chen JC, 2012, PHYSICA A, V391, P1848, DOI 10.1016/j.physa.2011.10.011; Chu X, 2009, J STAT MECH-THEORY E, V7; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kiss IZ, 2008, J R SOC INTERFACE, V5, P791, DOI 10.1098/rsif.2007.1272; Kumpula JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228701; Liu ZH, 2005, EUROPHYS LETT, V72, P315, DOI 10.1209/epl/i2004-10550-5; Masuda N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093009; May R., 2007, THEORETICAL ECOLOGY, V3rd; Min Y, 2011, ARXIV11101724; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Restrepo JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094102; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-11; Vazquez A, 2007, J THEOR BIOL, V245, P125, DOI 10.1016/j.jtbi.2006.09.018; Vespignani A, 2008, EUR PHYS J B, V64, P349, DOI 10.1140/epjb/e2008-00302-y; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160	34	15	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57100	10.1371/journal.pone.0057100	http://dx.doi.org/10.1371/journal.pone.0057100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437321	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200214
J	Sato, A; Yamada, N; Ogawa, Y; Ikegami, M				Sato, Atsuyasu; Yamada, Norishige; Ogawa, Yuya; Ikegami, Machiko			CCAAT/Enhancer-Binding Protein-alpha Suppresses Lung Tumor Development in Mice through the p38 alpha MAP Kinase Pathway	PLOS ONE			English	Article							FREQUENT DOWN-REGULATION; C/EBP-ALPHA; CELL-PROLIFERATION; CANCER; TUMORIGENESIS; INHIBITION; REVEALS; LESIONS; GROWTH; LIVER	The transcription factor CCAAT/enhancer-binding protein alpha (C/EBP alpha) is a basic leucine zipper transcription factor and is expressed in alveolar type II cells, alveolar macrophages and Clara cells in the lung. Although decrease or absence of C/EBP alpha expression in human non-small cell lung cancer suggests a possible role of C/EBP alpha as a lung tumor suppressor, there is no direct proof for this hypothesis. In this study, we investigated, for the first time, the role of C/EBP alpha in lung tumors in vivo using transgenic mice with lung epithelial specific conditional deletion of Cebpa (Cebp alpha(Delta/Delta) mice) and a urethane-induced lung tumor model. C/EBP alpha expression in the lung was dispensable, and its deletion was not oncogenic under unstressed conditions. However, at 28 wk after urethane injection, the number and size of tumors and the tumor burden were significantly higher in Cebp alpha(Delta/Delta) mice than in littermate control mice. Urethane-injected Cebp alpha(Delta/Delta) mice showed highly proliferative adenomas and adenocarcinomas in the lung, and survival time after urethane-injection was significantly shorter than that in control mice. In control mice, C/ EBP alpha was strongly induced in the tumor tissues at 28 weeks after urethane-injection, but became weakened or absent as tumors progressed after long-term observation for over 1 year. Using intraperitoneal injection of p38 inhibitor (SB203580), we demonstrated that the induction of C/EBP alpha is strongly regulated by the p38 MAP kinase in murine alveolar epithelial cells. A high correlation was demonstrated between the expression of C/EBP alpha and p38 alpha MAP kinase in tumor cells, suggesting that C/EBP alpha silencing in tumor cells is caused by down-regulation of p38 alpha MAP kinase. In conclusion, the role of C/EBP alpha as a lung tumor suppressor was demonstrated for the first time in the present study, and the extinguished C/EBP alpha expression through p38 alpha inactivation leads tumor promotion and progression.	[Sato, Atsuyasu; Ikegami, Machiko] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA; [Yamada, Norishige; Ogawa, Yuya] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Ikegami, M (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA.	machiko.ikegami@cchmc.org	Sato, Atsuyasu/H-9690-2016	Sato, Atsuyasu/0000-0001-8068-9984				Basseres DS, 2012, LUNG CANCER, V77, P31, DOI 10.1016/j.lungcan.2012.01.011; Biesalski HK, 1998, CA-CANCER J CLIN, V48, P167, DOI 10.3322/canjclin.48.3.167; Cheriyan J, 2011, CIRCULATION, V123, P515, DOI 10.1161/CIRCULATIONAHA.110.971986; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Costa DB, 2007, LUNG CANCER, V56, P97, DOI 10.1016/j.lungcan.2006.11.023; Costa DB, 2006, LUNG CANCER, V53, P253, DOI 10.1016/j.lungcan.2006.04.011; Dhawan P, 2009, J BIOL CHEM, V284, P3086, DOI 10.1074/jbc.M803602200; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Forkert PG, 2010, DRUG METAB REV, V42, P355, DOI 10.3109/03602531003611915; Geest CR, 2009, STEM CELLS, V27, P2271, DOI 10.1002/stem.152; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Grandinetti KB, 2011, ONCOGENE, V30, P3328, DOI 10.1038/onc.2011.57; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Halmos B, 2002, CANCER RES, V62, P528; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060; Khanna-Gupta A, 2008, BLOOD CELL MOL DIS, V41, P77, DOI 10.1016/j.bcmd.2008.02.011; Lomas DA, 2012, J CLIN PHARMACOL, V52, P416, DOI 10.1177/0091270010397050; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Nord M, 2000, ANN NY ACAD SCI, V923, P154; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Oikonomopoulou K, 2010, BIOL CHEM, V391, P299, DOI 10.1515/BC.2010.038; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Sato A, 2012, AM J RESP CELL MOL B; Sato A, 2012, AM J RESP CELL MOL, V47, P454, DOI 10.1165/rcmb.2011-0239OC; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Shim M, 2005, CANCER RES, V65, P861; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Xu Y, 2009, AM J PHYSIOL-LUNG C, V297, pL286, DOI 10.1152/ajplung.00094.2009	49	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57013	10.1371/journal.pone.0057013	http://dx.doi.org/10.1371/journal.pone.0057013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437297	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200200
J	Tochitani, S; Kondo, S				Tochitani, Shiro; Kondo, Shigeaki			Immunoreactivity for GABA, GAD65, GAD67 and Bestrophin-1 in the Meninges and the Choroid Plexus: Implications for Non-Neuronal Sources for GABA in the Developing Mouse Brain	PLOS ONE			English	Article							PROGENITOR CELLS; CEREBRAL-CORTEX; GLUTAMATE; RELEASE; ACID; NEUROGENESIS; INTERNEURONS; TRANSPORTER; EXPANSION; DELIVERY	Neural progenitors in the developing neocortex, neuroepithelial cells and radial glial cells, have a bipolar shape with a basal process contacting the basal membrane of the meninge and an apical plasma membrane facing the lateral ventricle, which the cerebrospinal fluid is filled with. Recent studies revealed that the meninges and the cerebrospinal fluid have certain roles to regulate brain development. gamma-aminobutyric acid (GABA) is a neurotransmitter which appears first during development and works as a diffusible factor to regulate the properties of neural progenitors. In this study, we examined whether GABA can be released from the meninges and the choroid plexus in the developing mouse brain. Immunohistochemical analyses showed that glutamic acid decarboxylase 65 and 67 (GAD65 and GAD67), both of which are GABA-synthesizing enzymes, are expressed in the meninges. The epithelial cells in the choroid plexus express GAD65. GABA immunoreactivity could be observed beneath the basal membrane of the meninge and in the epithelial cells of the choroid plexus. Expression analyses on Bestrophin-1, which is known as a GABA-permeable channel in differentiated glial cells, suggested that the cells in the meninges and the epithelial cells in the choroid plexus have the channels able to permeate non-synaptic GABA into the extracellular space. Further studies showed that GAD65/67-expressing meningeal cells appear in a manner with rostral to caudal and lateral to dorsal gradient to cover the entire neocortex by E14.5 during development, while the cells in the choroid plexus in the lateral ventricle start to express GAD65 on E11-E12, the time when the choroid plexus starts to develop in the developing brain. These results totally suggest that the meninges and the choroid plexus can work as non-neuronal sources for ambient GABA which can modulate the properties of neural progenitors during neocortical development.	[Tochitani, Shiro; Kondo, Shigeaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Anat & Dev Neurobiol, Tokushima 770, Japan; [Kondo, Shigeaki] Univ Tokushima, Fac Med, Student Lab, Tokushima 770, Japan	Tokushima University; Tokushima University	Tochitani, S (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Anat & Dev Neurobiol, Tokushima 770, Japan.	shiro@basic.med.tokushima-u.ac.jp		Tochitani, Shiro/0000-0001-5765-3668	Japan Society for the Promotion of Science [21791035, 23791227]; Ministry of Education, Science, Sports and Culture of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Young Scientists (B) #21791035 and #23791227 from the Japan Society for the Promotion of Science (to S. T.) and by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan (to S. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Cataltepe O, 1996, BRAIN RES, V709, P326, DOI 10.1016/0006-8993(95)01437-3; Conti F, 1999, J COMP NEUROL, V409, P482; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Evans JE, 1996, J COMP NEUROL, V376, P431, DOI 10.1002/(SICI)1096-9861(19961216)376:3<431::AID-CNE6>3.0.CO;2-3; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Gao XB, 2000, J PHYSIOL-LONDON, V523, P629, DOI 10.1111/j.1469-7793.2000.t01-1-00629.x; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Inoue T, 2007, J NEUROSCI, V27, P5461, DOI 10.1523/JNEUROSCI.4046-06.2007; John JE, 2007, EPILEPSY RES, V75, P10, DOI 10.1016/j.eplepsyres.2007.03.014; Lee R, 2009, J PSYCHIATR RES, V43, P353, DOI 10.1016/j.jpsychires.2008.04.004; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Owens DF, 1996, J NEUROSCI, V16, P6414; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382; Tochitani S, 2010, NEUROSCI LETT, V472, P128, DOI 10.1016/j.neulet.2010.01.071; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yoon BE, 2012, NEUROCHEM RES, V37, P2474, DOI 10.1007/s11064-012-0808-z	26	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56901	10.1371/journal.pone.0056901	http://dx.doi.org/10.1371/journal.pone.0056901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437266	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200181
J	Cesano, A; Putta, S; Rosen, DB; Cohen, AC; Gayko, U; Mathi, K; Woronicz, J; Hawtin, RE; Cripe, L; Sun, ZX; Tallman, MS; Paietta, E				Cesano, Alessandra; Putta, Santosh; Rosen, David B.; Cohen, Aileen C.; Gayko, Urte; Mathi, Kavita; Woronicz, John; Hawtin, Rachael E.; Cripe, Larry; Sun, Zhuoxin; Tallman, Martin S.; Paietta, Elisabeth			Functional Pathway Analysis Using SCNP of FLT3 Receptor Pathway Deregulation in AML Provides Prognostic Information Independent from Mutational Status	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; SIGNAL TRANSDUCER; NPM1 MUTATIONS; NORMAL CYTOGENETICS; POOR-PROGNOSIS; ADULT PATIENTS; OLDER-ADULTS; YOUNG-ADULT	FMS-like tyrosine kinase 3 receptor (FLT3) internal tandem duplication (ITD) mutations result in constitutive activation of this receptor and have been shown to increase the risk of relapse in patients with acute myeloid leukemia (AML); however, substantial heterogeneity in clinical outcomes still exists within both the ITD mutated and unmutated AML subgroups, suggesting alternative mechanisms of disease relapse not accounted by FLT3 mutational status. Single cell network profiling (SCNP) is a multiparametric flow cytometry based assay that simultaneously measures, in a quantitative fashion and at the single cell level, both extracellular surface marker levels and changes in intracellular signaling proteins in response to extracellular modulators. We previously reported an initial characterization of FLT3 ITD-mediated signaling using SCNP. Herein SCNP was applied sequentially to two separate cohorts of samples collected from elderly AML patients at diagnosis. In the first (training) study, AML samples carrying unmutated, wild-type FLT3 (FLT3 WT) displayed a wide range of induced signaling, with a fraction having signaling profiles comparable to FLT3 ITD AML samples. Conversely, the FLT3 ITD AML samples displayed more homogeneous induced signaling, with the exception of patients with low (, 40%) mutational load, which had profiles comparable to FLT3 WT AML samples. This observation was then confirmed in an independent (verification) cohort. Data from the second cohort were also used to assess the association between SCNP data and disease-free survival (DFS) in the context of FLT3 and nucleophosmin (NPM1) mutational status among patients who achieved complete remission (CR) to induction chemotherapy. The combination of SCNP read outs together with FLT3 and NPM1 molecular status improved the DFS prediction accuracy of the latter. Taken together, these results emphasize the value of comprehensive functional assessment of biologically relevant signaling pathways in AML as a basis for the development of highly predictive tests for guidance of post-remission therapy.	[Cesano, Alessandra; Putta, Santosh; Rosen, David B.; Cohen, Aileen C.; Gayko, Urte; Mathi, Kavita; Woronicz, John; Hawtin, Rachael E.] Nodality Inc, San Francisco, CA USA; [Cripe, Larry; Sun, Zhuoxin; Tallman, Martin S.; Paietta, Elisabeth] Eastern Cooperat Oncol Grp ECOG, Boston, MA USA; [Cripe, Larry] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA; [Sun, Zhuoxin] Dana Farber Canc Inst, Boston, MA 02115 USA; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Paietta, Elisabeth] Montefiore Med Ctr, North Div, Bronx, NY 10467 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Cesano, A (corresponding author), Nodality Inc, San Francisco, CA USA.	Alessandra.Cesano@Nodality.com			Nodality, Inc.; NATIONAL CANCER INSTITUTE [U24CA114737] Funding Source: NIH RePORTER	Nodality, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Nodality, Inc. The funder contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Benekli M, 2002, BLOOD, V99, P252, DOI 10.1182/blood.V99.1.252; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Beran M, 2004, LEUKEMIA RES, V28, P547, DOI 10.1016/j.leukres.2003.09.016; Brown P, 2004, BLOOD, V104, P1841, DOI 10.1182/blood-2004-03-1034; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Cesano A, 2010, ASH ANN M, V116, P2695; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Cheong JW, 2003, BRIT J HAEMATOL, V122, P454, DOI 10.1046/j.1365-2141.2003.04452.x; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Cripe LD, 2006, ASH ANN M, V108, P423; DOSIL M, 1993, MOL CELL BIOL, V13, P6572, DOI 10.1128/MCB.13.10.6572; Estey EH, 2012, AM J HEMATOL, V87, P90, DOI 10.1002/ajh.22246; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gale RE, 2005, BLOOD, V106, P3658, DOI 10.1182/blood-2005-03-1323; Gale RE, 2008, BLOOD, V111, P2776, DOI 10.1182/blood-2007-08-109090; Gorello P, 2006, LEUKEMIA, V20, P1103, DOI 10.1038/sj.leu.2404149; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Iwai T, 1999, LEUKEMIA, V13, P38, DOI 10.1038/sj.leu.2401241; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kiyoi H, 1999, BLOOD, V93, P3074; Kondo M, 1999, MED PEDIATR ONCOL, V33, P525; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lavagna-Sevenier C, 1998, LEUKEMIA, V12, P301, DOI 10.1038/sj.leu.2400921; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; O'Donnell MR, 2012, NCCN CLIN PRACTICE G; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Purvis N, 1998, CYTOMETRY, V33, P156, DOI 10.1002/(SICI)1097-0320(19981001)33:2<156::AID-CYTO10>3.0.CO;2-T; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; ROTTAPEL R, 1994, ONCOGENE, V9, P1755; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Schnittger S, 2011, LEUKEMIA, V25, P1297, DOI 10.1038/leu.2011.97; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Shults KE, 2006, CYTOM PART B-CLIN CY, V70B, P276, DOI 10.1002/cyto.b.20136; Stelzer GT, 2000, IMMUNOPHENOTYPING, P215; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Wang L, 2008, CYTOM PART A, V73A, P279, DOI 10.1002/cyto.a.20507; Whitman SP, 2001, CANCER RES, V61, P7233; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang SL, 2000, J EXP MED, V192, P719, DOI 10.1084/jem.192.5.719; Zhang SL, 1999, J LEUKOCYTE BIOL, V65, P372, DOI 10.1002/jlb.65.3.372	55	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56714	10.1371/journal.pone.0056714	http://dx.doi.org/10.1371/journal.pone.0056714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431389	Green Submitted, gold, Green Published			2022-12-27	WOS:000315182800032
J	Xie, CF; Ma, L; Liu, J; Li, XX; Pei, HY; Xiang, ML; Chen, LJ				Xie, Caifeng; Ma, Liang; Liu, Juan; Li, Xiuxia; Pei, Heying; Xiang, Mingli; Chen, Lijuan			SKLB023 Blocks Joint Inflammation and Cartilage Destruction in Arthritis Models via Suppression of Nuclear Factor-Kappa B Activation in Macrophage	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; SYNOVIAL TISSUE; DISEASE; MECHANISMS; THERAPY; CELLS; THERAPEUTICS; DEGRADATION	Rheumatoid arthritis (RA) is the most common arthritis and is mainly characterized by symmetric polyarticular joint disorders. Our previous study demonstrated a novel small molecule compound (Z)-N-(3-Chlorophenyl)-2-(4-((2,4-dioxothiazolidin-5-ylidene) methyl) phenoxy) acet-amide (SKLB023) showed potently anti-arthritic effects in a rat arthritis model, however, the underlying mechanisms for this are largely unknown. Both NF-kappa B and macrophages were reported to play important roles in the pathologic processes of RA. The purposes of this study were to indicate whether NF-kappa B and macrophages contributed to anti-arthritic effects of SKLB023 in two experimental arthritis models. Our results showed that SKLB023 could significantly improve joint inflammation and cartilage destruction both in adjuvant induced arthritis (AIA) and collagen-induced arthritis (CIA) models. We further found that the binding activation of NF-kappa B to DNA in joint tissues and RAW264.7 macrophages were suppressed by SKLB023. SKLB023 also inhibited the NF-kappa B activity in peritoneal macrophages by luciferase assay. Furthermore, the number of macrophages in synovial tissues was decreased after the treatment of different doses of SKLB023. The levels of TNF-alpha, IL-1 beta, and IL-6 in plasma, and the levels of TNF-alpha, NO, and IL-1 beta in peritoneal macrophages were down-regulated by SKLB023. Finally, SKLB023 attenuated the expression of iNOS and COX-2 in vivo and suppressed the phosphorylations of components of the mitogen-activated protein kinases (MAPKs). These observations identify a novel function for SKLB023 as an inhibitor of NF-kappa B in macrophages of RA, highlighting that SKLB023 was a potential therapeutic strategy for RA.	[Xie, Caifeng; Ma, Liang; Liu, Juan; Li, Xiuxia; Pei, Heying; Xiang, Mingli; Chen, Lijuan] Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University	Xiang, ML (corresponding author), Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	tmkxiang@gmail.com; lijuan17@hotmail.com		Ma, Liang/0000-0001-8327-7969	National Key Programs of China [2012ZX09103101-017]	National Key Programs of China	This work is supported by the National Key Programs of China during the 12th Five-Year Plan period (grant 2012ZX09103101-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin Ashok R., 1999, Current Opinion in Rheumatology, V11, P202, DOI 10.1097/00002281-199905000-00009; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P377; Bian ZM, 2003, EXP EYE RES, V76, P573, DOI 10.1016/S0014-4835(03)00029-0; Bingham CO, 2002, J RHEUMATOL, V29, P3; Bondeson J, 1999, P NATL ACAD SCI USA, V96, P5668, DOI 10.1073/pnas.96.10.5668; Bondeson J, 2011, EXPERT OPIN THER TAR, V15, P1355, DOI 10.1517/14728222.2011.636740; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Drosos AA, 2002, DRUGS, V62, P891, DOI 10.2165/00003495-200262060-00003; Dudler J, 2000, ANN RHEUM DIS, V59, P529, DOI 10.1136/ard.59.7.529; Emery P, 2006, BRIT MED J, V332, P152, DOI 10.1136/bmj.332.7534.152; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Gilmore TD, 2011, CURR TOP MICROBIOL, V349, P245, DOI 10.1007/82_2010_105; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Hammaker D, 2003, ANN RHEUM DIS, V62, P86; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Ma LA, 2011, J MED CHEM, V54, P2060, DOI 10.1021/jm1011534; Marok R, 1996, ARTHRITIS RHEUM, V39, P583, DOI 10.1002/art.1780390407; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Simmonds RE, 2008, RHEUMATOLOGY, V47, P584, DOI 10.1093/rheumatology/kem298; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Thurlings RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007865; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12	38	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56349	10.1371/journal.pone.0056349	http://dx.doi.org/10.1371/journal.pone.0056349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431370	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800012
J	Buzkova, P				Buzkova, Petra			Linear Regression in Genetic Association Studies	PLOS ONE			English	Article							LIPID-LEVELS; VARIANTS; MODELS; AGE	In genomic research phenotype transformations are commonly used as a straightforward way to reach normality of the model outcome. Many researchers still believe it to be necessary for proper inference. Using regression simulations, we show that phenotype transformations are typically not needed and, when used in phenotype with heteroscedasticity, result in inflated Type I error rates. We further explain that important is to address a combination of rare variant genotypes and heteroscedasticity. Incorrectly estimated parameter variability or incorrect choice of the distribution of the underlying test statistic provide spurious detection of associations. We conclude that it is a combination of heteroscedasticity, minor allele frequency, sample size, and to a much lesser extent the error distribution, that matter for proper statistical inference.	Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Buzkova, P (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	buzkova@u.washington.edu			National Human Genome Research Institute, Genetic Epidemiology of Causal Variants Across the Life Course [5U01HG004803-04]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004803] Funding Source: NIH RePORTER	National Human Genome Research Institute, Genetic Epidemiology of Causal Variants Across the Life Course; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by an award issued by the National Human Genome Research Institute, 5U01HG004803-04, Genetic Epidemiology of Causal Variants Across the Life Course. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Blom G., 1958, STAT ESTIMATES TRANS; BRESLOW N, 1990, J AM STAT ASSOC, V85, P565, DOI 10.2307/2289799; Davison AC, 1997, BOOTSTRAP METHODS TH; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Dumitrescu L, 2011, ANN HUM GENET, V75, P589, DOI 10.1111/j.1469-1809.2011.00664.x; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kinnamon DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030238; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lipsitz SR, 1999, J ROY STAT SOC D-STA, V48, P495, DOI 10.1111/1467-9884.00207; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; McCullagh P, 1992, J ROYAL STAT SOC B, V54, P24; Need AC, 2006, ANN HUM GENET, V70, P293, DOI 10.1111/j.1469-1809.2005.00228.x; R Core Team, 2020, R LANG ENV STAT COMP; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Talmud PJ, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e50; Voorman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019416; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zabaneh D, 2011, ANN HUM GENET, V75, P456, DOI 10.1111/j.1469-1809.2011.00654.x	24	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56976	10.1371/journal.pone.0056976	http://dx.doi.org/10.1371/journal.pone.0056976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437286	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000062
J	Choi, HJ; Sanders, TA; Tormos, KV; Ameri, K; Tsai, JD; Park, AM; Gonzalez, J; Rajah, AM; Liu, XW; Quinonez, DM; Rinaudo, PF; Maltepe, E				Choi, Hwa J.; Sanders, Timothy A.; Tormos, Kathryn V.; Ameri, Kurosh; Tsai, Justin D.; Park, Angela M.; Gonzalez, Julissa; Rajah, Anthony M.; Liu, Xiaowei; Quinonez, Diana M.; Rinaudo, Paolo F.; Maltepe, Emin			ECM-Dependent HIF Induction Directs Trophoblast Stem Cell Fate via LIMK1-Mediated Cytoskeletal Rearrangement	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; PLACENTAL DEVELOPMENT; EXTRACELLULAR-MATRIX; VULVAR INDUCTION; MAP KINASE; C-MYC; OXYGEN; MOUSE; INTEGRIN	The Hypoxia-inducible Factor (HIF) family of transcriptional regulators coordinates the expression of dozens of genes in response to oxygen deprivation. Mammalian development occurs in a hypoxic environment and HIF-null mice therefore die in utero due to multiple embryonic and placental defects. Mouse embryonic stem cells do not differentiate into placental cells; therefore, trophoblast stem cells (TSCs) are used to study mouse placental development. Consistent with a requirement for HIF activity during placental development in utero, TSCs derived from HIF-null mice exhibit severe differentiation defects and fail to form trophoblast giant cells (TGCs) in vitro. Interestingly, differentiating TSCs induce HIF activity independent of oxygen tension via unclear mechanisms. Here, we show that altering the extracellular matrix (ECM) composition upon which TSCs are cultured changes their differentiation potential from TGCs to multinucleated syncytiotropholasts (SynTs) and blocks oxygen-independent HIF induction. We further find that modulation of Mitogen Activated Protein Kinase Kinase-1/2 (MAP2K1/2, MEK-1/2) signaling by ECM composition is responsible for this effect. In the absence of ECM-dependent cues, hypoxia-signaling pathways activate this MAPK cascade to drive HIF induction and redirect TSC fate along the TGC lineage. In addition, we show that integrity of the microtubule and actin cytoskeleton is critical for TGC fate determination. HIF-2 alpha ensures TSC cytoskeletal integrity and promotes invasive TGC formation by interacting with c-MYC to induce non-canonical expression of Lim domain kinase 1-an enzyme that regulates microtubule and actin stability, as well as cell invasion. Thus, we find that HIF can integrate positional and metabolic cues from within the TSC niche to regulate placental development by modulating the cellular cytoskeleton via non-canonical gene expression.	[Choi, Hwa J.; Sanders, Timothy A.; Tormos, Kathryn V.; Ameri, Kurosh; Tsai, Justin D.; Park, Angela M.; Rajah, Anthony M.; Maltepe, Emin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Gonzalez, Julissa; Quinonez, Diana M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Liu, Xiaowei; Rinaudo, Paolo F.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Tormos, Kathryn V.; Liu, Xiaowei; Rinaudo, Paolo F.; Maltepe, Emin] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Maltepe, Emin] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Maltepe, Emin] Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; California State University System; San Francisco State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Maltepe, E (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	emin.maltepe@ucsf.edu			California Institute for Regenerative Medicine [TB1-01194]; National Institutes of Health [HL087754, HD072455]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072455, R01HD062803] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087754] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research was made possible by a grant from the California Institute for Regenerative Medicine (Grant Number TB1-01194) and the National Institutes of Health (HL087754, HD072455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; Asanoma K, 2007, J BIOL CHEM, V282, P24065, DOI 10.1074/jbc.M701380200; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Gauster M, 2010, CELL DEATH DIFFER, V17, P336, DOI 10.1038/cdd.2009.133; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hamanaka RB, 2012, TRENDS BIOCHEM SCI, V35, P505; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; HSU JC, 1994, GENE DEV, V8, P2176, DOI 10.1101/gad.8.18.2176; Hughes CS, 2011, PROTEOMICS, V11, P3983, DOI 10.1002/pmic.201100030; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karthikeyan VJ, 2012, J HUM HYPERTENS; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; KORNFELD K, 1995, GENE DEV, V9, P756, DOI 10.1101/gad.9.6.756; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Lee SH, 2012, J BIOL CHEM, V287, P14760, DOI 10.1074/jbc.M112.340232; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Nadeau V, 2009, DEVELOPMENT, V136, P1363, DOI 10.1242/dev.031872; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Pringle KG, 2009, HUM REPROD UPDATE; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rosario GX, 2008, DEV BIOL, V314, P362, DOI 10.1016/j.ydbio.2007.12.007; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Scales TME, 2011, CURR OPIN CELL BIOL, V23, P562, DOI 10.1016/j.ceb.2011.05.008; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shibukawa Y, 2012, MOL BIOL CELL; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158; Sutherland A, 2003, DEV BIOL, V258, P241, DOI 10.1016/S0012-1606(03)00130-1; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; Votteler M, 2010, MACROMOL BIOSCI, V10, P1302, DOI 10.1002/mabi.201000102; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2002, CELLS TISSUES ORGANS, V172, P190, DOI 10.1159/000066970; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; WU Y, 1995, GENE DEV, V9, P742, DOI 10.1101/gad.9.6.742; Yoshie M, 2008, HUM REPROD, V23, P2766, DOI 10.1093/humrep/den317; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang LJ, 2011, DEVELOPMENT, V138, P455, DOI 10.1242/dev.046870; ZHENG Q, 1991, J CELL SCI, V100, P431	77	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56949	10.1371/journal.pone.0056949	http://dx.doi.org/10.1371/journal.pone.0056949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437279	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000059
J	Eldor, R; Abel, R; Sever, D; Sadoun, G; Peled, A; Sionov, R; Melloul, D				Eldor, Roy; Abel, Roy; Sever, Dror; Sadoun, Gad; Peled, Amnon; Sionov, Ronit; Melloul, Danielle			Inhibition of Nuclear Factor-kappa B Activation in Pancreatic beta-Cells Has a Protective Effect on Allogeneic Pancreatic Islet Graft Survival	PLOS ONE			English	Article							XIAP OVEREXPRESSION; SIGNAL-TRANSDUCTION; INSULIN-SECRETION; GENE-TRANSFER; APOPTOSIS; TRANSPLANTATION; MASS; EXPRESSION; ALPHA; INTERLEUKIN-1-BETA	Pancreatic islet transplantation, a treatment for type 1 diabetes, has met significant challenges, as a substantial fraction of the islet mass fails to engraft, partly due to death by apoptosis in the peri- and post-transplantation periods. Previous evidence has suggested that NF-kappa B activation is involved in cytokine-mediated beta-cell apoptosis and regulates the expression of pro-inflammatory and chemokine genes. We therefore sought to explore the effects of beta-cell-specific inhibition of NF-kappa B activation as a means of cytoprotection in an allogeneic model of islet transplantation. To this end, we used islets isolated from the Tol-beta transgenic mouse, where NF-kappa B signalling can specifically and conditionally be inhibited in beta-cells by expressing an inducible and non-degradable form of I kappa beta alpha regulated by the tet-on system. Our results show that beta-cell-specific blockade of NF-kappa B led to a prolonged islet graft survival, with a relative higher preservation of the engrafted endocrine tissue and reduced inflammation. Importantly, a longer delay in allograft rejection was achieved when mice were systemically treated with the proteasome inhibitor, Bortezomib. Our findings emphasize the contribution of NF-kappa B activation in the allograft rejection process, and suggest an involvement of the CXCL10/IP-10 chemokine. Furthermore, we suggest a potential, readily available therapeutic agent that may temper this process.	[Eldor, Roy; Abel, Roy; Sever, Dror; Sadoun, Gad; Melloul, Danielle] Hadassah Univ Hosp, Dept Endocrinol, IL-91120 Jerusalem, Israel; [Peled, Amnon] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Sionov, Ronit] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Melloul, D (corresponding author), Hadassah Univ Hosp, Dept Endocrinol, IL-91120 Jerusalem, Israel.	daniellem@ekmd.huji.ac.il	Eldor, Roy/AAD-4397-2022		Juvenile Diabetes Research Foundation [1-2007-60]; European Union [036903]; Israel Ministry of Health	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); Israel Ministry of Health	This work was supported by grants from the Juvenile Diabetes Research Foundation (1-2007-60), and European Union (STREP Savebeta, contract nu 036903) in the Framework Programme 6 and the Israel Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MS, 2003, SURGERY, V134, P126, DOI 10.1067/msy.2003.213; Baker MS, 2001, J SURG RES, V97, P117, DOI 10.1006/jsre.2001.6121; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Contreras JL, 2001, TRANSPLANTATION, V71, P1015, DOI 10.1097/00007890-200104270-00001; Cottet S, 2002, DIABETES, V51, P1805, DOI 10.2337/diabetes.51.6.1805; De Paula D, 2007, J DRUG TARGET, V15, P358, DOI 10.1080/10611860701349695; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Eldor R, 2009, DIABETES RES CLIN PR, V86, pS7, DOI 10.1016/S0168-8227(09)70003-8; Emamaullee J, 2005, AM J TRANSPLANT, V5, P1297, DOI 10.1111/j.1600-6143.2005.00891.x; Emamaullee JA, 2005, DIABETES, V54, P2541, DOI 10.2337/diabetes.54.9.2541; Emamaullee JA, 2008, DIABETES, V57, P1556, DOI 10.2337/db07-1452; Emamaullee JA, 2007, DIABETES, V56, P1289, DOI 10.2337/db06-1653; Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254; Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; Grey ST, 2003, J IMMUNOL, V170, P6250, DOI 10.4049/jimmunol.170.12.6250; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Jelsing J, 2012, J ENDOCRINOL, V214, P381, DOI 10.1530/JOE-11-0479; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kuo YR, 2010, AM J TRANSPLANT, V10, P213; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Matsumoto S, 2006, EXPERT OPIN BIOL TH, V6, P23, DOI 10.1517/14712598.6.1.23; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Morimoto J, 2004, J IMMUNOL, V173, P7017, DOI 10.4049/jimmunol.173.11.7017; Nencioni A, 2006, CRIT REV IMMUNOL, V26, P487, DOI 10.1615/CritRevImmunol.v26.i6.20; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ou D, 2005, HUM IMMUNOL, V66, P799, DOI 10.1016/j.humimm.2005.03.009; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Plesner A, 2010, ISLETS, V2, P18, DOI 10.4161/isl.2.1.9997; Poff JA, 2008, RADIOLOGY, V248, P485, DOI 10.1148/radiol.2482071674; Qin J, 2009, LIFE SCI, V84, P810, DOI 10.1016/j.lfs.2009.03.010; Rehman KK, 2003, J BIOL CHEM, V278, P9862, DOI 10.1074/jbc.M207700200; Rink JS, 2012, SURGERY, V151, P330, DOI 10.1016/j.surg.2011.07.011; Rivas-Carrillo JD, 2007, DIABETES, V56, P1259, DOI 10.2337/db06-1679; Robertson RP, 2010, ENDOCRIN METAB CLIN, V39, P655, DOI 10.1016/j.ecl.2010.05.010; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Takahashi T, 2010, J SURG RES, V163, pE23, DOI 10.1016/j.jss.2010.04.044; Uno S, 2010, ENDOCR J, V57, P991, DOI 10.1507/endocrj.K10E-076; Yang H, 2002, TRANSPLANTATION, V74, P291, DOI 10.1097/00007890-200208150-00002; Zhao Yuxing, 2011, Inflammation & Allergy Drug Targets, V10, P208	51	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56924	10.1371/journal.pone.0056924	http://dx.doi.org/10.1371/journal.pone.0056924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437272	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000056
J	Galvao, TF; Silva, MT; Serruya, SJ; Newman, LM; Klausner, JD; Pereira, MG; Fescina, R				Galvao, Tais F.; Silva, Marcus T.; Serruya, Suzanne J.; Newman, Lori M.; Klausner, Jeffrey D.; Pereira, Mauricio G.; Fescina, Ricardo			Safety of Benzathine Penicillin for Preventing Congenital Syphilis: A Systematic Review	PLOS ONE			English	Review							RURAL SOUTH-AFRICA; SEXUALLY-TRANSMITTED-DISEASES; MATERNAL SYPHILIS; PREGNANT-WOMEN; DEMONSTRATION PROJECT; PERINATAL-MORTALITY; EPIDEMIOLOGY; MANAGEMENT; OPPORTUNITIES; INTERVENTION	Objective: To estimate the risk of serious adverse reactions to benzathine penicillin in pregnant women for preventing congenital syphilis. Methods: We searched for clinical trials or cohorts that assessed the incidence of serious adverse reactions to benzathine penicillin in pregnant women and the general population (indirect evidence). MEDLINE, EMBASE, Scopus and other databases were searched up to December 2012. The GRADE approach was used to assess quality of evidence. Absolute risks of each study were calculated along with their 95% confidence intervals (95% Cl). We employed the DerSimonian and Laird random effects model in the meta-analyses. Results: From 2,765 retrieved studies we included 13, representing 3,466,780 patients. The studies that included pregnant women were conducted to demonstrate the effectiveness of benzathine penicillin: no serious adverse reactions were reported among the 1,244 pregnant women included. In the general population, among 2,028,982 patients treated, 4 died from an adverse reaction. The pooled risk of death was virtually zero. Fifty-four cases of anaphylaxis were reported (pooled absolute risk = 0.002%; 95% Cl: 0%-0.003% I-2 = 12%). From that estimate, penicillin treatment would be expected to result in an incidence of 0 to 3 cases of anaphylaxis per 100,000 treated. Any adverse reactions were reported in 6,377 patients among 3,465,322 treated with penicillin (pooled absolute risk = 0.169%; 95% Cl: 0.073%-0.265% I-2 = 97%). The quality of evidence was very low. Conclusion: Studies that assessed the risk of serious adverse events due to benzathine penicillin treatment in pregnant women were scarce, but no reports of adverse reactions were found. The incidence of severe adverse outcomes was very low in the general population. The risk of treating pregnant women with benzathine penicillin to prevent congenital syphilis appears very low and does not outweigh its benefits. Further research is needed to improve the quality of evidence.	[Galvao, Tais F.; Silva, Marcus T.; Pereira, Mauricio G.] Univ Brasilia, Fac Med, Brasilia, DF, Brazil; [Serruya, Suzanne J.; Fescina, Ricardo] Pan Amer Hlth Org, Ctr Latinoamer Perinatol Salud Mujer & Reprod CLA, Montevideo, Uruguay; [Newman, Lori M.] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Klausner, Jeffrey D.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Klausner, Jeffrey D.] Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA	Universidade de Brasilia; Pan American Health Organization; World Health Organization; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Galvao, TF (corresponding author), Univ Brasilia, Fac Med, Brasilia, DF, Brazil.	taisgalvao@gmail.com	Galvao, Tais F/E-4317-2010; Silva, Marcus Tolentino/J-1791-2014	Galvao, Tais F/0000-0003-2072-4834; Silva, Marcus Tolentino/0000-0002-7186-9075	Centro Latinoamericano de Perinatologia/Salud de la Mujer y Reproductiva (CLAP/SMR); Pan-American Health Organization; World Health Organization	Centro Latinoamericano de Perinatologia/Salud de la Mujer y Reproductiva (CLAP/SMR); Pan-American Health Organization; World Health Organization(World Health Organization)	This research was partially funded by the Centro Latinoamericano de Perinatologia/Salud de la Mujer y Reproductiva (CLAP/SMR), Pan- American Health Organization, World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin Mikel, 2011, Perm J, V15, P89; Alexander JM, 1999, OBSTET GYNECOL, V93, P5, DOI 10.1016/S0029-7844(98)00338-X; Apter AJ, 2004, J ALLERGY CLIN IMMUN, V113, P764, DOI 10.1016/j.jaci.2003.11.032; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Berry G, 1995, STATISTICIAN, V44, P417, DOI 10.2307/2348891; Blank S, 1997, SEX TRANSM DIS, V24, P218, DOI 10.1097/00007435-199704000-00006; Blank S, 1999, J INFECT DIS, V180, P1159, DOI 10.1086/315038; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Borenstein M, 2009, INTRO META ANAL; BOWELL P, 1989, J CLIN PATHOL, V42, P1281, DOI 10.1136/jcp.42.12.1281; Bronzan RN, 2007, SEX TRANSM DIS, V34, pS55, DOI 10.1097/01.olq.0000245987.78067.0c; BROWN WJ, 1960, BRIT J VENER DIS, V36, P30; Caddy SC, 2011, J OBSTET GYNAECOL CA, V33, P453, DOI 10.1016/S1701-2163(16)34878-2; Cameron ST, 1997, BRIT J OBSTET GYNAEC, V104, P734, DOI 10.1111/j.1471-0528.1997.tb11987.x; Carles G, 2008, J GYNECOL OBST BIO R, V37, P353, DOI 10.1016/j.jgyn.2007.08.006; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Cheng JQ, 2007, SEX TRANSM INFECT, V83, P347, DOI 10.1136/sti.2006.023655; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Donders GGG, 1997, SEX TRANSM DIS, V24, P94, DOI 10.1097/00007435-199702000-00007; DONDERS GGG, 1993, GENITOURIN MED, V69, P98; Douglas JM, 2009, JAMA-J AM MED ASSOC, V301, P769, DOI 10.1001/jama.2009.143; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Fitzgerald D W, 1998, Int J Infect Dis, V2, P127, DOI 10.1016/S1201-9712(98)90113-8; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Garcia SG, 2007, SEX TRANSM DIS, V34, pS37, DOI 10.1097/olq.0000251236.48770.35; Gichangi P, 2004, East Afr Med J, V81, P589; GJESSING H C, 1960, Tidsskr Nor Laegeforen, V80, P977; GUINNESS LF, 1988, GENITOURIN MED, V64, P294; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Heikkinen T, 2000, BRIT J OBSTET GYNAEC, V107, P770, DOI 10.1111/j.1471-0528.2000.tb13339.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HIRA SK, 1990, GENITOURIN MED, V66, P159; Hong FC, 2010, SEX TRANSM DIS, V37, P26, DOI 10.1097/OLQ.0b013e3181b3915b; HSU I, 1958, NEW ENGL J MED, V259, P581, DOI 10.1056/NEJM195809182591206; Hurtig AK, 1998, BRIT MED J, V317, P1617, DOI 10.1136/bmj.317.7173.1617; INGRAHAM N R Jr, 1950, Acta Derm Venereol Suppl (Stockh), V31, P60; JENNISKENS F, 1995, INT J GYNECOL OBSTET, V48, pS121, DOI 10.1016/0020-7292(95)02326-8; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kamb ML, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/312798; KING PA, 1990, GENITOURIN MED, V66, P257; Lagace -Wiens P, 2012, EXPERT OPIN DRUG SAF, V11, P381, DOI 10.1517/14740338.2012.643866; Lee MJ, 1998, INT J GYNECOL OBSTET, V63, P247, DOI 10.1016/S0020-7292(98)00165-9; Li J, 2012, J EUR ACAD DERMATOL; Liu XS, 2011, BR J MATH STAT PSYCH; Lumbiganon P, 2002, INT J STD AIDS, V13, P486, DOI 10.1258/09564620260079653; Macy E, 2012, ANN ALLERG ASTHMA IM, V108, P88, DOI 10.1016/j.anai.2011.11.006; MARKOWITZ M, 1991, LANCET, V337, P1308; McClean H, 2006, INT J STD AIDS, V17, P334, DOI 10.1258/095646206776790150; MCFARLIN BL, 1995, MIDWIFERY, V11, P55, DOI 10.1016/0266-6138(95)90067-5; Menezes EV, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S4; Meyer Sauteur Patrick M, 2012, Swiss Med Wkly, V141, pw13325, DOI 10.4414/smw.2012.13325; Miguel A, 2012, PHARMACOEPIDEMIOL DR; MORTON RS, 1957, BRIT J VENER DIS, V33, P176; Mullick S, 2005, SEX TRANSM INFECT, V81, P220, DOI 10.1136/sti.2004.011999; Munkhuu B, 2009, SEX TRANSM DIS, V36, P714, DOI 10.1097/OLQ.0b013e3181bc0960; Myer L, 2004, TROP MED INT HEALTH, V9, P1216, DOI 10.1111/j.1365-3156.2004.01330.x; Napoli Diane C., 2000, Pediatric Asthma Allergy and Immunology, V14, P329, DOI 10.1089/088318700750070439; Nathan L, 1997, PRENATAL DIAG, V17, P119, DOI 10.1002/(SICI)1097-0223(199702)17:2<119::AID-PD39>3.0.CO;2-T; O'Connor Meghan, 2008, J Midwifery Womens Health, V53, pe17, DOI 10.1016/j.jmwh.2008.02.008; Osman NB, 2000, SEX TRANSM INFECT, V76, P203, DOI 10.1136/sti.76.3.203; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; PHAOSAVASDI S, 1989, Journal of the Medical Association of Thailand, V72, P101; Potter D, 2008, JAIDS-J ACQ IMM DEF, V47, P79, DOI 10.1097/QAI.0b013e31815d2f71; Pound MW, 2005, J CLIN PHARM THER, V30, P291, DOI 10.1111/j.1365-2710.2005.00631.x; Ramsey PS, 2003, AM J OBSTET GYNECOL, V188, P714, DOI 10.1067/mob.2003.141; Ramsey PS, 2000, INFECT DIS OBSTET GY, V8, P203; Reyna-Figueroa J, 2011, SEX TRANSM DIS, V38, P798, DOI 10.1097/OLQ.0b013e31821898ca; RICCI JM, 1989, OBSTET GYNECOL, V74, P687; Rotchford K, 2000, TROP MED INT HEALTH, V5, P800, DOI 10.1046/j.1365-3156.2000.00636.x; RUTGERS S, 1993, CENT AFR J MED, V39, P117; Salakhov E, 2004, SEX TRANSM DIS, V31, P127, DOI 10.1097/01.OLQ.0000109516.47951.B8; Sangtawesin Varaporn, 2005, Journal of the Medical Association of Thailand, V88, P1519; SCIPLE GW, 1959, NEW ENGL J MED, V261, P1123, DOI 10.1056/NEJM195911262612207; Shafer J, 1954, J SOC HYG, V40, P69; SHAFER J K, 1954, Bull World Health Organ, V10, P619; Sheffield JS, 2002, AM J OBSTET GYNECOL, V186, P569, DOI 10.1067/mob.2002.121541; Sia VMG, 2011, J PERINAT MED, V39, P71, DOI [10.1515/JPM.2010.123, 10.1515/jpm.2010.123]; SMITH C A, 1956, Bull World Health Organ, V15, P1087; Solensky R, 2012, J ALLERGY CLIN IMMUN, V130, P1442, DOI 10.1016/j.jaci.2012.08.021; STIGMA, 2019, GUID MAN SEX TRANSM; Su J. R., 2010, Morbidity and Mortality Weekly Report, V59, P413; SUSSMAN GL, 1986, CAN MED ASSOC J, V134, P1353; Swain GR, 1998, AM J PUBLIC HEALTH, V88, P1101; Temmerman M, 2000, SEX TRANSM INFECT, V76, P117, DOI 10.1136/sti.76.2.117; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; Tikhonova L, 2003, SEX TRANSM INFECT, V79, P106, DOI 10.1136/sti.79.2.106; Tridapalli E, 2012, ARCH DIS CHILD-FETAL, V97, pF211, DOI 10.1136/adc.2010.183863; Wabwire-Mangen F, 1999, J ACQ IMMUN DEF SYND, V22, P379; WAMMOCK VS, 1950, AM J OBSTET GYNECOL, V59, P806; WARRINGTON RJ, 1978, CAN MED ASSOC J, V118, P787; Watson-Jones D, 2005, TROP MED INT HEALTH, V10, P934, DOI 10.1111/j.1365-3156.2005.01473.x; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; Wendel GD, 2002, CLIN INFECT DIS, V35, pS200, DOI 10.1086/342108; Wilkinson D, 1997, TROP MED INT HEALTH, V2, P57, DOI 10.1046/j.1365-3156.1997.d01-127.x; WILLCOX R R, 1958, Bull World Health Organ, V18, P457; WILLCOX R R, 1955, Postgrad Med J, V31, P548; WILLCOX R R, 1954, Bull World Health Organ, V10, P579; WILLCOX RR, 1964, BRIT J VENER DIS, V40, P200; WILLCOX RR, 1957, BRIT J VENER DIS, V33, P209; Willcox RR, 1955, POSTGRAD MED J, V31, P557; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, 2012, INV CAS EL MOTH TO C; Yakubovsky A, 2006, SEX TRANSM DIS, V33, P244, DOI 10.1097/01.olq.0000204916.91780.d9; Zhu LP, 2010, INT J INFECT DIS, V14, pE45, DOI 10.1016/j.ijid.2009.09.009	106	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56463	10.1371/journal.pone.0056463	http://dx.doi.org/10.1371/journal.pone.0056463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437138	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000028
J	Gilks, CF; Walker, AS; Munderi, P; Kityo, C; Reid, A; Katabira, E; Goodall, RL; Grosskurth, H; Mugyenyi, P; Hakim, J; Gibb, DM				Gilks, Charles F.; Walker, A. Sarah; Munderi, Paula; Kityo, Cissy; Reid, Andrew; Katabira, Elly; Goodall, Ruth L.; Grosskurth, Heiner; Mugyenyi, Peter; Hakim, James; Gibb, Diana M.		DART Virology Grp; DART Trial Team	Single CD4 Test with 250 Cells/Mm(3) Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria	PLOS ONE			English	Article							RECEIVING ANTIRETROVIRAL THERAPY; RESOURCE-LIMITED SETTINGS; NON-INFERIORITY TRIAL; CELL COUNT; TREATMENT FAILURE; UGANDA; COMBINATION; ROUTINE; LOAD	Background: In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is rarely available in the public sector for HIV-infected adults or children. Using clinical failure alone to identify first-line ART failure and trigger regimen switch may result in unnecessary use of costly second-line therapy. Our objective was to identify CD4 threshold values to confirm clinically-determined ART failure when VL is unavailable. Methods: 3316 HIV-infected Ugandan/Zimbabwean adults were randomised to first-line ART with Clinically-Driven (CDM, CD4s measured but blinded) or routine Laboratory and Clinical Monitoring (LCM, 12-weekly CD4s) in the DART trial. CD4 at switch and ART failure criteria (new/recurrent WHO 4, single/multiple WHO 3 event; LCM: CD4<100 cells/mm(3)) were reviewed in 361 LCM, 314 CDM participants who switched over median 5 years follow-up. Retrospective VLs were available in 368 (55%) participants. Results: Overall, 265/361 (73%) LCM participants failed with CD4<100 cells/mm(3); only 7 (2%) switched with CD4 >= 250 cells/mm(3), four switches triggered by WHO events. Without CD4 monitoring, 207/314 (66%) CDM participants failed with WHO 4 events, and 77(25%)/30(10%) with single/multiple WHO 3 events. Failure/switching with single WHO 3 events was more likely with CD4 >= 250 cells/mm(3) (28/77; 36%) (p=0.0002). CD4 monitoring reduced switching with viral suppression: 23/187 (12%) LCM versus 49/181 (27%) CDM had VL, 400 copies/ml at failure/switch (p<0.0001). Amongst CDM participants with CD4<250 cells/mm(3) only 11/133 (8%) had VL<400copies/ml, compared with 38/48 (79%) with CD4 >= 250 cells/mm(3) (p<0.0001). Conclusion: Multiple, but not single, WHO 3 events predicted first-line ART failure. A CD4 threshold 'tiebreaker' of >= 250 cells/mm(3) for clinically-monitored patients failing first-line could identify similar to 80% with VL<400 copies/ml, who are unlikely to benefit from second-line. Targeting CD4s to single WHO stage 3 'clinical failures' would particularly avoid premature, costly switch to second-line ART.	[Gilks, Charles F.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Walker, A. Sarah; Goodall, Ruth L.; Gibb, Diana M.] MRC, Clin Trials Unit, London, England; [Munderi, Paula; Grosskurth, Heiner] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Kityo, Cissy; Mugyenyi, Peter] Joint Clin Res Ctr, Kampala, Uganda; [Reid, Andrew; Hakim, James] Univ Zimbabwe, Clin Res Ctr, Harare, Zimbabwe; [Katabira, Elly] Infect Dis Inst, Mulago, Uganda	Imperial College London; Medical Research Council Clinical Trials Unit; Uganda Virus Research Institute; Joint Clinic Research Center - United Arab Emirates; University of Zimbabwe	Walker, AS (corresponding author), MRC, Clin Trials Unit, London, England.	asw@ctu.mrc.ac.uk	Walker, Sarah/HDM-8717-2022; Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123; Goodall, Ruth/0000-0003-0622-5035; Gibb, Diana/0000-0002-9738-5490; Grosskurth, Heiner/0000-0001-9960-7280	United Kingdom Medical Research Council [G0600344]; United Kingdom Department for International Development; Rockefeller Foundation; Medical Research Council [MC_U950080931, G0600344, MC_U950080932] Funding Source: researchfish; MRC [G0600344, MC_U950080932, MC_U950080931] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Kingdom Department for International Development; Rockefeller Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DART was funded by the United Kingdom Medical Research Council [grant number G0600344], the United Kingdom Department for International Development, and the Rockefeller Foundation. Viiv Healthcare/GlaxoSmithKline, Gilead and Boehringer-Ingelheim donated first-line drugs for DART, and Abbott provided Kaletra/Aluvia as part of the second-line regimen for DART. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abongomera G, 2012, 19 INT AIDS C WASH D; [Anonymous], 2011, HIV TREATM REACH 6 6; Brennan A, 2011, 18 C RETR OPP INF BO; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Government of Malawi Ministry of Health, 2011, Q HIV PROGR REP; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Jani IV, 2011, LANCET; Jourdain G, 2011, 18 C RETR OPP INF BO; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Loutfy MR, 2011, J ACQ IMMUN DEF SYND, V55, P451; Mambule I, 2011, 18 C RETR OPP INF BO; Medina Lara A, PLOSONE IN PRESS; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mocroft A, 2007, AIDS, V21, P1867, DOI 10.1097/QAD.0b013e328270b877; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Munderi P, 2008, TROP MED INT HEALTH, V13, P6, DOI 10.1111/j.1365-3156.2007.01973.x; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; Walker AS, ANTIVIR THE IN PRESS; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2006, ANT THER HIV INF AD	26	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57580	10.1371/journal.pone.0057580	http://dx.doi.org/10.1371/journal.pone.0057580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437399	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315186000112
J	Kuo, YM; Andrews, AJ				Kuo, Yin-Ming; Andrews, Andrew J.			Quantitating the Specificity and Selectivity of Gcn5-Mediated Acetylation of Histone H3	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; ACETYLTRANSFERASE; GCN5; IDENTIFICATION; METHYLATION; MECHANISM; PATTERNS; ASSAY; P300; H4	Lysine acetyltransferases (KATs) play a unique role in regulating gene transcription as well as maintaining the epigenetic state of the cell. KATs such as Gcn5 and p300/CBP can modify multiple residues on a single histone; however, order and specificity of acetylation can be altered by factors such as histone chaperones, subunit proteins or external stimulus. While the importance of acetylation is well documented, it has been difficult to quantitatively measure the specificity and selectivity of acetylation at different residues within a histone. In this paper, we demonstrate a label-free quantitative high throughput mass spectrometry-based assay capable of quantitatively monitoring all known acetylation sites of H3 simultaneously. Using this assay, we are able to analyze the steady-state enzyme kinetics of Gcn5, an evolutionarily conserved KAT. In doing so, we measured Gcn5-mediated acetylation at six residues (K14>K9 approximate to K23> K18> K27 approximate to K36) and the catalytic efficiency (k(cat)/K-m) for K9, K14, K18, and K23 as well as the nonenzymatic acetylation rate. We observed selectivity differences of up to -4 kcal/mol between K14 and K18, the highest and lowest measurable k(cat)/K-m. These data provide a first look at quantitating the specificity and selectivity of multiple lysines on a single substrate (H3) by Gcn5.	[Kuo, Yin-Ming; Andrews, Andrew J.] Fox Chase Canc Ctr, Dept Canc Biol, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Andrews, AJ (corresponding author), Fox Chase Canc Ctr, Dept Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Andrew.Andrews@fccc.edu	Kuo, Yin-Ming/F-8244-2011	Kuo, Yin-Ming/0000-0002-3036-1902	Pennsylvania Department of Health	Pennsylvania Department of Health	This project is funded, in part, under a grant with the Pennsylvania Department of Health. The Pennsylvania Department of Health specifically disclaims responsibility for any analysis, interpretations or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; BENDER ML, 1965, ANNU REV BIOCHEM, V34, P49, DOI 10.1146/annurev.bi.34.070165.000405; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; BOSSHARD HR, 1976, EXPERIENTIA, V32, P949, DOI 10.1007/BF01933911; BROT FE, 1969, J AM CHEM SOC, V91, P7187, DOI 10.1021/ja01053a050; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Cornish-Bowden A, 2010, J PHYS CHEM B, V114, P16209, DOI 10.1021/jp106968p; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Deng LW, 2001, VIROLOGY, V289, P312, DOI 10.1006/viro.2001.1129; Fabris S, 2011, EPIGENETICS-US, V6, P188, DOI 10.4161/epi.6.2.13528; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Garcia BA, 2005, J PROTEOME RES, V4, P2032, DOI 10.1021/pr050188r; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Hedstrom, 2020, ENZYME SPECIFICITY S; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; HUDGIN RL, 1974, J BIOL CHEM, V249, P5536; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang L, 2007, J BIOL CHEM, V282, P27923, DOI 10.1074/jbc.M704194200; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kim SC, 2006, J PROTEOME RES, V5, P3446, DOI 10.1021/pr0603396; Kim Y, 2000, ANAL BIOCHEM, V280, P308, DOI 10.1006/abio.2000.4546; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lau OD, 2000, J BIOL CHEM, V275, P21953, DOI 10.1074/jbc.M003219200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li TT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011080; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Oliver SS, 2011, CHEMBIOCHEM, V12, P299, DOI 10.1002/cbic.201000474; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; RUCHEL R, 1981, BIOCHIM BIOPHYS ACTA, V659, P99, DOI 10.1016/0005-2744(81)90274-6; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Truscott RJW, 2012, EXP EYE RES, V99, P48, DOI 10.1016/j.exer.2012.04.002; Wagner G.R., 2011, J AGING RES, V2011, DOI [DOI 10.4061/2011/234875, 10.4061/2011/234875]; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	54	68	68	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e54896	10.1371/journal.pone.0054896	http://dx.doi.org/10.1371/journal.pone.0054896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437046	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000004
J	Luo, Y; Xu, DQ; Dong, HY; Zhang, B; Liu, Y; Niu, W; Dong, MQ; Li, ZC				Luo, Ying; Xu, Dun-Quan; Dong, Hai-Ying; Zhang, Bo; Liu, Yi; Niu, Wen; Dong, Ming-Qing; Li, Zhi-Chao			Tanshinone IIA Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via Akt/Skp2/p27-Associated Pathway	PLOS ONE			English	Article							SALVIA-MILTIORRHIZA BUNGE; DEPENDENT KINASE INHIBITORS; P27(KIP1); APOPTOSIS; SKP2; HYPERTENSION; EXPRESSION; CANCER; P27; ACTIVATION	We previously showed that tanshinone IIA ameliorated the hypoxia-induced pulmonary hypertension (HPH) partially by attenuating pulmonary artery remodeling. The hypoxia-induced proliferation of pulmonary artery smooth muscle cells (PASMCs) is one of the major causes for pulmonary arterial remodeling, therefore the present study was performed to explore the effects and underlying mechanism of tanshinone IIA on the hypoxia-induced PASMCs proliferation. PASMCs were isolated from male Sprague-Dawley rats and cultured in normoxic (21%) or hypoxic (3%) condition. Cell proliferation was measured with 3-(4, 5-dimethylthiazal-2-yl)-2, 5-diphenyltetrazoliumbromide assay and cell counting. Cell cycle was measured with flow cytometry. The expression of of p27, Skp-2 and the phosphorylation of Akt were measured using western blot and/or RT-PCR respectively. The results showed that tanshinone IIA significantly inhibited the hypoxia-induced PASMCs proliferation in a concentration-dependent manner and arrested the cells in G1/G0-phase. Tanshinone IIA reversed the hypoxia-induced reduction of p27 protein, a cyclin-dependent kinase inhibitor, in PASMCs by slowing down its degradation. Knockdown of p27 with specific siRNA abolished the anti-proliferation of tanshinone IIA. Moreover, tanshinone IIA inhibited the hypoxia-induced increase of S-phase kinase-associated protein 2 (Skp2) and the phosphorylation of Akt, both of which are involved in the degradation of p27 protein. In vivo tanshinone IIA significantly upregulated the hypoxia-induced p27 protein reduction and downregulated the hypoxia-induced Skp2 increase in pulmonary arteries in HPH rats. Therefore, we propose that the inhibition of tanshinone IIA on hypoxia-induce PASMCs proliferation may be due to arresting the cells in G1/G0-phase by slowing down the hypoxia-induced degradation of p27 via Akt/Skp2-associated pathway. The novel information partially explained the anti-remodeling property of tanshinone IIA on pulmonary artery in HPH.	[Luo, Ying; Li, Zhi-Chao] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian 710032, Peoples R China; [Luo, Ying; Xu, Dun-Quan; Dong, Hai-Ying; Zhang, Bo; Liu, Yi; Niu, Wen; Dong, Ming-Qing; Li, Zhi-Chao] Fourth Mil Med Univ, Dept Pathol & Pathophysiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Dong, MQ (corresponding author), Fourth Mil Med Univ, Dept Pathol & Pathophysiol, Xian 710032, Peoples R China.	dongmqxh@fmmu.edu.cn; lizhic@fmmu.edu.cn			National Natural Science Foundation of China [81270328, 81201506, 81072642]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (numbers 81270328, 81201506 and 81072642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek LM, 2010, BIOCHEM BIOPH RES CO, V396, P359, DOI 10.1016/j.bbrc.2010.04.097; Auld CA, 2006, BIOCHEM BIOPH RES CO, V346, P314, DOI 10.1016/j.bbrc.2006.05.117; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Chan P, 2011, AM J CHINESE MED, V39, P381, DOI 10.1142/S0192415X11008890; Chen J, 2012, ONCOL REP, V27, P523, DOI 10.3892/or.2011.1524; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Dai ZK, 2012, J NAT MED-TOKYO, V66, P192, DOI 10.1007/s11418-011-0576-0; Fouty BW, 2001, AM J RESP CELL MOL, V25, P652, DOI 10.1165/ajrcmb.25.5.4592; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hong HJ, 2010, ACTA PHARMACOL SIN, V31, P1569, DOI 10.1038/aps.2010.176; Hu L, 2009, CANCER RES, V69, P3374, DOI 10.1158/0008-5472.CAN-08-4290; Huang YF, 2009, J ETHNOPHARMACOL, V125, P436, DOI 10.1016/j.jep.2009.07.020; Jin UH, 2008, J CELL BIOCHEM, V104, P15, DOI 10.1002/jcb.21599; Kotoshiba Shuhei, 2005, Nihon Rinsho, V63, P2047; Li FL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/927658; Li Xin, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2146; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu W, 2002, AM J PATHOL, V160, P511, DOI 10.1016/S0002-9440(10)64870-5; Miyamoto T, 2010, GYNECOL ENDOCRINOL, V26, P220, DOI [10.1080/09513590903215482, 10.3109/09513590903215482]; Pak O, 2007, EUR RESPIR J, V30, P364, DOI 10.1183/09031936.00128706; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sung HJ, 1999, EXP MOL MED, V31, P174, DOI 10.1038/emm.1999.28; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Ungermannova D, 2005, J BIOL CHEM, V280, P30301, DOI 10.1074/jbc.M411103200; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wang J, 2012, AM J RESP CELL MOL B; Wang J, 2010, EUR J PHARMACOL, V640, P129, DOI 10.1016/j.ejphar.2010.04.047; Won SH, 2012, PHYTOTHER RES, V26, P669, DOI 10.1002/ptr.3616; Won SH, 2010, BIOL PHARM BULL, V33, P1828, DOI 10.1248/bpb.33.1828; Wu YJ, 2009, J VASC SURG, V50, P1135, DOI 10.1016/j.jvs.2009.07.066; Yi Bin, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P586; Yu LY, 2006, BIOCHEM BIOPH RES CO, V345, P1565, DOI 10.1016/j.bbrc.2006.05.060; Yu LY, 2005, CIRC RES, V97, P937, DOI 10.1161/01.RES.0000188211.83193.1a; Zakynthinos E, 2011, CURR DRUG TARGETS, V12, P501, DOI 10.2174/138945011794751483; Zhang Y, 2012, ANTI-CANCER DRUG, V23, P212, DOI 10.1097/CAD.0b013e32834e5592; Zhou LL, 2008, LIFE SCI, V83, P394, DOI 10.1016/j.lfs.2008.07.011; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	43	40	47	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56774	10.1371/journal.pone.0056774	http://dx.doi.org/10.1371/journal.pone.0056774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437233	gold, Green Submitted, Green Published			2022-12-27	WOS:000315186000045
J	Moncada, X; Payacan, C; Arriaza, F; Lobos, S; Seelenfreund, D; Seelenfreund, A				Moncada, Ximena; Payacan, Claudia; Arriaza, Francisco; Lobos, Sergio; Seelenfreund, Daniela; Seelenfreund, Andrea			DNA Extraction and Amplification from Contemporary Polynesian Bark-Cloth	PLOS ONE			English	Article							WOOD	Background: Paper mulberry has been used for thousands of years in Asia and Oceania for making paper and bark-cloth, respectively. Museums around the world hold valuable collections of Polynesian bark-cloth. Genetic analysis of the plant fibers from which the textiles were made may answer a number of questions of interest related to provenance, authenticity or species used in the manufacture of these textiles. Recovery of nucleic acids from paper mulberry bark-cloth has not been reported before. Methodology: We describe a simple method for the extraction of PCR-amplifiable DNA from small samples of contemporary Polynesian bark- cloth (tapa) using two types of nuclear markers. We report the amplification of about 300 bp sequences of the ITS1 region and of a microsatellite marker. Conclusions: Sufficient DNA was retrieved from all bark-cloth samples to permit successful PCR amplification. This method shows a means of obtaining useful genetic information from modern bark-cloth samples and opens perspectives for the analyses of small fragments derived from ethnographic materials.	[Moncada, Ximena] CEAZA, La Serena, Chile; [Payacan, Claudia; Arriaza, Francisco; Lobos, Sergio; Seelenfreund, Daniela] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Seelenfreund, Andrea] Univ Acad Humanismo Cristiano, Escuela Antropol, Area Ciencias Sociales, Santiago, Chile	Universidad de Chile; Universidad Academia de Humanismo Cristiano	Seelenfreund, D (corresponding author), Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile.	dseelen@ciq.uchile.cl			FONDECYT grant from the Government of Chile (CONICYT) [1120175]	FONDECYT grant from the Government of Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	FONDECYT grant 1120175 from the Government of Chile (CONICYT) (http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; Barker Christine, 2002, Curtis's Botanical Magazine, V19, P8, DOI 10.1111/1467-8748.00324; Bell L. A., 1988, PAPYRUS TAPA AMATE R; Blattner FR, 1999, BIOTECHNIQUES, V27, P1180, DOI 10.2144/99276st04; Borges DB, 2012, GENET MOL RES, V11, P1586, DOI 10.4238/2012.May.22.8; Brown, 1996, OCEANIC CULTURE HIST, P117; Colchester Chloe, 2003, CLOTHING PACIFIC; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Green RC, 1979, EXPLORING VISUAL ART, P13; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartnup K, 2011, MOL BIOL EVOL, V28, P2741, DOI 10.1093/molbev/msr107; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Howard M, 2006, STUDIES MAT CULTURES, V10; Kennedy R, 1934, J POLYNESIAN SOC, V43, P229; Kooijman S., 1988, POLYNESIAN BARKCLOTH; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Metraux A, 1971, BERNICE BISHOP MUSEU, V160; OHanlon M., 2005, ART CLOTHING PACIFIC, P61; Olsen ME, 2012, ANN ANAT, V194, P31, DOI 10.1016/j.aanat.2011.03.003; Prebble M, 2008, TERRA AUSTRALIS, V29, P227; Rachmayanti Y, 2009, FORENSIC SCI INT-GEN, V3, P185, DOI 10.1016/j.fsigen.2009.01.002; Schlumbaum A, 2008, VEG HIST ARCHAEOBOT, V17, P233, DOI 10.1007/s00334-007-0125-7; Seelenfreund D, 2011, NEW ZEAL J BOT, V49, P413, DOI 10.1080/0028825X.2011.579135; Seelenfreund D, 2010, NEW ZEAL J BOT, V48, P1; Speirs AK, 2009, TERRA AUSTRALIS, V30, P175; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varma Astha, 2007, Biotechnology Journal, V2, P386, DOI 10.1002/biot.200600195; Vuissoz A, 2007, J ARCHAEOL SCI, V34, P823, DOI 10.1016/j.jas.2006.09.002; Zhao WG, 2005, PLANT SCI, V168, P519, DOI 10.1016/j.plantsci.2004.09.020	31	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56549	10.1371/journal.pone.0056549	http://dx.doi.org/10.1371/journal.pone.0056549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437166	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000031
J	Park, CY; Kim, HS; Jang, J; Lee, H; Lee, JS; Yoo, JE; Lee, DR; Kim, DW				Park, Chul-Yong; Kim, Han-Soo; Jang, Jiho; Lee, Hyunji; Lee, Jae Souk; Yoo, Jeong-Eun; Lee, Dongjin R.; Kim, Dong-Wook			ABCD2 Is a Direct Target of beta-Catenin and TCF-4: Implications for X- Linked Adrenoleukodystrophy Therapy	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; WNT/BETA-CATENIN; SKIN FIBROBLASTS; GENE-THERAPY; EXPRESSION; LOVASTATIN; PROTEIN; ACTIVATION; ALD; METABOLISM	X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder caused by mutations in the ABCD1 gene that encodes the peroxisomal ATP-binding cassette (ABC) transporter subfamily D member 1 protein (ABCD1), which is referred to as the adrenoleukodystrophy protein (ALDP). Induction of the ABCD2 gene, the closest homolog of ABCD1, has been mentioned as a possible therapeutic option for the defective ABCD1 protein in X-ALD. However, little is known about the transcriptional regulation of ABCD2 gene expression. Here, through in silico analysis, we found two putative TCF-4 binding elements between nucleotide positions -360 and -260 of the promoter region of the ABCD2 gene. The transcriptional activity of the ABCD2 promoter was strongly increased by ectopic expression of beta-catenin and TCF-4. In addition, mutation of either or both TCF-4 binding elements by site-directed mutagenesis decreased promoter activity. This was further validated by the finding that beta-catenin and the promoter of the ABCD2 gene were pulled down with a beta-catenin antibody in a chromatin immunoprecipitation assay. Moreover, real-time PCR analysis revealed that beta-catenin and TCF-4 increased mRNA levels of ABCD2 in both a hepatocellular carcinoma cell line and primary fibroblasts from an X-ALD patient. Interestingly, we found that the levels of very long chain fatty acids were decreased by ectopic expression of ABCD2-GFP as well as beta-catenin and TCF-4. Taken together, our results demonstrate for the first time the direct regulation of ABCD2 by beta-catenin and TCF-4.	[Park, Chul-Yong; Jang, Jiho; Lee, Hyunji; Lee, Jae Souk; Yoo, Jeong-Eun; Lee, Dongjin R.; Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Park, Chul-Yong; Jang, Jiho; Lee, Hyunji; Lee, Jae Souk; Yoo, Jeong-Eun; Lee, Dongjin R.; Kim, Dong-Wook] Yonsei Univ, Coll Med, Severance Biomed Res Inst, Seoul, South Korea; [Kim, Han-Soo] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Han-Soo] Yonsei Univ, Coll Med, Cell Therapy Ctr, Seoul, South Korea; [Lee, Jae Souk; Yoo, Jeong-Eun; Lee, Dongjin R.; Kim, Dong-Wook] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, DW (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea.	dwkim2@yuhs.ac			National Research Foundation; Korean Ministry of Education, Science and Technology (the Bio & Medical Technology Development Program) [2012M3A9B4028631, 2012M3A9C7050126]; Korea Health technology R&D Project, Korean Ministry of Health Welfare [A120254, A100694]	National Research Foundation; Korean Ministry of Education, Science and Technology (the Bio & Medical Technology Development Program); Korea Health technology R&D Project, Korean Ministry of Health Welfare	This research was supported by grants from the National Research Foundation, Korean Ministry of Education, Science and Technology (the Bio & Medical Technology Development Program, 2012M3A9B4028631 and 2012M3A9C7050126), Korea Health technology R&D Project, Korean Ministry of Health & Welfare (A120254 and A100694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; AUBOURG P, 1993, NEW ENGL J MED, V329, P745, DOI 10.1056/NEJM199309093291101; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Engelen M, 2010, NEW ENGL J MED, V362, P276, DOI 10.1056/NEJMc0907735; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; Fourcade S, 2001, EUR J BIOCHEM, V268, P3490, DOI 10.1046/j.1432-1327.2001.02249.x; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; Kemp S, 2010, BRAIN PATHOL, V20, P831, DOI 10.1111/j.1750-3639.2010.00391.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morita M, 2011, CURR DRUG TARGETS, V12, P694, DOI 10.2174/138945011795378577; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421; MOSER HW, 1980, ANN NEUROL, V7, P542, DOI 10.1002/ana.410070607; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pai GS, 2000, MOL GENET METAB, V69, P312; Paik MJ, 2001, J CHROMATOGR B, V760, P149, DOI 10.1016/S0378-4347(01)00263-8; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Pujol A, 2000, GENOMICS, V70, P131, DOI 10.1006/geno.2000.6367; Pulukuri SMK, 2007, J BIOL CHEM, V282, P35594, DOI 10.1074/jbc.M705867200; Singh I, 1998, FEBS LETT, V426, P342, DOI 10.1016/S0014-5793(98)00370-6; Singh I, 1998, NEW ENGL J MED, V339, P702, DOI 10.1056/NEJM199809033391012; Singh I, 2010, BRAIN PATHOL, V20, P838, DOI 10.1111/j.1750-3639.2010.00392.x; Singh J, 2011, J LIPID RES, V52, P2056, DOI 10.1194/jlr.M017491; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Weinhofer I, 2005, J BIOL CHEM, V280, P41243, DOI 10.1074/jbc.M509450200; Weinhofer I, 2002, HUM MOL GENET, V11, P2701, DOI 10.1093/hmg/11.22.2701; Weinhofer I, 2008, EUR J CELL BIOL, V87, P933, DOI 10.1016/j.ejcb.2008.08.002	45	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56242	10.1371/journal.pone.0056242	http://dx.doi.org/10.1371/journal.pone.0056242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437103	gold, Green Submitted, Green Published			2022-12-27	WOS:000315186000020
J	Wong, KFE; Cheng, C				Wong, Kin Fai Ellick; Cheng, Cecilia			Predictable or Not? Individuals' Risk Decisions Do Not Necessarily Predict Their Next Ones	PLOS ONE			English	Article							FREE WILL; BEHAVIOR	This research examines the extent to which people may be free to make choices by testing their consistency in choosing risk options. In two experiments, participants were instructed to make the "same" type of risk decisions repeatedly. Experiment 1 showed that when the information for decision is positively framed in terms of gain, the participant's choice in a particular decision could not be predicted by his or her choice in another decision (R(2)s<.02). Experiment 2 showed a statistically significant predictability when the information is negatively framed in terms of loss, although the predictability was still very low (R(2)s<.07). These findings indicate the existence of a large room of variations in which a person may freely choose.	[Wong, Kin Fai Ellick] Hong Kong Univ Sci & Technol, Dept Management, Hong Kong, Hong Kong, Peoples R China; [Cheng, Cecilia] Univ Hong Kong, Dept Psychol, Pokfulam, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; University of Hong Kong	Cheng, C (corresponding author), Univ Hong Kong, Dept Psychol, Pokfulam, Hong Kong, Peoples R China.	ceccheng@hku.hk		Cheng, Cecilia/0000-0002-7250-2224; Wong, Kin Fai Ellick/0000-0002-7887-8732	Hong Kong Government; Hong Kong Research Grants Council's General Research Fund [742810, 643509]; Seed Funding Programme for Basic Research [201011159109]	Hong Kong Government; Hong Kong Research Grants Council's General Research Fund; Seed Funding Programme for Basic Research	Funded by Hong Kong Government. Preparation of this article was supported by the Hong Kong Research Grants Council's General Research Fund (742810) and Seed Funding Programme for Basic Research (201011159109) to CC, and by the Hong Kong Research Grants Council's General Research Fund (643509) awarded to KFEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister RF, 2011, ANNU REV PSYCHOL, V62, P331, DOI 10.1146/annurev.psych.093008.131126; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Brembs B, 2011, P ROY SOC B-BIOL SCI, V278, P930, DOI 10.1098/rspb.2010.2325; Cashmore AR, 2010, P NATL ACAD SCI USA, V107, P4499, DOI 10.1073/pnas.0915161107; Haggard P, 2011, NEURON, V69, P404, DOI 10.1016/j.neuron.2011.01.028; Heisenberg M, 2009, NATURE, V459, P164, DOI 10.1038/459164a; Heisenberg W., 1927, Z PHYS, V43, P172; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Mele AR, 2010, NEUROETHICS-NETH, V3, P161, DOI 10.1007/s12152-008-9027-3; Nichols S, 2011, SCIENCE, V331, P1401, DOI 10.1126/science.1192931; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Searle J., 1984, MINDS BRAINS SCI; Searle John Rogers, 2007, FREEDOM NEUROBIOLOGY; TAYLOR C, 2002, OXFORD HDB FREE WILL, P257; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Wegner DM, 2002, BRADFORD BOOKS, P1	18	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56811	10.1371/journal.pone.0056811	http://dx.doi.org/10.1371/journal.pone.0056811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437248	gold, Green Published			2022-12-27	WOS:000315186000049
J	Adzemovic, MZ; Zeitelhofer, M; Eriksson, U; Olsson, T; Nilsson, I				Adzemovic, Milena Z.; Zeitelhofer, Manuel; Eriksson, Ulf; Olsson, Tomas; Nilsson, Ingrid			Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TISSUE-PLASMINOGEN ACTIVATOR; PDGF-CC; CELLS; MICE; CHEMOKINES; DISORDERS; INDUCTION	Central nervous system (CNS) disorders such as ischemic stroke, multiple sclerosis (MS) or Alzheimers disease are characterized by the loss of blood-brain barrier (BBB) integrity. Here we demonstrate that the small tyrosine kinase inhibitor imatinib enhances BBB integrity in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis (MS). Treatment was accompanied by decreased CNS inflammation and demyelination and especially reduced T-cell recruitment. This was supported by downregulation of the chemokine receptor (CCR) 2 in CNS and lymph nodes, and by modulation of the peripheral immune response towards an anti-inflammatory phenotype. Interestingly, imatinib ameliorated neuroinflammation, even when the treatment was initiated after the clinical manifestation of the disease. We have previously shown that imatinib reduces BBB disruption and stroke volume after experimentally induced ischemic stroke by targeting platelet-derived growth factor receptor -alpha (PDGFR-alpha) signaling. Here we demonstrate that PDGFR-alpha signaling is a central regulator of BBB integrity during neuroinflammation and therefore imatinib should be considered as a potentially effective treatment for MS.	[Adzemovic, Milena Z.; Zeitelhofer, Manuel; Olsson, Tomas] Karolinska Inst, Ctr Mol Med, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden; [Eriksson, Ulf; Nilsson, Ingrid] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Olsson, T (corresponding author), Karolinska Inst, Ctr Mol Med, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden.	tomas.olsson@ki.se; ingrid.nilsson@ki.se		Zeitelhofer, Manuel/0000-0002-4324-2355; Olsson, Tomas/0000-0002-2938-1877	NHR Foundation; Wenner-Gren Fellowship; Soderberg's Foundation; AFA Foundation; Knut and Alice Wallenberg's Foundation; Swedish Research Council; LeDucq Foundation; Swedish Brain Foundation; Hallsten's Research Foundation; Swedish Agency for Innovation Systems (VINNOVA); Swedish Cancer Foundation; Swedish Stroke Foundation; Royal Swedish Agency; Magnus Bergwall's Foundation; Karolinska Institute	NHR Foundation; Wenner-Gren Fellowship; Soderberg's Foundation; AFA Foundation; Knut and Alice Wallenberg's Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); LeDucq Foundation(Leducq Foundation); Swedish Brain Foundation; Hallsten's Research Foundation; Swedish Agency for Innovation Systems (VINNOVA)(Vinnova); Swedish Cancer Foundation; Swedish Stroke Foundation; Royal Swedish Agency; Magnus Bergwall's Foundation; Karolinska Institute(Karolinska Institutet)	This study was supported by the NHR Foundation (MZA, MZ), Wenner-Gren Fellowship (MZ), Soderberg's Foundation (TO), AFA Foundation (TO), Knut and Alice Wallenberg's Foundation (TO), Swedish Research Council (TO, UE, IN), LeDucq Foundation (UE), Swedish Brain Foundation and Hallsten's Research Foundation (UE), the Swedish Agency for Innovation Systems (VINNOVA) (UE), the Swedish Cancer Foundation (UE), Swedish Stroke Foundation (IN), Royal Swedish Agency (IN), Magnus Bergwall's Foundation (IN) and Karolinska Institute (IN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Adzemovic MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039794; AMOR S, 1994, J IMMUNOL, V153, P4349; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Bradl M, 2005, AM J PATHOL, V166, P1441, DOI 10.1016/S0002-9440(10)62361-9; Couturier N, 2008, J NEUROIMMUNOL, V195, P176, DOI 10.1016/j.jneuroim.2008.01.017; Crespo O, 2011, J CLIN IMMUNOL, V31, P1010, DOI 10.1007/s10875-011-9579-6; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Hirase T, 1997, J CELL SCI, V110, P1603; Hochmeister S, 2006, J NEUROPATH EXP NEUR, V65, P855, DOI 10.1097/01.jnen.0000235119.52311.16; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Vermersch P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-36; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	36	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56586	10.1371/journal.pone.0056586	http://dx.doi.org/10.1371/journal.pone.0056586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437178	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200114
J	Astell-Burt, T; Feng, XQ				Astell-Burt, Thomas; Feng, Xiaoqi			Health and the 2008 Economic Recession: Evidence from the United Kingdom	PLOS ONE			English	Article							SELF-RATED HEALTH; MORTALITY; UNEMPLOYMENT; INEQUALITIES; CRISES; WOMEN; MEN; BAD	Introduction: The economic recession which began in 2008 has resulted in a substantial increase in unemployment across many countries, including the United Kingdom. Strong association between unemployment and poor health status among individuals is widely recognised. We investigated whether the prevalence of poor health at a population level increased concurrent to the rise in unemployment during the economic recession, and whether the impact on health varied by geographical and socioeconomic circumstances. Method: Health, demographic and socioeconomic measures on 1.36 million survey responses aged 16-64 were extracted from the Quarterly Labour Force Survey of the United Kingdom, collected every three months, from January 2006 to December 2010. The likelihood of self-reporting poor health status and specific types of health problems (depression, mental illness, cardiovascular and respiratory) across time were estimated separately using logistic regression. Explanatory variables included economic status (International Labour Organization definition), occupational class, age, gender, country of birth, ethnicity, educational qualifications, couple status, household tenure, number of dependents, and geographical region. Results: Unemployment (age-gender adjusted) rose from 4.5% in January 2008 to 7.1% by September 2009. The reporting of poor health status increased from 25.7% in July 2009 to 29.5% by December 2010. Similar increases were found for cardiovascular and respiratory health problems; not depression or mental illness. The prevalence of poor health status among the unemployed decreased from 28.8% in July 2008, to 24.9% by March 2009; but this was followed by an increase in poor health experienced across all regions and by all socioeconomic groups, including those who remained employed, regardless of their occupational class. Interpretation: Although our study found no exacerbation of pre-recession health inequalities, the rise in poor health status not only for the unemployed, but also among people who remained employed, regardless of their occupational class, justifies concern voiced among many public health commentators.	[Astell-Burt, Thomas] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [Feng, Xiaoqi] Univ Western Sydney, Ctr Hlth Res, Sch Med, Sydney, NSW, Australia; [Astell-Burt, Thomas; Feng, Xiaoqi] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland	Western Sydney University; Western Sydney University; University of St Andrews	Astell-Burt, T (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia.	T.Astell-Burt@uws.edu.au	Astell-Burt, Thomas/B-9341-2018; Feng, Xiaoqi/AAM-9592-2021	Astell-Burt, Thomas/0000-0002-1498-4851; Feng, Xiaoqi/0000-0002-3421-220X				Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Bartley M, 2004, J EPIDEMIOL COMMUN H, V58, P501, DOI 10.1136/jech.2003.009878; Bartley M, 2010, J EPIDEMIOL COMMUN H, V64, P5, DOI 10.1136/jech.2009.089797; Bockerman P, 2007, HEALTH ECON, V16, P103, DOI 10.1002/hec.1156; Brenner MH, 2005, INT J EPIDEMIOL, V34, P1214, DOI 10.1093/ije/dyi146; CATALANO R, 1991, AM J PUBLIC HEALTH, V81, P1148, DOI 10.2105/AJPH.81.9.1148; Catalano R, 2011, ANNU REV PUBL HEALTH, V32, P431, DOI 10.1146/annurev-publhealth-031210-101146; Catalano R, 2009, NEW ENGL J MED, V360, P749, DOI 10.1056/NEJMp0809122; Christian LM, 2011, PSYCHONEUROENDOCRINO, V36, P1495, DOI 10.1016/j.psyneuen.2011.04.003; Dorling D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b829; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P450, DOI 10.1136/jech.56.6.450; Gerdtham UG, 2005, SOC SCI MED, V60, P205, DOI 10.1016/j.socscimed.2004.05.004; Gregg P, 2010, NATL INST ECON REV, V212, pR61, DOI 10.1177/0027950110372445; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; International Labour Organisation (ILO), 2012, EMPL UN; Kaplan GA, 2012, SOC SCI MED, V74, P643, DOI 10.1016/j.socscimed.2011.12.013; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Khang YH, 2005, INT J EPIDEMIOL, V34, P1291, DOI 10.1093/ije/dyi224; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Marmot M, 2004, STATUS SYNDROME; Marmot M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1314; Marmot Review, 2010, FAIR SOC HLTH LIV ST; Martikainen PT, 1996, LANCET, V348, P909, DOI 10.1016/S0140-6736(96)03291-6; Neumayer E, 2004, SOC SCI MED, V58, P1037, DOI 10.1016/S0277-9536(03)00276-4; Office for National Statistics, 2012, NAT STAT SOC CLASS; [Office for National Statistics Social and Vital Statistics Division and Northern Ireland Statistics and Research Agency. Central Survey Unit], 2011, SOC VIT STAT DIV NO; Rugulies R, 2010, J EPIDEMIOL COMMUN H, V64, P75, DOI 10.1136/jech.2008.078493; Ruhm CJ, 1995, J HEALTH ECON, V14, P583, DOI 10.1016/0167-6296(95)00024-0; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2005, J HEALTH ECON, V24, P341, DOI 10.1016/j.jhealeco.2004.09.007; Ruhm CJ, 2002, J HEALTH ECON, V21, P659, DOI 10.1016/S0167-6296(02)00033-4; SHAPIRO C, 1984, AM ECON REV, V74, P433; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Suhrcke M, 2012, SOC SCI MED, V74, P647, DOI 10.1016/j.socscimed.2011.12.011; Valkonen T, 2000, EUR J PUBLIC HEALTH, V10, P274, DOI 10.1093/eurpub/10.4.274	36	51	52	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56674	10.1371/journal.pone.0056674	http://dx.doi.org/10.1371/journal.pone.0056674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437208	Green Published, gold			2022-12-27	WOS:000315184200138
J	Dorner, J; Struck, R; Zimmer, S; Peigney, C; Duerr, GD; Dewald, O; Kim, SC; Malan, D; Bettinger, T; Nickenig, G; Ghanem, A				Doerner, Jonas; Struck, Rafael; Zimmer, Sebastian; Peigney, Christine; Duerr, Georg Daniel; Dewald, Oliver; Kim, Se-Chan; Malan, Daniela; Bettinger, Thierry; Nickenig, Georg; Ghanem, Alexander			Ultrasound-Mediated Stimulation of Microbubbles after Acute Myocardial Infarction and Reperfusion Ameliorates Left-Ventricular Remodelling in Mice via Improvement of Borderzone Vascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; 3-DIMENSIONAL ECHOCARDIOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; IN-VITRO; ANGIOGENESIS; DELIVERY; INJURY; SURVIVAL; THERAPY	Aims: Post-infarction remodelling (PIR) determines left-ventricular (LV) function and prognosis after myocardial infarction. The aim of this study was to evaluate transthoracic ultrasound-mediated microbubble stimulation (UMS) as a novel gene- and cell-free therapeutic option after acute myocardial infarction and reperfusion (AMI/R) in mice. Methods and Results: For myocardial delivery of UMS, a novel therapeutic ultrasound-system (TIPS, Philips Medical) and commercially available microbubbles (BR1, Bracco Suisse SA) were utilized in a closed-chest mouse model. UMS was performed as myocardial post-conditioning (PC) on day four after 30 minutes of coronary occlusion and reperfusion. LV-morphology, as well as global and regional function were measured repeatedly with reconstructive 3-dimensional echocardiography applying an additional low-dose dobutamine protocol after two weeks. Scar size was quantified by means of histomorphometry. A total of 41 mice were investigated; 17 received PC with UMS. Mean ejection fraction (EF) prior UMS was similar in both groups 53%+/- 10 (w/o UMS) and 53%+/- 14 (UMS, p = 0.5), reflecting comparable myocardial mass at risk 17% +/- 8 (w/o UMS), 16%+/- 13 (UMS, p = 0.5). Two weeks after AMI/R, mice undergoing UMS demonstrated significantly better global LV-function (EF = 53% 67) as compared to the group without PC (EF = 39% +/- 11, p<0.01). The fraction of akinetic myocardial mass was significantly lower among mice undergoing UMS after AMI/R [27% +/- 10 (w/o UMS), 13% 68 (UMS), p<0.001)]. Our experiments showed a fast onset of transient, UMS-induced upregulation of vascular-endothelial and insulin-like growth factor (VEGF-a, IGF-1), as well as caveolin-3 (Cav-3). The mice undergoing PC with UMS after AMI/R showed a significantly lower scar size. In addition, the microvascular density was significantly higher in the borderzone of UMS-treated animals. Conclusion: UMS following AMI/R ameliorates PIR in mice via up-regulation of VEGF-a, IGF-1 and Cav-3, and consecutive improvement of myocardial borderzone vascularization.	[Doerner, Jonas; Struck, Rafael; Zimmer, Sebastian; Nickenig, Georg; Ghanem, Alexander] Univ Bonn, Dept Med Cardiol, Bonn, Germany; [Peigney, Christine; Duerr, Georg Daniel; Dewald, Oliver] Univ Clin Ctr Bonn, Dept Cardiac Surg, Bonn, Germany; [Kim, Se-Chan] Univ Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany; [Malan, Daniela] Univ Bonn, Inst Physiol 1, D-53115 Bonn, Germany; [Bettinger, Thierry] Bracco Suisse SA, Geneva Res Ctr, Plan Les Ouates, Switzerland	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Bracco	Ghanem, A (corresponding author), Univ Bonn, Dept Med Cardiol, Bonn, Germany.	ghanem@uni-bonn.de	Duerr, Georg Daniel/ABE-4511-2020	Duerr, Georg Daniel/0000-0002-0310-6236; Kim, Se-Chan/0000-0003-3456-5440	BONFOR (Intramural research foundation of the University of Bonn); German Heart Foundation	BONFOR (Intramural research foundation of the University of Bonn); German Heart Foundation	J.D. and A.G. were supported by BONFOR (Intramural research foundation of the University of Bonn). A.G. was supported by the German Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian R, 2007, ULTRASOUND MED BIOL, V33, P1592, DOI 10.1016/j.ultrasmedbio.2007.05.003; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143; Dawson D, 2004, CIRCULATION, V110, P1632, DOI 10.1161/01.CIR.0000142049.14227.AD; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Fujii H, 2009, JACC-CARDIOVASC IMAG, V2, P869, DOI 10.1016/j.jcmg.2009.04.008; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; GAUDRON P, 1993, CIRCULATION, V87, P755, DOI 10.1161/01.CIR.87.3.755; Ghanem A, 2008, ULTRASOUND MED BIOL, V34, P559, DOI 10.1016/j.ultrasmedbio.2007.09.013; Ghanem A, 2006, ECHOCARDIOGR-J CARD, V23, P900, DOI 10.1111/j.1540-8175.2006.00323.x; Ghanem A, 2011, CELL TRANSPLANT, V20, P1621, DOI 10.3727/096368910X564049; Ghanem A, 2009, CELL TRANSPLANT, V18, P1289, DOI 10.3727/096368909X12483162197286; Ghanem A, 2009, J MOL CELL CARDIOL, V47, P411, DOI 10.1016/j.yjmcc.2009.06.008; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Kim SC, 2012, JOVE-J VIS EXP, DOI 10.3791/3896; Kuntz-Hehner S, 2001, RADIOLOGY, V220, P647, DOI 10.1148/radiol.2203001628; Miller DL, 2006, J AM COLL CARDIOL, V47, P1464, DOI 10.1016/j.jacc.2005.09.078; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rosano Jenna M, 2012, Cardiovasc Eng Technol, V3, P237; SCHNEIDER M, 1995, INVEST RADIOL, V30, P451, DOI 10.1097/00004424-199508000-00001; Seip R, 2010, IEEE T BIO-MED ENG, V57, P61, DOI 10.1109/TBME.2009.2028874; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Swanson SD, 2006, MAGN RESON IMAGING, V24, P603, DOI 10.1016/j.mri.2005.12.014; Taniyama Y, 2002, CIRCULATION, V105, P1233, DOI 10.1161/hc1002.105228; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Vancraeynest D, 2006, EUR HEART J, V27, P237, DOI 10.1093/eurheartj/ehi479; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Yau TM, 2005, CIRCULATION, V112, pI123, DOI 10.1161/CIRCULATIONAHA.104.525147; Zarnitsyn VG, 2004, ULTRASOUND MED BIOL, V30, P527, DOI 10.1016/j.ultrasmedbio.2004.01.008; Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565	37	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56841	10.1371/journal.pone.0056841	http://dx.doi.org/10.1371/journal.pone.0056841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437254	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200170
J	Helbig, A; Kaasen, A; Malt, UF; Haugen, G				Helbig, Anne; Kaasen, Anne; Malt, Ulrik Fredrik; Haugen, Guttorm			Does Antenatal Maternal Psychological Distress Affect Placental Circulation in the Third Trimester?	PLOS ONE			English	Article							VEIN BLOOD-FLOW; GENERAL HEALTH QUESTIONNAIRE; UMBILICAL VEIN; UTERINE ARTERY; EVENT SCALE; VENOUS FLOW; PREGNANCY; STRESS; GROWTH; ANXIETY	Introduction: Some types of antenatal maternal psychological distress may be associated with reduced fetal growth and birthweight. A stress-mediated reduction in placental blood flow has been suggested as a mechanism. Previous studies have examined this using ultrasound-derived arterial resistance measures in the uterine (UtA) and umbilical (UA) arteries, with mixed conclusions. However, a reduction in placental volume blood flow may occur before changes in arterial resistance measures are seen. Fetoplacental volume blood flow can be quantified non-invasively in the umbilical vein (UV). Our objective was to study whether specific types of maternal psychological distress affect the placental circulation, using volume blood flow quantification in addition to arterial resistance measures. Methods: This was a prospective observational study of 104 non-smoking pregnant women (gestational age 30 weeks) with uncomplicated obstetric histories. Psychological distress was measured by General Health Questionnaire-28 (subscales anxiety and depression) and Impact of Event Scale-22 (subscales intrusion, avoidance and arousal). UtA and UA resistance measures and UV volume blood flow normalized for fetal abdominal circumference, were obtained by Doppler ultrasound. Results: IES intrusion scores above the mean were associated with a reduction in normalized UV volume blood flow (corresponding to -0.61 SD; P = 0.003). Adjusting for UA resistance increased the strength of this association (difference -0.66 SD; P<0.001). Other distress types were not associated with UV volume blood flow. Maternal distress was not associated with arterial resistance measures, despite adjustment for confounders. Conclusions: Intrusive thoughts and emotional distress regarding the fetus were associated with reduced fetoplacental volume blood flow in third trimester. Uterine and umbilical artery resistance measures were not associated with maternal distress. Our findings support a decrease in fetoplacental blood flow as a possible pathway between maternal distress and reduced fetal growth.	[Helbig, Anne; Kaasen, Anne] Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway; [Helbig, Anne; Haugen, Guttorm] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Kaasen, Anne] Oslo & Akershus Univ Coll Appl Sci, Dept Hlth Nutr & Management, Oslo, Norway; [Malt, Ulrik Fredrik] Oslo Univ Hosp, Dept Neuropsychiat & Psychosomat Med, Oslo, Norway; [Malt, Ulrik Fredrik; Haugen, Guttorm] Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway	University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Helbig, A (corresponding author), Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway.	helbig@frisurf.no	Kaasen, Anne/ABE-1562-2020	Kaasen, Anne/0000-0001-9291-0105; Malt, Ulrik/0000-0002-9881-2511	Norwegian Resource Centre for Women's Health; Norwegian Women's Public Health Association	Norwegian Resource Centre for Women's Health; Norwegian Women's Public Health Association	This study was financially supported by the Norwegian Resource Centre for Women's Health(http://www.oslo-universitetssykehus.no/omoss/avdelinger/kvinnehelse/Sider/enhet.aspx) and the Norwegian Women's Public Health Association (http://www.sanitetskvinnene.no/filestore/N.K.S.Hovedbrosjyre_Engelsk_Korr3.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2005, PRENATAL DIAG, V25, P99, DOI 10.1002/pd.1091; Acharya G, 2004, AM J PHYSIOL-HEART C, V286, pH1266, DOI 10.1152/ajpheart.00523.2003; Barbera A, 1999, AM J OBSTET GYNECOL, V181, P174, DOI 10.1016/S0002-9378(99)70456-4; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Di Naro E, 2002, ACTA OBSTET GYN SCAN, V81, P527, DOI 10.1034/j.1600-0412.2002.810609.x; DiPietro JA, 2012, J ADOLESCENT HEALTH, V51, pS3, DOI 10.1016/j.jadohealth.2012.04.008; Dunkel Schetter C., 2011, HDB HLTH PSYCHOL, P431; Ebbing C, 2011, ULTRASOUND OBST GYN, V38, P303, DOI 10.1002/uog.9046; Eid J, 2009, NORD J PSYCHIAT, V63, P426, DOI 10.1080/08039480903118190; GILL R W, 1979, Ultrasound in Medicine and Biology, V5, P223, DOI 10.1016/0301-5629(79)90014-0; GILL RW, 1984, ULTRASOUND MED BIOL, V10, P349, DOI 10.1016/0301-5629(84)90169-8; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; HARRINGTON KF, 1991, EUR J OBSTET GYN R B, V42, pS14; Harville EW, 2008, ULTRASOUND OBST GYN, V32, P23, DOI 10.1002/uog.5344; Helbig A, 2011, BJOG-INT J OBSTET GY, V118, P1653, DOI 10.1111/j.1471-0528.2011.03155.x; Henrichs J, 2010, PSYCHOL MED, V40, P633, DOI 10.1017/S0033291709990894; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; Kaasen A, 2010, BJOG-INT J OBSTET GY, V117, P1127, DOI 10.1111/j.1471-0528.2010.02622.x; Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d; Kiserud T, 1998, ULTRASOUND OBST GYN, V11, P419, DOI 10.1046/j.1469-0705.1998.11060419.x; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Lees C, 1999, ULTRASOUND OBST GYN, V14, P250, DOI 10.1046/j.1469-0705.1999.14040250.x; Littleton HL, 2010, J PSYCHOSOM OBST GYN, V31, P219, DOI 10.3109/0167482X.2010.518776; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; Ohman SG, 2004, ACTA OBSTET GYN SCAN, V83, P634; Rigano S, 2001, AM J OBSTET GYNECOL, V185, P834, DOI 10.1067/mob.2001.117356; Rizzo G, 2008, ULTRASOUND OBST GYN, V32, P155, DOI 10.1002/uog.5389; Roesch SC, 2004, ANXIETY STRESS COPIN, V17, P87, DOI 10.1080/1061580031000123667; Salvesen KA, 1997, ULTRASOUND OBST GYN, V9, P80, DOI 10.1046/j.1469-0705.1997.09020080.x; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Sjostrom K, 1997, EUR J OBSTET GYN R B, V74, P149, DOI 10.1016/S0301-2115(97)00100-0; Skari H, 2002, BJOG-INT J OBSTET GY, V109, P1154, DOI 10.1111/j.1471-0528.2002.00468.x; Statham H, 1997, BIRTH-ISS PERINAT C, V24, P223, DOI 10.1111/j.1523-536X.1997.tb00595.x; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; TRUDINGER BJ, 1985, BRIT J OBSTET GYNAEC, V92, P23, DOI 10.1111/j.1471-0528.1985.tb01044.x; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Vythilingum B, 2010, ARCH WOMEN MENT HLTH, V13, P359, DOI 10.1007/s00737-010-0144-8; Weiss Daniel S., 1997, P399; Willmott SA, 2004, SOC PSYCH PSYCH EPID, V39, P613, DOI 10.1007/s00127-004-0801-1	42	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57071	10.1371/journal.pone.0057071	http://dx.doi.org/10.1371/journal.pone.0057071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437312	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200209
J	Howey-Jordan, LA; Brooks, EJ; Abercrombie, DL; Jordan, LKB; Brooks, A; Williams, S; Gospodarczyk, E; Chapman, DD				Howey-Jordan, Lucy A.; Brooks, Edward J.; Abercrombie, Debra L.; Jordan, Lance K. B.; Brooks, Annabelle; Williams, Sean; Gospodarczyk, Emily; Chapman, Demian D.			Complex Movements, Philopatry and Expanded Depth Range of a Severely Threatened Pelagic Shark, the Oceanic Whitetip (Carcharhinus longimanus) in the Western North Atlantic	PLOS ONE			English	Article							POSTRELEASE SURVIVAL; DIVING BEHAVIOR; WHALE SHARKS; HABITAT USE; TRACKING; PACIFIC; NICHE	Oceanic whitetip sharks (Carcharhinus longimanus) have recently been targeted for conservation in the western North Atlantic following severe declines in abundance. Pop-up satellite archival tags were applied to 11 mature oceanic whitetips (10 females, 1 male) near Cat Island in the central Bahamas 1-8 May 2011 to provide information about the horizontal and vertical movements of this species. Another large female was opportunistically tagged in the U.S. Exclusive Economic Zone (EEZ). Data from 1,563 total tracking days and 1,142,598 combined depth and temperature readings were obtained. Sharks tagged at Cat Island stayed within 500 km of the tagging site for similar to 30 days before dispersing across 16,422 km(2) of the western North Atlantic. Maximum individual displacement from the tagging site ranged from 290-1940 km after times at liberty from 30-245 days, with individuals moving to several different destinations (the northern Lesser Antilles, the northern Bahamas, and north of the Windward Passage). Many sharks returned to The Bahamas after similar to 150 days. Estimated residency times within The Bahamas EEZ, where longlining and commercial trade of sharks is illegal, were generally high (mean = 68.2% of time). Sharks spent 99.7% of their time shallower than 200 m and did not exhibit differences in day and night mean depths. There was a positive correlation between daily sea surface temperature and mean depth occupied, suggesting possible behavioral thermoregulation. All individuals made short duration (mean = 13.06 minutes) dives into the mesopelagic zone (down to 1082 m and 7.75 degrees C), which occurred significantly more often at night. Ascent rates during these dives were significantly slower than descent rates, suggesting that these dives are for foraging. The sharks tracked appear to be most vulnerable to pelagic fishing gear deployed from 0-125 m depths, which they may encounter from June to October after leaving the protected waters of The Bahamas EEZ.	[Howey-Jordan, Lucy A.; Jordan, Lance K. B.; Gospodarczyk, Emily] Microwave Telemetry Inc, Columbia, MD USA; [Brooks, Edward J.; Brooks, Annabelle; Williams, Sean] Cape Eleuthera Inst, Shark Res & Conservat Program, Eleuthera, Bahamas; [Abercrombie, Debra L.] Abercrombie & Fish, New York, NY USA; [Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Chapman, Demian D.] SUNY Stony Brook, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chapman, DD (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	demian.chapman@stonybrook.edu	Patterson, Ruth/A-7540-2018	Abercrombie, Debra/0000-0002-2572-1862	Microwave Telemetry, Inc.; The Pew Charitable Trusts; Roe Foundation; Cape Eleuthera Foundation	Microwave Telemetry, Inc.; The Pew Charitable Trusts; Roe Foundation; Cape Eleuthera Foundation	This study was, in part, funded by Microwave Telemetry, Inc. by providing the satellite tags used in this study. The family of the lead author of this study (Lucy Howey-Jordan) owns and operates Microwave Telemetry, Inc. In no way did the author's financial invovlment bias the results or the authors' interpretation. Other funding sources are The Pew Charitable Trusts, the Roe Foundation and the Cape Eleuthera Foundation. Additionally, the authors declare that the authors' affiliations with both Microwave Telemetry, Inc. and Abercrombie & Fish does not alter their adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; [Anonymous], 1963, ANIMAL SPECIES EVOLU; BACKUS RH, 1956, DEEP-SEA RES, V3, P178, DOI 10.1016/0146-6313(56)90002-8; Baird RW, 2003, 15 BIENN C BIO UNPUB; Baum J, 2006, CARCHARHINUS LONGIMA; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Bonfil R, 2008, SHARKS OPEN OCEAN BI, P128; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Campana SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016854; Campana SE, 2010, CAN J FISH AQUAT SCI, V67, P769, DOI 10.1139/F10-020; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Carlson JK, 2011, SCRS2011099 NOAA SE; Cartamil DP, 2011, MAR BIOL, V158, P935, DOI 10.1007/s00227-010-1620-4; Castro J. I, 2011, SHARKS N AM; Chapman DD, 2007, MAR ECOL PROG SER, V344, P271, DOI 10.3354/meps06941; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; COMPAGNO L. J. V, 1984, FAO SPECIES CATALO 2; Cortes Enric, 2007, Gulf and Caribbean Research, V19, P37; Domeier ML, 2005, FISH B-NOAA, V103, P292; Galuardi B, 2010, ANALYZEPSAT; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Graves JE, 2009, FISH B-NOAA, V107, P373; HASTENRATH S, 1987, J PHYS OCEANOGR, V17, P1518, DOI 10.1175/1520-0485(1987)017<1518:ACOSTS>2.0.CO;2; James MC, 2006, CAN J ZOOL, V84, P754, DOI 10.1139/Z06-046; Johnson MP, 2008, J ANIM ECOL, V77, P1365; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Musyl MK, 2011, FISH B-NOAA, V109, P341; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Sarkar D., 2019, NLME LINEAR NONLINEA; Sedberry GR, 2001, MAR BIOL, V139, P355; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; Stafford-Deitsch J, 1989, SHARK PHOTOGRAPHERS; STEVENS JD, 1984, AUST J MAR FRESH RES, V35, P573, DOI 10.1071/MF9840573; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Walsh W.A., 2011, NRWCPFCSC7201EBWP03; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616	46	71	72	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56588	10.1371/journal.pone.0056588	http://dx.doi.org/10.1371/journal.pone.0056588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437180	gold, Green Published			2022-12-27	WOS:000315184200116
J	Huebbers, CU; Preuss, SF; Kolligs, J; Vent, J; Stenner, M; Wieland, U; Silling, S; Drebber, U; Speel, EJM; Klussmann, JP				Huebbers, Christian Ulrich; Preuss, Simon Florian; Kolligs, Jutta; Vent, Julia; Stenner, Markus; Wieland, Ulrike; Silling, Steffi; Drebber, Uta; Speel, Ernst-Jan M.; Klussmann, Jens Peter			Integration of HPV6 and Downregulation of AKR1C3 Expression Mark Malignant Transformation in a Patient with Juvenile-Onset Laryngeal Papillomatosis	PLOS ONE			English	Article							RECURRENT RESPIRATORY PAPILLOMATOSIS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CELLULAR FUSION TRANSCRIPTS; HUMAN-PAPILLOMAVIRUS; TONSILLAR CARCINOMAS; NECK-CANCER; HUMAN-PAPILLOMAVIRUS-16 DNA; P16 PROTEIN; HEAD; AMPLIFICATION	Juvenile-onset recurrent respiratory papillomatosis (RRP) is associated with low risk human papillomavirus (HPV) types 6 and 11. Malignant transformation has been reported solely for HPV11-associated RRP in 2-4% of all RRP-cases, but not for HPV6. The molecular mechanisms in the carcinogenesis of low risk HPV-associated cancers are to date unknown. We report of a female patient, who presented with a laryngeal carcinoma at the age of 24 years. She had a history of juvenile-onset RRP with an onset at the age of three and subsequently several hundred surgical interventions due to multiple recurrences of RRP. Polymerase chain reaction (PCR) or bead-based hybridization followed by direct sequencing identified HPV6 in tissue sections of previous papilloma and the carcinoma. P16(INK4A), p53 and pRb immunostainings were negative in all lesions. HPV6 specific fluorescence in situ hybridization (FISH) revealed nuclear staining suggesting episomal virus in the papilloma and a single integration site in the carcinoma. Integration-specific amplification of papillomavirus oncogene transcripts PCR (APOT-PCR) showed integration in the aldo-keto reductase 1C3 gene (AKR1C3) on chromosome 10p15.1. ArrayCGH detected loss of the other gene copy as part of a deletion at 10p14-p15.2. Western blot analysis and immunohistochemistry of the protein AKR1C3 showed a marked reduction of its expression in the carcinoma. In conclusion, we identified a novel molecular mechanism underlying a first case of HPV6-associated laryngeal carcinoma in juvenile-onset RRP, i.e. that HPV6 integration in the AKR1C3 gene resulted in loss of its expression. Alterations of AKR1C gene expression have previously been implicated in the tumorigenesis of other (HPV-related) malignancies.	[Huebbers, Christian Ulrich; Kolligs, Jutta] Univ Cologne, Jean Uhrmacher Inst Otorhinolaryngol Res, D-50931 Cologne, Germany; [Preuss, Simon Florian; Vent, Julia; Stenner, Markus] Univ Hosp Cologne, Dept Otorhinolaryngol Head & Neck Surg, Cologne, Germany; [Wieland, Ulrike; Silling, Steffi] Univ Hosp Cologne, Natl Reference Ctr Papilloma & Polyomaviruses, Inst Virol, Cologne, Germany; [Drebber, Uta] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Speel, Ernst-Jan M.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, Maastricht, Netherlands; [Klussmann, Jens Peter] Univ Hosp Giessen, Dept Otorhinolaryngol Head & Neck Surg, Giessen, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Maastricht University; University Hospital of Giessen & Marburg	Huebbers, CU (corresponding author), Univ Cologne, Jean Uhrmacher Inst Otorhinolaryngol Res, D-50931 Cologne, Germany.	christian.huebbers@uni-koeln.de		Klussmann, Jens Peter/0000-0002-8223-7954; Huebbers, Christian/0000-0002-2934-1218	Jean-Uhrmacher Foundation	Jean-Uhrmacher Foundation	This work was supported by the Jean-Uhrmacher Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON AL, 1987, LARYNGOSCOPE, V97, P678; Arany Istvan, 1993, Viral Immunology, V6, P255, DOI 10.1089/vim.1993.6.255; Armstrong DJ, 1997, VIROLOGY, V239, P238, DOI 10.1006/viro.1997.8885; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Campisi G, 2007, INT J ONCOL, V30, P813; CAPPER JWR, 1983, CLIN OTOLARYNGOL, V8, P109, DOI 10.1111/j.1365-2273.1983.tb01414.x; Cook JR, 2000, MODERN PATHOL, V13, P914, DOI 10.1038/modpathol.3880164; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gerein V, 2005, OTOLARYNG HEAD NECK, V132, P392, DOI 10.1016/j.otohns.2004.09.035; GISSMANN L, 1982, J VIROL, V44, P393, DOI 10.1128/JVI.44.1.393-400.1982; Goon PKC, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-36; Hafkamp HC, 2008, INT J CANCER, V122, P2656, DOI 10.1002/ijc.23458; Hafkamp HC, 2009, MODERN PATHOL, V22, P686, DOI 10.1038/modpathol.2009.23; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; HARTLEY BEJ, 1994, J LARYNGOL OTOL, V108, P921, DOI 10.1017/S002221510012852X; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; Hudelist G, 2004, GYNECOL ONCOL, V92, P873, DOI 10.1016/j.ygyno.2003.11.035; Ji Q, 2007, CANCER RES, V67, P1361, DOI 10.1158/0008-5472.CAN-06-1593; KAHN T, 1994, CANCER RES, V54, P1305; KASHIMA H, 1988, LARYNGOSCOPE, V98, P619; Kim L, 2010, ONCOLOGY-NY, V24, P915; Klaes R, 1999, CANCER RES, V59, P6132; Klozar J, 1997, ACTA OTO-LARYNGOL, P100, DOI 10.3109/00016489709124046; Klussmann JP, 2001, CANCER-AM CANCER SOC, V92, P2875, DOI 10.1002/1097-0142(20011201)92:11&lt;2875::AID-CNCR10130&gt;3.0.CO;2-7; Koskinen WJ, 2003, INT J CANCER, V107, P401, DOI 10.1002/ijc.11381; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Lace MJ, 2011, J VIROL, V85, P1645, DOI 10.1128/JVI.02093-10; Lin HW, 2010, AM J OTOLARYNG, V31, P291, DOI 10.1016/j.amjoto.2009.02.019; Lockwood WW, 2007, INT J CANCER, V120, P436, DOI 10.1002/ijc.22335; Major T, 2005, J CLIN PATHOL, V58, P51, DOI 10.1136/jcp.2004.016634; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Mooren J, 2012, EUR ARCH OTO-RHINO-L, V269, P1311, DOI [10.1007/s00405-012-1960-4, DOI 10.1007/S00405-012-1960-4]; Penning TM, 2009, ANN NY ACAD SCI, V1155, P33, DOI 10.1111/j.1749-6632.2009.03700.x; Preuss SF, 2007, ACTA OTO-LARYNGOL, V127, P1196, DOI 10.1080/00016480701200350; Ragin CCR, 2007, J DENT RES, V86, P104, DOI 10.1177/154405910708600202; Reidy PM, 2004, LARYNGOSCOPE, V114, P1906, DOI 10.1097/01.mlg.0000147918.81733.49; Sano T, 1998, AM J PATHOL, V153, P1741, DOI 10.1016/S0002-9440(10)65689-1; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; STRONG MS, 1976, ANN OTO RHINOL LARYN, V85, P508, DOI 10.1177/000348947608500412; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Ullmann, 1923, ACTA OTO-LARYNGOL, P317; WAGATSUMA M, 1990, J VIROL, V64, P813, DOI 10.1128/JVI.64.2.813-821.1990; Wanichwatanadecha P, 2012, J GEN VIROL, V93, P1081, DOI 10.1099/vir.0.038265-0; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Wieland U, 2000, J INVEST DERMATOL, V115, P124, DOI 10.1046/j.1523-1747.2000.00015.x; Wittekindt C, 2005, ADV OTO-RHINO-LARYNG, V62, P72	49	38	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57207	10.1371/journal.pone.0057207	http://dx.doi.org/10.1371/journal.pone.0057207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437342	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200227
J	Lv, Q; Meng, XF; He, FF; Chen, S; Su, H; Xiong, J; Gao, P; Tian, XJ; Liu, JS; Zhu, ZH; Huang, K; Zhang, C				Lv, Qin; Meng, Xian-Fang; He, Fang-Fang; Chen, Shan; Su, Hua; Xiong, Jing; Gao, Pan; Tian, Xiu-Juan; Liu, Jian-She; Zhu, Zhong-Hua; Huang, Kai; Zhang, Chun			High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED FASTING GLUCOSE; NATIONAL-HEALTH; HYPERTENSION; PREVALENCE; HYPERURICEMIA; ASSOCIATION; MORTALITY; WOMEN	Objective: Current evidence suggests high serum uric acid may increase the risk of type 2 diabetes, but the association is still uncertain. The aim of the study was to evaluate the association between serum uric acid and future risk of type 2 diabetes by conducting a meta-analysis of prospective cohort studies. Design and Methods: We conducted a systematic literature search of the PubMed database through April 2012. Prospective cohort studies were included in meta-analysis that reported the multivariate adjusted relative risks (RRs) and the corresponding 95% confidence intervals (CIs) for the association between serum uric acid and risk of type 2 diabetes. We used both fix-effects and random-effects models to calculate the overall effect estimate. The heterogeneity across studies was tested by both Q statistic and I-2 statistic. Begg's funnel plot and Egger's regression test were used to assess the potential publication bias. Results: We retrieved 7 eligible articles derived from 8 prospective cohort studies, involving a total of 32016 participants and 2930 incident type 2 diabetes. The combined RR of developing type 2 diabetes for the highest category of serum uric acid level compared with the lowest was 1.56(95% CI, 1.39-1.76). Dose-response analysis showed the risk of type 2 diabetes was increased by 6% per 1 mg/dl increment in serum uric acid level (RR 1.06, 95% CI: 1.04-1.07). The result from each subgroup showed a significant association between serum uric acid and risk of type 2 diabetes. In sensitive analysis, the combined RR was consistent every time omitting any one study. Little evidence of heterogeneity and publication bias was observed. Conclusions: Our meta-analysis of prospective cohort studies provided strong evidence that high level of serum uric acid is independent of other established risk factors, especially metabolic syndrome components, for developing type 2 diabetes in middle-aged and older people.	[Lv, Qin; He, Fang-Fang; Chen, Shan; Su, Hua; Xiong, Jing; Gao, Pan; Tian, Xiu-Juan; Liu, Jian-She; Zhu, Zhong-Hua; Zhang, Chun] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Nephrol, Wuhan 430074, Peoples R China; [Meng, Xian-Fang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurobiol, Wuhan 430074, Peoples R China; [Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Huang, K (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430074, Peoples R China.	huangkai1@mail.hust.edu.cn; drzhangchun@hust.edu.cn			National Natural Science Foundation of China [81170662, 30871174, 31200872]; Natural Science Foundation of Hubei Province [2012FFA038]; Medicine-Technology Interdisciplinary grant from Huazhong University of Science and Technology [2012-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Medicine-Technology Interdisciplinary grant from Huazhong University of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (no. 81170662, no. 30871174 and no. 31200872), a grant from Natural Science Foundation of Hubei Province (2012FFA038), and a Medicine-Technology Interdisciplinary grant from Huazhong University of Science and Technology (no. 2012-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Chien KL, 2008, CLIN CHEM, V54, P310, DOI 10.1373/clinchem.2007.095190; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; LEVINE W, 1989, J CLIN EPIDEMIOL, V42, P257, DOI 10.1016/0895-4356(89)90061-9; Liu B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-832; Loeffler LF, 2012, HYPERTENSION, V59, P811, DOI 10.1161/HYPERTENSIONAHA.111.183244; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nan HR, 2008, DIABETES RES CLIN PR, V80, P321, DOI 10.1016/j.diabres.2008.01.002; Osborne J., 2006, PRACT ASSESS RES EVA, V11, P1; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Viazzi F, 2011, DIABETES CARE, V34, P126, DOI 10.2337/dc10-0918; Villegas R, 2012, NUTR METAB CARDIOVAS, V22, P409, DOI 10.1016/j.numecd.2010.07.012; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamada T, 2011, DIABETES METAB, V37, P252, DOI 10.1016/j.diabet.2010.10.009; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	35	215	235	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56864	10.1371/journal.pone.0056864	http://dx.doi.org/10.1371/journal.pone.0056864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437258	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200174
J	Mugglin, C; Wandeler, G; Estill, J; Egger, M; Bender, N; Davies, MA; Keiser, O				Mugglin, Catrina; Wandeler, Gilles; Estill, Janne; Egger, Matthias; Bender, Nicole; Davies, Mary-Ann; Keiser, Olivia			Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review	PLOS ONE			English	Article							CD4 COUNT; FOLLOW-UP; PRE-ART; MORTALITY; TRANSMISSION; INITIATION; OUTCOMES; AFRICA; IMPLEMENTATION; PREVENTION	Background: In adults it is well documented that there are substantial losses to the programme between HIV testing and start of antiretroviral therapy (ART). The magnitude and reasons for loss to follow-up and death between HIV diagnosis and start of ART in children are not well defined. Methods: We searched the PubMed and EMBASE databases for studies on children followed between HIV diagnosis and start of ART in low-income settings. We examined the proportion of children with a CD4 cell count/percentage after after being diagnosed with HIV infection, the number of treatment-eligible children starting ART and predictors of loss to programme. Data were extracted in duplicate. Results: Eight studies from sub-Saharan Africa and two studies from Asia with a total of 10,741 children were included. Median age ranged from 2.2 to 6.5 years. Between 78.0 and 97.0% of HIV-infected children subsequently had a CD4 cell count/percentage measured, 63.2 to 90.7% of children with an eligibility assessment met the eligibility criteria for the particular setting and time and 39.5 to 99.4% of the eligible children started ART. Three studies reported an association between low CD4 count/percentage and ART initiation while no association was reported for gender. Only two studies reported on pre-ART mortality and found rates of 13 and 6 per 100 person-years. Conclusion: Most children who presented for HIV care met eligibility criteria for ART. There is an urgent need for strategies to improve the access to and retention to care of HIV-infected children in resource-limited settings.	[Mugglin, Catrina; Wandeler, Gilles; Estill, Janne; Egger, Matthias; Bender, Nicole; Keiser, Olivia] Univ Bern, Inst Social & Prevent Med ISPM, Div Int & Environm Hlth, CH-3012 Bern, Switzerland; [Wandeler, Gilles] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7700 Rondebosch, South Africa	University of Bern; University of Bern; University Hospital of Bern; University of Cape Town	Keiser, O (corresponding author), Univ Bern, Inst Social & Prevent Med ISPM, Div Int & Environm Hlth, CH-3012 Bern, Switzerland.	okeiser@ispm.unibe.ch	González-Rodríguez, Diego/F-3425-2016; Bender, Nicole/C-2237-2009; Wandeler, Gilles/ABB-2961-2020	González-Rodríguez, Diego/0000-0001-7584-9103; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132; Bender, Nicole/0000-0002-3838-587X; Mugglin, Catrina/0000-0001-7966-3939	National Institute of Allergy and Infectious Diseases (NIAID) [5U01-AI069924-05]; PROSPER fellowship grant; Swiss National Science Foundation [32333B_131629]; Swiss School of Public Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PROSPER fellowship grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss School of Public Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), Grant 5U01-AI069924-05, a PROSPER fellowship grant to O.K. funded by the Swiss National Science Foundation (Grant 32333B_131629) and a PhD student fellowship to J.E. from the Swiss School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaky MF, 2010, B WORLD HEALTH ORGAN, V88, P490, DOI 10.2471/BLT.09.068015; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Berhan Y, 2011, J TROP PEDIATRICS, V57, P14, DOI 10.1093/tropej/fmq032; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Feucht UD, 2007, J TROP PEDIATRICS, V53, P398, DOI 10.1093/tropej/fmm060; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Labhardt ND, 2009, TROP MED INT HEALTH, V14, P288, DOI 10.1111/j.1365-3156.2009.02221.x; Leeper Sarah C, 2010, J Int AIDS Soc, V13 Suppl 2, pS3, DOI 10.1186/1758-2652-13-S2-S3; Leyenaar JK, 2010, PEDIATR INFECT DIS J, V29, P340, DOI 10.1097/INF.0b013e3181bf8ecb; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Mugglin C, 2012, TROP MED INT HLTH; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nyandiko W M, 2009, East Afr Med J, V86, P364; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Seth A, 2012, INDIAN J PEDIATR, V79, P188, DOI 10.1007/s12098-011-0532-8; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Thomson KA, 2011, T ROY SOC TROP MED H, V105, P320, DOI 10.1016/j.trstmh.2011.02.011; Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2010, ANT THER HIV INF INF; Zachariah R, 2011, T ROY SOC TROP MED H, V105, P421, DOI 10.1016/j.trstmh.2011.04.014	33	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56446	10.1371/journal.pone.0056446	http://dx.doi.org/10.1371/journal.pone.0056446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437135	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200076
J	Nie, W; Liu, YG; Bian, JR; Li, B; Xiu, QY				Nie, Wei; Liu, Yongan; Bian, Jiarong; Li, Bin; Xiu, Qingyu			Effects of Polymorphisms-1112C/T and+2044A/G in Interleukin-13 Gene on Asthma Risk: A Meta-Analysis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SERUM IGE LEVELS; ALLERGIC-ASTHMA; PROMOTER POLYMORPHISMS; IL-13 POLYMORPHISMS; PEDIATRIC ASTHMA; KOREAN CHILDREN; CANDIDATE GENES; ASSOCIATION; ATOPY	Background: Associations between interleukin-13 (IL-13) polymorphisms and asthma risk remained controversial and ambiguous. Therefore, we performed a meta-analysis to assess the associations between IL-13 polymorphisms and asthma susceptibility. Methods: Pubmed, EMBASE, Chinese National Knowledge Infrastructure (CNKI) and Wangfang databases were searched. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to calculate the strength of association in the random-effects model. Results: Thirty-four studies were included in this meta-analysis. The results indicated that IL13 -1112C/T polymorphism was significantly associated with asthma risk (OR = 1.20, 95% CI 1.08-1.34, P = 0.0009) in a dominant genetic model. When stratifying for race, IL13 -1112C/T polymorphism exhibited increased asthma risk in Caucasians (OR = 1.30, 95% CI 1.09-1.55, P = 0.003), while no significant association was found in Asians and African Americans. In the subgroup analysis based on atopic status, significant association was observed in atopic patients (OR = 1.25, 95% CI 1.07-1.45, P = 0.004) but not in the non-atopic patients. In addition, a significant association between IL13+2044A/G polymorphism and asthma risk was observed (OR = 1.18, 95% CI 1.08-1.28, P = 0.0002). In the subgroup analysis by ethnicity, there were significant associations between IL13+2044A/G polymorphism and asthma risk in Asians (OR = 1.19, 95% CI 1.04-1.36, P = 0.01) and Caucasians (OR = 1.22, 95% CI 1.06-1.40, P = 0.005) but not in African Americans. In the subgroup analysis stratified by atopic status, a marginal significant association was found in atopic patients (OR = 1.12, 95% CI 1.00-1.26, P = 0.05). Conclusions: This meta-analysis suggested that the IL13 -1112C/T and +2044A/G polymorphisms were risk factors for asthma.	[Nie, Wei; Liu, Yongan; Bian, Jiarong; Xiu, Qingyu] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China; [Liu, Yongan] 411 Hosp PLA, Dept Intens Care Med, Shanghai, Peoples R China; [Li, Bin] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Radiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Xiu, QY (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China.	xiu_qingyu@126.com			National Natural Science Foundation of China [81170025]; National Ministry of Science and Technology [2011ZX09302-003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Science and Technology	This study was supported by grant 81170025 from National Natural Science Foundation of China and project of "Major New Drugs Innovation and Development" from the National Ministry of Science and Technology (2011ZX09302-003-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2002, J ALLERGY CLIN IMMUN, V109, P980, DOI 10.1067/mai.2002.124656; Battle NC, 2007, AM J RESP CRIT CARE, V175, P881, DOI 10.1164/rccm.200607-992OC; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Black S, 2009, ALLERGY, V64, P1172, DOI 10.1111/j.1398-9995.2009.01988.x; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Chan IHS, 2008, ALLERGY, V63, P1031, DOI 10.1111/j.1398-9995.2008.01639.x; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Cui L, 2012, CLIN BIOCHEM, V45, P285, DOI 10.1016/j.clinbiochem.2011.12.012; Daley D, 2009, HUM GENET, V125, P445, DOI 10.1007/s00439-009-0643-8; DeWan AT, 2010, J ALLERGY CLIN IMMUN, V126, P871, DOI 10.1016/j.jaci.2010.06.051; Dmitrieva-Zdorova E V, 2010, Genetika, V46, P111; Donfack J, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-145; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng D, 2009, HEILONGJIANG MED J, V33, P481; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hakonarson H, 2001, AM J RESP CRIT CARE, V164, P2036, DOI 10.1164/ajrccm.164.11.2101086; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; HUANG SK, 1995, J IMMUNOL, V155, P2688; Jiang P, 2009, ALLERGY ASTHMA PROC, V30, P413, DOI 10.2500/aap.2009.30.3255; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kaishu Z, 2005, J CLIN PEDIAT, P312; Kang MJ, 2008, PHARMACOGENET GENOM, V18, P551, DOI 10.1097/FPC.0b013e3282fe94c5; Kauppi P, 2001, GENOMICS, V77, P35, DOI 10.1006/geno.2001.6613; Kim HB, 2008, CLIN EXP ALLERGY, V38, P774, DOI 10.1111/j.1365-2222.2008.02965.x; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Lee YC, 2001, J ASTHMA, V38, P665, DOI 10.1081/JAS-100107544; Leung TF, 2001, CLIN EXP ALLERGY, V31, P1515, DOI 10.1046/j.1365-2222.2001.01212.x; Li H, 2009, J INVEST ALLERG CLIN, V19, P391; Li YF, 2008, RESP MED, V102, P984, DOI 10.1016/j.rmed.2008.02.008; Llanes E, 2009, INT ARCH ALLERGY IMM, V148, P228, DOI 10.1159/000161583; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Moissidis I, 2005, GENET MED, V7, P406, DOI 10.1097/01.GIM.0000170994.24960.48; Munoz B, 2012, ENVIRON TOXICOL PHAR, V33, P226, DOI 10.1016/j.etap.2011.12.007; Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895; Nie W, 2012, CYTOKINE, V60, P849, DOI 10.1016/j.cyto.2012.08.023; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042062; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Palikhe NS, 2010, ALLERGY ASTHMA IMMUN, V2, P134, DOI 10.4168/aair.2010.2.2.134; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Undarmaa S, 2010, J HUM GENET, V55, P342, DOI 10.1038/jhg.2010.32; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Wang JY, 2009, J CLIN IMMUNOL, V29, P205, DOI 10.1007/s10875-008-9256-6; Wang Xiu-hai, 2009, Zhonghua Jiehe He Huxi Zazhi, V32, P161; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wu Bin, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P668; Wu XH, 2010, J ASTHMA, V47, P238, DOI 10.3109/02770900903509099; Xi Dong, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P219; Yang HJ, 2011, RESPIROLOGY, V16, P1127, DOI 10.1111/j.1440-1843.2011.02021.x; Yang L, 2010, ZHONG GUO XIAN DAI Y, V12, P46; Yang XX, 2011, ASIAN PAC J ALLERGY, V29, P273	57	30	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56065	10.1371/journal.pone.0056065	http://dx.doi.org/10.1371/journal.pone.0056065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437086	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200040
J	Silva, JM; Georgi, N; Costa, R; Sher, P; Reis, RL; Van Blitterswijk, CA; Karperien, M; Mano, JF				Silva, Joana M.; Georgi, Nicole; Costa, Rui; Sher, Praveen; Reis, Rui L.; Van Blitterswijk, Clemens A.; Karperien, Marcel; Mano, Joao F.			Nanostructured 3D Constructs Based on Chitosan and Chondroitin Sulphate Multilayers for Cartilage Tissue Engineering	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; BIOMEDICAL APPLICATIONS; POLYELECTROLYTE MULTILAYERS; CELL-DIFFERENTIATION; HYALURONIC-ACID; STEM-CELLS; SCAFFOLDS; LAYER; FILMS; REGENERATION	Nanostructured three-dimensional constructs combining layer-by-layer technology (LbL) and template leaching were processed and evaluated as possible support structures for cartilage tissue engineering. Multilayered constructs were formed by depositing the polyelectrolytes chitosan (CHT) and chondroitin sulphate (CS) on either bidimensional glass surfaces or 3D packet of paraffin spheres. 2D CHT/CS multi-layered constructs proved to support the attachment and proliferation of bovine chondrocytes (BCH). The technology was transposed to 3D level and CHT/CS multi-layered hierarchical scaffolds were retrieved after paraffin leaching. The obtained nanostructured 3D constructs had a high porosity and water uptake capacity of about 300%. Dynamical mechanical analysis (DMA) showed the viscoelastic nature of the scaffolds. Cellular tests were performed with the culture of BCH and multipotent bone marrow derived stromal cells (hMSCs) up to 21 days in chondrogenic differentiation media. Together with scanning electronic microscopy analysis, viability tests and DNA quantification, our results clearly showed that cells attached, proliferated and were metabolically active over the entire scaffold. Cartilaginous extracellular matrix (ECM) formation was further assessed and results showed that GAG secretion occurred indicating the maintenance of the chondrogenic phenotype and the chondrogenic differentiation of hMSCs.	[Silva, Joana M.; Costa, Rui; Sher, Praveen; Reis, Rui L.; Mano, Joao F.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Taipas, Guimaraes, Portugal; [Silva, Joana M.; Costa, Rui; Sher, Praveen; Reis, Rui L.; Mano, Joao F.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Georgi, Nicole; Van Blitterswijk, Clemens A.; Karperien, Marcel] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands; [Georgi, Nicole; Van Blitterswijk, Clemens A.; Karperien, Marcel] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands	Universidade do Minho; University of Twente; University of Twente	Mano, JF (corresponding author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Taipas, Guimaraes, Portugal.	jmano@dep.uminho.pt	Silva, Joana/GYQ-9526-2022; Sher, Praveen/A-2721-2016; Silva, Joana M./AAQ-9354-2021; Mano, João F./A-4418-2009; Silva, Joana Marques/AAF-9867-2019; Reis, Rui L./A-8938-2008; Costa, Rui R/C-2526-2011; Karperien, Marcel/R-3270-2018	Sher, Praveen/0000-0003-2235-7855; Silva, Joana M./0000-0001-9487-4259; Mano, João F./0000-0002-2342-3765; Reis, Rui L./0000-0002-4295-6129; Costa, Rui R/0000-0001-8234-8729; Karperien, Marcel/0000-0003-0751-0604; UMinho, 3B's Research Group/0000-0002-5195-3456; van Blitterswijk, Clemens/0000-0003-2371-4615				Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Almodovar J, 2011, BIOMACROMOLECULES, V12, P2755, DOI 10.1021/bm200519y; Alves NM, 2009, MACROMOL BIOSCI, V9, P776, DOI 10.1002/mabi.200800336; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Chatterjee S, 2005, J COLLOID INTERF SCI, V288, P30, DOI 10.1016/j.jcis.2005.02.055; Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216; Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Correia C, 2011, TISSUE ENG PART C-ME; Costa RR, 2011, SMALL, V7, P2640, DOI 10.1002/smll.201100875; Costa RR, 2009, ADV FUNCT MATER, V19, P3210, DOI 10.1002/adfm.200900568; Crouzier T, 2010, CURR OPIN COLLOID IN, V15, P417, DOI 10.1016/j.cocis.2010.05.007; Detzel CJ, 2011, TISSUE ENG PART B-RE, V17, P101, DOI [10.1089/ten.teb.2010.0548, 10.1089/ten.TEB.2010.0548]; Fajardo AR, 2010, CARBOHYD POLYM, V80, P934, DOI 10.1016/j.carbpol.2010.01.009; Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013; Franke O, 2011, MAT SCI ENG C-MATER, V31, P789, DOI 10.1016/j.msec.2010.12.005; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ghosh S, 2008, ACTA BIOMATER, V4, P950, DOI 10.1016/j.actbio.2008.02.001; Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007; Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024; KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31; Kobo M, 2009, LIFE SCI, V85, P477, DOI [10.1016/j.lfs.209.08.005, 10.1016/j.lfs.2009.08.005]; Kohler K, 2005, J PHYS CHEM B, V109, P18250, DOI 10.1021/jp052208i; LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Liu YX, 2005, COLLOID SURFACE B, V46, P117, DOI 10.1016/j.colsurfb.2005.09.005; Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37; Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139; Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5; Martins AM, 2008, ACTA BIOMATER, V4, P1637, DOI 10.1016/j.actbio.2008.06.004; Martins GV, 2010, CARBOHYD POLYM, V80, P570, DOI 10.1016/j.carbpol.2009.10.030; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Miranda ES, 2011, TISSUE ENG PT A, V17, P2663, DOI 10.1089/ten.tea.2010.0635; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073; Piai JF, 2009, ACTA BIOMATER, V5, P2601, DOI 10.1016/j.actbio.2009.03.035; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006; Servaty R, 2001, INT J BIOL MACROMOL, V28, P121, DOI 10.1016/S0141-8130(00)00161-6; Sher P, 2010, SMALL, V6, P2644, DOI 10.1002/smll.201001066; Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Sui W, 2008, COLLOID SURFACE B, V65, P69, DOI 10.1016/j.colsurfb.2008.02.022; Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113; Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6; Varghese JM, 2008, SENSOR ACTUAT B-CHEM, V135, P336, DOI 10.1016/j.snb.2008.09.001; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wu L, 2011, TISSUE ENG PT A, V17, P1425, DOI [10.1089/ten.TEA.2010.0517, 10.1089/ten.tea.2010.0517]; Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037; Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869	55	108	108	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55451	10.1371/journal.pone.0055451	http://dx.doi.org/10.1371/journal.pone.0055451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437056	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200018
J	Zhang, EY; Yang, ZF; Wang, YF; Hu, YY; Song, XY; Xu, CW				Zhang, Enying; Yang, Zefeng; Wang, Yifan; Hu, Yunyun; Song, Xiyun; Xu, Chenwu			Nucleotide Polymorphisms and Haplotype Diversity of RTCS Gene in China Elite Maize Inbred Lines	PLOS ONE			English	Article							ZEA-MAYS L.; ROOT-SYSTEM ARCHITECTURE; LOB DOMAIN PROTEIN; DNA POLYMORPHISM; POPULATIONS; ENCODES; INITIATION; HETEROSIS; SELECTION; MARKERS	The maize RTCS gene, encoding a LOB domain transcription factor, plays important roles in the initiation of embryonic seminal and postembryonic shoot-borne root. In this study, the genomic sequences of this gene in 73 China elite inbred lines, including 63 lines from 5 temperate heteroric groups and 10 tropic germplasms, were obtained, and the nucleotide polymorphisms and haplotype diversity were detected. A total of 63 sequence variants, including 44 SNPs and 19 indels, were identified at this locus, and most of them were found to be located in the regions of UTR and intron. The coding region of this gene in all tested inbred lines carried 14 haplotypes, which encoding 7 deferring RTCS proteins. Analysis of the polymorphism sites revealed that at least 6 recombination events have occurred. Among all 6 groups tested, only the P heterotic group had a much lower nucleotide diversity than the whole set, and selection analysis also revealed that only this group was under strong negative selection. However, the set of Huangzaosi and its derived lines possessed a higher nucleotide diversity than the whole set, and no selection signal were identified.	[Zhang, Enying; Yang, Zefeng; Wang, Yifan; Hu, Yunyun; Xu, Chenwu] Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Peoples R China; [Zhang, Enying; Song, Xiyun] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Peoples R China	Yangzhou University; Qingdao Agricultural University	Yang, ZF (corresponding author), Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Peoples R China.	zfyang@yzu.edu.cn; qtls@yzu.edu.cn		Yang, Zefeng/0000-0002-3465-8594	National Program on the Development of Basic Research [2011CB100100]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundations [31200943, 31171187]; Natural Science Foundations of Jiangsu Province [BK2012261]	National Program on the Development of Basic Research(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Program on the Development of Basic Research (2011CB100100), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National Natural Science Foundations (31200943 and 31171187) and the Natural Science Foundations of Jiangsu Province (BK2012261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achon MA, 2012, ARCH VIROL; Aguiar CG, 2008, GENET MOL RES, V7, P1233, DOI 10.4238/vol7-4gmr495; Berilli APCG, 2011, GENET MOL RES, V10, P2589, DOI 10.4238/2011.October.25.6; Cai HG, 2012, THEOR APPL GENET, V125, P1313, DOI 10.1007/s00122-012-1915-6; Den Herder G, 2010, TRENDS PLANT SCI, V15, P600, DOI 10.1016/j.tplants.2010.08.009; FU YX, 1993, GENETICS, V133, P693; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Garcia-Arenal F, 2003, INT MICROBIOL, V6, P225, DOI 10.1007/s10123-003-0142-z; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hochholdinger F, 2004, ANN BOT-LONDON, V93, P359, DOI 10.1093/aob/mch056; Hochholdinger F, 2008, PLANT J, V54, P888, DOI 10.1111/j.1365-313X.2008.03459.x; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; HUDSON RR, 1985, GENETICS, V111, P147; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lestari P, 2011, J HERED, V102, P735, DOI 10.1093/jhered/esr094; Li L, 2011, GENETICA, V139, P479, DOI 10.1007/s10709-011-9568-y; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longin CFH, 2007, THEOR APPL GENET, V114, P393, DOI 10.1007/s00122-006-0422-z; Lu H, 2002, THEOR APPL GENET, V104, P119, DOI 10.1007/s001220200014; Majer C, 2012, PHILOS T R SOC B, V367, P1542, DOI 10.1098/rstb.2011.0238; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Reif JC, 2003, CROP SCI, V43, P1275, DOI 10.2135/cropsci2003.1275; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Smith S, 2012, PHILOS T R SOC B, V367, P1441, DOI 10.1098/rstb.2011.0234; TAJIMA F, 1989, GENETICS, V123, P585; Taramino G, 2007, PLANT J, V50, P649, DOI 10.1111/j.1365-313X.2007.03075.x; Wen TJ, 2005, PLANT PHYSIOL, V138, P1637, DOI 10.1104/pp.105.062174; Yu Y, 2007, MAYDICA, V52, P181; Zhang JJ, 2012, BIOCHEM GENET, V50, P508, DOI 10.1007/s10528-012-9495-3	29	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56495	10.1371/journal.pone.0056495	http://dx.doi.org/10.1371/journal.pone.0056495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437145	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200084
J	Cui, M; Bai, X; Li, TF; Chen, FZ; Dong, Q; Zhao, YX; Liu, XY				Cui, Mei; Bai, Xue; Li, Tianfu; Chen, Fangzhe; Dong, Qiang; Zhao, Yanxin; Liu, Xueyuan			Decreased Extracellular Adenosine Levels Lead to Loss of Hypoxia-Induced Neuroprotection after Repeated Episodes of Exposure to Hypoxia	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INDUCIBLE FACTOR-I; A(2A) RECEPTOR ANTAGONIST; SHORT-TERM PROGNOSIS; ISCHEMIC TOLERANCE; ECTO-5'-NUCLEOTIDASE CD73; FOCAL ISCHEMIA; TARGET GENES; ATP RELEASE; ERYTHROPOIETIN	Achieving a prolonged neuroprotective state following transient ischemic attacks (TIAs) is likely to effectively reduce the brain damage and neurological dysfunction associated with recurrent stroke. HPC is a phenomenon in which advanced exposure to mild hypoxia reduces the stroke volume produced by a subsequent TIA. However, this neuroprotection is not long-lasting, with the effects reaching a peak after 3 days. Therefore, in this study, we investigated the use of multiple episodes of hypoxic exposure at different time intervals to induce longer-term protection in a mouse stroke model. C57BL/6 mice were subjected to different hypoxic preconditioning protocols: a single episode of HPC or five identical episodes at intervals of 3 days (E3d HPC) or 6 days (E6d HPC). Three days after the last hypoxic exposure, temporary middle cerebral artery occlusion (MCAO) was induced. The effects of these HPC protocols on hypoxia-inducible factor (HIF) regulated gene mRNA expression were measured by quantitative PCR. Changes in extracellular adenosine concentrations, known to exert neuroprotective effects, were also measured using in vivo microdialysis and high pressure liquid chromatography (HPLC). Neuroprotection was provided by E6d HPC but not E3d HPC. HIF-regulated target gene expression increased significantly following all HPC protocols. However, E3d HPC significantly decreased extracellular adenosine and reduced cerebral blood flow in the ischemic region with upregulated expression of the adenosine transporter, equilibrative nucleoside transporter 1 (ENT1). An ENT1 inhibitor, propentofylline increased the cerebral blood flow and re-established neuroprotection in E3d HPC. Adenosine receptor specific antagonists showed that adenosine mainly through A1 receptor mediates HPC induced neuroprotection. Our data indicate that cooperation of HIF-regulated genes and extracellular adenosine is necessary for HPC-induced neuroprotection.	[Bai, Xue; Zhao, Yanxin; Liu, Xueyuan] Shanghai Tongji Univ, Affiliated Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China; [Cui, Mei; Chen, Fangzhe; Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Li, Tianfu] Capital Med Univ, Beijing Sanbo Brain Hosp, Epilepsy Ctr, Beijing, Peoples R China	Tongji University; Fudan University; Capital Medical University	Zhao, YX (corresponding author), Shanghai Tongji Univ, Affiliated Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China.	zhao_yanxin@126.com; Liuxy@tongji.edu.cn			National Natural Science Foundation of China [81000487, 81171023]; Shanghai Rising-Star Program [11QA1400900]; Shanghai Pujiang Program [12PJ1407200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by National Natural Science Foundation of China 81000487 (to M.C) 81171023 (to Y.Z) and Shanghai Rising-Star Program (11QA1400900) and Shanghai Pujiang Program (12PJ1407200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8; Bernaudin M, 2002, J CEREBR BLOOD F MET, V22, P393, DOI 10.1097/00004647-200204000-00003; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Correia M, 2006, STROKE, V37, P50, DOI 10.1161/01.STR.0000195209.26543.8f; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Feoktistov I, 2004, HYPERTENSION, V44, P649, DOI 10.1161/01.HYP.0000144800.21037.a5; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gui L, 2009, BRAIN RES, V1297, P185, DOI 10.1016/j.brainres.2009.08.050; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Hoyte LC, 2006, BRAIN RES, V1121, P231, DOI 10.1016/j.brainres.2006.08.107; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Jones NM, 2008, PEDIATR RES, V63, P620, DOI 10.1203/PDR.0b013e31816d9117; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; Jones PA, 1998, BRAIN RES, V800, P328, DOI 10.1016/S0006-8993(98)00540-X; Khorasani MZ, 2006, BRAIN RES, V1084, P61, DOI 10.1016/j.brainres.2006.01.106; Kim HH, 2008, J CEREBR BLOOD F MET, V28, P1285, DOI 10.1038/jcbfm.2008.24; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; KITAKAZE M, 1994, CIRCULATION, V89, P1237, DOI 10.1161/01.CIR.89.3.1237; Knutsen HK, 1996, BIOL REPROD, V55, P5, DOI 10.1095/biolreprod55.1.5; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kolar F, 2007, AM J PHYSIOL-HEART C, V292, pH224, DOI 10.1152/ajpheart.00689.2006; Leisewitz AV, 2011, BIOCHEM BIOPH RES CO, V404, P370, DOI 10.1016/j.bbrc.2010.11.125; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Li Yun-Xia, 2008, Neurosci Bull, V24, P89, DOI 10.1007/s12264-008-0089-3; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Melani A, 2003, BRAIN RES, V959, P243, DOI 10.1016/S0006-8993(02)03753-8; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Oberdorster G, 1972, PFLUGERS ARCH S332, V332, pR359; Olsson T, 2004, EUR J NEUROSCI, V20, P1197, DOI 10.1111/j.1460-9568.2004.03564.x; PARKINSON FE, 1994, GEN PHARMACOL, V25, P1053, DOI 10.1016/0306-3623(94)90119-8; Parkinson FE, 2000, J NEUROCHEM, V75, P795, DOI 10.1046/j.1471-4159.2000.0750795.x; Parkinson FE, 2005, NEUROL RES, V27, P153, DOI 10.1179/016164105X21878; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Prass K, 2002, J CEREBR BLOOD F MET, V22, P520, DOI 10.1097/00004647-200205000-00003; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sebastiao AM, 2001, J NEUROSCI, V21, P8564, DOI 10.1523/JNEUROSCI.21-21-08564.2001; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Stagliano NE, 1999, J CEREBR BLOOD F MET, V19, P757, DOI 10.1097/00004647-199907000-00005; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; VonLubitz DKJE, 1995, EUR J PHARMACOL, V287, P295, DOI 10.1016/0014-2999(95)00498-X; Wick A, 2002, J NEUROSCI, V22, P6401; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Zhang DL, 2011, J NEUROCHEM, V118, P4, DOI 10.1111/j.1471-4159.2011.07242.x; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230	63	33	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57065	10.1371/journal.pone.0057065	http://dx.doi.org/10.1371/journal.pone.0057065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437309	gold, Green Submitted, Green Published			2022-12-27	WOS:000315186000071
J	Li, YM; Lip, G; Chong, V; Yuan, JH; Ding, ZX				Li, Yumei; Lip, Gerald; Chong, Vincent; Yuan, Jianhua; Ding, Zhongxiang			Idiopathic Orbital Inflammation Syndrome with Retro-Orbital Involvement: A Retrospective Study of Eight Patients	PLOS ONE			English	Article							TOLOSA-HUNT-SYNDROME; PSEUDOTUMOR; EXTENSION	Background: The aim of this retrospective study was to document the clinical findings and radiological features of idiopathic orbital inflammation syndrome with retro-orbital involvement. Methods: We searched for ophthalmological patients who received orbital imaging at Zhejiang Provincial People's Hospital between October 2003 and April 2010. Seventy-three patients were diagnosed with idiopathic orbital inflammation syndrome based on clinicoradiological features, with pathological confirmation of nonspecific inflammatory conditions in 47 patients. Eight patients (11%) had MRI or CT evidence of retro-orbital involvement. All 8 patients were diagnosed with idiopathic orbital inflammation syndrome after biopsy of the orbital lesion. MR images were obtained for all 8 patients; 3 patients also had a contrast-enhanced CT scan. Results: Seven out of 8 patients with retro-orbital involvement also had orbital apex lesions. Of the 65 patients without retro-orbital involvement, 19 had orbital apex lesions. The difference in the number of patients with orbital apex lesions between the two populations was significant (Fisher exact test P = .002). In all 8 patients with retro-orbital involvement, the inflammation spread through the superior orbital fissure. The retro-orbital lesions were isointense to grey matter on T1-weighted images, hypointense on T2-weighted images, and displayed uniform contrast enhancement; on contrast-enhanced CT scans, they were hyperdense relative to the contralateral mirror area and had radiological contours that were similar to those seen on MR images. The diffuse inflammation with marked sclerosis and hyalinization that we observed in the patients with retro-orbital involvement is consistent with the diagnosis of the sclerosing subtype of idiopathic orbital inflammation syndrome. All 8 patients also complained of mild to moderate periorbital pain (headache). Conclusions: In patients with idiopathic orbital inflammation syndrome, it is important to perform MRI and CT scans to identify possible retro-orbital involvement. Retro-orbital involvement is more frequent when the lesion is present in the orbital apex.	[Li, Yumei; Yuan, Jianhua; Ding, Zhongxiang] Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Lip, Gerald; Chong, Vincent; Ding, Zhongxiang] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Diagnost Imaging, Singapore 117595, Singapore	Zhejiang Provincial People's Hospital; National University of Singapore	Ding, ZX (corresponding author), Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China.	hangzhoudzx73@126.com						Bag AK, 2010, AM J ROENTGENOL, V 195, pS37, DOI 10.2214/AJR.09.7200; Birch-Hirschfeld A., 1905, BER DTSCH OPHTHALMOL, V32, P127; Charkoudian LD, 2012, OCUL IMMUNOL INFLAMM, V20, P91, DOI 10.3109/09273948.2011.646382; Chua JLL, 2008, ANN ACAD MED SINGAP, V37, P964; CLIFTON AG, 1992, CLIN RADIOL, V45, P23, DOI 10.1016/S0009-9260(05)81462-X; Ding ZX, 2011, CLIN RADIOL, V66, P886, DOI 10.1016/j.crad.2011.03.018; Goh PS, 2008, EUR J RADIOL, V66, P387, DOI 10.1016/j.ejrad.2008.03.031; HARDMAN JA, 1995, NEURORADIOLOGY, V37, P475; Kapur R, 2009, AM J NEURORADIOL, V30, P64, DOI 10.3174/ajnr.A1315; Kline LB, 2001, J NEUROL NEUROSUR PS, V71, P577, DOI 10.1136/jnnp.71.5.577; Lee EJ, 2005, KOREAN J RADIOL, V6, P82, DOI 10.3348/kjr.2005.6.2.82; McKinney AM, 2006, AM J NEURORADIOL, V27, P2217; Pemberton JD, 2012, OPHTHAL PLAST RECONS, V28, P79, DOI 10.1097/IOP.0b013e318238ecf7; Som PM, 2003, HEAD NECK IMAGING, P329; Weber AL, 1999, RADIOL CLIN N AM, V37, P151, DOI 10.1016/S0033-8389(05)70084-1; YOUSEM DM, 1990, AM J ROENTGENOL, V154, P167, DOI 10.2214/ajr.154.1.2104703	16	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57126	10.1371/journal.pone.0057126	http://dx.doi.org/10.1371/journal.pone.0057126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437329	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000078
J	Lobelle, D; Kenyon, EJ; Cook, KJ; Bull, JC				Lobelle, Delphine; Kenyon, Emma J.; Cook, Kevan J.; Bull, James C.			Local Competition and Metapopulation Processes Drive Long-Term Seagrass-Epiphyte Population Dynamics	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; COLONIZATION-EXTINCTION DYNAMICS; POSIDONIA-OCEANICA; COMMUNITY STRUCTURE; WESTERN AUSTRALIA; ALGAL EPIPHYTES; WASTING DISEASE; COCKBURN SOUND; BIOMASS; ASSEMBLAGES	It is well known that ecological processes such as population regulation and natural enemy interactions potentially occur over a range of spatial scales, and there is a substantial body of literature developing theoretical understanding of the interplay between these processes. However, there are comparatively few studies quantifying the long-term effects of spatial scaling in natural ecosystems. A key challenge is that trophic complexity in real-world biological communities quickly obscures the signal from a focal process. Seagrass meadows provide an excellent opportunity in this respect: in many instances, seagrasses effectively form extensive natural monocultures, in which hypotheses about endogenous dynamics can be formulated and tested. We present amongst the longest unbroken, spatially explict time series of seagrass abundance published to date. Data include annual measures of shoot density, total above-ground abundance, and associated epiphyte cover from five Zostera marina meadows distributed around the Isles of Scilly, UK, from 1996 to 2011. We explore empirical patterns at the local and metapopulation scale using standard time series analysis and develop a simple population dynamic model, testing the hypothesis that both local and metapopulation scale feedback processes are important. We find little evidence of an interaction between scales in seagrass dynamics but that both scales contribute approximately equally to observed local epiphyte abundance. By quantifying the long-term dynamics of seagrass-epiphyte interactions we show how measures of density and extent are both important in establishing baseline information relevant to predicting responses to environmental change and developing management plans. We hope that this study complements existing mechanistic studies of physiology, genetics and productivity in seagrass, whilst highlighting the potential of seagrass as a model ecosystem. More generally, this study provides a rare opportunity to test some of the predictions of ecological theory in a natural ecosystem of global conservation and economic value.	[Lobelle, Delphine; Bull, James C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Kenyon, Emma J.] Univ Birmingham, Coll Med & Dent Sci, Birmingham, AL USA; [Cook, Kevan J.] Nat England, Truro, England	University of Warwick	Bull, JC (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	jimbull@gmail.com		Lobelle, Delphine/0000-0003-1517-4815; Bull, James/0000-0002-4373-6830				Alcoverro T, 1997, AQUAT BOT, V56, P93, DOI 10.1016/S0304-3770(96)01098-4; Amarasekare P, 1998, AM NAT, V152, P298, DOI 10.1086/286169; Bonsall MB, 2005, P ROY SOC B-BIOL SCI, V272, P1465, DOI 10.1098/rspb.2005.3111; Bonsall MB, 2004, J ANIM ECOL, V73, P1043, DOI 10.1111/j.0021-8790.2004.00874.x; Borowitzka M, 1989, BIOL SEAGRASSES, P458; BOROWITZKA MA, 1990, MAR ECOL PROG SER, V64, P281, DOI 10.3354/meps064281; Borowitzka MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P441; BORUM J, 1985, MAR BIOL, V87, P211, DOI 10.1007/BF00539431; Bowden DA, 2001, J EXP MAR BIOL ECOL, V259, P133, DOI 10.1016/S0022-0981(01)00236-2; Bull JC, 2006, J ANIM ECOL, V75, P899, DOI 10.1111/j.1365-2656.2006.01107.x; Bull JC, 2012, OECOLOGIA, V169, P135, DOI 10.1007/s00442-011-2187-6; BULTHUIS DA, 1983, AQUAT BOT, V16, P137, DOI 10.1016/0304-3770(83)90089-X; BURDICK DM, 1993, MAR ECOL PROG SER, V94, P83, DOI 10.3354/meps094083; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMBRIDGE ML, 1986, AQUAT BOT, V24, P269, DOI 10.1016/0304-3770(86)90062-8; Cardoso PG, 2004, J EXP MAR BIOL ECOL, V302, P233, DOI 10.1016/j.jembe.2003.10.014; Caruso A, 2010, OIKOS, V119, P1947, DOI 10.1111/j.1600-0706.2010.18713.x; COLEMAN VL, 1994, J EXP MAR BIOL ECOL, V179, P29, DOI 10.1016/0022-0981(94)90015-9; Cook K.J., 2002, ISLES SCILLY ZOSTERA; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CULLINANE J, 1985, CRYPTOGAMIE ALGOL, V6, P239; Cunha AH, 2009, ESTUAR COAST SHELF S, V84, P584, DOI 10.1016/j.ecss.2009.07.030; Cunha AH, 2005, ESTUAR COAST SHELF S, V64, P636, DOI 10.1016/j.ecss.2005.03.018; Cunha AH, 2012, RESTOR ECOL, V20, P427, DOI 10.1111/j.1526-100X.2012.00878.x; Deegan LA, 2002, AQUAT CONSERV, V12, P193, DOI 10.1002/aqc.490; DENNISON WC, 1987, AQUAT BOT, V27, P15, DOI 10.1016/0304-3770(87)90083-0; Duarte CM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P271; DUARTE CM, 1987, CAN J FISH AQUAT SCI, V44, P1759, DOI 10.1139/f87-215; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Fedrowitz K, 2012, J APPL ECOL, V49, P493, DOI 10.1111/j.1365-2664.2012.02113.x; Fourqurean JW, 2010, MAR ECOL PROG SER, V419, P223, DOI 10.3354/meps08853; Frankovich TA, 1997, MAR ECOL PROG SER, V159, P37, DOI 10.3354/meps159037; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Hanski I., 1999, METAPOPULATION ECOLO; HARLIN M M, 1975, Aquatic Botany, V1, P125, DOI 10.1016/0304-3770(75)90017-0; HEIJS FML, 1985, AQUAT BOT, V21, P295, DOI 10.1016/0304-3770(85)90074-9; HEIJS FML, 1984, AQUAT BOT, V20, P195, DOI 10.1016/0304-3770(84)90087-1; Jackson EL, 2011, 087 NAT ENGL; Johansson V, 2012, ECOLOGY, V93, P235, DOI 10.1890/11-0760.1; Johnson MP, 2005, AQUAT BOT, V82, P12, DOI 10.1016/j.aquabot.2005.02.003; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Lavery PS, 2002, MAR ECOL PROG SER, V236, P99, DOI 10.3354/meps236099; Lepoint G, 1999, HYDROBIOLOGIA, V394, P63, DOI 10.1023/A:1003557303904; LETHBRIDGE RC, 1988, AQUAT BOT, V31, P153, DOI 10.1016/0304-3770(88)90045-9; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; MacArthur R.H., 1972, pvii; Marba N, 1996, MAR ECOL PROG SER, V137, P203, DOI 10.3354/meps137203; McGlinn DJ, 2012, ECOLOGY, V93, P294, DOI 10.1890/11-0229.1; McLaughlin JF, 1992, THEOR POPUL BIOL, V41, P337; MONCREIFF CA, 1992, MAR ECOL PROG SER, V87, P161, DOI 10.3354/meps087161; Moore KA, 1997, J EXP MAR BIOL ECOL, V215, P115, DOI 10.1016/S0022-0981(96)02774-8; OLESEN B, 1994, J ECOL, V82, P379, DOI 10.2307/2261305; OLESEN B, 1994, MAR ECOL PROG SER, V109, P283, DOI 10.3354/meps109283; ORTH RJ, 1984, AQUAT BOT, V18, P43, DOI 10.1016/0304-3770(84)90080-9; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Peck SL, 2012, ECOL MODEL, V246, P99, DOI 10.1016/j.ecolmodel.2012.07.016; Piazzi L, 2000, CRYPTOGAMIE ALGOL, V21, P291, DOI 10.1016/S0181-1568(00)00116-1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plus M, 2001, J EXP MAR BIOL ECOL, V259, P63, DOI 10.1016/S0022-0981(01)00223-4; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Reusch TBH, 1999, MOL ECOL, V8, P317, DOI 10.1046/j.1365-294X.1999.00531.x; Reyes J, 1998, BOT MAR, V41, P543, DOI 10.1515/botm.1998.41.1-6.543; ROBBINS BD, 1994, TRENDS ECOL EVOL, V9, P301, DOI 10.1016/0169-5347(94)90041-8; Roberge JM, 2011, J APPL ECOL, V48, P650, DOI 10.1111/j.1365-2664.2011.01963.x; Romero J, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P227; Royama T., 1992, ANAL POPULATION ECOL; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; Ruiz JM, 2001, MAR ECOL PROG SER, V215, P107, DOI 10.3354/meps215107; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SAND-JENSEN K, 1977, Aquatic Botany, V3, P55, DOI 10.1016/0304-3770(77)90004-3; Saunders JE, 2003, MAR ECOL PROG SER, V249, P107, DOI 10.3354/meps249107; SILBERSTEIN K, 1986, AQUAT BOT, V24, P355, DOI 10.1016/0304-3770(86)90102-6; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Stankelis RM, 2003, ESTUARIES, V26, P186, DOI 10.1007/BF02695961; Sutcliffe OL, 1997, OECOLOGIA, V109, P235, DOI 10.1007/s004420050078; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; THOMAS CD, 1994, CONSERV BIOL, V8, P373, DOI 10.1046/j.1523-1739.1994.08020373.x; Thomsen MS, 2012, PLOS ONE, V7, P21, DOI 10.1371/journal.pone.0028595; Townsend C., 2008, ESSENTIALS ECOLOGY, P281; van der Heide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042060; Vanderklift MA, 2000, MAR ECOL PROG SER, V192, P127, DOI 10.3354/meps192127; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wear DJ, 1999, MAR ECOL PROG SER, V179, P201, DOI 10.3354/meps179201; Winkler M, 2009, ANN BOT-LONDON, V104, P995, DOI 10.1093/aob/mcp188; Yamamuro M, 1999, CORAL REEFS, V18, P263, DOI 10.1007/s003380050191; Zimmerman RC, 1987, STROKE MICROCIRCULAT, P303; Zipperle AM, 2011, ANN BOT-LONDON, V107, P127, DOI 10.1093/aob/mcq214; Zipperle AM, 2010, AQUAT BOT, V93, P202, DOI 10.1016/j.aquabot.2010.05.002	92	15	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57072	10.1371/journal.pone.0057072	http://dx.doi.org/10.1371/journal.pone.0057072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437313	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000315186000073
J	Archer, E; Shook, RP; Thomas, DM; Church, TS; Katzmarzyk, PT; Hebert, JR; McIver, KL; Hand, GA; Lavie, CJ; Blair, SN				Archer, Edward; Shook, Robin P.; Thomas, Diana M.; Church, Timothy S.; Katzmarzyk, Peter T.; Hebert, James R.; McIver, Kerry L.; Hand, Gregory A.; Lavie, Carl J.; Blair, Steven N.			45-Year Trends in Women's Use of Time and Household Management Energy Expenditure	PLOS ONE			English	Article							NATIONAL NUTRITION SURVEY; PHYSICAL-ACTIVITY; BODY-WEIGHT; SEDENTARY BEHAVIOR; OBESITY; DISEASE; LIFE; INACTIVITY; WALKING; ADULTS	Context: Relationships between socio-environmental factors and obesity are poorly understood due to a dearth of longitudinal population-level research. The objective of this analysis was to examine 45-year trends in time-use, household management (HM) and energy expenditure in women. Design and Participants: Using national time-use data from women 19-64 years of age, we quantified time allocation and household management energy expenditure (HMEE) from 1965 to 2010. HM was defined as the sum of time spent in food preparation, post-meal cleaning activities (e.g., dish-washing), clothing maintenance (e.g., laundry), and general housework. HMEE was calculated using body weights from national surveys and metabolic equivalents. Results: The time allocated to HM by women (19-64 yrs) decreased from 25.7 hr/week in 1965 to 13.3 hr/week in 2010 (P<0.001), with non-employed women decreasing by 16.6 hr/week and employed women by 6.7 hr/week (P<0.001). HMEE for non-employed women decreased 42% from 25.1 Mj/week (6004 kilocalories per week) in 1965 to 14.6 Mj/week (3486 kcal/week) in 2010, a decrement of 10.5 Mj/week or 1.5 Mj/day (2518 kcal/week; 360 kcal/day) (P<0.001), whereas employed women demonstrated a 30% decrement of 3.9 Mj/week, 0.55 Mj/day (923 kcal/week, 132 kcal/day) (P<0.001). The time women spent in screen-based media use increased from 8.3 hr/week in 1965 to 16.5 hr/week in 2010 (P<0.001), with non-employed women increasing 9.6 hr/week and employed women 7.5 hr/week (P<0.001). Conclusions: From 1965 to 2010, there was a large and significant decrease in the time allocated to HM. By 2010, women allocated 25% more time to screen-based media use than HM (i.e., cooking, cleaning, and laundry combined). The reallocation of time from active pursuits (i.e., housework) to sedentary pastimes (e.g., watching TV) has important health consequences. These results suggest that the decrement in HMEE may have contributed to the increasing prevalence of obesity in women during the last five decades.	[Archer, Edward; Shook, Robin P.; McIver, Kerry L.; Hand, Gregory A.; Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Thomas, Diana M.] Montclair State Univ, Ctr Quantitat Obes Res, Montclair, NJ USA; [Church, Timothy S.; Katzmarzyk, Peter T.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Hebert, James R.; Blair, Steven N.] Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Hebert, James R.] Univ S Carolina, Canc Prevent & Control Program, Columbia, SC 29208 USA; [Lavie, Carl J.] Univ Queensland, Ochsner Heart & Vasc Inst, Sch Med, New Orleans, LA USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Montclair State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Ochsner Health System; University of Queensland	Archer, E (corresponding author), Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.	archer.edwardc@gmail.com	Katzmarzyk, Peter T/N-1974-2017; Lavie, Carl J/A-6014-2011; Archer, Edward/J-9567-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Archer, Edward/0000-0002-9339-6918	Coca-Cola Company; Sanofi Aventis; Orexigen; Arena; Amylin; Body-Media	Coca-Cola Company; Sanofi Aventis(Sanofi-Aventis); Orexigen; Arena(Australian Renewable Energy Agency (ARENA)); Amylin; Body-Media	This study was funded via an unrestricted research grant from The Coca-Cola Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GAH has received consultancy fees from The Coca-Cola Company. TSC receives honoraria for lectures from scientific, educational, and lay groups. TSC has a book entitled "Move Yourself: The Cooper Clinic Medical Director''s Guide to All the Healing Benefits of Exercise." TSC has received unrestricted research funding Cover Letter from The Coca-Cola Company. TSC has overseen study sites for large pharmaceutical trials funded by Sanofi Aventis, Orexigen, Arena and Amylin. TSC is a member of the Jenny Craig Medical Advisory Board and has served as a consultant to Technogym, Trestle Tree, Vivus, Lockton-Dunning and Neuliven Health. In addition, he serves as the Senior Medical Advisor for Catapult Health. DMT has received honoraria for service on the Scientific/Medical Advisory Boards for Jenny Craig. SNB receives book royalties (<$5,000/year) from Human Kinetics; honoraria for service on the Scientific/Medical Advisory Boards for Clarity, Technogym, Body Media, Santech, and Jenny Craig; and honoraria for lectures and consultations from scientific, educational, and lay groups which are donated to the University of South Carolina or not-for-profit organizations. SNB is a consultant on research projects with the University of Texas-Southwestern Medical School and the University of Miami. During the past 5-year period SNB has received research grants from The Coca-Cola Company and Body-Media. There are no patents, products in development or marketed products to declare. This does not alter the authors'' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adamo KB, 2012, INT J ENV RES PUB HE, V9, P1263, DOI 10.3390/ijerph9041263; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 1985, World Health Organ Tech Rep Ser, V724, P1; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; Archer E, 2012, RES EXERC EPIDEMIOL, V14, P1; Archer E, 2011, PROG CARDIOVASC DIS, V53, P387, DOI 10.1016/j.pcad.2011.02.006; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bianchi SM, 2000, SOC FORCES, V79, P191, DOI 10.2307/2675569; Bianchi SM., 2006, CHANGING RHYTHMS AM; Bianchi SM., 2005, ATUS EARL RES C, P5; Bianchi SM., 2005, WORK FAMILY HLTH WEL; Bianchi SM, 2011, ANN AM ACAD POLIT SS, V638, P21, DOI 10.1177/0002716211413731; BLACK AE, 1993, J AM DIET ASSOC, V93, P572, DOI 10.1016/0002-8223(93)91820-G; Blair SN, 2012, SCAND J MED SCI SPOR, V22, pE24, DOI 10.1111/j.1600-0838.2012.01462.x; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Costa DL, 1997, HLTH WELFARE DUIRNG; DIAZ EO, 1992, AM J CLIN NUTR, V56, P641, DOI 10.1093/ajcn/56.4.641; Drake Amanda J, 2011, Pediatr Endocrinol Rev, V9, P566; Droyvold WB, 2004, INT J OBESITY, V28, P410, DOI 10.1038/sj.ijo.0802569; Egerton M, 2005, 200528 I SOC EC RES; England P., 1986, HOUSEHOLDS EMPLOYMEN; Evenson KR, 2011, PREV MED, V53, P39, DOI 10.1016/j.ypmed.2011.04.014; Evenson KR, 2010, PREV MED, V50, P123, DOI 10.1016/j.ypmed.2009.12.015; FAO/WHO/UNU, 2001, HUM EN REQ REP JOINT; Fisher K, 2011, AM HERITAGE TIME USE; Fitzhugh EC, 2009, J PHYS ACT HEALTH, V6, P393, DOI 10.1123/jpah.6.4.393; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Funatogawa I, 2009, INT J EPIDEMIOL, V38, P83, DOI 10.1093/ije/dyn182; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Gunn SM, 2005, EUR J APPL PHYSIOL, V94, P476, DOI 10.1007/s00421-004-1302-3; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hammermeister J, 2005, HEALTH COMMUN, V17, P253, DOI 10.1207/s15327027hc1703_3; Katanoda K, 2002, J NUTR SCI VITAMINOL, V48, P423, DOI 10.3177/jnsv.48.423; Keys A, 1950, BIOL HUMAN STARVATIO; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Krantz-Kent R, 2009, MON LABOR REV, V132, P46; Lanningham-Foster L, 2003, OBES RES, V11, P1178, DOI 10.1038/oby.2003.162; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matsumura Y, 2001, ASIA PAC J CLIN NUTR, V10, pS40, DOI 10.1046/j.1440-6047.2001.0100s1S40.x; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; NAS/IOM, 2005, REP PAN MACR DIET RE; Nayga RMJ, 2012, DEMAND FOOD AWAY HOM; [Nielsen Nielsen Media Research Research NM], 2006, AV DAIL VIEW 1950 20; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; PASQUET P, 1994, AM J CLIN NUTR, V60, P861, DOI 10.1093/ajcn/60.6.861; Rafferty AP, 2002, MED SCI SPORT EXER, V34, P1255, DOI 10.1097/00005768-200208000-00005; Ratzlaff CR, 2012, BRIT J SPORT MED, V46, P699, DOI 10.1136/bjsports-2011-090800; ROBERTS SB, 1990, AM J PHYSIOL, V259, pR461, DOI 10.1152/ajpregu.1990.259.3.R461; ROBINSON J, 1999, TIME LIFE; Robinson JP, 2009, SOC INDIC RES, V93, P47, DOI 10.1007/s11205-008-9370-0; ROSSITER JR, 1975, SOCIOMETRY, V38, P308, DOI 10.2307/2786167; SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X; Silventoinen K, 2004, INT J OBESITY, V28, P710, DOI 10.1038/sj.ijo.0802614; Sims E A, 1973, Recent Prog Horm Res, V29, P457; Speakman JR, 2002, P NUTR SOC, V61, P473, DOI 10.1079/PNS2002194; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Swinburn B, 2011, PUBLIC HEALTH NUTR, P1; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Toosi M, 2002, CENTURY LABOR CHANGE; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P347, DOI 10.1123/jpah.6.3.347; Tudor-Locke C, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-45; USDA, 2004, NUTR CONT US FOOD SU; van der Ploeg HP, 2010, AM J EPIDEMIOL, V172, P1199, DOI 10.1093/aje/kwq265; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Westerterp KR, 2004, CURR OPIN CLIN NUTR, V7, P607, DOI 10.1097/00075197-200411000-00004; Withers RT, 2006, EUR J APPL PHYSIOL, V97, P494, DOI 10.1007/s00421-006-0177-x; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x; Zick CD, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-84	75	106	108	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56620	10.1371/journal.pone.0056620	http://dx.doi.org/10.1371/journal.pone.0056620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437187	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200121
J	Fan, F; Xue, WQ; Wu, BH; He, MG; Xie, HL; Ouyang, WF; Tu, SL; Chen, YM				Fan, Fan; Xue, Wen-Qiong; Wu, Bao-Hua; He, Ming-Guang; Xie, Hai-Li; Ouyang, Wei-Fu; Tu, Su-lan; Chen, Yu-Ming			Higher Fish Intake Is Associated with a Lower Risk of Hip Fractures in Chinese Men and Women: A Matched Case-Control Study	PLOS ONE			English	Article							N-3 FATTY-ACIDS; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; VITAMIN-D; CALCIUM; OSTEOPOROSIS; CONSUMPTION; HEALTH; IMPACT; OMEGA-3-FATTY-ACIDS	Objectives: Fish is rich in nutrients that are favorable to bone health, but limited data are available regarding the relationship between fish intake and hip fractures. Our study examined the association between habitual fish intake and risk of hip fractures. Methods: A case-control study was performed between June 2009 and June 2012 in Guangdong Province, China. Five hundred and eighty-one hip fracture incident cases, aged 55 to 80 years (mean: 71 years), were enrolled from four hospitals. 1:1 matched controls by gender and age (+/- 3 years) were also recruited from communities and hospitals. Face-to-face interviews were used to obtain habitual dietary intake and information on various covariates. Results: Univariate conditional logistic regression analyses showed significantly dose-dependent inverse correlations between the risk of hip fractures and the intake of fresh-water fish, sea fish, mollusca, shellfish, and total fish in all of the subjects (p-trend: <0.001-0.016). After adjusting for covariates, the associations were slightly attenuated but remained significant for all (p-trend: <0.001-0.017) except for fresh-water fish (p = 0.553). The ORs (95% CI) of hip fractures for the highest (vs. lowest) quartile were 0.80 (0.48-1.31) for fresh-water fish, 0.31 (0.18-0.52) for sea fish, 0.55 (0.34-0.88) for mollusca and shellfish, and 0.47 (0.28-0.79) for total fish, respectively. Stratified and interaction analyses showed that the association was more significant in males than in females (p-interaction = 0.052). Conclusion: Higher intake of seafood is independently associated with lower risk of hip fractures in elderly Chinese. Increasing consumption of sea fish may benefit the prevention of hip fractures in this population.	[Fan, Fan; Xue, Wen-Qiong; Wu, Bao-Hua; Xie, Hai-Li; Ouyang, Wei-Fu; Tu, Su-lan; Chen, Yu-Ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Bao-Hua] Guangzhou Orthopaed Trauma Hosp, Guangzhou, Guangdong, Peoples R China; [He, Ming-Guang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Ouyang, Wei-Fu] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Tu, Su-lan] Orthopaed Hosp Baishi Dist, Jiangmen, Guangdong, Peoples R China; [Xue, Wen-Qiong] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn	Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019; He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810; chen, Yu-ming/0000-0003-1658-5528	National Natural Science Foundation of China [30872100, 81072299]; 5010 Program for Clinical Researches of Sun Yat-sen University [2007032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 5010 Program for Clinical Researches of Sun Yat-sen University	The study was jointly supported by the National Natural Science Foundation of China (No. 30872100, 81072299) and the 5010 Program for Clinical Researches of Sun Yat-sen University (No. 2007032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caughey GE, 1996, AM J CLIN NUTR, V63, P116, DOI 10.1093/ajcn/63.1.116; Chen YM, 2010, OSTEOPOROSIS INT, V21, P939, DOI 10.1007/s00198-009-1029-4; CLAASSEN N, 1995, PROSTAG LEUKOTR ESS, V53, P13, DOI 10.1016/0952-3278(95)90078-0; CLAASSEN N, 1995, BONE, V16, pS385, DOI 10.1016/S8756-3282(95)80481-1; Cumming RG, 1997, J BONE MINER RES, V12, P1321, DOI 10.1359/jbmr.1997.12.9.1321; Dargent-Molina P, 2008, J BONE MINER RES, V23, P1915, DOI 10.1359/JBMR.080712; Farina EK, 2011, AM J CLIN NUTR, V93, P1142, DOI 10.3945/ajcn.110.005926; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Feskanich D, 2003, AM J CLIN NUTR, V77, P504, DOI 10.1093/ajcn/77.2.504; Fujiwara S, 1997, J BONE MINER RES, V12, P998, DOI 10.1359/jbmr.1997.12.7.998; Haag M, 2003, PROSTAG LEUKOTR ESS, V68, P423, DOI 10.1016/S0952-3278(03)00067-X; Jin S. G., 2008, 2002 NATL NUTR HL 10, P62; Kerstetter JE, 2011, CURR OPIN LIPIDOL, V22, P16, DOI 10.1097/MOL.0b013e3283419441; Kruger MC, 1997, PROG LIPID RES, V36, P131, DOI 10.1016/S0163-7827(97)00007-6; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Macdonald HM, 2004, AM J CLIN NUTR, V79, P155; MacDonald HM, 2005, PUBLIC HEALTH NUTR, V8, P409, DOI 10.1079/PHN2005705; Maggio M, 2009, CURR PHARM DESIGN, V15, P4157, DOI 10.2174/138161209789909728; Mithal A, 2009, ASIAN AUDIT EPIDEMIO; NEW SA, 2003, NUTR ASPECTS BONE HL; Pongchaiyakul Chatlert, 2008, Journal of the Medical Association of Thailand, V91, P581; Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590; REMER T, 1995, J AM DIET ASSOC, V95, P791, DOI 10.1016/S0002-8223(95)00219-7; Salari P, 2008, MED SCI MONITOR, V14, pRA37; Sellmeyer DE, 2001, AM J CLIN NUTR, V73, P118; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Suzuki T, 1997, BONE, V21, P461, DOI 10.1016/S8756-3282(97)00179-8; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Virtanen JK, 2010, J BONE MINER RES, V25, P1972, DOI 10.1002/jbmr.87; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Zalloua P, 2007, MATURITAS, V56, P1, DOI 10.1016/j.maturitas.2006.05.001; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240	32	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56849	10.1371/journal.pone.0056849	http://dx.doi.org/10.1371/journal.pone.0056849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437256	gold, Green Published			2022-12-27	WOS:000315184200172
J	Gierszewski, S; Bleckmann, H; Schluessel, V				Gierszewski, Stefanie; Bleckmann, Horst; Schluessel, Vera			Cognitive Abilities in Malawi Cichlids (Pseudotropheus sp.): Matching-to-Sample and Image/Mirror-Image Discriminations	PLOS ONE			English	Article							VISUAL-PATTERN-RECOGNITION; MENTAL ROTATION; CONDITIONAL DISCRIMINATION; MIRROR IMAGES; ORIENTATION; PERFORMANCE; PERCEPTION; EVOLUTION; STIMULI; PIGEONS	The ability to recognize and distinguish between visual stimuli is fundamental for everyday survival of many species. While diverse aspects of cognition, including complex visual discrimination tasks were previously successfully assessed in fish, it remains unknown if fish can learn a matching-to-sample concept using geometrical shapes and discriminate between images and their mirror-image counterparts. For this purpose a total of nine Malawi cichlids (Pseudotropheus sp.) were trained in two matching-to-sample (MTS) and three two-choice discrimination tasks using geometrical, two-dimensional visual stimuli. Two out of the three discrimination experiments focused on the ability to discriminate between images and their mirror-images, the last was a general discrimination test. All fish showed quick associative learning but were unable to perform successfully in a simultaneous MTS procedure within a period of 40 sessions. Three out of eight fish learned to distinguish between an image and its mirror-image when reflected vertically; however none of the fish mastered the task when the stimulus was reflected horizontally. These results suggest a better discrimination ability of vertical compared to horizontal mirror-images, an observation that is widespread in literature on mirror-image discrimination in animals. All fish performed well in the general visual discrimination task, thereby supporting previous results obtained for this species.	[Gierszewski, Stefanie; Bleckmann, Horst; Schluessel, Vera] Univ Bonn, Inst Zool, Bonn, Nordrhein Westf, Germany	University of Bonn	Schluessel, V (corresponding author), Univ Bonn, Inst Zool, Bonn, Nordrhein Westf, Germany.	v.schluessel@uni-bonn.de	Gierszewski, Stefanie/AAE-8869-2020; Gierszewski, Stefanie/I-5925-2015	Gierszewski, Stefanie/0000-0002-0043-5077				APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Arthur D, 2001, ANIM COGN, V4, P125, DOI DOI 10.1007/S100710100111; Beale I.L., 2020, PSYCHOL LEFT RIGHT; BEHREND ER, 1961, AM J PSYCHOL, V74, P542, DOI 10.2307/1419664; BERRYMAN R, 1963, J EXP ANAL BEHAV, V6, P101, DOI 10.1901/jeab.1963.6-101; BLOUGH DS, 1959, J EXP ANAL BEHAV, V2, P151, DOI 10.1901/jeab.1959.2-151; BORNSTEIN MH, 1978, COGNITION, V6, P89, DOI 10.1016/0010-0277(78)90017-3; BOWMAN R, 1969, Q J EXP PSYCHOL, V21, P69, DOI 10.1080/14640746908400198; BRADSHAW J, 1976, Q J EXP PSYCHOL, V28, P221, DOI 10.1080/14640747608400553; BROWN JV, 1983, Q J EXP PSYCHOL-B, V35, P119, DOI 10.1080/14640748308400898; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Burmann B, 2005, BRAIN BEHAV EVOLUT, V65, P168, DOI 10.1159/000083626; CARTER DE, 1975, SCIENCE, V187, P662, DOI 10.1126/science.1114318; Colwill RM, 2005, BEHAV PROCESS, V70, P19, DOI 10.1016/j.beproc.2005.03.001; CORBALLIS MC, 1984, J EXP PSYCHOL HUMAN, V10, P318, DOI 10.1037/0096-1523.10.2.318; DAMATO MR, 1985, ANIM LEARN BEHAV, V13, P375, DOI 10.3758/BF03208013; DAMATO MR, 1985, J EXP PSYCHOL ANIM B, V11, P35, DOI 10.1037/0097-7403.11.1.35; Day LB, 2003, J COMP PSYCHOL, V117, P440, DOI 10.1037/0735-7036.117.4.440; DELIUS JD, 1995, J COMP PSYCHOL, V109, P278, DOI 10.1037/0735-7036.109.3.278; Demski L.S., 1983, P317; DUCKER G, 1979, Z TIERPSYCHOL, V51, P269; Ducker G, 1984, ZOOL BEITR, V28, P187; Dyer AG, 2012, J EXP BIOL, V215, P387, DOI 10.1242/jeb.038190; Engelmann WE, 2005, ZOOTIERHALTUNG TIERE, V3; ETTLINGER G, 1962, NATURE, V194, P1101, DOI 10.1038/1941101c0; FARTHING GW, 1974, J EXP ANAL BEHAV, V21, P199, DOI 10.1901/jeab.1974.21-199; FOSTER TM, 1995, J EXP ANAL BEHAV, V64, P19, DOI 10.1901/jeab.1995.64-19; Frech B, 2012, J COMP PHYSIOL A, V198, P53, DOI 10.1007/s00359-011-0685-y; Gellermann LW, 1933, PEDAGOG SEMIN J GEN, V42, P206; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GOLDMAN M, 1979, J EXP ANAL BEHAV, V31, P259, DOI 10.1901/jeab.1979.31-259; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; HEPPER PG, 1988, PERCEPTION, V17, P549, DOI 10.1068/p170549; HERMAN LM, 1974, J EXP ANAL BEHAV, V21, P17; HERT E, 1989, ANIM BEHAV, V37, P726, DOI 10.1016/0003-3472(89)90058-4; Herter K, 1953, FISCHDRESSUREN IHRE; HOLLARD VD, 1982, SCIENCE, V218, P804, DOI 10.1126/science.7134976; HOPKINS WD, 1993, J EXP PSYCHOL GEN, V122, P61, DOI 10.1037/0096-3445.122.1.61; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P167, DOI 10.1159/000113330; IVERSEN IH, 1993, J EXP ANAL BEHAV, V59, P471, DOI 10.1901/jeab.1993.59-471; Iversen IH, 1997, J EXP ANAL BEHAV, V68, P27, DOI 10.1901/jeab.1997.68-27; IVERSEN IH, 1986, J EXP ANAL BEHAV, V45, P297, DOI 10.1901/jeab.1986.45-297; Jenkin SEM, 2010, LEARN BEHAV, V38, P418, DOI 10.3758/LB.38.4.418; KASTAK D, 1994, ANIM LEARN BEHAV, V22, P427, DOI 10.3758/BF03209162; Keenleyside MHA, 1991, CHICHLID FISHES BEHA; Kirk SA, 1936, J COMP PSYCHOL, V21, P145, DOI 10.1037/h0057154; KONORSKI J., 1959, BULL ACAD POLONAISE SCI SER SCI BIOL, V7, P115; KORNELUK YG, 1995, BEHAVIOUR, V132, P87, DOI 10.1163/156853995X00306; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; Lashley KS, 1938, J GEN PSYCHOL, V18, P123, DOI 10.1080/00221309.1938.9709894; Leal M, 2012, BIOL LETTERS, V8, P28, DOI 10.1098/rsbl.2011.0480; LOHMANN A, 1988, J COMP PSYCHOL, V102, P3, DOI 10.1037/0735-7036.102.1.3; Mackay H.A., 1991, EXPT ANAL BEHAV, V6, P301; MACKINTOSH J., 1963, ANIMAL BEHAVIOUR, V11, P135, DOI 10.1016/0003-3472(63)90021-6; MARK RF, 1969, ANIM BEHAV, V17, P155, DOI 10.1016/0003-3472(69)90124-9; MARK RF, 1966, EXP NEUROL, V16, P215, DOI 10.1016/0014-4886(66)90100-2; Mauck B, 1997, J EXP BIOL, V200, P1309; Nissen HW, 1937, J COMP PSYCHOL, V23, P165, DOI 10.1037/h0062381; PACK AA, 1991, ANIM LEARN BEHAV, V19, P37, DOI 10.3758/BF03197858; Phillmore LS, 2008, BEHAV PROCESS, V77, P285, DOI 10.1016/j.beproc.2007.11.004; Plowright CMS, 1997, ANIM BEHAV, V53, P1295, DOI 10.1006/anbe.1996.0363; Preacher K.J., 2001, CALCULATION CHI SQUA; Range F, 2008, ACTA ETHOL, V11, P34, DOI 10.1007/s10211-008-0039-0; RIOPELLE AJ, 1964, PERCEPT MOTOR SKILL, V19, P383, DOI 10.2466/pms.1964.19.2.383; RUDEL RG, 1963, J COMP PHYSIOL PSYCH, V56, P892, DOI 10.1037/h0046592; SANFORD CG, 1986, PSYCHOL REC, V36, P439, DOI 10.1007/BF03394964; SCHALLER A., 1926, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V4, P370, DOI 10.1007/BF00340839; Schluessel V, 2012, ANIM COGN, V15, P525, DOI 10.1007/s10071-012-0480-3; SCHUCK JR, 1960, J COMP PHYSIOL PSYCH, V53, P251, DOI 10.1037/h0044769; Schuster S, 2002, J EXP BIOL, V205, P549; Schwarz S, 2011, ANIM COGN, V14, P861, DOI 10.1007/s10071-011-0419-0; Shettleworth S.J., 2009, COGNITION EVOLUTION; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; Shumway CA, 2010, CURR ZOOL, V56, P144, DOI 10.1093/czoolo/56.1.144; SIDMAN M, 1982, J EXP ANAL BEHAV, V37, P5, DOI 10.1901/jeab.1982.37-5; Siebeck UE, 2009, J EXP BIOL, V212, P2112, DOI 10.1242/jeb.028936; Smirnova AA, 2000, J EXP ANAL BEHAV, V73, P163, DOI 10.1901/jeab.2000.73-163; Smith NB, 1928, J EDUC PSYCHOL, V19, P560, DOI 10.1037/h0069779; Sovrano VA, 2008, ANIM COGN, V11, P161, DOI 10.1007/s10071-007-0100-9; Sovrano VA, 2009, PERCEPTION, V38, P579, DOI 10.1068/p6121; SUTHERLA.NS, 1969, Q J EXP PSYCHOL, V21, P330, DOI 10.1080/14640746908400228; SUTHERLAND NS, 1957, NATURE, V179, P11, DOI 10.1038/179011a0; SUTHERLAND NS, 1964, BRIT MED BULL, V20, P54, DOI 10.1093/oxfordjournals.bmb.a070283; SUTHERLAND NS, 1969, J COMP PHYSIOL PSYCH, V67, P160, DOI 10.1037/h0026798; SUTHERLAND NS, 1960, BRIT J PSYCHOL, V51, P9, DOI 10.1111/j.2044-8295.1960.tb00719.x; SUTHERLAND NS, 1958, J COMP PHYSIOL PSYCH, V51, P452, DOI 10.1037/h0048231; TODRIN DC, 1983, PERCEPT PSYCHOPHYS, V34, P397, DOI 10.3758/BF03203053; Tomina Y, 2012, BEHAV BRAIN RES, V229, P91, DOI 10.1016/j.bbr.2011.12.044; Vermaercke B, 2012, CURR BIOL, V22, P50, DOI 10.1016/j.cub.2011.11.041; WARREN JM, 1969, J COMP PHYSIOL PSYCH, V69, P9, DOI 10.1037/h0027954; WRIGHT AA, 1988, ANIM LEARN BEHAV, V16, P436, DOI 10.3758/BF03209384; WRIGHT AA, 2001, AVIAN VISUAL COGNITI; Wyzisk K, 2007, VISUAL NEUROSCI, V24, P291, DOI 10.1017/S095252380707023X; ZERBOLIO DJ, 1983, ANIM LEARN BEHAV, V11, P341, DOI 10.3758/BF03199786	95	32	32	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57363	10.1371/journal.pone.0057363	http://dx.doi.org/10.1371/journal.pone.0057363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437376	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200248
J	Hall, ML; Kingma, SA; Peters, A				Hall, Michelle L.; Kingma, Sjouke A.; Peters, Anne			Male Songbird Indicates Body Size with Low-Pitched Advertising Songs	PLOS ONE			English	Article							FEMALE MATE CHOICE; MULTIPLE BENEFITS; FAIRY-WRENS; FREQUENCY; BIRD; CALLS; EVOLUTION; CONTEXT; SIGNAL; COMMUNICATION	Body size is a key sexually selected trait in many animal species. If size imposes a physical limit on the production of loud low-frequency sounds, then low-pitched vocalisations could act as reliable signals of body size. However, the central prediction of this hypothesis - that the pitch of vocalisations decreases with size among competing individuals - has limited support in songbirds. One reason could be that only the lowest-frequency components of vocalisations are constrained, and this may go unnoticed when vocal ranges are large. Additionally, the constraint may only be apparent in contexts when individuals are indeed advertising their size. Here we explicitly consider signal diversity and performance limits to demonstrate that body size limits song frequency in an advertising context in a songbird. We show that in purple-crowned fairy-wrens, Malurus coronatus coronatus, larger males sing lower-pitched low-frequency advertising songs. The lower frequency bound of all advertising song types also has a significant negative relationship with body size. However, the average frequency of all their advertising songs is unrelated to body size. This comparison of different approaches to the analysis demonstrates how a negative relationship between body size and song frequency can be obscured by failing to consider signal design and the concept of performance limits. Since these considerations will be important in any complex communication system, our results imply that body size constraints on low-frequency vocalisations could be more widespread than is currently recognised.	[Hall, Michelle L.; Kingma, Sjouke A.; Peters, Anne] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Hall, Michelle L.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Kingma, Sjouke A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Peters, Anne] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Max Planck Society; University of Melbourne; University of East Anglia; Monash University	Hall, ML (corresponding author), Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany.	hall.m@unimelb.edu.au	Kingma, Sjouke Anne/B-3366-2011; Hall, Michelle L/A-1904-2010; Peters, Anne/A-1821-2010	Kingma, Sjouke Anne/0000-0002-6737-7975; Hall, Michelle L/0000-0002-1263-8314; Peters, Anne/0000-0001-8071-0560	Minerva Fellowship of the Max Planck Society; ARC Future Fellowship [FT110100505]	Minerva Fellowship of the Max Planck Society; ARC Future Fellowship(Australian Research Council)	This research was funded by a Minerva Fellowship of the Max Planck Society and an ARC Future Fellowship (FT110100505 to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bee MA, 2000, BEHAV ECOL, V11, P169, DOI 10.1093/beheco/11.2.169; Bradbury Jack W., 1998, pi; BYERS BE, 1995, CONDOR, V97, P390, DOI 10.2307/1369025; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Cardoso GC, 2008, ETHOLOGY, V114, P1084, DOI 10.1111/j.1439-0310.2008.01552.x; Cardoso GC, 2012, BEHAV ECOL, V23, P237, DOI 10.1093/beheco/arr200; Dalziell AH, 2008, ANIM BEHAV, V75, P489, DOI 10.1016/j.anbehav.2007.05.014; Donelson NC, 2005, BEHAVIOUR, V142, P761, DOI 10.1163/1568539054729088; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Fitch WT, 2000, ZOOL-ANAL COMPLEX SY, V103, P40; Fletcher NH, 2004, J ACOUST SOC AM, V115, P2334, DOI 10.1121/1.1694997; Galeotti P, 1997, ANIM BEHAV, V53, P687, DOI 10.1006/anbe.1996.0304; Geberzahn N, 2009, BEHAV ECOL SOCIOBIOL, V64, P193, DOI 10.1007/s00265-009-0836-0; Gillooly JF, 2010, P ROY SOC B-BIOL SCI, V277, P1325, DOI 10.1098/rspb.2009.2134; Greig EI, 2010, BEHAV ECOL, V21, P1360, DOI 10.1093/beheco/arq155; Hall ML, 2008, ANIM BEHAV, V76, P65, DOI 10.1016/j.anbehav.2008.01.010; Hall ML, 2009, BEHAV ECOL, V20, P222, DOI 10.1093/beheco/arn139; HANDFORD P, 1991, CONDOR, V93, P644, DOI 10.2307/1368196; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Kingma SA, 2011, AM NAT, V177, P486, DOI 10.1086/658989; Kingma SA, 2010, J ANIM ECOL, V79, P757, DOI 10.1111/j.1365-2656.2010.01697.x; LANGMORE NE, 1992, ETHOLOGY, V90, P143; Martin JP, 2011, J FIELD ORNITHOL, V82, P259, DOI 10.1111/j.1557-9263.2011.00329.x; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Patel R, 2010, ETHOLOGY, V116, P554, DOI 10.1111/j.1439-0310.2010.01769.x; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Riede T, 2010, J ANAT, V216, P23, DOI 10.1111/j.1469-7580.2009.01161.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Smith JM, 1995, J THEOR BIOL, V177, P305; Spencer KA, 2011, BEHAV ECOL, V22, P1, DOI 10.1093/beheco/arq068; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016	42	62	65	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56717	10.1371/journal.pone.0056717	http://dx.doi.org/10.1371/journal.pone.0056717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437221	Green Published, gold			2022-12-27	WOS:000315184200151
J	Jeon, JS; Zervantonakis, IK; Chung, S; Kamm, RD; Charest, JL				Jeon, Jessie S.; Zervantonakis, Ioannis K.; Chung, Seok; Kamm, Roger D.; Charest, Joseph L.			In Vitro Model of Tumor Cell Extravasation	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; MICROFLUIDIC PLATFORM; TRANSENDOTHELIAL MIGRATION; ENDOTHELIAL-CELLS; PERMEABILITY; GROWTH; ASSAY; PROLIFERATION; COCULTURE; ADHESION	Tumor cells that disseminate from the primary tumor and survive the vascular system can eventually extravasate across the endothelium to metastasize at a secondary site. In this study, we developed a microfluidic system to mimic tumor cell extravasation where cancer cells can transmigrate across an endothelial monolayer into a hydrogel that models the extracellular space. The experimental protocol is optimized to ensure the formation of an intact endothelium prior to the introduction of tumor cells and also to observe tumor cell extravasation by having a suitable tumor seeding density. Extravasation is observed for 38.8% of the tumor cells in contact with the endothelium within 1 day after their introduction. Permeability of the EC monolayer as measured by the diffusion of fluorescently-labeled dextran across the monolayer increased 3.8 fold 24 hours after introducing tumor cells, suggesting that the presence of tumor cells increases endothelial permeability. The percent of tumor cells extravasated remained nearly constant from1 to 3 days after tumor seeding, indicating extravasation in our system generally occurs within the first 24 hours of tumor cell contact with the endothelium.	[Jeon, Jessie S.; Zervantonakis, Ioannis K.; Kamm, Roger D.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Kamm, Roger D.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chung, Seok] Korea Univ, Sch Mech Engn, Seoul, South Korea; [Charest, Joseph L.] Charles Stark Draper Lab, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Korea University; The Charles Stark Draper Laboratory, Inc.	Kamm, RD (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	rdkamm@mit.edu; jcharest@draper.com	Jeon, Jessie Sungyun/J-2167-2015; Zervantonakis, Ioannis/N-9717-2019; Zervantonakis, Ioannis/C-2890-2011; Zervantonakis, Ioannis/ADS-2519-2022; Kamm, Roger D/I-7630-2012; Chung, Seok/B-1501-2015	Jeon, Jessie Sungyun/0000-0001-6690-5775; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; /0000-0002-7232-304X	National Cancer Institute [R21CA140096]; Repligen Fellowship in cancer research; Basic Science Research Program [2012-022481]; Human Resources Development Program [20124010203250]; Draper Laboratories Inc. (IRD Grant); Charles Stark Draper Laboratory; NATIONAL CANCER INSTITUTE [R33CA174550, R21CA140096] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Repligen Fellowship in cancer research; Basic Science Research Program; Human Resources Development Program; Draper Laboratories Inc. (IRD Grant); Charles Stark Draper Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by Award Number R21CA140096 from the National Cancer Institute, and Draper Laboratories Inc. (IR&D Grant). J. Jeon was supported by Repligen Fellowship in cancer research and S. Chung was supported by the Basic Science Research Program (grant No. 2012-022481) and the Human Resources Development Program (grant No. 20124010203250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Joseph L. Charest is employed by Charles Stark Draper Laboratory, one of the funders of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; ALBELDA SM, 1988, J APPL PHYSIOL, V64, P308, DOI 10.1152/jappl.1988.64.1.308; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chung S, 2009, ADV MATER, V21, P4863, DOI 10.1002/adma.200901727; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; CRISSMAN JD, 1988, CANCER RES, V48, P4065; DIMILLA PA, 1992, AICHE J, V38, P1092, DOI 10.1002/aic.690380712; Ewing J, 1928, NEOPLASTIC DIS TREAT; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gassmann P, 2009, INT J COLORECTAL DIS, V24, P851, DOI 10.1007/s00384-009-0694-2; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Han S, 2012, LAB CHIP; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; HENDRIX MJC, 1987, CANCER LETT, V38, P137, DOI 10.1016/0304-3835(87)90209-6; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; KOOP S, 1994, CANCER RES, V54, P4791; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Li YH, 1999, CLIN EXP METASTAS, V17, P423, DOI 10.1023/A:1006614232388; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Naumov GN, 1999, J CELL SCI, V112, P1835; Polacheck WJ, 2011, P NATL ACAD SCI USA, V108, P11115, DOI 10.1073/pnas.1103581108; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sahni A, 2009, INT J CANCER, V125, P577, DOI 10.1002/ijc.24340; Schluter K, 2006, AM J PATHOL, V169, P1064, DOI 10.2353/ajpath.2006.050566; Shin MK, 2011, LAB CHIP, V11, P3880, DOI 10.1039/c1lc20671k; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Shin Y, 2011, LAB CHIP, V11, P2175, DOI 10.1039/c1lc20039a; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang Q, 2012, LAB CHIP, V12, P2837, DOI 10.1039/c2lc00030j	46	143	151	0	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56910	10.1371/journal.pone.0056910	http://dx.doi.org/10.1371/journal.pone.0056910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437268	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200182
J	Meurer, SK; Alsamman, M; Sahin, H; Wasmuth, HE; Kisseleva, T; Brenner, DA; Trautwein, C; Weiskirchen, R; Scholten, D				Meurer, Steffen K.; Alsamman, Muhammad; Sahin, Hacer; Wasmuth, Hermann E.; Kisseleva, Tatiana; Brenner, David A.; Trautwein, Christian; Weiskirchen, Ralf; Scholten, David			Overexpression of Endoglin Modulates TGF-beta 1-Signalling Pathways in a Novel Immortalized Mouse Hepatic Stellate Cell Line	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LIVER FIBROSIS; ENDOTHELIAL-CELLS; EXPRESSION; MECHANISMS; MYOFIBROBLASTS; ACTIVATION; MIGRATION; TRANSDIFFERENTIATION; FIBROGENESIS	Hepatic stellate cells (HSCs) play a major role in the pathogenesis of liver fibrosis. Working on primary HSCs requires difficult isolation procedures; therefore we have generated and here characterize a mouse hepatic stellate cell line expressing GFP under control of the collagen 1(I) promoter/enhancer. These cells are responsive to pro-fibrogenic stimuIi, such as PDGF or TGF-beta 1, and are able to activate intracellular signalling pathways including Smads and MAP kinases. Nevertheless, due to the basal level of activation, TGF-beta 1 did not significantly induce GFP expression contrasting the TGF-beta 1 regulated endogenous collagen I expression. We could demonstrate that the accessory TGF-beta-receptor endoglin, which is endogenously expressed at very low levels, has a differential effect on signalling of these cells when transiently overexpressed. In the presence of endoglin activation of Smad1/5/8 was drastically enhanced. Moreover, the phosphorylation of ERK1/2 was increased, and the expression of vimentin, alpha-smooth muscle actin and connective tissue growth factor was upregulated. Endoglin induced a slight increase in expression of the inhibitor of differentiation-2 while the amount of endogenous collagen type I was reduced. Therefore, this profibrogenic cell line with hepatic stellate cell origin is not only a promising novel experimental tool, which can be used in vivo for cell tracing experiments. Furthermore it allows investigating the impact of various regulatory proteins (e. g. endoglin) on profibrogenic signal transduction, differentiation and hepatic stellate cell biology.	[Meurer, Steffen K.; Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Alsamman, Muhammad; Sahin, Hacer; Wasmuth, Hermann E.; Trautwein, Christian; Scholten, David] RWTH Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany; [Kisseleva, Tatiana; Brenner, David A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of California System; University of California San Diego	Scholten, D (corresponding author), RWTH Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany.	dscholten@ukaachen.de	Weiskirchen, Ralf/O-1734-2018	Weiskirchen, Ralf/0000-0003-3888-0931; Brenner, David/0000-0003-2573-525X	Deutsche Forschungsgemeinschaft [SFB/TRR 57 P13]; IZKF Aachen; START Program of the Medical Faculty of RWTH Aachen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Aachen; START Program of the Medical Faculty of RWTH Aachen	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB/TRR 57 P13), the IZKF Aachen, and the START Program of the Medical Faculty of RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BOROJEVIC R, 1985, IN VITRO CELL DEV B, V21, P382, DOI 10.1007/BF02623469; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Cassiman D, 1999, AM J PATHOL, V155, P1831, DOI 10.1016/S0002-9440(10)65501-0; Clemente M, 2006, J VIRAL HEPATITIS, V13, P625, DOI 10.1111/j.1365-2893.2006.00733.x; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Diez-Marques L, 2002, BBA-MOL BASIS DIS, V1587, P36, DOI 10.1016/S0925-4439(02)00051-0; Dooley S, 2000, HEPATOLOGY, V31, P1094, DOI 10.1053/he.2000.6126; Dudas J, 2007, CELL TISSUE RES, V329, P503, DOI 10.1007/s00441-007-0437-z; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Guerrero-Esteo M, 1999, EUR J CELL BIOL, V78, P614, DOI 10.1016/S0171-9335(99)80046-6; Herrmann J, 2007, J CELL MOL MED, V11, P704, DOI 10.1111/j.1582-4934.2007.00060.x; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Jerkic M, 2006, CIRC RES, V99, P248, DOI 10.1161/01.RES.0000236755.98627.69; Kamada Y, 2012, GLYCOBIOLOGY; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Meurer SK, 2005, BIOCHEM PHARMACOL, V70, P1026, DOI 10.1016/j.bcp.2005.07.001; Meurer SK, 2005, J BIOL CHEM, V280, P3078, DOI 10.1074/jbc.M405411200; Meurer SK, 2012, EUR J CELL BIOL, V91, P450, DOI 10.1016/j.ejcb.2011.09.004; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Santibanez JF, 2010, CARCINOGENESIS, V31, P2145, DOI 10.1093/carcin/bgq199; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; SCHAFER S, 1987, HEPATOLOGY, V7, P680, DOI 10.1002/hep.1840070411; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Schmidt-Weber CB, 2005, INT IMMUNOL, V17, P921, DOI 10.1093/intimm/dxh272; Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426; Scholten D, 2011, AM J PATHOL, V179, P189, DOI 10.1016/j.ajpath.2011.03.049; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Velasco S, 2008, J CELL SCI, V121, P913, DOI 10.1242/jcs.023283; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yagmur E, 2007, EUR J GASTROEN HEPAT, V19, P755, DOI 10.1097/MEG.0b013e3282202bea	50	33	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56116	10.1371/journal.pone.0056116	http://dx.doi.org/10.1371/journal.pone.0056116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437087	Green Published, gold			2022-12-27	WOS:000315184200041
J	Narusaka, M; Kubo, Y; Hatakeyama, K; Imamura, J; Ezura, H; Nanasato, Y; Tabei, Y; Takano, Y; Shirasu, K; Narusaka, Y				Narusaka, Mari; Kubo, Yasuyuki; Hatakeyama, Katsunori; Imamura, Jun; Ezura, Hiroshi; Nanasato, Yoshihiko; Tabei, Yutaka; Takano, Yoshitaka; Shirasu, Ken; Narusaka, Yoshihiro			Interfamily Transfer of Dual NB-LRR Genes Confers Resistance to Multiple Pathogens	PLOS ONE			English	Article							ARABIDOPSIS EDS1; EXPRESSION; DISEASE; PROTEIN; TOMATO; TRANSFORMATION; RECOGNITION; REQUIRES; AVRRPS4; CLONING	A major class of disease resistance (R) genes which encode nucleotide binding and leucine rich repeat (NB-LRR) proteins have been used in traditional breeding programs for crop protection. However, it has been difficult to functionally transfer NB-LRR-type R genes in taxonomically distinct families. Here we demonstrate that a pair of Arabidopsis (Brassicaceae) NB-LRR-type R genes, RPS4 and RRS1, properly function in two other Brassicaceae, Brassica rapa and Brassica napus, but also in two Solanaceae, Nicotiana benthamiana and tomato (Solanum lycopersicum). The solanaceous plants transformed with RPS4/RRS1 confer bacterial effector-specific immunity responses. Furthermore, RPS4 and RRS1, which confer resistance to a fungal pathogen Colletotrichum higginsianum in Brassicaceae, also protect against Colletotrichum orbiculare in cucumber (Cucurbitaceae). Importantly, RPS4/RRS1 transgenic plants show no autoimmune phenotypes, indicating that the NB-LRR proteins are tightly regulated. The successful transfer of two R genes at the family level implies that the downstream components of R genes are highly conserved. The functional interfamily transfer of R genes can be a powerful strategy for providing resistance to a broad range of pathogens.	[Narusaka, Mari; Narusaka, Yoshihiro] Res Inst Biol Sci Okayama, Okayama, Japan; [Kubo, Yasuyuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 606, Japan; [Hatakeyama, Katsunori] NARO Inst Vegetable & Tea Sci, Vegetable Breeding & Genome Res Div, Tsu, Mie, Japan; [Imamura, Jun] Tamagawa Univ, Grad Sch Agr, Tokyo, Japan; [Ezura, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Nanasato, Yoshihiko; Tabei, Yutaka] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Ibaraki, Japan; [Takano, Yoshitaka] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Shirasu, Ken] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	Kyoto Prefectural University; University of Tsukuba; National Institute of Agrobiological Sciences - Japan; Kyoto University; RIKEN	Shirasu, K (corresponding author), RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan.	ken.shirasu@psc.riken.jp; yo_narusaka@bio-ribs.com	Shirasu, Ken/ABF-5306-2020; Ezura, H/AAO-8184-2021; Shirasu, Ken/A-4455-2010	Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; JSPS [21580060, 21780038, 24228008]	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry to K.S., Y. Takano, Y. Narusaka and by JSPS Grant-in-Aid for Scientific Research (KAKENHI) (21580060 to Y. Narusaka, 21780038 to M.N. and 24228008 to K.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI S, 1968, MYCOPATH MYCOL APPL, V34, P337, DOI 10.1007/BF02051859; Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clemente T, 2006, METH MOL B, V343, P143; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang HE, 2007, PHYTOPATHOLOGY, V97, P900, DOI 10.1094/PHYTO-97-8-0900; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joshi RK, 2011, GENET MOL RES, V10, P2637, DOI 10.4238/2011.October.25.10; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; KOHNOMURASE J, 1994, PLANT MOL BIOL, V26, P1115, DOI 10.1007/BF00040693; KUBO Y, 1982, PHYTOPATHOLOGY, V72, P498, DOI 10.1094/Phyto-72-498; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; McDowell JM, 2011, SCIENCE, V334, P1354, DOI 10.1126/science.1216482; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mukaihara T, 2004, MOL MICROBIOL, V54, P863, DOI 10.1111/j.1365-2958.2004.04328.x; Nanasato Y, 2013, PLANT BIOTECHNOL REP, V7, P267, DOI 10.1007/s11816-012-0260-1; Narusaka M, 2010, J GEN PLANT PATHOL, V76, P1, DOI 10.1007/s10327-009-0211-z; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Sinapidou E, 2004, PLANT J, V38, P898, DOI 10.1111/j.1365-313X.2004.02099.x; Sohn KH, 2012, P NATL ACAD SCI USA, V109, P16371, DOI 10.1073/pnas.1212332109; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Tabei Y, 1998, PLANT CELL REP, V17, P159, DOI 10.1007/s002990050371; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Takasaki T, 1997, BREEDING SCI, V47, P127; Takken FLW, 2000, PLANT J, V24, P275, DOI 10.1046/j.1365-313x.2000.00866.x; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; Wulff BBH, 2011, CURR OPIN PLANT BIOL, V14, P468, DOI 10.1016/j.pbi.2011.04.002; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x	42	60	61	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55954	10.1371/journal.pone.0055954	http://dx.doi.org/10.1371/journal.pone.0055954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437080	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200035
J	Rijavec, M; Korosec, P; Silar, M; Zidarn, M; Miljkovic, J; Kosnik, M				Rijavec, Matija; Korosec, Peter; Silar, Mira; Zidarn, Mihaela; Miljkovic, Jovan; Kosnik, Mitja			Hereditary Angioedema Nationwide Study in Slovenia Reveals Four Novel Mutations in SERPING1 Gene	PLOS ONE			English	Article							C1 INHIBITOR GENE; DEFICIENCY; FAMILIES; SPECTRUM; SEQUENCE; EDEMA	Hereditary angioedema (HAE) is a rare autosomal dominant disease characterized by swelling of the face, lips, tongue, larynx, genitalia, or extremities, with abdominal pain caused by intra-abdominal edema. HAE is caused by mutations affecting the C1 inhibitor gene, SERPING1, resulting in low levels of C1 inhibitor (Type I HAE) or normal levels of ineffective C1 inhibitor (Type II HAE). A nationwide survey identified nine unrelated families with HAE in Slovenia, among whom 17 individuals from eight families were recruited for genetic analyses. A diagnosis of HAE was established in the presence of clinical and laboratory criteria (low C1 inhibitor antigenic levels and/or function), followed up by a positive family history. Genetic studies were carried out using PCR and sequencing to detect SERPING1 mutations in promoter, noncoding exon 1, the 7 coding exons, and exon-intron boundaries. Multiplex ligation-dependent probe amplification was performed in order to search for large deletions/duplications in SERPING1 gene. A mutation responsible for HAE was identified in patients from seven families with the disease. In HAE type I families, one previously reported substitution (Gln67Stop, c.265C>T) and four novel mutations were identified. The new mutations included two missense substitutions, Ser128Phe (c.449C>T), and Glu429Lys (c.1351G>A), together with two frameshift mutations, indel (c.49delGinsTT) and deletion (c.593_594delCT). Both families with HAE type II harbored the two well-known substitutions affecting the arginyl residue at the reactive center in exon 8, Arg444Cys (c.1396C>T) and Arg444His (c.1397G>A), respectively. In one patient only the homozygous variant g.566T>C (c.-21T>C) was identified. Our study identified four novel mutations in the Slovenian HAE population, highlighting the heterogeneity of mutations in the SERPING1 gene causing C1 inhibitor deficiency and HAE. In a single patient with HAE a homozygous variant g.566T>C (c.-21T>C) might be responsible for the disease.	[Rijavec, Matija; Korosec, Peter; Silar, Mira; Zidarn, Mihaela; Kosnik, Mitja] Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia; [Miljkovic, Jovan] Univ Clin Ctr Maribor, Dept Dermatovenerol, Maribor, Slovenia	University Clinic Golnik; University of Maribor	Rijavec, M (corresponding author), Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia.	matija.rijavec@klinika-golnik.si	Košnik, Mitja/AAI-2295-2019	Košnik, Mitja/0000-0002-4701-7374; Zidarn, Mihaela/0000-0003-0515-5207; Rijavec, Matija/0000-0002-2596-4952; Korosec, Peter/0000-0002-0835-1599				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Bowen B, 2001, CLIN IMMUNOL, V98, P157, DOI 10.1006/clim.2000.4947; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Bygum A, 2011, ALLERGY, V66, P76, DOI 10.1111/j.1398-9995.2010.02456.x; Bygum A, 2009, BRIT J DERMATOL, V161, P1153, DOI 10.1111/j.1365-2133.2009.09366.x; CARTER PE, 1991, EUR J BIOCHEM, V197, P301, DOI 10.1111/j.1432-1033.1991.tb15911.x; Cicardi M, 2012, ALLERGY, V67, P147, DOI 10.1111/j.1398-9995.2011.02751.x; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Cumming SA, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e114; Duponchel Christiane, 2006, Hum Mutat, V27, P295, DOI 10.1002/humu.9414; Faiyaz-Ul-Haque M, 2010, INT ARCH ALLERGY IMM, V151, P149, DOI 10.1159/000236005; Freiberger T, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9029; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gosswein T, 2008, CYTOGENET GENOME RES, V121, P181, DOI 10.1159/000138883; Kalmar L, 2005, HUM MUTAT, V25, P1, DOI 10.1002/humu.20112; Kalmar L, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9202; Kesim B, 2011, INT ARCH ALLERGY IMM, V156, P443, DOI 10.1159/000323915; Lopez-Lera A, 2011, MOL IMMUNOL, V49, P18, DOI 10.1016/j.molimm.2011.07.010; Pappalardo E, 2000, J ALLERGY CLIN IMMUN, V106, P1147, DOI 10.1067/mai.2000.110471; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; Roche O, 2005, ANN ALLERG ASTHMA IM, V94, P498, DOI 10.1016/S1081-1206(10)61121-0; Roche O, 2005, HUM MUTAT, V26, P135, DOI 10.1002/humu.20197; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; Speletas M, 2009, HUM IMMUNOL, V70, P925, DOI 10.1016/j.humimm.2009.08.010; Varga L, 2011, J ANGIOEDEMA, P36; Verpy E, 1996, AM J HUM GENET, V59, P308; Zuraw BL, 2000, J ALLERGY CLIN IMMUN, V105, P541, DOI 10.1067/mai.2000.104780; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977	28	25	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56712	10.1371/journal.pone.0056712	http://dx.doi.org/10.1371/journal.pone.0056712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437219	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200149
J	Song, MA; Tiirikainen, M; Kwee, S; Okimoto, G; Yu, H; Wong, LL				Song, Min-Ae; Tiirikainen, Maarit; Kwee, Sandi; Okimoto, Gordon; Yu, Herbert; Wong, Linda L.			Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma	PLOS ONE			English	Article							CPG ISLAND SHORES; PROMOTER METHYLATION; GNAS CLUSTER; RISK-FACTORS; CANCER; TUMOR; GENE; HYPERMETHYLATION; HYPOMETHYLATION; PATHOGENESIS	Background: Hepatocellular carcinoma (HCC) is one of the most common cancers and frequently presents with an advanced disease at diagnosis. There is only limited knowledge of genome-scale methylation changes in HCC. Methods and Findings: We performed genome-wide methylation profiling in a total of 47 samples including 27 HCC and 20 adjacent normal liver tissues using the Illumina HumanMethylation450 BeadChip. We focused on differential methylation patterns in the promoter CpG islands as well as in various less studied genomic regions such as those surrounding the CpG islands, i.e. shores and shelves. Of the 485,577 loci studied, significant differential methylation (DM) was observed between HCC and adjacent normal tissues at 62,692 loci or 13% (p<1.03e-07). Of them, 61,058 loci (97%) were hypomethylated and most of these loci were located in the intergenic regions (43%) or gene bodies (33%). Our analysis also identified 10,775 differentially methylated (DM) loci (17% out of 62,692 loci) located in or surrounding the gene promoters, 4% of which reside in known Differentially Methylated Regions (DMRs) including reprogramming specific DMRs and cancer specific DMRs, while the rest (10,315) involving 4,106 genes could be potential new HCC DMR loci. Interestingly, the promoter-related DM loci occurred twice as frequently in the shores than in the actual CpG islands. We further characterized 982 DM loci in the promoter CpG islands to evaluate their potential biological function and found that the methylation changes could have effect on the signaling networks of Cellular development, Gene expression and Cell death (p = 1.0e-38), with BMP4, CDKN2A, GSTP1, and NFATC1 on the top of the gene list. Conclusion: Substantial changes of DNA methylation at a genome-wide level were observed in HCC. Understanding epigenetic changes in HCC will help to elucidate the pathogenesis and may eventually lead to identification of molecular markers for liver cancer diagnosis, treatment and prognosis.	[Song, Min-Ae; Tiirikainen, Maarit] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Song, Min-Ae; Tiirikainen, Maarit] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Kwee, Sandi; Wong, Linda L.] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA; [Okimoto, Gordon; Yu, Herbert] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Kwee, Sandi] Queens Med Ctr, Hamamatsu Queens PET Imaging Ctr, Honolulu, HI USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; Cancer Research Center of Hawaii; University of Hawaii System; Cancer Research Center of Hawaii; University of Hawaii System; The Queen's Medical Center	Wong, LL (corresponding author), Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA.	hepatoma@aol.com	Song, Min-Ae/AAF-9672-2021; Tirikainen, M/B-6954-2012	Tirikainen, M/0000-0002-8124-3818; Kwee, Sandi/0000-0002-4624-8787	National Institutes of Health [3P30CA071789-12S6, P30CA071789-12S8]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded partially by the following National Institutes of Health grants: 3P30CA071789-12S6 & P30CA071789-12S8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Feitelson MA, 2006, CANCER LETT, V239, P10, DOI 10.1016/j.canlet.2005.07.009; GALACTEROS F, 1991, BLOOD, V78, P1121; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kwee S, 2012, CTS-CLIN TRANSL SCI, V5, P65, DOI 10.1111/j.1752-8062.2011.00375.x; Lin CH, 2001, CANCER RES, V61, P4238; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Peters J, 2007, EPIGENETICS, V2, P207, DOI 10.4161/epi.2.4.5380; Peters J, 2008, ADV EXP MED BIOL, V626, P16; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Tao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019862; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; Wang JH, 2006, CLIN BIOCHEM, V39, P344, DOI 10.1016/j.clinbiochem.2006.01.008; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Zhong S, 2002, CLIN CANCER RES, V8, P1087	31	121	130	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55761	10.1371/journal.pone.0055761	http://dx.doi.org/10.1371/journal.pone.0055761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437062	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200022
J	Walmsley, J; Rodriguez, JF; Mirams, GR; Burrage, K; Efimov, IR; Rodriguez, B				Walmsley, John; Rodriguez, Jose F.; Mirams, Gary R.; Burrage, Kevin; Efimov, Igor R.; Rodriguez, Blanca			mRNA Expression Levels in Failing Human Hearts Predict Cellular Electrophysiological Remodeling: A Population-Based Simulation Study	PLOS ONE			English	Article							HUMAN VENTRICULAR MYOCYTES; REPOLARIZATION; VARIABILITY; FAILURE; MODELS	Differences in mRNA expression levels have been observed in failing versus non-failing human hearts for several membrane channel proteins and accessory subunits. These differences may play a causal role in electrophysiological changes observed in human heart failure and atrial fibrillation, such as action potential (AP) prolongation, increased AP triangulation, decreased intracellular calcium transient (CaT) magnitude and decreased CaT triangulation. Our goal is to investigate whether the information contained in mRNA measurements can be used to predict cardiac electrophysiological remodeling in heart failure using computational modeling. Using mRNA data recently obtained from failing and non-failing human hearts, we construct failing and non-failing cell populations incorporating natural variability and up/down regulation of channel conductivities. Six biomarkers are calculated for each cell in each population, at cycle lengths between 1500 ms and 300 ms. Regression analysis is performed to determine which ion channels drive biomarker variability in failing versus non-failing cardiomyocytes. Our models suggest that reported mRNA expression changes are consistent with AP prolongation, increased AP triangulation, increased CaT duration, decreased CaT triangulation and amplitude, and increased delay between AP and CaT upstrokes in the failing population. Regression analysis reveals that changes in AP biomarkers are driven primarily by reduction in I-Kr, and changes in CaT biomarkers are driven predominantly by reduction in I-CaL and SERCA. In particular, the role of ICaL is pacing rate dependent. Additionally, alternans developed at fast pacing rates for both failing and non-failing cardiomyocytes, but the underlying mechanisms are different in control and heart failure.	[Walmsley, John; Mirams, Gary R.; Burrage, Kevin; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Oxford, England; [Rodriguez, Jose F.] Univ Zaragoza, Aragon Inst Engn Res, Zaragoza, Spain; [Rodriguez, Jose F.] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain; [Burrage, Kevin] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Efimov, Igor R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	University of Oxford; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Queensland University of Technology (QUT); Washington University (WUSTL)	Rodriguez, B (corresponding author), Univ Oxford, Dept Comp Sci, Oxford, England.	blanca@cs.ox.ac.uk	Mirams, Gary/B-6653-2008; Efimov, Igor R/B-8040-2010; Efimov, Igor R./AAJ-3234-2021; Efimov, Igor/R-5544-2017; Matas, Jose F Rodriguez/H-4589-2011	Mirams, Gary/0000-0002-4569-4312; Efimov, Igor R/0000-0002-1483-5039; Efimov, Igor/0000-0002-1483-5039; Matas, Jose F Rodriguez/0000-0001-7612-266X; Walmsley, John/0000-0001-9171-7530; Burrage, Kevin/0000-0002-8111-1137; Rodriguez, Blanca/0000-0001-6361-3339	Engineering and Physical Sciences Research Council (EPSRC) through the Systems Biology Doctoral Training Centre at the University of Oxford; Salvador de Madariaga Research Program [PR2010-0552]; University of Zaragoza [171-242]; GlaxoSmithKline; National Institutes of Health (NIH) [NIH R01-HL0853689, NIH R01-HL114395]; Medical Research Council; GlaxoSmithKline Ltd.; MRC [G0700278] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114395] Funding Source: NIH RePORTER; Medical Research Council [G0700278] Funding Source: researchfish; National Centre for the Replacement [NC/K001337/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC) through the Systems Biology Doctoral Training Centre at the University of Oxford(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Salvador de Madariaga Research Program; University of Zaragoza; GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline Ltd.(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	JW is funded by the Engineering and Physical Sciences Research Council (EPSRC) (www.epsrc.ac.uk) through the Systems Biology Doctoral Training Centre at the University of Oxford (www.sysbiodtc.ox.ac.uk). JR is funded by the Salvador de Madariaga Research Program (PR2010-0552) and the University of Zaragoza (Project 171-242) (http://wzar.unizar.es/servicios/ingles/prese.htm). GM is funded by a GlaxoSmithKline Grants and Affiliates award (www.gsk.com). IE is funded by National Institutes of Health (NIH) grants NIH R01-HL0853689 and NIH R01-HL114395 (www.nih.gov). BR is funded by the Medical Research Council including a MRC Career Development Award, a MRC Centenary Award and Partnership with Industry Award (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors on this paper, Dr. GM, has received research support from GlaxoSmithKline Ltd. The authors declare this as a competing interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ambrosi CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054635; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Carusi A, 2012, AM J PHYSIOL-HEART C, V303, pH144, DOI 10.1152/ajpheart.01151.2011; Cooper J, 2011, PROG BIOPHYS MOL BIO, V107, P11, DOI 10.1016/j.pbiomolbio.2011.06.003; Cutler MJ, 2011, TRENDS PHARMACOL SCI, V32, P174, DOI 10.1016/j.tips.2010.12.001; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Gaborit N, 2010, J MOL CELL CARDIOL, V49, P639, DOI 10.1016/j.yjmcc.2010.06.005; Glukhov A, 2010, CIRC RES, V106, P1; Glukhov AV, 2012, CIRCULATION, V125, P1835, DOI 10.1161/CIRCULATIONAHA.111.047274; GWATHMEY JK, 1987, CIRC RES, V61, P70, DOI 10.1161/01.RES.61.1.70; James AF, 2007, PROG BIOPHYS MOL BIO, V94, P265, DOI 10.1016/j.pbiomolbio.2005.05.010; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kubo H, 2001, CIRCULATION, V104, P1012, DOI 10.1161/hc3401.095073; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Lou Q, 2011, CIRCULATION, V123, P1881, DOI 10.1161/CIRCULATIONAHA.110.989707; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nattel S, 2010, J MOL CELL CARDIOL, V48, P96, DOI 10.1016/j.yjmcc.2009.07.016; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Quinn TA, 2011, PROG BIOPHYS MOL BIO, V107, P4, DOI 10.1016/j.pbiomolbio.2011.07.001; Rodriguez JF, 2012, BIOPHYS J, V102, p543A, DOI 10.1016/j.bpj.2011.11.2965; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Sarkar AX, 2011, HEART RHYTHM, V8, P1749, DOI 10.1016/j.hrthm.2011.05.023; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; Sipido KR, 1998, CARDIOVASC RES, V37, P478, DOI 10.1016/S0008-6363(97)00280-0; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Trenor B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032659; VAHL CF, 1994, CIRC RES, V74, P952, DOI 10.1161/01.RES.74.5.952	40	54	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56359	10.1371/journal.pone.0056359	http://dx.doi.org/10.1371/journal.pone.0056359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437117	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200062
J	Zhang, J; Shen, YJ; Yuan, ZY; Yin, JH; Zang, W; Xu, YX; Lu, WY; Wang, YJ; Wang, Y; Cao, JP				Zhang, Jing; Shen, Yujuan; Yuan, Zhongying; Yin, Jianhai; Zang, Wei; Xu, Yuxin; Lu, Weiyuan; Wang, Yanjuan; Wang, Ying; Cao, Jianping			Primary Analysis of the Expressed Sequence Tags in a Pentastomid Nymph cDNA Library	PLOS ONE			English	Article							CYSTEINE PROTEASES; PARASITE	Background: Pentastomiasis is a rare zoonotic disease caused by pentastomids. Despite their worm-like appearance, they are commonly placed into a separate sub-class of the subphylum Crustacea, phylum Arthropoda. However, until now, the systematic classification of the pentastomids and the diagnosis of pentastomiasis are immature, and genetic information about pentastomid nylum is almost nonexistent. The objective of this study was to obtain information on pentastomid nymph genes and identify the gene homologues related to host-parasite interactions or stage-specific antigens. Methodology/Principal Findings: Total pentastomid nymph RNA was used to construct a cDNA library and 500 colonies were sequenced. Analysis shows one hundred and ninety-seven unigenes were identified. In which, 147 genes were annotated, and 75 unigenes (53.19%) were mapped to 82 KEGG pathways, including 29 metabolism pathways, 29 genetic information processing pathways, 4 environmental information processing pathways, 7 cell motility pathways and 5 organismal systems pathways. Additionally, two host-parasite interaction-related gene homologues, a putative Kunitz inhibitor and a putative cysteine protease. Conclusion/Significance: We first successfully constructed a cDNA library and gained a number of expressed sequence tags (EST) from pentastomid nymphs, which will lay the foundation for the further study on pentastomids and pentastomiasis.	[Zhang, Jing; Shen, Yujuan; Yuan, Zhongying; Yin, Jianhai; Zang, Wei; Xu, Yuxin; Lu, Weiyuan; Wang, Yanjuan; Wang, Ying; Cao, Jianping] World Hlth Org Collaborating Ctr Malaria Schistos, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Shen, YJ (corresponding author), World Hlth Org Collaborating Ctr Malaria Schistos, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China.	amyshyj12@163.com; caojp@yahoo.com	Cao, Jianping/AFL-5468-2022; Yin, Jianhai/GRS-2880-2022; Yin, Jianhai/AAF-5820-2020	Cao, Jianping/0000-0002-1974-0047; Yin, Jianhai/0000-0003-1333-8732; 	National S & T Major Program [2012ZX10004-201, 2009ZX10004-201]; Chinese Special Program for Scientific Research of Public Health [200802012]	National S & T Major Program; Chinese Special Program for Scientific Research of Public Health	JC was supported by grants from the National S & T Major Program No. 2012ZX10004-201 and 2009ZX10004-201. YS was supported by grants from the Chinese Special Program for Scientific Research of Public Health No. 200802012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cannon D. A., 1942, ANN TROP MED AND PARASITOL, V36, P160; Chen SH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000647; Doumbo G, 1988, Med Trop (Mars), V48, P49; DRABICK JJ, 1987, REV INFECT DIS, V9, P1087; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Gonzalez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007009; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hami M, 2009, IRAN J PARASITOL, V4, P25; HERZOG U, 1985, ACTA TROP, V42, P261; JONES DAC, 1991, PARASITOLOGY, V103, P331, DOI 10.1017/S0031182000059849; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ma KC, 2002, TROP MED INT HEALTH, V7, P166, DOI 10.1046/j.1365-3156.2002.00839.x; Machado MAC, 2006, J GASTROEN HEPATOL, V21, P1218, DOI 10.1111/j.1440-1746.2006.03203.x; Mapp E M, 1976, J Natl Med Assoc, V68, P198; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Na BK, 2006, CELL MICROBIOL, V8, P1034, DOI 10.1111/j.1462-5822.2006.00685.x; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; SELF JT, 1972, T AM MICROSC SOC, V91, P2, DOI 10.2307/3224852	23	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56511	10.1371/journal.pone.0056511	http://dx.doi.org/10.1371/journal.pone.0056511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437150	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200088
J	Hu, N; Han, XF; Lane, EK; Gao, F; Zhang, YM; Ren, J				Hu, Nan; Han, Xuefeng; Lane, Erin K.; Gao, Feng; Zhang, Yingmei; Ren, Jun			Cardiac-Specific Overexpression of Metallothionein Rescues against Cigarette Smoking Exposure-Induced Myocardial Contractile and Mitochondrial Damage	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM STRESS; CHRONIC AKT ACTIVATION; NF-KAPPA-B; OXIDATIVE STRESS; CARDIOMYOCYTE DYSFUNCTION; CARDIOVASCULAR-DISEASE; PROTEIN-KINASE; APOPTOSIS; NICOTINE	Objectives: Second hand cigarette smoke is an independent risk factor for cardiovascular disease. Although a tie between smoking and cardiovascular disease is well established, the underlying mechanisms still remains elusive due to the lack of adequate animal models. This study was designed to use a mouse model of exposure to cigarette smoke, a surrogate of environmental tobacco smoke, to evaluate the impact of cardiac overexpression of heavy metal scavenger metallothionein on myocardial geometry, contractile and intracellular Ca2+ properties and apoptosis following side-stream smoke exposure. Methods: Adult male wild-type FVB and metallothionein transgenic mice were placed in a chamber exposed to cigarette smoke for 1 hour daily for 40 days. Echocardiographic, cardiomyocyte contractile and intracellular Ca2+ properties, fibrosis, apoptosis and mitochondrial damage were examined. Results: Our data revealed that smoke exposure enlarged ventricular end systolic and diastolic diameters, reduced myocardial and cardiomyocyte contractile function, disrupted intracellular Ca2+ homeostasis, facilitated fibrosis, apoptosis and mitochondrial damage (cytochrome C release and aconitase activity), the effects of which were attenuated or mitigated by metallothionein. In addition, side-stream smoke expose enhanced phosphorylation of Akt and GSK3 beta without affecting pan protein expression in the heart, the effect of which was abolished or ameliorated by metallothionein. Cigarette smoke extract interrupted cardiomyocyte contractile function and intracellular Ca2+ properties, the effect of which was mitigated by wortmannin and NAC. Conclusions: These data suggest that side-stream smoke exposure led to myocardial dysfunction, intracellular Ca2+ mishandling, apoptosis, fibrosis and mitochondrial damage, indicating the therapeutic potential of antioxidant against in second smoking-induced cardiac defects possibly via mitochondrial damage and apoptosis.	[Hu, Nan; Han, Xuefeng; Lane, Erin K.; Zhang, Yingmei; Ren, Jun] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Coll Hlth Sci, Laramie, WY 82071 USA; [Han, Xuefeng; Gao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Physiol, Xian 710032, Peoples R China; [Gao, Feng; Zhang, Yingmei; Ren, Jun] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China	University of Wyoming; Air Force Military Medical University; Air Force Military Medical University	Zhang, YM (corresponding author), Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Coll Hlth Sci, Laramie, WY 82071 USA.	zhangym197951@126.com; jren@uwyo.edu	Gao, Feng/X-4385-2019; Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	NIH [5P20RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH 5P20RR016474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V300, pL910, DOI 10.1152/ajplung.00232.2010; Bye A, 2008, INHAL TOXICOL, V20, P635, DOI [10.1080/08958370701883821, 10.1080/08958370701883821 ]; Ceylan-Isik AF, 2010, J MOL CELL CARDIOL, V48, P367, DOI 10.1016/j.yjmcc.2009.11.003; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Dong F, 2005, CLIN SCI, V109, P277, DOI 10.1042/CS20040278; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; GIDDING SS, 1995, J AM COLL CARDIOL, V26, P211, DOI 10.1016/0735-1097(95)00118-J; Gu LZ, 2008, EUR J HEART FAIL, V10, P1057, DOI 10.1016/j.ejheart.2008.08.009; Gumustekin K, 2010, CELL BIOCHEM FUNCT, V28, P329, DOI 10.1002/cbf.1663; Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Howard LA, 2001, J PHARMACOL EXP THER, V299, P542; Hu N, 2011, TOXICOL LETT, V202, P8, DOI 10.1016/j.toxlet.2011.01.007; Jefferis BJ, 2010, HEART, V96, P854, DOI 10.1136/hrt.2009.191148; Kang YJ, 1999, P SOC EXP BIOL MED, V222, P263, DOI 10.1046/j.1525-1373.1999.d01-143.x; Khanna A, 2013, J NEUROIMMUNOL, V254, P69, DOI 10.1016/j.jneuroim.2012.09.006; Lemaitre V, 2011, TOXICOL SCI, V123, P542, DOI 10.1093/toxsci/kfr181; Li L, 2012, OBESITY SILVER SPRIN; Li Q, 2006, ALCOHOL ALCOHOLISM, V41, P585, DOI 10.1093/alcalc/agl080; Li SY, 2006, DIABETOLOGIA, V49, P1434, DOI 10.1007/s00125-006-0229-0; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Macha MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014728; Matsui T, 2006, AM J PHYSIOL-ENDOC M, V290, pE789, DOI 10.1152/ajpendo.00564.2004; Miller LM, 2002, EXP LUNG RES, V28, P435, DOI 10.1080/01902140290096728; Minicucci Marcos F., 2009, Inflammation & Allergy Drug Targets, V8, P334; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; NEGRI E, 1993, BRIT MED J, V306, P1567, DOI 10.1136/bmj.306.6892.1567; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Ren J, 2008, CRIT CARE MED, V36, P2106, DOI 10.1097/CCM.0b013e31817bf925; Ren J, 2008, AM J PHYSIOL-REG I, V294, pR793, DOI 10.1152/ajpregu.00713.2007; Repace J., 2007, EXPOSURE ANAL, P201; Sadeu JC, 2011, FERTIL STERIL, V95, P2410, DOI 10.1016/j.fertnstert.2011.03.072; Soldin OP, 2011, STEROIDS, V76, P653, DOI 10.1016/j.steroids.2011.02.042; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Tafani M, 2002, J BIOL CHEM, V277, P10073, DOI 10.1074/jbc.M111350200; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Togo S, 2010, EXP CELL RES, V316, P3501, DOI 10.1016/j.yexcr.2010.09.006; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Turdi S, 2012, FREE RADICAL BIO MED, V53, P1327, DOI 10.1016/j.freeradbiomed.2012.07.084; Turgeon J, 2010, ATHEROSCLEROSIS, V208, P342, DOI 10.1016/j.atherosclerosis.2009.08.007; Ueno H, 2006, CARDIOVASC TOXICOL, V6, P39, DOI 10.1385/CT:6:1:39; Yang XP, 2006, FASEB J, V20, P1024, DOI 10.1096/fj.05-5288fje; Zhang YM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-40; Zhou JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021173; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278	50	37	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57151	10.1371/journal.pone.0057151	http://dx.doi.org/10.1371/journal.pone.0057151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431404	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800047
J	Simms, V; Gikaara, N; Munene, G; Atieno, M; Kataike, J; Nsubuga, C; Banga, G; Namisango, E; Penfold, S; Fayers, P; Powell, RA; Higginson, IJ; Harding, R				Simms, Victoria; Gikaara, Nancy; Munene, Grace; Atieno, Mackuline; Kataike, Jeniffer; Nsubuga, Clare; Banga, Geoffrey; Namisango, Eve; Penfold, Suzanne; Fayers, Peter; Powell, Richard A.; Higginson, Irene J.; Harding, Richard			Multidimensional Patient-Reported Problems within Two Weeks of HIV Diagnosis in East Africa: A Multicentre Observational Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PALLIATIVE CARE; DISCLOSURE; HIV/AIDS; OUTPATIENTS; DEPRESSION; EXPERIENCE; ADHERENCE; SYMPTOMS; BARRIERS	Objectives: We aimed to determine for the first time the prevalence and severity of multidimensional problems in a population newly diagnosed with HIV at outpatient clinics in Africa. Methods: Recently diagnosed patients (within previous 14 days) were consecutively recruited at 11 HIV clinics in Kenya and Uganda. Participants completed a validated questionnaire, the African Palliative Outcome Scale (POS), with three underpinning factors. Ordinal logistic regression was used to evaluate risk factors for prevalence and severity of physical, psychological, interpersonal and existential problems. Results: There were 438 participants (62% female, 30% with restricted physical function). The most prevalent problems were lack of help and advice (47% reported none in the previous 3 days) and difficulty sharing feelings. Patients with limited physical function reported more physical/psychological (OR = 3.22) and existential problems (OR = 1.54) but fewer interpersonal problems (OR = 0.50). All outcomes were independent of CD4 count or ART eligibility. Conclusions: Patients at all disease stages report widespread and burdensome multidimensional problems at HIV diagnosis. Newly diagnosed patients should receive assessment and care for these problems. Effective management of problems at diagnosis may help to remove barriers to retention in care.	[Simms, Victoria; Penfold, Suzanne] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Simms, Victoria; Higginson, Irene J.; Harding, Richard] Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England; [Gikaara, Nancy; Munene, Grace; Atieno, Mackuline; Kataike, Jeniffer; Nsubuga, Clare; Banga, Geoffrey; Namisango, Eve; Powell, Richard A.] African Palliat Care Assoc, Kampala, Uganda; [Fayers, Peter] Univ Aberdeen, Dept Populat Hlth, Aberdeen, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of Aberdeen	Simms, V (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Victoria.simms@lshtm.ac.uk	Simms, Victoria/C-3278-2009; Simms, Victoria/AAU-4134-2021; Higginson, Irene Julie/C-7309-2012	Simms, Victoria/0000-0002-4897-458X; Fayers, Peter/0000-0003-4778-1513; Harding, Richard/0000-0001-9653-8689; Higginson, Irene Julie/0000-0002-3687-1313	USAID [GPO-A-00-03-00003-00]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	USAID(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project was funded by USAID (www.usaid.gov) through Cooperative Agreement GPO-A-00-03-00003-00, under the authority provided to the University of North Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins DL, 2007, AIDS, V21, pS75, DOI 10.1097/01.aids.0000300538.28096.1c; Collins K, 2007, AIDS CARE, V19, P1304, DOI 10.1080/09540120701402863; Downing J, 2009, PEPFAR PUBLIC HLTH E; Gordillo V, 2009, J BEHAV MED, V32, P523, DOI 10.1007/s10865-009-9222-7; Harding R, 2009, PEPFAR PUBLIC HLTH E; Harding R, 2012, J PAIN SYMPT MANAGEM; Harding R, 2010, SEX TRANSM INFECT, V86, P520, DOI 10.1136/sti.2009.038505; Harding R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-584; Harding R, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-10; Holt R, 1998, AIDS CARE, V10, P49, DOI 10.1080/09540129850124578; Kaharuza FM, 2006, AIDS BEHAV, V10, pS105, DOI 10.1007/s10461-006-9142-2; Levine LJ, 2004, SOC COGNITION, V22, P530, DOI 10.1521/soco.22.5.530.50767; Makoae LN, 2005, J ASSOC NURSE AIDS C, V16, P22, DOI 10.1016/j.jana.2005.03.005; Maman S, 2009, SOC SCI MED, V68, P965, DOI 10.1016/j.socscimed.2008.12.028; Marwick KFM, 2010, AIDS CARE, V22, P415, DOI 10.1080/09540120903253981; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Meursing K, 2000, HEALTH POLICY PLANN, V15, P17, DOI 10.1093/heapol/15.1.17; Miller AN, 2007, AIDS BEHAV, V11, P687, DOI 10.1007/s10461-006-9198-z; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Olley BO, 2008, INT J STD AIDS, V19, P94, DOI 10.1258/ijsa.2007.007134; Powell RA, 2007, J PAIN SYMPTOM MANAG, V33, P229, DOI 10.1016/j.jpainsymman.2006.10.008; Ramirez-Avila L, 2012, AIDS BEHAV, V16, P2226, DOI 10.1007/s10461-012-0160-y; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Rutstein S., 2004, DHS COMPARATIVE REPO; Selman L, 2011, J PAIN SYMPTOM MANAG, V41, P728, DOI 10.1016/j.jpainsymman.2010.06.023; Selman LE, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-21; Simms VM, 2011, J PAIN SYMPTOM MANAG, V42, P734, DOI 10.1016/j.jpainsymman.2011.02.014; Steinhauser KE, 2006, ARCH INTERN MED, V166, P101, DOI 10.1001/archinte.166.1.101; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; Thomas F, 2006, SOC SCI MED, V63, P3174, DOI 10.1016/j.socscimed.2006.08.016; UNAIDS, 2010, REP GLOB AIDS EP 201; WHO, 2010, ANT THER HIV INF AD; Wig Naveet, 2008, Indian J Med Sci, V62, P87; Willard S, 2009, AIDS CARE, V21, P322, DOI 10.1080/09540120802183511; World Health Organization, 2010, HDB IMPR HIV TEST CO	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57203	10.1371/journal.pone.0057203	http://dx.doi.org/10.1371/journal.pone.0057203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093HR	23431405	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000315182800048
J	Grau, M; Pauly, S; Ali, J; Walpurgis, K; Thevis, M; Bloch, W; Suhr, F				Grau, Marijke; Pauly, Sebastian; Ali, Jamal; Walpurgis, Katja; Thevis, Mario; Bloch, Wilhelm; Suhr, Frank			RBC-NOS-Dependent S-Nitrosylation of Cytoskeletal Proteins Improves RBC Deformability	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RED-BLOOD-CELLS; PLASMA NITRITE; ENDOTHELIAL DYSFUNCTION; HYPOXIC VASODILATION; SIGNALING MOLECULE; HUMAN ERYTHROCYTES; HUMAN CIRCULATION; IN-VITRO; PATHWAY	Background: Red blood cells (RBC) possess a nitric oxide synthase (RBC-NOS) whose activation depends on the PI3-kinase/Akt kinase pathway. RBC-NOS-produced NO exhibits important biological functions like maintaining RBC deformability. Until now, the cellular target structure for NO, to exert its influence on RBC deformability, remains unknown. In the present study we analyzed the modification of RBC-NOS activity by pharmacological treatments, the resulting influence on RBC deformability and provide first evidence for possible target proteins of RBC-NOS-produced NO in the RBC cytoskeletal scaffold. Methods/Findings: Blood from fifteen male subjects was incubated with the NOS substrate L-arginine to directly stimulate enzyme activity. Direct inhibition of enzyme activity was induced by L-N5-(1-Iminoethyl)-ornithin (L-NIO). Indirect stimulation and inhibition of RBC-NOS were achieved by applying insulin and wortmannin, respectively, substances known to affect PI3-kinase/Akt kinase pathway. The NO donor sodium nitroprusside (SNP) and the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO) were additionally applied as NO positive and negative controls, respectively. Immunohistochemical staining was used to determine phosphorylation and thus activation of RBC-NOS. As a marker for NO synthesis nitrite was measured in plasma and RBCs using chemiluminescence detection. S-nitrosylation of erythrocyte proteins was determined by biotin switch assay and modified proteins were identified using LC-MS. RBC deformability was determined by ektacytometry. The data reveal that activated RBC-NOS leads to increased NO production, S-nitrosylation of RBC proteins and RBC deformability, whereas RBC-NOS inhibition resulted in contrary effects. Conclusion/Significance: This study first-time provides strong evidence that RBC-NOS-produced NO modifies RBC deformability through direct S-nitrosylation of cytoskeleton proteins, most likely alpha- and beta-spectrins. Our data, therefore, gain novel insights into biological functions of RBC-NOS by connecting impaired RBC deformability abilities to specific posttranslational modifications of RBC proteins. By identifying likely NO-target proteins in RBC, our results will stimulate new therapeutic approaches for patients with microvascular disorders.	[Grau, Marijke; Pauly, Sebastian; Ali, Jamal; Bloch, Wilhelm; Suhr, Frank] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany; [Walpurgis, Katja; Thevis, Mario] German Sport Univ Cologne, Inst Biochem, Ctr Prevent Doping Res, Cologne, Germany; [Bloch, Wilhelm; Suhr, Frank] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany	German Sport University Cologne; German Sport University Cologne; University of Cologne; German Sport University Cologne	Grau, M (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany.	m.grau@dshs-koeln.de	Suhr, Frank/AAU-5080-2021	Suhr, Frank/0000-0002-9013-3944; Grau, Dr. Marijke/0000-0003-1980-9195	German Research Center of Elite Sport	German Research Center of Elite Sport	The study was supported by The German Research Center of Elite Sport (momentum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal J, 1992, Indian J Pathol Microbiol, V35, P5; Banerjee R, 1998, CLIN HEMORHEOL MICRO, V19, P21; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Bateman RM, 2003, CRIT CARE, V7, P359, DOI 10.1186/cc2353; Bode-Boger SM, 1998, BRIT J CLIN PHARMACO, V46, P489, DOI 10.1046/j.1365-2125.1998.00803.x; Bohmer A, 2012, BLOOD, V119, P1322, DOI 10.1182/blood-2011-11-393124; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Chakrabarti A, 2006, BIOSCIENCE REP, V26, P369, DOI 10.1007/s10540-006-9024-x; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Cortese-Krott M.M., 2012, BLOOD; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Forsyth AM, 2012, MICROVASC RES, V83, P347, DOI 10.1016/j.mvr.2012.02.004; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Franco T, 2010, TRANSFUS CLIN BIOL, V17, P87, DOI 10.1016/j.tracli.2010.05.008; Gladwin MT, 2005, NAT CHEM BIOL, V1, P245, DOI 10.1038/nchembio1005-245; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hendgen-Cotta U, 2008, METHOD ENZYMOL, V441, P295, DOI 10.1016/S0076-6879(08)01216-0; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HISHIKAWA K, 1993, J HYPERTENS, V11, P639, DOI 10.1097/00004872-199306000-00008; IGNARRO LJ, 1989, SEMIN HEMATOL, V26, P63; Imbrogno S, 2001, J EXP BIOL, V204, P1719; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kang ES, 2000, J LAB CLIN MED, V135, P444, DOI 10.1067/mlc.2000.106805; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Lakshmi VM, 2007, LIFE SCI, V80, P644, DOI 10.1016/j.lfs.2006.10.010; Lane P, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.86.re1; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Ludolph B, 2007, VASC HEALTH RISK MAN, V3, P1069; Lundberg JO, 2005, ARTERIOSCL THROM VAS, V25, P915, DOI 10.1161/01.ATV.0000161048.72004.c2; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mihov D, 2009, AM J PHYSIOL-CELL PH, V297, pC378, DOI 10.1152/ajpcell.00543.2008; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Pelletier MM, 2006, FREE RADICAL BIO MED, V41, P541, DOI 10.1016/j.freeradbiomed.2006.05.001; Pries AR, 2003, CLIN HEMORHEOL MICRO, V29, P143; RADOMSKI MW, 1990, BRIT J PHARMACOL, V101, P325, DOI 10.1111/j.1476-5381.1990.tb12709.x; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Suhr F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045982; Suhr F, 2009, NITRIC OXIDE-BIOL CH, V20, P95, DOI 10.1016/j.niox.2008.10.004; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Tziakas DN, 2007, J AM COLL CARDIOL, V49, P2081, DOI 10.1016/j.jacc.2006.08.069; Ulker P, 2012, CLIN HEMORHEOL MICRO; Ulker P, 2011, NITRIC OXIDE-BIOL CH, V24, P184, DOI 10.1016/j.niox.2011.03.003; VALLANCE P, 1992, LANCET, V339, P572; Vallette G, 1998, BIOCHEM J, V331, P713, DOI 10.1042/bj3310713; Walpurgis K, 2012, PROTEOMICS, V12, P3263, DOI 10.1002/pmic.201200280; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557; ZICHE M, 1993, BIOCHEM BIOPH RES CO, V192, P1198, DOI 10.1006/bbrc.1993.1543	66	125	125	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56759	10.1371/journal.pone.0056759	http://dx.doi.org/10.1371/journal.pone.0056759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424675	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100063
J	Bhatia, S; Pilquil, C; Roth-Albin, I; Draper, JS				Bhatia, Sonam; Pilquil, Carlos; Roth-Albin, Ivana; Draper, Jonathan S.			Demarcation of Stable Subpopulations within the Pluripotent hESC Compartment	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MOUSE EPIBLAST; ES CELLS; EXTRAEMBRYONIC LINEAGES; MAINTAIN PLURIPOTENCY; NANOG EXPRESSION; PROGENITOR CELLS; GENE-EXPRESSION; SELF-RENEWAL; IN-VITRO	Heterogeneity is a feature of stem cell populations, resulting from innate cellular hierarchies that govern differentiation capability. How heterogeneity impacts human pluripotent stem cell populations is directly relevant to their efficacious use in regenerative medicine applications. The control of pluripotency is asserted by a core transcription factor network, of which Oct4 is a necessary member. In mouse embryonic stem cells (ESCs), the zinc finger transcription factor Rex1 (Zfp42) closely tracks the undifferentiated state and is capable of segregating Oct4 positive mESCs into metastable populations expressing or lacking Rex1 that are inter-convertible. However, little is currently understood about the extent or function of heterogeneous populations in the human pluripotent compartment. Human ESCs express REX1 transcripts but the distribution and properties of REX1 expressing cells have yet to be described. To address these questions, we used gene targeting in human ESCs to insert the fluorescent protein Venus and an antibiotic selection marker under the control of the endogenous REX1 transcription regulatory elements, generating a sensitive, selectable reporter of pluripotency. REX1 is co-expressed in OCT4 and TRA-1-60 positive hESCs and rapidly lost upon differentiation. Importantly, REX1 expression reveals significant heterogeneity within seemingly homogenous populations of OCT4 and TRA-1-60 hESCs. REX1 expression is extinguished before OCT4 during differentiation, but, in contrast to the mouse, loss of REX1 expression demarcates a stable, OCT4 positive lineage-primed state in pluripotent hESCs that does not revert back to REX1 positivity under normal conditions. We show that loss of REX1 expression correlates with altered patterns of DNA methylation at the REX1 locus, implying that epigenetic mechanisms may interfere with the metastable phenotype commonly found in murine pluripotency.	[Bhatia, Sonam; Pilquil, Carlos; Roth-Albin, Ivana; Draper, Jonathan S.] McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Draper, Jonathan S.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Bhatia, Sonam; Draper, Jonathan S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Draper, JS (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON, Canada.	draperj@mcmaster.ca		Bhatia, Sonam/0000-0002-0124-2621; Draper, Jonathan/0000-0002-3241-7009	CIHR; SCN; MEDI GL2 OCRIT; Canada Research Chair in Human Stem Cell Lineage Commitment	CIHR(Canadian Institutes of Health Research (CIHR)); SCN; MEDI GL2 OCRIT; Canada Research Chair in Human Stem Cell Lineage Commitment	This work was supported in part by funding to JSD from CIHR, SCN and a MEDI GL2 OCRIT. JSD is also supported by a Canada Research Chair in Human Stem Cell Lineage Commitment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Calder A, 2012, STEM CELLS DEV; CERDAN C, 2007, CURR PROTOC STEM CEL, pCH1; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cherry A, 2010, CELL STEM CELL, V7, P641, DOI 10.1016/j.stem.2010.11.020; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Deuve JL, 2010, ANN REV CELL DEV BIO; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Do Kim J, 2011, HUM MOL GENET, V20, P1353, DOI 10.1093/hmg/ddr017; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Egozi D, 2007, FASEB J, V21, P2807, DOI 10.1096/fj.06-7758com; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Garcia-Tunon I, 2011, STEM CELL RES, V7, P1, DOI 10.1016/j.scr.2011.02.005; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Migeon BR, 2011, HUM GENET, V130, P281, DOI 10.1007/s00439-011-1016-7; Migeon BR, 2003, NAT GENET, V33, P337, DOI 10.1038/ng0303-337a; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pelton TA, 2002, J CELL SCI, V115, P329; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Rezende NC, 2011, DEV BIOL, V356, P370, DOI 10.1016/j.ydbio.2011.05.664; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scotland KB, 2009, DEV DYNAM, V238, P1863, DOI 10.1002/dvdy.22037; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Stewart MH, 2010, NAT METHODS, V7, P917, DOI 10.1038/nmeth.1519; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027	70	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57276	10.1371/journal.pone.0057276	http://dx.doi.org/10.1371/journal.pone.0057276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437358	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000093
J	Micaroni, M; Stanley, AC; Khromykh, T; Venturato, J; Wong, CXF; Lim, JP; Marsh, BJ; Storrie, B; Gleeson, PA; Stow, JL				Micaroni, Massimo; Stanley, Amanda C.; Khromykh, Tatiana; Venturato, Juliana; Wong, Colin X. F.; Lim, Jet P.; Marsh, Brad J.; Storrie, Brian; Gleeson, Paul A.; Stow, Jennifer L.			Rab6a/a ' Are Important Golgi Regulators of Pro-Inflammatory TNF Secretion in Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; COILED-COIL PROTEINS; ACTIVATED MACROPHAGES; RETROGRADE TRANSPORT; CYTOKINE SECRETION; NETWORK GOLGIN; BINDING-SITES; RAB PROTEINS; GRIP DOMAINS; MEMBRANE	Lipopolysaccharide (LPS)-activated macrophages secrete pro-inflammatory cytokines, including tumor necrosis factor (TNF) to elicit innate immune responses. Secretion of these cytokines is also a major contributing factor in chronic inflammatory disease. In previous studies we have begun to elucidate the pathways and molecules that mediate the intracellular trafficking and secretion of TNF. Rab6a and Rab6a' (collectively Rab6) are trans-Golgi-localized GTPases known for roles in maintaining Golgi structure and Golgi-associated trafficking. We found that induction of TNF secretion by LPS promoted the selective increase of Rab6 expression. Depletion of Rab6 (via siRNA and shRNA) resulted in reorganization of the Golgi ribbon into more compact structures that at the resolution of electron microcopy consisted of elongated Golgi stacks that likely arose from fusion of smaller Golgi elements. Concomitantly, the delivery of TNF to the cell surface and subsequent release into the media was reduced. Dominant negative mutants of Rab6 had similar effects in disrupting TNF secretion. In live cells, Rab6-GFP were localized on trans-Golgi network (TGN)-derived tubular carriers demarked by the golgin p230. Rab6 depletion and inactive mutants altered carrier egress and partially reduced p230 membrane association. Our results show that Rab6 acts on TNF trafficking at the level of TGN exit in tubular carriers and our findings suggest Rab6 may stabilize p230 on the tubules to facilitate TNF transport. Both Rab6 isoforms are needed in macrophages for Golgi stack organization and for the efficient post-Golgi transport of TNF. This work provides new insights into Rab6 function and into the role of the Golgi complex in cytokine secretion in inflammatory macrophages.	[Micaroni, Massimo; Stanley, Amanda C.; Khromykh, Tatiana; Venturato, Juliana; Wong, Colin X. F.; Marsh, Brad J.; Stow, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Lim, Jet P.; Gleeson, Paul A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Lim, Jet P.; Gleeson, Paul A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Storrie, Brian] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	University of Queensland; University of Melbourne; University of Melbourne; University of Arkansas System; University of Arkansas Medical Sciences	Stow, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	j.stow@imb.uq.edu.au	Khromykh, Tatiana/D-3952-2017; Stow, Jennifer L/I-4723-2013	Khromykh, Tatiana/0000-0001-6629-6885; Stow, Jennifer L/0000-0002-5409-9101; Gleeson, Paul/0000-0002-5336-6503; Micaroni, Massimo/0000-0001-6405-0451	National Health and Medical Research Council (NHMRC, Australia) [569535, 631621]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081930] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding to support this work was provided by National Health and Medical Research Council (NHMRC, Australia) grants to BJM and BS (#569535) and to JLS and PAG (#631621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200; Beutler BA, 1999, J RHEUMATOL, V26, P16; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Di Paola S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037352; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Fernandes H, 2009, BIOCHEM SOC T, V37, P1037, DOI 10.1042/BST0371037; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Houghton FJ, 2009, CELL, V138, P787, DOI 10.1016/j.cell.2009.05.048; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jackson C L, 2000, Subcell Biochem, V34, P233; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Kakinuma T, 2004, EXP CELL RES, V298, P388, DOI 10.1016/j.yexcr.2004.04.047; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Kjer-Nielsen L, 1999, J CELL SCI, V112, P1645; Klumperman J., 2011, COLD SPRING HARB PER, V3; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Liu SJ, 2012, CELL MOL LIFE SCI, V69, P4093, DOI 10.1007/s00018-012-1021-6; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Low PC, 2010, J CELL BIOL, V190, P1053, DOI 10.1083/jcb.201001028; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Micaroni M, 2010, TRAFFIC, V11, P1315, DOI 10.1111/j.1600-0854.2010.01096.x; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Opdam FJM, 2000, J CELL SCI, V113, P2725; Pagan JK, 2003, CURR BIOL, V13, P156, DOI 10.1016/S0960-9822(03)00006-X; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pusapati GV, 2012, J BIOL CHEM, V287, P42129, DOI 10.1074/jbc.M112.414565; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rossi A, 2012, TRAFFIC, V13, P43, DOI 10.1111/j.1600-0854.2011.01299.x; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x; Stow JL, 2006, NAT REV IMMUNOL, V6, P919, DOI 10.1038/nri1980; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	71	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57034	10.1371/journal.pone.0057034	http://dx.doi.org/10.1371/journal.pone.0057034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437303	Green Published, gold			2022-12-27	WOS:000315186000068
J	Reyes-Palomares, A; Rodriguez-Lopez, R; Ranea, JAG; Jimenez, FS; Medina, MA				Reyes-Palomares, Armando; Rodriguez-Lopez, Rocio; Ranea, Juan A. G.; Sanchez Jimenez, Francisca; Angel Medina, Miguel			Global Analysis of the Human Pathophenotypic Similarity Gene Network Merges Disease Module Components	PLOS ONE			English	Article							PROTEIN-INTERACTION; PHENOTYPE; GENOME; BIOLOGY; TOPOLOGY; GENOTYPE; MEDICINE; ONTOLOGY; CLUSTERS	The molecular complexity of genetic diseases requires novel approaches to break it down into coherent biological modules. For this purpose, many disease network models have been created and analyzed. We highlight two of them, "the human diseases networks'' (HDN) and "the orphan disease networks" (ODN). However, in these models, each single node represents one disease or an ambiguous group of diseases. In these cases, the notion of diseases as unique entities reduces the usefulness of network-based methods. We hypothesize that using the clinical features (pathophenotypes) to define pathophenotypic connections between disease-causing genes improve our understanding of the molecular events originated by genetic disturbances. For this, we have built a pathophenotypic similarity gene network (PSGN) and compared it with the unipartite projections (based on gene-to-gene edges) similar to those used in previous network models (HDN and ODN). Unlike these disease network models, the PSGN uses semantic similarities. This pathophenotypic similarity has been calculated by comparing pathophenotypic annotations of genes (human abnormalities of HPO terms) in the "Human Phenotype Ontology". The resulting network contains 1075 genes (nodes) and 26197 significant pathophenotypic similarities (edges). A global analysis of this network reveals: unnoticed pairs of genes showing significant pathophenotypic similarity, a biological meaningful re-arrangement of the pathological relationships between genes, correlations of biochemical interactions with higher similarity scores and functional biases in metabolic and essential genes toward the pathophenotypic specificity and the pleiotropy, respectively. Additionally, pathophenotypic similarities and metabolic interactions of genes associated with maple syrup urine disease (MSUD) have been used to merge into a coherent pathological module. Our results indicate that pathophenotypes contribute to identify underlying co-dependencies among disease-causing genes that are useful to describe disease modularity.	[Reyes-Palomares, Armando; Rodriguez-Lopez, Rocio; Ranea, Juan A. G.; Sanchez Jimenez, Francisca; Angel Medina, Miguel] Univ Malaga, Dept Mol Biol & Biochem, Fac Sci, E-29071 Malaga, Spain; [Reyes-Palomares, Armando; Rodriguez-Lopez, Rocio; Ranea, Juan A. G.; Sanchez Jimenez, Francisca; Angel Medina, Miguel] CIBER Enfermedades Raras CIBERER, Malaga, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Medina, MA (corresponding author), Univ Malaga, Dept Mol Biol & Biochem, Fac Sci, E-29071 Malaga, Spain.	medina@uma.es	Medina, Miguel Ángel/K-1763-2014; Reyes-Palomares, Armando/A-1936-2009	Medina, Miguel Ángel/0000-0001-7275-6462; Reyes-Palomares, Armando/0000-0002-0289-6889; Garcia Ranea, Juan Antonio/0000-0003-0327-1837	Spanish Ministry of Economy and Competitiveness and FEDER [SAF2011/26518, SAF2009/09839, PI12/01096, PS09/02216]; Andalusian Government and FEDER [PIE P08-CTS-3759, CVI-6585, BIO-267]; INTERCONNECTA-AMER grant (Spanish Ministry of Economy and Competitiveness and FEDER);  [SAF2009-09839];  [SAF2012-33110]	Spanish Ministry of Economy and Competitiveness and FEDER(Spanish Government); Andalusian Government and FEDER; INTERCONNECTA-AMER grant (Spanish Ministry of Economy and Competitiveness and FEDER); ; 	The authors' experimental work is supported by grants SAF2011/26518, SAF2009/09839, PI12/01096 and PS09/02216 (Spanish Ministry of Economy and Competitiveness and FEDER), and PIE P08-CTS-3759, CVI-6585 and funds from group BIO-267 (Andalusian Government and FEDER). JR acknowledges grants SAF2009-09839 and SAF2012-33110 and FSJ acknowledges funds from an INTERCONNECTA-AMER grant (Spanish Ministry of Economy and Competitiveness and FEDER). The "CIBER de Enfermedades Raras" is an initiative from the ISCIII (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Ayme Segolene, 2003, Soins, P46; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Brohee S, 2012, METHODS MOL BIOL, V804, P327, DOI 10.1007/978-1-61779-361-5_18; Brohee S, 2008, NAT PROTOC, V3, P1616, DOI 10.1038/nprot.2008.100; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Espinosa O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019693; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Hill WG, 2012, GENETICS; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee DS, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12015; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Loscalzo J, 2011, WIRES SYST BIOL MED, V3, P619, DOI 10.1002/wsbm.144; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Montanez R, 2010, BIOESSAYS, V32, P246, DOI 10.1002/bies.200900145; Nellis MM, 2001, AM J HUM GENET, V68, P232, DOI 10.1086/316950; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Oti M, 2009, AM J HUM GENET, V85, P801, DOI 10.1016/j.ajhg.2009.10.026; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Veeramani B, 2009, J COMPUT BIOL, V16, P291, DOI 10.1089/cmb.2008.14TT; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wheelock CE, 2009, MOL BIOSYST, V5, P588, DOI 10.1039/b902356a; Xie MZ, 2012, BIOINFORMATICS, V28, P5, DOI 10.1093/bioinformatics/btr603; Xu T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-472; Zhang ML, 2011, AM J HUM GENET, V88, P755, DOI 10.1016/j.ajhg.2011.05.006; Zhang SZ, 2012, GENE, V497, P58, DOI 10.1016/j.gene.2012.01.014; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	51	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56653	10.1371/journal.pone.0056653	http://dx.doi.org/10.1371/journal.pone.0056653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437198	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000038
J	Soares, HP; Ni, Y; Kisfalvi, K; Sinnett-Smith, J; Rozengurt, E				Soares, Heloisa P.; Ni, Yang; Kisfalvi, Krisztina; Sinnett-Smith, James; Rozengurt, Enrique			Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; COMPETITIVE MAMMALIAN TARGET; INSULIN-RECEPTOR; TUMOR-SUPPRESSOR; GROWTH-FACTOR; PATHWAY ACTIVATION; SIGNALING SYSTEMS; DIABETIC-PATIENTS; KINASE; RISK	The mTOR pathway is aberrantly stimulated in many cancer cells, including pancreatic ductal adenocarcinoma (PDAC), and thus it is a potential target for therapy. However, the mTORC1/S6K axis also mediates negative feedback loops that attenuate signaling via insulin/IGF receptor and other tyrosine kinase receptors. Suppression of these feed-back loops unleashes over-activation of upstream pathways that potentially counterbalance the antiproliferative effects of mTOR inhibitors. Here, we demonstrate that treatment of PANC-1 or MiaPaCa-2 pancreatic cancer cells with either rapamycin or active-site mTOR inhibitors suppressed S6K and S6 phosphorylation induced by insulin and the GPCR agonist neurotensin. Rapamycin caused a striking increase in Akt phosphorylation at Ser(473) while the active-site inhibitors of mTOR (KU63794 and PP242) completely abrogated Akt phosphorylation at this site. Conversely, active-site inhibitors of mTOR cause a marked increase in ERK activation whereas rapamycin did not have any stimulatory effect on ERK activation. The results imply that first and second generation of mTOR inhibitors promote over-activation of different pro-oncogenic pathways in PDAC cells, suggesting that suppression of feed-back loops should be a major consideration in the use of these inhibitors for PDAC therapy. In contrast, metformin abolished mTORC1 activation without over-stimulating Akt phosphorylation on Ser(473) and prevented mitogen-stimulated ERK activation in PDAC cells. Metformin induced a more pronounced inhibition of proliferation than either KU63794 or rapamycin while, the active-site mTOR inhibitor was more effective than rapamycin. Thus, the effects of metformin on Akt and ERK activation are strikingly different from allosteric or active-site mTOR inhibitors in PDAC cells, though all these agents potently inhibited the mTORC1/S6K axis.	[Soares, Heloisa P.; Ni, Yang; Kisfalvi, Krisztina; Sinnett-Smith, James; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE Digest Dis Res Ctr,Div Digest Dis, Los Angeles, CA 90095 USA; [Soares, Heloisa P.; Ni, Yang; Kisfalvi, Krisztina; Sinnett-Smith, James; Rozengurt, Enrique] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Soares, Heloisa P.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Ni, Yang] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan, Shandong, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Shandong University	Rozengurt, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE Digest Dis Res Ctr,Div Digest Dis, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [P30DK41301, P01CA163200, R01DK55003]; Department of Veterans Affair Grant [1I01BX001473]; Ronald S. Hirshberg Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055003, P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affair Grant; Ronald S. Hirshberg Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants P30DK41301, P01CA163200 and R01DK55003, Department of Veterans Affair Grant 1I01BX001473 and funds from the endowed Ronald S. Hirshberg Chair of Pancreatic Cancer Research all to ER. (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Asano T, 2005, CANCER RES, V65, P9164, DOI 10.1158/0008-5472.CAN-05-0779; Asano T, 2005, BIOCHEM BIOPH RES CO, V331, P295, DOI 10.1016/j.bbrc.2005.03.166; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chong CR, 2009, ONCOLOGIST, V14, P1178, DOI 10.1634/theoncologist.2009-0286; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Dong XQ, 2010, GASTROENTEROLOGY, V139, P464, DOI 10.1053/j.gastro.2010.04.042; Easton JB, 2006, CANCER CELL, V9, P153, DOI 10.1016/j.ccr.2006.02.027; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Guha S, 2003, CANCER RES, V63, P2379; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Kisfalvi K, 2005, J CELL PHYSIOL, V202, P880, DOI 10.1002/jcp.20187; Kisfalvi K, 2007, ENDOCRINOLOGY, V148, P3246, DOI 10.1210/en.2006-1711; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Kolb S, 2007, CANCER RES, V67, P4679, DOI 10.1158/0008-5472.CAN-06-3308; Kornmann M, 1998, CANCER RES, V58, P4250; Kwon J, 2009, CANCER RES, V69, P1350, DOI 10.1158/0008-5472.CAN-08-1328; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pham NA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-43; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Ryder NM, 2001, J CELL PHYSIOL, V186, P53, DOI 10.1002/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sinnett-Smith J, 2012, BIOCH BIOPH IN PRESS; Stoeltzing O, 2003, AM J PATHOL, V163, P1001, DOI 10.1016/S0002-9440(10)63460-8; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wolpin BM, 2009, J CLIN ONCOL, V27, P193, DOI 10.1200/JCO.2008.18.9514; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Ying HQ, 2011, CANCER DISCOV, V1, P158, DOI 10.1158/2159-8290.CD-11-0031; Young SH, 2010, BIOCHEM BIOPH RES CO, V401, P154, DOI 10.1016/j.bbrc.2010.09.036; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	73	107	109	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57289	10.1371/journal.pone.0057289	http://dx.doi.org/10.1371/journal.pone.0057289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437362	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000095
J	Hirnstein, M; Westerhausen, R; Hugdahl, K				Hirnstein, Marco; Westerhausen, Rene; Hugdahl, Kenneth			The Right Planum Temporale Is Involved in Stimulus-Driven, Auditory Attention - Evidence from Transcranial Magnetic Stimulation	PLOS ONE			English	Article							DICHOTIC-LISTENING TASK; HEMISPHERIC-ASYMMETRY; SELECTIVE ATTENTION; CORPUS-CALLOSUM; CONSONANT-VOWEL; FMRI; CORTEX; BRAIN; PERCEPTION; MODULATION	It is well known that the planum temporale (PT) area in the posterior temporal lobe carries out spectro-temporal analysis of auditory stimuli, which is crucial for speech, for example. There are suggestions that the PT is also involved in auditory attention, specifically in the discrimination and selection of stimuli from the left and right ear. However, direct evidence is missing so far. To examine the role of the PT in auditory attention we asked fourteen participants to complete the Bergen Dichotic Listening Test. In this test two different consonant-vowel syllables (e.g., "ba" and "da") are presented simultaneously, one to each ear, and participants are asked to verbally report the syllable they heard best or most clearly. Thus attentional selection of a syllable is stimulus-driven. Each participant completed the test three times: after their left and right PT (located with anatomical brain scans) had been stimulated with repetitive transcranial magnetic stimulation (rTMS), which transiently interferes with normal brain functioning in the stimulated sites, and after sham stimulation, where participants were led to believe they had been stimulated but no rTMS was applied (control). After sham stimulation the typical right ear advantage emerged, that is, participants reported relatively more right than left ear syllables, reflecting a left-hemispheric dominance for language. rTMS over the right but not left PT significantly reduced the right ear advantage. This was the result of participants reporting more left and fewer right ear syllables after right PT stimulation, suggesting there was a leftward shift in stimulus selection. Taken together, our findings point to a new function of the PT in addition to auditory perception: particularly the right PT is involved in stimulus selection and (stimulus-driven), auditory attention.	[Hirnstein, Marco; Westerhausen, Rene; Hugdahl, Kenneth] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Westerhausen, Rene; Hugdahl, Kenneth] Haukeland Hosp, Div Psychiat, N-5021 Bergen, Norway; [Hugdahl, Kenneth] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Hirnstein, M (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	marco.hirnstein@psybp.uib.no	Hirnstein, Marco/A-4642-2015; Hirnstein, Marco/D-2450-2013; Westerhausen, René/D-2441-2013	Hirnstein, Marco/0000-0002-6291-0929; Westerhausen, René/0000-0001-7107-2712; Hugdahl, Kenneth/0000-0002-0008-4326	European Research Council (ERC) [249516]	European Research Council (ERC)(European Research Council (ERC))	This work was supported by the Advanced Grant VOICE 249516 from the European Research Council (ERC) to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho K, 2012, BRAIN RES, V1442, P47, DOI 10.1016/j.brainres.2012.01.007; [Anonymous], 1968, CORTEX, DOI [10.1016/S0010-9452(68)80009-7, DOI 10.1016/S0010-9452(68)80009-7]; Awiszus F., TMS MOTOR THRESHOLD; Beaton AA, 1997, BRAIN LANG, V60, P255, DOI 10.1006/brln.1997.1825; BIRKETT P, 1977, NEUROPSYCHOLOGIA, V15, P693, DOI 10.1016/0028-3932(77)90075-6; BROADBENT DE, 1954, J EXP PSYCHOL, V47, P191, DOI 10.1037/h0054182; BROADBENT DE, 1952, J EXP PSYCHOL, V44, P51, DOI 10.1037/h0056491; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cowey A, 2005, PHILOS T R SOC B, V360, P1185, DOI 10.1098/rstb.2005.1658; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Ellison A, 2004, BRAIN, V127, P2307, DOI 10.1093/brain/awh244; Frith CD, 1996, NEUROIMAGE, V4, P210, DOI 10.1006/nimg.1996.0072; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Hall DA, 2000, HUM BRAIN MAPP, V10, P107, DOI 10.1002/1097-0193(200007)10:3<107::AID-HBM20>3.0.CO;2-8; Hashimoto R, 2000, NEUROIMAGE, V12, P147, DOI 10.1006/nimg.2000.0603; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hirnstein M, 2011, NEUROPSYCHOLOGIA, V49, P29, DOI 10.1016/j.neuropsychologia.2010.10.028; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Hugdahl K, 1997, ARCH NEUROL-CHICAGO, V54, P1494, DOI 10.1001/archneur.1997.00550240046011; HUGDAHL K, 1986, CORTEX, V22, P417, DOI 10.1016/S0010-9452(86)80005-3; Hugdahl K, 2013, SEX DIFFERE IN PRESS; Hugdahl Kenneth, 1995, P123; Jacobs S, 2012, NEUROPSYCHOLOGIA, V50, P1029, DOI 10.1016/j.neuropsychologia.2012.03.018; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Jancke L, 2001, BRAIN LANG, V78, P349, DOI 10.1006/brln.2000.2476; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Kompus K, 2012, BRAIN LANG, V121, P240, DOI 10.1016/j.bandl.2012.03.004; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; LEE GP, 1994, EPILEPSY RES, V19, P153, DOI 10.1016/0920-1211(94)90025-6; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MAZZUCCHI A, 1985, EPILEPSIA, V26, P379, DOI 10.1111/j.1528-1157.1985.tb05668.x; MAZZUCCHI A, 1978, CORTEX, V14, P381, DOI 10.1016/S0010-9452(78)80064-1; MILNER B, 1968, SCIENCE, V161, P184, DOI 10.1126/science.161.3837.184; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OLeary DS, 1996, BRAIN LANG, V53, P20, DOI 10.1006/brln.1996.0034; Pollmann S, 2004, NEUROPSYCHOLOGY, V18, P710, DOI 10.1037/0894-4105.18.4.710; Pollmann S, 2002, NEUROPSYCHOLOGY, V16, P56, DOI 10.1037//0894-4105.16.1.56; Pollmann S, 2010, 2 HALVES BRAIN INFOR, P441; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rimol LM, 2006, NEUROPSYCHOLOGIA, V44, P191, DOI 10.1016/j.neuropsychologia.2005.05.006; Rimol LM, 2005, NEUROIMAGE, V26, P1059, DOI 10.1016/j.neuroimage.2005.03.028; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sequeira SD, 2006, NEUROPSYCHOLOGIA, V44, P622, DOI 10.1016/j.neuropsychologia.2005.06.014; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; STUDDERTKENNEDY M, 1970, J ACOUST SOC AM, V48, P579, DOI 10.1121/1.1912174; Thomsen T, 2004, NEUROIMAGE, V21, P211, DOI 10.1016/j.neuroimage.2003.08.039; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; van den Noort M, 2008, NEUROIMAGE, V40, P902, DOI 10.1016/j.neuroimage.2007.11.051; Walsh V, 2003, BRADFORD BOOKS, P1; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Westerhausen R, 2009, CEREB CORTEX, V19, P1322, DOI 10.1093/cercor/bhn173; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	63	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57316	10.1371/journal.pone.0057316	http://dx.doi.org/10.1371/journal.pone.0057316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437367	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200242
J	Long, Y; Li, Q; Zhou, BL; Song, GL; Li, T; Cui, ZB				Long, Yong; Li, Qing; Zhou, Bolan; Song, Guili; Li, Tao; Cui, Zongbin			De Novo Assembly of Mud Loach (Misgurnus anguillicaudatus) Skin Transcriptome to Identify Putative Genes Involved in Immunity and Epidermal Mucus Secretion	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; FISH SKIN; JAPANESE EEL; PARASIN-I; EXPRESSION; POLYSACCHARIDE; POLYPEPTIDE; ANNOTATION; MECHANISMS; COMPONENTS	Fish skin serves as the first line of defense against a wide variety of chemical, physical and biological stressors. Secretion of mucus is among the most prominent characteristics of fish skin and numerous innate immune factors have been identified in the epidermal mucus. However, molecular mechanisms underlying the mucus secretion and immune activities of fish skin remain largely unclear due to the lack of genomic and transcriptomic data for most economically important fish species. In this study, we characterized the skin transcriptome of mud loach using Illumia paired-end sequencing. A total of 40364 unigenes were assembled from 86.6 million (3.07 gigabases) filtered reads. The mean length, N50 size and maximum length of assembled transcripts were 387, 611 and 8670 bp, respectively. A total of 17336 (43.76%) unigenes were annotated by blast searches against the NCBI non-redundant protein database. Gene ontology mapping assigned a total of 108513 GO terms to 15369 (38.08%) unigenes. KEGG orthology mapping annotated 9337 (23.23%) unigenes. Among the identified KO categories, immune system is the largest category that contains various components of multiple immune pathways such as chemokine signaling, leukocyte transendothelial migration and T cell receptor signaling, suggesting the complexity of immune mechanisms in fish skin. As for mucin biosynthesis, 37 unigenes were mapped to 7 enzymes of the mucin type O-glycan biosynthesis pathway and 8 members of the polypeptide N-acetylgalactosaminyltransferase family were identified. Additionally, 38 unigenes were mapped to 23 factors of the SNARE interactions in vesicular transport pathway, indicating that the activity of this pathway is required for the processes of epidermal mucus storage and release. Moreover, 1754 simple sequence repeats (SSRs) were detected in 1564 unigenes and dinucleotide repeats represented the most abundant type. These findings have laid the foundation for further understanding the secretary processes and immune functions of loach skin mucus.	[Long, Yong; Li, Qing; Zhou, Bolan; Song, Guili; Li, Tao; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Zhou, Bolan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, ZB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zbcui@ihb.ac.cn			Knowledge Innovation Program of the Chinese 590 Academy of Sciences [Y25E05-1-501]; National Natural Science 591 Foundation of China [31101892]	Knowledge Innovation Program of the Chinese 590 Academy of Sciences; National Natural Science 591 Foundation of China	This study was supported by the Knowledge Innovation Program of the Chinese 590 Academy of Sciences (#Y25E05-1-501 to YL) and the National Natural Science 591 Foundation of China (#31101892 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; ALHASSAN JM, 1983, LANCET, V1, P1043; Aranishi F, 1999, FISH SHELLFISH IMMUN, V9, P61, DOI 10.1006/fsim.1998.0160; Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; BROWN GA, 1970, Z ZELLFORSCH MIK ANA, V103, P149, DOI 10.1007/BF00337309; Buchmann K, 1999, FOLIA PARASIT, V46, P1; Bureau of Fisheries MoA, 2011, CHIN FISH STAT YB; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; care Ccoa, 2005, GUID CAR US FISH RES; Chen J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-108; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dong XZ, 2002, PROTEIN EXPRES PURIF, V26, P235, DOI 10.1016/S1046-5928(02)00514-4; Easy RH, 2010, J FISH BIOL, V77, P1616, DOI 10.1111/j.1095-8649.2010.02796.x; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Goda Y, 1997, P NATL ACAD SCI USA, V94, P769, DOI 10.1073/pnas.94.3.769; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; HARRIS JE, 1975, CELL TISSUE RES, V157, P553; HAWKES JW, 1974, CELL TISSUE RES, V149, P147, DOI 10.1007/BF00222270; Hsiao CD, 2003, DEV DYNAM, V228, P745, DOI 10.1002/dvdy.10411; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kasai K, 2010, FEBS J, V277, P453, DOI 10.1111/j.1742-4658.2009.07497.x; Koo YS, 2008, PEPTIDES, V29, P1102, DOI 10.1016/j.peptides.2008.02.019; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Marel Maria van der, 2012, Fish Shellfish Immunol, V32, P494, DOI 10.1016/j.fsi.2011.12.008; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; Nam YK, 2011, FISH SHELLFISH IMMUN, V31, P1251, DOI 10.1016/j.fsi.2011.09.007; Palaksha KJ, 2008, FISH SHELLFISH IMMUN, V24, P479, DOI 10.1016/j.fsi.2008.01.005; Park CB, 1997, FEBS LETT, V411, P173, DOI 10.1016/S0014-5793(97)00684-4; Park IY, 1998, FEBS LETT, V437, P258, DOI 10.1016/S0014-5793(98)01238-1; Pereiro P, 2012, PLOS ONE, V7; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Qin CG, 2008, INT IMMUNOPHARMACOL, V8, P607, DOI 10.1016/j.intimp.2007.12.015; Raj VS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-92; Rakers S, 2010, EXP DERMATOL, V19, P313, DOI 10.1111/j.1600-0625.2009.01059.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SHAI Y, 1988, FEBS LETT, V242, P161, DOI 10.1016/0014-5793(88)81007-X; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Subramanian S, 2007, COMP BIOCHEM PHYS B, V148, P256, DOI 10.1016/j.cbpb.2007.06.003; Subramanian S, 2009, MAR BIOTECHNOL, V11, P748, DOI 10.1007/s10126-009-9189-y; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tasumi S, 2004, DEV COMP IMMUNOL, V28, P325, DOI 10.1016/j.dci.2003.08.006; Tasumi S, 2002, J BIOL CHEM, V277, P27305, DOI 10.1074/jbc.M202648200; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tsutsui S, 2011, J BIOCHEM, V150, P501, DOI 10.1093/jb/mvr085; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You LJ, 2011, J AGR FOOD CHEM, V59, P7948, DOI 10.1021/jf2016368; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang CX, 2006, TOXICOL APPL PHARM, V210, P236, DOI 10.1016/j.taap.2005.04.019; Zhang CX, 2005, J ETHNOPHARMACOL, V99, P385, DOI 10.1016/j.jep.2005.02.033	75	49	52	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56998	10.1371/journal.pone.0056998	http://dx.doi.org/10.1371/journal.pone.0056998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437293	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200197
J	Lotz, S; Goderie, S; Tokas, N; Hirsch, SE; Ahmad, F; Corneo, B; Le, S; Banerjee, A; Kane, RS; Stern, JH; Temple, S; Fasano, CA				Lotz, Steven; Goderie, Susan; Tokas, Nicolas; Hirsch, Sarah E.; Ahmad, Faizzan; Corneo, Barbara; Le, Sheila; Banerjee, Akhilesh; Kane, Ravi S.; Stern, Jeffrey H.; Temple, Sally; Fasano, Christopher A.			Sustained Levels of FGF2 Maintain Undifferentiated Stem Cell Cultures with Biweekly Feeding	PLOS ONE			English	Article							SELF-RENEWAL; PLGA MICROSPHERES; VASCULAR NICHE; HUMAN ES; DIFFERENTIATION; GROWTH; TROPHOBLAST; DERIVATION; LINES; FATE	An essential aspect of stem cell culture is the successful maintenance of the undifferentiated state. Many types of stem cells are FGF2 dependent, and pluripotent stem cells are maintained by replacing FGF2-containing media daily, while tissue-specific stem cells are typically fed every 3rd day. Frequent feeding, however, results in significant variation in growth factor levels due to FGF2 instability, which limits effective maintenance due to spontaneous differentiation. We report that stabilization of FGF2 levels using controlled release PLGA microspheres improves expression of stem cell markers, increases stem cell numbers and decreases spontaneous differentiation. The controlled release FGF2 additive reduces the frequency of media changes needed to maintain stem cell cultures, so that human embryonic stem cells and induced pluripotent stem cells can be maintained successfully with biweekly feedings.	[Lotz, Steven; Goderie, Susan; Tokas, Nicolas; Hirsch, Sarah E.; Ahmad, Faizzan; Corneo, Barbara; Le, Sheila; Stern, Jeffrey H.; Temple, Sally; Fasano, Christopher A.] Neural Stem Cell Inst, Rensselaer, NY USA; [Banerjee, Akhilesh; Kane, Ravi S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Tokas, Nicolas; Hirsch, Sarah E.; Ahmad, Faizzan; Corneo, Barbara; Temple, Sally; Fasano, Christopher A.] SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Dept Biomed Sci, Albany, NY USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Fasano, CA (corresponding author), Neural Stem Cell Inst, Rensselaer, NY USA.	chrisfasano@nstemcell.org		Corneo, Barbara/0000-0001-5189-6749	Regenerative Research Foundation, Rensselaer NY	Regenerative Research Foundation, Rensselaer NY	This work was supported by funding from the Regenerative Research Foundation, Rensselaer NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen G, 2012, STEM CELLS, V30, P623, DOI 10.1002/stem.1021; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gothard D, 2010, TISSUE ENG PART C-ME, V16, P583, DOI [10.1089/ten.tec.2009.0462, 10.1089/ten.TEC.2009.0462]; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Johnstone ED, 2005, BIOL REPROD, V73, P1282, DOI 10.1095/biolreprod.105.044206; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liang CZ, 2012, J MATER SCI-MATER M, V23, P1097, DOI 10.1007/s10856-012-4563-0; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Manuilova E S, 2001, Izv Akad Nauk Ser Biol, P704; Moioli EK, 2006, TISSUE ENG, V12, P537, DOI 10.1089/ten.2006.12.537; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Qian XM, 1998, DEVELOPMENT, V125, P3143; Sathananthan A. H., 2005, Italian Journal of Anatomy and Embryology, V110, P151; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shi L, 2002, J PHARM SCI-US, V91, P1019, DOI 10.1002/jps.10042; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson JA, 1998, APMIS, V106, P149, DOI 10.1111/j.1699-0463.1998.tb01330.x; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Yue ZC, 2010, SCI CHINA LIFE SCI, V53, P78, DOI 10.1007/s11427-010-0010-y; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52, DOI 10.1038/71916	40	67	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56289	10.1371/journal.pone.0056289	http://dx.doi.org/10.1371/journal.pone.0056289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437109	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200055
J	Reza, S; Shaukat, A; Arain, TM; Riaz, QS; Mahmud, M				Reza, Sara; Shaukat, Asma; Arain, Tariq M.; Riaz, Qasim Sarwar; Mahmud, Maria			Expression of Osteopontin in Patients with Thyroid Dysfunction	PLOS ONE			English	Article							PLASMA OSTEOPONTIN; INTRACELLULAR OSTEOPONTIN; BONE SIALOPROTEIN; FOLLOW-UP; BREAST; CALCIFICATION; ASSOCIATION; MACROPHAGES; CELLS; INFLAMMATION	Thyroid dysfunctions are common endocrine problems. They are often misdiagnosed, misunderstood, and frequently overlooked. These disorders affect almost every aspect of health. Most of them remain undetected because the clinical assessment alone lacks both sensitivity and specificity. As it is not sufficient enough we require the biochemical tests to confirm the diagnosis. As a consequence there is still great interest in new biomarkers that complement existing diagnostic tools. Osteopontin, a glycoprotein that can be detected in plasma, was found to be upregulated in several patients with hyperthyroidism and downregulated in hypothyroid patients so it may represent a new biomarker. 100 patients with thyroid dysfunctions (50 hyperthyroid, 50 hypothyroid) and 100 normal subjects were included in the study. Osteopontin and other clinical parameters for diagnosis of thyroid disorders were measured. Osteopontin is positively correlated with T3 and T4 (r = 0.62 and r = 0.75 respectively) while it is negatively correlated with thyroid stimulating hormone (r = -0.52) showing a significant correlation (p-value <0.001). Our findings suggest that osteopontin might be useful as a novel prognostic biomarker in patients with impaired thyroid function.	[Reza, Sara; Shaukat, Asma] Quaid e Azam Med Coll, Dept Pathol, Bahawalpur, Pakistan; [Arain, Tariq M.] Bahawal Victoria Hosp, Dept Ophthalmol, Bahawalpur, Pakistan; [Riaz, Qasim Sarwar] St John Providence Hlth Syst, Dept Med, Warren, MI USA; [Mahmud, Maria] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	St. John Hospital & Medical Center; Carleton University	Reza, S (corresponding author), Quaid e Azam Med Coll, Dept Pathol, Bahawalpur, Pakistan.	sara_qmc@hotmail.com						Agnholt J, 2007, SCAND J IMMUNOL, V65, P453, DOI 10.1111/j.1365-3083.2007.01908.x; Alam Khan V., J MED SCI, V2, P89, DOI [10.3923/jms.2002.89.94, DOI 10.3923/JMS.2002.89.94]; Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; Arora S, 2009, INDIAN J CLIN BIOCHE, V24, P370, DOI 10.1007/s12291-009-0067-1; Ashizawa N, 1996, J CLIN INVEST, V98, P2218, DOI 10.1172/JCI119031; Baral N., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P638; Blake CA, 2011, EXP BIOL MED, V236, P445, DOI 10.1258/ebm.2010.010334; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; Briese J, 2010, ANTICANCER RES, V30, P1681; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; FITZPATRICK LA, 1994, J CLIN INVEST, V94, P1597, DOI 10.1172/JCI117501; Golledge J, 2004, STROKE, V35, P1636, DOI 10.1161/01.STR.0000129790.00318.a3; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Guarino V, 2005, J CLIN ENDOCR METAB, V90, P5270, DOI 10.1210/jc.2005-0271; Guo HT, 2001, J IMMUNOL, V166, P1079, DOI 10.4049/jimmunol.166.2.1079; Gursoy G., 2010, CLIN REV OPIN, V2, P35; Gursoy G, 2010, J MED MED SCI, V1, P55; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; HEINEGARD D, 1989, CONNECT TISSUE RES, V21, P333; HIROTA S, 1993, AM J PATHOL, V143, P1003; Hullinger TG, 2001, EXP CELL RES, V262, P69, DOI 10.1006/excr.2000.5074; Junaid A, 2007, AM J PHYSIOL-CELL PH, V292, pC919, DOI 10.1152/ajpcell.00477.2006; Kurata M, 2006, CLIN SCI, V111, P319, DOI 10.1042/CS20060074; Kwon HM, 2000, J KOREAN MED SCI, V15, P485, DOI 10.3346/jkms.2000.15.5.485; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; Liou YM, 2005, J BIOMED SCI, V12, P869, DOI 10.1007/s11373-005-9023-0; Mansoor R., 2010, ANN PAK I MED SCI, V6, P101; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; MURRY CE, 1994, AM J PATHOL, V145, P1450; Nau GJ, 2000, CYTOKINE REFERENCE C, V1st, P689; Nau GJ, 2000, CYTOKINE REFERENCE C, V1st, P1859; NODA M, 1989, J CELL BIOL, V108, P713, DOI 10.1083/jcb.108.2.713; Phillips JA, 2001, THYROID HORMONE DISO; Riaz M, 2009, INT J ENDOCRINOL MET, V7, P12; Ricardo SD, 2000, AM J PHYSIOL-RENAL, V278, pF708, DOI 10.1152/ajprenal.2000.278.5.F708; Saha P. K., 2007, Indian Journal of Community Medicine, V32, P139; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Seiffge D, 1996, J RHEUMATOL, V23, P2086; Shamon M, 2009, HLTH DIS CONDITION; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Sharp JA, 1999, LAB INVEST, V79, P869; Singhal H, 1997, CLIN CANCER RES, V3, P605; Sodhi CP, 2001, AM J PHYSIOL-RENAL, V280, pF667, DOI 10.1152/ajprenal.2001.280.4.F667; Standal T, 2004, EXP ONCOL, V26, P179; Suzuki K, 2002, J BONE MINER RES, V17, P1486, DOI 10.1359/jbmr.2002.17.8.1486; Uaesoontrachoon K, 2008, INT J BIOCHEM CELL B, V40, P2303, DOI 10.1016/j.biocel.2008.03.020; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Xu L, 2011, J CLIN ENDOCR METAB, V96, P1866; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	54	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56533	10.1371/journal.pone.0056533	http://dx.doi.org/10.1371/journal.pone.0056533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437160	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200098
J	Rivas, AL; Jankowski, MD; Piccinini, R; Leitner, G; Schwarz, D; Anderson, KL; Fair, JM; Hoogesteijn, AL; Wolter, W; Chaffer, M; Blum, S; Were, T; Konah, SN; Kempaiah, P; Ong'echa, JM; Diesterbeck, US; Pilla, R; Czerny, CP; Hittner, JB; Hyman, JM; Perkins, DJ				Rivas, Ariel L.; Jankowski, Mark D.; Piccinini, Renata; Leitner, Gabriel; Schwarz, Daniel; Anderson, Kevin L.; Fair, Jeanne M.; Hoogesteijn, Almira L.; Wolter, Wilfried; Chaffer, Marcelo; Blum, Shlomo; Were, Tom; Konah, Stephen N.; Kempaiah, Prakash; Ong'echa, John M.; Diesterbeck, Ulrike S.; Pilla, Rachel; Czerny, Claus-Peter; Hittner, James B.; Hyman, James M.; Perkins, Douglas J.			Feedback-Based, System-Level Properties of Vertebrate-Microbial Interactions	PLOS ONE			English	Article							COMPOSITIONAL DATA-ANALYSIS; DIFFERENTIAL CELL COUNTS; STAPHYLOCOCCUS-AUREUS; INFLAMMATORY REACTIONS; CLINICALLY HEALTHY; NEGATIVE-FEEDBACK; MALARIAL ANEMIA; BIOLOGY; MILK; EVOLUTION	Background: Improved characterization of infectious disease dynamics is required. To that end, three-dimensional (3D) data analysis of feedback-like processes may be considered. Methods: To detect infectious disease data patterns, a systems biology (SB) and evolutionary biology (EB) approach was evaluated, which utilizes leukocyte data structures designed to diminish data variability and enhance discrimination. Using data collected from one avian and two mammalian (human and bovine) species infected with viral, parasite, or bacterial agents (both sensitive and resistant to antimicrobials), four data structures were explored: (i) counts or percentages of a single leukocyte type, such as lymphocytes, neutrophils, or macrophages (the classic approach), and three levels of the SB/EB approach, which assessed (ii) 2D, (iii) 3D, and (iv) multi-dimensional (rotating 3D) host-microbial interactions. Results: In all studies, no classic data structure discriminated disease-positive (D+, or observations in which a microbe was isolated) from disease-negative (D-, or microbial-negative) groups: D+ and D-data distributions overlapped. In contrast, multi-dimensional analysis of indicators designed to possess desirable features, such as a single line of observations, displayed a continuous, circular data structure, whose abrupt inflections facilitated partitioning into subsets statistically significantly different from one another. In all studies, the 3D, SB/EB approach distinguished three (steady, positive, and negative) feedback phases, in which D-data characterized the steady state phase, and D+ data were found in the positive and negative phases. In humans, spatial patterns revealed false-negative observations and three malaria-positive data classes. In both humans and bovines, methicillin-resistant Staphylococcus aureus (MRSA) infections were discriminated from non-MRSA infections. Conclusions: More information can be extracted, from the same data, provided that data are structured, their 3D relationships are considered, and well-conserved (feedback-like) functions are estimated. Patterns emerging from such structures may distinguish well-conserved from recently developed host-microbial interactions. Applications include diagnosis, error detection, and modeling.	[Rivas, Ariel L.; Were, Tom; Konah, Stephen N.; Kempaiah, Prakash; Ong'echa, John M.; Perkins, Douglas J.] Univ New Mexico, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Rivas, Ariel L.; Anderson, Kevin L.] N Carolina State Univ, Raleigh, NC 27695 USA; [Jankowski, Mark D.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Piccinini, Renata; Pilla, Rachel] Univ Milan, Milan, Italy; [Leitner, Gabriel; Blum, Shlomo] Kimron Vet Inst, IL-50250 Bet Dagan, Israel; [Schwarz, Daniel; Diesterbeck, Ulrike S.; Czerny, Claus-Peter] Univ Gottingen, Fac Agr Sci, Dept Anim Sci, D-37073 Gottingen, Germany; [Fair, Jeanne M.] Los Alamos Natl Lab, Los Alamos, NM USA; [Hoogesteijn, Almira L.] CINVESTAV, Ctr Invest & Estudios Avanzados, Merida, Yucatan, Mexico; [Wolter, Wilfried] Regierungsprasidium Giessen, Wetzlar, Germany; [Chaffer, Marcelo] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Hittner, James B.] Coll Charleston, Dept Psychol, Charleston, SC 29401 USA; [Hyman, James M.] Tulane Univ, Dept Math, New Orleans, LA 70118 USA	University of New Mexico; University of North Carolina; North Carolina State University; University of Wisconsin System; University of Wisconsin Madison; University of Milan; Kimron Veterinary Institute; University of Gottingen; United States Department of Energy (DOE); Los Alamos National Laboratory; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Prince Edward Island; College of Charleston; Tulane University	Rivas, AL (corresponding author), Univ New Mexico, Ctr Global Hlth, Albuquerque, NM 87131 USA.	alrivas@unm.edu	Hyman, James M/AAF-7389-2020; Piccinini, Renata/K-6321-2017; Were, Tom/AAJ-9664-2021	Hyman, James M/0000-0001-5247-5794; Piccinini, Renata/0000-0002-1003-3960; Were, Tom/0000-0002-0349-9906; Ong'echa, John/0000-0003-3928-6774; Pilla, Rachel/0000-0001-7758-2609; Kempaiah, Prakasha/0000-0002-2901-0339	Los Alamos National Laboratory, Los Alamos, New Mexico, USA; National Research Service Award; National Institutes of Environmental Health Sciences Training Grant [T32 ES07015]; FOGARTY INTERNATIONAL CENTER [D43TW005884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	Los Alamos National Laboratory, Los Alamos, New Mexico, USA(United States Department of Energy (DOE)Los Alamos National Laboratory); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Environmental Health Sciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Because this study is based on data already reported or generated by projects already funded, it did not have any funding support, except the support received from Los Alamos National Laboratory, meant to fund a preparatory meeting, which is indicated in Acknowledgments. The support of Los Alamos National Laboratory, Los Alamos, New Mexico, USA, is appreciated, as well as that of the National Research Service Award, which granted the Predoctoral Traineeship Award to M.J. (National Institutes of Environmental Health Sciences Training Grant T32 ES07015, Molecular and Environmental Toxicology Center, University of Wisconsin-Madison).	Abel J, 2011, J INNATE IMMUN, V3, P495, DOI 10.1159/000327714; Aitchison J, 2005, MATH GEOL, V37, P829, DOI 10.1007/s11004-005-7383-7; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Anderson KL, 2010, J DAIRY SCI, V93, P5673, DOI 10.3168/jds.2009-2885; Anderson KL, 2006, AM J VET RES, V67, P1185, DOI 10.2460/ajvr.67.7.1185; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Anwar S, 2009, CLIN EXP IMMUNOL, V157, P216, DOI 10.1111/j.1365-2249.2009.03950.x; Aubel D, 2010, CURR OPIN GENET DEV, V20, P634, DOI 10.1016/j.gde.2010.09.003; Auffray C, 2008, PROG BIOPHYS MOL BIO, V97, P79, DOI 10.1016/j.pbiomolbio.2007.09.002; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Baxter MJ, 2006, ARCHAEOMETRY, V48, P511, DOI 10.1111/j.1475-4754.2006.00270.x; Bocharov G, 2011, P NATL ACAD SCI USA, V108, P3318, DOI 10.1073/pnas.1019706108; Bogorad L, 2008, PHOTOSYNTH RES, V95, P11, DOI 10.1007/s11120-007-9236-3; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Boshra H, 2004, J IMMUNOL, V172, P4381, DOI 10.4049/jimmunol.172.7.4381; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Cannon W.B., 1932, WISDOM BODY; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Crofts AR, 2007, COMPLEXITY, V13, P14, DOI 10.1002/cplx.20180; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; Drack M, 2011, SEMIN CANCER BIOL, V21, P150, DOI 10.1016/j.semcancer.2011.05.001; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P109, DOI 10.1016/0895-4356(90)90064-V; Forrester J.W., 1961, IND DYNAMICS; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Goldbeter A, 2012, FEBS LETT, V586, P2955, DOI 10.1016/j.febslet.2012.07.041; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Groesser SN, 2012, SYST DYNAM REV, V28, P46, DOI 10.1002/sdr.476; Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hu ZY, 2011, NONLINEAR ANAL-REAL, V12, P2356, DOI 10.1016/j.nonrwa.2011.02.009; Jankowski MD, 2010, TOXICOLOGY, V269, P81, DOI 10.1016/j.tox.2010.01.010; Johnson BR, 2010, BIOL PHILOS, V25, P843, DOI 10.1007/s10539-010-9230-6; Katz JN, 1999, AM POLIT SCI REV, V93, P15, DOI 10.2307/2585758; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2011, NAT CHEM BIOL, V7, P323, DOI 10.1038/nchembio.574; Kurakin A, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-6; Laking G, 2006, HEALTH ECON, V15, P1109, DOI 10.1002/hec.1114; Leitner G, 2000, J VET MED B, V47, P581, DOI 10.1046/j.1439-0450.2000.00388.x; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Luni C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-161; Macklem PT, 2008, J APPL PHYSIOL, V104, P1844, DOI 10.1152/japplphysiol.00942.2007; Maina RN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S4; McBryde ES, 2009, INFECT CONT HOSP EP, V30, P1045, DOI 10.1086/606168; Mehr R, 2006, B MATH BIOL, V68, P1073, DOI 10.1007/s11538-006-9124-6; Melvin JA, 2011, BIOCHEMISTRY-US, V50, P7591, DOI 10.1021/bi200844h; Michod RE, 2006, J THEOR BIOL, V239, P257, DOI 10.1016/j.jtbi.2005.08.043; MILTON JG, 1989, J THEOR BIOL, V138, P129, DOI 10.1016/S0022-5193(89)80135-3; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Nesse RM, 2008, EVOL APPL, V1, P28, DOI 10.1111/j.1752-4571.2007.00006.x; Noble D, 2011, PHARMACOPSYCHIATRY, V44, pS9, DOI 10.1055/s-0031-1271703; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x; O'Meara WP, 2007, AM J TROP MED HYG, V77, P246, DOI 10.4269/ajtmh.2007.77.246; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Romero-Gomez MP, 2012, DIAGN MICR INFEC DIS, V72, P282, DOI 10.1016/j.diagmicrobio.2011.11.012; Pilla R, 2012, J DAIRY SCI, V95, P4410, DOI 10.3168/jds.2012-5331; Pilla R, 2012, VET REC, V170, DOI 10.1136/vr.100510; Popper K., 1968, SYST ZOOL; Pritchard L, 2011, PLANT SCI, V180, P584, DOI 10.1016/j.plantsci.2010.12.008; Qu ZL, 2011, PROG BIOPHYS MOL BIO, V107, P21, DOI 10.1016/j.pbiomolbio.2011.06.004; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Rerknimitr R, 2010, J GASTROEN HEPATOL, V25, P946, DOI 10.1111/j.1440-1746.2009.06153.x; Rivas AL, 2001, J VET DIAGN INVEST, V13, P399, DOI 10.1177/104063870101300506; Rivas AL, 2001, AM J VET RES, V62, P1840, DOI 10.2460/ajvr.2001.62.1840; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; Schindler M, 2006, CELL BIOCHEM BIOPHYS, V45, P215, DOI 10.1385/CBB:45:2:215; Schmidt NJ, 1989, DIAGNOSTIC PROCEDURE; Schmitz J, 2005, J MOL EVOL, V61, P1, DOI 10.1007/s00239-004-0293-3; Schwarz D, 2011, J DAIRY SCI, V94, P5033, DOI 10.3168/jds.2011-4348; Schwarz D, 2011, J DAIRY RES, V78, P448, DOI 10.1017/S0022029911000574; Senge P. M., 1999, 5 DISCIPLINE ART PRA; Shiraishi T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000851; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; Smilde AK, 2010, METABOLOMICS, V6, P3, DOI 10.1007/s11306-009-0191-1; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; Song Z, 2010, IEEE T PATTERN ANAL, V32, P1770, DOI 10.1109/TPAMI.2009.192; Stark J, 2007, IMMUNOL REV, V216, P213; Tarnok A, 2010, CURR MED CHEM, V17, P1719, DOI 10.2174/092986710791111251; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; UMBARGER HE, 1956, SCIENCE, V123, P848, DOI 10.1126/science.123.3202.848; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Way JC, 2007, COMPLEXITY, V13, P22, DOI 10.1002/cplx.20198; Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10; Wikler M. A., 2009, PERFORMANCE STANDARD; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x; Zeron ES, 2008, MATH MODEL NAT PHENO, V3, P67, DOI 10.1051/mmnp:2008055	94	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e53984	10.1371/journal.pone.0053984	http://dx.doi.org/10.1371/journal.pone.0053984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437039	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200006
J	Sharma, A; Krause, A; Xu, YQ; Sung, BI; Wu, W; Worgall, S				Sharma, Anurag; Krause, Anja; Xu, Yaqin; Sung, Biin; Wu, Wendy; Worgall, Stefan			Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa	PLOS ONE			English	Article							MEMBRANE PROTEIN-F; HETEROLOGOUS IMMUNOTYPE STRAINS; CHRONIC PULMONARY INFECTION; DENDRITIC CELLS; GENE-THERAPY; T-CELLS; VECTORS; LUNG; ANTIBODIES; RESPONSES	Adenovirus (Ad) vector-based vaccines displaying pathogen-derived epitopes on Ad capsid proteins can elicit antipathogen immunity. This approach seems to be particularly efficient with epitopes incorporated into the Ad fiber protein. Here, we explore epitope insertion into various sites of the Ad fiber to elicit epitope-specific immunity. Ad vectors expressing the 14-mer Pseudomonas aeruginosa immune-dominant outer membrane protein F (OprF) epitope 8 (Epi8) in five distinct sites of the Ad5 fiber, loops CD (AdZ.F(CD)Epi8), DE (AdZ.F(DE)Epi8), FG (AdZ.F(FG)Epi8), HI (AdZ.F(HI)Epi8) and C terminus (AdZ.F(CT)Epi8), or the hexon HVR5 loop (AdZ.HxEpi8) were compared in their capacity to elicit anti-P. aeruginosa immunity to AdOprF, an Ad expressing the entire OprF protein. Intramuscular immunization of BALB/c mice with AdZ.F(FG)Epi8 or AdZ.F(HI)Epi8 elicited higher anti-OprF humoral and cellular CD4 and CD8 responses as well as enhanced protection against respiratory infection with P. aeruginosa compared to immunization with AdZ.F(CD)Epi8, AdZ.F(DE)Epi8, AdZ.F(CT)Epi8 or AdZ.HxEpi8. Importantly, repeat administration of the fiber- and hexon-modified Ad vectors boosted the OprF-specific humoral immune response in contrast to immunization with AdOprF. Strikingly, following three doses of AdZ.F(FG)Epi8 or AdZ.F(HI)Epi8 anti-OprF immunity surpassed that induced by AdOprF. Furthermore, in the presence of anti-Ad5 immunity, immunization with AdZ.F(FG)Epi8 or AdZ.F(HI)Epi8, but not with AdOprF, induced protective immunity against P. aeruginosa. This suggests that incorporation of epitopes into distinct sites of the Ad fiber is a promising vaccine strategy.	[Sharma, Anurag; Krause, Anja; Sung, Biin; Wu, Wendy; Worgall, Stefan] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Xu, Yaqin; Worgall, Stefan] Weill Cornell Med Coll, Dept Pediat, New York, NY USA	Cornell University; Cornell University	Worgall, S (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.	stw2006@med.cornell.edu	SHARMA, ANURAG/GQA-9578-2022	SHARMA, ANURAG/0000-0002-5769-8185	National Heart, Lung, and Blood Institute (NHLBI) [U01 AI069032, RO1 AI72238]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072238, U01AI069032] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Heart, Lung, and Blood Institute (NHLBI) U01 AI069032 and RO1 AI72238 to Stefan Worgall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Motal U, 2006, J VIROL, V80, P6943, DOI 10.1128/JVI.00310-06; Ahi YS, 2011, CURR GENE THER, V11, P307; Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; CROMPTON J, 1994, J GEN VIROL, V75, P133, DOI 10.1099/0022-1317-75-1-133; Doring G, 2008, VACCINE, V26, P1011, DOI 10.1016/j.vaccine.2007.12.007; DUNKLEY ML, 1994, IMMUNOLOGY, V83, P362; GILLELAND HE, 1988, INFECT IMMUN, V56, P1017, DOI 10.1128/IAI.56.5.1017-1022.1988; GILLELAND LB, 1995, INFECT IMMUN, V63, P2347, DOI 10.1128/IAI.63.6.2347-2351.1995; Hackett NR, 2000, CURR OPIN MOL THER, V2, P376; Hashimoto M, 2005, INFECT IMMUN, V73, P6885, DOI 10.1128/IAI.73.10.6885-6891.2005; HERSH J, 1995, GENE THER, V2, P124; Hicks MJ, 2011, MOL THER, V19, P612, DOI 10.1038/mt.2010.280; HUGHES EE, 1992, INFECT IMMUN, V60, P3497, DOI 10.1128/IAI.60.9.3497-3503.1992; Kikuchi T, 2001, HUM GENE THER, V12, P1251, DOI 10.1089/104303401750270913; Koizumi N, 2003, J VIROL, V77, P13062, DOI 10.1128/JVI.77.24.13062-13072.2003; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Krause A, 2011, VACCINE, V29, P2131, DOI 10.1016/j.vaccine.2010.12.087; Lanzi A, 2011, VACCINE, V29, P1463, DOI 10.1016/j.vaccine.2010.12.025; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; MUTHARIA LM, 1982, J INFECT DIS, V146, P770, DOI 10.1093/infdis/146.6.770; MUTHARIA LM, 1983, INFECT IMMUN, V42, P1027, DOI 10.1128/IAI.42.3.1027-1033.1983; PORWOLL JM, 1983, INFECT IMMUN, V40, P670, DOI 10.1128/IAI.40.2.670-674.1983; Price BM, 2001, INFECT IMMUN, V69, P3510, DOI 10.1128/IAI.69.5.3510-3515.2001; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; Sharma A, 2011, HUM VACCINES, V7, P999, DOI 10.4161/hv.7.10.16369; Sharma A, 2009, CURR DRUG THER, V4, P117, DOI 10.2174/157488509788185123; Sharma A, 2009, VIRUS RES, V143, P184, DOI 10.1016/j.virusres.2009.02.010; Sharma A, 2009, VIROLOGY, V386, P44, DOI 10.1016/j.virol.2009.01.008; Song W, 1997, J EXP MED, V186, P1247, DOI 10.1084/jem.186.8.1247; Sorichter S, 2009, VACCINE, V27, P2755, DOI 10.1016/j.vaccine.2009.03.010; STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017; Stone D, 2006, CURR OPIN MOL THER, V8, P423; Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Worgall S, 2001, INFECT IMMUN, V69, P4521, DOI 10.1128/IAI.69.7.4521-4527.2001; Worgall S, 2007, J VIROL, V81, P13801, DOI 10.1128/JVI.01246-07; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; Zaiss AK, 2009, J CELL BIOCHEM, V108, P778, DOI 10.1002/jcb.22328; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	43	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56996	10.1371/journal.pone.0056996	http://dx.doi.org/10.1371/journal.pone.0056996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437292	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200196
J	Stanczyk, NM; Brookfield, JFY; Field, LM; Logan, JG				Stanczyk, Nina M.; Brookfield, John F. Y.; Field, Linda M.; Logan, James G.			Aedes aegypti Mosquitoes Exhibit Decreased Repellency by DEET following Previous Exposure	PLOS ONE			English	Article							RHODNIUS-PROLIXUS STAL; BLOOD 1ST EVIDENCE; DROSOPHILA-MELANOGASTER; BLOODSUCKING INSECT; HOST PREFERENCE; PARASITIC WASP; DIPTERA; ODOR; ADAPTATION; VECTORS	DEET (N,N-Diethyl-m-toluamide) is one of the most widely used mosquito repellents. Although DEET has been shown to be extremely effective, recent studies have revealed that certain individual insects are unaffected by its presence. A genetic basis for this has been shown in Aedes aegypti mosquitoes and the fruit fly Drosophila melanogaster, but, for the triatomine bug, Rhodnius prolixus, a decrease in response to DEET occurred shortly after previous exposure, indicating that non-genetic factors may also be involved in DEET "insensitivity". In this study, we examined host-seeking behaviour and electrophysiological responses of A. aegypti after pre-exposure to DEET. We found that three hours after pre-exposure the mosquitoes showed behavioural insensitivity, and electroantennography revealed this correlated with the olfactory receptor neurons responding less to DEET. The change in behaviour as a result of pre-exposure to DEET has implications for the use of repellents and the ability of mosquitoes to overcome them.	[Stanczyk, Nina M.; Field, Linda M.] Rothamsted Res, Biol Chem & Crop Protect Dept, Harpenden, Herts, England; [Stanczyk, Nina M.; Brookfield, John F. Y.] Univ Nottingham, Sch Biol, Ctr Genet & Genom, Nottingham NG7 2RD, England; [Logan, James G.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nottingham; University of London; London School of Hygiene & Tropical Medicine	Logan, JG (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	james.logan@lshtm.ac.uk		Field, Linda/0000-0002-3328-2513	Lawes Trust Foundation; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194, BBS/E/C/00005193] Funding Source: researchfish; BBSRC [BBS/E/C/00005193, BBS/E/C/00005194] Funding Source: UKRI	Lawes Trust Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Lawes Trust Foundation is acknowledged for studentship (to NMS). Rothamsted receives grant-aided support from the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2005, PSYCHOL REP, V97, P721, DOI 10.2466/pr0.97.3.721-731; Aldana E, 2008, PARASITOL RES, V103, P587, DOI 10.1007/s00436-008-1014-4; Alonso WJ, 2003, MEM I OSWALDO CRUZ, V98, P665, DOI 10.1590/S0074-02762003000500014; ARREDONDOJIMENEZ JI, 1992, J MED ENTOMOL, V29, P894, DOI 10.1093/jmedent/29.5.894; Barbarossa IT, 2007, CHEM SENSES, V32, P535, DOI 10.1093/chemse/bjm022; Barnard DR, 2002, J MED ENTOMOL, V39, P895, DOI 10.1603/0022-2585-39.6.895; BECKER HJ, 1970, MOL GEN GENET, V107, P194, DOI 10.1007/BF00333634; Bernhard N, 2000, LEARN MEMORY, V7, P199, DOI 10.1101/lm.7.4.199; Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; Boeckh J, 1996, PESTIC SCI, V48, P359, DOI 10.1002/(SICI)1096-9063(199612)48:4&lt;359::AID-PS490&gt;3.0.CO;2-Z; CURTIS CF, 1987, MED VET ENTOMOL, V1, P109, DOI 10.1111/j.1365-2915.1987.tb00331.x; DAVIS EE, 1972, J ECON ENTOMOL, V65, P1058, DOI 10.1093/jee/65.4.1058; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Frances SP, 2005, AUST J ENTOMOL, V44, P431, DOI 10.1111/j.1440-6055.2005.00498.x; Geier M, 1999, ENTOMOL EXP APPL, V92, P9, DOI 10.1023/A:1003797623701; Hamilton CE, 2011, MED VET ENTOMOL, V25, P428, DOI 10.1111/j.1365-2915.2011.00964.x; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Jhumur US, 2006, J MED ENTOMOL, V43, P1164, DOI 10.1603/0022-2585(2006)43[1164:NACROC]2.0.CO;2; Kaur JS, 2003, MED VET ENTOMOL, V17, P457, DOI 10.1111/j.1365-2915.2003.00455.x; Kelly DW, 2000, PARASITOLOGY, V120, P319, DOI 10.1017/S0031182099005442; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Kiszewski AE, 2010, J VECTOR DIS, V47, P217; KUENEN LPS, 1981, J INSECT PHYSIOL, V27, P721, DOI 10.1016/0022-1910(81)90010-X; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; McCall PJ, 2001, T ROY SOC TROP MED H, V95, P587, DOI 10.1016/S0035-9203(01)90087-2; McCall PJ, 2001, MED VET ENTOMOL, V15, P197, DOI 10.1046/j.0269-283x.2001.00304.x; Mwandawiro C, 2000, T ROY SOC TROP MED H, V94, P238, DOI 10.1016/S0035-9203(00)90303-1; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; Park KC, 2001, PHYSIOL ENTOMOL, V26, P69, DOI 10.1046/j.1365-3032.2001.00219.x; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; RUTLEDGE LC, 1994, J AM MOSQUITO CONTR, V10, P93; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024218; Sfara V, 2011, J INSECT PHYSIOL, V57, P1431, DOI 10.1016/j.jinsphys.2011.07.009; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Tawatsin A, 2001, J VECTOR ECOL, V26, P76; Tomberlin JK, 2006, NATURWISSENSCHAFTEN, V93, P551, DOI 10.1007/s00114-006-0143-9; Vinauger C, 2012, ACTA TROP, V122, P24, DOI 10.1016/j.actatropica.2011.11.007; Vinauger C, 2011, J EXP BIOL, V214, P3039, DOI 10.1242/jeb.057075; Vinauger C, 2011, J EXP BIOL, V214, P3032, DOI 10.1242/jeb.056697; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Who, 2009, GUID EFF TEST MOSQ R, P1	48	59	59	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54438	10.1371/journal.pone.0054438	http://dx.doi.org/10.1371/journal.pone.0054438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437043	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000315184200008
J	Zhou, WJ; Zhang, YP; Schaefer, DA; Sha, LQ; Deng, Y; Deng, XB; Dai, KJ				Zhou, Wen-Jun; Zhang, Yi-Ping; Schaefer, Douglas A.; Sha, Li-Qing; Deng, Yun; Deng, Xiao-Bao; Dai, Kai-Jie			The Role of Stream Water Carbon Dynamics and Export in the Carbon Balance of a Tropical Seasonal Rainforest, Southwest China	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; INORGANIC CARBON; XISHUANGBANNA; NITROGEN; CATCHMENTS; FLUXES; RESPIRATION; PHOSPHORUS; DECOMPOSITION; TRANSPORT	A two-year study (2009 similar to 2010) was carried out to investigate the dynamics of different carbon (C) forms, and the role of stream export in the C balance of a 23.4-ha headwater catchment in a tropical seasonal rainforest at Xishuangbanna (XSBN), southwest China. The seasonal volumetric weighted mean (VWM) concentrations of total inorganic C (TIC) and dissolved inorganic C (DIC) were higher, and particulate inorganic C (PIC) and organic C (POC) were lower, in the dry season than the rainy season, while the VWM concentrations of total organic C (TOC) and dissolved organic C (DOC) were similar between seasons. With increased monthly stream discharge and stream water temperature (SWT), only TIC and DIC concentrations decreased significantly. The most important C form in stream export was DIC, accounting for 51.8% of the total C (TC) export; DOC, POC, and PIC accounted for 21.8%, 14.9%, and 11.5% of the TC export, respectively. Dynamics of C flux were closely related to stream discharge, with the greatest export during the rainy season. C export in the headwater stream was 47.1 kg C ha(-1) yr(-1), about 2.85% of the annual net ecosystem exchange. This finding indicates that stream export represented a minor contribution to the C balance in this tropical seasonal rainforest.	[Zhou, Wen-Jun; Zhang, Yi-Ping; Schaefer, Douglas A.; Sha, Li-Qing; Deng, Yun; Deng, Xiao-Bao; Dai, Kai-Jie] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Zhou, Wen-Jun; Zhang, Yi-Ping; Schaefer, Douglas A.; Sha, Li-Qing; Deng, Yun; Deng, Xiao-Bao; Dai, Kai-Jie] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Zhou, Wen-Jun; Zhang, Yi-Ping; Sha, Li-Qing; Deng, Yun; Deng, Xiao-Bao] Chinese Ecosyst Res Net, Xishuangbanna Stn Trop Rain Forest Ecosyst Studie, Mengla, Yunnan, Peoples R China; [Zhou, Wen-Jun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YP (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	yipingzh@xtbg.ac.cn			National Science Foundation of China [40801035, 40571163]; CAS 135 program [XTBG-T03]; Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences [XDA05020302]; Development Program in Basic Science of China [2010CB833501]; Yunnan Natural Science Foundation of Yunnan Province, China [2008CD167]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS 135 program; Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences(Chinese Academy of Sciences); Development Program in Basic Science of China; Yunnan Natural Science Foundation of Yunnan Province, China	This study was funded by the National Science Foundation of China (40801035, 40571163), the CAS 135 program (XTBG-T03) and Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences(XDA05020302), the Development Program in Basic Science of China (No. 2010CB833501), and the Yunnan Natural Science Foundation of Yunnan Province, China (2008CD167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrian E, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000626; Baker A, 2008, AREA, V40, P117, DOI 10.1111/j.1475-4762.2007.00780.x; Benoy G, 2007, ENVIRON REV, V15, P175, DOI 10.1139/A07-006; Buffam I, 2001, BIOGEOCHEMISTRY, V53, P269, DOI 10.1023/A:1010643432253; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Butturini A, 2000, BIOGEOCHEMISTRY, V51, P303, DOI 10.1023/A:1006420229411; Cao Min, 1996, Tropical Ecology, V37, P183; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Doctor DH, 2008, HYDROL PROCESS, V22, P2410, DOI 10.1002/hyp.6833; Elder JF, 2000, WETLANDS, V20, P113, DOI 10.1672/0277-5212(2000)020[0113:SAYODC]2.0.CO;2; [房秋兰 Fang Qiulan], 2005, [山地学报, Journal of Mountain Science], V23, P488; Finlay JC, 2003, BIOGEOCHEMISTRY, V62, P231, DOI 10.1023/A:1021183023963; Fujii K, 2011, GEODERMA, V163, P119, DOI 10.1016/j.geoderma.2011.04.012; Fujii K, 2009, GEODERMA, V152, P127, DOI 10.1016/j.geoderma.2009.05.028; Goller R, 2006, BIOGEOCHEMISTRY, V77, P57, DOI 10.1007/s10533-005-1061-1; Haaland S, 2010, BIOGEOCHEMISTRY, V97, P45, DOI 10.1007/s10533-009-9373-1; Johnson MS, 2006, HYDROL PROCESS, V20, P2599, DOI 10.1002/hyp.6218; Liu WJ, 2011, WATER ENVIRON J, V25, P138, DOI 10.1111/j.1747-6593.2009.00211.x; Lloret E, 2010, CHEM GEOL, V230, P65; Lu XT, 2010, FOREST ECOL MANAG, V260, P1798, DOI 10.1016/j.foreco.2010.08.024; McClain ME, 1997, GLOBAL BIOGEOCHEM CY, V11, P295, DOI 10.1029/97GB01056; MCDOWELL WH, 1994, LIMNOL OCEANOGR, V39, P111, DOI 10.4319/lo.1994.39.1.0111; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; Meyer JL, 1998, ECOSYSTEMS, V1, P240, DOI 10.1007/s100219900019; Moller A, 2005, J PLANT NUTR SOIL SC, V168, P649, DOI 10.1002/jpln.200521804; Neu V, 2011, BIOGEOCHEMISTRY, V105, P133, DOI 10.1007/s10533-011-9581-3; Palmer SM, 2001, BIOGEOCHEMISTRY, V52, P321, DOI 10.1023/A:1006447706565; [乔玉娜 QIAO Yuna], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P2300; Rantakari M, 2010, SCI TOTAL ENVIRON, V408, P1649, DOI 10.1016/j.scitotenv.2009.12.025; Raymond PA, 2010, BIOGEOCHEMISTRY, V100, P197, DOI 10.1007/s10533-010-9416-7; Ren Y., 1999, ACTA PHYSIOL SINICA, V23, P418; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; RICHEY JE, 1980, SCIENCE, V207, P1348, DOI 10.1126/science.207.4437.1348; Saunders TJ, 2006, HYDROL PROCESS, V20, P2549, DOI 10.1002/hyp.6215; Sha LQ, 2005, SCI CHINA SER D, V48, P189, DOI 10.1360/05zd0019; Shibata H, 2005, ECOL RES, V20, P325, DOI 10.1007/s11284-005-0048-7; Sousa ED, 2011, BIOGEOCHEMISTRY, V105, P159, DOI 10.1007/s10533-011-9613-z; Tan ZH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050006; Tan ZH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012913; Tang JW, 2010, PLANT SOIL, V335, P271, DOI 10.1007/s11104-010-0414-2; [唐炎林 TANG Yanlin], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P779; [王馨 WANG Xin], 2005, [热带气象学报, Journal of Tropical Meteorology], V21, P658; Wilson HF, 2008, ECOSYSTEMS, V11, P555, DOI 10.1007/s10021-008-9142-3; Yan Yu-Ping, 2008, Zhiwu Shengtai Xuebao, V32, P23; Zhang YP, 2010, ATMOS ENVIRON, V44, P3886, DOI 10.1016/j.atmosenv.2010.07.027; [张一平 Zhang Yiping], 2003, [生态学报, Acta Ecologica Sinica], V23, P2653; Zheng Z, 2006, BIOTROPICA, V38, P342, DOI 10.1111/j.1744-7429.2006.00151.x; Zhou GY, 2006, SCI CHINA SER D, V49, P311, DOI 10.1007/s11430-006-0311-y	48	8	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56646	10.1371/journal.pone.0056646	http://dx.doi.org/10.1371/journal.pone.0056646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437195	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200126
J	Gawecka, JE; Marh, J; Ortega, M; Yamauchi, Y; Ward, MA; Ward, WS				Gawecka, Joanna E.; Marh, Joel; Ortega, Michael; Yamauchi, Yasuhiro; Ward, Monika A.; Ward, W. Steven			Mouse Zygotes Respond to Severe Sperm DNA Damage by Delaying Paternal DNA Replication and Embryonic Development	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PREIMPLANTATION DEVELOPMENT; CYCLOPHOSPHAMIDE EXPOSURE; MAMMALIAN-CELLS; NUCLEAR-MATRIX; BOVINE EMBRYO; RAT ZYGOTE; SPERMATOZOA; CHROMATIN; PHOSPHORYLATION	Mouse zygotes do not activate apoptosis in response to DNA damage. We previously reported a unique form of inducible sperm DNA damage termed sperm chromatin fragmentation (SCF). SCF mirrors some aspects of somatic cell apoptosis in that the DNA degradation is mediated by reversible double strand breaks caused by topoisomerase 2B (TOP2B) followed by irreversible DNA degradation by a nuclease(s). Here, we created zygotes using spermatozoa induced to undergo SCF (SCF zygotes) and tested how they responded to moderate and severe paternal DNA damage during the first cell cycle. We found that the TUNEL assay was not sensitive enough to identify the breaks caused by SCF in zygotes in either case. However, paternal pronuclei in both groups stained positively for gamma H2AX, a marker for DNA damage, at 5 hrs after fertilization, just before DNA synthesis, while the maternal pronuclei were negative. We also found that both pronuclei in SCF zygotes with moderate DNA damage replicated normally, but paternal pronuclei in the SCF zygotes with severe DNA damage delayed the initiation of DNA replication by up to 12 hrs even though the maternal pronuclei had no discernable delay. Chromosomal analysis of both groups confirmed that the paternal DNA was degraded after S-phase while the maternal pronuclei formed normal chromosomes. The DNA replication delay caused a marked retardation in progression to the 2-cell stage, and a large portion of the embryos arrested at the G2/M border, suggesting that this is an important checkpoint in zygotic development. Those embryos that progressed through the G2/M border died at later stages and none developed to the blastocyst stage. Our data demonstrate that the zygote responds to sperm DNA damage through a non-apoptotic mechanism that acts by slowing paternal DNA replication and ultimately leads to arrest in embryonic development.	[Gawecka, Joanna E.; Marh, Joel; Ortega, Michael; Yamauchi, Yasuhiro; Ward, Monika A.; Ward, W. Steven] Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Inst Biogenesis Res, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Ward, WS (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Inst Biogenesis Res, Honolulu, HI 96822 USA.	wward@hawaii.edu	Ortega, Michael/AAN-2379-2021		National Institutes of Health [1R01HD060722, 8P20GM103457, 1R01HD072380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072380, R01HD060722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grants 1R01HD060722, 8P20GM103457, and 1R01HD072380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga SK, 2007, ONCOGENE, V26, P6141, DOI 10.1038/sj.onc.1210444; Adiga SK, 2007, REPRODUCTION, V133, P415, DOI 10.1530/REP-06-0048; Ajduk A, 2006, BIOL REPROD, P90; Aoki F, 1999, ZYGOTE, V7, P165, DOI 10.1017/S0967199499000532; Austin C.R., 1961, MAMMALIAN EGG; Baart EB, 2004, HUM REPROD, V19, P1140, DOI 10.1093/humrep/deh184; Barton TS, 2007, TOXICOL SCI, V100, P495, DOI 10.1093/toxsci/kfm242; Barton TS, 2005, P NATL ACAD SCI USA, V102, P7865, DOI 10.1073/pnas.0501200102; BEREZNEY R, 1975, SCIENCE, V189, P291, DOI 10.1126/science.1145202; Byrne AT, 1999, J REPROD FERTIL, V117, P97, DOI 10.1530/jrf.0.1170097; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Derijck A, 2008, HUM MOL GENET, V17, P1922, DOI 10.1093/hmg/ddn090; Derijck AAHA, 2006, DNA REPAIR, V5, P959, DOI 10.1016/j.dnarep.2006.05.043; Dijkwel PA, 1995, INT REV CYTOL, V162A, P455; Fear JM, 2011, BIOL REPROD, V84, P43, DOI 10.1095/biolreprod.110.086249; Gall L, 2008, REPRODUCTION, V135, P431, DOI 10.1530/REP-07-0284; Garber JC, 2011, GUIDE CARE USE LAB A; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENEROSO WM, 1979, P NATL ACAD SCI USA, V76, P435, DOI 10.1073/pnas.76.1.435; Gjorret JO, 2003, BIOL REPROD, V69, P1193, DOI 10.1095/biolreprod.102.013243; Gonzalez-Marin C, 2012, INT J MOL SCI, V13, P14026, DOI 10.3390/ijms131114026; Grenier L, 2010, BIOL REPROD, V83, P195, DOI 10.1095/biolreprod.109.083345; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; HARDY K, 1989, DEVELOPMENT, V107, P597; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Jurisicova A, 1996, MOL HUM REPROD, V2, P93, DOI 10.1093/molehr/2.2.93; Jurisicova A, 1998, MOL HUM REPROD, V4, P139, DOI 10.1093/molehr/4.2.139; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; MATSUDA Y, 1989, INT J RADIAT BIOL, V55, P233, DOI 10.1080/09553008914550281; Matwee C, 2000, ZYGOTE, V8, P57, DOI 10.1017/S0967199400000836; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; MIKAMO K, 1983, MUTAT RES, V108, P265, DOI 10.1016/0027-5107(83)90125-2; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; PARDOLL DM, 1980, CELL, V19, P527, DOI 10.1016/0092-8674(80)90527-9; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Robinson L, 2012, HUM REPROD, V27, P2908, DOI 10.1093/humrep/des261; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Shaman JA, 2007, J CELL BIOCHEM, V102, P680, DOI 10.1002/jcb.21321; Shaman JA, 2006, BIOL REPROD, V75, P741, DOI 10.1095/biolreprod.106.055178; Shimura T, 2002, MOL CELL BIOL, V22, P2220, DOI 10.1128/MCB.22.7.2220-2228.2002; SIRLIN JL, 1959, EXP CELL RES, V18, P190, DOI 10.1016/0014-4827(59)90308-8; Sotolongo B, 2005, J ANDROL, V26, P272; Sotolongo B, 2003, BIOL REPROD, V69, P2029, DOI 10.1095/biolreprod.103.020594; Szczygiel M, 2003, MANIPULATING MOUSE E, P585; Szczygiel MA, 2003, BIOL REPROD, V68, P1903, DOI 10.1095/biolreprod.102.012377; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Yamauchi Y, 2007, BIOL REPROD, V77, P803, DOI 10.1095/biolreprod.107.063040; Yamauchi Y, 2007, BIOL REPROD, V77, P636, DOI 10.1095/biolreprod.107.062406; Yamauchi Y, 2007, BIOL REPROD, V77, P407, DOI 10.1095/biolreprod.107.061473; Yamauchi Y, 2007, BIOL REPROD, V76, P1002, DOI 10.1095/biolreprod.106.059881; Yamauchi Y, 2007, BIOL REPROD, V76, P666, DOI 10.1095/biolreprod.106.057067; Yamauchi Y, 2009, J CELL BIOCHEM, V107, P214, DOI 10.1002/jcb.22117; Ziegler-Birling C, 2009, INT J DEV BIOL, V53, P1003, DOI 10.1387/ijdb.082707cz	59	89	90	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56385	10.1371/journal.pone.0056385	http://dx.doi.org/10.1371/journal.pone.0056385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431372	Green Submitted, gold, Green Published			2022-12-27	WOS:000315182800014
J	Klucken, J; Barth, J; Kugler, P; Schlachetzki, J; Henze, T; Marxreiter, F; Kohl, Z; Steidl, R; Hornegger, J; Eskofier, B; Winkler, J				Klucken, Jochen; Barth, Jens; Kugler, Patrick; Schlachetzki, Johannes; Henze, Thore; Marxreiter, Franz; Kohl, Zacharias; Steidl, Ralph; Hornegger, Joachim; Eskofier, Bjoern; Winkler, Juergen			Unbiased and Mobile Gait Analysis Detects Motor Impairment in Parkinson's Disease	PLOS ONE			English	Article							SOCIETY-SPONSORED REVISION; SCALE MDS-UPDRS; RATING-SCALE; INTERRATER RELIABILITY; DIAGNOSIS; WALKING	Motor impairments are the prerequisite for the diagnosis in Parkinson's disease (PD). The cardinal symptoms (bradykinesia, rigor, tremor, and postural instability) are used for disease staging and assessment of progression. They serve as primary outcome measures for clinical studies aiming at symptomatic and disease modifying interventions. One major caveat of clinical scores such as the Unified Parkinson Disease Rating Scale (UPDRS) or Hoehn&Yahr (H&Y) staging is its rater and time-of-assessment dependency. Thus, we aimed to objectively and automatically classify specific stages and motor signs in PD using a mobile, biosensor based Embedded Gait Analysis using Intelligent Technology (eGaIT). eGaIT consist of accelerometers and gyroscopes attached to shoes that record motion signals during standardized gait and leg function. From sensor signals 694 features were calculated and pattern recognition algorithms were applied to classify PD, H&Y stages, and motor signs correlating to the UPDRS-III motor score in a training cohort of 50 PD patients and 42 age matched controls. Classification results were confirmed in a second independent validation cohort (42 patients, 39 controls). eGaIT was able to successfully distinguish PD patients from controls with an overall classification rate of 81%. Classification accuracy increased with higher levels of motor impairment (91% for more severely affected patients) or more advanced stages of PD (91% for H&Y III patients compared to controls), supporting the PD-specific type of analysis by eGaIT. In addition, eGaIT was able to classify different H&Y stages, or different levels of motor impairment (UPDRS-III). In conclusion, eGaIT as an unbiased, mobile, and automated assessment tool is able to identify PD patients and characterize their motor impairment. It may serve as a complementary mean for the daily clinical workup and support therapeutic decisions throughout the course of the disease.	[Klucken, Jochen; Barth, Jens; Schlachetzki, Johannes; Henze, Thore; Marxreiter, Franz; Kohl, Zacharias; Winkler, Juergen] Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany; [Barth, Jens; Kugler, Patrick; Hornegger, Joachim; Eskofier, Bjoern] Univ Erlangen Nurnberg, Dept Comp Sci, Pattern Recognit Lab, Erlangen, Germany; [Barth, Jens; Steidl, Ralph] ASTRUM IT GmbH, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Winkler, J (corresponding author), Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany.	jochen.klucken@uk-erlangen.de	Hornegger, Joachim/H-2465-2017; Eskofier, Bjoern/ABF-1284-2021; Marxreiter, Franz/ABB-6982-2020	Hornegger, Joachim/0000-0002-1834-8844; Eskofier, Bjoern/0000-0002-0417-0336; Marxreiter, Franz/0000-0002-5187-4344; Klucken, Jochen/0000-0001-6645-9437; Winkler, Jurgen/0000-0003-0630-9204; Schlachetzki, Johannes/0000-0002-7801-9743; Kugler, Patrick/0000-0002-1197-7621	Bavarian Research Foundation [AZ 974-11]; Bavarian Research Foundation ELAN ("Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung", University Hospital Erlangen, Germany) [AZ: 1008.17.1]; ASTRUM IT GmbH	Bavarian Research Foundation; Bavarian Research Foundation ELAN ("Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung", University Hospital Erlangen, Germany); ASTRUM IT GmbH	This work was funded by the Bavarian Research Foundation (AZ 974-11), ELAN ("Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung", University Hospital Erlangen, Germany - AZ: 1008.17.1), and by a project grant of ASTRUM IT GmbH. Shoes were provided by adidas (R) AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachlin M., 2009, P 4 INT C BOD AR NET, V7, P693; Barth J., 2011, C P IEEE ENG MED BIO; Barth J, 2012, C P IEEE ENG MED BIO, V2012; Bechtel N, 2010, NEUROLOGY, V75, P2150, DOI 10.1212/WNL.0b013e3182020123; Cabell L, 2013, J STRENGTH COND RES, V27, P1503, DOI 10.1519/JSC.0b013e318269f83d; Cancela J, 2010, IEEE ENG MED BIO, P1008, DOI 10.1109/IEMBS.2010.5627775; Cunningham L, 2011, IEEE T INF TECHNOL B, V15, P47, DOI 10.1109/TITB.2010.2091142; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Duda R.O., 2000, PATTERN CLASSIFICATI; Ellis T, 2011, PARKINSONISM RELAT D, V17, P693, DOI 10.1016/j.parkreldis.2011.07.004; Eskofier B, 2009, PATTERN RECOGN LETT, V30, P1448, DOI 10.1016/j.patrec.2009.08.004; Eskofier BM, 2012, COMPUT METHOD BIOMEC, V15, P467, DOI 10.1080/10255842.2010.542153; Eskofier BM, 2011, COMPUT METHODS BIOME; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goetz CG, 2004, MOVEMENT DISORD, V19, P1453, DOI 10.1002/mds.20220; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Goetz CG, 2010, MOVEMENT DISORD, V25, P1190, DOI 10.1002/mds.23096; Goetz CG, 2009, MOVEMENT DISORD, V24, P551, DOI 10.1002/mds.22379; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Keijsers NLW, 2006, MOVEMENT DISORD, V21, P34, DOI 10.1002/mds.20633; Klucken J, 2011, NERVENARZT, V82, P1604, DOI 10.1007/s00115-011-3329-0; Lord S, 2008, GAIT POSTURE, V27, P357, DOI 10.1016/j.gaitpost.2007.04.001; Maetzler W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032240; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Pansera M, 2009, IEEE ENG MED BIO, P1242, DOI 10.1109/IEMBS.2009.5333478; Patel S, 2010, IEEE ENG MED BIO, P4411, DOI 10.1109/IEMBS.2010.5627124; Patel S, 2009, IEEE T INF TECHNOL B, V13, P864, DOI 10.1109/TITB.2009.2033471; Poewe WH, 1998, ANN NEUROL, V44, pS1, DOI 10.1002/ana.410440703; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; RICHARDS M, 1994, MOVEMENT DISORD, V9, P89, DOI 10.1002/mds.870090114; Rissanen SM, 2008, MED BIOL ENG COMPUT, V46, P849, DOI 10.1007/s11517-008-0369-0; Rochester L, 2008, MOVEMENT DISORD, V23, P2312, DOI 10.1002/mds.22219; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023299; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Witten I. H., 2005, DATA MINING PRACTICA; Zung WWK, 1994, INT SKALEN PSYCHIAT, P101	44	141	145	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56956	10.1371/journal.pone.0056956	http://dx.doi.org/10.1371/journal.pone.0056956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431395	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800038
J	Le Borgne, M; Filbert, EL; Shaw, AS				Le Borgne, Marie; Filbert, Erin L.; Shaw, Andrey S.			Kinase Suppressor of Ras 1 Is Not Required for the Generation of Regulatory and Memory T Cells	PLOS ONE			English	Article							TUBEROUS SCLEROSIS; IN-VIVO; MAMMALIAN TARGET; S6 KINASE; MTOR; ACTIVATION; PHOSPHORYLATION; RAPAMYCIN; DIFFERENTIATION; KSR2	The mammalian target of rapamycin (mTOR) kinase is a critical regulator of the differentiation of helper and regulatory CD4+ T cells, as well as memory CD8+ T cells. In this study, we investigated the role of the ERK signaling pathway in regulating mTOR activation in T cells. We showed that activation of ERK following TCR engagement is required for sustained mTOR complex 1 (mTORC1) activation. Absence of kinase suppressor of Ras 1 (KSR1), a scaffold protein of the ERK signaling pathway, or inhibition of ERK resulted in decreased mTORC1 activity following T cell activation. However, KSR1-deficient mice displayed normal regulatory CD4+ T cell development, as well as normal memory CD8+ T cell responses to LCMV and Listeria monocytogenes infection. These data indicate that despite its role in mTORC1 activation, KSR1 is not required in vivo for mTOR-dependent T cell differentiation.	[Le Borgne, Marie; Filbert, Erin L.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Le Borgne, Marie; Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Le Borgne, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mleborgne@wustl.edu	Le Borgne, Marie/P-2313-2015	Le Borgne, Marie/0000-0002-3439-4867; Shaw, Andrey/0000-0001-5685-0272	Howard Hughes Medical Institute NIH [AI057966]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI057966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Howard Hughes Medical Institute NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Howard Hughes Medical Institute (http://www.hhmi.org/) NIH AI057966. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; Giurisato E, 2009, MOL CELL BIOL, V29, P1554, DOI 10.1128/MCB.01421-08; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Saxena M, 2000, SEMIN IMMUNOL, V12, P387, DOI 10.1006/smim.2000.0219; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57137	10.1371/journal.pone.0057137	http://dx.doi.org/10.1371/journal.pone.0057137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431403	Green Published, gold, Green Submitted			2022-12-27	WOS:000315182800046
J	Zhang, YX; Liu, Y; Dong, J; Wang, YX; Wang, J; Zhuang, GQ; Han, SJ; Guo, QQ; Luo, YX; Zhang, J; Peng, XX; Zhang, L; Yan, YX; Yang, XH; Wang, H; Han, X; Liu, GX; Kang, YH; Liu, YQ; Weng, SF; Zhang, H; Zhang, XQ; Jia, KB; Wang, L; Zhao, L; Xiao, ZX; Zhang, SH; Wu, HH; Lai, QX; Qi, N; Wang, W; Gaisano, H; Liu, F; He, Y				Zhang, Yu-Xiang; Liu, Yan; Dong, Jing; Wang, You-Xin; Wang, Jing; Zhuang, Guo-Qing; Han, Shu-Jing; Guo, Qing-Qing; Luo, Yan-Xia; Zhang, Jie; Peng, Xiao-Xia; Zhang, Ling; Yan, Yu-Xiang; Yang, Xing-Hua; Wang, Hong; Han, Xu; Liu, Guang-Xu; Kang, You-Hou; Liu, You-Qin; Weng, Sheng-Feng; Zhang, Hong; Zhang, Xiao-Qiang; Jia, Ke-Bao; Wang, Li; Zhao, Lei; Xiao, Zhong-Xin; Zhang, Shu-Hua; Wu, Hui-Hui; Lai, Qing-Xuan; Qi, Na; Wang, Wei; Gaisano, Herbert; Liu, Fen; He, Yan			An Exploratory Study of the Association between KCNB1 rs1051295 and Type 2 Diabetes and Its Related Traits in Chinese Han Population	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; POTASSIUM CHANNEL; INSULIN-SECRETION; K+ CHANNELS; VARIANTS; KCNQ1; SUSCEPTIBILITY; EXCITABILITY; GLUCOSE	Since the KCNB1 encoding Kv2.1 channel accounts for the majority of Kv currents modulating insulin secretion by pancreatic islet beta-cells, we postulated that KCNB1 is a plausible candidate gene for genetic variation contributing to the variable compensatory secretory function of beta-cells in type-2 diabetes (T2D). We conducted two studies, a case-control study and a cross-section study, to investigate the association of common single-nucleotide polymorphisms (SNPs) in KCNB1 with T2D and its linking traits. In the case-control study, we first examined the association of 20 tag SNPs of KCNB1 with T2D in a population with 226 T2D patients and non-diabetic subjects (screening study). We then identified the association in an enlarged population of 412 T2D patients and non-diabetic subjects (replication study). In the cross-sectional study, we investigated the linkage between the candidate SNP rs1051295 and T2D by comparing beta-cell function and insulin sensitivity among rs1051295 genotypes in a general population of 1051 subjects at fasting and after glucose loading (oral glucose tolerance tests, OGTT) in 84 fasting glucose impaired subjects, and several T2D-related traits. We found that among the 19 available tag SNPs, only the KCNB1 rs1051295 was associated with T2D (P = 0.027), with the rs1051295 TT genotype associated with an increased risk of T2D compared with genotypes CC (P = 0.009). At fasting, rs1051295 genotype TT was associated with a 9.8% reduction in insulin sensitivity compared to CC (P = 0.008); along with increased plasma triglycerides (TG) levels (TT/CC: P = 0.046) and increased waist/hip (W/H) ratio (TT/CC: P = 0.013; TT/TC: P = 0.002). OGTT confirmed that genotype TT exhibited reduced insulin sensitivity by 16.3% (P = 0.030) compared with genotype TC+CC in a fasting glucose impaired population. The KCNB1 rs1051295 genotype TT in the Chinese Han population is associated with decreased insulin sensitivity and increased plasma TG and W/H ratio, which together contribute to an increased risk for T2D.	[Zhang, Yu-Xiang; Liu, Yan; Wang, You-Xin; Han, Shu-Jing; Guo, Qing-Qing; Luo, Yan-Xia; Zhang, Jie; Peng, Xiao-Xia; Zhang, Ling; Yan, Yu-Xiang; Yang, Xing-Hua; Wang, Hong; Han, Xu; Liu, Guang-Xu; Liu, Fen; He, Yan] Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Zhang, Yu-Xiang; Wang, You-Xin; Han, Shu-Jing; Guo, Qing-Qing; Luo, Yan-Xia; Zhang, Jie; Peng, Xiao-Xia; Zhang, Ling; Yan, Yu-Xiang; Yang, Xing-Hua; Han, Xu; Liu, Guang-Xu; Liu, Fen; He, Yan] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Liu, Yan] Peking Univ, Peoples Hosp, Infect Control Off, Beijing 100871, Peoples R China; [Dong, Jing; Liu, You-Qin] Capital Med Univ, Beijing Xuanwu Hosp, Hlth Med Ctr, Beijing, Peoples R China; [Wang, Jing; Jia, Ke-Bao; Wang, Li; Zhao, Lei] Capital Med Univ, Beijing Xuanwu Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhuang, Guo-Qing; Lai, Qing-Xuan; Wang, Wei] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Kang, You-Hou; Gaisano, Herbert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kang, You-Hou; Gaisano, Herbert] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Weng, Sheng-Feng; Zhang, Hong; Zhang, Xiao-Qiang] Beijing Geriatr Hosp, Dept Clin Lab, Beijing, Peoples R China; [Xiao, Zhong-Xin; Zhang, Shu-Hua; Wu, Hui-Hui] Capital Med Univ, Expt Teaching Ctr, Beijing, Peoples R China; [Qi, Na] Capital Med Univ, Ctr Clin Lab, Beijing, Peoples R China	Capital Medical University; Peking University; Capital Medical University; Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Toronto; University of Toronto; Capital Medical University; Capital Medical University	Gaisano, H (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	herbert.gaisano@utoronto.ca; liufen05@ccmu.edu.cn; yanhe118@sina.com	wang, YA XING/K-9671-2016; Liu, Fen/R-7749-2019	wang, YA XING/0000-0003-2749-7793; Wang, Youxin/0000-0002-6574-6706	National Natural Science Foundation of China [30971178, 30670778, 30901239]; Canadian Institute for Health Research [MOP 69083]; Beijing Municipal Education Commission [KM201010025009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Beijing Municipal Education Commission(Beijing Municipal Commission of Education)	This work was supported by National Natural Science Foundation of China (30971178, 30670778) (http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html) to YH and (30901239) to FL, and Canadian Institute for Health Research (MOP 69083) (http://www.cihr-irsc.gc.ca/e/193.html) to HG. YH is also supported by Beijing Municipal Education Commission (KM201010025009) (http://www.usrn.edu.cn/pages/info_list.jsp?classcode = 704&boardid = 704&pageno = 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ashcroft FM, 2004, REV ENDOCR METAB DIS, V5, P135, DOI 10.1023/B:REMD.0000021435.87776.a7; Feinshreiber L, 2010, J CELL SCI, V123, P1940, DOI 10.1242/jcs.063719; Feinshreiber L, 2009, ANN NY ACAD SCI, V1152, P87, DOI 10.1111/j.1749-6632.2008.03997.x; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Herrington J, 2005, J PHYSIOL-LONDON, V567, P159, DOI 10.1113/jphysiol.2005.089375; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Pongs O., 2008, V44, P145, DOI 10.1007/400_2007_032; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Ramirez-Ponce MP, 2003, J MEMBRANE BIOL, V196, P129, DOI 10.1007/s00232-003-0631-1; Ramirez-Ponce MP, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740299; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Vliet-Ostaptchouk JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032148; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Xiao Xiangjun, 2009, BMC Proc, V3 Suppl 7, pS134; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhuang GQ, 2009, BIOCHEM BIOPH RES CO, V379, P812, DOI 10.1016/j.bbrc.2008.12.059	28	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56365	10.1371/journal.pone.0056365	http://dx.doi.org/10.1371/journal.pone.0056365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431371	gold, Green Submitted, Green Published			2022-12-27	WOS:000315182800013
J	Zou, QH; Li, RQ; Wang, YJ; Liu, SL				Zou, Qing-Hua; Li, Ren-Qing; Wang, Ye-Jun; Liu, Shu-Lin			Identification of Genes to Differentiate Closely Related Salmonella Lineages	PLOS ONE			English	Article							GENOMIC CLEAVAGE MAP; PATHOGENICITY ISLANDS; ENTERICA; PARATYPHI; TYPHI; EVOLUTION; SEQUENCE; CONVERGENCE; DIVERGENCE; PHYLOGENY	Background: Salmonella are important human and animal pathogens. Though highly related, the Salmonella lineages may be strictly adapted to different hosts or cause different diseases, from mild local illness like gastroenteritis to fatal systemic infections like typhoid. Therefore, rapid and accurate identification of Salmonella is essential for timely and correct diagnosis of Salmonella infections. The current identification methods such as 16S rRNA sequencing and multilocus sequence typing are expensive and time consuming. Additionally, these methods often do not have sufficient distinguishing resolution among the Salmonella lineages. Methodologies/Principal Findings: We compared 27 completely sequenced Salmonella genomes to identify possible genomic features that could be used for differentiation of individual lineages. We concatenated 2372 core genes in each of the 27 genomes and constructed a neighbor-joining tree. On the tree, strains of each serotype were clustered tightly together and different serotypes were unambiguously separated with clear genetic distances, demonstrating systematic genomic divergence among the Salmonella lineages. We made detailed comparisons among the 27 genomes and identified distinct sets of genomic differences, including nucleotide variations and genomic islands (GIs), among the Salmonella lineages. Two core genes STM4261 and entF together could unambiguously distinguish all Salmonella lineages compared in this study. Additionally, strains of a lineage have a common set of GIs and closely related lineages have similar sets of GIs. Conclusions: Salmonella lineages have accumulated distinct sets of mutations and laterally acquired DNA (e.g., GIs) in evolution. Two genes entF and STM4261 have diverged sufficiently among the Salmonella lineages to be used for their differentiation. Further investigation of the distinct sets of mutations and GIs will lead to novel insights into genomic evolution of Salmonella and greatly facilitate the elucidation of pathogeneses of Salmonella infections.	[Zou, Qing-Hua; Liu, Shu-Lin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China; [Li, Ren-Qing] Beijing Ctr Dis Control & Prevent, Inst Immunol, Beijing, Peoples R China; [Wang, Ye-Jun; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	Peking University; Harbin Medical University; University of Calgary	Liu, SL (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China.	slliu@ucalgary.ca			National Natural Science Foundation of China [31100134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a project of National Natural Science Foundation of China (31100134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; BARROW PA, 1994, INFECT IMMUN, V62, P4602, DOI 10.1128/IAI.62.10.4602-4610.1994; Chen C, FOODBORNE PATHOG DIS, V9, P325; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Feng Y, 2012, OMICS, MICROBIAL MODELING AND TECHNOLOGIES FOR FOODBORNE PATHOGENS, P43; Feng Y, 2012, J BACTERIOL, V194, P744, DOI 10.1128/JB.06507-11; Feng Y, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P49; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; KAUFFMANN F., 1957, ACTA PATHOL ET MICROBIOL SCAND, V41, P242; Kothapalli S, 2005, J BACTERIOL, V187, P2638, DOI 10.1128/JB.187.8.2638-2650.2005; Lienau EK, N ENGL J MED, V364, P981; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Liu GR, 2003, J BACTERIOL, V185, P2131, DOI 10.1128/JB.185.7.2131-2142.2003; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu GR, 2006, NEAR COMPLETE CONSER, P97; Liu Shu-Lin, 2007, V394, P39, DOI 10.1007/978-1-59745-512-1_3; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; LIU SL, 1994, J BACTERIOL, V176, P1014, DOI 10.1128/JB.176.4.1014-1024.1994; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; LIU SL, 1992, J BACTERIOL, V174, P1662, DOI 10.1128/jb.174.5.1662-1672.1992; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; LIU SL, 1993, MOL MICROBIOL, V10, P655, DOI 10.1111/j.1365-2958.1993.tb00937.x; LIU SL, 1995, J BACTERIOL, V177, P5099, DOI 10.1128/jb.177.17.5099-5107.1995; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Ochman H, 1996, INFECT IMMUN, V64, P5410, DOI 10.1128/IAI.64.12.5410-5412.1996; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OCHMAN H, 1995, CURR OPIN GENET DEV, V5, P734, DOI 10.1016/0959-437X(95)80005-P; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; STACKEBRANDT E, 1984, MICROBIOL SCI, V1, P117; Tang L, 2012, ANTON LEEUW INT J G, V101, P67, DOI 10.1007/s10482-011-9680-0; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005	44	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55988	10.1371/journal.pone.0055988	http://dx.doi.org/10.1371/journal.pone.0055988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441160	gold, Green Published, Green Submitted			2022-12-27	WOS:000315159200017
J	Eckman, DM; Stacey, RB; Rowe, R; D'Agostino, R; Kock, ND; Sane, DC; Torti, FM; Yeboah, J; Workman, S; Lane, KS; Hundley, WG				Eckman, Delrae M.; Stacey, R. Brandon; Rowe, Robert; D'Agostino, Ralph, Jr.; Kock, Nancy D.; Sane, David C.; Torti, Frank M.; Yeboah, Joseph; Workman, Susan; Lane, Kimberly S.; Hundley, W. Gregory			Weekly Doxorubicin Increases Coronary Arteriolar Wall and Adventitial Thickness	PLOS ONE			English	Article							ANTHRACYCLINE CARDIOTOXICITY; CANCER-THERAPY; BREAST-CANCER; DISEASE; RISK; CARDIOMYOCYTES; PROLIFERATION; MORTALITY; STRESS; DAMAGE	Background: Doxorubicin (DOX) is associated with premature cardiovascular events including myocardial infarction. This study was performed to determine if the weekly administration of DOX influenced coronary arteriolar medial and/or adventitial wall thickening. Methods: Thirty-two male Sprague-Dawley rats aged 25.16 +/- 2.4 weeks were randomly divided into three groups and received weekly intraperitoneal injections of normal saline (saline, n=7), or low (1.5 mg/kg to 1.75 mg/kg, n=14) or high (2.5 mg/kg, n = 11) doses of DOX. The animals were treated for 2-12 weeks, and euthanized at pre-specified intervals (2, 4, 7, or 10+ weeks) to obtain histopathologic assessments of coronary arteriolar lumen diameter, medial wall thickness, adventitial wall thickness, and total wall thickness (medial thickness + adventitial thickness). Results: Lumen diameter was similar across all groups (saline: 315 +/- 34 mu m, low DOX: 286 +/- 24 mu m, high DOX: 242 +/- 27 mu m; p=0.22). In comparison to animals receiving weekly saline, animals receiving weekly injections of 2.5 mg/kg of DOX experienced an increase in medial (23 +/- 2 mu m vs. 13 +/- 3 mu m; p=0.005), and total wall thickness (51 +/- 4 mu m vs. 36 +/- 5 mu m; p=0.022), respectively. These increases, as well as adventitial thickening became more prominent after normalizing for lumen diameter (p<0.05 to p<0.001) and after adjusting for age, weight, and total cumulative DOX dose (p=0.02 to p=0.01). Animals receiving low dose DOX trended toward increases in adventitial and total wall thickness after normalization to lumen diameter and accounting for age, weight, and total cumulative DOX dose (p=0.06 and 0.09, respectively). Conclusion: In conclusion, these data demonstrate that weekly treatment of rats with higher doses of DOX increases coronary arteriolar medial, adventitial, and total wall thickness. Future studies are warranted to determine if DOX related coronary arteriolar effects are reversible or preventable, exacerbate the known cardiomyopathic effects of DOX, influence altered resting or stress-induced myocardial perfusion, or contribute to the occurrence of myocardial infarction.	[Eckman, Delrae M.; Rowe, Robert] Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27103 USA; [Stacey, R. Brandon; Yeboah, Joseph; Workman, Susan; Lane, Kimberly S.; Hundley, W. Gregory] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC 27103 USA; [D'Agostino, Ralph, Jr.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Kock, Nancy D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA; [Sane, David C.] Virginia Tech, Caril Sch Med, Div Cardiol, Dept Internal Med, Roanoke, VA USA; [Torti, Frank M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Hundley, W. Gregory] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Virginia Polytechnic Institute & State University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Hundley, WG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC 27103 USA.	ghundley@wakehealth.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	National Institute of Health [R21CA109224, R33CA12196]; Susan G. Komen Foundation [BCTR0707769]; NATIONAL CANCER INSTITUTE [R21CA109224] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research supported in part by National Institute of Health (http://www.nih.gov) grants R21CA109224, R33CA12196, and a grant (BCTR0707769) from the Susan G. Komen Foundation (http://ww5.komen.org). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bar-Joseph H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023492; BARKER SGE, 1993, ARTERIOSCLER THROMB, V13, P70, DOI 10.1161/01.ATV.13.1.70; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Chaosuwannakit N, 2010, J CLIN ONCOL, V28, P166, DOI 10.1200/JCO.2009.23.8527; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Dalla Pozza R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-53; Du XL, 2008, AM J CLIN ONCOL-CANC, V31, P105, DOI 10.1097/COC.0b013e318142c865; FERRANS VJ, 1978, CANCER TREAT REP, V62, P955; Floyd JD, 2005, J CLIN ONCOL, V23, P7685, DOI 10.1200/JCO.2005.08.789; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Heon S, 2003, AM J PHYSIOL-HEART C, V285, pH499, DOI 10.1152/ajpheart.00047.2003; Jensen BV, 2006, SEMIN ONCOL, V33, pS15, DOI 10.1053/j.seminoncol.2006.04.022; Kotamraju S, 2004, METHOD ENZYMOL, V378, P362; Kuhnl A, 2005, J ENDOVASC THER, V12, P171, DOI 10.1583/1384R.1; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; Lightfoot JC, 2010, CIRC-CARDIOVASC IMAG, V3, P550, DOI 10.1161/CIRCIMAGING.109.918540; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; MEHRA MR, 1995, J HEART LUNG TRANSPL, V14, P632; Moser EC, 2006, BLOOD, V107, P2912, DOI 10.1182/blood-2005-08-3392; Murata T, 2001, LIFE SCI, V69, P2685, DOI 10.1016/S0024-3205(01)01352-2; Silber JH, 2004, J CLIN ONCOL, V22, P820, DOI 10.1200/JCO.2004.06.022; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; Ueno H, 2000, HYPERTENSION, V36, P89, DOI 10.1161/01.HYP.36.1.89; Wolf MB, 2006, BBA-GEN SUBJECTS, V1760, P267, DOI 10.1016/j.bbagen.2005.10.012; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664	31	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57554	10.1371/journal.pone.0057554	http://dx.doi.org/10.1371/journal.pone.0057554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437398	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000111
J	Paschalis, V; Theodorou, AA; Panayiotou, G; Kyparos, A; Patikas, D; Grivas, GV; Nikolaidis, MG; Vrabas, IS				Paschalis, Vassilis; Theodorou, Anastasios A.; Panayiotou, George; Kyparos, Antonios; Patikas, Dimitrios; Grivas, Gerasimos V.; Nikolaidis, Michalis G.; Vrabas, Ioannis S.			Stair Descending Exercise Using a Novel Automatic Escalator: Effects on Muscle Performance and Health-Related Parameters	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; BLOOD OXIDATIVE STRESS; DAMAGING EXERCISE; REPEATED BOUT; ECCENTRIC EXERCISE; PROLONGED CHANGES; SKELETAL-MUSCLE; CREATINE-KINASE; FREE-RADICALS; REHABILITATION	A novel automatic escalator was designed, constructed and used in the present investigation. The aim of the present investigation was to compare the effect of two repeated sessions of stair descending versus stair ascending exercise on muscle performance and health-related parameters in young healthy men. Twenty males participated and were randomly divided into two equal-sized groups: a stair descending group (muscle-damaging group) and a stair ascending group (non-muscle-damaging group). Each group performed two sessions of stair descending or stair ascending exercise on the automatic escalator while a three week period was elapsed between the two exercise sessions. Indices of muscle function, insulin sensitivity, blood lipid profile and redox status were assessed before and immediately after, as well as at day 2 and day 4 after both exercise sessions. It was found that the first bout of stair descending exercise caused muscle damage, induced insulin resistance and oxidative stress as well as affected positively blood lipid profile. However, after the second bout of stair descending exercise the alterations in all parameters were diminished or abolished. On the other hand, the stair ascending exercise induced only minor effects on muscle function and health-related parameters after both exercise bouts. The results of the present investigation indicate that stair descending exercise seems to be a promising way of exercise that can provoke positive effects on blood lipid profile and antioxidant status.	[Paschalis, Vassilis] Univ Thessaly, Dept Phys Educ & Sport Sci, Trikala, Greece; [Paschalis, Vassilis; Nikolaidis, Michalis G.] Ctr Res & Technol Thessaly, Inst Human Performance & Rehabil, Trikala, Greece; [Paschalis, Vassilis; Theodorou, Anastasios A.; Panayiotou, George] Res Ctr European Univ Cyprus, Lab Exercise Hlth & Human Performance, Nicosia, Cyprus; [Kyparos, Antonios; Patikas, Dimitrios; Grivas, Gerasimos V.; Nikolaidis, Michalis G.; Vrabas, Ioannis S.] Aristotle Univ Thessaloniki, Exercise Physiol & Biochem Lab, Dept Phys Educ & Sport Sci Serres, Serres, Greece	University of Thessaly; European University Cyprus; Aristotle University of Thessaloniki	Nikolaidis, MG (corresponding author), Ctr Res & Technol Thessaly, Inst Human Performance & Rehabil, Trikala, Greece.	nikolaidis@auth.gr	Grivas, Gerasimos V./AAG-8825-2019; Panayiotou, George/AFI-8471-2022; Patikas, Dimitrios A./C-7653-2014	Panayiotou, George/0000-0002-1242-9475; Patikas, Dimitrios A./0000-0001-8921-4176; Anastasios, Anastasios/0000-0002-9225-8177; Grivas, Gerasimos/0000-0002-7917-2512; Paschalis, Vassilis/0000-0002-9469-0457	European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation [YGammaEIA/DeltaYGammaEIA/0308(BIE)/27]	European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation	This work was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Project Upsilon Gamma EIA/Delta Upsilon Gamma EIA/0308(BIE)/27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2004, FREE RADICAL BIO MED, V37, P480, DOI 10.1016/j.freeradbiomed.2004.05.008; Bizzini M, 2007, ARCH ORTHOP TRAUM SU, V127, P781, DOI 10.1007/s00402-006-0200-z; Close GL, 2005, COMP BIOCHEM PHYS A, V142, P257, DOI 10.1016/j.cbpa.2005.08.005; Dolezal BA, 2000, MED SCI SPORT EXER, V32, P1202, DOI 10.1097/00005768-200007000-00003; Drexel H, 2008, EUR J CLIN INVEST, V38, P218, DOI 10.1111/j.1365-2362.2008.01937.x; Durrington P, 2003, LANCET, V362, P717, DOI 10.1016/S0140-6736(03)14234-1; Durstine J, 1994, EFFECTS EXERCISE TRA; Fleming BC, 1999, ARTHROSCOPY, V15, P185, DOI 10.1053/ar.1999.v15.015018; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hamel KA, 2004, J AM GERIATR SOC, V52, P563, DOI 10.1111/j.1532-5415.2004.52162.x; Hayes WC, 1996, BONE, V18, pS77, DOI 10.1016/8756-3282(95)00383-5; Herzberg GR, 2004, CAN J APPL PHYSIOL, V29, P800, DOI 10.1139/h04-052; Jackson MJ, 2009, FREE RADICAL BIO MED, V47, P1267, DOI 10.1016/j.freeradbiomed.2009.09.005; JANSSON E, 1987, J APPL PHYSIOL, V62, P999, DOI 10.1152/jappl.1987.62.3.999; Jones P P, 1996, J Cardiopulm Rehabil, V16, P47; Keller KB, 2003, AM J CRIT CARE, V12, P167, DOI 10.4037/ajcc2003.12.2.167; Kennedy G, 2005, FREE RADICAL BIO MED, V39, P584, DOI 10.1016/j.freeradbiomed.2005.04.020; Kim BJ, 2009, APPL ERGON, V40, P348, DOI 10.1016/j.apergo.2008.11.012; Kirwan JP, 2003, BIOCHEM SOC T, V31, P1281; Kokkinos PF, 1999, SPORTS MED, V28, P307, DOI 10.2165/00007256-199928050-00002; Lin SYC, 2004, CLIN REHABIL, V18, P92, DOI 10.1191/0269215504cr706oa; Looney Marilyn A, 2003, J Appl Meas, V4, P43; Marin R, 2008, J REHABIL RES DEV, V45, P125, DOI 10.1682/JRRD.2006.08.0105; McHugh MP, 1999, SPORTS MED, V27, P157, DOI 10.2165/00007256-199927030-00002; Merry TL, 2012, EXERC SPORT SCI REV, V40, P102, DOI 10.1097/JES.0b013e318245837b; Nikolaidis MG, 2008, MED SCI SPORT EXER, V40, P1483, DOI 10.1249/MSS.0b013e31817356f2; Nikolaidis MG, 2007, MED SCI SPORT EXER, V39, P1080, DOI 10.1249/mss.0b013e31804ca10c; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Nikolaidis MG, 2012, BIOMARKERS, V17, P28, DOI 10.3109/1354750X.2011.635805; OSCAI LB, 1990, J APPL PHYSIOL, V69, P1571, DOI 10.1152/jappl.1990.69.5.1571; Panayiotou G, 2013, SCAND J MED SCI SPOR, V23, P556, DOI 10.1111/j.1600-0838.2011.01437.x; Paschalis V, 2008, EUR J APPL PHYSIOL, V103, P9, DOI 10.1007/s00421-007-0663-9; Paschalis V, 2010, SCAND J MED SCI SPOR, V20, pE103, DOI 10.1111/j.1600-0838.2009.00920.x; Paschalis V, 2007, IN VIVO, V21, P877; Paschalis V, 2011, MED SCI SPORT EXER, V43, P64, DOI 10.1249/MSS.0b013e3181e91d90; Powers SK, 2011, J PHYSIOL-LONDON, V589, P2129, DOI 10.1113/jphysiol.2010.201327; Reid MB, 2008, FREE RADICAL BIO MED, V44, P169, DOI 10.1016/j.freeradbiomed.2007.03.002; REN JM, 1988, BIOCHEM J, V251, P183, DOI 10.1042/bj2510183; Roy JLP, 2004, J STRENGTH COND RES, V18, P92; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shah S, 2011, CAN MED ASSOC J, V183, pE1353, DOI 10.1503/cmaj.110961; Shahbazpour N, 2004, J SPORT MED PHYS FIT, V44, P193; SINGH N, 1995, MOL CELL BIOCHEM, V147, P77, DOI 10.1007/BF00944786; SMITH LL, 1994, BRIT J SPORT MED, V28, P267, DOI 10.1136/bjsm.28.4.267; Tee JC, 2007, SPORTS MED, V37, P827, DOI 10.2165/00007256-200737100-00001; Teixeira-Salmela LF, 2005, DISABIL REHABIL, V27, P1007, DOI 10.1080/09638280500030688; Theodorou AA, 2011, AM J CLIN NUTR, V93, P1373, DOI 10.3945/ajcn.110.009266; Theodorou AA, 2010, MED SCI SPORT EXER, V42, P1113, DOI 10.1249/MSS.0b013e3181c67ecd; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Westerblad H, 2011, ANTIOXID REDOX SIGN, V15, P2487, DOI 10.1089/ars.2011.3909; Zeppetzauer M, 2012, EUR J PREV CARDIOL	56	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56218	10.1371/journal.pone.0056218	http://dx.doi.org/10.1371/journal.pone.0056218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437093	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000016
J	Del Bello, B; Toscano, M; Moretti, D; Maellaro, E				Del Bello, Barbara; Toscano, Marzia; Moretti, Daniele; Maellaro, Emilia			Cisplatin-Induced Apoptosis Inhibits Autophagy, Which Acts as a Pro-Survival Mechanism in Human Melanoma Cells	PLOS ONE			English	Article							MEDIATED CLEAVAGE; TARGETING AUTOPHAGY; CALPAIN SYSTEM; CANCER-THERAPY; IN-VITRO; DEATH; PATHWAY; METASTASIS; EXPRESSION; PROTEINS	The interplay between a non-lethal autophagic response and apoptotic cell death is still a matter of debate in cancer cell biology. In the present study performed on human melanoma cells, we investigate the role of basal or stimulated autophagy in cisplatin-induced cytotoxicity, as well as the contribution of cisplatin-induced activation of caspases 3/7 and conventional calpains. The results show that, while down-regulating Beclin-1, Atg14 and LC3-II, cisplatin treatment inhibits the basal autophagic response, impairing a physiological pro-survival response. Consistently, exogenously stimulated autophagy, obtained with trehalose or calpains inhibitors (MDL-28170 and calpeptin), protects from cisplatin-induced apoptosis, and such a protection is reverted by inhibiting autophagy with 3-methyladenine or ATG5 silencing. In addition, during trehalose-stimulated autophagy, the cisplatin-induced activation of calpains is abrogated, suggesting the existence of a feedback loop between the autophagic process and calpains. On the whole, our results demonstrate that in human melanoma cells autophagy may function as a beneficial stress response, hindered by cisplatin-induced death mechanisms. In a therapeutic perspective, these findings suggest that the efficacy of cisplatin-based polychemotherapies for melanoma could be potentiated by inhibitors of autophagy.	[Del Bello, Barbara; Toscano, Marzia; Moretti, Daniele; Maellaro, Emilia] Univ Siena, Ist Toscano Tumori, Dept Pathophysiol Expt Med & Publ Hlth, I-53100 Siena, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena	Maellaro, E (corresponding author), Univ Siena, Ist Toscano Tumori, Dept Pathophysiol Expt Med & Publ Hlth, Via Laterina 8, I-53100 Siena, Italy.	emilia.maellaro@unisi.it			Istituto Toscano Tumori (ITT), Italy	Istituto Toscano Tumori (ITT), Italy	This work has received financial support from Istituto Toscano Tumori (ITT), Italy (www.ittumori.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JL, 2011, CLIN CANCER RES, V17, P2216, DOI 10.1158/1078-0432.CCR-10-3003; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276; Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079; Del Bello B, 2004, EXP CELL RES, V293, P302, DOI 10.1016/j.yexcr.2003.10.024; Demarchi F, 2007, CELL CYCLE, V6, P136; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Han CR, 2011, TOHOKU J EXP MED, V223, P243, DOI 10.1620/tjem.223.243; Harhaji-Trajkovic L, 2009, AMPK MEDIATED AUTOPH; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lazova R, 2010, J CUTAN PATHOL, V37, P256, DOI 10.1111/j.1600-0560.2009.01359.x; Lazova R, 2009, EXP DERMATOL, V18, P934, DOI 10.1111/j.1600-0625.2009.00933.x; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levy JMM, 2011, PHARMACOL THERAPEUT, V131, P130, DOI 10.1016/j.pharmthera.2011.03.009; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Madden DT, 2007, AUTOPHAGY, V3, P519; Mallya SK, 1998, BIOCHEM BIOPH RES CO, V248, P293, DOI 10.1006/bbrc.1998.8952; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moretti D, 2009, CARCINOGENESIS, V30, P960, DOI 10.1093/carcin/bgp098; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SUPINO R, 1992, MELANOMA RES, V2, P377, DOI 10.1097/00008390-199212000-00012; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Wangpaichitr M, 2008, EUR J PHARMACOL, V591, P124, DOI 10.1016/j.ejphar.2008.06.028; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Xia HG, 2010, AUTOPHAGY, V6, P61, DOI 10.4161/auto.6.1.10326; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yang ZS, 2010, CANCER SCI, V101, P494, DOI 10.1111/j.1349-7006.2009.01412.x; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang JY, 2009, J ALZHEIMERS DIS, V16, P39, DOI 10.3233/JAD-2009-0908	46	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57236	10.1371/journal.pone.0057236	http://dx.doi.org/10.1371/journal.pone.0057236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437349	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200229
J	El-Adawy, H; Hotzel, H; Tomaso, H; Neubauer, H; Taboada, EN; Ehricht, R; Hafez, HM				El-Adawy, Hosny; Hotzel, Helmut; Tomaso, Herbert; Neubauer, Heinrich; Taboada, Eduardo N.; Ehricht, Ralf; Hafez, Hafez M.			Detection of Genetic Diversity in Campylobacter jejuni Isolated from a Commercial Turkey Flock Using flaA Typing, MLST Analysis and Microarray Assay	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; COLI; SEQUENCE; RECOMBINATION; INSTABILITY; DYNAMICS; ABILITY	Campylobacter is genetically highly diverse and undergoes frequent intraspecific recombination. Turkeys have been identified as an important reservoir for Campylobacter jejuni which is of public health significance. The assessment of the genetic diversity among Campylobacter population is critical for our understanding of the epidemiology of this bacterium. The genetic profiles were different according to the molecular typing methods used. The performance of established flaA genotyping, multilocus sequencing typing (MLST) and DNA microarray assay based on the ArrayTube (TM) technology was evaluated using 14 Campylobacter jejuni isolated from a commercial turkey flock. The flaA typing was performed using PCR-RFLP with restriction enzymes Sau3AI, AluI, a 'composite' flaA analysis of AluI and Sau3AI and DdeI. The 14 isolates were differentiated into 3, 5, 7 and 9 genotypes, respectively. Entire flaA gene and short variable region (SVR) sequences were analysed. Sequencing of the entire flaA provided 11 different genotypes. flaA-SVR sequence analysis detected 8 flaA alleles and 4 flaA peptides. One new flaA allele type (528) was identified. MLST analysis represented 10 different sequence types (STs) and 5 clonal complexes (CCs). The microarray assay recognised 14 different genotypes. The discriminatory indices were 0.560, 0.802, 0.857, and 0.912 for flaA-RFLP depending on the used enzymes, 0.890 for flaA-SVR, 0.967 for entire flaA sequencing, 0.945 for MLST and 1.00 for the DNA microarray assay. The flaA gene was genetically stable over 20 passages on blood agar. In conclusion, the different typing tools demonstrated a high level of genetic heterogeneity of Campylobacter jejuni in a turkey flock, indicating that a single flock can be infected by multiple genotypes within one rearing cycle. DNA microarray-based assays had the highest discriminatory power when compared with other genotyping tools.	[El-Adawy, Hosny; Hotzel, Helmut; Tomaso, Herbert; Neubauer, Heinrich] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany; [El-Adawy, Hosny; Hafez, Hafez M.] Free Univ Berlin, Inst Poultry Dis, Berlin, Germany; [El-Adawy, Hosny] Kafrelsheikh Univ, Fac Vet Med, Dept Poultry Dis, Kafr Al Sheikh, Egypt; [Taboada, Eduardo N.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Lethbridge, AB, Canada; [Ehricht, Ralf] Alere Technol GmbH, Jena, Germany	Friedrich Loeffler Institute; Free University of Berlin; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Public Health Agency of Canada; Alere	El-Adawy, H (corresponding author), Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany.	hosnyeladawy@yahoo.com	Tomaso, Herbert/C-6327-2017; Taboada, Eduardo N/Y-4854-2018	Taboada, Eduardo N/0000-0001-8373-3653; El-Adawy, Hosny/0000-0002-8585-4237	Friedrich Loeffler Institute (Federal Research Institute for Animal Health), Institute of Bacterial Infections and Zoonoses, Jena, Germany; Egyptian ministry of higher education; Egyptian Cultural and Educational office of the Arab Republic of Egypt in Germany	Friedrich Loeffler Institute (Federal Research Institute for Animal Health), Institute of Bacterial Infections and Zoonoses, Jena, Germany; Egyptian ministry of higher education(Science and Technology Development Fund (STDF)); Egyptian Cultural and Educational office of the Arab Republic of Egypt in Germany(Egyptian Cultural & Educational Bureau)	This research was supported by grants from Friedrich Loeffler Institute (Federal Research Institute for Animal Health), Institute of Bacterial Infections and Zoonoses, Jena, Germany to HE and in part by a grant from the Egyptian ministry of higher education. HE is a scholarship recipient from the Egyptian Cultural and Educational office of the Arab Republic of Egypt in Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter T, 2011, VET MICROBIOL, V147, P90, DOI 10.1016/j.vetmic.2010.06.005; [Anonymous], 2006, 1027212006 ISO; Ayling RD, 1996, RES VET SCI, V60, P168, DOI 10.1016/S0034-5288(96)90013-2; Behringer M, 2011, J MICROBIOL METH, V84, P194, DOI 10.1016/j.mimet.2010.11.016; Buchanan CJ, 2011, P 16 INT WORKSH CAMP, P164; Chuma T, 1997, J VET MED SCI, V59, P1011, DOI 10.1292/jvms.59.1011; Clark CG, 2012, J CLIN MICROBIOL, V50, P798, DOI 10.1128/JCM.05733-11; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Drummond AJ, 2010, GENEIOUS V5 1; Eberle KN, 2012, POULTRY SCI, V91, P255, DOI 10.3382/ps.2011-01414; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; El-Adawy H, 2012, POULTRY SCI, V91, P454, DOI 10.3382/ps.2010-01810; European Food Safety Authority (EFSA), 2011, EFSA J, V10, P2597; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gu WM, 2009, APPL ENVIRON MICROB, V75, P474, DOI 10.1128/AEM.02012-08; Hafez HM, 2001, ARCH GEFLUGELKD, V65, P130; Hanninen ML, 1999, APPL ENVIRON MICROB, V65, P2272; Harrington CS, 2003, J APPL MICROBIOL, V95, P1321, DOI 10.1046/j.1365-2672.2003.02101.x; Harrington CS, 1997, J CLIN MICROBIOL, V35, P2386, DOI 10.1128/JCM.35.9.2386-2392.1997; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; NACHAMKIN I, 1993, J CLIN MICROBIOL, V31, P1531, DOI 10.1128/JCM.31.6.1531-1536.1993; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Petersen L, 2000, LETT APPL MICROBIOL, V31, P14, DOI 10.1046/j.1472-765X.2000.00757.x; Petersen L, 2001, J APPL MICROBIOL, V91, P217, DOI 10.1046/j.1365-2672.2001.01383.x; Ridley AM, 2008, J APPL MICROBIOL, V105, P95, DOI 10.1111/j.1365-2672.2008.03759.x; Ring M, 2005, AVIAN DIS, V49, P390, DOI 10.1637/7319-010305R1.1; Suerbaum S, 2001, J BACTERIOL, V183, P2553, DOI 10.1128/JB.183.8.2553-2559.2001; Taboada Eduardo N., 2007, V396, P223; Taboada EN, 2004, J CLIN MICROBIOL, V42, P4566, DOI 10.1128/JCM.42.10.4566-4576.2004; Thomas LM, 1997, APPL ENVIRON MICROB, V63, P1874, DOI 10.1128/AEM.63.5.1874-1877.1997; Volokhov D, 2003, J CLIN MICROBIOL, V41, P4071, DOI 10.1128/JCM.41.9.4071-4080.2003; Wassenaar TM, 2000, APPL ENVIRON MICROB, V66, P1, DOI 10.1128/AEM.66.1.1-9.2000; Wassenaar TM, 1998, APPL ENVIRON MICROB, V64, P1816	40	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e51582	10.1371/journal.pone.0051582	http://dx.doi.org/10.1371/journal.pone.0051582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437035	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200002
J	Jung, Y; Oh, J; Huh, S; Kawachi, I				Jung, Youn; Oh, Juhwan; Huh, Soonim; Kawachi, Ichiro			The Effects of Employment Conditions on Smoking Status and Smoking Intensity: The Analysis of Korean Labor & Income Panel 8th-10th Wave	PLOS ONE			English	Article							TEMPORARY EMPLOYMENT; GENERAL-POPULATION; CIGARETTE-SMOKING; JOB INSECURITY; HEALTH; UNEMPLOYMENT; MORTALITY; EMPLOYEES; DRINKING; WORKING	Background: The neoliberal policies and its socioeconomic consequences in Korea have made employment conditions insecure and affected employees' health as well. Methods and Findings: To examine the association between employment condition and smoking status, we selected male respondents aged 20-59 that participated in all of the 8th-10th wave of Korean Labor and Income Panel Study(KLIPS) which is a nationally representative data. Precarious working was significantly associated with smoking compared to standard working even after adjusting for socioeconomic indicators and self rated health status. After controlling for overall life satisfaction, the odds ratio of smoking among precarious workers decreased, but it was still marginally significant (OR = 1.43, 95% CI = 0.99 to 2.07). A relation between precarious working and heavy smoking was also significant. Precarious working was associated with a decreased likelihood of quitting smoking, while it was not significant any more after adjusting for overall satisfaction on life. Precarious work was also related to a higher likelihood of relapse among former smokers, but was not significant after adjusting for other confounders. Conclusions: Precarious workers were more likely to be smokers and heavy smokers than standard workers. Unemployment is also a significant risk factor for decreased quitting and smoking relapse. However, insecure employment was an even more consistent determinant of current smoking behavior than unemployment.	[Jung, Youn] Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea; [Oh, Juhwan] Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea; [Huh, Soonim] Univ Seoul, Dept Publ Adm, Seoul, South Korea; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Seoul National University (SNU); Seoul National University (SNU); University of Seoul; Harvard University; Harvard T.H. Chan School of Public Health	Oh, J (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea.	oh328@snu.ac.kr	Oh, Juhwan/O-6517-2019	Oh, Juhwan/0000-0003-0983-4872				Benavides FG, 2000, J EPIDEMIOL COMMUN H, V54, P494, DOI 10.1136/jech.54.7.494; Bielenski H, 1999, WHO REG PUB, P11; Cha, 2003, KOREAN J OCCUP ENV M, V16, P103; Cheng Y, 2005, SOC SCI MED, V61, P41, DOI 10.1016/j.socscimed.2004.11.039; CRAWFORD A, 1987, BRIT J ADDICT, V82, P1007; De Cuyper N, 2008, ECON IND DEMOCRACY, V29, P388, DOI 10.1177/0143831X08092462; Khlat M, 2004, EUR J EPIDEMIOL, V19, P445, DOI 10.1023/B:EJEP.0000027356.71414.bd; Kim IH, 2006, SOC SCI MED, V63, P566, DOI 10.1016/j.socscimed.2006.02.004; Kim Il-Ho, 2005, J Prev Med Public Health, V38, P337; Kim MH, 2008, SOC SCI MED, V67, P1982, DOI 10.1016/j.socscimed.2008.09.051; Kivimaki M, 2003, AM J EPIDEMIOL, V158, P663, DOI 10.1093/aje/kwg185; Korean Labor Institute, 2007, KLIPS US GUID; Kouvonen A, 2005, J EPIDEMIOL COMMUN H, V59, P63, DOI 10.1136/jech.2004.019752; 전은숙, 2009, Annals of Occupational and Environmental Medicine, V21, P28; Lee Won-Cheol, 2011, Annals of Occupational and Environmental Medicine, V23, P89; Marmot MG, 1999, WHO REG PUB, P1; McDonough P, 2000, INT J HEALTH SERV, V30, P453, DOI 10.2190/BPFG-X3ME-LHTA-6RPV; Montgomery SM, 1998, EUR J PUBLIC HEALTH, V8, P21, DOI 10.1093/eurpub/8.1.21; Morrell S, 1999, SOC SCI MED, V49, P383, DOI 10.1016/S0277-9536(99)00102-1; Organization of Economic Cooperation and Development [OECD], 2012, OECD HLTH DAT; Virtanen M, 2005, INT J EPIDEMIOL, V34, P610, DOI 10.1093/ije/dyi024; Virtanen P, 2008, EUR J PUBLIC HEALTH	22	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57109	10.1371/journal.pone.0057109	http://dx.doi.org/10.1371/journal.pone.0057109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437324	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200217
J	Podlas, K; Helfenstein, F; Richner, H				Podlas, Katarzyna; Helfenstein, Fabrice; Richner, Heinz			Brood Reduction via Intra-clutch Variation in Testosterone - An Experimental Test in the Great Tit	PLOS ONE			English	Article							MATERNAL YOLK TESTOSTERONE; IMMUNE FUNCTION; HATCHING ASYNCHRONY; SIBLING COMPETITION; HORMONE DEPOSITION; PRENATAL EXPOSURE; SEX-RATIOS; GROWTH; ANDROGENS; FEMALE	In birds, yolk androgen concentrations in eggs can increase or decrease over the laying sequence and common hypotheses hold that this serves to favour the competitive ability of either first- or last-hatched chicks depending on the prevailing conditions, and thus promote brood reduction or maintenance of original brood size respectively. Intra-clutch variation of testosterone can shift relative competitive ability of siblings and hence competitive dynamics. In a natural population of great tits, we experimentally investigated the effects and function of maternal testosterone on offspring phenotype in relation to the laying position of the egg in a context of hatching asynchrony. To this end, we created three types of clutches where either the first three or the last three eggs of a clutch were injected with testosterone (T) dissolved in sesame oil, and the remaining eggs with sesame oil only, or where all eggs of a clutch were injected with sesame oil. Increased levels of yolk T in the last-laid eggs resulted in the last-hatched chicks being significantly lighter and smaller than their siblings, while increased levels of T in the first-laid eggs had no direct effect on the first- hatched chicks, but an indirect negative effect on their siblings. Our results suggest that females can potentially adjust offspring phenotype by modulating, over the laying sequence, the amounts of T deposited in the eggs. These results are in contradiction, however, with current hypotheses and previous findings, which suggest that under good conditions higher levels of maternally derived T in the last-laid eggs should mitigate the negative effects of hatching asynchrony.	[Podlas, Katarzyna; Helfenstein, Fabrice; Richner, Heinz] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Helfenstein, Fabrice] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Bern; University of Neuchatel	Podlas, K (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	podlas.kasia@gmail.com	Richner, Heinz/B-1659-2008; Helfenstein, Fabrice/I-5634-2013	Richner, Heinz/0000-0001-7390-0526; Helfenstein, Fabrice/0000-0001-8412-0461	Swiss National Science Foundation grant [31003A_122566]	Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF))	The study was financially supported by a Swiss National Science Foundation grant, 31003A_122566 to HR (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DJ, 1989, PHYSIOL BEHAV, V46, P185, DOI 10.1016/0031-9384(89)90253-9; ALEXANDER J, 1988, PARASITOL TODAY, V4, P189, DOI 10.1016/0169-4758(88)90077-4; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Amundsen T, 1998, ECOLOGY, V79, P295, DOI 10.1890/0012-9658(1998)079[0295:HAIGTA]2.0.CO;2; Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; BATE LA, 1985, CAN J ANIM SCI, V65, P627, DOI 10.4141/cjas85-074; Beissinger SR, 1997, TRENDS ECOL EVOL, V12, P112, DOI 10.1016/S0169-5347(97)84921-X; Bernardo J, 1996, AM ZOOL, V36, P83; Berthouly A, 2007, FUNCT ECOL, V21, P335, DOI 10.1111/j.1365-2435.2006.01236.x; BIERE A, 1991, J EVOLUTION BIOL, V4, P447, DOI 10.1046/j.1420-9101.1991.4030447.x; Boncoraglio G, 2011, AM NAT, V178, P64, DOI 10.1086/660278; Bruggeman V, 2002, COMP BIOCHEM PHYS A, V131, P839, DOI 10.1016/S1095-6433(02)00022-3; Carere C, 2007, TRENDS ENDOCRIN MET, V18, P73, DOI 10.1016/j.tem.2007.01.003; CLARK MM, 1995, PHYSIOL BEHAV, V57, P297, DOI 10.1016/0031-9384(94)00239-2; Clark MM, 2002, ANIM BEHAV, V63, P1129, DOI 10.1006/anbe.2002.3019; Dijkstra C, 1998, BEHAV ECOL, V9, P287, DOI 10.1093/beheco/9.3.287; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; DVORAK M, 1981, VET MED-CZECH, V26, P65; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; FENNELL MJ, 1992, POULTRY SCI, V71, P357, DOI 10.3382/ps.0710357; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; FORD JJ, 1982, BIOL REPROD, V27, P425, DOI 10.1095/biolreprod27.2.425; Gaillard RC, 1998, DOMEST ANIM ENDOCRIN, V15, P345, DOI 10.1016/S0739-7240(98)00028-9; Galvan I, 2010, J EXP BIOL, V213, P3127, DOI 10.1242/jeb.045096; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; GRANT VJ, 1994, BRIT J MED PSYCHOL, V67, P343, DOI 10.1111/j.2044-8341.1994.tb01802.x; Groothuis TGG, 2005, BIOL LETTERS, V1, P78, DOI 10.1098/rsbl.2004.0233; Groothuis TGG, 2008, BIOL LETTERS, V4, P465, DOI 10.1098/rsbl.2008.0258; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Hadfield J.D, 2012, MCMCGLMM COURSE NOTE; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Hudson R, 2008, BEHAV ECOL SOCIOBIOL, V62, P299, DOI 10.1007/s00265-007-0417-z; Janzen FJ, 1998, GEN COMP ENDOCR, V111, P306, DOI 10.1006/gcen.1998.7115; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Lipar JL, 1999, AUK, V116, P231, DOI 10.2307/4089471; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Lovern MB, 2001, GEN COMP ENDOCR, V124, P226, DOI 10.1006/gcen.2001.7704; Manikkam M, 2004, ENDOCRINOLOGY, V145, P790, DOI 10.1210/en.2003-0478; Martin JT, 2000, EUR J PHARMACOL, V405, P251, DOI 10.1016/S0014-2999(00)00557-4; McCormick MI, 1999, OECOLOGIA, V118, P412, DOI 10.1007/s004420050743; Mock D. W., 1997, EVOLUTION SIBLING RI; MONTALVO AM, 1994, EVOLUTION, V48, P828, DOI 10.1111/j.1558-5646.1994.tb01365.x; Morales J, 2006, BIOL LETTERS, V2, P334, DOI 10.1098/rsbl.2006.0471; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Muller W, 2005, P ROY SOC B-BIOL SCI, V272, P1971, DOI 10.1098/rspb.2005.3178; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Navara KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P392, DOI 10.1007/s00265-006-0177-1; Nelson R. J., 2000, INTRO BEHAV ENDOCRIN; Nelson RJ, 2006, BIOL AGRESSION; Neuenschwander S, 2003, BEHAV ECOL, V14, P457, DOI 10.1093/beheco/arg025; Okuliarova M, 2011, COMP BIOCHEM PHYS A, V160, P81, DOI 10.1016/j.cbpa.2011.05.012; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; PARICHY DM, 1992, OECOLOGIA, V91, P579, DOI 10.1007/BF00650334; Pettifor RA, 2001, J ANIM ECOL, V70, P62, DOI 10.1046/j.1365-2656.2001.00465.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pitala N, 2009, J AVIAN BIOL, V40, P225, DOI 10.1111/j.1600-048X.2009.04452.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Randall P, 2002, PLAST RECONSTR SURG, V109, P1713, DOI 10.1097/00006534-200204150-00038; Remes V, 2011, BEHAV ECOL SOCIOBIOL, V65, P1257, DOI 10.1007/s00265-011-1139-9; Ros AFH, 1999, IBIS, V141, P451, DOI 10.1111/j.1474-919X.1999.tb04414.x; Rosser CB, 2003, BIOL REPROD, V68, P293; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Ruuskanen S, 2010, HORM BEHAV, V57, P119, DOI 10.1016/j.yhbeh.2009.09.017; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Schwabl H, 1997, CONTROL OFFFSPRING F, P1677; SCHWAEGERLE KE, 1990, J ECOL, V78, P15, DOI 10.2307/2261033; SLOB AK, 1980, J ENDOCRINOL, V87, P81, DOI 10.1677/joe.0.0870081; Smith AS, 2008, AM J PRIMATOL, V70, P46; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; Strasser R, 2004, BEHAV ECOL SOCIOBIOL, V56, P491, DOI 10.1007/s00265-004-0810-9; Tobler M, 2007, BIOLOGY LETT, V3, P408, DOI 10.1098/rsbl.2007.0127; Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; Urban RJ, 2011, HORM RES PAEDIAT, V76, P81, DOI 10.1159/000329184; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; Wolf CJ, 2002, TOXICOL SCI, V65, P71, DOI 10.1093/toxsci/65.1.71; Zuur Alain F., 2009, P1	90	8	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56672	10.1371/journal.pone.0056672	http://dx.doi.org/10.1371/journal.pone.0056672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437207	Green Published, gold			2022-12-27	WOS:000315184200137
J	Wang, XW; Buhimschi, CS; Temoin, S; Bhandari, V; Han, YPW; Buhimschi, IA				Wang, Xiaowei; Buhimschi, Catalin S.; Temoin, Stephanie; Bhandari, Vineet; Han, Yiping W.; Buhimschi, Irina A.			Comparative Microbial Analysis of Paired Amniotic Fluid and Cord Blood from Pregnancies Complicated by Preterm Birth and Early-Onset Neonatal Sepsis	PLOS ONE			English	Article							INTRAAMNIOTIC INFLAMMATION; PROTEOMIC BIOMARKERS; ORAL BACTERIA; PREMATURE; CHORIOAMNIONITIS; TRANSMISSION; INVASION; DISEASE; MARKERS; CAVITY	Background: 16S rRNA-based genomic analyses have revolutionized our understanding of infectious diseases. Many cases which were recognized as "idiopathic" are now known to have an infectious etiology. Here, we present a proof-of-concept study to examine the microbial link between intra-amniotic infection (IAI) and early-onset neonatal sepsis (EONS). Results: Using culture independent methods, we analyzed paired amniotic fluid (AF) and cord blood (CB) samples from 36 singleton pregnancies complicated by preterm birth (PTB), IAI, and/or EONS. PTB cases were grouped as 1) Group 1- neonatal blood culture-positive EONS (n = 6). 2) Group 2- neonatal blood culture-negative presumed EONS with positive IAI (n = 16). 3) Group 3- neonatal blood culture-negative presumed EONS with no IAI (n = 7); 4) Group 4- no EONS or IAI (n = 7). In addition, samples from term healthy deliveries (n = 8) served as technical controls. A total of 31 species (15 non-redundant) were identified in AF, of which only 1/3 were cultivated. Significantly fewer microorganisms were detected in CB, with a total of 18 species (7 non-redundant) identified, of which only 2 (Escherichia coli, Streptococcus agalactiae) were cultivated. Of those, Bergeyella, Fusobacterium nucleatum, and Sneathia sanguinegens had not been detected in EONS before. The novel species identified in AF by PCR include Peptoniphilus harei and Lachnospiraceae sp. The majority (72%) of CB species were also detected in the matching AF, with E. coli and F. nucleatum as the most prevalent. The 16S rRNA sequences of paired AF and CB were 99.9-100% identical, while no identical sequences were found between different pregnancies. Conclusions: Previously unrecognized, uncultivated or difficult-to-cultivate species are implicated in EONS. Microbial species in paired AF and CB likely share the same infectious origin. Given its prevalence in EONS, F. nucleatum should be placed on the same importance scale as E. coli.	[Wang, Xiaowei; Temoin, Stephanie; Han, Yiping W.] Case Western Reserve Univ, Dept Periodont, Cleveland, OH 44106 USA; [Buhimschi, Catalin S.; Bhandari, Vineet; Buhimschi, Irina A.] Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Bhandari, Vineet] Yale Univ, Dept Pediat, New Haven, CT 06520 USA; [Han, Yiping W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Han, Yiping W.] Case Western Reserve Univ, Dept Reprod Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Yale University; Yale University; Case Western Reserve University; Case Western Reserve University	Han, YPW (corresponding author), Case Western Reserve Univ, Dept Periodont, Cleveland, OH 44106 USA.	yiping.han@case.edu	Buhimschi, Irina/AAY-6619-2021; Bhandari, Vineet/AAS-3365-2020; Wang, Xiaowei/K-8352-2013	Buhimschi, Irina/0000-0002-1701-1326	National Institutes of Health (NIH) [RO1DE014924, RO1HD047321, RO1HD062007-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062007] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014924] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (NIH) grants RO1DE014924 (YWH), RO1HD047321 (IAB), and RO1HD062007-01A1 (CSB and IAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Razeq SS, 2010, OBSTET GYNECOL, V116, P344, DOI 10.1097/AOG.0b013e3181e8fec6; American College of Obstetrics and Gynecology, 2011, AM COLL OBST GYN PRA; American College of Obstetrics and Gynecology, 2011, COMM OP PREV EARL ON; American College of Obstetrics and Gynecology, 2012, AM COLL OBST GYN PRA; American College of Obstetrics and Gynecology, 2007, AM COLL OBST GYN PRA; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BARRON EJ, 2007, MANUAL CLIN BACTERIO, P974; BOBITT JR, 1978, OBSTET GYNECOL, V51, P56; Buhimschi CS, 2009, BJOG-INT J OBSTET GY, V116, P257, DOI 10.1111/j.1471-0528.2008.01925.x; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026111; Buhimschi IA, 2012, SEMIN FETAL NEONAT M, V17, P36, DOI 10.1016/j.siny.2011.10.002; Buhimschi IA, 2010, CLIN PERINATOL, V37, P355, DOI 10.1016/j.clp.2010.03.002; CHAIM W, 1992, ARCH GYNECOL OBSTET, V251, P1, DOI 10.1007/BF02718272; *COMM MET CHALL FU, 2007, NEW SCI MET REV SECR; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edwards R K, 2001, Infect Dis Obstet Gynecol, V9, P209, DOI 10.1155/S1064744901000345; El Kebir D, 2009, J IMMUNOL, V182, P4386, DOI 10.4049/jimmunol.0803044; Fardini Y, 2011, MOL MICROBIOL, V82, P1468, DOI 10.1111/j.1365-2958.2011.07905.x; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Figueroa-Damian R, 1999, ARCH MED RES, V30, P198, DOI 10.1016/S0188-0128(99)00015-9; Garry D, 1996, AM J OBSTET GYNECOL, V175, P1336, DOI 10.1016/S0002-9378(96)70051-0; Goldenberg RL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.033; Gonzalez BE, 2003, J PERINAT MED, V31, P60, DOI 10.1515/JPM.2003.009; GREENHOOD GP, 1981, INFECT CONT HOSP EP, V2, P460, DOI 10.1017/S0195941700055727; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Han YPW, 2006, J CLIN MICROBIOL, V44, P1475, DOI 10.1128/JCM.44.4.1475-1483.2006; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hebb JK, 2004, J INFECT DIS, V190, P2109, DOI 10.1086/425929; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Ikegami A, 2009, INFECT IMMUN, V77, P3075, DOI 10.1128/IAI.00209-09; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Manges AR, 2010, J INFECT DIS, V202, P1877, DOI 10.1086/657319; Mantovani E, 2007, BRAZ J MED BIOL RES, V40, P443, DOI 10.1590/S0100-879X2006005000082; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nithianantham S, 2009, J BIOL CHEM, V284, P3865, DOI 10.1074/jbc.M805503200; Ordovas JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.mol.0000217897.75068.ba; Pettker CM, 2007, OBSTET GYNECOL, V109, P739, DOI 10.1097/01.AOG.0000255663.47512.23; Smulian J C, 1997, J Matern Fetal Med, V6, P254, DOI 10.1002/(SICI)1520-6661(199709/10)6:5<254::AID-MFM2>3.0.CO;2-F; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Struthers Simon, 2002, J Perinatol, V22, P547, DOI 10.1038/sj.jp.7210792; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Veloo ACM, 2011, J CLIN MICROBIOL, V49, P1189, DOI 10.1128/JCM.00043-11; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wynn JL, 2010, CLIN PERINATOL, V37, P307, DOI 10.1016/j.clp.2010.04.001	52	71	76	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56131	10.1371/journal.pone.0056131	http://dx.doi.org/10.1371/journal.pone.0056131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437088	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200042
J	Emmert-Streib, F				Emmert-Streib, Frank			Structural Properties and Complexity of a New Network Class: Collatz Step Graphs	PLOS ONE			English	Article							STATISTICAL-MECHANICS; BIOLOGY; DYNAMICS; ENTROPY	In this paper, we introduce a biologically inspired model to generate complex networks. In contrast to many other construction procedures for growing networks introduced so far, our method generates networks from one-dimensional symbol sequences that are related to the so called Collatz problem from number theory. The major purpose of the present paper is, first, to derive a symbol sequence from the Collatz problem, we call the step sequence, and investigate its structural properties. Second, we introduce a construction procedure for growing networks that is based on these step sequences. Third, we investigate the structural properties of this new network class including their finite scaling and asymptotic behavior of their complexity, average shortest path lengths and clustering coefficients. Interestingly, in contrast to many other network models including the small-world network from Watts & Strogatz, we find that CS graphs become 'smaller' with an increasing size.	Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci,Fac Med Hlth & Life Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Emmert-Streib, F (corresponding author), Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci,Fac Med Hlth & Life Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/AAF-2878-2020; Emmert-Streib, Frank/G-8099-2011	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641				Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 1988, UNIVERSAL TURING MAC; Badii R, 1997, COMPLEXITY HIERARCHI; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bialek W, 2001, NEURAL COMPUT, V13, P2409, DOI 10.1162/089976601753195969; Bornholdt S, 2003, HDB GRAPHS NETWORKS; Chandra AK, 2005, PHYSICA A, V357, P436, DOI 10.1016/j.physa.2005.02.089; Claussen JC, 2007, PHYSICA A, V375, P365, DOI 10.1016/j.physa.2006.08.067; Corso G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036106; CRANDALL RE, 1978, MATH COMPUT, V32, P1281, DOI 10.2307/2006353; Crutchfield JP, 2012, NAT PHYS, V8, P17, DOI 10.1038/nphys2190; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Dehmer M., 2011, APPL STAT NETWORK BI; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008057; Donner RV, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033025; Dorogovtesev S, 2003, EVOLUTION NETWORKS B; Durrett R, 2006, RANDOM GRAPH DYNAMIC; EBELING W, 1987, PHYS SCRIPTA, V35, P761, DOI 10.1088/0031-8949/35/5/033; EBELING W, 1995, PHYSICA A, V215, P233, DOI 10.1016/0378-4371(95)00025-3; Emmert-Streib F, 2011, IET SYST BIOL, V5, P185, DOI 10.1049/iet-syb.2010.0025; Emmert-Streib F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034523; Emmert-Streib F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027733; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012884; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012256; Gell-Mann M., 1996, Complexity, V2, P44, DOI 10.1002/(SICI)1099-0526(199609/10)2:1<44::AID-CPLX10>3.0.CO;2-X; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; GRASSBERGER P, 1989, HELV PHYS ACTA, V62, P489; Harrell FE, 2001, REGRESSION MODELING; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Iguchi K, 2007, J THEOR BIOL, V247, P138, DOI 10.1016/j.jtbi.2007.02.010; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Lagarias J, 2006, ARXIVMATH0608208V5; Lagarias J, 2003, ARXIVMATH0309224V13; LAGARIAS JC, 1985, AM MATH MON, V92, P3, DOI 10.2307/2322189; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; LI M, 1997, INTRO KOLMOGOROV COM; Li W., 1997, COMPLEXITY, V3, P33, DOI 10.1002/(SICI)1099-0526(199711/12)3; LLOYD S, 1988, ANN PHYS-NEW YORK, V188, P186, DOI 10.1016/0003-4916(88)90094-2; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Mandelbrot B. B., 1982, FRACTAL GEOMETRY NAT, DOI DOI 10.1002/ESP3290080415; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Oliveira e Silva T, 2010, ULTIMATE CHALLENGE 3, P189; Palsson B O, 2006, SYSTEMS BIOL; Pearl R, 1920, P NATL ACAD SCI USA, V6, P275, DOI 10.1073/pnas.6.6.275; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Ribeiro AS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011901; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Solomonoff R., 1960, PRELIMINARY REPORT G; SOLOMONOFF RAY, 1951, BULL MATH BIOPHYS, V13, P107, DOI 10.1007/BF02478357; STANLEY HE, 1994, PHYSICA A, V205, P214, DOI 10.1016/0378-4371(94)90502-9; TRUCCO ERNESTO, 1956, BULL MATH BIOPHYS, V18, P129, DOI 10.1007/BF02477836; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang A, 2009, PROTEIN INTERACTION NETWORKS: COMPUTATIONAL ANALYSIS, P1, DOI 10.1017/CBO9780511626593; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zurek W., 1990, COMPLEXITY ENTROPY P	68	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56461	10.1371/journal.pone.0056461	http://dx.doi.org/10.1371/journal.pone.0056461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431377	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800019
J	Claesen, J; Clement, L; Shkedy, Z; Foulquie-Moreno, MR; Burzykowski, T				Claesen, Jurgen; Clement, Lieven; Shkedy, Ziv; Foulquie-Moreno, Maria R.; Burzykowski, Tomasz			Simultaneous Mapping of Multiple Gene Loci with Pooled Segregants	PLOS ONE			English	Article							SEQUENCING DATA; IDENTIFICATION; TRAIT	The analysis of polygenic, phenotypic characteristics such as quantitative traits or inheritable diseases remains an important challenge. It requires reliable scoring of many genetic markers covering the entire genome. The advent of high-throughput sequencing technologies provides a new way to evaluate large numbers of single nucleotide polymorphisms (SNPs) as genetic markers. Combining the technologies with pooling of segregants, as performed in bulked segregant analysis (BSA), should, in principle, allow the simultaneous mapping of multiple genetic loci present throughout the genome. The gene mapping process, applied here, consists of three steps: First, a controlled crossing of parents with and without a trait. Second, selection based on phenotypic screening of the offspring, followed by the mapping of short offspring sequences against the parental reference. The final step aims at detecting genetic markers such as SNPs, insertions and deletions with next generation sequencing (NGS). Markers in close proximity of genomic loci that are associated to the trait have a higher probability to be inherited together. Hence, these markers are very useful for discovering the loci and the genetic mechanism underlying the characteristic of interest. Within this context, NGS produces binomial counts along the genome, i.e., the number of sequenced reads that matches with the SNP of the parental reference strain, which is a proxy for the number of individuals in the offspring that share the SNP with the parent. Genomic loci associated with the trait can thus be discovered by analyzing trends in the counts along the genome. We exploit the link between smoothing splines and generalized mixed models for estimating the underlying structure present in the SNP scatterplots.	[Claesen, Jurgen; Clement, Lieven; Shkedy, Ziv; Burzykowski, Tomasz] Hasselt Univ, I BioStat, Diepenbeek, Belgium; [Clement, Lieven] KULeuven, I BioStat, Louvain, Belgium; [Clement, Lieven] Univ Ghent, Dept Appl Math & Comp Sci, B-9000 Ghent, Belgium; [Foulquie-Moreno, Maria R.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Louvain, Belgium; [Foulquie-Moreno, Maria R.] VIB, Dept Mol Microbiol, Louvain, Belgium	Hasselt University; KU Leuven; Ghent University; KU Leuven; Flanders Institute for Biotechnology (VIB)	Claesen, J (corresponding author), Hasselt Univ, I BioStat, Diepenbeek, Belgium.	jurgen.claesen@uhasselt.be	Shkedy, Ziv/AAQ-3096-2020; Burzykowski, Tomasz/T-2222-2018	Shkedy, Ziv/0000-0002-6306-0823; Burzykowski, Tomasz/0000-0003-3378-975X; clement, lieven/0000-0002-9050-4370; CLAESEN, Jurgen/0000-0001-7615-5322	Bijzonder Onderzoeksfonds Universiteit Hasselt [BOF09NI006]	Bijzonder Onderzoeksfonds Universiteit Hasselt	JC gratefully acknowledges financial support from Bijzonder Onderzoeksfonds Universiteit Hasselt (grant BOF09NI006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634; Bravo HC, 2010, BIOMETRICS, V66, P665, DOI 10.1111/j.1541-0420.2009.01353.x; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Rougemont J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-431; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Swindell S R, 1997, Methods Mol Biol, V70, P75, DOI 10.1385/0-89603-358-9:75; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Thevelein JM, 2003, EP1397513, Patent No. 1397513	11	7	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55133	10.1371/journal.pone.0055133	http://dx.doi.org/10.1371/journal.pone.0055133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441149	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200007
J	Kuebler, U; Wirtz, PH; Sakai, M; Stemmer, A; Ehlert, U				Kuebler, Ulrike; Wirtz, Petra H.; Sakai, Miho; Stemmer, Andreas; Ehlert, Ulrike			Acute Stress Reduces Wound-Induced Activation of Microbicidal Potential of Ex Vivo Isolated Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; NORADRENALINE; NEUTROPHILS; RESPONSES; INHIBITION; EXPRESSION; SYSTEM; ALPHA; CELLS	Background: Psychological stress delays wound healing but the precise underlying mechanisms are unclear. Macrophages play an important role in wound healing, in particular by killing microbes. We hypothesized that (a) acute psychological stress reduces wound-induced activation of microbicidal potential of human monocyte-derived macrophages (HMDM), and (b) that these reductions are modulated by stress hormone release. Methods: Fourty-one healthy men (mean age 35 +/- 13 years) were randomly assigned to either a stress or stress-control group. While the stress group underwent a standardized short-term psychological stress task after catheter-induced wound infliction, stress-controls did not. Catheter insertion was controlled. Assessing the microbicidal potential, we investigated PMA-activated superoxide anion production by HMDM immediately before and 1, 10 and 60 min after stress/rest. Moreover, plasma norepinephrine and epinephrine and salivary cortisol were repeatedly measured. In subsequent in vitro studies, whole blood was incubated with norepinephrine in the presence or absence of phentolamine (norepinephrine blocker) before assessing HMDM microbicidal potential. Results: Compared with stress-controls, HMDM of the stressed subjects displayed decreased superoxide anion-responses after stress (p's<.05). Higher plasma norepinephrine levels statistically mediated lower amounts of superoxide anion-responses (indirect effect 95% CI: 4.14-44.72). Norepinephrine-treated HMDM showed reduced superoxide anion-production (p<.001). This effect was blocked by prior incubation with phentolamine. Conclusions: Our results suggest that acute psychological stress reduces wound-induced activation of microbicidal potential of HMDM and that this reduction is mediated by norepinephrine. This might have implications for stress-induced impairment in wound healing.	[Kuebler, Ulrike; Wirtz, Petra H.; Ehlert, Ulrike] Univ Zurich, Dept Clin Psychol & Psychotherapy, Zurich, Switzerland; [Wirtz, Petra H.] Univ Bern, Bern, Switzerland; [Sakai, Miho; Stemmer, Andreas] Swiss Fed Inst Technol, Nanotechnol Grp, Zurich, Switzerland	University of Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wirtz, PH (corresponding author), Univ Zurich, Dept Clin Psychol & Psychotherapy, Zurich, Switzerland.	petra.wirtz@psy.unibe.ch	Wirtz, Petra/G-6317-2011		Chocosuisse Foundation [2009]; Swiss National Science Foundation [PP00P1_128565/1]	Chocosuisse Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Chocosuisse Foundation Grant 2009 (to PHW) and by the Swiss National Science Foundation Grant PP00P1_128565/1 (to PHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemus M, 2001, J INVEST DERMATOL, V117, P309, DOI 10.1046/j.1523-1747.2001.01373.x; Atanackovic D, 2003, J NEUROIMMUNOL, V142, P159, DOI 10.1016/S0165-5728(03)00267-4; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blotta MH, 1997, J IMMUNOL, V158, P5589; Colton CA, 1996, NEUROCHEM INT, V29, P43, DOI 10.1016/0197-0186(95)00139-5; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Dunston CR, 2010, CLIN EXP IMMUNOL, V161, P407, DOI 10.1111/j.1365-2249.2010.04213.x; Ehrenreich H, 1997, ALCOHOL CLIN EXP RES, V21, P1285, DOI 10.1097/00000374-199710000-00019; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Ellard DR, 2001, INT J PSYCHOPHYSIOL, V41, P93, DOI 10.1016/S0167-8760(00)00180-X; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gouin JP, 2011, IMMUNOL ALLERGY CLIN, V31, P81, DOI 10.1016/j.iac.2010.09.010; Reyes-Garcia MG, 2009, J NEUROIMMUNOL, V216, P20, DOI 10.1016/j.jneuroim.2009.06.024; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Hunter M, 2009, FRONT BIOSCI-LANDMRK, V14, P4079, DOI 10.2741/3514; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Palermo-Neto J, 2003, BRAIN BEHAV IMMUN, V17, P43, DOI 10.1016/S0889-1591(02)00057-0; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Persoons JHA, 1997, AM J RESP CELL MOL, V17, P203, DOI 10.1165/ajrcmb.17.2.2466; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Robles TF, 2007, PSYCHOSOM MED, V69, P807, DOI 10.1097/PSY.0b013e318157b12e; Robles TF, 2009, HEALTH PSYCHOL, V28, P373, DOI 10.1037/a0014662; Sakai M, 2009, BIOSENS BIOELECTRON, V25, P68, DOI 10.1016/j.bios.2009.06.005; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Siddiqi M, 2001, CYTOMETRY, V46, P243, DOI 10.1002/cyto.1134; SMEDES F, 1982, J CHROMATOGR, V231, P25, DOI 10.1016/S0378-4347(00)80506-X; Stanojevic S, 2007, STRESS, V10, P65, DOI 10.1080/10253890601181289; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Stroncek J. D., 2008, OVERVIEW WOUND HEALI; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; van der Voort CR, 2000, J NEUROIMMUNOL, V108, P82, DOI 10.1016/S0165-5728(00)00253-8; VANDERPOLL T, 1994, INFECT IMMUN, V62, P2046, DOI 10.1128/IAI.62.5.2046-2050.1994; Verhoeckx KCM, 2005, J VET PHARMACOL THER, V28, P531, DOI 10.1111/j.1365-2885.2005.00691.x; Walburn J, 2009, J PSYCHOSOM RES, V67, P253, DOI 10.1016/j.jpsychores.2009.04.002; Wirtz PH, 2008, PSYCHONEUROENDOCRINO, V33, P1102, DOI 10.1016/j.psyneuen.2008.05.002; Wirtz PH, 2004, AM J HYPERTENS, V17, P489, DOI 10.1016/j.amjhyper.2004.01.010; Wlaschek M, 2005, WOUND REPAIR REGEN, V13, P452, DOI 10.1111/j.1067-1927.2005.00065.x; Woods JA, 2000, INT J SPORTS MED, V21, pS24	48	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55875	10.1371/journal.pone.0055875	http://dx.doi.org/10.1371/journal.pone.0055875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23431364	Green Published, Green Accepted, gold			2022-12-27	WOS:000314660300042
J	De Bock, M; Fillet, M; Hannon, M; Seidel, L; Merville, MP; Gothot, A; Beguin, Y; Baron, F				De Bock, Muriel; Fillet, Marianne; Hannon, Muriel; Seidel, Laurence; Merville, Marie-Paule; Gothot, Andre; Beguin, Yves; Baron, Frederic			Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; IMMUNE RECONSTITUTION; T-CELLS; HOMEOSTATIC PROLIFERATION; THYMIC OUTPUT; PLASMA-LEVELS; IN-VIVO; GRAFT; NAIVE	Background: We analysed kinetics of IL-7 and IL-15 levels in 70 patients given peripheral blood stem cells after nonmyeloablative conditioning. Methods: EDTA-anticoagulated plasma and serum samples were obtained before conditioning and about once per week after transplantation until day 100. Samples were aliquoted and stored at -80 degrees C within 3 hours after collection until measurement of cytokines. IL-7 and IL-15 levels were measured by ELISAs. Results: Median IL-7 plasma levels remained below 6 pg/L throughout the first 100 days, although IL-7 plasma levels were significantly higher on days 7 (5.1 pg/mL, P = 0.002), 14 (5.2 pg/mL, P<0.001), and 28 (5.1 pg/mL, P = 0.03) (but not thereafter) than before transplantation (median value of 3.8 pg/mL). Median IL-15 serum levels were significantly higher on days 7 (12.5 pg/mL, P<0.001), 14 (10.5 pg/mL, P<0.001), and 28 (6.2 pg/mL, P<0.001) than before transplantation (median value of 2.4 pg/mL). Importantly, IL-7 and IL-15 levels on days 7 or 14 after transplantation did not predict grade II-IV acute GVHD. Conclusions: These data suggest that IL-7 and IL-15 levels remain relatively low after nonmyeloablative transplantation, and that IL-7 and IL-15 levels early after nonmyeloablative transplantation do not predict for acute GVHD.	[De Bock, Muriel; Fillet, Marianne; Hannon, Muriel; Merville, Marie-Paule; Gothot, Andre; Beguin, Yves; Baron, Frederic] Univ Liege, Grp Interdisciplinaire Genoprote Appl GIGA I3, Liege, Belgium; [Seidel, Laurence] Univ Liege, Dept Stat, Liege, Belgium; [Beguin, Yves; Baron, Frederic] Univ Liege, Div Hematol, Dept Med, Liege, Belgium; [Beguin, Yves; Baron, Frederic] Ctr Hosp Univ CHU Liege, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Baron, F (corresponding author), Univ Liege, Grp Interdisciplinaire Genoprote Appl GIGA I3, Liege, Belgium.	f.baron@ulg.ac.be		Fillet, Marianne/0000-0002-1453-6282	FNRS; Belgian Foundation against Cancer (FBC); anti-cancer; Leon Fredericq foundations from the ULg; CHU of Liege; Terry Fox foundation	FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Foundation against Cancer (FBC); anti-cancer; Leon Fredericq foundations from the ULg; CHU of Liege; Terry Fox foundation	The study was in part supported by funds from the FNRS (http://www2.frs-fnrs.be/), the Belgian Foundation against Cancer (FBC) (http://www.cancer.be/), the anti-cancer (http://www.cac.ulg.ac.be/) and the Leon Fredericq foundations (http://www.fondsleonfredericq.be/) from the ULg, the CHU of Liege, and by the Terry Fox foundation (http://www.terryfox.org/). MdB and MH are Televie Research Fellows, and MPM and FB are Senior Research Associates at the National Fund for Scientific Research (FNRS) Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghosh A, 1999, BONE MARROW TRANSPL, V24, P535, DOI 10.1038/sj.bmt.1701921; Almawi WY, 2001, CELL TRANSPLANT, V10, P615, DOI 10.3727/000000001783986387; Alpdogan O, 2005, BLOOD, V105, P865, DOI 10.1182/blood-2003-09-3344; Alpdogan O, 2001, BLOOD, V98, P2256, DOI 10.1182/blood.V98.7.2256; Alves NL, 2003, BLOOD, V102, P2541, DOI 10.1182/blood-2003-01-0183; Bahceci E, 2003, BRIT J HAEMATOL, V122, P934, DOI 10.1046/j.1365-2141.2003.04522.x; Baron F, 2006, LEUKEMIA, V20, P1690, DOI 10.1038/sj.leu.2404335; Baron F, 2005, J CLIN ONCOL, V23, P1993, DOI 10.1200/JCO.2005.08.136; Baron F, 2004, BLOOD, V104, P2254, DOI 10.1182/blood-2004-04-1506; Baron F, 2012, LEUKEMIA, V26, P2462, DOI 10.1038/leu.2012.135; Baron F, 2003, TRANSPLANTATION, V76, P1705, DOI 10.1097/01.TP.0000093987.11389.F7; Baron F, 2006, BIOL BLOOD MARROW TR, V12, P1176, DOI 10.1016/j.bbmt.2006.07.004; Baron F, 2010, BIOL BLOOD MARROW TR, V16, P838, DOI 10.1016/j.bbmt.2010.01.011; Baron F, 2009, BIOL BLOOD MARROW TR, V15, P580, DOI 10.1016/j.bbmt.2009.01.018; Beq S, 2006, J IMMUNOL, V176, P914, DOI 10.4049/jimmunol.176.2.914; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Castermans E, 2008, HAEMATOLOGICA, V93, P240, DOI 10.3324/haematol.11708; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Clave E, 2009, BLOOD, V113, P6477, DOI 10.1182/blood-2008-09-176594; Crooks GM, 2006, BIOL BLOOD MARROW TR, V12, P42, DOI 10.1016/j.bbmt.2005.10.015; De Bock M, 2012, BIOL BLOOD MARROW TR, V18, pS275, DOI 10.1016/j.bbmt.2011.12.194; Dean RM, 2008, J CLIN ONCOL, V26, P5735, DOI 10.1200/JCO.2008.17.1314; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Fallen PR, 2003, BONE MARROW TRANSPL, V32, P1001, DOI 10.1038/sj.bmt.1704235; Federmann B, 2011, LEUKEMIA, V25, P121, DOI 10.1038/leu.2010.235; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Gress RE, 2010, BIOL BLOOD MARROW TR, V16, pS133, DOI 10.1016/j.bbmt.2009.10.003; Hagel LM, 2010, ASH ANN M, V116, P1271; Hazenberg MD, 2002, BLOOD, V99, P3449, DOI 10.1182/blood.V99.9.3449; Hochberg EP, 2001, BLOOD, V98, P1116, DOI 10.1182/blood.V98.4.1116; Huntington ND, 2011, P NATL ACAD SCI USA, V108, P6217, DOI 10.1073/pnas.1019167108; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Lange T, 2011, LEUKEMIA, V25, P498, DOI 10.1038/leu.2010.283; Lewin SR, 2002, BLOOD, V100, P2235, DOI 10.1182/blood.V100.6.2235.h81802002235_2235_2242; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; MARANINCHI D, 1987, LANCET, V2, P175; Miller JS, 2010, BIOL BLOOD MARROW TR, V16, P565, DOI 10.1016/j.bbmt.2010.02.005; Mohty M, 2007, HAEMATOLOGICA, V92, P1004, DOI 10.3324/haematol.10971; Peggs KS, 2006, CYTOTHERAPY, V8, P427, DOI 10.1080/14653240600851938; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Ram R, 2012, BIOL BLOOD MARROW TR, V18, P414, DOI 10.1016/j.bbmt.2011.08.016; Sandmaier BM, 2007, BIOL BLOOD MARROW TR, V13, P87, DOI 10.1016/j.bbmt.2006.10.015; Soiffer RJ, 2011, BLOOD, V117, P6963, DOI 10.1182/blood-2011-01-332007; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Storek J, 2003, BIOL BLOOD MARROW TR, V9, P781, DOI 10.1016/j.bbmt.2003.09.003; Storek J, 2003, BLOOD, V101, P4209, DOI 10.1182/blood-2002-08-2671; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Thiant S, 2011, BONE MARROW TRANSPL, V46, P1374, DOI 10.1038/bmt.2010.300; Thiant S, 2010, BONE MARROW TRANSPL, V45, P1546, DOI 10.1038/bmt.2010.13; Toubert A, 2012, TISSUE ANTIGENS, V79, P83, DOI 10.1111/j.1399-0039.2011.01820.x; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; Weinberg K, 2001, BLOOD, V97, P1458, DOI 10.1182/blood.V97.5.1458	60	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55876	10.1371/journal.pone.0055876	http://dx.doi.org/10.1371/journal.pone.0055876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437070	Green Published, gold			2022-12-27	WOS:000315186000010
J	Rempel, H; Sun, B; Calosing, C; Abadjian, L; Monto, A; Pulliam, L				Rempel, Hans; Sun, Bing; Calosing, Cyrus; Abadjian, Linda; Monto, Alexander; Pulliam, Lynn			Monocyte Activation in HIV/HCV Coinfection Correlates with Cognitive Impairment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MAGNETIC-RESONANCE-SPECTROSCOPY; HIV-INFECTION; MICROBIAL TRANSLOCATION; NEUROPSYCHOLOGICAL IMPAIRMENT; IMMUNE ACTIVATION; VIRAL-HEPATITIS; GENE-EXPRESSION	Coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) challenges the immune system with two viruses that elicit distinct immune responses. Chronic immune activation is a hallmark of HIV infection and an accurate indicator of disease progression. Suppressing HIV viremia by antiretroviral therapy (ART) effectively prolongs life and significantly improves immune function. HIV/HCV coinfected individuals have peripheral immune activation despite effective ART control of HIV viral load. Here we examined freshly isolated CD14 monocytes for gene expression using high-density cDNA microarrays and analyzed T cell subsets, CD4 and CD8, by flow cytometry to characterize immune activation in monoinfected HCV and HIV, and HIV-suppressed coinfected subjects. To determine the impact of coinfection on cognition, subjects were evaluated in 7 domains for neuropsychological performance, which were summarized as a global deficit score (GDS). Monocyte gene expression analysis in HIV-suppressed coinfected subjects identified 43 genes that were elevated greater than 2.5 fold. Correlative analysis of subjects' GDS and gene expression found eight genes with significance after adjusting for multiple comparisons. Correlative expression of six genes was confirmed by qPCR, five of which were categorized as type 1 IFN response genes. Global deficit scores were not related to plasma lipopolysaccharide levels. In the T cell compartment, coinfection significantly increased expression of activation markers CD38 and HLADR on both CD4 and CD8 T cells but did not correlate with GDS. These findings indicate that coinfection is associated with a type 1 IFN monocyte activation profile which was further found to correlate with cognitive impairment, even in subjects with controlled HIV infection. HIV-suppressed coinfected subjects with controlled HIV viral load experiencing immune activation could benefit significantly from successful anti-HCV therapy and may be considered as preferential candidates.	[Rempel, Hans; Sun, Bing; Calosing, Cyrus; Pulliam, Lynn] Vet Affairs Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA; [Abadjian, Linda] Vet Affairs Med Ctr, Dept Mental Hlth, San Francisco, CA 94121 USA; [Monto, Alexander] Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Monto, Alexander; Pulliam, Lynn] Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Pulliam, L (corresponding author), Vet Affairs Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA.	lynn.pulliam@ucsf.edu			National Institutes of Health [RO1 MH085538]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant to Lynn Pulliam from the National Institutes of Health [RO1 MH085538]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; Aronow HA, 2008, AIDS READ, V18, P43; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P125; Bower M, 2006, CURR OPIN INFECT DIS, V19, P14, DOI 10.1097/01.qco.0000200295.30285.13; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Clifford DB, 2009, NEUROLOGY, V73, P309, DOI 10.1212/WNL.0b013e3181af7a10; Crystal H, 2012, JAIDS-J ACQ IMM DEF, V59, P149, DOI 10.1097/QAI.0b013e318240566b; El Yakoubi W, 2012, STEM CELLS; Garvey LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038980; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hinkin CH, 2008, J ADDICT DIS, V27, P11, DOI 10.1300/J069v27n02_02; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kottilil S, 2009, HEPATOLOGY, V50, P34, DOI 10.1002/hep.23055; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; McAndrews MP, 2005, HEPATOLOGY, V41, P801, DOI 10.1002/hep.20635; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Nelson DR, 2012, ANN HEPATOL, V11, P15, DOI 10.1016/S1665-2681(19)31482-6; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Perry W, 2005, AIDS, V19, pS79, DOI 10.1097/01.aids.0000192074.18691.31; Pulliam L, 2004, J NEUROIMMUNOL, V157, P93, DOI 10.1016/j.jneuroim.2004.08.039; Pulliam L, 2011, AIDS, V25, P1721, DOI 10.1097/QAD.0b013e328349f022; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Santer DM, 2012, J IMMUNOL, V188, P902, DOI 10.4049/jimmunol.1102797; Schouten J, 2011, AIDS, V25, P561, DOI 10.1097/QAD.0b013e3283437f9a; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Steel A, 2008, HIV MED, V9, P118, DOI 10.1111/j.1468-1293.2007.00528.x; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Sun B, 2012, J ACQUIR IMMUNE DEFI; Sun B, 2010, J NEUROVIROL, V16, P115, DOI 10.3109/13550280903559789; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Vivithanaporn P, 2012, J NEUROL SCI, V312, P45, DOI 10.1016/j.jns.2011.08.025; Weissenborn K, 2004, J HEPATOL, V41, P845, DOI 10.1016/j.jhep.2004.07.022	51	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55776	10.1371/journal.pone.0055776	http://dx.doi.org/10.1371/journal.pone.0055776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437063	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000009
J	Reuss, DE; Mucha, J; Hagenlocher, C; Ehemann, V; Kluwe, L; Mautner, V; von Deimling, A				Reuss, David E.; Mucha, Jana; Hagenlocher, Christian; Ehemann, Volker; Kluwe, Lan; Mautner, Victor; von Deimling, Andreas			Sensitivity of Malignant Peripheral Nerve Sheath Tumor Cells to TRAIL Is Augmented by Loss of NF1 through Modulation of MYC/MAD and Is Potentiated by Curcumin through Induction of ROS	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; DRUG-INDUCED APOPTOSIS; OXYGEN SPECIES ROS; CANCER-CELLS; KAPPA-B; DEATH RECEPTOR-4; COLON CELLS; IN-VIVO; C-MYC; RAS	Malignant peripheral nerve sheath tumor (MPNST) is a rare aggressive form of sarcoma often associated with the tumor syndrome neurofibromatosis type 1 (NF1). We investigated the effects of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) on NF1 associated MPNST and determinants of TRAIL sensitivity. MPNST cell lines with complete neurofibromin deficiency were sensitive to apoptotic cell death induced by TRAIL whereas MPNST cells with retained neurofibromin expression or normal human Schwann cells were resistant. Increased sensitivity to TRAIL was associated with overexpression of death receptors, especially DR5. Re-expression of the GAP related domain of neurofibromin (NF1-GRD) suppressed DR5 expression and decreased sensitivity to TRAIL. We show that death receptor expression and TRAIL sensitivity critically depend on c-MYC and that c-MYC amounts are increased by MEK/ERK and PI3K/AKT signalling pathways which are suppressed by neurofibromin. Furthermore PI3K/AKT signalling strongly suppresses the MYC-antagonist MAD1 which significantly contributes to TRAIL sensitivity. Re-expression of the NF1-GRD decreased c-MYC and increased MAD1 amounts suggesting that neurofibromin influences TRAIL sensitivity at least in part by modulating the MYC/MAX/MAD network. The phytochemical curcumin further increased the sensitivity of neurofibromin deficient MPNST cells to TRAIL. This was presumably mediated by ROS, as it correlated with increased ROS production, was blocked by N-acetylcysteine and mimicked by exogenous ROS.	[Reuss, David E.; Mucha, Jana; Hagenlocher, Christian; von Deimling, Andreas] CCU Neuropathol German Canc Res Ctr DKFZ, Heidelberg, Germany; [Reuss, David E.; von Deimling, Andreas] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Kluwe, Lan; Mautner, Victor] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Ehemann, Volker] Heidelberg Univ, Inst Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	von Deimling, A (corresponding author), CCU Neuropathol German Canc Res Ctr DKFZ, Heidelberg, Germany.	andreas.vondeimling@med.uni-heidelberg.de	von Deimling, Andreas/F-7774-2013	von Deimling, Andreas/0000-0002-5863-540X	Bundesministerium fur Bildung und Forschung (BMBF) program rare diseases [01GM0841]	Bundesministerium fur Bildung und Forschung (BMBF) program rare diseases	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) program rare diseases (grant 01GM0841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony B, 2008, INDIAN J PHARM SCI, V70, P445, DOI 10.4103/0250-474X.44591; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Bisht S, 2010, MOL CANCER THER, V9, P2255, DOI 10.1158/1535-7163.MCT-10-0172; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bottillo I, 2009, J PATHOL, V217, P693, DOI 10.1002/path.2494; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Carroll SL, 2005, J NEUROPATH EXP NEUR, V64, P1; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Dubska L, 2005, FEBS LETT, V579, P4149, DOI 10.1016/j.febslet.2005.06.047; Ehemann V, 2003, CANCER LETT, V194, P125, DOI 10.1016/S0304-3835(03)00054-5; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Frahm S, 2004, NEUROBIOL DIS, V16, P85, DOI 10.1016/j.nbd.2004.01.006; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Hagel C, 2007, J NEURO-ONCOL, V82, P187, DOI 10.1007/s11060-006-9266-2; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hoogwater FJH, 2010, GASTROENTEROLOGY, V138, P2357, DOI 10.1053/j.gastro.2010.02.046; Jacquemin G, 2010, CELL MOL LIFE SCI, V67, P3115, DOI 10.1007/s00018-010-0407-6; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Kim KH, 2000, CLIN CANCER RES, V6, P335; Mellier G, 2012, FREE RADICAL RES, V46, P996, DOI 10.3109/10715762.2012.690514; Mitsiades N, 2001, CANCER RES, V61, P2704; Nesterov A, 2004, CANCER RES, V64, P3922, DOI 10.1158/0008-5472.CAN-03-2219; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Opel D, 2011, CLIN CANC RES; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Perry A, 2001, AM J PATHOL, V159, P57, DOI 10.1016/S0002-9440(10)61673-2; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Prasad S, 2011, CANCER RES, V71, P538, DOI 10.1158/0008-5472.CAN-10-3121; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sheikh MS, 2004, CELL CYCLE, V3, P920; Siegelin MD, 2009, NEURO-ONCOLOGY, V11, P122, DOI 10.1215/15228517-2008-085; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Subramaniam D, 2008, CANCER RES, V68, P1962, DOI 10.1158/0008-5472.CAN-07-6011; Sussman RT, 2007, CANCER BIOL THER, V6, P1490, DOI 10.4161/cbt.6.9.4905; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Upadhyaya M, 2008, HUM MUTAT, V29, P74, DOI [10.1002/humu.20601, 10.1002/humu.20793]; Upadhyaya M, 2004, HUM MUTAT, V23, P134, DOI 10.1002/humu.10305; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Webb J, 1963, ENZYMES METABOL INH, P487; ZHANG K, 1992, SCIENCE, V257, P671, DOI 10.1126/science.1496380; Zhu JD, 2008, P NATL ACAD SCI USA, V105, P6584, DOI 10.1073/pnas.0802785105	49	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57152	10.1371/journal.pone.0057152	http://dx.doi.org/10.1371/journal.pone.0057152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437333	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000080
J	Chen, HY; Luo, ZL; Dong, LW; Tan, YX; Yang, JM; Feng, GS; Wu, MC; Li, Z; Wang, HY				Chen, Haiyang; Luo, Zaili; Dong, Liwei; Tan, Yexiong; Yang, Jiamei; Feng, Gensheng; Wu, Mengchao; Li, Zhong; Wang, Hongyang			CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival	PLOS ONE			English	Article							CANCER STEM-CELLS; EXTRACELLULAR MEMBRANE-PARTICLES; HEPATOCELLULAR-CARCINOMA CELLS; TUMOR-INITIATING CELLS; SELF-RENEWAL; STEM/PROGENITOR CELLS; THERAPEUTIC TARGET; NEURAL PROGENITORS; MARKER PROMININ-1; CD133 EXPRESSION	CD133/Prominin-1 is a pentaspan transmembrane protein that has been frequently used as a biomarker for cancer stem cells, although its biological function is unclear. The aim of our study was to explore the intrinsic functions of CD133 membrane protein in hepatoma cells during autophagy, apoptosis, tumorigenesis and cell survival through expression or downregulation of CD133. In this study, CD133 was found to be dynamically released from plasma membrane into cytoplasm in both of complete medium(CM) and low glucose medium (LGM), and LGM promoted this translocation. Expression of CD133 enhanced autophagic activity in LGM, while silencing CD133 attenuated this activity in HCC LM3 and Huh-7 cells, suggesting that CD133 is associated with autophagy. Immunofluorescence and time-lapsed confocal techniques confirmed that CD133 was associated with autophagy marker, microtubule-associated protein light chain3 (LC3) and lysosome marker during the glucose starvation. We further found that Huh-7 cells with stable expression of shCD133 (Huh-7sh133) impaired the ability of cell proliferation and formation of xenograft tumors in the NOD/SCID mice. Although loss of CD133 did not affect the rates of glucose uptake in Huh-7con and Huh-7sh133 cells under the CM, Huh-7sh133 cells obviously died fast than Huh-7con cells in the LGM and decreased the rate of glucose uptake and ATP production. Furthermore, targeting CD133 by CD133mAb resulted in cell death in HepG2 cells, especially in the LGM, via inhibition of autophagic activity and increase of apoptosis. The results demonstrated that CD133 is involved in cell survival through regulation of autophagy and glucose uptake, which may be necessary for cancer stem cells to survive in tumor microenvironment.	[Chen, Haiyang; Luo, Zaili; Dong, Liwei; Tan, Yexiong; Li, Zhong; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Int Cooperat Lab Signal Transduct, Shanghai, Peoples R China; [Yang, Jiamei; Wu, Mengchao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Surg, Shanghai, Peoples R China; [Feng, Gensheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feng, Gensheng] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Li, Zhong] Zhengzhou Univ, Affiliated Hosp 3, Zhengzhou, Peoples R China; [Li, Zhong] Zhengzhou Univ, Coll Med, Zhengzhou, Peoples R China; [Wang, Hongyang] Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; University of California System; University of California San Diego; University of California System; University of California San Diego; Zhengzhou University; Zhengzhou University; Shanghai Jiao Tong University	Li, Z (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Int Cooperat Lab Signal Transduct, Shanghai, Peoples R China.	zhli@smmu.edu.cn; hywangk@vip.sina.com		Dong, Li-Wei/0000-0003-2116-1674	National Natural Science Foundation of China [81041070, 81272427, 30921006]; Eastern Hepatobiliary Surgery Hospital/Institute; Ministry of Science and Technology Key Program [2012ZX10002-009, 2012ZX10002-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Eastern Hepatobiliary Surgery Hospital/Institute; Ministry of Science and Technology Key Program	This work was supported by grants from the National Natural Science Foundation of China to Z. Li (81041070, 81272427), and HYW(30921006); the start-up fund of Eastern Hepatobiliary Surgery Hospital/Institute to Z. Li and the Ministry of Science and Technology Key Program to MCW, HYW(2012ZX10002-009, -011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Angelastro JM, 2010, MOL CANCER RES, V8, P1105, DOI 10.1158/1541-7786.MCR-09-0383; Bakondi B, 2011, STEM CELLS DEV, V20, P1021, DOI 10.1089/scd.2010.0198; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bourseau-Guilmain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025515; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20, DOI 10.1002/jlb.62.1.20; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Corbo C, 2012, PROTEOMICS, V12, P2045, DOI 10.1002/pmic.201100370; Damek-Poprawa M, 2011, J DENT RES, V90, P638, DOI 10.1177/0022034510393511; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Eskelinen EL, 2011, CURR OPIN PHARMACOL, V11, P294, DOI 10.1016/j.coph.2011.03.009; Fargeas CA, 2011, WORLD J GASTROENTERO, V17, P4149, DOI 10.3748/wjg.v17.i36.4149; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Fu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043204; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Lardon J, 2008, PANCREAS, V36, pE1, DOI 10.1097/mpa.0b013e318149f2dc; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Mak AB, 2012, CANCER RES, V72, P1929, DOI 10.1158/0008-5472.CAN-11-3589; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Oliver L, 2012, STEM CELLS DEV; Piao LS, 2012, CANCER LETT, V315, P129, DOI 10.1016/j.canlet.2011.10.012; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Rausch V, 2012, J PATHOL, V227, P325, DOI 10.1002/path.3994; Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith LM, 2008, BRIT J CANCER, V99, P100, DOI 10.1038/sj.bjc.6604437; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Vessoni AT, 2012, STEM CELLS DEV, V21, P513, DOI 10.1089/scd.2011.0526; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Yang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028405; Yang ZL, 2012, ONCOL LETT, V4, P75, DOI 10.3892/ol.2012.694; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang CS, 2011, ANN SURG ONCOL, V18, P2373, DOI 10.1245/s10434-011-1599-1; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhang LX, 2012, CANCER RES, V72, P4276, DOI 10.1158/0008-5472.CAN-12-1013; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zobalova R, 2008, BIOCHEM BIOPH RES CO, V373, P567, DOI 10.1016/j.bbrc.2008.06.073	57	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56878	10.1371/journal.pone.0056878	http://dx.doi.org/10.1371/journal.pone.0056878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437259	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200175
J	Francis, MP				Francis, Malcolm P.			Temporal and Spatial Patterns of Habitat Use by Juveniles of a Small Coastal Shark (Mustelus lenticulatus) in an Estuarine Nursery	PLOS ONE			English	Article							TERM MOVEMENT PATTERNS; SMOOTH DOGFISH; SITE FIDELITY; TOMALES BAY; REEF SHARKS; CONSERVATION; AREAS; ABUNDANCE; INDEXES; GROWTH	Juvenile rig (Mustelus lenticulatus) were internally tagged with acoustic transmitters and tracked with acoustic receivers deployed throughout two arms of Porirua Harbour, a small (7 km(2)) estuary in New Zealand. Ten rig were tracked for up to four months during summer-autumn to determine their spatial and temporal use of the habitat. The overall goal was to estimate the size of Marine Protected Areas required to protect rig nursery areas from direct human impacts. Rig showed clear site preferences, but those preferences varied among rig and over time. They spent most of their time in large basins and on shallow sand and mud flats around the margins, and avoided deep channels. Habitat range increased during autumn for many of the rig. Only one shark spent time in both harbour arms, indicating that there was little movement between the two. Rig home ranges were 2-7 km(2), suggesting that an effective MPA would need to cover the entire Porirua Harbour. They moved to outer harbour sites following some high river flow rates, and most left the harbour permanently during or soon after a river spike, suggesting that they were avoiding low salinity water. Rig showed strong diel movements during summer, although the diel pattern weakened in autumn. Persistent use of the same day and night sites indicates that diel movements are directed rather than random. Further research is required to determine the sizes of rig home ranges in larger harbours where nursery habitat is more extensive. Marine Protected Areas do not control land-based impacts such as accelerated sedimentation and heavy metal pollution, so integration of marine and terrestrial management tools across a range of government agencies is essential to fully protect nursery areas.	Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Francis, MP (corresponding author), Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand.	malcolm.francis@niwa.co.nz			New Zealand Ministry of Business, Innovation and Employment [C01X0502]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This study was funded by the New Zealand Ministry of Business, Innovation and Employment under research contract C01X0502. (http://www.msi.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Barnett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015464; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Blaschke P., 2010, PORIRUA HARBOUR ITS; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; Briggs I, 1980, UPPER WAITEMATA HARB; Bush A, 2003, ENVIRON BIOL FISH, V67, P1, DOI 10.1023/A:1024438706814; Campos BR, 2009, ENVIRON BIOL FISH, V85, P3, DOI 10.1007/s10641-009-9462-y; CASTERLIN ME, 1979, B MAR SCI, V29, P440; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Discovery Marine, 2009, POR HARB SURV REP SU; Edren SMC, 2005, ENVIRON BIOL FISH, V72, P267, DOI 10.1007/s10641-004-2583-4; Espinoza M, 2011, J EXP MAR BIOL ECOL, V401, P63, DOI 10.1016/j.jembe.2011.03.001; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Forch EC, 1983, THESIS VICTORIA U NZ; Francis M, 2012, NZ AQUAT ENV BIODIV; FRANCIS MP, 1980, NEW ZEAL J MAR FRESH, V14, P303, DOI 10.1080/00288330.1980.9515873; FRANCIS MP, 1992, AUST J MAR FRESH RES, V43, P1157; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Getzlaff C, 2012, THESIS MASSEY U PALM; Gibb J.G., 2009, PATTERNS RATES SEDIM; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2012, ECOSIM 7 72; Healy WB, 1980, DSIR INF SER; Hendry RT, 2004, ASSESSMENT SPATIAL E; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Heupel MR, 2005, MAR TECHNOL SOC J, V39, P10, DOI 10.4031/002533205787521749; Heupel MR, 2004, ENVIRON BIOL FISH, V71, P135, DOI 10.1023/B:EBFI.0000045710.18997.f7; Heupel MR, 2002, MAR FRESHWATER RES, V53, P543, DOI 10.1071/MF01132; Heupel MR, 2003, J FISH BIOL, V63, P1357, DOI 10.1046/j.1095-8649.2003.00250.x; Hurst RJ, 2000, ATLAS JUVENILE ADULT; Jones E, NZ AQUAT EN IN PRESS; JONES JB, 1985, NEW ZEAL J MAR FRESH, V19, P477, DOI 10.1080/00288330.1985.9516112; KING KJ, 1984, NEW ZEAL J MAR FRESH, V18, P21, DOI 10.1080/00288330.1984.9516025; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Knip DM, 2011, MAR FRESHWATER RES, V62, P658, DOI 10.1071/MF10136; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; LINTON LR, 1981, J ANIM ECOL, V50, P283, DOI 10.2307/4045; Lucifora LO, 2005, MAR ECOL PROG SER, V289, P237, DOI 10.3354/meps289237; Lucifora LO, 2006, MAR ECOL PROG SER, V315, P259, DOI 10.3354/meps315259; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Ministry of Fisheries, 2008, NZ NAT PLAN ACT CONS; Ministry of Fisheries Science Group, 2011, REP MIDY FISH UNPUB; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Rechisky EL, 2003, ENVIRON BIOL FISH, V68, P113, DOI 10.1023/B:EBFI.0000003820.62411.cb; RICKLEFS RE, 1980, ECOLOGY, V61, P1019, DOI 10.2307/1936817; Rountree RA, 1996, FISH B-NOAA, V94, P522; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Sokal R. R., 1981, BIOMETRY; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581	59	18	18	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57021	10.1371/journal.pone.0057021	http://dx.doi.org/10.1371/journal.pone.0057021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437298	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200201
J	Hannula-Jouppi, K; Massinen, S; Siljander, T; Makela, S; Kivinen, K; Leinonen, R; Jiao, H; Aitos, P; Karppelin, M; Vuopio, J; Syrjanen, J; Kere, J				Hannula-Jouppi, Katariina; Massinen, Satu; Siljander, Tuula; Makela, Siru; Kivinen, Katja; Leinonen, Rasko; Jiao, Hong; Aitos, Paivi; Karppelin, Matti; Vuopio, Jaana; Syrjanen, Jaana; Kere, Juha			Genetic Susceptibility to Non-Necrotizing Erysipelas/Cellulitis	PLOS ONE			English	Article							PROINFLAMMATORY RESPONSES; INFECTIOUS-DISEASES; PROSTAGLANDIN E-2; POLYMORPHISM; CELLULITIS; RECEPTOR; ASSOCIATION; EXPRESSION; BACTERIAL; LEPROSY	Background: Bacterial non-necrotizing erysipelas and cellulitis are often recurring, diffusely spreading infections of the skin and subcutaneous tissues caused most commonly by streptococci. Host genetic factors influence infection susceptibility but no extensive studies on the genetic determinants of human erysipelas exist. Methods: We performed genome-wide linkage with the 10,000 variant Human Mapping Array (HMA10K) array on 52 Finnish families with multiple erysipelas cases followed by microsatellite fine mapping of suggestive linkage peaks. A scan with the HMA250K array was subsequently performed with a subset of cases and controls. Results: Significant linkage was found at 9q34 (nonparametric multipoint linkage score (NPLall) 3.84, p = 0.026), which is syntenic to a quantitative trait locus for susceptibility to group A streptococci infections on chromosome 2 in mouse. Sequencing of candidate genes in the 9q34 region did not conclusively associate any to erysipelas/cellulitis susceptibility. Suggestive linkage (NPLall>3.0) was found at three loci: 3q22-24, 21q22, and 22q13. A subsequent denser genome scan with the HMA250K array supported the 3q22 locus, in which several SNPs in the promoter of AGTR1 (Angiotensin II receptor type I) suggestively associated with erysipelas/cellulitis susceptibility. Conclusions: Specific host genetic factors may cause erysipelas/cellulitis susceptibility in humans.	[Hannula-Jouppi, Katariina; Massinen, Satu; Makela, Siru; Aitos, Paivi; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Hannula-Jouppi, Katariina; Massinen, Satu; Makela, Siru; Aitos, Paivi; Kere, Juha] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Siljander, Tuula; Vuopio, Jaana] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Kivinen, Katja; Leinonen, Rasko; Jiao, Hong; Kere, Juha] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden; [Karppelin, Matti; Syrjanen, Jaana] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Syrjanen, Jaana] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kere, Juha] Karolinska Inst, Sci Life Lab, Huddinge, Sweden	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Karolinska Institutet; Tampere University; Tampere University Hospital; Tampere University; Karolinska Institutet	Hannula-Jouppi, K (corresponding author), Univ Helsinki, Dept Med Genet, Helsinki, Finland.	katariina.hannula@helsinki.fi	Hannula-Jouppi, Katariina SE/F-4476-2011; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Karppelin, Matti/0000-0002-7503-6900; Syrjanen, Jaana/0000-0002-7335-573X; Kivinen, Katja/0000-0002-1135-7625; Leinonen, Rasko/0000-0002-2639-7187; Hannula-Jouppi, Katariina/0000-0003-3864-2853	Academy of Finland/Microbes and Man Research Program; Helsinki Biomedical Graduate School; Sigrid Juselius Foundation; Swedish Research Council	Academy of Finland/Microbes and Man Research Program; Helsinki Biomedical Graduate School; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Academy of Finland/Microbes and Man Research Program, Helsinki Biomedical Graduate School, Sigrid Juselius Foundation, and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeltawab NF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000042; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aziz RK, 2007, GENES IMMUN, V8, P404, DOI 10.1038/sj.gene.6364402; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bjorndottir S, 2005, CLIN INFECT DIS, V41, P1416, DOI 10.1086/497127; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Burton EA, 2006, APPL ENVIRON MICROB, V72, P5043, DOI 10.1128/AEM.00558-06; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Doerschug KC, 2010, CRIT CARE, V14, DOI 10.1186/cc8887; Goldmann O, 2005, J IMMUNOL, V175, P3862, DOI 10.4049/jimmunol.175.6.3862; Goldmann O, 2010, J IMMUNOL, V185, P2372, DOI 10.4049/jimmunol.1000838; Gu JJ, 2009, IMMUNOL REV, V228, P170, DOI 10.1111/j.1600-065X.2008.00751.x; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Jobin MC, 2006, MICROB PATHOGENESIS, V40, P29, DOI 10.1016/j.micpath.2005.10.003; Karppelin M, 2010, CLIN MICROBIOL INFEC, V16, P729, DOI 10.1111/j.1469-0691.2009.02906.x; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; MacKenzie A, 2011, PHARMACOL THERAPEUT, V131, P187, DOI 10.1016/j.pharmthera.2010.11.001; Maloney CG, 2000, J LEUKOCYTE BIOL, V67, P615, DOI 10.1002/jlb.67.5.615; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; McNamara DR, 2007, ARCH INTERN MED, V167, P709, DOI 10.1001/archinte.167.7.709; Medina Eva, 2005, Briefings in Functional Genomics & Proteomics, V4, P248, DOI 10.1093/bfgp/4.3.248; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Nakada T, 2011, CRIT CARE MED, V39, P1641, DOI 10.1097/CCM.0b013e318218665a; Nooh MM, 2011, J IMMUNOL, V186, P3156, DOI 10.4049/jimmunol.1002057; Palatini P, 2009, AM J HYPERTENS, V22, P208, DOI 10.1038/ajh.2008.319; Pavlotsky Felix, 2004, J Dtsch Dermatol Ges, V2, P89, DOI 10.1046/j.1439-0353.2004.03028.x; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Saha S, 2005, AM J PHYSIOL-REG I, V288, pR1100, DOI 10.1152/ajpregu.00872.2004; Sato H, 1998, LUPUS, V7, P530, DOI 10.1191/096120398678920622; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Siljander T, 2008, CLIN INFECT DIS, V46, P855, DOI 10.1086/527388; Stelnicki EJ, 1998, J INVEST DERMATOL, V111, P57, DOI 10.1046/j.1523-1747.1998.00238.x; Suchankova P, 2009, REGUL PEPTIDES, V152, P28, DOI 10.1016/j.regpep.2008.11.001; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Toivonen HTT, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P99, DOI 10.1109/BIBE.2000.889596; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Vasku V, 2000, ARCH DERMATOL RES, V292, P531, DOI 10.1007/s004030000176; Wang B, 1997, INFECT IMMUN, V65, P2119, DOI 10.1128/IAI.65.6.2119-2126.1997	49	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56225	10.1371/journal.pone.0056225	http://dx.doi.org/10.1371/journal.pone.0056225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437094	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200046
J	Haugaard, LK; Ajslev, TA; Zimmermann, E; Angquist, L; Sorensen, TIA				Haugaard, Line K.; Ajslev, Teresa A.; Zimmermann, Esther; Angquist, Lars; Sorensen, Thorkild I. A.			Being an Only or Last-Born Child Increases Later Risk of Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; BIRTH-ORDER; OVERWEIGHT; ASSOCIATION; WEIGHT; HEIGHT; COHORT; SIZE	Background: Studies have suggested that number of siblings and birth order is associated with obesity. However, studies combining these exposures are needed. This study aimed at investigating obesity in children and young adults in regard to different combinations of family size and birth order. Methods: Two cohorts selected from the general population were investigated: The Copenhagen School Health Records Register (CSHRR) and a Draft Board (DB) sample with measured heights and weights in childhood (age 13 years) and young adulthood (age 19 years), respectively. Information on birth order, number of siblings, and relevant covariates were available on 29 327 children, as well as on 323 obese young men and 575 randomly selected controls of young men representing approximately 58 000. The relation between number of siblings and birth order, respectively, and having a Body Mass Index (BMI) z-score above or equal to the 95th percentile in childhood or having a BMI of at least 31.00 kg/m(2) in young adulthood was analysed using logistic regression analyses adjusted for relevant confounders. Results: Only children had significantly higher odds of obesity both in childhood and in young adulthood compared with children with siblings, odds ratio (OR) = 1.44 (95% Confidence Interval (CI): 1.26-1.66) and OR = 1.76 (95% CI: 1.18-2.61), respectively. No association between first-born status and obesity was found. The OR of last-born children being obese was also significantly increased in childhood, e. g. OR = 1.93 (95% CI: 1.0923.43) of obesity if last-born in a family of four children. This was not found in young adulthood. Additionally, higher spacing to previous sibling (average 1872 vs. 1303 days; p = 0.026 in four children families) was observed in obese last-born compared to non-obese last-born children. Conclusion: Being an only or last-born child is associated with obesity. These associations may provide leads to targeted prevention of obesity in children.	[Haugaard, Line K.; Ajslev, Teresa A.; Zimmermann, Esther; Angquist, Lars; Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Haugaard, Line K.; Ajslev, Teresa A.; Zimmermann, Esther; Angquist, Lars; Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen	Ajslev, TA (corresponding author), Frederiksberg Univ Hosp, Inst Prevent Med, Frederiksberg, Denmark.	teresa.ajslev@regionh.dk		Zimmermann, Esther/0000-0001-5854-0542; Gjaerde, Line Klingen/0000-0001-6894-1024; Angquist, Lars/0000-0002-9516-4424	University Graduate Center - Food, Fitness and Pharma program through the Danish Strategic Research Council	University Graduate Center - Food, Fitness and Pharma program through the Danish Strategic Research Council	This study has been funded by the University Graduate Center - Food, Fitness and Pharma program through the Danish Strategic Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; BELMONT L, 1973, SCIENCE, V182, P1096, DOI 10.1126/science.182.4117.1096; Bruch H, 1940, PSYCHOSOM MED, V2, P141, DOI 10.1097/00006842-194004000-00005; Chen AY, 2010, PREV CHRONIC DIS, V7; CHRISTENSEN U, 1981, HUM BIOL, V53, P403; Dahly DL, 2010, INT J OBESITY, V34, P751, DOI 10.1038/ijo.2009.275; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Hunsberger M, 2012, NUTR DIABETES, V2, DOI 10.1038; Jappe E, 2005, FORAELDREMYNDIGHED S; Knudsen LB, 1998, DAN MED BULL, V45, P221; Knudsen LB, 1993, BEFOLKNING VALG STAT, V44; Kopelman P, 2007, OBES REV, V8, pVI; Lesthaeghe R, 2010, POPUL DEV REV, V36, P211, DOI 10.1111/j.1728-4457.2010.00328.x; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; RAVELLI GP, 1979, AM J EPIDEMIOL, V109, P66, DOI 10.1093/oxfordjournals.aje.a112660; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Shaw C, 1999, Popul Trends, P7; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; SONNEHOLM S, 1977, J CHRON DIS, V30, P351, DOI 10.1016/0021-9681(77)90029-7; SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795; SORENSEN TIA, 1988, AM J EPIDEMIOL, V127, P104, DOI 10.1093/oxfordjournals.aje.a114770; SORENSEN TIA, 1977, J CHRON DIS, V30, P359, DOI 10.1016/0021-9681(77)90030-3; Stenhammar C, 2010, ACTA PAEDIATR, V99, P1205, DOI 10.1111/j.1651-2227.2010.01776.x; Trombini E, 2003, PERCEPT MOTOR SKILL, V97, P613, DOI 10.2466/PMS.97.5.613-620; Wang HB, 2007, PREV MED, V44, P45, DOI 10.1016/j.ypmed.2006.07.015; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008	32	40	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56357	10.1371/journal.pone.0056357	http://dx.doi.org/10.1371/journal.pone.0056357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437116	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200061
J	McBride, S; Huelse, M; Lee, M				McBride, Sebastian; Huelse, Martin; Lee, Mark			Identifying the Computational Requirements of an Integrated Top-Down-Bottom-Up Model for Overt Visual Attention within an Active Vision System	PLOS ONE			English	Article							PARIETAL CORTEX; SUPERIOR COLLICULUS; PRIORITY MAP; INHIBITION; SALIENCE; IDENTIFICATION; PERCEPTION; SEARCH; MEMORY; RETURN	Computational visual attention systems have been constructed in order for robots and other devices to detect and locate regions of interest in their visual world. Such systems often attempt to take account of what is known of the human visual system and employ concepts, such as 'active vision', to gain various perceived advantages. However, despite the potential for gaining insights from such experiments, the computational requirements for visual attention processing are often not clearly presented from a biological perspective. This was the primary objective of this study, attained through two specific phases of investigation: 1) conceptual modeling of a top-down-bottom-up framework through critical analysis of the psychophysical and neurophysiological literature, 2) implementation and validation of the model into robotic hardware (as a representative of an active vision system). Seven computational requirements were identified: 1) transformation of retinotopic to egocentric mappings, 2) spatial memory for the purposes of medium-term inhibition of return, 3) synchronization of 'where' and 'what' information from the two visual streams, 4) convergence of top-down and bottom-up information to a centralized point of information processing, 5) a threshold function to elicit saccade action, 6) a function to represent task relevance as a ratio of excitation and inhibition, and 7) derivation of excitation and inhibition values from object-associated feature classes. The model provides further insight into the nature of data representation and transfer between brain regions associated with the vertebrate 'active' visual attention system. In particular, the model lends strong support to the functional role of the lateral intraparietal region of the brain as a primary area of information consolidation that directs putative action through the use of a 'priority map'.	[McBride, Sebastian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Huelse, Martin; Lee, Mark] Abersytwyth Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales	University of Cambridge; Aberystwyth University	McBride, S (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	sdm47@cam.ac.uk			EC; UK EPSRC [EP/C516303/1]; Engineering and Physical Sciences Research Council [EP/C516303/1] Funding Source: researchfish	EC(European CommissionEuropean Commission Joint Research Centre); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EC-FP7 projects IMCLeVeR and ROSSI and through UK EPSRC grant EP/C516303/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley RJ, 2006, VISION RES, V46, P2824, DOI 10.1016/j.visres.2006.02.024; Bendiksby MS, 2006, NEUROPSYCHOLOGIA, V44, P2411, DOI 10.1016/j.neuropsychologia.2006.04.011; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CASAGRANDE VA, 1972, SCIENCE, V177, P444, DOI 10.1126/science.177.4047.444; Chao F, 2010, ROBOT AUTON SYST, V58, P239, DOI 10.1016/j.robot.2009.08.002; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Falkner AL, 2010, J NEUROSCI, V30, P12787, DOI 10.1523/JNEUROSCI.2327-10.2010; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Foulsham T, 2007, PERCEPTION, V36, P1123, DOI 10.1068/p5659; Foulsham T, 2011, COGN COMPUT, V3, P48, DOI 10.1007/s12559-010-9069-9; Fuchs I, 2011, COGN COMPUT, V3, P25, DOI 10.1007/s12559-010-9062-3; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb J, 2009, VISION RES, V49, P1216, DOI 10.1016/j.visres.2008.03.023; Grabenhorst F, 2010, J NEUROPHYSIOL, V104, P1649, DOI 10.1152/jn.00352.2010; Hooge ITC, 2005, VISION RES, V45, P1901, DOI 10.1016/j.visres.2005.01.030; Hulse M, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON DEVELOPMENT AND LEARNING (ICDL); Hulse M, 2010, IEEE T AUTON MENT DE, V2, P355, DOI 10.1109/TAMD.2010.2081667; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Jacob M, 2011, COGN COMPUT, V3, P105, DOI 10.1007/s12559-010-9084-x; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Li L, 2010, BRAIN RES, V1344, P173, DOI 10.1016/j.brainres.2010.05.016; Ludwig CJH, 2009, COGNITIVE PSYCHOL, V59, P180, DOI 10.1016/j.cogpsych.2009.04.002; Macaluso E, 2003, EXP BRAIN RES, V149, P62, DOI 10.1007/s00221-002-1335-y; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; Mevorach C, 2010, J NEUROSCI, V30, P6072, DOI 10.1523/JNEUROSCI.0241-10.2010; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Mital PK, 2011, COGN COMPUT, V3, P5, DOI 10.1007/s12559-010-9074-z; Monosov IE, 2010, P NATL ACAD SCI USA, V107, P13105, DOI 10.1073/pnas.1002870107; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Platt ML, 2004, METH NE FRO NEUROSCI, P1; Rebhan S, 2011, COGN COMPUT, V3, P124, DOI 10.1007/s12559-010-9077-9; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Smith TJ, 2009, VIS COGN, V17, P1083, DOI 10.1080/13506280802678557; Stein Barry E., 1991, P85; Stein BE, 2009, HEARING RES, V258, P4, DOI 10.1016/j.heares.2009.03.012; Stein BE, 2002, NEUROSCIENTIST, V8, P306, DOI 10.1177/107385840200800406; Stottinger E, 2010, EXP BRAIN RES, V202, P79, DOI 10.1007/s00221-009-2114-9; Striemer C, 2009, NEUROPSYCHOLOGIA, V47, P1491, DOI 10.1016/j.neuropsychologia.2008.12.021; Tatler B, 2008, INT J PSYCHOL, V43, P37; Theeuwes J, 2006, PSYCHON B REV, V13, P608, DOI 10.3758/BF03193970; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; WESTWOOD DA, 2009, OXFORD HDB HUMAN ACT, P88; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Zylberberg A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.004.2009	51	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54585	10.1371/journal.pone.0054585	http://dx.doi.org/10.1371/journal.pone.0054585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437044	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200009
J	Napoli, N; Strollo, R; Pitocco, D; Bizzarri, C; Maddaloni, E; Maggi, D; Manfrini, S; Schwartz, A; Pozzilli, P				Napoli, Nicola; Strollo, Rocky; Pitocco, Dario; Bizzarri, Carla; Maddaloni, Ernesto; Maggi, Daria; Manfrini, Silvia; Schwartz, Ann; Pozzilli, Paolo		IMDIAB Grp	Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; BETA-CELL FUNCTION; INSULIN REQUIREMENT; BIOCHEMICAL MARKERS; SERUM OSTEOCALCIN; HEALTHY-CHILDREN; PLASMA-GLUCOSE; HIP-FRACTURES; MINERAL MASS; FAT MASS	Background: Vitamin D supplementation in childhood improves the achievement of peak bone mass. We investigated the effect of supplementation with calcitriol on bone turnover in recent-onset type 1 diabetes (T1D). Moreover, the association between osteocalcin and parameters of beta-cell function and metabolic control was examined. Methodology/Principal Findings: We conducted a post-hoc analysis of a double-blind, placebo-controlled study of calcitriol supplementation to preserve beta-cell function. 27 recent-onset T1D subjects, mean age 22 years, were randomized to 0.25 mu g calcitriol per day or placebo (1:1) and followed up for one year. Changes in bone formation (osteoclacin) and resorption (beta-CrossLaps) markers, and differences between placebo and calcitriol-treated group were evaluated. At baseline, osteocalcin levels were significantly lower in female than in male patients (P<0.01) while no other metabolic parameters as HbA1c and C-peptide differed between gender. No significant correlations were found in relation to HbA1c, insulin requirement and C-peptide. At 1 year follow-up, no significant differences were observed between calcitriol and placebo groups for osteocalcin and beta-CrossLaps. In the placebo group osteocalcin levels were unrelated with parameters of metabolic control, such as C-peptide, insulin requirement or HbA1c. Changes of C-peptide, insulin requirement and HbA1c were not related to osteocalcin levels. Conclusions: Supplementation with 0.25 mu g calcitriol per day to patients with new-onset T1D does not affect circulating markers of bone turnover. OC levels were unrelated to beta-cell function and other metabolic parameters suggesting that OC is ineffective to control pancreatic function in presence of aggressive autoimmune destruction.	[Napoli, Nicola; Strollo, Rocky; Maddaloni, Ernesto; Maggi, Daria; Manfrini, Silvia; Pozzilli, Paolo] Univ Campus Biomed, Dept Endocrinol & Diabet, Rome, Italy; [Napoli, Nicola] Washington Univ, Div Bone & Mineral Dis, St Louis, MO USA; [Strollo, Rocky] Univ London, Barts & London Sch Med, William Harvey Res Inst, Bone & Joint Res Unit, London, England; [Pitocco, Dario] Catholic Univ, Rome, Italy; [Bizzarri, Carla] Bambino Gesu Pediat Hosp, Rome, Italy; [Schwartz, Ann] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Pozzilli, Paolo] Univ London, Barts & London Sch Med, Ctr Diabet, London, England	University Campus Bio-Medico - Rome Italy; Washington University (WUSTL); University of London; Queen Mary University London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Bambino Gesu; University of California System; University of California San Francisco; University of London; Queen Mary University London	Pozzilli, P (corresponding author), Univ Campus Biomed, Dept Endocrinol & Diabet, Rome, Italy.	p.pozzilli@unicampus.it	Maddaloni, Ernesto/N-1891-2014; Strollo, Rocky/K-5015-2016; Buzzetti, Raffaella/K-3090-2016; Pitocco, Dario/K-4210-2018; palermo, andrea/D-7406-2015; Bizzarri, Carla/AAI-2429-2019; Napoli, Nicola/K-8242-2016	Maddaloni, Ernesto/0000-0003-3844-9463; Strollo, Rocky/0000-0001-8967-7613; Buzzetti, Raffaella/0000-0003-1490-6041; palermo, andrea/0000-0002-1143-4926; Bizzarri, Carla/0000-0002-5616-9185; Pozzilli, Paolo/0000-0001-5090-636X; Napoli, Nicola/0000-0002-3091-8205; Pitocco, Dario/0000-0002-6220-686X; cavallo, maria gisella/0000-0001-6630-8049	Ministero Universita e Ricerca Scientifica (Progetti di Interesse Nazionale PRIN)	Ministero Universita e Ricerca Scientifica (Progetti di Interesse Nazionale PRIN)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from Ministero Universita e Ricerca Scientifica (Progetti di Interesse Nazionale PRIN) to Paolo Pozzilli, P.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT F, 1948, J CLIN ENDOCRINOL, V8, P637, DOI 10.1210/jcem-8-8-637; Bizzarri C, 2010, DIABETES CARE, V33, P1962, DOI [10.2337/dc10-0814, 10.2337/dc10-1168]; Bock G, 2011, DIABETES-METAB RES, V27, P942, DOI 10.1002/dmrr.1276; Brandao FR, 2007, DIABETES RES CLIN PR, V78, P334, DOI 10.1016/j.diabres.2007.04.009; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; El-Hajj Fuleihan G, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210/jc.2005-1436; Fares JE, 2003, BONE, V33, P242, DOI 10.1016/S8756-3282(03)00160-1; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Iki M, 2012, OSTEOPOROSIS INT, V23, P761, DOI 10.1007/s00198-011-1600-7; Kanazawa I, 2011, OSTEOPOROSIS INT, V22, P187, DOI 10.1007/s00198-010-1184-7; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leger J, 2006, J CLIN ENDOCR METAB, V91, P3947, DOI 10.1210/jc.2006-0711; Lehtonen-Veromaa MKM, 2002, AM J CLIN NUTR, V76, P1446, DOI 10.1093/ajcn/76.6.1446; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007/BF00403372; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030; Oz SG, 2006, J NATL MED ASSOC, V98, P1598; Pater A, 2010, J PEDIATR ENDOCR MET, V23, P81; Peppone LJ, 2010, OSTEOPOROSIS INT, V21, P1133, DOI 10.1007/s00198-009-1136-2; Pozzilli P, 2005, HORM METAB RES, V37, P680, DOI 10.1055/s-2005-870578; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Schou AJ, 2003, ACTA PAEDIATR, V92, P797, DOI 10.1080/08035250310002984; Szulc P, 2000, OSTEOPOROSIS INT, V11, P281, DOI 10.1007/s001980070116; Thrailkill KM, 2012, OSTEOPOROSIS INT, V23, P1799, DOI 10.1007/s00198-011-1807-7; Thrailkill KM, 2005, DIABETES, V54, P2875, DOI 10.2337/diabetes.54.10.2875; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Viljakainen HT, 2006, J BONE MINER RES, V21, P836, DOI 10.1359/JBMR.060302; Walter M, 2010, DIABETES CARE, V33, P1443, DOI 10.2337/dc09-2297; Winzenberg T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7254; Zamora SA, 1999, J CLIN ENDOCR METAB, V84, P4541, DOI 10.1210/jc.84.12.4541; Zhou M, 2009, EUR J ENDOCRINOL, V161, P723, DOI 10.1530/EJE-09-0585	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56488	10.1371/journal.pone.0056488	http://dx.doi.org/10.1371/journal.pone.0056488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437144	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200083
J	Starosta, S; Gunturkun, O; Stuttgen, MC				Starosta, Sarah; Guentuerkuen, Onur; Stuettgen, Maik C.			Stimulus-Response-Outcome Coding in the Pigeon Nidopallium Caudolaterale	PLOS ONE			English	Article							AVIAN PREFRONTAL CORTEX; NEOSTRIATUM CAUDOLATERALE; DOPAMINE; LESIONS; REPRESENTATION; MICRODRIVE; STRIATUM; REVERSAL; AFFERENT; DEFICITS	A prerequisite for adaptive goal-directed behavior is that animals constantly evaluate action outcomes and relate them to both their antecedent behavior and to stimuli predictive of reward or non-reward. Here, we investigate whether single neurons in the avian nidopallium caudolaterale (NCL), a multimodal associative forebrain structure and a presumed analogue of mammalian prefrontal cortex, represent information useful for goal-directed behavior. We subjected pigeons to a go-nogo task, in which responding to one visual stimulus (S+) was partially reinforced, responding to another stimulus (S-) was punished, and responding to test stimuli from the same physical dimension (spatial frequency) was inconsequential. The birds responded most intensely to S+, and their response rates decreased monotonically as stimuli became progressively dissimilar to S+; thereby, response rates provided a behavioral index of reward expectancy. We found that many NCL neurons' responses were modulated in the stimulus discrimination phase, the outcome phase, or both. A substantial fraction of neurons increased firing for cues predicting non-reward or decreased firing for cues predicting reward. Interestingly, the same neurons also responded when reward was expected but not delivered, and could thus provide a negative reward prediction error or, alternatively, signal negative value. In addition, many cells showed motor-related response modulation. In summary, NCL neurons represent information about the reward value of specific stimuli, instrumental actions as well as action outcomes, and therefore provide signals useful for adaptive behavior in dynamically changing environments.	[Starosta, Sarah; Guentuerkuen, Onur; Stuettgen, Maik C.] Ruhr Univ Bochum, Fac Psychol, Dept Biopsychol, Bochum, Germany	Ruhr University Bochum	Stuttgen, MC (corresponding author), Ruhr Univ Bochum, Fac Psychol, Dept Biopsychol, Bochum, Germany.	maik.stuettgen@rub.de	Stüttgen, Maik C./K-1494-2019	Stüttgen, Maik C./0000-0002-7031-262X; Gunturkun, Onur/0000-0003-4173-5233	German Research Foundation (DFG) [STU 544/1-1, SFB 874]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by grants from the German Research Foundation (DFG) to MCS (STU 544/1-1) and OG (SFB 874). The website of the DFG is http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Bast T, 2002, J COMP NEUROL, V446, P58, DOI 10.1002/cne.10187; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Bilkey DK, 2003, METHODS, V30, P152, DOI 10.1016/S1046-2023(03)00076-8; Bilkey DK, 1999, J NEUROSCI METH, V92, P87, DOI 10.1016/S0165-0270(99)00102-8; BLOUGH DS, 1975, J EXP PSYCHOL-ANIM B, V104, P3, DOI 10.1037/0097-7403.1.1.3; BLOUGH DS, 1967, SCIENCE, V158, P940, DOI 10.1126/science.158.3803.940; BROWN PL, 1968, J EXP ANAL BEHAV, V11, P1, DOI 10.1901/jeab.1968.11-1; Browning R, 2011, EUR J NEUROSCI, V33, P726, DOI 10.1111/j.1460-9568.2010.07540.x; Diekamp B, 2002, J NEUROSCI, V22, P9573; Diekamp B, 2002, J NEUROSCI, V22; DIVAC I, 1985, BRAIN RES, V332, P365, DOI 10.1016/0006-8993(85)90606-7; Durstewitz D, 1999, PROG NEUROBIOL, V59, P161, DOI 10.1016/S0301-0082(98)00100-2; EPSTEIN R, 1984, NATURE, V308, P61, DOI 10.1038/308061a0; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GOODALE MA, 1983, BRAIN BEHAV EVOLUT, V22, P22, DOI 10.1159/000121504; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Gunturkun O, 2012, PSYCHOL RES-PSYCH FO, V76, P212, DOI 10.1007/s00426-011-0377-9; Gunturkun O, 2005, CURR OPIN NEUROBIOL, V15, P686, DOI 10.1016/j.conb.2005.10.003; Gunturkun O, 1997, J BRAIN RES, V38, P133; GUTTMAN N, 1956, J EXP PSYCHOL, V51, P79, DOI 10.1037/h0046219; Hartmann B, 1998, BEHAV BRAIN RES, V96, P125, DOI 10.1016/S0166-4328(98)00006-0; Hentschke H, 2011, EUR J NEUROSCI; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; HONIG WK, 1962, J EXP PSYCHOL, V64, P239, DOI 10.1037/h0048290; JENKINS HM, 1973, J EXP ANAL BEHAV, V20, P163, DOI 10.1901/jeab.1973.20-163; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kalt T, 1999, BRAIN RES, V839, P263, DOI 10.1016/S0006-8993(99)01727-8; Karakuyu D, 2007, EUR J NEUROSCI, V26, P2293, DOI 10.1111/j.1460-9568.2007.05840.x; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kirsch JA, 2009, BEHAV BRAIN RES, V198, P214, DOI 10.1016/j.bbr.2008.11.010; Kroner S, 1999, J COMP NEUROL, V407, P228, DOI 10.1002/(SICI)1096-9861(19990503)407:2<228::AID-CNE6>3.0.CO;2-2; Lissek S, 2005, BEHAV NEUROSCI, V119, P797, DOI 10.1037/0735-7044.119.3.797; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mazur JE, 2006, J EXP ANAL BEHAV, V85, P275, DOI 10.1901/jeab.2006.65-05; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; Milmine M, 2008, BEHAV NEUROSCI, V122, P199, DOI 10.1037/0735-7044.122.1.199; MOGENSEN J, 1982, BRAIN BEHAV EVOLUT, V21, P60, DOI 10.1159/000121617; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Rose J, 2005, PLOS BIOL, V3, P1139, DOI 10.1371/journal.pbio.0030190; Rose J, 2008, J NEUROSCI METH, V175, P104, DOI 10.1016/j.jneumeth.2008.08.006; Scarf D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014589; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Stuttgen MC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00125; Stuttgen MC, 2011, J EXP ANAL BEHAV, V96, P155, DOI 10.1901/jeab.2011.96-155; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Wallis JD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00124	55	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57407	10.1371/journal.pone.0057407	http://dx.doi.org/10.1371/journal.pone.0057407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437383	Green Published, gold			2022-12-27	WOS:000315184200253
J	Teng, Z; Wang, L; Cai, S; Yu, P; Wang, J; Gong, J; Liu, YP				Teng, Zan; Wang, Lei; Cai, Shuang; Yu, Ping; Wang, Jin; Gong, Jing; Liu, Yunpeng			The 677C > T (rs1801133) Polymorphism in the MTHFR Gene Contributes to Colorectal Cancer Risk: A Meta-Analysis Based on 71 Research Studies	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE-REDUCTASE C677T; GREATER-THAN T; AGE-OF-ONSET; COLON-CANCER; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; DNA METHYLATION; COMMON MUTATION; FUNCTIONAL POLYMORPHISM; A1298C POLYMORPHISMS; METABOLIZING ENZYMES	Background: The 677C>T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene is considered to have a significant effect on colorectal cancer susceptibility, but the results are inconsistent. In order to investigate the association between the MTHFR 677C>T polymorphism and the risk of colorectal cancer, a meta-analysis was held based on 71 published studies. Methods: Eligible studies were identified through searching the MEDLINE, EMBASE, PubMed, Web of Science, Chinese Biomedical Literature database (CBM) and CNKI database. Odds ratios (OR) and 95% confidence intervals (CIs) were used to assess the association. The statistical heterogeneity across studies was examined with x(2)-based Q-test. Begg's and Egger's test were also carried out to evaluate publication bias. Sensitive and subgroup analysis were also held in this meta-analysis. Results: Overall, 71 publications including 31,572 cases and 44,066 controls were identified. The MTHFR 677 C>T variant genotypes are significantly associated with increased risk of colorectal cancer. In the stratified analysis by ethnicity, significantly increased risks were also found among Caucasians for CC vs TT (OR = 1.076; 95% CI = 1.008-1.150; I-2 = 52.3%), CT vs TT (OR = 1.102; 95% CI = 1.032-1.177; I-2 = 51.4%) and dominant model (OR = 1.086; 95% CI = 1.021-1.156; I-2 = 53.6%). Asians for CC vs TT (OR = 1.226; 95% CI = 1.116-1.346; I-2 = 55.3%), CT vs TT (OR = 1.180; 95% CI = 1.079-1.291; I-2 = 36.2%), recessive (OR = 1.069; 95% CI = 1.003-1.140; I-2 = 30.9%) and dominant model (OR = 1.198; 95% CI = 1.101-1.303; I-2 = 52.4%), and Mixed populations for CT vs TT (OR = 1.142; 95% CI = 1.005-1.296; I-2 = 0.0%). However, no associations were found in Africans for all genetic models. Conclusion: This meta-analysis suggests that the MTHFR 677C>T polymorphism increases the risk for developing colorectal cancer, while there is no association among Africans found in subgroup analysis by ethnicity.	[Teng, Zan; Yu, Ping; Wang, Jin; Gong, Jing; Liu, Yunpeng] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China; [Wang, Lei] China Med Univ, Hosp 1, Dept Geriatr, Shenyang, Liaoning, Peoples R China; [Cai, Shuang] China Med Univ, Hosp 1, Dept Pharm, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, YP (corresponding author), China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China.	yunpengliu_doctor@163.com						Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; Battistelli S, 2006, WORLD J GASTROENTERO, V12, P6128, DOI 10.3748/wjg.v12.i38.6128; Cao HX, 2008, ASIAN PAC J CANCER P, V9, P203; Chandy S, 2010, INDIAN J MED RES, V131, P659; Chang SC, 2007, INT J COLORECTAL DIS, V22, P483, DOI 10.1007/s00384-006-0190-x; Chen J, 1996, CANCER RES, V56, P4862; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cui LH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-236; Curtin K, 2004, CANCER EPIDEM BIOMAR, V13, P285, DOI 10.1158/1055-9965.EPI-03-0083; de Vogel S, 2009, CANCER EPIDEM BIOMAR, V18, P3086, DOI 10.1158/1055-9965.EPI-09-0289; Deloughery TG, 1996, CIRCULATION, V94, P3074, DOI 10.1161/01.CIR.94.12.3074; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Derwinger K, 2009, CLIN COLORECTAL CANC, V8, P43, DOI 10.3816/CCC.2009.n.007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eklof V, 2008, SCAND J CLIN LAB INV, V68, P393, DOI 10.1080/00365510701805431; El Awady MK, 2009, CANCER BIOMARK, V5, P233, DOI 10.3233/CBM-2009-0108; Eussen SJPM, 2010, CANCER EPIDEM BIOMAR, V19, P1328, DOI 10.1158/1055-9965.EPI-09-0841; Fernandez-Peralta AM, 2010, INT J COLORECTAL DIS, V25, P141, DOI 10.1007/s00384-009-0779-y; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gallegos-Arreola M. P., 2009, Cancer Genomics & Proteomics, V6, P183; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; Haghighi M. M., 2008, GASTROENTEROL HEPATO, V1, P57; Heijmans BT, 2003, CANCER RES, V63, P1249; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iacopetta B, 2009, INT J CANCER, V125, P84, DOI 10.1002/ijc.24324; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang QT, 2005, CANCER DETECT PREV, V29, P146, DOI 10.1016/j.cdp.2004.11.004; Jin XX, 2007, SHIJIE HUAREN XIAO H, V15, P2754; Jokic M, 2011, DNA CELL BIOL, V30, P771, DOI 10.1089/dna.2010.1189; Kang Bong Su, 2011, J Korean Soc Coloproctol, V27, P78, DOI 10.3393/jksc.2011.27.2.78; Karpinski P, 2010, CANCER EPIDEMIOL, V34, P338, DOI 10.1016/j.canep.2010.03.002; Keku T, 2002, CANCER EPIDEM BIOMAR, V11, P1611; Kim DH, 2004, CANCER LETT, V216, P199, DOI 10.1016/j.canlet.2004.08.014; Kim JW, 2011, ONCOL REP, V25, P167, DOI 10.3892/or_00001057; Komlosi V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-525; Koushik A, 2006, CANCER EPIDEM BIOMAR, V15, P2408, DOI 10.1158/1055-9965.EPI-06-0624; Kury S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-326; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Le Marchand L, 2005, CANCER EPIDEM BIOMAR, V14, P1198, DOI 10.1158/1055-9965.EPI-04-0840; Lima CSP, 2007, INT J COLORECTAL DIS, V22, P757, DOI 10.1007/s00384-006-0237-z; Ma J, 1997, CANCER RES, V57, P1098; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marchand LL, 2002, CANCER CAUSE CONTROL, V13, P239, DOI 10.1023/A:1015057614870; Matsuo K, 2005, CARCINOGENESIS, V26, P2164, DOI 10.1093/carcin/bgi196; Matsuo Keitaro, 2002, Asian Pac J Cancer Prev, V3, P353; Miao Xiao-ping, 2005, Zhonghua Yufang Yixue Zazhi, V39, P409; Guimaraes JLM, 2011, TUMOR BIOL, V32, P853, DOI 10.1007/s13277-011-0185-2; Mokarram P, 2008, WORLD J GASTROENTERO, V14, P3662, DOI 10.3748/wjg.14.3662; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Murtaugh MA, 2007, CANCER CAUSE CONTROL, V18, P153, DOI 10.1007/s10552-006-0099-2; Naghibalhossaini F, 2010, CANCER GENET CYTOGEN, V197, P142, DOI 10.1016/j.cancergencyto.2009.11.014; Osian G, 2007, J GASTROINTEST LIVER, V16, P251; Otani T, 2005, NUTR CANCER, V53, P42, DOI 10.1207/s15327914nc5301_5; Pardini B, 2011, MUTAT RES-GEN TOX EN, V721, P74, DOI 10.1016/j.mrgentox.2010.12.008; Park KS, 1999, GENET TEST, V3, P233, DOI 10.1089/gte.1999.3.233; Plaschke J, 2003, CANCER LETT, V191, P179, DOI 10.1016/S0304-3835(02)00633-X; Prasad VVTS, 2011, ONKOLOGIE, V34, P422, DOI 10.1159/000331131; Promthet SS, 2010, J EPIDEMIOL, V20, P329, DOI 10.2188/jea.JE20090140; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Reeves SG, 2009, EUR J HUM GENET, V17, P629, DOI 10.1038/ejhg.2008.239; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Ryan BM, 2001, J GASTROINTEST CANC, V30, P105, DOI 10.1385/IJGC:30:3:105; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sameer AS, 2011, GENET MOL RES, V10, P1200, DOI 10.4238/vol10-2gmr1067; Schoenleber SJ, 2009, BRIT J CANCER, V100, P1385, DOI 10.1038/sj.bjc.6605017; Shannon B, 2002, GUT, V50, P520, DOI 10.1136/gut.50.4.520; Sharp L, 2008, BRIT J NUTR, V99, P379, DOI 10.1017/S0007114507801073; Shen HB, 2002, CANCER RES, V62, P4992; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Slattery ML, 2000, CANCER CAUSE CONTROL, V11, P799, DOI 10.1023/A:1008912317909; Slattery ML, 1999, CANCER EPIDEM BIOMAR, V8, P513; Taioli E, 2009, AM J EPIDEMIOL, V170, P1207, DOI 10.1093/aje/kwp275; The Cochrane Collaborative Review Group on HIV Infection and AIDS, 2009, ED POL INCL APPR EXP; Theodoratou E, 2008, CANCER EPIDEM BIOMAR, V17, P171, DOI 10.1158/1055-9965.EPI-07-0621; Toffoli G, 2003, CLIN CANCER RES, V9, P743; [黄萍 Huang Ping], 2003, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V25, P1710; Ulvik A, 2004, CANCER EPIDEM BIOMAR, V13, P2175; Van Guelpen B, 2006, GUT, V55, DOI 10.1136/gut.2005.085480; Vossen CY, 2011, J CLIN ONCOL, V29, P1722, DOI 10.1200/JCO.2010.31.8873; Wang JW, 2006, INT J CANCER, V118, P991, DOI 10.1002/ijc.21438; Wells GA., 2003, NEWCASTLE OTTAWA SCA; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yang Z, 2012, ASIAN PAC J CANCER P, V13, P1203, DOI 10.7314/APJCP.2012.13.4.1203; Yin G, 2004, CANCER SCI, V95, P908, DOI 10.1111/j.1349-7006.2004.tb02201.x; Yin GC, 2012, ONCOL LETT, V4, P365, DOI 10.3892/ol.2012.740; Zeybek U, 2007, CELL BIOCHEM FUNCT, V25, P419, DOI 10.1002/cbf.1317; Zhang YL, 2008, LINCHUANG ZHONG LIU, V13, P769; Zhu F, 2010, DONGNAN DA XUE XUE B, V29, P88; Zhu QH, 2011, SCAND J GASTROENTERO, V46, P436, DOI 10.3109/00365521.2010.537682; 杨学习, 2010, [广东医学, Guangdong Medical Journal], V31, P2375	93	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55332	10.1371/journal.pone.0055332	http://dx.doi.org/10.1371/journal.pone.0055332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437053	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200015
J	Tsurumoto, T; Saiki, K; Okamoto, K; Imamura, T; Maeda, J; Manabe, Y; Wakebe, T				Tsurumoto, Toshiyuki; Saiki, Kazunobu; Okamoto, Keishi; Imamura, Takeshi; Maeda, Junichiro; Manabe, Yoshitaka; Wakebe, Tetsuaki			Periarticular Osteophytes as an Appendicular Joint Stress Marker (JSM): Analysis in a Contemporary Japanese Skeletal Collection	PLOS ONE			English	Article							CALCIFYING NANOPARTICLES; OSTEOARTHRITIS; KNEE; ASSOCIATION; POPULATION; AGE; PREVALENCE; DISEASE; PATTERN; GOTLAND	Objective: The aim of this study was to investigate the possibility that periarticular osteophytes plays a role as a appendicular joint stress marker (JSM) which reflects the biomechanical stresses on individuals and populations. Methods: A total of 366 contemporary Japanese skeletons (231 males, 135 females) were examined closely to evaluate the periarticular osteophytes of six major joints, the shoulder, elbow, wrist, hip, knee, and ankle and osteophyte scores (OS) were determined using an original grading system. These scores were aggregated and analyzed statistically from some viewpoints. Results: All of the OS for the respective joints were correlated logarithmically with the age-at-death of the individuals. For 70 individuals, in whom both sides of all six joints were evaluated without missing values, the age-standardized OS were calculated. A right side dominancy was recognized in the joints of the upper extremities, shoulder and wrist joints, and the bilateral correlations were large in the three joints on the lower extremity. For the shoulder joint and the hip joint, it was inferred by some distinctions that systemic factors were relatively large. All of these six joints could be assorted by the extent of systemic and local factors on osteophytes formation. Moreover, when the age-standardized OS of all the joints was summed up, some individuals had significantly high total scores, and others had significantly low total scores; namely, all of the individuals varied greatly in their systemic predisposition for osteophytes formation. Conclusions: This study demonstrated the significance of periarticular osteophytes; the evaluating system for OS could be used to detect differences among joints and individuals. Periarticular osteophytes could be applied as an appendicular joint stress marker (JSM); by applying OS evaluating system for skeletal populations, intra-skeletal and inter-skeletal variations in biomechanical stresses throughout the lives could be clarified.	[Tsurumoto, Toshiyuki; Saiki, Kazunobu; Okamoto, Keishi; Wakebe, Tetsuaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Macroscop Anat, Nagasaki 852, Japan; [Imamura, Takeshi; Maeda, Junichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Nagasaki 852, Japan; [Manabe, Yoshitaka] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Anat & Dent Anthropol, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Tsurumoto, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Macroscop Anat, Nagasaki 852, Japan.	tsurumot@nagasaki-u.ac.jp		Tsurumoto, Toshiyuki/0000-0001-6069-6490	Grants-in-Aid for Scientific Research [25251042, 22370087] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Braga L, 2009, OSTEOARTHR CARTILAGE, V17, P1554, DOI 10.1016/j.joca.2009.07.011; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; Brickley M, 1998, BONE, V22, P279, DOI 10.1016/S8756-3282(97)00272-X; BRIDGES PS, 1991, AM J PHYS ANTHROPOL, V85, P379, DOI 10.1002/ajpa.1330850403; BUCKLANDWRIGHT JC, 1991, ANN RHEUM DIS, V50, P627, DOI 10.1136/ard.50.9.627; Candemir B, 2010, J HEART VALVE DIS, V19, P745; Cooper C, 1996, J RHEUMATOL, V23, P1938; Currey J.D., 2002, BONES STRUCTURE MECH; Dai J, 2010, J HUM GENET, V55, P77, DOI 10.1038/jhg.2009.137; Debono L, 2004, JOINT BONE SPINE, V71, P397, DOI 10.1016/j.jbspin.2003.11.005; Esposito A, 2006, SKELETAL RADIOL, V35, P847, DOI 10.1007/s00256-006-0134-0; Fischer A, 1932, ACTA RHEUMATOL, V4, P24; Guo YA, 2012, INT J NANOMED, V7, P1679, DOI 10.2147/IJN.S29786; HAWKEY DE, 1995, INT J OSTEOARCHAEOL, V5, P324, DOI 10.1002/oa.1390050403; Heine J, 1926, VIRCHOWS ARCH A, V260, P521, DOI 10.1007/BF01889359; HERNBORG J, 1973, ACTA ORTHOP SCAND, V44, P69, DOI 10.3109/17453677308988675; Inoue K, 2001, RHEUMATOLOGY, V40, P70, DOI 10.1093/rheumatology/40.1.70; Irlenbusch U, 2006, OSTEOARTHR CARTILAGE, V14, P423, DOI 10.1016/j.joca.2005.11.016; Jelic TM, 2008, INT J NANOMED, V3, P385; Jurmain R. D., 1991, INT J OSTEOARCHAEOL, V1, P247, DOI DOI 10.1002/OA.1390010319; JURMAIN RD, 1995, ANN RHEUM DIS, V54, P443, DOI 10.1136/ard.54.6.443; JURMAIN RD, 1977, AM J PHYS ANTHROPOL, V46, P353, DOI 10.1002/ajpa.1330460214; JURMAIN RD, 1980, AM J PHYS ANTHROPOL, V53, P143, DOI 10.1002/ajpa.1330530119; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Klaus HD, 2009, AM J PHYS ANTHROPOL, V139, P204, DOI 10.1002/ajpa.20973; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; Messent EA, 2007, OSTEOARTHR CARTILAGE, V15, P179, DOI 10.1016/j.joca.2006.06.020; Meulenbelt I, 2012, OSTEOARTHR CARTILAGE, V20, P218, DOI 10.1016/j.joca.2012.01.007; Molnar P, 2006, AM J PHYS ANTHROPOL, V129, P12, DOI 10.1002/ajpa.20234; Molnar P, 2011, INT J OSTEOARCHAEOL, V21, P283, DOI 10.1002/oa.1131; Neame R, 2004, ARTHRITIS RHEUM-US, V50, P1487, DOI 10.1002/art.20162; Petersson IF, 1996, ANN RHEUM DIS, V55, P659, DOI 10.1136/ard.55.9.659; Petersson IF, 2002, BEST PRACT RES CL RH, V16, P741, DOI 10.1053/berh.2002.0266; RALPHS JR, 1994, J ANAT, V184, P503; Rogers J, 1997, ANN RHEUM DIS, V56, P85, DOI 10.1136/ard.56.2.85; Rogers J, 2004, ARTHRITIS RHEUM-US, V50, P452, DOI 10.1002/art.20136; SPECTOR TD, 1993, ANN RHEUM DIS, V52, P790, DOI 10.1136/ard.52.11.790; Timms AE, 2002, RHEUMATOLOGY, V41, P725, DOI 10.1093/rheumatology/41.7.725; Tsurumoto T, 2006, J PROTEOME RES, V5, P1276, DOI 10.1021/pr050450w; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; VANSAASE JLCM, 1989, ANN RHEUM DIS, V48, P271, DOI 10.1136/ard.48.4.271; Waldron HA, 1997, ANN RHEUM DIS, V56, P116, DOI 10.1136/ard.56.2.116; WALDRON HA, 1991, ANN RHEUM DIS, V50, P301, DOI 10.1136/ard.50.5.301; Waldron HA, 1986, BR J IND MED, V46, P420; Watkins R, 2012, INT J OSTEOARCHAEOL, V22, P22, DOI 10.1002/oa.1178; Weiss E, 2007, INT J OSTEOARCHAEOL, V17, P437, DOI 10.1002/oa.889; Weiss E, 2003, AM J PHYS ANTHROPOL, V121, P230, DOI 10.1002/ajpa.10226; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	50	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57049	10.1371/journal.pone.0057049	http://dx.doi.org/10.1371/journal.pone.0057049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437307	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200206
J	Wang, SQ; Cao, Q; Wang, XX; Li, BJ; Tang, M; Yuan, WQ; Fang, JZ; Qian, J; Qin, C; Zhang, W				Wang, Shangqian; Cao, Qiang; Wang, Xiaoxiang; Li, Bingjie; Tang, Min; Yuan, Wanqing; Fang, Jianzheng; Qian, Jian; Qin, Chao; Zhang, Wei			PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; DEEP-VEIN THROMBOSIS; BREAST-CANCER; COLORECTAL-CANCER; GENE POLYMORPHISMS; MATRIX-METALLOPROTEINASE; OVARIAN-CANCER; SYSTEM; RISK; PROMOTER	Background: The plasminogen activator inhibitor-1 (PAI-1) is expressed in many cancer cell types and allows the modulation of cancer growth, invasion and angiogenesis. To date, studies investigated the association between a functional polymorphism in PAI-1 (4G/5G) and risk of cancer have shown inclusive results. Methods: A meta-analysis based on 25 case-control studies was performed to address this issue. Odds ratios (OR) with corresponding 95% confidence intervals (CIs) were used to assess the association. The statistical heterogeneity across studies was examined with I-2 test. Results: Overall, a significant increased risk of cancer was associated with the PAI-1 4G/4G polymorphism for the allele contrast (4G vs. 5G: OR = 1.10, CI = 1.03-1.18, I-2 = 49.5%), the additive genetic model (4G/4G vs. 5G/5G: OR = 1.21, CI = 1.06-1.39, I-2 = 51.9%), the recessive genetic model (4G/4G vs. 4G/5G+5G/5G: OR = 1.11, CI = 1.04-1.18, I-2 = 20.8%). In the subgroup analysis by ethnicity, the results indicated that individuals with 4G/4G genotype had a significantly higher cancer risk among Caucasians (4G/4G vs. 5G/5G: OR = 1.31, 95% CI = 1.09-1.59, I-2 = 59.6%; 4G/4G vs. 4G/5G: OR = 1.12, 95% CI = 1.04-1.21, I-2 = 3.6%; recessive model: OR = 1.12, 95% CI = 1.05-1.21, I-2 = 25.3%). Conclusions: The results of the present meta-analysis support an association between the PAI-1 4G/5G polymorphism and increasing cancer risk, especially among Caucasians, and those with 4G allele have a high risk to develop colorectal cancer and endometrial cancer.	[Wang, Shangqian; Cao, Qiang; Tang, Min; Fang, Jianzheng; Qian, Jian; Qin, Chao; Zhang, Wei] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaoxiang] Yangzhou 1 Peoples Hosp, Dept Urol, Yangzhou, Peoples R China; [Li, Bingjie] Univ Texas Hlth Sci Ctr, Div Epidemiol, Houston, TX USA; [Yuan, Wanqing] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Orthoped, Qingdao 266071, Peoples R China	Nanjing Medical University; University of Texas System; University of Texas Health Science Center Houston; Qingdao University	Qin, C (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	qinchao@njmu.edu.cn; zhangweinjmu@gmail.com	Cao, Qiang/K-2349-2019		Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China [81201571]	Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province, by the National Natural Science Foundation of China (grant numbers 81201571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bentov Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005918; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blasiak J, 2000, ACTA BIOCHIM POL, V47, P191; Burzotta F, 1998, THROMB HAEMOSTASIS, V79, P354, DOI 10.1055/s-0037-1614991; Castello R, 2006, THROMB RES, V117, P487, DOI 10.1016/j.thromres.2005.03.025; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; DAWSON S, 1991, ARTERIOSCLER THROMB, V11, P183, DOI 10.1161/01.ATV.11.1.183; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Eroglu A, 2006, J BUON, V11, P481; Eroglu A, 2007, J BUON, V12, P135; Fersching DMI, 2012, ANTICANCER RES, V32, P2047; Forsti A, 2007, ANN ONCOL, V18, P1990, DOI 10.1093/annonc/mdm361; Gilabert-Estelles J, 2012, THROMB RES, V130, P242, DOI 10.1016/j.thromres.2011.10.007; Grubic N, 1996, THROMB RES, V84, P431, DOI 10.1016/S0049-3848(96)00211-3; Han B, 2005, ONCOL REP, V14, P105; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; Jorgenson E, 2007, PROSTATE, V67, P172, DOI 10.1002/pros.20512; Ju HS, 2010, CANCER-AM CANCER SOC, V116, P4248, DOI 10.1002/cncr.25213; Lei H, 2008, BREAST CANCER RES TR, V109, P165, DOI 10.1007/s10549-007-9635-3; Loktionov A, 2003, CANCER LETT, V189, P189, DOI 10.1016/S0304-3835(02)00556-6; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Minisini AM, 2007, AM J CLIN PATHOL, V128, P112, DOI 10.1309/M0GXVXA89BVLJ5C9; Morgan H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-1; Onur E, 2012, MED PRIN PRACT, V21, P160, DOI 10.1159/000333394; Palmirotta R, 2009, THROMB RES, V124, P403, DOI 10.1016/j.thromres.2009.02.014; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Sartori MT, 2003, CLIN APPL THROMB-HEM, V9, P299, DOI 10.1177/107602960300900405; Sartori MT, 2001, THROMB HAEMOSTASIS, V86, P1161; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Stegnar M, 1998, THROMB HAEMOSTASIS, V79, P975; Sternlicht MD, 2006, CANCER EPIDEM BIOMAR, V15, P2107, DOI 10.1158/1055-9965.EPI-06-0351; Su CK, 2011, J SURG ONCOL, V104, P755, DOI 10.1002/jso.22035; Tee YT, 2012, J SURG ONCOL, V106, P204, DOI 10.1002/jso.23072; Turkmen B, 1997, ELECTROPHORESIS, V18, P686, DOI 10.1002/elps.1150180505; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Vairaktaris E, 2009, ORAL ONCOL, V45, P247, DOI 10.1016/j.oraloncology.2008.05.003; Vossen CY, 2011, J CLIN ONCOL, V29, P1722, DOI 10.1200/JCO.2010.31.8873; Weng CJ, 2011, ANN SURG ONCOL, V18, P805, DOI 10.1245/s10434-010-1432-2; Weng CJ, 2010, ANN SURG ONCOL, V17, P3394, DOI 10.1245/s10434-010-1124-y; Woo M, 2007, J GASTROEN HEPATOL, V22, P1064, DOI 10.1111/j.1440-1746.2006.04424.x; Zadrozny, 1999, MED SCI MONITOR, V5, P833; Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455	46	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56797	10.1371/journal.pone.0056797	http://dx.doi.org/10.1371/journal.pone.0056797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437240	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200164
J	Zhang, JY; Li, P; Wang, YP; Liu, JX; Zhang, ZJ; Cheng, WD; Wang, YY				Zhang, Junying; Li, Peng; Wang, Yanping; Liu, Jianxun; Zhang, Zhanjun; Cheng, Weidong; Wang, Yongyan			Ameliorative Effects of a Combination of Baicalin, Jasminoidin and Cholic Acid on Ibotenic Acid-Induced Dementia Model in Rats	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; THYROTROPIN-RELEASING-HORMONE; NEURAL STEM-CELLS; IMPAIRED RECOGNITION MEMORY; TRANSGENIC MOUSE MODEL; RETINOIC ACID; ALZHEIMERS-DISEASE; IN-VITRO; CARBONYL REDUCTASE; AMYLOID DEPOSITION	Aims: To investigate the therapeutic effects and acting mechanism of a combination of Chinese herb active components, i.e., a combination of baicalin, jasminoidin and cholic acid (CBJC) on Alzheimer's disease (AD). Methods: Male rats were intracerebroventricularly injected with ibotenic acid (IBO), and CBJC was orally administered. Therapeutic effect was evaluated with the Morris water maze test, FDG-PET examination, and histological examination, and the acting mechanism was studied with DNA microarrays and western blotting. Results: CBJC treatment significantly attenuated IBO-induced abnormalities in cognition, brain functional images, and brain histological morphology. Additionally, the expression levels of 19 genes in the forebrain were significantly influenced by CBJC; approximately 60% of these genes were related to neuroprotection and neurogenesis, whereas others were related to anti-oxidation, protein degradation, cholesterol metabolism, stress response, angiogenesis, and apoptosis. Expression of these genes was increased, except for the gene related to apoptosis. Changes in expression for 5 of these genes were confirmed by western blotting. Conclusion: CBJC can ameliorate the IBO-induced dementia in rats and may be significant in the treatment of AD. The therapeutic mechanism may be related to CBJC's modulation of a number of processes, mainly through promotion of neuroprotection and neurogenesis, with additional promotion of anti-oxidation, protein degradation, etc.	[Zhang, Junying; Cheng, Weidong] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Zhang, Junying; Zhang, Zhanjun] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Peng; Liu, Jianxun] China Acad Chinese Med Sci, Lab Res Ctr, Xiyuan Hosp, Beijing, Peoples R China; [Wang, Yanping; Wang, Yongyan] China Acad Chinese Med Sci, Inst Basic Clin Med, Beijing, Peoples R China	Lanzhou University; Beijing Normal University; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Zhang, ZJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zhang_rzs@bnu.edu; weidong_c@yahoo.cn			Fundamental Research Funds for the Central Universities [248-105102]; Program for New Century Excellent Talents in University [NCET-10]; Project of Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences [Z0175]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Project of Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences	This study was supported by the Fundamental Research Funds for the Central Universities (248-105102), Program for New Century Excellent Talents in University (NCET-10) and Project of Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences (Z0175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1992, NEUROSCI RES, V14, P117, DOI 10.1016/0168-0102(92)90087-S; Akama K, 2011, BBA-PROTEINS PROTEOM, V1814, P265, DOI 10.1016/j.bbapap.2010.10.009; Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Bennett GW, 1997, EXP GERONTOL, V32, P451, DOI 10.1016/S0531-5565(96)00159-3; Benoit BO, 2001, J NEUROBIOL, V46, P265, DOI 10.1002/1097-4695(200103)46:4<265::AID-NEU1007>3.0.CO;2-B; Bergink S, 2006, NEUROBIOL DIS, V23, P708, DOI 10.1016/j.nbd.2006.06.005; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Boneva NB, 2011, HIPPOCAMPUS, V21, P162, DOI 10.1002/hipo.20732; Botella JA, 2004, CURR BIOL, V14, P782, DOI 10.1016/j.cub.2004.04.036; Calza L, 2003, P NATL ACAD SCI USA, V100, P7325, DOI 10.1073/pnas.1132092100; Chen-Plotkin AS, 2011, ANN NEUROL, V69, P655, DOI 10.1002/ana.22271; Christie VB, 2010, J NEUROSCI METH, V193, P239, DOI 10.1016/j.jneumeth.2010.08.022; Clark RE, 2000, J NEUROSCI, V20, P8853; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Cui J, 2003, ZHONG GUO ZU ZHI HUA, V12, P81; Cunha-Reis D, 2006, ANN NY ACAD SCI, V1070, P210, DOI 10.1196/annals.1317.016; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Farias EF, 2005, J NATL CANCER I, V97, P21, DOI 10.1093/jnci/dji004; Flore M, 2002, PHYSIOL BEHAV, V77, P437; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; Guo XF, 2000, GUANG ZHOU ZHONG YI, V17, P9; Hauck SM, 2008, MOL CELL PROTEOMICS, V7, P1349, DOI 10.1074/mcp.M700456-MCP200; Heo H, 2009, J ETHNOPHARMACOL, V122, P20, DOI 10.1016/j.jep.2008.11.026; Hicks D, 1998, GEN PHARMACOL, V30, P265, DOI 10.1016/S0306-3623(97)00356-X; Hoffrogge R, 2006, PROTEOMICS, V6, P1833, DOI 10.1002/pmic.200500556; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Ishikawa E, 2009, J NEUROL SCI, V285, P78, DOI 10.1016/j.jns.2009.05.026; Ji C, 2009, J ALZHEIMERS DIS, V16, P331, DOI 10.3233/JAD-2009-0979; Johansson K, 2010, FREE RADICAL BIO MED, V49, P1638, DOI 10.1016/j.freeradbiomed.2010.08.013; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Kim DH, 2006, MECH AGEING DEV, V127, P719, DOI 10.1016/j.mad.2006.05.002; Kim YB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-42; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; Koriyama Y, 2010, J NEUROCHEM, V115, P79, DOI 10.1111/j.1471-4159.2010.06903.x; Kovacs T, 2001, NEUROREPORT, V12, P285, DOI 10.1097/00001756-200102120-00021; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laskowski A, 2005, BRAIN RES, V1037, P78, DOI 10.1016/j.brainres.2004.12.035; Lee JW, 2009, COOPERATION INTEGRIN; Lee KH, 2000, J FOOD DRUG ANAL, V8, P219; Li M, 2011, CHEMBIOCHEM, V12, P449, DOI 10.1002/cbic.201000570; Luo GA, 2006, SCI TECHNOL MOD TRAD, V8, P6; Luo LG, 2002, J ALZHEIMERS DIS, V4, P97, DOI 10.3233/JAD-2002-4204; Marchal-Victorion S, 2003, MOL CELL NEUROSCI, V24, P198, DOI 10.1016/S1044-7431(03)00161-1; Maser E, 2006, BIOCHEM BIOPH RES CO, V340, P1019, DOI 10.1016/j.bbrc.2005.12.113; Matt N, 2005, DEV DYNAM, V233, P167, DOI 10.1002/dvdy.20313; MELLOW AM, 1989, PSYCHOPHARMACOLOGY, V98, P403, DOI 10.1007/BF00451695; MIYAMOTO M, 1994, EUR J PHARMACOL, V271, P357; MORRISON RS, 1988, J NEUROSCI RES, V21, P71, DOI 10.1002/jnr.490210111; Nordberg A, 2001, ALZHEIMER'S DISEASE, P153, DOI 10.1002/0470846453.ch15; Ono K, 2004, EXP NEUROL, V189, P380, DOI 10.1016/j.expneurol.2004.05.035; Paspalas CD, 2009, CEREB CORTEX, V19, P1666, DOI 10.1093/cercor/bhn203; Pattnaik BR, 2009, AM J PHYSIOL-CELL PH, V297, pC1001, DOI 10.1152/ajpcell.00250.2009; Rangon CM, 2005, J PHARMACOL EXP THER, V314, P745, DOI 10.1124/jpet.105.086405; Rashid MA, 2010, FREE RADICAL BIO MED, V49, P1522, DOI 10.1016/j.freeradbiomed.2010.08.015; Reilly JF, 2003, P NATL ACAD SCI USA, V100, P4837, DOI 10.1073/pnas.0330745100; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Salama RHM, 2006, CANCER LETT, V233, P16, DOI 10.1016/j.canlet.2005.02.047; Sarang SS, 2002, PHYSIOL GENOMICS, V11, P45, DOI 10.1152/physiolgenomics.00064.2002; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Tak E, 2011, J HEPATOL, V54, P328, DOI 10.1016/j.jhep.2010.06.045; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; Wang TW, 2005, DEVELOPMENT, V132, P2721, DOI 10.1242/dev.01867; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Xiao Lin, 2005, Shengli Xuebao, V57, P705; Yamada M, 2003, THYROID, V13, P1111, DOI 10.1089/10507250360731505; Yamazaki M, 2009, BIOL PHARM BULL, V32, P1043, DOI 10.1248/bpb.32.1043; Yu J, 2009, CLIN EXP PHARMACOL P, V36, P539, DOI 10.1111/j.1440-1681.2008.05105.x; Zaben M, 2009, STEM CELLS, V27, P2539, DOI 10.1002/stem.184; Zannis VI, 2008, ANN MED, V40, P14, DOI 10.1080/07853890701687219; Zhang Zhan-jun, 2006, Chinese Pharmacological Bulletin, V22, P964; Zhang ZJ, 2006, THESIS BEIJING U TRA, P31; Zhao BQ, 2011, INT J PHARMACEUT, V405, P1, DOI 10.1016/j.ijpharm.2010.11.018; Zhong XG, 2004, BEI JING ZHONG YI YA, V27, P21; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007	79	19	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56658	10.1371/journal.pone.0056658	http://dx.doi.org/10.1371/journal.pone.0056658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437202	Green Published, gold			2022-12-27	WOS:000315184200132
J	Wang, YL; Feng, SH; Zhu, J; Zhu, GP; Li, DS; Wang, Y; Zhu, YX; Sun, GH; Ji, QH				Wang, Yu-Long; Feng, Shou-Hao; Zhu, Ji; Zhu, Guo-Pei; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Sun, Guo-Hua; Ji, Qing-Hai			Impact of Lymph Node Ratio on the Survival of Patients with Hypopharyngeal Squamous Cell Carcinoma: A Population-Based Analysis	PLOS ONE			English	Article							POSITIVE BREAST-CANCER; LARYNGEAL-CANCER; GASTRIC-CANCER; STAGING SYSTEM; UNITED-STATES; NECK CANCERS; HEAD; PATTERNS; ADEQUACY	Objective: To analyze the impact of the lymph node ratio (LNR, ratio of metastatic to examined nodes) on the prognosis of hypopharyngeal cancer patients. Methods: SEER (Surveillance, Epidemiology and End Results)-registered hypopharyngeal cancer patients with lymph node metastasis were evaluated using multivariate Cox regression analysis to identify the prognostic role of the LNR. The categorical LNR was compared with the continuous LNR and pN classifications to predict cause-specific survival (CSS) and overall survival (OS) rates of hypopharyngeal cancer patients. Results: Multivariate analysis of 916 pN+ hypopharyngeal cancer cases identified race, primary site, radiation sequence, T classification, N classification, M classification, the number of regional lymph nodes examined, the continuous LNR (Hazard ratio 2.415, 95% CI 1.707-3.416, P<0.001) and age as prognostic variables that were associated with CSS in hypopharyngeal cancer. The categorical LNR showed a higher C-index and lower Akaike information criterion (AIC) value than the continuous LNR. When patients (n = 1152) were classified into four risk groups according to LNR, R0 (LNR = 0), R1 (LNR <= 0.05), R2 (LNR 0.05-0.30) and R3 (LNR >0.30), the Cox regression model for CSS and OS using the R classification had a higher C-index value and lower AIC value than the model using the pN classification. Significant improvements in both CSS and OS were found for R2 and R3 patients with postoperative radiotherapy. Conclusions: LNR is a significant prognostic factor for the survival of hypopharyngeal cancer patients. Using the cutoff points 0.05/0.30, the R classification was more accurate than the pN classification in predicting survival and can be used to select high risk patients for postoperative treatment.	[Wang, Yu-Long; Feng, Shou-Hao; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Sun, Guo-Hua; Ji, Qing-Hai] Fudan Univ, Canc Hosp, Dept Head & Neck Surg, Shanghai 200433, Peoples R China; [Wang, Yu-Long; Feng, Shou-Hao; Zhu, Ji; Zhu, Guo-Pei; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Sun, Guo-Hua; Ji, Qing-Hai] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Zhu, Ji; Zhu, Guo-Pei] Fudan Univ, Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Zhu, Ji] Fudan Univ, Canc Hosp, Dept Clin Stat, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Ji, QH (corresponding author), Fudan Univ, Canc Hosp, Dept Head & Neck Surg, Shanghai 200433, Peoples R China.	jiqinghai@shca.org.cn	zhu, ji/HDM-1538-2022; Wang, Yu-Long/AEF-9362-2022	Wang, Yu-Long/0000-0002-3830-7257; Zhu, Ji/0000-0001-7134-9419	National Science Foundation of China [81001204]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (81001204 to Y-L Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2005, ONCOLOGIST, V10, P215, DOI 10.1634/theoncologist.10-3-215; Bisdas S, 2009, INT J RADIAT ONCOL, V73, P1313, DOI 10.1016/j.ijrobp.2008.06.1956; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Chen AY, 2011, ARCH OTOLARYNGOL, V137, P1017, DOI 10.1001/archoto.2011.171; Deng JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043925; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035021; Glynn RW, 2012, LARYNGOSCOPE, V122, P1967, DOI 10.1002/lary.23401; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hoffman HT, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236095.97947.26; Howlader N, 2011, SEER CANC STAT REV 1; KOTWALL C, 1987, AM J SURG, V154, P439, DOI 10.1016/0002-9610(89)90020-2; Ligier K, 2011, ORAL ONCOL, V47, P302, DOI 10.1016/j.oraloncology.2011.02.013; Mendenhall WM, 2003, HEAD NECK-J SCI SPEC, V25, P535, DOI 10.1002/hed.10253; Pfister DG, 2011, J NATL COMPR CANC NE, V9, P596, DOI 10.6004/jnccn.2011.0053; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Song YX, 2012, PLOS ONE, V6; Spillane AJ, 2011, ANN SURG, V253, P109, DOI 10.1097/SLA.0b013e3181f9b8b6; Suarez C, 2012, HEAD NECK; Takes RP, 2012, HEAD NECK-J SCI SPEC, V34, P270, DOI 10.1002/hed.21613; Vinh-Hung V, 2010, ONCOLOGIST, V15, P1050, DOI 10.1634/theoncologist.2010-0044; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Wang JP, 2012, ANN SURG, V255, P478, DOI 10.1097/SLA.0b013e31824857e2; Wang W, 2011, ANN ONCOL, V22, P2049, DOI 10.1093/annonc/mdq716	26	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56613	10.1371/journal.pone.0056613	http://dx.doi.org/10.1371/journal.pone.0056613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431384	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800027
J	Yamakawa, K; Matsumoto, N; Imamura, Y; Muroya, T; Yamada, T; Nakagawa, J; Shimazaki, J; Ogura, H; Kuwagata, Y; Shimazu, T				Yamakawa, Kazuma; Matsumoto, Naoya; Imamura, Yukio; Muroya, Takashi; Yamada, Tomoki; Nakagawa, Junichiro; Shimazaki, Junya; Ogura, Hiroshi; Kuwagata, Yasuyuki; Shimazu, Takeshi			Electrical Vagus Nerve Stimulation Attenuates Systemic Inflammation and Improves Survival in a Rat Heatstroke Model	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; HEAT-STRESS; RELEASE; INJURY; SHOCK; RESUSCITATION; ACETYLCHOLINE; ENDOTOXEMIA	This study was performed to gain insights into novel therapeutic approaches for the treatment of heatstroke. The central nervous system regulates peripheral immune responses via the vagus nerve, the primary neural component of the cholinergic anti-inflammatory pathway. Electrical vagus nerve stimulation (VNS) reportedly suppresses pro-inflammatory cytokine release in several models of inflammatory disease. Here, we evaluated whether electrical VNS attenuates severe heatstroke, which induces a systemic inflammatory response. Anesthetized rats were subjected to heat stress (41.5 degrees C for 30 minutes) with/without electrical VNS. In the VNS-treated group, the cervical vagus nerve was stimulated with constant voltage (10 V, 2 ms, 5 Hz) for 20 minutes immediately after completion of heat stress. Sham-operated animals underwent the same procedure without stimulation under a normothermic condition. Seven-day mortality improved significantly in the VNS-treated group versus control group. Electrical VNS significantly suppressed induction of pro-inflammatory cytokines such as tumor necrosis factor-alpha and interleukin-6 in the serum 6 hours after heat stress. Simultaneously, the increase of soluble thrombomodulin and E-selectin following heat stress was also suppressed by VNS treatment, suggesting its protective effect on endothelium. Immunohistochemical analysis using tissue preparations obtained 6 hours after heat stress revealed that VNS treatment attenuated infiltration of inflammatory (CD11b-positive) cells in lung and spleen. Interestingly, most cells with increased CD11b positivity in response to heat stress did not express alpha 7 nicotinic acetylcholine receptor in the spleen. These data indicate that electrical VNS modulated cholinergic anti-inflammatory pathway abnormalities induced by heat stress, and this protective effect was associated with improved mortality. These findings may provide a novel therapeutic strategy to combat severe heatstroke in the critical care setting.	[Yamakawa, Kazuma; Matsumoto, Naoya; Muroya, Takashi; Yamada, Tomoki; Nakagawa, Junichiro; Shimazaki, Junya; Ogura, Hiroshi; Kuwagata, Yasuyuki; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan; [Imamura, Yukio] Kyoto Univ, Grad Sch Med, Unit Liveable Cities, Kyoto, Japan	Osaka University; Kyoto University	Yamakawa, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan.	k.yamakawa0911@gmail.com	Yamakawa, Kazuma/AAD-3436-2022	Yamakawa, Kazuma/0000-0003-2999-4021	Ministry of Education, Culture, Sports, Science, and Technology in Japan [24791938]; Grants-in-Aid for Scientific Research [24592734, 24791938] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (No. 24791938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BOUCHAMA A, 1991, J APPL PHYSIOL, V70, P2640, DOI 10.1152/jappl.1991.70.6.2640; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; BOUCHAMA A, 1995, INTENS CARE MED, V21, P623, DOI 10.1007/BF01711537; Bouchama A, 2008, ARTERIOSCL THROM VAS, V28, P1318, DOI 10.1161/ATVBAHA.107.161737; Cai BL, 2009, J CELL MOL MED, V13, P3774, DOI 10.1111/j.1582-4934.2008.00550.x; Chang CK, 2006, CURR MED CHEM, V13, P3145, DOI 10.2174/092986706778742945; Chen CC, 2009, AM J MED SCI, V338, P382, DOI 10.1097/MAJ.0b013e3181b272ae; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Hagiwara S, 2011, J SURG RES, V171, P762, DOI 10.1016/j.jss.2010.05.008; Hagiwara S, 2010, INFLAMM RES, V59, P511, DOI 10.1007/s00011-009-0155-y; Hagiwara S, 2010, SHOCK, V33, P282, DOI 10.1097/SHK.0b013e3181b0ef7b; Hsiao SH, 2007, RESUSCITATION, V73, P437, DOI 10.1016/j.resuscitation.2006.11.003; Huang H, 2009, VET IMMUNOL IMMUNOP, V132, P116, DOI 10.1016/j.vetimm.2009.05.003; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Kondo Masahide, 2011, Environ Health Prev Med, V16, P279, DOI 10.1007/s12199-011-0228-8; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Niederbichler AD, 2009, BURNS, V35, P783, DOI 10.1016/j.burns.2008.08.023; Nybo L, 2007, PROG BRAIN RES, V162, P29, DOI 10.1016/S0079-6123(06)62003-7; Pohanka M, 2011, CURR MED CHEM, V18, P539, DOI 10.2174/092986711794480140; Roberts GT, 2008, ARTERIOSCL THROM VAS, V28, P1130, DOI 10.1161/ATVBAHA.107.158709; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Sharma HS, 2005, INDIAN J MED RES, V121, P621; Shen KH, 2008, SHOCK, V30, P668, DOI 10.1097/SHK.0b013e31817538cb; Song XM, 2010, BURNS, V36, P75, DOI 10.1016/j.burns.2009.02.002; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185	35	26	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56728	10.1371/journal.pone.0056728	http://dx.doi.org/10.1371/journal.pone.0056728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424673	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100061
J	Furtado, JM; Ashander, LM; Mohs, K; Chipps, TJ; Appukuttan, B; Smith, JR				Furtado, Joao M.; Ashander, Liam M.; Mohs, Kathleen; Chipps, Timothy J.; Appukuttan, Binoy; Smith, Justine R.			Toxoplasma gondii Migration within and Infection of Human Retina	PLOS ONE			English	Article							OCULAR TOXOPLASMOSIS; TRANSEPITHELIAL MIGRATION; VASCULAR ENDOTHELIUM; GLOBAL REASSESSMENT; MEMORIAL-LECTURE; GROWTH-FACTOR; IN-VITRO; CELLS; EXPRESSION; RETINOCHOROIDITIS	Toxoplasmic retinochoroiditis is a common blinding retinal infection caused by the parasite, Toxoplasma gondii. Basic processes relating to establishment of infection in the human eye by T. gondii tachyzoites have not been investigated. To evaluate the ability of tachyzoites to navigate the human retina, we developed an ex vivo assay, in which a suspension containing 1.5x10(7) parasites replaced vitreous in a posterior eyecup. After 8 hours, the retina was formalin-fixed and paraffin-embedded, and sections were immunostained to identify tachyzoites. To determine the preference of tachyzoites for human retinal neuronal versus glial populations, we infected dissociated retinal cultures, subsequently characterized by neuron-specific enolase or glial fibrillary acidic protein expression, and retinal cell lines, with YFP-expressing tachyzoites. In migration assays, retinas contained 110-250 live tachyzoites; 64.5-95.2% (mean = 79.6%) were localized to the nerve fiber layer, but some were detected in the outer retina. Epifluorescence imaging of dissociated retinal cultures 24 hours after infection indicated preferential infection of glia. This observation was confirmed in growth assays, with significantly higher (p <= 0.005) numbers of tachyzoites measured in glial verus neuronal cell lines. Our translational studies indicate that, after entering retina, tachyzoites may navigate multiple tissue layers. Tachyzoites preferentially infect glial cells, which exist throughout the retina. These properties may contribute to the success of T. gondii as a human pathogen.	[Furtado, Joao M.; Ashander, Liam M.; Mohs, Kathleen; Chipps, Timothy J.; Appukuttan, Binoy; Smith, Justine R.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Smith, Justine R.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Smith, JR (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	justine.smith@flinders.edu.au	Smith, Justine/Y-9044-2019; Furtado, Joao M./AAB-5356-2022; Furtado, Joao/D-4436-2012	Smith, Justine/0000-0002-4756-5493; Furtado, Joao M./0000-0003-2490-5747; 	National Institutes of Health [R21 EY019550]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY010572, R21EY019550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this study was provided by the National Institutes of Health (R21 EY019550) and Research to Prevent Blindness (unrestricted grant to Casey Eye Institute). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa BF, 2008, CLIN EXP IMMUNOL, V151, P536, DOI 10.1111/j.1365-2249.2007.03583.x; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; BULOW R, 1991, J IMMUNOL, V147, P3496; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Channon JY, 2000, INFECT IMMUN, V68, P4822, DOI 10.1128/IAI.68.8.4822-4826.2000; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Furtado JM, 2012, IMMUNOL CELL BIOL, V90, P912, DOI 10.1038/icb.2012.21; Furtado JM, 2012, INVEST OPHTH VIS SCI, V53, P6856, DOI 10.1167/iovs.12-10384; Gaudin C, 1996, INVEST OPHTH VIS SCI, V37, P2258; Gubbels MJ, 2003, ANTIMICROB AGENTS CH, V47, P309, DOI 10.1128/AAC.47.1.309-316.2003; Halonen SK, 1996, J NEUROPATH EXP NEUR, V55, P1150, DOI 10.1097/00005072-199611000-00006; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040; Khan A, 2009, EUKARYOT CELL, V8, P1828, DOI 10.1128/EC.00150-09; Knight BC, 2006, J NEUROIMMUNOL, V179, P126, DOI 10.1016/j.jneuroim.2006.06.002; KUWABARA T, 1960, ARCH OPHTHALMOL-CHIC, V64, P904, DOI 10.1001/archopht.1960.01840010906012; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lum F, 2005, AM J OPHTHALMOL, V140, P724; MCFALL RC, 1977, CANCER RES, V37, P1003; Montoya JG, 1997, CURRENT CONCEPTS IMM, P163; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; NICHOLSON DH, 1976, ARCH OPHTHALMOL-CHIC, V94, P248, DOI 10.1001/archopht.1976.03910030120009; Plattner F, 2008, ANNU REV MICROBIOL, V62, P471, DOI 10.1146/annurev.micro.62.081307.162802; Romano C, 2007, PROG RETIN EYE RES, V26, P379, DOI 10.1016/j.preteyeres.2007.03.001; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Smith JR, 2004, INVEST OPHTH VIS SCI, V45, P1157, DOI 10.1167/iovs.03-1105; Smith JR, 2007, BRIT J OPHTHALMOL, V91, P226, DOI 10.1136/bjo.2006.101121; Stanford MR, 2009, MEM I OSWALDO CRUZ, V104, P312, DOI 10.1590/S0074-02762009000200027; YEO JH, 1983, OPHTHALMOLOGY, V90, P885, DOI 10.1016/S0161-6420(83)80012-8	32	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e54358	10.1371/journal.pone.0054358	http://dx.doi.org/10.1371/journal.pone.0054358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437042	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000003
J	Raveney, BJE; Oki, S; Yamamura, T				Raveney, Ben J. E.; Oki, Shinji; Yamamura, Takashi			Nuclear Receptor NR4A2 Orchestrates Th17 Cell-Mediated Autoimmune Inflammation via IL-21 Signalling	PLOS ONE			English	Article							T-CELLS; DIFFERENTIATION; EXPRESSION; T(H)17; IL-17; INTERLEUKIN-21; GENERATION; INDUCTION; APOPTOSIS; PATHWAY	IL-17-producing CD4(+) T helper 17 (Th17) cells are pathogenic in a range of human autoimmune diseases and corresponding animal models. We now demonstrate that such T cells infiltrating the target organ during the induction of experimental autoimmune encephalomyelitis (EAE) and experimental autoimmune uveoretinitis (EAU) specifically express NR4A2. Further, we reveal a critical involvement of NR4A2 in Th17 cell functions and Th17 cell-driven autoimmune diseases. When NR4A2 expression was blocked with siRNA, full Th17 differentiation was prevented in vitro: although cells expressed the master Th17 regulator, ROR gamma t, they expressed reduced levels of IL-23R and were unable to produce IL-17 and IL-21. Notably, Th17 differentiation in the absence of NR4A2 was restored by exogenous IL-21, indicating that NR4A2 controls full maturation of Th17 cells via autocrine IL-21 signalling. Preventing NR4A2 expression in vivo by systemic treatment with NR4A2-specific siRNA also reduced Th17 effector responses and furthermore protected mice from EAE induction. In addition, the lack of disease was associated with a reduction in autocrine IL-21 production and IL-23R expression. Similar modulation of NR4A2 expression was also effective as an intervention, reversing established autoimmune responses and ameliorating clinical disease symptoms. Thus, NR4A2 appears to control Th17 differentiation and so plays an essential role in the development of Th17-mediated autoimmune disease. As NR4A2 is also upregulated during human autoimmune disease, targeting NR4A2 may provide a new therapeutic approach in treating autoimmune disease.	[Raveney, Ben J. E.; Oki, Shinji; Yamamura, Takashi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan	Yamamura, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Tokyo, Japan.	yamamura@ncnp.go.jp		Raveney, Ben/0000-0003-2641-5733	Ministry of Health, Labour, and Welfare of Japan, the Council for Science and Technology Policy (CSTP); Ministry of Education, Science, Culture, Sports, and Technology of Japan; JSPS [18109009]; JSPS KAKENHI Grant [21590087]; JSPS Postdoctoral Fellowship [P08517]; Grants-in-Aid for Scientific Research [24590108] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan, the Council for Science and Technology Policy (CSTP); Ministry of Education, Science, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants from the Ministry of Health, Labour, and Welfare of Japan, the Council for Science and Technology Policy (CSTP) and the Ministry of Education, Science, Culture, Sports, and Technology of Japan. TY is a recipient of a JSPS Grant-in-Aid for Scientific Research (KAKENHI) No. 18109009, SO is a recipient of a JSPS KAKENHI Grant No. 21590087, and BJER was a recipient of a JSPS Postdoctoral Fellowship for Foreign Researchers No. P08517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; ELIAS D, 1994, DIABETES, V43, P992, DOI 10.2337/diabetes.43.8.992; Fraser JM, 2006, IMMUNOLOGY, V119, P126, DOI 10.1111/j.1365-2567.2006.02414.x; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Mensah-Brown EPK, 2006, EUR J IMMUNOL, V36, P216, DOI 10.1002/eji.200535325; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Kane M, 2008, J INVEST DERMATOL, V128, P300, DOI 10.1038/sj.jid.5701023; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Raveney BJE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1390, DOI 10.1001/archopht.126.10.1390; Raveney BJE, 2009, J IMMUNOL, V183, P2321, DOI 10.4049/jimmunol.0901340; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shao H, 2006, EXP EYE RES, V82, P323, DOI 10.1016/j.exer.2005.07.008; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vollmer TL, 2005, J IMMUNOL, V174, P2696, DOI 10.4049/jimmunol.174.5.2696; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	52	56	57	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56595	10.1371/journal.pone.0056595	http://dx.doi.org/10.1371/journal.pone.0056595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437182	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000033
J	Bennett, TL; Kraft, SM; Reaves, BJ; Mima, J; O'Brien, KM; Starai, VJ				Bennett, Terry L.; Kraft, Shannon M.; Reaves, Barbara J.; Mima, Joji; O'Brien, Kevin M.; Starai, Vincent J.			LegC3, an Effector Protein from Legionella pneumophila, Inhibits Homotypic Yeast Vacuole Fusion In Vivo and In Vitro	PLOS ONE			English	Article							PHAGOSOME-LYSOSOME FUSION; TRANS-SNARE COMPLEX; MEMBRANE-FUSION; SACCHAROMYCES-CEREVISIAE; VESICLE TRAFFICKING; SYNAPTIC EXOCYTOSIS; MUTATIONAL ANALYSIS; PLASMA-MEMBRANE; ALPHA-SNAP; DOCKING	During infection, the intracellular pathogenic bacterium Legionella pneumophila causes an extensive remodeling of host membrane trafficking pathways, both in the construction of a replication-competent vacuole comprised of ER-derived vesicles and plasma membrane components, and in the inhibition of normal phagosome: endosome/lysosome fusion pathways. Here, we identify the LegC3 secreted effector protein from L. pneumophila as able to inhibit a SNARE- and Rab GTPase-dependent membrane fusion pathway in vitro, the homotypic fusion of yeast vacuoles (lysosomes). This vacuole fusion inhibition appeared to be specific, as similar secreted coiled-coiled domain containing proteins from L. pneumophila, LegC7/YlfA and LegC2/YlfB, did not inhibit vacuole fusion. The LegC3-mediated fusion inhibition was reversible by a yeast cytosolic extract, as well as by a purified soluble SNARE, Vam7p. LegC3 blocked the formation of trans-SNARE complexes during vacuole fusion, although we did not detect a direct interaction of LegC3 with the vacuolar SNARE protein complexes required for fusion. Additionally, LegC3 was incapable of inhibiting a defined synthetic model of vacuolar SNARE- driven membrane fusion, further suggesting that LegC3 does not directly inhibit the activity of vacuolar SNAREs, HOPS complex, or Sec17p/18p during membrane fusion. LegC3 is likely utilized by Legionella to modulate eukaryotic membrane fusion events during pathogenesis.	[Bennett, Terry L.; O'Brien, Kevin M.; Starai, Vincent J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Kraft, Shannon M.; Reaves, Barbara J.; Starai, Vincent J.] Infect Dis Univ Georgia, Athens, GA USA; [Mima, Joji] Osaka Univ, Inst Prot Res, Osaka, Japan	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Osaka University	Starai, VJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	vjstarai@uga.edu		Lenz, Shannon/0000-0001-5705-1819	University of Georgia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100913] Funding Source: NIH RePORTER	University of Georgia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	V.J.S. was supported by University of Georgia startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuKwaik Y, 1996, APPL ENVIRON MICROB, V62, P2022, DOI 10.1128/AEM.62.6.2022-2028.1996; Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Arasaki K, 2010, TRAFFIC, V11, P587, DOI 10.1111/j.1600-0854.2010.01050.x; BANTA LM, 1990, MOL CELL BIOL, V10, P4638, DOI 10.1128/MCB.10.9.4638; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Cheever ML, 2006, PROTEIN SCI, V15, P1873, DOI 10.1110/ps.062194906; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez-Moreira E, 2006, INFECT IMMUN, V74, P3285, DOI 10.1128/IAI.01382-05; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Gerrard SR, 2000, TRAFFIC, V1, P45, DOI 10.1034/j.1600-0854.2000.010108.x; Goody Roger S, 2011, Commun Integr Biol, V4, P72, DOI 10.4161/cib.4.1.13857; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Ivanov SS, 2010, J BIOL CHEM, V285, P34686, DOI 10.1074/jbc.M110.170746; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; Katz L, 2000, MOL BIOL CELL, V11, P3849, DOI 10.1091/mbc.11.11.3849; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Li JC, 2002, BIOTECHNOL PROGR, V18, P831, DOI 10.1021/bp020066t; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merz AJ, 2004, P NATL ACAD SCI USA, V101, P11548, DOI 10.1073/pnas.0404583101; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; NASH TW, 1984, J CLIN INVEST, V74, P771, DOI 10.1172/JCI111493; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; ROTHMAN JE, 1994, ADV SEC MESS PHOSPH, V29, P81; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Slusarewicz P, 1997, P NATL ACAD SCI USA, V94, P5582, DOI 10.1073/pnas.94.11.5582; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; WADA Y, 1990, MOL CELL BIOL, V10, P2214, DOI 10.1128/MCB.10.5.2214; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Webb GC, 1997, GENETICS, V147, P467; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEIDMAN PJ, 1989, J CELL BIOL, V108, P1589, DOI 10.1083/jcb.108.5.1589; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu ZY, 1996, J CELL BIOL, V132, P787, DOI 10.1083/jcb.132.5.787	92	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56798	10.1371/journal.pone.0056798	http://dx.doi.org/10.1371/journal.pone.0056798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437241	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200165
J	Cagnazzi, D; Parra, GJ; Westley, S; Harrison, PL				Cagnazzi, Daniele; Parra, Guido J.; Westley, Shane; Harrison, Peter L.			At the Heart of the Industrial Boom: Australian Snubfin Dolphins in the Capricorn Coast, Queensland, Need Urgent Conservation Action	PLOS ONE			English	Article							PACIFIC HUMPBACK DOLPHINS; ORCAELLA-BREVIROSTRIS; SITE FIDELITY; HOME-RANGE; POPULATION; SURVIVAL; EXTINCTION; MANAGEMENT; ABUNDANCE; HABITAT	The recent industrial boom along the Australian coastline has increased concerns about the long term conservation of snubfin dolphins along the Queensland coast. National assessment of the conservation status and management of the Australian snubfin dolphin is currently hindered by the lack of adequate biological and ecological information throughout most of its range. In response to the issue of determining the conservation status of species with broad ranges, the IUCN has provided a framework for assessing the threatened status of regional populations. In this study we assessed the conservation status of a small geographically isolated population of snubfin dolphins living in the Fitzroy River region, Queensland, Australia, against the IUCN criteria for regional populations. A review of all available sightings data and stranding information indicates that this is the southernmost resident population of snubfin dolphins in Australian waters. The Fitzroy River snubfin dolphin population is composed of less than 100 individuals, with a representative range and core area of less than 400 and 300 km(2) respectively. The area most often used by snubfin dolphins within the representative range and core area was estimated to be about 292 and 191 km(2), respectively. A decrease in representative range, core area and preferred habitat between 14 and 25% is projected to occur if a planned industrial port development were to occur. These results are robust to uncertainty and considering the low level of formal protection and future threats, a classification of this subpopulation under the IUCN Red List as "Endangered'' is appropriate.	[Cagnazzi, Daniele; Harrison, Peter L.] So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; [Parra, Guido J.] Flinders Univ S Australia, Sch Biol Sci, Cetacean Ecol Behav & Evolut Lab, Adelaide, SA 5001, Australia; [Parra, Guido J.] S Australian Res & Dev Inst SARDI, W Beach, Australia; [Westley, Shane] Fitzroy Basin Assoc Inc Level 1, Rockhampton, Qld, Australia	Southern Cross University; Flinders University South Australia	Cagnazzi, D (corresponding author), So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia.	daniele.cagnazzi@scu.edu.au	Cagnazzi, Daniele/AAT-6290-2020; Harrison, Peter L/B-4763-2011	Cagnazzi, Daniele/0000-0002-7901-4565; Harrison, Peter L/0000-0002-4048-2409; Parra, Guido J./0000-0002-1284-4898	Fitzroy River Basin Association trough the Natural Heritage Trust and Care of Your Country programs of the Australian Federal government	Fitzroy River Basin Association trough the Natural Heritage Trust and Care of Your Country programs of the Australian Federal government	Funding was provided by the Fitzroy River Basin Association trough the Natural Heritage Trust and Care of Your Country programs of the Australian Federal government (Website: www.fba.org.au/). The funders had no role in study design, data collection and analysis, and decision to publish, but only on the project development and manuscript preparation. No limitations have been imposed by the funding agencies.	Allen Simon J., 2012, Pacific Conservation Biology, V18, P56; Anderson DR, 1998, J APPL STAT, V25, P263, DOI 10.1080/02664769823250; Baker JD, 2007, P ROY SOC B-BIOL SCI, V274, P407, DOI 10.1098/rspb.2006.3737; Beasley I, 2005, MAR MAMMAL SCI, V21, P365, DOI 10.1111/j.1748-7692.2005.tb01239.x; Bejder L, 2012, CONSERV BIOL, V18; Beyer H. L., 2011, GEOSPATIAL MODELING; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burnham K. P., 1998, MODEL SELECTION INFE; Cagnazzi D., 2011, CONSERVATION STATUS; Cagnazzi DD, 2011, MAR MAMMAL SCI, V27, P255, DOI 10.1111/j.1748-7692.2009.00296.x; Chilvers BL, 2005, BIOL CONSERV, V122, P559, DOI 10.1016/j.biocon.2004.08.013; Chilvers BL, 2003, MAR MAMMAL SCI, V19, P85, DOI 10.1111/j.1748-7692.2003.tb01094.x; Choquet R., 2005, U CARE 2 2 USERS MAN; Corkrey R, 2008, J AM STAT ASSOC, V103, P948, DOI 10.1198/016214507000001256; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; DEHP, 2012, STRAND HOT SPOTS; Department of Sustainability Environment Water Population and Communities, 2013, ORC HEINS SPEC PROF; Douvere F, 2012, REACTIVE MONITORING; Eberhard R, 2012, FITZROY RIVER ESTUAR; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT V 10; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Frere CH, 2011, CONSERV GENET, V12, P1633, DOI 10.1007/s10592-011-0242-9; Gardenfors U, 2001, CONSERV BIOL, V15, P1206, DOI 10.1046/j.1523-1739.2001.00112.x; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; GBRMPA, 2009, GREAT BARR REEF OUTL GREAT BARR REEF OUTL; GBRMPA, 2007, OP POL WHAL DOLPH CO; Gladstone PC, 2012, W BASIN PORT DEV ENV; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hood G.M., 2010, POPTOOLS VERSION 3 2; IUCN, 2003, GUID APPL IUCN RED L; Jaramillo-Legorreta A, 2007, CONSERV BIOL, V21, P1653, DOI 10.1111/j.1523-1739.2007.00825.x; Jefferson TA, 2009, MAR POLICY, V33, P305, DOI 10.1016/j.marpol.2008.07.011; Karczmarski L, 1996, ECOLOGICAL STUDIES H; Kreb D, 2005, ORYX, V39, P178, DOI 10.1017/S0030605305000426; Lawler I. R., 2007, CLIMATE CHANGE GREAT, P497; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Manly B., 1993, RESOURCE SELECTION A; Manly BFJ, 1997, RANDOMIZATION BOOTST; Michell G, 2010, FITROY TERMINAL INNO; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Parra GJ, 2002, RAFFLES B ZOOL, P141; Parra GJ, 2006, J ANIM ECOL, V75, P862, DOI 10.1111/j.1365-2656.2006.01104.x; Parra GJ, 2006, ECOGRAPHY, V29, P396; Paterson R.A., 1998, Memoirs of the Queensland Museum, V42, P554; Pledger S., 2007, RESOURCE SELECTION T; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pradel R., 1993, P29; Rayment W, 2009, MAR MAMMAL SCI, V25, P537, DOI 10.1111/j.1748-7692.2008.00271.x; Reeves RR, 2008, SOUSA CHINENSIS E TA; Ross G.J., 2006, REV CONSERVATION STA; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Seabloom EW, 2002, P NATL ACAD SCI USA, V99, P11229, DOI 10.1073/pnas.162064899; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; SEBER GAF, 1992, INT STAT REV, V60, P129, DOI 10.2307/1403646; Slooten E, 2010, AQUAT CONSERV, V20, P334, DOI 10.1002/aqc.1084; Smith BD, 2004, IUCN 2012 IUCN RED L; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Taylor BL, 2000, CONSERV BIOL, V14, P1243, DOI 10.1046/j.1523-1739.2000.99409.x; Taylor BL, 2007, ADM REP; Turvey ST, 2010, P ROY SOC B-BIOL SCI, V277, P3139, DOI 10.1098/rspb.2010.0584; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Wang JY, 2007, MAMMALIA, V71, P157, DOI 10.1515/MAMM.2007.032; White G.C., 2002, P 2 INT WILDL MAN C, P368; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Xstrata, 2012, BAL ISL COAL EXP TER	69	38	39	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56729	10.1371/journal.pone.0056729	http://dx.doi.org/10.1371/journal.pone.0056729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437225	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200154
J	Delestras, S; Roustit, M; Bedouch, P; Minoves, M; Dobremez, V; Mazet, R; Lehmann, A; Baudrant, M; Allenet, B				Delestras, Stephanie; Roustit, Matthieu; Bedouch, Pierrick; Minoves, Melanie; Dobremez, Valerie; Mazet, Roseline; Lehmann, Audrey; Baudrant, Magalie; Allenet, Benoit			Comparison between Two Generic Questionnaires to Assess Satisfaction with Medication in Chronic Diseases	PLOS ONE			English	Article							ADHERENCE; PERSISTENCE; VALIDATION; PREDICTORS; MIGRAINE	Objective: The objective of this work was to compare two generic questionnaires assessing patients' satisfaction with medication. In addition we tested whether satisfaction can predict adherence to medication regimens in patients with chronic diseases, and which dimensions of satisfaction are most involved. Methods: This prospective, observational study was conducted over one year in a heterogeneous population of patients with various chronic diseases. Satisfaction with medication was assessed by using the TSQM (R) vII and the SatMed-Q (R) questionnaires, and adherence to treatment was assessed with the Morisky-Green questionnaire. Clinical pharmacists interviewed patients to collect clinical, demographic and therapeutic data. Results: 190 patients were enrolled. Both questionnaires showed excellent reliability and correlation was high (R = 0.70; p < 0.001). Adherence was correlated with satisfaction with medication whether assessed with the SatMed-Q (R) (R = 0.23; p = 0.002) or the TSQM (R) (R = 0.17; p = 0.02). Among different dimensions of satisfaction, convenience of use and side effects are prominent predictors of adherence. Conclusion: Adherence is related to the patient's satisfaction with medication whether assessed with the TSQM (R) vII or the SatMed-Q (R). Therefore, these simple questionnaires could be used as predictive tools to identify patients whos' adherence needs to be improved.	[Delestras, Stephanie; Bedouch, Pierrick; Minoves, Melanie; Dobremez, Valerie; Mazet, Roseline; Lehmann, Audrey; Baudrant, Magalie; Allenet, Benoit] Grenoble Univ Hosp, Dept Pharm, Grenoble, France; [Roustit, Matthieu] Grenoble Univ Hosp, Clin Res Ctr, Inserm CIC003, Grenoble, France; [Delestras, Stephanie; Bedouch, Pierrick; Baudrant, Magalie; Allenet, Benoit] TIMC UMR CNRS 5525, Grenoble, France; [Roustit, Matthieu; Bedouch, Pierrick; Allenet, Benoit] Univ Grenoble 1, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Roustit, M (corresponding author), Grenoble Univ Hosp, Clin Res Ctr, Inserm CIC003, Grenoble, France.	MRoustit@chu-grenoble.fr	Allenet, Benoit/M-5928-2014; Der-Avakian, Andre/Q-5201-2018; Young, Jared W/G-9601-2012; Roustit, Matthieu/M-6927-2014; Bedouch, Pierrick/M-6169-2014	Roustit, Matthieu/0000-0003-4475-1626; Bedouch, Pierrick/0000-0003-2245-0160; Mazet, Roseline/0000-0002-1841-6691	Grenoble University Hospital; Pfizer; Abbott	Grenoble University Hospital; Pfizer(Pfizer); Abbott(Abbott Laboratories)	The investigators received research grants from Grenoble University Hospital; Pfizer; and Abbott to finance the linguistic validation of the SatMed-Q(r) and study conduction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro K, 2004, QUAL LIFE RES, V14, P1791; Atkinson Mark J, 2004, Health Qual Life Outcomes, V2, P12, DOI 10.1186/1477-7525-2-12; Atkinson MJ, 2005, VALUE HEALTH, V8, pS9, DOI 10.1111/j.1524-4733.2005.00066.x; Barbosa CD, 2012, PATIENT PREFER ADHER, V6, P39, DOI 10.2147/PPA.S24752; Bharmal M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-36; Biderman A, 2009, FAM PRACT, V26, P102, DOI 10.1093/fampra/cmp007; Cady RK, 2009, HEADACHE, V49, P386, DOI 10.1111/j.1526-4610.2009.01343.x; Cobden DS, 2010, VALUE HEALTH, V13, P138, DOI 10.1111/j.1524-4733.2009.00587.x; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Gallwitz B, 2011, DIABETES CARE, V34, P604, DOI 10.2337/dc10-1900; Garfield S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-149; Girerd X, 2001, PRESSE MED, V30, P1044; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Hirsh AT, 2005, CLIN J PAIN, V21, P302, DOI 10.1097/01.ajp.0000113057.92184.90; Hughes D, 2007, VALUE HEALTH, V10, P498, DOI 10.1111/j.1524-4733.2007.00205.x; Li PX, 2010, VALUE HEALTH, V13, P805, DOI 10.1111/j.1524-4733.2010.00764.x; Luciani R, 2000, CEPHALALGIA, V20, P122, DOI 10.1046/j.1468-2982.2000.00030.x; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pollack MF, 2010, DIABETES RES CLIN PR, V87, P204, DOI 10.1016/j.diabres.2009.11.023; Rosa F, 2012, CLIN DRUG INVEST, V32, P267, DOI 10.2165/11599080-000000000-00000; Ruiz MA, 2008, VALUE HEALTH, V11, P913, DOI 10.1111/j.1524-4733.2008.00323.x; Seeburger JL, 2012, HEADACHE, V52, P57, DOI 10.1111/j.1526-4610.2011.02027.x; Strojek K, 2009, CURR MED RES OPIN, V25, P2887, DOI 10.1185/03007990903354674	23	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56247	10.1371/journal.pone.0056247	http://dx.doi.org/10.1371/journal.pone.0056247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437104	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200052
J	Giachello, CNG; Premoselli, F; Montarolo, PG; Ghirardi, M				Giachello, Carlo Natale Giuseppe; Premoselli, Federica; Montarolo, Pier Giorgio; Ghirardi, Mirella			Pentylenetetrazol-Induced Epileptiform Activity Affects Basal Synaptic Transmission and Short-Term Plasticity in Monosynaptic Connections	PLOS ONE			English	Article							SYNAPSIN-I PHOSPHORYLATION; READILY RELEASABLE POOL; ACTIVATED PROTEIN-KINASE; PAIRED-PULSE FACILITATION; INDUCED BURSTING ACTIVITY; RAB3 EFFECTOR PROTEIN; VESICLE POOLS; POSTTETANIC POTENTIATION; BUCCAL GANGLIA; HELIX-POMATIA	Epileptic activity is generally induced in experimental models by local application of epileptogenic drugs, including pentylenetetrazol (PTZ), widely used on both vertebrate and invertebrate neurons. Despite the high prevalence of this neurological disorder and the extensive research on it, the cellular and molecular mechanisms underlying epileptogenesis still remain unclear. In this work, we examined PTZ-induced neuronal changes in Helix monosynaptic circuits formed in vitro, as a simpler experimental model to investigate the effects of epileptiform activity on both basal release and post-tetanic potentiation (PTP), a form of short-term plasticity. We observed a significant enhancement of basal synaptic strength, with kinetics resembling those of previously described use-dependent forms of plasticity, determined by changes in estimated quantal parameters, such as the readily releasable pool and the release probability. Moreover, these neurons exhibited a strong reduction in PTP expression and in its decay time constant, suggesting an impairment in the dynamic reorganization of synaptic vesicle pools following prolonged stimulation of synaptic transmission. In order to explain this imbalance, we determined whether epileptic activity is related to the phosphorylation level of synapsin, which is known to modulate synaptic plasticity. Using western blot and immunocytochemical staining we found a PTZ-dependent increase in synapsin phosphorylation at both PKA/CaMKI/IV and MAPK/Erk sites, both of which are important for modulating synaptic plasticity. Taken together, our findings suggest that prolonged epileptiform activity leads to an increase in the synapsin phosphorylation status, thereby contributing to an alteration of synaptic strength in both basal condition and tetanus-induced potentiation.	[Giachello, Carlo Natale Giuseppe; Premoselli, Federica; Montarolo, Pier Giorgio; Ghirardi, Mirella] Univ Turin, Dept Neurosci, Physiol Sect, Turin, Italy; [Montarolo, Pier Giorgio; Ghirardi, Mirella] Ist Nazl Neurosci, Turin, Italy	University of Turin	Giachello, CNG (corresponding author), Univ Turin, Dept Neurosci, Physiol Sect, Turin, Italy.	carlo.giachello@unito.it	ghirardi, mirella/AEQ-0420-2022		Italian Ministry of the University and Research (PRIN); Compagnia di San Paolo	Italian Ministry of the University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo(Compagnia di San Paolo)	This work was supported by Grants from Italian Ministry of the University and Research (PRIN 2009 grants to PGM) and Compagnia di San Paolo (to PGM and MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTRUP U, 1988, BRAIN RES, V456, P401, DOI 10.1016/0006-8993(88)90248-X; ALTRUP U, 1991, COMP BIOCHEM PHYS C, V99, P579, DOI 10.1016/0742-8413(91)90290-A; Altrup U, 2003, BRAIN RES, V975, P73, DOI 10.1016/S0006-8993(03)02588-5; Altrup U, 1994, Neurosci Behav Physiol, V24, P23, DOI 10.1007/BF02355649; Altrup U, 2004, CURR DRUG TARGETS, V5, P473, DOI 10.2174/1389450043345344; ALTRUP U, 1987, BRAIN RES, V414, P271, DOI 10.1016/0006-8993(87)90007-2; APPLEGATE MD, 1988, J NEUROSCI, V8, P1096; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BENFENATI F, 1989, J CELL BIOL, V108, P1863, DOI 10.1083/jcb.108.5.1863; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; Berkeley JL, 2002, J NEUROCHEM, V82, P192, DOI 10.1046/j.1471-4159.2002.00977.x; BLOOM FE, 1979, P NATL ACAD SCI USA, V76, P5982, DOI 10.1073/pnas.76.11.5982; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; BOULTON CL, 1993, EUR J PHARMACOL, V236, P131, DOI 10.1016/0014-2999(93)90235-A; Bracey JM, 2009, BRAIN RES, V1283, P167, DOI 10.1016/j.brainres.2009.05.066; Casadio A, 2004, J NEUROSCI RES, V75, P32, DOI 10.1002/jnr.10841; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CECCARELLI B, 1980, PHYSIOL REV, V60, P396, DOI 10.1152/physrev.1980.60.2.396; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; CHALAZONITIS N, 1968, CR SOC BIOL, V162, P1552; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Christoffersen GRJ, 1997, PROG NEUROBIOL, V53, P45, DOI 10.1016/S0301-0082(97)00031-2; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DECAMILLI P, 1979, P NATL ACAD SCI USA, V76, P5977; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Doussau F, 1998, J NEUROSCI, V18, P3147; Etholm L, 2012, EPILEPSY RES, V99, P252, DOI 10.1016/j.eplepsyres.2011.12.004; Etholm L, 2009, EPILEPSY BEHAV, V14, P582, DOI 10.1016/j.yebeh.2009.02.021; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Felmy F, 2006, J NEUROPHYSIOL, V96, P2840, DOI 10.1152/jn.00783.2006; Fioravante D, 2007, J NEUROPHYSIOL, V98, P3568, DOI 10.1152/jn.00604.2007; FISCHER J, 1980, EPILEPSIA, V21, P571, DOI 10.1111/j.1528-1157.1980.tb04311.x; Fiumara F, 2004, J CELL SCI, V117, P5145, DOI 10.1242/jcs.01388; Fiumara F, 2007, J CELL SCI, V120, P3228, DOI 10.1242/jcs.012005; Fornasiero EF, 2012, J NEUROSCI, V32, P12214, DOI 10.1523/JNEUROSCI.1554-12.2012; FRIED G, 1982, P NATL ACAD SCI-BIOL, V79, P2717, DOI 10.1073/pnas.79.8.2717; Gaffield MA, 2006, NEURON, V51, P317, DOI 10.1016/j.neuron.2006.06.031; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Ghirardi M, 1996, INVERTEBR NEUROSCI, V2, P41, DOI 10.1007/BF02336659; Giachello CNG, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/670821; Giachello CNG, 2010, J CELL SCI, V123, P881, DOI 10.1242/jcs.056846; Giovedi S, 2004, J BIOL CHEM, V279, P43769, DOI 10.1074/jbc.M404168200; Giovedi S, 2004, J BIOL CHEM, V279, P43760, DOI 10.1074/jbc.M403293200; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Habets RLP, 2007, J PHYSIOL-LONDON, V581, P467, DOI 10.1113/jphysiol.2006.127365; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Higashima M, 2002, BRAIN RES, V949, P157, DOI 10.1016/S0006-8993(02)02976-1; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HOVORKA J, 1989, NEUROSCI LETT, V107, P179, DOI 10.1016/0304-3940(89)90813-6; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Humeau Y, 2007, J PHYSIOL-LONDON, V583, P983, DOI 10.1113/jphysiol.2007.139899; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kidokoro Y, 2004, BRAIN RES REV, V47, P18, DOI 10.1016/j.brainresrev.2004.05.004; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Kim SM, 2009, P NATL ACAD SCI USA, V106, P4000, DOI 10.1073/pnas.0806064106; Kopanitsa MV, 1997, NEUROPHYSIOLOGY+, V29, P357, DOI 10.1007/BF02463356; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Kuromi H, 2003, J NEUROCYTOL, V32, P551, DOI 10.1023/B:NEUR.0000020610.13554.3c; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; LANGMEIER M, 1980, EPILEPSIA, V21, P255, DOI 10.1111/j.1528-1157.1980.tb04071.x; LANGMEIER M, 1983, EPILEPSIA, V24, P616, DOI 10.1111/j.1528-1157.1983.tb03427.x; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luk CC, 2011, EUR J NEUROSCI, V34, P569, DOI 10.1111/j.1460-9568.2011.07784.x; MADEJA M, 1989, COMP BIOCHEM PHYS C, V94, P585, DOI 10.1016/0742-8413(89)90117-5; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Massobrio P, 2009, NEUROSCI LETT, V467, P121, DOI 10.1016/j.neulet.2009.10.019; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; MATSUMOTO H, 1964, SCIENCE, V144, P193, DOI 10.1126/science.144.3615.193; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Merlo D, 2004, J NEUROCHEM, V89, P654, DOI 10.1111/j.1471-4159.2004.02382.x; Millar AG, 2002, J NEUROSCI, V22, P9661; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; ONOZUKA M, 1987, BIOCHEM PHARMACOL, V36, P1407, DOI 10.1016/0006-2952(87)90106-7; ONOZUKA M, 1986, BRAIN RES, V362, P33, DOI 10.1016/0006-8993(86)91395-8; ONOZUKA M, 1989, GEN PHARMACOL-VASC S, V20, P627, DOI 10.1016/0306-3623(89)90098-0; ONOZUKA M, 1986, EXP NEUROL, V94, P802, DOI 10.1016/0014-4886(86)90260-8; Orenbuch A, 2012, J NEUROSCI, V32, P3969, DOI 10.1523/JNEUROSCI.5058-11.2012; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Pivovarov A S, 2002, Neurosci Behav Physiol, V32, P223, DOI 10.1023/A:1015045920384; PRINCE DA, 1969, ELECTROEN CLIN NEURO, V26, P476, DOI 10.1016/0013-4694(69)90124-2; PURPURA DP, 1966, J NEUROPHYSIOL, V29, P954, DOI 10.1152/jn.1966.29.5.954; Reijmers LGJE, 2000, NEUROSCIENCE, V101, P1023, DOI 10.1016/S0306-4522(00)00394-8; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; SCHULZE H, 1975, NEUROSCI LETT, V1, P277, DOI 10.1016/0304-3940(75)90043-9; SCHULZEBONHAGE A, 1993, COMP BIOCHEM PHYS A, V106, P537, DOI 10.1016/0300-9629(93)90250-8; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Sennepin AD, 2009, ANAL BIOCHEM, V393, P129, DOI 10.1016/j.ab.2009.06.004; Shoji Y, 1998, J NEUROPHYSIOL, V80, P638, DOI 10.1152/jn.1998.80.2.638; SPECKMAN.EJ, 1973, EPILEPSIA, V14, P397, DOI 10.1111/j.1528-1157.1973.tb03979.x; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; STEFFENS H, 1980, ZOOMORPHOLOGIE, V95, P195, DOI 10.1007/BF00998122; SUGAYA E, 1978, SCIENCE, V200, P797, DOI 10.1126/science.644325; SUGAYA E, 1987, BRAIN RES, V416, P183, DOI 10.1016/0006-8993(87)91515-0; Tao-Cheng JH, 2006, NEUROSCIENCE, V141, P1217, DOI 10.1016/j.neuroscience.2006.04.061; TEHRANI MHJ, 1995, EPILEPSY RES, V22, P13, DOI 10.1016/0920-1211(95)00033-7; Upadhaya R, 2011, ANAL BIOCHEM, V419, P342, DOI 10.1016/j.ab.2011.08.014; Ure A, 2006, NEUROSCI LETT, V392, P10, DOI 10.1016/j.neulet.2005.08.045; Valente P, 2012, J NEUROSCI, V32, P5868, DOI 10.1523/JNEUROSCI.5275-11.2012; VALTORTA F, 1988, NEUROSCIENCE, V24, P593, DOI 10.1016/0306-4522(88)90353-3; Vasileva M, 2012, EUR J NEUROSCI, V36, P3005, DOI 10.1111/j.1460-9568.2012.08225.x; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Xi ZQ, 2007, EUR J NEUROL, V14, P865, DOI 10.1111/j.1468-1331.2007.01777.x; Yechikhov S, 2001, EPILEPSY RES, V46, P15, DOI 10.1016/S0920-1211(01)00255-8; Zhao Y, 2004, J NEUROPHYSIOL, V91, P1500, DOI 10.1152/jn.01019.2003; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	128	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56968	10.1371/journal.pone.0056968	http://dx.doi.org/10.1371/journal.pone.0056968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437283	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200192
J	Ilina, EN; Shitikov, EA; Ikryannikova, LN; Alekseev, DG; Kamashev, DE; Malakhova, MV; Parfenova, TV; Afanas'ev, MV; Ischenko, DS; Bazaleev, NA; Smirnova, TG; Larionova, EE; Chernousova, LN; Beletsky, AV; Mardanov, AV; Ravin, NV; Skryabin, KG; Govorun, VM				Ilina, Elena N.; Shitikov, Egor A.; Ikryannikova, Larisa N.; Alekseev, Dmitry G.; Kamashev, Dmitri E.; Malakhova, Maja V.; Parfenova, Tatjana V.; Afanas'ev, Maxim V.; Ischenko, Dmitry S.; Bazaleev, Nikolai A.; Smirnova, Tatjana G.; Larionova, Elena E.; Chernousova, Larisa N.; Beletsky, Alexey V.; Mardanov, Andrei V.; Ravin, Nikolai V.; Skryabin, Konstantin G.; Govorun, Vadim M.			Comparative Genomic Analysis of Mycobacterium tuberculosis Drug Resistant Strains from Russia	PLOS ONE			English	Article							RIFAMPIN RESISTANCE; ETHAMBUTOL RESISTANCE; ISONIAZID RESISTANCE; POPULATION-GENETICS; EFFLUX PUMP; MUTATIONS; POLYMORPHISM; MECHANISMS; DIVERSITY; EVOLUTION	Tuberculosis caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis (MTB) strains is a growing problem in many countries. The availability of the complete nucleotide sequences of several MTB genomes allows to use the comparative genomics as a tool to study the relationships of strains and differences in their evolutionary history including acquisition of drug-resistance. In our work, we sequenced three genomes of Russian MTB strains of different phenotypes - drug susceptible, MDR and XDR. Of them, MDR and XDR strains were collected in Tomsk (Siberia, Russia) during the local TB outbreak in 1998-1999 and belonged to rare KQ and KY families in accordance with IS6110 typing, which are considered endemic for Russia. Based on phylogenetic analysis, our isolates belonged to different genetic families, Beijing, Ural and LAM, which made the direct comparison of their genomes impossible. For this reason we performed their comparison in the broader context of all M. tuberculosis genomes available in GenBank. The list of unique individual non-synonymous SNPs for each sequenced isolate was formed by comparison with all SNPs detected within the same phylogenetic group. For further functional analysis, all proteins with unique SNPs were ascribed to 20 different functional classes based on Clusters of Orthologous Groups (COG). We have confirmed drug resistant status of our isolates that harbored almost all known drug-resistance associated mutations. Unique SNPs of an XDR isolate CTRI-4(XDR), belonging to a Beijing family were compared in more detail with SNPs of additional 14 Russian XDR strains of the same family. Only type specific mutations in genes of repair, replication and recombination system (COG category L) were found common within this group. Probably the other unique SNPs discovered in CTRI-4(XDR) may have an important role in adaptation of this microorganism to its surrounding and in escape from antituberculosis drugs treatment.	[Ilina, Elena N.; Shitikov, Egor A.; Ikryannikova, Larisa N.; Alekseev, Dmitry G.; Kamashev, Dmitri E.; Malakhova, Maja V.; Parfenova, Tatjana V.; Afanas'ev, Maxim V.; Ischenko, Dmitry S.; Bazaleev, Nikolai A.; Govorun, Vadim M.] Res Inst Phys Chem Med, Moscow, Russia; [Smirnova, Tatjana G.; Larionova, Elena E.; Chernousova, Larisa N.] Cent TB Res Inst RAMS, Moscow, Russia; [Beletsky, Alexey V.; Mardanov, Andrei V.; Ravin, Nikolai V.; Skryabin, Konstantin G.] Ctr Bioengn RAS, Moscow, Russia; [Alekseev, Dmitry G.; Ischenko, Dmitry S.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Research Center of Biotechnology RAS; Russian Academy of Sciences; Moscow Institute of Physics & Technology	Shitikov, EA (corresponding author), Res Inst Phys Chem Med, Moscow, Russia.	egorshtkv@gmail.com	Ilina, Elena N/N-8190-2015; Beletsky, Alexey/AAA-5366-2019; Shitikov, Egor/AAJ-4171-2021; Mardanov, Andrey/S-2294-2016; Ravin, Nikolai V/C-5907-2014; Alexeev, Dmitry/A-6167-2013; Ilina, Elena/ABI-1172-2020; Govorun, Vadim M/A-9043-2018; Shitikov, Egor/Q-2520-2017; Ikryannikova, Larisa/AAT-7326-2021; Kamashev, Dmitri/K-6560-2017	Ilina, Elena N/0000-0003-0130-5079; Beletsky, Alexey/0000-0002-7611-2354; Shitikov, Egor/0000-0002-4865-6004; Mardanov, Andrey/0000-0002-8245-8757; Alexeev, Dmitry/0000-0003-0783-1176; Ilina, Elena/0000-0003-0130-5079; Shitikov, Egor/0000-0002-4865-6004; Kamashev, Dmitri/0000-0003-4158-5300; Ravin, Nikolai/0000-0002-1456-1832; Larionova, Elena/0000-0002-6032-175X	Ministry of Education and Science of the Russian Federation [16.522.11.2003]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was partly supported by 16.522.11.2003 grant of the Ministry of Education and Science of the Russian Federation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Andreevskaia S N, 2006, Probl Tuberk Bolezn Legk, P29; Brimacombe M, 2007, ANTIMICROB AGENTS CH, V51, P4157, DOI 10.1128/AAC.00619-07; Brossier F, 2011, ANTIMICROB AGENTS CH, V55, P355, DOI 10.1128/AAC.01030-10; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Brzostek A, 2004, INT J TUBERC LUNG D, V8, P1032; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P1176; Chakravorty S, 2008, J CLIN MICROBIOL, V46, P2555, DOI 10.1128/JCM.00666-08; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Das S, 2009, J BIOSCIENCES, V34, P397, DOI 10.1007/s12038-009-0046-y; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Farnia P, 2010, INT J CLIN EXP MED, V3, P308; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fukuda M, 1999, J ANTIMICROB CHEMOTH, V43, P281, DOI 10.1093/jac/43.2.281; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Gutacker MM, 2002, GENETICS, V162, P1533; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kim S, 2011, PROTEINS, V79, P2983, DOI 10.1002/prot.23119; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kurepina N, 2005, J CLIN MICROBIOL, V43, P2148, DOI 10.1128/JCM.43.5.2148-2154.2005; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2200, DOI 10.1128/AAC.49.6.2200-2209.2005; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Moodley P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017513; Motiwala AS, 2010, J INFECT DIS, V201, P881, DOI 10.1086/650999; Nisa S, 2010, J ANTIMICROB CHEMOTH, V65, P2347, DOI 10.1093/jac/dkq311; Pasca MR, 2004, ANTIMICROB AGENTS CH, V48, P3175, DOI 10.1128/AAC.48.8.3175-3178.2004; Plinke C, 2006, ANTIMICROB AGENTS CH, V50, P1900, DOI 10.1128/AAC.50.5.1900-1902.2006; Punga VV, 2009, INT J TUBERC LUNG D, V13, P1309; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schurch AC, 2011, INFECT GENET EVOL, V3, P3; Schurek KN, 2008, ANTIMICROB AGENTS CH, V52, P4213, DOI 10.1128/AAC.00507-08; Shah N. S., 2007, Morbidity and Mortality Weekly Report, V56, P250; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Shin SS, 2010, AM J RESP CRIT CARE, V182, P426, DOI 10.1164/rccm.200911-1768OC; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Suzuki Y, 1998, J CLIN MICROBIOL, V36, P1220, DOI 10.1128/JCM.36.5.1220-1225.1998; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; The Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being of the Russian Federation, 2009, STAT REP SAN EP SIT; Toungoussova OS, 2005, EUR J CLIN MICROBIOL, V24, P202, DOI 10.1007/s10096-005-1284-z; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Velayati AA, 2009, CHEMOTHERAPY, V55, P303, DOI 10.1159/000226425; Via LE, 2010, J CLIN MICROBIOL, V48, P402, DOI 10.1128/JCM.01476-09; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Wade MM, 2004, FRONT BIOSCI-LANDMRK, V9, P975, DOI 10.2741/1289; Wang QZ, 2007, J PROTEOME RES, V6, P4564, DOI 10.1021/pr070242z; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; World Health Organization, 2010, WHOHTMTB20107; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhang YY, 2011, J BACTERIOL, V193, P5591, DOI 10.1128/JB.05452-11	85	39	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56577	10.1371/journal.pone.0056577	http://dx.doi.org/10.1371/journal.pone.0056577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437175	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200111
J	Lee, EJ; De Winter, JM; Buck, D; Jasper, JR; Malik, FI; Labeit, S; Ottenheijm, CA; Granzier, H				Lee, Eun-Jeong; De Winter, Josine M.; Buck, Danielle; Jasper, Jeffrey R.; Malik, Fady I.; Labeit, Siegfried; Ottenheijm, Coen A.; Granzier, Henk			Fast Skeletal Muscle Troponin Activation Increases Force of Mouse Fast Skeletal Muscle and Ameliorates Weakness Due to Nebulin-Deficiency	PLOS ONE			English	Article							THIN FILAMENT LENGTH; NEMALINE MYOPATHY; DEPENDENT ACTIVATION; ACTIN; SARCOMERE; GENE; FIBERS; TITIN; MUTATIONS; DISEASE	The effect of the fast skeletal muscle troponin activator, CK-2066260, on calcium-induced force development was studied in skinned fast skeletal muscle fibers from wildtype (WT) and nebulin deficient (NEB KO) mice. Nebulin is a sarcomeric protein that when absent (NEB KO mouse) or present at low levels (nemaline myopathy (NM) patients with NEB mutations) causes muscle weakness. We studied the effect of fast skeletal troponin activation on WT muscle and tested whether it might be a therapeutic mechanism to increase muscle strength in nebulin deficient muscle. We measured tension-pCa relations with and without added CK-2066260. Maximal active tension in NEB KO tibialis cranialis fibers in the absence of CK-2066260 was similar to 60% less than in WT fibers, consistent with earlier work. CK-2066260 shifted the tension-calcium relationship leftwards, with the largest relative increase (up to 8-fold) at low to intermediate calcium levels. This was a general effect that was present in both WT and NEB KO fiber bundles. At pCa levels above similar to 6.0 (i.e., calcium concentrations <1 mu M), CK-2066260 increased tension of NEB KO fibers to beyond that of WT fibers. Crossbridge cycling kinetics were studied by measuring k(tr) (rate constant of force redevelopment following a rapid shortening/restretch). CK-2066260 greatly increased k(tr) at submaximal activation levels in both WT and NEB KO fiber bundles. We also studied the sarcomere length (SL) dependence of the CK-2066260 effect (SL 2.1 mu m and 2.6 mu m) and found that in the NEB KO fibers, CK-2066260 had a larger effect on calcium sensitivity at the long SL. We conclude that fast skeletal muscle troponin activation increases force at submaximal activation in both wildtype and NEB KO fiber bundles and, importantly, that this troponin activation is a potential therapeutic mechanism for increasing force in NM and other skeletal muscle diseases with loss of muscle strength.	[Lee, Eun-Jeong; Buck, Danielle; Ottenheijm, Coen A.; Granzier, Henk] Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA; [De Winter, Josine M.; Ottenheijm, Coen A.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands; [Jasper, Jeffrey R.; Malik, Fady I.] Cytokinetics Inc, Res & Early Dev, San Francisco, CA USA; [Labeit, Siegfried] Heidelberg Univ, Univ Med Mannheim, Dept Integrat Pathophysiol, Mannheim, Germany	University of Arizona; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg	Granzier, H (corresponding author), Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA.	Granzier@email.arizona.edu			A Foundation for Building Strength in Nemaline Myopathy; NIH [AR05387]; SarcoSI; NEMMYOP; VIDI [016.126.319]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053897] Funding Source: NIH RePORTER	A Foundation for Building Strength in Nemaline Myopathy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SarcoSI; NEMMYOP; VIDI(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Generous support by 'A Foundation for Building Strength in Nemaline Myopathy' is acknowledged. Additional support from NIH AR05387 (HG), SarcoSI and NEMMYOP(SL and CACO) and a VIDI grant (016.126.319) to CACO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Chandra M, 2009, J BIOL CHEM, V284, P30889, DOI 10.1074/jbc.M109.049718; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GRANZIER HLM, 1991, AM J PHYSIOL, V260, pC1060, DOI 10.1152/ajpcell.1991.260.5.C1060; Huxley HE, 2004, EUR J BIOCHEM, V271, P1403, DOI 10.1111/j.1432-1033.2004.04044.x; JASMIN BJ, 1987, J APPL PHYSIOL, V63, P713, DOI 10.1152/jappl.1987.63.2.713; JIN JP, 1991, J BIOL CHEM, V266, P21215; JIN JP, 1991, FEBS LETT, V281, P93, DOI 10.1016/0014-5793(91)80366-B; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; Kazmierski ST, 2003, J MOL BIOL, V328, P835, DOI 10.1016/S0022-2836(03)00348-6; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Konhilas JP, 2002, PFLUG ARCH EUR J PHY, V445, P305, DOI 10.1007/s00424-002-0902-1; Konhilas JP, 2002, J PHYSIOL-LONDON, V544, P225, DOI 10.1113/jphysiol.2002.024505; KRUGER M, 1991, J CELL BIOL, V115, P97, DOI 10.1083/jcb.115.1.97; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; LAING N, 1995, NAT GENET, V10, P249, DOI 10.1038/ng0695-249a; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Lawlor MW, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-23; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; METZGER JM, 1990, SCIENCE, V247, P1088, DOI 10.1126/science.2309121; Moreno-Gonzalez A, 2007, J PHYSIOL-LONDON, V579, P313, DOI 10.1113/jphysiol.2006.124164; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Ottenheijm CAC, 2006, AM J RESP CRIT CARE, V173, P527, DOI 10.1164/rccm.200507-1056OC; Ottenheijm CAC, 2010, J STRUCT BIOL, V170, P334, DOI 10.1016/j.jsb.2009.11.013; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; Pappas CT, 2010, J CELL BIOL, V189, P859, DOI 10.1083/jcb.201001043; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Regnier M, 1996, BIOPHYS J, V71, P2786, DOI 10.1016/S0006-3495(96)79471-7; Russell AJ, 2012, NAT MED, V18, P452, DOI 10.1038/nm.2618; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; WANG SM, 1988, J CELL BIOL, V107, P1075, DOI 10.1083/jcb.107.3.1075; WANG SM, 1985, J MUSCLE RES CELL M, V6, P293, DOI 10.1007/BF00713171; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242; WRIGHT J, 1993, J MUSCLE RES CELL M, V14, P476, DOI 10.1007/BF00297210	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55861	10.1371/journal.pone.0055861	http://dx.doi.org/10.1371/journal.pone.0055861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437068	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200027
J	Leroux-Roels, G; Maes, C; Clement, F; van Engelenburg, F; van den Dobbelsteen, M; Adler, M; Amacker, M; Lopalco, L; Bomsel, M; Chalifour, A; Fleury, S				Leroux-Roels, Geert; Maes, Cathy; Clement, Frederic; van Engelenburg, Frank; van den Dobbelsteen, Marieke; Adler, Michael; Amacker, Mario; Lopalco, Lucia; Bomsel, Morgane; Chalifour, Anick; Fleury, Sylvain			Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL REGION; EXPOSED SERONEGATIVE INDIVIDUALS; GENITAL-TRACT SECRETIONS; INFLUENZA-A VIRUSES; FC-ALPHA-RI; ANTIBODY-RESPONSES; IMMUNO-PCR; NEUTRALIZING ANTIBODIES; EPITHELIAL TRANSCYTOSIS	Mucosal antibodies harboring various antiviral activities may best protect mucosal surfaces against early HIV-1 entry at mucosal sites and they should be ideally induced by prophylactic HIV-1 vaccines for optimal prevention of sexually transmitted HIV-1. A phase I, double-blind, randomized, placebo-controlled trial was conducted in twenty-four healthy HIV-uninfected young women. The study objectives were to assess the safety, tolerability and immunogenicity of virosomes harboring surface HIV-1 gp41-derived P1 lipidated peptides (MYM-V101). Participants received placebo or MYM-V101 vaccine at 10 mu g/dose or 50 mu g/dose intramuscularly at week 0 and 8, and intranasally at week 16 and 24. MYM-V101 was safe and well-tolerated at both doses administered by the intramuscular and intranasal routes, with the majority of subjects remaining free of local and general symptoms. P1-specific serum IgGs and IgAs were induced in all high dose recipients after the first injection. After the last vaccination, vaginal and rectal P1-specific IgGs could be detected in all high dose recipients. Approximately 63% and 43% of the low and high dose recipients were respectively tested positive for vaginal P1-IgAs, while 29% of the subjects from the high dose group tested positive for rectal IgAs. Serum samples had total specific IgG and IgA antibody concentrations >= 0.4 mu g/mL, while mucosal samples were usually below 0.01 mu g/mL. Vaginal secretions from MYM-V101 vaccinated subjects were inhibiting HIV-1 transcytosis but had no detectable neutralizing activity. P1-specific Th1 responses could not be detected on PBMC. This study demonstrates the excellent safety and tolerability of MYM-V101, eliciting systemic and mucosal antibodies in the majority of subjects. Vaccine-induced mucosal anti-gp41 antibodies toward conserved gp41 motifs were harboring HIV-1 transcytosis inhibition activity and may contribute to reduce sexually-transmitted HIV-1. Trial Registration: ClinicalTrials.gov NCT01084343 http://www.clinicaltrials.gov/ct2/show/NCT01084343?term=NCT01084343&rank=1	[Leroux-Roels, Geert; Maes, Cathy; Clement, Frederic] Ghent Univ Hosp, Ctr Vaccinol CEVAC, Ghent, Belgium; [van Engelenburg, Frank; van den Dobbelsteen, Marieke] Kinesis Pharma BV, Breda, Netherlands; [Adler, Michael] Chimera Biotec GmbH, Dortmund, Germany; [Amacker, Mario] Pev Biotech AG, Ittigen Bern, Switzerland; [Lopalco, Lucia] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Bomsel, Morgane] Univ Paris 05, Cochin Inst, Cell Biol & Host Pathogen Interact Dept, Paris, France; [Bomsel, Morgane] CNRS, UMR8104, Paris, France; [Bomsel, Morgane] INSERM, U1016, Paris, France; [Chalifour, Anick; Fleury, Sylvain] Mymetics Corp, Epalinges, Switzerland	Ghent University; Ghent University Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fleury, S (corresponding author), Mymetics Corp, Epalinges, Switzerland.	sylvain.fleury@mymetics.com	, Lopalco/AAN-2429-2020; Maes, Cathy/P-8368-2018; Bomsel, Morgane/GSN-1948-2022; Clement, Frederic P/B-2204-2009	Maes, Cathy/0000-0001-5932-2272; Clement, Frederic P/0000-0002-2720-3655; Bomsel, Morgane/0000-0002-9577-7474; Lopalco, Lucia/0000-0003-3812-1759	Mymetics Corporation; Mymetics	Mymetics Corporation; Mymetics	This study was sponsored by Mymetics Corporation that is funded through private investments. The investors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mymetics Corporation is the sole sponsor and it does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; GL-R, CM, FC, FE, MD, M. Adler, M. Amacker, LL and MB received hononaria as consultants for Mymetics as sponsor. AC and SF are Mymetics employees. MB and SF own equity in the company. The commercial company's affiliations of FE, MD, M. Adler, M. Amacker, AC and SF do not alter the authors' ability to adhere to PLOS ONE policies on sharing data and materials.	Adler M, 2003, BIOCHEM BIOPH RES CO, V308, P240, DOI 10.1016/S0006-291X(03)01364-0; Adler M, 2008, ANALYST, V133, P702, DOI 10.1039/b718587c; Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Anderson D, 2011, AM J REPROD IMMUNOL, V65, P220, DOI 10.1111/j.1600-0897.2010.00941.x; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Anderson DJ, 1998, AIDS RES HUM RETROV, V14, pS43; Ansari AA, 2004, AUTOIMMUN REV, V3, P530, DOI 10.1016/j.autrev.2004.07.009; Anton PA, 2008, VACCINE, V26, P4617, DOI 10.1016/j.vaccine.2008.05.084; Bakema JE, 2011, MUCOSAL IMMUNOL, V4, P612, DOI 10.1038/mi.2011.36; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bernard NF, 1998, AIDS, V12, P2125, DOI 10.1097/00002030-199816000-00007; Berneman A, 1998, INFECT IMMUN, V66, P4163; Billich Andreas, 2004, Curr Opin Investig Drugs, V5, P214; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Broliden K, 2001, IMMUNOL LETT, V79, P29, DOI 10.1016/S0165-2478(01)00263-2; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Choi RY, 2012, AIDS, V26, P2155, DOI 10.1097/QAD.0b013e328359b99b; Clerici M, 2002, AIDS, V16, P1731, DOI 10.1097/00002030-200209060-00004; Coutant J, 2008, FASEB J, V22, P4338, DOI 10.1096/fj.08-113142; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Devito C, 2002, J ACQ IMMUN DEF SYND, V30, P413, DOI [10.1097/00042560-200208010-00007, 10.1097/01.QAI.0000021664.20213.5A]; Diomede L, 2012, J VIROL; Donadoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009920; Dugast AS, 2011, VIROLOGY, V415, P160, DOI 10.1016/j.virol.2011.03.012; Duval M, 2008, J VIROL, V82, P4671, DOI 10.1128/JVI.02499-07; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Fuchs JD, 2010, JAIDS-J ACQ IMM DEF, V55, pS128, DOI 10.1097/QAI.0b013e3181fbca02; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Herzog C, 2009, VACCINE, V27, P4381, DOI 10.1016/j.vaccine.2009.05.029; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hildesheim A, 1999, J IMMUNOL METHODS, V225, P131, DOI 10.1016/S0022-1759(99)00037-X; Hocini H, 1997, AIDS RES HUM RETROV, V13, P1179, DOI 10.1089/aid.1997.13.1179; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Horton RE, 2009, AIDS RES HUM RETROV, V25, P83, DOI 10.1089/aid.2008.0207; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hwang K.K., 2012, J VIROL; IAVI, 2010, DAT AIDS VACC CAND C; Johansson EL, 2001, INFECT IMMUN, V69, P7481, DOI 10.1128/IAI.69.12.7481-7486.2001; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Maecker Holden T., 2009, V485, P375, DOI 10.1007/978-1-59745-170-3_25; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mestecky J, 2011, AIDS RES HUM RETROV, V27, P469, DOI 10.1089/aid.2010.0169; Mestecky J, 2010, J REPROD IMMUNOL, V85, P81, DOI 10.1016/j.jri.2010.02.003; Mischler R, 2002, VACCINE, V20, pB17, DOI 10.1016/S0264-410X(02)00512-1; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Moser C, 2007, EXPERT REV VACCINES, V6, P711, DOI 10.1586/14760584.6.5.711; Moser C, 2011, EXPERT REV VACCINES, V10, P437, DOI [10.1586/erv.11.15, 10.1586/ERV.11.15]; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Niemeyer CM, 2007, NAT PROTOC, V2, P1918, DOI 10.1038/nprot.2007.267; Otten MA, 2005, J IMMUNOL, V174, P5472, DOI 10.4049/jimmunol.174.9.5472; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pastori C, 2000, J BIOL REG HOMEOS AG, V14, P15; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Peduzzi E, 2008, CLIN IMMUNOL, V127, P188, DOI 10.1016/j.clim.2008.01.012; Pialoux G, 2008, VACCINE, V26, P2657, DOI 10.1016/j.vaccine.2007.11.002; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Plotkin SA, 2013, VACCINES; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Poignard P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042209; Pontesilli O, 1998, J INFECT DIS, V178, P1008, DOI 10.1086/515659; Pudney J, 2011, J REPROD IMMUNOL, V88, P219, DOI 10.1016/j.jri.2011.01.006; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rothaeusler K, 2012, J VIROL, V86, P7098, DOI 10.1128/JVI.00410-12; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; SILVESTRIS F, 1995, CLIN IMMUNOL IMMUNOP, V75, P197, DOI 10.1006/clin.1995.1072; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; TAMURA M, 1991, VIROLOGY, V182, P211, DOI 10.1016/0042-6822(91)90664-W; TAMURA M, 1994, J VIROL, V68, P3499, DOI 10.1128/JVI.68.6.3499-3504.1994; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Tudor D, 2012, P NATL ACAD SCI US; UNAIDS, 2012, GLOB REP UNAIDS REP, P1; van Spriel AB, 1999, J INFECT DIS, V179, P661, DOI 10.1086/314643; Wilschut J, 2009, IMMUNOL LETT, V122, P118, DOI 10.1016/j.imlet.2008.11.006; Yu QG, 2010, CELL MOL IMMUNOL, V7, P334, DOI 10.1038/cmi.2010.8; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zuccotti G, 2007, VACCINE, V25, P6692, DOI 10.1016/j.vaccine.2007.07.013; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	108	53	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55438	10.1371/journal.pone.0055438	http://dx.doi.org/10.1371/journal.pone.0055438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437055	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200017
J	Nagy-Szakal, D; Hollister, EB; Luna, RA; Szigeti, R; Tatevian, N; Smith, CW; Versalovic, J; Kellermayer, R				Nagy-Szakal, Dorottya; Hollister, Emily B.; Luna, Ruth Ann; Szigeti, Reka; Tatevian, Nina; Smith, C. Wayne; Versalovic, James; Kellermayer, Richard			Cellulose Supplementation Early in Life Ameliorates Colitis in Adult Mice	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; DEXTRAN SULFATE SODIUM; HUMAN LARGE-INTESTINE; DIETARY FIBER; ULCERATIVE-COLITIS; COLONIC-MUCOSA; GUT MICROBIOTA; FERMENTATION; DIVERSITY; SEQUENCES	Decreased consumption of dietary fibers, such as cellulose, has been proposed to promote the emergence of inflammatory bowel diseases (IBD: Crohn disease [CD] and ulcerative colitis [UC]) where intestinal microbes are recognized to play an etiologic role. However, it is not known if transient fiber consumption during critical developmental periods may prevent consecutive intestinal inflammation. The incidence of IBD peaks in young adulthood indicating that pediatric environmental exposures may be important in the etiology of this disease group. We studied the effects of transient dietary cellulose supplementation on dextran sulfate sodium (DSS) colitis susceptibility during the pediatric period in mice. Cellulose supplementation stimulated substantial shifts in the colonic mucosal microbiome. Several bacterial taxa decreased in relative abundance (e.g., Coriobacteriaceae [p = 0.001]), and other taxa increased in abundance (e.g., Peptostreptococcaceae [p = 0.008] and Clostridiaceae [p = 0.048]). Some of these shifts persisted for 10 days following the cessation of cellulose supplementation. The changes in the gut microbiome were associated with transient trophic and anticolitic effects 10 days following the cessation of a cellulose-enriched diet, but these changes diminished by 40 days following reversal to a low cellulose diet. These findings emphasize the transient protective effect of dietary cellulose in the mammalian large bowel and highlight the potential role of dietary fibers in amelioration of intestinal inflammation.	[Nagy-Szakal, Dorottya; Kellermayer, Richard] Baylor Coll Med, Dept Pediat, Sect Pediat Gastroenterol, Houston, TX 77030 USA; [Nagy-Szakal, Dorottya; Smith, C. Wayne; Kellermayer, Richard] ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Hollister, Emily B.; Luna, Ruth Ann; Szigeti, Reka; Versalovic, James] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Hollister, Emily B.; Luna, Ruth Ann; Smith, C. Wayne; Versalovic, James; Kellermayer, Richard] Texas Childrens Hosp, Houston, TX 77030 USA; [Tatevian, Nina] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Kellermayer, R (corresponding author), Baylor Coll Med, Dept Pediat, Sect Pediat Gastroenterol, Houston, TX 77030 USA.	kellerma@bcm.edu			Broad Medical Research Program, the Broad Foundation [IBD-0252]; Child Health Research Career Development Agency of the Baylor College of Medicine; Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition, (CCFA) [2426]; United States Department of Agriculture [6250-51000-046]	Broad Medical Research Program, the Broad Foundation; Child Health Research Career Development Agency of the Baylor College of Medicine; Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition, (CCFA); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported in part by the Broad Medical Research Program, the Broad Foundation (IBD-0252); the Child Health Research Career Development Agency of the Baylor College of Medicine; the Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition, (CCFA Ref #2426); the United States Department of Agriculture 6250-51000-046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKITT DP, 1973, P NUTR SOC, V32, P145, DOI 10.1079/PNS19730032; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CUMMINGS JH, 1983, LANCET, V1, P1206; CUMMINGS JH, 1984, GUT, V25, P805, DOI 10.1136/gut.25.8.805; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; GOODLAD RA, 1983, BRIT J NUTR, V50, P91, DOI 10.1079/BJN19830075; GOODLAD RA, 1987, GUT, V28, P221, DOI 10.1136/gut.28.Suppl.221; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kellermayer R, 2011, FASEB J, V25, P1449, DOI 10.1096/fj.10-172205; Kellermayer R, 2010, AM J MED GENET A, V152A, P3022, DOI 10.1002/ajmg.a.33726; Kellermayer R, 2010, HUM MOL GENET, V19, P2168, DOI 10.1093/hmg/ddq095; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Komiyama Y, 2011, SCAND J GASTROENTERO, V46, P40, DOI 10.3109/00365521.2010.513062; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McCullough JS, 1998, GUT, V42, P799, DOI 10.1136/gut.42.6.799; Nagy-Szakal D, 2012, GUT MICROBES, V3; Nagy-Szakal D, 2012, J PEDIAT GA IN PRESS; Nagy-Szakal D, 2011, GUT MICROBES, V2, P178, DOI 10.4161/gmic.2.3.16107; Naito Y, 2006, J NUTR BIOCHEM, V17, P402, DOI 10.1016/j.jnutbio.2005.08.010; Packey CD, 2008, J INTERN MED, V263, P597, DOI 10.1111/j.1365-2796.2008.01962.x; PELL JD, 1995, GASTROENTEROLOGY, V108, P1745, DOI 10.1016/0016-5085(95)90136-1; PERRET V, 1977, GUT, V18, P382, DOI 10.1136/gut.18.5.382; Riehle K, BCM BIOINFO IN PRESS; Rodriguez-Cabezas ME, 2003, CLIN NUTR, V22, P463, DOI 10.1016/S0261-5614(03)00045-1; Sartor RB, 2011, MUCOSAL IMMUNOL, V4, P127, DOI 10.1038/mi.2010.87; Scarpa M, 2011, SURGERY, V150, P56, DOI 10.1016/j.surg.2011.02.009; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Schwartz L, 2008, AM J PHYSIOL-GASTR L, V295, pG934, DOI 10.1152/ajpgi.90296.2008; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tannock GW, 2012, INFLAMM BOWEL DIS, V18, P925, DOI 10.1002/ibd.21936; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOLIN MJ, 1981, SCIENCE, V213, P1463, DOI 10.1126/science.7280665	43	40	41	8	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56685	10.1371/journal.pone.0056685	http://dx.doi.org/10.1371/journal.pone.0056685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437211	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200141
J	Zhang, B; McDaniel, SS; Rensing, NR				Zhang, Bo; McDaniel, Sharon S.; Rensing, Nicholas R.			Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex	PLOS ONE			English	Article							MAMMALIAN TARGET; ANTIEPILEPTIC DRUGS; REFRACTORY EPILEPSY; INFANTILE SPASMS; NATURAL-HISTORY; METABOLISM; ASTROCYTES; THERAPY	Epilepsy is a common neurological disorder and cause of significant morbidity and mortality. Although antiseizure medication is the first-line treatment for epilepsy, currently available medications are ineffective in a significant percentage of patients and have not clearly been demonstrated to have disease-specific effects for epilepsy. While seizures are usually intractable to medication in tuberous sclerosis complex (TSC), a common genetic cause of epilepsy, vigabatrin appears to have unique efficacy for epilepsy in TSC. While vigabatrin increases gamma-aminobutyric acid (GABA) levels, the precise mechanism of action of vigabatrin in TSC is not known. In this study, we investigated the effects of vigabatrin on epilepsy in a knock-out mouse model of TSC and tested the novel hypothesis that vigabatrin inhibits the mammalian target of rapamycin (mTOR) pathway, a key signaling pathway that is dysregulated in TSC. We found that vigabatrin caused a modest increase in brain GABA levels and inhibited seizures in the mouse model of TSC. Furthermore, vigabatrin partially inhibited mTOR pathway activity and glial proliferation in the knock-out mice in vivo, as well as reduced mTOR pathway activation in cultured astrocytes from both knock-out and control mice. This study identifies a potential novel mechanism of action of an antiseizure medication involving the mTOR pathway, which may account for the unique efficacy of this drug for a genetic epilepsy.	[Rensing, Nicholas R.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Rensing, NR (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wong_m@wustl.edu			National Institutes of Health [R01 NS056872, P20 NS080199, NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS056872, P20NS080199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (R01 NS056872 and P20 NS080199 to M.W.; NIH Neuroscience Blueprint Core Grant NS057105 to Washington University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Menachem E, 2011, ACTA NEUROL SCAND, V124, P5, DOI 10.1111/j.1600-0404.2011.01596.x; Bombardieri R, 2010, EUR J PAEDIATR NEURO, V14, P146, DOI 10.1016/j.ejpn.2009.03.003; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo P, 2001, BRAIN DEV-JPN, V23, P649, DOI 10.1016/S0387-7604(01)00290-X; Elger CE, 2008, EPILEPSY BEHAV, V12, P501, DOI 10.1016/j.yebeh.2008.01.003; Erbayat-Altay E, 2007, EPILEPSIA, V48, P1470, DOI 10.1111/j.1528-1167.2007.01110.x; French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Hancock E, 1999, J CHILD NEUROL, V14, P71, DOI 10.1177/088307389901400201; HERTZ E, 1986, NEUROPHARMACOLOGY, V25, P533, DOI 10.1016/0028-3908(86)90180-2; HERTZ L, 1980, CAN J PHYSIOL PHARM, V58, P217, DOI 10.1139/y80-036; Holmes GL, 2007, EPILEPSIA, V48, P617, DOI 10.1111/j.1528-1167.2007.01035.x; Jozwiak S, 2011, EUR J PAEDIATR NEURO, V15, P424, DOI 10.1016/j.ejpn.2011.03.010; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; SCHULZ DW, 1981, BRAIN RES, V209, P177, DOI 10.1016/0006-8993(81)91179-3; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Willmore LJ, 2009, EPILEPSIA, V50, P163, DOI 10.1111/j.1528-1167.2008.01988.x; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Wu YM, 2001, J NEUROSCI, V21, P2630, DOI 10.1523/JNEUROSCI.21-08-02630.2001; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2007, NEUROBIOL DIS, V28, P184, DOI 10.1016/j.nbd.2007.07.015; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang B, 2002, NEUROPHARMACOLOGY, V42, P262, DOI 10.1016/S0028-3908(01)00174-5; Zhang B, 2012, EPILEPSIA, V53, P506, DOI 10.1111/j.1528-1167.2011.03384.x	35	75	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57445	10.1371/journal.pone.0057445	http://dx.doi.org/10.1371/journal.pone.0057445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437388	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200256
J	Yu, LL; Chang, K; Han, J; Deng, SL; Chen, M				Yu, Lili; Chang, Kai; Han, Jian; Deng, Shaoli; Chen, Ming			Association between Methylenetetrahydrofolate Reductase C677T Polymorphism and Susceptibility to Cervical Cancer: A Meta-Analysis	PLOS ONE			English	Article							REDUCTASE MTHFR; RISK; C677T; HOMOCYSTEINE; MUTATION; FOLATE; SCALE; GENE	Background: To assess the association between MTHFR polymorphism and cervical cancer risk, a meta-analysis was performed. Methods: Based on comprehensive searches of the PubMed, Embase, and Web of Science databases, we identified outcome data from all articles estimating the association between MTHFR polymorphism and cervical cancer risk. The pooled odds ratio (OR) with 95% confidence intervals (CIs) were calculated. Results: A total of 12 studies with 2,924 cases (331 cervical intraepithelial neoplasia (CIN) I, 742 CIN II/III, 1851 invasive cervical cancer) and 2,581 controls were identified. There was no significant association between MTHFR C677T polymorphism and CIN I risk (T vs. C, OR = 1.10, 95% CI = 0.92-1.31; TT vs. CC, OR = 1.14, 95% CI = 0.78-1.68; TT+CT vs. CC, OR = 1.22, 95% CI = 0.94-1.58; TT vs. CT+CC, OR = 0.99, 95% CI = 0.70-1.40). For the CIN II/III, lack of an association was also found (T vs. C, OR = 1.08, 95% CI = 0.95-1.23; TT vs. CC, OR = 1.15, 95% CI = 0.87-1.52; TT+CT vs. CC, OR = 1.13, 95% CI = 0.94-1.35; TT vs. CT+CC, OR = 1.07, 95% CI = 0.83-1.38). The T allele had significant association to susceptibility of invasive cervical cancer in recessive model (TT vs. CT+CC, OR = 1.23, 95% CI = 1.02-1.49). On subgroup analysis by ethnicity, similarly significant differences in T vs. C, TT vs. CC, and recessive model were found in Asians. Conclusion: The present meta-analysis suggested that MTHFR C677T polymorphism were to substantially contribute to invasive cervical cancer in recessive model.	[Yu, Lili; Han, Jian] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Obstet & Gynecol, Chongqing, Peoples R China; [Chang, Kai; Deng, Shaoli; Chen, Ming] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Lab Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Deng, SL (corresponding author), Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Lab Med, Chongqing, Peoples R China.	DengSL072@yahoo.com.cn; chenming1971@yahoo.com			Chinese National Natural Science Foundation [81071428, 81070505]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese National Natural Science Foundation (No. 81071428, 81070505). The authors have declared that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Echelman D, 2012, HEMATOL ONCOL CLIN N, V26, P31, DOI 10.1016/j.hoc.2011.11.005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2011, IARC CANCERBASE; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Goodman MT, 2000, CANCER-AM CANCER SOC, V89, P376, DOI 10.1002/1097-0142(20000715)89:2&lt;376::AID-CNCR24&gt;3.0.CO;2-O; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Josefsson AM, 2000, LANCET, V355, P2189, DOI 10.1016/S0140-6736(00)02401-6; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; Kim YI, 2009, FUTURE ONCOL, V5, P523, DOI 10.2217/FON.09.26; Kohaar I, 2010, BIOMARKERS, V15, P61, DOI 10.3109/13547500903295881; Lambropoulos AF, 2003, CANCER LETT, V191, P187, DOI 10.1016/S0304-3835(02)00675-4; Ma X, 2006, CHIN J PUBLIC HLTH, V22, P1427; MANTEL N, 1959, J NATL CANCER I, V22, P719; Misra UK, 2010, BIOCHEM GENET, V48, P229, DOI 10.1007/s10528-009-9312-9; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mostowska A, 2011, CLIN BIOCHEM, V44, P596, DOI 10.1016/j.clinbiochem.2011.02.007; Nandan Naveen Kumar, 2008, Drug Metab Lett, V2, P18; Piyathilake CJ, 2000, ANTICANCER RES, V20, P1751; Prasad VVTS, 2011, ONKOLOGIE, V34, P422, DOI 10.1159/000331131; Sankaranarayanan R, 2008, MED PRIN PRACT, V17, P351, DOI 10.1159/000141498; Shekari M, 2008, ARCH GYNECOL OBSTET, V278, P517, DOI 10.1007/s00404-008-0623-6; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stankova J, 2008, CURR PHARM DESIGN, V14, P1143, DOI 10.2174/138161208784246171; Sull JW, 2004, GYNECOL ONCOL, V95, P557, DOI 10.1016/j.ygyno.2004.08.008; Tong SY, 2011, CANCER CAUSE CONTROL, V22, P63, DOI 10.1007/s10552-010-9675-6; Ulvik A, 2007, HUM GENET, V121, P57, DOI 10.1007/s00439-006-0290-2; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zoodsma M, 2005, HUM GENET, V116, P247, DOI 10.1007/s00439-004-1233-4	31	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55835	10.1371/journal.pone.0055835	http://dx.doi.org/10.1371/journal.pone.0055835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431363	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800006
J	Hairston, WD; Letowski, TR; McDowell, K				Hairston, W. David; Letowski, Tomasz R.; McDowell, Kaleb			Task-Related Suppression of the Brainstem Frequency following Response	PLOS ONE			English	Article							AUDITORY SELECTIVE ATTENTION; EVOKED-POTENTIALS; INFERIOR COLLICULUS; MUSICAL EXPERIENCE; VISUAL-CORTEX; SPEECH; MODULATION; PITCH; STIMULI; DEACTIVATION	Recent evidence has shown top-down modulation of the brainstem frequency following response (FFR), generally in the form of signal enhancement from concurrent stimuli or from switching between attention-demanding task stimuli. However, it is also possible that the opposite may be true - the addition of a task, instead of a resting, passive state may suppress the FFR. Here we examined the influence of a subsequent task, and the relevance of the task modality, on signal clarity within the FFR. Participants performed visual and auditory discrimination tasks in the presence of an irrelevant background sound, as well as a baseline consisting of the same background stimuli in the absence of a task. FFR pitch strength and amplitude of the primary frequency response were assessed within non-task stimulus periods in order to examine influences due solely to general cognitive state, independent of stimulus-driven effects. Results show decreased signal clarity with the addition of a task, especially within the auditory modality. We additionally found consistent relationships between the extent of this suppressive effect and perceptual measures such as response time and proclivity towards one sensory modality. Together these results suggest that the current focus of attention can have a global, top-down effect on the quality of encoding early in the auditory pathway.	[Hairston, W. David; Letowski, Tomasz R.; McDowell, Kaleb] USA, Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Hairston, WD (corresponding author), USA, Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA.	William.d.hairston4.civ@mail.mil		Hairston, W. David/0000-0003-4432-8430				Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Akhoun I, 2008, CLIN NEUROPHYSIOL, V119, P922, DOI 10.1016/j.clinph.2007.12.010; Alain C, 2008, CURR OPIN OTOLARYNGO, V16, P485, DOI 10.1097/MOO.0b013e32830e2096; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Bidelman GM, 2009, J NEUROSCI, V29, P13165, DOI 10.1523/JNEUROSCI.3900-09.2009; Burkard RF., 2007, AUDITORY EVOKED POTE; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; CONNOLLY JF, 1989, PSYCHOPHYSIOLOGY, V26, P292, DOI 10.1111/j.1469-8986.1989.tb01920.x; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Diederich A, 2009, PROG BRAIN RES, V174, P119, DOI 10.1016/S0079-6123(09)01311-9; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Fujiwara N, 1998, COGNITIVE BRAIN RES, V7, P99, DOI 10.1016/S0926-6410(98)00014-7; GALBRAITH GC, 1995, INT J PSYCHOPHYSIOL, V19, P203, DOI 10.1016/0167-8760(95)00008-G; Galbraith GC, 1998, NEUROREPORT, V9, P1889, DOI 10.1097/00001756-199806010-00041; Galbraith GC, 2003, NEUROREPORT, V14, P735, DOI 10.1097/00001756-200304150-00015; Galbraith GC, 2000, NEUROSCI LETT, V292, P123, DOI 10.1016/S0304-3940(00)01436-1; GIARD MH, 1994, BRAIN RES, V633, P353, DOI 10.1016/0006-8993(94)91561-X; Gondan M, 2011, J EXP PSYCHOL HUMAN, V37, P1887, DOI 10.1037/a0025635; GREGORY SD, 1989, ELECTROEN CLIN NEURO, V73, P557, DOI 10.1016/0013-4694(89)90266-6; HACKLEY SA, 1990, PSYCHOPHYSIOLOGY, V27, P195, DOI 10.1111/j.1469-8986.1990.tb00370.x; Hairston WD, 2008, NEUROREPORT, V19, P151, DOI 10.1097/WNR.0b013e3282f42509; Hairston WD, 2006, NEUROREPORT, V17, P791, DOI 10.1097/01.wnr.0000220141.29413.b4; Hairston WD, 2009, COMPUT METH PROG BIO, V93, P104, DOI 10.1016/j.cmpb.2008.08.003; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; HIRSCHHORN TN, 1990, PSYCHOPHYSIOLOGY, V27, P495, DOI 10.1111/j.1469-8986.1990.tb01964.x; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; HOORMANN J, 1994, NEUROREPORT, V5, P1609, DOI 10.1097/00001756-199408150-00017; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Kaiser J, 2005, NEUROREPORT, V16, P207, DOI 10.1097/00001756-200502280-00001; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Kraus N, 2009, ANN NY ACAD SCI, V1169, P543, DOI 10.1111/j.1749-6632.2009.04549.x; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Krishnan A, 2002, HEARING RES, V166, P192, DOI 10.1016/S0378-5955(02)00327-1; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LUKAS JH, 1981, INT J NEUROSCI, V12, P137, DOI 10.3109/00207458108985796; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; Musacchia G, 2006, EXP BRAIN RES, V168, P1, DOI 10.1007/s00221-005-0071-5; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Okamoto H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-1; PAPANICOLAOU AC, 1984, INT J NEUROSCI, V24, P107, DOI 10.3109/00207458409089800; Posner M. I., 2011, NEUROIMAGE; Saldana E, 1996, J COMP NEUROL, V371, P15, DOI 10.1002/(SICI)1096-9861(19960715)371:1<15::AID-CNE2>3.0.CO;2-O; Santangelo V, 2010, NEUROIMAGE, V49, P2717, DOI 10.1016/j.neuroimage.2009.10.061; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Skoe E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013645; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872	60	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55215	10.1371/journal.pone.0055215	http://dx.doi.org/10.1371/journal.pone.0055215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441150	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200008
J	Klemencic, M; Novinec, M; Maier, S; Hartmann, U; Lenarcic, B				Klemencic, Marina; Novinec, Marko; Maier, Silke; Hartmann, Ursula; Lenarcic, Brigita			The Heparin-Binding Activity of Secreted Modular Calcium-Binding Protein 1 (SMOC-1) Modulates Its Cell Adhesion Properties	PLOS ONE			English	Article							GROWTH-FACTOR; SULFATE; IDENTIFICATION; SITE; PROTEOGLYCANS; INTEGRINS; MIGRATION; RECEPTOR	Secreted modular calcium-binding proteins 1 and 2 (SMOC-1 and SMOC-1) are extracellular calcium-binding proteins belonging to the BM-40 family of proteins. In this work we have identified a highly basic region in the extracellular calcium-binding (EC) domain of the SMOC-1 similar to other known glycosaminoglycan-binding motifs. Size-exclusion chromatography shows that full length SMOC-1 as well as its C-terminal EC domain alone bind heparin and heparan sulfate, but not the related chondroitin sulfate or dermatan sulfate glycosaminoglycans. Intrinsic tryptophan fluorescence measurements were used to quantify the binding of heparin to full length SMOC-1 and the EC domain alone. The calculated equilibrium dissociation constants were in the lower micromolar range. The binding site consists of two antiparallel alpha helices and mutagenesis experiments have shown that heparin-binding residues in both helices must be replaced in order to abolish heparin binding. Furthermore, we show that the SMOC-1 EC domain, like the SMOC-2 EC domain, supports the adhesion of epithelial HaCaT cells. Heparin-binding impaired mutants failed to support S1EC-mediated cell adhesion and together with the observation that S1EC in complex with soluble heparin attenuated cell adhesion we conclude that a functional and accessible S1EC heparin-binding site mediates adhesion of epithelial cells to SMOC-1.	[Klemencic, Marina; Novinec, Marko; Lenarcic, Brigita] Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Maier, Silke; Hartmann, Ursula] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Hartmann, Ursula] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Lenarcic, Brigita] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia	University of Ljubljana; University of Cologne; University of Cologne; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Lenarcic, B (corresponding author), Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia.	brigita.lenarcic@fkkt.uni-lj.si	Novinec, Marko/J-9789-2019	Novinec, Marko/0000-0003-1824-1649; Lenarcic, Brigita/0000-0002-2508-3776	Slovenian Research Agency; Slovene Human Resources, Development and Scholarship Fund	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovene Human Resources, Development and Scholarship Fund	This work was supported by the Slovenian Research Agency and by the Slovene Human Resources, Development and Scholarship Fund with a travel grant to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; Abouzeid H, 2011, AM J HUM GENET, V88, P92, DOI 10.1016/j.ajhg.2010.12.002; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Choi YA, 2010, J PROTEOME RES, V9, P2946, DOI 10.1021/pr901110q; Copeland R.A., 2000, ENZYMES PRACTICAL IN, Vsecond, P94; Dreieicher E, 2009, J AM SOC NEPHROL, V20, P1963, DOI 10.1681/ASN.2008060653; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Girard JP, 1996, J BIOL CHEM, V271, P4511; Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Ishitsuka R, 1998, J BIOL CHEM, V273, P9935, DOI 10.1074/jbc.273.16.9935; Katsumoto TR, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/208219; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Koivisto L, 1999, CELL ADHES COMMUN, V7, P245, DOI 10.3109/15419069909010806; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lecona E, 2003, BIOCHEM J, V373, P437, DOI 10.1042/BJ20021721; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Lortat-Jacob H, 2012, J BIOL CHEM, V287, P18005, DOI 10.1074/jbc.M111.337089; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; MURPHYULLRICH JE, 1995, J CELL BIOCHEM, V57, P341, DOI 10.1002/jcb.240570218; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Novinec M, 2008, PROTEIN EXPRES PURIF, V62, P75, DOI 10.1016/j.pep.2008.07.009; Okada I, 2011, AM J HUM GENET, V88, P30, DOI 10.1016/j.ajhg.2010.11.012; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Rainger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002114; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Torrent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042692; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; VOGEL BE, 1990, J BIOL CHEM, V265, P5934; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Woods A, 2001, J CLIN INVEST, V107, P935, DOI 10.1172/JCI12802; ZHU HY, 1995, J BIOL CHEM, V270, P21869, DOI 10.1074/jbc.270.37.21869	40	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56839	10.1371/journal.pone.0056839	http://dx.doi.org/10.1371/journal.pone.0056839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437253	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000053
J	Li, SY; Liu, QQ; Wang, YJ; Gu, Y; Liu, D; Wang, CM; Ding, GH; Chen, JP; Liu, J; Gu, XS				Li, Shiying; Liu, Qianqian; Wang, Yongjun; Gu, Yun; Liu, Dong; Wang, Chunming; Ding, Guohui; Chen, Jianping; Liu, Jie; Gu, Xiaosong			Differential Gene Expression Profiling and Biological Process Analysis in Proximal Nerve Segments after Sciatic Nerve Transection	PLOS ONE			English	Article							OLFACTORY RECEPTOR; AXON REGENERATION; SCHWANN-CELLS; MULTIGENE FAMILY; ODORANT RECEPTOR; INJURY; RAT; MYELINATION; DEMYELINATION; RECOGNITION	After traumatic injury, peripheral nerves can spontaneously regenerate through highly sophisticated and dynamic processes that are regulated by multiple cellular elements and molecular factors. Despite evidence of morphological changes and of expression changes of a few regulatory genes, global knowledge of gene expression changes and related biological processes during peripheral nerve injury and regeneration is still lacking. Here we aimed to profile global mRNA expression changes in proximal nerve segments of adult rats after sciatic nerve transection. According to DNA microarray analysis, the huge number of genes was differentially expressed at different time points (0.5 h-14 d) post nerve transection, exhibiting multiple distinct temporal expression patterns. The expression changes of several genes were further validated by quantitative real-time RT-PCR analysis. The gene ontology enrichment analysis was performed to decipher the biological processes involving the differentially expressed genes. Collectively, our results highlighted the dynamic change of the important biological processes and the time-dependent expression of key regulatory genes after peripheral nerve injury. Interestingly, we, for the first time, reported the presence of olfactory receptors in sciatic nerves. Hopefully, this study may provide a useful platform for deeply studying peripheral nerve injury and regeneration from a molecular-level perspective.	[Li, Shiying; Liu, Qianqian; Wang, Yongjun; Gu, Yun; Liu, Dong; Liu, Jie; Gu, Xiaosong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China; [Wang, Chunming; Chen, Jianping] Nantong Univ, Sch Comp Sci & Technol, Nantong, Peoples R China; [Ding, Guohui] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Nantong University; Nantong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gu, XS (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	nervegu@ntu.edu.cn	liu, qian/HDM-2936-2022; Liu, Dong/O-1271-2013	Liu, Dong/0000-0002-2764-6544	Hi-Tech Research and Development Program of China (863 Program) [2012AA020502]; State Key Program of National Natural Science of China [81130080]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the Hi-Tech Research and Development Program of China (863 Program, grant no. 2012AA020502), the State Key Program of National Natural Science of China (grant no. 81130080) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Belanger E, 2011, BIOMED OPT EXPRESS, V2, P2698, DOI 10.1364/BOE.2.002698; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buser AM, 2009, EUR J NEUROSCI, V29, P2276, DOI 10.1111/j.1460-9568.2009.06785.x; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Donnerer J, 2003, PHARMACOLOGY, V67, P169, DOI 10.1159/000068405; DRUTEL G, 1995, RECEPTOR CHANNEL, V3, P33; Goto T, 2001, MOL HUM REPROD, V7, P553, DOI 10.1093/molehr/7.6.553; Grinspan JB, 1996, J NEUROSCI, V16, P6107; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kerr BJ, 2001, NEUROREPORT, V12, P3331, DOI 10.1097/00001756-200110290-00037; Koenig HL, 2000, REV REPROD, V5, P189; Kosins AM, 2012, ANN PLAS SURG, V68, P290, DOI 10.1097/SAP.0b013e31823dce7e; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Lee S K, 2000, J Am Acad Orthop Surg, V8, P243; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nef S, 1997, P NATL ACAD SCI USA, V94, P4766, DOI 10.1073/pnas.94.9.4766; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; ROBERSON MD, 1995, MOL BRAIN RES, V28, P231, DOI 10.1016/0169-328X(94)00211-V; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Schmidhammer R, 2007, ACTA NEUROCHIR SUPPL, V100, P161; Sheth S, 2011, MODERN PATHOL, V24, P343, DOI 10.1038/modpathol.2010.203; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Thomas MB, 1996, GENE, V178, P1, DOI 10.1016/0378-1119(96)00311-3; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Wang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030635, 10.1371/journal.pone.0047302, 10.1371/journal.pone.0048669]; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zhou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044768; Zochodne DW, 2000, MUSCLE NERVE, pS33	41	81	81	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57000	10.1371/journal.pone.0057000	http://dx.doi.org/10.1371/journal.pone.0057000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437294	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000066
J	Lin, YR; Chen, YL; Wang, KB; Wu, YF; Wang, YK; Huang, SC; Liu, TA; Nayak, M; Yip, BS; Wu, TK				Lin, Yan-Ren; Chen, Yao-Li; Wang, Keh-Bin; Wu, Yi-Fang; Wang, Yu-Kuo; Huang, Sheng-Cih; Liu, Tzu-An; Nayak, Manoswini; Yip, Bak-Sau; Wu, Tung-Kung			The Thermostable Direct Hemolysin from Grimontia hollisae Causes Acute Hepatotoxicity In Vitro and In Vivo	PLOS ONE			English	Article							VIBRIO-HOLLISAE; SEVERE GASTROENTERITIS; ENDOTOXIN REMOVAL; PARAHAEMOLYTICUS; IDENTIFICATION; ENTEROTOXICITY; CYTOTOXICITY; BACTEREMIA; DIARRHEA; ZONATION	Background: G. hollisae thermostable direct hemolysin (Gh-TDH) is produced by most strains of G. hollisae. This toxin has been reported to be absorbed in the intestines in humans. Secondary liver injury might be caused by venous return of the toxin through the portal system. We aimed to firstly analyze the in vitro and in vivo hepatotoxicity of Gh-TDH. Methods: Liver cells (primary human non-cancer cell and FL83B mouse cells) were treated and mice (BALB/c) were fed with this toxin to investigate its hepatotoxicity. Morphological examination and cytotoxicity assays using liver cells were also performed. Fluorescein isothiocyanate-conjugated toxin was used to analyze the localization of this protein in liver cells. Mice were subjected to liver function measurements and liver biopsies following toxin treatment and wild-type bacterial infection. PET (positron emission tomography)/CT (computed tomography) images were taken to assess liver metabolism during acute injury and recovery. Results: The effect of hepatotoxicity was dose and time dependent. Cellular localization showed that the toxin was initially located around the cellular margins and subsequently entered the nucleus. Liver function measurements and liver biopsies of the mice following treatment with toxin or infection with wild-type Grimontia hollisae showed elevated levels of transaminases and damage to the periportal area, respectively. The PET/CT images revealed that the reconstruction of the liver continued for at least one week after exposure to a single dose of the toxin or bacterial infection. Conclusions: The hepatotoxicity of Gh-TDH was firstly demonstrated. The damage was located in the periportal area of the liver, and the liver became functionally insufficient.	[Lin, Yan-Ren; Wu, Yi-Fang; Wang, Yu-Kuo; Huang, Sheng-Cih; Nayak, Manoswini; Wu, Tung-Kung] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Wang, Keh-Bin] Kuang Tien Gen Hosp, Dept Nucl Med, Taichung, Taiwan; [Liu, Tzu-An] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan; [Yip, Bak-Sau] Natl Taiwan Univ Hosp, Dept Neurol, Hsin Chu Branch, Hsinchu, Taiwan; [Lin, Yan-Ren; Chen, Yao-Li] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University	Wang, YK (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	yu.kuo@yahoo.com.tw; neuron.nctu@gmail.com; tkwmll@mail.nctu.edu.tw	Lin, Yan-Ren/AAU-4136-2020	Lin, Yan-Ren/0000-0002-9015-2678; Yip, Bak-Sau/0000-0001-7942-8293	National Chiao Tung University; Ministry of Education, Aiming for Top University Plan (MOE ATU Program); National Science Council [NSC-99-2113-M-009 -004 -MY2]	National Chiao Tung University; Ministry of Education, Aiming for Top University Plan (MOE ATU Program); National Science Council(Ministry of Science and Technology, Taiwan)	The authors thank National Chiao Tung University and the Ministry of Education, Aiming for Top University Plan (MOE ATU Program), and the National Science Council (NSC-99-2113-M-009 -004 -MY2) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT SL, 1994, CLIN INFECT DIS, V18, P310, DOI 10.1093/clinids/18.3.310; Anspach FB, 2001, J BIOCHEM BIOPH METH, V49, P665, DOI 10.1016/S0165-022X(01)00228-7; Cai SH, 2007, J APPL MICROBIOL, V103, P289, DOI 10.1111/j.1365-2672.2006.03250.x; CARNAHAN AM, 1994, J CLIN MICROBIOL, V32, P1805, DOI 10.1128/JCM.32.7.1805-1806.1994; Fukui T, 2005, BIOCHEMISTRY-US, V44, P9825, DOI 10.1021/bi050311s; GrasRouzet S, 1996, EUR J CLIN MICROBIOL, V15, P864, DOI 10.1007/BF01691217; HICKMAN FW, 1982, J CLIN MICROBIOL, V15, P395, DOI 10.1128/JCM.15.3.395-401.1982; JUNGERMANN K, 1988, SEMIN LIVER DIS, V8, P329, DOI 10.1055/s-2008-1040554; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; JUNGERMANN K, 1986, ENZYME, V35, P161, DOI 10.1159/000469338; Lesmana M, 2002, DIAGN MICR INFEC DIS, V43, P91, DOI 10.1016/S0732-8893(02)00373-5; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; MORRIS JG, 1982, LANCET, V1, P1294; Naim R, 2001, FEMS MICROBIOL LETT, V195, P237, DOI 10.1016/S0378-1097(01)00015-5; Nishibuchi M, 1996, MICROBIOL IMMUNOL, V40, P59, DOI 10.1111/j.1348-0421.1996.tb03304.x; NISHIBUCHI M, 1988, APPL ENVIRON MICROB, V54, P2144, DOI 10.1128/AEM.54.8.2144-2146.1988; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Raimondi F, 2000, INFECT IMMUN, V68, P3180, DOI 10.1128/IAI.68.6.3180-3185.2000; RANK EL, 1988, J CLIN MICROBIOL, V26, P375, DOI 10.1128/JCM.26.2.375-376.1988; Shinoda S, 2004, MICROBIOL IMMUNOL, V48, P547, DOI 10.1111/j.1348-0421.2004.tb03551.x; Shinoda S, 1999, J NAT TOXINS, V8, P259; Tatsumi M, 2003, CANCER RES, V63, P6252; Wang YK, 2011, INT J BIOL SCI, V7, P333, DOI 10.7150/ijbs.7.333; Wang YK, 2011, ACTA CRYSTALLOGR F, V67, P224, DOI 10.1107/S1744309110050219; Wu TK, 2007, J BACTERIOL, V189, P8215, DOI 10.1128/JB.01039-07; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; YOH M, 1986, CAN J MICROBIOL, V32, P632, DOI 10.1139/m86-118; YOH M, 1989, J BACTERIOL, V171, P6859, DOI 10.1128/jb.171.12.6859-6861.1989	29	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56226	10.1371/journal.pone.0056226	http://dx.doi.org/10.1371/journal.pone.0056226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437095	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000017
J	Miao, Y; Sun, YB; Wang, WJ; Du, BJ; Xiao, SE; Hu, YJ; Hu, ZQ				Miao, Yong; Sun, Yabin; Wang, Wenjun; Du, Benjun; Xiao, Shun-e; Hu, Yijue; Hu, Zhiqi			6-Gingerol Inhibits Hair Shaft Growth in Cultured Human Hair Follicles and Modulates Hair Growth in Mice	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; IN-VITRO; APOPTOSIS; BCL-2; PROLIFERATION; MITOCHONDRIA; PROTEINS; ALOPECIA; SURVIVAL; EXTRACT	Ginger (Zingiber officinale) has been traditionally used to check hair loss and stimulate hair growth in East Asia. Several companies produce shampoo containing an extract of ginger claimed to have anti-hair loss and hair growth promotion properties. However, there is no scientific evidence to back up these claims. This study was undertaken to measure 6-gingerol, the main active component of ginger, on hair shaft elongation in vitro and hair growth in vivo, and to investigate its effect on human dermal papilla cells (DPCs) in vivo and in vitro. 6-Gingerol suppressed hair growth in hair follicles in culture and the proliferation of cultured DPCs. The growth inhibition of DPCs by 6-gingerol in vitro may reflect a decrease in the Bcl-2/Bax ratio. Similar results were obtained in vivo. The results of this study showed that 6-gingerol does not have the ability to promote hair growth, on the contrary, can suppress human hair growth via its inhibitory and pro-apoptotic effects on DPCs in vitro, and can cause prolongation of telogen phase in vivo. Thus, 6-gingerol rather than being a hair growth stimulating drug, it is a potential hair growth suppressive drug; i.e. for hair removal.	[Miao, Yong; Du, Benjun; Xiao, Shun-e; Hu, Yijue; Hu, Zhiqi] So Med Univ, Nanfang Hosp, Dept Plast & Aesthet Surg, Guangzhou, Guangdong, Peoples R China; [Sun, Yabin] So Med Univ, Nanfang Hosp, GCP Off, Guangzhou, Guangdong, Peoples R China; [Wang, Wenjun] So Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Hu, ZQ (corresponding author), So Med Univ, Nanfang Hosp, Dept Plast & Aesthet Surg, Guangzhou, Guangdong, Peoples R China.	doctorhzq@hotmail.com	Hu, Zhi/AAD-1479-2020		Natural Science Foundation of China [31170949]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No. 31170949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085; Baliga MS, 2011, CRIT REV FOOD SCI, V51, P499, DOI 10.1080/10408391003698669; Blume-Peytavi U, 2011, BRIT J DERMATOL, V165, P19, DOI 10.1111/j.1365-2133.2011.10632.x; Botchkareva NV, 2006, J INVEST DERMATOL, V126, P258, DOI 10.1038/sj.jid.5700007; Cash TF, 1999, BRIT J DERMATOL, V141, P398; Datta K, 2009, J ETHNOPHARMACOL, V124, P450, DOI 10.1016/j.jep.2009.05.023; Han JH, 2004, J DERMATOL SCI, V34, P91, DOI 10.1016/j.jdermsci.2004.01.002; Kawano M, 2009, J NAT MED-TOKYO, V63, P335, DOI 10.1007/s11418-009-0324-x; Kim SC, 2010, EUR J DERMATOL, V20, P42, DOI 10.1684/ejd.2010.0807; Kwon OS, 2007, PHYTOMEDICINE, V14, P551, DOI 10.1016/j.phymed.2006.09.009; Lee C, 2011, FOOD CHEM TOXICOL, V49, P1261, DOI 10.1016/j.fct.2011.03.005; Lindner G, 1997, AM J PATHOL, V151, P1601; Luanpitpong S, 2011, APOPTOSIS, V16, P769, DOI 10.1007/s10495-011-0609-x; Magerl M, 2002, EXP DERMATOL, V11, P381, DOI 10.1034/j.1600-0625.2002.110414.x; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller-Rover S, 1999, J INVEST DERM SYMP P, V4, P272, DOI 10.1038/sj.jidsp.5640228; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nigam N, 2010, CANCER CHEMOTH PHARM, V65, P687, DOI 10.1007/s00280-009-1074-x; Park HJ, 2011, J ETHNOPHARMACOL, V135, P369, DOI 10.1016/j.jep.2011.03.028; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Philpott MP, 1990, CELL SCI, V97, P471; Price VH, 1999, NEW ENGL J MED, V341, P964, DOI 10.1056/NEJM199909233411307; Schmidt S, 2001, BRIT J DERMATOL, V144, P1038, DOI 10.1046/j.1365-2133.2001.04195.x; Shukla Y, 2007, MOL NUTR FOOD RES, V51, P1492, DOI 10.1002/mnfr.200700197; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Zoumaras J, 2008, BURNS, V34, P254, DOI 10.1016/j.burns.2007.03.018	28	16	16	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57226	10.1371/journal.pone.0057226	http://dx.doi.org/10.1371/journal.pone.0057226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437345	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000086
J	Xu, Y; Luo, QQ; Zhou, MG				Xu, Ying; Luo, Qing-quan; Zhou, Ming-guo			Identification and Characterization of Integron-Mediated Antibiotic Resistance in the Phytopathogen Xanthomonas oryzae pv. oryzae	PLOS ONE			English	Article							STREPTOMYCIN-RESISTANCE; GENE CASSETTES; SPREAD; PREVALENCE; MICHIGAN; SEQUENCE; ELEMENTS; HUMANS	Four streptomycin-resistant isolates of Xanthomonas oryzae pv. oryzae (YNA7-1, YNA10-2, YNA11-2, and YNA12-2) were examined via PCR amplification for the presence of class 1, class 2, and class 3 integrons and aadA1 and aadA2 genes, which confer resistance to streptomycin and spectinomycin. The class 1 integrase gene intI1 and the aminoglycoside adenylyltransferase gene aadA1 were identified in all four resistant isolates but not in 25 sensitive isolates. PCR amplifications showed that 7790-bp, 7162-bp, 7790-bp, and 7240-bp resistance integrons with transposition gene modules (tni module) in 3' conserved segments existed in YNA7-1, YNA10-2, YNA11-2, and YNA12-2, respectively. Subsequent analysis of sequences indicated that the integrons of YNA7-1 and YNA11-2 carried three gene cassettes in the order vertical bar aacA3 vertical bar arr3 vertical bar aadA1 vertical bar. The integron of YNA10-2 carried only vertical bar arr3 vertical bar aadA1 vertical bar gene cassettes. The integron of YNA12-2 lacked a 550-bp sequence including part of intI1 but it still carried vertical bar aacA3 vertical bar arr3 vertical bar aadA1 vertical bar gene cassettes. The analysis of inactive mutants and complementation tests confirmed that the aacA3 gene conferred resistance to tobramycin, kanamycin, gentamicin and netilmicin; the arr3 gene conferred resistance to rifampicin; and the aadA1 gene conferred resistance to streptomycin and spectinomycin. The resistance phenotypes of the four isolates corresponded with their resistance gene cassettes, except that YNA7-1 and YNA12-2 did not show rifampicin resistance. Sequence comparison revealed that no gene cassette array in GenBank was in the same order as in the integrons of the four resistant isolates in this study and the aadA1, which was identical in the four resistant isolates, showed 99% identity with aadA1 sequences in GenBank. The result of a stability test showed that the resistance phenotype, the aadA1 gene, and the intI1 gene were completely stable in YNA7-1 and YNA12-2 but unstable in YNA10-2 and YNA11-2. To our knowledge, this is the first report of resistance integron in a phytopathogenic bacteria.	[Xu, Ying; Zhou, Ming-guo] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Xu, Ying; Luo, Qing-quan] Shanghai Landscape Gardening Res Inst, Shanghai, Peoples R China	Nanjing Agricultural University	Zhou, MG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	xuying2002@gmail.com		Luo, Qingquan/0000-0003-4371-273X	National Natural Science Foundation of China [31100100]; Agro-scientific Research in the Public Interest [201303023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agro-scientific Research in the Public Interest	This study was sponsored by the National Natural Science Foundation of China (No. 31100100) and Agro-scientific Research in the Public Interest (No. 201303023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, M2A9 CLSI; Binh CTT, 2009, RES MICROBIOL, V160, P427, DOI 10.1016/j.resmic.2009.06.005; Cambray G, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-6; Chen GongYou, 2004, Scientia Agricultura Sinica, V37, P1301; CHIOU CS, 1995, PHYTOPATHOLOGY, V85, P324, DOI 10.1094/Phyto-85-324; CHIOU CS, 1991, PHYTOPATHOLOGY, V81, P710, DOI 10.1094/Phyto-81-710; Clinical and Laboratory Standards Institute (CLSI), 2011, M100S12 CLSI; Cox KD, 2007, PHYTOPATHOLOGY, V97, P448, DOI 10.1094/PHYTO-97-4-0448; DEFEYTER R, 1990, GENE, V88, P65, DOI 10.1016/0378-1119(90)90060-5; Dubois W, 2002, ANTIMICROB AGENTS CH, V46, P638, DOI 10.1128/AAC.46.3.638-645.2002; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Jeung JU, 2006, PHYTOPATHOLOGY, V96, P867, DOI 10.1094/PHYTO-96-0867; Lee K, 2005, ANTIMICROB AGENTS CH, V49, P4485, DOI 10.1128/AAC.49.11.4485-4491.2005; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; MCMANUS PS, 1994, PHYTOPATHOLOGY, V84, P627, DOI 10.1094/Phyto-84-627; Miko A, 2005, J ANTIMICROB CHEMOTH, V56, P1025, DOI 10.1093/jac/dki365; Mongkolsuk S, 1998, FEMS MICROBIOL LETT, V169, P269, DOI 10.1111/j.1574-6968.1998.tb13328.x; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Post V, 2007, ANTIMICROB AGENTS CH, V51, P3467, DOI 10.1128/AAC.00220-07; Rayamajhi N, 2008, J VET MED SCI, V70, P1133, DOI 10.1292/jvms.70.1133; Rowe-Magnus DA, 2002, INT J MED MICROBIOL, V292, P115, DOI 10.1078/1438-4221-00197; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schnabel EL, 1999, APPL ENVIRON MICROB, V65, P4898; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SHAW KJ, 1989, ANTIMICROB AGENTS CH, V33, P2052, DOI 10.1128/AAC.33.12.2052; [沈光斌 Shen Guangbin], 2002, [植物保护, Plant Protection], V28, P9; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Sun QH, 2003, FEMS MICROBIOL LETT, V226, P145, DOI 10.1016/S0378-1097(03)00583-4; Sunde M, 2005, J ANTIMICROB CHEMOTH, V56, P87, DOI 10.1093/jac/dki150; Sundin GW, 2000, J ANTIMICROB CHEMOTH, V46, P848, DOI 10.1093/jac/46.5.848; SUNDIN GW, 1993, APPL ENVIRON MICROB, V59, P1018, DOI 10.1128/AEM.59.4.1018-1024.1993; Sundin GW, 2002, CURR MICROBIOL, V45, P63, DOI 10.1007/s00284-001-0100-y; Vinue L, 2008, J ANTIMICROB CHEMOTH, V62, P934, DOI 10.1093/jac/dkn331; Wang WenXiang, 1998, Acta Phytophylacica Sinica, V25, P171; Weldhagen GF, 2004, INT J ANTIMICROB AG, V23, P556, DOI 10.1016/j.ijantimicag.2004.03.007; Xu Y, 2010, J PHYTOPATHOL, V158, P601, DOI 10.1111/j.1439-0434.2009.01657.x; Xue N, 1973, B AGR SCI TECHNOL, P21; Xue YH, 2002, JIANGXI PLANT PROTEC, V25, P68; Zhao SH, 2001, APPL ENVIRON MICROB, V67, P1558, DOI 10.1128/AEM.67.4.1558-1564.2001; Zhu M. J., 1992, Plant Protection, V18, P26	46	16	18	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55962	10.1371/journal.pone.0055962	http://dx.doi.org/10.1371/journal.pone.0055962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437082	gold, Green Published, Green Submitted			2022-12-27	WOS:000315186000014
J	Zhang, T; Liu, JC; Zhang, J; Thekkethottiyil, EB; Macatee, TL; Ismat, FA; Wang, F; Stoller, JZ				Zhang, Tao; Liu, Junchen; Zhang, Jue; Thekkethottiyil, Eldhose B.; Macatee, Timothy L.; Ismat, Fraz A.; Wang, Fen; Stoller, Jason Z.			Jun Is Required in Isl1-Expressing Progenitor Cells for Cardiovascular Development	PLOS ONE			English	Article							CARDIAC NEURAL CREST; CONGENITAL HEART-DISEASE; FACTOR C-JUN; TISSUE-SPECIFIC EXPRESSION; OUTFLOW TRACT; MOUSE DEVELOPMENT; LINEAGE DEVELOPMENT; LIVER-REGENERATION; VENTRICULAR SEPTUM; REPORTER MOUSE	Jun is a highly conserved member of the multimeric activator protein 1 transcription factor complex and plays an important role in human cancer where it is known to be critical for proliferation, cell cycle regulation, differentiation, and cell death. All of these biological functions are also crucial for embryonic development. Although all Jun null mouse embryos die at mid-gestation with persistent truncus arteriosus, a severe cardiac outflow tract defect also seen in human congenital heart disease, the developmental mechanisms are poorly understood. Here we show that murine Jun is expressed in a restricted pattern in several cell populations important for cardiovascular development, including the second heart field, pharyngeal endoderm, outflow tract and atrioventricular endocardial cushions and post-migratory neural crest derivatives. Several genes, including Isl1, molecularly mark the second heart field. Isl1 lineages include myocardium, smooth muscle, neural crest, endocardium, and endothelium. We demonstrate that conditional knockout mouse embryos lacking Jun in Isl1-expressing progenitors display ventricular septal defects, double outlet right ventricle, semilunar valve hyperplasia and aortic arch artery patterning defects. In contrast, we show that conditional deletion of Jun in Tie2-expressing endothelial and endocardial precursors does not result in aortic arch artery patterning defects or embryonic death, but does result in ventricular septal defects and a low incidence of semilunar valve defects, atrioventricular valve defects and double outlet right ventricle. Our results demonstrate that Jun is required in Isl1-expressing progenitors and, to a lesser extent, in endothelial cells and endothelial-derived endocardium for cardiovascular development but is dispensable in both cell types for embryonic survival. These data provide a cellular framework for understanding the role of Jun in the pathogenesis of congenital heart disease.	[Zhang, Tao; Thekkethottiyil, Eldhose B.; Stoller, Jason Z.] Univ Penn, Childrens Hosp Philadelphia, Div Neonatol, Dept Pediat,Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Junchen; Wang, Fen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX USA; [Zhang, Jue] Morgridge Inst Res, Madison, WI USA; [Macatee, Timothy L.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ismat, Fraz A.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Cardiol,Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Pennsylvania; University of Pennsylvania; Childrens Hospital of Philadelphia	Stoller, JZ (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Div Neonatol, Dept Pediat,Perelman Sch Med, Philadelphia, PA 19104 USA.	stoller@email.chop.edu	Ismat, Fraz Ahmed/AAG-7470-2019; Stoller, Jason/AAA-2535-2020	Stoller, Jason/0000-0002-8475-690X; Liu, Junchen/0000-0003-2765-9780; Ismat, Fraz/0000-0002-2172-146X	National Institutes of Health (NIH); American Heart Association (AHA); Cancer Prevention and Research Institute of Texas (CPRIT); AHA [2010130, 11BGIA7370043]; NIH [R01-2R01CA096824, K08-HL086633]; CPRIT [RP110555]; NATIONAL CANCER INSTITUTE [P50CA140388, R01CA096824] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL086633] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Cancer Prevention and Research Institute of Texas (CPRIT); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH, www.nih.gov), American Heart Association (AHA, www.heart.org) and the Cancer Prevention and Research Institute of Texas (CPRIT, www.cprit.state.tx.us). JZ was supported by the AHA (2010130). FW was supported by the NIH (R01-2R01CA096824) and the CPRIT (RP110555). JZS was supported by the NIH (K08-HL086633) and AHA (11BGIA7370043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Anderson RH, 2010, CARDIOL YOUNG, V20, P92, DOI 10.1017/S1047951110001137; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Brown CB, 2001, DEVELOPMENT, V128, P3071; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; CARRASCO D, 1995, ONCOGENE, V10, P1069; Chen L, 2009, CIRC RES, V105, P842, DOI 10.1161/CIRCRESAHA.109.200295; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; DeLaughter DM, 2011, BIRTH DEFECTS RES A, V91, P511, DOI 10.1002/bdra.20809; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; FOLETTA VC, 1994, ONCOGENE, V9, P3305; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Huynh T, 2007, GENESIS, V45, P470, DOI 10.1002/dvg.20317; Ishii Y, 2009, CELL TISSUE RES, V335, P67, DOI 10.1007/s00441-008-0663-z; Jiang XB, 2000, DEVELOPMENT, V127, P1607; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Katabami M, 2005, J BIOL CHEM, V280, P16728, DOI 10.1074/jbc.M413892200; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Meixner A, 2010, CELL DEATH DIFFER, V17, P1409, DOI 10.1038/cdd.2010.22; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Parisot P, 2011, BIRTH DEFECTS RES A, V91, P477, DOI 10.1002/bdra.20803; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; Scambler PJ, 2010, PEDIATR CARDIOL, V31, P378, DOI 10.1007/s00246-009-9613-0; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Sclafani AM, 2006, GENESIS, V44, P336, DOI 10.1002/dvg.20220; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shimomura H, 2000, DIABETES, V49, P1597, DOI 10.2337/diabetes.49.9.1597; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Smith TK, 2007, SEMIN CELL DEV BIOL, V18, P84, DOI 10.1016/j.semcdb.2006.12.013; Snarr BS, 2008, DEV DYNAM, V237, P2804, DOI 10.1002/dvdy.21725; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Stevens KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010855; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; SZABO E, 1991, CELL GROWTH DIFFER, V2, P475; Thepot D, 2000, DEVELOPMENT, V127, P143; THIENE G, 1980, BRIT HEART J, V43, P605; Tian Y, 2012, CIRC RES, V110, P1023, DOI 10.1161/CIRCRESAHA.111.243899; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Webb S, 2003, J ANAT, V202, P327, DOI 10.1046/j.1469-7580.2003.00168.x; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wu BR, 2011, CIRC RES, V109, P183, DOI 10.1161/CIRCRESAHA.111.245035; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338; Zhang J, 2008, DEVELOPMENT, V135, P3611, DOI 10.1242/dev.025361; Zhang J, 2010, CIRC RES, V107, P1209, DOI 10.1161/CIRCRESAHA.110.225318; Zhang Z, 2006, DEVELOPMENT, V133, P3587, DOI 10.1242/dev.02539	89	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57032	10.1371/journal.pone.0057032	http://dx.doi.org/10.1371/journal.pone.0057032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437302	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000067
J	Budatha, M; Silva, S; Montoya, TI; Suzuki, A; Shah-Simpson, S; Wieslander, CK; Yanagisawa, M; Word, RA; Yanagisawa, H				Budatha, Madhusudhan; Silva, Simone; Montoya, Teodoro Ignacio; Suzuki, Ayako; Shah-Simpson, Sheena; Wieslander, Cecilia Karin; Yanagisawa, Masashi; Word, Ruth Ann; Yanagisawa, Hiromi			Dysregulation of Protease and Protease Inhibitors in a Mouse Model of Human Pelvic Organ Prolapse	PLOS ONE			English	Article							ELASTIC FIBER HOMEOSTASIS; UTEROSACRAL LIGAMENTS; EXTRACELLULAR-MATRIX; CELL APOPTOSIS; KNOCKOUT MICE; VAGINAL WALL; RAT UTERUS; IN-VIVO; FIBULIN-5; WOMEN	Mice deficient for the fibulin-5 gene (Fbln5(-/-)) develop pelvic organ prolapse (POP) due to compromised elastic fibers and upregulation of matrix metalloprotease (MMP)-9. Here, we used casein zymography, inhibitor profiling, affinity pull-down, and mass spectrometry to discover additional protease upregulated in the vaginal wall of Fbln5(-/-) mice, herein named V1 (25 kDa). V1 was a serine protease with trypsin-like activity similar to protease, serine (PRSS) 3, a major extrapancreatic trypsinogen, was optimum at pH 8.0, and predominantly detected in estrogenized vaginal epithelium of Fbln5(-/-) mice. PRSS3 was (a) localized in epithelial secretions, (b) detected in media of vaginal organ culture from both Fbln5(-/-) and wild type mice, and (c) cleaved fibulin-5 in vitro. Expression of two serine protease inhibitors [Serpina1a (alpha 1-antitrypsin) and Elafin] was dysregulated in Fbln5(-/-) epithelium. Finally, we confirmed that PRSS3 was expressed in human vaginal epithelium and that SERPINA1 and Elafin were downregulated in vaginal tissues from women with POP. These data collectively suggest that the balance between proteases and their inhibitors contributes to support of the pelvic organs in humans and mice.	[Budatha, Madhusudhan; Shah-Simpson, Sheena; Yanagisawa, Hiromi] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Silva, Simone; Montoya, Teodoro Ignacio; Wieslander, Cecilia Karin; Word, Ruth Ann] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Suzuki, Ayako; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Suzuki, Ayako; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Word, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA.	ruth.word@utsouthwestern.edu; hiromi.yanagisawa@utsouthwestern.edu	Budatha, Madhusudhan/A-1523-2015; Yanagisawa, Hiromi/Y-2843-2019	Yanagisawa, Hiromi/0000-0002-7576-9186; Suzuki, Ayako/0000-0001-9581-6341; Tomko, Sheena/0000-0002-2355-2794	NIH [R01AG028048, R01HD06482401]; Human Tissue and Biological Fluid Repository [P01HD11149]; Welch Foundation [I1646]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD011149, R01HD064824] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Tissue and Biological Fluid Repository; Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Grants from the NIH (R01AG028048, R01HD06482401), the Human Tissue and Biological Fluid Repository supported by P01HD11149, and The Welch Foundation (I1646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awla D, 2012, J LEUKOCYTE BIOL, V91, P711, DOI 10.1189/jlb.0811443; Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; Bump RC, 1998, OBSTET GYN CLIN N AM, V25, P723, DOI 10.1016/S0889-8545(05)70039-5; Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662; Gustilo-Ashby Arlan Marcus, 2010, Female Pelvic Med Reconstr Surg, V16, P21, DOI 10.1097/SPV.0b013e3181d00035; HAVRAN RT, 1977, J HISTOCHEM CYTOCHEM, V25, P1178, DOI 10.1177/25.10.72100; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239; KOIVUNEN E, 1991, CANCER RES, V51, P2107; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Man WC, 2009, INT UROGYNECOL J, V20, P1423, DOI 10.1007/s00192-009-0905-y; Moon YJ, 2011, J UROLOGY, V185, P1786, DOI 10.1016/j.juro.2010.12.040; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Rahn DD, 2008, AM J PHYSIOL-REG I, V295, pR1351, DOI 10.1152/ajpregu.90447.2008; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Sahin-Toth M, 2005, PROTEIN PEPTIDE LETT, V12, P457, DOI 10.2174/0929866054395356; SHARROW L, 1989, P SOC EXP BIOL MED, V192, P121; Shaw JLV, 2008, BIOL CHEM, V389, P1513, DOI 10.1515/BC.2008.171; Soderberg MW, 2009, MOL HUM REPROD, V15, P251, DOI 10.1093/molehr/gap011; STARCHER B, 1985, CONNECT TISSUE RES, V13, P207, DOI 10.3109/03008208509152400; Suzuki A, 1996, REPROD TOXICOL, V10, P129, DOI 10.1016/0890-6238(95)02055-1; Takacs P, 2008, INT UROGYNECOL J, V19, P1559, DOI 10.1007/s00192-008-0690-z; Takacs P, 2010, ARCH GYNECOL OBSTET, V282, P389, DOI 10.1007/s00404-009-1262-2; Takacs P, 2009, INT UROGYNECOL J, V20, P207, DOI 10.1007/s00192-008-0757-x; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wieslander CK, 2008, BIOL REPROD, V78, P521, DOI 10.1095/biolreprod.107.063024; Wieslander CK, 2009, BIOL REPROD, V80, P407, DOI 10.1095/biolreprod.108.072900; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhao BH, 2012, J OBSTET GYNAECOL RE, V38, P925, DOI 10.1111/j.1447-0756.2011.01814.x	35	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56376	10.1371/journal.pone.0056376	http://dx.doi.org/10.1371/journal.pone.0056376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437119	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200063
J	Liu, Q; Emadi, S; Shen, JX; Sierks, MR; Wu, J				Liu, Qiang; Emadi, Sharareh; Shen, Jian-Xin; Sierks, Michael R.; Wu, Jie			Human alpha 4 beta 2 Nicotinic Acetylcholine Receptor as a Novel Target of Oligomeric alpha-Synuclein	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; PARKINSONS-DISEASE; LEWY BODIES; RAT-BRAIN; GABAERGIC INTERNEURONS; SYNAPTIC-TRANSMISSION; DOPAMINERGIC-NEURONS; CHOLINERGIC RECEPTOR; HIPPOCAMPAL-NEURONS; CIGARETTE-SMOKING	Cigarette smoking is associated with a decreased incidence of Parkinson disease (PD) through unknown mechanisms. Interestingly, a decrease in the numbers of alpha 4 beta 2 nicotinic acetylcholine receptors (alpha 4 beta 2-nAChRs) in PD patients suggests an alpha 4 beta 2-nAChR-mediated cholinergic deficit in PD. Although oligomeric forms of alpha-synuclein have been recognized to be toxic and involved in the pathogenesis of PD, their direct effects on nAChR-mediated cholinergic signaling remains undefined. Here, we report for the first time that oligomeric alpha-synuclein selectively inhibits human alpha 4 beta 2-nAChR-mediated currents in a dose-dependent, non-competitive and use-independent manner. We show that pre-loading cells with guanyl-59-yl thiophosphate fails to prevent this inhibition, suggesting that the alpha-synuclein-induced inhibition of alpha 4 beta 2-nAChR function is not mediated by nAChR internalization. By using a pharmacological approach and cultures expressing transfected human nAChRs, we have shown a clear effect of oligomeric alpha-synuclein on alpha 4 beta 2-nAChRs, but not on alpha 4 beta 4- or alpha 7-nAChRs, suggesting nAChR subunit selectivity of oligomeric alpha-synuclein-induced inhibition. In addition, by combining the size exclusion chromatography and atomic force microscopy (AFM) analyses, we find that only large (>4 nm) oligomeric alpha-synuclein aggregates (but not monomeric, small oligomeric or fibrillar alpha-synuclein aggregates) exhibit the inhibitory effect on human alpha 4 beta 2-nAChRs. Collectively, we have provided direct evidence that alpha 4 beta 2-nAChR is a sensitive target to mediate oligomeric alpha-synuclein-induced modulation of cholinergic signaling, and our data imply that therapeutic strategies targeted toward alpha 4 beta 2-nAChRs may have potential for developing new treatments for PD.	[Liu, Qiang; Wu, Jie] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ USA; [Emadi, Sharareh; Sierks, Michael R.] Arizona State Univ, Dept Chem Engn, Tempe, AZ USA; [Shen, Jian-Xin; Wu, Jie] Shantou Univ, Coll Med, Dept Physiol, Shantou, Peoples R China; [Wu, Jie] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Arizona State University; Arizona State University-Tempe; Shantou University; University of Arizona	Wu, J (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ USA.	Jie.Wu@chw.edu	Liu, Qiang/HHZ-3181-2022		Michael J. Fox Foundation; Arizona Biomedical Research Commission	Michael J. Fox Foundation; Arizona Biomedical Research Commission	This work was supported by grants from the Michael J. Fox Foundation and the Arizona Biomedical Research Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Allison DW, 2011, SYNAPSE, V65, P804, DOI 10.1002/syn.20907; Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Baba M, 1998, AM J PATHOL, V152, P879; BENCHERIF M, 1993, J NEUROCHEM, V61, P852, DOI 10.1111/j.1471-4159.1993.tb03596.x; Brown RE, 2008, EUR J NEUROSCI, V27, P352, DOI 10.1111/j.1460-9568.2008.06024.x; Buhler AV, 2002, J NEUROPHYSIOL, V87, P548, DOI 10.1152/jn.00316.2001; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Eaton JB, 2003, MOL PHARMACOL, V64, P1283, DOI 10.1124/mol.64.6.1283; Emadi S, 2009, J BIOL CHEM, V284, P11048, DOI 10.1074/jbc.M806559200; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fayuk D, 2004, MOL PHARMACOL, V66, P658, DOI 10.1124/mol.104.000042; FLORES CM, 1992, MOL PHARMACOL, V41, P31; FRANDSEN A, 1989, J NEUROCHEM, V53, P297, DOI 10.1111/j.1471-4159.1989.tb07327.x; Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005; Guan ZZ, 2002, BRAIN RES, V956, P358, DOI 10.1016/S0006-8993(02)03571-0; Hall S., 2012, ARCH NEUROL-CHICAGO, P1; He P, 2012, FASEB J, V26, P334, DOI 10.1096/fj.11-192716; Jeyarasasingam G, 2002, NEUROSCIENCE, V109, P275, DOI 10.1016/S0306-4522(01)00488-2; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; Kawamata J, 2012, CURR DRUG TARGETS, V13, P623, DOI 10.2174/138945012800399026; Kiyohara Chikako, 2011, Fukuoka Acta Medica, V102, P254; Lester DB, 2010, CNS NEUROSCI THER, V16, P137, DOI 10.1111/j.1755-5949.2010.00142.x; Lindstrom J, 1996, Ion Channels, V4, P377; Liu QA, 2006, ACTA PHARMACOL SIN, V27, P1277, DOI 10.1111/j.1745-7254.2006.00430.x; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Louis ED, 2008, NEUROLOGY, V70, P1682, DOI 10.1212/01.wnl.0000311271.42596.32; LUKAS RJ, 1993, MOL CELL NEUROSCI, V4, P1, DOI 10.1006/mcne.1993.1001; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Martin-Ruiz CM, 2000, NEUROPHARMACOLOGY, V39, P2830, DOI 10.1016/S0028-3908(00)00110-6; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; PATEL MN, 1993, NEUROTOXICOLOGY, V14, P35; Peng JH, 1999, BRAIN RES, V825, P172, DOI 10.1016/S0006-8993(99)01066-5; PERRY EK, 1986, CAN J NEUROL SCI, V13, P521; PUCHACZ E, 1994, FEBS LETT, V354, P155, DOI 10.1016/0014-5793(94)01108-7; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Takeuchi H, 2009, J NEUROSCI RES, V87, P576, DOI 10.1002/jnr.21869; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Texido L, 2005, BRIT J PHARMACOL, V145, P672, DOI 10.1038/sj.bjp.0706221; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Velez-Fort M, 2009, GLIA, V57, P1104, DOI 10.1002/glia.20834; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645	58	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55886	10.1371/journal.pone.0055886	http://dx.doi.org/10.1371/journal.pone.0055886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437071	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200029
J	Men, H; Bryda, EC				Men, Hongsheng; Bryda, Elizabeth C.			Derivation of a Germline Competent Transgenic Fischer 344 Embryonic Stem Cell Line	PLOS ONE			English	Article							GENE KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; TRANSMISSION; BLASTOCYSTS; GENERATION; EXPRESSION; CULTURE	Embryonic stem (ES) cell-based gene manipulation is an effective method for the generation of mutant animal models in mice and rats. Availability of germline-competent ES cell lines from inbred rat strains would allow for creation of new genetically modified models in the desired genetic background. Fischer344 (F344) males carrying an enhanced green fluorescence protein (EGFP) transgene were used as the founder animals for the derivation of ES cell lines. After establishment of ES cell lines, rigorous quality control testing that included assessment of pluripotency factor expression, karyotype analysis, and pathogen/sterility testing was conducted in selected ES cell lines. One male ES cell line, F344-Tg.EC4011, was further evaluated for germline competence by injection into Dark Agouti (DA) X Sprague Dawley (SD) blastocysts. Resulting chimeric animals were bred with wild-type SD mates and germline transmissibility of the ES cell line was confirmed by identification of pups carrying the ES cell line-derived EGFP transgene. This is the first report of a germline competent F344 ES cell line. The availability of a new germline competent ES cell line with a stable fluorescence reporter from an inbred transgenic rat strain provides an important new resource for genetic manipulations to create new rat models.	[Men, Hongsheng; Bryda, Elizabeth C.] Univ Missouri, Dept Vet Pathobiol, Rat Resource & Res Ctr, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Bryda, EC (corresponding author), Univ Missouri, Dept Vet Pathobiol, Rat Resource & Res Ctr, Columbia, MO 65212 USA.	brydae@missouri.edu			National Institutes of Health [8P40 OD011062-12]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by grant funding to the Rat Resource and Research Center (RRRC) from the National Institutes of Health (8P40 OD011062-12) (URL http://dpcpsi.nih.gov/orip/cm/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; Bryda EC, 2006, BIOTECHNIQUES, V41, P715, DOI 10.2144/000112289; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carstea Ana Claudia, 2009, World J Stem Cells, V1, P22, DOI 10.4252/wjsc.v1.i1.22; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; Hong J, 2012, STEM CELLS DEV, V21, P1571, DOI 10.1089/scd.2011.0370; Kakinoki Ryosuke, 2002, J Orthop Sci, V7, P252, DOI 10.1007/s007760200042; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Linder CC, 2001, LAB ANIMAL, V30, P34; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Men HS, 2012, STEM CELLS DEV, V21, P2606, DOI 10.1089/scd.2012.0040; Nichols Jennifer, 2006, V329, P91; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409; Zhao XY, 2010, J GENET GENOMICS, V37, P467, DOI 10.1016/S1673-8527(09)60066-7	21	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56518	10.1371/journal.pone.0056518	http://dx.doi.org/10.1371/journal.pone.0056518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437152	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200090
J	Mineau, P; Whiteside, M				Mineau, Pierre; Whiteside, Melanie			Pesticide Acute Toxicity Is a Better Correlate of US Grassland Bird Declines than Agricultural Intensification	PLOS ONE			English	Article							INSECTICIDE USE	Common agricultural birds are in decline, both in Europe and in North America. Evidence from Europe suggests that agricultural intensification and, for some species, the indirect effects of pesticides mediated through a loss of insect food resource is in part responsible. On a state-by-state basis for the conterminous Unites States (U.S.), we looked at several agronomic variables to predict the number of grassland species increasing or declining according to breeding bird surveys conducted between 1980 and 2003. Best predictors of species declines were the lethal risk from insecticide use modeled from pesticide impact studies, followed by the loss of cropped pasture. Loss of permanent pasture or simple measures of agricultural intensification such as the proportion of land under crop or the proportion of farmland treated with herbicides did not explain bird declines as well. Because the proportion of farmland treated with insecticides, and more particularly the lethal risk to birds from the use of current insecticides feature so prominently in the best models, this suggests that, in the U.S. at least, pesticide toxicity to birds should be considered as an important factor in grassland bird declines.	[Mineau, Pierre; Whiteside, Melanie] Environm Canada, Natl Wildlife Res Ctr, Sci & Technol Branch, Ottawa, ON K1A 0H3, Canada; [Whiteside, Melanie] Hlth Canada, Pest Management Regulatory Agcy, Ottawa, ON K1A 0L2, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Health Canada	Mineau, P (corresponding author), Environm Canada, Natl Wildlife Res Ctr, Sci & Technol Branch, Carleton Univ Campus, Ottawa, ON K1A 0H3, Canada.	pierre.mineau@ec.gc.ca			Environment Canada	Environment Canada(CGIAR)	The work was funded by Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, EFSA J, VXXXVI, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMPBELL LH, 1997, 227 JOINT NAT CONS C; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Dunn E, 2000, 216 CAN WILDL SERV E; Evans KL, 2004, IBIS, V146, P1, DOI 10.1111/j.1474-919X.2004.00231.x; Fox AD, 2004, J APPL ECOL, V41, P427, DOI 10.1111/j.0021-8901.2004.00917.x; Fuller RJ, 2000, ECOLOGY AND CONSERVATION OF LOWLAND FARMLAND BIRDS, P5; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Heath SA, 2008, THESIS G MASON U FAI; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Mineau P, 2005, ECOSCIENCE, V12, P267, DOI 10.2980/i1195-6860-12-2-267.1; Mineau P, 2002, ENVIRON TOXICOL CHEM, V21, P1497, DOI 10.1897/1551-5028(2002)021&lt;1497:ETPOBM&gt;2.0.CO;2; Mineau P, 2001, REV ENVIRON CONTAM T, V170, P13; Mineau P, 1999, J RAPTOR RES, V33, P1; Mineau P., 2004, WILLIAM MARY ENV LAW, V28, P313; Mineau P, 2006, ENVIRON TOXICOL CHEM, V25, P1214, DOI 10.1897/05-035R.1; Mineau Pierre, 2005, U S Forest Service General Technical Report PSW, V191, P1065; Murphy MT, 2003, AUK, V120, P20, DOI 10.1642/0004-8038(2003)120[0020:APTWTE]2.0.CO;2; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Pain DJ, 1997, FARMING BIRDS EUROPE; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; RODENHOUSE NL, 1993, USDA ROCKY, V229, P280; Sauer J.R., 2000, N AM BREEDING BIRD S	25	125	129	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57457	10.1371/journal.pone.0057457	http://dx.doi.org/10.1371/journal.pone.0057457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437392	Green Published, gold			2022-12-27	WOS:000315184200257
J	Sansom, FM; Tang, L; Ralton, JE; Saunders, EC; Naderer, T; McConville, MJ				Sansom, Fiona M.; Tang, Leonie; Ralton, Julie E.; Saunders, Eleanor C.; Naderer, Thomas; McConville, Malcolm J.			Leishmania major Methionine Sulfoxide Reductase A Is Required for Resistance to Oxidative Stress and Efficient Replication in Macrophages	PLOS ONE			English	Article							TRYPANOTHIONE REDUCTASE; ESCHERICHIA-COLI; MYCOBACTERIUM-SMEGMATIS; ANTIOXIDANT DEFENSE; PROTEIN-REGULATION; A MSRA; GENE; EXPRESSION; VIRULENCE; ENZYME	Leishmania are protozoan parasites that proliferate within the phagolysome of mammalian macrophages. While a number of anti-oxidant systems in these parasites have been shown to protect against endogenous as well as host-generated reactive oxygen species, the potential role of enzymes involved in the repair of oxidatively damaged proteins remains uncharacterized. The Leishmania spp genomes encode a single putative methionine sulfoxide reductase (MsrA) that could have a role in reducing oxidized free and proteinogenic methionine residues. A GFP-fusion of L. major MsrA was shown to have a cytoplasmic localization by immunofluorescence microscopy and subcellular fractionation. An L. major msrA null mutant, generated by targeted replacement of both chromosomal allelles, was viable in rich medium but was unable to reduce exogenous methionine sulfoxide when cultivated in the presence of this amino acid, indicating that msrA encodes a functional MsrA. The Delta msrA mutant exhibited increased sensitivity to H2O2 compared to wild type parasites and was unable to proliferate normally in macrophages. Wild type sensitivity to H2O2 and infectivity in macrophages was restored by complementation of the mutant with a plasmid encoding MsrA. Unexpectedly, the Delta msrA mutant was able to induce normal lesions in susceptible BALB/c indicating that this protein is not essential for pathogenesis in vivo. Our results suggest that Leishmania MsrA contributes to the anti-oxidative defences of these parasites, but that complementary oxidative defence mechansims are up-regulated in lesion amastigotes.	[Sansom, Fiona M.; Tang, Leonie; Ralton, Julie E.; Saunders, Eleanor C.; Naderer, Thomas; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Sansom, Fiona M.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	McConville, MJ (corresponding author), Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia.	malcolmm@unimelb.edu.au	Sansom, Fiona M/W-8445-2019	Sansom, Fiona/0000-0002-9433-2545; Naderer, Thomas/0000-0003-2691-0283; Saunders, Eleanor/0000-0002-3247-8522	National Health and Medical Research Council [APP1006023]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (http://www.nhmrc.gov.au/), under project grant APP1006023. FMS is a NH&MRC Peter Doherty Australian Biomedical Fellow. MJM is a NH&MRC Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arias DG, 2011, FREE RADICAL BIO MED, V50, P37, DOI 10.1016/j.freeradbiomed.2010.10.695; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Boughton BA, 2011, ANAL CHEM, V83, P7523, DOI 10.1021/ac201610x; CHAN J, 1989, P NATL ACAD SCI USA, V86, P2453, DOI 10.1073/pnas.86.7.2453; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Das K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036247; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Dhandayuthapani S, 2009, TUBERCULOSIS, V89, pS26, DOI 10.1016/S1472-9792(09)70008-3; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; El Hassouni M, 1999, P NATL ACAD SCI USA, V96, P887, DOI 10.1073/pnas.96.3.887; Etienne F, 2003, BIOCHEM BIOPH RES CO, V300, P378, DOI 10.1016/S0006-291X(02)02870-X; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hansel A, 2002, FASEB J, V16, P911, DOI 10.1096/fj.01-0737fje; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kaya A, 2010, BIOCHEMISTRY-US, V49, P8618, DOI 10.1021/bi100908v; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei Y, 2011, MOL MICROBIOL, V80, P726, DOI 10.1111/j.1365-2958.2011.07603.x; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; Merlen T, 1999, AM J TROP MED HYG, V60, P41, DOI 10.4269/ajtmh.1999.60.41; Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107; Moreira W, 2009, FREE RADICAL BIO MED, V46, P367, DOI 10.1016/j.freeradbiomed.2008.10.034; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Moskovitz J, 2000, J BIOL CHEM, V275, P14167, DOI 10.1074/jbc.275.19.14167; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Mukherjee A, 2009, MOL MICROBIOL, V74, P914, DOI 10.1111/j.1365-2958.2009.06907.x; Mullin KA, 2001, MOL BIOL CELL, V12, P2364, DOI 10.1091/mbc.12.8.2364; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Naderer T, 2008, MOL MICROBIOL, V69, P858, DOI 10.1111/j.1365-2958.2008.06314.x; Naderer T, 2011, MOL MICROBIOL, V80, P471, DOI 10.1111/j.1365-2958.2011.07584.x; Nare B, 2009, CURR GENET, V55, P287, DOI 10.1007/s00294-009-0244-z; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Plewes KA, 2003, INFECT IMMUN, V71, P5910, DOI 10.1128/IAI.71.10.5910-5920.2003; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Spath GF, 2003, P NATL ACAD SCI USA, V100, P9536, DOI 10.1073/pnas.1530604100; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Tovar J, 1998, MOL MICROBIOL, V29, P653, DOI 10.1046/j.1365-2958.1998.00968.x; Tovar J, 1998, P NATL ACAD SCI USA, V95, P5311, DOI 10.1073/pnas.95.9.5311; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; Vickers TJ, 2006, J BIOL CHEM, V281, P38150, DOI 10.1074/jbc.M608387200; Vickers TJ, 2004, J BIOL CHEM, V279, P49003, DOI 10.1074/jbc.M407958200; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Williams RAM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002695; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	67	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56064	10.1371/journal.pone.0056064	http://dx.doi.org/10.1371/journal.pone.0056064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437085	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200039
J	Wascher, CAF; Bugnyar, T				Wascher, Claudia A. F.; Bugnyar, Thomas			Behavioral Responses to Inequity in Reward Distribution and Working Effort in Crows and Ravens	PLOS ONE			English	Article							CAPUCHIN MONKEYS; CARRION CROWS; TOKEN-EXCHANGE; AVERSION; PERCEPTIONS; PERFORMANCE; EVOLUTION; COGNITION; FAIRNESS; CORVIDS	Sensitivity to inequity is considered to be a crucial cognitive tool in the evolution of human cooperation. The ability has recently been shown also in primates and dogs, raising the question of an evolutionary basis of inequity aversion. We present first evidence that two bird species are sensitive to other individuals' efforts and payoffs. In a token exchange task we tested both behavioral responses to inequity in the quality of reward (preferred versus non-preferred food) and to the absence of reward in the presence of a rewarded partner, in 5 pairs of corvids (6 crows, 4 ravens). Birds decreased their exchange performance when the experimental partner received the reward as a gift, which indicates that they are sensitive to other individuals' working effort. They also decreased their exchange performance in the inequity compared with the equity condition. Notably, corvids refused to take the reward after a successful exchange more often in the inequity compared with the other conditions. Our findings indicate that awareness to other individuals' efforts and payoffs may evolve independently of phylogeny in systems with a given degree of social complexity.	[Wascher, Claudia A. F.; Bugnyar, Thomas] Univ Vienna, Core Facil, Konrad Lorenz Forsch Stelle, Gruenau, Austria; [Wascher, Claudia A. F.] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wascher, Claudia A. F.; Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Wascher, CAF (corresponding author), Univ Vienna, Core Facil, Konrad Lorenz Forsch Stelle, Gruenau, Austria.	claudia.wascher@klf.ac.at	Wascher, Claudia/I-4060-2019	Wascher, Claudia/0000-0003-4360-363X	L'Oreal Women in Science scholarship; European Science Foundation EUROCORES program "The evolution of cooperation and trading: Cooperation in Corvids" [I105-G11]; Austrian Science Foundation (FWF) [Y366-B17]; Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish	L'Oreal Women in Science scholarship; European Science Foundation EUROCORES program "The evolution of cooperation and trading: Cooperation in Corvids"; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was funded by a L'Oreal Women in Science scholarship to CAFW, and the European Science Foundation EUROCORES program "The evolution of cooperation and trading: Cooperation in Corvids" (I105-G11; http://www.esf.org)) and Austrian Science Foundation (FWF Start Y366-B17; http://www.fwf.ac.at) to TB. Permanent support was provided by the "Verein der Forderer" and the Herzog von Cumberland Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglione V, 2003, SCIENCE, V300, P1947, DOI 10.1126/science.1082429; Baglione V, 2002, ANIM BEHAV, V64, P887, DOI 10.1006/anbe.2002.2007; Bettencourt LA, 1997, J RETAILING, V73, P39, DOI 10.1016/S0022-4359(97)90014-2; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brosnan S.F., 2006, SOC JUSTICE RES, V19, P153, DOI [10.1007/s11211-006-0002-z, DOI 10.1007/S11211-006-0002-Z]; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2699, DOI 10.1098/rstb.2010.0154; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2009, ANIM COGN, V12, P587, DOI 10.1007/s10071-009-0218-z; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Bugnyar T, 2007, CURR BIOL, V17, P1804, DOI 10.1016/j.cub.2007.09.048; Bugnyar T, 2007, ANIM BEHAV, V74, P757, DOI 10.1016/j.anbehav.2006.08.019; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clayton N, 2005, CURR BIOL, V15, pR80, DOI 10.1016/j.cub.2005.01.020; Dufour V, 2012, BIOL LETTERS, V8, P201, DOI 10.1098/rsbl.2011.0726; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fletcher GE, 2008, AM J PRIMATOL, V70, P901, DOI 10.1002/ajp.20576; Fontenot MB, 2007, ANIM BEHAV, V74, P487, DOI 10.1016/j.anbehav.2007.01.015; Fraser ON, 2012, ANIM BEHAV, V83, P171, DOI 10.1016/j.anbehav.2011.10.023; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; GUTH W, 1990, J ECON PSYCHOL, V11, P417, DOI 10.1016/0167-4870(90)90021-Z; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; Heinrich B, 2007, SCI AM, V296, P64, DOI 10.1038/scientificamerican0407-64; Hodge SJ, 2009, BEHAV ECOL, V20, P930, DOI 10.1093/beheco/arp071; Janssen O, 2001, ACAD MANAGE J, V44, P1039, DOI 10.2307/3069447; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; Mcgowan A, 2007, IBIS, V149, P170; PRITCHARD RD, 1972, J APPL PSYCHOL, V56, P75, DOI 10.1037/h0032135; Raihani NJ, 2012, ANIM BEHAV, V84, P665, DOI 10.1016/j.anbehav.2012.06.023; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Roma PG, 2006, J COMP PSYCHOL, V120, P67, DOI 10.1037/0735-7036.120.1.67; Roth A.E., 1995, HDB EXPT EC, P253; Scheid C, 2010, ANIM COGN, V13, P545, DOI 10.1007/s10071-009-0305-1; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Takimoto A, 2010, ANIM COGN, V13, P249, DOI 10.1007/s10071-009-0262-8; Talbot CF, 2011, BIOL LETTERS, V7, P680, DOI 10.1098/rsbl.2011.0211; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Wascher CAF, 2012, ANIM COGN, V15, P1015, DOI 10.1007/s10071-012-0508-8; Wascher CAF, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00118; Wynne CDL, 2004, NATURE, V428, P140, DOI [10.1038/428140a, 10.1038/428140b]	44	58	60	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56885	10.1371/journal.pone.0056885	http://dx.doi.org/10.1371/journal.pone.0056885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437262	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200177
J	Welcker, J; Chastel, O; Gabrielsen, GW; Guillaumin, J; Kitaysky, AS; Speakman, JR; Tremblay, Y; Bech, C				Welcker, Jorg; Chastel, Olivier; Gabrielsen, Geir W.; Guillaumin, Jerome; Kitaysky, Alexander S.; Speakman, John R.; Tremblay, Yann; Bech, Claus			Thyroid Hormones Correlate with Basal Metabolic Rate but Not Field Metabolic Rate in a Wild Bird Species	PLOS ONE			English	Article							DOUBLY-LABELED WATER; KITTIWAKES RISSA-TRIDACTYLA; DAILY ENERGY-EXPENDITURE; BODY-COMPOSITION; PHYSICAL-ACTIVITY; INDIVIDUAL VARIATION; THYROXINE; VOLES; THERMOGENESIS; REPEATABILITY	Thyroid hormones (TH) are known to stimulate in vitro oxygen consumption of tissues in mammals and birds. Hence, in many laboratory studies a positive relationship between TH concentrations and basal metabolic rate (BMR) has been demonstrated whereas evidence from species in the wild is scarce. Even though basal and field metabolic rates (FMR) are often thought to be intrinsically linked it is still unknown whether a relationship between TH and FMR exists. Here we determine the relationship between the primary thyroid hormone triiodothyronine (T3) with both BMR and FMR in a wild bird species, the black-legged kittiwake (Rissa tridactyla). As predicted we found a strong and positive relationship between plasma concentrations of T3 and both BMR and mass-independent BMR with coefficients of determination ranging from 0.36 to 0.60. In contrast there was no association of T3 levels with either whole-body or mass-independent FMR (R-2 = 0.06 and 0.02, respectively). In accordance with in vitro studies our data suggests that TH play an important role in modulating BMR and may serve as a proxy for basal metabolism in wild birds. However, the lack of a relationship between TH and FMR indicates that levels of physical activity in kittiwakes are largely independent of TH concentrations and support recent studies that cast doubt on a direct linkage between BMR and FMR.	[Welcker, Jorg; Gabrielsen, Geir W.] Norwegian Polar Res Inst, Tromso, Norway; [Welcker, Jorg; Kitaysky, Alexander S.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Chastel, Olivier; Guillaumin, Jerome; Tremblay, Yann] CNRS, Ctr Etud Biol Chize, Chize, France; [Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Tremblay, Yann] Ctr Rech Halieut Mediterraneenne & Trop, Sete, France; [Bech, Claus] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	Norwegian Polar Institute; University of Alaska System; University of Alaska Fairbanks; Centre National de la Recherche Scientifique (CNRS); University of Aberdeen; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Norwegian University of Science & Technology (NTNU)	Welcker, J (corresponding author), Norwegian Polar Res Inst, Tromso, Norway.	jorg.welcker@npolar.no	Bech, Claus/C-1086-2011; Bech, Claus/N-1077-2019; Speakman, John R./A-9494-2008	Bech, Claus/0000-0002-0860-0663; Bech, Claus/0000-0002-0860-0663; Speakman, John R./0000-0002-2457-1823	French Polar Institute (IPEV Program) [330]; Research Council of Norway [197192/V40]; Norwegian Polar Institute	French Polar Institute (IPEV Program); Research Council of Norway(Research Council of Norway); Norwegian Polar Institute	The study was financially supported by the French Polar Institute (IPEV Program 330 to O. Chastel), the Research Council of Norway (project 197192/V40 to JW) and the Norwegian Polar Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER SB, 1951, PHYSIOL REV, V31, P205, DOI 10.1152/physrev.1951.31.3.205; BARKER SB, 1952, AM J PHYSIOL, V170, P81, DOI 10.1152/ajplegacy.1952.170.1.81; Barrett RT, 2007, MAR ECOL PROG SER, V349, P269, DOI 10.3354/meps07116; Bech C, 2002, COMP BIOCHEM PHYS A, V133, P765, DOI 10.1016/S1095-6433(02)00153-8; Bech C, 1999, P ROY SOC B-BIOL SCI, V266, P2161, DOI 10.1098/rspb.1999.0903; Berteaux D, 1996, FUNCT ECOL, V10, P751, DOI 10.2307/2390510; BOBEK S, 1977, GEN COMP ENDOCR, V31, P169, DOI 10.1016/0016-6480(77)90014-4; Burger MF, 2002, PHYSIOL BIOCHEM ZOOL, V75, P187, DOI 10.1086/338955; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Careau V, 2012, J EXPT BIOL IN PRESS; Chastel O, 2003, J AVIAN BIOL, V34, P298, DOI 10.1034/j.1600-048X.2003.02528.x; Corbel H, 2008, GEN COMP ENDOCR, V155, P804, DOI 10.1016/j.ygcen.2007.11.006; DAAN S, 1989, J BIOL RHYTHM, V4, P267; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DAWSON WR, 1992, ORNIS SCAND, V23, P381, DOI 10.2307/3676664; DuBois E, 1936, BASAL METABOLISM HLT; Duriez O, 2004, ARDEA, V92, P31; EALES JG, 1988, AM ZOOL, V28, P351; Ellis HI, 2002, BIOL MARINE BIRDS; EMLEN W, 1972, SCIENCE, V175, P79, DOI 10.1126/science.175.4017.79; FREAKE HC, 1995, ANNU REV NUTR, V15, P263, DOI 10.1146/annurev.nu.15.070195.001403; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fyhn M, 2001, PHYSIOL BIOCHEM ZOOL, V74, P343, DOI 10.1086/320419; GABRIELSEN GW, 1988, J COMP PHYSIOL B, V157, P703, DOI 10.1007/BF00691000; GRATTOTREVOR CL, 1991, J FIELD ORNITHOL, V62, P19; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; HARPER ME, 1993, J BIOL CHEM, V268, P14850; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; JOOS B, 1990, PHYSIOL ZOOL, V63, P873, DOI 10.1086/physzool.63.5.30152618; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; KLANDORF H, 1978, GEN COMP ENDOCR, V36, P238, DOI 10.1016/0016-6480(78)90029-1; Levine JA, 2003, J APPL PHYSIOL, V94, P165, DOI 10.1152/japplphysiol.00499.2002; Li YG, 2010, COMP BIOCHEM PHYS A, V157, P204, DOI 10.1016/j.cbpa.2010.06.183; McNabb F.M. Anne, 2000, P461; Meerlo P, 1997, PHYSIOL ZOOL, V70, P362, DOI 10.1086/639616; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Moe B, 2002, J AVIAN BIOL, V33, P225, DOI 10.1034/j.1600-048X.2002.330304.x; Nagy K. A., 1983, DOUBLY LABELLED WATE; NIIMI AJ, 1978, J FISH RES BOARD CAN, V35, P1265, DOI 10.1139/f78-197; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; R Development Core Team, 2012, R LANG ENV STAT COMP; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ronning B, 2008, J COMP PHYSIOL B, V178, P779, DOI 10.1007/s00360-008-0268-6; Silvestri E, 2005, ACTA PHYSIOL SCAND, V184, P265, DOI 10.1111/j.1365-201X.2005.01463.x; Speakman J.R., 1997, DOUBLY LABELLED WATE; Speakman JR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P900, DOI 10.1086/427059; Speakman JR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P650, DOI 10.1086/430234; Speakman JR, 2000, ADV ECOL RES, V30, P177; Speakman JR, 2003, P NATL ACAD SCI USA, V100, P14057, DOI 10.1073/pnas.2235671100; SPEAKMAN JR, 1987, J THEOR BIOL, V127, P79, DOI 10.1016/S0022-5193(87)80162-5; SPEAKMAN JR, 1990, ANAL CHEM, V62, P703, DOI 10.1021/ac00206a011; SPEAKMAN JR, 1993, FUNCT ECOL, V7, P746; SPEAKMAN JR, 1994, FUNCT ECOL, V8, P336, DOI 10.2307/2389826; Starling RD, 1998, J APPL PHYSIOL, V85, P1063, DOI 10.1152/jappl.1998.85.3.1063; STENLOF K, 1993, SCAND J CLIN LAB INV, V53, P793, DOI 10.3109/00365519309086491; Tieleman BI, 2008, BEHAV ECOL, V19, P949, DOI 10.1093/beheco/arn051; Toubro S, 1996, J CLIN ENDOCR METAB, V81, P2670, DOI 10.1210/jc.81.7.2670; Van Trigt R, 2002, J APPL PHYSIOL, V93, P2147, DOI 10.1152/japplphysiol.01134.2001; Vezina F, 2009, PHYSIOL BIOCHEM ZOOL, V82, P129, DOI 10.1086/596512; Visser GH, 1999, PHYSIOL BIOCHEM ZOOL, V72, P740, DOI 10.1086/316713; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; Welcker J, 2010, J ANIM ECOL, V79, P205, DOI 10.1111/j.1365-2656.2009.01626.x; Welcker J, 2009, FUNCT ECOL, V23, P1081, DOI 10.1111/j.1365-2435.2009.01585.x; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; White CR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P929, DOI 10.1086/425186; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120	68	42	43	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56229	10.1371/journal.pone.0056229	http://dx.doi.org/10.1371/journal.pone.0056229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437096	Green Published, Green Accepted, gold			2022-12-27	WOS:000315184200047
J	Mutyal, NN; Radosevich, A; Tiwari, AK; Stypula, Y; Wali, R; Kunte, D; Roy, HK; Backman, V				Mutyal, Nikhil N.; Radosevich, Andrew; Tiwari, Ashish K.; Stypula, Yolanda; Wali, Ramesh; Kunte, Dhananjay; Roy, Hemant K.; Backman, Vadim			Biological Mechanisms Underlying Structural Changes Induced by Colorectal Field Carcinogenesis Measured with Low-Coherence Enhanced Backscattering (LEBS) Spectroscopy	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; PROTEIN-KINASE-C; LIGHT-SCATTERING; CELL-PROLIFERATION; COLONIC NEOPLASIA; GENE-EXPRESSION; CANCER CELLS; STEM-CELL; RISK; MUCOSA	We previously reported the utility of Low-Coherence Enhanced Backscattering (LEBS) Spectroscopy in detecting optical changes in uninvolved rectal mucosa, changes that are indicative of the presence of advanced colorectal adenomas elsewhere in the colon (field carcinogenesis). We hypothesized that the alterations in optical signatures are due to structural changes in colonocytes. To elucidate those colonocyte changes, we used LEBS and an early time point in an animal model of colorectal field carcinogenesis - rats treated with azoxymethane (AOM). Changes in LEBS markers in intact mucosa from AOM-treated rats could be at least partially attributed to changes in colonocytes. To investigate the molecular mechanisms underlying the colonocyte abnormalities in premalignant colon, we took a candidate approach. We compared expression profiles of genes implicated directly or indirectly in cytoskeletal dysregulation in colorectal tissues from saline-treated versus AOM-treated rats. Our data suggest that a number of genes known to affect colon tumorigenesis are up-regulated in colonocytes, and genes previously reported to be tumor suppressors in metastatic cancer are down-regulated in colonocytes, despite the colonocytes being histologically normal. To further understand the role of the cytoskeleton in generating changes in optical markers of cells, we used pharmacological disruption (using colchicine) of the cytoskeleton. We found that differences in optical markers (between AOM- and control-treated rats) were negated by the disruption, suggesting cytoskeletal involvement in the optical changes. These studies provide significant insights into the micro-architectural alterations in early colon carcinogenesis, and may enable optimization of both bio-photonic and molecular risk stratification techniques to personalize colorectal cancer screening.	[Mutyal, Nikhil N.; Radosevich, Andrew; Stypula, Yolanda; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Tiwari, Ashish K.; Wali, Ramesh; Kunte, Dhananjay; Roy, Hemant K.] NorthShore Univ Healthsyst, Dept Internal Med, Evanston, IL USA	Northwestern University; NorthShore University Health System	Roy, HK (corresponding author), NorthShore Univ Healthsyst, Dept Internal Med, Evanston, IL USA.	h-roy@northwestern.edu	Backman, Vadim/B-6689-2009; Roy, Hemant/AAC-9096-2020		NIH [R01CA128641, R01 EB003682, R01CA156186 U01CA111257]; NSF [CBET-0937987]; NATIONAL CANCER INSTITUTE [R01CA128641, U01CA111257, R01CA156186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grants R01CA128641, R01 EB003682, R01CA156186 U01CA111257, and NSF grant CBET-0937987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTI M, 1993, GUT, V34, P525, DOI 10.1136/gut.34.4.525; Arifler D, 2007, BIOPHYS J, V92, P3260, DOI 10.1529/biophysj.106.089839; BARER R, 1954, Q J MICROSC SCI, V95, P399; Barnes CJ, 1999, INT J CANCER, V80, P68; Bernstein C, 1999, CANCER RES, V59, P2353; BISSONNETTE M, 1995, J CLIN INVEST, V95, P2215, DOI 10.1172/JCI117911; Brittan M, 2004, GUT, V53, P899, DOI 10.1136/gut.2003.025478; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; Caro-Gonzalez HY, 2012, J CELL SCI, V125, P1247, DOI 10.1242/jcs.095166; Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264; Dakubo GD, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-2; Damania D, 2012, CANCER RES, V72, P2720, DOI 10.1158/0008-5472.CAN-11-3807; Damania D, 2010, BIOPHYS J, V99, P989, DOI 10.1016/j.bpj.2010.05.023; Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183; KOPELOVICH L, 1977, P NATL ACAD SCI USA, V74, P3019, DOI 10.1073/pnas.74.7.3019; Marshall TW, 2011, MOL BIOL CELL, V22, P3962, DOI 10.1091/mbc.E11-05-0469; MCGARRITY TJ, 1994, DIGEST DIS SCI, V39, P458, DOI 10.1007/BF02088328; Polley ACJ, 2006, CANCER RES, V66, P6553, DOI 10.1158/0008-5472.CAN-06-0534; Preston SL, 2003, CANCER RES, V63, P3819; RAO JY, 1991, CANCER RES, V51, P2762; RICHTER A, 1993, CANCER LETT, V74, P65, DOI 10.1016/0304-3835(93)90045-B; Rogers JD, 2009, OPT LETT, V34, P1891, DOI 10.1364/OL.34.001891; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Roy HK, 2009, CANCER RES, V69, P4476, DOI 10.1158/0008-5472.CAN-08-4780; Roy HK, 2006, CLIN CANCER RES, V12, P961, DOI 10.1158/1078-0432.CCR-05-1605; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Stypula Y, 2012, GASTROENTEROLOGY S1, V138, pS; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Turzhitsky V, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3589349; Vandecandelaere A, 1997, BIOCHEM J, V323, P189, DOI 10.1042/bj3230189; Vlecken DH, 2009, ZEBRAFISH, V6, P433, DOI 10.1089/zeb.2009.0602	32	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57206	10.1371/journal.pone.0057206	http://dx.doi.org/10.1371/journal.pone.0057206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431406	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800049
J	Vaupel, JW; Missov, TI; Metcalf, CJE				Vaupel, James W.; Missov, Trifon I.; Metcalf, C. Jessica E.			Optimal Semelparity	PLOS ONE			English	Article							SEED SIZE; NATURAL-SELECTION; MONOCARPIC PLANTS; GENERAL-MODEL; REPRODUCTION; DYNAMICS; HISTORY; GROWTH; AGE	Semelparous organisms have a simple life cycle characterized by immediate death after reproduction. We assume that semelparous life histories can be separated into a juvenile non-reproductive period followed by an adult period during which reproduction is possible. We derive formulae for the optimal age and size at reproduction and for the optimal size of the offspring (e.g., seeds). Our main contribution is to determine the conditions under which the optimal size of the offspring does not depend on the optimal size at reproduction and vice versa.	[Vaupel, James W.; Missov, Trifon I.] Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany; [Vaupel, James W.] Univ So Denmark, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark; [Vaupel, James W.] Duke Univ, Populat Res Inst, Durham, NC USA; [Missov, Trifon I.] Univ Rostock, Inst Sociol & Demog, Fac Econ & Social Sci, D-18055 Rostock, Germany; [Metcalf, C. Jessica E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Max Planck Society; University of Southern Denmark; Duke University; University of Rostock; University of Oxford	Missov, TI (corresponding author), Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany.	missov@demogr.mpg.de	Missov, Trifon I./AAE-6540-2020	Missov, Trifon I./0000-0002-7312-4261; Vaupel, James/0000-0003-0783-3905	Max Planck Institute for Demographic Rsearch; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER	Max Planck Institute for Demographic Rsearch; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded by the Max Planck Institute for Demographic Rsearch (http://www.demogr.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; ARTHUR WB, 1984, POPUL INDEX, V50, P214, DOI 10.2307/2736755; BRAITHWAITE RW, 1979, AM NAT, V113, P151, DOI 10.1086/283372; Burd M, 2006, ECOLOGY, V87, P2755, DOI 10.1890/0012-9658(2006)87[2755:APFRIM]2.0.CO;2; Charnov Eric L., 1993, P1; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Falster DS, 2008, AM NAT, V172, P299, DOI 10.1086/589889; FRITZ RS, 1982, AM NAT, V120, P264, DOI 10.1086/283987; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Kiawi M, 2006, OIKOS, V113, P168; KLINKHAMER PGL, 1992, FUNCT ECOL, V6, P308, DOI 10.2307/2389522; Lewontin R. C., 1965, P77; Metcalf JC, 2003, TRENDS ECOL EVOL, V18, P471, DOI 10.1016/S0169-5347(03)00162-9; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Rees M., 2000, ECOLOGICAL CONSEQUEN, P237; Rees M, 2007, J ECOL, V95, P926, DOI 10.1111/j.1365-2745.2007.01277.x; Rees M, 2006, AM NAT, V168, pE53, DOI 10.1086/505762; Rees M, 2010, AM NAT, V176, pE152, DOI 10.1086/657037; Roff Derek, 2002, pi; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; TAYLOR HM, 1974, THEOR POPUL BIOL, V5, P104, DOI 10.1016/0040-5809(74)90053-7; TULJAPURKAR S, 1990, P NATL ACAD SCI USA, V87, P1139, DOI 10.1073/pnas.87.3.1139; Venable DL, 2009, J ECOL, V97, P27, DOI 10.1111/j.1365-2745.2008.01461.x; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	27	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57133	10.1371/journal.pone.0057133	http://dx.doi.org/10.1371/journal.pone.0057133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431401	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800044
J	Wang, H; Wang, HS; Zhou, BH; Li, CL; Zhang, F; Wang, XF; Zhang, G; Bu, XZ; Cai, SH; Du, J				Wang, Hao; Wang, Hong-Sheng; Zhou, Bin-Hua; Li, Cui-Lin; Zhang, Fan; Wang, Xian-Feng; Zhang, Ge; Bu, Xian-Zhang; Cai, Shao-Hui; Du, Jun			Epithelial-Mesenchymal Transition (EMT) Induced by TNF-alpha Requires AKT/GSK-3 beta-Mediated Stabilization of Snail in Colorectal Cancer	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR SNAIL; TUMOR-NECROSIS-FACTOR; E-CADHERIN; GENE-EXPRESSION; CELL-MIGRATION; BETA-CATENIN; INFLAMMATION; CARCINOMA; PHOSPHORYLATION	Chronic inflammation-promoted metastasis has been considered as a major challenge in cancer therapy. Pro-inflammatory cytokine TNF alpha can induce cancer invasion and metastasis associated with epithelial-mesenchymal transition (EMT). However, the underlying mechanisms are not entirely clear. In this study, we showed that TNF alpha induces EMT in human HCT116 cells and thereby promotes colorectal cancer (CRC) invasion and metastasis. TNF alpha-induced EMT was characterized by acquiring mesenchymal spindle-like morphology and increasing the expression of N-cadherin and fibronectin with a concomitant decrease of E-cadherin and Zona occludin-1(ZO-1). TNF alpha treatment also increased the expression of transcription factor Snail, but not Slug, ZEB1 and Twist. Overexpression of Snail induced a switch from E-cadherin to N-cadherin expression in HCT116 cells, which is a characteristic of EMT. Conversely, knockdown of Snail significantly attenuated TNF alpha-induced EMT in HCT116 cells, suggesting that Snail plays a crucial role in TNF alpha-induced EMT. Interestingly, exposure to TNF alpha rapidly increased Snail protein expression and Snail nuclear localization but not mRNA level upregulation. Finally, we demonstrated that TNF alpha elevated Snail stability by activating AKT pathway and subsequently repressing GSK-3 beta activity and decreasing the association of Snail with GSK-3 beta. Knockdown of GSK-3 beta further verified our finding. Taken together, these results revealed that AKT/GSK-3 beta-mediated stabilization of Snail is required for TNF alpha-induced EMT in CRC cells. Our study provides a better understanding of inflammation-induced CRC metastasis.	[Wang, Hao; Wang, Hong-Sheng; Zhou, Bin-Hua; Li, Cui-Lin; Zhang, Fan; Wang, Xian-Feng; Zhang, Ge; Bu, Xian-Zhang; Du, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Shao-Hui] Jinan Univ, Coll Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University	Cai, SH (corresponding author), Jinan Univ, Coll Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	csh5689@sina.com; dujun@mail.sysu.edu.cn	Wang, Hongsheng/N-1940-2019; Bu, Xianzhang/E-9180-2012	Wang, Hongsheng/0000-0002-0054-4820; 	National Basic Research Program of China (973 Program) [2011CB935800]; National Natural Science Foundation of China [30873032, 81071712]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Basic Research Program of China (973 Program, No. 2011CB935800), and the National Natural Science Foundation of China (No. 30873032 and No. 81071712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Burke F, 1996, CYTOKINE, V8, P578, DOI 10.1006/cyto.1996.0077; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen RQ, 2012, CANCER RES, V72, P1579, DOI 10.1158/0008-5472.CAN-11-2055; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Choo MK, 2005, CANCER LETT, V230, P47, DOI 10.1016/j.canlet.2004.12.027; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Csiszar A, 2004, PATHOL ONCOL RES, V10, P109, DOI 10.1007/BF02893465; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Fan XJ, 2013, HUM PATHOL, V44, P173, DOI 10.1016/j.humpath.2012.03.029; Grille SJ, 2003, CANCER RES, V63, P2172; Grimm M, 2011, CELL ONCOL, V34, P315, DOI 10.1007/s13402-011-0027-7; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Sheehan KM, 2008, ONCOGENE, V27, P323, DOI 10.1038/sj.onc.1210647; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Kempen LCLT, 2003, EUR J CELL BIOL, V82, P539, DOI 10.1078/0171-9335-00346; Vandromme M, 1996, TRENDS BIOCHEM SCI, V21, P59, DOI 10.1016/S0968-0004(96)80182-4; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Xue CS, 2003, CANCER RES, V63, P3386; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	50	144	148	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56664	10.1371/journal.pone.0056664	http://dx.doi.org/10.1371/journal.pone.0056664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431386	gold, Green Submitted, Green Published			2022-12-27	WOS:000315182800029
J	Yang, YF; Ye, YM; Lin, XC; Wu, KL; Yu, MB				Yang, Yangfan; Ye, Yiming; Lin, Xianchai; Wu, Kaili; Yu, Minbin			Inhibition of Pirfenidone on TGF-beta2 Induced Proliferation, Migration and Epithlial-Mesenchymal Transition of Human Lens Epithelial Cells Line SRA01/04	PLOS ONE			English	Article							POSTERIOR CAPSULE OPACIFICATION; IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; INTRAOCULAR-LENS; COLLAGEN PRODUCTION; CATARACT-SURGERY; IN-VITRO; BAG; TRANSDIFFERENTIATION; IMPLANTATION	Background: Posterior capsular opacification (PCO) is a common complication of cataract surgery. Transforming growth factor-beta 2 (TGF-beta 2) plays important roles in the development of PCO. The existing pharmacological treatments are not satisfactory and can have toxic side effects. Methodologies/Principal Findings: We evaluated the effect of pirfenidone on proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cell line SRA01/04 (HLECs) in vitro. After treatment with 0, 0.25, and 0.5 mg/ml pirfenidone, cell proliferation was measured by MTT assay. Cell viability was determined by trypan blue exclusion assay and measurement of lactate dehydrogenase (LDH) activity released from the damaged cells. And cell migration was measured by scratch assay in the absence or presence of transforming growth factor-beta 2 (TGF-beta 2). The expressions of TGF-beta 2 and SMADs were evaluated with real-time RT-PCR, western blot, and immunofluorescence analyses. The mesenchymal phenotypic marker fibronectin (FN) was demonstrated by Immunocytofluorescence analyses. The cells had high viability, which did not vary across different concentrations of pirfenidone (0 [control] 0.3, 0.5 or 1.0 mg/ml) after 24 hours. Pirfenidone (0 similar to 0.5 mg/ml) had no significant cytotoxicity effect on SRA01/04 by LDH assay. Pirfenidone significantly inhibited the proliferation and TGF-beta 2-induced cell migration and the effects were dose-dependent, and inhibited TGF-beta 2-induced fibroblastic phenotypes and TGF-beta 2-induced expression of FN in SRA01/04 cells. The cells showed dose-dependent decreases in mRNA and protein levels of TGF-beta 2 and SMADs. Pirfenidone also depressed the TGF-beta 2-induced expression of SMADs and blocked the nuclear translocation of SMADs in cells. Conclusion: Pirfenidone inhibits TGF-beta 2-induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04 at nontoxic concentrations. This effect may be achieved by down regulation of TGF-beta/SAMD signaling in SRA01/04 cells.	[Yang, Yangfan; Ye, Yiming; Lin, Xianchai; Wu, Kaili; Yu, Minbin] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yu, MB (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	yuminbin@mail.sysu.edu.cn		Yang, Yangfan/0000-0002-0007-6481	Guangdong Science and Technology Fund [2009B030801193]; Medical Scientific Research Foundation of Guangdong Province [B2012128]; Fundamental Research Funds of State Key Laboratory of Ophthalmology, People's Republic of China	Guangdong Science and Technology Fund; Medical Scientific Research Foundation of Guangdong Province; Fundamental Research Funds of State Key Laboratory of Ophthalmology, People's Republic of China	This study was funded by Guangdong Science and Technology Fund (Grant No. 2009B030801193), Medical Scientific Research Foundation of Guangdong Province (Grant No. B2012128) and Fundamental Research Funds of State Key Laboratory of Ophthalmology, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buehl W, 2008, J CATARACT REFR SURG, V34, P1976, DOI 10.1016/j.jcrs.2008.07.029; Choi K, 2012, MOL VIS, V18, P1010; Dawes LJ, 2007, EXP EYE RES, V84, P1009, DOI 10.1016/j.exer.2006.12.017; Dawes LJ, 2009, INVEST OPHTH VIS SCI, V50, P5318, DOI 10.1167/iovs.08-3223; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Sario A, 2002, J HEPATOL, V37, P584, DOI 10.1016/S0168-8278(02)00245-3; Findl O, 2010, COCHRANE DB SYST REV, V41, P507; Hazra S, 2012, INT J OPHTHALMOL-CHI, V5, P59, DOI 10.3980/j.issn.2222-3959.2012.01.12; Hewitson TD, 2001, J NEPHROL, V14, P453; Hilberg O, 2012, CLIN RESPIR J, V6, P131, DOI 10.1111/j.1752-699X.2012.00302.x; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Kim H, 2010, INVEST OPHTH VIS SCI, V51, P3061, DOI 10.1167/iovs.09-4257; Kim SY, 2007, CLIN EXP OPHTHALMOL, V35, P755, DOI 10.1111/j.1442-9071.2007.01588.x; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; Lee EH, 1999, INVEST OPHTH VIS SCI, V40, P2025; Lin XC, 2009, INVEST OPHTH VIS SCI, V50, P3763, DOI 10.1167/iovs.08-2815; Lukaszewska-Smyk Agnieszka, 2011, Klin Oczna, V113, P175; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Menapace R, 2008, GRAEF ARCH CLIN EXP, V246, P787, DOI 10.1007/s00417-008-0779-6; Ozes ON, 2006, CHEST, V130, p230S, DOI 10.1378/chest.130.4_MeetingAbstracts.230S-a; Pandey SK, 2002, J CATARACT REFR SURG, V28, P139, DOI 10.1016/S0886-3350(01)01069-0; Sun GY, 2011, MOL VIS, V17, P2191; Symonds JG, 2006, EXP EYE RES, V83, P771, DOI 10.1016/j.exer.2006.03.017; Tassignon MJ, 2011, J CATARACT REFR SURG, V37, P2120, DOI 10.1016/j.jcrs.2011.06.025; Wang GQ, 2010, INT J OPHTHALMOL-CHI, V3, P141, DOI 10.3980/j.issn.2222-3959.2010.02.11; Wang M, 2007, J CATARACT REFR SURG, V33, P2122, DOI 10.1016/j.jcrs.2007.07.041; Wormstone IM, 2006, EXP EYE RES, V83, P1238, DOI 10.1016/j.exer.2006.06.013; Wormstone IM, 2009, EXP EYE RES, V88, P257, DOI 10.1016/j.exer.2008.10.016; Wormstone IM, 2002, INVEST OPHTH VIS SCI, V43, P2301; Yazici AT, 2012, MIDDLE EAST AFR J OP, V19, P115, DOI 10.4103/0974-9233.92126; Zhong H, 2011, INVEST OPHTH VIS SCI, V52, P3136, DOI 10.1167/iovs.10-6240	31	12	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56837	10.1371/journal.pone.0056837	http://dx.doi.org/10.1371/journal.pone.0056837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437252	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000052
J	Chojnicka, I; Gajos, K; Strawa, K; Broda, G; Fudalej, S; Fudalej, M; Stawinski, P; Pawlak, A; Krajewski, P; Wojnar, M; Ploski, R				Chojnicka, Izabela; Gajos, Krzysztof; Strawa, Katarzyna; Broda, Grazyna; Fudalej, Sylwia; Fudalej, Marcin; Stawinski, Piotr; Pawlak, Aleksandra; Krajewski, Pawel; Wojnar, Marcin; Ploski, Rafal			Possible Association between Suicide Committed under Influence of Ethanol and a Variant in the AUTS2 Gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSLOCATION BREAKPOINT; EXECUTIVE FUNCTION; ALCOHOL; AUTISM; DISORDER; IDENTIFICATION	Background: rs6943555 in AUTS2 has been shown to modulate ethanol consumption. We hypothesized that rs6943555 might be associated with completed suicide. Methods: We genotyped rs6943555 in 625 completed suicides and 3861 controls using real-time TaqMan Allelic Discrimination Assay. All individuals were Polish Caucasians. Results: We detected an association between suicide and rs6943555 A allele (OR = 1.17, P = 0.018 for allelic comparison, OR = 1.24, P = 0.013 for dominant, and OR = 1.18, P = 0.020 for co-dominant model of inheritance). The association remained significant after adjusting for age and gender (co-dominant: P = 0.002 and dominant model: P = 0.001). After stratifying suicides according to blood ethanol concentration (BAC <= 20 mg/dl and BAC > 20 mg/dl) the association remained significant only for cases who committed suicide under influence of alcohol (co-dominant: OR = 1.37, P = 0.004 and dominant model: OR = 1.45, P = 0.006). To validate this finding we genotyped another cohort of 132 cases. We reproduced the association between rs6943555 A allele and suicide under influence of ethanol (allelic comparison: OR = 1.55, P = 0.023; co-dominant : OR = 1.54, P = 0.031; dominant model: OR = 1.84, P = 0.015). Analyzing pooled suicides with BAC > 20 mg/dl (N = 300) we found the association of rs6943555 A allele not only vs. controls (allelic OR = 1.41, P = 0.00029) but also vs. cases with BAC <= 20 mg/dl (N = 449, allelic OR = 1.33, P = 0.019). Conclusions: In our study rs6943555 A allele is associated with suicide committed after drinking ethanol shortly before death. The rs6943555 A allele may be linked to adverse emotional reaction to ethanol, which could explain the association with lower consumption in general population as well as the predisposition to suicide under influence of ethanol.	[Chojnicka, Izabela; Gajos, Krzysztof; Strawa, Katarzyna; Stawinski, Piotr; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Fudalej, Sylwia; Wojnar, Marcin] Med Univ Warsaw, Dept Psychiat, Warsaw, Poland; [Fudalej, Marcin; Pawlak, Aleksandra; Krajewski, Pawel] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Broda, Grazyna] Inst Cardiol, Dept Cardiovasc Dis Epidemiol Prevent & Hlth Prom, Warsaw, Poland; [Wojnar, Marcin] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Institute of Cardiology - Poland; University of Michigan System; University of Michigan	Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl	Wojnar, Marcin/N-7111-2018; Fudalej, Sylwia/X-1511-2018	Wojnar, Marcin/0000-0001-5138-9050; Fudalej, Sylwia/0000-0003-3610-7312; Ploski, Rafal/0000-0001-6286-5526; krajewski, Pawel/0000-0001-8352-4077; Chojnicka, Izabela/0000-0001-8723-6873	Medical University of Warsaw Grant [1WY/WB1/10]; Fogarty International Center/NIAAA Grant [5 D43 TW007569]; FOGARTY INTERNATIONAL CENTER [D43TW007569] Funding Source: NIH RePORTER	Medical University of Warsaw Grant; Fogarty International Center/NIAAA Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Research was supported by the Medical University of Warsaw Grant 1WY/WB1/10 and by the Fogarty International Center/NIAAA Grant 5 D43 TW007569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2011, INT J CIRCUMPOL HEAL, V70, P473, DOI 10.3402/ijch.v70i5.17847; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Bolling-Sternevald E, 2002, SCAND J GASTROENTERO, V37, P1395, DOI 10.1080/003655202762671260; Branas CC, 2011, SUBST USE MISUSE, V46, P1592, DOI 10.3109/10826084.2011.604371; Brent DA, 2005, AM J MED GENET C, V133C, P13, DOI 10.1002/ajmg.c.30042; BRODA G, 2005, POL POPUL REV, V27, P29; Burton CZ, 2011, J NEUROPSYCH CLIN N, V23, P173, DOI 10.1176/appi.neuropsych.23.2.173; Butler AW, 2010, AM J MED GENET B, V153B, P1465, DOI 10.1002/ajmg.b.31127; Christ SE, 2010, NEUROPSYCHOLOGY, V24, P590, DOI 10.1037/a0019176; Courtet P, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.6; de la Barra F, 1986, Rev Chil Pediatr, V57, P549; Duberstein PR, 2004, PSYCHOL MED, V34, P1331, DOI 10.1017/S0033291704002600; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Embregts P, 2009, J INTELL DISABIL RES, V53, P922, DOI 10.1111/j.1365-2788.2009.01204.x; Gibbs LM, 2009, INT J GERIATR PSYCH, V24, P1396, DOI 10.1002/gps.2276; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Hansen SK, 2004, DIABETOLOGIA, V47, P1079, DOI 10.1007/s00125-004-1418-3; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Huang XL, 2010, AM J MED GENET A, V152A, P2112, DOI 10.1002/ajmg.a.33497; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kim S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-413; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell DGV, 2011, BEHAV BRAIN RES, V217, P215, DOI 10.1016/j.bbr.2010.10.030; Orui Masatsugu, 2011, Environmental Health and Preventive Medicine, V16, P384, DOI 10.1007/s12199-011-0209-y; Parnowski T, 1977, Psychiatr Pol, V11, P417; Pedersen NL, 2010, EUR PSYCHIAT, V25, P264, DOI 10.1016/j.eurpsy.2009.12.008; Pellicano E, 2010, DEV PSYCHOL, V46, P530, DOI 10.1037/a0018287; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Pollock LR, 1998, SUICIDE LIFE-THREAT, V28, P375; Porteri C, 2012, MED HLTH CARE PHILOS; Raja Michele, 2011, Clin Pract Epidemiol Ment Health, V7, P97, DOI 10.2174/1745017901107010097; Rywik S, 2005, POL POPUL REV, V27, P37; Schosser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020690; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Stickley A, 2011, J STUD ALCOHOL DRUGS, V72, P341, DOI 10.15288/jsad.2011.72.341; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Szanto K, 2012, AM J GERIAT PSYCHIAT, V20, P257, DOI 10.1097/JGP.0b013e31820eea0c; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Tsai SJ, 2011, PROG NEURO-PSYCHOPH, V35, P809, DOI 10.1016/j.pnpbp.2010.10.014; Voracek M, 2007, WIEN KLIN WOCHENSCHR, V119, P463, DOI 10.1007/s00508-007-0823-2; Westheide J, 2008, EUR ARCH PSY CLIN N, V258, P414, DOI 10.1007/s00406-008-0811-1; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4; Zhang YL, 2012, J STUD ALCOHOL DRUGS, V73, P15, DOI 10.15288/jsad.2012.73.15	48	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57199	10.1371/journal.pone.0057199	http://dx.doi.org/10.1371/journal.pone.0057199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437340	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200226
J	Muratore, CR; Hodgson, NW; Trivedi, MS; Abdolmaleky, HM; Persico, AM; Lintas, C; De la Monte, S; Deth, RC				Muratore, Christina R.; Hodgson, Nathaniel W.; Trivedi, Malav S.; Abdolmaleky, Hamid M.; Persico, Antonio M.; Lintas, Carla; De la Monte, Suzanne; Deth, Richard C.			Age-Dependent Decrease and Alternative Splicing of Methionine Synthase mRNA in Human Cerebral Cortex and an Accelerated Decrease in Autism	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; MTHFR GENE POLYMORPHISM; HUMAN PREFRONTAL CORTEX; NECROSIS-FACTOR-ALPHA; N-ACETYL-CYSTEINE; OXIDATIVE STRESS; HUMAN PLASMA; CEREBROSPINAL-FLUID; GLUTATHIONE CONCENTRATIONS; PHOSPHOLIPID METHYLATION	The folate and vitamin B12-dependent enzyme methionine synthase (MS) is highly sensitive to cellular oxidative status, and lower MS activity increases production of the antioxidant glutathione, while simultaneously decreasing more than 200 methylation reactions, broadly affecting metabolic activity. MS mRNA levels in postmortem human cortex from subjects across the lifespan were measured and a dramatic progressive biphasic decrease of more than 400-fold from 28 weeks of gestation to 84 years was observed. Further analysis revealed alternative splicing of MS mRNA, including deletion of folate-binding domain exons and age-dependent deletion of exons from the cap domain, which protects vitamin B12 (cobalamin) from oxidation. Although three species of MS were evident at the protein level, corresponding to full-length and alternatively spliced mRNA transcripts, decreasing mRNA levels across the lifespan were not associated with significant changes in MS protein or methionine levels. MS mRNA levels were significantly lower in autistic subjects, especially at younger ages, and this decrease was replicated in cultured human neuronal cells by treatment with TNF-alpha, whose CSF levels are elevated in autism. These novel findings suggest that rather than serving as a housekeeping enzyme, MS has a broad and dynamic role in coordinating metabolism in the brain during development and aging. Factors adversely affecting MS activity, such as oxidative stress, can be a source of risk for neurological disorders across the lifespan via their impact on methylation reactions, including epigenetic regulation of gene expression.	[Muratore, Christina R.; Hodgson, Nathaniel W.; Trivedi, Malav S.; Deth, Richard C.] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA 02115 USA; [Abdolmaleky, Hamid M.] Boston Univ, Sch Med, Genet Program, Boston, MA 02118 USA; [Persico, Antonio M.; Lintas, Carla] Univ Campus Biomed, Lab Mol Psychiat & Neurogenet, Rome, Italy; [De la Monte, Suzanne] Brown Univ, Rhode Isl Hosp, Dept Pathol & Med, Providence, RI 02903 USA; [De la Monte, Suzanne] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA	Northeastern University; Boston University; University Campus Bio-Medico - Rome Italy; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Deth, RC (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA 02115 USA.	r.deth@neu.edu	LINTAS, CARLA/AAB-6248-2022; Persico, Antonio/AAB-9504-2022; de la monte, suzanne/L-7670-2019; Deth, Richard/AFV-2608-2022	de la monte, suzanne/0000-0001-5886-2306; Persico, Antonio/0000-0001-8910-4479; Lintas, Carla/0000-0003-1209-8554; Mostafavi Abdolmaleky, Hamid/0000-0002-8872-5174; Hodgson, Nathaniel/0000-0001-8299-3963	Autism Research Institute; SafeMinds; National Autism Association; Autism Speaks; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	Autism Research Institute; SafeMinds; National Autism Association; Autism Speaks; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by research grants to RCD from the Autism Research Institute (http://www.autism.com/), SafeMinds(http://www.safeminds.org/) the National Autism Association (http://www.nationalautismassociation.org/) and to CRM from Autism Speaks (http://www.autismspeaks.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MW, 2011, WORLD J BIOL PS 1219; Al-Gadani Y, 2009, CLIN BIOCHEM, V42, P1032, DOI 10.1016/j.clinbiochem.2009.03.011; Mico JA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-26; Bandarian V, 2002, NAT STRUCT BIOL, V9, P53; Bandarian V, 2003, P NATL ACAD SCI USA, V100, P8156, DOI 10.1073/pnas.1133218100; Ben Othmen L, 2008, PROG NEURO-PSYCHOPH, V32, P155, DOI 10.1016/j.pnpbp.2007.08.003; BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI 10.1016/j.biopsych.2008.03.004; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Beyer K, 2005, ANN NY ACAD SCI, V1057, P260, DOI 10.1196/annals.1322.021; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; CASTAGNA A, 1995, NEUROLOGY, V45, P1678, DOI 10.1212/WNL.45.9.1678; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4; Chez MG, 2007, PEDIATR NEUROL, V36, P361, DOI 10.1016/j.pediatrneurol.2007.01.012; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352; Dietrich-Muszalska A, 2009, NEUROPSYCHOBIOLOGY, V59, P1, DOI 10.1159/000202822; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Gawryluk JW, 2011, INT J NEUROPSYCHOPH, V14, P123, DOI 10.1017/S1461145710000805; Gawryluk JW, 2010, INT J NEUROPSYCHOPH, V16, P1; Geier DA, 2009, J NEUROL SCI, V280, P101, DOI 10.1016/j.jns.2008.08.021; Giustarini D, 2006, J GERONTOL A-BIOL, V61, P1030, DOI 10.1093/gerona/61.10.1030; Gottfries CG, 1998, J NEURAL TRANSM, V105, P773, DOI 10.1007/s007020050094; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Hack V, 1998, BLOOD, V92, P59, DOI 10.1182/blood.V92.1.59.413a05_59_67; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jarrett JT, 1998, BIOCHEMISTRY-US, V37, P5372, DOI 10.1021/bi9730893; Jensen KP, 2005, J PHYS CHEM B, V109, P10505, DOI 10.1021/jp050802m; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Karijolich J, 2010, METHODS MOL BIOL, V629, P1, DOI 10.1007/978-1-60761-657-3_1; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; LaSalle JM, 1998, P NATL ACAD SCI USA, V95, P1675, DOI 10.1073/pnas.95.4.1675; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Maruyama Y, 2009, NUCLEIC ACIDS RES, V37, pD762, DOI 10.1093/nar/gkn872; Matsuzawa D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001944; McCaddon A, 2006, J ALZHEIMERS DIS, V9, P361; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Moreira Paula I, 2005, Curr Alzheimer Res, V2, P403; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Nishiyama M, 2000, J Epidemiol, V10, P163; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Obeid R, 2007, CLIN CHEM, V53, P1129, DOI 10.1373/clinchem.2006.085241; Oulhaj A, 2010, INT J GERIATR PSYCH, V25, P82, DOI 10.1002/gps.2303; Page MM, 2010, MECH AGEING DEV, V131, P242, DOI 10.1016/j.mad.2010.02.005; Pasca SP, 2009, J CELL MOL MED, V13, P4229, DOI 10.1111/j.1582-4934.2008.00463.x; Pastural E, 2009, PROSTAG LEUKOTR ESS, V81, P253, DOI 10.1016/j.plefa.2009.06.003; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Raffa M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-124; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; Sati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031621; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seripa D, 2003, NEUROBIOL AGING, V24, P933, DOI 10.1016/S0197-4580(03)00040-X; Sharma A, 1999, MOL PSYCHIATR, V4, P235, DOI 10.1038/sj.mp.4000522; Shungu DC, 2012, NMR BIOMED, V25, P1073, DOI 10.1002/nbm.2772; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; TALLAN HH, 1958, J BIOL CHEM, V230, P707; Thatcher KN, 2005, HUM MOL GENET, V14, P785, DOI 10.1093/hmg/ddi073; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Waly M, 2004, MOL PSYCHIATR, V9, P358, DOI 10.1038/sj.mp.4001476; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Wang BB, 2005, J MOL NEUROSCI, V27, P23, DOI 10.1385/JMN:27:1:023; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Wood SJ, 2009, NEUROBIOL DIS, V33, P354, DOI 10.1016/j.nbd.2008.11.018; YANG CS, 1995, J CHROMATOGR B, V674, P23; Yorbik O, 2002, PROSTAG LEUKOTR ESS, V67, P341, DOI 10.1054/plef.2002.0439; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhao R, 2001, J NEUROCHEM, V78, P788, DOI 10.1046/j.1471-4159.2001.00471.x; Zhao XY, 2007, EPIGENETICS-US, V2, P126, DOI 10.4161/epi.2.2.4236; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547; Zou CG, 2003, J BIOL CHEM, V278, P16802, DOI 10.1074/jbc.M212376200	95	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56927	10.1371/journal.pone.0056927	http://dx.doi.org/10.1371/journal.pone.0056927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437274	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200186
J	Soderholm, J; Waldenstrom, J; Askarieh, G; Pilli, M; Bochud, PY; Negro, F; Pawlotsky, JM; Zeuzem, S; Ferrari, C; Norkrans, G; Wejstal, R; Westin, J; Neumann, AU; Haagmans, BL; Lindh, M; Missale, G; Hellstrand, K; Lagging, M				Soderholm, Jonas; Waldenstrom, Jesper; Askarieh, Galia; Pilli, Massimo; Bochud, Pierre-Yves; Negro, Francesco; Pawlotsky, Jean-Michel; Zeuzem, Stefan; Ferrari, Carlo; Norkrans, Gunnar; Wejstal, Rune; Westin, Johan; Neumann, Avidan U.; Haagmans, Bart L.; Lindh, Magnus; Missale, Gabriele; Hellstrand, Kristoffer; Lagging, Martin			Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection	PLOS ONE			English	Article							INTERFERON-GAMMA; INDUCIBLE PROTEIN-10; RIBAVIRIN THERAPY; ANTIVIRAL THERAPY; GENETIC-VARIATION; VIRAL CLEARANCE; HCV INFECTION; ASSOCIATION; PREDICTS; IL28B	Background: Interferon and ribavirin therapy for chronic hepatitis C virus (HCV) infection yields sustained virological response (SVR) rates of 50-80%. Several factors such as non-1 genotype, beneficial IL28B genetic variants, low baseline IP-10, and the functionality of HCV-specific T cells predict SVR. With the pending introduction of new therapies for HCV entailing very rapid clearance of plasma HCV RNA, the importance of baseline biomarkers likely will increase in order to tailor therapy. CD26 (DPPIV) truncates the chemokine IP-10 into a shorter antagonistic form, and this truncation of IP-10 has been suggested to influence treatment outcome in patients with chronic HCV infection patients. In addition, previous reports have shown CD26 to be a co-stimulator for T cells. The aim of the present study was to assess the utility of CD26 as a biomarker for treatment outcome in chronic hepatitis C and to define its association with HCV-specific T cells. Methods: Baseline plasma from 153 genotype 1 and 58 genotype 2/3 infected patients enrolled in an international multicenter phase III trial (DITTO-HCV) and 36 genotype 1 infected patients participating in a Swedish trial (TTG1) were evaluated regarding baseline soluble CD26 (sCD26) and the functionality of HCV-specific CD8(+) T cells. Results: Genotype 1 infected patients achieving SVR in the DITTO (P = 0.002) and the TTG1 (P = 0.02) studies had lower pretreatment sCD26 concentrations compared with non-SVR patients. Sixty-five percent of patients with sCD26 concentrations below 600 ng/mL achieved SVR compared with 39% of the patients with sCD26 exceeding 600 ng/mL (P = 0.01). Patients with sCD26 concentrations below 600 ng/mL had significantly higher frequencies of HCV-specific CD8(+) T cells (P = 0.02). Conclusions: Low baseline systemic concentrations of sCD26 predict favorable treatment outcome in chronic HCV infection and may be associated with higher blood counts of HCV-specific CD8(+) T cells.	[Soderholm, Jonas; Waldenstrom, Jesper; Askarieh, Galia; Norkrans, Gunnar; Wejstal, Rune; Westin, Johan; Lindh, Magnus; Hellstrand, Kristoffer; Lagging, Martin] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Pilli, Massimo; Ferrari, Carlo; Missale, Gabriele] Azienda Osped Parma, Parma, Italy; [Bochud, Pierre-Yves] Univ Lausanne Hosp, Dept Med, Infect Dis Serv, Lausanne, Switzerland; [Bochud, Pierre-Yves] Univ Lausanne, Lausanne, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Geneva, Switzerland; [Pawlotsky, Jean-Michel] Univ Paris 12, Hop Henri Mondor, F-94010 Creteil, France; [Pawlotsky, Jean-Michel] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Zeuzem, Stefan] JW Goethe Univ Hosp, Dept Med 1, Frankfurt, Germany; [Neumann, Avidan U.] Bar Ilan Univ, Ramat Gan, Israel; [Haagmans, Bart L.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	University of Gothenburg; University of Parma; University Hospital of Parma; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Bar Ilan University; Erasmus University Rotterdam; Erasmus MC	Soderholm, J (corresponding author), Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden.	jonas.soderholm@gmail.com	Söderholm, Jonas/U-2091-2019; Haagmans, Bart/E-9791-2015; Bochud, Pierre-Yves/ABE-5979-2020; Ferrari, Carlo/D-5663-2017; Pawlotsky, Jean-Michel/R-8159-2018; Negro, Francesco/E-2183-2012; Zeuzem, Stefan/AAE-7435-2019; Missale, Gabriele/J-6083-2016; Lagging, Martin/D-7734-2015	Söderholm, Jonas/0000-0002-7810-3005; Haagmans, Bart/0000-0001-6221-2015; Ferrari, Carlo/0000-0002-5461-6842; Missale, Gabriele/0000-0001-6691-8701; Lagging, Martin/0000-0002-7995-3626; Bochud, Pierre-Yves/0000-0002-2208-4757; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Ferrari, Carlo/0000-0002-7843-4963; Hellstrand, Kristoffer/0000-0002-6617-5976	Wilhelm and Martina Lundgren's Scientific Foundation; Swedish Society of Medicine; Swedish Medical Research Council; Cancerfonden; Torsten and Ragnar Soderberg Foundation; Swedish Society of Microbiology; ALF (Avtal om Lakarutbildning och Forskning) Funds at the Sahlgrenska University Hospital; FIRB grant from the Italian Ministry of the University and Research [RBAP10RPXK]	Wilhelm and Martina Lundgren's Scientific Foundation; Swedish Society of Medicine; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Cancerfonden(Swedish Cancer Society); Torsten and Ragnar Soderberg Foundation; Swedish Society of Microbiology; ALF (Avtal om Lakarutbildning och Forskning) Funds at the Sahlgrenska University Hospital; FIRB grant from the Italian Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR))	JS and J. Waldenstrom were supported by the Wilhelm and Martina Lundgren's Scientific Foundation. The Swedish Society of Medicine, The Swedish Medical Research Council, Cancerfonden, The Torsten and Ragnar Soderberg Foundation, The Swedish Society of Microbiology, and ALF (Avtal om Lakarutbildning och Forskning) Funds at the Sahlgrenska University Hospital supported this study, as did a FIRB grant from the Italian Ministry of the University and Research, Protocol RBAP10RPXK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge S, 2011, BIOL CHEM, V392, P153, DOI 10.1515/BC.2011.008; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bochud PY, 2011, J HEPATOL; Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Denney H, 2009, BIOCHEM BIOPH RES CO, V382, P341, DOI 10.1016/j.bbrc.2009.02.164; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; eBioscience, HUM SCD26 PLAT ELISA; Firneisz G, 2001, SCAND J GASTROENTERO, V36, P877, DOI 10.1080/003655201750313423; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; GREINER M, 1995, J IMMUNOL METHODS, V185, P145, DOI 10.1016/0022-1759(95)00078-O; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Hyland R.H., 2012, 46 ANN M EUR ASS STU; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lindh M, 2005, J CLIN VIROL, V34, P108, DOI 10.1016/j.jcv.2005.02.002; Lindh M, 2011, J VIRAL HEPATITIS, V18, pE325, DOI 10.1111/j.1365-2893.2010.01425.x; Munir S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-296; Ohnuma K, 2001, J IMMUNOL, V167, P6745, DOI 10.4049/jimmunol.167.12.6745; Pilli M, 2007, GASTROENTEROLOGY, V133, P1132, DOI 10.1053/j.gastro.2007.06.059; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Romagnani P, 2001, BLOOD, V97, P601, DOI 10.1182/blood.V97.3.601; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Systems RD, HUM CXCL10 IP 10 IMM; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Yusim Karina, 2005, Appl Bioinformatics, V4, P217, DOI 10.2165/00822942-200504040-00002; Zeuzem S, 2005, J HEPATOL, V43, P250, DOI 10.1016/j.jhep.2005.05.016; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56991	10.1371/journal.pone.0056991	http://dx.doi.org/10.1371/journal.pone.0056991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437290	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200194
J	Wang, XD; Liu, AP; Wu, YY; Wang, P				Wang, Xiao-Dong; Liu, A-Ping; Wu, Yin-Yuan; Wang, Peng			Rapid Extraction of Lexical Tone Phonology in Chinese Characters: A Visual Mismatch Negativity Study	PLOS ONE			English	Article							CATEGORICAL PERCEPTION; ELECTROPHYSIOLOGICAL EVIDENCE; AUTOMATIC ACTIVATION; LINGUISTIC PITCH; WORD RECOGNITION; MEMORY TRACES; SPEECH; BRAIN; ORTHOGRAPHY; ORIENTATION	Background: In alphabetic languages, emerging evidence from behavioral and neuroimaging studies shows the rapid and automatic activation of phonological information in visual word recognition. In the mapping from orthography to phonology, unlike most alphabetic languages in which there is a natural correspondence between the visual and phonological forms, in logographic Chinese, the mapping between visual and phonological forms is rather arbitrary and depends on learning and experience. The issue of whether the phonological information is rapidly and automatically extracted in Chinese characters by the brain has not yet been thoroughly addressed. Methodology/Principal Findings: We continuously presented Chinese characters differing in orthography and meaning to adult native Mandarin Chinese speakers to construct a constant varying visual stream. In the stream, most stimuli were homophones of Chinese characters: The phonological features embedded in these visual characters were the same, including consonants, vowels and the lexical tone. Occasionally, the rule of phonology was randomly violated by characters whose phonological features differed in the lexical tone. Conclusions/Significance: We showed that the violation of the lexical tone phonology evoked an early, robust visual response, as revealed by whole-head electrical recordings of the visual mismatch negativity (vMMN), indicating the rapid extraction of phonological information embedded in Chinese characters. Source analysis revealed that the vMMN was involved in neural activations of the visual cortex, suggesting that the visual sensory memory is sensitive to phonological information embedded in visual words at an early processing stage.	[Wang, Xiao-Dong] Nanyang Technol Univ, Div Psychol, Sch Humanities & Social Sci, Singapore 639798, Singapore; [Liu, A-Ping] Anhui Univ, Dept Econ, Hefei 230039, Peoples R China; [Wu, Yin-Yuan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wu, Yin-Yuan] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Liu, A-Ping; Wang, Peng] Chinese Acad Sci, Inst Tech Biol & Agr Engn, CAS Key Lab Ion Beam Bioengn, Hefei, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Anhui University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese Academy of Sciences	Wang, XD (corresponding author), Nanyang Technol Univ, Div Psychol, Sch Humanities & Social Sci, Singapore 639798, Singapore.	XD-Wang@ntu.edu.sg						Alario FX, 2007, J EXP CHILD PSYCHOL, V97, P205, DOI 10.1016/j.jecp.2007.02.001; [Anonymous], 1976, ACOUSTICAL STUDIES M; Astikainen P., 2009, BEHAV BRAIN FUNCT, V20, P5; Astikainen P, 2008, EUR J NEUROSCI, V28, P2319, DOI 10.1111/j.1460-9568.2008.06510.x; BAO ZM, 1995, J EAST ASIAN LINGUIS, V4, P175, DOI 10.1007/BF01731508; BENTAL E, 1968, EXP NEUROL, V20, P341, DOI 10.1016/0014-4886(68)90077-0; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Bles M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-20; Booth JR, 2008, BRAIN RES, V1189, P78, DOI 10.1016/j.brainres.2007.10.080; Booth JR, 1999, DEV PSYCHOL, V35, P3, DOI 10.1037/0012-1649.35.1.3; Brem S, 2005, NEUROREPORT, V16, P45, DOI 10.1097/00001756-200501190-00011; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Chandrasekaran B, 2009, EAR HEARING, V30, P552, DOI 10.1097/AUD.0b013e3181a7e1c2; Chang Y, 2011, BIOL PSYCHIAT, V69, P742, DOI 10.1016/j.biopsych.2010.12.024; CHEN HC, 1982, MEM COGNITION, V10, P216, DOI 10.3758/BF03197632; Czigler I, 2002, PSYCHOPHYSIOLOGY, V39, P869, DOI 10.1111/1469-8986.3960869; Czigler I, 2007, J PSYCHOPHYSIOL, V21, P224, DOI 10.1027/0269-8803.21.34.224; DEHAENE S, 1995, NEUROREPORT, V6, P2153, DOI 10.1097/00001756-199511000-00014; Ehri LC, 2005, BL HBK DEV PSYCHOL, P135, DOI 10.1002/9780470757642.ch8; FERRAND L, 1992, Q J EXP PSYCHOL-A, V45, P353, DOI 10.1080/02724989208250619; FOX E, 1994, BRIT J PSYCHOL, V85, P41, DOI 10.1111/j.2044-8295.1994.tb02507.x; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; Ganis G, 2012, NEUROIMAGE, V62, P1563, DOI 10.1016/j.neuroimage.2012.05.043; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hickok G, 2000, NEUROSCI LETT, V287, P156, DOI 10.1016/S0304-3940(00)01143-5; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Ilmoniemi R J, 1993, Brain Topogr, V5, P331, DOI 10.1007/BF01128686; KATZ RB, 1992, Q J EXP PSYCHOL-A, V45, P575, DOI 10.1080/14640749208401334; Kenemans JL, 2003, NEUROREPORT, V14, P1239, DOI 10.1097/00001756-200307010-00010; Kimura M, 2011, NEUROREPORT, V22, P669, DOI 10.1097/WNR.0b013e32834973ba; Klein D, 2001, NEUROIMAGE, V13, P646, DOI 10.1006/nimg.2000.0738; LESCH MF, 1993, J EXP PSYCHOL LEARN, V19, P285, DOI 10.1037/0278-7393.19.2.285; Lin SE, 2011, NEUROSCIENCE, V190, P200, DOI 10.1016/j.neuroscience.2011.05.071; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Macaluso E, 2004, NEUROIMAGE, V21, P725, DOI 10.1016/j.neuroimage.2003.09.049; Maekawa T, 2005, CLIN NEUROPHYSIOL, V116, P2392, DOI 10.1016/j.clinph.2005.07.006; Maekawa T, 2009, NEUROSCI RES, V65, P107, DOI 10.1016/j.neures.2009.06.005; MARSOLEK CJ, 1992, J EXP PSYCHOL LEARN, V18, P492, DOI 10.1037/0278-7393.18.3.492; Marsolek CJ, 1996, MEM COGNITION, V24, P539, DOI 10.3758/BF03201082; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; Mo L, 2011, P NATL ACAD SCI USA, V108, P14026, DOI 10.1073/pnas.1111860108; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 2003, INT J PSYCHOPHYSIOL, V48, P179, DOI 10.1016/S0167-8760(03)00053-9; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Newman RL, 2004, COGNITIVE BRAIN RES, V21, P94, DOI 10.1016/j.cogbrainres.2004.05.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peng DS, 2004, COGNITIVE BRAIN RES, V20, P156, DOI 10.1016/j.cogbrainres.2004.02.006; Pike Kenneth, 1948, TONE LANGUAGES TECHN; Proverbio AM, 2004, J COGNITIVE NEUROSCI, V16, P301, DOI 10.1162/089892904322984580; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Qiu XH, 2011, NEUROSCI LETT, V491, P53, DOI 10.1016/j.neulet.2011.01.006; Ren GQ, 2009, NEUROSCIENCE, V162, P87, DOI 10.1016/j.neuroscience.2009.04.021; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; RUGG MD, 1984, NEUROPSYCHOLOGIA, V22, P435, DOI 10.1016/0028-3932(84)90038-1; Schulte-Korne G, 1999, NEUROREPORT, V10, P3697, DOI 10.1097/00001756-199911260-00043; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Shtyrov Y, 2002, NEUROREPORT, V13, P521, DOI 10.1097/00001756-200203250-00033; Stefanics G, 2011, NEUROIMAGE; Stefanics G, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00046; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Tales A, 1999, NEUROREPORT, V10, P3363, DOI 10.1097/00001756-199911080-00020; Tales A, 2006, NEUROREPORT, V17, P887, DOI 10.1097/01.wnr.0000223383.42295.fa; Thierry G, 2009, P NATL ACAD SCI USA, V106, P4567, DOI 10.1073/pnas.0811155106; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Wang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030027; Whatmough C, 1999, BRAIN LANG, V66, P275, DOI 10.1006/brln.1998.1996; Wilson LB, 2011, NEUROIMAGE, V55, P724, DOI 10.1016/j.neuroimage.2010.12.019; Wong Patrick C. M., 2009, Seminars in Speech and Language, V30, P162, DOI 10.1055/s-0029-1225953; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; Zhao L, 2006, NEUROSCI LETT, V410, P126, DOI 10.1016/j.neulet.2006.09.081; Ziegler JC, 2000, Q J EXP PSYCHOL-A, V53, P671, DOI 10.1080/027249800410508	77	15	15	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56778	10.1371/journal.pone.0056778	http://dx.doi.org/10.1371/journal.pone.0056778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437235	Green Published, gold			2022-12-27	WOS:000315184200159
J	Kamshilin, AA; Teplov, V; Nippolainen, E; Miridonov, S; Giniatullin, R				Kamshilin, Alexei A.; Teplov, Victor; Nippolainen, Ervin; Miridonov, Serguei; Giniatullin, Rashid			Variability of Microcirculation Detected by Blood Pulsation Imaging	PLOS ONE			English	Article							LASER; PHOTOPLETHYSMOGRAPHY; LIGHT; FLOW; SKIN; WAVELENGTH; CAMERA; RANGE	The non-invasive assessment of blood flow is invaluable for the diagnostic and monitoring treatment of numerous vascular and neurological diseases. We developed a non-invasive and non-contact method of blood pulsation imaging capable of visualizing and monitoring of the two-dimensional distribution of two key parameters of peripheral blood flow: the blood pulsation amplitude and blood pulsation phase. The method is based on the photoplethysmographic imaging in the reflection mode. In contrast with previous imaging systems we use new algorithm for data processing which allows two dimensional mapping of blood pulsations in large object's areas after every cardiac cycle. In our study we carried out the occlusion test of the arm and found (i) the extensive variability of 2D-distribution of blood pulsation amplitude from one cardiac cycle to another, and (ii) existence of the adjacent spots to which the blood is asynchronously supplied. These observations show that the method can be used for studying of the multicomponent regulation of peripheral blood circulation. The proposed technique is technologically simple and cost-effective, which makes it applicable for monitoring the peripheral microcirculation in clinical settings for example, in diagnostics or testing the efficiency of new medicines.	[Kamshilin, Alexei A.; Teplov, Victor; Nippolainen, Ervin] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Miridonov, Serguei] Ctr Invest Cient & Educ Super Ensenada, Opt Dept, Ensenada, Baja California, Mexico; [Giniatullin, Rashid] Univ Eastern Finland, AI Virtanen Inst, Dept Neurobiol, Kuopio, Finland	University of Eastern Finland; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Eastern Finland	Kamshilin, AA (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.	alexei.kamshilin@uef.fi	Giniatullin, Rashid/Y-9687-2018; Kamshilin, Alexei A./Q-9775-2016; Miridonov, Serguei/A-6109-2009; Nippolainen, Ervin/J-9123-2014	Kamshilin, Alexei A./0000-0003-2506-9736; Miridonov, Serguei/0000-0002-4069-9229; Giniatullin, Rashid/0000-0002-1580-6280; Nippolainen, Ervin/0000-0002-1317-2683	Academy of Finland [128582]	Academy of Finland(Academy of Finland)	Partial financial support provided by the Academy of Finland, http://www.aka.fi/en-GB/A/ (project no. 128582), is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; Bernjak A, 2012, J PHYSIOL-LONDON, V590, P363, DOI 10.1113/jphysiol.2011.214528; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Burton AC, 1939, AM J PHYSIOL, V127, P437, DOI 10.1152/ajplegacy.1939.127.3.437; CUI W, 1990, IEEE T BIO-MED ENG, V37, P632, DOI 10.1109/10.55667; DETRAFFORD J, 1984, MED BIOL ENG COMPUT, V22, P479, DOI 10.1007/BF02447713; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Figueiras E, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3694571; FUJII H, 1985, OPT LETT, V10, P104, DOI 10.1364/OL.10.000104; Guyton A.C., 1981, TXB MED PHYSL; Hertzman A B, 1937, AM J PHYSIOL, V119, P334; Humeau A, 2007, MED BIOL ENG COMPUT, V45, P421, DOI 10.1007/s11517-007-0170-5; ISHIMARU A, 1989, APPL OPTICS, V28, P2210, DOI 10.1364/AO.28.002210; KAMAL AAR, 1989, COMPUT METH PROG BIO, V28, P257, DOI 10.1016/0169-2607(89)90159-4; Kamshilin AA, 2011, BIOMED OPT EXPRESS, V2, P996, DOI 10.1364/BOE.2.000996; Khanokh B, 2004, MED BIOL ENG COMPUT, V42, P80, DOI 10.1007/BF02351014; Leutenegger M, 2011, BIOMED OPT EXPRESS, V2, P1470, DOI 10.1364/BOE.2.001470; O'Doherty J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149863; Serov A, 2005, OPT EXPRESS, V13, P6416, DOI 10.1364/OPEX.13.006416; Serov A, 2005, OPT EXPRESS, V13, P3681, DOI 10.1364/OPEX.13.003681; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Ulyanov SS, 2000, APPL OPTICS, V39, P6385, DOI 10.1364/AO.39.006385; Wieringa FP, 2005, ANN BIOMED ENG, V33, P1034, DOI 10.1007/s10439-005-5763-2; Xu RX, 2010, J VIS EXP, V46, P2095	26	37	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57117	10.1371/journal.pone.0057117	http://dx.doi.org/10.1371/journal.pone.0057117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431399	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800042
J	Penner, J; Adum, GB; McElroy, MT; Doherty-Bone, T; Hirschfeld, M; Sandberger, L; Weldon, C; Cunningham, AA; Ohst, T; Wombwell, E; Portik, DM; Reid, D; Hillers, A; Ofori-Boateng, C; Oduro, W; Plotner, J; Ohler, A; Leache, AD; Rodel, MO				Penner, Johannes; Adum, Gilbert B.; McElroy, Matthew T.; Doherty-Bone, Thomas; Hirschfeld, Mareike; Sandberger, Laura; Weldon, Che; Cunningham, Andrew A.; Ohst, Torsten; Wombwell, Emma; Portik, Daniel M.; Reid, Duncan; Hillers, Annika; Ofori-Boateng, Caleb; Oduro, William; Ploetner, Joerg; Ohler, Annemarie; Leache, Adam D.; Roedel, Mark-Oliver			West Africa - A Safe Haven for Frogs? A Sub-Continental Assessment of the Chytrid Fungus (Batrachochytrium dendrobatidis)	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; NORTH-AMERICAN BULLFROG; AMPHIBIAN CHYTRIDIOMYCOSIS; POPULATION DECLINES; SPECIES DISTRIBUTIONS; HIGH PREVALENCE; RECENT HISTORY; PATHOGEN; TRADE; CONSERVATION	A putative driver of global amphibian decline is the panzootic chytrid fungus Batrachochytrium dendrobatidis (Bd). While Bd has been documented across continental Africa, its distribution in West Africa remains ambiguous. We tested 793 West African amphibians (one caecilian and 61 anuran species) for the presence of Bd. The samples originated from seven West African countries - Benin, Burkina Faso, Cote d'Ivoire, Ghana, Guinea, Liberia, Sierra Leone - and were collected from a variety of habitats, ranging from lowland rainforests to montane forests, montane grasslands to humid and dry lowland savannahs. The species investigated comprised various life-history strategies, but we focused particularly on aquatic and riparian species. We used diagnostic PCR to screen 656 specimen swabs and histology to analyse 137 specimen toe tips. All samples tested negative for Bd, including a widespread habitat generalist Hoplobatrachus occipitalis which is intensively traded on the West African food market and thus could be a potential dispersal agent for Bd. Continental fine-grained (30 arc seconds) environmental niche models suggest that Bd should have a broad distribution across West Africa that includes most of the regions and habitats that we surveyed. The surprising apparent absence of Bd in West Africa indicates that the Dahomey Gap may have acted as a natural barrier. Herein we highlight the importance of this Bd-free region of the African continent especially for the long-term conservation of several threatened species depending on fast flowing forest streams (Conraua alleni ("Vulnerable'') and Petropedetes natator ("Near Threatened'')) as well as the "Critically Endangered'' viviparous toad endemic to the montane grasslands of Mount Nimba (Nimbaphrynoides occidentalis).	[Penner, Johannes; Hirschfeld, Mareike; Sandberger, Laura; Ohst, Torsten; Ploetner, Joerg; Roedel, Mark-Oliver] Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, Berlin, Germany; [Adum, Gilbert B.; Ofori-Boateng, Caleb; Oduro, William] KNUST, CANR, Fac Renewable Nat Resources, Dept Wildlife & Range Management, Kumasi, Ghana; [McElroy, Matthew T.; Reid, Duncan; Leache, Adam D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [McElroy, Matthew T.; Reid, Duncan; Leache, Adam D.] Univ Washington, Burke Museum, Seattle, WA 98195 USA; [Doherty-Bone, Thomas] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Doherty-Bone, Thomas; Cunningham, Andrew A.; Wombwell, Emma] Zool Soc London, Inst Zool, London NW1 4RY, England; [Weldon, Che] North West Univ, Unit Environm Res, Potchefstroom, South Africa; [Ohst, Torsten] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Portik, Daniel M.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Portik, Daniel M.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Hillers, Annika] Royal Soc Protect Birds, Kenema, Sierra Leone; [Ofori-Boateng, Caleb] Forestry Res Inst Ghana, Kumasi, Ghana; [Ohler, Annemarie] Museum Natl Hist Nat, Dept Systemat & Evolut Origine Struct & Evolut Bi, F-75231 Paris, France	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Kwame Nkrumah University Science & Technology; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Natural History Museum London; Zoological Society of London; North West University - South Africa; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Royal Society for Protection of Birds; Museum National d'Histoire Naturelle (MNHN)	Penner, J (corresponding author), Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, Berlin, Germany.	johannes.penner@mfn-berlin.de	Doherty-Bone, Thomas/L-7109-2016; Cunningham, Andrew A/E-7536-2010; Ohler, Annemarie/AAB-7721-2019	Doherty-Bone, Thomas/0000-0002-8074-5955; Ohler, Annemarie/0000-0001-6531-464X; Penner, Johannes/0000-0001-8166-5992; Sandberger-Loua, Laura/0000-0001-6731-6411; Weldon, Che/0000-0001-6716-0787; Petersen, Mareike/0000-0001-8666-1931	German Ministry for Education and Research (BMBF) through the BIOTA-West project [01LC0617J]; Defra's Darwin Initiative/ZSL's Wildlife Wood Project; Rufford Small Grants Foundation; German Science Foundation [DFG PL 213/6-1]; DFG [VE 183/4-1, RO 3064/1-2]; Rapid Assessment Program and Critical Ecosystem Partnership Fund of Conservation International; World Wide Fund for Nature and BirdLife International	German Ministry for Education and Research (BMBF) through the BIOTA-West project(Federal Ministry of Education & Research (BMBF)); Defra's Darwin Initiative/ZSL's Wildlife Wood Project; Rufford Small Grants Foundation; German Science Foundation(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Rapid Assessment Program and Critical Ecosystem Partnership Fund of Conservation International; World Wide Fund for Nature and BirdLife International	Fieldwork in Benin, Burkina Faso and Cote d'Ivoire was funded by the German Ministry for Education and Research (BMBF) through the BIOTA-West project (01LC0617J). In Ghana, fieldwork for GBA, COB and WO was supported by Defra's Darwin Initiative/ZSL's Wildlife Wood Project and the Rufford Small Grants Foundation respectively. Analyses of samples in Berlin were conducted within a project financed by the German Science Foundation (DFG PL 213/6-1). The authors further thank the DFG (VE 183/4-1, RO 3064/1-2), the Rapid Assessment Program and Critical Ecosystem Partnership Fund of Conservation International, the World Wide Fund for Nature and BirdLife International for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; [Anonymous], 2010, MAPPING SPECIES DIST; ARNAUD M, 1991, ISPRS J PHOTOGRAMM, V46, P205, DOI 10.1016/0924-2716(91)90054-Y; Bai CM, 2012, DIVERS DISTRIB, V18, P307, DOI 10.1111/j.1472-4642.2011.00878.x; Balaz V, 2012, HERPETOL J, V22, P191; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Bell RC, 2011, ECOHEALTH, V8, P116, DOI 10.1007/s10393-010-0364-4; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Berger L, 2001, DEV MANAGEMENT STRAT, P83; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burgess N.D., 2004, TERRESTRIAL ECOREGIO; Burgin Shelley, 2005, Acta Zoologica Sinica, V51, P344; Burrowes Patricia A., 2011, Herpetological Review, V42, P359; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Catenazzi A, 2010, DIS AQUAT ORGAN, V92, P187, DOI 10.3354/dao02250; Channing Alan, 2006, Journal of East African Natural History, V95, P117, DOI 10.2982/0012-8317(2006)95[117:TBARHO]2.0.CO;2; Chatelain C., 2004, Biodiversity of West African forests: an ecological atlas of woody plant species, P15, DOI 10.1079/9780851997346.0015; Chatelain C, 1996, BIODIVERS CONSERV, V5, P37, DOI 10.1007/BF00056291; Conradie Werner, 2011, Herpetological Review, V42, P369; Conradie W, 2011, AFR ZOOL, V46, P95, DOI 10.3377/004.046.0122; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Daversa David, 2011, Herpetological Review, V42, P67; Doherty-Bone TM, 2013, DIS AQUAT ORGAN, V102, P187, DOI 10.3354/dao02557; Drew A, 2006, DIS AQUAT ORGAN, V68, P245, DOI 10.3354/dao068245; El Mouden E. H., 2011, Herpetological Review, V42, P71; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garland S, 2011, DIS AQUAT ORGAN, V94, P101, DOI 10.3354/dao02327; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Goldberg TL, 2007, J WILDLIFE DIS, V43, P521, DOI 10.7589/0090-3558-43.3.521; Gower DJ, 2012, HERPETOL J, V22, P225; Grafe TU, 2011, J HERPETOL, V45, P28, DOI 10.1670/10-016.1; Greenbaum Eli, 2008, Herpetological Review, V39, P70; Hansen M, 2003, VEGETATION CONTINUOU; Heard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023150; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillers A., 2008, Endangered Species Research, V5, P13, DOI 10.3354/esr00099; Hopkins Samantha, 2003, Herpetological Review, V34, P334; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Imasuen AA, 2009, FROGLOG, V90, P6; Imasuen Abigail A., 2011, Herpetological Review, V42, P379; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kilburn VL, 2011, DIS AQUAT ORGAN, V97, P127, DOI 10.3354/dao02409; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2009, ECOHEALTH, V6, P6, DOI 10.1007/s10393-009-0228-y; Lamirande EW, 2002, P 6 INT S PATH REPT, P3; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Lotters S, 2009, ECOHEALTH, V6, P358, DOI 10.1007/s10393-010-0281-6; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Mayaux P, 2004, J BIOGEOGR, V31, P861, DOI 10.1111/j.1365-2699.2004.01073.x; Mazzoni R, 2003, EMERG INFECT DIS, V9, P995; McDonald K, 1999, DECLINES DISAPPEARAN, P14; Mohneke M., 2010, Traffic Bulletin, V22, P117; Mohneke Meike, 2009, Salamandra, V45, P193; Murray K, 2011, HYGIENE PROTOCOLS CO; Murray KA, 2012, HUM ECOL RISK ASSESS, V18, P200, DOI 10.1080/10807039.2012.632310; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Parker JM, 2002, COMPARATIVE MED, V52, P265; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Reeder Natalie M.M., 2011, Herpetology Notes, V4, P83; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rodel M-O, 2000, HERPETOFAUNA W AFRIC, VI; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Roedder Dennis, 2009, Diversity, V1, P52; Rodder D, 2010, DIS AQUAT ORGAN, V92, P201, DOI 10.3354/dao02197; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Sandberger L, 2010, ZOOTAXA, P56; Schloegel LM, 2010, ANIM CONSERV, V13, P53, DOI 10.1111/j.1469-1795.2009.00307.x; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; SCHMIDT B. R., 2009, METHODEN FELDHERPETO, P229; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2010, DIS AQUAT ORGAN, V92, P117, DOI 10.3354/dao02272; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soto-Azat C, 2009, DIS AQUAT ORGAN, V84, P163, DOI 10.3354/dao02029; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; St-Amour V, 2008, EMERG INFECT DIS, V14, P1175, DOI 10.3201/eid1407.070602; Stockwell MP, 2010, ANIM CONSERV, V13, P62, DOI 10.1111/j.1469-1795.2010.00407.x; Stuart S. N., 2008, THREATENED AMPHIBIAN; Tinoco BA, 2009, BIRD CONSERV INT, V19, P63, DOI 10.1017/S0959270908007703; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Van Sluys M, 2008, DIS AQUAT ORGAN, V81, P93, DOI 10.3354/dao01953; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vredenburg VT, 2012, HERPETOLOGY NOTES, V5, P507, DOI DOI 10.1186/1756-0500-5-507; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; Waldman B., 2001, Surveillance (Wellington), V28, P9; Webb R, 2007, DIS AQUAT ORGAN, V74, P13, DOI 10.3354/dao074013; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Weldon C., 2004, FROGLOG, V62, P2; Weldon C, 2011, FUNGAL DIS EMERGING, P355; Weldon C, 2007, AFR J HERPETOL, V56, P77, DOI 10.1080/21564574.2007.9635553; Weldon Che, 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P95; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x; Wollenberg KC, 2010, ECOHEALTH, V7, P248, DOI 10.1007/s10393-010-0313-2; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	134	26	30	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56236	10.1371/journal.pone.0056236	http://dx.doi.org/10.1371/journal.pone.0056236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23426141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300133
J	Friedman, SR; West, BS; Pouget, ER; Hall, HI; Cantrell, J; Tempalski, B; Chatterjee, S; Hu, XH; Cooper, HLF; Galea, S; Jarlais, DCD				Friedman, Samuel R.; West, Brooke S.; Pouget, Enrique R.; Hall, H. Irene; Cantrell, Jennifer; Tempalski, Barbara; Chatterjee, Sudip; Hu, Xiaohong; Cooper, Hannah L. F.; Galea, Sandro; Des Jarlais, Don C.			Metropolitan Social Environments and Pre-HAART/HAART Era Changes in Mortality Rates (per 10,000 Adult Residents) among Injection Drug Users Living with AIDS	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INCOME INEQUALITY; TREATMENT COVERAGE; HIV PREVALENCE; UNITED-STATES; US; AREAS; INCARCERATION; HEALTH; IMPACT	Background: Among the largest US metropolitan areas, trends in mortality rates for injection drug users (IDUs) with AIDS vary substantially. Ecosocial, risk environment and dialectical theories suggest many metropolitan areas characteristics that might drive this variation. We assess metropolitan area characteristics associated with decline in mortality rates among IDUs living with AIDS (per 10,000 adult MSA residents) after highly active antiretroviral therapy (HAART) was developed. Methods: This is an ecological cohort study of 86 large US metropolitan areas from 1993-2006. The proportional rate of decline in mortality among IDUs diagnosed with AIDS (as a proportion of adult residents) from 1993-1995 to 2004-2006 was the outcome of interest. This rate of decline was modeled as a function of MSA-level variables suggested by ecosocial, risk environment and dialectical theories. In multiple regression analyses, we used 1993-1995 mortality rates to (partially) control for pre-HAART epidemic history and study how other independent variables affected the outcomes. Results: In multivariable models, pre-HAART to HAART era increases in 'hard drug' arrest rates and higher pre-HAART income inequality were associated with lower relative declines in mortality rates. Pre-HAART per capita health expenditure and drug abuse treatment rates, and pre- to HAART-era increases in HIV counseling and testing rates, were weakly associated with greater decline in AIDS mortality. Conclusions: Mortality among IDUs living with AIDS might be decreased by reducing metropolitan income inequality, increasing public health expenditures, and perhaps increasing drug abuse treatment and HIV testing services. Given prior evidence that drug-related arrest rates are associated with higher HIV prevalence rates among IDUs and do not seem to decrease IDU population prevalence, changes in laws and policing practices to reduce such arrests while still protecting public order should be considered.	[Friedman, Samuel R.; West, Brooke S.; Pouget, Enrique R.; Tempalski, Barbara; Des Jarlais, Don C.] Natl Dev & Res Inst Inc, Inst Infect Dis Res, New York, NY USA; [Hall, H. Irene; Hu, Xiaohong] Ctr Dis Control, Atlanta, GA 30333 USA; [Cantrell, Jennifer] Legacy Fdn, Washington, DC USA; [Cooper, Hannah L. F.] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Galea, Sandro] Columbia Univ, Dept Epidemiol, New York, NY USA; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY 10003 USA	National Development & Research Institutes, Inc; Centers for Disease Control & Prevention - USA; Emory University; Columbia University; Harvard University; Beth Israel Deaconess Medical Center	Friedman, SR (corresponding author), Natl Dev & Res Inst Inc, Inst Infect Dis Res, New York, NY USA.	friedman@ndri.org	Pouget, Enrique Rodriguez/AAJ-5786-2020; Galea, Sandro/GLR-6066-2022	Pouget, Enrique Rodriguez/0000-0002-5907-1909; Galea, Sandro/0000-0002-7534-0945; West, Brooke S./0000-0003-0496-5769; Friedman, Sam/0000-0003-2083-1226; Tempalski, Barbara/0000-0002-6128-2510	National Institute of Drug Abuse [R01 DA013336, R01 DA 003574, 5T32 DA007233]; Public Health Solutions; National Development and Research Institutes; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013336, T32DA007233, R01DA003574] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Public Health Solutions; National Development and Research Institutes; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Drug Abuse grants # R01 DA013336 (Community Vulnerability and Responses to Drug-User-Related HIV/AIDS), R01 DA 003574 (Risk Factors for AIDS among Intravenous Drug Users), and 5T32 DA007233 (Behavioral Sciences Training in Drug Abuse Research program sponsored by Public Health Solutions and National Development and Research Institutes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2002, INT J DRUG POLICY, DOI [DOI 10.1016/S0955-3959(02)00075-0, DOI 10.1016/S0955-3959]; Backlund E, 2007, INT J EPIDEMIOL, V36, P590, DOI 10.1093/ije/dym012; Beal D. J., 2005, SAS CODE SELECT BEST; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Bluthenthal R N, 1997, Med Anthropol, V18, P61, DOI 10.1080/01459740.1997.9966150; Bluthenthal RN, 1999, J DRUG ISSUES, V29, P1; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brown B. S., 1993, HDB RISK AIDS INJECT; Bureau of Labor Statistics, 2009, LOC AR UN STAT; [Bureau UC US Census Bureau], 1990, HOUS HOUS EC STAT DI; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chaix B, 2010, EPIDEMIOLOGY, V21, P124, DOI 10.1097/EDE.0b013e3181c04e70; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Cooper H, 2005, SOC SCI MED, V61, P673, DOI 10.1016/j.socscimed.2004.12.030; Cooper H, 2005, ANN EPIDEMIOL, V15, P326, DOI 10.1016/j.annepidem.2004.10.008; Cooper HLF, 2007, AM J PUBLIC HEALTH, V97, P344, DOI 10.2105/AJPH.2005.074542; Cooper HLF, 2009, J URBAN HEALTH, V86, P929, DOI 10.1007/s11524-009-9399-7; Cooper HLF, 2008, J URBAN HEALTH, V85, P826, DOI 10.1007/s11524-008-9304-9; Cooper RS, 2001, PUBLIC HEALTH REP, V116, P464, DOI 10.1016/S0033-3549(04)50074-2; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Federal Bureau of Investigation, 2009, CRIM US; Friedman S, 2008, GEOGRAPHY DRUG ADDIC; Friedman SR, 2011, DIALECT ANTHROPOL, V35, P453, DOI 10.1007/s10624-011-9257-3; Friedman SR, 2011, DIALECT ANTHROPOL, V35, P403, DOI 10.1007/s10624-011-9222-1; Friedman SR, 2007, INT J DRUG POLICY, V18, P475, DOI 10.1016/j.drugpo.2006.10.004; Friedman SR, 2011, AM J PUBLIC HEALTH, V101, P344, DOI 10.2105/AJPH.2010.191759; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Friedman SR, 2001, 2000 GLOB RES NETW M, P147; Galea S, 2005, J EPIDEMIOL COMMUN H, V59, P822, DOI 10.1136/jech.2005.033084; Galea S, 2011, AM J PUBLIC HEALTH, V101, P1456, DOI 10.2105/AJPH.2010.300086; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Harper S, 2005, ESTIMATES GINI COEFF; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Kerr T, 2005, AIDS CARE, V17, P539, DOI 10.1080/09540120412331319778; Khan MR, 2008, ANN EPIDEMIOL, V18, P403, DOI 10.1016/j.annepidem.2007.12.003; Kondo N, 2009, BMJ, V10; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Link BG, 2005, POLICY CHALLENGES MO, P71; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Marmot M., 2004, STATUS SYNDROME SOCI; Marmot M., 2005, PUBLIC HEALTH; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Milloy MJ, 2011, J INFECT DIS, V203, P1215, DOI 10.1093/infdis/jir032; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; Nandi A, 2006, SOC SCI MED, V63, P662, DOI 10.1016/j.socscimed.2006.02.001; Office of Management and Budget, 2000, FED REG, V65, P8228; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Roberts ET, 2010, DRUG ALCOHOL DEPEN, V106, P142, DOI 10.1016/j.drugalcdep.2009.08.007; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; Rubin MS, 2010, AM J PUBLIC HEALTH, V100, P1053, DOI 10.2105/AJPH.2009.170241; SAS, 2002, SAS 9 2; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Small W, 2007, INT J DRUG POLICY, V18, P27, DOI 10.1016/j.drugpo.2006.11.019; Small W, 2009, AIDS CARE, V21, P708, DOI 10.1080/09540120802511869; Song RG, 2011, PUBLIC HEALTH REP, V126, P70, DOI 10.1177/00333549111260S312; Springer KW, 1999, SUBST USE MISUSE, V34, P1917, DOI 10.3109/10826089909039432; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Substance Abuse and Mental Health Services Administration, 1998, NAT HOUS SURV DRUG A; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 1992, TREATMENT EPISODE DA; Syme S, 2005, EPIDEMIOL PERSPECT I, V2; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tempalski B, 2009, INT J DRUG POLICY, V20, P4, DOI 10.1016/j.drugpo.2008.02.002; Tempalski B, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-23; Thomas JC, 2005, J INFECT DIS, V191, pS55, DOI 10.1086/425278; Uhlmann S, 2010, ADDICTION, V105, P907, DOI 10.1111/j.1360-0443.2010.02905.x; United States Census Bureau, 2002, CENS GOV; *US BUR CENS, 1990, POP EST; US Census Bureau, 1992, CENS GOV; US Census Bureau, 2000, POP EST; [US Census Bureau Bureau UC], 2000, HOUS HOUS EC STAT DI; Wilkinson R, 1999, SOCIAL DETERMINANTS, pp256; Wood E, 2004, CAN MED ASSOC J, V170, P1551, DOI 10.1503/cmaj.1031928	79	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57201	10.1371/journal.pone.0057201	http://dx.doi.org/10.1371/journal.pone.0057201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437341	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000084
J	Urbizu, A; Toma, C; Poca, MA; Sahuquillo, J; Cuenca-Leon, E; Cormand, B; Macaya, A				Urbizu, Aintzane; Toma, Claudio; Poca, Maria A.; Sahuquillo, Juan; Cuenca-Leon, Ester; Cormand, Bru; Macaya, Alfons			Chiari Malformation Type I: A Case-Control Association Study of 58 Developmental Genes	PLOS ONE			English	Article							POSTERIOR CRANIAL FOSSA; NEURAL-TUBE DEFECTS; RETINOIC ACID; LINKAGE DISEQUILIBRIUM; TYROSINE KINASE; AXIAL SKELETON; GROWTH-FACTOR; VASCULOGENESIS; ANGIOGENESIS; EXPRESSION	Chiari malformation type I (CMI) is a disorder characterized by hindbrain overcrowding into an underdeveloped posterior cranial fossa (PCF), often causing progressive neurological symptoms. The etiology of CMI remains unclear and is most likely multifactorial. A putative genetic contribution to CMI is suggested by familial aggregation and twin studies. Experimental models and human morphometric studies have suggested an underlying paraxial mesoderm insufficiency. We performed a case-control association study of 303 tag single nucleotide polymorphisms (SNP) across 58 candidate genes involved in early paraxial mesoderm development in a sample of 415 CMI patients and 524 sex-matched controls. A subgroup of patients diagnosed with classical, small-PCF CMI by means of MRI-based PCF morphometry (n = 186), underwent additional analysis. The genes selected are involved in signalling gradients occurring during segmental patterning of the occipital somites (FGF8, Wnt, and retinoic acid pathways and from bone morphogenetic proteins or BMP, Notch, Cdx and Hox pathways) or in placental angiogenesis, sclerotome development or CMI-associated syndromes. Single-marker analysis identified nominal associations with 18 SNPs in 14 genes (CDX1, FLT1, RARG, NKD2, MSGN1, RBPJ1, FGFR1, RDH10, NOG, RARA, LFNG, KDR, ALDH1A2, BMPR1A) considering the whole CMI sample. None of these overcame corrections for multiple comparisons, in contrast with four SNPs in CDX1, FLT1 and ALDH1A2 in the classical CMI group. Multiple marker analysis identified a risk haplotype for classical CMI in ALDH1A2 and CDX1. Furthermore, we analyzed the possible contributions of the most significantly associated SNPs to different PCF morphometric traits. These findings suggest that common variants in genes involved in somitogenesis and fetal vascular development may confer susceptibility to CMI.	[Urbizu, Aintzane; Cuenca-Leon, Ester; Macaya, Alfons] Univ Autonoma Barcelona, Vall dHebron Res Inst, Pediat Neurol Res Grp, E-08193 Barcelona, Spain; [Poca, Maria A.; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Res Unit, Dept Neurosurg, E-08193 Barcelona, Spain; [Poca, Maria A.; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Res Unit, E-08193 Barcelona, Spain; [Toma, Claudio; Cormand, Bru] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Toma, Claudio; Cormand, Bru] Biomed Network Res Ctr Rare Dis, Barcelona, Spain; [Cormand, Bru] Univ Barcelona, Inst Biomed, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona	Macaya, A (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Pediat Neurol Res Grp, E-08193 Barcelona, Spain.	amacaya@vhebron.net	Toma, Claudio/L-7853-2014; Urbizu, Aintzane/A-8208-2018; Sahuquillo, Juan/B-3577-2008; Cormand, Bru/H-5338-2015; Poca, Maria A./B-8475-2008	Toma, Claudio/0000-0003-3901-7507; Urbizu, Aintzane/0000-0001-8458-1209; Sahuquillo, Juan/0000-0003-0713-5875; Cormand, Bru/0000-0001-5318-4382; Poca, Maria A./0000-0002-3831-0536; Macaya Ruiz, Alfons/0000-0001-7998-4185	Instituto de Salud Carlos III, Spain [PI061606]; Fundacio La Marato TV3, Spain [062710]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Spain [2009SGR -0078]; AGAUR (Spain); European Union (Marie Curie) [PIEF-GA-2009-254930]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Fundacio La Marato TV3, Spain; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); AGAUR (Spain)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Union (Marie Curie)(European Commission)	Work supported by Instituto de Salud Carlos III, Spain, grant PI061606; Fundacio La Marato TV3, Spain, grant 062710; and Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Spain, grant 2009SGR -0078. A.U. is the recipient of a scholarship from AGAUR (Spain). C.T. was supported by the European Union (Marie Curie, PIEF-GA-2009-254930). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Aulehla A, 2009, COLD SPRING HARB PER, V2; Aydin S, 2005, SURG NEUROL, V64, P237, DOI 10.1016/j.surneu.2005.02.021; BARKOVICH AJ, 1986, AM J NEURORADIOL, V7, P795; Barnes MR, 2006, BRIEF BIOINFORM, V7, P211, DOI 10.1093/bib/bbl021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BARRY A, 1957, J NEUROSURG, V14, P285, DOI 10.3171/jns.1957.14.3.0285; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Boyles AL, 2006, AM J MED GENET A, V140A, P2776, DOI 10.1002/ajmg.a.31546; Boyles AL, 2005, AM J MED GENET C, V135C, P9, DOI 10.1002/ajmg.c.30048; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CHIARI H, 1987, PEDIATR NEUROSCI, V13, P3, DOI 10.1159/000120293; Demir R, 2004, PLACENTA, V25, P560, DOI 10.1016/j.placenta.2003.11.011; Demir R, 2007, ACTA HISTOCHEM, V109, P257, DOI 10.1016/j.acthis.2007.02.008; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Freeman AF, 1993, GENEREVIEWS; Fujisawa H, 2002, J NEUROSURG, V97, P396, DOI 10.3171/jns.2002.97.2.0396; Fujita K, 2009, AM J NEURORADIOL, V30, P629, DOI 10.3174/ajnr.A1380; GARDNER WJ, 1950, J NEUROSURG, V7, P199, DOI 10.3171/jns.1950.7.3.0199; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Greenlee JDW, 2002, PEDIATRICS, V110, P1212, DOI 10.1542/peds.110.6.1212; Gu CC, 2008, ADV GENET, V60, P407, DOI 10.1016/S0065-2660(07)00415-4; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Kageyama R, 2009, MOL CELLS, V27, P497, DOI 10.1007/s10059-009-0068-1; KANE WJ, 1977, CLIN ORTHOP RELAT R, P43; Karagoz F, 2002, ACTA NEUROCHIR, V144, P165, DOI 10.1007/s007010200020; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; MARINPADILLA M, 1981, J NEUROL SCI, V50, P29, DOI 10.1016/0022-510X(81)90040-X; MARINPADILLA M, 1991, CAN J NEUROL SCI, V18, P153, DOI 10.1017/S0317167100031632; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MARTINOT A, 1993, INTENS CARE MED, V19, P73, DOI 10.1007/BF01708364; MCLONE DG, 1989, PEDIATR NEUROSCI, V15, P1, DOI 10.1159/000120432; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Milhorat TH, 2010, ACTA NEUROCHIR, V152, P1117, DOI 10.1007/s00701-010-0636-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miura S, 2006, DEVELOPMENT, V133, P3767, DOI 10.1242/dev.02552; Monsoro-Burq AH, 2005, INT J DEV BIOL, V49, P301, DOI 10.1387/ijdb.041953am; Morris Z, 2009, BMJ-BRIT MED J, V339, pb3016, DOI [10.1136/bmj.b3016, DOI 10.1136/BMJ.B3016]; Mueller JC, 2004, BRIEF BIOINFORM, V5, P355, DOI 10.1093/bib/5.4.355; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Noudel R, 2009, J NEUROSURG, V111, P1046, DOI 10.3171/2009.2.JNS08284; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SCHADY W, 1987, J NEUROL SCI, V82, P193, DOI 10.1016/0022-510X(87)90018-9; Schanker BD, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.6.FOCUS11104; Schimmenti LA, 1999, HUM MUTAT, V14, P369, DOI 10.1002/(SICI)1098-1004(199911)14:5<369::AID-HUMU2>3.0.CO;2-E; SHAPIRO R, 1976, AM J ROENTGENOL, V126, P1063, DOI 10.2214/ajr.126.5.1063; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Speer M C, 2000, Neurosurg Focus, V8, pE12; Speer Marcy C, 2003, J Genet Couns, V12, P297, DOI 10.1023/A:1023948921381; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; STOVNER LJ, 1993, NEURORADIOLOGY, V35, P113, DOI 10.1007/BF00593966; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tubbs RS, 2011, J NEUROSURG-PEDIATR, V7, P248, DOI 10.3171/2010.12.PEDS10379; Tubbs RS, 2004, PEDIATR NEUROL, V30, P278, DOI 10.1016/j.pediatrneurol.2003.09.013; Urbizu A, 2012, J NEUROIMAG IN PRESS; VEGA A, 1990, J NEUROL SCI, V99, P137, DOI 10.1016/0022-510X(90)90150-L; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; William DA, 2007, DEV BIOL, V305, P172, DOI 10.1016/j.ydbio.2007.02.007; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Wojcik C, 2010, AM J MED GENET A, V152A, P479, DOI 10.1002/ajmg.a.33303; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	73	43	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57241	10.1371/journal.pone.0057241	http://dx.doi.org/10.1371/journal.pone.0057241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437350	gold, Green Published			2022-12-27	WOS:000315186000090
J	Chattopadhyay, S; Basak, T; Nayak, MK; Bhardwaj, G; Mukherjee, A; Bhowmick, R; Sengupta, S; Chakrabarti, O; Chatterjee, NS; Chawla-Sarkar, M				Chattopadhyay, Shiladitya; Basak, Trayambak; Nayak, Mukti Kant; Bhardwaj, Gourav; Mukherjee, Anupam; Bhowmick, Rahul; Sengupta, Shantanu; Chakrabarti, Oishee; Chatterjee, Nabendu S.; Chawla-Sarkar, Mamta			Identification of Cellular Calcium Binding Protein Calmodulin as a Regulator of Rotavirus A Infection during Comparative Proteomic Study	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; MAJOR CAPSID PROTEIN; VP6 PROTEIN; IN-VITRO; EXPRESSION; INCREASE; ASSAY; NEUTRALIZATION; MECHANISMS; INHIBITION	Rotavirus (RV) being the major diarrhoegenic virus causes around 527000 children death (< 5years age) worldwide. In cellular environment, viruses constantly adapt and modulate to survive and replicate while the host cell also responds to combat the situation and this results in the differential regulation of cellular proteins. To identify the virus induced differential expression of proteins, 2D-DIGE (Two-dimensional Difference Gel Electrophoresis) based proteomics was used. For this, HT-29 cells were infected with RV strain SA11 for 0 hours, 3 hours and 9 hours post infection (hpi), differentially expressed spots were excised from the gel and identified using MALDI-TOF/TOF mass spectrometry. 2D-DIGE based proteomics study identified 32 differentially modulated proteins, of which 22 were unique. Some of these were validated in HT-29 cell line and in BALB/c mice model. One of the modulated cellular proteins, calmodulin (CaM) was found to directly interact with RV protein VP6 in the presence of Ca2+. Ca2+-CaM/VP6 interaction positively regulates RV propagation since both CaM inhibitor (W-7) and Ca2+ chelator (BAPTA-AM) resulted in decreased viral titers. This study not only identifies differentially modulated cellular proteins upon infection with rotavirus in 2D-DIGE but also confirmed positive engagement of cellular Ca2+/CaM during viral pathogenesis.	[Chattopadhyay, Shiladitya; Mukherjee, Anupam; Bhowmick, Rahul; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India; [Basak, Trayambak; Bhardwaj, Gourav] CSIR Inst Genom & Integrat Biol, Delhi, India; [Nayak, Mukti Kant; Sengupta, Shantanu] Univ Calcutta, Dept Zool, Kolkata, W Bengal, India; [Chakrabarti, Oishee] Saha Inst Nucl Phys, Struct Genom Sect, Kolkata, W Bengal, India; [Chatterjee, Nabendu S.] Natl Inst Cholera & Enter Dis, Div Biochem, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Calcutta; Saha Institute of Nuclear Physics; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India.	chawlam70@gmail.com	Basak, Trayambak/AAB-8534-2020; Bhowmick, Rahul/AAD-4433-2022; Mukherjee, Anupam/ABB-9438-2020; Bhardwaj, Gourav/L-1746-2019	Bhowmick, Rahul/0000-0002-5412-1209; Mukherjee, Anupam/0000-0002-0612-2258; Bhardwaj, Gourav/0000-0002-9543-8237; Basak, Trayambak/0000-0001-7683-3189	Indian Council of Medical Research (ICMR); Okayama University, Japan; Dr. D.S. Kothari Postdoctoral Research Fellowship (UGC)	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Okayama University, Japan; Dr. D.S. Kothari Postdoctoral Research Fellowship (UGC)	Financial assistance and support from Indian Council of Medical Research (ICMR) and Okayama University, Japan are acknowledged. The authors are thankful to CSIR-IGIB for their generous support. MKN is financially supported by Dr. D.S. Kothari Postdoctoral Research Fellowship (UGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; Albrecht D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-32; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1255; Bagchi P, 2012, VIRUS RES, V169, P144, DOI 10.1016/j.virusres.2012.07.021; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Banos DM, 1997, J VIROL, V71, P419; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Bhowmick R, 2012, J BIOL CHEM, V287, P35004, DOI 10.1074/jbc.M112.369595; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet JP, 2000, J VIROL, V74, P10801, DOI 10.1128/JVI.74.22.10801-10806.2000; Brunet JP, 2000, J VIROL, V74, P2323, DOI 10.1128/JVI.74.5.2323-2332.2000; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Campagna M, 2012, J VIROL IN PRESS; CARPIO M, 1981, CAN J COMP MED, V45, P38; Chaplin PJ, 1996, J INTERF CYTOK RES, V16, P25, DOI 10.1089/jir.1996.16.25; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Crawford SE, 2012, P NATL ACAD IN PRESS; Cuadras MA, 2002, J VIROL, V76, P4467, DOI 10.1128/JVI.76.9.4467-4482.2002; Dhillon NK, 2003, LETT APPL MICROBIOL, V36, P382, DOI 10.1046/j.1472-765X.2003.01324.x; Dutta D, 2011, J BIOL CHEM, V286, P20065, DOI 10.1074/jbc.M111.231878; Dutta D, 2009, VIROLOGY, V391, P325, DOI 10.1016/j.virol.2009.06.044; Estes MK, 2007, FIELDS VIROLOGY, P1917; FORMAL SB, 1961, BRIT J EXP PATHOL, V42, P504; FRANCO MA, 1994, J GEN VIROL, V75, P589, DOI 10.1099/0022-1317-75-3-589; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; GINN DI, 1992, J GEN VIROL, V73, P3017, DOI 10.1099/0022-1317-73-11-3017; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Holloway G, 2006, J VIROL, V80, P10624, DOI 10.1128/JVI.00390-06; Holloway G, 2009, J VIROL, V83, P4942, DOI 10.1128/JVI.01450-08; Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jain V, 2001, J CLIN MICROBIOL, V39, P3524, DOI 10.1128/JCM.39.10.3524-3529.2001; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KALICA AR, 1981, VIROLOGY, V112, P385, DOI 10.1016/0042-6822(81)90285-3; KAPIKIAN AZ, 1981, INFECT IMMUN, V33, P415, DOI 10.1128/IAI.33.2.415-425.1981; McNeal MM, 2007, VIRAL IMMUNOL, V20, P571, DOI 10.1089/vim.2007.0055; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Murthy AK, 2004, CELL IMMUNOL, V230, P56, DOI 10.1016/j.cellimm.2004.09.002; NISHIKAWA M, 1980, NATURE, V287, P863, DOI 10.1038/287863a0; Pammit MA, 2004, ANTIMICROB AGENTS CH, V48, P4513, DOI 10.1128/AAC.48.12.4513-4519.2004; Parez N, 2004, J VIROL, V78, P12489, DOI 10.1128/JVI.78.22.12489-12496.2004; Perez JF, 1998, VIROLOGY, V252, P17, DOI 10.1006/viro.1998.9433; Ponnudurai RP, 2012, J PROTEOMICS, V75, P1004, DOI 10.1016/j.jprot.2011.10.016; RASMUSSEN CD, 1992, CELL MOTIL CYTOSKEL, V21, P45, DOI 10.1002/cm.970210106; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rollo EE, 1999, J IMMUNOL, V163, P4442; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Saha A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001275; SAKAGUCHI T, 1988, J CLIN MICROBIOL, V26, P600, DOI 10.1128/JCM.26.3.600-601.1988; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; SMITH EM, 1979, J GEN VIROL, V43, P513, DOI 10.1099/0022-1317-43-3-513; Tsunemitsu H, 2005, J GEN VIROL, V86, P2569, DOI 10.1099/vir.0.80938-0; Wang JF, 2011, BLOOD, V117, P1260, DOI 10.1182/blood-2010-06-289215; Xu AM, 1998, J VIROL, V72, P9865, DOI 10.1128/JVI.72.12.9865-9872.1998; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zambrano JL, 2011, VIROL J, V20, P348; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313	66	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56655	10.1371/journal.pone.0056655	http://dx.doi.org/10.1371/journal.pone.0056655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437200	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200130
J	Chen, P; Yu, CB; Ruan, B; Yang, SG; Ren, JJ; Xu, WJ; Luo, ZB; Li, LJ				Chen, Ping; Yu, Chengbo; Ruan, Bing; Yang, Shigui; Ren, Jingjing; Xu, Weijian; Luo, Zhuanbo; Li, Lanjuan			Prevalence of Hepatitis B in Insular Regions of Southeast China: A Community-Based Study	PLOS ONE			English	Article							C VIRUS-INFECTIONS; HEPATOCELLULAR-CARCINOMA; DISEASE BURDEN; HBSAG-CARRIERS; POPULATION; RISK; JAPAN; HBEAG	Objective: Hepatitis B virus (HBV) infection remains a significant public health problem. The purpose of this study was to investigate the seroepidemiology of HBV in people living in the insular regions, and to provide the most recent baseline data for planning and monitoring of health. Methods: A cross-sectional, community-based survey was conducted without age restriction, on two isolated islands, Zhoushan and Yuhuan, China. The study sample was selected by random multistage cluster sampling. Serological samples and demographic information were collected from 15878 participants. Results: The prevalences of anti-HBV core antibody (anti-HBc), hepatitis B virus surface antigen (HBsAg), and anti-HBV surface antibody (anti-HBs) were 33.1, 10.4, and 56.1%, respectively. We found statistically significant differences of HBV markers in men versus women (P < 0.01). The prevalence of HBV infection increased with age. There were significant differences in the rates of HBsAg and anti-HBc positivity between the two islands (P, 0.01). Alanine aminotransferase (ALT) levels were elevated (>38 IU/L) in 15.6% and 7.2% of the HBsAg-positive and negative groups, respectively. Elevated ALT levels were significantly higher in males (12.0%) compared with females (5.8%) (P, 0.01). The alpha-fetoprotein (AFP) positivity rate was 0.6% in HBsAg-positive participants over the age of 30. Conclusion: Due to the geographic location, we found that the HBV prevalence and potential for the development of hepatocellular carcinoma remained high in insular regions of southeast China, and are far above the national figures. Although a vaccination program has been in effect over the last 20 years, several additional measures should be adopted by the government to limit the spread of hepatitis B. These include the management of high risk persons and the floating population living on the islands, expansion of the immune population, and increased health education for fisherman.	[Chen, Ping; Yu, Chengbo; Ruan, Bing; Yang, Shigui; Ren, Jingjing; Luo, Zhuanbo; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Weijian] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			National Scientific and Technological Major Project of China [2009ZX10004-901, 2011ZX10004-901]	National Scientific and Technological Major Project of China	This study was funded by the National Scientific and Technological Major Project of China (Grant No. 2009ZX10004-901,2011ZX10004-901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2000, VACCINE, V18, pS20, DOI 10.1016/S0264-410X(99)00456-9; Bwogi J, 2009, AFR HEALTH SCI, V9, P98; Chen K, 2009, ZHEJINAGPREV MED, V5, P1; Chen YS, 2007, CHIN J EXP CLIN INFE, V1, P5; CHU CM, 1993, CLIN INFECT DIS, V16, P709, DOI 10.1093/clind/16.5.709; Cui FQ, 2007, CHIN J VACCINES IMMU, V13, P1; Fu YX, 2002, ZHEJINAGPREV MED, V3, P49; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gogos CA, 2003, EUR J EPIDEMIOL, V18, P551, DOI 10.1023/A:1024698715741; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; HAYASHI J, 1988, MICROBIOL IMMUNOL, V32, P843, DOI 10.1111/j.1348-0421.1988.tb01445.x; Ishiguro S, 2009, EUR J CANCER PREV, V18, P26, DOI 10.1097/CEJ.0b013e3282fa9edd; Li Q, 2008, ZHEJIANG J PREVENTIV, V12, P18; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Luo ZB, 2011, EUR J GASTROEN HEPAT, V23, P695, DOI 10.1097/MEG.0b013e328347322b; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240; Shi J, 2005, BRIT J CANCER, V92, P607, DOI 10.1038/sj.bjc.6602333; Statistics ZPBo, 2011, MAIN DAT B 6 NAT CEN; Tang A, 2007, STRAIT J PREVENTIVE, V6, P43; Torpy Janet M, 2011, JAMA, V305, P1500, DOI 10.1001/jama.305.14.1500; Wang CS, 2002, AM J TROP MED HYG, V66, P389, DOI 10.4269/ajtmh.2002.66.389; [王鸣 WANG Ming], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P1317; Wu Jiang, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P555; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047808; Yao J, 2004, B CHINESE FDN HEPATI; Yao J, 2006, CHIN J VACCINE IMMUN, V6, P132; Yu AJ, 1997, SCI TRAVEL MED, V1, P14	31	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56444	10.1371/journal.pone.0056444	http://dx.doi.org/10.1371/journal.pone.0056444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437134	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200075
J	Cheng, XB; Jiang, HQ; Li, WZ; Lv, HL; Gong, ZF; Liu, L				Cheng, Xuebo; Jiang, Huoqing; Li, Weizhe; Lv, Hailong; Gong, Zhefeng; Liu, Li			Ten-a Affects Fusion of Central Complex Primordia in Drosophila	PLOS ONE			English	Article							INTRACELLULAR DOMAIN; LOCOMOTOR-ACTIVITY; GLIAL-CELLS; BRAIN; BODY; ORGANIZATION; ARCHITECTURE; ORIENTATION; TENEURINS; PROTEINS	The central complex of Drosophila melanogaster plays important functions in various behaviors, such as visual and olfactory memory, visual orientation, sleep, and movement control. However little is known about the genes regulating the development of the central complex. Here we report that a mutant gene affecting central complex morphology, cbd (central brain defect), was mapped to ten-a, a type II trans-membrane protein coding gene. Down-regulation of ten-a in pan-neural cells contributed to abnormal morphology of central complex. Over-expression of ten-a by C767-Gal4 was able to partially restore the abnormal central complex morphology in the cbd mutant. Tracking the development of FB primordia revealed that C767-Gal4 labeled interhemispheric junction that separated fan-shaped body precursors at larval stage withdrew to allow the fusion of the precursors. While the C767-Gal4 labeled structure did not withdraw properly and detached from FB primordia, the two fan-shaped body precursors failed to fuse in the cbd mutant. We propose that the withdrawal of C767-Gal4 labeled structure is related to the formation of the fan-shaped body. Our result revealed the function of ten-a in central brain development, and possible cellular mechanism underlying Drosophila fan-shaped body formation.	[Cheng, Xuebo; Jiang, Huoqing; Li, Weizhe; Lv, Hailong; Gong, Zhefeng; Liu, Li] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Cheng, Xuebo] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gong, Zhefeng] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Li] Chinese Acad Sci, Key Lab Mental Hlth, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; Chinese Academy of Sciences	Gong, ZF (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	zfgong@gmail.com; liuli@sun5.ibp.ac.cn		Lv, Hailong/0000-0002-3714-9859	'973 Program' [2009CB918702, 2012CB825504]; National Natural Sciences Foundation of China [31030037, 30921064, 31070944]; External Cooperation Program of the Chinese Academy of Sciences [GJHZ1005]	'973 Program'(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the '973 Program' (2009CB918702, 2012CB825504), the National Natural Sciences Foundation of China (31030037, 30921064 and 31070944), and the External Cooperation Program of the Chinese Academy of Sciences (GJHZ1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; Boyan GS, 2011, TRENDS NEUROSCI, V34, P247, DOI 10.1016/j.tins.2011.02.002; Callaerts P, 2003, DEV BIOL, V259, P464; Carhan A, 2005, GENES BRAIN BEHAV, V4, P449, DOI 10.1111/j.1601-183X.2004.00117.x; Chand D, 2012, NEUROSCIENCE, V219, P255, DOI 10.1016/j.neuroscience.2012.05.069; Chen WT, 2008, DEV NEUROBIOL, V68, P1029, DOI 10.1002/dneu.20644; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Goossens T, 2011, DEVELOPMENT, V138, P1595, DOI 10.1242/dev.052787; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hanesch U, 1987, THESIS U WUERZBURG G; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hitier R, 2000, MECH DEVELOP, V99, P93, DOI 10.1016/S0925-4773(00)00483-4; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9; Kenzelmann D, 2007, CELL MOL LIFE SCI, V64, P1452, DOI 10.1007/s00018-007-7108-9; Kurumaji A, 2001, AM J MED GENET, V105, P99; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Li WZ, 2009, CELL TISSUE RES, V336, P509, DOI 10.1007/s00441-009-0781-2; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Lovejoy DA, 2006, GEN COMP ENDOCR, V148, P299, DOI 10.1016/j.ygcen.2006.01.012; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Minet AD, 2000, GENE, V257, P87, DOI 10.1016/S0378-1119(00)00388-7; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Qian XJ, 2004, GEN COMP ENDOCR, V137, P205, DOI 10.1016/j.ygcen.2004.02.007; Raabe T, 2004, P NATL ACAD SCI USA, V101, P14276, DOI 10.1073/pnas.0405887101; Silies M, 2011, CURR OPIN NEUROBIOL, V21, P11, DOI 10.1016/j.conb.2010.08.011; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Wang LQ, 2005, MOL BRAIN RES, V133, P253, DOI 10.1016/j.molbrainres.2004.10.019; Xiong Y, 2010, FLY, V4, P194, DOI 10.4161/fly.12668; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061; Young JM, 2010, J COMP NEUROL, V518, P1525, DOI 10.1002/cne.22285	41	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57129	10.1371/journal.pone.0057129	http://dx.doi.org/10.1371/journal.pone.0057129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437330	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200221
J	Datta, S; Mukhopadhyay, S				Datta, Sutapa; Mukhopadhyay, Subhasis			A Composite Method Based on Formal Grammar and DNA Structural Features in Detecting Human Polymerase II Promoter Region	PLOS ONE			English	Article							CONTEXT-FREE GRAMMARS; CORE PROMOTER; REGULATORY ELEMENTS; GENE MARKERS; CPG ISLANDS; PREDICTION; RNA; IDENTIFICATION; LANGUAGE; SEQUENCES	An important step in understanding gene regulation is to identify the promoter regions where the transcription factor binding takes place. Predicting a promoter region de novo has been a theoretical goal for many researchers for a long time. There exists a number of in silico methods to predict the promoter region de novo but most of these methods are still suffering from various shortcomings, a major one being the selection of appropriate features of promoter region distinguishing them from non-promoters. In this communication, we have proposed a new composite method that predicts promoter sequences based on the interrelationship between structural profiles of DNA and primary sequence elements of the promoter regions. We have shown that a Context Free Grammar (CFG) can formalize the relationships between different primary sequence features and by utilizing the CFG, we demonstrate that an efficient parser can be constructed for extracting these relationships from DNA sequences to distinguish the true promoter sequences from non-promoter sequences. Along with CFG, we have extracted the structural features of the promoter region to improve upon the efficiency of our prediction system. Extensive experiments performed on different datasets reveals that our method is effective in predicting promoter sequences on a genome-wide scale and performs satisfactorily as compared to other promoter prediction techniques.	[Datta, Sutapa] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; Univ Calcutta, Distributed Informat Ctr Bioinformat, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta	Datta, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India.	sutapadatta2005@gmail.com			Department of Biotechnology, Government of India [BT/BI/04/001/93, BT/BI/10/019/99]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Financial support was received from the Department of Biotechnology, Government of India, grant no. BT/BI/04/001/93 and BT/BI/10/019/99 (http://dbtindia.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3560, DOI 10.1093/nar/gkg570; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Baldi P, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P35; Bianchi D, 1996, P 1 ONL WORKSH SOFT, P113; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; Burden S, 2005, BIOINFORMATICS, V21, P601, DOI 10.1093/bioinformatics/bti047; Cai Y, 2007, BIOINFORMATICS, V23, P2760, DOI 10.1093/bioinformatics/btm446; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Choi CH, 2004, NUCLEIC ACIDS RES, V32, P1584, DOI 10.1093/nar/gkh335; COLLADOVIDES J, 1992, P NATL ACAD SCI USA, V89, P9405, DOI 10.1073/pnas.89.20.9405; Cross SH, 1999, NUCLEIC ACIDS RES, V27, P2099, DOI 10.1093/nar/27.10.2099; Damasevicius R, 2010, NEUROCOMPUTING, V73, P633, DOI 10.1016/j.neucom.2009.09.018; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dyrka W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-323; Florquin K, 2005, NUCLEIC ACIDS RES, V33, P4255, DOI 10.1093/nar/gki737; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gan YL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-4; Gan YL, 2009, BIOINFORMATICS, V25, P2006, DOI 10.1093/bioinformatics/btp359; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goni JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r263; Hannenhalli S, 2001, Bioinformatics, V17 Suppl 1, pS90; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Leung SW, 2001, BIOINFORMATICS, V17, P226, DOI 10.1093/bioinformatics/17.3.226; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Liu RX, 2002, GENOME RES, V12, P462, DOI 10.1101/gr.198002; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Park Hyun-Seok, 2011, Genomics & Informatics, V9, P5; Pedersen AG, 1999, COMPUT CHEM, V23, P191, DOI 10.1016/S0097-8485(99)00015-7; Rivas E, 2000, BIOINFORMATICS, V16, P334, DOI 10.1093/bioinformatics/16.4.334; Rombauts S, 2003, PLANT PHYSIOL, V132, P1162, DOI 10.1104/pp.102.017715; Sakakibara Y, 2005, IEEE T PATTERN ANAL, V27, P1051, DOI 10.1109/TPAMI.2005.140; SAKAKIBARA Y, 1994, NUCLEIC ACIDS RES, V22, P5112, DOI 10.1093/nar/22.23.5112; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Searls DB, 1997, COMPUT APPL BIOSCI, V13, P333; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Sonnenburg S, 2006, BIOINFORMATICS, V22, pE472, DOI 10.1093/bioinformatics/btl250; Tsafnat G, 2011, BIOINFORMATICS, V27, P791, DOI 10.1093/bioinformatics/btr036; Zeng J, 2009, BRIEF BIOINFORM, V10, P498, DOI 10.1093/bib/bbp027	53	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54843	10.1371/journal.pone.0054843	http://dx.doi.org/10.1371/journal.pone.0054843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437045	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200010
J	Erfmeier, A; Hantsch, L; Bruelheide, H				Erfmeier, Alexandra; Hantsch, Lydia; Bruelheide, Helge			The Role of Propagule Pressure, Genetic Diversity and Microsite Availability for Senecio vernalis Invasion	PLOS ONE			English	Article							SPECIES-DIVERSITY; ECOLOGICAL RESISTANCE; GENOTYPIC DIVERSITY; DENSITY-DEPENDENCE; PLANT COMMUNITY; LIFE-HISTORY; SEED DENSITY; BIODIVERSITY; FACILITATION; ECOSYSTEM	Genetic diversity is supposed to support the colonization success of expanding species, in particular in situations where microsite availability is constrained. Addressing the role of genetic diversity in plant invasion experimentally requires its manipulation independent of propagule pressure. To assess the relative importance of these components for the invasion of Senecio vernalis, we created propagule mixtures of four levels of genotype diversity by combining seeds across remote populations, across proximate populations, within single populations and within seed families. In a first container experiment with constant Festuca rupicola density as matrix, genotype diversity was crossed with three levels of seed density. In a second experiment, we tested for effects of establishment limitation and genotype diversity by manipulating Festuca densities. Increasing genetic diversity had no effects on abundance and biomass of S. vernalis but positively affected the proportion of large individuals to small individuals. Mixtures composed from proximate populations had a significantly higher proportion of large individuals than mixtures composed from within seed families only. High propagule pressure increased emergence and establishment of S. vernalis but had no effect on individual growth performance. Establishment was favoured in containers with Festuca, but performance of surviving seedlings was higher in open soil treatments. For S. vernalis invasion, we found a shift in driving factors from density dependence to effects of genetic diversity across life stages. While initial abundance was mostly linked to the amount of seed input, genetic diversity, in contrast, affected later stages of colonization probably via sampling effects and seemed to contribute to filtering the genotypes that finally grew up. In consequence, when disentangling the mechanistic relationships of genetic diversity, seed density and microsite limitation in colonization of invasive plants, a clear differentiation between initial emergence and subsequent survival to juvenile and adult stages is required.	[Erfmeier, Alexandra; Hantsch, Lydia; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Saale, Germany; [Erfmeier, Alexandra; Bruelheide, Helge] German Inst Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg	Erfmeier, A (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Saale, Germany.	alexandra.erfmeier@botanik.uni-halle.de	Erfmeier, Alexandra/C-3381-2013; Erfmeier, Alexandra/L-1986-2016; Bruelheide, Helge/G-3907-2013	Bruelheide, Helge/0000-0003-3135-0356; Erfmeier, Alexandra/0000-0002-1002-9216				Baeten L, 2009, J ECOL, V97, P109, DOI 10.1111/j.1365-2745.2008.01455.x; BERGELSON J, 1993, ECOLOGY, V74, P999, DOI 10.2307/1940470; Brown RL, 2003, OIKOS, V102, P15, DOI 10.1034/j.1600-0706.2003.12191.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Comes HP, 1999, EVOLUTION, V53, P36, DOI [10.2307/2640918, 10.1111/j.1558-5646.1999.tb05331.x]; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Drake JM, 2006, BIOL INVASIONS, V8, P843, DOI 10.1007/s10530-005-4205-2; Duncan RP, 2009, ECOLOGY, V90, P2129, DOI 10.1890/08-1436.1; Erfmeier A, 2011, INT J PLANT SCI, V172, P795, DOI 10.1086/660194; Erfmeier A, 2011, BIOL INVASIONS, V13, P1599, DOI 10.1007/s10530-010-9917-2; Filin I, 2008, AM NAT, V172, P233, DOI 10.1086/589459; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Garcia-Serrano H, 2008, BOTANY, V86, P63, DOI 10.1139/B07-117; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; HARPER JL, 1961, EVOLUTION, V15, P209, DOI 10.2307/2406081; Hegi G, 1928, ILLUSTRIERTE FLORA M, V2; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Jager EJ, 2002, ROTHMALER EXKURSIONS, V2; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Leger EA, 2010, PLANT ECOL, V208, P333, DOI 10.1007/s11258-009-9710-4; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lortie CJ, 2008, OIKOS, V117, P1511, DOI 10.1111/j.0030-1299.2008.16664.x; Lortie CJ, 2002, J ECOL, V90, P435, DOI 10.1046/j.1365-2745.2002.00686.x; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; Marrs RA, 2008, MOL ECOL, V17, P4197, DOI 10.1111/j.1365-294X.2008.03903.x; Meusel H., 1992, VERGLEICHENDE CHOROL, VVolume 3; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Peterson-Smith J, 2010, J TORREY BOT SOC, V137, P287, DOI 10.3159/09-RA-070R1.1; Ramula S, 2009, OIKOS, V118, P1164, DOI 10.1111/j.1600-0706.2009.17595.x; Saccone P, 2010, NEW PHYTOL, V187, P831, DOI 10.1111/j.1469-8137.2010.03289.x; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Sanders NJ, 2010, MOL ECOL, V19, P1079, DOI 10.1111/j.1365-294X.2010.04551.x; *SAS I INC, 2002, SAS WIND SAS 9 2 TS; Schiffers K, 2006, J ECOL, V94, P336, DOI 10.1111/j.1365-2745.2006.01097.x; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Thomsen MA, 2006, ECOL LETT, V9, P160, DOI 10.1111/j.1461-0248.2005.00857.x; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Vellend M, 2006, ECOLOGY, V87, P304, DOI 10.1890/05-0173; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Vellend M, 2010, OECOLOGIA, V162, P371, DOI 10.1007/s00442-009-1480-0; Vellend M, 2009, WEED SCI, V57, P410, DOI 10.1614/WS-09-004.1; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wang XY, 2012, MOL ECOL, V21, P2542, DOI 10.1111/j.1365-294X.2012.05531.x; Warren RJ, 2012, OIKOS, V121, P874, DOI 10.1111/j.1600-0706.2011.20174.x; Weltzin JF, 2003, OIKOS, V103, P505, DOI 10.1034/j.1600-0706.2003.12389.x; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitlock R, 2007, J ECOL, V95, P895, DOI 10.1111/j.1365-2745.2007.01275.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0	69	16	17	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57029	10.1371/journal.pone.0057029	http://dx.doi.org/10.1371/journal.pone.0057029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437301	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200204
J	Lee, HS; Park, CK; Oh, E; Erkin, OC; Jung, HS; Cho, MH; Kwon, MJ; Chae, SW; Kim, SH; Wang, LH; Park, MJ; Lee, SY; Bin Yang, H; Jia, LN; Choi, YL; Shin, YK				Lee, Hun Seok; Park, Cheol-Keun; Oh, Ensel; Erkin, Oezguer Cem; Jung, Hun Soon; Cho, Mi-Hyun; Kwon, Mi Jeong; Chae, Seoung Wan; Kim, Seok-Hyung; Wang, Li-Hui; Park, Min-Jeong; Lee, Su-Yeon; Bin Yang, Ho; Jia, Lina; Choi, Yoon-La; Shin, Young Kee			Low SP1 Expression Differentially Affects Intestinal-Type Compared with Diffuse-Type Gastric Adenocarcinoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP1; ENDOTHELIAL GROWTH-FACTOR; DOWN-REGULATION; FACTOR RECEPTOR; FACTOR FAMILY; CANCER; SURVIVAL; CELL; CARCINOMA; PROTEINS	Specificity protein 1 (SP1) is an essential transcription factor that regulates multiple cancer-related genes. Because aberrant expression of SP1 is related to cancer development and progression, we focused on SP1 expression in gastric carcinoma and its correlation with disease outcomes. Although patient survival decreased as SP1 expression increased (P<0.05) in diffuse-type gastric cancer, the lack of SP1 expression in intestinal-type gastric cancer was significantly correlated with poor survival (P<0.05). The knockdown of SP1 in a high SP1-expressing intestinal-type gastric cell line, MKN28, increased migration and invasion but decreased proliferation. Microarray data in SP1 siRNA-transfected MKN28 revealed that the genes inhibiting migration were downregulated, whereas the genes negatively facilitating proliferation were increased. However, both migration and invasion were decreased by forced SP1 expression in a low SP1-expressing intestinal-type gastric cell line, AGS. Unlike the intestinal-type, in a high SP1-expressing diffuse-type gastric cell line, SNU484, migration and invasion were decreased by SP1 siRNA. In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.	[Lee, Hun Seok; Oh, Ensel; Erkin, Oezguer Cem; Jung, Hun Soon; Cho, Mi-Hyun; Park, Min-Jeong; Lee, Su-Yeon; Bin Yang, Ho; Shin, Young Kee] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Park, Cheol-Keun; Kim, Seok-Hyung; Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Kwon, Mi Jeong] Kyungpook Natl Univ, Coll Pathol, Taegu 702701, South Korea; [Chae, Seoung Wan] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Pathol, Seoul, South Korea; [Wang, Li-Hui; Jia, Lina] Shenyang Pharmaceut Univ, Coll Pharm, Dept Pharmacol, Shenyang, Peoples R China	Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Kyungpook National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Shenyang Pharmaceutical University	Shin, YK (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea.	ykeeshin@snu.ac.kr	Shin, Young Kee/C-8929-2011; Erkin, Özgür Cem/K-9883-2015; Jia, li/GPW-8015-2022; Erkin, Ozgur Cem/ABE-6436-2020; li, jia/GVT-7587-2022	Shin, Young Kee/0000-0003-0896-718X; Erkin, Özgür Cem/0000-0001-9818-3447; Kwon, Mi Jeong/0000-0002-7599-878X	Samsung Medical Center Clinical Research Development Program [SBRI C-A9-213-1]; Global Frontier Project of National Research Foundation [NRF-M1AXA002-2010-0029795]; Ministry of Education, Science and Technology of Korea	Samsung Medical Center Clinical Research Development Program(Samsung); Global Frontier Project of National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by Samsung Medical Center Clinical Research Development Program grant #SBRI C-A9-213-1 and the Global Frontier Project grant (NRF-M1AXA002-2010-0029795) of National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Birchmeier W, 1996, CURR TOP MICROBIOL, V213, P117; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Campanella GSV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012700; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hay R, 1994, ATLAS HUMAN TUMOR CE, Vxii; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2007, CLIN CANCER RES, V13, P2584, DOI 10.1158/1078-0432.CCR-06-1785; MAYER B, 1993, CANCER RES, V53, P1690; Roukos DH, 2002, GASTRIC BREAST CANC, V1, P1; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sankpal UT, 2011, MED CHEM, V7, P518; Sheibani N, 2007, J CELL PHYSIOL, V210, P616, DOI 10.1002/jcp.20858; Shi Q, 2001, CANCER RES, V61, P4143; Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tahara Eiichi, 2004, IARC Sci Publ, P327; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Wang LH, 2007, CLIN CANCER RES, V13, P102, DOI 10.1158/1078-0432.CCR-06-1467; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang LW, 2005, CLIN EXP METASTAS, V22, P205, DOI 10.1007/s10585-005-5684-3; WRIGHT C, 1987, J PATHOL, V153, P325, DOI 10.1002/path.1711530406; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Zhang J, 2005, WORLD J GASTROENTERO, V11, P2213, DOI 10.3748/wjg.v11.i15.2213	33	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55522	10.1371/journal.pone.0055522	http://dx.doi.org/10.1371/journal.pone.0055522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437057	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200019
J	Lei, XH; Bochner, BR				Lei, Xiang-He; Bochner, Barry R.			Using Phenotype MicroArrays to Determine Culture Conditions That Induce or Repress Toxin Production by Clostridium difficile and Other Microorganisms	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; BIOTIN-LIMITED CONDITIONS; PSEUDOMEMBRANOUS COLITIS; COLORIMETRIC ASSAY; ESCHERICHIA-COLI; GENE-EXPRESSION; RHO-PROTEINS; SIGMA-FACTOR; RIBOTYPE 027; INFECTION	Toxin production is a central issue in the pathogenesis of Clostridium difficile and many other pathogenic microorganisms. Toxin synthesis is influenced by a variety of known and unknown factors of genetics, physiology, and environment. To facilitate the study of toxin production by C. difficile, we have developed a new, reliable, quantitative, and robust cell-based cytotoxicity assay. Then we combined this new assay with Phenotype MicroArrays (PM) technology which provides high throughput testing of culture conditions. This allowed us to quantitatively measure toxin production by C. difficile type strain ATCC 9689 under 768 culture conditions. The culture conditions include different carbon, nitrogen, phosphorus, and sulfur sources. Among these, 89 conditions produced strong toxin induction and 31 produced strong toxin repression. Strong toxin inducers included adenine, guanosine, arginine dipeptides, gamma-D-Glu-Gly, methylamine, and others. Some leucine dipeptides and the triple-leucine tripeptide were among the strongest toxin repressors. While some results are consistent with previous observations, others are new observations that provide insights into toxin regulation and pathogenesis of C. difficile. Additionally, we have demonstrated that this combined assay technology can be applied broadly to a wide range of toxin producing microorganisms. This study is the first demonstration of simultaneous assessment of a large number of culture conditions influencing bacterial toxin production. The new functional cytotoxin quantitation method developed provides a valuable tool for studying toxigenic microorganisms and may also find applications in clinical and epidemiological research.	[Lei, Xiang-He; Bochner, Barry R.] Biolog Inc, Hayward, CA 94545 USA		Lei, XH (corresponding author), Biolog Inc, Hayward, CA 94545 USA.	xlei@biolog.com			National Institute of Health (NIH) STTR Grant [GM073965]; Biolog Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R41GM073965, R42GM073965] Funding Source: NIH RePORTER	National Institute of Health (NIH) STTR Grant; Biolog Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Principal funding for the research at Biolog was provided by National Institute of Health (NIH) STTR Grant GM073965. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by Biolog Inc. Xiang-He Lei is employed by Biolog Inc. Barry Bochner is the CEO and CSO of Biolog Inc., has ownership of stock and made the decision to publish the manuscript. Patents 6,271,022, 6,387,651, 6,436,631, 6,472,201, 6,686,173, 6,696,239 and 6,727,076 have been issued to Biolog, Inc., and the Phenotype MicroArrays described in this manuscript are produced and marketed by Biolog, Inc. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. The authors include the names of the patents ( Journal requirement 3) as follows: 6,271,022: Device for Incubating and Monitoring Multiwell Assays; 6,387,651: Comparative Phenotype Analysis of Two or More Microorganisms Using a Plurality of Substrates within a Microwell Device; 6,436,631: Comparative Phenotype Analysis for Assessment of Biological Active Compounds such as Antimicrobials; 6,472,201: Comparative Phenotype Analysis; 6,686,173: Comparative Phenotype Analysis of Two or More Microorganisms Using a Plurality of Substrates within a Multiwell Testing Device; 6,696,239: Comparative Phenotype Analysis for Assessment of Biological Active Compounds such as Antimicrobials; 6,727,076: Comparative Phenotype Analysis.	Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; ARONSSON B, 1981, MED MICROBIOL IMMUN, V170, P27, DOI 10.1007/BF02123794; BARTLETT JG, 1978, GASTROENTEROLOGY, V75, P778; Bochner BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018147; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BONGAERTS GPA, 1994, MICROB PATHOGENESIS, V17, P1, DOI 10.1006/mpat.1994.1047; Bouvet PJM, 2008, J CLIN MICROBIOL, V46, P3703, DOI 10.1128/JCM.00866-08; CHANG TW, 1978, INFECT IMMUN, V20, P526, DOI 10.1128/IAI.20.2.526-529.1978; CHUNG WB, 1993, CAN J VET RES, V57, P159; Cloud J, 2009, CLIN GASTROENTEROL H, V7, P868, DOI 10.1016/j.cgh.2009.05.018; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; CZUPRYNSKI CJ, 1983, INFECT IMMUN, V39, P1368, DOI 10.1128/IAI.39.3.1368-1376.1983; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Dineen SS, 2010, J BACTERIOL, V192, P5350, DOI 10.1128/JB.00341-10; Dupuy B, 2008, J MED MICROBIOL, V57, P685, DOI 10.1099/jmm.0.47775-0; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; FLORIN I, 1981, INFECT IMMUN, V33, P67, DOI 10.1128/IAI.33.1.67-74.1981; Gardiner DM, 2009, MICROBIOL-SGM, V155, P3149, DOI 10.1099/mic.0.029546-0; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; GEORGE WL, 1978, LANCET, V1, P802; Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0; Goldblith S. A., 1961, ANAL HUMAN FECAL COM; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; HAMMOND GA, 1995, MICROB PATHOGENESIS, V19, P203, DOI 10.1016/S0882-4010(95)90263-5; HASLAM SC, 1986, J MED MICROBIOL, V21, P293, DOI 10.1099/00222615-21-4-293; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; JUST I, 1994, J BIOL CHEM, V269, P10706; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Karasawa T, 1997, MICROBIOL IMMUNOL, V41, P581, DOI 10.1111/j.1348-0421.1997.tb01895.x; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; Karlsson S, 1999, MICROBIOL-UK, V145, P1683, DOI 10.1099/13500872-145-7-1683; Karlsson S, 2003, INFECT IMMUN, V71, P1784, DOI 10.1128/IAI.71.4.1784-1793.2003; Karlsson S, 2008, MICROBIOL-SGM, V154, P3430, DOI 10.1099/mic.0.2008/019778-0; KNOOP FC, 1979, INFECT IMMUN, V23, P31, DOI 10.1128/IAI.23.1.31-33.1979; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; KUSHNARYOV VM, 1992, CANCER RES, V52, P5096; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lanis JM, 2012, MOL MICROBIOL, V84, P66, DOI 10.1111/j.1365-2958.2012.08009.x; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Lim PL, 2011, SINGAP MED J, V52, P361; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; MacCannell DR, 2006, J CLIN MICROBIOL, V44, P2147, DOI 10.1128/JCM.02563-05; Maegavva T, 2002, J MED MICROBIOL, V51, P34, DOI 10.1099/0022-1317-51-1-34; Mahida YR, 1996, GUT, V38, P337, DOI 10.1136/gut.38.3.337; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mullan N, 2011, INFECT IMMUN, V79, P1623, DOI 10.1128/IAI.00686-10; Murray R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-103; OSGOOD DP, 1993, APPL ENVIRON MICROB, V59, P3985, DOI 10.1128/AEM.59.12.3985-3988.1993; Planche T, 2011, J CLIN PATHOL, V64, P1, DOI 10.1136/jcp.2010.080135; Puri AW, 2010, CHEM BIOL, V17, P1201, DOI 10.1016/j.chembiol.2010.09.011; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; ROTHMAN SW, 1986, J CLIN PATHOL, V39, P672, DOI 10.1136/jcp.39.6.672; ROTHMAN SW, 1984, INFECT IMMUN, V46, P324, DOI 10.1128/IAI.46.2.324-331.1984; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2010, METHODS MOL BIOL, V646, P67, DOI 10.1007/978-1-60327-365-7_5; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryder AB, 2010, J CLIN MICROBIOL, V48, P4129, DOI 10.1128/JCM.01104-10; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Savidge TC, 2011, NAT MED, V17, P1136, DOI 10.1038/nm.2405; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Singh MP, 2009, J MICROBIOL METH, V77, P102, DOI 10.1016/j.mimet.2009.01.014; Sirard S, 2011, J CLIN MICROBIOL, V49, P4040, DOI 10.1128/JCM.05053-11; Songer JG, 2006, ANAEROBE, V12, P1, DOI 10.1016/j.anaerobe.2005.09.001; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2010, GUT MICROBES, V1, P269, DOI 10.4161/gmic.1.4.11870; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Tae CH, 2009, J KOREAN MED SCI, V24, P520, DOI 10.3346/jkms.2009.24.3.520; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Verdoorn BP, 2010, DIAGN MICR INFEC DIS, V66, P24, DOI 10.1016/j.diagmicrobio.2009.08.015; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003; WILSON KH, 1986, J INFECT DIS, V153, P547, DOI 10.1093/infdis/153.3.547; WILSON KH, 1986, INFECT IMMUN, V54, P354, DOI 10.1128/IAI.54.2.354-358.1986; WILSON KH, 1988, INFECT IMMUN, V56, P2610, DOI 10.1128/IAI.56.10.2610-2614.1988; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012; Wolff D, 2009, EUR J CLIN MICROBIOL, V28, P959, DOI 10.1007/s10096-009-0731-7; Yamakawa K, 1996, J MED MICROBIOL, V44, P111, DOI 10.1099/00222615-44-2-111; Yamakawa K, 1998, J MED MICROBIOL, V47, P767, DOI 10.1099/00222615-47-9-767; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192	93	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56545	10.1371/journal.pone.0056545	http://dx.doi.org/10.1371/journal.pone.0056545			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437164	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200102
J	Martinez-Haro, M; Taggart, MA; Lefranc, H; Martin-Doimeadios, RC; Green, AJ; Mateo, R				Martinez-Haro, Monica; Taggart, Mark A.; Lefranc, Hugues; Martin-Doimeadios, Rosa C.; Green, Andy J.; Mateo, Rafael			Monitoring of Pb Exposure in Waterfowl Ten Years after a Mine Spill through the Use of Noninvasive Sampling	PLOS ONE			English	Article							MASSIVE SULFIDE DEPOSITS; STORKS CICONIA-CICONIA; IBERIAN PYRITE BELT; LEAD-EXPOSURE; HEAVY-METALS; SEDIMENT INGESTION; TAILING ACCIDENT; OXIDATIVE STRESS; GUADIAMAR RIVER; TRACE-ELEMENTS	Lead exposure in waterfowl was studied using noninvasive fecal sampling in the Guadalquivir Marshes in Spain, an area affected by the 1998 Aznalcollar mine disaster. Feces of greylag geese (Anser anser, n = 191) and purple gallinule (Porphyrio porphyrio, n = 91) were collected from three different impacted sites (Entremuros, Caracoles and Cerro de los Ansares) during the winters of 2004 to 2008. Lead and aluminium (an indicator of sediment ingestion) and Pb isotope signatures (to discriminate between sources of Pb exposure) were analyzed in freeze-dried, acid digested samples. The concentrations of fecal porphyrins and biliverdin were determined as noninvasive biomarkers to study Pb exposure effects. Results showed a decrease in Pb exposure over time in wintering greylag geese. In contrast, for purple gallinule resident in the Entremuros a clear trend was not evident. For both species, sediment ingestion appeared to be the main source of exposure to Pb. In the Entremuros, some samples from purple gallinule were detected with higher Pb levels than expected for simple soil ingestion, and these had Pb isotopic profiles compatible with mining sludge or Pb shot. Whilst fecal Pb isotopic profiles were effective in differentiating between samples from sites with different levels and sources of pollution, the combined use of element ratios (such as Pb/Al) and other non-traditional stable isotope signatures may also prove worthwhile. Overall, the fecal Pb levels detected were below those described in feces for waterfowl from other uncontaminated areas(<10 mu g/g d.w.). Despite this, for both species fecal Pb levels were positively correlated with porphyrin excretion, and for purple gallinule, with the coproporphyrin III/I ratio, suggesting some subtle effects on heme synthesis in birds. Ten years after the mine spill, Pb contamination in birds by this pollution source was still detectable and subtlethal effects may persist.	[Martinez-Haro, Monica; Taggart, Mark A.; Mateo, Rafael] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain; [Martinez-Haro, Monica; Lefranc, Hugues; Green, Andy J.] Estn Biol Donana EBD CSIC, Dept Wetland Ecol, Seville, Spain; [Taggart, Mark A.] Univ Highlands & Isl, ERI, Thurso, Scotland; [Martin-Doimeadios, Rosa C.] Univ Castilla La Mancha, Fac Environm Sci & Biochem, Dept Analyt Chem & Food Technol, Toledo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UHI Millennium Institute; Universidad de Castilla-La Mancha	Martinez-Haro, M (corresponding author), Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain.	monica.martinezharo@gmail.com	Green, Andy J/A-5189-2008; Martín-Doimeadios, Rosa C. Rodriguez/L-3354-2014; Martinez-Haro, Mónica/B-8363-2015; Mateo, Rafael/A-3117-2011; Mateo, Rafael/AAU-1480-2020	Green, Andy J/0000-0002-1268-4951; Martín-Doimeadios, Rosa C. Rodriguez/0000-0001-6922-6460; Martinez-Haro, Mónica/0000-0002-4326-5805; Mateo, Rafael/0000-0003-1307-9152; Mateo, Rafael/0000-0003-1307-9152; Taggart, Mark/0000-0002-0649-8490	Consejeria, de Medio Ambiente, Junta de Andalucia; MICINN [CGL2007-62797]; Portuguese Foundation for Science and Technology (FCT); European Social Fund; POPH programme;  [SFRH/BPD/73890/2010]	Consejeria, de Medio Ambiente, Junta de Andalucia(Junta de Andalucia); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); POPH programme; 	M. Martinez-Haro was supported by a project funded by the Consejeria, de Medio Ambiente, Junta de Andalucia, under a CSIC contract. This study was also funded by MICINN (under CGL2007-62797). Currently, M. Martinez-Haro is supported by a postdoctoral grant (Ref: SFRH/BPD/73890/2010) funded by the Portuguese Foundation for Science and Technology (FCT) the European Social Fund and POPH programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2012, J ANIM ECOL, V81, P1113, DOI 10.1111/j.1365-2656.2012.01972.x; Almodovar GR, 1998, MINER DEPOSITA, V33, P111; AMAT JA, 1991, ARDEA, V79, P271; Amat JA, 2008, WATERBIRDS, V31, P133, DOI 10.1675/1524-4695(2008)31[133:GIASCO]2.0.CO;2; Badosa A, 2010, HYDROBIOLOGIA, V654, P67, DOI 10.1007/s10750-010-0370-0; Baos R, 2006, ENVIRON TOXICOL CHEM, V25, P2794, DOI 10.1897/05-570R.1; Baos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034716; Benito V, 1999, SCI TOTAL ENVIRON, V242, P309, DOI 10.1016/S0048-9697(99)00398-8; Beyer WN, 1999, SCI TOTAL ENVIRON, V231, P235; Beyer WN, 2000, ECOTOXICOLOGY, V9, P207, DOI 10.1023/A:1008998821913; BEYER WN, 1994, J WILDLIFE MANAGE, V58, P375, DOI 10.2307/3809405; Beyer WN, 1998, ENVIRON TOXICOL CHEM, V17, P2298, DOI [10.1897/1551-5028(1998)017&lt;2298:ROLETS&gt;2.3.CO;2, 10.1002/etc.5620171121]; Beyer WN, 1997, ECOTOXICOLOGY, V6, P181; Beyer WN, 1998, J ENVIRON QUAL, V27, P1533, DOI 10.2134/jeq1998.00472425002700060033x; BURTON BA, 1979, J WILDLIFE MANAGE, V43, P728, DOI 10.2307/3808751; Cabrera F, 1999, SCI TOTAL ENVIRON, V242, P117, DOI 10.1016/S0048-9697(99)00379-4; Carlisle MC, 2004, LEAD POISONING SPANI; Casini S, 2003, ECOTOXICOLOGY, V12, P297, DOI 10.1023/A:1022519214505; Chanton JP, 2008, ENVIRON SCI TECHNOL, V42, P655, DOI 10.1021/es0870855; Galan E, 2002, SCI TOTAL ENVIRON, V286, P167, DOI 10.1016/S0048-9697(01)00974-3; Gomez G, 2004, ARCH ENVIRON CON TOX, V47, P521, DOI 10.1007/s00244-004-0189-z; Goyer R.A., 2001, CASARETT DOULLS TOXI, P811; Grimalt JO, 1999, SCI TOTAL ENVIRON, V242, P3, DOI 10.1016/S0048-9697(99)00372-1; Hahn S, 2008, FRESHWATER BIOL, V53, P181, DOI 10.1111/j.1365-2427.2007.01881.x; Hansel CM, 2001, ENVIRON SCI TECHNOL, V35, P3863, DOI 10.1021/es0105459; Hernandez LM, 1999, SCI TOTAL ENVIRON, V242, P293, DOI 10.1016/S0048-9697(99)00397-6; Karasov W.H., 1990, Studies in Avian Biology, P391; Leistel JM, 1998, MINER DEPOSITA, V33, P2; Lopez-Pamo E, 1999, SCI TOTAL ENVIRON, V242, P57, DOI 10.1016/S0048-9697(99)00376-9; Madejon P, 2006, CHEMOSPHERE, V64, P742, DOI 10.1016/j.chemosphere.2005.11.032; Marquez-Ferrando R, 2009, ARCH ENVIRON CON TOX, V56, P276, DOI 10.1007/s00244-008-9189-3; Martinez-Haro M, 2010, ENVIRON POLLUT, V158, P2485, DOI 10.1016/j.envpol.2010.03.018; Martinez-Haro M, 2011, ENVIRON SCI TECHNOL, V45, P6153, DOI 10.1021/es2009242; Martinez-Haro M, 2011, ENVIRON RES, V111, P530, DOI 10.1016/j.envres.2011.02.012; Mateo R, 2007, ECOTOX ENVIRON SAFE, V66, P119, DOI 10.1016/j.ecoenv.2005.12.010; Mateo R, 2006, ENVIRON TOXICOL CHEM, V25, P203, DOI 10.1897/04-460R.1; Mateo R, 2004, J CHROMATOGR B, V810, P305, DOI 10.1016/j.jchromb.2004.08.019; Mateo R, 2003, J TOXICOL ENV HEAL A, V66, P1371, DOI 10.1080/15287390306390; Mateo R, 1998, ARCH ENVIRON CON TOX, V35, P342, DOI 10.1007/s002449900385; Mateo R, 2000, ECOTOXICOLOGY ENV RE, V3, P76; Mayhew Peter W., 1993, Wildfowl, V44, P174; Meharg AA, 2002, SCI TOTAL ENVIRON, V300, P81, DOI 10.1016/S0048-9697(02)00283-8; Meharg AA, 1999, ENVIRON POLLUT, V105, P387, DOI 10.1016/S0269-7491(99)00033-0; Pain DJ, 1998, SCI TOTAL ENVIRON, V222, P45, DOI 10.1016/S0048-9697(98)00290-3; Prat N, 1999, SCI TOTAL ENVIRON, V242, P231, DOI 10.1016/S0048-9697(99)00393-9; Quarterman J, 1986, TRACE ELEMENTS HUMAN, P281; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Rodriguez R., 1975, Doiiana Acta vert, V2, P201; Sakai T, 2000, IND HEALTH, V38, P127, DOI 10.2486/indhealth.38.127; Scheuhammer AM, 1998, ECOTOXICOLOGY, V7, P37, DOI 10.1023/A:1008855617453; Simon M, 2008, SCI TOTAL ENVIRON, V407, P23, DOI 10.1016/j.scitotenv.2008.07.040; Simon M, 2009, WATER AIR SOIL POLL, V198, P77, DOI 10.1007/s11270-008-9827-4; Sola C, 2004, SCI TOTAL ENVIRON, V333, P109, DOI 10.1016/j.scitotenv.2004.05.011; Svanberg F, 2006, SCI TOTAL ENVIRON, V370, P416, DOI 10.1016/j.scitotenv.2006.07.006; Taggart MA, 2009, ENVIRON POLLUT, V157, P946, DOI 10.1016/j.envpol.2008.10.020; Taggart MA, 2006, ENVIRON RES, V100, P349, DOI 10.1016/j.envres.2005.07.009; Taggart MA, 2004, SCI TOTAL ENVIRON, V323, P137, DOI 10.1016/j.scitotenv.2003.10.008	57	16	16	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57295	10.1371/journal.pone.0057295	http://dx.doi.org/10.1371/journal.pone.0057295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437364	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200239
J	Mattii, L; Ippolito, C; Segnani, C; Battolla, B; Colucci, R; Dolfi, A; Bassotti, G; Blandizzi, C; Bernardini, N				Mattii, Letizia; Ippolito, Chiara; Segnani, Cristina; Battolla, Barbara; Colucci, Rocchina; Dolfi, Amelio; Bassotti, Gabrio; Blandizzi, Corrado; Bernardini, Nunzia			Altered Expression Pattern of Molecular Factors Involved in Colonic Smooth Muscle Functions: An Immunohistochemical Study in Patients with Diverticular Disease	PLOS ONE			English	Article							INTERSTITIAL-CELLS; NITRIC-OXIDE; CONNEXIN PHOSPHORYLATION; ULCERATIVE-COLITIS; GAP-JUNCTION; RHO-GTPASES; MOTILITY; ACTIN; CAJAL; ABNORMALITIES	Background: The pathogenesis of diverticular disease (DD) is thought to result from complex interactions among dietary habits, genetic factors and coexistence of other bowel abnormalities. These conditions lead to alterations in colonic pressure and motility, facilitating the formation of diverticula. Although electrophysiological studies on smooth muscle cells (SMCs) have investigated colonic motor dysfunctions, scarce attention has been paid to their molecular abnormalities, and data on SMCs in DD are lacking. Accordingly, the main purpose of this study was to evaluate the expression patterns of molecular factors involved in the contractile functions of SMCs in the tunica muscularis of colonic specimens from patients with DD. Methods and Findings: By means of immunohistochemistry and image analysis, we examined the expression of Cx26 and Cx43, which are prominent components of gap junctions in human colonic SMCs, as well as pS368-Cx43, PKCps, RhoA and alpha SMA, all known to regulate the functions of gap junctions and the contractile activity of SMCs. The immunohistochemical analysis revealed significant abnormalities in DD samples, concerning both the expression and distribution patterns of most of the investigated molecular factors. Conclusion: This study demonstrates, for the first time, that an altered pattern of factors involved in SMC contractility is present at level of the tunica muscularis of DD patients. Moreover, considering that our analysis was conducted on colonic tissues not directly affected by diverticular lesions or inflammatory reactions, it is conceivable that these molecular alterations may precede and predispose to the formation of diverticula, rather than being mere consequences of the disease.	[Mattii, Letizia; Ippolito, Chiara; Segnani, Cristina; Battolla, Barbara; Dolfi, Amelio; Bernardini, Nunzia] Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embriol, Pisa, Italy; [Colucci, Rocchina; Blandizzi, Corrado] Univ Pisa, Dept Clin & Expt Med, Pharmacol Unit, Pisa, Italy; [Bassotti, Gabrio] Univ Perugia, Dept Clin & Expt Med, Unit Gastroenterol & Hepatol, I-06100 Perugia, Italy	University of Pisa; University of Pisa; University of Perugia	Mattii, L (corresponding author), Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embriol, Pisa, Italy.	letizia.mattii@med.unipi.it	Blandizzi, Corrado/AAB-8736-2019; mattii, letizia/K-3023-2019; Bernardini, Nunzia/AAC-4602-2021; Mattii, Letizia/AAZ-4735-2021; MATTII, LETIZIA/B-6123-2018	MATTII, LETIZIA/0000-0001-6835-7987; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; BERNARDINI, NUNZIA/0000-0001-9061-9402; BLANDIZZI, CORRADO/0000-0001-9927-5386; Ippolito, Chiara/0000-0001-8671-313X	Interdepartmental Centre for research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa	Interdepartmental Centre for research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa	This work is partially supported by the Interdepartmental Centre for research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen V, 2006, J HISTOCHEM CYTOCHEM, V54, P795, DOI 10.1369/jhc.5A6839.2006; Aronica E, 2001, ACTA NEUROPATHOL, V101, P449; Bassotti G, 2005, CLIN GASTROENTEROL H, V3, P248, DOI 10.1016/S1542-3565(04)00614-7; Bassotti G, 2005, J CLIN PATHOL, V58, P973, DOI 10.1136/jcp.2005.026112; Bassotti G, 2011, TECH COLOPROCTOL, V15, P371, DOI 10.1007/s10151-011-0721-5; Bassotti G, 1999, AM J GASTROENTEROL, V94, P1760; BASSOTTI G, 1995, INT J COLORECTAL DIS, V10, P173, DOI 10.1007/BF00298543; Bassotti G, 2003, WORLD J GASTROENTERO, V9, P2140; Bassotti G, 2001, DIS COLON RECTUM, V44, P1814, DOI 10.1007/BF02234460; Bassotti G, 2012, DIGEST DIS, V30, P24, DOI 10.1159/000335702; Bernardini N, 2012, J CELL MOL MED, V16, P318, DOI 10.1111/j.1582-4934.2011.01298.x; Bivi N, 2011, J CELL BIOCHEM, V112, P2920, DOI 10.1002/jcb.23208; Derangeon M, 2008, J BIOL CHEM, V283, P30754, DOI 10.1074/jbc.M801556200; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Fornai M, 2007, BRIT J PHARMACOL, V151, P1246, DOI 10.1038/sj.bjp.0707339; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2006, HISTOCHEM CELL BIOL, V126, P537, DOI 10.1007/s00418-006-0190-5; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jee H, 2001, DIGEST DIS SCI, V56, P1323; Kanczuga-Koda L, 2004, FOLIA HISTOCHEM CYTO, V42, P203; Kanczuga-Koda L, 2010, IN VIVO, V24, P101; Knowles CH, 2004, GUT, V53, P1583, DOI 10.1136/gut.2003.037275; Knowles CH, 2009, ACTA NEUROPATHOL, V118, P271, DOI 10.1007/s00401-009-0527-y; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Liu L, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2011.01685.x; Liu L, 2002, J PHARMACOL EXP THER, V302, P627, DOI 10.1124/jpet.102.034702; Liu L, 2011, NEUROGASTROENT MOTIL, V23, pe179; Matrana Marc R, 2009, Clin Colon Rectal Surg, V22, P141, DOI 10.1055/s-0029-1236157; Mattii L, 2005, LEUKEMIA RES, V29, P1285, DOI 10.1016/j.leukres.2005.04.011; Mattii L, 2004, J CELL BIOCHEM, V93, P1231, DOI 10.1002/jcb.20248; Mattii L, 2011, LEUKEMIA RES, V35, P265, DOI 10.1016/j.leukres.2010.05.027; Ohama T, 2008, J GASTROENTEROL, V43, P858, DOI 10.1007/s00535-008-2241-2; Olbina G, 2003, MOL CANCER RES, V1, P690; Rattan S, 2010, GASTROENTEROLOGY, V138, P13, DOI 10.1053/j.gastro.2009.11.016; Richards RJ, 2002, DIGEST DIS SCI, V47, P1903, DOI 10.1023/A:1019624101225; Salem L, 2004, J AM COLL SURGEONS, V199, P904, DOI 10.1016/j.jamcollsurg.2004.07.029; Sanders KM, 2006, J PHYSIOL-LONDON, V576, P721, DOI 10.1113/jphysiol.2006.115279; Sarna SK., 2010, COLONIC MOTILITY BEN, DOI 10.4199/C00020ED1V01Y201011ISP011; Straub AC, 2010, J VASC RES, V47, P277, DOI 10.1159/000265562; Takahashi A, 2005, J GASTROENTEROL, V40, P1043, DOI 10.1007/s00535-005-1688-7; ter Beek WP, 2008, INFLAMM BOWEL DIS, V14, P612, DOI 10.1002/ibd.20364; Tomita R, 2000, HEPATO-GASTROENTEROL, V47, P692; Wedel T, 2006, NEUROGASTROENT MOTIL, V18, P526, DOI 10.1111/j.1365-2982.2006.00781.x; Wedel T, 2010, NEUROGASTROENT MOTIL, V22, P407, DOI 10.1111/j.1365-2982.2009.01445.x	49	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57023	10.1371/journal.pone.0057023	http://dx.doi.org/10.1371/journal.pone.0057023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437299	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200202
J	Mondal, P; Datta, S; Maiti, GP; Baral, A; Jha, GN; Panda, CK; Chowdhury, S; Ghosh, S; Roy, B; Roychoudhury, S				Mondal, Pinaki; Datta, Sayantan; Maiti, Guru Prasad; Baral, Aradhita; Jha, Ganga Nath; Panda, Chinmay Kumar; Chowdhury, Shantanu; Ghosh, Saurabh; Roy, Bidyut; Roychoudhury, Susanta			Comprehensive SNP Scan of DNA Repair and DNA Damage Response Genes Reveal Multiple Susceptibility Loci Conferring Risk to Tobacco Associated Leukoplakia and Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; PROTEIN-KINASE; COMMON VARIANTS; INDIAN POPULATION; NECK-CANCER; POLYMORPHISMS; HEAD; EXPRESSION; MODULATE; ATM	Polymorphic variants of DNA repair and damage response genes play major role in carcinogenesis. These variants are suspected as predisposition factors to Oral Squamous Cell Carcinoma (OSCC). For identification of susceptible variants affecting OSCC development in Indian population, the "maximally informative'' method of SNP selection from HapMap data to non-HapMap populations was applied. Three hundred twenty-five SNPs from 11 key genes involved in double strand break repair, mismatch repair and DNA damage response pathways were genotyped on a total of 373 OSCC, 253 leukoplakia and 535 unrelated control individuals. The significantly associated SNPs were validated in an additional cohort of 144 OSCC patients and 160 controls. The rs12515548 of MSH3 showed significant association with OSCC both in the discovery and validation phases (discovery P-value: 1.43E-05, replication P-value: 4.84E-03). Two SNPs (rs12360870 of MRE11A, P-value: 2.37E-07 and rs7003908 of PRKDC, P-value: 7.99E-05) were found to be significantly associated only with leukoplakia. Stratification of subjects based on amount of tobacco consumption identified SNPs that were associated with either high or low tobacco exposed group. The study reveals a synergism between associated SNPs and lifestyle factors in predisposition to OSCC and leukoplakia.	[Mondal, Pinaki; Roychoudhury, Susanta] Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India; [Datta, Sayantan; Ghosh, Saurabh; Roy, Bidyut] Indian Stat Inst, Human Genet Unit, Kolkata, W Bengal, India; [Maiti, Guru Prasad; Panda, Chinmay Kumar] Chittaranjan Natl Canc Inst, Kolkata, W Bengal, India; [Baral, Aradhita; Chowdhury, Shantanu] Inst Genom & Integrat Biol, CSIR, Prote & Struct Biol Unit, New Delhi, India; [Jha, Ganga Nath] Vinoba Bhave Univ, Dept Anthropol, Hazaribagh, Bihar, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Indian Statistical Institute; Indian Statistical Institute Kolkata; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Vinoba Bhave University	Roychoudhury, S (corresponding author), Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India.	susantarc@gmail.com	Roychoudhury, Susanta/AAD-7946-2021; Mondal, Pinaki/AAB-8998-2022; Maiti, Prasad/M-7729-2014	Maiti, Prasad/0000-0003-1936-363X	Department of Biotechnology [BT/PR/5524/Med/14/649/2004, BT/01/COE/05/04]	Department of Biotechnology	This study was supported in part by Department of Biotechnology Grants BT/PR/5524/Med/14/649/2004 and BT/01/COE/05/04. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Anantharaman D, 2011, ORAL ONCOL, V47, P866, DOI 10.1016/j.oraloncology.2011.06.015; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; BANNISTER AJ, 1993, NUCLEIC ACIDS RES, V21, P1289, DOI 10.1093/nar/21.5.1289; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Bau DT, 2010, LARYNGOSCOPE, V120, P2417, DOI 10.1002/lary.21009; Belitsky GA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P543, DOI 10.1134/S0006297908050076; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt SI, 2007, INT J CANCER, V120, P1548, DOI 10.1002/ijc.22510; Brahmachari SK, 2008, J GENET, V87, P3; Bujalkova M, 2008, CLIN CHEM, V54, P1844, DOI 10.1373/clinchem.2008.108902; Castrilli G, 2002, J ORAL PATHOL MED, V31, P234, DOI 10.1034/j.1600-0714.2002.310407.x; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; Demsar J, 2004, ORANGE EXPT MACHINE; Dhillon VS, 2011, MUTAGENESIS, V26, P33, DOI 10.1093/mutage/geq076; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Dong XQ, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2010-0127; Efimova EV, 2008, CANCER RES, V70, P6277; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Farnebo L, 2009, INT J MOL MED, V24, P549, DOI 10.3892/ijmm_00000264; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furness S, 2010, COCHRANE DB SYST REV, P1; Gangwar R, 2009, MUTAT RES-GEN TOX EN, V680, P56, DOI 10.1016/j.mrgentox.2009.09.008; Hine CM, 2008, P NATL ACAD SCI USA, V105, P20810, DOI 10.1073/pnas.0807990106; Hoffmann M, 2009, ONCOL REP, V21, P809, DOI 10.3892/or_00000288; IIJIMA S, 1992, EUR J BIOCHEM, V206, P595, DOI 10.1111/j.1432-1033.1992.tb16964.x; Jakulin A, 2003, LECT NOTES ARTIFICIA, V2838; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Koessler T, 2008, GUT, V57, P1097, DOI 10.1136/gut.2007.137265; Kolodner RD, 2000, NATURE, V407, P687, DOI 10.1038/35037701; Kumar A, 2012, MUTAT RES-FUND MOL M, V729, P24, DOI 10.1016/j.mrfmmm.2011.09.001; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Majumder M, 2007, INT J CANCER, V120, P2148, DOI 10.1002/ijc.22547; Mandal RK, 2010, DNA CELL BIOL, V29, P669, DOI 10.1089/dna.2010.1047; Mangoni M, 2010, INT J RAD ONCOL BIOL; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; MICHALSKI RS, 1983, ARTIF INTELL, V20, P111, DOI 10.1016/0004-3702(83)90016-4; Misra C, 2009, MOL CARCINOGEN, V48, P790, DOI 10.1002/mc.20523; Mitra AK, 2011, INDIAN J MED RES, V133, P605; Mitra AK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-104; Mitra S, 2005, INT J CANCER, V117, P786, DOI 10.1002/ijc.21263; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Mukherjee S, 2012, J ORAL PATHOL MED, V41, P292, DOI 10.1111/j.1600-0714.2011.01097.x; Mukherjee Sanjit, 2011, Indian J Dent Res, V22, P735, DOI 10.4103/0970-9290.93475; Narang A, 2011, AM J HUM GENET, V89, P111, DOI 10.1016/j.ajhg.2011.06.004; Picelli S, 2010, EUR J CANCER, V46, P1041, DOI 10.1016/j.ejca.2010.01.013; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; [Registrar General of India Centre for Global Health Research Ministry of Home Affairs], 2009, CAUS DEATH IND 2001; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sarkar-Roy N, 2011, INT J DATA MIN BIOIN, V5, P706, DOI 10.1504/IJDMB.2011.045418; Sengupta S, 2007, CANCER-AM CANCER SOC, V109, P703, DOI 10.1002/cncr.22430; Song HL, 2006, CARCINOGENESIS, V27, P2235, DOI 10.1093/carcin/bgl089; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang J, 2010, PLOS GENET, V6; WHO Tobacco Free Initiative, 2011, WHO CRIT IMP ANT HUM, P38; Wrangle JM, 2007, CURR OPIN ONCOL, V19, P180, DOI 10.1097/CCO.0b013e3280f01026; Zhou F, 2011, J HUAZHONG U SCI-MED, V31, P154, DOI 10.1007/s11596-011-0242-5	69	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56952	10.1371/journal.pone.0056952	http://dx.doi.org/10.1371/journal.pone.0056952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437280	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200190
J	Murthy, S; Wu, M; Bai, VU; Hou, ZZ; Menon, M; Barrack, ER; Kim, SH; Reddy, GPV				Murthy, Shalini; Wu, Min; Bai, V. Uma; Hou, Zizheng; Menon, Mani; Barrack, Evelyn R.; Kim, Sahn-Ho; Reddy, G. Prem-Veer			Role of Androgen Receptor in Progression of LNCaP Prostate Cancer Cells from G(1) to S Phase	PLOS ONE			English	Article							DNA-REPLICATION; CYCLE PROGRESSION; GROWTH-INHIBITION; HUMAN-CHROMOSOMES; TRANSCRIPTION; RNA; COMPLEX; PROLIFERATION; CASTRATION; CDC6	Background: The androgen receptor (AR) plays a critical role in the proliferation of prostate cancer cells. However, its mechanism of action in proliferation remains unknown. An understanding of the mechanism of AR action in proliferation may lead to the development of effective strategies for the treatment of prostate cancer. Methodology/Principal Findings: In this study we report that pulse treatment of synchronized LNCaP cells with Casodex, an AR-antagonist, for 4 hours in mid-G(1) phase was sufficient to prevent cells from entering S phase. Since the assembly of pre-replication complex (pre-RC) in G(1) is required for the progression of cells from G(1) to S phase, the effect of Casodex during mid-G(1) suggested that the role of AR in proliferation might be to regulate the assembly of pre-RC. To test this possibility, we investigated the interaction between AR and Cdc6, an essential component of pre-RC in LNCaP cells. AR co-localized and co-immunoprecipitated with Cdc6, and Casodex treatment disrupted this interaction. AR-immunoprecipitate (AR-IP) also contained cyclin E and cyclin A, which play a critical role in pre-RC assembly and cell cycle entry into S phase, and DNA polymerase-alpha, PCNA, and ribonucleotide reductase, which are essential for the initiation of DNA synthesis. In addition, in cells in S phase, AR co-sedimented with components of the DNA replication machinery of cells that entered S phase. Conclusions/Significance: Together, these observations suggest a novel role of AR as a component of the pre-RC to exert control over progression of LNCaP cells from G(1) to S phase through a mechanism that is independent of its role as a transcription factor.	[Murthy, Shalini; Wu, Min; Bai, V. Uma; Hou, Zizheng; Menon, Mani; Barrack, Evelyn R.; Kim, Sahn-Ho; Reddy, G. Prem-Veer] Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Reddy, GPV (corresponding author), Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48202 USA.	preddy1@hfhs.org		Murthy, Shalini/0000-0001-5517-9894	Department of Defense [W81XWH-05-1-0071]	Department of Defense(United States Department of Defense)	This work was supported in part by grant W81XWH-05-1-0071 from the Department of Defense to GPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JT, 2007, PROSTATE, V67, P1152, DOI 10.1002/pros.20585; Bai VU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034875; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Carter MF, 1972, FETSCHRIFT UROLOGICA, P27; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cifuentes E, 2004, P NATL ACAD SCI USA, V101, P464, DOI 10.1073/pnas.0307161101; Cifuentes E, 2003, J CELL PHYSIOL, V195, P337, DOI 10.1002/jcp.10317; Compagno D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001006; D'Antonio JM, 2009, ENDOCR-RELAT CANCER, V16, P325, DOI 10.1677/ERC-08-0205; Dai HQ, 2009, J CELL BIOCHEM, V106, P798, DOI 10.1002/jcb.22015; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Frouin I, 2003, EMBO REP, V4, P666, DOI 10.1038/sj.embor.embor886; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; Huggins C, 2002, J UROLOGY, V167, P948, DOI 10.1016/S0022-5347(02)80307-X; JAUMOT M, 1994, BIOCHEM BIOPH RES CO, V203, P1527, DOI 10.1006/bbrc.1994.2359; Jin F, 2009, NUCLEIC ACIDS RES, V37, P4826, DOI 10.1093/nar/gkp510; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Koochekpour S, 2007, PROSTATE, V67, P178, DOI 10.1002/pros.20513; Lee ECY, 2003, CELL DEATH DIFFER, V10, P761, DOI 10.1038/sj.cdd.4401228; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Mendoza-Maldonado R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013720; Murthy S, 2006, J CELL PHYSIOL, V209, P711, DOI 10.1002/jcp.20842; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Quero L, 2010, PROSTATE, V70, P401, DOI 10.1002/pros.21074; Reddy G P, 1993, Crit Rev Eukaryot Gene Expr, V3, P255; Reddy G.P., 2004, CELL CYCLE GROWTH CO, P149; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; Ricciardelli C, 2005, PROSTATE, V63, P19, DOI 10.1002/pros.20154; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; Sathya G, 2003, CANCER RES, V63, P8029; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shi YK, 2008, AM J PATHOL, V173, P1758, DOI 10.2353/ajpath.2008.080363; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sivanandam A, 2010, CURR PROTEIN PEPT SC, V11, P451, DOI 10.2174/138920310791824075; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Snyder M, 2009, J BIOL CHEM, V284, P13466, DOI 10.1074/jbc.M809471200; SUBRAMANYAM C, 1990, J CELL PHYSIOL, V144, P423, DOI 10.1002/jcp.1041440309; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; YUNIS JJ, 1977, CHROMOSOMA, V61, P335, DOI 10.1007/BF00288617; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhan P, 2002, J STEROID BIOCHEM, V83, P101, DOI 10.1016/S0960-0760(02)00275-3	49	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56692	10.1371/journal.pone.0056692	http://dx.doi.org/10.1371/journal.pone.0056692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437213	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200143
J	Schuettengruber, B; Cavalli, G				Schuettengruber, Bernd; Cavalli, Giacomo			Polycomb Domain Formation Depends on Short and Long Distance Regulatory Cues	PLOS ONE			English	Article							DROSOPHILA GAGA FACTOR; EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; GROUP PROTEINS; RESPONSE ELEMENTS; DEVELOPMENTAL REGULATORS; DYNAMIC REGULATION; BITHORAX COMPLEX; PCG PROTEINS; HISTONE H3	Background: Polycomb group (PcG) proteins dynamically define cellular identities through the epigenetic repression of key developmental genes. In Drosophila, cis-regulatory regions termed PcG response elements (PREs) act as nucleation sites for PcG proteins to create large repressive PcG domains that are marked by trimethylation of lysine 27 on histone H3 (H3K27me3). In addition to an action in cis, PREs can interact over long distances, thereby enhancing PcG dependent silencing. How PcG domains are established, which factors limit their propagation in cis, and how long range interactions of PREs in trans affect the chromatin structure is largely unknown. Principal Findings: We demonstrate that the insertion of a PRE-containing transgene in the Drosophila genome generates an artificial PcG domain and we analyze its organization by quantitative ChIP and ChIP-on-chip experiments. Intriguingly, a boundary element and known insulator proteins do not necessarily interfere with spreading of H3K27me3. Instead, domain borders correlate with the presence of promoter regions bound by RNA Polymerase II and active chromatin marks. In contrast, genes that are silent during early fly development get included within the PcG domain and this incorporation interferes with gene activation at later developmental stages. Moreover, trans-interaction of the transgenic PRE with its homologous endogenous PRE results in increased PcG binding, correlating with reinforced silencing of genes within the domain borders. Conclusions: Our results suggest that higher-order organization of PcG-bound chromatin can stabilize gene silencing within PcG domains. Further we propose that multi-protein complexes associated with active promoters are able to define the limits of PcG domains. Future work aimed to pinpoint the factors providing this barrier function will be required to understand the precise molecular mechanism by which active promoter regions can act as boundaries to stop spreading of H3K27me3.	[Schuettengruber, Bernd; Cavalli, Giacomo] CNRS, Inst Genet Humaine, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Schuettengruber, B (corresponding author), CNRS, Inst Genet Humaine, Montpellier, France.	bernd.schuttengruber@igh.cnrs.fr; Giacomo.Cavalli@igh.cnrs.fr	cavalli, giacomo/Z-2754-2019; Cavalli, Giacomo/A-7958-2008	cavalli, giacomo/0000-0003-3709-3469; Cavalli, Giacomo/0000-0003-3709-3469; Schuettengruber, Bernd/0000-0001-7338-4648	Centre National de la Recherche Scientifique; Human Frontiers in Science Program Organization; European Union FP 6 (Network of Excellence "The Epigenome''); European Union FP 7 (Network of Excellence EpigeneSys), the Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche (ANR - iPolycomb); European Research Council (Advanced Investigator grant FlyingPolycomb); Fondation de la Recherche Medicale; Institut National de la Sante et de la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Human Frontiers in Science Program Organization(Human Frontier Science Program); European Union FP 6 (Network of Excellence "The Epigenome''); European Union FP 7 (Network of Excellence EpigeneSys), the Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche (ANR - iPolycomb)(French National Research Agency (ANR)); European Research Council (Advanced Investigator grant FlyingPolycomb); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	Research in the lab of GC was funded by the Centre National de la Recherche Scientifique, the Human Frontiers in Science Program Organization, the European Union FP 6 (Network of Excellence "The Epigenome'') and FP 7 (Network of Excellence EpigeneSys), the Association pour la Recherche sur le Cancer, the Agence Nationale pour la Recherche (ANR - iPolycomb) and the European Research Council (Advanced Investigator grant FlyingPolycomb). BS was supported by a fellowship of the Fondation de la Recherche Medicale and by the Institut National de la Sante et de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Comet I, 2011, P NATL ACAD SCI USA, V108, P2294, DOI 10.1073/pnas.1002059108; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Negre N, 2006, METHOD ENZYMOL, V410, P316, DOI 10.1016/S0076-6879(06)10015-4; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	47	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56531	10.1371/journal.pone.0056531	http://dx.doi.org/10.1371/journal.pone.0056531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437158	Green Submitted, gold, Green Published			2022-12-27	WOS:000315184200096
J	Takahara, T; Minamoto, T; Doi, H				Takahara, Teruhiko; Minamoto, Toshifumi; Doi, Hideyuki			Using Environmental DNA to Estimate the Distribution of an Invasive Fish Species in Ponds	PLOS ONE			English	Article							LEPOMIS-MACROCHIRUS; BLUEGILL SUNFISH; TROPHIC POLYMORPHISM; RICHNESS	Knowledge of the presence of an invasive species is critical to monitoring the sustainability of communities and ecosystems. Environmental DNA (eDNA), DNA fragments that are likely to be bound to organic matters in the water or in shed cells, has been used to monitor the presence of aquatic animals. Using an eDNA-based method, we estimated the presence of the invasive bluegill sunfish, Lepomis macrochirus, in 70 ponds located in seven locales on the Japanese mainland and on surrounding islands. We quantified the concentration of DNA copies in a 1 L water sample using quantitative real-time polymerase chain reaction (qPCR) with a primer/probe set. In addition, we visually observed the bluegill presence in the ponds from the shoreline. We detected bluegill eDNA in all the ponds where bluegills were observed visually and some where bluegills were not observed. Bluegills were also less prevalent on the islands than the mainland, likely owing to limited dispersal and introduction by humans. Our eDNA method simply and rapidly detects the presence of this invasive fish species with less disturbance to the environment during field surveys than traditional methods.	[Takahara, Teruhiko; Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima, Japan; [Minamoto, Toshifumi] Res Inst Human & Nat, Kyoto, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo 657, Japan	Hiroshima University; Research Institute for Humanity & Nature (RIHN); Kobe University	Takahara, T (corresponding author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima, Japan.	takahara@hiroshima-u.ac.jp	Doi, Hideyuki/D-2012-2010; Minamoto, Toshifumi/C-6453-2009	Doi, Hideyuki/0000-0002-2701-3982; Minamoto, Toshifumi/0000-0002-5379-1622	JSPS KAKENHI [24770022, 24657020]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number: 24770022 and 24657020 to HD and TM, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZUMA M, 1992, HYDROBIOLOGIA, V243, P269, DOI 10.1007/BF00007042; Bayley PB, 2001, T AM FISH SOC, V130, P620, DOI 10.1577/1548-8659(2001)130<0620:AATEPO>2.0.CO;2; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; IMAI S, 1987, ATLAS FISH KAGOSHIMA; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kawamura K, 2006, MOL ECOL, V15, P613, DOI 10.1111/j.1365-294X.2006.02823.x; Kawamura K, 2010, MOL ECOL, V19, P5371, DOI 10.1111/j.1365-294X.2010.04886.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; KIRYU T, 1992, REV EXOTIC LARGEMOUT, P89; Lockwood J, 2006, INVASION ECOLOGY; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; MACARTHUR RH, 1968, THEORY ISLAND BIOGEO; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Maruyama T, 1987, INTRO PROCESS FOREIG; Matsuzaki SS, 2009, OECOLOGIA, V158, P673, DOI 10.1007/s00442-008-1180-1; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Mito Toshikazu, 2004, Global Environmental Research, V8, P171; Mooney H.A., 1986, Ecological Studies, P250; R Development Core Team, 2012, R LANG ENV STAT COMP; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; TERASHIMA A., 1977, TANSUIGYO, V3, P38; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Uchii K, 2007, LIMNOLOGY, V8, P59, DOI 10.1007/s10201-006-0196-7; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; YOKOGAWA K, 1992, REV EXOTIC LARGEMOUT, P75; Yonekura R, 2002, ECOL RES, V17, P49, DOI 10.1046/j.1440-1703.2002.00462.x; ZARET TM, 1973, SCIENCE, V182, P449, DOI 10.1126/science.182.4111.449	34	246	268	7	270	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56584	10.1371/journal.pone.0056584	http://dx.doi.org/10.1371/journal.pone.0056584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437177	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200113
J	Taliaferro, JM; Marwha, D; Aspden, JL; Mavrici, D; Cheng, NE; Kohlstaedt, LA; Rio, DC				Taliaferro, J. Matthew; Marwha, Dhruv; Aspden, Julie L.; Mavrici, Daniela; Cheng, Nathalie E.; Kohlstaedt, Lori A.; Rio, Donald C.			The Drosophila Splicing Factor PSI Is Phosphorylated by Casein Kinase II and Tousled-Like Kinase	PLOS ONE			English	Article							BINDING PROTEIN-PSI; DNA-DAMAGE; NUCLEAR ACTIN; IN-VIVO; RNA; ELEMENT; PURIFICATION; MELANOGASTER; DOMAIN; SITE	Alternative splicing of pre-mRNA is a highly regulated process that allows cells to change their genetic informational output. These changes are mediated by protein factors that directly bind specific pre-mRNA sequences. Although much is known about how these splicing factors regulate pre-mRNA splicing events, comparatively little is known about the regulation of the splicing factors themselves. Here, we show that the Drosophila splicing factor P element Somatic Inhibitor (PSI) is phosphorylated at at least two different sites by at minimum two different kinases, casein kinase II (CK II) and tousled-like kinase (tlk). These phosphorylation events may be important for regulating protein-protein interactions involving PSI. Additionally, we show that PSI interacts with several proteins in Drosophila S2 tissue culture cells, the majority of which are splicing factors.	[Taliaferro, J. Matthew; Marwha, Dhruv; Aspden, Julie L.; Mavrici, Daniela; Cheng, Nathalie E.; Kohlstaedt, Lori A.; Rio, Donald C.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rio, Donald C.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Kohlstaedt, Lori A.; Rio, Donald C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rio, DC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	don_rio@berkeley.edu		Taliaferro, Matthew/0000-0001-7580-1433; Aspden, Julie/0000-0002-8537-6204	United States National Institutes of Health (NIH) [GM61987, GM097352-01A1, GM094890-01, S10RR025622]; University of California CRCC graduate fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061987, R01GM097352, R01GM094890, R01GM104385] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California CRCC graduate fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health (NIH) grants GM61987, GM097352-01A1, GM094890-01 and S10RR025622. JMT was supported by a University of California CRCC graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 1997, GENE DEV, V11, P129, DOI 10.1101/gad.11.1.129; Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; Chaouki AS, 2006, PLOS GENET, V2, P1974, DOI 10.1371/journal.pgen.0020178; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; GLOVER CVC, 1983, J BIOL CHEM, V258, P3258; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Ignjatovic T, 2005, J MOL BIOL, V351, P52, DOI 10.1016/j.jmb.2005.04.077; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; Labourier E, 2002, GENE DEV, V16, P72, DOI 10.1101/gad.948602; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MENKO AS, 1980, BIOCHIM BIOPHYS ACTA, V629, P359, DOI 10.1016/0304-4165(80)90108-7; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Packman LC, 1997, FEBS LETT, V400, P45, DOI 10.1016/S0014-5793(96)01324-5; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pilyugin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008328; PINOLROMA S, 1990, METHOD ENZYMOL, V181, P317; PINOLROMA S, 1990, METHOD ENZYMOL, V181, P326; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; SIEBEL CW, 1995, GENE DEV, V9, P269, DOI 10.1101/gad.9.3.269; Szakmary A, 1996, P NATL ACAD SCI USA, V93, P1607, DOI 10.1073/pnas.93.4.1607; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang JW, 1997, J BIOL CHEM, V272, P22227, DOI 10.1074/jbc.272.35.22227; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	45	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56401	10.1371/journal.pone.0056401	http://dx.doi.org/10.1371/journal.pone.0056401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437125	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200069
J	Xing, YM; Zhang, LC; Liang, HQ; Lv, J; Song, C; Guo, SX; Wang, CL; Lee, TS; Lee, MW				Xing, Yong-Mei; Zhang, Li-Chun; Liang, Han-Qiao; Lv, Jing; Song, Chao; Guo, Shun-Xing; Wang, Chun-Lan; Lee, Tae-Soo; Lee, Min-Woong			Sclerotial Formation of Polyporus umbellatus by Low Temperature Treatment under Artificial Conditions	PLOS ONE			English	Article							OXALIC-ACID; DIFFERENTIATION; GROWTH; ROLFSII; EXTRACT	Background: Polyporus umbellatus sclerotia have been used as a diuretic agent in China for over two thousand years. A shortage of the natural P. umbellatus has prompted researchers to induce sclerotial formation in the laboratory. Methodology/Principal Finding: P. umbellatus cultivation in a sawdust-based substrate was investigated to evaluate the effect of low temperature conditions on sclerotial formation. A phenol-sulfuric acid method was employed to determine the polysaccharide content of wild P. umbellatus sclerotia and mycelia and sclerotia grown in low-temperature treatments. In addition, reactive oxygen species (ROS) content, expressed as the fluorescence intensity of mycelia during sclerotial differentiation was determined. Analysis of ROS generation and sclerotial formation in mycelia after treatment with the antioxidants such as diphenyleneiodonium chloride (DPI), apocynin (Apo), or vitamin C were studied. Furthermore, macroscopic and microscopic characteristics of sclerotial differentiation were observed. Sclerotia were not induced by continuous cultivation at 25 degrees C. The polysaccharide content of the artificial sclerotia is 78% of that of wild sclerotia. In the low-temperature treatment group, the fluorescent intensity of ROS was higher than that of the room temperature (25 degrees C) group which did not induce sclerotial formation all through the cultivation. The antioxidants DPI and Apo reduced ROS levels and did not induce sclerotial formation. Although the concentration-dependent effects of vitamin C (5-15 mg mL(-1)) also reduced ROS generation and inhibited sclerotial formation, using a low concentration of vitamin C (1 mg mL(-1)) successfully induced sclerotial differentiation and increased ROS production. Conclusions/Significance: Exposure to low temperatures induced P. umbellatus sclerotial morphogenesis during cultivation. Low temperature treatment enhanced ROS in mycelia, which may be important in triggering sclerotial differentiation in P. umbellatus. Moreover, the application of antioxidants impaired ROS generation and inhibited sclerotial formation. Our findings may help to provide new insights into the biological mechanisms underlying sclerotial morphogenesis in P. umbellatus.	[Xing, Yong-Mei; Zhang, Li-Chun; Liang, Han-Qiao; Lv, Jing; Song, Chao; Guo, Shun-Xing; Wang, Chun-Lan] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Xing, Yong-Mei; Zhang, Li-Chun; Liang, Han-Qiao; Lv, Jing; Song, Chao; Guo, Shun-Xing; Wang, Chun-Lan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lee, Tae-Soo] Univ Incheon, Dept Life Sci, Inchon, South Korea; [Lee, Min-Woong] Dongguk Univ, Dept Life Sci, Seoul, South Korea	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Incheon National University; Dongguk University	Guo, SX (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	sxguo2006@yahoo.com.cn; clwang@implad.ac.cn	Cubała, Wiesław J./N-6113-2018	Cubała, Wiesław J./0000-0001-6343-8454	National Natural Sciences Foundation of China [30830117, 31201666]; International Science and Technology Cooperation Projects of China [2011DFA31260]; National Research Foundation [NRF 2011-0016999]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Projects of China; National Research Foundation	The research was financially supported by the National Natural Sciences Foundation of China (No. 30830117, 31201666), the International Science and Technology Cooperation Projects of China (No. 2011DFA31260) and the National Research Foundation (NRF 2011-0016999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; [Anonymous], [No title captured]; Belozerskaya TA, 2006, MICROBIOLOGY+, V75, P427, DOI 10.1134/S0026261706040102; Brys K, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-91; Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115; Cheng XH, 2006, J INTEGR PLANT BIOL, V48, P1312, DOI 10.1111/j.1744-7909.2006.00349.x; CHET I, 1975, ANNU REV PHYTOPATHOL, V13, P169, DOI 10.1146/annurev.py.13.090175.001125; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Erental A., 2008, Fungal Biology Reviews, V22, P6, DOI 10.1016/j.fbr.2007.10.001; Georgiou CD, 2003, MYCOLOGIA, V95, P308, DOI 10.2307/3762041; Georgiou CD, 2001, FUNGAL GENET BIOL, V34, P11, DOI 10.1006/fgbi.2001.1285; Georgiou CD, 2000, MYCOL RES, V104, P1191, DOI 10.1017/S0953756200002707; Georgiou CD, 1997, MYCOL RES, V101, P460, DOI 10.1017/S0953756296002882; Georgiou CD, 2000, MYCOLOGIA, V92, P825, DOI 10.2307/3761577; Georgiou CD, 2006, INTEGR COMP BIOL, V46, P609; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; GUO S., 1992, MYCOSYSTEMA, V11, P49; Guo SX, 1996, CHIN J CHIN METER ME, V21, P515; Guo WJ, 2011, CRYPTOGAMIE MYCOL, V32, P171, DOI 10.7872/crym.v32.iss2.2011.171; HADAR Y, 1983, CAN J MICROBIOL, V29, P21, DOI 10.1139/m83-004; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HANSBERG W, 1990, J THEOR BIOL, V142, P201, DOI 10.1016/S0022-5193(05)80222-X; Kang Peng, 2012, African Journal of Pharmacy and Pharmacology, V6, P2686; Kim HJ, 2011, APPL ENVIRON MICROB, V77, P7721, DOI 10.1128/AEM.05472-11; Knutson CA, 1997, CEREAL CHEM, V74, P471, DOI 10.1094/CCHEM.1997.74.4.471; Kyung-DalChoi, 2003, Mycobiology, V31, P105; Li XQ, 2011, J ETHNOPHARMACOL, V135, P1, DOI 10.1016/j.jep.2010.06.028; Li XQ, 2010, CELL IMMUNOL, V265, P50, DOI 10.1016/j.cellimm.2010.07.002; Lin Y F, 1988, Zhongguo Yao Li Xue Bao, V9, P345; Liu YY, 2009, LETT APPL MICROBIOL, V49, P283, DOI 10.1111/j.1472-765X.2009.02656.x; Liu YY, 2010, MYCOPATHOLOGIA, V169, P139, DOI 10.1007/s11046-009-9238-0; OHSAWA T, 1992, CHEM PHARM BULL, V40, P143, DOI 10.1248/cpb.40.143; Patsoukis N, 2008, CAN J MICROBIOL, V54, P28, DOI [10.1139/W07-108, 10.1139/w07-108]; PUNJA ZK, 1985, CAN J PLANT PATHOL, V7, P109, DOI 10.1080/07060668509501485; RAWN CD, 1991, J GEN MICROBIOL, V137, P1063, DOI 10.1099/00221287-137-5-1063; Singh UP, 2002, CAN J MICROBIOL, V48, P443, DOI [10.1139/w02-040, 10.1139/W02-040]; Wang GF, 2006, HERALD MED, V25, P346; [邢晓科 Xing Xiaoke], 2004, [微生物学通报, Microbiology], V31, P34; Xing XK, 2005, MYCOPATHOLOGIA, V159, P583, DOI 10.1007/s11046-005-0255-3; Xing YM, 2011, CURR MICROBIOL, V62, P1218, DOI 10.1007/s00284-010-9848-2; Xing YM, 2011, MYCOL PROG, V10, P121, DOI 10.1007/s11557-010-0725-y; Yan S C, 1988, Zhong Xi Yi Jie He Za Zhi, V8, P141; YOU JS, 1994, AM J CHINESE MED, V22, P19, DOI 10.1142/S0192415X94000048; Yun L.L., 2010, J LIAONING FORESTRY, V3, P35; Zhao YY, 2010, PLANTA MED, V76, P1755, DOI 10.1055/s-0030-1249926; Zhao YY, 2010, BIOMED CHROMATOGR, V24, P222, DOI 10.1002/bmc.1277	47	18	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56190	10.1371/journal.pone.0056190	http://dx.doi.org/10.1371/journal.pone.0056190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437090	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200044
J	Poole, DN; Tracy, JK; Levitz, L; Rochas, M; Sangare, K; Yekta, S; Tounkara, K; Aboubacar, B; Koita, O; Lurie, M; De Groot, AS				Poole, Danielle N.; Tracy, J. Kathleen; Levitz, Lauren; Rochas, Mali; Sangare, Kotou; Yekta, Shahla; Tounkara, Karamoko; Aboubacar, Ben; Koita, Ousmane; Lurie, Mark; De Groot, Anne S.			A Cross-Sectional Study to Assess HPV Knowledge and HPV Vaccine Acceptability in Mali	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER; RISK-FACTORS; HEALTH; WOMEN; PREVALENCE; DETERMINANTS; PREVENTION; AWARENESS	Despite a high prevalence of oncogenic human papilloma virus (HPV) infection and cervical cancer mortality, HPV vaccination is not currently available in Mali. Knowledge of HPV and cervical cancer in Mali, and thereby vaccine readiness, may be limited. Research staff visited homes in a radial pattern from a central location to recruit adolescent females and males aged 12-17 years and men and women aged >= 18 years (N = 51) in a peri-urban village of Bamako, Mali. Participants took part in structured interviews assessing knowledge, attitudes, and practices related to HPV, cervical cancer, and HPV vaccination. We found low levels of HPV and cervical cancer knowledge. While only 2.0% of respondents knew that HPV is a sexually transmitted infection (STI), 100% said they would be willing to receive HPV vaccination and would like the HPV vaccine to be available in Mali. Moreover, 74.5% said they would vaccinate their child(ren) against HPV. Men were found to have significantly greater autonomy in the decision to vaccinate themselves than women and adolescents (p = 0.005), a potential barrier to be addressed by immunization campaigns. HPV vaccination would be highly acceptable if the vaccine became widely available in Bamako, Mali. This study demonstrates the need for a significant investment in health education if truly informed consent is to be obtained for HPV vaccination. Potential HPV vaccination campaigns should provide more information about HPV and the vaccine. Barriers to vaccination, including the significantly lower ability of the majority of the target population to autonomously decide to get vaccinated, must also be addressed in future HPV vaccine campaigns.	[Poole, Danielle N.; Lurie, Mark] Brown Univ, Publ Hlth Program, Providence, RI 02912 USA; [Tracy, J. Kathleen] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA; [Tracy, J. Kathleen] Univ Maryland, Sch Med, Dept Publ Hlth, Baltimore, MD 21201 USA; [Levitz, Lauren; Rochas, Mali; Tounkara, Karamoko; Aboubacar, Ben; De Groot, Anne S.] GAIA Vaccine Fdn, Providence, RI USA; [Levitz, Lauren; Rochas, Mali; Tounkara, Karamoko; Aboubacar, Ben; De Groot, Anne S.] GAIA Vaccine Fdn, Bamako, Mali; [Sangare, Kotou; Koita, Ousmane] Univ Bamako, Bamako, Mali; [Yekta, Shahla; De Groot, Anne S.] Univ Rhode Isl, Providence, RI 02908 USA	Brown University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Bamako; University of Rhode Island	Poole, DN (corresponding author), Brown Univ, Publ Hlth Program, Providence, RI 02912 USA.	danielle.n.poole@gmail.com	De Groot, Annie/B-6221-2013; Lurie, Mark N/I-3133-2014	De Groot, Annie/0000-0001-5911-1459; Levitz, Lauren/0000-0002-5103-0221; Sangare, Kotou/0000-0002-6750-820X	Merck Company Foundation, United States through Merck Sharp Dohme Corp.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER	Merck Company Foundation, United States through Merck Sharp Dohme Corp.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors received funding from the Merck Company Foundation, a United States-based, private, charitable foundation funded entirely through Merck Sharp & Dohme Corp. No additional external funding was received for this study. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arrossi S, 2012, VACCINE, V30, P2467, DOI 10.1016/j.vaccine.2012.01.032; Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; Bekele A, 2010, TROP MED INT HEALTH, V15, P890, DOI 10.1111/j.1365-3156.2010.02552.x; Biddlecom A, 2006, LANCET, V367, P1299, DOI 10.1016/S0140-6736(06)68555-3; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Buys P, 2009, WORLD DEV, V37, P1494, DOI 10.1016/j.worlddev.2009.01.011; Castle PE, 2005, JNCI-J NATL CANCER I, V97, P1066, DOI 10.1093/jnci/dji186; Centre WIICoHaCCHI, 2012, HUM PAP REL CANC MAL; Coleman MA, 2011, VACCINE, V29, P3945, DOI 10.1016/j.vaccine.2011.03.093; Collumbien M, 2000, Cult Health Sex, V2, P135, DOI 10.1080/136910500300769; Dudgeon MR, 2004, SOC SCI MED, V59, P1379, DOI 10.1016/j.socscimed.2003.11.035; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Haupt RM, 2011, J ADOLESCENT HEALTH, V49, P467, DOI 10.1016/j.jadohealth.2011.07.003; Hawkes S, 1998, HEALTH POLICY PLANN, V13, P121, DOI 10.1093/heapol/13.2.121; IPPF, 2000, REPR RIGHTS 2000; Kruger-Kjaer S, 1998, INT J CANCER, V76, P613, DOI 10.1002/(SICI)1097-0215(19980529)76:5&lt;613::AID-IJC1&gt;3.0.CO;2-T; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Leplege A, 2006, QUAL LIFE RES, V15, P1373, DOI 10.1007/s11136-006-0023-y; Leyva M, 2006, CALIF J HLTH PROMOT, V4, P13, DOI DOI 10.32398/CJHP.V4I2.1930; Louie KS, 2009, BRIT J CANCER, V100, P1191, DOI 10.1038/sj.bjc.6604974; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; Markovic M, 2005, SOC SCI MED, V61, P2528, DOI 10.1016/j.socscimed.2005.05.001; Marlow LAV, 2007, BRIT J CANCER, V97, P691, DOI 10.1038/sj.bjc.6603927; Marshall H, 2007, AUST NZ J PUBL HEAL, V31, P235, DOI 10.1111/j.1467-842X.2007.00054.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Oh JK, 2010, VACCINE, V28, P1854, DOI 10.1016/j.vaccine.2009.11.079; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perkins RB, 2010, WOMEN HEALTH ISS, V20, P35, DOI 10.1016/j.whi.2009.09.001; Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025; Reyes-Ortiz CA, 2007, J AM GERIATR SOC, V55, pS159; Sauvain-Dugerdil C, 2008, STUD FAMILY PLANN, V39, P263, DOI 10.1111/j.1728-4465.2008.00174.x; StataCorp LP, 2007, STAT STAT SOFTW REL, P10; Tracy JK, 2011, TROP MED INT HEALTH, V16, P1432, DOI 10.1111/j.1365-3156.2011.02843.x; Tracy L, 2011, CLIN INFECT DIS, V52, P641, DOI 10.1093/cid/ciq190; (UNAIDS) JUNPoHA, 2010, GLOB REP UNAIDS REP; USAID, 2007, USAID COUNTR HLTH ST; Waller J, 2004, PREV MED, V38, P745, DOI 10.1016/j.ypmed.2004.01.003; Winkler JL, 2008, VACCINE, V26, pL73, DOI 10.1016/j.vaccine.2008.05.027; Wong LP, 2011, INT J BEHAV MED, V18, P105, DOI 10.1007/s12529-010-9104-y; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591	44	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56402	10.1371/journal.pone.0056402	http://dx.doi.org/10.1371/journal.pone.0056402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093HR	23431375	gold, Green Published			2022-12-27	WOS:000315182800017
J	Hackett, TD; Korine, C; Holderied, MW				Hackett, Talya D.; Korine, Carmi; Holderied, Marc W.			The Importance of Acacia Trees for Insectivorous Bats and Arthropods in the Arava Desert	PLOS ONE			English	Article							LARGE MAMMALIAN HERBIVORES; MKOMAZI-GAME-RESERVE; HABITAT USE; RHINOLOPHUS-HIPPOSIDEROS; NEGEV DESERT; FORAGING BEHAVIOR; ACTIVITY PATTERNS; FEEDING-HABITS; ECHOLOCATION; CHIROPTERA	Anthropogenic habitat modification often has a profound negative impact on the flora and fauna of an ecosystem. In parts of the Middle East, ephemeral rivers (wadis) are characterised by stands of acacia trees. Green, flourishing assemblages of these trees are in decline in several countries, most likely due to human-induced water stress and habitat changes. We examined the importance of healthy acacia stands for bats and their arthropod prey in comparison to other natural and artificial habitats available in the Arava desert of Israel. We assessed bat activity and species richness through acoustic monitoring for entire nights and concurrently collected arthropods using light and pit traps. Dense green stands of acacia trees were the most important natural desert habitat for insectivorous bats. Irrigated gardens and parks in villages and fields of date palms had high arthropod levels but only village sites rivalled acacia trees in bat activity level. We confirmed up to 13 bat species around a single patch of acacia trees; one of the richest sites in any natural desert habitat in Israel. Some bat species utilised artificial sites; others were found almost exclusively in natural habitats. Two rare species (Barbastella leucomelas and Nycteris the baica) were identified solely around acacia trees. We provide strong evidence that acacia trees are of unique importance to the community of insectivorous desert-dwelling bats, and that the health of the trees is crucial to their value as a foraging resource. Consequently, conservation efforts for acacia habitats, and in particular for the green more densely packed stands of trees, need to increase to protect this vital habitat for an entire community of protected bats.	[Hackett, Talya D.; Holderied, Marc W.] Univ Bristol, Dept Biol Sci, Bristol, Avon, England; [Korine, Carmi] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Swiss Inst Dryland Environm & Energy Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Korine, Carmi] Tamar Reg Council, Dead Sea & Arava Sci Ctr, Neveh Zohar, Israel	University of Bristol; Ben Gurion University	Holderied, MW (corresponding author), Univ Bristol, Dept Biol Sci, Bristol, Avon, England.	Marc.Holderied@bristol.ac.uk	Holderied, Marc/M-9382-2013	Holderied, Marc/0000-0002-1573-7908; Hackett, Talya/0000-0001-7727-8842	Israeli Ministry of Science and Technology; Explorers Club Exploration Fund; European Commission Dryland Research Specific Support Action Plan; BBSRC [BB/F002386/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F002386/1] Funding Source: researchfish	Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Explorers Club Exploration Fund; European Commission Dryland Research Specific Support Action Plan; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Israeli Ministry of Science and Technology (to C.K.): US $13333; The Explorers Club Exploration Fund (to T.D.H.): US $750; European Commission Dryland Research Specific Support Action Plan (to T.D.H.): 9,000 pound. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM MD, 1994, J WILDLIFE MANAGE, V58, P462, DOI 10.2307/3809317; Adams AM, 2012, METHODS ECOLOGY EVOL; ANTHONY ELP, 1981, OECOLOGIA, V51, P151, DOI 10.1007/BF00540593; ARLETTAZ R, 1995, J MAMMAL, V76, P873, DOI 10.2307/1382757; Ashkenazi S, 1995, ACACIA TREES NEGEV I; Barclay RMR, 1999, J MAMMAL, V80, P290, DOI 10.2307/1383229; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; Benda Petr, 2008, Acta Societatis Zoologicae Bohemicae, V72, P1; Bohm SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017857; Bontadina F, 2002, J ZOOL, V258, P281, DOI 10.1017/S0952836902001401; Bruins HJ, 2012, LAND DEGRAD DEV, V23, P365, DOI 10.1002/ldr.2149; Ciechanowski M, 2007, CAN J ZOOL, V85, P1249, DOI 10.1139/Z07-090; Dietz C, 2004, ILLUSTRATED IDENTIFI; Dolev A., 2004, RED BOOK VERTEBRATES; Downs CT, 2003, J CHEM ECOL, V29, P845, DOI 10.1023/A:1022975531372; ERNST WHO, 1989, OIKOS, V54, P294, DOI 10.2307/3565288; Feldman R, 2000, ACTA CHIROPTEROL, V2, P15; FENTON MB, 1983, J ZOOL, V200, P347; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; FENTON MB, 1977, BIOTROPICA, V9, P73, DOI 10.2307/2387662; Fenton MB, 1999, ISR J ZOOL, V45, P501; Gharaibeh Burhan M., 1995, Mammalian Species, V514, P1; Ginat H., 2011, J DEAD SEA ARAV RES, V1, P1; Goldreich Yair, 2001, Israel Journal of Earth Sciences, V50, P53, DOI 10.1560/1V61-FPGF-Y5VK-ADAG; Gray PA, 1999, NYCTERIS THEBAICA, P1; HAUSER TP, 1994, OIKOS, V70, P421, DOI 10.2307/3545781; Hayes John P., 2009, P112; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; Holderied M, 2011, J COMP PHYSIOL A, V197, P425, DOI 10.1007/s00359-010-0608-3; HOROVITZ A, 1983, ISRAEL J BOT, V32, P75; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kruger O, 1998, ECOGRAPHY, V21, P261, DOI 10.1111/j.1600-0587.1998.tb00563.x; Kruger O, 1998, AFR J ECOL, V36, P213, DOI 10.1046/j.1365-2028.1998.00130.x; Kruger O, 2000, ACTA OECOL, V21, P21, DOI 10.1016/S1146-609X(00)00112-0; KUNZ TH, 1973, J MAMMAL, V54, P14, DOI 10.2307/1378869; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Lovich JE, 1999, ENVIRON MANAGE, V24, P309, DOI 10.1007/s002679900235; Martins Dino J., 2004, International Journal of Tropical Insect Science, V24, P105, DOI 10.1079/IJT200411; Mendelssohn H., 1999, FAUNA PALAESTINA MAM; Meyer CFJ, 2004, J TROP ECOL, V20, P397, DOI 10.1017/S0266467404001373; MILLER MF, 1995, AFR J ECOL, V33, P194, DOI 10.1111/j.1365-2028.1995.tb00797.x; Milne DJ, 2005, J MAMMAL, V86, P909, DOI 10.1644/1545-1542(2005)86[909:TPOBIT]2.0.CO;2; Monadjem A, 2008, ACTA CHIROPTEROL, V10, P339, DOI 10.3161/150811008X414917; Munzbergova Z, 2002, J VEG SCI, V13, P227, DOI 10.1658/1100-9233(2002)013[0227:ATAKSI]2.0.CO;2; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; O'Donnell CFJ, 2000, NEW ZEAL J ZOOL, V27, P207, DOI 10.1080/03014223.2000.9518228; Or K, 2003, AFR J ECOL, V41, P257, DOI 10.1046/j.1365-2028.2003.00451.x; Palmer TM, 2003, ECOLOGY, V84, P2843, DOI 10.1890/02-0528; Polak T, 2011, J ZOOL, V285, P21, DOI 10.1111/j.1469-7998.2011.00808.x; Razgour O, 2011, OECOLOGIA, V167, P493, DOI 10.1007/s00442-011-1995-z; Rebelo H, 2007, AFR J ECOL, V45, P228, DOI 10.1111/j.1365-2028.2006.00721.x; Riskin DK, 2001, PIPISTRELLUS BODENHE, P1; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rohner C, 1999, CONSERV BIOL, V13, P1162, DOI 10.1046/j.1523-1739.1999.97300.x; Russ JM, 2002, BIOL CONSERV, V108, P49, DOI 10.1016/S0006-3207(02)00089-7; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; RYDELL J, 1991, HOLARCTIC ECOL, V14, P203; Schlitter Duane A., 1996, Mammalian Species, V0, P1; SCHNITZLER H-U, 1971, Zeitschrift fuer Vergleichende Physiologie, V73, P209, DOI 10.1007/BF00304133; Shalmon B., 1993, FIELD GUIDE LAND MAM; Sher AA, 2010, J ARID ENVIRON, V74, P338, DOI 10.1016/j.jaridenv.2009.09.007; Shrestha MK, 2003, PLANT ECOL, V168, P297, DOI 10.1023/A:1024431124954; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Spitzenberger F, 2006, ZOOL SCR, V35, P187, DOI 10.1111/j.1463-6409.2006.00224.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Stone G, 1996, P ROY SOC B-BIOL SCI, V263, P1389, DOI 10.1098/rspb.1996.0203; Stone GN, 1998, ECOLOGY, V79, P2808, DOI 10.1890/0012-9658(1998)079[2808:POPDFI]2.0.CO;2; VAUGHAN TA, 1986, J MAMMAL, V67, P91, DOI 10.2307/1381005; Ward D, 1997, BIODIVERS CONSERV, V6, P877, DOI 10.1023/B:BIOC.0000010408.90955.48; Webala PW, 2001, AFRICAN J ECOLOGY, V42, P171; WELTZIN JF, 1990, J VEG SCI, V1, P325, DOI 10.2307/3235707; Whitaker JO, 2002, MAMM BIOL, V67, P378, DOI 10.1078/1616-5047-00053; WHITAKER JO, 1994, Z SAUGETIERKD, V59, P74; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Yom-Tov Yoram, 1998, Diversity and Distributions, V4, P63, DOI 10.1046/j.1472-4642.1998.00012.x; YOMTOV Y, 1993, J ZOOL, V230, P347; Young M, 2005, METH ECOL, P116, DOI 10.1002/9780470750513.ch6; Young TP, 1997, OECOLOGIA, V109, P98, DOI 10.1007/s004420050063; Zahn A, 2008, MAMM BIOL, V73, P222, DOI 10.1016/j.mambio.2007.02.005	82	27	27	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e52999	10.1371/journal.pone.0052999	http://dx.doi.org/10.1371/journal.pone.0052999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441145	Green Submitted, gold, Green Published			2022-12-27	WOS:000315159200003
J	Cheng, KD; Drebot, M; McCrea, J; Peterson, L; Lee, D; McCorrister, S; Nickel, R; Gerbasi, A; Sloan, A; Janella, D; Van Domselaar, G; Beniac, D; Booth, T; Chui, LD; Tabor, H; Westmacott, G; Gilmour, M; Wang, GH				Cheng, Keding; Drebot, Mike; McCrea, Joanne; Peterson, Lorea; Lee, David; McCorrister, Stuart; Nickel, Richard; Gerbasi, Alyssia; Sloan, Angela; Janella, Debra; Van Domselaar, Gary; Beniac, Daniel; Booth, Tim; Chui, Linda; Tabor, Helen; Westmacott, Garrett; Gilmour, Matthew; Wang, Gehua			MS-H: A Novel Proteomic Approach to Isolate and Type the E. coli H Antigen Using Membrane Filtration and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)	PLOS ONE			English	Article							ESCHERICHIA-COLI; IDENTIFICATION; RESTRICTION; SPECIFICITY; SENSITIVITY; TIME	Serotyping is the long-standing gold standard method to determine E. coli H antigens; however, this method requires a panel of H-antigen specific antibodies and often culture-based induction of the H-antigen flagellar motility. In this study, a rapid and accurate method to isolate and identify the Escherichia coli (E. coli) H flagellar antigen was developed using membrane filtration and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Flagella were isolated from pure culture, digested with trypsin, and then subjected to LC-MS/MS using one of two systems (Agilent-nano-LC-QSTAR XL or Proxeon-nano-LC-LTQ-Orbitrap XL). The resulting peptide sequence data were searched against a custom E. coli flagella/H antigen database. This approach was evaluated using flagella isolated from reference E. coli strains representing all 53 known H antigen types and 41 clinical E. coli strains. The resulting LC-MS/MS classifications of H antigen types (MS-H) were concordant with the known H serogroup for all 53 reference types, and of 41 clinical isolates tested, 38 (92.7%) were concordant with the known H serogroup. MS-H clearly also identified two clinical isolates (4.9%) that were untypeable by serotyping. Notably, successful detection and classification of flagellar antigens with MS-H did not generally require induction of motility, establishing this proteomic approach as more rapid and cost-effective than traditional methods, while providing equitable specificity for typing E. coli H antigens.	[Cheng, Keding; Drebot, Mike; McCrea, Joanne; Peterson, Lorea; Lee, David; McCorrister, Stuart; Nickel, Richard; Gerbasi, Alyssia; Sloan, Angela; Janella, Debra; Van Domselaar, Gary; Beniac, Daniel; Booth, Tim; Tabor, Helen; Westmacott, Garrett; Gilmour, Matthew; Wang, Gehua] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Cheng, Keding] Univ Manitoba, Fac Med, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Chui, Linda] Alberta Prov Lab Publ Hlth, Calgary, AB, Canada	Public Health Agency of Canada; University of Manitoba	Cheng, KD (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Keding.Cheng@phac-aspc.gc.ca; Gehua.Wang@phac-aspc.gc.ca			Public Agency of Canada	Public Agency of Canada	The project was supported by the yearly budget of Public Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aygan A., 2007, INT J AGRIC BIOL, V9, P193; Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Beutin L, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-4; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P376, DOI 10.1128/JB.105.1.376-383.1971; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ewing W.H., 1986, EDWARDS EWINGS IDENT; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Goldman E, 2009, PRACTICAL HDB MICROB, P217; Graham Ciaren, 2011, Bioeng Bugs, V2, P17, DOI 10.4161/bbug.2.1.14413; GROSS RJ, 1985, VIRULENCE ESCHERICHI, V13, P345; Karger A, 2011, APPL ENVIRON MICROB, V77, P896, DOI 10.1128/AEM.01686-10; KAUFFMANN F, 1947, J IMMUNOL, V57, P71; Kim MS, 2010, J AM SOC MASS SPECTR, V21, P1606, DOI 10.1016/j.jasms.2010.04.011; Koskinen MT, 2009, J DAIRY SCI, V92, P952, DOI 10.3168/jds.2008-1549; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; POWER ME, 1994, J BACTERIOL, V176, P3303, DOI 10.1128/jb.176.11.3303-3313.1994; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Ratiner YA, 2010, ARCH MICROBIOL, V192, P267, DOI 10.1007/s00203-010-0556-x; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Taylor GK, 2005, RAPID COMMUN MASS SP, V19, P3420, DOI 10.1002/rcm.2225; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; The International Conference on Harmonization (ICH), 2005, HARM TRIP GUID VAL A, V2, P1; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	28	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57339	10.1371/journal.pone.0057339	http://dx.doi.org/10.1371/journal.pone.0057339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437374	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000098
J	Persak, H; Pitzschke, A				Persak, Helene; Pitzschke, Andrea			Tight Interconnection and Multi-Level Control of Arabidopsis MYB44 in MAPK Cascade Signalling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; CONSERVED DOCKING SITE; TRANSCRIPTION FACTOR; ABSCISIC-ACID; GENE-EXPRESSION; INNATE IMMUNITY; SEED-GERMINATION; STRESS TOLERANCE; FLORAL ORGANS; THALIANA	Abiotic stress poses a huge, ever-increasing problem to plants and agriculture. The dissection of signalling pathways mediating stress tolerance is a prerequisite to develop more resistant plant species. Mitogen-activated protein kinase (MAPK) cascades are universal signalling modules. In Arabidopsis, the MAPK MPK3 and its upstream regulator MAPK kinase MKK4 initiate the adaptation response to numerous abiotic and biotic stresses. Yet, molecular steps directly linked with MKK4 - MPK3 activation are largely unknown. Starting with a yeast-two-hybrid screen for interacting partners of MKK4, we identified a transcription factor, MYB44. MYB44 is controlled at multiple levels by and strongly inter-connected with MAPK signalling. As we had shown earlier, stress-induced expression of the MYB44 gene is regulated by a MPK3-targeted bZIP transcription factor VIP1. At the protein level, MYB44 interacts with MPK3 in vivo. MYB44 is phosphorylated by MPK3 in vitro at a single residue, Ser145. Although replacement of Ser145 by a non-phosphorylatable (S145A) or phosphomimetic (S145D) residue did not alter MYB44 subcellular localisation, dimerization behaviour nor DNA-binding characteristics, abiotic stress tolerance tests in stable transgenic Arabidopsis plants clearly related S145 phosphorylation to MYB44 function: Compared to Arabidopsis wild type plants, MYB44 overexpressing lines exhibit an enhanced tolerance to osmotic stress and are slightly more sensitive to abscisic acid. Interestingly, overexpression of the S145A variant revealed that impaired phosphorylation does not render the MYB44 protein non-functional. Instead, S145A lines are highly sensitive to abiotic stress, and thereby remarkably similar to mpk3-deficient plants. Its in vivo interaction with the nuclear sub-pools of both MPK3 and MKK4 renders MYB44 the first plant transcription factor to have a second function as putative MAPK cascade scaffolding protein.	[Persak, Helene; Pitzschke, Andrea] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Persak, H (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	Helene.Persak@boku.ac.at; Andrea.Pitzschke@boku.ac.at		Pitzschke, Andrea/0000-0002-3451-1429	Austrian Science Foundation, FWF [P21851]; Austrian Science Fund (FWF) [P 21851] Funding Source: researchfish	Austrian Science Foundation, FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project was funded by the Austrian Science Foundation, FWF (P21851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; [Anonymous], 2002, TRENDS PLANT SCI, V7, P301; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Assmann SM, 2003, TRENDS PLANT SCI, V8, P151, DOI 10.1016/S1360-1385(03)00052-9; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Bhat RA, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-12; Brock AK, 2010, PLANT PHYSIOL, V153, P1098, DOI 10.1104/pp.110.156109; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Djamei A, 2007, SCIENCE, V318, P453, DOI 10.1126/science.1148110; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Galletti R, 2011, PLANT PHYSIOL, V157, P804, DOI 10.1104/pp.111.174003; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hilder TL, 2007, METHOD ENZYMOL, V428, P297, DOI 10.1016/S0076-6879(07)28017-6; Hong JY, 2011, PHYTOCHEMISTRY, V72, P27, DOI 10.1016/j.phytochem.2010.10.005; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; HOWE KM, 1991, NUCLEIC ACIDS RES, V19, P3913, DOI 10.1093/nar/19.14.3913; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kim SH, 2011, BIOCHEM BIOPH RES CO, V412, P150, DOI 10.1016/j.bbrc.2011.07.064; Kirchler T, 2010, EUR J CELL BIOL, V89, P175, DOI 10.1016/j.ejcb.2009.11.023; Kirik V, 1998, PLANT MOL BIOL, V37, P819, DOI 10.1023/A:1006011002499; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Liu RX, 2011, MOL PLANT MICROBE IN, V24, P377, DOI 10.1094/MPMI-07-10-0170; Lu C, 2002, P NATL ACAD SCI USA, V99, P15812, DOI 10.1073/pnas.242607499; Lu BB, 2011, J BIOSCIENCES, V36, P123, DOI 10.1007/s12038-011-9016-2; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Morse AM, 2009, NEW PHYTOL, V183, P1001, DOI 10.1111/j.1469-8137.2009.02900.x; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Pajonk S, 2008, J BIOL CHEM, V283, P26974, DOI 10.1074/jbc.M805236200; Pitzschke A, 2012, MAKE YOUR BEST MYB T, P481; Pitzschke A, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-14; Pitzschke A, 2009, P NATL ACAD SCI USA, V106, P18414, DOI 10.1073/pnas.0905599106; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Pitzschke A, 2009, PLANT PHYSIOL, V149, P606, DOI 10.1104/pp.108.131557; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Seo JS, 2012, MOL BREEDING, V29, P601, DOI 10.1007/s11032-011-9576-8; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Spoel SH, 2010, NEW PHYTOL, V186, P333, DOI 10.1111/j.1469-8137.2009.03125.x; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; van Bentem SD, 2008, J PROTEOME RES, V7, P2458, DOI 10.1021/pr8000173; Verslues PE, 2006, J EXP BOT, V57, P201, DOI 10.1093/jxb/erj026; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Williams CE, 1997, J BIOL CHEM, V272, P563, DOI 10.1074/jbc.272.1.563; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Nguyen XC, 2012, BIOCHEM BIOPH RES CO, V423, P703, DOI 10.1016/j.bbrc.2012.06.019; Yang SH, 2010, METHODS MOL BIOL, V661, P343, DOI 10.1007/978-1-60761-795-2_21; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543	71	65	70	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57547	10.1371/journal.pone.0057547	http://dx.doi.org/10.1371/journal.pone.0057547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437396	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000109
J	Biddle, A; Gammon, L; Fazil, B; Mackenzie, IC				Biddle, Adrian; Gammon, Luke; Fazil, Bilal; Mackenzie, Ian C.			CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; BREAST-CANCER; PROSPECTIVE IDENTIFICATION; PANCREATIC-CANCER; MELANOMA-CELLS; NECK-CANCER; CARCINOMA; HEAD; METASTASIS; GROWTH	CD44 is commonly used as a cell surface marker of cancer stem-like cells in epithelial tumours, and we have previously demonstrated the existence of two different CD44(high) cancer stem-like cell populations in squamous cell carcinoma, one having undergone epithelial-to-mesenchymal transition and the other maintaining an epithelial phenotype. Alternative splicing of CD44 variant exons generates a great many isoforms, and it is not known which isoforms are expressed on the surface of the two different cancer stem-like cell phenotypes. Here, we demonstrate that cancer stem-like cells with an epithelial phenotype predominantly express isoforms containing the variant exons, whereas the cancer stem-like cells that have undergone an epithelial-to-mesenchymal transition down-regulate these variant isoforms and up-regulate expression of the standard CD44 isoform that contains no variant exons. In addition, we find that enzymatic treatments used to dissociate cells from tissue culture or fresh tumour specimens cause destruction of variant CD44 isoforms at the cell surface whereas expression of the standard CD44 isoform is preserved. This results in enrichment within the CD44(high) population of cancer stem-like cells that have undergone an epithelial-to-mesenchymal transition and depletion from the CD44(high) population of cancer stem-like cells that maintain an epithelial phenotype, and therefore greatly effects the characteristics of any cancer stem-like cell population isolated based on expression of CD44. As well as effecting the CD44(high) population, enzymatic treatment also reduces the percentage of the total epithelial cancer cell population staining CD44-positive, with potential implications for studies that aim to use CD44-positive staining as a prognostic indicator. Analyses of the properties of cancer stem-like cells are largely dependent on the ability to accurately identify and assay these populations. It is therefore critical that consideration be given to use of multiple cancer stem-like cell markers and suitable procedures for cell isolation in order that the correct populations are assayed.	[Biddle, Adrian; Gammon, Luke; Fazil, Bilal; Mackenzie, Ian C.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Gammon, Luke] Univ Bergen, Haukeland Univ Hosp, Gade Inst, Bergen, Norway	University of London; Queen Mary University London; University of Bergen; Haukeland University Hospital	Biddle, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	a.biddle@qmul.ac.uk	Mackenzie, Ian C/B-9653-2013	Mackenzie, Ian C/0000-0003-1373-062X; Biddle, Adrian/0000-0003-4371-9720	The National Centre for the Replacement, Refinement and Reduction of Animals in Research; Barts and the London Charity; National Centre for the Replacement [NC/K500495/1, G0900799/1] Funding Source: researchfish	The National Centre for the Replacement, Refinement and Reduction of Animals in Research; Barts and the London Charity; National Centre for the Replacement	This study was funded by the The National Centre for the Replacement, Refinement and Reduction of Animals in Research, Barts and the London Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cao C, 2012, MOL CANCER RES, V10, P892, DOI 10.1158/1541-7786.MCR-12-0169; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; FRIEDRICHS K, 1995, CANCER RES, V55, P5424; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Joshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Mackenzie IC, 2004, J ORAL PATHOL MED, V33, P71, DOI 10.1111/j.1600-0714.2004.00157.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2003, CANCER RES, V63, P5821; Skvortsova I, 2010, RADIOTHER ONCOL, V96, P108, DOI 10.1016/j.radonc.2010.04.017; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	41	55	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57314	10.1371/journal.pone.0057314	http://dx.doi.org/10.1371/journal.pone.0057314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437366	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200241
J	Cao, HR; Yin, XL; Cao, YJ; Jin, YC; Wang, S; Kong, YH; Chen, YX; Gao, JG; Heller, S; Xu, ZG				Cao, Huiren; Yin, Xiaolei; Cao, Yujie; Jin, Yecheng; Wang, Shan; Kong, Yanhui; Chen, Yuexing; Gao, Jiangang; Heller, Stefan; Xu, Zhigang			FCHSD1 and FCHSD2 Are Expressed in Hair Cell Stereocilia and Cuticular Plate and Regulate Actin Polymerization In Vitro	PLOS ONE			English	Article							AMES WALTZER MICE; INNER-EAR; SYNAPTIC GROWTH; NERVOUS WRECK; MYOSIN VIIA; MOLECULAR TREADMILL; PLASMA-MEMBRANE; PCH PROTEINS; LOCALIZATION; TIPS	Mammalian FCHSD1 and FCHSD2 are homologous proteins containing an amino-terminal F-BAR domain and two SH3 domains near their carboxyl-termini. We report here that FCHSD1 and FCHSD2 are expressed in mouse cochlear sensory hair cells. FCHSD1 mainly localizes to the cuticular plate, whereas FCHSD2 mainly localizes along the stereocilia in a punctuate pattern. Nervous Wreck (Nwk), the Drosophila ortholog of FCHSD1 and FCHSD2, has been shown to bind Wsp and play an important role in F-actin assembly. We show that, like its Drosophila counterpart, FCHSD2 interacts with WASP and N-WASP, the mammalian orthologs of Drosophila Wsp, and stimulates F-actin assembly in vitro. In contrast, FCHSD1 doesn't bind WASP or N-WASP, and can't stimulate F-actin assembly when tested in vitro. We found, however, that FCHSD1 binds via its F-BAR domain to the SH3 domain of Sorting Nexin 9 (SNX9), a well characterized BAR protein that has been shown to promote WASP-Arp2/3-dependent F-actin polymerization. FCHSD1 greatly enhances SNX9's WASP-Arp2/3-dependent F-actin polymerization activity. In hair cells, SNX9 was detected in the cuticular plate, where it colocalizes with FCHSD1. Our results suggest that FCHSD1 and FCHSD2 could modulate F-actin assembly or maintenance in hair cell stereocilia and cuticular plate.	[Cao, Huiren; Yin, Xiaolei; Cao, Yujie; Jin, Yecheng; Wang, Shan; Kong, Yanhui; Chen, Yuexing; Gao, Jiangang; Xu, Zhigang] Shandong Univ, Sch Life Sci, Inst Dev Biol, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan, Shandong, Peoples R China; [Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA USA; [Heller, Stefan] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA USA	Shandong University; Stanford University; Stanford University	Xu, ZG (corresponding author), Shandong Univ, Sch Life Sci, Inst Dev Biol, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan, Shandong, Peoples R China.	xuzg@sdu.edu.cn			National Basic Research Program of China (973) [2011CB504505]; National Natural Science Foundation of China [31070969]; Excellent Young Scientists Foundation of Shandong Province [BS2010SW017]; National Institutes of Health [DC004563, DC010363]	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Scientists Foundation of Shandong Province; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from National Basic Research Program of China (973) (2011CB504505) to ZX, National Natural Science Foundation of China (31070969) to ZX, Excellent Young Scientists Foundation of Shandong Province (BS2010SW017) to ZX, and National Institutes of Health grants DC004563 and DC010363 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; FLOCK A, 1977, J CELL BIOL, V75, P339, DOI 10.1083/jcb.75.2.339; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Heller S, 1998, P NATL ACAD SCI USA, V95, P11400, DOI 10.1073/pnas.95.19.11400; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Katoh M, 2004, INT J MOL MED, V13, P749; Kikkawa YS, 2008, ANAT REC, V291, P224, DOI 10.1002/ar.20632; Kruth KA, 2012, J BIOL CHEM, V287, P27217, DOI 10.1074/jbc.M112.377283; Legendre K, 2008, J CELL SCI, V121, P3347, DOI 10.1242/jcs.028134; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Merritt RC, 2012, CURR BIOL, V22, P320, DOI 10.1016/j.cub.2011.12.053; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; Ohno H, 2003, ONCOGENE, V22, P8422, DOI 10.1038/sj.onc.1206996; Pawlowski KS, 2006, JARO-J ASSOC RES OTO, V7, P83, DOI 10.1007/s10162-005-0024-5; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Rodal AA, 2011, J CELL BIOL, V193, P201, DOI 10.1083/jcb.201009052; Rzadzinska AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007097; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; SCARFONE E, 1988, NEUROSCI LETT, V93, P13, DOI 10.1016/0304-3940(88)90004-3; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Self T, 1998, DEVELOPMENT, V125, P557; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; SLEPECKY N, 1985, HEARING RES, V20, P245, DOI 10.1016/0378-5955(85)90029-2; SOBIN A, 1983, ACTA OTO-LARYNGOL, V96, P407, DOI 10.3109/00016488309132726; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Yan D, 2011, INT J EXP PATHOL, V92, P66, DOI 10.1111/j.1365-2613.2010.00751.x; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745	53	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56516	10.1371/journal.pone.0056516	http://dx.doi.org/10.1371/journal.pone.0056516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437151	gold, Green Submitted, Green Published			2022-12-27	WOS:000315184200089
J	Chung, PY; Chung, LY; Navaratnam, P				Chung, Pooi Yin; Chung, Lip Yong; Navaratnam, Parasakthi			Transcriptional Profiles of the Response of Methicillin-Resistant Staphylococcus aureus to Pentacyclic Triterpenoids	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; VIRULENCE DETERMINANTS; ANTIBIOTICS; EXPRESSION; MECA; INHIBITION; TARGETS	Staphylococcus aureus is an important human pathogen in both hospital and the community that has demonstrated resistance to all currently available antibiotics over the last two decades. Multidrug-resistant isolates of methicillin-resistant S. aureus (MRSA) exhibiting decreased susceptibilities to glycopeptides has also emerged, representing a crucial challenge for antimicrobial therapy and infection control. The availability of complete whole-genome nucleotide sequence data of various strains of S. aureus presents an opportunity to explore novel compounds and their targets to address the challenges presented by antimicrobial drug resistance in this organism. Study compounds alpha-amyrin [3 beta-hydroxy-urs-12-en-3-ol (AM)], betulinic acid [3 beta-hydroxy-20(29)-lupaene-28-oic acid (BA)] and betulinaldehyde [3 beta-hydroxy-20(29)-lupen-28-al (BE)] belong to pentacyclic triterpenoids and were reported to exhibit antimicrobial activities against bacteria and fungi, including S. aureus. The MIC values of these compounds against a reference strain of methicillin-resistant S. aureus (MRSA) (ATCC 43300) ranged from 64 mu g/ml to 512 mu g/ml. However, the response mechanisms of S. aureus to these compounds are still poorly understood. The transcription profile of reference strain of MRSA treated with sub-inhibitory concentrations of the three compounds was determined using Affymetrix GeneChips. The findings showed that these compounds regulate multiple desirable targets in cell division, two-component system, ABC transporters, fatty acid biosynthesis, peptidoglycan biosynthesis, aminoacyl-tRNA synthetase, ribosome and beta-lactam resistance pathways which could be further explored in the development of therapeutic agents for the treatment of S. aureus infections.	[Chung, Pooi Yin; Navaratnam, Parasakthi] Monash Univ, Sch Med & Hlth Sci, Selangor, Malaysia; [Chung, Lip Yong] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	Monash University; Monash University Sunway; Universiti Malaya	Chung, PY (corresponding author), Int Med Univ, Kuala Lumpur 57000, Malaysia.	pychu6@student.monash.edu	CHUNG, LIP YONG/B-7764-2010	CHUNG, LIP YONG/0000-0002-3596-768X	Ministry of Science, Technology and Innovation, Malaysia [02-02-10-SF0056]; Monash University [5140029-000-00]	Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Monash University(Monash University)	This project was partly funded by the Ministry of Science, Technology and Innovation, Malaysia (eScience 02-02-10-SF0056) (March 2010 to February 2012) and Monash University (Seed Grant 5140029-000-00) (April 2009 to March 2010) under Parasakthi Navaratnam. Both the funding bodies provided financial support for the conduct of the research and are not involved in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CT, 2003, CURR OPIN BIOTECH, V14, P621, DOI 10.1016/j.copbio.2003.10.003; Bio-Rad Laboratories, 2006, REAL TIM PCR APPL GU; Brotz-Oesterhelt H, 2010, FUTURE MICROBIOL, V5, P1553, DOI 10.2217/FMB.10.119; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; CASSELS R, 1995, J BACTERIOL, V177, P5161, DOI 10.1128/jb.177.17.5161-5165.1995; Champney W. Scott, 2006, Infectious Disorders - Drug Targets, V6, P377; Chandramu C, 2003, PHYTOTHER RES, V17, P129, DOI 10.1002/ptr.1088; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chung PY, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-25; Chung PY, 2004, PHARM BIOL, V42, P292, DOI 10.1080/13880200490511837; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Feng HH, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/617509; Gibbons S, 2004, NAT PROD REP, V21, P263, DOI 10.1039/b212695h; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Infectious Diseases Society of America (IDSA), 2004, BAD BUGS NO DRUGS AN; KuwaharaArai K, 1996, ANTIMICROB AGENTS CH, V40, P2680, DOI 10.1128/AAC.40.12.2680; Lange RP, 2007, CURR PHARM DESIGN, V13, P3140, DOI 10.2174/138161207782110408; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Maguire BA, 2009, MICROBIOL MOL BIOL R, V73, P22, DOI 10.1128/MMBR.00030-08; Mallavadhani UV, 2004, BIOL PHARM BULL, V27, P1576, DOI 10.1248/bpb.27.1576; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Monaghan RL, 2006, BIOCHEM PHARMACOL, V71, P901, DOI 10.1016/j.bcp.2005.11.023; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Ohlsen K, 2007, FUTURE MICROBIOL, V2, P655, DOI 10.2217/17460913.2.6.655; Park HS, 2007, J ANTIMICROB CHEMOTH, V60, P568, DOI 10.1093/jac/dkm236; Qiu JF, 2006, FEMS MICROBIOL LETT, V263, P26, DOI 10.1111/j.1574-6968.2006.00394.x; RYFFEL C, 1992, ANTIMICROB AGENTS CH, V36, P25, DOI 10.1128/AAC.36.1.25; Schuhly W, 1999, PLANTA MED, V65, P740, DOI 10.1055/s-1999-14054; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Singh B, 2003, PHYTOTHER RES, V17, P814, DOI 10.1002/ptr.1202; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Tao JS, 2000, EXPERT OPIN INV DRUG, V9, P1767, DOI 10.1517/13543784.9.8.1767; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Vollmer W, 2008, CHEM BIOL, V15, P93, DOI 10.1016/j.chembiol.2008.02.001; Wang DC, 2008, FEMS MICROBIOL LETT, V279, P217, DOI 10.1111/j.1574-6968.2007.01031.x; Weller TMA, 1999, J ANTIMICROB CHEMOTH, V43, P15, DOI 10.1093/jac/43.1.15; Xue T, 2011, INFECT IMMUN, V79, P2154, DOI 10.1128/IAI.01180-10; Yu L, 2008, J BIOTECHNOL, V135, P304, DOI 10.1016/j.jbiotec.2008.04.010; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	45	17	18	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56687	10.1371/journal.pone.0056687	http://dx.doi.org/10.1371/journal.pone.0056687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437212	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200142
J	Zhang, Y; Guo, XA; Wu, AH				Zhang, Yang; Guo, Xianan; Wu, Anhua			Association between a Novel Mutation in SLC20A2 and Familial Idiopathic Basal Ganglia Calcification	PLOS ONE			English	Article							APE LEUKEMIA-VIRUS; PHOSPHATE COTRANSPORTER; FAHR-DISEASE; IDENTIFICATION; BRAIN; LOCUS; PIT-1	Familial idiopathic basal ganglia calcification (FIBGC) is a rare, autosomal dominant disorder involving bilateral calcification of the basal ganglia. To identify gene mutations related to a Chinese FIBGC lineage, we evaluated available individuals in the family using CT scans. DNA was extracted from the peripheral blood of available family members, and both exonic and flanking intronic sequences of the SLC20A2 gene were amplified by PCR and then sequenced. Non-denaturing polyacrylamide gel electrophoresis (PAGE) was used to confirm the presence of mutations. Allele imbalances of the SLC20A2 gene or relative quantity of SLC20A2 transcripts were evaluated using qRT-PCR. A novel heterozygous single base-pair deletion (c.510delA) within the SLC20A2 gene was identified. This deletion mutation was found to co-segregate with basal ganglia calcification in all of the affected family members but was not detected in unaffected individuals or in 167 unrelated Han Chinese controls. The mutation will cause a frameshift, producing a truncated SLC20A2 protein with a premature termination codon, most likely leading to the complete loss of function of the SLC20A2 protein. This mutation may also lead to a reduction in SLC20A2 mRNA expression by approximately 30% in cells from affected individuals. In conclusion, we identified a novel mutation in SLC20A2 that is linked to FIBGC. In addition to the loss of function at the protein level, decreasing the expression of SLC20A2 mRNA may be another mechanism that can regulate SLC20A2 function in IBGC individuals. We propose that the regional expression pattern of SLC20A1 and SLC20A2 might explain the unique calcification pattern observed in FIBGC patients.	[Zhang, Yang; Guo, Xianan; Wu, Anhua] China Med Univ, Coll Basic Med Sci, Minist Educ, Res Ctr Med Genom,Key Lab Med Cell Biol, Shenyang, Peoples R China; [Wu, Anhua] China Med Univ, Affiliated Hosp 1, Dept Neurosurg, Shenyang, Peoples R China	China Medical University; China Medical University	Wu, AH (corresponding author), China Med Univ, Coll Basic Med Sci, Minist Educ, Res Ctr Med Genom,Key Lab Med Cell Biol, Shenyang, Peoples R China.	wuanhua@yahoo.com			National Natural Science Foundation of China [81071283]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was mainly supported by the National Natural Science Foundation of China (81071283). The funder's website: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barker PB, 1999, MAGNET RESON MED, V41, P400, DOI 10.1002/(SICI)1522-2594(199902)41:2<400::AID-MRM26>3.0.CO;2-E; Bottger P, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-21; Casanova MF, 2003, PSYCHIAT RES, V121, P59, DOI 10.1016/S0165-1781(03)00202-6; Dai XH, 2010, AM J MED GENET B, V153B, P1305, DOI 10.1002/ajmg.b.31102; Geschwind DH, 1999, AM J HUM GENET, V65, P764, DOI 10.1086/302558; Gonzalez M, 2009, CURR VASC PHARMACOL, V7, P506, DOI 10.2174/157016109789043946; Lagrue E, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-91; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Manyam BV, 2001, MOVEMENT DISORD, V16, P258, DOI 10.1002/mds.1049; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; Oliveira JRM, 2004, NEUROLOGY, V63, P2165, DOI 10.1212/01.WNL.0000145601.88274.88; Tsuchiya Y, 2011, INTERNAL MED, V50, P2351, DOI 10.2169/internalmedicine.50.5747; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; Villa-Bellosta R, 2010, PFLUG ARCH EUR J PHY, V459, P499, DOI 10.1007/s00424-009-0746-z; Volpato CB, 2009, J MOL NEUROSCI, V39, P346, DOI 10.1007/s12031-009-9287-3; Waleria-Aleixo A, 2000, DIAGN MICR INFEC DIS, V36, P225, DOI 10.1016/S0732-8893(00)00112-7; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Werner A, 1998, J EXP BIOL, V201, P3135	21	43	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57060	10.1371/journal.pone.0057060	http://dx.doi.org/10.1371/journal.pone.0057060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437308	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200207
J	Pang, ZL; Shao, JP; Chen, L; Lu, XH; Hu, J; Qin, ZH; Liu, XL				Pang, Zhili; Shao, Jingpeng; Chen, Lei; Lu, Xiaohong; Hu, Jian; Qin, Zhaohai; Liu, Xili			Resistance to the Novel Fungicide Pyrimorph in Phytophthora capsici: Risk Assessment and Detection of Point Mutations in CesA3 That Confer Resistance	PLOS ONE			English	Article							BASE-LINE SENSITIVITY; PLANT PATHOGEN; HOST-RANGE; BLIGHT; VIRULENCE; MEFENOXAM; POPULATION; DIVERSITY; METALAXYL; GENES	Pyrimorph is a novel fungicide with high activity against the plant pathogen Phytophthora capsici. We investigated the risk that P. capsici can develop resistance to pyrimorph. The baseline sensitivities of 226 P. capsici isolates, tested by mycelial growth inhibition, showed a unimodal distribution with a mean EC50 value of 1.4261 (+/-0.4002) mu g/ml. Twelve pyrimorph-resistant mutants were obtained by repeated exposure to pyrimorph in vitro with a frequency of approximately 1 x 10(-4). The resistance factors of the mutants ranged from 10.67 to 56.02. Pyrimorph resistance of the mutants was stable after 10 transfers on pyrimorph-free medium. Fitness in sporulation, cystospore germination, and pathogenicity in the pyrimorph-resistant mutants was similar to or less than that in the parental wild-type isolates. On detached pepper leaves and pepper plants treated with the recommended maximum dose of pyrimorph, however, virulence was greater for mutants with a high level of pyrimorph resistance than for the wild type. The results suggest that the risk of P. capsici developing resistance to pyrimorph is low to moderate. Among mutants with a high level of pyrimorph resistance, EC50 values for pyrimorph and CAA fungicides flumorph, dimethomorph, and mandipropamid were positively correlated. This indicated that point mutations in cellulose synthase 3 (CesA3) may confer resistance to pyrimorph. Comparison of CesA3 in isolates with a high level of pyrimorph resistance and parental isolates showed that an amino acid change from glutamine to lysine at position 1077 resulted in stable, high resistance in the mutants. Based on the point mutations, an allele-specific PCR method was developed to detect pyrimorph resistance in P. capsici populations.	[Pang, Zhili; Shao, Jingpeng; Chen, Lei; Lu, Xiaohong; Hu, Jian; Liu, Xili] China Agr Univ, Coll Agr & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China; [Qin, Zhaohai] China Agr Univ, Coll Sci, Dept Appl Chem, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Liu, XL (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China.	seedling@cau.edu.cn	Chen, Lei/A-2487-2015	Chen, Lei/0000-0001-5331-9574; Pang, Zhili/0000-0001-8047-1272	China National Science Foundation [31272061]; special Fund for Agro-scientific Research in the Public Interest [201003004, 201303023]	China National Science Foundation(National Natural Science Foundation of China (NSFC)); special Fund for Agro-scientific Research in the Public Interest	This work was funded by the China National Science Foundation (NO. 31272061) and special Fund for Agro-scientific Research in the Public Interest (No. 201003004, 201303023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2011, PEST MANAG SCI, V67, P1557, DOI 10.1002/ps.2214; Bi Y, 2011, PHYTOPATHOLOGY, V101, P1104, DOI 10.1094/PHYTO-01-11-0010; Blum M, 2011, PEST MANAG SCI, V67, P1211, DOI 10.1002/ps.2238; Blum M, 2010, FUNGAL GENET BIOL, V47, P499, DOI 10.1016/j.fgb.2010.02.009; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; BRASIER CM, 1979, T BRIT MYCOL SOC, V72, P111, DOI 10.1016/S0007-1536(79)80015-7; Cafe AC, 1995, PLANT PATHOL, V44, P1025, DOI 10.1111/j.1365-3059.1995.tb02661.x; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042069; Chen Xiao-xia, 2007, Nongyaoxue Xuebao, V9, P229; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davidson CR, 2002, PLANT DIS, V86, P1049, DOI [10.1094/PDIS.2002.86.9.1049A, 10.1094/PDIS.2002.86.7.813B]; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Dunn AR, 2010, PLANT DIS, V94, P1461, DOI 10.1094/PDIS-03-10-0221; Enzenbacher TB, 2012, PLANT DIS, V96, P1404, DOI 10.1094/PDIS-09-11-0771-RE; Gevens AJ, 2007, PHYTOPATHOLOGY, V97, P421, DOI 10.1094/PHYTO-97-4-0421; Granke LL, 2012, EUR J PLANT PATHOL, V132, P281, DOI 10.1007/s10658-011-9873-4; HARTMAN GL, 1993, PLANT DIS, V77, P588, DOI 10.1094/PD-77-0588; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Hayashi K, 2004, THEOR APPL GENET, V108, P1212, DOI 10.1007/s00122-003-1553-0; Huang Xiong-ying, 2007, Nongyaoxue Xuebao, V9, P376; HWANG BK, 1995, PLANT DIS, V79, P221, DOI 10.1094/PD-79-0221; KIM FS, 1992, PLANT DIS, V76, P486, DOI 10.1094/PD-76-0486; Kreutzer WA, 1940, PHYTOPATHOLOGY, V30, P972; Lamour KH, 2000, PHYTOPATHOLOGY, V90, P396, DOI 10.1094/PHYTO.2000.90.4.396; Lamour KH, 2012, MOL PLANT PATHOL, V13, P329, DOI 10.1111/j.1364-3703.2011.00754.x; Leonian LH, 1922, PHYTOPATHOLOGY, V12, P401; Liu YongGang, 2008, Acta Phytophylacica Sinica, V35, P448; Lu XH, 2010, PHYTOPATHOLOGY, V100, P1162, DOI 10.1094/PHYTO-12-09-0351; Luo HeRong, 1999, Journal of Hunan Agricultural University, V25, P52; McINTOSH D. L., 1964, CAN J BOT, V42, P1411, DOI 10.1139/b64-137; Parra G, 2001, PLANT DIS, V85, P1069, DOI 10.1094/PDIS.2001.85.10.1069; [戚仁德 Qi Rende], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P45; Qin Z., 2005, China Patent CN, Patent No. 566095; Quesada-Ocampo LM, 2011, PHYTOPATHOLOGY, V101, P1061, DOI 10.1094/PHYTO-11-10-0325; RAMSEY G. B., 1960, PLANT DIS REPORTER, V44, P692; Ristaino JB, 1998, APPL ENVIRON MICROB, V64, P948; Silvar C, 2006, PLANT DIS, V90, P1135, DOI 10.1094/PD-90-1135; Sun HY, 2010, J PHYTOPATHOL, V158, P244, DOI 10.1111/j.1439-0434.2009.01606.x; Sun WX, 2008, CAN J PLANT PATHOL, V30, P414, DOI 10.1080/07060660809507539; Tian D, 2004, PLANT DIS, V88, P485, DOI 10.1094/PDIS.2004.88.5.485; Wang HC, 2009, PLANT PATHOL, V58, P571, DOI 10.1111/j.1365-3059.2008.01990.x; Yan XJ, 2010, J AGR FOOD CHEM, V58, P2720, DOI 10.1021/jf902410x; Yin YN, 2010, PESTIC BIOCHEM PHYS, V97, P36, DOI 10.1016/j.pestbp.2009.12.002; Zhao CQ, 2011, PEST MANAG SCI, V67, P1178, DOI 10.1002/ps.2198; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06; Zhu SS, 2008, PEST MANAG SCI, V64, P255, DOI 10.1002/ps.1515	46	52	59	10	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56513	10.1371/journal.pone.0056513	http://dx.doi.org/10.1371/journal.pone.0056513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431382	gold, Green Published, Green Submitted			2022-12-27	WOS:000315182800024
J	Rana, S; Lattoo, SK; Dhar, N; Razdan, S; Bhat, WW; Dhar, RS; Vishwakarma, R				Rana, Satiander; Lattoo, Surrinder K.; Dhar, Niha; Razdan, Sumeer; Bhat, Wajid Waheed; Dhar, Rekha S.; Vishwakarma, Ram			NADPH-Cytochrome P450 Reductase: Molecular Cloning and Functional Characterization of Two Paralogs from Withania somnifera (L.) Dunal	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; CDNA CLONING; ARABIDOPSIS-THALIANA; STRUCTURE PREDICTION; SQUALENE SYNTHASE; ELECTRON-TRANSFER; ESCHERICHIA-COLI; GENE-EXPRESSION; WITHAFERIN-A; BIOSYNTHESIS	Withania somnifera (L.) Dunal, a highly reputed medicinal plant, synthesizes a large array of steroidal lactone triterpenoids called withanolides. Although its chemical profile and pharmacological activities have been studied extensively during the last two decades, limited attempts have been made to decipher the biosynthetic route and identification of key regulatory genes involved in withanolide biosynthesis. Cytochrome P450 reductase is the most imperative redox partner of multiple P450s involved in primary and secondary metabolite biosynthesis. We describe here the cloning and characterization of two paralogs of cytochrome P450 reductase from W. somnifera. The full length paralogs of WsCPR1 and WsCPR2 have open reading frames of 2058 and 2142 bp encoding 685 and 713 amino acid residues, respectively. Phylogenetic analysis demonstrated that grouping of dual CPRs was in accordance with class I and class II of eudicotyledon CPRs. The corresponding coding sequences were expressed in Escherichia coli as glutathione-S-transferase fusion proteins, purified and characterized. Recombinant proteins of both the paralogs were purified with their intact membrane anchor regions and it is hitherto unreported for other CPRs which have been purified from microsomal fraction. Southern blot analysis suggested that two divergent isoforms of CPR exist independently in Withania genome. Quantitative real-time PCR analysis indicated that both genes were widely expressed in leaves, stalks, roots, flowers and berries with higher expression level of WsCPR2 in comparison to WsCPR1. Similar to CPRs of other plant species, WsCPR1 was un-inducible while WsCPR2 transcript level increased in a time-dependent manner after elicitor treatments. High performance liquid chromatography of withanolides extracted from elicitor-treated samples showed a significant increase in two of the key withanolides, withanolide A and withaferin A, possibly indicating the role of WsCPR2 in withanolide biosynthesis. Present investigation so far is the only report of characterization of CPR paralogs from W. somnifera.	[Rana, Satiander; Lattoo, Surrinder K.; Dhar, Niha; Razdan, Sumeer; Bhat, Wajid Waheed; Dhar, Rekha S.; Vishwakarma, Ram] Indian Inst Integrat Med CSIR, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Lattoo, SK (corresponding author), Indian Inst Integrat Med CSIR, Canal Rd, Jammu, India.	sklattoo@iiim.ac.in	Rana, Satiander/G-3696-2012; Bhat, Wajid Waheed/E-6645-2012	Rana, Satiander/0000-0001-9197-8378; Bhat, Wajid Waheed/0000-0002-7049-8671; DHAR, NIHA/0000-0002-3295-8016	Council of Scientific and Industrial Research, Government of India, New Delhi [NWP 0008]	Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The financial grant from Council of Scientific and Industrial Research, Government of India, New Delhi under Network Project NWP 0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigrain L, 2009, ACTA CRYSTALLOGR F, V65, P210, DOI 10.1107/S1744309109000700; ANDERSEN JF, 1994, BIOCHEMISTRY-US, V33, P2171, DOI 10.1021/bi00174a025; BENVENISTE I, 1991, BIOCHEM BIOPH RES CO, V177, P105, DOI 10.1016/0006-291X(91)91954-B; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Dhar RS, 2006, PHYTOCHEMISTRY, V67, P2269, DOI 10.1016/j.phytochem.2006.07.014; Duan Hui, 2006, Phytochemistry Reviews, V5, P507, DOI 10.1007/s11101-006-9009-1; Eberle D, 2009, PLANT MOL BIOL, V69, P239, DOI 10.1007/s11103-008-9420-7; ELSAKKA M, 1990, Revista Medico-Chirurgicala Societatii di Medici si Naturalisti din Iasi, V94, P385; Feldmann KA, 2001, CURR OPIN PLANT BIOL, V4, P162, DOI 10.1016/S1369-5266(00)00154-0; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hrycay EG, 2012, ARCH BIOCHEM BIOPHYS, V522, P71, DOI 10.1016/j.abb.2012.01.003; Huang FC, 2012, PLANT SCI, V190, P16, DOI 10.1016/j.plantsci.2012.03.007; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Jayaprakasam B, 2010, PHYTOTHER RES, V24, P859, DOI 10.1002/ptr.3033; Jennewein S, 2005, BIOTECHNOL BIOENG, V89, P588, DOI 10.1002/bit.20390; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim OT, 2010, PLANT CELL REP, V29, P403, DOI 10.1007/s00299-010-0831-y; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Koopmann E, 1997, P NATL ACAD SCI USA, V94, P14954, DOI 10.1073/pnas.94.26.14954; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lattoo SK, 2007, CURR SCI INDIA, V92, P1390; Lee MH, 2004, PLANT CELL PHYSIOL, V45, P976, DOI 10.1093/pcp/pch126; McLean KJ, 2005, BIOCHEM SOC T, V33, P796, DOI 10.1042/BST0330796; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Mizutani M, 1998, PLANT PHYSIOL, V116, P357, DOI 10.1104/pp.116.1.357; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Pal S, 2011, J HORTIC SCI BIOTECH, V86, P391, DOI 10.1080/14620316.2011.11512779; Pritchard MP, 1998, PHARMACOGENETICS, V8, P33, DOI 10.1097/00008571-199802000-00005; Ranathunga S., 2012, INTERFACING COGNITIV, P1; Razdan S, 2012, MOL BIOL REP, P1; Ro DK, 2002, PLANT PHYSIOL, V130, P1837, DOI 10.1104/pp.008011; Rosco A, 1997, ARCH BIOCHEM BIOPHYS, V348, P369, DOI 10.1006/abbi.1997.0374; Sambrook J., 2001, MOL CLONING LAB MANU; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Schwarz H, 2009, PLANT BIOLOGY, V11, P300, DOI 10.1111/j.1438-8677.2008.00137.x; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHEN A, 1993, PROTEIN ENG, V6, P50; SHET MS, 1993, P NATL ACAD SCI USA, V90, P2890, DOI 10.1073/pnas.90.7.2890; SIMMONS DL, 1985, J BIOL CHEM, V260, P515; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Varadarajan J, 2010, NEW PHYTOL, V187, P67, DOI 10.1111/j.1469-8137.2010.03254.x; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Yang CQ, 2010, PHYTOCHEMISTRY, V71, P27, DOI 10.1016/j.phytochem.2009.09.026	57	43	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57068	10.1371/journal.pone.0057068	http://dx.doi.org/10.1371/journal.pone.0057068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437311	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000072
J	Werzner, A; Pavlidis, P; Ometto, L; Stephan, W; Laurent, S				Werzner, Annegret; Pavlidis, Pavlos; Ometto, Lino; Stephan, Wolfgang; Laurent, Stefan			Selective Sweep in the Flotillin-2 Region of European Drosophila melanogaster	PLOS ONE			English	Article							POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; GENE-EXPRESSION; SEGREGATING SITES; HITCHHIKING; POLYMORPHISM; POPULATIONS; DEMOGRAPHY; SIGNATURE; PROTEINS	Localizing genes that are subject to recent positive selection is a major goal of evolutionary biology. In the model organism Drosophila melanogaster many attempts have been made in recent years to identify such genes by conducting so-called genome scans of selection. These analyses consisted in typing a large number of genetic markers along the genomes of a sample of individuals and then identifying those loci that harbor patterns of genetic variation, which are compatible with the ones generated by a selective sweep. In this study we conduct an in-depth analysis of a genomic region located on the X chromosome of D. melanogaster that was identified as a potential target of recent positive selection by a previous genome scan of selection. To this end we re-sequenced 20 kilobases around the Flotillin-2 gene (Flo-2) and conducted a detailed analysis of the allele frequencies and linkage disequilibria observed in this new dataset. The results of this analysis reveal eight genetic novelties that are specific to temperate populations of D. melanogaster and that may have arisen during the expansion of the species outside its ancestral sub-Saharan habitat since about 16,000 years ago.	[Werzner, Annegret; Pavlidis, Pavlos; Ometto, Lino; Stephan, Wolfgang; Laurent, Stefan] Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany	University of Munich	Laurent, S (corresponding author), Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany.	laurent@bio.lmu.de	Ometto, Lino/C-3609-2008; Stephan, Wolfgang/GOV-6503-2022	Ometto, Lino/0000-0002-2679-625X; 	DFG Research Unit "Natural selection in structured populations" [STE 325/12]; Volkswagen-Foundation [I/824234]	DFG Research Unit "Natural selection in structured populations"; Volkswagen-Foundation(Volkswagen)	This work has been supported by funds from the DFG Research Unit "Natural selection in structured populations" (grant STE 325/12) to WS and grant I/824234 from the Volkswagen-Foundation to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2002, GENETICS, V162, P2025; Beisswanger S, 2006, GENETICS, V172, P265, DOI 10.1534/genetics.105.049346; Beisswanger S, 2008, P NATL ACAD SCI USA, V105, P5447, DOI 10.1073/pnas.0710892105; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Duchen P, 2013, GENETICS; Fay JC, 2000, GENETICS, V155, P1405; Fiston-Lavier AS, 2010, GENE, V463, P18, DOI 10.1016/j.gene.2010.04.015; Glinka S, 2003, GENETICS, V165, P1269; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Hoehne M, 2005, MOL CELL NEUROSCI, V30, P326, DOI 10.1016/j.mcn.2005.07.007; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Juarez MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002424; KAPLAN NL, 1989, GENETICS, V123, P887; Katanaev VL, 2008, EMBO J, V27, P509, DOI 10.1038/sj.emboj.7601981; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Kim Y, 2002, GENETICS, V160, P765; Laurent SJY, 2011, MOL BIOL EVOL, V28, P2041, DOI 10.1093/molbev/msr031; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MEREDITH J, 1993, DEV BIOL, V159, P500, DOI 10.1006/dbio.1993.1259; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Pavlidis P, 2010, GENETICS, V185, P907, DOI 10.1534/genetics.110.116459; Przeworski M, 2002, GENETICS, V160, P1179; Ramos-Onsins SE, 2007, GENET RES, V89, P231, DOI 10.1017/S0016672307008877; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; Stephan W, 2006, GENETICS, V172, P2647, DOI 10.1534/genetics.105.050179; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Stuermer CAO, 2005, BIOCHEM SOC SYMP, V72, P109, DOI 10.1042/bss0720109; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Svetec N, 2011, MOL ECOL, V20, P530, DOI 10.1111/j.1365-294X.2010.04951.x; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Takeuchi H, 2005, BIOCHEM J, V389, P637, DOI 10.1042/BJ20050498; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002478	49	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56629	10.1371/journal.pone.0056629	http://dx.doi.org/10.1371/journal.pone.0056629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437190	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000036
J	Cheng, PH; Rao, XM; McMasters, KM; Zhou, HS				Cheng, Pei-Hsin; Rao, Xiao-Mei; McMasters, Kelly M.; Zhou, Heshan Sam			Molecular Basis for Viral Selective Replication in Cancer Cells: Activation of CDK2 by Adenovirus-Induced Cyclin E	PLOS ONE			English	Article							E1B 55-KILODALTON PROTEIN; P53 TUMOR-SUPPRESSOR; BREAST-CANCER; RETINOBLASTOMA PROTEIN; DEPENDENT KINASES; IN-VIVO; DNA-REPLICATION; WEIGHT FORMS; RNA OVEREXPRESSION; REPRESSES P53	Adenoviruses (Ads) with deletion of E1b55K preferentially replicate in cancer cells and have been used in cancer therapies. We have previously shown that Ad E1B55K protein is involved in induction of cyclin E for Ad replication, but this E1B55K function is not required in cancer cells in which deregulation of cyclin E is frequently observed. In this study, we investigated the interaction of cyclin E and CDK2 in Ad-infected cells. Ad infection significantly increased the large form of cyclin E (cyclin EL), promoted cyclin E/CDK2 complex formation and increased CDK2 phosphorylation at the T160 site. Activated CDK2 caused pRb phosphorylation at the S612 site. Repression of CDK2 activity with the chemical inhibitor roscovitine or with specific small interfering RNAs significantly decreased pRb phosphorylation, with concomitant repression of viral replication. Our results suggest that Ad-induced cyclin E activates CDK2 that targets the transcriptional repressor pRb to generate a cellular environment for viral productive replication. This study reveals a new molecular basis for oncolytic replication of E1b-deleted Ads and will aid in the development of new strategies for Ad oncolytic virotherapies.	[Cheng, Pei-Hsin; McMasters, Kelly M.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McMasters, Kelly M.; Zhou, Heshan Sam] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA; [Rao, Xiao-Mei; Zhou, Heshan Sam] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Zhou, Heshan Sam] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Zhou, HS (corresponding author), Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA.	hszhou01@louisville.edu			NIH Grant [R01 CA129975]; K. C. Huang Scholarship from the University of Louisville; NATIONAL CANCER INSTITUTE [R01CA129975] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); K. C. Huang Scholarship from the University of Louisville; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grant R01 CA129975 (to HSZ http://www.nih.gov/). PHC is partially supported by the K. C. Huang Scholarship from the University of Louisville (http://louisville.edu/medschool/pharmacology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akli S, 2004, CANCER RES, V64, P3198, DOI 10.1158/0008-5472.CAN-03-3672; Akli S, 2010, CLIN CANCER RES, V16, P1179, DOI 10.1158/1078-0432.CCR-09-1787; Avvakumov N, 2002, J GEN VIROL, V83, P517, DOI 10.1099/0022-1317-83-3-517; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; Ben-Israel H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1369, DOI 10.2741/ben; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; BRAITHWAITE A, 1990, VIROLOGY, V177, P595, DOI 10.1016/0042-6822(90)90525-V; Chou MM, 2003, J BIOL CHEM, V278, P35241, DOI 10.1074/jbc.M305246200; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; Dix BR, 2001, J VIROL, V75, P5443, DOI 10.1128/JVI.75.12.5443-5447.2001; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; DYSON N, 1992, CANCER SURV, V12, P161; Freemantle SJ, 2010, CANCER PREV RES, V3, P1513, DOI 10.1158/1940-6207.CAPR-10-0297; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Geoerger B, 2002, CANCER RES, V62, P764; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Goodrum FD, 1998, J VIROL, V72, P9479, DOI 10.1128/JVI.72.12.9479-9490.1998; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Harwell RM, 2004, J BIOL CHEM, V279, P12695, DOI 10.1074/jbc.M313407200; HAYFLICK L, 1962, AM J HYG, V75, P240, DOI 10.1093/oxfordjournals.aje.a120247; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hobom U, 2004, J VIROL, V78, P7685, DOI 10.1128/JVI.78.14.7685-7697.2004; Hsieh WS, 2009, CLIN CANCER RES, V15, P1435, DOI 10.1158/1078-0432.CCR-08-1748; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; KAO CC, 1990, VIROLOGY, V179, P806, DOI 10.1016/0042-6822(90)90148-K; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Loeb KR, 2005, CANCER CELL, V8, P35, DOI 10.1016/j.ccr.2005.06.010; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; LUDLOW JW, 1995, VIRUS RES, V35, P113, DOI 10.1016/0168-1702(94)00094-S; Marone M, 1998, INT J CANCER, V75, P34, DOI 10.1002/(SICI)1097-0215(19980105)75:1<34::AID-IJC6>3.0.CO;2-2; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Nevels M, 1997, P NATL ACAD SCI USA, V94, P1206, DOI 10.1073/pnas.94.4.1206; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Pelka P, 2011, J VIROL, V85, P8841, DOI 10.1128/JVI.00539-11; Pennella MA, 2010, J VIROL, V84, P12210, DOI 10.1128/JVI.01442-10; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Querido E, 1997, J VIROL, V71, P3788, DOI 10.1128/JVI.71.5.3788-3798.1997; Rao XM, 2006, VIROLOGY, V350, P418, DOI 10.1016/j.virol.2006.02.009; Rao XM, 2004, CANCER GENE THER, V11, P585, DOI 10.1038/sj.cgt.7700739; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Rogulski KR, 2000, CANCER RES, V60, P1193; Rothmann T, 1998, J VIROL, V72, P9470, DOI 10.1128/JVI.72.12.9470-9478.1998; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Sawasaki T, 2001, J SOC GYNECOL INVEST, V8, P179, DOI 10.1016/S1071-5576(01)00102-2; Schmitz NMR, 2005, LEUKEMIA, V19, P1783, DOI 10.1038/sj.leu.2403900; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shenk T, 2001, VIROLOGY, P2265; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wienzek S, 2000, J VIROL, V74, P193, DOI 10.1128/JVI.74.1.193-202.2000; Wingate H, 2009, CELL CYCLE, V8, P1062, DOI 10.4161/cc.8.7.8119; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhao TJ, 2003, CANCER RES, V63, P3073; Zheng X, 2006, CANCER GENE THER, V13, P572, DOI 10.1038/sj.cgt.7700923; Zheng X, 2008, J VIROL, V82, P3415, DOI 10.1128/JVI.01708-07; Zhu HY, 2005, J BIOL CHEM, V280, P29282, DOI 10.1074/jbc.M407352200	93	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57340	10.1371/journal.pone.0057340	http://dx.doi.org/10.1371/journal.pone.0057340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437375	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200247
J	Fujimoto, Z; Suzuki, R; Shiotsuki, T; Tsuchiya, W; Tase, A; Momma, M; Yamazaki, T				Fujimoto, Zui; Suzuki, Rintaro; Shiotsuki, Takahiro; Tsuchiya, Wataru; Tase, Akira; Momma, Mitsuru; Yamazaki, Toshimasa			Crystal Structure of Silkworm Bombyx mori JHBP in Complex With 2-Methyl-2,4-Pentanediol: Plasticity of JH-Binding Pocket and Ligand-Induced Conformational Change of the Second Cavity in JHBP	PLOS ONE			English	Article							JUVENILE-HORMONE-BINDING; PROTEIN; HEMOLYMPH; AFFINITY; MODEL; SPECTROSCOPY; ISOMERS	Juvenile hormones (JHs) control a diversity of crucial life events in insects. In Lepidoptera which major agricultural pests belong to, JH signaling is critically controlled by a species-specific high-affinity, low molecular weight JH-binding protein (JHBP) in hemolymph, which transports JH from the site of its synthesis to target tissues. Hence, JHBP is expected to be an excellent target for the development of novel specific insect growth regulators (IGRs) and insecticides. A better understanding of the structural biology of JHBP should pave the way for the structure-based drug design of such compounds. Here, we report the crystal structure of the silkworm Bombyx mori JHBP in complex with two molecules of 2-methyl-2,4-pentanediol (MPD), one molecule (MPD1) bound in the JH-binding pocket while the other (MPD2) in a second cavity. Detailed comparison with the apo-JHBP and JHBP-JH II complex structures previously reported by us led to a number of intriguing findings. First, the JH-binding pocket changes its size in a ligand-dependent manner due to flexibility of the gate alpha 1 helix. Second, MPD1 mimics interactions of the epoxide moiety of JH previously observed in the JHBP-JH complex, and MPD can compete with JH in binding to the JH-binding pocket. We also confirmed that methoprene, which has an MPD-like structure, inhibits the complex formation between JHBP and JH while the unepoxydated JH III (methyl farnesoate) does not. These findings may open the door to the development of novel IGRs targeted against JHBP. Third, binding of MPD to the second cavity of JHBP induces significant conformational changes accompanied with a cavity expansion. This finding, together with MPD2-JHBP interaction mechanism identified in the JHBP-MPD complex, should provide important guidance in the search for the natural ligand of the second cavity.	[Fujimoto, Zui; Suzuki, Rintaro; Tsuchiya, Wataru; Tase, Akira; Momma, Mitsuru; Yamazaki, Toshimasa] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki, Japan; [Shiotsuki, Takahiro] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Yamazaki, T (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki, Japan.	tyamazak@nias.affrc.go.jp	Suzuki, Rintaro/J-8016-2012	Fujimoto, Zui/0000-0002-3551-6854; tu wu, she/0000-0001-6693-7320	Program for Promotion of Basic Research Activities for Innovative Bioscience of Japan (PROBRAIN); NIAS Strategic Research Fund	Program for Promotion of Basic Research Activities for Innovative Bioscience of Japan (PROBRAIN); NIAS Strategic Research Fund	The authors acknowledge the financial support from the Program for Promotion of Basic Research Activities for Innovative Bioscience of Japan (PROBRAIN) and the NIAS Strategic Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Dobryszycki P, 2004, BIOPHYS J, V86, P1138, DOI 10.1016/S0006-3495(04)74188-0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; GOODMAN W, 1978, P NATL ACAD SCI USA, V75, P185, DOI 10.1073/pnas.75.1.185; Goodman W.G., 1985, P491; GRENIER S, 1993, ANN APPL BIOL, V122, P369, DOI 10.1111/j.1744-7348.1993.tb04042.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamiaux C, 2009, J BIOL CHEM, V284, P3496, DOI 10.1074/jbc.M807467200; Henrick CA, 2007, J AM MOSQUITO CONTR, V23, P225, DOI 10.2987/8756-971X(2007)23[225:M]2.0.CO;2; HIDAYAT P, 1994, INSECT BIOCHEM MOLEC, V24, P709, DOI 10.1016/0965-1748(94)90058-2; Kawabata T, 2010, PROTEINS, V78, P1195, DOI 10.1002/prot.22639; Kolodziejczyk R, 2008, J MOL BIOL, V377, P870, DOI 10.1016/j.jmb.2008.01.026; KRAMER KJ, 1974, P NATL ACAD SCI USA, V71, P493, DOI 10.1073/pnas.71.2.493; Krzyzanowska D, 1998, J PEPT RES, V51, P96; KURATA K, 1994, COMP BIOCHEM PHYS B, V109, P105, DOI 10.1016/0305-0491(94)90147-3; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Metcalf R. L., 1993, DESTRUCTIVE USEFUL I; MIYAMOTO J, 1993, ACS SYM SER, V524, P144; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OZYHAR A, 1987, EUR J BIOCHEM, V162, P675, DOI 10.1111/j.1432-1033.1987.tb10690.x; PRESTWICH GD, 1985, P NATL ACAD SCI USA, V82, P5290, DOI 10.1073/pnas.82.16.5290; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; ROLLER H, 1967, ANGEW CHEM INT EDIT, V6, P179, DOI 10.1002/anie.196701792; SCHOOLEY DA, 1978, BIOCHEM BIOPH RES CO, V81, P743, DOI 10.1016/0006-291X(78)91414-6; SEVALA VL, 1993, INVERTEBR REPROD DEV, V23, P189, DOI 10.1080/07924259.1993.9672314; Shimanuki H., 1992, HIVE HONEY BE, VRev. ed.; Stobiecka A, 2008, FRONT BIOSCI-LANDMRK, V13, P2866, DOI 10.2741/2891; Suzuki R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00133; Suzuki R, 2009, BIOMOL NMR ASSIGN, V3, P73, DOI 10.1007/s12104-009-9144-x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TOUHARA K, 1993, BIOCHEMISTRY-US, V32, P2068, DOI 10.1021/bi00059a026; TROWELL SC, 1992, COMP BIOCHEM PHYS B, V103, P795, DOI 10.1016/0305-0491(92)90196-X; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Vermunt AMW, 2001, INSECT MOL BIOL, V10, P147, DOI 10.1046/j.1365-2583.2001.00249.x; WIECZOREK E, 1991, EUR J BIOCHEM, V201, P347, DOI 10.1111/j.1432-1033.1991.tb16292.x; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2	42	10	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56261	10.1371/journal.pone.0056261	http://dx.doi.org/10.1371/journal.pone.0056261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437107	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200054
J	He, J; Jing, Y; Li, W; Qian, X; Xu, Q; Li, FS; Liu, LZ; Jiang, BH; Jiang, Y				He, Jun; Jing, Yi; Li, Wei; Qian, Xu; Xu, Qing; Li, Feng-Shan; Liu, Ling-Zhi; Jiang, Bing-Hua; Jiang, Yue			Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis	PLOS ONE			English	Article							HUMAN OVARIAN-CANCER; RIBOSOMAL S6 KINASE; GROWTH-FACTOR; MICRORNA EXPRESSION; DOWN-REGULATION; ACTIVATION; CELLS; ERBB2; STATISTICS; INCREASES	MicroRNAs (miRNAs) have been shown to be involved in different aspects of cancer biology including tumor angiogenesis. In this study, we identified that two miRNAs, miR-199a and miR-125b were downregulated in ovarian cancer tissues and cell lines. Overexpression of miR-199a and miR-125b inhibited tumor-induced angiogenesis associated with the decrease of HIF-1 alpha and VEGF expression in ovarian cancer cells. Moreover, the levels of miR-199a and miR-125b were negatively correlated with VEGF mRNA levels in ovarian tissues. We further showed that direct targets of miR-199a and miR-125b HER2 and HER3 were functionally relevant. Forced expression of HER2 and HER3 rescued miR-199a- and miR-125b-inhibiting angiogenesis responses and Akt/p70S6K1/HIF-1 alpha pathway. This study provides a rationale for new therapeutic approach to suppress tumor angiogenesis using miR-199a, miR-125b, or their mimics for ovarian cancer treatment in the future.	[He, Jun; Li, Wei; Qian, Xu; Xu, Qing; Jiang, Bing-Hua] Nanjing Med Univ, State Key Lab Reprod Med, Dept Pathol, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [He, Jun; Jing, Yi; Liu, Ling-Zhi; Jiang, Bing-Hua] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Li, Feng-Shan] Nanjing Maternal & Child Care Serv Ctr, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Jiang, Yue] Fujian Normal Univ, Fac Software, Fuzhou, Fujian, Peoples R China; [Jiang, Yue] Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China	Nanjing Medical University; Jefferson University; Fujian Normal University; Fujian Normal University	Jiang, BH (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Dept Pathol, Ctr Canc, Nanjing, Jiangsu, Peoples R China.	binghjiang@yahoo.com; yuejiang123@hotmail.com		Liu, Ling-Zhi/0000-0001-9234-457X; Jiang, Bing-Hua/0000-0003-4526-2031; He, Jun/0000-0002-5162-6041; Hartl, Carla/0000-0001-9769-7462	National Natural Science Foundation of China [81071642, 30871296]; National Cancer Institute, NIH [R01CA109460]; NATIONAL CANCER INSTITUTE [R01CA109460] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Natural Science Foundation of China (81071642 and 30871296), and by National Cancer Institute, NIH (R01CA109460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; He J, 2012, EMBO REP, V13, P1116, DOI 10.1038/embor.2012.162; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Plummer PN, 2013, CANCER RES, V73, P341, DOI 10.1158/0008-5472.CAN-12-0271; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Staszel T, 2011, POL ARCH MED WEWN, V121, P361, DOI 10.20452/pamw.1093; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	26	92	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56647	10.1371/journal.pone.0056647	http://dx.doi.org/10.1371/journal.pone.0056647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437196	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200127
J	Khalifeh, H; Howard, LM; Osborn, D; Moran, P; Johnson, S				Khalifeh, Hind; Howard, Louise M.; Osborn, David; Moran, Paul; Johnson, Sonia			Violence against People with Disability in England and Wales: Findings from a National Cross-Sectional Survey	PLOS ONE			English	Article							SEVERE MENTAL-ILLNESS; SEXUAL ASSAULT; VICTIMIZATION; PREVALENCE; WOMEN; ADULTS; RISK; DISORDER	Background: The recent World Report on Disability highlighted violence as a leading cause of morbidity among disabled people. However, we know little about the extent to which people with disability experience different violence types, and associated health/economic costs. The recent introduction of disability measures into the England&Wales victimization survey provided an opportunity to address this gap. Methods and Findings: Analysis of the 2009/10 British Crime Survey (BCS), a nationally representative cross-sectional survey of 44,398 adults living in residential households in England&Wales. Using multivariate logistic regression, we estimated the relative odds of being a victim of past-year violence (physical/sexual domestic or non-domestic violence) in people with disability compared to those without, after adjusting for socio-demographics, behavioural and area confounders. 1256/44398(2.4%) participants had one or more disabilities including mental illness ('mental illness') and 7781(13.9%) had one or more disabilities excluding mental illness ('non-mental disability'). Compared with the non-disabled, those with mental illness had adjusted relative odds (aOR) of 3.0(95% confidence interval (CI) 2.3-3.8) and those with non-mental disability had aOR of 1.8(95% CI: 1.5-2.2) of being a victim of past-year violence (with similar relative odds for domestic and non-domestic violence). Disabled victims were more likely to suffer mental ill health as a result of violence than non-disabled victims. The proportion of violence that could be attributed to the independent effect of disability in the general population was 7.5%(CI 5.7-9.3%), at an estimated cost of 1.51 pound billion. The main study limitation is the exclusion of institutionalised people with disability. Conclusions: People with disability are at increased risk of being victims of domestic and non-domestic violence, and of suffering mental ill health when victimized. The related public health and economic burden calls for an urgent assessment of the causes of this violence, and national policies on violence prevention in this vulnerable group.	[Khalifeh, Hind; Osborn, David; Johnson, Sonia] UCL, Mental Hlth Sci Unit, London, England; [Howard, Louise M.; Moran, Paul] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; University College London; University of London; King's College London	Khalifeh, H (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	h.khalifeh@ucl.ac.uk	Johnson, Sonia/A-5220-2008; Howard, Louise/E-3495-2010; Johnson, Sonia/ABF-1457-2020; Moran, Paul A/B-1740-2010; Osborn PhD FRCPsych, David/B-8165-2009	Johnson, Sonia/0000-0002-2219-1384; Howard, Louise/0000-0001-9942-744X; Johnson, Sonia/0000-0002-2219-1384; Moran, Paul A/0000-0002-9257-8699; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Khalifeh, Hind/0000-0002-4627-0546	MRC Population Health Scientist Fellowship; National Institute for Health Research (NIHR) South London; Maudsley NHS Foundation Trust/King's College London specialist Biomedical Research Centre for Mental Health; NIHR Programme Grant for Applied Research [RP-PG-0108-10084]; Medical Research Council [G0802434] Funding Source: researchfish; MRC [G0802434] Funding Source: UKRI	MRC Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust/King's College London specialist Biomedical Research Centre for Mental Health; NIHR Programme Grant for Applied Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HK was funded by an MRC Population Health Scientist Fellowship. LH and PM were supported by the National Institute for Health Research (NIHR) South London and Maudsley NHS Foundation Trust/King's College London specialist Biomedical Research Centre for Mental Health. LH was supported by an NIHR Programme Grant for Applied Research (RP-PG-0108-10084: Improving the healthcare response to domestic violence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Casteel C, 2008, INJURY PREV, V14, P87, DOI 10.1136/ip.2007.016451; Chapple B, 2004, SOC PSYCH PSYCH EPID, V39, P836, DOI 10.1007/s00127-004-0819-4; Dean K, 2007, ACTA PSYCHIAT SCAND, V116, P345, DOI 10.1111/j.1600-0447.2007.01078.x; Department for Work and Pensions, 2011, FAM RES SURV UK 2009; Dubourg R., 2005, ESTIMATES EC SOCIAL; Equality and Human Rights Commission, 2011, HIDD PLAIN SIGHT INQ; Goodman LA, 1999, J TRAUMA STRESS, V12, P587, DOI 10.1023/A:1024708916143; Goodman LA, 2001, J TRAUMA STRESS, V14, P615, DOI 10.1023/A:1013026318450; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hall P., 2010, CRIME ENGLAND WALES; Hiday VA, 1999, PSYCHIATR SERV, V50, P62, DOI 10.1176/ps.50.1.62; Hodgins S, 2009, SOC PSYCH PSYCH EPID, V44, P448, DOI 10.1007/s00127-008-0460-8; Home Office, 2011, PROV MAD MULT UN COS; Home Office, 2018, EC SOCIAL COSTS CRIM; Home Office Research Development and Statistics Directorate and BMRB, 2010, SOC RES BRIT CRIM SU; Howard LM, 2010, PSYCHOL MED, V40, P881, DOI 10.1017/S0033291709991589; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Khalifeh H, 2010, INT REV PSYCHIATR, V22, P535, DOI 10.3109/09540261.2010.506185; Lin LP, 2009, RES DEV DISABIL, V30, P969, DOI 10.1016/j.ridd.2009.02.001; Lund EM, 2011, TRAUMA VIOLENCE ABUS, V12, P171, DOI 10.1177/1524838011416377; Marge Dorothy K., 2003, CALL ACTION ENDING C; Martin SL, 2006, VIOLENCE AGAINST WOM, V12, P823, DOI 10.1177/1077801206292672; Meade CS, 2009, AIDS BEHAV, V13, P207, DOI 10.1007/s10461-007-9326-4; Nocon A, 2011, DISABLED PEOPLES EXP; Office for National Statistics, 2010, POP EST UK ENGL WAL; Organisation WH, 2010, VIOL PREV EV OV; Plummer SB, 2012, TRAUMA VIOLENCE ABUS, V13, P15, DOI 10.1177/1524838011426014; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Silver E, 2005, AM J PUBLIC HEALTH, V95, P2015, DOI 10.2105/AJPH.2003.021436; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; TNS-BMRB, 2010, BRIT CRIM SURV 2009; Walby S., 2009, COST DOMESTIC VIOLEN; Walby S., 2004, HOME OFFICE RES STUD; Walby S., 2004, COST DOMESTIC VIOLEN; Walsh E, 2003, BRIT J PSYCHIAT, V183, P233, DOI 10.1192/bjp.183.3.233; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organisation, 2009, VIOL PREV EV RED VIO; World Health Organization, 2002, WORLD REPORT VIOLENC	39	40	40	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55952	10.1371/journal.pone.0055952	http://dx.doi.org/10.1371/journal.pone.0055952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437079	gold, Green Published			2022-12-27	WOS:000315184200034
J	Looi, CY; Arya, A; Cheah, FK; Muharram, B; Leong, KH; Mohamad, K; Wong, WF; Rai, N; Mustafa, MR				Looi, Chung Yeng; Arya, Aditya; Cheah, Foo Kit; Muharram, Bushra; Leong, Kok Hoong; Mohamad, Khalit; Wong, Won Fen; Rai, Nitika; Mustafa, Mohd Rais			Induction of Apoptosis in Human Breast Cancer Cells via Caspase Pathway by Vernodalin Isolated from Centratherum anthelminticum (L.) Seeds	PLOS ONE			English	Article							CHROMATOGRAPHY MASS-SPECTROMETRY; DEPENDENT KINASE INHIBITOR; L KUNTZE SEED; SESQUITERPENE LACTONES; LIQUID-CHROMATOGRAPHY; TRADITIONAL MEDICINE; VERNONIA-AMYGDALINA; VERNOLIC ACID; MCF-7 CELLS; T-CELLS	Background: Centratherum anthelminticum (L.) seeds (CA) is a well known medicinal herb in Indian sub-continent. We recently reported anti-oxidant property of chloroform fraction of Centratherum anthelminticum (L.) seeds (CACF) by inhibiting tumor necrosis factor-alpha (TNF-alpha)-induced growth of human breast cancer cells. However, the active compounds in CACF have not been investigated previously. Methodology/Principal Findings: In this study, we showed that CACF inhibited growth of MCF-7 human breast cancer cells. CACF induced apoptosis in MCF-7 cells as marked by cell size shrinkage, deformed cytoskeletal structure and DNA fragmentation. To identify the cytotoxic compound, CACF was subjected to bioassay-guided fractionation which yielded 6 fractions. CACF fraction A and B (CACF-A, -B) demonstrated highest activity among all the fractions. Further HPLC isolation, NMR and LC-MS analysis of CACF-A led to identification of vernodalin as the cytotoxic agent in CACF-A, and -B. 12,13-dihydroxyoleic acid, another major compound in CACF-C fraction was isolated for the first time from Centratherum anthelminticum (L.) seeds but showed no cytotoxic effect against MCF-7 cells. Vernodalin inhibited cell growth of human breast cancer cells MCF-7 and MDA-MB-231 by induction of cell cycle arrest and apoptosis. Increased of reactive oxygen species (ROS) production, coupled with downregulation of anti-apoptotic molecules (Bcl-2, Bcl-xL) led to reduction of mitochondrial membrane potential (MMP) and release of cytochrome c in both human breast cancer cells treated with vernodalin. Release of cytochrome c from mitochondria to cytosol triggered activation of caspase cascade, PARP cleavage, DNA damage and eventually cell death. Conclusions/Significance: To the best of our knowledge, this is the first comprehensive study on cytotoxic and apoptotic mechanism of vernodalin isolated from the Centratherum anthelminticum (L.) seeds in human breast cancer cells. Overall, our data suggest a potential therapeutic value of vernodalin to be further developed as new anti-cancer drug.	[Looi, Chung Yeng; Arya, Aditya; Cheah, Foo Kit; Muharram, Bushra; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Arya, Aditya; Leong, Kok Hoong; Mohamad, Khalit] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Rai, Nitika] Amritum Biobot Herbs Res Lab Pvt Ltd, Jogli, India	Universiti Malaya; Universiti Malaya; Universiti Malaya	Looi, CY (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	looicy@um.edu.my	Looi, Chung Yeng/A-2623-2013; Mustafa, Mohamed R/B-1647-2009; Mohd, Mustafa b Ali/B-9184-2010; Leong, Kok Hoong/D-9505-2012; Leong, Kok Hoong/J-1956-2015; Wong, Won Fen/D-3087-2012	Looi, Chung Yeng/0000-0002-4830-3495; Mustafa, Mohamed R/0000-0002-7864-5189; Mohd, Mustafa b Ali/0000-0002-4220-5384; Leong, Kok Hoong/0000-0002-7317-6117; Leong, Kok Hoong/0000-0002-7317-6117; Wong, Won Fen/0000-0003-1082-1956; Arya, Aditya/0000-0002-8747-3462	University Malaya [RP001-2012B]; University Malaya High Impact research grant from Ministry of Higher Education (MOHE), Malaysia [H-20001-E00002]	University Malaya(Universiti Malaya); University Malaya High Impact research grant from Ministry of Higher Education (MOHE), Malaysia	This study was supported by University Malaya research grant (RP001-2012B) and University Malaya High Impact research grant (H-20001-E00002) from Ministry of Higher Education (MOHE), Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwood JW, 2010, PHYTOCHEM ANALYSIS, V21, P33, DOI 10.1002/pca.1187; Ani V, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-40; Arya A, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/627256; Ashok P, 2010, INDIAN J PHARM SCI, V72, P697, DOI 10.4103/0250-474X.84577; Azaizeh H, 2006, EVID-BASED COMPL ALT, V3, P229, DOI 10.1093/ecam/nel034; Ballot C, 2009, MOL CANCER THER, V8, P3307, DOI 10.1158/1535-7163.MCT-09-0639; BHAKUNI DS, 1969, INDIAN J EXP BIOL, V7, P250; Cheng JT, 2000, J CLIN PHARMACOL, V40, P445, DOI 10.1177/00912700022009198; Chinnaiyan Arul M., 1999, Neoplasia (New York), V1, P5; Chukwujekwu JC, 2009, S AFR J BOT, V75, P176, DOI 10.1016/j.sajb.2008.10.001; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; DEKOK TMCM, 1994, CARCINOGENESIS, V15, P1399, DOI 10.1093/carcin/15.7.1399; Drexler HG, 1998, LEUKEMIA, V12, P845, DOI 10.1038/sj.leu.2401043; Engel RH, 2006, FRONT BIOSCI-LANDMRK, V11, P300, DOI 10.2741/1798; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hedenfalk IA, 2002, ADV CANCER RES, V84, P1, DOI 10.1016/S0065-230X(02)84001-5; HENION JD, 1980, BIOMED MASS SPECTROM, V7, P115, DOI 10.1002/bms.1200070306; Hosamani KM, 2000, IND CROP PROD, V12, P93, DOI 10.1016/S0926-6690(00)00041-8; Hosamani KM, 2003, IND CROP PROD, V18, P111, DOI 10.1016/S0926-6690(03)00031-1; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Kasim LS, 2011, PAK J PHARM SCI, V24, P475; KOSHIMIZU K, 1994, PHYSIOL BEHAV, V56, P1209, DOI 10.1016/0031-9384(94)90368-9; Kottke TJ, 2002, J BIOL CHEM, V277, P804, DOI 10.1074/jbc.M108419200; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kumar S, 1999, CLIN EXP PHARMACOL P, V26, P295, DOI 10.1046/j.1440-1681.1999.03031.x; KUPCHAN SM, 1969, J ORG CHEM, V34, P3908, DOI 10.1021/jo01264a035; Lambertini E, 2004, INT J ONCOL, V24, P419; Lev E, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-4; Liu Wen-Zhe, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P405; Liu YQ, 2010, TETRAHEDRON LETT, V51, P6584, DOI 10.1016/j.tetlet.2010.10.031; Looi CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023640; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mc Gee MM, 2002, FEBS LETT, V515, P66, DOI 10.1016/S0014-5793(02)02440-7; MORRIS LJ, 1969, LIPIDS, V4, P50, DOI 10.1007/BF02531794; Niessen WMA, 1998, J CHROMATOGR A, V794, P407, DOI 10.1016/S0021-9673(97)01112-6; Oh SY, 2007, MOL CANCER THER, V6, P2178, DOI 10.1158/1535-7163.MCT-07-0111; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Pan MH, 2010, J AGR FOOD CHEM, V58, P226, DOI 10.1021/jf903067g; Paris F, 2002, MOL CELL ENDOCRINOL, V193, P43, DOI 10.1016/S0303-7207(02)00094-1; Pedersen MM, 2009, PHYTOCHEMISTRY, V70, P601, DOI 10.1016/j.phytochem.2009.02.005; Purnima A, 2009, INDIAN J PHARM SCI, V71, P461, DOI 10.4103/0250-474X.57302; Rabe T, 2002, J ETHNOPHARMACOL, V80, P91, DOI 10.1016/S0378-8741(02)00010-7; Sarkar FH, 2007, ACTA PHARMACOL SIN, V28, P1305, DOI 10.1111/j.1745-7254.2007.00689.x; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Sharma S, 1991, J Hyg Epidemiol Microbiol Immunol, V35, P157; Shimizu S, 1996, ONCOGENE, V13, P21; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; SINGHAL K C, 1992, Indian Journal of Experimental Biology, V30, P546; Tan AR, 2002, SEMIN ONCOL, V29, P77, DOI 10.1053/sonc.2002.34059; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; VOLKOV SK, 1994, J CHROMATOGR B, V660, P405, DOI 10.1016/0378-4347(94)00290-8; Wang Q, 2011, CURR MED CHEM, V18, P2025, DOI 10.2174/092986711795590110; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Wong WF, 2012, J IMMUNOL, V188, P5408, DOI 10.4049/jimmunol.1102991; Wong YH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/164689; Woo HJ, 2011, J ETHNOPHARMACOL, V135, P626, DOI 10.1016/j.jep.2011.03.067; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yesilada E, 2004, J ETHNOPHARMACOL, V95, P213, DOI 10.1016/j.jep.2004.07.021; Yu R, 2006, J INT MED RES, V34, P231, DOI 10.1177/147323000603400301	67	100	101	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56643	10.1371/journal.pone.0056643	http://dx.doi.org/10.1371/journal.pone.0056643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437193	gold, Green Published, Green Accepted			2022-12-27	WOS:000315184200125
J	Lucchi, NW; Narayanan, J; Karell, MA; Xayavong, M; Kariuki, S; DaSilva, AJ; Hill, V; Udhayakumar, V				Lucchi, Naomi W.; Narayanan, Jothikumar; Karell, Mara A.; Xayavong, Maniphet; Kariuki, Simon; DaSilva, Alexandre J.; Hill, Vincent; Udhayakumar, Venkatachalam			Molecular Diagnosis of Malaria by Photo-Induced Electron Transfer Fluorogenic Primers: PET-PCR	PLOS ONE			English	Article							18S RIBOSOMAL-RNA; PLASMODIUM-FALCIPARUM; TESTS; EPIDEMIOLOGY; ELIMINATION; GAMETOCYTES; MICROSCOPY; TANZANIA; VIVAX; ASSAY	There is a critical need for developing new malaria diagnostic tools that are sensitive, cost effective and capable of performing large scale diagnosis. The real-time PCR methods are particularly robust for large scale screening and they can be used in malaria control and elimination programs. We have designed novel self-quenching photo-induced electron transfer (PET) fluorogenic primers for the detection of P. falciparum and the Plasmodium genus by real-time PCR. A total of 119 samples consisting of different malaria species and mixed infections were used to test the utility of the novel PET-PCR primers in the diagnosis of clinical samples. The sensitivity and specificity were calculated using a nested PCR as the gold standard and the novel primer sets demonstrated 100% sensitivity and specificity. The limits of detection for P. falciparum was shown to be 3.2 parasites/mu l using both Plasmodium genus and P. falciparum-specific primers and 5.8 parasites/mu l for P. ovale, 3.5 parasites/mu l for P. malariae and 5 parasites/mu l for P. vivax using the genus specific primer set. Moreover, the reaction can be duplexed to detect both Plasmodium spp. and P. falciparum in a single reaction. The PET-PCR assay does not require internal probes or intercalating dyes which makes it convenient to use and less expensive than other real-time PCR diagnostic formats. Further validation of this technique in the field will help to assess its utility for large scale screening in malaria control and elimination programs.	[Lucchi, Naomi W.; Xayavong, Maniphet; DaSilva, Alexandre J.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Narayanan, Jothikumar; Hill, Vincent] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Karell, Mara A.; Udhayakumar, Venkatachalam] Atlanta Res & Educ Fdn, VA Med Ctr, Decatur, GA USA; [Kariuki, Simon] Ctr Dis Control & Prevent, Malaria Branch, Kenya Med Res Inst, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Kenya Medical Research Institute	Lucchi, NW (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	NLucchi@cdc.gov	Hill, Vincent/G-1789-2012; Kariuki, Simon/AFT-6596-2022	Hill, Vincent/0000-0001-7069-7737; Lucchi, Naomi/0000-0001-8789-8041; Karell, Mara/0000-0003-3875-4679	Atlanta Research and Education Foundation, Atlanta, Georgia; Malaria Branch, CDC	Atlanta Research and Education Foundation, Atlanta, Georgia; Malaria Branch, CDC	This study was supported by the Atlanta Research and Education Foundation, Atlanta, Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Malaria Branch, CDC, for supporting this project and Dr. John W. Barnwell for proving some of the samples used in this study. The use of trade names and names of commercial sources is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention or the U.S. Department of Health and Human Services. The findings and conclusions in this presentation are those of the authors and do not necessarily represent those of the Centers for Disease Control and Prevention.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], 2011, PLOS MED, V8; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Erdman Laura K, 2008, Travel Med Infect Dis, V6, P82, DOI 10.1016/j.tmaid.2007.10.001; Gamboa D, PLOS ONE, V5, pe8091; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Nazarenko Irina, 2006, V335, P95; Ngasala B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-199; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	22	82	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56677	10.1371/journal.pone.0056677	http://dx.doi.org/10.1371/journal.pone.0056677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437209	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200139
J	Powers, KE; Heatherton, TF				Powers, Katherine E.; Heatherton, Todd F.			Implicitly Priming the Social Brain: Failure to Find Neural Effects	PLOS ONE			English	Article							EXCLUSION; BELONG; NEED; SELF; ACTIVATION; REJECTION; BEHAVIOR; TRAIT; AUTOMATICITY; PURSUIT	Humans have a fundamental need for social relationships. Rejection from social groups is especially detrimental, rendering the ability to detect threats to social relationships and respond in adaptive ways critical. Indeed, previous research has shown that experiencing social rejection alters the processing of subsequent social cues in a variety of socially affiliative and avoidant ways. Because social perception and cognition occurs spontaneously and automatically, detecting threats to social relationships may occur without conscious awareness or control. Here, we investigated the automaticity of social threat detection by examining how implicit primes affect neural responses to social stimuli. However, despite using a well-established implicit priming paradigm and large sample size, we failed to find any evidence that implicit primes induced changes at the neural level. That implicit primes influence behavior has been demonstrated repeatedly and across a variety of domains, and our goal is not to question these effects. Rather, we offer the present study as cautionary evidence that such a paradigm may not be amenable to scanning in an fMRI environment.	[Powers, Katherine E.; Heatherton, Todd F.] Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College	Powers, KE (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA.	katherine.e.powers@dartmouth.edu			National Institute of Mental Health [R01MH059282]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059282] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant from the National Institute of Mental Health (R01MH059282) to TFH. (www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2002, BRIT J SOC PSYCHOL, V41, P123, DOI 10.1348/014466602165090; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P506, DOI 10.1111/j.1751-9004.2007.00020.x; Bowlby J, 1969, ATTACHMENT LOSS SEPA; DeWall CN, 2006, J PERS SOC PSYCHOL, V91, P1, DOI 10.1037/0022-3514.91.1.1; DeWall CN, 2011, J PERS, V79, P979, DOI 10.1111/j.1467-6494.2010.00695.x; DeWall CN, 2010, SOC PSYCHOL PERS SCI, V1, P168, DOI 10.1177/1948550610361387; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2005, SOCIAL OUTCAST OSTRA, P109; Fitzsimons GM, 2003, J PERS SOC PSYCHOL, V84, P148, DOI 10.1037/0022-3514.84.1.148; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gardner WL, 2000, PERS SOC PSYCHOL B, V26, P486, DOI 10.1177/0146167200266007; Heatherton TF, 2011, ANNU REV PSYCHOL, V62, P363, DOI 10.1146/annurev.psych.121208.131616; Levesque C, 2003, PERS SOC PSYCHOL B, V29, P1570, DOI 10.1177/0146167203256877; Maner JK, 2007, J PERS SOC PSYCHOL, V92, P42, DOI 10.1037/0022-3514.92.1.42; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; MITCHELL JP, 2009, COGNITIVE NEUROSCIEN, P951; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; Powers KE, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00046; Powers KE, SOC COGN AF IN PRESS; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Sommer KL, 2002, PERS SOC PSYCHOL B, V28, P926, DOI 10.1177/01467202028007006; SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037/0022-3514.37.10.1660; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Twenge JM, 2003, J PERS SOC PSYCHOL, V85, P409, DOI 10.1037/0022-3514.85.3.409; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; Vohs KD, 2001, J PERS SOC PSYCHOL, V81, P1103, DOI 10.1037/0022-3514.81.6.1103; Wagner DD, 2011, CEREB CORTEX, V21, P2788, DOI 10.1093/cercor/bhr074; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548	36	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56596	10.1371/journal.pone.0056596	http://dx.doi.org/10.1371/journal.pone.0056596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437183	Green Published, gold			2022-12-27	WOS:000315184200118
J	Telwala, Y; Brook, BW; Manish, K; Pandit, MK				Telwala, Yasmeen; Brook, Barry W.; Manish, Kumar; Pandit, Maharaj K.			Climate-Induced Elevational Range Shifts and Increase in Plant Species Richness in a Himalayan Biodiversity Epicentre	PLOS ONE			English	Article							MOUNTAIN PLANTS; INDIAN HIMALAYA; VASCULAR PLANTS; NEPAL HIMALAYA; ALPS; DISTRIBUTIONS; VEGETATION; DIVERSITY; MIGRATION; RESPONSES	Global average temperature increase during the last century has induced species geographic range shifts and extinctions. Montane floras, in particular, are highly sensitive to climate change and mountains serve as suitable observation sites for tracing climate-induced biological response. The Himalaya constitute an important global biodiversity hotspot, yet studies on species' response to climate change from this region are lacking. Here we use historical (1849-50) and the recent (2007-2010) data on temperature and endemic species' elevational ranges to perform a correlative study in the two alpine valleys of Sikkim. We show that the ongoing warming in the alpine Sikkim Himalaya has transformed the plant assemblages. This study lends support to the hypothesis that changing climate is causing species distribution changes. We provide first evidence of warmer winters in the region compared to the last two centuries, with mean temperatures of the warmest and the coldest months may have increased by 0.76 +/- 0.25 degrees C and 3.65 +/- 2 degrees C, respectively. Warming-driven geographical range shifts were recorded in 87% of 124 endemic plant species studied in the region; upper range extensions of species have resulted in increased species richness in the upper alpine zone, compared to the 19th century. We recorded a shift of 23998 m in species' upper elevation limit and a mean upward displacement rate of 27.53 +/- 22.04 m/decade in the present study. We infer that the present-day plant assemblages and community structure in the Himalaya is substantially different from the last century and is, therefore, in a state of flux under the impact of warming. The continued trend of warming is likely to result in ongoing elevational range contractions and eventually, species extinctions, particularly at mountaintops.	[Telwala, Yasmeen; Manish, Kumar; Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Telwala, Yasmeen; Manish, Kumar; Pandit, Maharaj K.] Univ Delhi, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India; [Brook, Barry W.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Brook, Barry W.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Pandit, Maharaj K.] Natl Univ Singapore, Univ Scholars Programme, Singapore 117548, Singapore	University of Delhi; University of Delhi; University of Adelaide; University of Adelaide; National University of Singapore	Pandit, MK (corresponding author), Univ Delhi, Dept Environm Studies, Delhi 110007, India.	rajkpandit@gmail.com	Pandit, Maharaj K/A-4065-2014; Brook, Barry W./G-2686-2011; Manish, Kumar/M-5034-2019	Pandit, Maharaj K/0000-0001-6611-560X; Brook, Barry W./0000-0002-2491-1517; Manish, Kumar/0000-0002-0373-0426	Research Fellowship award of the University Grants Commission (UGC), Government of India	Research Fellowship award of the University Grants Commission (UGC), Government of India	The study was supported by Research Fellowship award of the University Grants Commission (UGC), Government of India to YT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann D., 1995, P81; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bluemle P, 1999, ENV GEOSCI, V6, P63; CISMHE, 2007, CARR CAP STUD TEEST, VII; DAS SM, 1966, NATURE, V212, P1327, DOI 10.1038/2121327a0; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Folland CK, 2001, CLIMATE CHANGE 2001; Gansser A., 1964, GEOLOGY HIMALAYA; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Grumbine RE, 2013, SCIENCE, V339, P36, DOI 10.1126/science.1227211; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Guisan A, 2000, INTEGRAT ASS, V1, P307; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Harris SA, 2007, ERDKUNDE, V61, P344, DOI 10.3112/erdkunde.2007.04.05; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holzinger B, 2008, PLANT ECOL, V195, P179, DOI 10.1007/s11258-007-9314-9; HOOKER JD, 1854, HIMALAYAN J; Klanderud K, 2003, HOLOCENE, V13, P1, DOI 10.1191/0959683603hl589ft; KORNER C, 1988, SYM SOC EXP BIOL, V42, P25; Korner C, 1999, ALPINE PLANT LIFE FU; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Liu X., 1998, CHINESE GEOGR SCI, V8, P289, DOI DOI 10.1007/S11769-997-0034-9; Meehl GA, 1996, GEOPHYS RES LETT, V23, P3755, DOI 10.1029/96GL03478; Miehe G, 1996, PALAEOGEOGR PALAEOCL, V120, P5, DOI 10.1016/0031-0182(95)00031-3; OHSAWA M, 1986, MT RES DEV, V6, P143, DOI 10.2307/3673268; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Pandit MK, 2009, CONSERV BIOL, V23, P1346, DOI 10.1111/j.1523-1739.2009.01359.x; Pandit MK, 2012, CONSERV BIOL, V26, P1061, DOI 10.1111/j.1523-1739.2012.01918.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Price LW, 1981, MOUNTAINS MAN; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; Salick J, 2009, GLOBAL ENVIRON CHANG, V19, P147, DOI 10.1016/j.gloenvcha.2009.01.008; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shrestha AB, 2000, INT J CLIMATOL, V20, P317, DOI 10.1002/(SICI)1097-0088(20000315)20:3&lt;317::AID-JOC476&gt;3.0.CO;2-G; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; SINGH JS, 1987, BOT REV, V53, P80, DOI 10.1007/BF02858183; Smith WW, 1911, VEGETATION ZEMU LHON; STOHLGREN TJ, 1995, VEGETATIO, V117, P113, DOI 10.1007/BF00045503; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	49	176	180	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57103	10.1371/journal.pone.0057103	http://dx.doi.org/10.1371/journal.pone.0057103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437322	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200215
J	Chang, SX; Wang, YK; Lu, JJ; Gai, JY; Li, JJ; Chu, P; Guan, RZ; Zhao, TJ				Chang, Shengxin; Wang, Yankun; Lu, Jiangjie; Gai, Junyi; Li, Jijie; Chu, Pu; Guan, Rongzhan; Zhao, Tuanjie			The Mitochondrial Genome of Soybean Reveals Complex Genome Structures and Gene Evolution at Intercellular and Phylogenetic Levels	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CHLOROPLAST GENOME; NUCLEAR GENOME; MALE-STERILITY; DNA; RNA; L.; CLASSIFICATION; RECOMBINATION; ORGANIZATION	Determining mitochondrial genomes is important for elucidating vital activities of seed plants. Mitochondrial genomes are specific to each plant species because of their variable size, complex structures and patterns of gene losses and gains during evolution. This complexity has made research on the soybean mitochondrial genome difficult compared with its nuclear and chloroplast genomes. The present study helps to solve a 30-year mystery regarding the most complex mitochondrial genome structure, showing that pairwise rearrangements among the many large repeats may produce an enriched molecular pool of 760 circles in seed plants. The soybean mitochondrial genome harbors 58 genes of known function in addition to 52 predicted open reading frames of unknown function. The genome contains sequences of multiple identifiable origins, including 6.8 kb and 7.1 kb DNA fragments that have been transferred from the nuclear and chloroplast genomes, respectively, and some horizontal DNA transfers. The soybean mitochondrial genome has lost 16 genes, including nine protein-coding genes and seven tRNA genes; however, it has acquired five chloroplast-derived genes during evolution. Four tRNA genes, common among the three genomes, are derived from the chloroplast. Sizeable DNA transfers to the nucleus, with pericentromeric regions as hotspots, are observed, including DNA transfers of 125.0 kb and 151.6 kb identified unambiguously from the soybean mitochondrial and chloroplast genomes, respectively. The soybean nuclear genome has acquired five genes from its mitochondrial genome. These results provide biological insights into the mitochondrial genome of seed plants, and are especially helpful for deciphering vital activities in soybean.	[Chang, Shengxin; Lu, Jiangjie; Gai, Junyi; Guan, Rongzhan; Zhao, Tuanjie] Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [Chang, Shengxin; Lu, Jiangjie; Gai, Junyi; Guan, Rongzhan; Zhao, Tuanjie] Minist Agr, Key Lab Biol & Genet Improvement Soybean, Nanjing, Jiangsu, Peoples R China; [Chang, Shengxin; Wang, Yankun; Gai, Junyi; Li, Jijie; Chu, Pu; Guan, Rongzhan; Zhao, Tuanjie] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Guan, RZ (corresponding author), Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China.	guanrzh@njau.edu.cn; tjzhao@njau.edu.cn	lujiang, grant/E-4785-2010	Guan, Rongzhan/0000-0001-9177-6610	National Key Basic Research Program of China [2011CB1093, 2010CB1259, 2011CB109300]; National Hightech R&D Program of China [2012AA101106]; National Key Technology RD Program [2010BAD01B02, 2011BAD13B09]; National Natural Science Foundation of China [31071442, 30970289]	National Key Basic Research Program of China(National Basic Research Program of China); National Hightech R&D Program of China(National High Technology Research and Development Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (2011CB1093, 2010CB1259, 2011CB109300), the National Hightech R&D Program of China (2012AA101106), the National Key Technology R&D Program (2010BAD01B02, 2011BAD13B09) and the National Natural Science Foundation of China (31071442, 30970289). The authors wish to thank Shanghai Majorbio Bio-pharm Biotechnology Company (China) for their help with sequencing of the mtDNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Adams KL, 2001, GENETICS, V158, P1289; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Arrieta-Montiel M, 2001, GENETICS, V158, P851; BAILEYSERRES J, 1987, CURR GENET, V12, P49, DOI 10.1007/BF00420727; Berg OG, 2000, MOL BIOL EVOL, V17, P951, DOI 10.1093/oxfordjournals.molbev.a026376; Blanchard JL, 1996, MOL BIOL EVOL, V13, P893, DOI 10.1093/oxfordjournals.molbev.a025650; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Chen J, 2011, PLOS ONE, V10; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Du JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-113; EHARA T, 1990, EXP CELL RES, V190, P104, DOI 10.1016/0014-4827(90)90150-9; Feng X, 2009, THEOR APPL GENET, V118, P1361, DOI 10.1007/s00122-009-0986-5; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; GRABAU EA, 1992, CROP SCI, V32, P271, DOI 10.2135/cropsci1992.0011183X003200010055x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Henze K, 2001, TRENDS GENET, V17, P383, DOI 10.1016/S0168-9525(01)02312-5; Hong YG, 1998, VIROLOGY, V246, P158, DOI 10.1006/viro.1998.9178; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Janska H, 1998, PLANT CELL, V10, P1163, DOI 10.1105/tpc.10.7.1163; JOYCE PBM, 1989, NUCLEIC ACIDS RES, V17, P5461, DOI 10.1093/nar/17.14.5461; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Kwok EY, 2004, J MICROSC-OXFORD, V214, P124, DOI 10.1111/j.0022-2720.2004.01317.x; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Liu HT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-163; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; LONSDALE DM, 1984, NUCLEIC ACIDS RES, V12, P9249, DOI 10.1093/nar/12.24.9249; Manchekar M, 2006, J MOL BIOL, V356, P288, DOI 10.1016/j.jmb.2005.11.070; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MOEYKENS CA, 1995, PLANT MOL BIOL, V29, P245, DOI 10.1007/BF00043649; MOTA M, 1963, CYTOLOGIA, V28, P409, DOI 10.1508/cytologia.28.409; Mower JP, 2012, GENOME BIOL EVOL, V4, P670, DOI 10.1093/gbe/evs042; Newton K.J., 2004, PLANT MITOCHONDRIA; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rousseau-Gueutin M, 2011, PLANT PHYSIOL, V157, P2181, DOI 10.1104/pp.111.185074; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr001, 10.1093/gbe/evr068]; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; SYNENKI RM, 1978, PLANT PHYSIOL, V61, P460, DOI 10.1104/pp.61.3.460; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thorsness PE, 1996, INT REV CYTOL, V165, P207, DOI 10.1016/S0074-7696(08)62223-8; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; YU HS, 1994, PLANT CELL, V6, P1477, DOI 10.1105/tpc.6.10.1477; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531	65	53	62	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56502	10.1371/journal.pone.0056502	http://dx.doi.org/10.1371/journal.pone.0056502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431381	Green Submitted, Green Published, gold			2022-12-27	WOS:000315182800023
J	Drong, AW; Nicholson, G; Hedman, AK; Meduri, E; Grundberg, E; Small, KS; Shin, SY; Bell, JT; Karpe, F; Soranzo, N; Spector, TD; McCarthy, MI; Deloukas, P; Rantalainen, M; Lindgren, CM				Drong, Alexander W.; Nicholson, George; Hedman, Asa K.; Meduri, Eshwar; Grundberg, Elin; Small, Kerrin S.; Shin, So-Youn; Bell, Jordana T.; Karpe, Fredrik; Soranzo, Nicole; Spector, Tim D.; McCarthy, Mark I.; Deloukas, Panos; Rantalainen, Mattias; Lindgren, Cecilia M.		MolPAGE Consortia	The Presence of Methylation Quantitative Trait Loci Indicates a Direct Genetic Influence on the Level of DNA Methylation in Adipose Tissue	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; TOOL	Genetic variants that associate with DNA methylation at CpG sites (methylation quantitative trait loci, meQTLs) offer a potential biological mechanism of action for disease associated SNPs. We investigated whether meQTLs exist in abdominal subcutaneous adipose tissue (SAT) and if CpG methylation associates with metabolic syndrome (MetSyn) phenotypes. We profiled 27,718 genomic regions in abdominal SAT samples of 38 unrelated individuals using differential methylation hybridization (DMH) together with genotypes at 5,227,243 SNPs and expression of 17,209 mRNA transcripts. Validation and replication of significant meQTLs was pursued in an independent cohort of 181 female twins. We find that, at 5% false discovery rate, methylation levels of 149 DMH regions associate with at least one SNP in a +/-500 kilobase cis-region in our primary study. We sought to validate 19 of these in the replication study and find that five of these significantly associate with the corresponding meQTL SNPs from the primary study. We find that none of the 149 meQTL top SNPs is a significant expression quantitative trait locus in our expression data, but we observed association between expression levels of two mRNA transcripts and cis-methylation status. Our results indicate that DNA CpG methylation in abdominal SAT is partly under genetic control. This study provides a starting point for future investigations of DNA methylation in adipose tissue.	[Drong, Alexander W.; Hedman, Asa K.; Bell, Jordana T.; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Nicholson, George; Rantalainen, Mattias] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Meduri, Eshwar; Grundberg, Elin; Shin, So-Youn; Soranzo, Nicole; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Grundberg, Elin; Small, Kerrin S.; Bell, Jordana T.; Spector, Tim D.] Kings Coll London, Dept Twin Res, London WC2R 2LS, England; [Karpe, Fredrik; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Trust Sanger Institute; University of London; King's College London; University of Oxford	Lindgren, CM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	celi@well.ox.ac.uk	Rantalainen, Mattias/J-3125-2012; Bell, Jordana/AAH-7312-2019; Drong, Alexander/AAG-1115-2020; Deloukas, Panos/B-2922-2013; McCarthy, Mark/M-3763-2015	Deloukas, Panos/0000-0001-9251-070X; Meduri, Eshwar/0000-0002-3821-312X; Soranzo, Nicole/0000-0003-1095-3852; Hedman, Asa/0000-0001-5413-204X; McCarthy, Mark/0000-0002-4393-0510; Lindgren, Cecilia/0000-0002-4903-9374; Bell, Jordana/0000-0002-3858-5986; Small, Kerrin/0000-0003-4566-0005; Karpe, Fredrik/0000-0002-2751-1770; Nicholson, George/0000-0001-9588-6075	Wellcome Trust [090532/Z/09/Z, 091746/Z/10/Z, 098051]; European Community's Sixth Framework Programme, MolPAGE Consortium [LSHG-CT-2004-512066]; Epigenomics AG; MolPAGE; Sir Henry Wellcome Trust postdoctoral fellowship; Medical Research Council [G0802460]; MRC [G0802460] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); European Community's Sixth Framework Programme, MolPAGE Consortium; Epigenomics AG; MolPAGE; Sir Henry Wellcome Trust postdoctoral fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (090532/Z/09/Z) and the European Community's Sixth Framework Programme, MolPAGE Consortium (LSHG-CT-2004-512066), which included both academic and commercial partners. The latter, included Epigenomics AG, whose involvement in MolPAGE was funded on a 50/50 basis. Epigenomics took no patents on the work and has no active products in the field of diabetes and obesity. None of the authors own stocks or shares of Epigenomics AG, are employed or members of the board of Epigenomics AG, or have received research grants, travel grants, or any gifts of any kind from Epigenomics AG. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. AWD is a Wellcome Trust Student (093933Z/10/Z). JTB was funded by a Sir Henry Wellcome Trust postdoctoral fellowship. NS is supported by the Wellcome Trust (Core Grant Number 091746/Z/10/Z). PD is supported by the Wellcome Trust core grant 098051 which also covered costs for methylation profiling with the 27K methylation array, carried out by the Genotyping Facility at the Wellcome Trust Sanger Institute. MR is a MRC biomedical informatics fellow (Medical Research Council, fellowship G0802460). CML is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z).	AGGERBECK M, 1993, BIOCHEMISTRY-US, V32, P9065, DOI 10.1021/bi00086a011; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Chang YH, 2011, METABOLISM, V60, P1064, DOI 10.1016/j.metabol.2010.11.002; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fassbender A, 2010, METHODS MOL BIOL, V576, P155, DOI 10.1007/978-1-59745-545-9_9; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; *IDF, 2009, IDF WORLDW DEF MET S; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kuehnen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002543; Lewin J, 2007, INT J BIOCHEM CELL B, V39, P1539, DOI 10.1016/j.biocel.2007.03.006; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Nabipour I, 2010, METABOLISM, V59, P742, DOI 10.1016/j.metabol.2009.09.019; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; PANTEGHINI M, 1990, CLIN BIOCHEM, V23, P311, DOI 10.1016/0009-9120(90)80062-N; Pinnick KE, 2011, P NUTR SOC, V70, P57, DOI 10.1017/S0029665110004015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reinhard H, 2010, DIABETES CARE, V33, P2561, DOI 10.2337/dc10-0858; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tan GD, 2006, DIABETOLOGIA, V49, P158, DOI 10.1007/s00125-005-0044-z; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	43	63	64	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55923	10.1371/journal.pone.0055923	http://dx.doi.org/10.1371/journal.pone.0055923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431366	Green Published, Green Submitted, gold			2022-12-27	WOS:000315182800008
J	Brandt, J; Sullivan, C; Burrell, LE; Rogerson, M; Anderson, A				Brandt, Jason; Sullivan, Campbell; Burrell, Larry E., II; Rogerson, Mark; Anderson, Allan			Internet-Based Screening for Dementia Risk	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VERBAL-LEARNING TEST; INFORMANT QUESTIONNAIRE; ELDERLY IQCODE; PERFORMANCE-CHARACTERISTICS; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; POPULATION; DECLINE; HUNTINGTONS	The Dementia Risk Assessment (DRA) is an online tool consisting of questions about known risk factors for dementia, a novel verbal memory test, and an informant report of cognitive decline. Its primary goal is to educate the public about dementia risk factors and encourage clinical evaluation where appropriate. In Study 1, more than 3,000 anonymous persons over age 50 completed the DRA about themselves; 1,000 people also completed proxy reports about another person. Advanced age, lower education, male sex, complaints of severe memory impairment, and histories of cerebrovascular disease, Parkinson's disease, and brain tumor all contributed significantly to poor memory performance. A high correlation was obtained between proxy-reported decline and actual memory test performance. In Study 2, 52 persons seeking first-time evaluation at dementia clinics completed the DRA prior to their visits. Their responses (and those of their proxy informants) were compared to the results of independent evaluation by geriatric neuropsychiatrists. The 30 patients found to meet criteria for probable Alzheimer's disease, vascular dementia, or frontotemporal dementia differed on the DRA from the 22 patients without dementia (most other neuropsychiatric conditions). Scoring below criterion on the DRA's memory test had moderately high predictive validity for clinically diagnosed dementia. Although additional studies of larger clinical samples are needed, the DRA holds promise for wide-scale screening for dementia risk.	[Brandt, Jason; Sullivan, Campbell; Anderson, Allan] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Brandt, Jason] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Brandt, Jason; Burrell, Larry E., II; Anderson, Allan] Copper Ridge Inst, Sykesville, MD USA; [Anderson, Allan] William Hill Manor, Samuel & Alexia Bratton Memory Clin, Easton, MD USA	Johns Hopkins University; Johns Hopkins University	Brandt, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	jbrandt@jhmi.edu		Brandt, Jason/0000-0001-7381-6244	Geoffrey Beene Gives Back Alzheimer's Initiative	Geoffrey Beene Gives Back Alzheimer's Initiative	Development of the Dementia Risk Assessment was supported by the Geoffrey Beene Gives Back Alzheimer's Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford JW, 2007, ALZHEIMERS DEMENT, V3, P75, DOI 10.1016/j.jalz.2006.02.005; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; BRANDT J, 1988, ANN NEUROL, V23, P555, DOI 10.1002/ana.410230605; Brandt J, 2001, AM FAM PHYSICIAN, V63, P620; BRANDT J, 1992, J CLIN EXP NEUROPSYC, V14, P773, DOI 10.1080/01688639208402862; Brandt J., 2001, HOPKINS VERBAL LEARN; Brandt Jason, 2011, Alzheimers Dement, V7, pe94, DOI 10.1016/j.jalz.2010.08.229; Brodaty H, 2006, AM J GERIAT PSYCHIAT, V14, P391, DOI 10.1097/01.JGP.0000216181.20416.b2; Brodaty H, 1998, ALZ DIS ASSOC DIS, V12, P1, DOI 10.1097/00002093-199803000-00001; Cherbuin N, 2008, INT PSYCHOGERIATR, V20, P431, DOI 10.1017/S104161020800673X; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; Dickerson BC, 2011, NEUROLOGY, V76, P1395, DOI 10.1212/WNL.0b013e3182166e96; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank RM, 2000, INT J GERIATR PSYCH, V15, P317, DOI 10.1002/(SICI)1099-1166(200004)15:4<317::AID-GPS116>3.3.CO;2-Z; GALLO JJ, 1995, PSYCHOL MED, V25, P1211, DOI 10.1017/S0033291700033183; Galvin JE, 2006, NEUROLOGY, V67, P1942, DOI 10.1212/01.wnl.0000247042.15547.eb; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Gifford DR, 1999, NEUROLOGY, V52, P224, DOI 10.1212/WNL.52.2.224; Hogervorst E, 2002, DEMENT GERIATR COGN, V13, P13, DOI 10.1159/000048628; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; JORM AF, 1991, PSYCHOL MED, V21, P785, DOI 10.1017/S0033291700022418; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Khachaturian AS, 2000, J CLIN EPIDEMIOL, V53, P531, DOI 10.1016/S0895-4356(99)00196-1; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Larner AJ, 2007, AGE AGEING, V36, P326, DOI 10.1093/ageing/afl183; Luszcz MA, 1997, PSYCHOL AGING, V12, P340, DOI 10.1037/0882-7974.12.2.340; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; Mayes AR, 2004, HIPPOCAMPUS, V14, P763, DOI 10.1002/hipo.10211; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Nunes PV, 2008, INT J GERIATR PSYCH, V23, P1127, DOI 10.1002/gps.2038; Parra MA, 2009, BRAIN, V132, P1057, DOI 10.1093/brain/awp036; Patterson C, 2008, CAN MED ASSOC J, V178, P548, DOI 10.1503/cmaj.070796; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Roe CM, 2011, ARCH NEUROL-CHICAGO, V68, P1145, DOI 10.1001/archneurol.2011.192; Selverstein SM, 2007, BEHAV RES METHODS, V39, P940, DOI 10.3758/BF03192989; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stephan BCM, 2010, NAT REV NEUROL, V6, P318, DOI 10.1038/nrneurol.2010.54	39	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57476	10.1371/journal.pone.0057476	http://dx.doi.org/10.1371/journal.pone.0057476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437393	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000106
J	Dustan, P; Doherty, O; Pardede, S				Dustan, Phillip; Doherty, Orla; Pardede, Shinta			Digital Reef Rugosity Estimates Coral Reef Habitat Complexity	PLOS ONE			English	Article							FISH ASSEMBLAGES; ABUNDANCE; FLORIDA	Ecological habitats with greater structural complexity contain more species due to increased niche diversity. This is especially apparent on coral reefs where individual coral colonies aggregate to give a reef its morphology, species zonation, and three dimensionality. Structural complexity is classically measured with a reef rugosity index, which is the ratio of a straight line transect to the distance a flexible chain of equal length travels when draped over the reef substrate; yet, other techniques from visual categories to remote sensing have been used to characterize structural complexity at scales from microhabitats to reefscapes. Reef-scale methods either lack quantitative precision or are too time consuming to be routinely practical, while remotely sensed indices are mismatched to the finer scale morphology of coral colonies and reef habitats. In this communication a new digital technique, Digital Reef Rugosity (DRR) is described which utilizes a self-contained water level gauge enabling a diver to quickly and accurately characterize rugosity with non-invasive millimeter scale measurements of coral reef surface height at decimeter intervals along meter scale transects. The precise measurements require very little post-processing and are easily imported into a spreadsheet for statistical analyses and modeling. To assess its applicability we investigated the relationship between DRR and fish community structure at four coral reef sites on Menjangan Island off the northwest corner of Bali, Indonesia and one on mainland Bali to the west of Menjangan Island; our findings show a positive relationship between DRR and fish diversity. Since structural complexity drives key ecological processes on coral reefs, we consider that DRR may become a useful quantitative community-level descriptor to characterize reef complexity.	[Dustan, Phillip] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Dustan, Phillip; Doherty, Orla] Biosphere Fdn, Coral Reef Projects, Big Pine, CA USA; [Pardede, Shinta] Wildlife Conservat Soc, Indonesia Marine Program, Bogor, Jawa Barat, Indonesia	College of Charleston; Wildlife Conservation Society - Indonesia	Dustan, P (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	dustanp@cofc.edu			Biosphere Foundation; Wildlife Conservation Society; Marisla Foundation; Kopcho Family Foundation; Roy A Hunt Foundation; Ward Family Foundation; Threshold Foundation; Yayasan Dwi Asih Sejahtera; Menjangan Beach Resort	Biosphere Foundation; Wildlife Conservation Society; Marisla Foundation; Kopcho Family Foundation; Roy A Hunt Foundation; Ward Family Foundation; Threshold Foundation; Yayasan Dwi Asih Sejahtera; Menjangan Beach Resort	Support for this research was provided by the Biosphere Foundation, Wildlife Conservation Society, Marisla Foundation, the Kopcho Family Foundation, Roy A Hunt Foundation, Ward Family Foundation, Threshold Foundation, Yayasan Dwi Asih Sejahtera and the Menjangan Beach Resort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Carpenter K.E., 1982, Proceedings of the International Coral Reef Symposium, P497; Dustan P, 1999, POINTCOUNT 99 USER M; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Green S. J., 2011, Conservation and Society, V9, P173, DOI 10.4103/0972-4923.86986; Grenander U., 1959, PROBABILITY STAT HAR; He H., 2012, P 12 INT COR REEF S, P1; Hoeksema BW, 2000, P 9 INT COR REEF S, V1, P173; Knudby A, 2007, P AM ACAD UNDERWATER, P181; Kuffner IB, 2007, ENVIRON BIOL FISH, V78, P71, DOI 10.1007/s10641-006-9078-4; Kulbicki M, 2005, CYBIUM, V29, P235; Lambin EF, 1999, GLOBAL ECOL BIOGEOGR, V8, P191, DOI 10.1046/j.1365-2699.1999.00123.x; Lieske E., 2001, CORAL REEF FISHES, V2nd ed.; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Munk W.H., 1948, EOS T AM GEOPHYS UN, V29, P855, DOI [10.1029/TR029i006p00855, DOI 10.1029/TR029I006P00855]; POLUNIN NVC, 1983, BIOL CONSERV, V25, P171, DOI 10.1016/0006-3207(83)90059-9; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; Randall JE, 1990, FISHES GREAT BARRIER; Risk MJ, 1972, ATOLL RES B, P153; ROBINSON A, 1981, B MAR SCI, V31, P774; Shumway CA, 2007, FRESHWATER BIOL, V52, P1065, DOI 10.1111/j.1365-2427.2007.01754.x; Turnigan RG, 1991, P 44 GULF CAR FISH I, P759; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; Wildlife Conservation Society CS, 2010, WCS FIJ MAR BIOL HDB; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Zawada DG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043789; Zawada DG, 2009, J COASTAL RES, V25, P6, DOI [10.2112/SI53-002.1, 10.2112/S153-002.1]	32	60	62	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57386	10.1371/journal.pone.0057386	http://dx.doi.org/10.1371/journal.pone.0057386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437380	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000099
J	Bion, RAH; Miyazawa, K; Kikuchi, H; Mazuka, R				Bion, Ricardo A. H.; Miyazawa, Kouki; Kikuchi, Hideaki; Mazuka, Reiko			Learning Phonemic Vowel Length from Naturalistic Recordings of Japanese Infant-Directed Speech	PLOS ONE			English	Article							ENGLISH	In Japanese, vowel duration can distinguish the meaning of words. In order for infants to learn this phonemic contrast using simple distributional analyses, there should be reliable differences in the duration of short and long vowels, and the frequency distribution of vowels must make these differences salient enough in the input. In this study, we evaluate these requirements of phonemic learning by analyzing the duration of vowels from over 11 hours of Japanese infant-directed speech. We found that long vowels are substantially longer than short vowels in the input directed to infants, for each of the five oral vowels. However, we also found that learning phonemic length from the overall distribution of vowel duration is not going to be easy for a simple distributional learner, because of the large base-rate effect (i.e., 94% of vowels are short), and because of the many factors that influence vowel duration (e.g., intonational phrase boundaries, word boundaries, and vowel height). Therefore, a successful learner would need to take into account additional factors such as prosodic and lexical cues in order to discover that duration can contrast the meaning of words in Japanese. These findings highlight the importance of taking into account the naturalistic distributions of lexicons and acoustic cues when modeling early phonemic learning.	[Bion, Ricardo A. H.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Miyazawa, Kouki] RIKEN, Brain Sci Inst, Lab Language Dev, Wako, Saitama, Japan; [Miyazawa, Kouki; Kikuchi, Hideaki; Mazuka, Reiko] Fac Human Sci, Tokorozawa, Saitama, Japan; [Mazuka, Reiko] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Stanford University; RIKEN; Duke University	Bion, RAH (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	ricardoh@stanford.edu	Mazuka, Reiko/N-7400-2015	Mazuka, Reiko/0000-0001-7862-7768	Kakenhi, the Japanese Ministry of Education, Culture, Sports, Science and Techonology [21610028]; RIKEN Brain Science Institute summer school program	Kakenhi, the Japanese Ministry of Education, Culture, Sports, Science and Techonology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Brain Science Institute summer school program	The research reported in this paper was in part supported by Grants-In-Aid for Scientific Research to the last author (RM) (Kakenhi, the Japanese Ministry of Education, Culture, Sports, Science and Techonology No. 21610028), and RIKEN Brain Science Institute summer school program, during which first author conducted most of the analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Boersma Paul, 2002, GLOT INT, V5, P341; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cooper W.E., 1980, SYNTAX SPEECH; Feldman N. H., 2009, P 31 ANN M COGN SCI, P2208; Feldman N, 2011, PROC ANN BUCLD, P197; FRY DB, 1955, J ACOUST SOC AM, V27, P765, DOI 10.1121/1.1908022; Klatt D., 1975, J PHONETICS, V3, P129, DOI DOI 10.1016/S0095-4470(19)31360-9; Kunnari S., 2001, PSYCHOL LANGUAGE COM, V5, P13; Maekawa K., 2003, ISCA IEEE WORKSH SPO, P7; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Maye J, 2000, PROC ANN BUCLD, P522; Mazuka R., 2006, IEICE TECHNICAL REPO, V106, P11; Mugitani R, 2009, DEV PSYCHOL, V45, P236, DOI 10.1037/a0014043; PETERSON GE, 1960, J ACOUST SOC AM, V32, P693, DOI 10.1121/1.1908183; Sato Y, 2010, DEV PSYCHOL, V46, P106, DOI 10.1037/a0016718; Swingley D, 2007, COGNITIVE PSYCHOL, V54, P99, DOI 10.1016/j.cogpsych.2006.05.001; Swingley D, 2009, PHILOS T R SOC B, V364, P3617, DOI 10.1098/rstb.2009.0107; Vallabha GK, 2007, P NATL ACAD SCI USA, V104, P13273, DOI 10.1073/pnas.0705369104; Werker JF, 2007, COGNITION, V103, P147, DOI 10.1016/j.cognition.2006.03.006	20	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e51594	10.1371/journal.pone.0051594	http://dx.doi.org/10.1371/journal.pone.0051594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437036	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200003
J	Blasco, R; Rosell, J; Dominguez-Rodrigo, M; Lozano, S; Pasto, I; Riba, D; Vaquero, M; Peris, JF; Arsuaga, JL; de Castro, JMB; Carbonell, E				Blasco, Ruth; Rosell, Jordi; Dominguez-Rodrigo, Manuel; Lozano, Sergi; Pasto, Ignasi; Riba, David; Vaquero, Manuel; Fernandez Peris, Josep; Luis Arsuaga, Juan; Maria Bermudez de Castro, Jose; Carbonell, Eudald			Learning by Heart: Cultural Patterns in the Faunal Processing Sequence during the Middle Pleistocene	PLOS ONE			English	Article							CARNIVORE TOOTH-MARKS; GRAN DOLINA SITE; BOLOMOR CAVE VALENCIA; FLK 22 ZINJANTHROPUS; SIERRA-DE-ATAPUERCA; HUMAN CONSUMPTION; PERCUSSION MARKS; OLDUVAI GORGE; CUT MARKS; HAMMERSTONE PERCUSSION	Social learning, as an information acquisition process, enables intergenerational transmission and the stabilisation of cultural forms, generating and sustaining behavioural traditions within human groups. Archaeologically, such social processes might become observable by identifying repetitions in the record that result from the execution of standardised actions. From a zooarchaeological perspective, the processing and consumption of carcasses may be used to identify these types of phenomena at the sites. To investigate this idea, several faunal assemblages from Bolomor Cave (Valencia, Spain, MIS 9-5e) and Gran Dolina TD10-1 (Burgos, Spain, MIS 9) were analysed. The data show that some butchery activities exhibit variability as a result of multiple conditioning factors and, therefore, the identification of cultural patterns through the resulting cut-marks presents additional difficulties. However, other activities, such as marrow removal by means of intentional breakage, seem to reflect standardised actions unrelated to the physical characteristics of the bones. The statistical tests we applied show no correlation between the less dense areas of the bones and the location of impacts. Comparison of our experimental series with the archaeological samples indicates a counter-intuitive selection of the preferred locus of impact, especially marked in the case of Bolomor IV. This fact supports the view that bone breakage was executed counter-intuitively and repetitively on specific sections because it may have been part of an acquired behavioural repertoire. These reiterations differ between levels and sites, suggesting the possible existence of cultural identities or behavioural predispositions dependant on groups. On this basis, the study of patterns could significantly contribute to the identification of occupational strategies and organisation of the hominids in a territory. In this study, we use faunal data in identifying the mechanics of intergenerational information transmission within Middle Pleistocene human communities and provide new ideas for the investigation of occupational dynamics from a zooarchaeological approach.	[Blasco, Ruth; Rosell, Jordi; Lozano, Sergi; Pasto, Ignasi; Riba, David; Vaquero, Manuel; Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Blasco, Ruth; Rosell, Jordi; Lozano, Sergi; Pasto, Ignasi; Riba, David; Vaquero, Manuel; Carbonell, Eudald] Univ Rovira & Virgili, Area Prehist, Tarragona, Spain; [Blasco, Ruth] Gibraltar Museum, Gibraltar, Spain; [Dominguez-Rodrigo, Manuel] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Dominguez-Rodrigo, Manuel] Museo Origenes, IDEA Inst Evolucio Africa, Madrid, Spain; [Fernandez Peris, Josep] Diputac Valencia, Museo Prehist, SIP Serv Invest Prehist, Valencia, Spain; [Luis Arsuaga, Juan] Univ Complutense, Dept Paleontol, Fac Ciencias Geol, E-28040 Madrid, Spain; [Luis Arsuaga, Juan] Ctr Invest UCM ISCIII Evoluc & Comportamiento Hum, Madrid, Spain; [Maria Bermudez de Castro, Jose] CENIEH Ctr Nacl Invest Sobre Evoluc Humana, Burgos, Spain; [Carbonell, Eudald] Inst Vertebrate Paleontol & Paleoanthropol IVPP, Beijing, Peoples R China	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; UCM-ISCIII Center for Human Evolution & Behavior; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Blasco, R (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain.	rblascolopez@gmail.com	Rosell, Jordi/G-8705-2015; Carbonell, Eudald/G-3003-2015; Lozano, Sergi/B-5974-2015; Blasco, Ruth/AAG-8200-2019; Vaquero, Manuel/W-1405-2019	Rosell, Jordi/0000-0002-6758-6291; Lozano, Sergi/0000-0003-1895-9327; Blasco, Ruth/0000-0001-9804-739X; Vaquero, Manuel/0000-0001-6572-8543; Pasto, Ignasi/0000-0003-1780-4577; Arsuaga, Juan Luis/0000-0001-5361-2295; Bermudez de Castro, Jose Maria/0000-0003-1314-3273	Junta de Castilla y Leon and Atapuerca Foundation; Spanish Ministry of Science and Innovation [CGL2012-38434-C03-01, CGL2012-38434-C03-02, CGL2012-38434-C03-03, CGL2012-38358, HAR2010-18952-C02-01]; Generalitat de Catalunya [2009 SGR 188]; COFUND Marie Curie Actions, EU-FP7; Atapuerca Foundation	Junta de Castilla y Leon and Atapuerca Foundation(Junta de Castilla y Leon); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); COFUND Marie Curie Actions, EU-FP7; Atapuerca Foundation	The Bolomor excavation is part of the program of archaeological excavations conducted by the SIP (Prehistoric Investigation Service) of the Prehistory Museum of Valencia under the authority of the Provincial Council of Valencia, Spain. The field excavation work in the Atapuerca sites is supported by Junta de Castilla y Leon and Atapuerca Foundation. This research was supported with funding from the Spanish Ministry of Science and Innovation, project nos. CGL2012-38434-C03-01, CGL2012-38434-C03-02, CGL2012-38434-C03-03, CGL2012-38358 and HAR2010-18952-C02-01, and from Generalitat de Catalunya, 2009 SGR 188. R. Blasco and S. Lozano are Beatriu de Pinos post-doctoral research fellowships (Generalitat de Catalunya and COFUND Marie Curie Actions, EU-FP7) and D. Riba is a pre-doctoral research fellowship from Atapuerca Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allue E, 2010, ARCHAEOL ANTHROP SCI, V2, P11, DOI 10.1007/s12520-010-0023-2; Aura J. E., 2009, MONOGRAFIAS ARQUEOLO, V44, P343; Aura Tortosa JE, 2002, J ARCHAEOL METHOD TH, V9, P215; Banks WE, 2008, J ARCHAEOL SCI, V35, P481, DOI 10.1016/j.jas.2007.05.011; Barba R, 2005, J TAPHONOMY, V3, P29; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; Bicho N, 2006, J ANTHROPOL ARCHAEOL, V25, P485, DOI 10.1016/j.jaa.2006.03.009; Binford L., 1987, PLEISTOCENE OLD WORL, P17; Binford L.R., 1981, BONES ANCIENT MEN MO; Binford L.R., 2001, CONSTRUCTING FRAMES; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Binford LR., 1984, FAUNAL REMAINS KLASI; Blackmore S, 2000, SCI AM, V283, P64, DOI 10.1038/scientificamerican1000-64; Blasco R, 2011, AMPLITUD DIETA CARNI; Blasco R, 2008, J ARCHAEOL SCI, V35, P2839, DOI 10.1016/j.jas.2008.05.013; Blasco R, 2012, CR PALEVOL, V11, P265, DOI 10.1016/j.crpv.2012.01.003; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2010, J ARCHAEOL SCI, V37, P2051, DOI 10.1016/j.jas.2010.03.010; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; BLUMENSCHINE RJ, 1988, J ARCHAEOL SCI, V15, P483, DOI 10.1016/0305-4403(88)90078-7; Blumenschine RJ, 2007, J HUM EVOL, V53, P420, DOI 10.1016/j.jhevol.2007.01.011; Bodu P, 1990, PALEOLITHIQUE MOYEN, V3, P309; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V65, P359, DOI 10.1002/ajpa.1330650404; Buikstra J.E., 1989, BONE MODIFICATION, P247; Bunn H.T., 1983, BAR International Series, V163, P143; BUNN HT, 1988, J ANTHROPOL ARCHAEOL, V7, P412, DOI 10.1016/0278-4165(88)90004-9; Bunn HT, 2001, MEAT EATING HUMAN EV, P350; Butzer KW, 1982, ARCHAEOLOGY HUMAN EC; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Capaldo S.D., 1995, THESIS RUTGERS U NEW; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Capaldo SD, 1998, J HUM EVOL, V35, P323; Carbonell E, 2004, ZONA ARQUEOLOGICA, V4, P102; Cochard D., 2004, THESIS U BORDEAUX 1, P1; Cochard D, 2012, QUATERN INT, V264, P32, DOI 10.1016/j.quaint.2012.02.014; Csibra G, 2006, ATTENTION PERFORM, P249; Csibra G, 2011, PHILOS T R SOC B, V366, P1149, DOI 10.1098/rstb.2010.0319; Cuartero F., 2008, SAGUNTUM, V39, P27; David N, 2001, ETHNOARCHAEOLOGY ACT; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; Dominguez-Rodrigo A, 2007, J HUM EVOL, V53, P427, DOI 10.1016/j.jhevol.2007.05.010; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2003, EVOL ANTHROPOL, V12, P275, DOI 10.1002/evan.10119; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P381, DOI 10.1006/jasc.2002.0842; Dominguez-Rodrigo M, 2002, J WORLD PREHIST, V16, P1, DOI 10.1023/A:1014507129795; Dominguez-Rodrigo M, 2008, WORLD ARCHAEOL, V40, P67, DOI 10.1080/00438240701843629; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P884, DOI 10.1016/j.jas.2008.11.007; Emerson AM., 1993, BONES BEHAV ETHNOARC, P138; Enloe J. G., 1993, BONES BEHAV ETHNOARC, P82; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Fernandez Peris J, 2007, IND LITICAS PLEISTOC, V108; Peris JF, 2012, QUATERN INT, V247, P267, DOI 10.1016/j.quaint.2010.10.014; FernandezPenis J., 2008, TREBALLS ARQUEOL, V14, P141; Ferreira Bicho N, 2000, ANTIQUITY, V74, P500; Fisher J.W., 1995, J ARCHAEOL METHOD TH, V2, P7, DOI [10.1007/bf02228434, DOI 10.1007/BF02228434]; Flannery K.V., 1986, GUIL A NAQUITZ ARCHA, P285; Frison G.C., 1978, PREHISTORIC HUNTERS; Frison GC, 1970, PLAINS ANTHR MEMOIR, V7; Fumanal M. P., 1995, CUATERNARIO PAIS VAL, P115; Galan AB, 2009, J ARCHAEOL SCI, V36, P776, DOI 10.1016/j.jas.2008.11.003; Gamble Clive, 2005, P154; Chacon MG, 2007, BAR INT SER, V1725, P187; Gergely G., 2006, ROOTS HUMAN SOCIALIT, P229; Gifford-Gonzalez Diane, 1989, BONE MODIFICATION, P61; GIFFORDGONZALEZ D, 1991, J ANTHROPOL ARCHAEOL, V10, P215, DOI 10.1016/0278-4165(91)90014-O; Goren-Inbar N, 2011, PHILOS T R SOC B, V366, P1038, DOI 10.1098/rstb.2010.0365; Gowlett JAJ., 1996, MODELLING EARLY HUMA, P191; Guillon F, 1986, BRULES SECS FRAICHES, P191; Hahn J, 1987, WURTTEMBERG, V14, P1; Hanson M, 2007, J ARCHAEOL SCI, V34, P1902, DOI 10.1016/j.jas.2007.01.009; Haws JA, 2003, THESIS U WISCONSIN M; Hockett B, 2002, J ARCHAEOL METHOD TH, V9, P269, DOI 10.1023/A:1019503030246; Hockett BS, 2006, ANIMAIS PREHISTORIA, P137; Isaac GL., 1967, KROEBER ANTHR SOC PA, V37, P31; Jacobi R., 2004, P PREHIST SOC, V70, P1, DOI [10.1017/S0079497X00001110, DOI 10.1017/S0079497X00001110]; Johansen L., 2004, OLDEHOLTWOLDE HAMBUR; Jones K.T., 1983, CARNIVORES HUMAN SCA, P171; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; Landt MJ, 2007, J ARCHAEOL SCI, V34, P1629, DOI 10.1016/j.jas.2006.12.001; Laroulandie V, 2005, BIOSPHERE TO LITHOSPHERE: NEW STUDIES IN VERTEBRATE TAPHONOMY, P25; Lloveras Lluis, 2009, Journal of Taphonomy, V7, P179; Lopez-Ortega E, 2011, J ARCHAEOL SCI, V38, P3112, DOI 10.1016/j.jas.2011.07.011; Louchart A., 2002, QUATERNAIRE, V3-4, P297; Lupo KD, 2002, J ARCHAEOL SCI, V29, P85, DOI 10.1006/jasc.2001.0690; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Lyman RL, 2005, J ARCHAEOL SCI, V32, P1722, DOI 10.1016/j.jas.2005.06.003; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; Lyman RL, 2003, J ARCHAEOL SCI, V30, P595, DOI 10.1016/S0305-4403(02)00236-4; Lyman RL., 1995, ANCIENT PEOPLES LAND, P233; Mallol C, 2008, GEOARCHAEOLOGY, V23, P13, DOI 10.1002/gea.20206; MAREAN CW, 1992, J ARCHAEOL SCI, V19, P101, DOI 10.1016/0305-4403(92)90009-R; Martinez I, 2008, J HUM EVOL, V54, P118, DOI 10.1016/j.jhevol.2007.07.006; Martinez I, 2009, MUNIBE, V60, P1; Martinez I, 2009, ANTHROPOLOGIE, V113, P255, DOI 10.1016/j.anthro.2009.01.003; Mayne Correia P., 1997, FORENSIC TAPHONOMY P, P275, DOI DOI 10.1201/9781439821923.CH18; Meltzoff Andrew N., 1996, P347, DOI 10.1016/B978-012273965-1/50017-0; Menendez L., 2009, THESIS U ROVIRA VIRG; Mithen S., 1994, CAMB ARCHAEOL J, V4, P3, DOI DOI 10.1017/S0959774300000949; MURDOCK GP, 1973, ETHNOLOGY, V12, P203, DOI 10.2307/3773347; Nadel D, 2004, P NATL ACAD SCI USA, V101, P6821, DOI 10.1073/pnas.0308557101; NICHOLSON RA, 1993, J ARCHAEOL SCI, V20, P411, DOI 10.1006/jasc.1993.1025; Nilssen P.J., 2000, THESIS U CAPE TOWN; Noe-Nygaard N., 1989, HUMAN EVOLUTION, V4, P461; OConnell JF, 1997, CURR ANTHROPOL, V38, P86, DOI 10.1086/204585; Oliver JS, 1993, OCCASIONAL PAPER, P200; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Outram A, 1998, J ARCHAEOL SCI, V25, P839, DOI 10.1006/jasc.1997.0229; Outram AK, 2001, J ARCHAEOL SCI, V28, P401, DOI 10.1006/jasc.2000.0619; Padilla M., 2008, ARQUEOWEB, V9, P1; Pares JM, 1999, J HUM EVOL, V37, P325, DOI 10.1006/jhev.1999.0331; Peretto C., 1996, REPERTI PALEONTOLOGI, P187; Perez Ripoll M, 2004, 24 RENC INT ARCH HIS, P191; Perez-Gonzalez A, 2001, ANTHROPOLOGIE, V105, P27; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; RIPOLL MP, 2005, MUNIBE, V57, P239; Rodriguez J, 2011, QUATERNARY SCI REV, V30, P1396, DOI 10.1016/j.quascirev.2010.02.021; Rodriguez X.P., 2004, BAR INT SERIES, V1323; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499; Rosell J, 2011, J HUM EVOL, V61, P125, DOI 10.1016/j.jhevol.2011.02.001; Rosell J, 2012, QUATERN INT, V252, P56, DOI 10.1016/j.quaint.2011.02.019; Rosell Jordi, 2009, Journal of Taphonomy, V7, P305; Sampson CG, 1998, J ARCHAEOL SCI, V25, P985, DOI 10.1006/jasc.1997.0282; Sanchis Serra A, 2010, THESIS U VALENCIA; Schmider B, 1992, MARSANGY UNCAMPEMENT, V55; SELVAGGIO MM, 1994, J HUM EVOL, V27, P215, DOI 10.1006/jhev.1994.1043; SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X; SHIPMAN P, 1984, PALEOBIOLOGY, V10, P358, DOI 10.1017/S0094837300008320; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Speth J., 2012, FARMING, V2012, P1; Speth JD, 2002, J ARCHAEOL SCI, V29, P471, DOI 10.1006/jasc.2001.0740; Stahl PW, 2007, J ANTHROPOL ARCHAEOL, V26, P329, DOI 10.1016/j.jaa.2007.02.004; Stapert D, 2006, PALEO AKTUEEL, V17, P18; Stapert D, 2007, PAL ARCHS J ARCHAEOL, V1, P1; Steadman DW, 2002, J ARCHAEOL SCI, V29, P571, DOI 10.1006/jasc.2001.0739; STEVENSON MG, 1985, AM ANTIQUITY, V50, P63, DOI 10.2307/280634; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Vaquero M, 2001, J FIELD ARCHAEOL, V28, P93, DOI 10.1179/jfa.2001.28.1-2.93; Vaquero M, 2001, J ARCHAEOL SCI, V28, P1209, DOI 10.1006/jasc.2001.0656; Vaquero M., 2004, SETTLEMENT DYNAMICS, V2, P367; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Werner D, 1990, AMAZON JOURNEY ANTHR; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White T.D., 1992, PREHISTORIC CANNIBAL; Whiten A, 2000, COGNITIVE SCI, V24, P477; Yellen J.E., 1977, STUDIES ARCHEOLOGY; Yellen J. E., 1977, EXPT ARCHAEOLOGY, V271, P1; YELLEN JE, 1991, J ANTHROPOL ARCHAEOL, V10, P1, DOI 10.1016/0278-4165(91)90019-T; Zubrow E, 2010, I EUROPEAN MEDITERRA	159	48	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55863	10.1371/journal.pone.0055863	http://dx.doi.org/10.1371/journal.pone.0055863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	093IE	23437069	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000315184200028
J	Kirk-Ballard, H; Wang, ZQ; Acharya, P; Zhang, XH; Yu, YM; Kilroy, G; Ribnicky, D; Cefalu, WT; Floyd, ZE				Kirk-Ballard, Heather; Wang, Zhong Q.; Acharya, Priyanka; Zhang, Xian H.; Yu, Yongmei; Kilroy, Gail; Ribnicky, David; Cefalu, William T.; Floyd, Z. Elizabeth			An Extract of Artemisia dracunculus L. Inhibits Ubiquitin-Proteasome Activity and Preserves Skeletal Muscle Mass in a Murine Model of Diabetes	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; GENE-EXPRESSION; ATROPHY; PATHWAYS; PROTEOLYSIS; MECHANISMS; ATROGIN-1; LIGASES; MURF1	Impaired insulin signaling is a key feature of type 2 diabetes and is associated with increased ubiquitin-proteasome-dependent protein degradation in skeletal muscle. An extract of Artemisia dracunculus L. (termed PMI5011) improves insulin action by increasing insulin signaling in skeletal muscle. We sought to determine if the effect of PMI5011 on insulin signaling extends to regulation of the ubiquitin-proteasome system. C2C12 myotubes and the KK-A(y) murine model of type 2 diabetes were used to evaluate the effect of PMI5011 on steady-state levels of ubiquitylation, proteasome activity and expression of Atrogin-1 and MuRF-1, muscle-specific ubiquitin ligases that are upregulated with impaired insulin signaling. Our results show that PMI5011 inhibits proteasome activity and steady-state ubiquitylation levels in vitro and in vivo. The effect of PMI5011 is mediated by PI3K/Akt signaling and correlates with decreased expression of Atrogin-1 and MuRF-1. Under in vitro conditions of hormonal or fatty acid-induced insulin resistance, PMI5011 improves insulin signaling and reduces Atrogin-1 and MuRF-1 protein levels. In the KK-A(y) murine model of type 2 diabetes, skeletal muscle ubiquitylation and proteasome activity is inhibited and Atrogin-1 and MuRF-1 expression is decreased by PMI5011. PMI5011-mediated changes in the ubiquitin-proteasome system in vivo correlate with increased phosphorylation of Akt and FoxO3a and increased myofiber size. The changes in Atrogin-1 and MuRF-1 expression, ubiquitin-proteasome activity and myofiber size modulated by PMI5011 in the presence of insulin resistance indicate the botanical extract PMI5011 may have therapeutic potential in the preservation of muscle mass in type 2 diabetes.	[Kirk-Ballard, Heather; Acharya, Priyanka; Kilroy, Gail; Floyd, Z. Elizabeth] Pennington Biomed Res Ctr, Ubiquitin Biol Lab, Baton Rouge, LA USA; [Wang, Zhong Q.; Acharya, Priyanka; Zhang, Xian H.; Yu, Yongmei; Cefalu, William T.] Pennington Biomed Res Ctr, Diabet & Nutr Lab, Baton Rouge, LA USA; [Ribnicky, David] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Rutgers State University New Brunswick	Floyd, ZE (corresponding author), Pennington Biomed Res Ctr, Ubiquitin Biol Lab, Baton Rouge, LA USA.	elizabeth.floyd@pbrc.edu	Floyd, Elizabeth/N-1962-2017; Floyd, Elizabeth/W-2758-2019	Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186	Botanical Research Center of Pennington Biomedical Research Center; The Biotech Center of Rutgers University; National Center for Complementary and Alternative Medicine; Office of Dietary Supplements [P50AT002776-01]; American Diabetes Association [1-10-BS-55]; Centers of Biomedical Research Excellence [NIH P20-RR021945]; Nutrition Obesity Research Centers [NIH P30-DK072476]; National Institutes of Health; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Botanical Research Center of Pennington Biomedical Research Center; The Biotech Center of Rutgers University; National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nutrition Obesity Research Centers; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by pilot funding (ZEF and ZQW) from the Botanical Research Center of Pennington Biomedical Research Center and The Biotech Center of Rutgers University, which is funded by the National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements P50AT002776-01, and the American Diabetes Association (grant 1-10-BS-55, awarded to ZEF). This project used Genomics Core and Cell Biology and Imaging Core facilities that are supported in part by Centers of Biomedical Research Excellence (NIH P20-RR021945) and Nutrition Obesity Research Centers (NIH P30-DK072476) center grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2011, J NUTR HEALTH AGING, V15, P890, DOI 10.1007/s12603-011-0366-0; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bennett RG, 2000, ENDOCRINOLOGY, V141, P2508, DOI 10.1210/en.141.7.2508; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Carballo-Jane E, 2004, J STEROID BIOCHEM, V88, P191, DOI 10.1016/j.jsbmb.2003.11.012; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Edstrom E, 2006, J GERONTOL A-BIOL, V61, P663, DOI 10.1093/gerona/61.7.663; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Ibrahim RM, 2008, J ANIM SCI, V86, P1426, DOI 10.2527/jas.2007-0618; IKEDA H, 1994, DIABETES RES CLIN PR, V24, pS313, DOI 10.1016/0168-8227(94)90268-2; KETTELHUT IC, 1994, BRAZ J MED BIOL RES, V27, P981; Kim TN, 2012, CLIN ENDOCRINOLOGY; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Koyama S, 2008, J MOL BIOL, V376, P1224, DOI 10.1016/j.jmb.2007.11.049; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee CG, 2011, J AM GERIATR SOC, V59, P1217, DOI 10.1111/j.1532-5415.2011.03472.x; Levine ME, 2012, IMPACT INSULIN RESIS; Logendra S, 2006, PHYTOCHEMISTRY, V67, P1539, DOI 10.1016/j.phytochem.2006.05.015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MUNOZ KA, 1993, METABOLISM, V42, P1006, DOI 10.1016/0026-0495(93)90014-F; Park SW, 2009, DIABETES CARE, V32, P1993, DOI 10.2337/dc09-0264; Ribnicky DM, 2006, PHYTOMEDICINE, V13, P550, DOI 10.1016/j.phymed.2005.09.007; Ribnicky DM, 2009, INT J PHARMACEUT, V370, P87, DOI 10.1016/j.ijpharm.2008.11.012; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Sishi B, 2010, EXP PHYSL; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sultan KR, 2006, AM J PHYSIOL-CELL PH, V290, pC650, DOI 10.1152/ajpcell.00163.2005; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang ZQ, 2008, METABOLISM, V57, pS58, DOI 10.1016/j.metabol.2008.04.003; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P71, DOI 10.1016/j.jnutbio.2009.11.015; Wang ZQ, 2009, DIABETES, V58, P1488, DOI 10.2337/db08-0977; Wing SS, 2011, CRIT REV CL LAB SCI, V48, P49, DOI 10.3109/10408363.2011.586171; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Zuberi AR, 2008, METABOLISM, V57, pS10, DOI 10.1016/j.metabol.2008.03.002	49	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57112	10.1371/journal.pone.0057112	http://dx.doi.org/10.1371/journal.pone.0057112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437325	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200218
J	Luque-Casado, A; Zabala, M; Morales, E; Mateo-March, M; Sanabria, D				Luque-Casado, Antonio; Zabala, Mikel; Morales, Esther; Mateo-March, Manuel; Sanabria, Daniel			Cognitive Performance and Heart Rate Variability: The Influence of Fitness Level	PLOS ONE			English	Article							AEROBIC EXERCISE; BRAIN; ATTENTION; ADULTS	In the present study, we investigated the relation between cognitive performance and heart rate variability as a function of fitness level. We measured the effect of three cognitive tasks (the psychomotor vigilance task, a temporal orienting task, and a duration discrimination task) on the heart rate variability of two groups of participants: a high-fit group and a low-fit group. Two major novel findings emerged from this study. First, the lowest values of heart rate variability were found during performance of the duration discrimination task, compared to the other two tasks. Second, the results showed a decrement in heart rate variability as a function of the time on task, although only in the low-fit group. Moreover, the high-fit group showed overall faster reaction times than the low-fit group in the psychomotor vigilance task, while there were not significant differences in performance between the two groups of participants in the other two cognitive tasks. In sum, our results highlighted the influence of cognitive processing on heart rate variability. Importantly, both behavioral and physiological results suggested that the main benefit obtained as a result of fitness level appeared to be associated with processes involving sustained attention.	[Luque-Casado, Antonio; Sanabria, Daniel] Univ Granada, Dept Psicol Expt, Granada, Spain; [Luque-Casado, Antonio; Zabala, Mikel; Morales, Esther] Univ Granada, Dept Educ Fis & Deport, Granada, Spain; [Mateo-March, Manuel] Univ Miguel Hernandez, Elche, Spain	University of Granada; University of Granada; Universidad Miguel Hernandez de Elche	Luque-Casado, A (corresponding author), Univ Granada, Dept Psicol Expt, Granada, Spain.	antonioluque@ugr.es	Sanabria, Daniel/C-3409-2012; Zabala, Mikel/AAE-8977-2021; Mateo-March, Manuel/AAF-8979-2021; Luque-Casado, Antonio/AAA-2072-2019; March, Manuel Mateo/A-8938-2012	Sanabria, Daniel/0000-0002-4164-7607; Mateo-March, Manuel/0000-0003-4418-8263; Luque-Casado, Antonio/0000-0002-9293-637X; March, Manuel Mateo/0000-0003-4418-8263	Spanish Ministerio de Educacion y Cultura [FPU-AP2010-3630]; Junta de Andalucia [SEJ2007-63645]; CONSOLIDER INGENIO (Direccion General de Investigacion) [CSD2008-00048]	Spanish Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Junta de Andalucia(Junta de Andalucia); CONSOLIDER INGENIO (Direccion General de Investigacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the Spanish Ministerio de Educacion y Cultura with a predoctoral grant (FPU-AP2010-3630) to the first author, Spanish grants SEJ2007-63645 from the Junta de Andalucia to Daniel Sanabria, Mikel Zabala and Esther Morales, and the CSD2008-00048 CONSOLIDER INGENIO (Direccion General de Investigacion) to Daniel Sanabria (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html, http://www.educacion.gob.es/portada.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo E.O., 2006, PSYCHOBIOLOGY PHYS A; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; *AM COLL SPORTS ME, 2005, ACSMS GUID EX TEST P; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Camm AJ, 1996, EUR HEART J, V17, P354; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2009, PSYCHOL SPORT EXERC, V10, P19, DOI 10.1016/j.psychsport.2008.05.004; Cinaz Burcu, 2010, IADIS Multi Conference on Computer Science and Information Systems (MCCSIS 2010). Proceedings of the IADIS International Conferences. Computer Graphics, Visualization, Computer Vision and Image Processing 2010. Visual Communication 2010: Creative Industries Photography and Culture. Web Virtual Reality and Three-Dimensional Worlds 2010. Part of the IADIS Multi Conference on Computer Science and Information Systems 2010, P189; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Correa A, 2006, EXP BRAIN RES, V169, P58, DOI 10.1007/s00221-005-0131-x; Correa A, 2006, BRAIN RES, V1070, P202, DOI 10.1016/j.brainres.2005.11.094; Correa A, 2004, PERCEPT PSYCHOPHYS, V66, P264, DOI 10.3758/BF03194878; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Erickson KI, 2011, PNAS; FINNEY D, 1964, PROBIT ANAL STAT TRE; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Huertas F, 2011, J SPORT EXERCISE PSY, V33, P649, DOI 10.1123/jsep.33.5.649; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; LEVY MN, 1994, VAGAL CONTROL HEART; Loh S, 2004, BEHAV RES METH INS C, V36, P339, DOI 10.3758/BF03195580; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; MALIK M, 1989, MED BIOL ENG COMPUT, V27, P603, DOI 10.1007/BF02441642; Mateo M, 2012, EUR J APPL PHYSIOL, V112, P113, DOI 10.1007/s00421-011-1962-8; McMorris T., 2009, EXERCISE COGNITIVE F, DOI [10.1002/9780470740668.ch2, DOI 10.1002/9780470740668.CH2]; Mukherjee S, 2011, CLIN NEUROPHYSIOL, V122, P2059, DOI 10.1016/j.clinph.2011.02.032; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Posner MI, 2005, PLOS BIOL, V3, P204, DOI 10.1371/journal.pbio.0030051; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Renaud M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00148; Sanabria D, 2011, PSYCHOL SPORT EXERC, V12, P570, DOI 10.1016/j.psychsport.2011.04.002; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Taelman J, 2011, EUR J APPL PHYSIOL, V111, P1497, DOI 10.1007/s00421-010-1776-0; Tarvainen MP, 2009, IFMBE PROC, V22, P1022; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Trivino M, 2010, BRAIN, V133, P1173, DOI 10.1093/brain/awp346; WILKINSON RT, 1982, HUM FACTORS, V24, P487, DOI 10.1177/001872088202400409	47	86	88	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56935	10.1371/journal.pone.0056935	http://dx.doi.org/10.1371/journal.pone.0056935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437276	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200188
J	Reiffel, AJ; Kafka, C; Hernandez, KA; Popa, S; Perez, JL; Zhou, S; Pramanik, S; Brown, BN; Ryu, WS; Bonassar, LJ; Spector, JA				Reiffel, Alyssa J.; Kafka, Concepcion; Hernandez, Karina A.; Popa, Samantha; Perez, Justin L.; Zhou, Sherry; Pramanik, Satadru; Brown, Bryan N.; Ryu, Won Seuk; Bonassar, Lawrence J.; Spector, Jason A.			High-Fidelity Tissue Engineering of Patient-Specific Auricles for Reconstruction of Pediatric Microtia and Other Auricular Deformities	PLOS ONE			English	Article							HUMAN EAR; CULTURED CHONDROCYTES; IN-VITRO; CARTILAGE; RABBIT; MODEL; SHAPE; BEHAVIOR; CONSTRUCT; IMPLANTS	Introduction: Autologous techniques for the reconstruction of pediatric microtia often result in suboptimal aesthetic outcomes and morbidity at the costal cartilage donor site. We therefore sought to combine digital photogrammetry with CAD/CAM techniques to develop collagen type I hydrogel scaffolds and their respective molds that would precisely mimic the normal anatomy of the patient-specific external ear as well as recapitulate the complex biomechanical properties of native auricular elastic cartilage while avoiding the morbidity of traditional autologous reconstructions. Methods: Three-dimensional structures of normal pediatric ears were digitized and converted to virtual solids for mold design. Image-based synthetic reconstructions of these ears were fabricated from collagen type I hydrogels. Half were seeded with bovine auricular chondrocytes. Cellular and acellular constructs were implanted subcutaneously in the dorsa of nude rats and harvested after 1 and 3 months. Results: Gross inspection revealed that acellular implants had significantly decreased in size by 1 month. Cellular constructs retained their contour/projection from the animals' dorsa, even after 3 months. Post-harvest weight of cellular constructs was significantly greater than that of acellular constructs after 1 and 3 months. Safranin O-staining revealed that cellular constructs demonstrated evidence of a self-assembled perichondrial layer and copious neocartilage deposition. Verhoeff staining of 1 month cellular constructs revealed de novo elastic cartilage deposition, which was even more extensive and robust after 3 months. The equilibrium modulus and hydraulic permeability of cellular constructs were not significantly different from native bovine auricular cartilage after 3 months. Conclusions: We have developed high-fidelity, biocompatible, patient-specific tissue-engineered constructs for auricular reconstruction which largely mimic the native auricle both biomechanically and histologically, even after an extended period of implantation. This strategy holds immense potential for durable patient-specific tissue-engineered anatomically proper auricular reconstructions in the future.	[Reiffel, Alyssa J.; Hernandez, Karina A.; Perez, Justin L.; Spector, Jason A.] Weill Cornell Med Coll, Div Plast Surg, Lab Bioregenerat Med & Surg, New York, NY 10021 USA; [Kafka, Concepcion; Popa, Samantha; Zhou, Sherry; Pramanik, Satadru; Brown, Bryan N.; Ryu, Won Seuk; Bonassar, Lawrence J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Brown, Bryan N.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Cornell University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reiffel, AJ (corresponding author), Weill Cornell Med Coll, Div Plast Surg, Lab Bioregenerat Med & Surg, New York, NY 10021 USA.	Jas2037@med.cornell.edu	Bonassar, Lawrence J/C-2103-2016	Bonassar, Lawrence J/0000-0003-1094-6433	Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant [T32 HL083824-05]; Morgan Seed Grant Award for Collaborative Multidisciplinary Research in Tissue Engineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083824] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morgan Seed Grant Award for Collaborative Multidisciplinary Research in Tissue Engineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant T32 HL083824-05 (Dr. Reiffel) and a Morgan Seed Grant Award for Collaborative Multidisciplinary Research in Tissue Engineering (Drs. Spector and Bonassar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bichara DA, 2012, TISSUE ENG PART B-RE, V18, P51, DOI [10.1089/ten.teb.2011.0326, 10.1089/ten.TEB.2011.0326]; Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI [10.1089/ten.tea.2009.0442, 10.1089/ten.TEA.2009.0442]; Britt JC, 1998, ARCH OTOLARYNGOL, V124, P671, DOI 10.1001/archotol.124.6.671; Cai H, 2005, BIO-MED MATER ENG, V15, P375; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Chang SCN, 2003, PLAST RECONSTR SURG, V112, P793, DOI 10.1097/01.PRS.0000069711.31021.94; Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S; Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Dahl JP, 2011, OTOLARYNG HEAD NECK, V145, P915, DOI 10.1177/0194599811419092; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Funayama A, 2008, J ORTHOP SCI, V13, P225, DOI 10.1007/s00776-008-1220-z; Gleghorn JP, 2007, EUR CELLS MATER, V14, P20, DOI 10.22203/eCM.v014a02; Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1; Henderson JH, 2007, TISSUE ENG, V13, P843, DOI 10.1089/ten.2006.0256; Ibusuki Shinichi, 2009, J Knee Surg, V22, P72; Isogai N, 2004, TISSUE ENG, V10, P673, DOI 10.1089/1076327041348527; Kusuhara H, 2009, WOUND REPAIR REGEN, V17, P136, DOI 10.1111/j.1524-475X.2008.00451.x; Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g; Liu Y, 2010, BIOMATERIALS, V31, P2176, DOI 10.1016/j.biomaterials.2009.11.080; Luquetti DV, 2012, AM J MED GENET A, V158A, P124, DOI 10.1002/ajmg.a.34352; Park SS, 2004, BIOMATERIALS, V25, P2363, DOI 10.1016/j.biomaterials.2003.09.019; Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001; Romo T, 2009, ANN PLAS SURG, V62, P384, DOI 10.1097/SAP.0b013e31819fae51; Rotter N, 2002, ARCH BIOCHEM BIOPHYS, V403, P132, DOI 10.1016/S0003-9861(02)00263-1; Roy R, 2004, J BIOMED MATER RES A, V68A, P597, DOI 10.1002/jbm.a.10068; Ruszymah BHI, 2011, INT J PEDIATR OTORHI, V75, P805, DOI 10.1016/j.ijporl.2011.03.012; Sanz E, 2007, PLAST RECONSTR SURG, V119, P1707, DOI 10.1097/01.prs.0000258849.76630.d2; Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5; VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001; Viren T, 2010, ULTRASOUND MED BIOL, V36, P833, DOI 10.1016/j.ultrasmedbio.2010.02.015; Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627	33	120	137	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56506	10.1371/journal.pone.0056506	http://dx.doi.org/10.1371/journal.pone.0056506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437148	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315184200086
J	Santoleri, F; Sorice, P; Lasala, R; Rizzo, RC; Costantini, A				Santoleri, Fiorenzo; Sorice, Paola; Lasala, Ruggero; Rizzo, Rosa Carmela; Costantini, Alberto			Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice	PLOS ONE			English	Article							MEDICATION COMPLIANCE; THERAPY	Introduction: The aim of this study is to evaluate adherence and persistence of patients treated with Imatinib, Nilotinib or Dasatinib, also giving economic evaluations on therapy costs for Received Daily Dose (RDD). Materials and Methods: In this retrospective study, we took into account 3 years from 1st Jan. 2009 to 31st March. 2012. Treatment adherence was quantified utilizing ratio between RDD and PDD (Prescribed Daily Dose). Persistence is reckoned taking into account the actual therapy days, comparing posology with supplied dose, drawing the graph using Kaplan-Meir method. Results: Adherence results in values between 0.8 and 1.0 for Nilotinib (Adh =0.93), Imatinib (Adh =0.83) and Dasatinib (0.85). Imatinib has better persistence, 90% of patients in treatment exceed one year of treatment versus 83.3% for Nilotinib and 80% for Dasatinib. The cost per single day of treatment (cost per RDD) was (sic) 39.41 for Imatinib, (sic) 113.60 for Nilotinib and (sic) 94.84 for Dasatinib. Conclusion: Patients with CML have a loose of adherence both in first line with Imatinib and in second line of therapy with Dasatinib and Nilotinib. Loss of adherence remains a big problem and could be minimized by a patient-oriented project invlolving physicians, nurses, pharmacists and caregiver.	[Santoleri, Fiorenzo; Sorice, Paola; Lasala, Ruggero; Rizzo, Rosa Carmela; Costantini, Alberto] Gen Hosp Pescara, Pescara, Italy		Santoleri, F (corresponding author), Gen Hosp Pescara, Pescara, Italy.	fiorenzosantoleri@hotmail.com		Santoleri, Fiorenzo/0000-0002-9105-0745; Lasala, Ruggero/0000-0003-2411-8743				[Anonymous], MED COMPL PERS SPEC; Bartel SB, 2007, AM J HEALTH-SYST PH, V64, pS8, DOI 10.2146/ajhp070036; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Cassidy J, 2006, BRIT J CANCER, V94, P1122, DOI 10.1038/sj.bjc.6603059; Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Foulon V, 2011, ACTA CLIN BELG, V66, P85, DOI 10.2143/ACB.66.2.2062525; Gebbia V, 2011, EXPERT OPINDRUG 1213; Goodin S, 2011, J ONCOL PRACT, V7, P7, DOI 10.1200/JOP.2010.000068; Guerin A, 2012, CURR MED RES OPIN, V28, P1155, DOI 10.1185/03007995.2012.705264; Halpern R, 2011, PATIENT PREFER ADHER, V5, P73, DOI 10.2147/PPA.S15702; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Mahtani KR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005025.pub3; Mancini R, 2012, J SUPPORTONCOL  0120; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Schwappach DLB, 2010, EUR J CANCER CARE, V19, P285, DOI 10.1111/j.1365-2354.2009.01127.x; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Zedler BK, 2011, CLIN THER, V33, P581, DOI 10.1016/j.clinthera.2011.04.020; Zedler BK, 2011, CLIN THER, V33, P62, DOI 10.1016/j.clinthera.2011.02.003	20	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56813	10.1371/journal.pone.0056813	http://dx.doi.org/10.1371/journal.pone.0056813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437249	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200169
J	Zhang, FY; Lu, X; Lv, ZY; Zhang, L; Zhu, MM; Jiang, WM; Wang, GF; Sun, XF; Tang, KX				Zhang, Fangyuan; Lu, Xu; Lv, Zongyou; Zhang, Ling; Zhu, Mengmeng; Jiang, Weiming; Wang, Guofeng; Sun, Xiaofen; Tang, Kexuan			Overexpression of the Artemisia Orthologue of ABA Receptor, AaPYL9, Enhances ABA Sensitivity and Improves Artemisinin Content in Artemisia annua L.	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHETIC GENES; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; POSITIVE REGULATOR; ANTIMALARIAL-DRUG; PLANT HORMONES; LEAF GROWTH; ARABIDOPSIS; EXPRESSION	The phytohormone abscisic acid (ABA) plays an important role in plant development and environmental stress response. In this study, we cloned an ABA receptor orthologue, AaPYL9, from Artemisia annua L. AaPYL9 is expressed highly in leaf and flower. AaPYL9 protein can be localized in both nucleus and cytoplasm. Yeast two-hybrid assay shows AaPYL9 can specifically interact with AtABI1 but not with AtABI2, AtHAB1 or AtHAB2. ABA can enhance the interaction between AaPYL9 and AtABI1 while AaPYL9-89 Pro -> Ser and AaPYL9-116 His -> Ala point mutations abolishes the interaction. BiFC assay shows that AaPYL9 interacts with AtABI1 in nucleus in planta. Transgenic Arabidopsis plants over-expressing AaPYL9 are more sensitive to ABA in the seed germination and primary root growth than wild type. Consistent with this, ABA report genes have higher expression in AaPYL9 overexpressing plants compared to wild type after ABA treatment. Moreover, overexpression of AaPYL9 in A. annua increases not only drought tolerance, but also artemisinin content after ABA treatment, with significant enhancement of the expression of key genes in artemisinin biosynthesis. This study provides a way to develop A. annua with high-yielding artemisinin and high drought resistance.	[Zhang, Fangyuan; Lu, Xu; Lv, Zongyou; Zhang, Ling; Zhu, Mengmeng; Jiang, Weiming; Wang, Guofeng; Sun, Xiaofen; Tang, Kexuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Tang, KX (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China.	kxtang1@yahoo.com	Tang, Kexuan/E-3555-2013	Tang, Kexuan/0000-0002-8748-9624; Jiang, Weimin/0000-0002-2546-5256	China National High-Tech 863 Program [2011AA100605]; Shanghai Leading Academic Discipline Project [B209]	China National High-Tech 863 Program(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was funded by China National High-Tech 863 Program (2011AA100605) and Shanghai Leading Academic Discipline Project (B209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai YM, 2011, J EXP BOT, V62, P5079, DOI 10.1093/jxb/err207; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Cutler S, 2005, PLANT PHYSIOL, V138, P558, DOI 10.1104/pp.104.900152; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; De Smet I, 2006, TRENDS PLANT SCI, V11, P434, DOI 10.1016/j.tplants.2006.07.003; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; El-Sayed M, 2004, PLANT GROWTH REGUL, V44, P53, DOI 10.1007/s10725-004-2604-5; Ferreira JFS, 1996, PHYTOCHEMISTRY, V41, P97, DOI 10.1016/0031-9422(95)00542-0; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Jeannette E, 1999, PLANT J, V18, P13, DOI 10.1046/j.1365-313X.1999.00423.x; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jing FY, 2009, BIOLOGIA, V64, P319, DOI 10.2478/s11756-009-0040-8; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Kim JS, 2006, J PLANT BIOL, V49, P16, DOI 10.1007/BF03030784; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li G, 2012, PLANT BIOLOGY, V14, P244, DOI 10.1111/j.1438-8677.2011.00504.x; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2010, NAT STRUCT MOL BIOL, V17, P1102, DOI 10.1038/nsmb.1887; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Mori K, 2005, VITIS, V44, P161; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Reymond M, 2003, PLANT PHYSIOL, V131, P664, DOI 10.1104/pp.013839; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Romero MR, 2006, PLANTA MED, V72, P1169, DOI 10.1055/s-2006-947198; Saavedra X, 2010, PLANT PHYSIOL, V152, P133, DOI 10.1104/pp.109.146381; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANDENBERGHE DR, 1995, J NAT PRODUCTS, V58, P798, DOI 10.1021/np50119a027; Wang RS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-216; Weiner JJ, 2010, CURR OPIN PLANT BIOL, V13, P495, DOI 10.1016/j.pbi.2010.09.007; Welcker C, 2007, J EXP BOT, V58, P339, DOI 10.1093/jxb/erl227; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhang L, 2009, BIOTECHNOL APPL BIOC, V52, P199, DOI 10.1042/BA20080068; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	64	35	43	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56697	10.1371/journal.pone.0056697	http://dx.doi.org/10.1371/journal.pone.0056697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437216	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200146
J	Delaune, A; Cabin-Flaman, A; Legent, G; Gibouin, D; Smet-Nocca, C; Lefebvre, F; Benecke, A; Vasse, M; Ripoll, C				Delaune, Anthony; Cabin-Flaman, Armelle; Legent, Guillaume; Gibouin, David; Smet-Nocca, Caroline; Lefebvre, Fabrice; Benecke, Arndt; Vasse, Marc; Ripoll, Camille			50nm-Scale Localization of Single Unmodified, Isotopically Enriched, Proteins in Cells	PLOS ONE			English	Article							ION MASS-SPECTROMETRY; NEUTRAL CESIUM DEPOSITION; NONNATURAL AMINO-ACIDS; SIMS MICROSCOPY; DYNAMIC SIMS; GENETIC-CODE; LIVING CELLS; THYMINE-DNA; IN-VITRO; MOLECULES	Imaging single proteins within cells is challenging if the possibility of artefacts due to tagging or to recognition by antibodies is to be avoided. It is generally believed that the biological properties of proteins remain unaltered when N-14 isotopes are replaced with N-15. N-15-enriched proteins can be localised by dynamic Secondary Ion Mass Spectrometry (D-SIMS). We describe here a novel imaging analysis algorithm to detect a few N-15-enriched proteins - and even a single protein - within a cell using D-SIMS. The algorithm distinguishes statistically between a low local increase in N-15 isotopic fraction due to an enriched protein and a stochastic increase due to the background. To determine the number of enriched proteins responsible for the increase in the isotopic fraction, we use sequential D-SIMS images in which we compare the measured isotopic fractions to those expected if 1, 2 or more enriched proteins are present. The number of enriched proteins is the one that gives the best fit between the measured and the expected values. We used our method to localise N-15-enriched thymine DNA glycosylase (TDG) and retinoid X receptor alpha (RXR alpha) proteins delivered to COS-7 cells. We show that both a single TDG and a single RXR alpha can be detected. After 4 h incubation, both proteins were found mainly in the nucleus; RXR alpha as a monomer or dimer and TDG only as a monomer. After 7 h, RXR alpha was found in the nucleus as a monomer, dimer or tetramer, whilst TDG was no longer in the nucleus and instead formed clusters in the cytoplasm. After 24 h, RXR alpha formed clusters in the cytoplasm, and TDG was no longer detectable. In conclusion, single unmodified proteins in cells can be counted and localised with 50 nm resolution by combining D-SIMS with our method of analysis.	[Delaune, Anthony; Cabin-Flaman, Armelle; Legent, Guillaume; Gibouin, David; Lefebvre, Fabrice; Vasse, Marc; Ripoll, Camille] Univ Rouen, Fac Sci, Equipe AMMIS, Lab MERCI EA3829, Mont St Aignan, France; [Delaune, Anthony; Vasse, Marc] Univ Rouen, Fac Med Pharm, Rouen, France; [Smet-Nocca, Caroline; Benecke, Arndt] Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France; [Smet-Nocca, Caroline; Benecke, Arndt] CNRS, USR3078, Bures Sur Yvette, France	Universite de Rouen Normandie; Universite de Rouen Normandie; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Delaune, A (corresponding author), Univ Rouen, Fac Sci, Equipe AMMIS, Lab MERCI EA3829, Mont St Aignan, France.	anthony.delaune@univ-rouen.fr	Smet-Nocca, Caroline/G-2868-2012; Benecke, Arndt G./T-1079-2019; Smet-Nocca, Caroline/U-3427-2019; vasse, marc/B-9595-2018	Smet-Nocca, Caroline/0000-0002-9793-0882; Smet-Nocca, Caroline/0000-0002-9793-0882; vasse, marc/0000-0002-8784-7209	"Vie & Espoir'' association; "Titoine'' association; Genopole	"Vie & Espoir'' association; "Titoine'' association; Genopole	This work was funded in part by the "Vie & Espoir'' and "Titoine'' associations, and by Genopole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benninghoven A., 1987, SECONDARY ION MASS S; Berglund M, 2011, PURE APPL CHEM, V83, P397, DOI 10.1351/PAC-REP-10-06-02; Boggio KJ, 2011, EXPERT REV PROTEOMIC, V8, P591, DOI [10.1586/epr.11.53, 10.1586/EPR.11.53]; Cabin-Flaman A, 2011, ANAL CHEM, V83, P6940, DOI 10.1021/ac201685t; Castaing R., 1962, J MICROSC PARIS, V1, P395; Chandra S, 2000, ANAL CHEM, V72, p104A, DOI 10.1021/ac002716i; Chen ZP, 1998, J MOL BIOL, V275, P55, DOI 10.1006/jmbi.1997.1413; Delaune A, 2008, J NEUROCHEM, V104, P89, DOI 10.1111/j.1471-4159.2007.05019.x; Doring V, 1998, GENETICS, V150, P543; Fleming RH, 1995, ISOTOPE RATIO TRACE, P143; Fletcher JS, 2011, CURR OPIN CHEM BIOL, V15, P733, DOI 10.1016/j.cbpa.2011.05.016; Fujita K, 2008, MOL CELLS, V26, P530; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Hillion F, 1993, NEW HIGH PERFORMANCE; HINDIE E, 1992, BIOL CELL, V74, P81, DOI 10.1016/0248-4900(92)90011-O; Hindie E, 1990, ORIGIN CYANIDE SECON, P335; IBBA M, 1994, BIO-TECHNOL, V12, P678, DOI 10.1038/nbt0794-678; Jones DH, 2010, J BIOMOL NMR, V46, P89, DOI 10.1007/s10858-009-9365-4; Kaneko K, 2007, ORIGINS LIFE EVOL B, V37, P465, DOI 10.1007/s11084-007-9083-4; Koning RI, 2010, METHOD CELL BIOL, V97, P455, DOI 10.1016/S0091-679X(10)97024-6; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Legent G, 2008, J PHYS CHEM B, V112, P5534, DOI 10.1021/jp7100489; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; McMahon G, 2006, J AM SOC MASS SPECTR, V17, P1181, DOI 10.1016/j.jasms.2006.04.031; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Nikolov SG, 1996, CHEMOMETR INTELL LAB, V34, P263, DOI 10.1016/0169-7439(96)00003-2; Ortuno F, 1997, HAEMATOLOGICA, V82, P334; Philipp P, 2007, INT J MASS SPECTROM, V264, P70, DOI 10.1016/j.ijms.2007.03.019; Philipp P, 2007, INT J MASS SPECTROM, V261, P91, DOI 10.1016/j.ijms.2006.07.020; Philipp P, 2006, APPL SURF SCI, V252, P7205, DOI 10.1016/j.apsusc.2006.02.119; Rietmann T, 2006, APPL SURF SCI, V252, P6640, DOI 10.1016/j.apsusc.2006.02.102; Smet-Nocca C, 2008, BIOCHEMISTRY-US, V47, P6519, DOI 10.1021/bi7022283; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Thellier M, 2001, J TRACE MICROPROBE T, V19, P143, DOI 10.1081/TMA-100001469; Tyler BJ, 2006, APPL SURF SCI, V252, P6875, DOI 10.1016/j.apsusc.2006.02.160; Wessels JT, 2010, CYTOM PART A, V77A, P667, DOI 10.1002/cyto.a.20931; Willse A, 2002, ANAL CHEM, V74, P6314, DOI 10.1021/ac025561i; Xie JM, 2005, METHODS, V36, P227, DOI 10.1016/j.ymeth.2005.04.010	41	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56559	10.1371/journal.pone.0056559	http://dx.doi.org/10.1371/journal.pone.0056559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431383	Green Published, gold, Green Submitted			2022-12-27	WOS:000315182800026
J	Liu, AH; Gao, F; Kanno, Y; Jordan, MC; Kamiya, Y; Seo, M; Ayele, BT				Liu, Aihua; Gao, Feng; Kanno, Yuri; Jordan, Mark C.; Kamiya, Yuji; Seo, Mitsunori; Ayele, Belay T.			Regulation of Wheat Seed Dormancy by After-Ripening Is Mediated by Specific Transcriptional Switches That Induce Changes in Seed Hormone Metabolism and Signaling	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA SEEDS; ACTIVATED PROTEIN-KINASES; ABSCISIC-ACID; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; GIBBERELLIN METABOLISM; CONJUGATE HYDROLASES; FLORAL DEVELOPMENT; JASMONIC ACID; CROSS-TALK	Treatments that promote dormancy release are often correlated with changes in seed hormone content and/or sensitivity. To understand the molecular mechanisms underlying the role of after-ripening (seed dry storage) in triggering hormone related changes and dormancy decay in wheat (Triticum aestivum), temporal expression patterns of genes related to abscisic acid (ABA), gibberellin (GA), jasmonate and indole acetic acid (IAA) metabolism and signaling, and levels of the respective hormones were examined in dormant and after-ripened seeds in both dry and imbibed states. After-ripening mediated developmental switch from dormancy to germination appears to be associated with declines in seed sensitivity to ABA and IAA, which are mediated by transcriptional repressions of PROTEIN PHOSPHATASE 2C, SNF1-RELATED PROTEIN KINASE2, ABA INSENSITIVE5 and LIPID PHOSPHATE PHOSPHTASE2, and AUXIN RESPONSE FACTOR and RELATED TO UBIQUITIN1 genes. Transcriptomic analysis of wheat seed responsiveness to ABA suggests that ABA inhibits the germination of wheat seeds partly by repressing the transcription of genes related to chromatin assembly and cell wall modification, and activating that of GA catabolic genes. After-ripening induced seed dormancy decay in wheat is also associated with the modulation of seed IAA and jasmonate contents. Transcriptional control of members of the ALLENE OXIDE SYNTHASE, 3-KETOACYL COENZYME A THIOLASE, LIPOXYGENASE and 12-OXOPHYTODIENOATE REDUCTASE gene families appears to regulate seed jasmonate levels. Changes in the expression of GA biosynthesis genes, GA 20-OXIDASE and GA 3-OXIDASE, in response to after-ripening implicate this hormone in enhancing dormancy release and germination. These findings have important implications in the dissection of molecular mechanisms underlying regulation of seed dormancy in cereals.	[Liu, Aihua; Gao, Feng; Ayele, Belay T.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Jordan, Mark C.] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Kanno, Yuri; Kamiya, Yuji; Seo, Mitsunori] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	University of Manitoba; Agriculture & Agri Food Canada; RIKEN	Ayele, BT (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada.	b_ayele@umanitoba.ca	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to BTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YQ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-105; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Ayele BT, 2012, J PLANT GROWTH REGUL, V31, P235, DOI 10.1007/s00344-011-9234-8; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; BERESTETZKY V, 1991, BIOCHEM PHYSIOL PFL, V187, P13, DOI 10.1016/S0015-3796(11)80178-2; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIALEK K, 1989, PLANT PHYSIOL, V91, P775, DOI 10.1104/pp.91.2.775; BIALEK K, 1992, PLANT PHYSIOL, V100, P509, DOI 10.1104/pp.100.1.509; BIALEK K, 1992, PLANT PHYSIOL, V100, P2002, DOI 10.1104/pp.100.4.2002; Blazejczyk M, 2007, FLEXARRAY VERSION 1; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Chen KG, 2010, ACTA PHYSIOL PLANT, V32, P789, DOI 10.1007/s11738-010-0464-3; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Gomez-Cadenas A, 1999, P NATL ACAD SCI USA, V96, P1767, DOI 10.1073/pnas.96.4.1767; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; HILHORST HWM, 1995, SEED SCI RES, V5, P61, DOI 10.1017/S0960258500002634; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Jacobsen JV, 2002, PHYSIOL PLANTARUM, V115, P428, DOI 10.1034/j.1399-3054.2002.1150313.x; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; Kline KG, 2010, PLANT PHYSIOL, V154, P479, DOI 10.1104/pp.110.160846; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Li CJ, 2012, PLANT CELL ENVIRON, V35, P952, DOI 10.1111/j.1365-3040.2011.02464.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; LIU YQ, 1994, PLANTA, V194, P368, DOI 10.1007/BF00197537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; MORRIS CF, 1989, PLANT PHYSIOL, V90, P643, DOI 10.1104/pp.90.2.643; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Nakamura S, 2001, J EXP BOT, V52, P875, DOI 10.1093/jexbot/52.357.875; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Penfield S, 2006, CURR BIOL, V16, P2366, DOI 10.1016/j.cub.2006.10.057; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Preston J, 2009, PLANT CELL PHYSIOL, V50, P1786, DOI 10.1093/pcp/pcp121; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; ROUSSELIN P, 1992, THEOR APPL GENET, V85, P213, DOI 10.1007/BF00222862; Saavedra L, 2009, PLANT CELL PHYSIOL, V50, P595, DOI 10.1093/pcp/pcp018; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Simpson G. M., 1990, SEED DORMANCY GRASSE; Steber CM, 1998, GENETICS, V149, P509; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Rodriguez MV, 2009, ANN BOT-LONDON, V104, P975, DOI 10.1093/aob/mcp184; WALKERSIMMONS M, 1987, PLANT PHYSIOL, V84, P61, DOI 10.1104/pp.84.1.61; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yao Z, 2012, J PLANT PHYSIOL, V169, P1477, DOI 10.1016/j.jplph.2012.06.001; Yildiz K, 2007, ASIAN J CHEM, V19, P1098; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	104	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56570	10.1371/journal.pone.0056570	http://dx.doi.org/10.1371/journal.pone.0056570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200108
J	Liu, EK; Yan, CR; Mei, XR; Zhang, YQ; Fan, TL				Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing; Fan, Tinglu			Long-Term Effect of Manure and Fertilizer on Soil Organic Carbon Pools in Dryland Farming in Northwest China	PLOS ONE			English	Article							DIFFERENT CROPPING SYSTEMS; SEQUESTRATION RATES; DEPTH DISTRIBUTION; LOESS PLATEAU; MATTER; TILLAGE; MANAGEMENT; FRACTIONS; DYNAMICS; QUALITY	An understanding of the dynamics of soil organic carbon (SOC) as affected by farming practices is imperative for maintaining soil productivity and mitigating global warming. The objectives of this study were to investigate the effects of long-term fertilization on SOC and SOC fractions for the whole soil profile (0-100 cm) in northwest China. The study was initiated in 1979 in Gansu, China and included six treatments: unfertilized control (CK), nitrogen fertilizer (N), nitrogen and phosphorus (P) fertilizers (NP), straw plus N and P fertilizers (NP+S), farmyard manure (FYM), and farmyard manure plus N and P fertilizers (NP+FYM). Results showed that SOC concentration in the 0-20 cm soil layer increased with time except in the CK and N treatments. Long-term fertilization significantly influenced SOC concentrations and storage to 60 cm depth. Below 60 cm, SOC concentrations and storages were statistically not significant between all treatments. The concentration of SOC at different depths in 0-60 cm soil profile was higher under NP+FYM follow by under NP+S, compared to under CK. The SOC storage in 0-60 cm in NP+FYM, NP+S, FYM and NP treatments were increased by 41.3%, 32.9%, 28.1% and 17.9%, respectively, as compared to the CK treatment. Organic manure plus inorganic fertilizer application also increased labile soil organic carbon pools in 0-60 cm depth. The average concentration of particulate organic carbon (POC), dissolved organic carbon (DOC) and microbial biomass carbon (MBC) in organic manure plus inorganic fertilizer treatments (NP+S and NP+FYM) in 0-60 cm depth were increased by 64.9-91.9%, 42.5-56.9%, and 74.7-99.4%, respectively, over the CK treatment. The POC, MBC and DOC concentrations increased linearly with increasing SOC content. These results indicate that long-term additions of organic manure have the most beneficial effects in building carbon pools among the investigated types of fertilization.	[Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Minist Agr Peoples Republ China MOA, Key Lab Dryland Farming g Agr, Beijing, Peoples R China; [Fan, Tinglu] Gansu Acad Agr Sci, Dryland Agr Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Yan, CR (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	yancr@ieda.org.cn; zhangyq@ieda.org.cn	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Basic Research Program of China (973 Program) [2012CB955904]; Chinese National Scientific Foundation [31000253, 31170490]; National Key Technologies RD Program [2012BAD09B01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Scientific Foundation; National Key Technologies RD Program(National Key Technology R&D Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Basic Research Program of China (973 Program) (No.2012CB955904), the Chinese National Scientific Foundation (No. 31000253, 31170490), the 12th five-year plan of the National Key Technologies R&D Program (No. 2012BAD09B01). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black C.A, 1965, AM SOC AGRON MADISON, P482; Blair N, 2006, SOIL TILL RES, V91, P39, DOI 10.1016/j.still.2005.11.001; Bronson KF, 1998, ADV SOIL S, P35; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chakraborty A, 2011, BIOL FERT SOILS, V47, P227, DOI 10.1007/s00374-010-0509-1; Chan KY, 1997, SOIL SCI SOC AM J, V61, P1376, DOI 10.2136/sssaj1997.03615995006100050013x; Chapman H.D., 1965, METHODS SOIL ANAL 2, P891; Doran JW, 1996, ADV AGRON, V56, P1, DOI 10.1016/S0065-2113(08)60178-9; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; Dou F, 2007, SOIL TILL RES, V94, P530, DOI 10.1016/j.still.2006.10.001; FAO-UNESCO, 1988, SOIL MAP WORLD; Gami SK, 2009, SOIL TILL RES, V106, P95, DOI 10.1016/j.still.2009.10.003; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; GOYAL S, 1992, SOIL BIOL BIOCHEM, V24, P1081, DOI 10.1016/0038-0717(92)90056-4; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Janzen HH, 1997, DEV SOIL SCI, V25, P277; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; Liang Q, 2012, NUTR CYCL AGROECOSYS, V92, P21, DOI 10.1007/s10705-011-9469-6; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Lou YL, 2011, CATENA, V87, P386, DOI 10.1016/j.catena.2011.07.006; LYNCH JM, 1980, SOIL BIOL BIOCHEM, V12, P547, DOI 10.1016/0038-0717(80)90033-4; Majumder B, 2008, SOIL SCI SOC AM J, V72, P775, DOI 10.2136/sssaj2006.0378; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Melero S, 2009, SOIL TILL RES, V104, P292, DOI 10.1016/j.still.2009.04.001; Nayak AK, 2012, FIELD CROP RES, V127, P129, DOI 10.1016/j.fcr.2011.11.011; OCIO JA, 1991, SOIL BIOL BIOCHEM, V23, P655, DOI 10.1016/0038-0717(91)90079-Y; Ouedraogo E, 2007, SOIL TILL RES, V94, P64, DOI 10.1016/j.still.2006.07.001; Powlson DS, 2012, AGR ECOSYST ENVIRON, V146, P23, DOI 10.1016/j.agee.2011.10.004; Puget P, 2001, SOIL SCI SOC AM J, V65, P771, DOI 10.2136/sssaj2001.653771x; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Saviozzi A, 2001, PLANT SOIL, V233, P251, DOI 10.1023/A:1010526209076; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Verma S, 2007, BIOL FERT SOILS, V44, P235, DOI 10.1007/s00374-007-0207-9; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wu TY, 2005, J PLANT NUTR SOIL SC, V168, P100, DOI 10.1002/jpln.200321295; Xing N., 2001, STUDY DRYLAND AGR N; Xu MG, 2011, BIOL FERT SOILS, V47, P745, DOI 10.1007/s00374-011-0579-8; Zhang WJ, 2009, NUTR CYCL AGROECOSYS, V84, P59, DOI 10.1007/s10705-008-9226-7; Zhang X, 1998, HYDROL PROCESS, V12, P171, DOI 10.1002/(SICI)1099-1085(199801)12:1&lt;171::AID-HYP570&gt;3.0.CO;2-L	48	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56536	10.1371/journal.pone.0056536	http://dx.doi.org/10.1371/journal.pone.0056536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200099
J	Liu, N; He, S; Ma, L; Ponnusamy, M; Tang, JH; Tolbert, E; Bayliss, G; Zhao, TC; Yan, HD; Zhuang, SG				Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhao, Ting C.; Yan, Haidong; Zhuang, Shougang			Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; OBSTRUCTIVE NEPHROPATHY; INTERSTITIAL FIBROSIS; MOLECULAR-MECHANISMS; CARDIAC-HYPERTROPHY; FACTOR RECEPTOR; ANGIOTENSIN-II; SOLID TUMORS; INJURY	Background: Histone deacetylase (HDAC) inhibitors are promising anti-fibrosis drugs; however, nonselective inhibition of class I and class II HDACs does not allow a detailed elucidation of the individual HDAC functions in renal fibrosis. In this study, we investigated the effect of MS-275, a selective class I HDAC inhibitor, on the development of renal fibrosis in a murine model of unilateral ureteral obstruction (UUO) and activation of cultured renal interstitial fibroblasts. Methods/Findings: The UUO model was established by ligation of the left ureter and the contralateral kidney was used as a control. At seven days after UUO injury, kidney developed fibrosis as indicated by deposition of collagen fibrils and increased expression of collagen I, fibronectin and alpha-smooth muscle actin (alpha-SMA). Administration of MS-275 inhibited all these fibrotic responses and suppressed UUO-induced production of transforming growth factor-beta1 (TGF- beta), increased expression of TGF-beta receptor I, and phosphorylation of Smad-3. MS-275 was also effective in suppressing phosphorylation and expression of epidermal growth factor receptor (EGFR) and its downstream signaling molecule, signal transducer and activator of transcription-3. Moreover, class I HDAC inhibition reduced the number of renal tubular cells arrested in the G2/M phase of the cell cycle, a cellular event associated with TGF-beta1overproduction. In cultured renal interstitial fibroblasts, MS-275 treatment inhibited TGF-beta induced phosphorylation of Smad-3, differentiation of renal fibroblasts to myofibroblasts and proliferation of myofibroblasts. Conclusions and Significance: These results demonstrate that class I HDACs are critically involved in renal fibrogenesis and renal fibroblast activation through modulating TGF-beta and EGFR signaling and suggest that blockade of class I HDAC may be a useful treatment for renal fibrosis.	[Liu, Na; Tang, Jinhua; Yan, Haidong; Zhuang, Shougang] Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [He, Song] Shekou Peoples Hosp, Dept Lab Med, Shenzhen, Guangdong, Peoples R China; [Zhao, Ting C.] Boston Univ, Sch Med, Roger William Med Ctr, Dept Surg, Providence, RI USA	Tongji University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Boston University; Roger Williams Medical Center	Yan, HD (corresponding author), Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China.	yhdcmu@sina.com; szhuang@lifespan.org	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Institutes of Health [DK-085065]; national nature science foundation of China [81270778, 81170638, 81200492]; Pudong New District Foundation of China [PWZxk2010-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national nature science foundation of China(National Natural Science Foundation of China (NSFC)); Pudong New District Foundation of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK-085065 to SZ), the national nature science foundation of China (81270778 to SZ, 81170638 to HY, 81200492 to NL), and Pudong New District Foundation of China (PWZxk2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Fraczek J, 2009, J CELL MOL MED, V13, P2990, DOI 10.1111/j.1582-4934.2009.00831.x; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gilbert RE, 2011, KIDNEY INT, V79, P1312, DOI 10.1038/ki.2011.39; Glasgow E, 2008, ENDOCR-RELAT CANCER, V15, P59, DOI 10.1677/ERC-07-0168; Hemmatazad H, 2009, ARTHRITIS RHEUM-US, V60, P1519, DOI 10.1002/art.24494; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Knipstein J, 2011, EXPERT OPIN INV DRUG, V20, P1455, DOI 10.1517/13543784.2011.613822; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2011, CONTRIB NEPHROL, V170, P75, DOI 10.1159/000324949; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Walkinshaw DR, 2008, J CELL BIOCHEM, V104, P1541, DOI 10.1002/jcb.21746; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	52	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54001	10.1371/journal.pone.0054001	http://dx.doi.org/10.1371/journal.pone.0054001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23468976	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700073
J	Sampaio-Silva, F; Magalhaes, T; Carvalho, F; Dinis-Oliveira, RJ; Silvestre, R				Sampaio-Silva, Fernanda; Magalhaes, Teresa; Carvalho, Felix; Dinis-Oliveira, Ricardo Jorge; Silvestre, Ricardo			Profiling of RNA Degradation for Estimation of Post Morterm Interval	PLOS ONE			English	Article							REAL-TIME PCR; MESSENGER-RNA; GENE-EXPRESSION; POSTMORTEM INTERVAL; HOUSEKEEPING GENES; QUALITY-CONTROL; HUMAN BRAIN; RT-PCR; QUANTIFICATION; IDENTIFICATION	An estimation of the post mortem interval (PMI) is frequently touted as the Holy Grail of forensic pathology. During the first hours after death, PMI estimation is dependent on the rate of physical observable modifications including algor, rigor and livor mortis. However, these assessment methods are still largely unreliable and inaccurate. Alternatively, RNA has been put forward as a valuable tool in forensic pathology, namely to identify body fluids, estimate the age of biological stains and to study the mechanism of death. Nevertheless, the attempts to find correlation between RNA degradation and PMI have been unsuccessful. The aim of this study was to characterize the RNA degradation in different post mortem tissues in order to develop a mathematical model that can be used as coadjuvant method for a more accurate PMI determination. For this purpose, we performed an eleven-hour kinetic analysis of total extracted RNA from murine's visceral and muscle tissues. The degradation profile of total RNA and the expression levels of several reference genes were analyzed by quantitative real-time PCR. A quantitative analysis of normalized transcript levels on the former tissues allowed the identification of four quadriceps muscle genes (Actb, Gapdh, Ppia and Srp72) that were found to significantly correlate with PMI. These results allowed us to develop a mathematical model with predictive value for estimation of the PMI (confidence interval of +/-51 minutes at 95%) that can become an important complementary tool for traditional methods.	[Sampaio-Silva, Fernanda; Silvestre, Ricardo] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Oporto, Portugal; [Sampaio-Silva, Fernanda; Dinis-Oliveira, Ricardo Jorge; Silvestre, Ricardo] Adv Inst Hlth Sci North, Dept Sci, CESPU, CRL, Gandra, Portugal; [Magalhaes, Teresa; Dinis-Oliveira, Ricardo Jorge] Univ Porto, Fac Med, Dept Legal Med & Forens Sci, P-4100 Oporto, Portugal; [Magalhaes, Teresa; Dinis-Oliveira, Ricardo Jorge] Ctr Forens Sci CENCIFOR, Coimbra, Portugal; [Carvalho, Felix; Dinis-Oliveira, Ricardo Jorge] Univ Porto, Fac Pharm, Dept Biol Sci, REQUIMTE,Lab Toxicol, P-4100 Oporto, Portugal; [Dinis-Oliveira, Ricardo Jorge] Polytech Hlth Inst North, Dept Diagnost & Therapeut Technol, CESPU, CRL, Vila Nova De Famalicao, Portugal; [Magalhaes, Teresa] Natl Inst Legal Med & Forens Sci, North Branch, Oporto, Portugal; [Magalhaes, Teresa] Univ Porto, Biomed Sci Inst Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Instituto Nacional de Medicina Legal e Ciencias Forenses, IP; Universidade do Porto	Silvestre, R (corresponding author), Univ Porto, Inst Mol & Cell Biol IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	rleal@ibmc.up.pt	Magalhães, Teresa/J-7897-2013; Silvestre, Ricardo/C-7243-2011; Carvalho, Félix/D-4914-2013; Dinis-Oliveira, Ricardo Jorge/D-9186-2013	Silvestre, Ricardo/0000-0002-9270-2717; Carvalho, Félix/0000-0003-3858-3494; Dinis-Oliveira, Ricardo Jorge/0000-0001-7430-6297; Magalhaes, Teresa/0000-0002-8098-8076; Sampaio Silva, Fernanda/0000-0002-7936-5154	FCT [SFRH/BPD/36865/2007]; Programa Ciencia; Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico; Fundo Social Europeu; Ministry of Science, Technology and Higher Education (MCTES)	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Ciencia(Spanish Government); Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico; Fundo Social Europeu; Ministry of Science, Technology and Higher Education (MCTES)	Ricardo Jorge Dinis-Oliveira acknowledges FCT for his Post-Doc grant (SFRH/BPD/36865/2007). Ricardo Silvestre was supported by Programa Ciencia, financed by Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico, co-funded by Fundo Social Europeu and National funding from Ministry of Science, Technology and Higher Education (MCTES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2005, FORENSIC SCI INT, V148, P37, DOI 10.1016/j.forsciint.2004.04.071; Bahar B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-108; Bauer M, 2007, FORENSIC SCI INT-GEN, V1, P69, DOI 10.1016/j.fsigen.2006.11.002; Bauer M, 2003, FORENSIC SCI INT, V138, P94, DOI 10.1016/j.forsciint.2003.09.008; Bauer Martin, 2003, Leg Med (Tokyo), V5, P220, DOI 10.1016/j.legalmed.2003.08.001; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catts VS, 2005, MOL BRAIN RES, V138, P164, DOI 10.1016/j.molbrainres.2005.04.017; Courts C, 2010, FORENSIC SCI INT, V203, P106, DOI 10.1016/j.forsciint.2010.07.002; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dinis-Oliveira RJ, 2010, TOXICOL MECH METHOD, V20, P363, DOI 10.3109/15376516.2010.497976; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Haas C, 2009, FORENSIC SCI INT-GEN, V3, P80, DOI 10.1016/j.fsigen.2008.11.003; Heinrich M, 2007, INT J LEGAL MED, V121, P136, DOI 10.1007/s00414-006-0131-9; Heinrich M, 2007, FORENSIC SCI INT-GEN, V1, P163, DOI 10.1016/j.fsigen.2007.01.002; Henssge C, 2007, FORENSIC SCI INT, V165, P182, DOI 10.1016/j.forsciint.2006.05.017; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; HUMPHREYS-BEHER M G, 1986, Biotechnology and Applied Biochemistry, V8, P392; Juusola J, 2005, FORENSIC SCI INT, V152, P1, DOI 10.1016/j.forsciint.2005.02.020; Juusola J, 2007, J FORENSIC SCI, V52, P1252, DOI 10.1111/j.1556-4029.2007.00550.x; Koppelkamm A, 2011, INT J LEGAL MED, V125, P573, DOI 10.1007/s00414-011-0578-1; Koppelkamm A, 2010, INT J LEGAL MED, V124, P371, DOI 10.1007/s00414-010-0433-9; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Liu LJ, 2007, J HUAZHONG U SCI-MED, V27, P362, DOI 10.1007/s11596-007-0404-7; MADEA B, 1994, FORENSIC SCI INT, V69, P221, DOI 10.1016/0379-0738(94)90386-7; Madea B, 2005, FORENSIC SCI INT, V151, P139, DOI 10.1016/j.forsciint.2005.01.013; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Partemi S, 2010, FORENSIC SCI INT, V203, P99, DOI 10.1016/j.forsciint.2010.07.005; Prahlow J, 2010, FORENSIC PATHOLOGY FOR POLICE, DEATH INVESTIGATORS, ATTORNEYS, AND FORENSIC SCIENTISTS, P1, DOI 10.1007/978-1-59745-404-9; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Sieger J, 2000, ENCY FORENSIC SCI; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vennemann M, 2010, FORENSIC SCI INT, V203, P71, DOI 10.1016/j.forsciint.2010.07.006; Vennemann M, 2010, FORENSIC SCI INT, V203, P76, DOI 10.1016/j.forsciint.2010.07.007; Weis S, 2007, J NEUROSCI METH, V165, P198, DOI 10.1016/j.jneumeth.2007.06.001; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4; Zhao Dong, 2006, Legal Medicine, V8, P132, DOI 10.1016/j.legalmed.2005.09.001	46	89	93	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56507	10.1371/journal.pone.0056507	http://dx.doi.org/10.1371/journal.pone.0056507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437149	Green Published, gold			2022-12-27	WOS:000315184200087
J	Yeh, CB; Hsieh, MJ; Lin, CW; Chiou, HL; Lin, PY; Chen, TY; Yang, SF				Yeh, Chao-Bin; Hsieh, Ming-Ju; Lin, Chiao-Wen; Chiou, Hui-Ling; Lin, Pen-Yuan; Chen, Tzy-Yen; Yang, Shun-Fa			The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; ORAL-CANCER; SIGNALING PATHWAY; KAPPA-B; EXPRESSION; INVASION; CELLS; INHIBITION; ANGIOGENESIS; APOPTOSIS	Background: The mortality and morbidity rates from cancer metastasis have not declined in Taiwan, especially because of hepatocellular carcinoma (HCC). Resveratrol has been shown to have benefits such as cardioprotection, providing antioxidative, anti-inflammatory, anti-cancer properties in previous studies. Therefore, HCC cells were subjected to treatment with resveratrol and then analyzed to determine the effects of resveratrol on the migration and invasion. Methodology and Principal Findings: Modified Boyden chamber assays revealed that resveratrol treatment significantly inhibited cell migration and invasion capacities of Huh7 cell lines that have low cytotoxicity in vitro, even at a high concentration of 100 mu M. The results of casein zymography and western blotting revealed that the activities and protein levels of the urokinase-type plasminogen activator (u-PA) were inhibited by resveratrol. Western blot analysis also showed that resveratrol inhibits phosphorylation of JNK1/2. Tests of the mRNA level, real-time PCR, and promoter assays evaluated the inhibitory effects of resveratrol on u-PA expression in HCC cells. The chromatin immunoprecipitation (ChIP) assay showed that reactive in transcription protein of nuclear factor SP-1 was inhibited by resveratrol. Conclusions: Resveratrol inhibits u-PA expression and the metastasis of HCC cells and is a powerful chemopreventive agent. The inhibitory effects were associated with the downregulation of the transcription factors of SP-1 signaling pathways.	[Yeh, Chao-Bin; Chen, Tzy-Yen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Hsieh, Ming-Ju; Chiou, Hui-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Pen-Yuan] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Chen, Tzy-Yen] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, TY (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	cshy042@csh.org.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Yeh, Chao-Bin/0000-0002-3978-5576; Ryu, Soojin/0000-0002-7059-0160; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University Hospital, Taiwan [CSH-2012-C-006]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a research grant from Chung Shan Medical University Hospital, Taiwan (CSH-2012-C-006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bae S, 2011, MOL CELLS, V32, P243, DOI 10.1007/s10059-011-1037-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan CF, 2004, CLIN CANCER RES, V10, P4140, DOI 10.1158/1078-0432.CCR-03-0574; Chen TY, 2011, ANN SURG ONCOL, V18, P2348, DOI 10.1245/s10434-011-1574-x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Fabre KM, 2011, CANCER BIOL THER, V12, P915, DOI 10.4161/cbt.12.10.17714; Freeman MR, 2011, CANCER BIOL THER, V12, P966, DOI 10.4161/cbt.12.11.18136; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hsu WH, 2012, J CELL PHYSIOL, V227, P697, DOI 10.1002/jcp.22777; Johnson WD, 2011, FOOD CHEM TOXICOL, V49, P3319, DOI 10.1016/j.fct.2011.08.023; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Kunimasa K, 2011, MOL NUTR FOOD RES, V55, P1730, DOI 10.1002/mnfr.201100098; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Liu M, 2011, COMMUN INTEGR BIOL, P4382; Mohapatra P, 2011, ONCOL RES, V19, P311, DOI 10.3727/096504011X13079697132844; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; Piotrowska H., 2011, MUTAT RES, V750, P60; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Roy S, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/703676; Ryu J, 2011, ANTICANCER RES, V31, P4223; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Szekeres T, 2010, PHARM RES-DORDR, V27, P1042, DOI 10.1007/s11095-010-0090-1; Thummarati P, 2012, WORLD J GASTROENTERO, V18, P244, DOI 10.3748/wjg.v18.i3.244; VONDERAHE D, 1988, NUCLEIC ACIDS RES, V16, P7527, DOI 10.1093/nar/16.15.7527; Weng CJ, 2012, CANCER TREAT REV, V38, P76, DOI 10.1016/j.ctrv.2011.03.001; Weng CJ, 2010, ANN SURG ONCOL, V17, P3394, DOI 10.1245/s10434-010-1124-y; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5235, DOI 10.1021/jf900531m; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Yang SF, 2007, J ETHNOPHARMACOL, V110, P483, DOI 10.1016/j.jep.2006.10.010; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yeh CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031055	36	51	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56661	10.1371/journal.pone.0056661	http://dx.doi.org/10.1371/journal.pone.0056661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24223943	Green Published, gold			2022-12-27	WOS:000315184200133
J	Li, ZY; Xu, ZS; Chen, Y; He, GY; Yang, GX; Chen, M; Li, LC; Ma, YZ				Li, Zhi-Yong; Xu, Zhao-Shi; Chen, Yang; He, Guang-Yuan; Yang, Guang-Xiao; Chen, Ming; Li, Lian-Cheng; Ma, You-Zhi			A Novel Role for Arabidopsis CBL1 in Affecting Plant Responses to Glucose and Gibberellin during Germination and Seedling Development	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; SUGAR SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ABSCISIC-ACID; CALCIUM SENSORS; PROTEIN-KINASE; BETA-AMYLASE; BINDING; CA2+; ABA	Glucose and phytohormones such as abscisic acid (ABA), ethylene, and gibberellin (GA) coordinately regulate germination and seedling development. However, there is still inadequate evidence to link their molecular roles in affecting plant responses. Calcium acts as a second messenger in a diverse range of signal transduction pathways. As calcium sensors unique to plants, calcineurin B-like (CBL) proteins are well known to modulate abiotic stress responses. In this study, it was found that CBL1 was induced by glucose in Arabidopsis. Loss-of-function mutant cbl1 exhibited hypersensitivity to glucose and paclobutrazol, a GA biosynthetic inhibitor. Several sugar-responsive and GA biosynthetic gene expressions were altered in the cbl1 mutant. CBL1 protein physically interacted with AKIN beta 1, the regulatory beta subunit of the SnRK1 complex which has a central role in sugar signaling. Our results indicate a novel role for CBL1 in modulating responses to glucose and GA signals.	[Li, Zhi-Yong; Xu, Zhao-Shi; Chen, Yang; Chen, Ming; Li, Lian-Cheng; Ma, You-Zhi] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China; [Li, Zhi-Yong; He, Guang-Yuan; Yang, Guang-Xiao] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base,Chinese Minist Sci &, Wuhan 430074, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong University of Science & Technology	Xu, ZS (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China.	xuzhaoshi@yahoo.com.cn; tuissa_2009@yahoo.com.cn; mayouzhi@yahoo.com.cn	LI, ZHIYONG/AAE-3158-2019; Li, Zhiyong/U-9472-2018	LI, ZHIYONG/0000-0002-2151-5535; Li, Zhiyong/0000-0002-2151-5535	National Transgenic Key Project of MOA [2011ZX08002-002]; International S & T Cooperation Key Projects of MoST [2009DFB30340]	National Transgenic Key Project of MOA; International S & T Cooperation Key Projects of MoST	This research was financially supported by National Transgenic Key Project of MOA (2011ZX08002-002) and International S & T Cooperation Key Projects of MoST (Grant No. 2009DFB30340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Arenas-Huertero F, 2000, GENE DEV, V14, P2085; Avila J, 2012, PLANT PHYSIOL, V159, P1277, DOI 10.1104/pp.112.198432; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Barker L, 2000, PLANT CELL, V12, P1153, DOI 10.1105/tpc.12.7.1153; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; BENTSINK L, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0050; Chan MT, 1998, P NATL ACAD SCI USA, V95, P6543, DOI 10.1073/pnas.95.11.6543; Chen PW, 2006, PLANT CELL, V18, P2326, DOI 10.1105/tpc.105.038844; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Daviere JM, 2008, CURR OPIN GENET DEV, V18, P295, DOI 10.1016/j.gde.2008.05.004; Dekkers BJW, 2004, PLANTA, V218, P579, DOI 10.1007/s00425-003-1154-9; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P1149, DOI 10.1093/pcp/pce150; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Gibson SI, 2001, BIOCHEM BIOPH RES CO, V280, P196, DOI 10.1006/bbrc.2000.4062; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Gu ZM, 2008, GENE, V415, P1, DOI 10.1016/j.gene.2008.02.011; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JF, 2001, TRENDS PLANT SCI, V6, P395, DOI 10.1016/S1360-1385(01)02023-4; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Huang CL, 2011, PLANT SCI, V181, P57, DOI 10.1016/j.plantsci.2011.03.011; Huijser C, 2000, PLANT J, V23, P577, DOI 10.1046/j.1365-313x.2000.00822.x; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Li XF, 2009, J INTEGR PLANT BIOL, V51, P513, DOI 10.1111/j.1744-7909.2009.00811.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Maeo K, 2001, PLANT MOL BIOL, V46, P627, DOI 10.1023/A:1010684908364; Martin T, 1997, PLANT J, V11, P53, DOI 10.1046/j.1365-313X.1997.11010053.x; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Mitsui T, 1999, PLANT CELL PHYSIOL, V40, P884, DOI 10.1093/oxfordjournals.pcp.a029618; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; MORELL MK, 1987, PLANT PHYSIOL, V85, P182, DOI 10.1104/pp.85.1.182; Nagira Y, 2006, J PLANT RES, V119, P137, DOI 10.1007/s10265-005-0256-9; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Pego JV, 2000, TRENDS PLANT SCI, V5, P531, DOI 10.1016/S1360-1385(00)01783-0; Pierre M, 2007, PLANT CELL, V19, P2804, DOI 10.1105/tpc.107.051870; Polge C, 2008, PLANT PHYSIOL, V148, P1570, DOI 10.1104/pp.108.123026; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Preuss ML, 2006, J CELL BIOL, V172, P991, DOI 10.1083/jcb.200508116; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Price J, 2003, PLANT PHYSIOL, V132, P1424, DOI 10.1104/pp.103.020347; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; SADKA A, 1994, PLANT CELL, V6, P737, DOI 10.1105/tpc.6.5.737; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Sivak M.N., 1998, ADV FOOD NUTR RES, V41, P1; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Urwin NAR, 1997, PLANT MOL BIOL, V35, P929, DOI 10.1023/A:1005950915499; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang MY, 2007, PLANT MOL BIOL, V65, P733, DOI 10.1007/s11103-007-9238-8; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan K, 2006, J EXP BOT, V57, P3359, DOI 10.1093/jxb/erl096; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294	83	51	60	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56412	10.1371/journal.pone.0056412	http://dx.doi.org/10.1371/journal.pone.0056412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24086647	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200070
J	Zhu, ZW; Zhang, XH; Shen, ZJ; Zhong, S; Wang, XJ; Lu, YL; Xu, C				Zhu, Zhaowei; Zhang, Xiaohua; Shen, Zhoujun; Zhong, Shan; Wang, Xianjin; Lu, Yingli; Xu, Chen			Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies	PLOS ONE			English	Article							POPULATION-BASED COHORT; GROWTH-FACTOR-I; FOLLOW-UP; PROSTATE-CANCER; INCIDENT CANCER; PLASMA-LEVELS; US ADULTS; MORTALITY; ASSOCIATION; METFORMIN	Background: Increasing evidence suggests that diabetes mellitus (DM) may be associated with an increased risk of bladder cancer. To provide a quantitative assessment of this association, we evaluated the relation between DM and incidence and mortality of bladder cancer in an updated meta-analysis of cohort studies. Methods We identified cohort studies by searching the EMBASE and MEDLINE databases, through 31 March 2012. Summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated with random-effects models. Results: A total of 29 cohort studies (27 articles) were included in this meta-analysis. DM was associated with an increased incidence of bladder cancer (RR 1.29, 95% CI: 1.08-1.54), with significant evidence of heterogeneity among these studies (p<0.001, I-2 = 94.9%). In stratified analysis, the RRs of bladder cancer were 1.36 (1.05-1.77) for diabetic men and 1.28 (0.75-2.19) for diabetic women, respectively. DM was also positively associated with bladder cancer mortality (RR 1.33, 95% CI: 1.14-1.55), with evident heterogeneity between studies (p = 0.002, I-2 = 63.3%). The positive association was observed for both men (RR 1.54, 95% CI: 1.30-1.82) and women (RR 1.50, 95% CI: 1.05-2.14). Conclusion: These findings suggest that compared to non-diabetic individuals, diabetic individuals have an increased incidence and mortality of bladder cancer.	[Zhu, Zhaowei; Zhang, Xiaohua; Shen, Zhoujun; Zhong, Shan; Wang, Xianjin] Shanghai Jiao Tong Univ, Dept Urol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Lu, Yingli] Shanghai Jiao Tong Univ, Inst & Dept Endocrinol & Metab, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Xu, Chen] Shanghai Jiao Tong Univ, Dept Histol & Embryol, Sch Med, Shanghai 200030, Peoples R China; [Xu, Chen] Shanghai Jiao Tong Univ, Shanghai Key Lab Reprod Med, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, ZJ (corresponding author), Shanghai Jiao Tong Univ, Dept Urol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	shenzj6@sina.com; luy662003@yahoo.com.cn			National Natural Science Foundation of China [81072098]; Science and Technology Commission of Shanghai Municipality [10DZ2270600]; Shanghai Leading Academic Discipline Project [S30201]; Shanghai Basic Research Project [09DJ1400400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Basic Research Project	This work was supported by The National Natural Science Foundation of China (No. 81072098), Science and Technology Commission of Shanghai Municipality (No. 10DZ2270600), Shanghai Leading Academic Discipline Project (No. S30201) and Shanghai Basic Research Project (No. 09DJ1400400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behrens T, 2009, J OCCUP ENVIRON HYG, V6, P555, DOI 10.1080/15459620903077682; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; BULBULYAN MA, 1995, INT J EPIDEMIOL, V24, P266, DOI 10.1093/ije/24.2.266; Chung H, 2009, UROLOGY, V74, pS36, DOI DOI 10.1016/J.UROLOGY.2009.07.1106; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Colmers IN, 2012, DIABETES METAB, V38, P475, DOI 10.1016/j.diabet.2012.06.003; Colmers IN, 2012, CAN MED ASSOC J, V184, pE675, DOI 10.1503/cmaj.112102; Corona G, 2011, INT J ANDROL, V34, P528, DOI 10.1111/j.1365-2605.2010.01117.x; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunn SE, 1997, CANCER RES, V57, P4667; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fernandez MI, 2012, J UROLOGY, V187, P856, DOI 10.1016/j.juro.2011.10.157; Ferrucci LM, 2010, CANCER-AM CANCER SOC, V116, P4345, DOI 10.1002/cncr.25463; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Guha N, 2010, OCCUP ENVIRON MED, V67, P568, DOI 10.1136/oem.2009.051565; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hwang EC, 2011, INT J UROL, V18, P769, DOI 10.1111/j.1442-2042.2011.02845.x; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KESSLER II, 1970, J NATL CANCER I, V44, P673; Kessler TM, 2008, EUR UROL, V53, P1040, DOI 10.1016/j.eururo.2007.09.044; Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253; Lam EKK, 2011, ANN ONCOL, V22, P730, DOI 10.1093/annonc/mdq405; Larsson SC, 2006, DIABETOLOGIA, V49, P2819, DOI 10.1007/s00125-006-0468-0; Larsson SC, 2011, DIABETOLOGIA, V54, P1013, DOI 10.1007/s00125-011-2051-6; Larsson SC, 2008, EUR J CANCER, V44, P2655, DOI 10.1016/j.ejca.2008.07.012; Lee MY, 2012, METABOLISM, V61, P242, DOI 10.1016/j.metabol.2011.06.020; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Li CY, 2011, DIABETES CARE, V34, P1365, DOI 10.2337/dc11-0020; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu XD, 2012, EUR J CANCER PREV, V21, P300, DOI 10.1097/CEJ.0b013e32834c9cd9; Liu XD, 2012, CANCER-AM CANCER SOC, V118, P1353, DOI 10.1002/cncr.26420; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Pira E, 2010, JNCI-J NATL CANCER I, V102, P1096, DOI 10.1093/jnci/djq214; RAGOZZINO M, 1982, J CHRON DIS, V35, P13, DOI 10.1016/0021-9681(82)90025-X; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shariat SF, 2003, UROLOGY, V61, P359, DOI 10.1016/S0090-4295(02)02253-7; Shu X, 2010, DIABETIC MED, V27, P791, DOI 10.1111/j.1464-5491.2010.03011.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Swerdlow AJ, 2005, BRIT J CANCER, V92, P2070, DOI 10.1038/sj.bjc.6602611; Tripathi A, 2002, CANCER-AM CANCER SOC, V95, P2316, DOI 10.1002/cncr.10975; Tseng CH, 2011, DIABETOLOGIA, V54, P2009, DOI 10.1007/s00125-011-2171-z; Tseng CH, 2009, ANN MED, V41, P371, DOI 10.1080/07853890902729778; Verlato G, 2003, DIABETES CARE, V26, P1047, DOI 10.2337/diacare.26.4.1047; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vigneri R, 2009, NAT REV ENDOCRINOL, V5, P651, DOI 10.1038/nrendo.2009.219; Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Woolcott CG, 2011, CANCER EPIDEMIOL, V35, P551, DOI 10.1016/j.canep.2011.02.014; Wotton CJ, 2011, DIABETOLOGIA, V54, P527, DOI 10.1007/s00125-010-1987-2; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yood MU, 2009, DIABETES METAB SYND, V3, P12, DOI 10.1016/j.dsx.2008.10.003; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105; Zhang F, 2012, ACTA DIABETOL, V49, pS235, DOI 10.1007/s00592-012-0439-5; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512; Zhao H, 2003, J UROLOGY, V169, P714, DOI 10.1016/S0022-5347(05)63999-7; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	71	69	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56662	10.1371/journal.pone.0056662	http://dx.doi.org/10.1371/journal.pone.0056662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24278234	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200134
J	Zhang, C; Kong, LX; Liu, Q; Lei, X; Zhu, T; Yin, J; Lin, BR; Deng, ZX; You, DL				Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Lin, Birun; Deng, Zixin; You, Delin			In Vitro Characterization of Echinomycin Biosynthesis: Formation and Hydroxylation of L-Tryptophanyl-S-Enzyme and Oxidation of (2S,3S) beta- Hydroxytryptophan	PLOS ONE			English	Article							MBTH-LIKE PROTEINS; ESCHERICHIA-COLI; CROSS-TALK; ANTIBIOTICS; GENE; 2,3-DIOXYGENASE; THIOCORALINE; ACID; ADENYLATION; SEQUENCE	Quinoxaline-2-carboxylic acid (QXC) and 3-hydroxyquinaldic acid (HQA) feature in quinomycin family and confer anticancer activity. In light of the significant potency against cancer, the biosynthetic gene clusters have been reported from many different Streptomyces strains, and the biosynthetic pathway were proposed mainly based on the in vivo feeding experiment with isotope labeled putative intermediates. Herein we report another gene cluster from Streptomyces griseovariabilis subsp. bandungensis subsp. nov responsible for the biosynthesis of echinomycin (a member of quinomycin family, also named quinomycin A) and presented in vitro evidence to corroborate the previous hypothesis on QXC biosynthesis, showing that only with the assistance of a MbtH-like protein Qui5, did the didomain NRPS protein (Qui18) perform the loading of a L-tryptophan onto its own PCP domain. Particularly, it was found that Qui5 and Qui18 subunits form a functional tetramer through size exclusion chromatography. The subsequent hydroxylation on beta-carbon of the loaded L-tryptophan proved in vitro to be completed by cytochrome P450-dependent hydroxylase Qui15. Importantly, only the Qui18 loaded L-tryptophan can be hydroxylated by Qui15 and the enzyme was inactive on free L-tryptophan. Additionally, the chemically synthesized (2S,3S) b-hydroxytryptophan was detected to be converted by the tryptophan 2,3-dioxygenase Qui17 through LC-MS, which enriched our previous knowledge that tryptophan 2,3-dioxygenase nearly exclusively acted on L-tryptophan and 6-fluoro-tryptophan.	[Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Deng, Zixin; You, Delin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Deng, Zixin; You, Delin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Lin, Birun] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangdong Academy of Agricultural Sciences	You, DL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	dlyou@sjtu.edu.cn	Moreno, Carlos S/B-3863-2009; Teodoro, George/L-3216-2013	Moreno, Carlos S/0000-0002-5582-0028; Wang, Fusheng/0000-0002-9369-9361	National Science Foundation of China (973 Program); Ministry of Science and Technology (863 Program); Shanghai Municipal Council of Science and Technology	National Science Foundation of China (973 Program)(National Basic Research Program of ChinaNational Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (863 Program); Shanghai Municipal Council of Science and Technology(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Science Foundation of China, the Ministry of Science and Technology (973 and 863 Programs), Shanghai Pujiang Program from the Shanghai Municipal Council of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESS KJ, 1994, BIOCHEMISTRY-US, V33, P12386, DOI 10.1021/bi00207a005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Erba E, 1999, BRIT J CANCER, V80, P971, DOI 10.1038/sj.bjc.6690451; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Furuya K, 1998, FEMS MICROBIOL LETT, V168, P243, DOI 10.1111/j.1574-6968.1998.tb13280.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HUANG CH, 1982, BIOCHEMISTRY-US, V21, P3704, DOI 10.1021/bi00258a028; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koketsu K, 2006, ORG LETT, V8, P4719, DOI 10.1021/ol061738+; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Mady ASA, 2011, MOL BIOSYST, V7, P1999, DOI 10.1039/c1mb05044c; Menendez N, 2007, MICROBIOL-SGM, V153, P3061, DOI 10.1099/mic.0.2007/007922-0; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Praseuth AP, 2008, BIOTECHNOL PROGR, V24, P1226, DOI 10.1002/btpr.34; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schmoock G, 2005, J BIOL CHEM, V280, P4339, DOI 10.1074/jbc.M411026200; Sheoran A, 2008, MOL BIOSYST, V4, P622, DOI 10.1039/b801391h; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Watanabe K, 2009, J AM CHEM SOC, V131, P9347, DOI 10.1021/ja902261a; Watanabe K, 2009, CURR OPIN CHEM BIOL, V13, P189, DOI 10.1016/j.cbpa.2009.02.012; Zhang WK, 2012, CHEM BIOL, V19, P422, DOI 10.1016/j.chembiol.2012.01.016; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	27	91	93	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56772	10.1371/journal.pone.0056772	http://dx.doi.org/10.1371/journal.pone.0056772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	24236209	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000044
J	Kong, J; Cooper, LAD; Wang, FS; Gao, JJ; Teodoro, G; Scarpace, L; Mikkelsen, T; Schniederjan, MJ; Moreno, CS; Saltz, JH; Brat, DJ				Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Gao, Jingjing; Teodoro, George; Scarpace, Lisa; Mikkelsen, Tom; Schniederjan, Matthew J.; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.			Machine-Based Morphologic Analysis of Glioblastoma Using Whole-Slide Pathology Images Uncovers Clinically Relevant Molecular Correlates	PLOS ONE			English	Article							MICROSCOPY IMAGES; NUCLEAR-STRUCTURE; CLASSIFICATION; OLIGODENDROGLIOMA; SURVIVAL; RECONSTRUCTION; SEGMENTATION; FRAMEWORK; COMPONENT; UPDATE	Pathologic review of tumor morphology in histologic sections is the traditional method for cancer classification and grading, yet human review has limitations that can result in low reproducibility and inter-observer agreement. Computerized image analysis can partially overcome these shortcomings due to its capacity to quantitatively and reproducibly measure histologic structures on a large-scale. In this paper, we present an end-to-end image analysis and data integration pipeline for large-scale morphologic analysis of pathology images and demonstrate the ability to correlate phenotypic groups with molecular data and clinical outcomes. We demonstrate our method in the context of glioblastoma (GBM), with specific focus on the degree of the oligodendroglioma component. Over 200 million nuclei in digitized pathology slides from 117 GBMs in the Cancer Genome Atlas were quantitatively analyzed, followed by multiplatform correlation of nuclear features with molecular and clinical data. For each nucleus, a Nuclear Score (NS) was calculated based on the degree of oligodendroglioma appearance, using a regression model trained from the optimal feature set. Using the frequencies of neoplastic nuclei in low and high NS intervals, we were able to cluster patients into three well-separated disease groups that contained low, medium, or high Oligodendroglioma Component (OC). We showed that machine-based classification of GBMs with high oligodendroglioma component uncovered a set of tumors with strong associations with PDGFRA amplification, proneural transcriptional class, and expression of the oligodendrocyte signature genes MBP, HOXD1, PLP1, MOBP and PDGFRA. Quantitative morphologic features within the GBMs that correlated most strongly with oligodendrocyte gene expression were high nuclear circularity and low eccentricity. These findings highlight the potential of high throughput morphologic analysis to complement and inform human-based pathologic review.	[Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Gao, Jingjing; Teodoro, George; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Teodoro, George; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA; [Teodoro, George] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA; [Scarpace, Lisa; Mikkelsen, Tom] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Schniederjan, Matthew J.; Moreno, Carlos S.; Brat, Daniel J.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Moreno, Carlos S.; Brat, Daniel J.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Henry Ford Health System; Henry Ford Hospital; Emory University; Emory University	Kong, J (corresponding author), Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA.	jun.kong@emory.edu	Moreno, Carlos S/B-3863-2009; Teodoro, George/L-3216-2013	Moreno, Carlos S/0000-0002-5582-0028; Wang, Fusheng/0000-0002-9369-9361	PHS from the Clinical and Translational Science Award Program, National Institutes of Health [UL 1RR025008]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Georgia Cancer Coalition; Winship Cancer Institute Cancer Center Support Grant [P30 CA138292]	PHS from the Clinical and Translational Science Award Program, National Institutes of Health; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition; Winship Cancer Institute Cancer Center Support Grant	This work was supported in part by PHS Grant UL 1RR025008 from the Clinical and Translational Science Award Program, National Institutes of Health, Contract No. HHSN261200800001E from the National Cancer Institute, National Institutes of Health, the Georgia Cancer Coalition, and the Winship Cancer Institute Cancer Center Support Grant P30 CA138292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appin CL, 2013, BRAIN PATHOL, V23, P454, DOI 10.1111/bpa.12018; Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Brat DJ, 2008, J NEURO-ONCOL, V89, P287, DOI 10.1007/s11060-008-9618-1; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cooper LAD, 2012, J AM MED INFORM ASSN, V19, P317, DOI 10.1136/amiajnl-2011-000700; Cooper LAD, 2011, I S BIOMED IMAGING, P1624, DOI 10.1109/ISBI.2011.5872714; Cooper LAD, 2010, IEEE T BIO-MED ENG, V57, P2617, DOI 10.1109/TBME.2010.2060338; DAVID H, 2005, LINEAR RANK TESTS SU; Deb P, 2005, NEUROL INDIA, V53, P329; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FOX J, 2002, ROBUST REGRESSION; Freedman D. A., 2005, STAT MODELS THEORY P; Gupta M, 2005, AM J CLIN PATHOL, V124, P755, DOI 10.1309/6JNX4PA60TQ5U5VG; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Hu MX, 2007, LECT NOTES COMPUT SC, V4791, P68; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kong J, 2011, I S BIOMED IMAGING, P2128, DOI 10.1109/ISBI.2011.5872833; Kong J, 2011, IEEE ENG MED BIO, P6605, DOI 10.1109/IEMBS.2011.6091629; Kong J, 2011, IEEE ENG MED BIO, P87, DOI 10.1109/IEMBS.2011.6089903; Kong J, 2011, IEEE T BIO-MED ENG, V58, P3469, DOI 10.1109/TBME.2011.2169256; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; *NCI, 2001, HE CANC GEN ATL; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; PASTORINO S, 2012, P 103 ANN M AM ASS C, V72; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Pytel P, 2009, ARCH PATHOL LAB MED, V133, P1062, DOI 10.1043/1543-2165-133.7.1062; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Rohde GK, 2008, CYTOM PART A, V73A, P341, DOI 10.1002/cyto.a.20506; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Smith JS, 2000, J NEUROPATH EXP NEUR, V59, P495, DOI 10.1093/jnen/59.6.495; Tsai A, 2003, IEEE T MED IMAGING, V22, P137, DOI 10.1109/TMI.2002.808355; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang W, 2011, IEEE T MED IMAGING, V30, P621, DOI 10.1109/TMI.2010.2089693; Wang W, 2010, CYTOM PART A, V77A, P485, DOI 10.1002/cyto.a.20853	40	91	93	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81049	10.1371/journal.pone.0081049	http://dx.doi.org/10.1371/journal.pone.0081049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236209	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700212
J	Hung, CJ; Wu, CC; Chen, WY; Chang, CY; Kuan, YH; Pan, HC; Liao, SL; Chen, CJ				Hung, Chih-Jen; Wu, Chih-Cheng; Chen, Wen-Ying; Chang, Cheng-Yi; Kuan, Yu-Hsiang; Pan, Hung-Chuan; Liao, Su-Lan; Chen, Chun-Jung			Depression-Like Effect of Prenatal Buprenorphine Exposure in Rats	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; OXIDATIVE STRESS; METHADONE TREATMENT; PREFRONTAL CORTEX; POSTMORTEM BRAIN; OPIOID RECEPTOR; GENE-EXPRESSION; SUICIDE VICTIMS; MECHANISMS; INCREASES	Studies indicate that perinatal opioid exposure produces a variety of short-and long-term neurobehavioral consequences. However, the precise modes of action are incompletely understood. Buprenorphine, a mixed agonist/antagonist at the opioid receptors, is currently being used in clinical trials for managing pregnant opioid addicts. This study provides evidence of depression-like consequence following prenatal exposure to supra-therapeutic dose of buprenorphine and sheds light on potential mechanisms of action in a rat model involving administration of intraperitoneal injection to pregnant Sprague-Dawley rats starting from gestation day 7 and lasting for 14 days. Results showed that pups at postnatal day 21 but not the dams had worse parameters of depression-like neurobehaviors using a forced swimming test and tail suspension test, independent of gender. Neurobehavioral changes were accompanied by elevation of oxidative stress, reduction of plasma levels of brain-derived neurotrophic factor (BDNF) and serotonin, and attenuation of tropomyosin-related kinase receptor type B (TrkB) phosphorylation, extracellular signal-regulated kinase (ERK) phosphorylation, protein kinase A activity, cAMP response element-binding protein (CREB) phosphorylation, and CREB DNA-binding activity. Since BDNF/serotonin and CREB signaling could orchestrate a positive feedback loop, our findings suggest that the induction of oxidative stress, reduction of BDNF and serotonin expression, and attenuation of CREB signaling induced by prenatal exposure to supra-therapeutic dose of buprenorphine provide evidence of potential mechanism for the development of depression-like neurobehavior.	[Hung, Chih-Jen; Wu, Chih-Cheng] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Hung, Chih-Jen; Chen, Chun-Jung] HungKuang Univ, Grad Sch Nursing, Taichung, Taiwan; [Wu, Chih-Cheng] Providence Univ, Dept Financial & Computat Math, Taichung, Taiwan; [Chen, Wen-Ying] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Chang, Cheng-Yi] Fong Yuan Hosp, Dept Surg, Taichung, Taiwan; [Kuan, Yu-Hsiang] Chung Shan Med Univ, Dept Pharmacol, Taichung, Taiwan; [Pan, Hung-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Pan, Hung-Chuan] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Liao, Su-Lan; Chen, Chun-Jung] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Chen, Chun-Jung] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Chun-Jung] Tunghai Univ, Ctr Gen Educ, Taichung 40704, Taiwan	Taichung Veterans General Hospital; Hungkuang University; Providence University - Taiwan; National Chung Hsing University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; Tunghai University	Chen, CJ (corresponding author), HungKuang Univ, Grad Sch Nursing, Taichung, Taiwan.	cjchen@vghtc.gov.tw	Kuan, Yu-Hsiang/R-1181-2019	Kuan, Yu-Hsiang/0000-0002-8991-6394	Taichung Veterans General Hospital [TCVGH-1007306C]; Yen Tjing Ling Medical Foundation, Taiwan, Republic of China [CI-98-10]	Taichung Veterans General Hospital; Yen Tjing Ling Medical Foundation, Taiwan, Republic of China	This study was supported by grants from Taichung Veterans General Hospital [TCVGH-1007306C] and the Yen Tjing Ling Medical Foundation [CI-98-10], Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto WA, 2011, AM J OBSTET GYNECOL, V205, P302, DOI 10.1016/j.ajog.2011.04.001; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blandthorn J, 2011, WOMEN BIRTH, V24, P32, DOI 10.1016/j.wombi.2010.07.001; Chung CP, 2013, PSYCHIAT RES, V206, P213, DOI 10.1016/j.psychres.2012.10.018; Coyle MG, 2012, ADDICTION, V107, P63, DOI 10.1111/j.1360-0443.2012.04040.x; Dwivedi Y, 2002, AM J PSYCHIAT, V159, P66, DOI 10.1176/appi.ajp.159.1.66; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; Englberger W, 2006, EUR J PHARMACOL, V534, P95, DOI 10.1016/j.ejphar.2006.01.022; Farid WO, 2008, CURR NEUROPHARMACOL, V6, P125, DOI 10.2174/157015908784533842; Guzman DC, 2006, NEUROCHEM RES, V31, P549, DOI 10.1007/s11064-006-9053-7; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Jansson LM, 2011, NEUROTOXICOL TERATOL, V33, P240, DOI 10.1016/j.ntt.2010.09.003; JARVIS MAE, 1994, J PSYCHOACTIVE DRUGS, V26, P155, DOI 10.1080/02791072.1994.10472263; Kakko J, 2008, DRUG ALCOHOL DEPEN, V96, P69, DOI 10.1016/j.drugalcdep.2008.01.025; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lesch KP, 2001, J AFFECT DISORDERS, V62, P57, DOI 10.1016/S0165-0327(00)00351-7; Li J, 2013, EUR J PHARMACOL, V707, P112, DOI 10.1016/j.ejphar.2013.03.010; Liebenberg N, 2011, NEUROSCI LETT, V498, P158, DOI 10.1016/j.neulet.2011.05.004; Lund IO, 2013, SUBST ABUS-RES TREAT, V7, P61, DOI 10.4137/SART.S10955; Malanga CJ, 1999, CLIN PERINATOL, V26, P17, DOI 10.1016/S0095-5108(18)30070-8; Marquez P, 2007, NEUROPHARMACOLOGY, V52, P1336, DOI 10.1016/j.neuropharm.2007.01.005; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Pandey GN, 2007, INT J NEUROPSYCHOPH, V10, P621, DOI 10.1017/S1461145706007231; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pettit AS, 2012, NEUROSCIENCE, V200, P211, DOI 10.1016/j.neuroscience.2011.10.039; Qi XL, 2008, NEUROBIOL DIS, V31, P278, DOI 10.1016/j.nbd.2008.05.003; Reus GZ, 2011, BEHAV BRAIN RES, V221, P166, DOI 10.1016/j.bbr.2011.02.024; Robinson SE, 2002, NEUROTOXICOL TERATOL, V24, P137, DOI 10.1016/S0892-0362(01)00185-4; ROUNSAVILLE BJ, 1982, ARCH GEN PSYCHIAT, V39, P151; Sanchez ES, 2008, GLIA, V56, P1017, DOI 10.1002/glia.20675; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Velez ML, 2009, PEDIATR RES, V66, P704, DOI 10.1203/PDR.0b013e3181bc035d; Walsh SL, 2003, DRUG ALCOHOL DEPEN, V70, pS13, DOI 10.1016/S0376-8716(03)00056-5; Wu VW, 2001, EUR J PHARMACOL, V414, P211, DOI 10.1016/S0014-2999(01)00807-X; Xuan AG, 2012, LIFE SCI, V90, P463, DOI 10.1016/j.lfs.2012.01.001; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069	41	55	55	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82262	10.1371/journal.pone.0082262	http://dx.doi.org/10.1371/journal.pone.0082262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	23437111	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300026
J	Zhao, QH; Guo, QH; Li, F; Zhou, Y; Wang, B; Hong, Z				Zhao, Qianhua; Guo, Qihao; Li, Fang; Zhou, Yan; Wang, Bei; Hong, Zhen			The Shape Trail Test: Application of a New Variant of the Trail Making Test	PLOS ONE			English	Article							NORMATIVE DATA; ELDERLY-PEOPLE; AGE; EQUIVALENCE; EDUCATION; VALIDITY; PROJECT; NORMS	Objective: The Trail making test (TMT) is culture-loaded because of reliance on the Latin alphabet, limiting its application in Eastern populations. The Shape Trail Test (STT) has been developed as a new variant. This study is to examine the applicability of the STT in a senile Chinese population and to evaluate its potential advantages and disadvantages. Method: A total of 2470 participants were recruited, including 1151 cognitively normal control (NC), 898 amnestic mild cognitive impairment (aMCI), and 421 mild Alzheimer disease (AD) patients. Besides the STT, the Mini mental state examination and a comprehensive neuropsychological battery involving memory, language, attention, executive function and visuospatial ability were administered to all the participants. In a subgroup of 100 NC and 50 AD patients, both the STT and the Color Trail Test (CTT) were performed. Results: In NC, the time consumed for Part A and B (STT-A and STT-B) significantly correlated with age and negatively correlated with education (p<0.01). STT-A and B significantly differed among the AD, aMCI and NC. The number that successfully connected within one minute in Part B (STT-B-1 min) correlated well with STT-B (r = 0.71, p<0.01) and distinguished well among NC, aMCI and AD. In the receiver operating characteristic curve analysis, the AUCs (area under the curve) for STT-A, STT-B, and STT-B-1min in identifying AD were 0.698, 0.694 and 0.709, respectively. The STT correlated with the CTT, but the time for completion was longer. Conclusion: The TMT is a sensitive test of visual search and sequencing. The STT is a meaningful attempt to develop a "culture-fair" variant of the TMT in addition to the CTT.	[Zhao, Qianhua; Guo, Qihao; Zhou, Yan; Wang, Bei; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Li, Fang] Capital Med Univ, Fuxing Hosp, Dept Gerontol, Beijing, Peoples R China	Fudan University; Capital Medical University	Guo, QH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	dr.guoqihao@126.com; lifangwa@sina.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Science and Technology Commission of Shanghai Municipality, China [09DZ1950400, 08411951000]; National Natural Science Foundation of China [81200835]	Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Science and Technology Commission of Shanghai Municipality, China (09DZ1950400, 08411951000) and National Natural Science Foundation of China (81200835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NB, 2005, J GERONTOL A-BIOL, V60, P1558, DOI 10.1093/gerona/60.12.1558; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Barncord S W, 2001, Appl Neuropsychol, V8, P99, DOI 10.1207/S15324826AN0802_4; DAVIES ADM, 1968, J CLIN PSYCHOL, V24, P98; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Dugbartey AT, 2000, ARCH CLIN NEUROPSYCH, V15, P425, DOI 10.1016/S0887-6177(99)00034-7; Elkin-Frankston S, 2007, ARCH CLIN NEUROPSYCH, V22, P631, DOI 10.1016/j.acn.2007.04.004; Fernandez AL, 2008, SCAND J PSYCHOL, V49, P239, DOI 10.1111/j.1467-9450.2008.00637.x; Hartman-Maeir A, 2008, BRAIN INJURY, V22, P994, DOI 10.1080/02699050802491305; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; KENNEDY KJ, 1981, PERCEPT MOTOR SKILL, V52, P671, DOI 10.2466/pms.1981.52.2.671; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P772, DOI 10.1076/jcen.22.6.772.954; Lu JC, 2006, CHIN J CLIN PSYCHOL, V14, P118; Lu L, 2000, Appl Neuropsychol, V7, P243, DOI 10.1207/S15324826AN0704_6; Lu Lei, 2002, Appl Neuropsychol, V9, P219, DOI 10.1207/S15324826AN0904_4; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Petersen R. C., 1999, ARCH NEUROL-CHICAGO, V56, P6; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Seo EH, 2006, INT J GERIATR PSYCH, V21, P844, DOI 10.1002/gps.1570; Spreen O, 1998, COMPENDIUM NEUROPSYC; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8	29	171	180	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57333	10.1371/journal.pone.0057333	http://dx.doi.org/10.1371/journal.pone.0057333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437370	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200244
J	Hung, CM; Lin, RC; Chu, JH; Yeh, CF; Yao, CJ; Li, SH				Hung, Chih-Ming; Lin, Rong-Chien; Chu, Jui-Hua; Yeh, Chia-Fen; Yao, Chiou-Ju; Li, Shou-Hsien			The De Novo Assembly of Mitochondrial Genomes of the Extinct Passenger Pigeon (Ectopistes migratorius) with Next Generation Sequencing	PLOS ONE			English	Article							ANCIENT DNA; NUCLEAR GENOME; AMPLIFICATION; MTDNA	The information from ancient DNA (aDNA) provides an unparalleled opportunity to infer phylogenetic relationships and population history of extinct species and to investigate genetic evolution directly. However, the degraded and fragmented nature of aDNA has posed technical challenges for studies based on conventional PCR amplification. In this study, we present an approach based on next generation sequencing to efficiently sequence the complete mitochondrial genome (mitogenome) of two extinct passenger pigeons (Ectopistes migratorius) using de novo assembly of massive short (90 bp), paired-end or single-end reads. Although varying levels of human contamination and low levels of postmortem nucleotide lesion were observed, they did not impact sequencing accuracy. Our results demonstrated that the de novo assembly of shotgun sequence reads could be a potent approach to sequence mitogenomes, and offered an efficient way to infer evolutionary history of extinct species.	[Hung, Chih-Ming] Univ Minnesota, Bell Museum, St Paul, MN 55108 USA; [Hung, Chih-Ming] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hung, Chih-Ming; Lin, Rong-Chien; Chu, Jui-Hua; Yeh, Chia-Fen; Li, Shou-Hsien] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Yao, Chiou-Ju] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Taiwan Normal University	Li, SH (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43028@ntnu.edu.tw	Kuan, Yu-Hsiang/R-1181-2019	Kuan, Yu-Hsiang/0000-0002-8991-6394	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This project is funded by the National Science Council of Taiwan to SHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson E, 2008, MOL BIOL EVOL, V25, P2181, DOI 10.1093/molbev/msn163; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Cassista S, 2009, UNDERGRADUATE J ANTH, V1, P141; Catling Paul M., 2001, Biodiversity, V2, P2; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; de Moraes-Barros N, 2007, GENET MOL BIOL, V30, P1181, DOI 10.1590/S1415-47572007000600024; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Ho SYW, 2010, MITOCHONDRION, V10, P1, DOI 10.1016/j.mito.2009.09.005; Kan XZ, 2010, GENET MOL RES, V9, P1234, DOI 10.4238/vol9-2gmr853; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Leonard JA, 2008, MOL ECOL, V17, P4186, DOI 10.1111/j.1365-294X.2008.03891.x; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Schorger A, 1955, PASSENGER PIGEON; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Shapiro B, 2002, SCIENCE, V295, P1683, DOI 10.1126/science.295.5560.1683; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109	42	55	55	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56301	10.1371/journal.pone.0056301	http://dx.doi.org/10.1371/journal.pone.0056301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437111	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200057
J	Liu, Y; Luo, HS; Liang, CB; Xia, H; Xu, WJ; Chen, JH; Chen, MK				Liu, Ying; Luo, Hesheng; Liang, Chengbo; Xia, Hong; Xu, Wenjuan; Chen, Jihong; Chen, Mingkai			Actions of Hydrogen Sulfide and ATP-Sensitive Potassium Channels on Colonic Hypermotility in a Rat Model of Chronic Stress	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IRRITABLE-BOWEL-SYNDROME; ENTERIC NERVOUS-SYSTEM; K+ CHANNELS; GASTROINTESTINAL-TRACT; VISCERAL HYPERSENSITIVITY; CALCIUM-CHANNELS; IN-VITRO; MOTILITY; COLITIS	Objective: To investigate the potential role of hydrogen sulphide (H2S) and ATP-sensitive potassium (K-ATP) channels in chronic stress-induced colonic hypermotility. Methods: Male Wistar rats were submitted daily to 1 h of water avoidance stress (WAS) or sham WAS (SWAS) for 10 consecutive days. Organ bath recordings, H2S production, immunohistochemistry and western blotting were performed on rat colonic samples to investigate the role of endogenous H2S in repeated WAS-induced hypermotility. Organ bath recordings and western blotting were used to detect the role of K-ATP channels in repeated WAS. Results: Repeated WAS increased the number of fecal pellets per hour and the area under the curve of the spontaneous contractions of colonic strips, and decreased the endogenous production of H2S and the expression of H2S-producing enzymes in the colon devoid of mucosa and submucosa. Inhibitors of H2S-producing enzymes increased the contractile activity of colonic strips in the SWAS rats. NaHS concentration-dependently inhibited the spontaneous contractions of the strips and the NaHS IC50 for the WAS rats was significantly lower than that for the SWAS rats. The inhibitory effect of NaHS was significantly reduced by glybenclamide. Repeated WAS treatment resulted in up-regulation of Kir6.1 and SUR2B of K-ATP channels in the colon devoid of mucosa and submucosa. Conclusion: The colonic hypermotility induced by repeated WAS may be associated with the decreased production of endogenous H2S. The increased expression of the subunits of K-ATP channels in colonic smooth muscle cells may be a defensive response to repeated WAS. H2S donor may have potential clinical utility in treating chronic stress-induced colonic hypermotility.	[Liu, Ying; Luo, Hesheng; Liang, Chengbo; Xia, Hong; Xu, Wenjuan; Chen, Jihong; Chen, Mingkai] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Liu, Ying] Guilin Med Coll, Affiliated Hosp, Dept Gastroenterol, Guilin, Peoples R China	Wuhan University; Guilin Medical University	Luo, HS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	xhkhsluo@126.com		Chen, Mingkai/0000-0001-6771-0523; Chen, Mingkai/0000-0003-2652-6863	National Natural Science Foundation of China [81070297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070297). The URL of the funder's website is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataka K, 2012, AM J PHYSIOL-GASTR L, V303, pG519, DOI 10.1152/ajpgi.00390.2011; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bulbul M, 2012, AM J PHYSIOL-GASTR L, V302, pG702, DOI 10.1152/ajpgi.00447.2011; Choudhury BK, 2009, AM J PHYSIOL-GASTR L, V296, pG1238, DOI 10.1152/ajpgi.90712.2008; Dhaese I, 2010, EUR J PHARMACOL, V628, P179, DOI 10.1016/j.ejphar.2009.11.024; Dhaese I, 2009, EUR J PHARMACOL, V606, P180, DOI 10.1016/j.ejphar.2009.01.011; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P1306, DOI 10.1111/j.1365-2982.2008.01201.x; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Hansen MB, 2003, PHARMACOL TOXICOL, V92, P249, DOI 10.1034/j.1600-0773.2003.920601.x; Hennig B, 2009, BRIT J PHARMACOL, V158, P1263, DOI 10.1111/j.1476-5381.2009.00385.x; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jimenez M, 2010, NEUROGASTROENT MOTIL, V22, P1149, DOI 10.1111/j.1365-2982.2010.01600.x; Jin XC, 2004, AM J PHYSIOL-GASTR L, V287, pG274, DOI 10.1152/ajpgi.00472.2003; Jun JY, 2001, AM J PHYSIOL-CELL PH, V281, pC857, DOI 10.1152/ajpcell.2001.281.3.C857; Kasparek MS, 2012, J SURG RES, V175, P234, DOI 10.1016/j.jss.2011.03.069; Koh SD, 1998, BIOPHYS J, V75, P1793, DOI 10.1016/S0006-3495(98)77621-0; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Li QJ, 2011, AM J PHYSIOL-GASTR L, V300, pG154, DOI 10.1152/ajpgi.00393.2010; Liang CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031774; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Linden DR, 2010, ANTIOXID REDOX SIGN, V12, P1135, DOI 10.1089/ars.2009.2885; Martin GR, 2010, DIGEST LIVER DIS, V42, P103, DOI 10.1016/j.dld.2009.05.016; Paravicini TM, 2003, CLIN EXP PHARMACOL P, V30, P855, DOI 10.1046/j.1440-1681.2003.03920.x; Pluja L, 1998, CAN J PHYSIOL PHARM, V76, P1166, DOI 10.1139/cjpp-76-12-1166; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Tian XY, 2006, BRAIN RES, V1088, P101, DOI 10.1016/j.brainres.2006.03.014; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Xu GY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-44; Zhang M, 2010, NEUROGASTROENT MOTIL, V22, pe162, DOI 10.1111/j.1365-2982.2009.01467.x; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014	38	130	141	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55853	10.1371/journal.pone.0055853	http://dx.doi.org/10.1371/journal.pone.0055853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23437170	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400167
J	Srinivasan, K; Raman, R; Jayaraman, A; Viswanathan, K; Sasisekharan, R				Srinivasan, Karunya; Raman, Rahul; Jayaraman, Akila; Viswanathan, Karthik; Sasisekharan, Ram			Quantitative Description of Glycan-Receptor Binding of Influenza A Virus H7 Hemagglutinin	PLOS ONE			English	Article							RESPIRATORY DROPLET TRANSMISSION	In the context of recently emerged novel influenza strains through reassortment, avian influenza subtypes such as H5N1, H7N7, H7N2, H7N3 and H9N2 pose a constant threat in terms of their adaptation to the human host. Among these subtypes, it was recently demonstrated that mutations in H5 and H9 hemagglutinin (HA) in the context of lab-generated reassorted viruses conferred aerosol transmissibility in ferrets (a property shared by human adapted viruses). We previously demonstrated that the quantitative binding affinity of HA to alpha 2 -> 6 sialylated glycans (human receptors) is one of the important factors governing human adaptation of HA. Although the H7 subtype has infected humans causing varied clinical outcomes from mild conjunctivitis to severe respiratory illnesses, it is not clear where the HA of these subtypes stand in regard to human adaptation since its binding affinity to glycan receptors has not yet been quantified. In this study, we have quantitatively characterized the glycan receptor-binding specificity of HAs from representative strains of Eurasian (H7N7) and North American (H7N2) lineages that have caused human infection. Furthermore, we have demonstrated for the first time that two specific mutations; Gln226 -> Leu and Gly228 -> Ser in glycan receptor-binding site of H7 HA substantially increase its binding affinity to human receptor. Our findings contribute to a framework for monitoring the evolution of H7 HA to be able to adapt to human host.	[Srinivasan, Karunya; Raman, Rahul; Jayaraman, Akila; Viswanathan, Karthik; Sasisekharan, Ram] MIT, Dept Biol Engn, Singapore MIT Alliance Res & Technol, Koch Inst Integrat Canc Res,Harvard MIT Div Hlth, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Sasisekharan, R (corresponding author), MIT, Dept Biol Engn, Singapore MIT Alliance Res & Technol, Koch Inst Integrat Canc Res,Harvard MIT Div Hlth, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM R37 GM057073-13]; Singapore - MIT Alliance for Research and Technology (SMART); NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore - MIT Alliance for Research and Technology (SMART); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM R37 GM057073-13 and in part by the Singapore - MIT Alliance for Research and Technology (SMART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2009, J VIROL, V83, P7075, DOI 10.1128/JVI.00535-09; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; de Wit E, 2008, VACCINE, V26, pD54, DOI 10.1016/j.vaccine.2008.07.072; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Ge SQ, 2011, CRIT REV MICROBIOL, V37, P157, DOI 10.3109/1040841X.2010.536523; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jayaraman A, 2012, PLOS ONE IN PRESS; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Shriver Z, 2009, CHEM BIOL, V16, P803, DOI 10.1016/j.chembiol.2009.08.002; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	27	67	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e49597	10.1371/journal.pone.0049597	http://dx.doi.org/10.1371/journal.pone.0049597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23626667	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200001
J	Zhang, DY; Ali, Z; Wang, CB; Xu, L; Yi, JX; Xu, ZL; Liu, XQ; He, XL; Huang, YH; Khan, IA; Trethowan, RM; Ma, HX				Zhang, Da Yong; Ali, Zulfiqar; Wang, Chang Biao; Xu, Ling; Yi, Jin Xin; Xu, Zhao Long; Liu, Xiao Qing; He, Xiao Lan; Huang, Yi Hong; Khan, Iqrar Ahmad; Trethowan, Richard M.; Ma, Hong Xiang			Genome-Wide Sequence Characterization and Expression Analysis of Major Intrinsic Proteins in Soybean (Glycine max L.)	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; PLANT AQUAPORINS; PLASMA-MEMBRANE; WATER TRANSPORT; GENE FAMILY; ARABIDOPSIS; IDENTIFICATION; CHANNELS; NODULIN; SELECTIVITY	Water is essential for all living organisms. Aquaporin proteins are the major facilitator of water transport activity through cell membranes of plants including soybean. These proteins are diverse in plants and belong to a large major intrinsic (MIP) protein family. In higher plants, MIPs are classified into five subfamilies including plasma membrane intrinsic proteins (PIP), tonoplast intrinsic proteins (TIP), NOD26-like intrinsic proteins (NIP), small basic intrinsic proteins (SIP), and the recently discovered X intrinsic proteins (XIP). This paper reports genome wide assembly of soybean MIPs, their functional prediction and expression analysis. Using a bioinformatic homology search, 66 GmMIPs were identified in the soybean genome. Phylogenetic analysis of amino acid sequences of GmMIPs divided the large and highly similar multi-gene family into 5 subfamilies: GmPIPs, GmTIPs, GmNIPs, GmSIPs and GmXIPs. GmPIPs consisted of 22 genes and GmTIPs 23, which showed high sequence similarity within subfamilies. GmNIPs contained 13 and GmSIPs 6 members which were diverse. In addition, we also identified a two member GmXIP, a distinct 5th subfamily. GmMIPs were further classified into twelve subgroups based on substrate selectivity filter analysis. Expression analyses were performed for a selected set of GmMIPs using semi-quantitative reverse transcription (semi-RT-qPCR) and qPCR. Our results suggested that many GmMIPs have high sequence similarity but diverse roles as evidenced by analysis of sequences and their expression. It can be speculated that GmMIPs contains true aquaporins, glyceroporins, aquaglyceroporins and mixed transport facilitators.	[Zhang, Da Yong; Ali, Zulfiqar; Xu, Ling; Yi, Jin Xin; Xu, Zhao Long; Liu, Xiao Qing; He, Xiao Lan; Huang, Yi Hong; Ma, Hong Xiang] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China; [Ali, Zulfiqar] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Wang, Chang Biao] Shanxi Agr Sci, Cotton Res Inst, Yuncheng, Peoples R China; [Xu, Zhao Long] Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China; [Khan, Iqrar Ahmad] Univ Agr Faisalabad, Coll Agr & Appl Biol, Faisalabad, Pakistan; [Trethowan, Richard M.] Univ Sydney, Plant Breeding Inst, Sydney, NSW 2006, Australia	Jiangsu Academy of Agricultural Sciences; University of Agriculture Faisalabad; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University; University of Agriculture Faisalabad; University of Sydney	Ali, Z (corresponding author), Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China.	zulfiqarpbg@hotmail.com; hxma@jaas.ac.cn	Ali, Zulfiqar/AAF-2663-2019; Wang, Changbiao/S-8473-2019; Ali, Zulfiqar/AAF-4171-2021; Trethowan, Richard/ADZ-7680-2022	Ali, Zulfiqar/0000-0003-1228-3338; Zhang, Dan-Dan/0000-0002-1498-6718; Trethowan, Richard/0000-0003-0105-875X	Jiangsu sister province of China; Punjab sister province of China; National Science Foundation of China [31101166, 30971798]; Jiangsu Natural Science Foundation, China [BK2010474]; Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu [CX(12)5132, CX(12)1005-2]; Jiangsu Key Laboratory for Bioresources of Saline Soils [JKLBS2012002]; Project in the National Science & Technology Pillar Program [2011BAD35B06-4-3]	Jiangsu sister province of China; Punjab sister province of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation, China(Natural Science Foundation of Jiangsu Province); Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu; Jiangsu Key Laboratory for Bioresources of Saline Soils; Project in the National Science & Technology Pillar Program	ZA is thankful for financial assistance from Jiangsu and Punjab sister provinces of China and Pakistan for his visit at Jiangsu Academy of Agricultural Sciences, Nanjing, People's Republic of China. This study was sponsored by National Science Foundation of China (31101166, 30971798); the Jiangsu Natural Science Foundation, China (BK2010474); the Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu (CX(12)5132, CX(12) 1005-2); Jiangsu Key Laboratory for Bioresources of Saline Soils (JKLBS2012002) and the Project in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2011BAD35B06-4-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Barkla BJ, 1999, TRENDS PLANT SCI, V4, P86, DOI 10.1016/S1360-1385(99)01388-6; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 1998, PLANT PHYSIOL, V117, P1143, DOI 10.1104/pp.117.4.1143; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; DENKER BM, 1988, J BIOL CHEM, V263, P15634; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Guenther JF, 2000, PLANTA, V210, P741, DOI 10.1007/s004250050675; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Gustafson CE, 2000, AM J PHYSIOL-RENAL, V278, pF317, DOI 10.1152/ajprenal.2000.278.2.F317; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; Maurel C, 2002, INT REV CYTOL, V215, P105; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Mitani-Ueno N, 2011, J EXP BOT, V62, P4391, DOI 10.1093/jxb/err158; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Wallace IS, 2006, BBA-BIOMEMBRANES, V1758, P1165, DOI 10.1016/j.bbamem.2006.03.024; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	44	116	128	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56312	10.1371/journal.pone.0056312	http://dx.doi.org/10.1371/journal.pone.0056312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437113	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200059
J	Dobson-Stone, C; Hallupp, M; Loy, CT; Thompson, EM; Haan, E; Sue, CM; Panegyres, PK; Razquin, C; Seijo-Martinez, M; Rene, R; Gascon, J; Campdelacreu, J; Schmoll, B; Volk, AE; Brooks, WS; Schofield, PR; Pastor, P; Kwok, JBJ				Dobson-Stone, Carol; Hallupp, Marianne; Loy, Clement T.; Thompson, Elizabeth M.; Haan, Eric; Sue, Carolyn M.; Panegyres, Peter K.; Razquin, Cristina; Seijo-Martinez, Manuel; Rene, Ramon; Gascon, Jordi; Campdelacreu, Jaume; Schmoll, Birgit; Volk, Alexander E.; Brooks, William S.; Schofield, Peter R.; Pastor, Pau; Kwok, John B. J.			C9ORF72 Repeat Expansion in Australian and Spanish Frontotemporal Dementia Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; HEXANUCLEOTIDE REPEAT; LOBAR DEGENERATION; HETEROGENEITY; MUTATIONS; FTD; ALS	A hexanucleotide repeat expansion in C9ORF72 has been established as a common cause of frontotemporal dementia (FTD). However, the minimum repeat number necessary for disease pathogenesis is not known. The aims of our study were to determine the frequency of the C9ORF72 repeat expansion in two FTD patient collections (one Australian and one Spanish, combined n = 190), to examine C9ORF72 expansion allele length in a subset of FTD patients, and to examine C9ORF72 allele length in 'non-expansion' patients (those with <30 repeats). The C9ORF72 repeat expansion was detected in 5-17% of patients (21-41% of familial FTD patients). For one family, the expansion was present in the proband but absent in the mother, who was diagnosed with dementia at age 68. No association was found between C9ORF72 non-expanded allele length and age of onset and in the Spanish sample mean allele length was shorter in cases than in controls. Southern blotting analysis revealed that one of the nine 'expansion-positive' patients examined, who had neuropathologically confirmed frontotemporal lobar degeneration with TDP-43 pathology, harboured an 'intermediate' allele with a mean size of only similar to 65 repeats. Our study indicates that the C9ORF72 repeat expansion accounts for a significant proportion of Australian and Spanish FTD cases. However, C9ORF72 allele length does not influence the age at onset of 'non-expansion' FTD patients in the series examined. Expansion of the C9ORF72 allele to as little as similar to 65 repeats may be sufficient to cause disease.	[Dobson-Stone, Carol; Hallupp, Marianne; Loy, Clement T.; Brooks, William S.; Schofield, Peter R.; Kwok, John B. J.] Neurosci Res Australia, Sydney, NSW, Australia; [Dobson-Stone, Carol; Loy, Clement T.; Brooks, William S.; Schofield, Peter R.; Kwok, John B. J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Loy, Clement T.] Westmead Hosp, Huntington Dis Serv, Sydney, NSW, Australia; [Loy, Clement T.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Thompson, Elizabeth M.; Haan, Eric] Womens & Childrens Hosp, S Australia Clin Genet Serv, Adelaide, SA, Australia; [Thompson, Elizabeth M.; Haan, Eric] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Sue, Carolyn M.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, Sydney, NSW, Australia; [Sue, Carolyn M.] Univ Sydney, Sydney, NSW 2006, Australia; [Panegyres, Peter K.] Neurodegenerat Disorders Res Pty Ltd, Subiaco, WA, Australia; [Razquin, Cristina; Pastor, Pau] Univ Navarra, Ctr Appl Med Res, Div Neurosci, Neurogenet Lab, E-31080 Pamplona, Spain; [Seijo-Martinez, Manuel] Hosp Salnes, Dept Neurol, Pontevedra, Spain; [Rene, Ramon; Gascon, Jordi; Campdelacreu, Jaume] Bellvitge Hosp, Dept Neurol, Barcelona, Spain; [Schmoll, Birgit; Volk, Alexander E.] Univ Hosp Ulm, Inst Human Genet, Ulm, Germany; [Pastor, Pau] Univ Navarra, Sch Med, Univ Navarra Clin, Dept Neurol, E-31080 Pamplona, Spain; [Pastor, Pau] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain	Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Sydney; Womens & Childrens Hospital Australia; University of Adelaide; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Navarra; Complexo Hospitalario Universitario de Pontevedra; Hospital Salnes; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Ulm University; University of Navarra; CIBERNED; Instituto de Salud Carlos III	Kwok, JBJ (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	j.kwok@neura.edu.au	Razquin, Cristina/H-2366-2017; Pastor, Pau/C-9834-2009; Schofield, Peter/C-9669-2011	Razquin, Cristina/0000-0003-3480-2645; Pastor, Pau/0000-0002-7493-8777; Schofield, Peter/0000-0003-2967-9662; Brooks, William Seymour/0000-0001-8603-4233; Dobson-Stone, Carol/0000-0002-2211-0257; Kwok, John/0000-0001-9574-6195	National Health and Medical Research Council of Australia (NHMRC) [630428, 510217, 630434]; UTE project FIMA; European Social Fund [PTQ-10-03810]; NHMRC; Australian Research Council; National Institute of Health; Wicking Foundation; Beyond Blue Foundation; Janssen-Cilag	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); UTE project FIMA; European Social Fund(European Social Fund (ESF)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wicking Foundation; Beyond Blue Foundation; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was funded by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) (NHMRC Project Grants #630428 to Dr. Dobson-Stone, #510217 to Dr. Kwok and Prof. Schofield, and Senior Principal Research Fellowship #630434 to Prof. Halliday) and by the UTE project FIMA to P.P. C.R. holds a 'Torres Quevedo' fellowship from the Spanish Ministry of Science and Technology, co-financed by the European Social Fund (PTQ-10-03810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Dobson-Stone and Dr. Kwok receive grant funding from the National Health and Medical Research Council of Australia (NHMRC). Dr. Panegyres provides services for Neurodegenerative Disorders Research Pty Ltd, a not-for-profit organization. Prof. Schofield receives grant funding from the NHMRC, Australian Research Council, National Institute of Health, Wicking Foundation and Beyond Blue Foundation. He has received speaker fees from Janssen-Cilag. He has held stock options (unexercised and now lapsed) in Brain Resource Ltd. He is Executive Director & CEO (paid employment) of Neuroscience Research Australia (a not-for-profit company) and Director (unpaid) of not-for-profit companies Neuroscience Research Australia Foundation, The Health-Science Alliance, and Neuroscience Australia (NSA). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Chio A, 2012, J NEUROL NEUROSUR PS, V83, P730, DOI 10.1136/jnnp-2012-302219; Dejesus-Hernandez M, 2012, PARKINSONISM RELAT D; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dobson-Stone C, 2012, NEUROLOGY, V79, P995, DOI 10.1212/WNL.0b013e3182684634; Garcia-Redondo A, 2012, HUM MUTAT; Hsiung GYR, 2012, BRAIN, V135, P709, DOI 10.1093/brain/awr354; Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; Lattante S, 2012, NEUROLOGY, V79, P66, DOI 10.1212/WNL.0b013e31825dceca; Luty AA, 2010, ANN NEUROL, V68, P639, DOI 10.1002/ana.22274; Luty AA, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-32; Majounie E, 2012, NEUROBIOL AGING, V33; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Mok K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.005; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Ratti A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.06.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rollinson S, 2009, NEUROBIOL AGING, V30, P656, DOI 10.1016/j.neurobiolaging.2009.01.009; Rutherford NJ, 2012, NEUROBIOL AGING, V33; Schoser B, 2010, CURR GENOMICS, V11, P77, DOI 10.2174/138920210790886844; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Simon-Sanchez J, 2012, BRAIN, V135, P723, DOI 10.1093/brain/awr353; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Smith BN, 2012, EUR J HUM GENET; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199	29	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56899	10.1371/journal.pone.0056899	http://dx.doi.org/10.1371/journal.pone.0056899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23653281	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200179
J	Kumar, AHS; Martin, K; Turner, EC; Buneker, CK; Dorgham, K; Deterre, P; Caplice, NM				Kumar, Arun H. S.; Martin, Kenneth; Turner, Elizebeth C.; Buneker, Chirlei K.; Dorgham, Karim; Deterre, Philippe; Caplice, Noel M.			Role of CX(3)CR1 Receptor in Monocyte/Macrophage Driven Neovascularization	PLOS ONE			English	Article							MUSCLE-CELL DIFFERENTIATION; PLAQUE RUPTURE; ANTIANGIOGENIC THERAPY; PROGENITOR CELLS; ANGIOGENESIS; MACROPHAGES; FRACTALKINE; ATHEROSCLEROSIS; MICE; COLLAGEN	Monocyte/Macrophages are implicated in initiation of angiogenesis, tissue/organ perfusion and atherosclerosis biology. We recently showed that chemokine receptor CX(3)CR1 is an essential regulator of monocyte/macrophage derived smooth muscle cell differentiation in the vessel wall after injury. Here we hypothesised the contribution of CX(3)CR1- CX(3)CL1 interaction to in vivo neovascularization and studied the functional consequences of genetic and pharmacologic targeting of CX(3)CR1 in formation, maturation and maintenance of microvascular integrity. Cells functionally deficient in CX(3)CR1 lacked matrix tunnelling and tubulation capacity in a 3D Matrigel assay. These morphogenic and cytokinetic responses were driven by CX(3)CL1-CX(3)CR1 interaction and totally abrogated by a Rho antagonist. To evaluate the role of CX(3)CR1 system in vivo, Matrigel plugs were implanted in competent CX(3)CR1(+/gfp) and functionally deficient CX(3)CR1(gfp/gfp) mice. Leaky microvessels (MV) were formed in the Matrigel implanted in CX(3)CR1(gfp/gfp) but not in CX(3)CR1(+/gfp) mice. In experimental plaque neovascularization immature MV phenotype was observed in CX(3)CR1(gfp/gfp) mice, lacking CX(3)CR1 positive smooth muscle-like cells, extracellular collagen and basement membrane (BM) laminin compared to competent CX(3)CR1(+/gfp) mice. This was associated with increased extravasation of platelets into the intima of CX(3)CR1(gfp/gfp) but not functionally competent CX(3)CR1 mice. Pharmacologic targeting using CX(3)CR1 receptor antagonist in wild type mice resulted in formation of plaque MV with poor BM coverage and a leaky phenotype. Our data indicate a hitherto unrecognised role for functional CX(3)CR1 in Matrigel and experimental plaque neovascularization in vivo, which may buttress MV collectively in favour of a more stable non-leaky phenotype.	[Kumar, Arun H. S.; Martin, Kenneth; Turner, Elizebeth C.; Buneker, Chirlei K.; Caplice, Noel M.] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Ctr Res Vasc Biol CRVB, Cork, Ireland; [Dorgham, Karim; Deterre, Philippe] UPMC, INSERM, UMR S 945, Lab Immunite & Infect, Paris, France	University College Cork; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Caplice, NM (corresponding author), Natl Univ Ireland Univ Coll Cork, Biosci Inst, Ctr Res Vasc Biol CRVB, Cork, Ireland.	n.caplice@ucc.ie	Kumar, Arun/C-9149-2009; Dorgham, karim/A-2241-2016; Deterre, Philippe/O-8984-2017; Singh, Aditya/N-4130-2016	Kumar, Arun/0000-0001-8422-0219; Dorgham, karim/0000-0001-9539-3203; Deterre, Philippe/0000-0001-9303-0791; Singh, Aditya/0000-0003-3031-5225; Caplice, Noel/0000-0001-5445-1016	Science Foundation Ireland (PI); Science Foundation Ireland (RFP-NMC); ANR (France) [ANR-09-PIRI-0003]	Science Foundation Ireland (PI)(Science Foundation Ireland); Science Foundation Ireland (RFP-NMC)(Science Foundation Ireland); ANR (France)(French National Research Agency (ANR))	This work was supported by grants from Science Foundation Ireland (PI and RFP-NMC) and from ANR (France) (noANR-09-PIRI-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelillo-Scherrer A, 2012, CIRC RES, V110, P356, DOI 10.1161/CIRCRESAHA.110.233403; Anghelina M, 2004, STEM CELLS DEV, V13, P665, DOI 10.1089/scd.2004.13.665; Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Bell SE, 2001, J CELL SCI, V114, P2755; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Daher IN, 2008, NAT CLIN PRACT CARD, V5, P797, DOI 10.1038/ncpcardio1375; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Finn AV, 2010, JACC-CARDIOVASC IMAG, V3, P41, DOI 10.1016/j.jcmg.2009.11.001; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Jain RK, 2007, NAT CLIN PRACT CARD, V4, P491, DOI 10.1038/ncpcardio0979; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu P, 2006, ARTERIOSCL THROM VAS, V26, P2056, DOI 10.1161/01.ATV.0000234947.47788.8c; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lucerna M, 2007, BLOOD, V109, P122, DOI 10.1182/blood-2006-07-031773; Martin K, 2009, CIRC RES, V105, P214, DOI 10.1161/CIRCRESAHA.109.199984; Metharom P, 2010, ARTERIOSCL THROM VAS, V30, P533, DOI 10.1161/ATVBAHA.109.200097; Moldovan NI, 2000, CIRC RES, V87, P378; Moldovan NI, 2002, J HEMATOTH STEM CELL, V11, P179, DOI 10.1089/152581602753658394; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Pedraza C, 2000, J IMMUNOL, V165, P5831, DOI 10.4049/jimmunol.165.10.5831; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Sasaki T, 2006, ARTERIOSCL THROM VAS, V26, P1304, DOI 10.1161/01.ATV.0000219687.71607.f7; Sasaki Takeshi, 2007, V139, P67; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Sinclair P R, 2001, Curr Protoc Toxicol, VChapter 8, DOI 10.1002/0471140856.tx0803s00; Sprague L, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-35; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; White GE, 2010, CARDIOVASC RES, V85, P825, DOI 10.1093/cvr/cvp341	47	72	75	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57230	10.1371/journal.pone.0057230	http://dx.doi.org/10.1371/journal.pone.0057230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437346	Green Submitted, gold, Green Published			2022-12-27	WOS:000315186000087
J	Wang, YP; Hu, YJ; Chao, C; Yuksel, M; Colle, I; Flavell, RA; Ma, Y; Yan, HP; Wen, L				Wang, Yipeng; Hu, Youjia; Chao, Chen; Yuksel, Muhammed; Colle, Isabelle; Flavell, Richard A.; Ma, Yun; Yan, Huiping; Wen, Li			Role of IRAK-M in Alcohol Induced Liver Injury	PLOS ONE			English	Article							INNATE IMMUNITY; KUPFFER CELLS; T-CELLS; NEGATIVE REGULATOR; DISEASE; MICE; LIPOPOLYSACCHARIDE; INTERLEUKIN-1; INFLAMMATION; PERMEABILITY	Increasing evidence suggests that innate immunity plays an important role in alcohol-induced liver injury and most studies have focused on positive regulation of innate immunity. The main objective of this study was to investigate the negative regulator of innate immunity, IL-1/Toll-like receptor (TLR) signaling pathways and interleukin receptor-associated kinase-M (IRAK-M) in alcoholic liver injury. We established an alcohol-induced liver injury model using wild type and IRAK-M deficient B6 mice and investigated the possible mechanisms. We found that in the absence of IRAK-M, liver damage by alcohol was worse with higher alanine transaminase (ALT), more immune cell infiltration and increased numbers of IFN gamma producing cells. We also found enhanced phagocytic activity in CD68(+) cells. Moreover, our results revealed altered gut bacteria after alcohol consumption and this was more striking in the absence of IRAK-M. Our study provides evidence that IRAK-M plays an important role in alcohol-induced liver injury and IRAK-M negatively regulates the innate and possibly the adaptive immune response in the liver reacting to acute insult by alcohol. In the absence of IRAK-M, the hosts developed worse liver injury, enhanced gut permeability and altered gut microbiota.	[Wang, Yipeng; Hu, Youjia; Chao, Chen; Yuksel, Muhammed; Wen, Li] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Wang, Yipeng; Yan, Huiping] Capital Med Univ, Beijing You An Hosp, Clin Res Ctr Autoimmune Liver Dis, Beijing, Peoples R China; [Yuksel, Muhammed; Colle, Isabelle] Ghent Univ Hosp, Dept Gastroenterol, Ghent, Belgium; [Yuksel, Muhammed; Colle, Isabelle; Ma, Yun] Univ London, Inst Liver Study, Kings Coll, Sch Med, London, England	Yale University; Yale University; Capital Medical University; Ghent University; Ghent University Hospital; University of London; King's College London	Wen, L (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA.	li.wen@yale.edu	yuksel, muhammed/AAT-4783-2021; yuksel, muhammed/F-1706-2019; yuksel, muhammed/C-7861-2017; Wang, Yilong/E-3536-2015; Chen, Bingdi/I-5857-2012	yuksel, muhammed/0000-0002-3390-6007; Wen, Li/0000-0002-8805-2934; Wang, Yilong/0000-0001-7483-9296; Chen, Bingdi/0000-0002-2086-0898	National Institutes of Health [RC1DK087699]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (RC1DK087699 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye M, 2011, MOL MED REP, V4, P597, DOI 10.3892/mmr.2011.471; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; Aziz-Seible RS, 2011, ALCOHOL CLIN EXP RES, V35, P717, DOI 10.1111/j.1530-0277.2010.01389.x; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, p51S, DOI 10.1097/00000374-200106001-00012; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; FOX ES, 1989, GASTROENTEROLOGY, V96, P456, DOI 10.1016/0016-5085(89)91571-0; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Hubbard L. L., 2010, INFECT DIS REP, V2; Kim SK, 2011, DIGESTION, V84, P43, DOI 10.1159/000333212; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kirpich IA, 2012, ALCOHOL CLIN EXP RES, V36, P835, DOI 10.1111/j.1530-0277.2011.01673.x; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Koop DR, 2006, ALCOHOL RES HEALTH, V29, P274; Laso FJ, 1999, ALCOHOL CLIN EXP RES, V23, P1306, DOI 10.1097/00000374-199908000-00003; Lech M, 2011, ANN RHEUM DIS, V70, P2207, DOI 10.1136/ard.2011.155515; Li TK, 2008, J GASTROEN HEPATOL, V23, pS2, DOI 10.1111/j.1440-1746.2007.05298.x; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Mehal WZ, 2001, GASTROENTEROLOGY, V120, P250, DOI 10.1053/gast.2001.20947; Miller AM, 2011, ALCOHOL CLIN EXP RES, V35, P787, DOI 10.1111/j.1530-0277.2010.01399.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Szabo G, 2011, ALCOHOL CLIN EXP RES, V35, P782, DOI 10.1111/j.1530-0277.2010.01398.x; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Vidali M, 2008, TRENDS MOL MED, V14, P63, DOI 10.1016/j.molmed.2007.12.005; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	38	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57085	10.1371/journal.pone.0057085	http://dx.doi.org/10.1371/journal.pone.0057085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23776514	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000074
J	Park, SG; Long, MX; Kang, JA; Kim, WS; Lee, CR; Im, SH; Strickland, I; Schulze-Luehrmann, J; Hayden, MS; Ghosh, S				Park, Sung-Gyoo; Long, Meixiao; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog; Strickland, Ian; Schulze-Luehrmann, Jan; Hayden, Matthew S.; Ghosh, Sankar			The Kinase PDK1 Is Essential for B-Cell Receptor Mediated Survival Signaling	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; ANTIGEN-RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; ACTIVATION; PHOSPHORYLATION; IMMUNODEFICIENCY; PROLIFERATION; REGULATOR; RICTOR	Phosphoinositide-dependent kinase 1 (PDK1) plays an important role in integrating the T cell antigen receptor (TCR) and CD28 signals to achieve efficient NF-kappa B activation. PDK1 is also an important regulator of T cell development, mediating pre-TCR induced proliferation signals. However, the role of PDK1 in B cell antigen receptor (BCR) signaling and B cell development remains largely unknown. In this study we provide genetic evidence supporting the role of PDK1 in B cell survival. We found PDK1 is required for BCR mediated survival in resting B cells, likely through regulation of Foxo activation. PDK1-dependent signaling to NF-kappa B is not crucial to resting B cell viability. However, PDK1 is necessary for triggering NF-kappa B during B cell activation and is required for activated B cell survival. Together these studies demonstrate that PDK1 is essential for BCR-induced signal transduction to Foxo and NF-kappa B and is indispensable for both resting and activated B cell survival.	[Park, Sung-Gyoo; Long, Meixiao; Strickland, Ian; Schulze-Luehrmann, Jan; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10027 USA; [Park, Sung-Gyoo; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog] GIST, Sch Life Sci, Kwangju, South Korea; [Park, Sung-Gyoo; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog] GIST, Immune Synapse Res Ctr, Kwangju, South Korea; [Hayden, Matthew S.] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY USA	Columbia University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Columbia University	Park, SG (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10027 USA.	sgpark@gist.ac.kr; sg2715@columbia.edu	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013; Park, Sung-Gyoo/H-8652-2019	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Hayden, Matthew/0000-0003-1670-6430; Park, Sung-Gyoo/0000-0003-3702-5765	National Institutes of Health [NIH R37-AI33443, RO1-AI068977]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0029942, 2011-0005477]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI068977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work in this study was supported by grants from the National Institutes of Health (NIH R37-AI33443 and RO1-AI068977) and by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0029942 and 2011-0005477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; delPeso L, 1997, SCIENCE, V278, P687; Donahue AC, 2004, SEMIN CELL DEV BIOL, V15, P183, DOI 10.1016/j.semcdb.2003.12.024; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hayashi T, 2007, P NATL ACAD SCI USA, V104, P18619, DOI 10.1073/pnas.0709261104; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hess KL, 2004, EUR J IMMUNOL, V34, P2968, DOI 10.1002/eji.200425326; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki Y, 2007, ADV EXP MED BIOL, V596, P149; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	33	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55378	10.1371/journal.pone.0055378	http://dx.doi.org/10.1371/journal.pone.0055378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23437331	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800025
J	Chen, WF; Chang, KP; Chen, CH; Shyu, VBH; Kao, HK				Chen, Wei F.; Chang, Kai-Ping; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai			Outcomes of Anterolateral Thigh Flap Reconstruction for Salvage Laryngopharyngectomy for Hypopharyngeal Cancer after Concurrent Chemoradiotherapy	PLOS ONE			English	Article							FUNCTIONAL OUTCOMES; PHARYNGOESOPHAGEAL RECONSTRUCTION; CARCINOMA; HEAD; RESECTION	Objective: To evaluate the functional and oncological outcomes of anterolateral thigh flap reconstruction for salvage laryngopharyngectomy after concurrent chemoradiotherapy for patients with hypopharyngeal carcinoma. Materials/Methods: A retrospective review was conducted on patients who underwent pharyngoesophageal reconstruction using anterolateral thigh flap after salvage laryngopharyngectomy for recurrent hypopharyngeal carcinoma between June 2003 and May 2010 at Chang Gung Memorial Hospital. The perioperative morbidity, mortality, functional outcomes, and oncological outcomes were evaluated. Results: 33 patients were entered into the study. The mean follow-up time was 19.5 +/- 12.3 months. Recurrent pathological TNM stages included 3 (9.1%), 2 (6.1%), and 28 (84.8%) patients with stage II, III, and IV disease, respectively. Mean ICU stay was 10.3 days and the mean hospital stay was 39.9 days. Peri-operative mortality occurred in one patient (3%). 16 patients (48.5%) developed recipient site complications. Among them, 14 patients (42.4%) developed fistulas and 9 patients (27.3%) developed strictures. Except for 4 patients (12.1%), all achieved varying degree of oral intake with 29 patients (60.6%) being completely independent from tube feeding. The mean interval to start oral intake was 15.1 days. The 5-year overall survival and disease-free survival rates were 51.8% and 53.7%, respectively. The pN status is an independent predictor of overall survival and disease-free survival (P = 0.027 and 0.038, respectively). Conclusion: Pharyngoesophageal reconstruction after salvage laryngopharyngectomy remains challenging even in the experienced hands. Reconstructive microsurgeons who are prepared to take on these cases should be equally well prepared to manage the potential postoperative complications.	[Chen, Wei F.] Univ Iowa Hosp & Clin, Dept Surg, Div Plast & Reconstruct Surg, Iowa City, IA 52242 USA; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Chang, Kai-Ping; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan	University of Iowa; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Kao, HK (corresponding author), Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan.	kai3488@gmail.com		Chen, Wei/0000-0002-4163-6641; Liu, Jianping/0000-0002-0320-061X; Liu, Bo/0000-0003-3101-650X; Yang, Guoyan (Emily)/0000-0002-8012-2379	NCCIH NIH HHS [R24 AT001293] Funding Source: Medline	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Ali Rozina S, 2009, Plast Reconstr Surg, V124, pe395, DOI 10.1097/PRS.0b013e3181bcf05c; Chan YW, 2011, J PLAST RECONSTR AES, V64, P1022, DOI 10.1016/j.bjps.2011.03.021; Chang MFT, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-91; Chen KT, 2007, PLAST RECONSTR SURG, V120, P187, DOI 10.1097/01.prs.0000264077.07779.50; Chu PY, 2005, HEAD NECK-J SCI SPEC, V27, P901, DOI 10.1002/hed.20262; Guibert M, 2011, EUR ANN OTORHINOLARY, V128, P218, DOI 10.1016/j.anorl.2011.02.010; Kadota H, 2010, LARYNGOSCOPE, V120, P1103, DOI 10.1002/lary.20887; Kao HK, 2009, ORAL ONCOL, V45, P1058, DOI 10.1016/j.oraloncology.2009.07.010; Lewin JS, 2005, LARYNGOSCOPE, V115, P1266, DOI 10.1097/01.MLG.0000165456.01648.B8; Lutz BS, 2005, CLIN PLAST SURG, V32, P421, DOI 10.1016/j.cps.2005.02.006; Murray DJ, 2007, HEAD NECK-J SCI SPEC, V29, P147, DOI 10.1002/hed.20489; Paximadis P, 2012, INT J RADIAT ONCOL, V82, P1515, DOI 10.1016/j.ijrobp.2011.04.064; Relic A, 2009, EUR ARCH OTO-RHINO-L, V266, P1799, DOI 10.1007/s00405-009-0946-3; Sagar B, 2010, J PLAST RECONSTR AES, V63, P970, DOI 10.1016/j.bjps.2009.04.019; Shellenberger TD, 2011, ARCH OTOLARYNGOL, V137, P1086, DOI 10.1001/archoto.2011.177; Takes RP, 2012, HEAD NECK-J SCI SPEC, V34, P270, DOI 10.1002/hed.21613; Tsou YA, 2010, HEAD NECK-J SCI SPEC, V32, P1494, DOI 10.1002/hed.21352; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Wong CH, 2010, HEAD NECK-J SCI SPEC, V32, P1236, DOI 10.1002/hed.21284; Yu PR, 2006, PLAST RECONSTR SURG, V117, P968, DOI 10.1097/01.prs.0000200622.13312.d3	20	205	209	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53985	10.1371/journal.pone.0053985	http://dx.doi.org/10.1371/journal.pone.0053985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23437162	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800078
J	Wu, DM; Kraut, JA; Abraham, WM				Wu, Dongmei; Kraut, Jeffrey A.; Abraham, William M.			Sabiporide Improves Cardiovascular Function, Decreases the Inflammatory Response and Reduces Mortality in Acute Metabolic Acidosis in Pigs	PLOS ONE			English	Article							EXTRACELLULAR ACIDOSIS; EXCHANGE INHIBITION; SODIUM-BICARBONATE; LACTIC-ACIDOSIS; MECHANISMS; CONTRACTILITY; MYOCARDIUM; ACTIVATION; MANAGEMENT; DIAGNOSIS	Introduction: Acute metabolic acidosis impairs cardiovascular function and increases the mortality of critically ill patients. However, the precise mechanism(s) underlying these effects remain unclear. We hypothesized that targeting pH-regulatory protein, Na+/H+ exchanger (NHE1) could be a novel approach for the treatment of acute metabolic acidosis. The aim of the present study was to examine the impact of a novel NHE1 inhibitor, sabiporide, on cardiovascular function, blood oxygen transportation, and inflammatory response in an experimental model of metabolic acidosis produced by hemorrhage-induced hypovolemia followed by an infusion of lactic acid. Methods and Results: Anesthetized pigs were subjected to hypovolemia for 30 minutes. The animals then received a bolus infusion of sabiporide (3 mg/kg) or vehicle, followed by an infusion of lactic acid for 2 hours. The animals were continuously monitored for additional 3 hours. Hypovolemia followed by a lactic acid infusion resulted in a severe metabolic acidosis with blood pH falling to 6.8. In association with production of the acidemia, there was an excessive increase in pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). Treatment with sabiporide significantly attenuated the increase in PAP by 38% and PVR by 67%, as well as significantly improved cardiac output by 51%. Sabiporide treatment also improved mixed venous blood oxygen saturation (55% in sabiporide group vs. 28% in control group), and improved systemic blood oxygen delivery by 36%. In addition, sabiporide treatment reduced plasma levels of TNF-alpha (by 33%), IL-6 (by 63%), troponin-I (by 54%), ALT (by 34%), AST (by 35%), and urea (by 40%). Conclusion: These findings support the possible beneficial effects of sabiporide in the treatment of acute metabolic acidosis and could have implications for the treatment of metabolic acidosis in man.	[Wu, Dongmei] Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA; [Abraham, William M.] Mt Sinai Med Ctr, Div Pulm & Crit Care Med, Miami Beach, FL 33140 USA; [Wu, Dongmei] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju, South Korea; [Kraut, Jeffrey A.] Vet Adm Greater Angeles Healthcare Syst, Div Nephrol Med & Res Serv, Los Angeles, CA USA; [Kraut, Jeffrey A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Mount Sinai Medical Center; Mount Sinai Medical Center; Jeonbuk National University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, DM (corresponding author), Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA.	dongmeiwu@bellsouth.net	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	USAMRMC [W81XWH-06-1-0719]; Ministry of Education, Science and Technology [R31-20029, 2012007331]; National Research Foundation of Korea (NRF); honbuk National University, Korea	USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); honbuk National University, Korea	This work was supported by a USAMRMC grant W81XWH-06-1-0719 (to DW); and in part by the World Class University Program (R31-20029) funded by the Ministry of Education, Science and Technology; by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012007331); and by New Faculty funding from Chonbuk National University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 1998, NEW ENGL J MED, V338, P107, DOI 10.1056/NEJM199801083380207; ANDERSON SE, 1990, AM J PHYSIOL, V259, pC940, DOI 10.1152/ajpcell.1990.259.6.C940; BRIMIOULLE S, 1990, AM J PHYSIOL, V258, pH347, DOI 10.1152/ajpheart.1990.258.2.H347; CINGOLANI HE, 1975, SURGERY, V77, P427; COOPER DJ, 1993, AM REV RESPIR DIS, V148, P317, DOI 10.1164/ajrccm/148.2.317; Doods H, 2013, J BIOMEDICI IN PRESS; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; HUSEBY JS, 1981, CHEST, V79, P552, DOI 10.1378/chest.79.5.552; Karmazyn M, 1999, J THROMB THROMBOLYS, V8, P33, DOI 10.1023/A:1008990530176; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Lin X, 2012, RESUSCITATION; MARSIGLIA JC, 1973, CARDIOVASC RES, V7, P336, DOI 10.1093/cvr/7.3.336; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; Nemeth ZH, 2002, AM J PHYSIOL-CELL PH, V283, pC396, DOI 10.1152/ajpcell.00491.2001; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Siesjo BK, 1996, ACT NEUR S, V66, P8; Sikes PJ, 2005, CRIT CARE MED, V33, P605, DOI 10.1097/01.ccm.0000155910.89252.FE; Vaughan-Jones Richard D, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS134, DOI 10.1111/j.1540-8167.2006.00394.x; Webster KA, 1999, J CLIN INVEST, V104, P239; WIKLUND L, 1985, CRIT CARE MED, V13, P109, DOI 10.1097/00003246-198502000-00012; Wu DM, 2000, BASIC RES CARDIOL, V95, P449, DOI 10.1007/s003950070020; Wu DM, 2008, SHOCK, V29, P519, DOI 10.1097/SHK.0b013e318150757a; Wu DM, 2012, RESUSCITATION, V83, P774, DOI 10.1016/j.resuscitation.2011.11.025; Wu DM, 2009, CRIT CARE MED, V37, P1994, DOI 10.1097/CCM.0b013e3181a0052e	32	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53932	10.1371/journal.pone.0053932	http://dx.doi.org/10.1371/journal.pone.0053932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23437188	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400061
J	Chen, WK; Miao, CH				Chen, Wan-Kun; Miao, Chang-Hong			The Effect of Anesthetic Technique on Survival in Human Cancers: A Meta-Analysis of Retrospective and Prospective Studies	PLOS ONE			English	Article							EPIDURAL-ANESTHESIA; COLORECTAL-CANCER; NEURAXIAL ANESTHESIA; SPINAL-ANESTHESIA; SURGERY; RECURRENCE; ANALGESIA; REDUCTION; ASSOCIATION; MORTALITY	Animal models have shown that regional anesthesia (combined with or without general anesthesia) would attenuate the surgical stress response by preserving immune function and result in better long-term outcome. In order to test the hypothesis that cancer patients who had surgery with epidural anesthesia (EA) would have better outcome (either overall survival [OS] or recurrence-free survival [RFS]) than those who were general anesthesia (GA), we performed this meta-analysis. By searching relevant literature, a total of 14 studies containing 18 sub-studies (seven in OS analysis and eleven in RFS analysis) were identified and meta-analyzed. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were used to assess the strength of association. For OS, the random-effects model was used to analyze the data and demonstrated an OS benefit in favor of EA compared with GA alone (HR = 0.84, 95% CI 0.74-0.96, P = 0.013). The influence analysis showed the robustness of the results. Specifically, a significantly positive association between EA and improved OS was observed in colorectal cancer (HR = 0.65, 95% CI 0.43-0.99, P = 0.045). For RFS, the random-effects model was used to analyze the data and no significant relationship between RFS benefit and EA (HR = 0.88, 95% CI 0.64-1.22, P = 0.457) was detected. In conclusion, our meta-analysis suggests that epidural anesthesia and/or analgesia might be associated with improved overall survival in patients with operable cancer undergoing surgery (especially in colorectal cancer), but it does not support an association between epidural anesthesia and cancer control. Prospective studies are needed to determine whether the association between epidural use and survival is causative.	[Chen, Wan-Kun] Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Inst Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chen, WK (corresponding author), Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	wkchen1981@hotmail.com; miaochh@yahoo.com.cn		Chen, Wei/0000-0002-4163-6641; Liu, Jianping/0000-0002-0320-061X; Liu, Bo/0000-0003-3101-650X; Yang, Guoyan (Emily)/0000-0002-8012-2379	Shanghai Committee of Science and Technology [114119a4400]; NCCIH NIH HHS [R24 AT001293] Funding Source: Medline	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research is supported by grants from Guide Project of Shanghai Committee of Science and Technology (2011-2013, 114119a4400). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Yosef S, 2001, ANESTHESIOLOGY, V94, P1066, DOI 10.1097/00000542-200106000-00022; BEILIN B, 1989, Brain Behavior and Immunity, V3, P129, DOI 10.1016/0889-1591(89)90013-5; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; Cummings KC, 2012, ANESTHESIOLOGY, V116, P797, DOI 10.1097/ALN.0b013e31824674f6; de Oliveira GS, 2011, REGION ANESTH PAIN M, V36, P271, DOI 10.1097/AAP.0b013e318217aada; ERSKINE R, 1992, CAN J ANAESTH, V39, P905, DOI 10.1007/BF03008337; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Gottschalk A, 2010, ANESTHESIOLOGY, V113, P27, DOI 10.1097/ALN.0b013e3181de6d0d; Gupta A, 2011, BRIT J ANAESTH, V107, P164, DOI 10.1093/bja/aer100; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ismail H, 2010, BRIT J ANAESTH, V105, P145, DOI 10.1093/bja/aeq156; Koodie L, 2010, AM J PATHOL, V177, P984, DOI 10.2353/ajpath.2010.090621; Lai RC, 2012, ANESTH ANALG, V114, P290, DOI 10.1213/ANE.0b013e318239c2e3; Landoni G, 2012, J CARDIOTHOR VASC AN, V26, P764, DOI 10.1053/j.jvca.2012.04.018; Larsson SC, 2010, JAMA-J AM MED ASSOC, V303, P1077, DOI 10.1001/jama.2010.263; LEWIS J W, 1983, Natural Immunity and Cell Growth Regulation, V3, P43; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin L, 2011, BRIT J ANAESTH, V106, P814, DOI 10.1093/bja/aer055; Luo CF, 2010, EUR J ANAESTH, V27, P212, DOI 10.1097/00003643-201006121-00682; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MARKOVIC SN, 1993, ANESTHESIOLOGY, V78, P700, DOI 10.1097/00000542-199304000-00013; Myles PS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1491; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Tsui BCH, 2010, CAN J ANAESTH, V57, P107, DOI 10.1007/s12630-009-9214-7; Urwin SC, 2000, BRIT J ANAESTH, V84, P450, DOI 10.1093/oxfordjournals.bja.a013468; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wuethrich PY, 2010, ANESTHESIOLOGY, V113, P570, DOI 10.1097/ALN.0b013e3181e4f6ec; Zhou D, 2012, WORLD J GASTROENTERO, V18, P3089, DOI 10.3748/wjg.v18.i24.3089	31	205	209	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56540	10.1371/journal.pone.0056540	http://dx.doi.org/10.1371/journal.pone.0056540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437162	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200100
J	Wu, DZ; Cai, SG; Chen, MX; Ye, LZ; Chen, ZH; Zhang, HT; Dai, F; Wu, FB; Zhang, GP				Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Chen, Zhonghua; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping			Tissue Metabolic Responses to Salt Stress in Wild and Cultivated Barley	PLOS ONE			English	Article							PROLINE ACCUMULATION; GAS-CHROMATOGRAPHY; SODIUM-TRANSPORT; ABIOTIC STRESS; DROUGHT STRESS; TOLERANCE; PLANTS; ARABIDOPSIS; HOMEOSTASIS; MANNITOL	A thorough understanding of the mechanisms underlying barley salt tolerance and exploitation of elite genetic resource are essential for utilizing wild barley germplasm in developing barley varieties with salt tolerance. In order to reveal the physiological and molecular difference in salt tolerance between Tibetan wild barley (Hordeum spontaneum) and cultivated barley (Hordeum vulgare), profiles of 82 key metabolites were studies in wild and cultivated barley in response to salinity. According to shoot dry biomass under salt stress, XZ16 is a fast growing and salt tolerant wild barley. The results of metabolite profiling analysis suggested osmotic adjustment was a basic mechanism, and polyols played important roles in developing salt tolerance only in roots, and high level of sugars and energy in roots and active photosynthesis in leaves were important for barley to develop salt tolerance. The metabolites involved in tolerance enhancement differed between roots and shoots, and also between genotypes. Tibetan wild barley, XZ16 had higher chlorophyll content and higher contents of compatible solutes than CM72, while the cultivated barley, CM72 probably enhanced its salt tolerance mainly through increasing glycolysis and energy consumption, when the plants were exposed to high salinity. The current research extends our understanding of the mechanisms involved in barley salt tolerance and provides possible utilization of Tibetan wild barley in developing barley cultivars with salt tolerance.	[Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping] Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhonghua] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia	Zhejiang University; Western Sydney University	Zhang, GP (corresponding author), Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	Natural Science Foundation of China [31129005, 31171544]; Natural Science Foundation of Zhejiang Province, China [Z3110054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by Natural Science Foundation of China (31129005 and 31171544), Natural Science Foundation of Zhejiang Province, China (Z3110054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2003, PLANT PHYSIOL, V131, P1748, DOI 10.1104/pp.102.003616; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Cuin TA, 2007, PLANTA, V225, P753, DOI 10.1007/s00425-006-0386-x; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dai HX, 2011, J PLANT NUTR SOIL SC, V174, P952, DOI 10.1002/jpln.201100148; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Du J, 2008, PLANT J, V56, P653, DOI 10.1111/j.1365-313X.2008.03602.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kim HK, 2010, PHYTOCHEM ANALYSIS, V21, P4, DOI 10.1002/pca.1188; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; PHARR DM, 1995, HORTSCIENCE, V30, P1182, DOI 10.21273/HORTSCI.30.6.1182; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Renberg L, 2010, PLANT PHYSIOL, V154, P187, DOI 10.1104/pp.110.157651; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2006, PLANT PHYSIOL, V142, P1087, DOI 10.1104/pp.106.084053; Sakamoto A, 1998, PLANT MOL BIOL, V38, P1011, DOI 10.1023/A:1006095015717; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Shabala S, 2005, J EXP BOT, V56, P1369, DOI 10.1093/jxb/eri138; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Wang X, 2008, PLANTA, V227, P611, DOI 10.1007/s00425-007-0643-7; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; XU T, 1982, Acta Genetica Sinica, V9, P440; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	54	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55431	10.1371/journal.pone.0055431	http://dx.doi.org/10.1371/journal.pone.0055431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23437188	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600104
J	Hu, YF; Jiang, HS; Wang, Q; Xie, ZS; Pan, SY				Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue			Identification of a Novel Nonsense Mutation p.Tyr1957Ter of CACNA1A in a Chinese Family with Episodic Ataxia 2	PLOS ONE			English	Article							CALCIUM-CHANNEL; CLINICAL SPECTRUM; TYPE-2; GENE; SCA6	Type 2 episodic ataxia (EA2) is the most common subtype among a group of rare hereditary syndromes characterized by recurrent attacks of ataxia. More than 60 mutations and several gene rearrangements due to large deletions in CACNA1A gene have been reported so far for the cause of EA2. Because CACNA1A gene is a large gene containing 47 exons and there is no hot spot mutation, direct sequencing will be a challenge in clinical genetic testing. In this study, we used next generation sequencing technology to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncated protein without 305 amino acids in the c-terminus. Sanger sequencing confirmed the heterozygous mutation of CACNA1A in a Chinese family with 11 affected individuals. Affected individuals experienced recurrent attacks with or without nystagmus, dysarthria, seizure, myokymia, dystonia, weakness, blurred vision, visual field defects, diplopia, migraine, dizziness, nausea and vomiting, sweating and abdominal pain. This is the first report of EA2 in a Chinese family that carries a novel mutation in CACNA1A gene and had abdominal pain as a novel phenotype associated with EA2.	[Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue] So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Pan, SY (corresponding author), So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	pansuyue82@yahoo.com.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Nanfang Hospital, Southern Medical University, China	Nanfang Hospital, Southern Medical University, China	This work was supported by the chief program funding of Nanfang Hospital, Southern Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Eunson LH, 2005, NEUROLOGY, V65, P308, DOI 10.1212/01.wnl.0000169020.82223.dd; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Jen J, 2004, NEUROLOGY, V62, P17, DOI 10.1212/01.WNL.0000101675.61074.50; Jen JC, 2007, BRAIN, V130, P2484, DOI 10.1093/brain/awm126; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Labrum RW, 2009, J MED GENET, V46, P786, DOI 10.1136/jmg.2009.067967; Mantuano E, 2010, J NEUROL SCI, V291, P30, DOI 10.1016/j.jns.2010.01.010; Matsuyama Z, 2003, J NEUROL SCI, V210, P91, DOI 10.1016/S0022-510X(03)00008-X; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Riant F, 2008, ARCH NEUROL-CHICAGO, V65, P817, DOI 10.1001/archneur.65.6.817; Riant F, 2010, NEUROGENETICS, V11, P101, DOI 10.1007/s10048-009-0208-y; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Tang BS, 2000, ARCH NEUROL-CHICAGO, V57, P540, DOI 10.1001/archneur.57.4.540; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wan Jijun, 2011, Front Neurol, V2, P51, DOI 10.3389/fneur.2011.00051; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	25	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56362	10.1371/journal.pone.0056362	http://dx.doi.org/10.1371/journal.pone.0056362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441182	Green Submitted, gold, Green Published			2022-12-27	WOS:000315159200039
J	Hu, YJ; Rillig, MC; Xiang, D; Hao, ZP; Chen, BD				Hu, Yajun; Rillig, Matthias C.; Xiang, Dan; Hao, Zhipeng; Chen, Baodong			Changes of AM Fungal Abundance along Environmental Gradients in the Arid and Semi-Arid Grasslands of Northern China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SOIL ORGANIC-CARBON; PARTICLE-SIZE; NITROGEN; GROWTH; TEMPERATURE; PLANT; PHOSPHORUS; DISTRIBUTIONS; COMMUNITIES	Arbuscular mycorrhizal (AM) fungi are ubiquitous symbionts of higher plants in terrestrial ecosystems, while the occurrence of the AM symbiosis is influenced by a complex set of abiotic and biotic factors. To reveal the regional distribution pattern of AM fungi as driven by multiple environmental factors, and to understand the ecological importance of AM fungi in natural ecosystems, we conducted a field investigation on AM fungal abundance along environmental gradients in the arid and semi-arid grasslands of northern China. In addition to plant parameters recorded in situ, soil samples were collected, and soil chemo-physical and biological parameters were measured in the lab. Statistical analyses were performed to reveal the relative contribution of climatic, edaphic and vegetation factors to AM fungal abundance, especially for extraradical hyphal length density (HLD) in the soil. The results indicated that HLD were positively correlated with mean annual temperature (MAT), soil clay content and soil pH, but negatively correlated with both soil organic carbon (SOC) and soil available N. The multiple regressions and structural equation model showed that MAT was the key positive contributor and soil fertility was the key negative contributor to HLD. Furthermore, both the intraradical AM colonization (IMC) and relative abundance of AM fungi, which was quantified by real-time PCR assay, tended to decrease along the increasing SOC content. With regard to the obvious negative correlation between MAT and SOC in the research area, the positive correlation between MAT and HLD implied that AM fungi could potentially mitigate soil carbon losses especially in infertile soils under global warming. However, direct evidence from long-term experiments is still expected to support the AM fungal contribution to soil carbon pools.	[Hu, Yajun; Xiang, Dan; Hao, Zhipeng; Chen, Baodong] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, Berlin, Germany; [Rillig, Matthias C.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Free University of Berlin	Chen, BD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bdchen@rcees.ac.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-JC403, KZCX2-YW-BR-17]; Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences [STSN-21-04]; State Key Laboratory of Urban and Regional Ecology, P.R. China [SKLURE2008-1-03]; Alexander-von-Humboldt Foundation fellowship	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Urban and Regional Ecology, P.R. China; Alexander-von-Humboldt Foundation fellowship(Alexander von Humboldt Foundation)	The study was financially supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-JC403 and KZCX2-YW-BR-17), Joint Project of Ministry of Environmental Protection, P.R. China and the Chinese Academy of Sciences (STSN-21-04) and State Key Laboratory of Urban and Regional Ecology, P.R. China (Project SKLURE2008-1-03). BC was supported by an Alexander-von-Humboldt Foundation fellowship during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bohrer G, 2001, J VEG SCI, V12, P279, DOI 10.2307/3236612; Cai Xiaobu, 2005, Yingyong Shengtai Xuebao, V16, P859; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; Ekschmitt K, 2008, J PLANT NUTR SOIL SC, V171, P27, DOI 10.1002/jpln.200700051; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Gaur A, 2000, MYCORRHIZA, V10, P43, DOI 10.1007/s005720050286; Gavito ME, 2005, NEW PHYTOL, V168, P179, DOI 10.1111/j.1469-8137.2005.01481.x; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; HAYMAN DS, 1982, PHYTOPATHOLOGY, V72, P1119; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Jennings D.H., 1995, PHYSL FUNGAL NUTR; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; KOSKE RE, 1987, MYCOLOGIA, V79, P55, DOI 10.2307/3807744; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Liu A, 2000, PLANT SOIL, V221, P157, DOI 10.1023/A:1004777821422; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nilsson LO, 2005, NEW PHYTOL, V165, P613, DOI 10.1111/j.1469-8137.2004.01233.x; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; READ DJ, 1991, FRONTIERS IN MYCOLOGY, P101; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Roda JJ, 2008, ARID LAND RES MANAG, V22, P310, DOI 10.1080/15324980802388199; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sato Kouichi, 2005, Grassland Science, V51, P179, DOI 10.1111/j.1744-697X.2005.00023.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; SOEDARJO M, 1995, MYCORRHIZA, V5, P337, DOI 10.1007/BF00207406; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tian H, 2009, LAND DEGRAD DEV, V20, P41, DOI 10.1002/ldr.876; Treseder KK, 2006, ECOSYSTEMS, V9, P305, DOI 10.1007/s10021-005-0110-x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Trouvelot A., 1986, PHYSL GENETICAL ASPE, V39, P217, DOI DOI 10.1177/004057368303900411; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Verbruggen E, 2013, NEW PHYTOL, V197, P366, DOI 10.1111/nph.12079; Wan YF, 2011, AGR ECOSYST ENVIRON, V141, P23, DOI 10.1016/j.agee.2011.02.004; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Yang HS, 2011, CATENA, V87, P70, DOI 10.1016/j.catena.2011.05.009; [周涛 Zhou Tao], 2003, [地理学报, Acta Geographica Sinica], V58, P727; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	55	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57593	10.1371/journal.pone.0057593	http://dx.doi.org/10.1371/journal.pone.0057593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23441182	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500118
J	Lin, CW; Chen, PN; Chen, MK; Yang, WE; Tang, CH; Yang, SF; Hsieh, YS				Lin, Chiao-Wen; Chen, Pei-Ni; Chen, Mu-Kuan; Yang, Wei-En; Tang, Chih-Hsin; Yang, Shun-Fa; Hsieh, Yih-Shou			Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; TISSUE INHIBITOR; INVASION; FLAVONOIDS; CARCINOMA; MIGRATION; INACTIVATION; INFLAMMATION	Background: Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in plant-based foods. Recent studies have demonstrated that kaempferol protects against cardiovascular disease and cancer. Based on this finding, we investigated the mechanisms by which kaempferol produces the anti-metastatic effect in human tongue squamous cell carcinoma SCC4 cells. Methodology/Principal Findings: In this study, we provided molecular evidence associated with the anti-metastatic effect of kaempferol by demonstrating a substantial suppression of SCC4 cell migration and invasion. This effect was associated with reduced expressions of MMP-2 and TIMP-2 mRNA and protein levels. Analysis of the transcriptional regulation indicated that kaempferol inhibited MMP-2 transcription by suppressing c-Jun activity. Kaempferol also produced an inhibitory effect on the phosphorylation of ERK1/2. Conclusions: These findings provide new insights into the molecular mechanisms involved in the anti-metastatic effect of kaempferol, and are valuable in the prevention of oral cancer metastasis.	[Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Yang, Wei-En; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; csmcysh@csmu.edu.tw	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Bosetti C, 2005, CANCER EPIDEM BIOMAR, V14, P805, DOI 10.1158/1055-9965.EPI-04-0838; Bosetti C, 2006, NUTR CANCER, V56, P123, DOI 10.1207/s15327914nc5602_1; Bourboulia D, 2013, ONCOTARGET, V4, P166; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen HJ, 2013, ONCOL REP, V30, P925, DOI 10.3892/or.2013.2490; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vicente JC, 2005, ORAL ONCOL, V41, P568, DOI 10.1016/j.oraloncology.2004.12.008; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008; Gohji K, 1996, CANCER RES, V56, P3196; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Huang YB, 2013, INT J UROL; Iype E M, 2001, J Postgrad Med, V47, P171; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kang JW, 2010, PHYTOTHER RES, V24, pS77, DOI 10.1002/ptr.2913; Kawabata K, 2005, BIOSCI BIOTECH BIOCH, V69, P307, DOI 10.1271/bbb.69.307; Labbe D, 2009, J NUTR, V139, P646, DOI 10.3945/jn.108.102616; Leifler KS, 2013, J IMMUNOL, V190, P4420, DOI 10.4049/jimmunol.1202610; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Luo HT, 2009, NUTR CANCER, V61, P554, DOI 10.1080/01635580802666281; Ma CY, 2011, J AGR FOOD CHEM, V59, P9032, DOI 10.1021/jf202027n; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Peng CY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/732578; Rossi M, 2006, CANCER EPIDEM BIOMAR, V15, P1555, DOI 10.1158/1055-9965.EPI-06-0017; Shan B, 2013, ASIAN PAC J TROP MED, V6, P826, DOI 10.1016/S1995-7645(13)60146-7; Sun CY, 2006, ACTA PHARMACOL SIN, V27, P1447, DOI 10.1111/j.1745-7254.2006.00343.x; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; Wang XX, 2013, TUMOUR BIOL; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xiao HB, 2009, EUR J PHARMACOL, V616, P213, DOI 10.1016/j.ejphar.2009.06.022; Yang JS, 2013, FOOD CHEM TOXICOL, V59, P801, DOI 10.1016/j.fct.2013.06.028; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zhao MJ, 2013, INT J MED SCI, V10, P995, DOI 10.7150/ijms.5963	50	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80883	10.1371/journal.pone.0080883	http://dx.doi.org/10.1371/journal.pone.0080883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278338	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100123
J	Lin, C; Zou, Y; Qin, J; Liu, XR; Jiang, Y; Ke, CH; Zou, Q				Lin, Chen; Zou, Ying; Qin, Ji; Liu, Xiangrong; Jiang, Yi; Ke, Caihuan; Zou, Quan			Hierarchical Classification of Protein Folds Using a Novel Ensemble Classifier	PLOS ONE			English	Article							REPRESENTATIVE SET; SCOP; RECOGNITION; SELECTION; DATABASE; IMPACT	The analysis of biological information from protein sequences is important for the study of cellular functions and interactions, and protein fold recognition plays a key role in the prediction of protein structures. Unfortunately, the prediction of protein fold patterns is challenging due to the existence of compound protein structures. Here, we processed the latest release of the Structural Classification of Proteins (SCOP, version 1.75) database and exploited novel techniques to impressively increase the accuracy of protein fold classification. The techniques proposed in this paper include ensemble classifying and a hierarchical framework, in the first layer of which similar or redundant sequences were deleted in two manners; a set of base classifiers, fused by various selection strategies, divides the input into seven classes; in the second layer of which, an analogous ensemble method is adopted to predict all protein folds. To our knowledge, it is the first time all protein folds can be intelligently detected hierarchically. Compared with prior studies, our experimental results demonstrated the efficiency and effectiveness of our proposed method, which achieved a success rate of 74.21%, which is much higher than results obtained with previous methods (ranging from 45.6% to 70.5%). When applied to the second layer of classification, the prediction accuracy was in the range between 23.13% and 46.05%. This value, which may not be remarkably high, is scientifically admirable and encouraging as compared to the relatively low counts of proteins from most fold recognition programs. The web server Hierarchical Protein Fold Prediction (HPFP) is available at http://datamining.xmu.edu.cn/software/hpfp.	[Lin, Chen; Zou, Ying; Liu, Xiangrong; Jiang, Yi; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China; [Qin, Ji; Ke, Caihuan] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Peoples R China; [Lin, Chen; Liu, Xiangrong] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Lin, C (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China.	chenlin@xmu.edu.cn; zouquan@xmu.edu.cn	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	Natural Science Foundation of China [61001013, 61102136]; Natural Science Foundation of Fujian Province of China [2011J05158, 2010J01350]; National Basic Research Program of China [2010CB1264000]; Base Research Project of Shenzhen Bureau of Science, Technology and Information [JC201006030858A, JCYJ20120618155655087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National Basic Research Program of China(National Basic Research Program of China); Base Research Project of Shenzhen Bureau of Science, Technology and Information	The work was supported by the Natural Science Foundation of China (No. 61001013, No. 61102136), Natural Science Foundation of Fujian Province of China (No. 2011J05158, No. 2010J01350), The National Basic Research Program of China (No. 2010CB1264000) and the Base Research Project of Shenzhen Bureau of Science, Technology and Information(JC201006030858A, JCYJ20120618155655087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BOBERG J, 1992, PROTEINS, V14, P265, DOI 10.1002/prot.340140212; Boisvert S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-110; Bologna G, 2003, ARTIF INTELL MED, V28, P141, DOI 10.1016/S0933-3657(03)00055-1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2003, ANAL BIOCHEM, V268, P407; Cai YD, 2010, MOL CELLS, V30, P99, DOI 10.1007/s10059-010-0093-0; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen W, 2012, GENET MOL RES, V11, P174, DOI 10.4238/2012.January.27.4; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Feng JH, 2012, VLDB J, V21, P437, DOI 10.1007/s00778-011-0252-8; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOBOHM U, 1994, PROTEIN SCI, V3, P522; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Honda M, 2005, J AUTOIMMUN, V25, P133, DOI 10.1016/j.jaut.2005.03.009; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nanni L, 2006, NEUROCOMPUTING, V69, P2434, DOI 10.1016/j.neucom.2006.01.026; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Vendruscolo M, 2005, P NATL ACAD SCI USA, V102, P5641, DOI 10.1073/pnas.0500274102; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	31	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56499	10.1371/journal.pone.0056499	http://dx.doi.org/10.1371/journal.pone.0056499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24278338	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200085
